US20050064391A1 - Lectin compositions and methods for modulating an immune response to an antigen - Google Patents

Abstract

The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.

Description

RELATED APPLICATIONS
• The present application is a divisional application to U.S. Utility Application with Ser. No. 10/645,000, filed Aug. 20, 2003, which claims priority to U.S. Provisional application 60/404,823, filed Aug. 20, 2002 and 60/487,407, filed Jul. 15, 2003, the entirety of each is hereby incorporated by reference.
BACKGROUND OF THE INVENTION
• Typically, the specific modulation of an immune response to an antigen in a subject requires the administration of another substance, e.g. an adjuvant, in admixture with the antigen in order to initiate and/or direct the modulation. Traditional adjuvants, though, have a number of weaknesses. For example, many are crude, heterogeneous preparations. In addition, many are relatively weak immunomodulators, and some cause severe local inflammation that is unacceptable in humans. Purified soluble polypeptides, such as cytokines, have some advantages over crude adjuvants, but their value is limited because they diffuse away from the antigen upon administration. While certain cell-surface molecules may be potential immunomdulators as components of cell-based vaccines, their application generally involves gene transfer into the cells, which is often problematic.
• The invention therefore fills heretofore unmet needs by providing molecules that can bind to antigen bearing targets, such as cells, viruses, and isolated antigens, and that can serve as immunomodulators when administered with an antigen bearing target. In addition, the invention provides compositions comprising these molecules and related methods. The compositions and methods of the invention are also useful for other applications, e.g. any application in which it is desirable to attach a biological effeector, such as a polypeptide ligand for a cell surface receptor, to a target structure, such as a virus or a cell.
SUMMARY OF THE INVENTION
• The present invention relates to a multifunctional molecule, e.g. a fusion polypeptide, comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell. In a preferred embodiment, the first part is a first cell surface binding moiety and the second part is a second cell surface binding moiety. In this embodiment, the first cell surface binding moiety can attach to a virus or cell, e.g. a tumor cell, which comprises an antigen. It is also particularly preferred that the second cell surface binding moiety can bind to a cell-surface polypeptide, e.g. a non-immunoglobulin polypeptide, of an antigen presenting cell (APC). Thus, in some embodiments, a multifunctional molecule of the invention can serve as a bridge or link between an antigen bearing target and an APC.
• As used herein an “antigen bearing target” is an entity which comprises an antigen. As used herein an “antigen bearing target” includes, for example, a whole cell which expresses an antigen a cell fraction comprising an antigen, a membrane fraction comprising an antigen, a virus comprising an antigen, a viral particle comprising an antigen, or an antigen, e.g. a polypeptide antigen, which may be free of any other cell-derived or virus-derived material. Cellular fractions may be prepared using methods known to those of skill in the art such as those taught in Cell Biology A Laboratory Handbook (Academic Press 1994 Editor J. E. Celis ISBN 0-12-164715-3)
• The term “antigen” as used herein refers to a molecule against which a subject can initiate a humoral and/or cellular immune response. Antigens can be any type of biologic molecule including, for example, simple intermediary metabolites, sugars, lipids, and hormones as well as macromolecules such as complex carbohydrates, phospholipids, nucleic acids and proteins. Common categories of antigens include, but are not limited to, viral antigens, bacterial antigens, fungal antigens, protozoa and other parasitic antigens, tumor antigens, antigens involved in autoimmune disease, allergy and graft rejection, and other miscellaneous antigens. In the compositions and methods of the invention, it is preferred that the antigen is a polypeptide, e.g., one comprising at least seven amino acids.
• As used herein, “antigen presenting cell” or “APC” refers to cells that ingest and present antigen to T cells. These cells include phagocytic leukocytes, macrophages, and dendritic cells, B lymphocytes, and endothelial cells. A “professional APC” is an APC that is constitutively able to activate a T lymphocyte. Professional APCs typically constitutively express class II major histocompatibility molecules and costimulatory molecules such as B7-1 and/or B7-2.
• In one embodiment, the invention encompasses a multifunctional molecule, the first part of which is a lectin. Thus, the multifunctional molecule can bind to one or more carbohydrates of an antigen bearing target. In a preferred embodiment of the invention, the first part of the multifunctional molecule is a lectin and the second portion is a ligand for a cell surface protein (e.g., a ligand for a cell surface receptor). Preferably, the cell surface protein is a cell surface receptor of an APC. Ligands for a cell surface receptor include any ligand which will bind to a cell surface protein, and preferably include, but are not limited to, an opsonin, cytokine, adhesion molecule, counterreceptor of a T cell costimulatory molecule, a defensin, a ligand for a CD40 molecule, or a heat shock protein, or a portion of any of these ligands, including about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 50, 60, 70, 80, 100, or 120 contiguous amino acids of such a ligand. Preferably, the multifunctional molecule which comprises first and second parts comprises an amino acid sequence which can bind to a cell surface protein (e.g., a cell surface receptor) including, but not limited to an adhesion molecule, a costimulatory molecule for a T cell, or a receptor for at least one of the following types of molecules: a cytokine, a defensin, a heat shock protein, a CD40 molecule, or an opsonin.
• A cell surface protein (e.g., a cell surface receptor) useful in the present invention is any cell surface molecule which can bind the ligand portion of a multifunctional molecule of the invention. Preferably, the cell surface receptor is a CD40 molecule, a T cell costimulatory molecule, an adhesion molecule, or a receptor for a cytokine, a defensin, a heat shock protein, an opsonin, or an adhesion molecule. Cell surface proteins, useful in the invention include, but are not limited to the cell surface molecules identified by GenBank Accession number in Appendix I and II, or those cell surface molecules which are encoded by a nucleic acid molecule identified by GenBank Accession number in Appendix I or II.
• The term “cytokine” as used herein refers to a polypeptide molecule that is naturally secreted by mammalian cells and that binds to a cell surface protein on a leukocyte, inducing a change (e.g., a change in the proliferative state, a change in the transcriptional profile or a change in the propensity to migrate) in the leukocyte (other than mere occupancy of the leukocyte's receptors for the cytokine). “Change” refers to at least about a 5% increase or decrease as compared to in the absence of a cytokine. The term “cytokine” also refers herein to a polypeptide molecule that is a ligand for a receptor for a naturally occurring cytokine.
• Examples of cytokines which are useful in the methods and compositions of the invention include the following: GM-CSF, Il-2, IL-4, IL-6, IL-12, ligands for hematopoietin receptors, ligands for immunoglobulin superfamily receptors, ligands for interferon receptors, ligands for TNF receptors, and ligands for chemokine receptors. An antibody against a cytokine receptor can also be a cytokine.
• In one embodiment of the invention, it is preferred that a cytokine comprised by a composition of the invention promote a Th1 immune response, i.e., the generation of T cells that express Th1 cytokines such as IL-2 and IFN-γ. In another embodiment, it is preferred that a cytokine comprised by a composition of the invention promote a Th2 immune response, i.e., the generation of T cells that express Th2 cytokines such as IL-4 and IL-10.
• “Engineered cytokines” as described herein are cytokines which comprise a heterologous cell surface binding moiety.
• The term “opsonin” as used herein refers to naturally occurring and non-naturally occurring molecules which are capable, by virtue of being contemporaneously bound or attached to both an antigen-containing cell and an antigen-presenting cell (APC), of acting as a link or coupling agent (an adapter) between the antigen and the APC to allow more efficient binding, engulfment, and internalization of the antigen-containing cell by the APC. An opsonin useful according to the invention, also includes non-naturally occurring opsonins capable of binding to APCs via receptors that can bind naturally occurring opsonins.
• The term “opsonin” as used herein can also refer to molecules which can be processed such that at least one product of the processing step or steps is capable of, by virtue of being contemporaneously bound or attached to both an antigen-containing cell and an APC, acting as a link or coupling agent to allow more efficient binding, engulfment, and internalization of other antigen-containing cells by the APC. An opsonin can also be any polypeptide chain of a multichain opsonin.
• Examples of opsonins which are useful in the methods and compositions of the invention include the following: vitronectin, fibronectin, complement components such as C1q (including any of its component polypeptide chains A, B and C), complement fragments such as C3d, C3b and C4b, mannose binding protein, conglutinin, surfactant proteins A and D, C-reactive protein (CRP), alpha-2-macroglobulin, and immunoglobulins, for example, the Fc portion of an immunoglobulin.
• “Innate opsonins” are opsonins of the innate immune system and are known in the art as secreted polypeptide molecules of the innate immune system and are believed to bind contemporaneously to an antigen and to the surface of an APC. They can thus act as “bridges”, and are thought, by virtue of this property, to promote internalization of antigens by APCs. The mode in which opsonins bind to antigens varies among opsonins, and can be covalent or noncovalent. In general, the antigen-binding moieties of innate opsonins differ from the antigen-binding moieties of immunoglobulins in that the former are relatively invariant among members of the same species, and do not undergo diversification during the ontogeny of an individual.
• A molecule containing a naturally occurring APC-binding moiety shall be considered an opsonin if it contains a moiety through which it can be stably bound or attached to a cell such that the APC-binding moiety is located in the extracellular space, whether or not the opsonin molecule contains its natural antigen-binding domain.
• “Engineered opsonins”, as described herein, include molecules in which a cell surface binding moiety is substituted for the natural antigen-binding domain of an opsonin or where a cell surface binding moiety is linked to the opsonin without modification or removal of the natural antigen-binding domain of the opsonin.
• A “cell surface binding moiety” is a moiety through which a molecule can be stably bound to a cell surface, e.g. a cell wall, a polysaccharide capsule, or the lipid or protein component of a plasma membrane, or to the surface of a virus. Such moieties include but are not limited to crosslinking moieties and lipid moieties. It is preferred that the cell surface binding moiety bind to a cell by a means other than interaction of a polypeptide with its cognate cell-surface polypeptide. It is further preferred that the cell surface binding moiety comprise a non-polypeptide moiety. In a preferred embodiment, a lipid moiety is linked to the engineered molecule via a glycosylphosphatidylinositol (GPI) moiety. In another preferred embodiment, the lipid comprises a fatty acid, e.g. palmitate. In yet another preferred embodiment of the invention, the cell surface binding moiety is linked to an opsonin or an antigen-binding domain-truncated opsonin at the antigen-binding end of the opsonin. In another preferred embodiment, the multifunctional molecule comprises an idiotypic portion of an immunoglobulin which can bind to an APC. Preferably, the opsonin of an opsonin-enhanced cell is one of alpha′ chain C3b or mannose binding protein.
• If the opsonin is a fragment of C3, it is preferred hat it bind to CR1 with a greater affinity than to CR2. It is further preferred that the fragment of C3 not be a ligand for CR2. Preferably, the opsonin is neither C3bi, C3d, nor C3dg.
• It is preferred that the opsonins bind to receptors that trigger phagocytosis and that are non-clonotypic and thus do not vary from cell to cell as, for example, clonotypic receptors do. Non-clonotypic receptors are present on cells which play a role in innate immunity, and include, e.g., non-idiotypic receptors. Examples of such receptors include CR1, CR2, CR3, CR4, and C1q receptor, receptors containing a component of the C1q receptor, collectin receptors, receptors for α2m, receptors for CRP, and Fc receptors for immunoglobulins.
• “Exogenous” refers to something which is introduced from or produced outside the cell.
• “Endogenous” refers to something which is expressed or present naturally in a cell.
• “Heterologous” refers to something which is not naturally expressed in a cell.
• Preferably, the multifunctional molecule which comprises first and second parts can bind, via the second part, to the surface or plasma membrane of an antigen presenting cell (APC), i.e. a cell that can present antigen to a T cell, e.g. a cell that can activate a T cell, at least in part by presenting antigen to the T cell. The APC may be a leukocyte, e.g. a cell of monocytic lineage and/or a dendritic cell. Preferably, binding of the multifunctional molecule is independent of expression of an idiotype, e.g. a clonotypic determinant of an immunoglobulin, on the APC. Most preferably, the multifunctional molecule comprises a first end which can bind to a cell that comprises an antigen and a second end which can bind to a APC.
• The multifunctional molecule may bind to an antigen bearing target cell by, e.g., inserting into the lipid portion of a cell membrane or by binding to a structure, e.g. a polypeptide or a carbohydrate, that is physically associated with the lipid portion of the membrane. The structure need not be directly in contact with the lipid portion of the membrane, but may be indirectly attached, e.g. a carbohydrate that is part of a cell-surface glycoprotein. Preferably the multifunctional molecule can bind via a first part to an antigen bearing target, preferably a mammalian cell that comprises an antigen, and via a second part to an APC. The invention also encompasses the use of a molecule that can bind via a first part to a virus or to a non-mammalian cell, e.g. a fungal or bacterial cell, and via a second part to an APC. In the latter cases, the first part may bind, e.g., to a component of a cell wall or a capsule.
• In a preferred embodiment, the multifunctional molecule which comprises first and second parts comprises a first part which comprises a lectin and a second part that can bind to a leukocyte, e.g. an APC, e.g. a cell of monocytic lineage or a dendritic cell (which may itself be of monocytic lineage). A “lectin”, according to the invention, is a molecule or part of a molecule, e.g. an amino acid sequence, which can bind to a carbohydrate, e.g. a polysaccharide. Families of naturally occurring lectins include:
• 1) Galectins, a rapidly growing family of animal lectins. All of them share galactose-specificity.
• 2) Calcium-dependent (C-type) animal lectins, an extremely large family composed of members having diverse structures and functions.
• 3) Among this C-type lectin family, selectins form a distinguishable subfamily by their specific function in leukocyte adhesion to endothelial cells through sialyl-Lewis X recognition.
• 4) Collectins, another subfamily of C-type lectins specific for mannose, which have a unique structure consisting of a C-type lectin domain and a collagen-like domain. They are involved in innate immunity.
• 5) Invertebrates are known to contain various lectins in their body fluids, probably as body-protection factors. Recently, some lectins from an echinoderm were found to show hemolytic activity.
• 6) Annexins, a group of proteins having affinity to lipids that were recently shown to be lectins showing binding to glycosaminoglycans.
• 7) The legume lectin family, which consists of a large number of members, such as ConA, with variable saccharide specificity comparable to C-type lectins.
• 8) Ricin, the first lectin investigated in Russia more than 100 years ago. It is now evident that the ricin family has many other homologous members which differ in either toxicity or sugar-binding specificities.
• Thus, a multifunctional molecule of the invention may bind to one or more carbohydrates. Carbohydrates to which lectins may bind also include, for example, carbohydrates comprising lactose, D-mannose, D-glucose, D-fucose, L-fucose (e.g. alpha-L-fucose), D-galactose, blood group A oligosaccharides, blood group B oligosaccharides, saccharides comprising alpha-D-Gal(1->3)[alpha-Lfuc(1->2)]-beta-D-Gal(1->3/4-beta-D-GlcNAc, saccharides comprising alpha-sialyl [2->3]-lactose, alpha-D-mannosyl glycoconjugates, alpha-NeuNAc-[2->6]-Gal, alpha-NeuNAc-[2->6]-GalNAc, alpha-NeuNAc-[2->3]-Gal, N-acetyl-beta-D-glucosamine, terminal alpha-D-galactosyl residues, terminal beta-D-galactosyl residues, N-acetyllactosamine, terminal alpha-D-mannosyl residues, N-acetyl-beta-D-glucosamine, terminal N-acetyl-D-galactosamine, N-acetylneuraminic acid, and terminal alpha-D-galactosaminyl residues.
• The multifunctional molecule which comprises a lectin may comprise, for example, the whole of a naturally occurring lectin or a portion of a naturally occurring lectin, e.g about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 50, 60, 70, 80, 100, or 120 contiguous amino acids of a naturally occurring polypeptide lectin. In one embodiment the multifunctional molecule comprises a carbohydrate-binding domain of a naturally occurring lectin, i.e., a portion of a lectin that can bind to a carbohydrate in the absence of the remainder of the lectin. In another embodiment the lectin may be non-naturally occurring, e.g. identified from an artificial library of molecules or designed by modifying the structure of a naturally occurring lectin.
• Lectins known as “hemagglutinins” bind to carbohydrates on erythrocytes, e.g. blood group antigens, and when incubated with these cells cause them to aggregate. The influenza virus hemagglutinin, for example, binds to sialic acid (as does the human parainfluenza virus 3 hemagglutinin/neuraminidase). There are at least 15 known influenza hemagglutinin subtypes, defined by their distinct antigenic properties. Any of these subtypes, designated, e.g., H1, H2, H3, H4, H5, H6, H7, H8, H9, H10, H11, H12, H13, H14, and H15, may provide amino acid sequences useful in the compositions and methods of the invention. In one embodiment of the invention, the hemagglutinin is of a subtype from a virus that infects humans, e.g. H1, H2, or H3. In another embodiment, the hemagglutinin is of a subtype from a virus that does not infect humans, e.g. one of H4 through H15. Amino acid sequences can vary up to about 20% for influenza hemagglutinins within a given subtype, and can vary between about 30% and about 70% for influenza hemagglutinins from different subtypes.
• Influenza hemagglutinin is expressed as a single polypeptide chain, designated HA0, which trimerizes post-translationally. HA0 is proteolytically cleaved to yield two domains, HA1 and HA2, which are disulfide-bonded to each other. HA1 comprises significant sialic acid binding activity, while HA2 is anchored to the viral membrane and facilitates fusion of this membrane with a host cell membrane. In preferred embodiments of the invention, the multifunctional molecule comprising first and second parts comprises an amino acid sequence of an HA1 domain.
• The molecule may be a fusion polypeptide which comprises one or more amino acids interposed between the first and second parts which bind to cells, e.g. a fusion polypeptide which comprises a first amino acid sequence which can bind to an antigen bearing target and a second amino acid sequence which can bind to a leukocyte, and which further comprises at least one amino acid interposed between the first and second parts. The interposed amino acids may comprise, e.g., a linker sequence intended to lessen steric hindrance or other undesirable interactions between the aforementioned first and second parts. For, example, one such type of sequence takes the form (Gly₃Ser)_n. Additional useful linkers include, but are not limited to (Arg-Ala-Arg-Asp-Pro-Arg-Val-Pro-Val-Ala-Thr)_1-5 (Xu et al., 1999, Proc. Natl. Acad. Sci. U.S.A. 96: 151-156), (Gly-Ser)_n (Shao et al., 2000, Bioconjug. Chem. 11: 822-826), (Thr-Ser-Pro), (Kroon et al., 2000, Eur. J. Biochem. 267: 6740-6752), (Gly-Gly-Gly)_n (Kluczyk et al., 2000, Peptides 21: 1411-1420), and (Glu-Lys), (Klyczyk et al., 2000, supra), wherein n is 1 to 15 (each of the preceding references is also incorporated herein by reference). In another embodiment, no amino acids are interposed between the first and second parts.
• The present invention further provides a nucleic acid molecule, preferably a recombinant nucleic acid molecule which encodes a multifunctional polypeptide of the present invention. The nucleic acid molecule may be, for example, DNA, RNA, cDNA, or mRNA. The nucleic acid molecule may be naturally occuring or may be partially or wholly synthesized using techniques known to those of skill in the art. In a preferred embodiment, the nucleic acid molecule is a DNA molecule comprising a first nucleic acid sequence encoding a first amino acid sequence which can bind to an antigen bearing target, and a second nucleic acid sequence encoding a second amino acid sequence which can bind to a cell surface receptor on an APC.
• The present invention still further provides a vector comprising the nucleic acid molecule encoding a multifunctional polypeptide of the invention, e.g. an expression vector suitable for expressing in a host cell, wherein the host cell is preferably a eukaryotic cell, more preferably an animal cell, more preferably a mammalian cell, and still more preferably a human cell. In another preferred embodiment the host cell is a yeast cell, e.g. Saccharomyces cerevesiae.
• The invention also provides a host cell comprising a nucleic acid vector which comprises a sequence encoding the multifunctional molecule of the present invention. Preferably, the host cell is a eukaryotic cell, such as a yeast cell- or an animal cell, preferably a human cell. The host cell may also be a prokaryotic cell.
• The invention also encompasses a molecule, e.g. a polypeptide, e.g. a fusion polypeptide, which comprises a first part that can bind to an antigen bearing target, e.g. a cell, e.g. a cell that comprises an antigen, and a second part that can bind to a cell, e.g. a leukocyte, e.g. an APC. The molecule may have any of the characteristics taught in the descriptions of methods and compositions herein. Preferably the first and second parts are heterologous to each other. The molecule may be, e.g., a recombinant polypeptide expressed in a mammalian cell, an insect cell, a plant cell, a yeast cell, or a bacterial cell.
• The invention also encompasses a method of modulating an immune response in an animal comprising the step of expressing in an animal, e.g. expressing in a host cell of the animal, a multifunctional molecule of the invention, e.g. a polypeptide which comprises a first part that can bind to a antigen bearing target and a second part that can bind to a cell. According to the invention, “expressing in an animal” means “causing to be present in an animal”. When the molecule is a polypeptide, it is preferably expressed by introducing into the host cell, in vivo or ex vivo, a nucleic acid encoding the polypeptide. If the nucleic acid is introduced into the host cell ex vivo, the host cell may subsequently be administered to the animal. In a preferred embodiment, the method further comprises administering to the animal the antigen to which the immune response is modulated. For example, the antigen may be administered to the animal as part of a composition which further comprises a nucleic acid that encodes the multifunctional molecule. In another preferred embodiment, the antigen is already present in the animal at the time the multifunctional molecule is expressed. In yet another preferred embodiment, the antigen is administered to the animal after administration of the multifunctional molecule. In still other preferred embodiments, the antigen is expressed in the animal, e.g. by administering to the animal a composition comprising a nucleic acid encoding the antigen, either before or after expression of the multifunctional molecule in the animal. In another embodiment, nucleic acid sequences encoding the multifunctional molecule and the antigen are introduced into one or more host cells of the animal, e.g. by administering to the animal a composition comprising those nucleic acid sequences.
• As used herein, the term “modulating an immune response” to a selected antigen using the methods and compositions of the invention means rendering the response more or less efficient, more or less rapid, greater or lesser in magnitude, and/or more or less easily induced than the response obtained from administration of a composition which is identical in every respect except that it does not comprise a multifunctional molecule of the invention. In a preferred embodiment, the response is between about 5 and 100%, or preferably between about 5 and 50% or more preferably between about 5 and 25% more or less efficient, more or less rapid, greater or lesser in magnitude, and/or more or less easily induced than the response obtained from administration of a composition which is identical in every respect except that it does not comprise a multifunctional molecule of the invention.
• The term “modulate the immune response” may refer to stimulation/activation of an immune response to a selected antigen, or it may refer to suppression, elimination, or attenuation of an immune response to a selected antigen. In a preferred embodiment, modulating the immune response results in stimulation/activation of an immune response to a selected antigen by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100%, as compared to an immune response in the absence of vaccination, or it may result in suppression, elimination, or attenuation of an immune response to a selected antigen by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100%, as compared to an immune response in the absence of vaccination. In some cases, one immune response to an antigen (e.g. a Th1 response) may be increased while another immune response to the same antigen (e.g. a Th2 response) may be diminished.
• The invention also encompasses a composition comprising a multifunctional molecule of the invention and antigen bearing target, e.g. a virus, a prion, or a cell. Preferably, when the antigen bearing target is a cell, the multifunctional molecule is exogenous to the cell. The multifunctional molecule may be heterologous to the cell. In one embodiment, the multifunctional molecule is expressed within the cell, e.g. from a recombinant nucleic acid within the cell. The invention also encompasses a cell comprising a nucleic acid encoding a multifunctional molecule of the invention. The multifunctional molecule may have any of the characteristics set forth herein. An antigen bearing target (e.g., a cell) useful in the invention includes, for example, malignant cells, benign tumor cells, lymphocytes, e.g. B or T lymphocytes which may be pathogenic and/or autoreactive, cells expressing an antigen from an exogenously introduced nucleic acid molecule, eukaryotic cells such as mammalian cells, human cells, fibroblasts, insect and fungal cells, and prokaryotic cells such as bacterial cells. Examples of viruses useful in the invention include, e.g., retroviruses such as human immunodeficiency viruses 1 and 2; herpesviruses such as herpes simplex viruses 1 and 2, cytomegalovirus, and varicella zoster virus; human papilloma virus; rabies virus; rotavirus; influenza viruses A, B, and C; hepatitis viruses A, B, C, and E or delta agent; adenoviruses; measles virus; mumps virus; polio virus; rubella virus; parainflunza viruses; coxsackie viruses A and B; variola virus; yellow fever virus; dengue and other hemorrhagic fever viruses; West Nile fever virus; Eastern equine encephalitis virus; Western equine encephalitis virus; Venezuelan equine encephalitis virus; Japanese encephalitis virus; rhinoviruses; and foot and mouth disease virus. Prions include the agents of scrapie, kuru, and bovine spongiform encephalitis. The cell, virus, or prion may be attenuated, i.e. rendered non-pathogenic, by, e.g, killing, irradiation, chemical fixation, passaging in culture with selection for diminished pathogenicity, or genetic manipulation. Preferably, the composition further comprises a leukocyte, e.g. a monocyte, a cell of monocytic lineage, a macrophage, or a dendritic cell or another APC.
• Preferably, in the inventive methods and compositions, the cell is substantially unable to divide in vitro. “Substantially unable to divide in vitro” means that the cell divides at a rate that is less than about 50% of the rate of division of corresponding cells which are not treated to prevent cell division. In a preferred embodiment, the cell divides at a rate that is less than about 30-50% of the rate of division of corresponding cells which are not treated to prevent cell division.
• Preferably, the composition is substantially free of culture medium. As used herein, “culture medium” refers to medium that is used in cell culture containing at least 2% animal serum, such as fetal calf serum.
• More particularly, the present invention provides a multifunctional molecule which is a fusion polypeptide comprising: a lectin which comprises at least about 10 contiguous amino acids of an influenza virus hemagglutinin, and at least about 5 contiguous amino acids of a naturally occurring GM-CSF molecule.
• In one embodiment, the lectin is N-terminal to the contiguous amino acids of a naturally occurring GM-CSF molecule.
• In an alternate embodiment, the lectin is C-terminal to the contiguous amino acids of a naturally occurring GM-CSF molecule.
• In one embodiment, the lectin comprises at least about 10 contiguous amino acids of the HA1 domain of an influenza virus hemagglutinin.
• In one embodiment, the lectin is the HA1 domain of an influenza virus hemagglutinin.
• Preferably, the influenza virus hemagglutinin is a hemagglutinin of an influenza A virus. In other preferred embodiments the influenza virus hemagglutinin is a hemagglutinin of an influenza B or influenza C virus.
• In one embodiment, the influenza virus hemagglutinin is of a subtype from a virus that infects humans. Preferably, the influenza virus hemagglutinin is of an H1 subtype. Still more preferably, the influenza virus hemagglutinin is from the influenza A strain PR/8/34.
• In one embodiment, the influenza virus hemagglutinin is of an H2 subtype.
• In one embodiment, the influenza virus hemagglutinin is of an H3 subtype.
• In one embodiment, the influenza virus hemagglutinin is of a subtype from a virus that does not infect humans.
• In one embodiment the fusion polypeptide comprises the entire amino acid sequence of a naturally occurring GM-CSF molecule.
• Preferably, the GM-CSF molecule is a murine GM-CSF. Still more preferably, the GM-CSF molecule is a human GM-CSF.
• In one aspect, the invention encompasses a method of reducing the number of metastases, e.g. tumor metastases, in a subject, e.g. a mammal, e.g. a human, comprising the step of administering to the subject any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein.
• The invention provides, a method of reducing the number of metastasis in an animal comprising administering to said animal a composition comprising a cell comprising an antigen, said composition further comprising a fusion protein comprising a lectin and a ligand for a cell surface protein.
• As used herein, a “metastasis” refers to a focus of disease that is caused by a malignent cell or infectious organism which has traveled from one site in a host to a second site in the host (e.g., from one site to a non-contiguous site; e.g., from a first organ to a second organ). More specifically, “metastasis” refers to a detectable focus of malignant tumor or infection that is derived from, and spread from, and is distinct from the primary site of disease. Accordingly, “metastases” refers to a plurality of foci either in a single organ or tissue in a subject, or in two or more organs or tissues in a subject. A “focus” as used herein may be at least a single malignant or infectious cell, or may be a detectable focus, which is detectable by one or more of the methods described hereinbelow. Metastases is said to be detected where a metastases is able to be detected by one of skill in the art using one or more of the assay methods described hereinbelow.
• According to the invention, “reducing the number of metastases” may mean either causing there to be fewer (e.g., at least 10% fewer, 20%, 30%, 50%, 70%, 90%, and up to at least 100% fewer) metastases than expected (where the number or severity of metastases expected is based on the observations made in a set (e.g., more than one) or similar subjects which has not received the multifunctional molecule of the invention). In one embodiment “reducing the number of metastases” may encompass preventing metastases (e.g. a subject does not develop any detectable foci of disease), e.g. in a subject with a tumor, or causing one or more preexisting metastases to become undetectable, e.g. by radiologic, non-invasive imaging techniques, or other techniques as described herein. Those skilled in the art will recognize that a metastasis itself may become undetectable even though residual scarring or fibrosis may be detectable. Metastases may be, for example, to bone, brain, liver, lung, or spinal cord, or any other organ or tissue.
• In another aspect, the invention encompasses a method of reducing the number of metastases in a population of subjects comprising the step of administering to one or more subjects any of the compositions described herein e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein.
• In another aspect, the invention encompasses a method of reducing the size of a metastasis in a subject comprising the step of administering to the subject any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein. The “size” of a metastasis, as used herein refers to the one, two or three dimensional area encompassed by a metastasis, or alternatively, refers to the number of malignant or infectious cells present in a metastasis. The size of the metastasis, which may be measured by direct visualization or by noninvasive imaging, may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%.
• The invention provides a method of reducing the size of a metastasis in an animal comprising administering to said animal a composition comprising a cell comprising an antigen, said composition further comprising a fusion protein comprising a lectin and a ligand for a cell surface protein.
• In another aspect, the invention encompasses a method of reducing the average size of metastases in a subject comprising the step of administering to the subject any of the compositions described herein. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein. According to the invention, “reducing the average size of metastases” may mean either causing metastases to be smaller on average than expected, e.g. by preventing one or more of them from growing to the expected size, or causing one or more preexisting metastases to become smaller, thus decreasing the mean size of the metastases. The average size of the metastases, which may be determined by direct visualization or by noninvasive imaging, may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%.
• In another aspect, the invention encompasses a method of reducing the average size of metastases in a population comprising the step of administering to one or more subjects any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein.
• Thus, in another aspect the invention encompasses preventing or treating a disease in a subject by administering to the subject any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The disease may be, for example, a benign or malignant tumor, an infectious disease, an allergy, or an autoimmune disease. “Treating a disease” means decreasing morbidity or mortality associated with the disease in a patient or population afflicted with the disease. For example, survival, relapse-free survival, or disease-free survival may be prolonged by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%, or the number of metastases may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%. For preventive applications, the incidence of the targeted disease may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention and 2) administering to the subject a composition comprising the antigen and not comprising (i.e. free of) the nucleic acid molecule administered in step 1. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule. In another embodiment, the composition which is free of the nucleic acid molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. The nucleic acid molecule may be comprised by an expression vector.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. One or more of the nucleic acid molecules may be comprised by an expression vector.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. The nucleic acid molecule may be comprised by an expression vector.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or a least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. The nucleic acid molecule may be comprised by an expression vector.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and not comprising (i.e. free of) the nucleic acid molecule encoding the multifunctional molecule, which was administered in step 1. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule encoding the multifunctional molecule. In another embodiment, the composition which is free of the nucleic acid molecule encoding the multifunctional molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule encoding the multifunctional molecule. One or more of the nucleic acid molecules may be comprised by an expression vector.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention. The multifunctional molecules of step 1 and step 2 may be the same or different. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or a least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule encoding the multifunctional molecule. In another embodiment, the composition which is free of the nucleic acid molecule encoding the multifunctional molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule encoding the multifunctional molecule. One or more of the nucleic acid molecules may be comprised by an expression vector.
• In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention. The multifunctional molecules of step 1 and step 2 may be the same or different. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule encoding the multifunctional molecule. In another embodiment, the composition which is free of the nucleic acid molecule encoding the multifunctional molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule encoding the multifunctional molecule. One or more of the nucleic acid molecules may be comprised by an expression vector.
• The present invention encompasses a method of modulating an immune response in an animal comprising the step of administering a composition comprising a multifunctional molecule, e.g. a polypeptide, e.g. a fusion polypeptide, which comprises a first part that can bind to a antigen bearing target and a second part that can bind to a cell. In a preferred embodiment, the composition further comprises an antigen, an immune response to which is modulated by administration of the composition. The antigen may be, for example, a polypeptide (e.g. a recombinant polypeptide), a lipid (e.g. a glycolipid), or a carbohydrate (e.g. a polysaccharide or a component of a bacterial or fungal cell wall). The composition therefore comprises an antigen bearing target, whether, e.g., a homogeneous antigen or a heterogeneous structure such as a cell or a virus. When the antigen bearing target is a cell, it may be autologous, syngeneic, allogeneic, or xenogeneic to the animal. In other preferred embodiments, the antigen is already present in the animal at the time the molecule is administered, and/or the antigen is administered to the animal prior to administration of the molecule. In yet another preferred embodiment, the antigen is administered to the animal after administration of the molecule.
• Preferably, the composition comprises multifunctional molecules which are not bound to an antigen bearing target. In a preferred embodiment, the composition further comprises an antigen bearing target, e.g. a cell. In one embodiment of the invention, the composition comprises multifunctional molecules, some of which are bound to a antigen bearing target, e.g. to the surface of a cell, and some of which are external to and not bound to any target. In another embodiment, the composition comprises a multifunctional molecule and further comprises a portion of a cell, e.g. a membrane fraction of a cell (i.e., an antigen bearing target). In yet another embodiment, the composition comprises a multifunctional molecule and further comprises a multiplicity of different molecules derived from a cell, as is found, e.g., in a cell lysate. Cells may be lysed, for example, by freezing and thawing, preferably repeatedly. In a preferred embodiment, the composition is cell-free.
• The present invention further encompasses a method of vaccinating a mammal to a selected antigen comprising administering to the animal a vaccine composition comprising a multifunctional molecule of the invention comprising a first part which is a lectin, and a second part which is a ligand for a cell surface protein, e.g. a cell surface receptor of an APC. Preferably, the lectin can bind to an antigen bearing target which comprises the antigen.
• In one embodiment, the invention provides a method of vaccinating a mammal to a selected antigen comprising removing at least one cell from the mammal, wherein the cell comprises the antigen, contacting the cell ex vivo with a multifunctional molecule comprising a first part which is a lectin and is capable of binding to at least one carbohydrate molecule on the surface of the antigen bearing cell, and a second part which is a ligand for a cell surface protein of an APC, so as to form an antigen bearing cell/multifunctional molecule complex; and placing the complex back into the mammal.
• In a preferred embodiment, the composition comprises an antigen, an immune response to which is modulated by administration of the composition.
• The invention provides a method of modulating an immune response to a selected antigen in a mammal comprising administering to said animal a composition comprising a cell comprising said antigen, and a multifunctional molecule comprising a lectin and a ligand for a cell surface protein.
• The invention also relates to a method of vaccinating an animal to a selected antigen comprising removing at least one cell from said animal, wherein the cell comprises said antigen; contacting said cell ex vivo with a fusion polypeptide comprising a lecting and a ligand for a cell surface protein of an antigen presenting cell so as to form a complex; and placing said complex back in said animal.
• The present invention provides a method for juxtaposing an APC with an antigen bearing target comprising: contacting an APC and antigen bearing target with a multifunctional molecule comprising a first part comprising a lectin which is able to bind to at least one carbohydrate moiety on the antigen bearing target and a second part comprising a ligand for a cell surface protein on the APC. Preferably, the multifunctional molecule is first contacted with the antigen bearing target and the resulting antigen bearing target/multifunctional molecule complex is subsequently contacted with the APC. In one embodiment the antigen bearing target is a cell from an animal comprising an antigen, and is contacted with the multifunctional molecule ex vivo under conditions which permit the binding of the lectin to at least one carbohydrate moiety of the cell. The resulting multifunctional molecule/antigen bearing cell complex is then administered back to the animal from which the antigen bearing cell was derived wherein it is able to bind to a cell surface receptor on an APC via the ligand portion of the multifunctional molecule, thereby juxtaposing the antigen bearing target and the APC.
• “Juxtaposition”, in the context of the present invention, includes but is not limited to physical contact. An APC and antigen bearing target are “juxtaposed” with one another if they are sufficiently close for the APC to internalize the antigen bearing target. An APC and antigen bearing target are also “juxtaposed” if they are separated by no more that 20 μm, preferably no more than 10 μm, and still more preferably no more than 5 μm, and more preferably no more than 1 μm.
• As used herein, “contacting” refers to admixing in vitro or in vivo.
• The invention also encompasses a method of modulating an immune response to an antigen comprising contacting in vitro an antigen bearing target, a multifunctional molecule of the invention, and an APC and administering the resultant composition to a subject. In one embodiment the antigen bearing target/multifunctional molecule complex is contacted with an APC for a time sufficient to permit internalization of the antigen bearing target by the APC. In other embodiments the antigen bearing target/multifunctional molecule complex is contacted with an APC for a time that allows internalization of less than about 80%, less than about 60%, less than about 40%, less than about 20%, less than about 10%, or less than about 5% of the antigen bearing target by the APC. Methods for determining the amount of target internalized, e.g. by measuring the amount remaining outside the APC and subtracting from the starting amount, are well-known in the art. Preferably, the antigen bearing target/multifunctional molecule complex is contacted with an APC for less than about 10 minutes, less than about 30 minutes, less than about 60 minutes, less than about 90 minutes, less than about 120 minutes, or less than about 180 minutes.
• As used herein, “time sufficient to permit internalization” refers to a period of time that is of a sufficient duration to allow internalization of the selected antigen or antigen bearing targtet by the APC (for example, no more than about fourteen days, or seven days, or five or three days, or as little as about 24, 12, 6, 3, 2 or 1 hour, or even as little as about 30, 20, 10, 5, or 1 minute).
• The invention also encompasses a method of attaching a ligand for a cell surface polypeptide to an antigen bearing target comprising admixing the antigen bearing target with a multifunctional molecule which comprises the ligand. The invention also encompasses a method of attaching an amino acid sequence to an antigen bearing target comprising admixing the antigen bearing target with a fusion polypeptide which comprises the amino acid sequence and further comprises a lectin. The invention also encompasses a composition comprising an antigen bearing target admixed with a fusion polypeptide which comprises a first amino acid sequence which is not a lectin and a second amino acid sequence which comprises a lectin.
• The invention also comprises methods of producing a multifunctional molecule of the invention in each of the following cell types: a yeast cell, a mammalian cell, a bacterial cell, an insect cell. Each of these methods comprises the step of introducing a nucleic acid encoding a multifunctional molecule into the respective cell type, as taught hereinbelow.
• The invention also encompasses methods of detecting or quantifying a multifunctional molecule of the invention comprising contacting the multifunctional molecule with an antibody or other ligand that binds to the multfunctional molecule. Such methods include ELISA assays and flow cytometry, as described hereinbelow. Preferably, the multifunctional molecule to be detected or quantitated is bound to an antigen bearing target.
DETAILED DESCRIPTION
• The present invention is based, in part, on the discovery that a multifunctional fusion protein comprising a first polypeptide which is a lectin and a second polypeptide which is a ligand of a cell surface receptor of an APC, can effectively target an antigen bearing target, such as a cell bearing an antigen of interest, to an APC, wherein the antigen is engulfed by the APC, and an appropriate immune response to the antigen is mounted by an animal to which the multifunctional molecule is administered.
• Accordingly, the present invention provides a method for vaccinating a mammal comprising administering to the animal a vaccine composition comprising a multifunctional molecule of the invention comprising a first part which is a lectin and which can bind to a target bearing the antigen, and a second part which is a ligand for a cell surface protein of an APC. In one embodiment, the method comprises removing at least one cell from the mammal, wherein the cell comprises the antigen, contacting the cell ex vivo with a multifunctional molecule comprising a first part which is a lectin and is capable of binding to at lease one carbohydrate molecule on the surface of the antigen bearing cell, and a second part which is a ligand for a cell surface protein of an APC, so as to form an antigen bearing cell/multifunctional molecule complex; and placing the complex back into the mammal.
• Multifunctional Molecules
• The present invention encompasses a multifunctional molecule comprising a first part which can bind to an antigen bearing target, and a second part which is a ligand for a cell surface protein of a cell, e.g. an antigen presenting cell. Preferably, the first part which can bind to an antigen bearing target is a lectin which binds to at least one carbohydrate molecule present on the antigen bearing target. Preferably the lectin is an influenza hemagglutinin and binds to sialic acid residues present on the antigen bearing target. Preferably, the ligand of a cell surface protein of an antigen presenting cell is selected from an opsonin, a cytokine, a ligand for a CD40 molecule, an adhesion molecule, a defensin, a heat shock protein, or a counterreceptor for a T cell costimulatory molecule. Cell surface molecules which can act as receptors for the second part of the multifunctional molecule include CD40 molecules and specific receptors for an opsonin, a cytokine, an adhesion molecule, a defensin, a heat shock protein, or a counterreceptor for a T cell costimulatory molecule, and also include, but are not limited to the cell surface molecules listed in Apendix I and II.
• Lectins
• The multifunctional molecule which comprises first and second parts can comprise a first part which comprises a lectin and a second part that can bind to a leukocyte, e.g. an APC, e.g. a cell of monocytic lineage or a dendritic cell (which may itself be of monocytic lineage). A “lectin”, according to the invention, is a molecule or part of a molecule, e.g. an amino acid sequence, which can bind to a carbohydrate, e.g. a polysaccharide. Families of naturally occurring lectins include:
• 1) Galectins, a rapidly growing family of animal lectins. All of them share galactose-specificity.
• 2) Calcium-dependent (C-type) animal lectins, an extremely large family composed of members having diverse structures and functions.
• 3) Among this C-type lectin family, selectins form a distinguishable subfamily by their specific function in leukocyte adhesion to endothelial cells through sialyl-Lewis X recognition.
• 4) Collectins, another subfamily of C-type lectins specific for mannose, which have a unique structure consisting of a C-type lectin domain and a collagen-like domain. They are involved in innate immunity.
• 5) Invertebrates are known to contain various lectins in their body fluids, probably as body-protection factors. Recently, some lectins from an echinoderm were found to show hemolytic activity.
• 6) Annexins, a group of proteins having affinity to lipids that were recently shown to be lectins showing binding to glycosaminoglycans.
• 7) The legume lectin family, which consists of a large number of members, such as ConA, with variable saccharide specificity comparable to C-type lectins.
• 8) Ricin, the first lectin investigated in Russia more than 100 years ago. It is now evident that the ricin family has many other homologous members which differ in either toxicity or sugar-binding specificities.
• Thus, a multifunctional molecule of the invention may bind to one or more carbohydrates. Carbohydrates to which lectins may bind also include, for example, carbohydrates comprising lactose, D-mannose, D-glucose, D-fucose, L-fucose (e.g. alpha-L-fucose), D-galactose, blood group A oligosaccharides, blood group B oligosaccharides, saccharides comprising alpha-D-Gal(1->3)[alpha-Lfuc(1->2)]-beta-D-Gal(1->3/4-beta-D-GlcNAc, saccharides comprising alpha-sialyl-[2->3]-lactose, alpha-D-mannosyl glycoconjugates, alpha-NeuNAc-[2->6]-Gal, alpha-NeuNAc-[2->6]-GalNAc, alpha-NeuNAc-[2->3]-Gal, N-acetyl-beta-D-glucosamine, terminal alpha-D-galactosyl residues, terminal beta-D-galactosyl residues, N-acetyllactosamine, terminal alpha-D-mannosyl residues, N-acetyl-beta-D-glucosamine, terminal N-acetyl-D-galactosamine, N-acetylneuraminic acid, and terminal alpha-D-galactosaminyl residues.
• The multifunctional molecule which comprises a lectin may comprise, for example, the whole of a naturally occurring lectin or a portion of a naturally occurring lectin, e.g about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 50, 60, 70, 80, 100, or 120 contiguous amino acids of a naturally occurring polypeptide lectin. In one embodiment the multifunctional molecule comprises a carbohydrate-binding domain of a naturally occurring lectin, i.e., a portion of a lectin that can bind to a carbohydrate in the absence of the remainder of the lectin. In another embodiment the lectin may be non-naturally occurring, e.g. identified from an artificial library of molecules or designed by modifying the structure of a naturally occurring lectin.
• Lectins known as “hemagglutinins” bind to carbohydrates on erythrocytes, e.g. blood group antigens, and when incubated with these cells cause them to aggregate. The influenza virus hemagglutinin, for example, binds to sialic acid. There are at least 15 known influenza hemagglutinin subtypes, defined by their distinct antigenic properties. Any of these subtypes, designated, e.g., H1, H2, H3, H4, H5, H6, H7, H8, H9, H10, H11, H12, H13, H14, and H15, may provide amino acid sequences useful in the compositions and methods of the invention. In one embodiment of the invention, the hemagglutinin is of a subtype from a virus that infects humans, e.g. H1, H2, or H3. In another embodiment, the hemagglutinin is of a subtype from a virus that does not infect humans, e.g. one of H4 through H15. Amino acid sequences can vary up to about 20% for influenza hemagglutinins within a given subtype, and can vary between about 30% and about 70% for influenza hemagglutinins from different subtypes. Methods for determining amino acid sequence homology are known to those of skill in the art. Examples of other software that can perform sequence comparisons to determine the % identity between hemagglutanin variants (or variants of any portion of the multifunctional molecules disclosed herein) include, but are not limited to, the BLAST package (Ausubel et al., 1995, Short Protocols in Molecular Biology, 3rd Edition, John Wiley & Sons), FASTA (Atschul et al., 1990, J. Mol. Biol., 403-410) and the GENEWORKS suite of comparison tools. Both BLAST and FASTA are available for offline and online searching.
• Although the final % homology can be measured in terms of identity, the alignment process itself is typically not based on an all-or-nothing pair comparison. Instead, a scaled similarity score matrix is generally used that assigns scores to each pairwise comparison based on chemical similarity or evolutionary distance. An example of such a matrix commonly used is the BLOSUM62 matrix the default matrix for the BLAST suite of programs. GCG Wisconsin programs generally use either the public default values or a custom symbol comparison table if supplied. It is preferred to use the public default values for the GCG package, or in the case of other software, the default matrix, such as BLOSUM62.
• Advantageously, the BLAST algorithm is employed, with parameters set to default values. The BLAST algorithm is described in detail in Altschul et al., (1990) J. Mol. Biol. 215:403-410, which is incorporated herein by reference. The search parameters are defined as follows, and can be advantageously set to the defined default parameters.
• Advantageously, “substantial identity” when assessed by BLAST equates to sequences which match with an EXPECT value of at least about 7, preferably at least about 9 and most preferably 10 or more. The default threshold for EXPECT in BLAST searching is usually 10.
• BLAST (Basic Local Alignment Search Tool) is the heuristic search algorithm employed by the programs blastp, blastn, blastx, tblastn, and tblastx; these programs ascribe significance to their findings using the statistical methods of Karlin and Altschul (Karlin and Altschul 1990, Proc. Natl. Acad. Sci. USA 87:2264-68; Karlin and Altschul, 1993, Proc. Natl. Acad. Sci. USA 90:5873-7) with a few enhancements. The BLAST programs are tailored for sequence similarity searching, for example to identify homologues to a query sequence. For a discussion of basic issues in similarity searching of sequence databases, see Altschul et al (1994) Nature Genetics 6:119-129.
• The five BLAST programs available through the National Institutes of Health (NIII; Bethesda, Md.) perform the following tasks: blastp compares an amino acid query sequence against a protein sequence database; blastn compares a nucleotide query sequence against a nucleotide sequence database; blastx compares the six-frame conceptual translation products of a nucleotide query sequence (both strands) against a protein sequence database; tblastn compares a protein query sequence against a nucleotide sequence database dynamically translated in all six reading frames (both strands); tblastx compares the six-frame translations of a nucleotide query sequence against the six-frame translations of a nucleotide sequence database.
• BLAST uses the following search parameters:
• HISTOGRAM—Display a histogram of scores for each search; default is yes. (See parameter H in the BLAST Manual).
• DESCRIPTIONS—Restricts the number of short descriptions of matching sequences reported to the number specified; default limit is 100 descriptions. (See parameter V in the manual page).
• EXPECT—The statistical significance threshold for reporting matches against database sequences; the default value is 10, such that 10 matches are expected to be found merely by chance, according to the stochastic model of Karlin and Altschul (1990). If the statistical significance ascribed to a match is greater than the EXPECT threshold, the match will not be reported. Lower EXPECT thresholds are more stringent, leading to fewer chance matches being reported. Fractional values are acceptable. (See parameter E in the BLAST Manual).
• CUTOFF—Cutoff score for reporting high-scoring segment pairs. The default value is calculated from the EXPECT value (see above). HSPs are reported for a database sequence only if the statistical significance ascribed to them is at least as high as would be ascribed to a lone HSP having a score equal to the CUTOFF value. Higher CUTOFF values are more stringent, leading to fewer chance matches being reported. (See parameter S in the BLAST Manual). Typically, significance thresholds can be more intuitively managed using EXPECT.
• ALIGNMENTS—Restricts database sequences to the number specified for which high-scoring segment pairs (HSPs) are reported; the default limit is 50. If more database sequences than this happen to satisfy the statistical significance threshold for reporting (see EXPECT and CUTOFF below), only the matches ascribed the greatest statistical significance are reported. (See parameter B in the BLAST Manual).
• MATRIX—Specify an alternate scoring matrix for BLASTP, BLASTX, TBLASTN and TBLASTX. The default matrix is BLOSUM62 (Henikoff & Henikoff, 1992). The valid alternative choices include: PAM40, PAM120, PAM250 and IDENTITY. No alternate scoring matrices are available for BLASTN; specifying the MATRIX directive in BLASTN requests returns an error response.
• STRAND—Restrict a TBLASTN search to just the top or bottom strand of the database sequences; or restrict a BLASTN, BLASTX or TBLASTX search to just reading frames on the top or bottom strand of the query sequence.
• FILTER—Mask off segments of the query sequence that have low compositional complexity, as determined by the SEG program of Wootton & Federhen (1993) Computers and Chemistry 17:149-163, or segments consisting of short-periodicity internal repeats, as determined by the XNU program of Clayerie & States (1993) Computers and Chemistry 17:191-201, or, for BLASTN, by the DUST program of Tatusov and Lipman (NIH). Filtering can eliminate statistically significant but biologically uninteresting reports from the blast output (e.g., hits against common acidic-, basic- or proline-rich regions), leaving the more biologically interesting regions of the query sequence available for specific matching against database sequences.
• Low complexity sequence found by a filter program is substituted using the letter “N” in nucleotide sequence (e.g., “NNNNNNNNNNN”) and the letter “X” in protein sequences (e.g., “XXXXXXXXX”).
• Filtering is only applied to the query sequence (or its translation products), not to database sequences. Default filtering is DUST for BLASTN, SEG for other programs.
• It is not unusual for nothing at all to be masked by SEG, XNU, or both, when applied to sequences in SWISS-PROT, so filtering should not be expected to always yield an effect. Furthermore, in some cases, sequences are masked in their entirety, indicating that the statistical significance of any matches reported against the unfiltered query sequence should be suspect.
• NCBI-gi—Causes NCBI gi identifiers to be shown in the output, in addition to the accession and/or locus name.
• Most preferably, sequence comparisons are conducted using the simple BLAST search algorithm provided by the NIH. In some embodiments of the present invention, no gap penalties are used when determining sequence identity.
• Influenza hemagglutinin is expressed as a single polypeptide chain, designated HA0, which trimerizes post-translationally. HA0 is proteolytically cleaved to yield two domains, HA1 and HA2, which are disulfide-bonded to each other. HA1 comprises significant sialic acid binding activity, while HA2 is anchored to the viral membrane and facilitates fusion of this membrane with a host cell membrane. In preferred embodiments of the invention, the
• multifunctional molecule comprising first and second parts comprises an amino acid sequence of an HA1 domain.
• Additional examples of lectin molecules useful in the present invention include, but are not limited to, those lectins shown in Table 1, and variants thereof having at least 50%, 70%, 90%, and up to 99% sequence homology with the sequences of the lectins shown in Table 1.

  TABLE 1
  KEY	NAME	ABBREVIATION	CLASS	LECTIN CODE
  [1]	/../.	Quail Intestinal	—	LECa.Ggg.Sss.xx.Xxxx.
  		Lectin.
  [2]	/../.	Porcine Heart Lectin	—	LECa.Ggg.Sss.xx.Xxxx.
  		(PHL).
  [3]	/../.	Hepatic beta-	S-lectin or	GLTa.Ggg.Sss.xx.Xxxx.
  		galactoside binding	Galectin.
  		lectins.
  [4]	/../.	Mammalian Brain	S-lectin or	GLTa.Ggg.Sss.xx.Xxxx.
  		Beta-Galactoside-	Galectin.
  		binding Lectin.
  [5]	Aaptos papillata.	—	—	LECi.Ada.Pap.xx.Xxxx.
  [6]	Abelmoschus	—	—	LECp.Abe.Esc.xx.Xxxx.
  	esculentus.
  [7]	Abramis brana.	—	—	LECp.Abr.Bra.xx.Xxxx.
  [8]	Abrus precatorius.	APA; APA-A; APA-	beta-trefoil lectin	LECp.AbrPre.se.Cga1
  		C; Abrin.	(APA); Type 2	(abrin)
  			RIP.	LECp.AbrPre.se.Cga2
  				(APA).
  [10]	Achatina fulica.	Achatina fulica Cold	—	LECi.Ach.ful.xx.Xsi1.
  		Aggltutinin;
  		achatinin-H.
  [13]	Actinomyces	—	—	LECf.Act.Vis.xx.Xga1.
  	viscosus.
  [14]	Adenia digitata.	Modeccin.	Type 2 RIP.	LECp.AdeDig.ro.Cga1.
  [15]	Adenia volksensii.	Volkensin.	Type 2 RIP.	LECp.AdeVol.ro.Cga1.
  [16]	Aegilops	—	Hevein domain	LECp.Aeg.Gen.se.Hch1.
  	geniculata.		lectin, chitin
  			binding.
  [19]	Aegopodium	APA.	—	LECp.Aeg.Pod.rh.Hga1.
  	podagraria.
  [20]	Aeromonas	—	—	LECb.Aer.Sa1.xx.Xxxx.
  	salmonicida.
  [21]	Afzelia africana.	—	—	LECz.Afz.Afr.xx.Xxxx.
  [22]	Agardhiella tenera.	—	—	LECz.Aga.Ten.xx.Xxxx.
  [23]	Agaricales.	—	—	LECz.Aga.sss.xx.Xxxx.
  [24]	Agaricus bisporus.	ABA-I, ABA-II,	—	LECf.Aga.Bis.xx.Xga1.
  		ABA-III, ABA-IV.
  [25]	Agaricus blazei.	—	—	LECf.Aga.Bla.xx.Xxxx.
  [26]	Agaricus	—	—	LECf.Aga.Cam.xx.Xxxx.
  	campestris.
  [27]	Agaricus edulis.	—	—	LECf.Aga.Edu.xx.Xxxx.
  [28]	Agrobacterium	—	—	LECu.Agr.Rad.xx.Xxxx.
  	radiobacter.
  [29]	Agrocybe aegerita.	—	—	LECf.Agr.Aeg.xx.Xxxx.
  [30]	Agropyrum	AREL, ARLL.	Hololectin;	LECp.Agr.Rep.se.Hch1
  	repens.		Monocot	(AREL)
  			mannose-binding	LECp.Agr.Rep.le.Hch1
  			lectins.	(ARLL).
  [31]	Aleuria aurantia.	—	—	LECf.Ale.Aur.xx.Xfu1.
  [32]	Allium	AAA.	Monocot	LECp.All.Asc.bu.Hma1.
  	ascalonicum.		mannose-binding
  			lectins.
  [36]	Allium cepa.	ACA.	Monocot	LECp.All.Cep.bu.Hma1.
  			mannose-binding
  			lectins.
  [37]	Allium moly.	AMA.	Monocot	LECp.All.Mol.bu.Hma1.
  			mannose-binding
  			lectins.
  [38]	Allium porrum.	APA.	Monocot	LECp.All.Por.le.Hma1.
  			mannose-binding
  			lectins.
  [39]	Allium sativum.	ASA.	Monocot	LECp.All.Sat.bu.Hma1
  			Mannose-binding	(ASA-I)
  			lectin.	LECp.All.Sat.bu.Hma1
  				(ASA-I)
  				LECp.All.Sat.bu.Hmal
  				(ASA-I)
  				LECp.All.Sat.bu.Hmal
  				(ASA-I)
  				LECp.All.Sat.bu.Hma2
  				(ASA-II)
  				LECp.All.Sat.le.Hma1
  				(ASA-III)
  				LECp.All.Sat.ro.Hma1
  				(ASA-IV).
  [40]	Allium ursinum.	AUA-I, AUA-II,	Monocot	LECp.All.Urs.bu.Hma1
  		AUA-III, AUA-Ir,	Mannose-binding	(AUA-I)
  		AUA-L, AUA-Iir.	lectin.	LECp.All.Urs.bu.Hma2
  				(AUA-II)
  				LECp.All.Urs.le.Hma1
  				(AUA-L)
  				LECp.All.Urs.ro.Hma1
  				(AUA-Ir)
  				LECp.All.Urs.ro.Hma2
  				(AUA-IIr).
  [42]	Allium vineale.	AVA.	Monocot	LECp.All.Vin.bu.Hma1.
  			Mannose-binding
  			lectin.
  [43]	Allomyrina	—	—	LECi.All.Dic.xx.Xxxx.
  	dichotoma.
  [44]	Alocasia indica.	—	—	LECp.Alo.Ind.tu.Hcu1.
  [45]	Aloe arborescens.	Aloctin, AAA.	AAA: Monocot	LECp.Alo.Arb.le.?
  			Mannose-binding	(Aloctin-A)
  			proteins Aloctin-	LECp.Alo.Arb.le.Hma1
  			A: u.	(AAA).
  [46]	Amaranthus	ACA, Amaranthin,	beta-trefoil lectin,	LECp.Ama.Cau.se.Hga1.
  	caudatus.	ACL.	Amaranthin
  			group.
  [47]	Amaranthus	—	Amaranthin	LECp.Ama.Cru.se.Hga1.
  	cruentus.		group.
  [48]	Amaranthus	AHML, Amaranthin.	Amaranthin	LECp.Ama.Hyp.xx.Xgal1.
  	hypochondriacus.		group.
  [49]	Amaranthus	—	Amaranthin	LECp.Ama.Leu.se.Hga1.
  	leucocarpus.		group.
  [50]	Amaranthus	ASL.	Amaranthin	LECp.Ama.Spi.se.Hga1.
  	spinosus.		group.
  [51]	Amphicarpaea	ABrA.	Legume lectins.	LECp.Amp.Bra.se.Hma1.
  	bracteata.
  [52]	Anadara granosa.	Anadarin MS.	—	LECi.Ana.Gra.xx.Xsi1.
  [53]	Anguilla anguilla.	AAL.	—	LECi.Ang.Ang.xx.Xfu1.
  [54]	Anthocidaris	—	Novel, unique	LECi.Ant.Cra.xx.Xxxx.
  	crassispina.		lectin class.
  [55]	Anthocidaris	—	—	LECi.Ant.Cra.xx.Xxxx.
  	crassispina Ovum.
  [57]	Apium graveolens.	—	—	LECp.Api.Gra.xx.Xxxx.
  [58]	Aplysia	—	—	LECi.Apl.Dac.xx.Xxxx.
  	dactylomela.
  [59]	Aplysia depilans.	—	—	LECi.Apl.Dep.xx.Xga1.
  [60]	Aplysina archeria.	—	—	LECu.Apl.Arc.xx.Xxxx.
  [61]	Arachis hypogea.	PNA, GNL, MNL,	All Arachnis	LECp.Ara.Hyp.se.Hga1
  		PRA-I, PRA-II.	lectins are classed	(PNA)
  			as legume lectins.	LECp.Ara.Hyp.no.Hga1
  				(GNL)
  				LECp.Ara.Hyp.se.Hga1
  				(MNL)
  				LECp.Ara.Hyp.se.Hga1
  				(PRA-I)
  				LECp.Ara.Hyp.se.Hga1
  				(PRA-II).
  [62]	Araucaria	Lectin I, Lectin II.	—	LECp.Ara.Bra.se.Hmg1
  	brasiliensis.			(Lectin I)
  				LECp.Ara.Bra.se.Hmg2
  				(Lectin II).
  [63]	Arion	—	—	LECi.Ari.Emp.xx.Xxxx.
  	empiricorum.
  [64]	Arisaema	ACA.	—	LECp.Ari.Con.tu.Hcu1.
  	consanguineum.
  [65]	Arisaema	ACmA.	—	LECz.Ari.Cur.tu.Hcu1.
  	curvatum.
  [66]	Arthrobotrys	AOL.	—	LECf.Art.Oli.xx.Xxxx.
  	oligospora.
  [68]	Artocarpus hirsuta.	—	—	LECp.Art.Hir.xx.Xxxx.
  [69]	Artocarpus incisa.	—	—	LECp.Art.Inc.xx.Xxxx.
  [70]	Artocarpus	Jacalin, AIA, KM+,	beta-prism plant	LECp.Art.Int.se.Hga1.
  	integrifolia.	Artocarpin.	lectin, Jacalin-
  			related lectins.
  [71]	Artocarpus	Artocarpin, ALA-I,	Jacalin-related	LECp.Art.Lak.se.Hga1.
  	lakoocha.	ALA-II.	lectins.
  [72]	Arum maculatum.	AMA.	Monocot binding	LECp.Aru.Mac.tu.Hma1.
  			lectins.
  [73]	Ascaris	—	—	LECi.Asc.Lum.xx.Xxxx.
  	lumbricoides.
  [74]	Asparagus	—	—	LECp.Asp.Off.xx.Xxxx.
  	officinalis.
  [75]	Bacillus	—	—	LECb.Bac.Pols.xx.Xxxx.
  	polymyxa.
  [76]	Bacterioides	—	—	LECb.Bac.Fra.xx.Xxxx.
  	fragilis.
  [77]	Bandeiraea	BS-I, BS-I-A4, BS-I-	—	LECp.Ban.Sim.xx.Xxxx.
  	simplicifolia.	B4, BS-II.
  [78]	Basidiomycotina.	—	—	LECf.Bas.Sss.xx.Xxxx.
  [79]	Bauhinia purpurea.	BPA.	Legume lectin.	LECp.Bau.Pur.se.Hga1.
  [80]	Bauhinia	—	—	LECz.Bau.Tom.xx.Xxxx.
  	tomentosa.
  [81]	Beauveria	—	—	LECf.Bea.Bas.xx.Xsi1.
  	bassiana.
  [82]	Beta vulgaris.	—	—	LECp.Bet.Vul.xx.Xxxx.
  [83]	Beta vulgaris.	—	—	LECp.Bet.Vul.xx.Xxxx.
  [84]	Biomphalaria	BGL-I, BGL-II.	—	LECp.Bio.Gla.xx.Xxxx.
  	glabrata.
  [85]	Biomphalaria	—	—	LECi.Bio.Gla.xx.Xxxx.
  	glabrata.
  [86]	Birgus latro.	—	—	LECz.Bir.Lat.xx.Xxxx.
  [87]	Blaberus	BDL1, BDL2, BDL3.	—	LECi.Bla.Dis.xx.Xxxx.
  	discoidalis.
  [88]	Bordetella	Pertussis toxin 1PRT.	—	LECz.Ggg.Sss.xx.Xxxx.
  	pertussis.
  [89]	Bos Taurus.	Mannose 6-phosphate	P-lectin.	LECa.Bos.Tau.xx.Xxxx.
  		receptor (1C39).
  [90]	Bos taurus.	Bovine Conglutinin.	C-lectin or	LECa.Bos.Tau.xx.Xxxx.
  			Collectin.
  [91]	Bos taurus.	Bovine collectin-43	C-lectin or	Leca.Bos.Tau.xx.Xxxx.
  		(CL-43).	Collectin.
  [92]	Botryllus	—	S-lectin.	LECi.Bot.Sch.xx.Xxxx.
  	schlosseri.
  [93]	Botrytis cinerea.	—	—	LECz.Bot.Cin.xx.Xxxx.
  [94]	Bowringia	BMA.	Legume lectins.	LECp.Bow.Mil.se.Hmg1.
  	milbraedii.
  [95]	Brachypodium	BsyL.	Chitin-binding	LECp.Bra.Syl.se.Hch1.
  	sylvaticum.		lectins.
  [96]	Bradyrhizobium	—	—	LECp.Bra.Jap.xx.Xga1.
  	japonicum.
  [97]	Branchiostoma	—	—	LECi.Bra.Lan.xx.Xxxx.
  	lanceolatum.
  [98]	Brassica	—	—	LECp.Bra.Cam.xx.Xxxx.
  	campetsris.
  [99]	Brassica	—	—	LECp.Bra.Nap.xx.Xxxx.
  	napobrassica.
  [100]	Brassica napus.	—	—	LECp.Bra.Nap.xx.Xxxx.
  [101]	Bryonia dioica.	BDA.	—	LECp.Bry.Dio.tu.Hga1.
  [113]	Cancer	—	—	LECi.Can.Ant.xx.Xsi1.
  	antennarius.
  [114]	Candida albican	Adhesins.	—	LECf.Can.Alb.xx.Xfu1.
  	adhesin.
  [115]	Canna generalis.	—	—	LECp.Can.Gen.rh.Hma1.
  [116]	Capnocytophaga	—	—	LECu.Cap.Gin.xx.Xxxx.
  	gingivalis
  	Actinomyces
  	Israelii
  	Coaggregation
  	agglutinin.
  [117]	Capsicum annum.	—	—	LECp.Cap.Ann.xx.Xxxx.
  [118]	Caragana	CAA-I, CAA-II.	—	LECp.Car.Arb.se.Hga1
  	arborescens.			(CAA-I)
  				LECp.Car.Arb.se.Hga2
  				(CAA-II).
  [119]	Carcharhinus	—	—	LECa.Car.Spr.xx.Xxxx.
  	springeri.
  [120]	Carcinoscorpious	L10; carcinoscorpin.	—	LECi.Car.Rot.xx.Xsi1.
  	rotundacauda.
  [121]	Carica papya.	—	—	LECp.Car.Pap.xx.Xxxx.
  [123]	Carum carvia.	—	—	LECp.Car.Car.xx.Xxxx.
  [124]	Carybdea alata	—	—	LECi.Car.Ala.xx.Xxxx.
  	Hemolysin.
  [125]	Castanea crenata.	CCA.	—	LECp.Cas.Cre.xx.Xxxx.
  [126]	Cepaea hortensis.	CHA-I.	—	LECi.Cep.Hor.xx.Xxxx.
  [127]	Channa punctatus.	—	—	LECa.Cha.Pun.xx.Xxxx.
  [129]	Chelidonium	—	—	LECp.Che.Maj.se.Hch1.
  	majus.
  [132]	Chicorium	—	—	LECp.Chi.Int.xx.Xxxx.
  	intybus.
  [133]	Cholla opuntia.	—	—	LECp.Cho.Opu.xx.Xxxx.
  [134]	Cicer arietinum.	CAA.	—	LECp.Cic.Ari.se.Hcu1.
  [135]	Cinachyrella	—	—	LECi.Cin.All.xx.Xxxx.
  	alloclada.
  [136]	Cinnamonum	—	—	LECp.Cin.Cam.xx.Xxxx.
  	camphora.
  [137]	Citrullus vulgaris.	—	—	LECp.Cit.Vul.xx.Xxxx.
  [139]	Citrus aurantium.	—	—	LECp.Cit.Aur.se.Cnd1.
  [140]	Citrus aurantium.	—	—	LECp.Cit.Aur.xx.Xxxx.
  [141]	Citrus medica.	—	—	LECp.Cit.Med.xx.Xxxx.
  [142]	Cladrastis lutea.	CLA-I, CLA-II.	—	LECp.Cla.Lut.ba.Hmg1
  				(CLA-I)
  				LECp.Cla.Lut.ba.Hmg2
  				(CLA-II).
  [143]	Clerodendron	CTA.	—	LECp.Cle.Tri.fr.Hga1.
  	trichotomum.
  [144]	Clitocyba	—	—	LECf.Cli.Neb.xx.Xxxx.
  	nebularis.
  [145]	Clivia miniata.	CMA.	—	LECp.Cli.Min.le.Hma1.
  [146]	Clostridium	—	—	LECb.Clo.Bot.xx.Xxxx.
  	botulinum.
  [147]	Clostridium tetani.	Tetanus toxin	—	LECb.Ggg.Sss.xx.Xxxx.
  		(1A8D).
  [148]	Clupea harengus.	—	—	LECa.Clu.Har.xx.Xxxx.
  [149]	Coccinia grandis.	CIA.	—	LECp.Coc.Gra.fr.Hch1.
  [151]	Cocus nucifera.	—	—	LECp.Coc.Nuc.xx.Xxxx.
  [152]	Codium fragilis.	—	—	LECu.Cod.Fra.xx.Xxxx.
  [153]	Cofea arabica.	—	—	LECp.Cof.Ara.xx.Xxxx.
  [154]	Colchicum	CAA.	—	LECp.Col.Aut.bu.Hcu1.
  	autumnale.
  [155]	Collybia velutipes.	—	—	LECf.Col.Vels.xx.Xxxx.
  [156]	Colocasia	CEA.	—	LECp.Col.Esc.tu.Hma1.
  	esculentum.
  [157]	Conger myriaster.	Congerin I, Congerin	S-lectin.	LECi.Con.Myr.xx.Xga1.
  		II.
  [159]	Conidiobolus	—	—	LECf.Con.Obs.xx.Xga1.
  	obscurus.
  [160]	Coprinus cinereus.	Cg1, Cg2.	Galectin.	LECf.Cop.Cin.xx.Xxxx.
  [161]	Corbicula	—	—	LECi.Cor.Flu.xx.Xxxx.
  	fluminea
  	Hemolysin.
  [163]	Corylus avellania.	—	—	LECp.Cor.Ave.xx.Xxxx.
  [164]	Cratylia mollis.	—	—	LECz.Cra.Mol.xx.Xxxx.
  [165]	Crenomytilus	CGL.	—	LECi.Cre.Gra.xx.Xxxx.
  	grayanus.
  [166]	Crocus sativum.	—	—	LECp.Cro.Sat.bu.Hma1.
  [167]	Crocus vernus.	CVA.	—	LECp.Cro.Ver.xx.Xxxx.
  [169]	Crotalaria striata.	—	—	LECp.Cro.Str.se.Hga1.
  [170]	Crotolaria	—	—	LECz.Cro.Aeg.xx.Xxxx.
  	aegyptica.
  [171]	Crotolaria falcata.	—	—	LECz.Cro.Fal.xx.Xxxx.
  [172]	Crotolaria juncea.	—	—	LECp.Cro.Jun.se.Hga1.
  [174]	Croton tiglium.	—	—	LECp.Cro.Tig.se.Hcu1.
  [175]	Cucumaria	CEL-III.	—	LECi.Cuc.Ech.xx.Xxxx.
  	echinata.
  [176]	Cucumis	—	—	LECp.Cuc.Cat.xx.Xxxx.
  	catalupensis.
  [177]	Cucumis melo.	—	—	LECp.Cuc.Mel.xx.Xch1.
  [178]	Cucumis sativus.	—	—	LECp.Cuc.Sat.xx.Xch1.
  [180]	Cucurbita ficifolia.	—	—	LECp.Cuc.Fic.xx.Xxxx.
  [181]	Cucurbita maxima.	CMA, PP2.	—	LECp.Cuc.Max.ps.Hch1.
  [182]	Cucurbita pepe.	—	—	LECp.Cuc.Pep.xx.Xxxx.
  [183]	Cucurbita pepo.	CPA.	—	LECp.Cuc.Pep.fr.Hch1.
  [184]	Cucurbita sativus.	—	—	LECp.Cuc.Sat.xx.Xxxx.
  [185]	Cydonia oblonja.	—	—	LECp.Cyd.Obl.xx.Xxxx.
  [186]	Cymbidium	—	—	LECz.Cym.Hyb.le.Hma1.
  	hybrid.
  [187]	Cyphomandra	—	—	LECp.Cyp.Bet.xx.Xxxx.
  	betacea.
  [188]	Cytisis	CMA-I, CMA-II.	—	LECp.Cyt.Mul.se.Hch1
  	multiflorus.			(CMA-I)
  				LECp.Cyt.Mul.se.Hfu1
  				(CMA-II).
  [189]	Cytisus scoparius.	CSA-I, CSA-II,	—	LECp.Cyt.Sco.se.Hga1
  		CMH-I, CMH-II.		(CS-I)
  				LECp.Cyt.Sco.se.Hga2
  				(CS-II).
  [190]	Cytisus	—	—	LECp.Cyt.Ses.se.Hch1
  	sessilfolius.			(CSA-I)
  				LECp.Cyt.Ses.se.Hga1
  				(CSA-II).
  [191]	Dacrymycetales.	—	—	LECz.Dac.sss.xx.Xxxx.
  [192]	Dalbergia.	—	—	LECz.Dal.sss.xx.Xxxx.
  [193]	Datura innoxia.	—	—	LECp.Dat.Inn.xx.Xxxx.
  [194]	Datura	DSA.	Chitin-bindng	LECp.Dat.Str.se.Hch1.
  	stramonium.		lectins.
  [195]	Daucus carrota.	—	—	LECp.Dau.Car.xx.Xxxx.
  [196]	Dendroaspis	JML, Jameson's	—	LECi.Den.Jam.xx.Xga1.
  	jamesoni.	Mamba Venon.
  [198]	Deuteromycetes.	—	—	LECz.Deu.sss.xx.Xxxx.
  [199]	Dicolea lehmani.	—	—	LECz.Dio.Leh.xx.Xxxx.
  [200]	Dictyostelium	Discoidin I.	—	LECu.Dic.Dis.xx.Xxxx.
  	discoideum.
  [201]	Dictyostelium	Purpurin.	—	LECu.Dic.Pur.xx.Xxxx.
  	purpureum.
  [202]	Didemnum	DTL, DCL-I, DCL-	—	LECi.Did.Sss.xx.Xga1.
  	candidum.	II.
  [203]	Dieffenbachia	—	—	LECp.Dif.Seq.xx.Xxxx.
  	sequina.
  [204]	Dioclea	—	Legume lectin.	LECp.Dio.Gra.xx.Xxxx.
  	grandifolia.
  [205]	Dioclea	DLL-I, DLL-II,	Legume lectin.	LECp.Dio.Gui.xx.Xmg1.
  	guianensis.	DLL-III.
  [206]	Dioclea virgata.	—	Legume lectin.	LECz.Dio.Vir.xx.Xxxx.
  [207]	Dolichos biflorus.	DBA-S, DBA-R,	Legume lectin.	LECp.Dol.Bif.se.Hga1
  		DB-58, DB-57,		(DBA)
  		DB46.		LECp.Dol.Bif.pl.Hcu1
  				(DB58)
  				LECp.Dol.Bif.pl.Hcu2
  				(DB57)
  				LECp.Dol.Bif.ro.?ga1
  				(DB46).
  [208]	Drosophila.	—	—	LECi.Dro.Meg.xx.Xxxx.
  [209]	Dumasia.	—	—	LECz.Dum.sss.xx.Xxxx.
  [210]	Echinocereus	—	—	LECp.Echi.Eng.xx.Xxxx.
  	engelmanii.
  [211]	Echis	EMS16.	—	LECi.Ech.Mul.xx.Xxxx.
  	multisquamatus.
  [212]	Electrophorus	Electrolectin.	—	LECi.Ele.Ele.xx.Xxxx.
  	electricus.
  [213]	Elymus	—	Hevein domain	LECp.Ely.Can.se.Hch1.
  	canadensis.		lectin, chitin
  			binding.
  [223]	Erythrina velutina.	—	—	LECp.Ery.Vel.xx.Xxxx.
  [224]	Escherichia coli.	Pili mannose-specific	Verotoxin-1:	LECb.Ech.Col.xx.Xxxx.
  		FimH adhesin	ADP-ribosylating
  		(1QUN),.	toxins.
  [225]	Euhadra	—	—	LECz.Euh.Cal.xx.Xxxx.
  	callizoma.
  [226]	Euphorbia	—	—	LECp.Eup.Sss.xx.Xxxx.
  	characias.
  [227]	Euphorbia	—	—	LECp.Eup.Het.xx.Xga1.
  	heterophylla.
  [228]	Evonymus	—	—	LECp.Evo.Eur.se.Hcu1.
  	europaea.
  [229]	Falcata japonica.	—	—	LECp.Fal.Jap.se.Hga1.
  [230]	Ficus cunia.	—	—	LECp.Fic.Cun.xx.Xxxx.
  [231]	Flammulina	—	—	LECf.Fla.Vel.xx.Xxxx.
  	veltipes.
  [232]	Fomes	—	—	LECz.Fom.Fom.xx.Xxxx.
  	fomentarius.
  [233]	Fragaria vesca.	—	—	LECp.Fra.Ves.xx.Xxxx.
  [234]	Fucus serratus.	—	—	LECu.Fuc.Ser.xx.Xxxx.
  [235]	Fucus vesiculosis.	—	—	LECu.Fuc.Ves.xx.Xxxx.
  [236]	Galactia tashiroi.	—	—	LECp.Gal.Tas.se.Hga1.
  [237]	Galactia	—	—	LECp.Gal.Ten.se.Hga1.
  	tenuiflora.
  [238]	Galanthus nivalis.	—	Monocot lectin.	LECp.Gal.Niv.bu.Hma1.
  [239]	Galleria	—	—	LECi.Gal.Mel.xx.Xxxx.
  	mellonella.
  [240]	Gallus gallus.	GGL.	S-lectin or	GLTa.Gal.Gal.xx.Xxxx.
  			Galectin.
  [241]	Gallus gallus.	Chicken Hepatic	—	LECa.Gal.Gal.xx.Xxxx.
  		lectins (CHL).
  [242]	Gallus gallus.	Chicken egg	—	LECa.Gal.Gal.xx.Xxxx.
  		agglutinins.
  [243]	Gallus gallus.	Chick Beta-	S-lectin or	LECa.Gal.Gal.xx.Xxxx.
  		galactoside-Binding	Galectin.
  		lectins.
  [244]	Gallus gallus.	Chicken Serum	C-lectin or	LECa.Gal.Gal.xx.Xxxx.
  		Mannose-Binding	Collectin.
  		Protein.
  [245]	Gallus gallus.	Chicken Liver	C-lectin or	LECa.Gal.Gal.xx.Xxxx.
  		Mannose-Binding	Collectin.
  		Protein.
  [246]	Gallus gallus.	Chicken Thymic	S-lectin or	GLTa.Gal.Gal..xx.Xxxx.
  		Electrolectin (CTE).	Galectin.
  [247]	Gallus gallus.	Chick Embryonic	S-lectin or	GLTa.Gal.Gal.xx.Xxxx.
  		Skin Lectins.	Galectin.
  [248]	Genypterus	—	—	LECi.Epi.Tre.xx.Xxxx.
  	blacodes.
  [249]	Geodia cydonium.	—	—	LECi.Geo.Cyd.xx.Xga1.
  [250]	Giardia lambia	Taglin.	—	LECu.Gia.Lam.xx.Xxxx.
  	Surface lectin.
  [251]	Gliricida sepium.	Lectin A, Lectin B.	—	LECp.Gli.Sep.se.Hga1
  				(Lectin A)
  				LECp.Gli.Sep.se.Hga2
  				(Lectin B).
  [252]	Glossina	—	—	LECi.Glo.Lon.xx.Xxxx.
  	longipennis lectin.
  [253]	Glycine max.	SBA.	Legume lectin.	LECp.Gly.Max.se.Hga1.
  [254]	Gonatanthus	—	—	LECz.Gon.Pum.ti.Hcu1.
  	pumilus.
  [256]	Grateulopia	—	—	LECu.Gra.Fil.xx.Xxxx.
  	filicina.
  [257]	Griffithsia	—	—	LECu.Gri.Flo.xx.Xxxx.
  	flosculosa.
  [258]	Griffonia	GS-I-A4, GS-I-A4,	Legume lectin.	LECp.Gri.Sim.se.Hga1
  	Simplicifolia	GS-I-B4, GS-II, GS-IV.		(GS-I-A4)
  	lectins.			LECp.Gri.Sim.se.Hga2
  				(GS-I-B4)
  				LECp.Gri.Sim.se.Hch1
  				(GS-II)
  				LECp.Gri.Sim.se.Hfu1 (GS-
  				IV) LECp.Gri.Sim.le.Hga1
  				(GS-I-A4)
  				LECp.Gri.Sim.le.Hga2 (GS-
  				I-B4)
  				LECp.Gri.Sim.le.Hch1 (GS-
  				II) LECp.Gri.Sim.le.Hfu1
  				(GS-IV).
  [260]	Grifola frondosa.	GFL.	—	LECf.Gri.Fro.xx.Xga1.
  [261]	Haemonchus	—	—	LECz.Xxx.Xxx.xx.Xxxx.
  	contortus.
  [262]	Halidrys siliquosa.	—	—	LECu.Hal.Sil.xx.Xxxx.
  [263]	Halimeda opuntia.	—	—	LECu.Hal.Opu.xx.Xxxx.
  [264]	Halocynthia	—	—	LECi.Hal.Pyr.xx.Xxxx.
  	pyriformis.
  [265]	Halocynthia	—	—	LECi.Hal.Ror.xx.Xga1.
  	roretzi.
  [266]	Haynaldia villosa.	—	Hevein domain	LECp.Hay.Vil.se.Hch1.
  			lectin, chitin
  			binding.
  [269]	Helianthus annus.	—	beta-prism plant	LECp.Hel.Ann.xx.Xxxx.
  			lectin.
  [270]	Helianthus	HTA.	Jacalin-related	LECp.Hel.Tub.tu.Hmmm1.
  	tuberosus.		lectins.
  [271]	Helicobacter	HP-SAL.	—	LECb.Hel.Pyl.xx.Xxxx.
  	pylori.
  [272]	Helix aspersa.	—	—	LECi.Hel.Asp.xx.Xxxx.
  [273]	Helix pomatia.	HPA.	—	LECi.Hel.Pom.xx.Xxxx.
  [274]	Herpetomonas.	—	—	LECz.Her.xx.Xxxx.
  [276]	Heteranthelium	—	Hevein domain	LECp.Het.Pil.se.Hch1.
  	piliferum.		lectin, chitin
  			binding.
  [277]	Heterometrus	—	—	LECi.Het.gra.xx.Xsi1.
  	granulomanus.
  [279]	Hevea brasiliensis.	HBA, Hevein.	Chitin-binding	LECp.Hev.Bra.la.Mch1.
  			lectin with hevein
  			domain.
  [280]	Hippeastrum	HHA.	Monocot lectin.	LECp.Hip.Hyb.bu.Hma1.
  	hybrid.
  [281]	Hippopus	Tridacnin.	C-lectin.	LECi.Hip.Hip.xx.Xxxx.
  	hippopus.
  [282]	Hizoctonia solani.	—	—	LECz.Hiz.Sol.xx.Xxxx.
  [283]	Hohenbuehelia	—	—	LECf.Hoh.Ser.xx.Xxxx.
  	serotina.
  [284]	Homarus	HAA.	—	LECi.Hom.Ame.xx.Xxxx.
  	americanus.
  [285]	Homo sapiens.	P-selectin (1KJD).	C-lectin.	LECh.Hom.Sap.xx.Xxxx.
  [286]	Homo sapiens.	Human Mannose	C-lectin.	LECh.Hom.Sap.xx.Xxxx.
  		Binding Protein
  		(MBP) (1HUP).
  [287]	Homo sapiens.	Gut Mucus Anti-	—	LECh.Hom.Sap.xx.Xxxx.
  		Salmonella Lectin.
  [288]	Homo sapiens.	Human Membrane	—	LECh.Hom.Sap.Xxxx.
  		Lectins (HKML,
  		HCCML).
  [289]	Homo sapiens.	Human Synovial	—	LECh.Hom.Sap.xx.Xxxx.
  		Tissue Lectins.
  [290]	Homo sapiens.	Human Placenta	—	LECh.Hom.Sap.xx.Xxxx.
  		Lectins (HPL-H,
  		HPL-BG).
  [291]	Homo sapiens.	Human Brain	—	LECh.Hom.Sap.xx.Xxxx.
  		Galactoside-binding
  		Lectin.
  [292]	Homo sapiens.	Human 14-kDa	—	LECh.Hom.Sap.xx.Xxxx.
  		Lectins.
  [293]	Homo sapiens.	Human Core-specific	—	LECh.Hom.Sap.xx.Xxxx.
  		Lectin (HCSL).
  [294]	Homo sapiens.	Cell Membrane	—	LECh.Hom.Sap.xx.Xxxx.
  		Lectins.
  [295]	Homo sapiens.	Tumoricidal	—	LECh.Hom.Sap.xx.Xga1.
  		Macrophage Lectin.
  [296]	Homo sapiens.	Tumor-associated	—	LECa.Ggg.Sss.xx.Xxxx.
  		Vertebrate Lectin.
  [297]	Homo sapiens.	Human Conglutinin-	—	LECh.Hom.Sap.xx.Xxxx.
  		like Protein.
  [298]	Homo sapiens.	Mannose-Specific	—	LECh.Hom.Sap.xx.Xma1.
  		Endocytosis
  		Receptor.
  [299]	Homo sapiens.	Human Penultimate	—	LECh.Hom.Sap.xx.Xxxx.
  		Galactose Lectin.
  [300]	Homo sapiens.	Thrombospondin.	—	LECh.Hom.Sap.xx.Xxxx.
  [301]	Homo sapiens.	Tetranectin.	—	LECh.Hom.Sap.xx.Xxxx.
  [302]	Homo sapiens.	Human Dendritic	—	LECh.Hom.Sap.xx.Xxxx.
  		Cell Immunoreceptor
  		(DCIR).
  [303]	Homo sapiens.	Human Seminal	—	LECh.Hom.Sap.xx.Xxxx.
  		Lectin (HSL).
  [304]	Homo sapiens.	Charcot-Leyden	S-lectin or	GLTh.Hom.Sap.xx.Xxxx.
  		crystal protein	Galectin.
  		(1LCL).
  [305]	Homo sapiens.	Galectin II L-14-II	Proto S-lectin or	GLTh.Hom.Sap.xx.Xxxx.
  		(1HLC).	Galectin.
  [306]	Homo sapiens.	Human Lung	C-lectin or	GLTh.Hom.Sap.xx.Xxxx.
  		Surfactant Protein	Collectin.
  		(1B08).
  [307]	Homo sapiens.	Galectin III.	Chimera S-lectin	GLTh.Hom.Sap.xx.Xxxx.
  			or Galectin.
  [308]	Homo sapiens.	Galectin VII, hGal-7.	Proto S-lectin or	GLTh.Hom.Sap.xx.Xxxx.
  			Galectin.
  [309]	Homo sapiens.	Pentraxin(1CRV).	Pentraxin, S-	GLTh.Hom.Sap.xx.Xxxx.
  			lectin or Galectin.
  [310]	Homo sapiens.	Sialoadhesin.	I-lectin.	LECz.Ggg.Sss.xx.Xxxx.
  [311]	Homo sapiens.	Serum Amyloid P	Pentraxin.	LECh.Hom.Sap.xx.Xxxx.
  		Component.
  [312]	Homo sapiens.	E-Selectin (1ESL).	C-lectin.	SELh.Hom.Sap.xx.Xxxx.
  [313]	Homo sapiens.	L-Selectin (1KJB).	C-lectin.	SELh.Hom.Sap.xx.Xxxx.
  [314]	Homo sapiens.	C-Reactive protein	Pentraxin, S-	GLTh.Hom.Sap.xx.Xxxx.
  		(1CRV).	lectin or Galectin.
  [315]	Homo sapiens.	Galectin XII.	S-lectin or	GLTh.Hom.Sap.xx.Xxxx.
  			Galectin.
  [316]	Homo sapiens.	Galectin I.	Proto S-lectin or	GLTh.Hom.Sap.xx.Xxxx.
  			Galectin.
  [317]	Homo sapiens.	Galectin IX,	Tandem Repeat	GLTh.Hom.Sap.sr.Xxxx.
  		Ecalectin.	S-lectin or
  			Galectin.
  [318]	Homo sapiens.	Galectin VIII.	Tandem Repeat	GLTh.Hom.Sap.xx.Xxxx.
  			S-lectin or
  			Galectin.
  [319]	Homo sapiens.	Galectin IV.	Tandem Repeat	GLTh.Hom.Sap.xx.Xxxx.
  			S-lectin or
  			Galectin.
  [320]	Homo sapiens.	Alpha-1/Beta-1	Integrin A (or I)	INTh.Hom.Sap.xx.Xxxx.
  		integrin.	domain.
  [321]	Homo sapiens.	Alpha-2/Beta-1	Integrin A (or I)	INTh.Hom.Sap.xx.Xxxx.
  		integrin.	domain.
  [322]	Homo sapiens.	Alpha-3/Beta-1	Integrin A (or I)	INTh.Xxx.Xxx.xx.Xxxx.
  		integrin.	domain.
  [323]	Homo sapiens.	Alpha-4/Beta-1	Integrin A (or I)	INTh.Xxx.Xxx.xx.Xxxx.
  		integrin.	domain.
  [338]	Homo sapiens.	Alpha-5/Beta-8	Integrin A (or I)	INTh.Hom.Sap.xx.Xxxx.
  		integrin.	domain.
  [339]	Homo sapiens.	Alpha-4/Beta-7	Integrin.	INTh.Hom.Sap.xx.Xxxx.
  		Integrin.
  [340]	Homo sapiens.	Alpha-E/Beta-7.	Integrin.	INTh.Hom.Sap.xx.Xxxx.
  [341]	Homo sapiens.	Mucosal addressin	Addressin.	LECh.Xxx.Xxx.xx.Xxxx.
  		cell adhesion
  		molecule-1
  		(MADCAM-1).
  [342]	Homo sapiens.	Vascular Adhesion	—	LECh.Xxx.Xxx.xx.Xxxx.
  		Molecule (VCAM-1.
  [343]	Homo sapiens.	P-Selectin.	Selectin.	SELh.Xxx.Xxx.xx.Xxxx.
  [344]	Homo sapiens.	Intercellular	Addressin?.	LECh.Xxx.Xxx.xx.Xxxx.
  		Adhesion Molecule
  		(ICAM-1, ICAM-2).
  [345]	Homo sapiens.	Peripheral Lymph	Addressin.	LECh.Xxx.Xxx.xx.Xxxx.
  		Node Addressin
  		(PNAd).
  [346]	Homo sapiens.	Vascular Adhesion	—	LECh.Xxx.Xxx.xx.Xxxx.
  		Protein (VAP-1).
  [347]	Homo sapiens.	LFA-3.	Addressin?.	LECh.Xxx.Xxx.xx.Xxxx.
  [348]	Homo sapiens.	Versican.	Soluble C-lectin	LECh.Xxx.Xxx.xx.Xxxx.
  			(‘Lecticans’).
  [349]	Homo sapiens.	Aggrecan.	Soluble C-lectin	LECh.Xxx.Xxx.xx.Xxxx.
  			(‘Lecticans’).
  [350]	Homo sapiens.	Neurocan.	Soluble C-lectin	LECh.Xxx.Xxx.xx.Xxxx.
  			(‘Lecticans’).
  [351]	Homo sapiens.	Brevican.	Soluble C-lectin	LECh.Xxx.Xxx.xx.Xxxx.
  			(‘Lecticans’).
  [352]	Homo sapiens.	Annexin V.	Annexin.	ANNh.Hom.Sap.xx.Xxx5.
  [353]	Homo sapiens.	Annexin II.	Annexin.	ANNh.Hom.Sap.xx.Xxx2.
  [354]	Homo sapiens.	Annexin IV.	Annexin.	ANNh.Hom.Sap.xx.Xxx4.
  [355]	Homo sapiens.	Annexin I	Annexin.	ANNh.Hom.Sap.xx.Xxx1.
  		(Lipocortin-1),
  		ANX1.
  [356]	Homo sapiens.	Annexin VII,	—	ANNh.Hom.Sap.xx.Xxx7.
  		Synexin.
  [357]	Homo sapiens.	Activated Leukocyte	—	LECh.Hom.Sapxx.
  		Adhesion Molecule
  		(ALCAM).
  [358]	Homo sapiens.	E-cadherin.	—	CDHh.Hom.Sap.xx.XxxE.
  [360]	Homo sapiens.	N-cadherin	—	CDHh.Hom.Sap.xx.XxxN.
  		(uvomorulin).
  [361]	Homo sapiens.	VE-cadherin	—	CDHh.Hom.Sap.xx.XxxVE.
  		(Vascular Endothelial
  		Cadherin).
  [362]	Homo sapiens.	P-cadherin.	—	CDHh.Hom.Sap.xx.XxxP.
  [363]	Homo sapiens.	Annexin XI (CAP-	—	ANNh.Hom.Sap.xx.Xxx9.
  		50).
  [364]	Homo sapiens.	Endothelial Cell-	—	CDHh.Hom.Sapxxx.
  		Selective Adhesion
  		Molecule (ESAM).
  [365]	Homo sapiens.	ELAM-1.	—	CDHh.Xxx.Xxx.xx.Xxxx.
  [366]	Homo sapiens.	GMP-140.	—	CDHh.Xxx.Xxx.xx.Xxxx.
  [367]	Homo sapiens.	Cutaneous	—	LECh.Xxx.Xxx.xx.Xxxx.
  		Lymphocyte Antigen
  		(CLA).
  [369]	Homo sapiens.	Lymphocyte	—	LECh.Xxx.Xxx.xx.Xxxx.
  		Function-Associated
  		Antigen-1 (LFA-1).
  [370]	Homo sapiens.	Very Late Antigen 4	—	LECh.Xxx.Xxx.xx.Xxxx.
  		(VLA-4).
  [371]	Hordeum vulgare.	HVA.	—	LECp.Hor.Vul.se.Hch1.
  [372]	Hura crepitans.	HCA.	Type 2 RIP.	LECp.Hur.Cre.se.Cga1
  				(HCA)
  				LECp.Hur.Cre.la.Cga1.
  [373]	Hygrophorus	—	—	LECf.Hyg.Hyp.xx.Xxxx.
  	hypothejus.
  [374]	Hypnea	—	—	LECu.Hyp.Cer.xx.Xxxx.
  	cervicornis.
  [375]	Hyptos	—	—	LECz.Hyp.Sua.xx.Xxxx.
  	suaveolens.
  [376]	Iberis amara.	—	—	LECp.Ibe.Ama.xx.Xxxx.
  [377]	Influenza virus.	Hemagglutinin.	Hemagglutinin.	LECv.Inf.Vir.xx.Xxxx.
  [378]	Ipomoea batatas.	—	—	LECp.Ipo.Bat.xx.Xxxx.
  [379]	Iris hollandica.	—	—	LECp.Iri.Hol.xx.Xxxx.
  [380]	Iris hybrid.	IRA.	Type 2 RIP.	LECp.Iri.Hyb.bu.Cga1.
  [381]	Juglans regia.	—	—	LECp.Jug.Reg.xx.Xxxx.
  [382]	Klyveromyces	—	—	LECz.Kly.Bul.xx.Xxxx.
  	bulgaricus.
  [383]	Kuehneromyces	—	—	LECu.Kue.Mut.xx.Xxxx.
  	mutabilis.
  [384]	Labiaceae	—	—	LECp.Lab.Ori.xx.Xxxx.
  	origanum.
  [385]	Lablab purpureus.	DLA, LPA.	Legum lectin.	LECp.Lab.Pur.se.Hmg1.
  [386]	Laburnum	LAA-I, LAA-II.	Legume lectin.	LECp.Lab.Alp.se.Hch1
  	alpinum.			(LAA-I)
  				LECp.Lab.Alp.se.Hga1
  				(LAA-II).
  [387]	Laccaria	—	—	LECz.Lac.Ame.xx.Xxxx.
  	amethystina.
  [389]	Lachesis huta.	BML.	—	LECi.Lac.Jut.xx.Xxxx.
  [390]	Lactarius	LDL.	—	LECf.Lac.Del.xx.Xgal1.
  	deliciosus.
  [391]	Lactarius	—	—	LECz.Lac.Lig.xx.Xxxx.
  	lignyotus.
  [392]	Lactuca scariole.	PLA-I, PLA-II.	—	LECa.Lac.Sca.xx.Xxxx.
  [393]	Laelia autumnalis.	—	—	LECp.Lae.Aut.xx.Xxxx.
  [394]	Laetiporus	PSL.	—	LECf.Lae.Sul.xx.Xxxx.
  	sulfureus.
  [395]	Lathyrus cicera.	LcLI, LcLII.	—	LECp.Lat.Cic.xx.Xxxx.
  [396]	Lathyrus nissolia.	—	—	LECp.Lat.Nis.xx.Xxxx.
  [397]	Lathyrus ochrus.	LOL-I, LOL-II.	Legume lectin.	LECp.Lat.Och.xx.Xxxx.
  [398]	Lathyrus odoratus.	—	—	LECp.Lat.Odo.xx.Xxxx.
  [399]	Lathyrus silvestris.	—	—	LECp.Lat.Sil.xx.Xxxx.
  [400]	Lathyrus	—	—	LECp.Lat.Tub.xx.Xxxx.
  	tuberosus.
  [401]	Lens culinaris.	LCA, LcH.	Legume lectins.	LECp.Len.Cul.se.Hmg1.
  [402]	Lepidium	—	—	LECp.Lep.Sat.xx.Xxxx.
  	sativuum.
  [403]	Leptonychotes	—	—	LECz.Lep.Wed.xx.Xxxx.
  	weddelli.
  [404]	Leptospermum	LAA.	—	LECp.Lep.Arc.xx.Xxxx.
  	archinoides.
  [405]	Leucojum.	—	—	LECz.Leu.sss.xx.Xxxx.
  [406]	Leucojum	LAA.	Monocot	LECp.Leu.Aes.bu.Hma1.
  	aestivum.		mannose-binding
  			lectins.
  [407]	Leucojum vernum.	LVA.	Monocot	LECp.Leu.Ver.bu.Hma1.
  			mannose-binding
  			lectins.
  [408]	Limulus	Limulin.	Pentraxin.	LECi.Lim.Pol.xx.Xsi1.
  	polyphemus.
  [409]	Liocarcinus	—	—	LECi.Lio.Dep.xx.Xxxx.
  	depurator.
  [410]	Listeria ovata.	LOA, LOMBP.	Monocot	LECp.Lis.Ova.le.Hma1
  			mannose binding	(LOA)
  			proteins.	LECp.Lis.Ova.le.Mma1
  				(LMOBP).
  [411]	Litchi chinensis.	LCL.	—	LECp.Lit.Chi.xx.Xxxx.
  [412]	Lonchocarpus	—	Legume lectin.	LECp.Lon.Cap.se.Hga1.
  	capassa.
  [413]	Lontonis bainesii.	—	Legum lectins.	LECp.Lon.Bai.se.Hga1
  				LECp.Lon.Bai.ro.Hga1.
  [414]	Lophocereus	—	—	LECp.Lop.Sho.xx.Xxxx.
  	shotti.
  [415]	Lotus	LTA.	Legume lectins.	LECp.Lot.Tet.se.Hfu1.
  	tetragonolobus.
  [416]	Luffa acutangula.	LAA.	Cucurbtaceae	LECp.Luf.Acu.fr.Hch1.
  			phloem lectins.
  [417]	Lumbricus	EW29.	—	LECi.Lum.Ter.xx.Xxxx.
  	terrestris.
  [418]	Lycopersicon	LEA, TL, LEL.	Chitin-binding	LECp.Lyc.Esc.fr.Hch1.
  	esculentum.		lectins.
  [419]	Lycoris aurea.	—	Monocot	LECp.Lyc.Aur.bu.Hma1.
  			mannose-binding
  			lectins.
  [420]	Maackia	MALb, MAHb,	Legume lectins.	LECp.Maa.Amu.se.Hsi1
  	amurensis.	MAL, MAHs.		(MAHs, MAH)
  				LECp.Maa.Amu.se.Hsi2
  				(MAHs, MAH)
  				LECp.Maa.Amu.ba.Hsi1
  				(MAHb)
  				LECp.Maa.Amu.ba.Hsi1
  				(MALb).
  [421]	Machaerocereus	MEA-I, MEA-II.	?.	LECp.Mac.Eru.st.Hga1.
  	eruca.
  [422]	Machaerocereus	—	Hevein domain	LECp.Mac.Gum.xx.Xxxx.
  	gummosus.		lectin, chitin
  			binding.
  [423]	Maclura pomifera.	MPA.	beta-prism plant	LECi.Mac.Pom.xx.Xxxx.
  			lectin.
  [424]	Macrobdella	LL1-63.	—	LECi.Mac.Dec.xx.Xxxx.
  	decora.
  [425]	Macrobrachium	MrL.	—	LECi.Mac.Ros.xx.Xxxx.
  	rosenbergii.
  [426]	Macrotyloma	—	—	LECp.Mac.Axi.xx.Xxxx.
  	axillare.
  [427]	Malus officinalis.	—	—	LECp.Mal.Off.xx.Xxxx.
  [428]	Manduca sexta.	Immulectin.	C-lectin.	LECi.Man.Sex.xx.Xxxx.
  [429]	Mangifera indica.	MIA.	—	LECp.Man.Ind.xx.Xxxx.
  [430]	Marah	—	—	LECp.Mar.Mac.xx.Xxxx.
  	macrocarpus.
  [431]	Marasmius	—	—	LECf.Mar.Ore.xx.Xxxx.
  	oreades.
  [432]	Medicago sativa.	—	—	LECp.Med.Sat.xx.Xxxx.
  [433]	Medicago	—	—	LECp.Med.Tru.xx.Xxxx.
  	truncatula.
  [434]	Megabalanus rosa.	—	—	LECi.Mag.Ros.xx.Xxxx.
  [435]	Megapitaria	—	—	LECi.Meg.Squ.xx.Xxxx.
  	squalida.
  [436]	Melanoleuca	—	—	LECf.Mel.Mel.xx.Xxxx.
  	melaleuca.
  [437]	Melastiza chateri.	—	—	LECf.Mel.Cha.xx.Xxxx.
  [438]	Mesocricetus	—	Pentraxin.	LECz.Ggg.Sss.xx.Xxxx.
  	auratus.
  [474]	Orchidaceae.	—	—	LECp.Orc.Sss.xx.Xxxx.
  [475]	Omithodoros	Dorin-M.	—	LECi.Orn.Mou.xx.Xxxx.
  	moubata.
  [476]	Oryza sativa.	OSA.	Chitin binding	LECp.Ory.Sat.see.Hch1.
  			lectins.
  [477]	Oscillatoria	—	—	LECu.Osc.Aga.xx.Xxxx.
  	agardhii.
  [478]	Otala lactea.	—	—	LECi.Ota.Lac.xx.Xxxx.
  [480]	Pachydereus	—	—	LECp.Pac.Pri.se.Hch1.
  	pringleii.
  [481]	Pacifastacus	—	—	LECi.Pac.Len.xx.Xxxx.
  	leniusculus.
  [482]	Palmaria palmata.	—	—	LECz.Pal.Pal.xx.Xxxx.
  [483]	Paracentrotus	—	—	LECi.Par.Liv.xx.Xxxx.
  	lividus.
  [484]	Parkia	—	—	LECp.Par.Big.xx.Xxxx.
  	biglandulosa.
  [485]	Parkia discolor.	—	—	LECz.Par.Dis.xx.Xxxx.
  [486]	Parkia	—	—	LECz.Par.Pla.xx.Xxxx.
  	platycephala.
  [487]	Parkia speciosa.	—	—	LECp.Park.Spe.xx.Xxxx.
  [488]	Paxillus	—	—	LECz.Pax.Atr.xx.Xxxx.
  	atrotomentosus.
  [489]	Paxillus	—	—	LECf.Pax.Pan.Sss.xx.Xxxx.
  	panuoides.
  [490]	Penaeus	—	—	LECp.Pen.Cal.xx.Xxxx.
  	californiensis.
  [492]	Penaeus	—	—	LECi.Pen.Sty.xx.Xxxx.
  	stylirostris.
  [494]	Penaeus vannamei.	—	—	LECi.Pen.Van.xx.Xxxx.
  [495]	Perca fluviatilis.	—	—	LECa.Per.Flu.xx.Xxxx.
  [496]	Peresea gratissima.	—	—	LECz.Per.Gra.xx.Xxxx.
  [497]	Persea americana.	PAA.	—	LECp.Per.Ame.xx.Xxxx.
  [498]	Petromyzon	—	—	LECz.Pet.Mar.xx.Xxxx.
  	marinus.
  [499]	Petrosecinum	—	—	LECp.Pet.Hor.xx.Xxxx.
  	hortense.
  [500]	Peziza badia.	—	—	LECp.Pez.Bad.xx.Xxxx.
  [501]	Phage p22.	Phage P22	—	LECb.Ggg.Sss.xx.Xxxx.
  		TailspikeProteins
  		(1TSP).
  [502]	Phalera flavescens.	PFA.	—	LECi.Pha.Fla.xx.Xxxx.
  [503]	Phallus impudicus.	—	—	LECf.Pha.Imp.xx.Xxxx.
  [504]	Phallusia	—	—	LECi.Pha.Mam.xx.Xxxx.
  	mamillata.
  [505]	Phaseolus	—	Legume lectins.	LECp.Pha.Acu.se.Hcu1
  	acutifolius.			(erythroagglutinin)
  				LECp.Pha.Acu.se.Hcu2
  				(lymphoagglutinin).
  [506]	Phaseolus aureus.	—	—	LECp.Pha.Aur.xx.Xxxx.
  [507]	Phaseolus	PCA.	Legume lectin.	LECp.Pha.Coc.se.Hcu1
  	coccineus.			(PCA)
  				LECp.Pha.Coc.se.Hcu2.
  [508]	Phaseolus	—	—	LECp.Pha.Coc.xx.Xxxx.
  	coccineus.
  [509]	Phaseolus	PLA, LBA, LBL.	Legume lectins.	LECp.Pha.Lim.se.Hga1.
  	limenesis.
  [510]	Phaseolus lunatus.	—	—	LECp.Pha.Lun.se.Xxxx.
  [511]	Phaseolus	PHA-E, PHA-L.	Legume lectin.	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [512]	Phaseolus	GN1L, GNpL, GNsL.	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [513]	Phaseolus	Pinto III.	—	LECa.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [514]	Phaseolus	—	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [515]	Phaseolus	—	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [516]	Phaseolus	—	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [517]	Phaseolus	—	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [518]	Phaseolus	—	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [519]	Phaseolus	—	—	LECp.Pha.Vul.xx.Xxxx.
  	vulgaris.
  [520]	Phlomis	—	—	LECz.Phl.Fru.xx.Xxxx.
  	fructicosa.
  [521]	Pholiota aurivella.	PAA.	—	LECf.Ggg.Sss.xx.Xxxx.
  [522]	Pholiota squarrosa.	—	—	LECf.Pho.Squ.xx.Xxxx.
  [524]	Phoradendron	—	—	LECz.Pjo.Cal.xx.Xxxx.
  	californicum.
  [525]	Phragmites.	—	—	LECz.Phr.sss.xx.Xxxx.
  [526]	Phragmites	—	—	LECp.Phr.Aus.xx.Xxxx.
  	austalis.
  [527]	Physalia physalis.	Physalitoxin.	—	LECi.Phy.Phy.xx.Xxxx.
  [528]	Physalis angulata.	PA-VII-A, PA-VII-B	—	LECz.Phy.Ang.xx.Xxxx.
  		and PA-VII-C.
  [529]	Physarum	—	—	LECu.Phy.Pol.xx.Xxxx.
  	polycephalum.
  [530]	Phytolacca	PWM, Pa-1, Pa-2	—	LECp.Phy.Ame.ro.Hch1(Pa-1)
  	americana.	(PL-A) Pa-3, Pa-4		LECp.Phy.Ame.ro.Hch2(Pa-2)
  		(PL-C), Pa-5.		LECp.Phy.Ame.ro.Hch3(Pa-3)
  				LECp.Phy.Ame.ro.Hch4(Pa-4)
  				LECp.Phy.Ame.ro.Hch5(Pa-5)
  				LECp.Phy.Ame.ro.Hch6(PL-B).
  [531]	Pimenta	—	—	LECp.Pim.Off.xx.Xxxx.
  	officinalis.
  [532]	Pisum sativum.	PSA, PsA.	Legume lectins.	LECp.Pis.Sat.se.Hmg1
  				(PSA, PsA)
  				LECp.Pis.Sat.ro.Hmg1.
  [533]	Plecoglossus	PAL.	—	LECa.Ple.Alt.xx.Xxxx.
  	altivelis.
  [535]	Pleurocybella	—	—	LECf.Ggg.Sss.xx.Xxxx.
  	porrigens.
  [536]	Pleurotus	—	—	LECf.Ple.Ost.xx.Xxxx.
  	ostreatus.
  [537]	Plumaria elegans.	—	—	LECu.Plu.Ele.xx.Xxxx.
  [538]	Polyandrocarpa	—	C-lectin.	LECi.Pol.Mis.xx.Xga1.
  	misakiensis.
  [539]	Polygonum	—	—	LECp.Pol.Mul.xx.Xxxx.
  	multiformum.
  [540]	Polyomavirus.	1VPN.	—	LECV.Pol.Vir.xx.Xxxx.
  [541]	Polyporus	—	—	LECf.Pol.Fom.xx.Xxxx.
  	fomentarius.
  [542]	Polyporus	—	—	LECf.Pol.Squ.xx.Xxxx.
  	squamosus.
  [543]	Polysphondylium	—	—	LECu.Pol.Pal.xx.Xxxx.
  	pallidum.
  [544]	Potamon	—	—	LECi.Pot.Pot.xx.Xxxx.
  	potamios.
  [545]	Prunus Americana.	—	—	LECp.Pru.Ame.xx.Xxxx.
  [546]	Prunus avium.	—	—	LECp.Pru.Avi.xx.Xxxx.
  [547]	Psathyrostachys	—	Hevein domain	LECp.Psa.Jun.se.Hch1.
  	juncea.		lectin, chitin
  			binding.
  [548]	Pseudomonas	—	—	LECb.Pse.Aer.xx.Xga1.
  	aeruginosa.
  [549]	Pseudomonas	—	—	LECb.Pse.Apl.xx.Xxxx.
  	aplysia.
  [550]	Psophocarpus	PTL-I (WBA-I),	—	LECp.Pso.Tet.se.Hga1
  	tetragonolobus.	PTL-II (WBA-II),		(PTL-I)
  		WBTL, L-I, L-II.		LECp.Pso.Tet.se.Hga2
  				(PTL-II)
  				LECp.Pso.Tet.ro.Hga1
  				(WBTL)
  				LECp.Pso.Tet.so.Hga2
  				LECp.Pso.Tet.le.Hga1 (L-I)
  				LECp.Pso.Tet.le.Hga2 (L-II).
  [551]	Ptilota serrata.	—	—	LECu.Pxx.Ser.xx.Xxxx.
  [552]	Punica granatum.	—	—	LECp.Pun.Gra.xx.Xxxx.
  [553]	Rana catesbeiana.	—	Lectins	LECa.Ran.Cat.xx.Xxxx.
  			Displaying RNase
  			Activity
  			(Leczymes).
  [554]	Rana catesbeiana	cSBL.	Lectins	LECa.Ran.Cat.xx.Xxxx.
  	ovum lectin.		Displaying RNase
  			Activity
  			(Leczymes).
  [555]	Rana japonica.	jSBL.	Lectins	LECa.Ran.Jap.xx.Xxxx.
  			Displaying RNase
  			Activity
  			(Leczymes).
  [557]	Rana	—	—	LECa.Ran.Nig.xx.Xxxx.
  	nigromaculata.
  [558]	Raphanus sativus.	—	—	LECp.Rap.Sat.xx.Xxxx.
  [559]	Ratus norvegicus.	Mannan Binding	C-lectin or	LECa.Rat.Nor.xx.Xxxx.
  		Protein (MBP-A).	Collectin.
  [560]	Ratus ratus.	Rat peritioneal	—	LECa.Rat.Rat.xx.Xfu1
  		macrophage lectin.		LECa.Rat.Rat.xx.Xga1.
  [561]	Ratus ratus.	—	—	LECa.Rat.Rat.xx.Xxxx.
  [562]	Ratus ratus.	Galectin II.	S-lectin or	GLT2.Rat.Rat.xx.Xxxx.
  			Galectin.
  [563]	Ratus ratus.	Galectin IV.	Tandem Repeat	GLTa.Rat.Rat.xx.Xxxx.
  			S-lectin or
  			Galectin.
  [564]	Rheum	—	—	LECp.Rhe.Rhas.xx.Xxxx.
  	rhapontium.
  [565]	Ribes rubrum.	—	—	LECp.Rib.Rubs.xx.Xxxx.
  [566]	Ricinus	RCA-I, RCA-II,	beta-trefoil lectin.	LECp.Ric.Com.se.Cga1
  	communis.	Ricin.		(Ricin D)
  				LECp.Ric.Com.se.Cga2
  				(Ricin E)
  				LECp.Ric.Com.se.Cga2
  				(RCA, RSL).
  [567]	Robinia	RPA-I, RCA-III.	—	LECp.Rob.Pse.se.Hcu1
  	pseudoacacia.			(RPsA-I)
  				LECp.Rob.Pse.se.Hcu2
  				(RPsA-II)
  				LECp.Rob.Pse.se.Hcu1
  				(RPbA-I)
  				LECp.Rob.Pse.se.Hcu2
  				(RPbA-II).
  [568]	Rubus fructicosus.	RFA.	?.	LECp.Rub.Fru.tc.Xga1.
  [569]	Rubus idaeus.	—	—	LECp.Rub.Ida.xx.Xxxx.
  [570]	Rutilus rutilus.	—	—	LECv.Rut.Rut.xx.Xxxx.
  [571]	Salmo gairdneri.	—	—	LECa.Sal.Gai.xx.Xxxx.
  [572]	Salmo salar v.	—	—	LECa.Sal.Sal.xx.Xma1.
  	Atlantica.
  [573]	Salmo salar v.	—	—	LECa.Sal.Sal.xx.Xxxx.
  	Chinook.
  [574]	Salmo trutta.	—	—	LECa.Sal.Tru.xx.Xxxx.
  [618]	Tetragonolobus	—	—	LECp.Tet.Pur.xx.Xxxx.
  	pupurea.
  [619]	Thermopsis.	—	—	LECz.The.sss.xx.Xxxx.
  [621]	Toxopneustes	—	C-lectin.	LECi.Xxx.Xxx.xx.Xxxx.
  	pileolu.
  [622]	Trichoderma.	—	—	LECf.Tri.Sss.xx.Xxxx.
  [623]	Tricholoma	—	—	LECf.Tri.Mon.xx.Xxxx.
  	mongolicum.
  [624]	Tricholomataceae	—	—	LECf.Tri.Sss.xx.Xxxx.
  	93-138.
  [625]	Tricholomataceae	—	—	LECz.Tri.Sss.xx.Xxxx.
  	93-34.
  [626]	Trichosanthes	TJA-II, TJA-I, TK-I,	—	LECp.Tri.Jap.xx.Xxxx.
  	japonica.	TK-II.
  [627]	Trifolium repens.	—	—	LECp.Tri.Rep.xx.Xxxx.
  [628]	Triticum	WGA.	Hevein domain	LECp.Tri.Aes.se.Hch1.
  	aestivium.		lectin, chitin
  			binding lectin.
  [629]	Tulipa gesneriana.	TGA.	—	LECp.Tul.Ges.xx.Xxxx.
  [630]	Udotea petiolata.	—	—	LECp.Udo.Pet.xx.Xxxx.
  [631]	Ulex europaeus.	UEA-I, UEA-II,	Legume lectin.	LECp.Ule.Eur.xx.Xxxx.
  		UEA-III.
  [632]	Ulva lactuca.	—	—	LECu.Ulv.Lac.xx.Xxxx.
  [633]	Ulva laetevirens.	—	—	LECu.Ulv.Lae.xx.Xxxx.
  [635]	Ulva rigida.	—	—	LECz.Ulv.Rig.xx.Xxxx.
  [637]	Urtica dioica.	UDA.	Chitin-binding	LECp.Urt.Dio.rh.Hch1.
  			lectins.
  [638]	Vaejovis	—	—	LECi.Vae.Con.xx.Xxxx.
  	confuscius.
  [639]	Vatairea	VML.	—	LECp.Vat.Mac.xx.Xxxx.
  	macrocarpa.
  [640]	Vibrio	—	—	LECb.Vib.Alg.xx.Xch1.
  	alginolyticus.
  [641]	Vibrio chlolera.	VPCV; Chitovibrin.	—	LECb.Vib.Cho.xx.Xxxx.
  [642]	Vicia cracca.	—	—	LECp.Vic.Cra.xx.Xxxx.
  [643]	Vicia ervilia.	—	—	LECp.Vic.Erv.xx.Xxxx.
  [644]	Vicia faba.	VFA, Favin.	Legume lectin.	LECp.Vic.Fab.xx.Xxxx.
  [645]	Vicia graminea.	VGA.	—	LECp.Vic.Gra.xx.Xxxx.
  [646]	Vicia hyrcanica.	—	—	LECp.Vic.Hyr.xx.Xxxx.
  [647]	Vicia sativa.	—	—	LECp.Vic.Sat.xx.Xxxx.
  [648]	Vicia unijuga.	VUA.	—	LECp.Vic.Unj.xx.Xxxx.
  [649]	Vicia villosa.	VVA-A4, VVL-A4.	Legume lectin.	LECp.Vic.Vil.xx.Xxxx.
  [650]	Vigna radiata.	MBL-I, MBL-II.	—	LECp.Vig.Rad.xx.Xxxx.
  [651]	Vigna unguiculata.	—	—	LECp.Vig.Ung.xx.Xxxx.
  [652]	Viscum album.	ML-I, ML-II, ML-III,	Beta-trefoil lectin	LECp.Vis.Alb.pl.Cga1
  		Viscumin,	(ML-I).	(ML-I, viscumin)
  		VisAlbCBA.		LECp.Vis.Alb.pl.Cga2
  				(ML-II, viscumin)
  				LECp.Vis.Alb.pl.Cga3
  				(ML-III, VAA-II)
  				LECp.Vis.Alb.pl.Hch1
  				(VisAlbCBA).
  [653]	Vitis vinifera.	—	—	LECp.Vit.Vin.xx.Xxxx.
  [654]	Volvariella	VVL.	—	LECf.Vol.Vol.xx.Xxxx.
  	volvacea.
  [655]	Wistaria	WFA.	—	LECp.Wis.Flo.xx.Xxxx.
  	floribunda.
  [656]	Wistaria	—	—	LECp.Wis.Flo.xx.Xxxx.
  	floribunda.
  [657]	Wistaria sinensis.	—	—	LECp.Wis.Sin.xx.Xxxx.
  [658]	Wistaris	—	—	LECz.Wis.Bra.xx.Xxxx.
  	brachbotrys.
  [659]	Xanthosoma	—	—	LECp.Xan.Sag.xx.Xxxx.
  	sagittifolium.
  [660]	Xenopus laevis	—	—	LECa.Xen.Lae.xx.Xga1.
  	ovum.
  [661]	Xeromus	—	—	LECz.Xer.Chr.xx.Xxxx.
  	chrysenteron.
  [662]	Xylaria	—	—	LECf.Xyl.Pol.xx.Xxxx.
  	polymorpha.
  [663]	Zea mays.	ZMA-I, ZMA-II,	—	LECp.Zea.May.xx.Xxxx.
  		ZMEA.
  [664]	Cannabis sativa.	CSA.	—	LECp.CanSat.se.Glu.
  [665]	Smilax glabra.	Sarparilla.	—	LECp.SmiGla.rh.xxx.
  [666]	Trichosanthes	Snake gourd.	—
  	anguina.

• Lectin codes take the following form:

  	LLLx.Ggg.Sss.ti.TspN

  
  An explanation of each index variable follows.
• LLL refers to the general category of agglutinin. At this point six general categories are recognized: lectins (LEC), integrins (INT), cadherins (CDH), annexins (ANN), selectins (SEL) and galectins (GLT). The x value refers to the taxonomic groups of the agglutinin, Table 1 summarizes these categories:

  	Category	Taxonomic group
  	LECa, GLTa	Lectin or galectin from
  		higher animal, typically
  		vertebrates.
  	LECh, GLTh	Lectin or galectin from
  		humans
  	LECi, GLTi	Lectin or galectin from
  		invertebrates
  	LECp.	Plant lectins
  	LECf.	Lectin from fungi
  	LECu.	Lectin from unicellular
  		organisms
  	LECb.	Lectin from Bacteria
  	LECv.	Viral lectins

• Ggg stands for the three first letters of the plant genus name (in Latin).
• Sss stands for the three first letters of the plant species name (in Latin).
• ti refers to the tissue from which the lectin has been isolated. Table 2 summarizes the indices used for the various tissues:

  	Tissue,	Taxonomic
  	cell or organ	grouping	Index
  	Bark	Plant	Ba
  	Bulb	Plant	Bu
  	Cell membrane	Bacteria, Unicellular	Cm
  	Epidermis	Human, vertebrates	Ep
  	Fruit	Plant	Fr
  	Hemolymph	Invertebrates	He
  	Latex	Plant	La
  	Leaf	Plant	Le
  	Nodule	Plant	No
  	Organ or cell type	Human, vertebrates,	Oc
  		Invertebrates
  	Phloem sap	Plant	Ps
  	Rhizome	Plant	Rh
  	Root	Plant	Ro
  	Seed	Plant	Se
  	Serum or plasma	Human, vertebrates,	Sr
  		Invertebrates
  	Spores or fruiting bodies	Fungi	Sp
  	Stem	Plant	St
  	Tentacles	Invertebrates	Te
  	Tuber	Plant	Tu
  	Whole body homogenate	Invertebrates	Wb
  	Venom	Invertebrates	Ve
  	Undefined	Human, vertebrates,	Un
  		Invertebrates, Bacteria,
  		Unicellular, Virus, Fungal

• T refers to the lectin subtype. Hololectins, merolectins, chimerolectins and superlectins are indicated by the letters H, M, C and S, respectively.
• sp refers to the specificity group. Each group is indicated by the index given in Table 3:

  	Specificity	Index of group
  	Mannose-binding lectins	ma
  	Mannose/maltose-binding	mm
  	lectins
  	Mannose/glucose-binding	mg
  	lectins
  	GlcNAc/(GlcNAc)-binding	ch
  	lectins
  	Gal/GalNAc-binding lectins	ga
  	Fucose-binding lectins	fu
  	Sialic acid-binding lectins	si
  	Lectins with a complex but	co
  	known specificity
  	Lectins with a complex and	cu
  	unknown specificity
  	Lectins with a dual	du
  	specificity
  	Lectins with an undetermined	nd
  	specificity

• Lipids
• A multifunctional molecule of the invention can also be a molecule that comprises a first part which comprises a lipid and a second part which comprises an amino acid sequence which can bind to a cell surface molecule, e.g. a cell surface molecule of an APC. The attachment of a lipid, e.g. a long-chain fatty acid, to a molecule, e.g. a polypeptide, can permit the complex to become stably associated with the plasma membrane when the complex is admixed with a cell (Nagarajan et al, 1995, J Immunol Methods 184:241-51; McHugh et al, 1995, PNAS 92:8059-63; van den Berg et al, 1995, J Cell Biol, 131:669-77). This is believed to occur through intercalation of the lipid into the membrane. A convenient method of producing a lipid-associated polypeptide comprises expressing, in a suitable host cell, a nucleic acid encoding, in part, a signal sequence directing the post-translational addition of a GPI moiety. Using recombinant DNA technology, a naturally non-GPI linked protein can be expressed as a GPI-linked protein by constructing a nucleic acid that encodes the protein linked to a heterologous GPI signal sequence. Nucleotide sequences encoding GPI signal sequences useful for this purpose include, for example, those comprised by decay accelerating factor (e.g., sequences encoding amino acid sequence “22” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32; sequences encoding signal sequences disclosed in Caras et al, U.S. Pat. No. 5,109,113); brevican (e.g., nt 1982-2047 of Genbank accession number X86406), mesothelin (e.g., nt 1858-1983 of Genbank U40434), coccidioides immitis antigen 2 (e.g., sequences encoding amino acids 172-194 of NCBI Entrez protein database accession #1256444, Zhu et al, 1996, Gene 181:121-5), acetylcholinesterase (e.g., sequences encoding the peptide “HC” as described in Duval et al, 1992, EMBO J. 11:3255-61; (e.g., sequences encoding amino acid sequence “19” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32)), human folate receptors alpha and beta (e.g., sequences encoding amino acids 230-257 of NCBI Entrez protein database accession #182416 or amino acids 228-255 of NCBI Entrez protein database accession #1655592, Yan and Ratnam, 1995, Biochemistry 34:14594-600), 5′ nucleotidase (e.g., sequences encoding amino acids 547-570 or 547-574 of NCBI Entrez protein database accession #404502, Furukawa et al, 1994, Biochim Biophys Acta 1190:273-8; (e.g., sequences encoding amino acid sequences “5” or “6” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32)), CD59 (e.g. encoded by nt 393-473 of Genbank U48255; sequences encoding amino acid sequence “20” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32; sequences encoding amino acids 74-101 of FIG. 2 of Powell et al, 1997, J Immunol 158:1692-1702), T-cadherin (e.g., sequences encoding the 76 C-terminal amino acids of chick T cadherin as described by Koller and Ranscht, 1996, J Biol Chem 271:30061-7), aminopeptidase P (e.g., sequences encoding amino acids 649-673 of NCBI Entrez protein database accession #1517942, Hyde et al, 1996, Biochem J 319:197-201), carboxypeptidase M, CD16B, Thy 1, carbonic anhydrase IV (e.g., sequences encoding amino acids 284-312 of NCBI Entrez protein database accession #179791, Okuyama et al, 1995, Arch Biochem Biophys 320:315-22), placental alkaline phosphatase (e.g., sequences encoding amino acids 498-529 of NCBI Entrez protein database accession #178464, Oda et al, 1994, Biochem J 301:577-83), neuronal glycoprotein F3, carcinoembryonic antigen (e.g., sequences encoding amino acid sequence “28” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), MRC-OX45 (e.g., sequences encoding amino acid sequence “2” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), RT 6.2 (e.g., sequences encoding amino acid sequence “3” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), D. discoideum prespore-specific antigen (e.g., sequences encoding amino acid sequence “4” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), microsomal dipeptidase (e.g., sequences encoding amino acid sequence “8” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), CAMPATH-1 (e.g., sequences encoding amino acid sequence “9” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei PARP (e.g., sequences encoding amino acid sequence “10” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG Mit 118a (e.g., sequences encoding amino acid sequence “11” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG Mit 117a (e.g., sequences encoding amino acid sequence “12” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG MITat 1.1000 BC (e.g., sequences encoding amino acid sequence “13” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG MITat 1.5b (e.g., sequences encoding amino acid sequence “14” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG ILTat 1.1 (e.g., sequences encoding amino acid sequence “15” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG TxTat 1 (e.g., sequences encoding amino acid sequence “16” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG Mit 221 (e.g., sequences encoding amino acid sequence “17” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), prion proteins (e.g., sequences encoding amino acid sequence “18” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), urokinase receptor (e.g., sequences encoding amino acid sequence “21” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. congolense VSG YNat 1.1 (e.g., sequences encoding amino acid sequence “23” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), S. cerevesiae GAS-1 (e.g., sequences encoding amino acid sequence “24” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), Thy-1 (e.g., sequences encoding amino acid sequences “25” or “26” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), L. major PSP (e.g., sequences encoding amino acid sequence “29” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), D. discoideum contact site A glycoprotein (e.g., sequences encoding the 25 C-terminal amino acids as described in Barth et al, 1996, Biochem J 317:533-40) CD24, and synthetic sequences (e.g. as described by Coyne et al, 1993, J Biol Chem 268:6689-93).
• GPI-linked polypeptides can be extracted from cells using the following method. 5×10⁶ cells are spun down and frozen at −80° C. The pellet is thawed in 14 ml of 0.15M NaCl/10 mM Tris 7.4/0.1 mM primaquine/2% Trito X-114 with stirring at 0° C. for 1 h, then centrifuged at 8800 g at 0° C. for 10 min. The supernatant is maintained at −20° C. overnight, thawed at room temperature, and then placed at 32° C. for 12 min. It is then centrifuged at 3000 g for 3 min at 32° C. The top layer is decanted and 11 ml of cold Buffer A (0.15M NaCl/10 mM Tris 7.4/0.1 mM primaquine/0.06% Triton X-114) is added to the bottom layer. This is incubated on ice for 10 min. The 12 min 32° C. incubation 32° C. 30002 centrifugation, decanting of top layer, and addition of 11 ml cold Buffer A to bottom layer are repeated. The solution is centrifuged at 18000 g for 10 min at 0° C. The 12 min 32° C. incubation, 32° C. 3000 g centrifugation, and decanting of top layer are repeated. 3 vol of cold acetone are added to the final bottom phase. The solution is centrifuged at 12, 000 RPM for 30 min, the supernatant removed, and the protein pellet containing the GPI fraction dried under vacuum. Specific proteins can be purified by methods well-known to those skilled in the art, e.g. immunoaffinity purification.
• Another method of producing a lipid-linked polypeptide is to chemically link the polypeptide to a fatty acid such as palmitate. 1.5 mg/ml of the polypeptide is suspended in PBS, pH 7.8, containing 0.3% deeoxycholic acid, 0.1% sodium bicarbonate, and 0.1% sodium azide. The optimal final pH of the solution is 7.6-8.0. The mixture is warmed to 37° C. and the N-hydroxysuccinimide ester of palmitic acid (Research Organics, Cleveland, Ohio) is added to a final concentration of 0.1 mg/ml. The solution is incubated overnight at room temperature. The polypeptide is purified by passage through a 16×250 mm Sephadex G-75 chromatography column equilibrated with 0.15% deoxycholic acid in PBS, pH 7.6.
• Crosslinking Moieties Useful According to the Invention
• Another convenient method of linking a ligand to an antigen bearing target is to use a crosslinking agent. A “crosslinking agent” is a chemical entity that can react with functional groups on at least two other molecules, e.g. two polypeptides or a polypeptide and a lipid, such that upon reaction with the crosslinking agent the two molecules become covalently linked. Thus, a ligand for CD40 can be crosslinked to a molecule on the surface of a cell.
• A wide variety of crosslinking agents, both bifunctional and polyfunctional, are known in the art and are commercially available, e.g. from Sigma (St. Louis, Mo.). These include, for example, S-acetylmercaptosuccinic anhydride, 5-acetylthioglycolic acid N-hydroxysuccinimide ester, S-acetylthiopropionic acid N-hydroxysuccinimide ester, adipic acid dihydrazide, 4-azidobenzoic acid N-hydroxysuccinimide ester, N-(5-azido-2-nitrobenzyloxy)succinimide, 6-(4-azido-2-nitrophenylamino)hexanoic acid N-hydroxysuccinimide ester, p-azidophenacyl bromide, N-(4-azidophenylthio)phthalimide, 4-azidosalicylic acid N-hydroxysuccinimide ester, bromoacetic acid N-hydroxysuccinimide ester, 1,4-butanediol diglycidyl ether, carbonyl-bis(L-methionine p-nitrophenyl ester), 2-diazo-3,3,3-trifluoropropionic acid p-nitrophenyl ester, diethyl malonimidate, 1,5-difluoro-2,4-dinitrobenzene, 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid, dimethyl adipimidate, dimethyl 3,3′-dithiobispropionimidate, dimethyl pimelimidate, dimethyl suberimidate, 4,4′-dithiobisphenyl azide, dithiobis(propionic acid N-hydroxysuccinimide ester), ethylene glycol bis-(succinic acid N-hydroxysuccinimide ester), 4-fluoro-3-nitrophenyl azide, bis-(4-fluoro-3-nitrophenyl) sulfone, p-formylbenzoic acid N-hydroxysuccinimide ester, glutaraldehyde, 2-iminothiolane, 6-(iodoacetamido)caproic acid N-hydroxysuccinimide ester, iodoacetic acid N-hydroxysuccinimide ester, 3-malemidoacetic acid N-hydroxysuccinimide ester, 3-malemidobenzoic acid N-hydroxysuccinimide ester, 4-(N-malemido)benzophenone, gamma-malemidobutyric acid N-hydroxysuccinimide ester, epsilon-malemidocaproic acid N-hydroxysuccinimide ester, 4-(N-malemidomethyl)cyclohexanecarboxylic acid N-hydroxysuccinimide ester, 4-(N-malemidomethyl)cyclohexanecarboxylic acid 3-sulfo-N-hydroxysuccinimide ester, beta-malemidopropionic acid N-hydroxysuccinimide ester, N,N′-bis(3-malemidopropionyl)-2-hydroxy-1,3-propanediamine, 1,4-phenylene diisothiocyanate, N,N′-o-phenylene dimalemide, N,N′-p-phenylene dimalemide, polyoxyethylene bis(glycidyl ether), bis(polyoxyethylene bis(glycidyl ether)), polyoxyethylene bis(imidazolylcarbonyl), bis(polyoxyethylene bis(imidazolylcarbonyl)), polyoxyethylene bis(p-nitrophenyl carbonate), 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester, suberic acid bis(N-hydroxysuccinimide) ester, succinic acid malemidoethyl N-hydroxysuccinimide ester, 1, 5 bis(succinimidooxycarbonyloxy)-pentane, and bis(N-succinimidyl) carbonate.
• Ligands of a Cell Surface Protein
• The multifunctional molecules of the present invention comprise one part which is a lectin and is capable of binding to at least one carbohydrate molecule on an antigen bearing target, and a second part comprising a ligand for a cell surface protein of an antigen presenting cell. The ligand can be any ligand which binds to one or more of the cell surface molecules indicated by GenBank Accession number in Appendix I or II. More preferably, however, the ligand includes, but is not limited to an opsonin, a cytokine, a heat shock protein, an adhesion molecule. a defensin, or a counterreceptor for a T cell costimulatory molecule; or a portion of any of these molecules, e.g., about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 40, 50, 60, 70, 80, 100, or 120 contiguous amino acid residues, up to the full length of such a molecule.
• Cytokines Useful According to the Invention
• The term “cytokine” as defined hereinabove refers to a polypeptide molecule that is naturally secreted by mammalian cells and that binds to a cell surface receptor on a leukocyte. The term “cytokine” also refers herein to a polypeptide molecule that is a ligand for a receptor for a naturally occurring cytokine. Unlike an opsonin, a cytokine does not naturally contemporaneously bind an antigen and a cell-surface receptor.
• Leukocytes which bear receptors for cytokines include, for example, monocytes, macrophages, dendritic cells, neutrophils, eosinophils, basophils, platelets, lymphocytes, T lymphocytes, B lymphocytes, NK cells, myeloma cells, lymphoma cells, and leukemic cells.
• Without being bound by any one mechanism, it is believed that cell-surface associated cytokines provide an advantage over freely diffusible cytokines by allowing stable juxtaposition of the cytokine to the cell, thus increasing the concentration of cytokine in the vicinity of the cell.
• Preferred cytokines are non-rodent cytokines, e.g primate, e.g. human cytokines.
• Some cytokines can be regarded as belonging to one or more families of cytokines based on structural and/or functional properties. One such family consists of the interleukins. Interleukins are structurally diverse, but share the property of both being expressed by and acting on leukocytes. Examples of interleukins include IL-1 (e.g. polypeptides encoded by Genbank Accession No. M15330, M28983, E04743, M15131) IL-2 (e.g. polypeptides encoded by Genbank Accession No. E01108, K02797), IL-3 (e.g. polypeptides encoded by Genbank Accession No. A02046, M14743), IL-4 (e.g. polypeptides encoded by M13982, M25892), IL-5 (e.g. polypeptides encoded by X06270, J03478), IL-6 (e.g. polypeptides encoded by E02772, M20572), IL-7 (e.g. polypeptides encoded by J04156, M29054-29057), IL-8 (e.g. polypeptides encoded by M28130), IL-9 (e.g. sequences disclosed in Kelleher et al, Blood. 1991; 77: 1436-1441, Immunogenetics 1990;31(4):265-270), IL-10 (e.g. polypeptides encoded by M84340, U16720), IL-11 (e.g. sequences disclosed in Paul et al, Proc Natl Acad Sci USA. 1990; 87: 7512-7516, Morris et al, Exp Hematol. 1996; 24: 1369-1376), IL-12 (e.g. polypeptides encoded by Genbank Accession No. M86671, S82412; Genbank protein P29459, P29460), IL-13 (e.g. polypeptides encoded by U31120, L13028), 1L-14 (e.g. sequences disclosed in Ambrus et al, Proceedings of the National Academy of Science (USA) 1993; 90: 6330-4), IL-15 (e.g. polypeptides encoded by AF031167, U22339), 1L-16 (e.g. polypeptides encoded by AF006001, M90391), IL-17 (e.g. polypeptides encoded by U32659, U43088), IL-18 (e.g. polypeptides encoded by D49949, D49950), IL-19 (e.g. polypeptides encoded by AY040367), IL-20 (e.g. polypeptides encoded by NM02130, NM018724), IL-21 (e.g. polypeptides encoded by AF254069, AF254070), IL-22 (e.g. polypeptides encoded by AF279437), IL-23 (e.g. polypeptides encoded by AF301619, AF301620, AY055379 [p19 alpha chain combines with IL-12 p40 chain to form IL-23]), IL-24 (e.g. polypeptides encoded by AF276916, NM053095), IL-25 (e.g. polypeptides encoded by NM080837), TNF-alpha (e.g. polypeptides encoded by M16441, Y00467), and GM-CSF (e.g. polypeptides encoded by X03019, M11220) and their homologues among species. Nucleotide sequences encoding homologues will hybridize to each other under moderate- to high-stringency conditions.
• Another family consists of the hematopoietins. Members of this family comprise helical regions, known as helices A, B, C, and D. Helices A and B and helices C and D run roughly parallel to each other, respectively. Examples of hematopoietins include IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, GM-CSF, G-CSF (e.g. polypeptides encoded by Genbank Accession No. E01219, M13926), oncostatin M (e.g. polypeptides encoded by Genbank Accession No. D31942, sequences disclosed in Malik et al, Mol Cell Biol 1989, 9:2847-2853), LIF (e.g. polypeptides encoded by Genbank Accession No. X13967, X06381), CNTF (e.g. polypeptides encoded by Genbank Accession No. U05342, X60542), and their homologues among species. Nucleotide sequences encoding homologues will hybridize to each other under moderate- to high-stringency conditions.
• Human IL2 is a protein of 133 amino acids (15.4 kDa) with a slightly basic pI. Murine and human IL2 display a homology of approximately 65%. IL2 is synthesized as a precursor protein of 153 amino acids with the first 20 amino-terminal amino acids functioning as a hydrophobic secretory signal sequence. The protein contains a single disulfide bond (positions Cys58/105) essential for biological activity.
• IL2 is O-glycosylated at threonine at position 3. Variants with different molecular masses and charges are due to variable glycosylation. Non-glycosylated IL2 is also biologically active. Glycosylation appears to promote elimination of the factor by hepatocytes.
• A dimeric form of human IL2, produced by the action of a transglutaminase isolated from regenerating fish optic nerves, has been shown to be a cytotoxic factor for rat brain oligodendrocytes in culture.
• The human IL2 gene contains four exons. The IL2 gene maps to human chromosome 4q26-28 (murine chromosome 3). The homology of murine and human IL2 is 72% at the nucleotide level in the coding region.
• The biological activities of IL2 are mediated by a membrane receptor that is expressed almost exclusively on activated, but not on resting, T-cells at densities of 4-12×13 receptors/cell. Activated B-cells and resting mononuclear leukocytes rarely express this receptor. The expression of the IL2 receptor is modulated by IL5 and IL6. Three different types of IL2 receptors are distinguished that are expressed differentially and independently. The high affinity IL2 receptor (Kdis ˜10 pM) constitutes approximately 10% of all IL2 receptors expressed by a cells. This receptor is a membrane receptor complex consisting of the two subunits IL2R-alpha (TAC antigen=T-cell activation antigen; p55) and IL2R-beta (p75; CD122) as the ligand binding domains and a gamma chain as a signaling component. p75 is expressed constitutively on resting T-lymphocytes, NK-cells, and a number of other cell types while the expression of p55 is usually observed only after cell activation. p55 is, however, synthesized constitutively by a number of tumor cells and by HTLV-1-infected cells.
• IL2 receptor expression of monocytes is induced by IFN-gamma, so that these cells become tumor-cytotoxic. In T-cells the expression of p75 can be reduced by IL3. An intermediate affinity IL2 receptor (Kdis=100 pM) consists of the p75 subunit and a gamma chain (see below) while a low affinity receptor (Kdis=10 nM) is formed by p55 alone.
• p55 (e.g. polypeptides encoded by Genbank Accession No. X01057) has a length of 251 amino acids with an extracellular domain of 219 amino acids an a very short cytoplasmic domain of 13 amino acids. The p55 gene maps to human chromosome 10p14-p15.
• p75 (e.g. polypeptides encoded by Genbank Accession No. M26062, M28052) has a length of 525 amino acids with an extracellular domain of 214 amino acids and a cytoplasmic domain of 286 amino acids. The p75 gene contains 10 exons and has a length of approximately 24 kb. It maps to human chromosome 22q11.2-q12 and to murine chromosome 15 (band E).
• A third 64 kDa subunit of the IL2 receptor, designated gamma, has been described (e.g. polypeptides encoded by Genbank Accession No. D13821, D11086). Murine and human gamma subunits of the receptor have approximately 70% sequence identity at the nucleotide and amino acid levels. This subunit is required for the generation of high and intermediate affinity IL2 receptors but does not bind IL2 by itself. These two receptor types consist of an alpha-beta-gamma heterotrimer and a beta-gamma heterodimer, respectively. The gene encoding the gamma subunit of the IL2 receptor maps to human chromosome Xq13, spans approximately 4.2 kb and contains eight exons. The gamma subunit of the IL2 receptor has been shown recently to be a component of the receptors for IL4 and IL7. It is also believed to be a component of the IL13 receptor.
• The amino acids at positions 267-317 lying directly adjacent to the transmembrane region of p75 are involved in IL2-mediated signal transduction. In addition the IL2 receptor is associated with a number of other proteins (p22, p40, p100) which are thought to be involved in mediating conformational changes in the receptor chains, receptor-mediated endocytosis, and further signal transduction processes. One of the identified proteins is the 95 kDa cell adhesion molecule ICAM-1 which probably focuses IL2 receptors at regions of cell-to-cell contacts and thus may mediate paracrine activities, for example, during IL2-mediated stimulation of T-cells. Another protein associated with p75 is a tyrosine-specific protein kinase called lck. The observation that proliferation of cells induced by IL2 is inhibited by specific inhibitors of protein tyrosine kinases in an lck negative cell line suggests that other kinases may also be associated with IL2 receptors. Two such kinases, called fyn and lyn, have been identified. In addition, IL2 receptor signaling may also be mediated by vav.
• Activated lymphocytes continuously secrete a 42 kDa fragment of the TAC antigen. This fragment circulates in the serum and plasma and functions as a soluble IL2 receptor (sIL2R). The concentrations of this soluble receptor vary markedly in different pathological situations, for example, infections, autoimmune diseases, leukemias, or after organ transplantation. Levels may increase up to 100-fold. The levels of sIL2R appear to correlate with the severity of HIV-induces diseases and may be of diagnostic value also in other settings.
• Mouse and human IL2 both cause proliferation of T-cells of the homologous species at high efficiency. Human IL2 also stimulates proliferation of mouse T-cells at similar concentrations, whereas mouse IL2 stimulates human T-cells at a lower (sixfold to 170-fold) efficiency.
• IL2 is a growth factor for all subpopulations of T-lymphocytes. It is an antigen-unspecific proliferation factor for T-cells that induces cell cycle progression in resting cells and thus allows clonal expansion of activated T-lymphocytes. This effect is modulated by hormones such as prolactin.
• IL2 also promotes the proliferation of activated B-cells also this requires the presence of additional factors, for example, IL4.
• Due to its effects on T-cells and B-cells IL2 is a central regulator of immune responses. It also plays a role in anti-inflammatory reactions, in hematopoiesis and in tumor surveillance. IL2 stimulates the synthesis of IFN-gamma in peripheral leukocytes and also induces the secretion of IL1, TNF-alpha and TNF-beta.
• It is believed that he induction of the secretion of tumoricidal cytokines apart from the activity in the expansion of LAK cells (lymphokine-activated killer cells) are probably the main factors responsible for the antitumor activity of IL2.
• IL2 can be assayed in bioassays employing cell lines that respond to the factor (e.g., ATH8, CT6, CTLL-2, FDCPmix, HT-2, NKC3, TALL-103). Specific ELISA assays for IL2 and enzyme immunoassays for the soluble receptor are also available. The soluble receptor can be detected also by employing biotinylated IL2 and flow-through cytometry or ELISA assays.
• IL2 displays significant anti-tumor activity for a variety of tumor cell types since it supports the proliferation and clonal expansion of T-cells that specifically attack certain tumors. IL2 is increasingly used to treat patients with cancers refractory to conventional treatment. Combination therapy with systemically administered IL2 has resulted in long-term remissions in 30% of patients with metastatic renal cell carcinoma, for which there is no standard treatment. Objective and long-lived clinical responses have been documented also in a proportion of patients with melanoma or acute myeloid leukemia.
• High dose systemic IL2 therapy is also associated with a great number of unwanted toxic side-effects. IL2 has additional effects on other components of the cellular immune system, including B-cells and macrophages, and induces the secretion of other soluble mediators, including TNF-alpha, TNF-beta, and IFN-gamma. These effects may contribute to the antitumor activity of IL2 as well as to its dose-related toxicity.
• The transduction of murine tumor cells with a functional IL2 gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Altered tumor cells expressing IL2 also increase systemic immunity.
• Human IL4 is a protein of 129 amino acids (20 kDa) that is synthesized as a precursor containing a hydrophobic secretory signal sequence of 24 amino acids. IL4 is glycosylated at two arginine residues (positions 38 and 105) and contains six cysteine residues involved in disulfide bond formation. The disulfide bonds are essential for biological activity. Some glycosylation variants of IL4 have been described that differ in their biological activities. A comparison of murine and human IL4 shows that both proteins only diverge at positions 91-128.
• An IL4 variant, Y124D, in which Tyr124 of the recombinant human protein is substituted by an aspartic acid residue, binds with high affinity to the IL4 receptor (Kd=310 pM). This variant is a powerful antagonist for the IL4 receptor system. It retains no detectable proliferative activity for T-cells and competitively inhibits IL4-dependent T-cell proliferation (K(i)=620 pM). The existence of this mutant demonstrates that high affinity binding and signal generation can be uncoupled efficiently in a ligand. Y124D also acts as a powerful antagonist for the IL13 receptor.
• The human IL4 gene contains four exons and has a length of approximately 10 kb. It maps to chromosome 5q23-31. The murine gene maps to chromosome 11. The IL4 gene is in close proximity to other genes encoding hematopoietic growth factors (e.g., GM-CSF, M-CSF, IL3, IL5). The distance between the IL4 and the IL5 gene is approximately 90-240 kb.
• At the nucleotide level the human and the murine IL4 gene display approximately 70% homology. The 5′ region of the IL4 contains several sequence elements, designated CLE (conserved lymphokine element), that are binding sites for transcription factors controlling the expression of this and other genes. A sequence motif, called P sequence (CGAAAATTTCC; SEQ ID NO: 1) in the 5′ region of the human IL4 gene (positions −79-−69) is the binding site for a nuclear factor, called NF(P), mediating the response to T-cell activation signals.
• The biological activities of IL4 are mediated by a specific receptor (Kdis=20-100 pM) which is expressed at densities of 100-5000 copies/cell (e.g. polypeptides encoded by Genbank Accession No. M29854, X52425). The extracellular domain of the IL4 receptor is related to the receptors for erythropoietin (Epo), IL6, and the beta chain of the IL2 receptor. It has been given the name CD124.
• The cDNA for the murine IL4 receptor encodes a transmembrane protein of 810 amino acids (including a secretory signal sequence). This receptor has a large intracellular domain of 553 amino acids. The human receptor has an extracellular domain of 207 amino acids, a transmembrane domain of 24 residues, and a large intracellular domain of 569 amino acids.
• The IL4 receptor has been shown recently to contain the gamma subunit of the IL2 receptor as a signaling component. This gamma subunit is also associated with the receptors for IL4 and IL7 and probably also of IL13. Two forms of the receptor have been described, one of which is secreted. The secreted receptor only contains the extracellular IL4 binding domain and is capable of blocking IL4 activities. An IL4 binding protein (IL4-BP) that binds IL4 with the same affinity as the IL4 receptor has been shown also to be a soluble IL4 receptor variant. These soluble receptors probably function as physiological regulators of cytokine activities by inhibiting receptor binding or act as transport proteins. Soluble receptors or binding proteins have been described also for IL1 (IL1 receptor antagonist), IL2, IL6, IL7, TNF-alpha, IGF, and IFN-gamma.
• The biological activities of IL4 are species-specific; mouse IL4 is inactive on human cells and human IL4 is inactive on murine cells. IL4 promotes the proliferation and differentiation of activated B-cells, the expression of class II MHC antigens, and of low-affinity IgE receptors in resting B-cells. IL4 enhances expression of class II MHC antigens on B-cells. It can promote their capacity to respond to other B-cell stimuli and to present antigens for T-cells. This may be one way to promote the clonal expansion of specific B-cells and the immune system may thus be able to respond to very low concentrations of antigens. The production of IL4 by non-B non-T-cells is stimulated if these cells interact with other cells via their Fc receptors for IgE or IgG. This effect can be enhanced by IL3. IL2 and PAF (platelet activating factor) induce the synthesis of IL4 while TGF-beta inhibits it.
• IL3 antagonizes the IL2-induced effects in B-cells and causes a slow decrease of the expression of IL2 receptors, thus inhibiting the proliferation of human B-cells stimulated by IL2. In activated B-cells IL4 stimulates the synthesis of IgG1 and IgE and inhibits the synthesis of IgM, IgG3, IgG2a and IgG2b. This isotype switching induced by IL4 in B-cells is antagonized by IFN-gamma. The growth of multiple myelomas can be suppressed by IL4 which inhibits the synthesis of IL6, a myeloma growth factor. IL4 also inhibits the synthesis of IL6 in human alveolar macrophages.
• Pretreatment of macrophages with IL4 prevents the production of IL1, TNF-alpha and prostaglandins in response to activation of the cells by bacterial endotoxins or IFN-gamma.
• IL4 synergises with Epo and G-CSF/Epo in the generation of colonies containing granulocytes or erythroid progenitor cells in a colony formation assay.
• The classical detection method for IL4 is a B-cell costimulation assay measuring the enhanced proliferation of stimulated purified B-cells. IL4 can be detected also in bioassays, employing IL4-responsive cells (e.g., BALM-4; BCL1; CT.4S; CTL44; CTLL-2; Da; FDCPmix; HT-2; L4; L138.8A; M07E; MC/9; NFS-60; Ramos, Sez627, TF-1; TS1). A specific detection method for human IL4 is the induction of CD23 in a number of B-cell lines with CD23 detected either by flow-through cytometry or by a fluorescence immunoassay. An immunoassay that allows rapid determination of the rate of IN production under conditions preventing consumption/degradation is cytokine immunotrapping.
• IL4 inhibits the growth of colon and mammary carcinomas. It has been shown to augment the development of LAK cells. The transduction of murine tumor cells with a functional IL4 gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Altered tumor cells expressing IL4 also increase systemic immunity. Mice vaccinated with transduced cells reject a subsequent challenge of non-transduced cells, and, in some cases, a pre-existing tumor.
• Human IL6 is a protein of 185 amino acids glycosylated at positions 73 and 172. It is synthesized as a precursor protein of 212 amino acids. Monocytes express at least five different molecular forms of IL6 with molecular masses of 21.5-28 kDa. They mainly differ by post-translational alterations such as glycosylation and phosphorylation.
• IL6 isolated from various cell types shows some microheterogeneity in its N terminus. A 42-45 kDa form has been observed in plasma that is probably complexed with a carrier protein, alpha-2-macroglobulin (α2M). Murine and human IL6 show 65% sequence homology at the DNA level and 42% homology at the protein level.
• IL6 is a member of a family of cytokines which also includes LIF, CNTF, Oncostatin M, IL11, and CT-1. All known members of the IL6 cytokine family induce hepatic expression of acute phase proteins.
• A stable and highly bioactive designer cytokine consisting of a fusion protein between IL6 and a soluble IL6 receptor, designated H-IL6, has been used for human hematopoietic progenitor cell expansion and is useful in cases in which cells do not respond to IL6 but require a stable complex consisting of IL6 and a soluble IL6 receptor.
• The human IL6 gene has a length of approximately 5 kb and contains five exons. It maps to human chromosome 7p21-p14 between the markers D7S135 and D7S370. The murine gene maps to chromosome 5. The nucleotide sequences of IL6 and G-CSF genes resemble each other in a way suggesting a possible evolutionary relationship.
• The IL6 receptor (e.g. polypeptides encoded by Genbank Accession No. M20566, E03515) is expressed on T-cells, mitogen-activated B-cells, peripheral monocytes and some macrophage- and B-cell-derived tumor cell types. It is not expressed in resting B-cells but is in resting T-cells. In hepatocytes the IL6 receptor expression is enhanced after treatment with IL6 or IL1. In several cell types the expression of the IL6 receptor is also enhanced by glucocorticoids. The IL6 receptor gene maps to human chromosome 1q21.
• The IL6 receptor is a strongly glycosylated protein of 80 kDa and a length of 449 amino acids. It has been designated CD126. It is synthesized as a precursor of 468 amino acids. The molecular structure resembles that of receptors for M-CSF, PDGF and IL1 in that the receptor contains an immunoglobulin-like sequence domain in the aminoterminal region of the extracellular receptor domain.
• The intracellular domain of the IL6 receptor has a length of approximately 82 amino acids and does not show any homology to other proteins involved in intracellular signal transduction. Two different forms of the receptor have been described that bind IL6 with different affinities (Kdis=10⁻⁹ and 10⁻¹¹ M) and most likely arise by post-translational modification of the same receptor protein. Biological activities of IL6 have been found also at concentrations of 10⁻¹³-10⁻¹⁵ M suggesting either the existence of other high-affinity receptor conformations or the existence of further receptor molecules with higher affinities.
• IL6 receptor-mediated signal transduction involves protein kinase C and also adenylate cyclase.
• The complex formed between IL6 and its receptor associates with a transmembrane glycoprotein, gp130 (918 amino acids; cytoplasmic domain of 277 amino acids), that is involved in signal transduction. Binding of IL6 to its receptor leads to disulfide-linked homodimerization of gp130 and the associated activation of a tyrosine kinase as the first step of signal transduction. gp130 is expressed also in cells that do not express IL6 receptors. It has been found to be a component of other receptors, including those for IL11, LIF, Oncostatin M, and CNTF, and CT-1. This explains why LIF, CNTF, and IL6 share many biological activities although the factors themselves are not related to each other. A factor resembling STAT proteins, termed LIL factor, has been found to be involved in signaling pathways of IL6, and also of IL1 and bacterial lipopolysaccharides.
• A soluble form of the IL6 receptor (IL6R-SUP (IL6 receptor soluble urinary protein)) has been described also that also interacts with gp130. These soluble receptors probably function as physiological regulators of cytokine activities by inhibiting receptor binding or act as transport proteins. Similar soluble receptors or binding proteins have been described also for IL1 (IL1ra, IL1 receptor antagonist), IL2, IL4, IL7, TNF-alpha, IGF, and IFN-gamma.
• Some cells, including hematopoietic progenitor cells and neuronal cells, are only responsive towards a combination of IL6 and soluble IL6 receptor but not to IL6 alone.
• Human IL6 is biologically active in monkeys, rats, and mice. Murine IL6 is not active in human cells. The plethora of biological activities is exemplified by the many different acronyms under which IL6 has been described. IL6 is a pleiotropic cytokine influencing antigen-specific immune responses and inflammatory reactions. It is one of the major physiological mediators of cute phase reaction. In hepatocytes IL6 in combination with glucocorticoids induces the synthesis of metallothioneins and increases intracellular zinc levels, thus preventing CCL4-induced hepatotoxicity. IL6 is a neurotrophic factor for cholinergic neurons that promotes their survival in culture. Some neuronal cell lines can be induced to differentiate by IL6.
• IL6, like IL1, stimulates the synthesis of ACTH (Corticotropin) in the pituitary. Glucocorticoids synthesized in response to ACTH inhibit the production of IL6, IL1 and TNF in vivo, thus establishing a sort of negative feedback loop between the immune system and neuroendocrine functions. In astrocytes IL6 induces the synthesis of Nerve Growth Factor (NGF).
• IL6 is a B-cell differentiation factor in vivo and in vitro and an activation factor for T-cells. In the presence of IL2 IL6 induces the differentiation of mature and immature T-cells into cytotoxic T-cells. IL6 also induces the proliferation of thymocytes and probably plays a role in the development of thymic T-cells.
• IL6 is capable of inducing the final maturation of B-cells into immunoglobulin-secreting plasma cells if the cells have been pre-activated by IL4. In B-cells IL6 stimulates the secretion of antibodies to such a degree that serum IgG1 levels can rise 120-400-fold.
• IL6 at concentrations of only 0.002 ng/mL is one of the major autocrine growth modulator for many human myelomas. The growth of these cells can be inhibited by monoclonal antibodies directed against IL6. It can be inhibited also by the introduction of antisense oligonucleotides against IL6 or by IL4. The growth-inhibitory effects of corticosteroids on myeloma cells is probably due to the steroid-induced reduction in the expression of IL6. The growth of human IL6 dependent myeloma cells can be inhibited also by IFN-gamma. IL6 may also function as an autocrine growth modulator for other tumor types, some of which have been found to secrete IL6 constitutively. IL6 has been shown to be an autocrine modulator of growth for in vitro cervical tumor cell growth. On the other hand IL6 blocks the growth of some solid tumors such as mammary carcinomas, cervical carcinomas, human lung cancer cell lines, histiocytic lymphomas, and melanomas.
• IL6 and IL3 synergise in vitro in promoting the proliferation of multipotent hematopoietic progenitor cells. IL6 is also a thrombopoietin that induces the maturation of megakaryocytes in vitro and increases platelet counts in vivo. In murine, but not in human bone marrow cultures IL6 shows activities resembling those of GM-CSF.
• Plasmacytoma cells produce IL6 and also the IL6 receptor. It has been suggested that these cells are stimulated in an autocrine fashion. A paracrine mechanism involving the presence of two different cell populations, one producing the factor and the other expressing the receptor, has been described also.
• IL6 can be detected in bioassays employing IL6 responsive cell lines (e.g., 7TD1; B19; CESS, KPMM2, KT-3; M1, MH60-BSF-2, M07E; Mono Mac 6; NFS-60; PIL-6; SKW6-C14; T1165; XG-1). IL6 can be assayed also by its activity as a hybridoma growth factor. Sensitive immunoassays and colorimetric tests are also available. An ELISA assay exists for detecting the receptor-associated gp130 protein.
• In combination with other cytokines (for example, IL2) IL6 may be useful in the treatment of some tumor types. The transduction of murine tumor cells with a functional IL6 gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Altered tumor cells expressing IL6 also increase systemic immunity. Mice vaccinated with transduced cells reject a subsequent challenge of non-transduced cells, and, in some cases, a pre-existing tumor.
• Human IL10 is a homodimeric protein with subunits having a length of 160 amino acids. Human IL10 shows 73% amino acid homology with murine IL10. The human IL10 contains four exons. It is closely related to the product of the BCRF-1 gene (Bam HI C fragment rightward reading frame) of Epstein-Barr virus (84% homology at the protein level). These two proteins are more closely related to each other than human and murine IL10. BCRF-1 has therefore also been called viral IL10 (vIL10). The human IL10 gene maps to chromosome 1. The human IL10 shows 81% homology with murine IL10 at the nucleotide level.
• A receptor has been identified on murine and human cells by using radiolabeled IL10 (e.g. polypeptides encoded by Genbank Accession No. L12120, U00672). Mouse IL10 is capable of blocking binding of human IL10 to mouse but not human cells. The murine IL10 receptor has been cloned. This receptor is a protein of approximately 110 kDa that binds murine IL10 specifically. This receptor is structurally related to receptors for IFN.
• IL10 inhibits the synthesis of a number of cytokines such as IFN-gamma, IL2 and TNF-beta in Th1 subpopulations of T-cells but not of Th2 cells. This activity is antagonized by IL4. The inhibitory effect on IFN-gamma production is indirect and appears to be the result of a suppression of IL12 synthesis by accessory cells. In the human system, IL10 is produced by, and down-regulates the function of, Th1 and Th2 cells. In macrophages stimulated by bacterial lipopolysaccharides IL10 inhibits the synthesis of IL1, IL6 and TNF-alpha by promoting, among other things, the degradation of cytokine mRNA. It also leads to an inhibition of antigen presentation. In human monocytes IFN-gamma and IL1 antagonize each other's production and function. IL10 has been shown also to be a physiologic antagonist of IL12.
• IL10 also inhibits mitogen- or anti-CD3-induced proliferation of T-cells in the presence of accessory cells and reduces the production of IFN-gamma and IL2. Exogenous 1L2 and IL4 inhibit the proliferation-inhibitory effect but do not influence the production of IFN-gamma. In LPS-stimulated macrophages IFN-gamma increases the synthesis of IL6 by inhibiting the production of IL10. IL10 appears to be responsible for most or all of the ability of Th2 supernatants to inhibit cytokine synthesis by Th1 cells.
• IL10 inhibits secretion of Ig by T-cell-independent antigens induced by IL5 but not that induced by IL2.
• Murine Ly-1 B cells are the principal source of IL10. In contrast to other B-cells, Ly-1 B-cells express greatly elevated constitutive and inducible levels of IL10. These cells also have the distinctive property of continuous self-replenishment. The continuous treatment of newborn mice with anti-IL10 antibodies leads to a depletion of the Ly-1 B-cells while maintaining a normal population of splenic B-cells. These mice also contain greatly reduced serum immunoglobulin M levels and are also impaired in their antibody responses to specific antigens. IL10 is therefore a regulator of Ly-1 B-cell development. The mechanism of Ly-1 B-cell depletion appears to involve the increased production of IFN-gamma since co-administration of neutralizing anti-IFN-gamma antibodies substantially restores the number of peritoneal-resident Ly-1 B-cells in these mice.
• IL10 is also a costimulator for the growth of mature and immature thymocytes (together with IL2, IL4 and IL7) and functions as a cytotoxic T-cell differentiation factor, promoting a higher number of IL2-activated cytotoxic T-lymphocyte precursors to proliferate and differentiate into cytotoxic effector cells. IL10 sustains viability of B-cells in vitro and also stimulates B-cells and promotes their differentiation. It enhances the expression of MHC class II antigens on B-cells whereas it inhibits MHC class II expression on monocytes. In B-cells activated via their antigen receptors or via CD40 IL10 induces the secretion of IgG, IgA and IgM. This effect is synergised by IL4 while the synthesis of immunoglobulins induced by IL10 is antagonized by TGF-beta. The activation of macrophages can be prevented by IL10.
• It has been shown that human IL10 is a potent and specific chemoattractant for human T-lymphocytes. The chemotactic activity is directed towards cells expressing CD8 and not towards CD4 (+)cells. IL10 also inhibits the chemotactic response of CD4 (+)cells, but not of CD8 (+)cells, towards IL8. IL10 can be detected with a sensitive ELISA assay. The murine mast cell line D36 can be used to bioassay human IL10. The intracellular factor can be detected also by flow cytometry.
• The introduction of an IL10 expression vector into CHO cells has been used to analyze the consequences of local IL10 production in vivo. These altered cells were no longer tumorigenic in nude mice or severe combined immunodeficient SCID mice and also suppressed the growth of equal numbers of co-injected normal CHO cells. While normal CHO tumors are usually substantially infiltrated by macrophages, these were virtually absent within CHO-IL10 tumor tissues, suggesting that IL10 indirectly suppresses tumor growth of certain tumors by inhibiting infiltration of macrophages which may provide tumor growth promoting activity.
• Human IL12 is a heterodimeric 70 kDa glycoprotein consisting of a 40 kDa subunit (p40, 306 amino acids; 10% carbohydrate) and a 35 kDa subunit (p35, 197 amino acids; 20% carbohydrate) linked by disulfide bonds that are essential for the biological activity of IL12. p40 contains 10 cysteines and a binding site for heparin; p35 contains 7 cysteines.
• The two subunits of IL12 are not related to any other known proteins. p40 shows some homology with the extracellular domain of the receptor for IL6, and p35 appears to be a homologue of IL6.
• Bioactive murine and human IL12 fusion proteins combining the two IL12 subunits in a single molecule have been described. This designer cytokine retains antitumor activity in vivo. Flexi 12, a single chain protein retaining all of the biological characteristics of the dimeric recombinant IL12, has also been described.
• The gene encoding the p40 subunit of IL12 (IL12B) maps to human chromosome 5q31-q33 in the same region that also harbors other cytokine genes. The gene encoding the p35 subunit of IL12 (IL12A) maps to human chromosome 3p 12-q 13.2. The expression of the two genes is regulated independently of each other.
• The IL12 receptor appears to be a single protein of approximately 110 kDa (e.g. polypeptides encoded by Genbank Accession No. U03187, U23922, U64198, U64199). Up to 1000-9000 high affinity IL12 receptors/cell are expressed on peripheral blood mononuclear cells activated by various T-cell mitogens or by IL2. IL12 receptors are present on activated T-cells expressing CD4 and CD8 and on activated CD56 positive natural killer cells. Resting peripheral blood mononuclear cells, tonsillar B-cells, or tonsillar B-cells activated by anti-IgM/Dx, anti-IgM/Dx+IL2, or SAC+IL2 do not express the receptor. High affinity IL12 receptors are expressed constitutively on a transformed marmoset NK-like cell line, HVS.SILVA 40.
• Binding of IL12 to its receptor can be prevented by monoclonal antibodies directed against the p40 subunit which therefore contains the binding site. The p40 subunit of IL12 shows homology with the extracellular domain of the IL6 receptor. A virus-encoded homologue of the p40 subunit is EBV-induced gene-3.
• Human IL12 is not active in murine lymphocytes. Hybrid heterodimers consisting of murine p35 and human p40 subunits retain bioactivity on murine cells; however, the combination of human p35 and murine p40 is completely inactive on murine cells. Murine IL12 is active on both murine and human lymphocytes. The p40 subunit of murine IL12 subunit p40 (IL12p40) has been shown to specifically antagonize the effects of the IL12 heterodimer in different assay systems and to function as an endogenous specific inhibitor for the IL12 heterodimer.
• IL12 stimulates the proliferation of human lymphoblasts activated by phytohemagglutinin. IL12 activates NK-cells positive for CD56, and this activity is blocked by antibodies specific for TNF-alpha. IL12 promotes specific allogenic CTL reactions. IL12 synergizes also with anti-CD3 antibodies and with allogeneic stimulation in mixed lymphocyte cultures in inducing T-cell proliferation.
• In peripheral lymphocytes of the Th1 type IL12 induces the synthesis of IFN-gamma and IL2, and TNF. TNF-alpha also appears to be involved in mediating the effects of IL12 on natural killer cells since the effects of IL12 are inhibited by an antibody directed against TNF-alpha. IL12 and TNF-alpha are costimulators for IFN-gamma production with IL12 maximizing the IFN-gamma response; the production of IL12, TNF, and IFN-gamma is inhibited by IL10. In Th2 helper cells IL12 reduces the synthesis of IL4, IL5, and IL10.
• IL12 synergises with suboptimal amounts of IL2 in promoting the proliferation of mononuclear cells in the peripheral blood and in promoting the generation of LAK cells (lymphokine activated killer cells). Picomolar concentrations of IL12 are as effective as nanomolar concentrations of IL2 in augmenting the cytolytic activity of natural killer cells expanded in vivo by IL2. IL12 also acts as a co-mitogen and potentiates the proliferation of resting peripheral cells induced by IL2.
• IL12 enhances myelopoiesis of primitive bone marrow progenitor cells induced by SCF (stem cell factor) and synergizes with colony stimulating factors to induce proliferation. IL12 also has synergistic effects on more committed bone marrow progenitors, synergising with IL3, IL11, or IL3 plus SCF.
• IL12 is potential clinical interest since it allows the reduction of doses of IL2 required for the generation of LAK cells (lymphokine-activated killer cells). IL12 has been shown to inhibit the growth of a variety of experimental tumors in vivo and to have antiangiogenic effects in vivo, which are, at least in part, mediated by IFN-gamma. IL12 therefore seems to be a potential candidate also for the treatment of angiogenesis-dependent malignancies.
• IL19 and IL10 share 21 percent amino acid identity and are probably homologs. In monocytes treatment with bacterial lipopolysaccharides induces the synthesis of IL19 and this effect is potentiated in the presence of IL4 or IL13 but is unaffected by IFN-gamma. GM-CSF directly induces IL19 gene expression in monocytes. IL19 has been shown to bind to the IL20 receptor complex (Dumoutier L et al Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 167(7): 3545-9 (2001); Gallagher G et al Cloning, expression and initial characterization of interleukin-19 (IL-i 9), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1(7): 442-50 (2000)).
• IL20 is structurally related to IL10. IL20 appears to be an autocrine factor for keratinocytes that regulates their participation in inflammation. Overexpression of IL20 in transgenic mice causes neonatal lethality with skin abnormalities characterized by an impairment of epidermal differentiation (Blumberg H et al Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104(1): 9-19 (2001); Dumoutier L et al Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 167(7): 3545-9 (2001); Rich BE and Kupper TS Cytokines: IL-20-a new effector in skin inflammation. Current Biology 11(13): R531-4 (2001)).
• An IL20 receptor has been identified to consist of two orphan class 2 cytokine receptor subunits. The receptor is expressed in skin and its expression is upregulated dramatically in psoriatic skin. Engagement of the receptor in a keratinocyte cell line involves signaling by one member of the STAT proteins, STAT3.
• The IL20 receptor complex has been shown to bind also IL19 and IL24.
• IL21 has been isolated by Parrish-Novak et al from a cDNA library derived from activated CD3 (+)T-cells in a search for the ligand of a type-I cytokine receptor isolated previously. The cDNA encodes a secreted protein of 131 amino acids protein most closely related to IL2 and IL15. The IL21 gene maps to human chromosome 4q26-q27 near the IL2 gene. IL21 mRNA is expressed in CD4 (+) but not in CD8 (+) T-cells after cell activation. It is not expressed also in B-cells and monocytes (Asao H et al Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. Journal of Immunology 167(1):1-5 (2001); Ozaki K et al Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proceedings of the National Academy of Science (USA) 97: 11439-11444 (2000); Parrish-Novak J et al Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63 (2000)).
• IL21 stimulates proliferation of B-cell stimulated by crosslinking of the CD40 antigen. It inhibits proliferation stimulated by IL4 plus anti-IgM. IL21 augments stimulation of the proliferation of naive (CD45RA (+)) but not memory (CD45RO (+)) T-cells mediated by engagement of CD3. IL21 stimulates the proliferation of bone marrow progenitor cells and the expression of the NK-cell marker CD56 in the presence of IL15.
• The IL21 receptor has been isolated by Parrish-Novak et al and found to be expressed by CD23 (+)B-cells, B-cell lines, a T-cell leukemia line, and NK-cell lines. The receptor gene has been mapped to human chromosome 16p12. The same receptor has been isolated by Ozaki et al, who called it NILR (novel interleukin receptor). The receptor (538 amino acids) is most closely related to human IL2 beta receptor. The receptor contains a WSXWS motif in the extracellular region, typical of type-1 cytokine receptors. The receptor is expressed on NK-cells, T-cells, and B-cell lines.
• The common gamma chain, which is an indispensable subunit of the functional receptor complexes for IL2, IL4, 1L7, IL9, and IL15 has been shows also to be part of the IL21 receptor complex. The functional signalling complex activates Janus kinases JAK1, JAK3, and the STAT proteins STAT1, and STAT3 (Asao et al).
• IL22 (180 amino acids including a signal sequence; 25 kDa; also called IL-TIF) was identified by a cDNA subtraction method as a gene induced specifically by IL9 in mouse T lymphocytes. The protein shows limited homology with IL10 (22 percent amino acid identity). Human and murine IL-TIF proteins share 79 percent amino acid identity.
• The murine and human IL-TIF genes both consist of 6 exons. The human single-copy gene maps to chromosome 12q15 (90 Kb from the IFN-gamma gene, and 27 Kb from the AK155 gene encoding another IL10-related cytokine. In mice the gene is located also in the same region as the IFN-gamma gene. In BALB/c and DBA/2 mice the gene is a single copy gene. In C57B1/6, FVB and 129 mice the gene is duplicated. The two copies, termed IL-TIF-alpha and IL-TIF-beta show 98 percent nucleotide identity in the coding region and differ by a deletion of 658 nucleotide in IL-TIF-beta. This gene may be inactive.
• Expression of IL-TIF is induced by IL9 in thymic lymphomas, T-cells, and mast cells, and by lectins in freshly isolated splenocytes. IL-TIF expression in T-cells does not require protein synthesis, and depends on the activation Janus kinases and STAT proteins. IL-TIF is expressed constitutively in thymus and brain.
• In HepG2 human hepatoma cells IL-TIF up-regulates the production of acute phase proteins. IL-TIF also acts as a pro-inflammatory cytokine in vivo because injection of the protein also induces the synthesis of acute phase proteins. Synthesis of IL-TIF is induced rapidly after injection of bacterial lipopolysaccharides. In contrast to IL10, IL22 does not inhibit the production of pro-inflammatory cytokines by monocytes in response to bacterial lipopolysaccharides. It also does not impair IL10 function on monocytes. IL-TIF has some inhibitory effects on IL4 production from Th2 T-helper cells.
• IL10 and IL-TIF utilise a common receptor subunit. Antibodies directed against the beta chain of the IL10 receptor block the induction of acute phase proteins by IL-TIF. The functional IL-TIF receptor complex consists of two receptor chains. One chain has been identified as the orphan receptor CRF2-4 that is expressed in normal liver and kidney. The other chain is the L10 receptor-2, the second chain of the IL10 receptor complex. Monkey COS expressing CRF2-9 alone respond to IL-TIF. In hamster cells both chains must be expressed to yield functional IL-TIF receptors. Although both receptor chains can bind IL-TIF independently binding of IL-TIF to the receptor complex is greater. This sharing of receptor subunits is similar to the shared use of the common gamma chain by cytokines such as IL2, IL4, IL7, IL9, and IL15. Some cell lines that do not respond to IL10 respond to IL-TIF by activation of STAT-1, STAT-3, and STAT-5.
• A soluble secreted receptor (231 amino acids), designated IL22BP [IL22 binding protein] has been described (Kotenko et al). The protein demonstrates 34 percent amino acid identity with the extracellular domain of the IL22R1 chain and is known also as CRF2-10. The gene maps to human chromosome 6q24, 35 kb from the IFN-gamma R1 gene. It is expressed in various tissues with maximal expression in breast, lungs, and colon. The protein binds IL-TIF and inhibits its activity, blocking its interaction with the cell surface IL22 receptor complex and thus acting as a natural cytokine antagonist. IL22BP also blocks induction of the suppressors of cytokine signaling-3 (SOCS-3) gene expression by IL22 in HepG2 cells (Dumoutier L et al Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. Journal of Immunology 164(4): 1814-1819 (2000); Dumoutier L et al Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proceedings of the National Academy of Science (USA) 97(18): 10144-9 (2000); Dumoutier L et al IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1(8): 488-494 (2000); Dumoutier L et al Cloning and characterization of il-22 binding protein, a natural antagonist of il-10-related t cell-derived inducible factor/il-22. Journal of Immunology 166(12): 7090-5 (2001); Kotenko S V et al Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. Journal of Immunology 166(12): 7096-7103 (2001); Kotenko S V et al Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276(4): 2725-32 (2001); Xie M H et al Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. Journal of Biological Chemistry 275(40): 31335-9 (2000)).
• IL-23 is the name given to a factor that is composed of the p40 subunit of IL12 (IL12B) and another protein of 19 kDa, designated p19. p19 is structurally related to IL6, G-CSF, and the p35 subunit of IL12. In databanks the p19 subunit is found also under the acronym SGRF (IL6 G-CSF related factor).
• p19 by itself is biologically inactive while the complex of p19 with p40 is active. The active complex is secreted by dendritic cells after cell activation.
• Mouse memory T-cells (CD4 (+) CD45 Rb(low)) proliferate in response to IL23 but not in response to IL12. Human IL23 has been shown to stimulate the production of IFN-gamma by PHA blast T-cells and memory T-cells. It also induces proliferation of both cell types.
• IL23 binds to the beta-1 subunit but not to the beta-2 subunit of the IL12 receptor, activating one of the STAT proteins, STAT4, in PHA blast T-cells.
• Expression of p19 in transgenic mice leads to runting, systemic inflammation, infertility, and death before 3 months of age. The animals show high serum concentrations of the pro-inflammatory cytokines TNF-alpha and IL1. The number of circulating neutrophils is increased. Acute phase proteins are expressed constitutively. Animals expressing p19 specifically in the liver do not show these abnormalities. Expression of p19 is most likely due to hematopoietic cells as bone marrow transplantation of cells expressing p19 causes the same phenotype as that observed in the transgenic animals (Oppmann B et al Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5): 715-25 (2000); Wiekowski M T et al Ubiquitous Transgenic Expression of the IL-23 Subunit p 19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death. Journal of Immunology 166(12): 7563-70 (2001)).
• IL24 is a name given to a protein that is known also as ST16 [suppression of tumorigenicity-16] and MDA-7 [melanoma differentiation-associated gene 7]. The rat counterpart of IL24 has been identified as mob-5 or C49a. The murine counterpart is FISP.
• MDA-7 protein (206 amino acids) was identified initially as a melanoma differentiation-associated cDNA in a study using cultured human melanoma cells that lose proliferative capacity and terminally differentiate in response to human IFN-beta and mezerein. The expression of MDA-7 is upregulated as a consequence of terminal differentiation. H0-1 and C8161 human melanoma cells engineered to express MDA-7 show reduces growth and do not form colonies in a colony formation assay. MDA-7 selectively suppresses the growth of human breast cancer cells by promoting cell death by apoptosis. Ectopic expression of MDA-7 by means of a replication defective adenovirus results in growth suppression and induction of apoptosis in a broad spectrum of additional cancers, including melanoma, glioblastoma multiforme, osteosarcoma and carcinomas of the breast, cervix, colon, lung, nasopharynx and prostate. No apparent harmful effects are observed after expression of MDA-7 in normal epithelial or fibroblast cells.
• In human hematopoietic cells MDA-7 expression is induced during megakaryocyte differentiation in response to treatment with TPA (12-O-tetradecanoyl-phorbol-13-acetate).
• The human MDA-7 gene maps to chromosome 1q32 and is tightly linked (within a region of 195 kb) to the genes encoding IL10, IL19, and IL20.
• The receptor for IL24 has been identified as the IL20 receptor complex. This receptor also binds to IL19 (Blumberg H et al Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104(1): 9-19 (2001); Dumoutier L et al Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 167(7): 3545-9 (2001); Huang E Y et al Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20(48): 7051-63 (2001); Jiang H et al Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486 (1995); Jiang H et al The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proceedings of the National Academy of Science (USA) 93: 9160-9165 (1996); Su Z et al The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proceedings of the National Academy of Science (USA) 95: 14400-14405 (1998)).
• IL25 (also known as SF20) has been identified in a search for factors that stimulate cell proliferation. The factor is secreted by bone marrow stromal cells
• The IL25 receptor has been identified as mouse thymic shared antigen-1 (TSA-1). Enforced expression of the receptor in one of the factor-dependent cell lines, BaF3, which does not express the receptor, causes cell proliferation. FDCP2 cells, which express the receptor, also proliferate in response to SF20/IL25. In both cases proliferation is abolished by specific blocking antibodies directed against the receptor.
• SF20/IL-25 has no detectable myelopoietic activity but supports proliferation of cells in the lymphoid lineage (Tulin E E et al SF20/IL-25, a Novel Bone Marrow Stroma-Derived Growth Factor That Binds to Mouse Thymic Shared Antigen-1 and Supports Lymphoid Cell Proliferation. Journal of Immunology 167(11): 6338-47 (2001)).
• The members of the TNF ligand superfamily (TNFalpha, TNF-beta, LT beta, CD27 ligand, CD30 ligand, CD40 ligand, CD95 ligand, 41BB, OX40 ligand, TRAIL) share common biological activities, but some properties are shared by only some ligands, while others are unique. Human TNF-alpha is a non-glycosylated protein of 17 kDa and a length of 157 amino acids. Murine TNF-alpha is N-glycosylated. Homology with TNF-beta is approximately 30%. TNF-alpha forms dimers and trimers. The 17 kDa form of the factor is produced by processing of a precursor protein of 233 amino acids. A TNF-alpha converting enzyme has been shown to mediate this conversion. A transmembrane form of 26 kDa has been described also.
• TNF-alpha contains a single disulfide bond that can be destroyed without altering the biological activity of the factor. Mutations Ala84 to Val and Val91 to Ala reduce the cytotoxic activity of the factor almost completely. These sites are involved in receptor binding. The deletion of 7 N-terminal amino acids and the replacement of Pro8Ser9Asp10 by ArgLysArg yields a mutated factor with an approximately 10-fold enhanced antitumor activity and increased receptor binding, as demonstrated by the L-M cell assay, while at the same time reducing the toxicity.
• The gene has a length of approximately 3.6 kb and contains four exons. The primary transcript has a length of 2762 nucleotides and encodes a precursor protein of 233 amino acids. The aminoterminal 78 amino acids function as a presequence. The human gene maps to chromosome 6p23-6q12. It is located between class I HLA region for HLA-B and the gene encoding complement factor C. The gene encoding TNF-beta is approximately 1.2 kb downstream of the TNF-alpha gene. However, both genes are regulated independently. The two genes also lie close to each other on murine chromosome 17.
• Approximately 500-10000 high-affinity receptors (Ka=2.5×10⁻⁹ M) for ‘I’ N-alpha are expressed on all somatic cell types with the exception of erythrocytes. Two receptors of 55 kDa (TNF-R1; new designation: CD120a) (e.g. polypeptides encoded by Genbank Accession No. X55313) and 75 kDa (TNF-R2; new designation: CD120b) (e.g. as described in Goodwin R G et al (1991) Molecular Cellular Biology 11: 3020-6) have been described. One receptor is a glycosylated protein of 455 amino acids that contains an extracellular domain of 171 and a cytoplasmic domain of 221 amino acids. Sequence homologies in the cysteine-rich domains of the extracellular portion reveal that the receptor is related to the low-affinity receptor of NGF and to human cell surface antigen CD40.
• Deletion analysis in the C-terminal intracellular region of the 55 kDa receptor, TNF-R1 has revealed the existence of a so-called death domain, which is involved in signaling processes leading to programmed cell death. The death domain of TNF-R1 interacts with a variety of other signaling adaptor molecules, including TRADD, and RIP.
• The two known receptors bind both TNF-alpha and TNF-beta. p55 is expressed particularly on cells susceptible to the cytotoxic action of TNF. p75 is also present on many cell types, especially those of myeloid origin (a virus-encoded homologue of the receptor subunit is EBV-induced gene-6). It is strongly expressed on stimulated T-cells and B-lymphocytes. The differential activities of TNF on various cell types, i.e. growth-promoting and growth-inhibiting activities, are probably mediated by the differential expression and/or regulation of multiple receptors in combination with other distinct receptor-associated proteins. p55 appears to play a critical role in host defenses against microorganisms and their pathogenic factors.
• A third receptor subtype is expressed in normal human liver. It binds TNF-alpha but not TNF-beta. Some viruses contain genes encoding secreted proteins with TNF binding properties that are closely homologous to the p55 and p75 TNF receptors. Differential effects of the two receptor subtypes have been found also in TNF-mediated adhesion of leukocytes to the endothelium. It appears that engagement of the p55 receptor specifically leads to the induction of the cellular adhesion molecules ICAM-1, E-selectin, V-CAM-1, and CD44, while engagement of both the p55 and the p75 receptor induces expression of alpha-2 integrin.
• Truncated soluble forms of the receptor have been found also. The soluble forms, in particular the soluble extracellular domain of the p60 receptor, block the antiproliferative effects of TNF and, therefore, may modulate the harmful effects of TNF.
• Receptor densities are reduced by IL1 and tumor promoters such as phorbol esters. The expression of TNF-alpha receptor density is induced by IFN-alpha, IFN-beta, and IFN-gamma.
• Signal transducers that associate with the cytoplasmic domains of members of the TNF receptor superfamily comprise TRAF (Tumor necrosis factor receptor-associated factors).
• Human TNF-alpha is active on murine cells with a slightly reduced specific activity. In general, TNF-alpha and TNF-beta display similar spectra of biological activities in in-vitro systems, although TNF-beta is often less potent or displays apparent partial agonist activity.
• TNF-alpha shows a wide spectrum of biological activities. It causes cytolysis and cytostasis of many tumor cell lines in vitro. Sensitive cells die within hours after exposure to picomolar concentrations of the factor and this involves, at least in part, mitochondria-derived second messenger molecules serving as common mediators of TNF cytotoxic and gene-regulatory signaling pathways. The factor induces hemorrhagic necrosis of transplanted tumors. Within hours after injection TNF-alpha leads to the destruction of small blood vessels within malignant tumors. The factor also enhances phagocytosis and cytotoxicity in neutrophilic granulocytes and also modulates the expression of many other proteins, including fos, myc, IL1 and IL6.
• The 26 kDa form of TNF is found predominantly on activated monocytes and T-cells. It is also biologically active and mediates cell destruction by direct cell-to-cell contacts.
• The chemotactic properties of fMLP (Formyl-Met-Leu-Phe) for neutrophils are enhanced by TNF-alpha. TNF-alpha induces the synthesis of a number of chemoattractant cytokines, including IP-10, JE, KC, in a cell-type and tissue-specific manner.
• TNF-alpha is a growth factor for normal human diploid fibroblasts. It promotes the synthesis of collagenase and prostaglandin E2 in fibroblasts. It may also function as an autocrine growth modulator for human chronic lymphocytic leukemia cells in vivo and has been described to be an autocrine growth modulator for neuroblastoma cells. The autocrine growth-promoting activity is inhibited by IL4.
• In resting macrophages TNF induces the synthesis of IL1 and prostaglandin E2. It also stimulates phagocytosis and the synthesis of superoxide dismutase in macrophages. TNF activates osteoclasts and thus induces bone resorption.
• In leukocyte and lymphocyte progenitors TNF stimulates the expression of class I and II HLA and differentiation antigens, and the production of IL1, colony stimulating factors, IFN-gamma, and arachidonic acid metabolism. It also stimulates the biosynthesis of collagenases in endothelial cells and synovial cells.
• IL6 suppresses the synthesis of IL1 induced by bacterial endotoxins and TNF, and the synthesis of TNF induced by endotoxins.
• The neurotransmitter SP (substance P) induces the synthesis of TNF and IL1 in macrophages. IL1, like IL6, stimulates the synthesis of ACTH (corticotropin) in the pituitary. Glucocorticoids synthesized in response to ACTH in turn inhibit the synthesis of IL6, IL1 and TNF in vivo, thus establishing a negative feedback loop between the immune system and neuroendocrine functions.
• TNF-alpha enhances the proliferation of T-cells induced by various stimuli in the absence of IL2. Some subpopulations of T-cells only respond to IL2 in the presence of TNF-alpha. In The presence of IL2 TNF-alpha promotes the proliferation and differentiation of B-cells.
• The functional capacities of skin Langerhans cells are also influenced by TNF-alpha. These cells are not capable of initiating primary immune responses such as contact sensibilisation. They are converted into immunostimulatory dendritic cells by GM-CSF and also IL1. These cells therefore are a reservoir for immunologically immature lymphoid dendritic cells. The enhanced ability of maturated Langerhans cells to process antigens is significantly reduced by TNF-alpha.
• Although TNF-alpha is also required for normal immune responses the overexpression has severe pathological consequences. TNF-alpha is the major mediator of cachexia observed in tumor patients (hence its name, cachectin). TNF is also responsible for some of the severe effects during Gram-negative sepsis.
• TNF-alpha can be detected in bioassays involving cell lines that respond to it (e.g., BT-20, CT6, EL4; PK15; L929; L-M; M07E; T1165; WEHI-3B). TNF-alpha can be detected also by a sensitive sandwich enzyme immunoassay, ELISA, an immunoradiometric assay (IRMA), and by an assay designated RELAY (receptor-mediated label-transfer assay). Intracellular factor is detected by two color immunofluorescence flow cytometry. Higuchi et al have described an assay based on the release of tritiated thymidine from cells undergoing apoptosis after treatment with either TNF-alpha or TNF-beta. IFN-alpha, IFN-beta, IFN-gamma, TGF-beta, IL4, LIF and GM-CSF have been shown not to interfere with this assay.
• In contrast to chemotherapeutic drugs TNF specifically attacks malignant cells. Extensive preclinical studies have documented a direct cytostatic and cytotoxic effect of TNF-alpha against subcutaneous human xenografts and lymph node metastases in nude mice, as well as a variety of immunomodulatory effects on various immune effector cells, including neutrophils, macrophages, and T-cells. Single- and multiple-dose phase I studies have confirmed that TNF can be administered safely to patients with advanced malignancies in a dose range associated with anticancer effect without concomitant serious toxicities such as shock and cachexia. However, clinical trials on the whole have unfortunately so far failed to demonstrate significant improvements in cancer treatment, with TNF-induced systemic toxicity being a major limitation for the use of TNF as an antineoplastic agent in most cases. The combined use of TNF and cytotoxic or immune modulatory agents, particularly IFN-gamma and possibly IL2, may be of advantage in the treatment of some tumors. In some cases intratumoral application of TNF has been found to be of advantage in tumor control.
• Some mutant forms of TNF-beta with selective activity on the p55 receptor have been described recently. It has been shown that activation of the p55 receptor is sufficient to trigger cytotoxic activity towards transformed cells. Some of these mutants have been described to retain their antitumor activity in nude mice carrying transplanted human tumors.
• TNF can also be used to increase the aggressiveness of lymphokine-activated killer cells. Studies with an experimental fibrosarcoma metastasis model have shown that TNF induces significant enhancement of the number of metastases in the lung. It has been suggested that low doses of endogenous TNF or administration of TNF during cytokine therapy may enhance the metastatic potential of circulating tumor cells. The transduction of murine tumor cells with a functional TNF-alpha gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts.
• The interferons are a family of cytokines that induce a virus-nonspecific antiviral state in target cells. Binding of an interferon to its receptor induces new protein synthesis which, in turn, results in the inactivation of initiation factor eIF-2. The inactivation is thought to contribute to the antiviral state induced by the interferons. Interferons also induce pathways that activate intracellular endonucleases which degrade viral mRNA. Many interferons also possess immunomodulatory activities, such as activation of macrophages and lymphocytes. Examples of interferons include IFN-gamma (e.g. polypeptides encoded by Genbank Accession No. K01900, J00209, M12350, J00213, J00216, J00214, M11003, M11026, M34913, M54886, X01974, L38698, M13710, K01238, M13660, M68944, X01972, X01971, X01973, X01969), IFN-gamma (e.g. polypeptides encoded by Genbank Accession No.M28622, X14029, X14455, K00020, J00218, E00171, X04430, A09363, M27327, M16656, M25460, K03196), IFN-gamma e.g. polypeptides encoded by Genbank Accession No. A34532, X87308, E00756, K00083), IFN-gamma e.g. polypeptides encoded by Genbank Accession No. X58822, A12140), bovine trophoblast protein-1 (IFN-gamma) e.g. polypeptides encoded by Genbank Accession No. M31556, M31557, M31558), and their homologues among species. Human IFN-gamma and IFN-gamma are thought to bind to a common receptor (e.g. polypeptides encoded by Genbank Accession No. X60459, M89641) which is distinct from the receptor for IFN-gamma (e.g. polypeptides encoded by Genbank Accession No. J03143, M28233).
• At least 23 different variants of IFN-alpha are known. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172
• amino acids. All IFN-alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN-alpha subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxy-terminal end. Disulfide bonds are formed between cysteines at positions 1/98 and 29/138. The disulfide bond 29/138 is essential for biological activity while the 1/98 bond can be reduces without affecting bioactivity.
• Human IFN-beta is a glycoprotein (approximately 20% sugar moiety) of 20 kDa and has a length of 166 amino acids. Glycosylation is not required for biological activity in vitro. The protein contains a disulfide bond Cys31/141) required for biological activity. At the DNA level IFN-beta displays 34% sequence homology with IFN-beta-2 and approximately 30% homology with other IFN-alpha subtypes. In contrast to IFN-gamma IFN-beta is stable at pH2.
• Human IFN-gamma is a dimeric protein with subunits of 146 amino acids. The protein is glycosylated at two sites. The pI is 8.3-8.5. IFN-gamma is synthesized as a precursor protein of 166 amino acids including a secretory signal sequence of 23 amino acids. Two molecular forms of the biologically active protein of 20 and 25 kDa have been described. Both of them are glycosylated at position 25. The 25 kDa form is also glycosylated at position 97. The observed differences of natural IFN-gamma with respect to molecular mass and charge are due to variable glycosylation patterns. 40-60 kDa forms observed under non-denaturing conditions are dimers and tetramers of IFN-gamma.
• Members of the CSF family of cytokines allow the growth and differentiation of bone marrow cells immobilized on soft agar or methylcellulose. While hematopoietic progenitor cells can be maintained only for short periods of time in the absence of such factors, their presence allows the development of colonies containing erythroid cells, neutrophils, eosinophils, macrophages, and/or megakaryocytes, depending on the particular factor. The biochemical analysis of various activities stimulating colony formation supporting the growth and development of these cell types revealed that there existed many different and distinct factors of this sort.
• Many of these factors are either N- or O-glycosylated. Glycosylation has been shown to enhance the solubility, stability and resistance to proteolytic enzymes. It does not appear to be required for the full spectrum of biological activities of these factors. The genes encoding many of the human colony stimulating factors have been cloned and mapped. Some of the genes are in close vicinity but they do not show great homology among each other with the exception of some conserved regions.
• Colony stimulating factors are produced by many different cell types, including, for example, B-lymphocytes, epithelial cells, fibroblasts, endothelial cells, macrophages, Stromal cell line, T-lymphocytes. They are synthesized as precursor molecules containing a classical hydrophobic secretory signal sequence of approximately 25-32 amino acids. The secreted factors have an extremely high specific biological activity are active at very low concentrations (1-100 pM). These factors are absolutely required for the proliferation of hematopoietic progenitor cells. The concentrations required for mere maintenance of viability are usually orders of magnitude lower than those required to induce cell proliferation or to elicit specific functional activities of the cells.
• The names of the individual factors usually indicate the cell types that respond to these factors. The classical colony stimulating factors include M-CSF (e.g. polypeptides encoded by Genbank Accession No. E03235, M64592, U22386, X05010) (macrophage-specific), G-CSF (granulocyte-specific), GM-CSF (macrophage/granulocyte-specific), IL3 (multifunctional) and MEG-CSF (e.g. polypeptides encoded by Genbank Accession No.D86370, U70136) (megakaryocyte-specific). G-CSF and M-CSF are lineage-specific while GM-CSF and IL3 are multifunctional hematopoietic growth factors acting on earlier stages of differentiation of hematopoietic progenitor cells.
• Human GM-CSF is a monomeric protein of 127 amino acids with two glycosylation sites. The protein is synthesized as a precursor of 144 amino acids, which included a hydrophobic secretory signal sequence at the aminoterminal end. The sugar moiety is not required for the full spectrum of biological activities. Non-glycosylated and glycosylated GM-CSF show the same activities in vitro. Fully glycosylated GM-CSF is biologically more active in vivo than the non-glycosylated protein. The different molecular weight forms of GM-CSF (14 kDa, 35 kDa) described in the literature are the result of varying degrees of glycosylation. GM-CSF contains four cysteine residues (positions 54/96 and 88/121).
• A comparison of the protein sequence of GM-CSF with those of the other colony stimulating factors reveals that they are not strongly homologous to each other. Human and murine GM-CSF display 60% homology at the protein level and 70% at the nucleotide level. The two factors do not, however, cross-react immunologically. GM-CSF can be associated with the extracellular matrix of cells as a complex with heparan sulfate proteoglycans. This allows storage of the factor in a biologically inactive form. The exact mechanism by which the factor is eventually released from these depots is not known.
• The human gene has a length of approximately 2.5 kb and contains four exons. The distance between the GM-CSF gene and the IL3 gene is approximately 9 kb. The human GM-CSF gene maps to chromosome 5q22-31 in the vicinity of other genes encoding hematopoietic growth factors (M-CSF, IL3, IL4, IL5) and the gene encoding the M-CSF receptor. The 5′ region of the GM-CSF gene contains several sequence elements known as CLE (conserved lymphokine element). They function as binding sites for transcription factors, modulating the expression of the GM-CSF gene.
• GM-CSF receptors are expressed at densities of several 100 to several 1000 copies/cell on the cell surface of myeloid cells. The receptor is expressed also on non-hematopoietic cells such as endothelial cells and small cell lung carcinoma cells. In receptor-positive cell lineages the receptor density decreases with increasing degrees of maturation.
• The receptor shows significant homologies with other receptors for hematopoietic growth factors, including IL2-beta, IL3, IL6, IL7, Epo and the prolactin receptors. One cloned subunit of the GM-CSF receptor (GM-R alpha, 45 kDa) binds GM-CSF with low affinity (e.g. polypeptides encoded by Genbank Accession No. SEG_HUMGRAS). The second subunit (GM-R beta, 120 kDa) does not bind GM-CSF. GM-R alpha is a protein of 400 amino acids that contains only a short cytoplasmic domain of 54 amino acids. The high affinity GM-CSF receptor is formed by the aggregation of the two receptor subunits. The GM-R beta subunit of the receptor (e.g. polypeptides encoded by Genbank Accession No. SEG_MUSAIC2B, M59941) is also a constituent of other cytokine receptor systems. It is a component of the high affinity receptors for IL3 and IL5, both of which also contain a cytokine-specific subunit (AIC2A).
• Human GM-CSF is not active on murine cells and vice versa. GM-CSF was isolated initially as a factor stimulating the growth of macrophage/granulocyte-containing colonies in soft agar cultures (colony formation assay). GM-CSF is indispensable for the growth and development of granulocyte and macrophage progenitor cells. It stimulates myeloblasts and monoblasts and triggers irreversible differentiation of these cells. GM-CSF synergises with Epo in the proliferation of erythroid and megakaryocytic progenitor cells. In combination with another colony stimulating factor, M-CSF, one observes the phenomenon of synergistic suppression, i.e., the combination of these two factors leads to a partial suppression of the generation of macrophage-containing cell colonies.
• For some types of blast cells from patients with acute myeloid leukemia GM-CSF acts as an autocrine mediator of growth. GM-CSF is a strong chemoattractant for neutrophils. It enhances microbicidal activity, oxidative metabolism, and phagocytotic activity of neutrophils and macrophages. It also improves the cytotoxicity of these cells. GM-CSF displays a less pronounced specificity than, for example, G-CSF. It stimulates the proliferation and differentiation of neutrophilic, eosinophilic, and monocytic lineages. It also functionally activates the corresponding mature forms, enhancing, for example, the expression of certain cell surface adhesion proteins (CD-11A, CD-11C). The overexpression of these proteins could be one explanation for the observed local accumulation of granulocytes at sites of inflammation. In addition, GM-CSF also enhances expression of receptors for fMLP (Formyl-Met-Leu-Phe) which is a stimulator of neutrophil activity.
• At pico to nanomolar concentrations GM-CSF is chemotactic for eosinophils and also influences the chemotactic behavior of these cells in response to other chemotactic factors.
• In granulocytes GM-CSF stimulates the release of arachidonic acid metabolites and the increased generation of reactive oxygen species. The activation of the Na⁺/H+ antiport system leads to a rapid alkalization of the cytosol. Phagocytotic activities of neutrophil granulocytes and the cytotoxicity of eosinophils is also enhanced considerably by GM-CSF. Since GM-CSF is produced by cells (T-lymphocytes, tissue macrophages, endothelial cells, mast cells) present at sites of inflammatory responses it can be assumed that it is an important mediator for inflammatory reactions.
• The functional state of Langerhans cells of the skin is also influenced by GM-CSF. These cells are not capable of initiating primary immune responses, for example, contact sensibilization. They are converted to highly potent immunostimulatory dendritic cells by GM-CSF (and also IL1). Langerhans cells therefore form an in situ reservoir for immunologically immature lymphoid dendritic cells. The maturation of these cells which is seen as an increased ability to process antigens, can be down-regulated by TNF-alpha.
• At nanomolar concentrations GM-CSF induces the expression of complement C3a receptors on basophils. Cells which normally do not respond to C3a and which have been activated by GM-CSF degranulate in response to the C3a stimulus. This is accompanied by the release of histamine and leukotriene C4. This process may be of significance in hypersensitivity reactions associated with inflammatory responses (T-lymphocytes, tissue macrophages, endothelial cells, mast cells). GM-CSF has been shown also to be a potent inducer of trophoblast interferon (TP-1).
• GM-CSF synergises with some other cytokines, including IL1, IL3 and G-CSF. GM-CSF and G-CSF must act in concert to allow the development of neutrophil-containing colonies in vitro.
• IL3 by itself only negligibly expands the number of circulating blood cells; a subsequent dose of GM-CSF, however, significantly increases cell numbers, probably because IL3 first leads to an expansion of those cells capable of responding to GM-CSF.
• The observations that most IL3-dependent cell lines can also grow in the presence of GM-CSF and IL4 and that several synergistic effects are observed between GM-CSF and IL4 suggest that these three factors perform similar functions in controlling the growth of cells. There are some indications that the mechanism of signal transduction contains at least some common factors.
• Experiments with tyrosine-specific protein kinases encoded by an oncogene have shown that the expression of this kinase activity in factor-dependent cells abolishes their dependence on GM-CSF, IL3 and IL4. The exact mechanism by which these factors regulate the proliferation and differentiation of cells is still unknown.
• The consequences of a deregulated expression of GM-CSF have been studied in transgenic mice harboring a constitutively expressed GM-CSF gene. The overexpression of the transgene encoding GM-CSF leads to pathological alterations in the retina and causes blindness and also causes muscle deterioration. These mice are characterized by a very pronounced increase in activated macrophages. In addition, the overexpression of GM-CSF leads to the activation of mature macrophages secreting large amounts of IL1 and TNF, suggesting that these cytokines may be responsible for some aspects of the transgenic mouse disease.
• Histopathological examination demonstrates a pronounced increase in the progenitor cell population of the monocytic lineage. GM-CSF-transgenic animals usually die within months from the massive tissue damage resulting from the overexpression of these factors. Similar results have been obtained with mice possessing a bone marrow manipulated to overexpress GM-CSF by transformation with suitable retrovirus vectors. These findings do not seem to be of clinical significance, though. The long-term treatment of primates and mice with GM-CSF has shown that life-threatening complications do not occur.
• The biological consequences of GM-CSF gene disruption have been studied in mice generated from ES cells carrying a targeted deletion of the gene. Mice homozygous for a targeted disruption of the GM-CSF gene are characterized by an unimpaired steady-state hematopoiesis, demonstrating that GM-CSF is not essential for maintaining normal levels of the major types of mature hematopoietic cells and their precursors in blood, marrow, and spleen.
• Most GM-CSF-deficient mice are superficially healthy and fertile but develop abnormal lungs. GM-CSF-deficient mice develop a progressive accumulation of surfactant lipids and proteins in the alveolar space, the defining characteristics of the idiopathic human disorder pulmonary alveolar proteinosis. Extensive lymphoid hyperplasia associated with lung airways and blood vessels is found also. These results demonstrate an unexpected, critical role for GM-CSF in pulmonary homeostasis.
• Transgenic mice homozygous for null mutations of the gene encoding the common beta subunit (beta C) of the GM-CSF, IL3, and IL5 receptor complexes exhibit normal development and survive to young adult life. They develop pulmonary peribroncnovascular lymphoid infiltrates and areas resembling alveolar proteinosis. Eosinophil numbers in peripheral blood and bone marrow of homozygous deletion mutants are reduced, while other hematological parameters are normal. Bone marrow cells from homozygous deletion mutants do not show high-affinity binding of GM-CSF, while cells from heterozygous animals show an intermediate number of high-affinity receptors. In clonal cultures of bone marrow cells derived from homozygous deletion mutants, even high concentrations of GM-CSF and IL5 do not stimulate colony formation in the colony formation assay. Differences in the systemic clearance and distribution of GM-CSF between mutant and wild-type littermates are not observed.
• Nishinakamura et al have crossed beta-c mutant mice with mice deficient for IL3. The double-mutant mice lacking all IL3, GM-CSF, and IL5 functions are apparently normally fertile. The animals show the same reduced numbers of eosinophils and a lack of eosinophilic response to parasites as beta-c mutant mice. The immune response of the double mutant mice to Listeria monocytogenes is normal. Hematopoietic recovery after treatment with fluorouracil is also normal. These findings suggest the existence of alternative mechanism to produce blood cells that do not depend on the presence of IL3, GM-CSF, and IL5.
• GM-CSF can be assayed in a colony formation assay by the development of colonies containing macrophages, neutrophils, eosinophils, and megakaryocytes. GM-CSF is also detected in specific bioassays with cells lines that depend in their growth on the presence of GM-CSF or that respond to this factor (e.g., AML-193; B6SUt-A; BAC1.2F5; BCL1; Da; FDCP1; GF-D8; GM/SO; IC-2; M07E; NFS-60; PT-18; TALL-103; TF-1; UT-7).
• GM-CSF can be employed for the physiological reconstitution of hematopoiesis in all diseases characterized either by an aberrant maturation of blood cells or by a reduced production of leukocytes. The main and most important clinical application of GM-CSF is probably the treatment of life-threatening neutropenia following chemo and/or radiotherapy, which is markedly reduced under GM-CSF treatment. GM-CSF can be used also to correct chemotherapy-induced cytopenias and to counteract cytopenia-related predisposition to infections and hemorrhages.
• In order to avoid potential complications following the administration of GM-CSF careful clinical monitoring is required in certain patient groups, for example those with myelodysplastic syndrome, acute myeloid leukemia, inflammatory disease, autoimmune thrombocytopenia or malfunctional immunological responsiveness.
• Several studies have demonstrated that the use of GM-CSF enhances tolerance to cytotoxic drug treatment and can be used to prevent dose reductions necessitated by the side effects of cytotoxic drug treatment. GM-CSF treatment frequently permits to increase the doses of cytotoxic drugs per course. These studies have also revealed a significantly reduced morbidity under GM-CSF treatment.
• The transduction of murine tumor cells with a functional GM-CSF gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Moreover, vaccination with GM-CSF transduced tumor cells prevents growth of a subsequent inoculum of wild-type syngeneic tumor cells.
• The chemokine family of cytokines consists of relatively small, structurally similar polypeptides that induce chemotaxis in leukocytes. Chemokines have molecular masses of 8-10 kDa and show approximately 20-50% sequence homology among each other at the protein level. The proteins also share common gene structures and tertiary structures. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation.
• According to the chromosomal locations of individual genes two different subfamilies of chemokines are distinguished. Members of the alpha-chemokines are referred to also as the 4q chemokine family because the genes encoding members of this family map to human chromosome 4q12-21. The first two cysteine residues of members of this family are separated by a single amino acids and these proteins, therefore, are called also C-X-C chemokines. This subfamily includes 9E3 (e.g. Genbank protein P08317), AMCF (e.g. polypeptides encoded by Genbank Accession No. M99367, M99368), beta-thromboglobulin (e.g. as disclosed in Begg G S et al (1978), Biochemistry 17: 1739-44), CINC family members (e.g. polypeptides encoded by Genbank Accession No. D21095), ENA-78 (e.g. polypeptides encoded by Genbank Accession No. X78686), eotaxin (e.g. polypeptides encoded by Genbank Accession No. U46572, U40672), GCP-2 (e.g. polypeptides encoded by Genbank Accession No. Y08770, U83303), IL8, IP-10 (e.g. polypeptides encoded by Genbank Accession No. L07417, X02530), KC (e.g. polypeptides encoded by Genbank Accession No. J04596), LIX (e.g. polypeptides encoded by Genbank Accession No. U27267), mig (e.g. polypeptides encoded by Genbank Accession No. M34815, Z24725), MGSA (e.g. polypeptides encoded by Genbank Accession No. X12510), mob-1 (e.g. polypeptides encoded by Genbank Accession No. U17035), NAP-2 (as described in Clark-Lewis I et al (1991) Biochemistry 30: 3128-35, Cohen A B et al (1992) American Journal of Physiology 263: L249-56), NAP-3 (as described in: Schröder J M et al (1991) Journal of Experimental Medicine 171: 1091-100), NAP-4 (as described in Schröder T M et al (1990) Biochemical zui Biophysical Research Communications 172: 898-904), PBSF (SDF) (e.g. polypeptides encoded by Genbank Accession No. D21072, U16752, D50645), and PF4 (e.g. polypeptides encoded by Genbank Accession No. M25897).
• IL8, MGSA, mouse KC, MIP-2 (e.g. polypeptides encoded by Genbank Accession No. X65647 and as described in Blum S et al Three human homologues of a murine gene encoding an inhibitor of stem cell proliferation. DNA Cell Biol. 9: 589-602 (1990); Clements J M et al Biological and structural properties of MIP-1 alpha expressed in yeast. Cytokine 4: 76-82 (1992); Devatelis G et al Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. Journal of Experimental Medicine 167: 1939-44 (1988) (erratum in JEM 170: 2189 (1989)); Farber J M A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proceedings of the National Academy of Science (USA) 87: 5238-42 (1990); Haskill S et al Identification of three related human GRO genes encoding cytokine functions. Proceedings of the National Academy of Science (USA) 87: 7732-6 (1990); Poltorak A N et al (1995) Journal of Inflammation 45(3): 207-19; Rossi D L et al (1997) Journal of Immunology 158(3): 1033-1036; Sherry B et al (1988) Journal of Experimental Medicine 168: 2251-9; Tekamp-Olson P et al (1990) Journal of Experimental Medicine 172: 911-9; Wolpe S D et al (1989) Proceedings of the National Academy of Science (USA) 86: 612-16; Wolpe S D et al (1989) FASEB Journal 3: 2565-73), NAP-2, ENA-78, and GCP-2 comprise a subgroup of the human C-X-C-chemokines defined by the conserved ELR sequence motif (glutamic acid-leucine-arginine) immediately preceding the first cysteine residue near the amino-terminal end. Chemokines with an ELR sequence motif have been found to chemoattract and activate primarily neutrophils. Chemokines without the ELR sequence motif appear to chemoattract and activate monocytes, dendritic cells, T-cells, NK-cells, B-lymphocytes, basophils, and eosinophils.
• Members of the beta-chemokines or 17q chemokine family map to human chromosome 17q11-32 (murine chromosomel 1). The first two cysteine residues are adjacent and, therefore, these proteins are called also C-C chemokines. This subfamily includes ACT-2 (e.g. polypeptides encoded by Genbank Accession No. J04130), CdO (e.g. as described in Berger M S et al (1993) DNA Cell Biol. 12: 839-47. Berger M S et al (1996) δ: 439-447), CCF18 (e.g. as described in Hara T et al (1995) Journal of Immunology 155: 5352-8), DC-CK1 (e.g. as described in Adema G J et al (1997) Nature 387: 713-717), ELC (e.g. polypeptides encoded by Genbank Accession No. AB000887, AF059208), Eotaxin-2 (e.g. as described in Forssmann U et al (1997) Journal of Experimental Medicine 185: 2171-2176), Exodus (e.g. polypeptides encoded by Genbank Accession No. U64197, U88320, U88321, U88322), FIC (e.g. polypeptides encoded by Genbank Accession No. L04694), GDCF and GDCF-2 (e.g. as described in Kuratsu J et al (1989) Journal of the National Cancer Institute 81: 347-51; Yoshimura T et al (1989) Journal of Experimental Medicine 169: 1449-59; Yoshimura T et al (1989) Journal of Immunology 142: 1956-62), HC-21 (e.g. as described in Chang H C & Reinherz E L (1989) European Journal of Immunology 19:1045-1051), HCC-1 (e.g. polypeptides encoded by Genbank Accession No. Z49270), I-309 (e.g. polypeptides encoded by Genbank Accession No. M57502), JE (e.g. polypeptides encoded by Genbank Accession No. AF058786, M28226), LAG-1 (lymphocyte activation gene-1) (e.g. polypeptides encoded by Genbank Accession No. X53683), LARC D86955), LD78 E03130, E03131, MARC (e.g. as described in Thirion S et al (1994) Biochemical and Biophysical Research Communications 201: 493-499), MCAF M24545 and as described in Apella E et al (1990) Progress in Clinical and Biological Research 349: 405-17), MCP-1 (e.g. polypeptides encoded by Genbank Accession No. X14768), MCP-2 (e.g. polypeptides encoded by Genbank Accession No. Y16645), MCP-3 (e.g. polypeptides encoded by Genbank Accession No. X72308, S71251), MCP-4 (e.g. polypeptides encoded by Genbank Accession No. X98306), MCP-5 (e.g. polypeptides encoded by Genbank Accession No. U50712), MIP (macrophage inflammatory protein) (e.g. polypeptides encoded by Genbank Accession No. U77180, U77035, U49513, M35590), MRP-2 (e.g. as described in Youn B S et al (1995) Journal of Immunology 155: 2661-7), RANTES SDF (e.g. polypeptides encoded by Genbank Accession No. M21121, M77747), TARC (e.g Genbank protein Accession No. Q92583).
• In addition there are several other factors that are related to chemokines but that either have not been assigned yet to one of the two chemokine groups or that do not possess the classical features of either of the two chemokine groups (for example, ATAC (e.g. polypeptides encoded by Genbank Accession No. X86474), Ltn (e.g. polypeptides encoded by Genbank Accession No. U15607, U23772), SCM-1 (e.g. polypeptides encoded by Genbank Accession No. D63789, D637090, D43769). These have been referred to as C-type chemokines or gamma-chemokines.
• Yet another group of chemokines has been identified that comprises neurotactin (e.g. polypeptides encoded by Genbank Accession No. AF010586, which is characterized by a CX(3)C cysteine signature motif. The existence of clearly defined subgroups of chemokines on the basis of structural and functional properties illustrates the importance of chemoattractant diversity in the regulation of leukocyte movement through the body.
• The biological activities of chemokines are mediated by specific receptors and also by receptors with overlapping ligand specificities that bind several of these proteins which always belong either to the C-C-chemokines or the group of C-X-C-chemokines. Chemokine receptors belong to the large group of G-protein-coupled seven transmembrane domain receptors which contain seven hydrophobic alpha-helical segments that transverse the membrane. These receptors form a structurally related group within the superfamily of G-protein-coupled receptors which mediate signalling via heterotrimeric G-proteins.
• The receptors that bind C-X-C chemokines are designated CXCR followed by a number (e.g., CXCR-1 (e.g. polypeptides encoded by Genbank Accession No. L19591), CXCR-2 (e.g. polypeptides encoded by Genbank Accession No. M94582), CXCR-3 (e.g. polypeptides encoded by Genbank Accession No. X95876), CXCR-4 (e.g. polypeptides encoded by Genbank Accession No. D87747, AF025375) while those binding C-C chemokines are designated CCR followed by a number (e.g., CCR-1 (e.g. polypeptides encoded by Genbank Accession No.L09230, U29678), CCR-2 (e.g. polypeptides encoded by Genbank Accession No. U29677, U95626), CCR-3 (e.g. polypeptides encoded by Genbank Accession No. U51241), CCR-4 (e.g. polypeptides encoded by Genbank Accession No. X90862, X85740), CCR-5 (e.g. polypeptides encoded by Genbank Accession No. U54994, U83327), CCR-6 (e.g. polypeptides encoded by Genbank Accession No. U95626), CCR-7 (e.g. polypeptides encoded by Genbank Accession No. L31581), CCR-8 (e.g. polypeptides encoded by Genbank Accession No. Z98206, U45983). Viral chemokine receptor homologues include ECRF-3, EBI-1 (EBV-induced gene-1), and US28.
• It is now assumed that the combinatorial effects of multiple chemokines and other mediators are responsible for the cellular composition at inflammatory sites. In addition, many chemokines also directly activate cells. Some of them activate granulocytes and/or monocytes and cause respiratory bursts, degranulation, and the release of lysosomal enzymes. Others prime immune cells to respond to sub-optimal amounts of other inflammatory mediators. Yet others have been shown to be potent histamine releasing factors for basophils. It has been proposed that erythrocytes through their promiscuous chemokine receptor play an important role in regulating the chemokine network. Chemokines bound to the erythrocyte receptor are known to be inaccessible to their normal target cells. This appears to provide a sink for superfluous chemokines and may serve to limit the systemic effects of these mediators without disrupting localized processes taking place at the site of inflammation.
• Certain C-C chemokines exhibit biological activities other than mere chemotaxis. Some chemokines have been shown to be capable of inducing the proliferation and activation of killer cells known as CHAK (C-C-chemokine-activated killer), which are similar to cells activated by IL2.
• Another particularly useful cytokine according to the invention is flt-3 ligand (e.g., polypeptides encoded by Genbank Accession Nos. U04806, U04807, U03858, L23636, U29874, U29875, U44024). This cytokine binds to the flt-3 tyrosine kinase (e.g., polypeptides encoded by Genbank Accession Nos. Z26652, X59398). The human flt-3 ligand also stimulates the proliferation of cells expressing murine flt-3 receptors.
• The effects of flt-3 ligand are synergized by coexpression of G-C SF, GM-C SF, M-CSF, IL3, PIXY-321, and SCF. In combination with SCF and IL3 flt-3 ligand can cause expansion of cells with the marker spectrum CD34 (+)CD38 (−). Alone flt-3 ligand supports the survival of precursor cell types in the lineage of blood-forming cells such as CFU-GM, CFU-GEMM, and the very primitive high proliferative potential colony-forming cells. flt-3 ligand only has marginal effects on erythroid and megakaryocyte progenitor cells.
• In the mouse, flt-3 ligand potently enhances growth of various types of progenitor/precursor cells in synergy with G-CSF, GM-CSF, M-CSF, IL3, IL6, IL7, IL11, IL12 and SCF. flt-3 ligand supports growth of LTC-IC (long-term culture-initiating cells). The ability of flt-3 ligand to promote the survival of hematopoietic progenitor cells is abrogated by TGF-beta and counteracted by TNF-alpha.
• A study of the expression of functional flt-3 receptor and the responses to the ligand in AML (acute myeloid leukemia) and ALL (acute lymphoblastic leukemia) shows a considerable heterogeneity. BCP-ALL in particular fails to proliferate in the presence of flt-3 ligand despite strong expression of surface flt-3 receptor.
• It has been shown that in patients with aplastic anemia and in cancer patients with chemotherapy-induced transient suppression of hematopoiesis, serum levels of flt-3 ligand fluctuate in an inverse relationship to the degree of bone marrow failure. flt-3 ligand levels in serum inversely correlate with the colony forming ability in vitro of bone marrow precursors from patients with aplastic anemia. flt-3 ligand treatment of mice challenged with syngeneic fibrosarcoma cells has been shown to result in complete tumor regression and in decreased tumor growth rates.
• Antitumor cytokines are especially useful in the methods and compositions of the invention. According to the invention, an “antitumor cytokine” is a cytokine that can limit the growth or metastasis of tumor cells in vitro or in vivo, or can prolong the survival of a tumor-bearing animal, when either admixed with the cells or administered to the animal. The cytokine can be formulated as a solution in a biologically compatible buffer, e.g. PBS, and admixed with tumor cells in vitro. The concentration of cytokine may be from about the picomolar range to about the micromolar range. An antitumor cytokine will, for example, reduce the growth rate of the cells, e.g. by at least 10% compared to buffer alone, or inhibit metastatic properties of the cells, as may be evidenced by, e.g., increased cell adhesiveness or decreased ability to invade an extracellular matrix substrate, such as an artificial basement membrane. Alternatively, an antitumor cytokine may inhibit the growth or metastasis of a tumor in vivo, or may prolong the survival of a tumor-bearing animal. To evaluate the in vivo antitumor effects of a cytokine, the cytokine may be formulated in a pharmaceutically acceptable carrier and administered, e.g., by intravenous, intratumoral, or intraperitoneal injection. The cytokine may also be administered in association with cells, such as tumor cells that express or are coated with the cytokine.
• Assays for Bioactivity
• According to the invention, it is preferred that a cytokine be “bioactive”, “highly bioactive”, “extremely bioactive”, “natively bioactive”, or “suprabioactive”. Different levels of bioactivity relate to the ability to induce a change in a leukocyte (other than mere occupancy of the leukocyte's receptors for the cytokine). According to the invention, all naturally occuring cytokines are natively bioactive. Many types of assay can demonstrate the bioactivity of a non-naturally occurring cytokine. For example, a cytokine may be shown to induce survival and/or proliferation of a particular cell type. As another example, a cytokine may change the concentration of an intracellular second messenger, such as cAMP, arachidonic acid, calcium ions, or inositol triphosphate. The following are examples of assays for bioactivity:
• Assay 1
• Each well of one or more 60-well Lux microtiter trays is loaded with 200 FDC-P1 cells in 10 ul Dulbecco's modified Eagle's medium with a final concentration of 10% newborn calf serum. Cytokine in a concentration in at most the micromolar range is added to each well in a volume of 5 ul. The tray is incubated for 48 h at 37° C. in 10% CO₂. Viable cell counts are performed. The average number of viable cells/well is counted. This assay is useful, for example, for identifying bioactivity mediated through a murine GM-CSF receptor.
• Assay 2
• Cytokine sample and a recombinant standard identical to a naturally occurring cytokine are each diluted serially in complete RPM1-10 in 96-well flat-bottom microtiter plates. Each dilution is plated in triplicate. CT.4S cells in active log-phase growth are collected, washed at least twice in complete RPM1-10, and resuspended in complete RPM1-10 at 1×10⁵ cells/ml. 50 ul of the cell suspension is added to each well of the plate, which is then incubated for 24 h at 37° C. in 5% CO₂ Tritiated thymidine is added to each well and the plate is incubated for an additional 24 h. The cells are then harvested and tritium incorporation is measured by liquid scintillation counting. This assay is useful, for example, for identifying bioactivity mediated through an IL-4 receptor.
• Assay 3 (Colony Formation Assay)
• Agar (4% w/v) is melted in sterile water by boiling 3 min. The agar is then cooled to 42° C. and added to 42° C. RPM1-15 to a final concentration of 0.4%. The solution is maintained at 42° C. Femurs are removed from young mice using sterile technique. Marrow is collected by flushing the opened ends of the bones with sterile Hank's Balanced Salt Solution (HBSS) using a syringe equipped with a 23G needle. Marrow is placed in a 15 ml tissue culture tube and vortexed into a cell suspension. Bone fragments are allowed to settle for 5 min, and the supernatant suspension is removed. The suspension is adjusted to 7.5×10⁶ nucleated cells/ml and diluted 1:100 by adding the 42° C. RPMI with 0.4% agar. 2-fold serial dilutions of cytokine are added to 35 mm tissue culture dishes in a volume<=0.2 ml. Control dishes have no cytokine added. 1 ml warm cell suspension is added to each dish and the agar is allowed to set at room temperature. The cultures are incubated for 5-7 days at 37° C. in 5% CO₂. Colony formation is then evaluated by microscopy. The average number of colonies of a given type (or aggregate number of colonies of given different types) on the cytokine plates and the average number on the control plates is counted. This assay is useful, for example, for identifying bioactivity mediated through CSF receptors.
• Assay 4
• Cytokine is diluted serially in RPMI 1640/25 mM HEPES/1% BSA. 25 ul of each dilution is plated in triplicate in a multiwell chemotaxis chamber bottom. Wells containing medium alone serve as negative controls and wells containing chemotaxis-inducing naturally occurring cytokine serve as positive controls. A polycarbonate membrane is placed over the chamber bottom and the chamber is assembled. 50 ul of peripheral blood mononuclear cells at 1.5×10⁶ cells/ml in the RPMI/HEPES/BSA is added to each of the upper wells of the chamber. The chamber is incubated for 90 min at 37° C. in 5% CO₂. The membrane is removed, washed, and stained. Migrated cells in 3-5 random fields of each well are counted by microscopy.
• Assay 5
• Naturally-occurring cytokine reference standard is diluted to 2 ng/ml in a 17×100 mm tube using supplemented medium. 3 further 5-fold serial dilutions are also prepared. Serial dilutions of cytokine are prepared in 17×100 mm tubes from 2 ng/ml to 20 pg/ml. 50 ul of PHA-activated human lymphoblasts 4×10⁵ cells/ml in supplemental medium is added to each well of a 96-well flat-bottom microtiter plate. 50 ul of each dilution of reference standard or cytokine is added to triplicate wells. Negative control wells receive 50 ul of supplemented media alone. The plate is incubated for 48 h at 37° C. in 5% CO₂ and the cells are labeled with tritiated thymidine. Incorporation is measured by liquid scintillation counting. This assay is useful, for example, for identifying bioactivity mediated through an IL-12 receptor.
• Assay 6
• In another assay for bioactivity, an immunocompetent animal is vaccinated with on the order of 10⁴-10⁸ irradiated cytokine-transduced or cytokine-coated tumor cells, and challenged with on the order of 10⁴-10⁸ live wild-type tumor cells (in any temporal sequence). Readouts of the assay are survival, tumor onset, or number of metastases.
• Further examples of cytokine assays can be found, e.g., in: Callard R E et al Assay for human B cell growth and differentiation factors. in: Clemens M J et al (eds) Lymphokines and Interferons. A practical Approach, pp. 345-64, IRL Press, Oxford 1987; Coligan J E et al Current protocols in immunology. Grene and Wiley-Interscience, New York 1991); Dotsika E N Assays for mediators affecting cellular immune functions. Current Opinion in Immunology 2: 932-5 (1989); Feldmann M et al Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunological Reviews 119: 105-123 (1991); Guiguet M et al Misinterpretation of the biological activity of cytokine-containing preparations attributable to unrecognized interacting components. Analytical Biochemistry 247(2): 441-442 (1997); Hamblin A S & O'Garra A Assays for interleukins and other related factors. In: Lymphocytes, a practical approach, Klaus G G B (edt), pp. 209-28, IRL Press, Oxford, (1987); Laska E M & Meisner M J Statistical methods and applications of bioassay. Annu. Rev. Pharmacol. Toxicol. 27: 385-97 (1987); Mosman T R & Fong T A T Specific assays for cytokine production by T cells Journal of Immunological Methods 116: 151-8 (1989); Newton R C & Uhl J Assays relevant to the detection and quantitation of cytokines and their inhibitors. Modem Methods in Pharmacol. 5: 83-99 (1989); Thorpe R et al Detection and measurement of cytokines. Blood Rev. 6: 133-48 (1992); van Zoelen E J The use of biological assays for detection of polypeptide growth factors. Progress in Growth Factor Research 2: 131-52 (1990); Winstanley F P Cytokine bioassay. In: Gallagher G et al (eds) Tumor Immunobiology, A practical Approach. Oxford University Press, pp. 179-303 (1993); Wadha M et al Quantitative biological assays for individual cytokines. In: Balkwill F R (edt) Cytokines, A practical approach. Oxford University press, pp. 309-330 (1991)
• According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 10% but not more than 29% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 30% but not more than 49% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “highly bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 50% but not more than 69% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “extremely bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 70% but not more than 100% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “natively bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is greater than 100% of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “suprabioactive”.
• Ligands for CD40 Useful According to the Invention
• Nucleotide sequences encoding the CD40 proteins of various species are provided by, e.g. Genbank Accession Nos. Y10507, M83312, and U57745. Human CD40 is a transmembrane glycoprotein with a length of 277 amino acids (48 kDa). CD40 is a phosphoprotein and can be expressed as a homodimer. A soluble form of CD40 (28 kDa) has also been described. CD40 protein is expressed on all B-lymphocytes during various stages of development, activated T-cells and monocytes, follicular dendritic cells, thymic epithelial cells, and various carcinoma cell lines. It is expressed on most mature B-cell malignancies and on some early B-cell acute lymphocytic leukemias. CD40 has been demonstrated on the majority of myeloma cell lines and myeloma cells from patients with plasma cell dyscrasia.
• Induction of CD40 mRNA and enhancement of cell surface protein expression in primary human monocytes is observed after treatment with GM-CSF, IL3, or IFN-gamma. The human CD40 gene maps to chromosome 20.
• CD40 has been proposed to play a role in the development of memory cells. It also plays a role in cell activation, functioning as a competence factor and progression factor. Crosslinking of the CD40 antigen (in combination with cytokines such as IL4 and IL5) leads to B-cell proliferation and induces immunoglobulin class switching from IgM to the synthesis of IgG, IgA, and IgE in the absence of activated T-cells. CD40 is one of the obligatory signals required for commitment of naive B-cells to IgA secretion; the mechanism of IgA induction requires the cooperation of IL10 and TGF-beta. Soluble CD40 inhibits T-cell-dependent B-cell proliferation.
• Monoclonal antibodies against CD40 mediate a variety of effects on B-lymphocytes, including induction of intercellular adhesion (via CD11a/CD18 (LFA-1)), short- and long-term proliferation, differentiation and enhanced tyrosine phosphorylation of proteins. Germinal center centrocytes are prevented from undergoing cell death by apoptosis by activation through CD40 and antigen receptors.
• In human resting B-cells expression of CD40 is induced by IL4. Treatment of human B-cells with IL6 leads to the phosphorylation of the intracellular CD40 domain. CD40 does not, however, function as a receptor for IL6. In activated human B-cells the synthesis of IL6 is induced by treatment of the cells with monoclonal antibodies directed against CD40, suggesting that CD40 participates in signal transduction mechanisms dependent on IL6.
• Some limited sequence homologies have been found with receptors for Nerve Growth Factor, TNF-alpha and CD27 and it has been assumed that CD40 may be involved also in modulating the biological activity of these and other cytokines.
• CD40 has biological functions also in non-immune cells although these are still largely unknown. CD40 ligation has been shown to induce cell death by apotosis in transformed cells of mesenchymai and epithelial origin. In part these processes are mediated through the death domain present in the cytoplasmic domain of CD40.
• A particularly useful ligand for CD40 is CD154. CD154 (“CD40 ligand”; human protein 29.3 kDa, 261 amino acids) is a member of the TNF family of proteins. The human protein shows 82.8% and 77.4% identity at the cDNA and protein level, respectively, with a similar protein isolated from murine EL4 thymoma cells. Both proteins are the ligands for the CD40 cell surface antigen expressed on resting B-cells. The human gene encoding CD154 maps to chromosome Xq26.3-q27. Nucleotide sequences encoding the native CD40 ligands of various species are provided by, e.g., Genbank Accession Nos. X67878, X96710, X68550, X65453, Z48469, and L07414. Amino acid sequences of the CD154 molecules of various species are provided, e.g., by Entrez protein database Accession Nos. 1705713, 231718, 560693, 3047129, 116000, 1518170, 38412, 109639, 1083014, 38484, and 37270.
• CD154 is naturally synthesized as a transmembrane polypeptide. Nevertheless, a biologically active soluble fragment of human CD154 has been described (Pietravalle et al, 1996, J Biol Chem 271:5965-5967.) Mazzei et al (1995, J Biol Chem 270:7025-7028) identified a biologically active soluble fragment of CD154 as a homotrimer of polypeptides consisting of amino acids Glu 108 through Leu 261 of intact transmembrane CD154. Graf et al (1995, Eur J Immunol 25:1749) describe another active fragment consisting of the C-terminal fragment produced by proteolyttic cleavage at Met 113. Aruffo et al disclose soluble forms of CD154 and their use to stimulate B cells in vitro in U.S. Pat. No. 5,540,926. In the present invention, particularly useful ligands for CD40 include polypeptides that comprise a sequence as set forth in SEQ ID NO. 2 of the '926 patent, from amino acid residues 47 to 261. These residues are comprised by the extracellular domain of human CD154.
• Another particularly useful type of ligand for CD40 is an antibody to CD40. Examples of such antibodies include the monoclonal antibodies designated product numbers MCA1143 and MCA1590 of Harlan Bioproducts for Science (Indianapolis, Ind.); monoclonal antibodies designated catalog numbers P61640F (produced by clone 14G7), P42374M (produced by clone MAB89), P61046M (produced by clone BL-C4), and P54486M (produced by clone B-B20) of Biodesign International (Kennebunk, Me.); monoclonal antibody designated catalog number 05-422 (produced by clone 626.1) of Upstate Biotechnology (Lake Placid, N.Y.); monoclonal antibody designated catalog number 3601 (produced by clone S2C6) of Mabtech (Nacka, Sweden); monoclonal antibodies designated catalog numbers RDI-CBL486 (produced by clone BB20), RDI-M1691clb (produced by clone CLB-14G7), RDI-mCD40-323 (produced by clone 3/23) of Research Diagnostics (Flanders, N.J.); monoclonal antibodies described in Schwabe et al, 1997, Hybridoma 16:217-226; monoclonal antibodies described in Bjorck et al, 1994, Immunology 83:430-437; monoclonal antibody G28-5 described by Ledbetter et al, 1994, Circ Shock 44:67-72; and monoclonal antibodies described in Buske et al, 1997, Exp Hematol 25:329-337.
• Opsonins Useful According to the Invention
• As defined hereinabove, “opsonin” refers to naturally occurring and non-naturally occurring molecules which bind to both antigens and antigen presenting cells (APCs), such as, for example, phagocytic leukocytes (including monocytes and macrophages), dendritic cells (for example, Langerhans cells of the skin), B lymphocytes and, in humans, endothelial cells, or molecules which can be processed such that at least one product of the processing step or steps can bind to both antigens and antigen presenting cells (APCs), such as, for example, phagocytic leukocytes, dendritic cells, B lymphocytes, and, in humans, endothelial cells.
• Without being bound to any one mechanism of action, it is believed that opsonin-enhanced cells provide a beneficial effect according to the invention because the opsonin portion acts as a link or coupling agent between the antigen and the APC to allow more efficient binding, engulfment, and internalization of the antigen. In addition, the opsonin itself can be internalized with the antigen. “Internalization” refers to the cellular uptake of a molecule such that it is brought into the cytoplasm or a compartment within the cytoplasm of the cell. Phagocytosis is a process by which a molecule is internalized by a cell.
• Preferred opsonins are non-rodent opsonins, e.g., primate, e.g., human, opsonins. Opsonins useful according to the invention bind to receptors on APCs (e.g., phagocytic leukocytes, e.g., macrophages and other cells of the phagocytic system) such as receptors on cells which play a role in innate immunity, as described herein.
• Some sets of opsonins can be regarded as structurally and functionally similar. For example, one family comprises fragments of complement components C3 and C4. These two components are highly structurally homologous, and each possesses an intramolecular thiolester bond that is broken when a peptide (C3a or C4a respectively) is proteolytically cleaved from the native molecule. Disruption of the thiolester makes available a chemical structure that can form an ester linkage with an antigen. The moiety of C3 on which this ester bond resides, i.e. the non-C3a moiety, is designated C3b, and C4b is the analogous product of C4 cleavage. C3b can be further proteolysed by proteins such as factor I to yield fragments such as C3bi and C3d, which also remain linked to the antigen via the ester bond.
• There are four structurally unique proteins that are known to function as high affinity receptors for biologically active, membrane-bound fragments of C3 and/or C4. CR1 is the major receptor for the C3b fragment of C3 and C4b fragment of C4. It is expressed on monocytes and monocyte-derived APCs, among other cell types. CR2 is the major receptor for the fragment of C3 known as C3d, and is expressed on, e.g., mature B lymphocytes, but not on cells of monocytic lineage. The major role of CR2 on B lymphocytes is believed to be direct costimulation of B cells in concert with their cognate antigens.
• CR3 is expressed primarily by neutrophils and monocytes and is also expressed on FDC, Kupffer cells, and NK cells. CR3 is a C3 fragment receptor with a primary specificity for C3bi. CR3 has been proposed as an important organizer of cytoskeletal events necessary for adhesive interactions and membrane reorganization during processes such as phagocytosis.
• CR4 is a member of the beta2 integrin family, and its alpha chain is structurally similar to the alpha chain of CR3 and LFA-1. Its primary physiologic ligands are believed to be C3d and C3d,g;, however, its biologic activities are less well understood than CR3.
• Another example of a family of innate opsonins is the collectins, a group of collagenous C-type lectins that comprises complement component C1q, mannose binding protein, surfactant proteins A and D, and conglutinin. Each molecule comprises a lectin domain that can bind to an antigen, and a collagenous domain that can bind to receptors on phagocytic mononuclear cells, including receptors that are wholly or partially identical to the C1q receptor (Nepomuceno et al, Immunity 6:11'9-29; Tenner et al, Immunity 3:485-93; Guan et al, J Immunol 152:4005-16; Geertsma et al, Am J Physiol 267:L578-84; Miyamura et al, Biochem J 300:237-42; Malhotra et al, J Exp Med 172:955-9; Malhotra et al, Biochem J 293:15-19). Most known collectins comprise multiple polypeptide chains, in some cases homomeric and in others heteromeric, that are assembled post-translationally, in part by covalent cross-linkage of hydroxyproline and hydroxylysine residues. Collectins are demonstrated to be opsonins in, for example, Pikaar et al, J Infect Dis 172:481-9; Alvarez-Dominguez et al, Infection & Immunity 61:3664-72; Kuhlman et al, J Exp Med 169:1733-45; and Geertsma et al, op cit.
• Among the other innate opsonins useful according to the invention are C-reactive protein (CRP), alpha-2 macroglobulin, and fibronectin. CRP, a member of the pentraxin family of molecules, binds to receptors on cells of monocytic lineage and has been shown to be an opsonin (Tebo and Mortenson, J Immunol 144:231-8; Holzer et al, J Immunol 133:1424-30). Alpha-2 macroglobulin, like C3 and C4, comprises an internal thiolester bond that can be disrupted when the molecule is proteolysed. Such disruption allows covalent binding of the molecule to an antigen, and binding of alpha-2 macroglobulin to an APC can promote uptake of the conjugate. Fibronectin binds to the alpha 5 beta 1 integrin and can also bind to various antigens, allowing it to function as an opsonin (Cosio, J Lab Clin Med 103:613-9; Czop and Austen, J Immunol 129:2678-81).
• Immunoglobulins (antibodies) can function as opsonins by binding antigens via their variable regions and APCs via their constant regions. Typically, an immunoglobulin comprises two heavy chains which are covalently bound to each other and each of which is bound to one light chain. These heterotetramers can further assemble into higher-order structures, such as the pentamers of IgM. Both heavy and light chain variable regions can contribute to the structure of the antigen binding site, whereas the APC binding site is located on the heavy chain constant region. Recombinant single-chain antibodies have also been described. APC receptors for immunoglobulins include Fc alpha, Fc gamma, Fc epsilon, and Fc mu receptors for IgA, IgG, IgE, and IgM, respectively.
• Opsonins that are naturally expressed by multicellular eukaryotic organisms are secreted. The latter characteristic distinguishes opsonins from adhesion molecules. A non-naturally occurring molecule containing a naturally occurring APC-binding moiety shall be considered an opsonin if it contains a moiety through which it can be stably bound or attached to a cell such that the APC-binding moiety is located in the extracellular space, whether or not the molecule contains an antigen-binding moiety of a naturally occurring antigen. Moieties through which molecules can be stably bound to a cell include crosslinking moieties, transmembrane sequences, and lipid moieties. The preparation of proteins containing these sequences or moieties is well-known to one of skill in the art.
• An “APC binding moiety of an opsonin” is a sequence or domain of an opsonin which when included in a chimeric molecule permits binding of the chimeric molecule to a receptor that is physiologically expressed on an APC with an affinity at least in the nanomolar range.
• There are a number of examples of opsonin fragments that comprise APC binding moieties. Such a fragment may be any length so long as it retains an APC binding function; for example, it may be about 40 amino acids, 100 amino acids, 150 amino acids, 500 amino acids, 800 amino acids, or even as long as 3000 amino acids. For example, Las Holtet et al, 1994, FEBS Lett 344:242 describe a carboxy-terminal fragment of human α2m (val1299-ala1451) that binds with high affinity to the α2m receptor. Fragments comprising amino acids 1314-1451 of human α2m and the corresponding domain of rat α2m also bind to α2m receptors, albeit with 1-2% of the affinities of native α2m (Van Leuven et al, 1986, J Biol Chem 261:11369; Enghild et al, 1989, Biochemistry 28:1406; Salvesen et al, 1992, FEBS Lett 313:198; Sottrup-Jensen et al, 1986, FEBS Lett 205:20).
• Becherer and Lambris, 1988, J Biol Chem 263:14586 describe fragments of C3b that bind to CR1, e.g., C3c, fragments of C3 generated by elastase treatment and comprising the N-terminal of the alpha′ chain of C3b, and a synthetic peptide comprising the 42 N-terminal amino acids of the C3b alpha′ chain. A binding sequence in C3 for CR3 has also been described (Wright et al, 1987, PNAS 84:4235).
• “Collagen stalks” of C1q, which are N-terminal fragments obtained by pepsin digestion, bind to the C1q receptor (Reid, 1981, Methods Enzymol 80:16; Malhotra et al, 1993, Biochem J 293:15). Malhotra et al, ibid., also provide evidence that an APC binding moiety of conglutinin is comprised by its 55 N-terminal amino acids. Ezekowitz (U.S. Pat. No. 5,270,199) offers a putative APC binding site in human mannose binding protein consisting of nucleotides 370-438 of FIG. 2 in the '199 patent. In addition, by homology with conglutinin, exon 1 disclosed in the '199 patent may comprise an APC binding moiety.
• An APC binding moiety of IgG comprises the CH2 domain and the lower hinge region, including residues 234-237, as described by Canfield and Morrison, 1991, J Exp Med 173:1483-91; Lund et al, 1991, J Immunol 147:2657-62; and Sarmay et al, 1992, Mol Immunol, 29:633-9.
• Examples of opsonins which can be used in the compositions and methods of the invention include fibronectin (e.g., Genbank accessions X02761, K00799, K02273, X82402, X00307, X00739), CRP (e.g., Genbank accessions X17496, M11880, M11881, M11882), complement components such as C1q (e.g., Genbank accessions X66295, M22531, X03084, X58861, and Swiss-Prot accessions P02747, P02745), complement fragments such as C3b and C3d (e.g., Genbank accessions K02782, K02765), mannose binding protein (e.g., Genbank accessions S42292, S42294, X15422), conglutinin (e.g., Genbank accession X71774), alpha-2-macroglobulin (e.g., Genbank accessions M93264, M11313), and surfactant proteins A (e.g., Genbank accessions M68519, S48768) and D (e.g., Genbank accessions L40156, X65018, S38981), immunoglobulins, and their homologues among species.

  TABLE 2
  Exemplary Opsonin, APC binding moiety/APC receptor
  pairs useful according to the invention.

  	Exemplary APC
  Opsonin	Binding Moiety	Receptor
  α-2	Val(1299)-Ala(1451) of	α-2m receptor,
  macroglobulin	human α-2m	CD91
  C3b	42 N-terminal amino	CR1
  	acids of the α′
  	chain of human C3b
  C3bi	C3bi	CR2, CR3
  C3d	C3d	CR2, CR4
  Clq	Collagen stalks (Reid,	Collectin receptor
  	1981, Methods	(Nepomuceno et al.,
  	Enzymol. 80: 16)	1997, Immunity 6:
  		119), CD93
  Conglutinin	55 N-terminal amino	Collectin receptor
  	acids of bovine
  	conglutinin
  MBP	1. Polypeptide encoded	Collectin receptor,
  	by nt 370-438 of	CD35, CD14
  	FIG. 2,
  	U.S. Pat. No. 5,270,199
  	2. Polypeptide encoded
  	by Econ . . . I of FIG. 2,
  	U.S. Pat. No. 5,270,199
  CRP	CRP	CRP receptor, FcγRI,
  		FcγRIIa (CD32)
  Fibronectin	Fibronectin	α5bl integrin
  IgG	CH2 domain plus lower	FcγRI, FcγRII,
  	hinge including amino	FcγRIII
  	acids 234-237, as
  	described by
  	Lund et al., 1991, J.
  	Immunol. 147: 2657
  Surfactant	Surfactant Protein A	Collectin receptor,
  Protein A	Surfactant Protein D	CD 14
  Surfactant
  Protein D

• Determination of Opsonicity According to the Invention
• A given naturally occurring opsonin is considered useful according to the invention if it is determined to possess opsonicity according to one or more of the following assays, and if it is a secreted molecule.
• Assay 1
• In one assay of opsonicity, as described by O'Rear and Ross in Current Protocols in Immunology, 1994, John Wiley & Sons, pp. 13.4.5-9, SRBC bound via a physiologically occurring linkage to the candidate opsonin molecule are obtained. APCs from the species to which the candidate opsonin is native are suspended at 4×10⁶/ml in ice-cold HBSS with 1% (w/v) Cohn fraction of BSA. If the candidate opsonin is a fragment of C3, the APCs are freshly drawn, uncultivated peripheral blood monocytes. SRBC linked to the candidate opsonin or control SRBC (identical to the former but not linked to the candidate opsonin) are suspended in the same solution at 2×10⁸/ml. 100 ul of SRBC suspension and 100 ul of APC suspension are mixed in a 10×75 mm plastic tube. The tube is rotated at 40 rpm at 37° C. for 2-20 min. A small drop of the suspension is placed on a slide, covered with a coverslip, and allowed to stand for 5-10 min. Excess fluid can be removed by pressure on the coverslip, and the coverslip can be sealed to the slide, e.g. with clear nail polish. The slide is examined microscopically, and the percentage of APCs visibly adherent to 4 or more SRBCs is determined. If the percentage is 50% or greater when there are up to 4×10⁴ candidate opsonin molecules/SRBC′, the candidate opsonin can be an opsonin.
• Assay 2 (For Protease-Activated Candidate Opsonin)
• Candidate opsonin or radiolabeled Candidate opsonin is treated with a 1.5-3 fold molar excess of protease (0.05 M triethanolamine-0.1 M NaCl, pH 8.0, room temperature overnight). In this assay, the protease can serve as the antigen or an excess of another antigen can be added. Prior to binding studies, the candidate opsonin-antigen complex is dialyzed against HBSS (4° C.).
• Candidate opsonin-antigen complex binding to monocytes is measured by incubating labeled ligand at a concentration up to 1.0 M with (1.5-4.0)×10⁶ monocytes in 200 ml volume on ice. Nonspecific binding of radiolabeled ligands is determined in the presence of a 100-fold molar excess labeled candidate opsonin-antigen complex. The unbound ligand is separated from the cells and cell-bound ligand by rapid vacuum filtration on glass fiber filters. Studies are performed on ice to avoid potential complications due to endocytosis. Binding constarts and the number of sites per cell are determined by analysis and by nonlinear curve fit. If candidate opsonin-antigen complex affinity for a monocyte binding site is in at least the nanomolar range, the candidate opsonin is an opsonin.
• Assay 3
• Part I
• To directly evaluate whether candidate opsonin is bound to the surface of P. carinii, immunoelectron microscopy is performed. P. carinii are isolated from bronchoaveolar lavage (BAL) of moribund infected rats using TBS with 1 mM calcium to preserve surface-bound candidate opsonin. Isolated organisms are fixed in periodate-lysine-paraformaldehyde buffer and embedded in Lowacryl mounting medium (Ted Pella, Inc., Redding, Calif.). Ultrathin sections are obtained, blocked with normal goat serum (2%) for 1 h, and incubated with either rabbit anti-candidate opsonin or nonimmune rabbit IgG (25 mg/ml) overnight. After washing, the sections are subsequently incubated with goat and rabbit IgG conjugated to 15 nM colloidal gold (Amersham Corp., Arlington Heights, Ill.). The sections are washed again and examined on a transmission electron microscope (model 6400:JEOL USA, Inc., Peabody, Mass.).
• Part II
• The attachment of P. carinii to cultured alveolar macrophages in the presence or absence of antibody to the candidate opsonin or with the addition of purified candidate is quantified as follows. Adherence of P. carinii to alveolar macrophages is assayed by ⁵¹Cr-labeling the organisms. P. carinii are isolated from infected rats with TBS containing 1 mM calcium to prevent loss of surface-bound candidate opsonin. The organisms are radiolabeled by incubation for 8 h at 37° C. in 2 ml of DME containing 20% FCS and 200 mCi of ⁵¹Cr-sodium chromate (New England Nuclear). Normal alveolar macrophages are lavaged from healthy rats and plated in tissue culture plates (1×10⁵) cells/well) which are been precoated with normal rat IgG (100 mg/ml×60 min) in order to ensure firm adherence of the macrophages. After 1 h, the macrophages are gently washed with HBSS to remove nonadherent cells. >95% of macrophages are adherent after this wash. ⁵¹Cr-P. carinii (1×10⁶) containing surface-associated candidate opsonin are added to the macrophages and incubated at 37° C. for an additional hour. Subsequently, nonadherent P. carinii are removed by washing. The macrophage monolayers containing adherent P. carinii are solubilized in 1 N NaOH and quantified. Adherence of P. carinii is defined as: percentage of adherence=(A/A+B)×100, where A=⁵¹Cr-P. carinii associated with the monolayer, and B=unattached ⁵¹Cr-P. carinii. To assess the effect of candidate opsonin on the attachment of P. carinii to alveolar macrophage lung cells in culture, P. carinii adherence assays are conducted in the presence or absence of a polyclonal rabbit antibody generated against the candidate opsonin (100 mg/ml).
• If candidate opsonin binding to P. carinii is apparent in Part I and if, in Part II, % adherence is diminished in the presence of anti-candidate opsonin with statistical significance of P<0.05, the candidate opsonin is an opsonin.
• Assay 4
• Association of bacteria with adherent monocytes is measured as follows. Endotoxin level in the modified PBS and in all buffers used is below 50 pg/ml as determined by the Limulus assay. 5×10³ monocytes in modified PBS are allowed to adhere to the wells of a Terasaki plate for 2 h at 37° C. After nonadherent cells are removed by three washes with PBS, 5×10⁴ FITC-labeled bacteria in 0.5 ml buffer with or without 10-50 micrograms/ml of candidate opsonin are added. A bacteria-to-monocyte ratio of 10:1 to 50:1 is used. After 30 min of incubation at 37° C. in the dark, the nonadherent bacteria are removed by five washes with warm PBS. Assays are performed in quadruplicate; in each well, the number of bacteria associated with ³ 100 monocytes is counted under a flourescence microscope using ×400 magnification. Results are expressed as the number of bacteria associated with 100 monocytes. If this number with candidate opsonin can be at least twice that without candidate opsonin, the candidate opsonin is an opsonin.
• Assay 5
• Part I
• About 1×10⁷ to 6×10⁷ bacteria per ml are incubated (20 min, 0° C.) with 10 mcg/ml of ¹²⁵I-candidate opsonin in a total volume of 0.7 ml. of PBS aliquots, 100 ml, of the reaction mixtures are layered over 150 ml of an oil cushion (60% dibutyl phthalate, 40% dioctyl phthalate [Eastman Kodak Co., Rochester, N.Y.]), and the mixtures are centrifuged (10,000×g, 60 s, 4° C.). The tip of the tube, containing the cell pellet, is cut with a Mozart razor blade, and the radioactivity is counted.
• Part II
• APCs are plated in 96-well tissue culture plates (Costar, Cambridge, Mass.) at 2×10⁵ cells per ml the evening before use. 2×10⁶ bacteria per well (0.1 ml per well) are added to the culture plates with or without 100 mcg/ml of candidate opsonin. The plates are then centrifuged at 1,000×g for 7 min. After 15 min at 37° C. to allow the uptake of bacteria, free bacteria are removed by several washes with cold PBS. They are then incubated (45 min, 37° C.) in RPMI 1640 plus an amount of antibiotic that, when present in the culture for 45 min, kills all extracellular bacteria. The end of this incubation period is considered time zero. Monolayers are washed three times with Hanks' balanced saline solution, and the same volume of RPMI 1640 (R0) is added. The cells are lysed by using several cycles of freezing and thawing. The number (CFU) of viable bacteria per well is determined by quantitative plate counts on blood agar plates (Columbia blood agar; Becton Dickinson, San Jose, Calif.) after 24 h of incubation. Each result is given as the mean of three determinations.
• If, in Part I, candidate opsonin-treated bacterial pellet has >75 KCPM and this incorporation can be inhibited by unlabeled candidate opsonin, and if in Part II the CFU with candidate opsonin is greater than without (P<0.05), the candidate opsonin can be an opsonin.
• Assay 6
• 200 μl of GHBSS (Hanks Balanced Salt Solution)+0.1% of gelatin containing 10 m mol CaCl₂) containing 10⁷ bacteria is prepared. The bacteria are then incubated at 4° C. with 20-100 μg/ml of candidate opsonin. Binding assays are done in the presence or absence of a competitive inhibitor. After incubation for 30 minutes, the bacteria are washed five times in a GHBSS+10 mmol CaCl₂ at room temperature in a microfuge at 1,300 g for 3 minutes. Thereafter, a 1:1,000 dilution of rabbit anti-candidate opsonin antiserum is incubated with the bacteria for 1 h in PBS+5% FCS and 10 mmol CaCl₂ and then the bacteria are washed three times in GHBSS+10 mmol CaCl₂ plus 0.05% Tween 20. Binding of anti-serum to bacteria is detected by a 1:1,000 dilution of goat anti-rabbit IgG conjugated to rhodamine (Fisher Pharmaceuticals, Orangeburg, N.Y.). After incubation, the bacteria are washed five times in GHBSS+10 mmol CaCl₂ plus 0.05% Tween 20, smeared onto glass slides and allowed to air dry. Thereafter bacteria are fixed with 100% ice cold methanol for 5 minutes. Negative controls included the absence of candidate opsonin and no first step antibody. Numerous fields of triplicate assays are examined by fluorescence microscopy.
• Part II Association of Radiolabeled Bacteria with Cells.
• 10⁷ radiolabeled bacteria are resuspended in 200 μl of GHBSS+10 mmol CaCl₂ and are incubated with or without candidate opsonin ranging from 2 μg/ml to 40 μg/ml at 4° C. for 30 min. The bacteria are then washed three times in GHBSS+10 mmol CaCl₂ for 3 min at room temperature in a microfuge at 1,300 g, resuspended in 50 μl of GHBSS and added to a 1-ml suspension containing on the order of 10⁶ APCs (GHBSS). The bacteria and APCs are gently rocked at 37° C. for 20 min and thereafter the unattached bacteria are removed by five washes using differential centrifugation at 82 g in a microfuge. Before the last wash, an aliquot from each sample is plated on a Labtek slide and cells are adhered for 10 min, fixed in methanol, stained with Giemsa, and scored by light microscopy. To score the cells plated on the Labtek slides, at least 400 cells are counted. The phagocytic index represented the number of attached or ingested particles per 100 PMNs. The pellet from above containing cells and radiolabeled bacteria is then lysed in 100 μl PBS+0.5% Triton X-100 and the radioactivity is measured in a scintillation counter. If, in Part I, specific binding of candidate opsonin to bacteria is evident, and in Part II the specific uptake of bacteria, in cpm, is more than three times greater with candidate opsonin than without, the candidate opsonin can be an opsonin.
• Assay 7
• Part I
• To investigate binding to L donovani promastigotes cultures are seeded at 5×10⁵ parasites ml. At regular time points up to 9 days, a fraction of parasites are counted, washed, and resuspended in 1% BSA, 0.5 mM Ca²⁺. 0.05% NaN₃, Tris-buffered saline (TBS), (10 mM Tris-HCl, 0.15 M NaCl, pH 8.0) (diluent) to 2×10⁵ ml⁻¹. Fifty microliters of this suspension are then added to 200-μl microfuge tubes containing 70 μl 5 μg/ml radiolabled candidate opsonin (0.12 μCi/μg) in diluent without EDTA, which had been layered over 150 μl of a dinonyl phthalate/dibutyl phthalate (40:60 v/v) oil mixture. Parasites are incubated for 1 h and centrifuged through the oil layer, the cell pellet is cut off, and associated candidate is detected by gamma counting. Each assay is performed in triplicate. The concentration dependency of candidate binding to promastigotes is also measured as above, using an activity of 0.045 μCi/μg and a twofold dilution series from 60 to 0.015 μg/ml candidate.
• Part II
• APCs are plated out at 1×10⁶ cells/well on glass coverslips in a 24-well tissue culture plate. Cells are incubated in RPMI 1640 (Life Technologies) supplemented with 10% PCS, 1 mM glutamine, 200 U/ml penicillin and 200 μg/ml streptomycin in a humidified incubator at 37° C. After 24 h, nonadherent cells are removed and remaining cells are used after 6 days. Promastigotes are incubated with or without candidate at 30 μg/ml in RPMI 1640 for 1 h and then washed three times before adding to the APC cultures at 10⁶/well. Promastigotes are allowed to infect APCs for 1 h, then cells are washed, fixed with methanol, and Geimsa stained (BDH, Poole, Dorset, U.K.) before counting. The percentage of APCs infected and the number of parasites/100 macrophages is determined from quadruplicate cultures.
• If in Part I the affinity of candidate opsonin for parasites is at least in the nanomolar range and in Part II the number of parasites taken up/100 APCs is, with candidate opsonin, at least twice that without candidate opsonin, the candidate opsonin can be an opsonin.
• Assay 8
• Part I
• Portions (0.5 ml) of [³⁵S] methionine-labeled culture medium containing 5 percent fetal calf serum and the candidate opsonin are incubated for 30 minutes at room temperature with 0.1 ml or 0.2 ml of a 10 percent suspension of a microorganism). The microorganisms tested may include, for example, Salmonella typhimurium, Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Saccharomyces cerevisiae. Bound proteins are released by boiling in buffer containing 2 percent SDS and 0.1 M dithiothreitol and are analyzed on a 5 percent SDS gel.
• Part II
• Fixed bacteria (0.1 ml; 10 percent by volume; 10¹⁰ organisms per millileter), labeled with [³H]thymidine, are incubated with 0.1 ml of serum with or without depletion of the candidate opsonin. After being washed with PBS, the bacteria are incubated with on the order of 1×10⁷ APCs in a final volume of 0.9 ml PBS containing divalent cations. At intervals 0.2 ml is removed to ice-cold PBS with N-ethylmaleimide (2 mM) to block further endocytosis, and the cells are washed (at about 100 g for 10 seconds)
• If in Part I a band corresponding to the candidate opsonin is apparent, and if in Part II the CPM after 6-10 min of incubation is at least three times greater for undepleted samples with serum than with depleted serum, the candidate opsonin can be an opsonin.
• In lieu of results form Parts I of assays 3, 5, 6, 7, 8, a candidate opsonin that satisfies Part II of an assay can be an opsonin if it can bind to the antigen of the assay with an affinity in at least the nanomolar range.
• Assay 9
• SRBC coated with at least 1.2×10⁴ molecules/cell of a fragment of C3 are prepared as described by O'Rear and Ross in Current Protocols in Immunology, 1994, John Wiley & Sons, pp. 13.4.5-9. 250 ul of monocytes at 2×10⁵ cells/ml of RPMI with 10% fetal calf serum are added to each well of an 8-well glass tissue culture plate and incubated at 37° C., 5% CO₂ for 3 h. The monocytes are washed twice with HBSS, and 50 ul of the SRBC at 1.5×10⁸/ml of DVBS²⁺ are added to each well. The plate is centrifuged at 50 g for 5 min and then incubated at 37° C., 5% CO₂ for 3 h. The walls are washed twice with HBSS, fixed with 0.5% glutaraldehyde, and stained with Giemsa stain. If >40% of the monocytes form rosettes with at least 1 SRBC as determined by light microscopy, the candidate can be an opsonin.
• Heat Shock Proteins Useful in the Invention
• Heat shock proteins (HSPs) are associated in cells with a broad spectrum of peptides, polypeptides, denatured proteins and antigens with which they form complexes. Such HSP-peptide complexes have been described as being useful in vaccines against cancers and infectious diseases by Srivastava et al., “Heat shock protein-peptide complexes in cancer immunotherapy” in Current Opinion in Immunology (1994), 6:728-732; Srivastava, “Peptide-Binding Heat Shock Proteins in the Endoplasmic Reticulum” in Advances in Cancer Research (1993), 62:153-177. The HSP-peptide complexes appear to work as vaccines, because they may function as antigen carrying and presentation molecules. The development of vaccines using such antigens has been described by Baltz, “Vaccines in the treatment of Cancer” in Am. J. Health-Syst. Pharm. (1995), 52:2574-2585. The antigenicity of heat shock proteins appears to derive not from the heat shock protein itself, but from the associated peptides, see Udono et al., “Heat Shock Protein 70-associated Peptides Elicit Specific Cancer Immunity” in J. Exp. Med. (1993), 178:1391-1396; Srivastava et al., “Heat shock proteins transfer peptides during antigen processing and CTL priming” in Immunogenetics (1994), 39:93-98; Srivastava, “A Critical Contemplation on the Roles of Heat Shock Proteins in Transfer of Antigenic Peptides During Antigen Presentation” in Behring Inst. Mitt. (1994), 94:37-47. HSPs appear to be part of the process by which peptides are transported to the Major Histocompatibility Complex (MHC) molecules for surface presentation.
• A number of different HSPs have been shown to exhibit immunogenicity, and are useful in the present invention, including, but not limited to: gp96, hsp90, hsp100, hsp60, hsp 25 and hsp70, see Udono et al., supra. and Udono et al., “Comparison of Tumor-Specific Immunogenicities of Stress-Induced Proteins gp96, hsp90, and hsp 70” in Journal of Immunology (1994), 5398-5403; gp96 and grp94, Li et al., “Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation” in The EMBO Journal, Vol. 12, No. 8 (1993), 3143-3151; and gp96, hsp90 and hsp70, Blachere et al., “Heat Shock Protein Vaccines Against Cancer” in Journal Of Immunotherapy (1993), 14:352-356.
• Heat shock proteins may be purified for use in the present invention using a procedure employing DE52 ionexchange chromatography followed by affinity chromatography on ATP-agarose, see Welch et al., “Rapid Purification of Mammalian 70,000-Dalton Stress Proteins: Affinity of the Proteins for Nucleotides” in Molecular and Cellular Biology (June 1985), 1229-1237.
• Adhesion Molecules Useful in the Invention
• Adhesion molecules useful in the present invention include any cell-surface protein which is involved in bediating the recognition and adhesion of cell sto their substrate and to other cells. Cellular adhesion molecules can be divided into two primary classes: Ca²⁺ dependent (cadherins) and Ca²⁺ independent.
• There are over a dozen different types of Ca²⁺ dependent adhesion molecules called cadherins. Most cadherins are single-pass transmembrane glycoproteins composed of about 700-750 amino acid residues. The large extracellular part of the molecule is usually folded into five domains, each containing about 100 amino acid residues. Four of these domains contain presumptive Ca²⁺ binding sites. Cadherins are often present in the cell membrane as dimers.
• Cadherens useful in the present invention include, but are not limited to cadherin E, cadherin N, cadherin BR, cadherin P, cadherin R, cadherin M, cadherin VE, cadherin T&H, cadherin OB, cadherin K, cadherin 7, cadherin 8, cadherin KSP, cadherin LI, cadherin 18, fibroblast 1, cadherin, fibroblast 2, cadherin, fibroblast 3, cadherin 23, desmocollin 1, desmocollin 2, desmoglein 1, desmoglein 2, desmoglein 3, and protocadherin 1, 2, 3, 7, 8, and 9.
• The remaining adhesion molecules are Ca²⁺ independent, and, like the cadherins, may be used as ligands of a cell surface protein on an APC in the present invention. General classes of adhesion molecules as well as specific adhesion molecules useful in the present invention are shown below in Table 3.

  TABLE 3
  Selectins
  	L-selectin; E-selectin; P-selectin
  Integrins
  	α1β1; α2β1; α3β1; α4β1; α5β1; α6β1; α7β1; α8β1; α9β1;
  	ανβ1; αLβ2; αMβ2; αXβ2; αIIbβ3; ανβ3; α6β4; ανβ5; ανβ6;
  	ανβ7; αIELβ7; α11
  Immunoglobulin
  Superfamily
  	Neural Specific: Adhesion molecule on glia (AMOG);
  	L1CAM; Myelin-associated glycoprotein (MAG); Myelin-
  	oligodendrocyte glycoprotein (MOG); NCAM-1 (CD-56);
  	NrCAM; OBCAM; P0protein; PMP-22protein; Neurofascin;
  	NgCAM
  	Systemic IgCAMS: ALCAM; Basigin (CD147); BL-CAM
  	(CD22); CD44; ICAM-1 (CD54); ICAM-3 (CD50); Lymphocyte
  	function antigen-2 (LFA-2); LFA-3 (CD58; MHC molecules;
  	MAdCAM-1; PECAM (CD31); T-cell receptor; VACM-1
  Other Adhesion
  Molecules
  	Agrin; CD34; GlyCAM-1; Oligodendrocyte-myelin
  	glycoprotein (OMGP)

• Defensins Useful in the Invention
• In one embodiment, the portion of the multifunctional molecule which is a ligand of a cell surface protein of an APC is a defensin. Defensins are a large family of broad-spectrum antimicrobial peptides, identified originally in leukocytes of rabbits and humans. Defensins, cationic, polar peptides (30-35 aa, 3-4 kDa), are distinguished by a conserved tri-disulfide and largely beta sheet structure. When expressed at the cell surface, defensins have been hypothesized to function as a biocheical barrier against microbial invection by inhibiting colonization of the epithelium by a wide range of pathogenic microorganisms. Defensins useful in the present invention include, but are not limited to human alpha defensins 1-6, human neutrophil peptides 1-4, human beta defensin 1 and 2, and rat beta defeinsin 1 and 2.
• Counter-Receptors of T Cell Co-Stimulatory Molecules of the Invention
• In one embodiment of the invention the portion of the multifunctional molecule which is a ligand of a cell surface protein of an APC is a counter-receptor of a T cell co-stimulatory molecule. Costimulation is defined as a signaling pathway that does more than simply augment antigen receptor-proximal activation events, but that intersects with antigen-specific signals synergistically to allow lymphocyte activation. Accordingly, a counter-receptor of a co-stimulatory molecule, useful in the present invention includes, but is not limited to a receptor for one or more of B7-1, B7-2, ICOS:B7h, PD-1:PD-L1/PD-L2, CD48, CD40 ligand, and OX40. Counter-receptors useful in the present invention include, but are not limited to CD28, CTLA-4, ICOS, PD-1, members of the TNF receptor family, CD40, the major B cell costimulatory molecule, as well as OX-40, 4-1BB, CD30, and CD27.
• Peptide Linkers
• In one embodiment, the multifunctional molecule is a fusion polypeptide which comprises one or more amino acids interposed between the first and second parts which bind to cells, e.g. a fusion polypeptide which comprises a first amino acid sequence which can bind to an antigen bearing target and a second amino acid sequence which can bind to a leukocyte, and which further comprises at least one amino acid interposed between the first and second parts. The interposed amino acids may comprise, e.g., a linker sequence intended to lessen steric hindrance or other undesirable interactions between the aforementioned first and second parts. For, example, one such type of sequence takes the form (Gly_xSer)_n, wherein n is an integer from between 1 and 15, and x is an integer betewen 1 and 10. Additional useful linkers include, but are not limited to (Arg-Ala-Arg-Asp-Pro-Arg-Val-Pro-Val-Ala-Thr)_1-5 (Xu et al., 1999, Proc. Natl. Acad. Sci. U.S.A. 96: 151-156), (Gly-Ser), (Shao et al., 2000, Bioconjug. Chem. 11: 822-826), (Thr-Ser-Pro)_n (Kroon et al., 2000, Eur. J. Biochem. 267: 6740-6752), (Gly-Gly-Gly), (Kluczyk et al., 2000, Peptides 21: 1411-1420), and (Glu-Lys)_n (Klyczyk et al., 2000, supra), wherein n is 1 to 15 (each of the preceding references is also incorporated herein by reference). In another embodiment, no amino acids are interposed between the first and second parts.
• Antigens Useful According to the Invention
• 1. Viral Antigens
• Examples of viral antigens include, but are not limited to, retroviral antigens such as retroviral antigens from the human immunodeficiency virus (HIV) antigens such as gene products of the gag, pol, and env genes, the Nef protein, reverse transcriptase, and other HIV components; hepatitis viral antigens such as the S. M, and L proteins of hepatitis B virus, the pre-S antigen of hepatitis B virus, and other hepatitis, e.g., hepatitis A, B. and C, viral components such as hepatitis C viral RNA; influenza viral antigens such as hemagglutinin and neuraminidase and other influenza viral components; measles viral antigens such as the measles virus fusion protein and other measles virus components; rubella viral antigens such as proteins E1 and E2 and other rubella virus components; rotaviral antigens such as VP7sc and other rotaviral components; cytomegaloviral antigens such as envelope glycoprotein B and other cytomegaloviral antigen components; respiratory syncytial viral antigens such as the RSV fusion protein, the M2 protein and other respiratory syncytial viral antigen components; herpes simplex viral antigens such as immediate early proteins, glycoprotein D, and other herpes simplex viral antigen components; varicella zoster viral antigens such as gpI, gpII, and other varicella zoster viral antigen components; Japanese encephalitis viral antigens such as proteins E, M-E, M-E-NS 1, NS 1, NS 1-NS2A, 80% E, and other Japanese encephalitis viral antigen components; rabies viral antigens such as rabies glycoprotein, rabies nucleoprotein and other rabies viral antigen components. See Fundamental Virology, Second Edition, e's. Fields, B. N. and Knipe, D. M. (Raven Press, New York, 1991) for additional examples of viral antigens.
• 2. Bacterial Antigens
• Bacterial antigens which can be used in the compositions and methods of the invention include, but are not limited to, pertussis bacterial antigens such as pertussis toxin, filamentous hemagglutinin, pertactin, FIM2, FIM3, adenylate cyclase and other pertussis bacterial antigen components; diptheria bacterial antigens such as diptheria toxin or toxoid and other diphtheria bacterial antigen components; tetanus bacterial antigens such as tetanus toxin or toxoid and other tetanus bacterial antigen components; streptococcal bacterial antigens such as M proteins and other streptococcal bacterial antigen components; grarn-negative bacilli bacterial antigens such as lipopolysaccharides and other gram-negative bacterial antigen components; Mycobacterium tuberculosis bacterial antigens such as mycolic acid, heat shock protein 65 (HSP65), the 30 kDa major secreted protein, antigen 85A and other mycobacterial antigen components; Helicobacter pylori bacterial antigen components; pneumococcal bacterial antigens such as pneumolysin, pneumococcal capsular polysaccharides and other pneumococcal bacterial antigen components; hemophilus influenza bacterial antigens such as capsular polysaccharides and other hemophilus influenza bacterial antigen components; anthrax bacterial antigens such as anthrax protective antigen and other anthrax bacterial antigen components; rickettsiae bacterial antigens such as romps and other rickettsiae bacterial antigen component. Also included with the bacterial antigens described herein are any other bacterial, mycobacterial, mycoplasmal, rickettsial, or chlamydial antigens.
• 3. Fungal Antigens
• Fungal antigens which can be used in the compositions and methods of the invention include, but are not limited to, candida fungal antigen components; histoplasma fungal antigens such as heat shock protein 60 (HSP60) and other histoplasma fungal antigen components; cryptococcal fungal antigens such as capsular polysaccharides and other cryptococcal fungal antigen components; coccidiodes fungal antigens such as spherule antigens and other coccidiodes fungal antigen components; and tinea fungal antigens such as trichophytin and other coccidiodes fungal antigen components.
• 4. Parasite Antigens
• Examples of protozoa and other parasitic antigens include, but are not limited to, plasmodium falciparum antigens such as merozoite surface antigens, sporozoite surface antigens, circumsporozoite antigens, gametocyte/gamete surface antigens, blood-stage antigen pf 1 55/RESA and other plasmodial antigen components; toxoplasma antigens such as SAG-1, p30 and other toxoplasma antigen components; schistosomae antigens such as glutathione-S-transferase, paramyosin, and other schistosomal antigen components; leishmania major and other leishmaniae antigens such as gp63, lipophosphoglycan and its associated protein and other leishmanial antigen components; and trypanosoma cruzi antigens such as the 75-77 kDa antigen, the 56 kDa antigen and other trypanosomal antigen components.
• 5. Tumor Antigens.
• Tumor antigens which can be used in the compositions and methods of the invention include, but are not limited to, telomerase components; multidrug resistance proteins such as P-glycoprotein; MAGE-1, alpha fetoprotein, carcinoembryonic antigen, mutant p53, immunoglobulins of B-cell derived malignancies, fusion polypeptides expressed from genes that have been juxtaposed by chromosomal translocations, human chorionic gonadotrpin, calcitonin, tyrosinase, papillomavirus antigens, gangliosides or other carbohydrate-containing components of melanoma or other tumor cells. It is contemplated by the invention that antigens from any type of tumor cell can be used in the compositions and methods described herein.
• 6. Antigens Relating to Autoimmunity.
• Antigens involved in autoimmune diseases, allergy, and graft rejection can be used in the compositions and methods of the invention. For example, an antigen involved in any one or more of the following autoimmune diseases or disorders can be used in the present invention: diabetes mellitus, arthritis (including rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthritis, psoriatic arthritis), multiple sclerosis, myasthenia gravis, systemic lupus erythematosis, autoimmune thyroiditis, dermatitis (including atopic dermatitis and eczematous dermatitis), psoriasis, Sjogren's Syndrome, including keratoconjunctivitis sicca secondary to Sjogren's Syndrome, alopecia areata, allergic responses due to arthropod bite reactions, Crohn's disease, aphthous ulcer, iritis, conjunctivitis, keratoconjunctivitis, ulcerative colitis, asthma, allergic asthma, cutaneous lupus erythematosus, scleroderma, vaginitis, proctitis, drug eruptions, leprosy reversal reactions, erythema nodosum leprosum, autoimmune uveitis, allergic encephalomyelitis, acute necrotizing hemorrhagic encephalopathy, idiopathic bilateral progressive sensorineural hearing loss, aplastic anemia, pure red cell anemia, idiopathic thrombocytopenia, polychondritis, Wegener's granulomatosis, chronic active hepatitis, Stevens-Johnson syndrome, idiopathic sprue, lichen planus, Crohn's disease, Graves ophthalmopathy, sarcoidosis, primary biliary cirrhosis, uveitis posterior, and interstitial lung fibrosis. Examples of antigens involved in autoimmune disease include glutamic acid decarboxylase 65 (GAD 65), native DNA, myelin basic protein, myelin proteolipid protein, acetylcholine receptor components, thyroglobulin, and the thyroid stimulating hormone (TSH) reception. Examples of antigens involved in allergy include pollen antigens such as Japanese cedar pollen antigens, ragweed pollen antigens, rye grass pollen antigens, animal derived antigens such as dust mite antigens and feline antigens, histocompatiblity antigens, and penicillin and other therapeutic drugs. Examples of antigens involved in graft rejection include antigenic components of the graft to be transplanted into the graft recipient such as heart, lung, liver, pancreas, kidney, and neural graft components. An antigen can also be an altered peptide ligand useful in treating an autoimmune disease.
• Examples of miscellaneous antigens which can be can be used in the compositions and methods of the invention include endogenous hormones such as luteinizing hormone, follicular stimulating hormone, testosterone, growth hormone, prolactin, and other hormones, drugs of addiction such as cocaine and heroin, and idiotypic fragments of antigen receptors such as Fab-containing portions of an anti-leptin receptor antibody.
• Determination of Binding of a Multifunctional Molecule to a Antigen Bearing Target or APC
• Multiple techniques are known to those of skill in the art for detecting protein-protein binding. That is, the binding of a multifunctional molecule of the invention to either or both of an antigen bearing target and an APC.
• The association between the multifunctional molecule and an antigen bearing target and/or an APC may be measured for example by Fluorescent Resonance Energy Transfer (FRET), wherein one peptide (i.e., the multifunctional molecule) comprises a fluorescent label moiety, and the antigen bearing target or APC harbours a second such moiety, and where excitation at an appropriate wavelength may result in absorption of photons by one label, followed by FRET, and emission at a second wavelength characteristic of the second fluorophore, this emission being measured and corresponding to the amount of antigen bearing target or APC which is associated with the multifunctional molecule. Alternatively, this association may be measured in one of many other ways which are described more fully below.
• A “fluorescent tag” or “fluorescent group” refers to either a fluorophore or a fluorescent protein or fluorescent fragment thereof, or refers to a fluorescent amino acid such as tryptophan which may be incorporated into a polypeptide. “Fluorescent protein” refers to any protein which fluoresces when excited with appropriate electromagnetic radiation. This includes proteins whose amino acid sequences are either natural or engineered.
• It is additionally preferred that the fluorophores comprise fluorescein and tetramethylrhodamine or another suitable pair. In another preferred embodiment, the label comprises two different fluorescent proteins. It is preferred that fluorescent proteins comprise any protein selected from the group consisting of green fluorescent protein (GFP), blue fluorescent protein, red fluorescent protein and other engineered forms of GFP.
• Preferably, the polypeptide comprises a cysteine amino acid through which the label is attached via a covalent bond. More preferably, the label may be attached via a primary amine group such as via a lysine residue. As will be apparent to a person skilled in the art, it is preferable to avoid using the same chemistry for both labelling and immobilising polypeptides of the invention. For example, if the polypeptide is immobilised via cysteine residues, the label is advantageously attached via lysine residues.
• Preferably, the measuring is performed by fluorescent resonance energy transfer (FRET), fluorescence anisotropy or fluorescence correlation spectroscopy, or by measuring the binding of a fluorescent partner polypeptide to an immobilised polypeptide. Techniques for performing such measurements are well known to those of skill in the art.
• It is preferred that the fluorescence emitting means comprise two different fluorophores, and particularly preferred that the fluorophores comprise fluorescein and tetramethylrhodamine or another suitable pair.
• As used herein with regard to fluorescent labels for use in FRET, the term “appropriate combination” refers to a choice of reporter labels such that the emission wavelength spectrum of one (the “donor” moiety) is within the excitation wavelength spectrum of the other (the “acceptor” moiety).
• Methods of detection without use of label are known in the art. These include detection using surface plasmon resonance to detect changes in the mass of, for example the multifunctional molecule, which would occur if binding of the partner polypeptide increased or decreased. Such measurements may be made for example using a BIACORE machine. In this embodiment, the multifunctional molecule is immobilized on a solid support prior to contacting the molecule with the antigen bearing moiety and/or APC.
• In addition to the above methods, one technique for determing the binding of a multifunctional molecule of the invention to an antigen bearing moiety and/or and APC involves the use of antibodies specifically directed to the multifunctional molecule. Briefly, antigen bearing cells, for example, are incubated with the multifunctional molecule of the invention in RPMI 1640, or other suitable buffer, for 1-4 hours at 37° C. with shaking. The cells are then washed in PBS containing 2% FBS, or other cell culture serum. The antigen bearing cells are then incubated with, for example, an FITC labeled anti-multifunctional molecule antibody for 1 hour at 4° C. After additional washing in PBS, the cells are analyzed by flow cytometry, wherein the identification of labeled cells is indicative of the binding of the multifunctional molecule of the invention to the antigen bearing cell.
• Preparation of a Cell Containing a Recombinant Nucleic Acid According to the Invention
• In one embodiment of the present invention, a nucleic acid molecule encoding a multifunctional molecule of the present invention is introduced into a host cell capable of expressing the nucleic acid molecule so as to produce the multifunctional molecule. In one embodiment, the host cell is permitted to express the nucleic acid ex vivo. In an alternate embodiment, the host cell is transfected with the nucleic acid molecule encoding the multifunctional molecule, and then placed back into the host animal from which it was obtained, wherein the multifunctional polypeptide molecule is expressed in vivo in the host animal.
• Host cells are transfected, as taught herein, via conventional methods well-known in the art. Suitable methods for transforming or transfecting host cells can be found in Sambrook et al. (Molecular Cloning: A Laboratory Manual, 2nd Edition, Cold Spring Harbor Laboratory press (1989)), and other laboratory manuals. Additional examples of methods of introducing nucleic acid molecules encoding multifunctional molecules are described below. The cells containing the introduced nucleic acid molecules encoding, for example, multifunctional molecule and/or an antigen, can themselves be administered to a subject (as the antigen) according to the methods of the invention, e.g., in a vaccine composition.
• A. Introduction of Naked Nucleic Acid into Cells
• 1. Transfection mediated by DEAE-dextran: Naked nucleic acid can be introduced into cells by forming a mixture of the nucleic acid and DEAE-dextran and incubating the mixture with the cells. A dimethylsulfoxide or chloroquine shock step can be added to increase the amount of nucleic acid uptake. DEAE-dextran transfection is only applicable to in vitro modification of cells and can be used to introduce nucleic acid transiently into cells but is not preferred for creating stably transfected cells. Thus, this method can be used for short term production of a gene product but is not a method of choice for long-term production of a gene product. Protocols for DEAE-dextran-mediated transfection can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (e's.) Greene Publishing Associates, (1989), Section 9.2 and in Molecular Cloning: A Laboratory Manual. 2nd Edition. Sambrook et al. Cold Spring Harbor Laboratory Press, (1989), Sections 16.41-16.46 or other standard laboratory manuals.
• 2. Electroporation: Naked nucleic acid can also be introduced into cells by incubating the cells and the nucleic acid together in an appropriate buffer and subjecting the cells to a high-voltage electric pulse. The efficiency with which nucleic acid is introduced into cells by electroporation is influenced by the strength of the applied field, the length of the electric pulse, the temperature, the conformation and concentration of the nucleic acid and the ionic composition of the media. Electroporation can be used to stably (or transiently) transfect a wide variety of cell types and is only applicable to in vitro modification of cells. Protocols for electroporating cells can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (e's.) Greene Publishing Associates, (1989), Section 9.3 and in Molecular Cloning: A Laboratory Manual, 2nd Edition, Sambrook et al. Cold Spring Harbor Laboratory Press, (1989), Sections 16.54-16.55 or other standard laboratory manuals.
• 3. Liposome-mediated transfection (“lipofection”): Naked nucleic acid can be introduced into cells by mixing the nucleic acid with a liposome suspension containing cationic lipids. The nucleic acid/liposome complex is then incubated with cells. Liposome mediated transfection can be used to stably (or transiently) transfect cells in culture in vitro. Protocols can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (e's.) Greene Publishing Associates, (1989), Section 9.4 and other standard laboratory manuals. Additionally, gene delivery in vivo has been accomplished using liposomes. See for example Nicolau et al. (1987) Meth. Enz. 149:157-176; Wang and Huang (1987) Proc. Natl. Acad. Sci. SA 84:7851-785S; Brigham et al. (1989) Am. J. Med. Sci. 298:278; and Gould-Fogerite et al. (1989) Gene 84:429-438.
• 4. Direct Injection: Naked nucleic acid can be introduced into cells by directly injecting the nucleic acid into the cells. For an in vitro culture of cells, nucleic acid can be introduced by microinjection. Since each cell is microinjected individually, this approach is very labor intensive when modifying large numbers of cells. However, a situation wherein microinjection is a method of choice is in the production of transgenic animals (discussed in greater detail below). In this situation, the nucleic acid is stably introduced into a fertilized oocyte which is then allowed to develop into an animal. The resultant animal contains cells carrying the nucleic acid introduced into the oocyte. Direct injection has also been used to introduce naked nucleic acid into cells in vivo (see e.g., Acsadi et al. (1991) Nature 332: 815-818; Wolff et al. (1990) Science 247:1465-1468). A delivery apparatus (e.g., a “gene gun”) for injecting DNA into cells in vivo can be used. Such an apparatus is commercially available (e.g., from BioRad).
• 5. Receptor-Mediated DNA Uptake: Naked nucleic acid can also be introduced into cells by complexing the nucleic acid to a cation, such as polylysine, which is coupled to a ligand for a cell-surface receptor (see for example Wu, G. and Wu, C. H. (1988) J. Biol. Chem 263:14621; Wilson et al. (1992) J. Biol. Chem. 267:963-967; and U.S. Pat. No. 5,166,320). Binding of the nucleic acid-ligand complex to the receptor facilitates uptake of the nucleic acid by receptor-mediated endocytosis. Receptors to which a nucleic acid-ligand complex have targeted include the transferrin receptor and the asialoglycoprotein receptor. A nucleic acid-ligand complex linked to adenovirus capsids which naturally disrupt endosomes, thereby releasing material into the cytoplasm can be used to avoid degradation of the complex by intracellular lysosomes (see for example Curiel et al. (1991) Proc. Natl. Acad. Sci. USA 88:8850; Cristiano et al. (1993) Proc. Natl. Acad. Sci USA 90:2122-2126). Receptor-mediated nucleic acid uptake can be used to introduce nucleic acid into cells either in vitro or in vivo and, additionally, has the added feature that nucleic acid can be selectively targeted to a particular cell type by use of a ligand which binds to a receptor selectively expressed on a target cell of interest.
• Generally, when naked nucleic acid is introduced into cells in culture (e.g., by one of the transfection techniques described above) only a small fraction of cells (about 1 out of 105) typically integrate the transfected nucleic acid into their genomes (i.e., the nucleic acid is maintained in the cell episomally). Thus, in order to identify cells which have taken up exogenous nucleic acid, it is advantageous to transfect nucleic acid encoding a selectable marker into the cell along with the nucleic acid(s) of interest. Preferred selectable markers include those which confer resistance to drugs such as G418, hygromycin and methotrexate. Alternatively, a selectable marker maybe one which emits a detectable signal upon expression such as green fluorescen protein or blue fluorescent protein. Selectable markers may be introduced on the same plasmid as the gene(s) of interest or may be introduced on a separate plasmid.
• B. Viral-Mediated Gene Transfer
• A preferred approach for introducing nucleic acid encoding a gene product into a cell is by use of a viral vector containing nucleic acid, e.g. a cDNA, encoding the gene product. Infection of cells with a viral vector has the advantage that a large proportion of cells receive the nucleic acid, which can obviate the need for selection of cells which have received the nucleic acid. Additionally, molecules encoded within the viral vector, e.g., by a cDNA contained in the viral vector, are expressed efficiently in cells which have taken up viral vector nucleic acid and viral vector systems can be used either in vitro or in vivo.
• 1. Retroviruses: Defective retroviruses are well characterized for use in gene transfer for gene therapy purposes (for a review see Miller, A. D. (1990) Blood 76:271). A recombinant retrovirus can be constructed having a nucleic acid encoding a gene product of interest inserted into the retroviral genome. Additionally, portions of the retroviral genome can be removed to render the retrovirus replication defective. The replication defective retrovirus is then packaged into virions which can be used to infect a target cell through the use of a helper virus by standard techniques. Protocols for producing recombinant retroviruses and for infecting cells in vitro or in vivo with such viruses can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (eds.) Greene Publishing Associates, (1989), Sections 9.10-9.14 and other standard laboratory manuals. Examples of suitable retroviruses include pLJ, pZIP, pWE and pEM which are well known to those skilled in the art. Examples of suitable packaging virus lines include φCrip, φCre, _—2, and_Am. Retroviruses have been used to introduce a variety of genes into many different cell types, including epithelial cells, endothelial cells, lymphocytes, myoblasts, hepatocytes, bone marrow cells, in vitro and/or in vivo (see for example Eglitis, et al. (1985) Science 230:1395-1398; Danos and Mulligan (1988) Proc. Natl. Acad. Sci. USA 85:6460-6464; Wilson et al. (1988) Proc. Natl. Acad. Sci. USA 85:3014-3018; Armentano et al. (1990) Proc. Natl. Acad. Sci. USA 87:6141-6145; Huber et al. (1991) Proc. Natl. Acad. Sci. USA 88:8039-8043; Ferry et al. (1991) Proc. Natl. Acad. Sci. USA 88:8377-8381; Chowdhury et al. (1991) Science 254:1802-1805; van Beusechem et al. (1992) Proc. Natl. Acad. Sci. USA 89:7640-7644; Kay et al. (1992) Human Gene Therapy 3:641-647; Dai et al. (1992) Proc. Natl. Acad. Sci. USA 89:10892-10895; Hwu et al. (1993) J. Immunol. 150:4104-115; U.S. Pat. No. 4,868,116; U.S. Pat. No. 4,980,286; PCT Application WO 89/07136; PCT Application WO 89/02468; PCT Application WO 89/05345; and PCT Application WO 92/07573). Retroviral vectors require target cell division in order for the retroviral genome (and foreign nucleic acid inserted into it) to be integrated into the host genome to stably introduce nucleic acid into the cell. Thus, it may be necessary to stimulate replication of the target cell.
• 2. Adenoviruses: The genome of an adenovirus can be manipulated such that it encodes and expresses a gene product of interest but is inactivated in terms of its ability to replicate in a normal lytic viral life cycle. See for example Berkner et al. (1988) BioTechniques 6:616; Rosenfeld et al. (1991) Science 252:431-434; and Rosenfeld et al. (1992) Cell 68:143-155. Suitable adenoviral vectors derived from the adenovirus strain Ad type 5 d1324 or other strains of adenovirus (e.g., Adz, Ad3, Ad7 etc.) are well known to those skilled in the art. Recombinant adenoviruses are advantageous in that they do not require dividing cells to be effective gene delivery vehicles and can be used to infect a wide variety of cell types, including airway epithelium (Rosenfeld et al. (1992) cited supra), endothelial cells (Lemarchand et al. (1992) Proc. Natl. Acad. Sci. USA 89:6482-6486), hepatocytes (Herz and Gerard (1993) Proc. Natl. Acad. Sci. USA 90:2812-2816) and muscle cells (Quantin et al. (1992) Proc. Natl. Acad. Sci. USA 89:2581-2584). Additionally, introduced adenoviral nucleic acid (and foreign DNA contained therein) is not integrated into the genome of a host cell but remains episomal, thereby avoiding potential problems that can occur as a result of insertional mutagenesis in situations where introduced nucleic acid becomes integrated into the host genome (e.g., retroviral DNA). Moreover, the carrying capacity of the adenoviral genome for foreign DNA is large (up to 8 kilobases) relative to other gene delivery vectors (Berkner et al. cited supra; Haj-Ahmand and Graham (1986) J. Virol. 57:267). Most replication-defective adenoviral vectors currently in use are deleted for all or parts of the viral E1 and E3 genes but retain as much as 80% of the adenoviral genetic material.
• 3. Adeno-Associated Viruses: Adeno-associated virus (AAV) is a naturally occurring defective virus that requires another virus, such as an adenovirus or a herpes virus, as a helper virus for efficient replication and a productive life cycle. (For a review see Muzyczka et al. Curr. Topics in Micro. and Immunol. (1992) 158:97-129). It is also one of the few viruses that may integrate its DNA into non-dividing cells, and exhibits a high frequency of stable integration (see for example Flotte et al. (1992) Am. J. Respir. Cell. Mol. Biol. 7:349-356; Samulski et al. (1989) J. Virol. 63:3822-3828; and McLaughlin et al. (1989) J. Virol 62:1963-1973). Vectors containing as little as 300 base pairs of AAV can be packaged and can integrate. Space for exogenous nucleic acid is limited to about 4.5 kb. An AAV vector such as that described in Tratschin et al. (1985) Mol. Cell. Biol. 5:3251-3260 can be used to introduce nucleic acid into cells. A variety of nucleic acids have been introduced into different cell types using AAV vectors (see for example Hermonat et al. (1984) Proc. Natl. Acad. Sci. USA 81 :6466-6470; Tratschin et al. (1985) Mol. Cell. Biol. 4:2072-2081; Wondisford et al. (1988) Mol. Endocrinol. 2:32-39; Tratschin et al. (1984) J. Virol.51:611-619; and Flotte et al. (1993) J. Biol. Chem. 268:3781-3790).
• The efficacy of a particular expression vector system and method of introducing nucleic acid into a cell can be assessed by standard approaches routinely used in the art. For example, nucleic acid introduced into a cell can be detected by a filter hybridization technique (e.g., Southern blotting) and RNA produced by transcription of introduced nucleic acid can be detected, for example, by Northern blotting, RNase protection or reverse transcriptase-polymerase chain reaction (RI-PCR). The gene product can be detected by an appropriate assay, for example by immunological detection of a produced protein, such as with a specific antibody, or by a functional assay to detect a functional activity of the gene product, such as an enzymatic assay. If the gene product of interest to be expressed by a cell is not readily assayable, an expression system can first be optimized using a reporter gene linked to the regulatory elements and vector to be used. The reporter gene encodes a gene product which is easily detectable and, thus, can be used to evaluate the efficacy of the system. Standard reporter genes used in the art include genes encoding beta-galactosidase, chloramphenicol acetyl transferase, luciferase and human growth hormone.
• Cells Useful According to the Invention
• The invention provides for host cells transfected with nucleic acid constructs encoding a multifunctional molecule of the invention. Host cells useful in the invention include but are not limited to the following.
• A host cell can be any cell which is able to act as a carrier for an antigen according to the invention and thus may be a nucleated cell or a procaryotic cell into which nucleic acid can be artificially introduced. Procaryotic cells useful according to the invention include bacterial cells. Eucaryotic (nucleated) cells useful according to the invention include cells of a yeast, fungus, cells of a parasite and mammalian cells. Mammalian cells useful according to the invention include but are not limited to fibroblasts, including specialized mesenchymal cells such as a synoviocytes; keratinocytes, epithelial cells, endothelial cells, leukocytes and tumor cells.
• Cell lines useful according to the invention include but are not limited to B16, CMS-5 fibrosarcoma cells, Cos1 cells and CHO cells, TS/A, Lewis lung carcinoma, RENCA, Dunning rat prostate carcinoma, and cell lines included in the catalogue of the American Type Culture Collection (Manassas, Va.).
• Host cells comprising a nucleic acid molecule encoding a multifunctional molecule of the invention can be prepared from pathogenic cells according to the invention. Pathogenic cells include tumor cells (e.g. B16 cells, CMS-5 fibrosarcoma cells, and cells derived from the tumors included in the section entitled “Tumors for which the Invention is Useful”), and cells derived from pathogenic bacterium, pathogenic fungus, pathogenic virus, pathogenic parasite, or a pathogenic arthropod.
• Methods of Detecting Expression From an Artificially Introduced Recombinant Nucleic Acid Sequence
• The invention provides for methods of detecting a protein (e.g., a multifunctional molecule) that is expressed from a recombinant nucleic acid molecule that has been artificially introduced into a cell.
• Preparation of Antibodies
• Antibodies specific for a protein useful according to the invention (e.g., a multifunctional molecule) are useful for protein purification, and for the detection of expression of these proteins from cells into which a recombinant nucleic acid molecule expressing these proteins has been artificially introduced. By antibody, we include constructions using the binding (variable) region of such an antibody, and other antibody modifications. Thus, an antibody useful in the invention may comprise a whole antibody, an antibody fragment, a polyfunctional antibody aggregate, or in general a substance comprising one or more specific binding sites from an antibody. The antibody fragment may be a fragment such as an Fv, Fab or F(ab′)₂ fragment or a derivative thereof, such as a single chain Fv fragment. The antibody or antibody fragment may be non-recombinant, recombinant or humanized. The antibody may be of an immunoglobulin isotype, e.g., IgG, IgM, and so forth. In addition, an aggregate, polymer, derivative and conjugate of an immunoglobulin or a fragment thereof can be used where appropriate.
• Although a protein product (or fragment or oligopeptide thereof) of a protein according to the invention (e.g., a multifunctional molecule according to the invention) that is useful for the production of antibodies does not require biological activity, it must be antigenic. Antibodies may be directed to any portion of the multifunctional molecule of the invention. For example, an antibody may be directed to the lecting portion of the multifunctional molecule or to the ligand portion of the multifunctional molecule. Peptides used to induce specific antibodies may have an amino acid sequence consisting of at least five amino acids and preferably at least 10 amino acids. Preferably, they should be identical to a region of the natural protein and may contain the entire amino acid sequence of a small, naturally occurring molecule. Short stretches of amino acids corresponding to the protein product of a recombinant nucleic acid encoding a protein useful according to the invention (e.g., a multifunctional molecule according to the invention) may be fused with amino acids from another protein such as keyhole limpet hemocyanin or GST, and antibody will be produced against the chimeric molecule. Procedures well known in the art can be used for the production of antibodies to the protein products of recombinant nucleic acids of the invention.
• For the production of antibodies, various hosts including goats, rabbits, rats, mice etc. may be immunized by injection with the protein products (or any portion, fragment, or oligonucleotide thereof which retains immunogenic properties) of the recombinant nucleic acid molecules encoding proteins useful according to the invention. Depending on the host species, various adjuvants may be used to increase the immunological response. Such adjuvants include but are not limited to Freund's, mineral gels such as aluminum hydroxide, and surface active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemocyanin, and dinitrophenol. BCG (bacilli Calmette-Guerin) and Corynebacterium parvum are potentially useful human adjuvants.
• I. Polyclonal Antibodies.
• The antigen protein may be conjugated to a conventional carrier in order to increase its immunogenicity, and an antiserum to the peptide-carrier conjugate will be raised. Coupling of a peptide to a carrier protein and immunizations may be performed as described (Dymecki et al., 1992, J. Biol. Chem., 267: 4815). The serum can be titered against protein antigen by ELISA (below) or alternatively by dot or spot blotting (Boersma and Van Leeuwen, 1994, J. Neurosci. Methods, 51: 317). At the same time, the antiserum may be used in tissue sections prepared as described. A useful serum will react strongly with the appropriate peptides by ELISA, for example, following the procedures of Green et al., 1982, Cell, 28: 477.
• 2. Monoclonal Antibodies.
• Techniques for preparing monoclonal antibodies are well known, and monoclonal antibodies may be prepared using a candidate antigen (e.g., a mulispecific molecule or a lectin whose level is to be measured or which is to be either inactivated or affinity-purified, preferably bound to a carrier, as described by Arnheiter et al., 1981, Nature, 294;278.
• Monoclonal antibodies are typically obtained from hybridoma tissue cultures or from ascites fluid obtained from animals into which the hybridoma tissue was introduced.
• Monoclonal antibody-producing hybridomas (or polyclonal sera) can be screened for antibody binding to the target protein.
• 3. Antibody Detection Methods
• Particularly preferred immunological tests rely on the use of either monoclonal or polyclonal antibodies and include enzyme-linked immunoassays (ELISA), immunoblotting and immunoprecipitation (see Voller, 1978, Diagnostic Horizons, 2:1, Microbiological Associates Quarterly Publication, Walkersville, Md.; Voller et al., 1978, J. Clin. Pathol., 31: 507; U.S. Reissue Pat. No. 31,006; UK Patent 2,019,408; Butler, 1981, Methods Enzymol., 73: 482; Maggio, E. (ed.), 1980, Enzyme Immunoassay, CRC Press, Boca Raton, Fla.) or radioimmunoassays (RIA) (Weintraub, B., Principles of radioimmunoassays, Seventh Training Course on Radioligand Assay Techniques, The Endocrine Society, March 1986, pp. 1-5, 46-49 and 68-78). For analysing tissues for the presence or absence of a protein produced by a recombinant nucleic acid encoding a protein useful according to the invention (e.g., multifunctional molecule or portion thereof), immunohistochemistry techniques may be used. It will be apparent to one skilled in the art that the antibody molecule may have to be labelled to facilitate easy detection of a target protein. Techniques for labelling antibody molecules are well known to those skilled in the art (see Harlow and Lane, 1989, Antibodies, Cold Spring Harbor Laboratory).
• Determining Whether an Immune Response is Modulated According to the Invention
• The multifunctional molecules described herein are useful according to the invention to modulate an immune response in a mammalian, preferably a human, to an antigen or antigens contained in the antigen bearing target which is bound to the lectin portion of the multifunctional molecule. In one embodiment, a composition comprising a multifunctional molecule bound to an antigen bearing target is administered to an animal, preferably a human. The second portion of the multifunctional molecule comprising a ligand for a cell-surface molecule of an APC targets the composition to antigen presenting cells in the animal to which the composition has been administered. The antigen bearing target is taken up (i.e., ingested or phagocytosed) by antigen presenting cells. Alternatively, the multifunctional molecule/antigen bearing target complex is contacted with antigen presenting cells in vitro under conditions which allow phagocytosis, wherein the APCs are subsequently returned to the host organinsm from which they were derived.
• The present invention thus provides a method for modulating an immune response in an mammal comprising administering to the mammal a composition comprising at least a multifunctional molecule as described herein. In one embodiment, the composition further comprises an antigen bearing target. In a further embodiment, the composition still further comprises an APC.
• An “immune response” refers to stimulation/activation of a selected response involving the immune system, or suppression, elimination, or attenuation of a selected response. In a preferred embodiment, an immune response refers to stimulation/activation of a selected response involving the immune system by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100% or at least 100% or greater, or suppression, elimination, or attenuation of a selected response by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100% or at least 100% or greater, as compared to control cells that are not CD 40-ligand enhanced cells. Thus, to modulate an immune response means that the desired response is more efficient, more rapid, greater in magnitude, and/or more easily induced than when an antigen bearing target is contacted with an APC in the absence of a multifunctional molecule. Different immune responses in the subject may be modulated differentially, e.g., the cellular immune response may be selectively enhanced while the humoral response may be selectively attenuated, and vice versa.
• The following in vitro and in vivo assays are useful for determining whether an immune response is modulated according to the invention. The assays described in detail below measure stimulation or suppression of cellular or humoral immune responses to an antigen. The antigens referred to in the following assays are representative. It will be apparent to one of skill in the art that an immune response to a selected antigen useful according to the invention may be measured using one or more of the following assays by adapting the assay to that antigen.
• I. Detection of Increased Phagocytosis
• The following assay may be used in order to determine whether opsonin-enhanced cells stimulate phagocytosis by antigen presenting cells.
• Phagocytosis is examined using monocytes that have been adhered at 37° for 30 min in RPMI without added FCS. Sheep erythrocytes are incubated with an opsonin, or its precursor, under conditions such that there are no more than 300 of such molecules, on average, are deposited on each erythrocyte. If a precursor is used, coated erythrocytes are then processed to convert all precursors to the actual candidate molecule (e.g., See Carlo et al., J. Immunol. 123:523-8(1979)). Fresh monocytes are isolated from the subject, and 5×-1×10⁵ of these cells suspended in 0.25-0.5 ml of RPMI medium with 1% BSA. This aliquot is placed in a tissue culture well and incubated for 30 min at 37° C. An excess of coated erythrocytes, suspended at 1.2×10⁸ cells/ml, is overlain on the monocytes, the plate is centrifuged for 5 min at 50 g, and incubated for 30 min at 37° C. Non-ingested material is removed in two hypotonic lysis steps using ice-cold lysing buffer before fixing and staining the adherent cells, and examining the cells under light microscopy. Phagocytosis is quantified by determining the percentage of 100 monocytes ingesting one or more target cells, and the total number of ingested E/100 monocyptes (PI) is recorded. Stimulation of phagocytosis according to the invention is indicated by a phagocytic index of equal to or greater than 40.
• Another assay for phagocytosis is as follows: Cells of the murine macrophage line are harvested and suspended in DMEM-10 at 4×10⁵/ml. 2.0 ml of this suspension is aliquoted into individual 3.5 cm cell culture plates, and the dishes incubated at 37° C. in 5% CO₂ overnight. Target cells, as well as control cells, are harvested on the same day as the macrophages, washed in PBS, and resuspended 2 min in PKH26 dye (a 2 μM solution in 1 ml of the supplied diluent) at 5×10⁶ cells/ml. The fluorescent PKH26 dye emits in the red spectrum when excited, whereas the FITC label that is used for the phagocytes emits in the green spectrum. PKH26 is stable in the endosomal/lysosomal compartment of phagocytes. The dyed target cells are washed 3 times with PBS and cultured overnight to allow leaching of PKH26 out into the medium. This minimizes leakage of dye during the assay. The following day the target cells are harvested, washed 3 times with PBS, and resuspended in serum-free DMEM at 5×10⁵/ml. The phagocytic cells are rinsed vigorously with PBS on the culture plates in order to remove serum, and 2 ml of target cells is added to each plate After 0, 2, 4, or 8 h, the plates are rinsed 3 times with PBS to remove all non-adhered cells and the remaining cells are incubated with 2 mM EDTA to release them from the plate. The released cells are washed with 1% FBS/PBS, and suspending in 100 μl of the same buffer. 2 μg anti-phagocyte (e.g. anti-CR3) antibody is added and the cells placed on ice for 25 min. The cells are washed 3 times with 1% FBS/PBS, resuspended in 100 μl of this solution, and stained with a 1:25 dilution of FITC-conjugated secondary IgG for 25 min on ice. Cells are washed 3 times and resuspended in 500 μl 1% FBS/PBS, then analyzed on a Becton Dickinson FACScan with CellQuest software.
• FL-1 (green) fluorescence is used to gate phagocytes. The FL-2 (red) fluorescence of these cells, which reflects internalization of PKH26-labeled target cells, is then measured. Phagocytosis induced by, e.g., an opsonin is indicated by the difference between mean FL-2 fluorescence of macrophages incubated with opsonin-coated versus non-opsonin-coated target cells. Use of an opsonin will increase mean FL-2 fluorescence by, e.g. at least 10%., or enough to obtain ap value less than or equal to 0.05 by student t-test.
• II. Amplification of the Immune Response Usually Involves Proliferation of Particular Subpopulations of Lymphoid Cells that are Normally in the Resting State.
• Proliferative assays have the following applications in clinical studies: (1) Assessment of overall immunologic competence of T cells or B cells as manifested in their ability to respond to polyclonal proliferation signals such as mitogens or anti-CD3 antibodies. Defects in the proliferation may be indicative of fundamental cellular immunologic defect. Low proliferation is often found as a nonspecific secondary effect of chronic disease. (2) Assessment of an individual's response to specific antigens, where low responses are indicative of general or specific immunologic defect. (3) Determination of MHC compatibility by the mixed lymphocyte reaction (MLR).
• In addition, proliferative assays are useful for estimating lymphokine production, investigating signal transduction, and assessing growth factor requirements (e.g., lymphokines) for T or B cells. The procedure outlined here measures incorporation of [³H]thymidine into DNA, which usually correlates well with cell growth as measured by changes in cell number. However, when the activation stimulus is toxic, as with chemical activators such as ionomycin plus phorbol myristate acetate (PMA), the burst of new DNA synthesis following activation may not be accompanied with a net increase in viable cells, and, in fact, a decline in cell number may be observed. In this instance, [³H]thymidine incorporation in DNA is more indicative of initial cell stimulation than estimation of cell number. In addition, [³H]thymidine incorporation provides information on cell populations, not on individual cells. Alternate methods, such as flow cytometry may be used for studies requiring that type of information.
• Assay for Antigen-Induced T Cell Proliferation
• This protocol is designed to test the proliferation of T cells in response to a specific antigen—tetanus toxoid. It can be modified to test T cell proliferation in response to any protein or polysaccharide antigen. Materials: (T cell suspension, autologous antigen-presenting cell suspension (non-T cells), Tetanus toxoid solution (Connaught or State Laboratory Institute of Massachusetts)). (1) Count T cells and adjust to 1×10⁶ cells/ml with complete RPM1-10 AB. (2) Treat antigen-presenting cells with mitomycin C (or irradiate with 2500 rad) as in step 2 of one-way MLR protocol. Adjust concentration of antigen-presenting cells to 2×10⁵ cells/ml. Antigen-presenting cells can consist of autologous non-T cells or autologous monocytes/macrophages. (3) Add 100 ul T cell suspension and 50 ul antigen-presenting cell population to wells; mix just before dispensing. (4) Add 50 ul tetanus toxoid solution to give final concentrations of 0, 1, 5, 10, and 20 ug/ml. Prepare three wells for each dilution. (5) Incubate 6 days in a humidified 37° C., 5% CO₂ incubator. (6) Pulse with [³H]thymidine and harvest as described in support protocol.
• Assay for Lymphokine-Dependent Cell Proliferation
• This protocol assays the lymphokine-dependent proliferation of a lymphocyte population, in this case, the IL-4 dependent proliferation of B cells. Materials: (Tonsil B cell suspension, Anti-Img cross-linked to Sepharose beads (Bio-Rad), 10,000 U/ml human rIL-4 (Genzyme) in complete RPM1-10). (1) Count tonsil B cells and adjust concentration to 1×10⁶ cells/ml with complete RPM1-10. (2) Dispense 100 ul of tonsil B cells into each well. Prepare three wells for each experimental condition. (3) Dilute 10,000 U/ml rIL-4 solution 1:10, 1:100, and 1:1000. Add 20 ul of the stock or dilution to appropriate wells to yield 1000 U/ml, 100 U/ml, 10 U/ml, and 1 U/ml. Include a control well with no rIL-4. (4) Pipet anti-IgM beads into appropriate wells.
• Determine the optimal concentration of beads with pilot experiments. It is best to include several concentrations of beads in each experiment to “bracket” the optimal dose. Prepare wells with tonsil B cells and IL-4 dilutions alone, anti-IgM beads alone, culture medium alone, and all the combinations of IL-4 and anti-IgM bead dilutions. (5) Increase the volume of each well to 200 ul with complete RPM1-10 as necessary. (6) Culture 5 days in a humidified 37° C., 5% CO₂ incubator. (7) Pulse with [³H]thymidine and harvest as described in support protocol.
• [³H]Thymidine Pulse and Harvest of Cell Cultures
• This protocol is used in conjunction with the preceding protocols to complete the [³H] thymidine incorporation assay. (1) Add 20 ul of 50 uCi/ml [³H]thymidine to each culture (1.0 uCi) at a fixed time before terminating the culture (usually 6 or 18 hr). (2) Harvest cell cultures using an automated multiwell harvester that aspirates cells, lyses cells, and transfers DNA onto filter paper, while allowing unincorporated [³H]thymidine to wash out. Fill and aspirate each row of the microtiter plate ten times to ensure complete cell transfer and complete removal of unincorporated thymidine. Wash each filter strip with 100% ethanol to facilitate drying. Transfer to scintillation vials. For semiautomated harvester, transfer filter dots for each well into scintillation counting vials. For manual transfer, dry filters under lamp and transfer to scintillation vial with forceps. Add scintillation fluid to each vial. (3) Count samples in scintillation counter until standard deviation is less than 2%. Calculate mean cpm for background cultures and for each experimental condition. There should be less than 20% variation in replicate cultures.
• III. Induction and Measurement of In Vitro Antibody Responses
• The capacity of the human immune system to mount an antibody response following in vivo immunization with a protein or polysaccharide antigen is a revealing indication of the overall integrity of both the B and T cell arms of the immune system. As such, in vivo immunization followed by measurement of the antibody response is an appropriate test of immune function in the various acquired and congenital immunodeficiencies and in a host of other conditions affecting the immune system. The following procedures are for in vivo immunization and for the measurement of the subsequent immune response using an ELISA technique.
• Immuno-Enzymetric Assay for Cytokines Using NIP- and HRPO-Labeled Antibodies
• This protocol describes an immunonoenzymetric assay for cytokines using a heterogeneous, noncompetitive immunoassay reaction in which the cytokine is immobilized by a coating antibody bound to a microtiter plate. Unbound material is washed free, and detection is carried out using a different anti-cytokine antibody labeled with the hapten nitroiodophenyl (NIP). This is in turn detected by a horseradish peroxidase (HRPO) conjugate of an anti-NIP antibody, which is revealed with the chromogenic substrate ABTS. In this noncompetitive immunoassay, the immunoassay signal (A₄₀₅) increases as a direct function of the amount of cytokine present in the sample. Antibodies are prepared as described in Current Protocols in Immunology, 1995, 6.20.2-6.20.10.
• Coat assay plate. (1) Using a multichannel pipettor, transfer 100 ul of an appropriate dilution of coating antibody into all wells of the assay plate that are to be used. (2) Seal plates with microtiter plate sealer or Parafilm and incubate 2 hr. At 37° C. Prepare samples and standards in preparation plate. (3) Dilute each sample (or aliquot of conditioned medium) to be assayed with an equal volume of immunoassay diluent. (4) Pipet less than or equal to 1 ml of each diluted sample to be assayed into the upper chamber of a separate Spin-X microfiltration device. Microcentifuge 5 min. At 10,000 rpm and save the filtrates that collect in the lower chambers. (5) Add 65 ul of each diluted sample to the appropriate well of a preparation plate (i.e., a separate 96-well microtiter plate). (6) Thaw an aliquot of cytokine standard at room temperature and make sure that it is well mixed. Pipet 130 ul into the well of the preparation plate representing the highest concentration on the standard curve. Transfer 65 ul from this well into the next, then continue performing serial 1:1 dilutions in immunoassay diluent so that 65 ul of each concentration represented on the standard curve is placed in appropriate well of the preparation plate. (7) Thaw an aliquot of calibrator at room temperature (if used). Dilute with an equal volume of immunoassay diluent, then pipet 65 ul of diluted calibrator into appropriate well or wells of preparation plate.
• Incubate with coating antibody. (8) Remove coated assay plate from incubator. Dip in 2-liter beaker filled with 1× with buffer, then invert over sink and flick to remove liquid. Repeat two more times, then bang dry on paper towel. (9) Transfer 50 ul of solution from each well of preparation plate to corresponding well of the assay plate using multichannel pipettor. (10) Seal plate with microtiter plate sealer or Parafilm and incubate 2 hr. at room temperature.
• Incubate with detecting antibody. (11) Dilute NIP-labeled detecting antibody specific to cytokine of interest to 1 ug/ml in detecting buffer. (12) Wash assay plate as in step 8. (13) Add 75 ul diluted detecting antibody from step 11 to all wells of assay plate, including unused outer walls. (14) Reseal plate with microtiter plate sealer or Parafilm and incubate 1 hr. at room temperature.
• Incubate with HRPO-conjugated anti-NIP antibody. (15) Dilute HRPO-conjugated anti-NIP Mab 1:3000 in detecting buffer. (16) Wash assay plate as in step 8. (17) Add 75 ul of diluted HRPO-labeled anti-NIP antibody from step 15 to all wells of assay plate. (18) Reseal plate with microtiter plate sealer or Parafilm and incubate 1 hr. at room temperature.
• Incubate with chromogenic substrate. (19) Wash assay plate as in step 8. (20) Add 100 ul ABTS substrate working solutions to all wells of assay plate. Cover plate and incubate at room temperature until color development reaches desired level (generally until A₄₀₅ for wells containing the highest concentration of standard is between 1.5 and 2). This protocol usually produces an assay that can be read after 30 to 60 min.
• Read plate and analyze data. (21) Using microtiter plate reader with computer interface, measure absorbance in all wells at 405 nm in single-wavelength mode or at 405 and 650 nm in dual-wavelength mode. (22) Fit standard data to a curve described by a first-degree (linear), second degree (quadratic), or four-parameter (nonlinear) mathematical function using curve-fitting software. (23) Interpolate absorbance data from unknown cytokine samples to fitted standard curve, and calculate cytokine concentrations.
• IV. Induction of an In Vivo Antibody Response Provides an Approach to the Evaluation of the Overall Integrity of the Immune System.
• In the protocols presented here, diptheria and tetanus toxoids are used as representative protein antigens and pneumococcal polysaccharides are used as representative polysaccharide antigens because of their safety and availability. It should be noted, however, that the responses elicited by these antigens are likely to be secondary responses because of past vaccination or natural exposure. To obtain a primary response, an unusual antigen such as keyhole limpet hemocyanin should be used.
• When antigens are administered by the intramuscular or subcutaneous route, as they are here, a “systemic” immune response is induced and measurement of circulating antibody is most appropriate. It is, however, sometimes of interest to evaluate “local” or mucosal immune responses. In this case, the antigen is given either intranasally to stimulate respiratory lymphoid tissue or orally to stimulate gastrointestinal lymphoid tissue and bronchial washings or intestinal fluids, rather than blood, is assayed for antibody content; in addition, antigens are used that are more appropriate for stimulation of the local/mucosal response (i.e., influenza virus antigen for respiratory responses and cholera toxin for gastrointestinal responses).
• In assaying the in vivo antibody response, it is important to determine responses to both protein and polysaccharide antigens because these antigens stimulate different components of the immune system. In this regard, the major antibody response to protein antigen is composed of IgG1 and IgG3 subclass antibodies, whereas the major antibody response to polysaccharide antigen is composed of IgG2 subclass antibody.
• A variety of immunoassay techniques have been used to measure antibody responses in materials obtained after in vivo immunization. Of these, the ELISA assay is perhaps the most useful because it yields a stable, easily measurable, reproducible, and safe readout.
• Induction of In Vivo Antibody Responses to Protein/Polysaccharide Antigens
• In this protocol antigens are administered by the intramuscular or subcutaneous route and serum is collected for measurement of responses. (1) Draw preimmunized blood sample, allow blood to clot, and separate serum from clot by centrifugation. Store serum at −20° C. to −70° C. in appropriately labeled plastic tubes. (2) Inject 0.5 ml of toxoid mixture into an appropriately prepared intramuscular site (deltoid or thigh), taking care not to inject material intravenously. (3) Inject 0.5 ml polyvalent pneumococcal vaccine into an appropriately prepared subcutaneous site, taking care not to inject material intravenously. (4) Draw post-immunization blood samples at desired intervals, usually at 1, 2, and 3 weeks. Separate serum and store at −20° C. to −70° C. (5) After all serum samples are collected, assay samples for presence of antibodies using ELISA.
• The ELISA offers a rapid, sensitive, reproducible, nonradioactive method for measuring in vivo antibody responses to a variety of antigens, including protein and polysaccharide antigens in sera obtained from individuals vaccinated with tetanus and diphtheria boosters and the polyvalent pneumococcal polysaccharide vaccine. Assays specific for tetanus, diphtheria and the pneumococcal polysaccharide types I, II, and III are detailed in Current Protocols in Immunology, 1995, Vols. 6 and 7.
• Assay Using Tumor Rejection
• In another assay for immunomodulation, an immunocompent animal is vaccinated with on the order of 10⁴-10⁸ irradiated cytokine-coated tumor cells, and challenged with on the order of 10⁴-10⁸ live wild-type tumor cells (in any temporal sequence). If survival or tumor onset in these animals differs from that of animal vaccinated, using identical parameters, with irradiated non-cytokine coated cells instead of opsonin-enhanced cells, immunomodulation has occurred. For example, if at least 10% of the animals in the test group survive 100% longer than mean survival in the control group, the test is positive. As another example, onset of tumors in 20% of the test animals might be 50% later than mean onset in the control animals.
• Dosage and Administration
• The invention encompasses methods of modulating an immune response in a mammal to a selected antigen, the method comprising administering to a mammal a therapeutic amount of a composition comprising a multifunctional molecule as described herein, or a composition comprising a multifunctional molecule of the invention and an antigen bearing target, or administering a composition comprising a therapeutic amount of APCs which have been contacted with a multifunctional molecule and antigen bearing target in vitro.
• Compositions described herein may be prepared as injectables, either as liquid solutions or suspensions; solid forms suitable for solution in or suspension in, liquid prior to infection can also be prepared. The preparation can also be emulsified, or encapsulated in liposomes. The active immunogenic ingredients are often mixed with carriers which are pharmaceutically acceptable and compatible with the active ingredient. The term “pharmaceutically acceptable carrier” refers to a carrier that does not cause an allergic reaction or other untoward effect in subjects to whom it is administered. As used herein, a “pharmaceutically acceptable carrier” does not include culture medium, or any solution containing about 0.2-2% serum or greater. Suitable pharmaceutically acceptable carriers include, for example, one or more of water, saline, phosphate buffered saline, dextrose, glycerol, ethanol, or the like and combinations thereof. In addition, if desired, the vaccine can contain minor amounts of auxiliary substances such as wetting or emulsifying agents, pH buffering agents, and/or adjuvants which enhance the effectiveness of the vaccine. Examples of adjuvants which may be effective include but are not limited to: aluminum hydroxide, N-acetyl-muramyl-L-threonyl-D-isoglutamine (thr-MDP), N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine (CGP 11637, referred to as nor-MDP), N-acetylmuramyl-L-alanyl-D-isoglutaminyl-alanine-2-1′-2′-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy)-ethylamine (COP) 19835A, referred to as MTP-PE), and RIBI, which contains three components extracted from bacteria, monophosporyl lipid A, trehalose dimycolate and cell wall skeleton (MPL+TDM+CWS) in a 2% squalene/Tween 80 emulsion. Other examples of adjuvants include DDA (dimethyldioctadecylammonium bromide), Freund's complete and incomplete adjuvants and QuilA. In addition, immune modulating substances such as lymphokines (e.g., IFN-, IL-2 and IL-12) or synthetic IFN-inducers such as poly I:C can be used in combination with adjuvants described herein.
• Compositions of the invention can be administered parenterally, by injection, for example, either subcutaneously or intramuscularly. Additional formulations which are suitable for other modes of administration include suppositories, and in some cases, oral formulations or formulations suitable for distribution as aerosols. In the case of the oral formulations, the manipulation of T-cell subsets employing adjuvants, antigen packaging, or the addition of individual cytokines to various formulations can result in improved oral vaccines with optimized immune responses. For suppositories, traditional binders and carriers may include, for example, polyalkylene glycols or triglycerides; such suppositories may be formed from mixtures containing the active ingredient in the range of 0.5% to 10%, preferably 1%-2%. Oral formulations include such normally employed excipients as, for example, pharmaceutical grades of mannitol, lactose, starch magnesium stearate, sodium saccharine, cellulose, magnesium carbonate, and the like. These compositions take the form of solutions, suspensions, tablets, pills, capsules, sustained release formulations or powders and contain 10%-95% of active ingredient, preferably 25-70%.
• The compositions of the invention can be formulated into the vaccine compositions as neutral or salt forms. Pharmaceutically acceptable salts include the acid addition salts (formed with free amino groups of the peptide) and which are formed with inorganic acids such as, for example, hydrochloric or phosphoric acids, or with organic acids such as acetic, oxalic, tartaric, maleic, and the like. Salts formed with the free carboxyl groups can also be derived from inorganic bases such as, for example, sodium, potassium, ammonium, calcium, or ferric hydroides, and such organic bases as isopropylamine, trimethylamine, 2-ethylamino ethanol, histidine, procaine, and the like.
• Any cellular component of such vaccine compositions can, in preparation for inclusion in such compositions, be subjected to treatments which involve attenuation or inactivation of the cells of the vaccine, including, for example, exposure to ionizing radiation, which can inhibit cell division, antiproliferative agents such as cyclophosphamide, cytochalasin D, or colchicine, or killing with or without fixation.
• The compositions, including antigen bearing targets and APCs are administered in a manner compatible with the dosage formulation, and in such amount as will be prophylactically and/or therapeutically effective. The quantity to be administered depends on the subject to be treated, including, e.g., capacity of the subject's immune system to synthesize antibodies, and the degree of protection desired. Suitable dose ranges are on the order of several hundred micrograms active ingredient per vaccination with a preferred range from about 0.1 μg to 1000 μg, such as in the range from about 1 μg to 300 μg, and preferably in the range from about 10 μg to 50 μg. Suitable regiments for initial administration and booster shots are also variable but are typified by an initial administration followed by subsequent inoculations or other administrations. Precise amounts of active ingredient required to be administered depend on the judgment of the practitioner and may be peculiar to each subject. It will be apparent to those of skill in the art that the therapeutically effective amount of cells of this invention will depend, inter alia, upon the administration schedule, the unit dose of antigen administered, whether the cells are administered in combination with other therapeutic agents, the immune status and health of the recipient, and the therapeutic activity of the particular composition.
• The compositions can be given in a single dose schedule, or preferably in a multiple dose schedule. A multiple dose schedule is one in which a primary course of vaccination can include 1-10 separate doses, followed by other doses given at subsequent time intervals required to maintain and or reinforce the immune response, for example, at 1-4 months for a second dose, and if needed, a subsequent dose(s) after several months. Periodic boosters at intervals of 1-5 years, usually 3 years, are preferable to maintain the desired levels of protective immunity. The course of the immunization can be followed by in vitro proliferation assays of peripheral blood lymphocytes (PBLs) co-cultured with ESAT6 or ST-CF, and by measuring the levels of IFN-released from the primed lymphocytes. The assays can be performed using conventional labels, such as radionucleotides, enzymes, fluorescent labels and the like. These techniques are known to one skilled in the art and can be found in U.S. Pat. Nos. 3,791,932, 4,174,384 and 3,949,064, which are hereby incorporated by reference.
• Tumors for Which the Invention is Applicable
• The invention contemplates treatment of tumors including but not limited to the following:
• Melanomas, squamous cell tumors, basal cell carcinomas, astrocytomas, gliomas, glioblastoma multiforme, meningiomas, ependymomas, schwannomas, neuroblastomas, retinoblastomas, meningiomas, glomus tumors, sarcomas, including, e.g., osteosarcomas, Ewing's sarcomas, chondrosarcomas, myosarcomas, synovial cell sarcomas, fibrosarcomas, spindle cell tumors, angiosarcomas, primitive neuroectodermal cell tumors, and Kaposi's sarcomas, lymphomas, acute and chronic leukemias, tumors of the head and neck, nasopharyngeal carcinomas, carcinomas of the pharynx, laryngeal carcinomas, carcinomas of the thyroid, carcinomas of the parathyroids, thymomas, esophageal carcinomas, gastric carcinomas, tumors of the small bowel, carcinomas of the colon and rectum, mesotheliomas, lung carcinomas, including adenocarcinomas, squamous cell carcinomas, bronchoalveolar carcinomas, and small cell tumors, pancreatic carcinomas, islet cell and non-islet cell tumors, carcinomas of the breast, cardiac myxomas, pituitary tumors, carcinoid tumors, nepatomas, cholangiocarcinomas, hepatoblastomas, renal cell carcinomas, nephroblastomas, Wilms' tumors, adrenal carcinomas, pheochromocytomas, germ cell tumors, choriocarcinomas, ovarian carcinomas, testicular tumors, seminomas, endometrial tumors, carcinomas of the prostate, carcinomas of the seminal vesicles, vaginal tumors, carcinomas of the penis, hydatiform moles, carcinomas of the gall bladder, and carcinomas of the urinary bladder.
• Subjects for Treatment According to the Invention
• The present invention provides a method for reducing the size and/or number of metastases in a subject. The method comprises administering to the subject a vaccine composition comprising a multifunctional molecule of the invention. A “subject” as used herein, may refer to an organism of the Kingdom animalia, preferably a mammal, and still more preferably a human. A “subject”, according to the invention may also be an animal in need of anti-metastases therapy, e.g., a patient with malignant metastases to one or more organs or tissues, e.g., a human patient with lung or lymph node metastases. A “subject”, according to the invention may also be an animal model of metastases, in which the animal is manipulated, either genetically, or by injection of malignant cells, or by other methods known to those of skill in the art, to simulate the appearance of foci of malignant cells or infected cells which are observed in a similar animal with naturally occurring metastases. The generation of animal models of metastasis is well known in the art, and examples of such models may be found in, for example, Ryan M H et al., J. Immunol. 2001;167:4286-92; Specht J M et al., J Exp Med. 1997;186:1213-21; Nakanishi et al., Tumour Biol. 2003 24:70-6; Wang et al., Int J Gastrointest Cancer, 2001;29(1):37-46; Muralidharan et al., J Clin Laser Med Surg. 2003 21(2):75-83; Tanaka et al., Chest 2003, 123(4):1248-53; Huang et al., Clin Exp Metastasis 2002;19(4):359; and Irvine K R et al., J. Immunol. 1996;156:238-45. One of skill in the art would be able to readily adapt the animal models of metastasis known in the art to generate a metastasis model of interest for any given application.
• Detection of Metastases
• The present invention provides a method of reducing the number and/or size of metastases in a subject comprising administering to a subject, a multifunctional molecule as described herein. One of skill in the art will recognize that the detection and measurement of metastases is routine in the art and may be accomplished using well established methods. For example, metastases may be detected using gross examination of a subject, such as exploratory surgery (e.g., laparotomy). Alternatively, metastases may be detected, measure, and/or observed using less invasive techniques and methods such as thorascopy, mediastinoscopy, and laparoscopy. One of skill in the art may also detect the presence of metastases using imaging techniques known to those of skill in the art. Such techniques include, but are not limited to radiographic imaging, computerized tomography (CT scan), magnetic resonance imaging (MRI), positron emission tomography (PET scan), single photon excitation (SPECT), and radionuclide scintigraphy (e.g., bone scan). The sensitivity of many of the above imaging methods may be enhanced, as known by those of skill in the art by injection or IV administration of contrast agents (e.g., iodine or barium) to a subject to be imaged. Additional methods for assessing the presence of, or detecting, or measuring metastasis is through the use of gross or histological pathologic examination (i.e., in which a tissue sample is removed from a subject an examined at eaither or both of the gross anatomical level, or at the histological or ultrastructural level according to methods which are well known in the art). The above methods for the detection, measurement, and imaging of metastases are known to those of skill in the art and may be adapted according to the knowledge in the art to particular tissues, organs, or cells which one of skill in the art wishes to asses according to the methods of the invention. More detailed descriptions of such methods may be found in the art, for example, the Oxford Textbook of Oncology, 2^nd Ed., New York, Oxford University Press, 2002.
• According to the invention, metastasis is detected if any amount of metastasis is detected in a subject. That is, upon the detection of even a single foci in a subject, metastasis may be said to have been detected. Preferably, metastasis is detected as plural metastatic foci, in one or preferably one or more organs in a subject.
• Transgenic Animals According to the Invention
• A nucleic acid molecule encoding a multifunctional molecule as described herein can be used to produce nonhuman transgenic animals, and cells of such transgenic animals can be isolated and used in a vaccine formulation in animal or human vaccination.
• For example, in one embodiment, a nucleic acid molecule is introduced into a fertilized oocyte or an embryonic stem cell. Such cells can then be used to create non-human transgenic animals in which exogenous nucleic acid molecules encoding the polypeptides of the invention have been introduced into their genome or homologous recombinant animals in which endogenous nucleic acid molecules have been altered. Such animals are useful for studying the function and/or activity of the molecules of the invention and for identifying and/or evaluating modulators of the activity of the molecules of the invention. As used herein, a “transgenic animal” is a non-human animal, prefers mammal, more preferably a mouse, in which one or more of the cells of the animal includes a transgene. A transgene is exogenous nucleic acid which is integrated into the genome of a cell from which a transgenic animal develops and which remains in the genome of the mature animal, thereby directing the expression of an encoded gene product in one or more cell types or tissues of the transgenic animal.
• A transgenic animal of the invention can be created by introducing nucleic acid molecules encoding the polypeptides described herein (i.e., a multifunctional molecule) into the male pronuclei of a fertilized oocyte, e.g., by microinjection, and allowing the oocyte to develop in a pseudopregnant female foster animal. Intronic sequences and polyadenylation signals can also be included in the transgene to increase the efficiency of expression of the transgene. A tissue-specific regulatory sequence(s) can be operably linked to the transgene to direct expression of a polypeptide of the invention to particular cells. Methods for generating transgenic animals via embryo manipulation and microinjection, particularly animals such as mice, have become conventional in the art and are described, for example, in U.S. Pat. Nos. 4,736,866 and 4,870,009, both by Leder et al., U.S. Pat. No. 4,873,191 by Wagner et al. and in Hogan, B., Manipulating the Mouse Embryo, (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1986). Similar methods are used for production of other transgenic animals. A transgenic founder animal can be identified based upon the presence of the nucleic acid molecule of the invention, e.g., the transgene in its genome and/or expression of the transgene mRNA in tissues or cells of the animals. A transgenic founder animal can then be used to breed additional animals carrying the transgene. Moreover, transgenic animals carrying a transgene encoding polypeptides of the invention can further be bred to other transgenic animals carrying other transgenes.
• The invention is further illustrated by the following exemplifications which should not be construed as being further limiting.
EXAMPLES Example 1 Cloning of a Murine GM-CSF Fused to the S. cerevesiae Gas1 GPI Modification Signal Sequence
• The starting point for producing a yeast expression vector was the pUC 19-GM-CSF-mammalian GPI signal sequence plasmid (pUC19-GM-CSF-GPI). This plasmid encodes murine GM-CSF (upstream) fused in-frame to the human Thy-1 GPI modification signal sequence (downstream). The following two oligonucleotides were purchased from Midland Certified Reagent Company (Midland, Tex.):

  GTX-5
  5′pAATTCCGCGCCGGCACAGTGCTCAGAGACAAACTGGTCAAGTGTGAG
  GGCATCAGCCTGCTGGCTCAGAACACCTCGTGGCTGCTGCTGCTCCTGCT
  GTCCCTCTCCCTCCTCCAGGCCACGGATTTCATGTCCCTGTGACTGGGTA
  C3′

  
  GTX-5 comprises:
• a. Sequences at the 5′ end suitable for ligating to an EcoRI site (bases 1-5)
• b. An NgoM1 site for creating an in-frame chimeric coding sequence (bases 9-14)
• c. The coding sequence for the GPI modification sequence of human Thy-1 (Genbank Accession No. M11749) (bases 15-137)
• d. A termination codon (bases 138-140)
• e. Sequences at the 3′ end for ligating to a KpnI site (bases 144-148)

  GTX-6
  5′pCCAGTCACAGGGACATGAAATCCGTGGCCTGGAGGAGGGAGAGGGAC
  AGCAGGAGCAGCAGCAGCCACGAGGTGTTCTGAGCCAGCAGGCTGATGCC
  CTCACACTTGACCAGTTTGTCTCTGAGCACTGTGCCGGCGCGG3′

• This oligonucleotide is complementary to GTX-5, except for staggered ends.
• GTX-5 and GTX-6 were dissolved in individual tubes in sterile water at a final concentration of 1 microgram/lambda. GTX-5 and GTX-6 were mixed at a final concentration of 100 ng/lambda and allowed to anneal for 60 minutes at room temperature.
• The GTX-5:GTX-6 double stranded oligonucleotide was then cloned into the plasmid pUC19. Four micrograms of pUC19 DNA was digested with EcoRI and KpnI. After electrophoresis, the linear DNA was purified from a 0.7% agarose gel using a Qiagen (Santa Clarita, Calif.) gel purification kit according to instructions provided by the manufacturer. 100 ng of the GTX-5:GTX-6 oligonucleotide was ligated to 200 ng of the EcoRI-KpnI digested pUC19 in a final volume of 20 microliters at room temperature for 60 minutes.
• The plasmid was transformed into competent AG-1 cells, which were purchased from Stratagene. Transformed E. coli were inoculated onto LB-amp plates. Bacterial colonies grown on LB plates containing ampicillin (100 micrograms/ml) were picked and inoculated into one ml of LB with amp and grown overnight at 37° with shaking.
• Plasmid DNA was isolated using a standard alkaline lysis miniprep protocol and DNA was digested with EcoRI and KpnI. DNA was electrophoresed on 1.6% agarose gels stained with ethidium bromide, and colonies containing an EcoRI-KpnI fragment of approximately 148 bp were thus identified. Positive colonies were inoculated into 100 ml of LB with ampicillin and grown overnight. Plasmid DNA was again purified using kits purchased from Qiagen.
• The nucleotide sequence of a Thy-GPI positive clone, designated pUC-GPI 21, was sequenced, confirming its identity.
• The GM-CSF coding sequence was amplified by PCR from a mouse lung cDNA library purchased from Clontech. PCR was performed for 35 cycles using pfu polymerase and the following primers:

  Upstream
  5′CCGAATTCATGTGGCTGCAGAATTTACTTTTCCTGGGCATTGTGGTCT
  AC3′
  Downstream
  5′CAGCCGGCTTTTTGGACTGGTTTTTTGCATTCAAAGGGGATATCAGTC
  AG3′

• PCR parameters were denaturation at 90° for 1 minute, annealing at 60° for 1 minute, and extension at 720 for 1 minute.
• The GM-CSF chain PCR product was purified after electrophoresis through a 1% agarose gel. The DNA band was excised and the DNA fragment purified using a kit purchased from Qiagen.
• The purified GM-CSF DNA fragment was digested with EcoRI and NgoM1. After digestion, the reaction mix was extracted with phenol:chloroform (1:1) followed by chloroform. The aqueous phase was adjusted to 0.3M sodium acetate pH 5.2 and the DNA was precipitated with 2 volumes of ethanol at −80° for 2 hours. The DNA was pelleted by centrifugation, ethanol was removed, and the pellet was rinsed with 70% ethanol. The pellet was dried under vacuum.
• The GM-CSF DNA was resuspended in sterile water and ligated to pUC19-GPI 21 that had been digested with EcoRI-NgoM1. Ligation was for one hour at room temperature. PUC19 GPI 21 ligated to GM-CSF DNA was used to transform competent AG-1 cells. Transformed AG-1 cells were selected on LB plates with ampicillin. Plasmid DNA was isolated and analyzed as above. Restriction digests were performed to confirm the pUC 19 GPI-GM-CSF chimeric construct. The DNA from several positive clones was isolated and sequenced.
• This plasmid was digested with NgoMIV and KpnI, and the larger resulting fragment isolated after electrophoresis through a 1% agarose gel.
• The 280 bp GPI modification signal sequence from the yeast protein Gas1 was amplified by PCR from the yeast cosmid clone C9952 (ATCC). This PCR employed pfu polymerase and the primers:

  	Upstream Primer
  	5′GTAGCCGGCGCTAGCTCGGGGTCTTCTTCCAAGTCTA
  	Downstream Primer
  	5′TACGGTACCCCTAGGCCACAATGAAATAAGATACCATACC3′

• These primers add a 5′ NgoMIV site and a 3′ KpnI site to the Gas I fragment.
• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute
  	Cycles	25

• The PCR product was purified after electrophoresis through a 1% agarose gel and digested with NgoM IV and KpnI. The Gas1 GPI signal sequence was then ligated into the pUC19-GM-CSF-GPI plasmid prepared above so that the Gas1 signal sequence was fused in-frame downstream of the GM-CSF sequence, replacing the Thy-1 sequence. This vector is termed pUC19-GMCSF-Gas1.1. The resultant plasmid was then transformed into AG-1 competent E. coli (Stratagene) and plasmid clones were isolated by alkaline lysis mini-prep. Plamids were then screened for inserts by restriction digest. DNA from a positive clone was sequenced to confirm the identity of the GAS1 coding region.
• A yeast expression plasmid for GPI-GM-CSF was then generated utilizing the pITY-4 vector, which was kindly provided by Dr. K. Dane Wittrup (University of Illinois). This plasmid stably integrates into the yeast genome and allows high-level expression of heterologous genes. Features of pITY-4 include: a delta sequence (LTR of Ty element) that enables multiple integration events by homologous recombination; a neo/kanamycin resistance gene that provides for selection in E. coli and tunable selection in yeast; the Gal1 promoter for high-level inducible transcription; a unique EagI cloning site; a synthetic Pre-Pro sequence optimized for efficient secretion of expressed genes; the alpha factor termination sequence; and an origin of replication for propagation in E. coli. In this system, yeast are grown in dextrose-containing media for 3 days, then are switched to media containing galactose to induce transcription of genes inserted downstream of the Gal1 promoter.
• The GMCSF-Gas1 insert described above was amplified by PCR from pUC 19-GMCSF-Gas1.1 using pfu polymerase and the primers:

  	Upstream
  	5′TACGGCCGGCACCCACCCGCTCACCC3′
  	Downstream
  	5′TACGGCCGCCACAATGAAAATAAGATACCAT3′

  
  These primers add EagI sites at both ends for cloning into the pITY-4 plasmid.
• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute
  	Cycles	25

• The PCR product was purified after electrophoresis through a 1% agarose gel and digested with EagI. The EagI-flanked GMCSF-Gas1 fragment was ligated into EagI-digested pITY-4 and used to transform E. coli AG1 cells. E. coli were then grown on kanamycin-containing LB plates (100 ug/ml). Plasmids from kanamycin resistant colonies were purified by mini-prep and mapped by restriction digests for presence and correct orientation of inserts. The identity of a positive clone was confirmed by sequencing. This plasmid is termed pITY-GMCSF-Gas1.1.
Example 2 Expression of Murine GM-CSF Fused to the Gas1 GPI Modification Signal Sequence in Yeast
• A 50 ml culture of the E. coli clone containing pITY-GMCSF-Gas1.1 was grown in LB with 100 ug/ml kanamycin and the plasmid purified using a Midi-Prep Kit from Qiagen. The S. cerevesiae strain BJ5464 (ATCC) was then transformed with pITY-GMCSF-Gas 1.1 using a lithium acetate (LiAc) protocol. A 10 ml overnight culture of BJ5464 in YPD (Per liter: 20 g Bactotryptone, 10 g yeast extract, 20 g dextrose) was used to inoculate a 100 ml flask. Yeast were grown for 3 hours at 30° and then harvested by centrifugation at 12,000×g for 2 minutes at room temperature. Cells were washed with sterile water and centrifuged again. The cells were resuspended in 1.0 ml of 100 mM LiAc, transferred to a 1.5 ml microfuge tube and centrifuged in an Eppendorf microfuge at top speed for 15 seconds. The cells were then resuspended in 0.5 ml of 100 mM LiAc and 50 uL samples were aliquoted to individual tubes. The cells were pelleted. 240 uL of PEG (50% w/v), 36 uL 1.0M LiAc, 5 uL (10 mg/ml) boiled carrier DNA (salmon sperm DNA, Sigma), and 2 ug plasmid in 75 uL water, were then added in that order. After the addition of plasmid, the tube was vortexed, incubated at 30° for 30 minutes and heat-shocked at 42° for 15 minutes. The cells were then pelleted, resuspended in sterile water and plated on YPD plates containing 1 mg/ml G418.
• Individual colonies of G418-resistant yeast were picked and grown in one ml of YPD with 1 mg/ml G418 for 3 days. The cells were then pelleted by centrifugation in a microfuge and the YPD (dextrose-containing, galactose-free) media was replaced with YPG (20 g bactotryptone, 10 g yeast extract, 20 g galactose per liter) with 1 mg/ml G418. Yeast were grown in YPG for 3 days to allow full induction of transcription from the Gal1 promoter. After induction, cells were pelleted, washed with TN (0.15M NaCl, 25 mM Tris pH 7.4) and lysed in TN containing 20 mM octyl glucopyranoside (OGP), 1 mM PMSF, and lug/ml each aprotinin, leupeptin and pepstatin. Yeast were lysed by vortexing with acid-washed glass beads (425-600 microns, Sigma). Insoluble material was pelleted and the supernatant assayed using a murine GM-CSF ELISA (Endogen). A colony expressing high levels of GPI-GM-CSF was identified. Based on standard curve of soluble GMCSF, we estimate expression to be approximately 25 ug/L, a significant improvement over mammalian expression and sufficient for in vivo experiments. This yeast clone is designated SC-GM-GPI.
• One of the advantages of stably integrating vectors for expression in yeast is that, after the initial cloning and colony isolation, antibiotic maintenance is no longer required. To confirm this, cells were grown with and without G418 and tested for GPI-GM-CSF expression. We have seen no decrease in expression levels in the absence of G418 over 8 months.
• To produce GPI-GM-CSF on a scale suitable for in vitro and in vivo functional characterization, 500 ml of YPD was inoculated with SC-GM-GPI and grown for three days at 300 with shaking. Cells were pelleted by centrifugation at 12,000×g for 2 minutes at room temperature and transferred to an equal volume of YPG for an additional three days of growth. Cells were then pelleted, washed with TN and lysed in 25 ml of TN containing 20 mM OGP, 1 mM PMSF, and lug/ml each aprotinin, leupeptin and pepstatin. Cells were then lysed by vortexing with acid washed glass beads, 20 g/500 ml culture, (425-600 microns, Sigma). Insoluble material was pelleted at 8,000×g for 10 minutes at room temperature and the soluble material was applied to an immunoaffinity column of anti-murine GMCSF monoclonal antibody (Endogen) linked to cyanogen bromide-activated Sepharose 4B (Sigma). Coupling of the monoclonal to the Sepharose was performed according to the manufacturer's instructions. Efficiency of coupling was monitored using OD₂₈₀ and binding of murine GM-CSF to immobolized antibody was confirmed using commercially available, recombinant cytokine.
• Soluble yeast-derived material was applied to the column and allowed to flow by gravity. The column was washed sequentially with: (a) 20 volumes of TN with 1% Triton X-100; (b) 5 volumes of 50 mM Tris pH 8.0, 1 mM OGP; (c) 20 volumes TN with 1 mM OGP. Bound material was then eluted with 10 volumes of 0.15M NaCl, 25 mM Tris pH 2.5 with 1 mM OGP. Eluted material was neutralized with {fraction (1/200)} volume of 1.5M Tris pH8.8. The purified material was concentrated using a Microsep 3K centrifugal device (Pall Gelman Laboratory). Yields of GPI-GM-CSF were determined by ELISA (Endogen) to be 25 ug/L of culture. Final concentration was adjusted to 40 ug/ml by addition of 0.15M NaCl, 25 mM Tris pH 7.4 with 1 mM OGP.
• Purified GPI-GM-CSF was analyzed by stained gel and western blot. Approximately lug of purified GPI-GM-CSF or recombinant soluble murine GM-CSF per lane were electrophoresed. Gels were then stained with silver nitrate using the Sigma silver staining kit according to the manufacturer's directions (Sigma). For western blots, gels were transferred to Protran BA83 (Schleicher and Schuell) using an Owl Scientific electric transblotter and blocked with TBS (Tris Buffered Saline) containing 0.05% Tween 20 and 2% nonfat dry milk overnight at room temperature. The blot was then incubated with primary antibody (rat monoclonal anti-murine GMCSF, Endogen) at 1:5000 dilution in blocking buffer for 2 hours at room temperature. The blot was washed with TBS-0.05% Tween 20, and incubated with a secondary antibody, alkaline phosphatase conjugated goat anti-rat IgG (Sigma) at 1:10,000 for 1 hour at room temperature. After washing, color was developed with NBT-BCIP (Sigma). A single dominant band migrating at approximately the same rate as a recombinant soluble GM-CSF standard was clearly present on both the gel and the blot (the molecular weight of the GPI moiety is only approximately 1500 compared to approximately 14,000 for the protein moiety]. Given the immunoreactivity with anti-GM-CSF and the ability of this material to bind to tumor cell membranes, these bands appear to represent GPI-GM-CSF. While some high molecular weight material, possibly representing aggregates, is visible in the blot, this material is not visible in the less sensitive silver stain, indicating that it is present in lower amount than the dominant band.
Example 3 Attachment of Murine GM-CSF Fused to the Gas1 GPI Modification Signal Sequence to Cells
• Wild type CMS-5 murine fibrosarcoma cells grown in DMEM, 10% FBS, Pen-Strep were harvested, washed twice with RPMI 1640 (Life Technologies) and resuspended in RPMI 1640 at a concentration of 5×10⁵ cells/ml. 0.9 ml aliquots of the cell suspension were dispensed to Eppendorf siliconized microfuge tubes. Each aliquot received either 1 ug of purified GPI-GM-CSF prepared as in Example 2, 1 ug of soluble recombinant murine GM-CSF (Intergen, supplied as lyophilized powder and reconstituted at 40 ug/ml in the same buffer as GPI-GM-CSF), or media alone. Cells were then incubated for 3 hours at 37° C. with shaking and then washed 3 times with PBS containing 2% FBS.
• For detection of GPI-GM-CSF by flow cytometry, cells were incubated with a rat anti-murine GM-CSF monoclonal antibody (Endogen) for one hour at 4° C. The cells were then washed 3 times with PBS containing 2% FBS, and incubated with FITC-labeled goat anti-rat IgG antibody (Sigma) for one hour at 4° C., and again washed 3 times with PBS containing 2% FBS. The cells were analyzed by flow cytometry on a Becton-Dickinson Facscalibur. Decoration with GPI-GM-CSF caused an approximately 10-fold increase in peak and mean FL-1 fluorescence relative to cells incubated with media alone. In contrast, cells incubated with soluble GM-CSF had virtually the same profile as the negative control cells. This data indicates that GPI-GM-CSF, but not soluble recombinant GM-CSF, can bind to tumor cells.
• GPI-GM-CSF attached to CMS-5 cells was also detected and quantitated by ELISA. CMS-5 cells were harvested and washed as described above. 1×10⁶ cells in 1 ml of RPMI 1640 were incubated with 1 ug of purified GPI-GM-CSF. After incubation for 2 hours at 37° C., the cells were washed 3 times with PBS containing 2% FBS. The cell pellet was lysed with 50 microliters of PBS containing 0.15% deoxycholate and the detergent subsequently diluted by the addition of 200 microliters of PBS. The material was serially diluted with PBS and amounts of GM-CSF determined using an ELISA kit (Endogen) against a soluble, recombinant GM-CSF standard provided by the manufacturer. Based on this data, the mean number of GPI-GM-CSF molecules incorporated/cell over five experiments was 37,000+/−33,000. The large standard deviation was due to one experiment in which the number of molecules/cell was 66,000. Excluding this experiment, the mean was 29,500+/−4,500.
• “Decoration” of B16 murine melanoma cells with GPI-GM-CSF was also quantitated by ELISA. Decoration and ELISA were performed exactly as described for CMS-5 cells. The mean number of molecules/cell over three experiments was 21,000+/−11,500.
Example 4 Stability of Murine GM-CSF Fused to the Gas1 GPI Modification Signal Sequence on Cells
• To study the stability of incorporated GPI-GM-CSF on cells, CMS-5 cells were harvested and decorated as described above in Example 3. After decoration, the cells were washed 3 times with PBS containing 2% FBS and then resuspended at 4×10⁶ cells/ml in RPMI 1640. The cells were irradiated at 3500 rads from a ¹³⁷CS source. The cells were then incubated at 37° C. in 5% CO₂ and aliquots were removed at hourly intervals, washed three times, and lysed in 50 ul PBS with 0.15% deoxycholate. 200 ul of PBS was then added to dilute the deoxycholate. Cell-associated GM-CSF was measured by ELISA. Even at 6 hours, cells showed only about a 20% loss of cell-surface GPI-GM-CSF. After 6 hours, viability of irradiated cells (both decorated and non-decorated) as measured by microscopic inspection with trypan blue staining was significantly compromised. However, in vivo data (see below) indicates that both cell-surface retention of GPI-GM-CSF and post-irradiation cellular viability are sufficient to sustain a biological effect.
Example 5 Bioactivity of Murine GM-CSF Fused to the Gas I GPI Modification Signal Sequence to Cells
• The bioactivity of GPI-GM-CSF was assayed by determining the molecule's ability to support the proliferation of the FDC-P1 cell line, a murine bone-marrow derived, GM-CSF dependent cell line. Proliferation of FDC cells was measured with the Biotrak Cell Proliferation ELISA (Amersham Pharmacia), an assay that utilizes the thymidine analogue 5-bromo-2′-deoxyuridine (BrdU). WEHI cells (ATCC) were grown in Iscove MEM, 10% FBS, Penicillin-streptomycin, as a source of conditioned media for FDC-P1 cells. FDC-P1 cells were grown in DMEM, 10% FBS, Penicillin-streptomycin with 25% WEHI conditioned media, harvested, and washed 3 times with DMEM, 10% FBS, Penicillin-streptomycin. The cells were resuspended at 1×10⁵/ml in DMEM, 10% FBS, Penicillin-streptomycin and 100 uL was aliquoted to individual wells of a 96 well microtitre plate. Groups, done in triplicate, were as follows:
• • A. Media—No Cells
  • B. FDC-P1 Cells-Unstimulated
  • C. FDC-P1 Cells+10 ng soluble GM-CSF
  • D. FDC-P1 Cells+10 ng GM-CSF as GPI-GM-CSF (as determined by ELISA against GM-CSF standard)
  • E. FDC-P1 Cells+10 ng GPI-GM-CSF (as in “D”) denatured by extraction of the protein with chloroform:methanol (3:1) followed by acetone precipitation and resuspension.
    All protein solutions were diluted to 100 ng/ml in 0.15M NaCl, 25 mM Tris pH 7.4 with 1 mM OGP, so that the volume added to each well was 100 uL.
• The non-isotopic proliferation assay was performed according to the manufacturer's instructions. The plated cells were grown for two days at 37° C. in 5% CO₂. On day 3, 10 ul of the BrdU solution was added to individual wells and the cells incubated for 3 more hours. The plate was then centrifuged at 300×g for 10 minutes and the supernatant removed. The plate was dried by incubating at 60° C. for one hour. The plate was then fixed and blocked according to the manufacturer's instructions. The fixed cells were then incubated with peroxidase-labelled anti-BrdU for 90 minutes. The wells were then washed and color developed with TMB according to the manufacturer's instructions. In two experiments, GPI-GM-CSF consistently sustained proliferation at a level somewhat (about 25%) higher than did soluble recombinant GM-CSF, indicating that GPI-GM-CSF is suprabioactive. The effect of GPI-GM-CSF was not due to the GPI moiety alone, since denatured GPI-GM-CSF did not support proliferation. The GPI moiety remained linked to the protein after denaturation, since the protein was still able to decorate cells as demonstrated by ELISA, which recognizes linear epitopes on GM-CSF.
Example 6 Effective Immunization with Cells Admixed with GPI-GM-CSF
• These experiments included mice vaccinated with:
• (a) Wild-type cells (WT)
• (b) Cells incubated with soluble GM-CSF—Unwashed (total GM-CSF in dose: 1 microgram)
• (c) Cells decorated with GPI-GM-CSF—Unbound GPI-GM-CSF Washed off Following Incubation (total GPI-GM-CSF in dose: 0.74 nanograms by ELISA [mean of 2 experiments; 73 and 75 ng individually]
• (d) Cells decorated with GPI-GM-CSF-Unwashed (total GM-CSF in dose: 1 microgram)
  GPI-GM-CSF mass and concentration values are expressed in terms of equivalence to GM-CSF as determined by ELISA against a soluble GM-CSF standard.
• CMS-5 cells were grown to 70% confluence in DMEM, 10% FBS, Penicillin-streptomycin, harvested trypsinization, and washed 3 times with RPMI 1640. Viability was determined by trypan blue staining of an aliquot and the cells were then resuspended at a concentration of 4×10⁶ cells/ml a 1 ul aliquots dispensed into siliconized microfuge tubes. The cells were incubated with 1 ug GPI-GM-CSF or 1 ug soluble recombinant murine GM-CSF per 10⁶ cells for 3 hours at 37° C. “Washed” groups were then washed 3 times with PBS, 2% FBS and resuspended at 4×10⁶ cells/ml in RPMI 1640. An aliquot of the washed GPI-GM-CSF decorated cells was removed and the amount of cell-associated GM-CSF measured by ELISA as described above. There were approximately 31,000 and 32,000 GPI-GM-CSF molecules/cell in the washed decorated groups in the two experiments, respectively.
• The cells were irradiated at 3500 rads from a ¹³⁷CS source. 8-10 week-old female Balb/c mice (which are syngeneic for CMS-5) were anesthetized by metofane inhalation and vaccinated subcutaneously in the left inguinal fold with 1×10⁶ cells in 0.25 ml. Seven days later, wild-type CMS-5 cells at 70% confluence were harvested and washed 3 times in HBSS. Viability was determined by trypan blue staining of an aliquot and cells were adjusted to 4×10⁶/ml in HBSS. The previously vaccinated mice were then injected subcutaneously behind the neck, under metofane anesthesia, with 2×10⁶ live, wild-type CMS-5 cells in 0.5 ml HBSS.
• Tumor development was assessed daily by palpation and visual inspection. “Onset” was defined as the first day on which a tumor mass was both palpable and visible. The observer was blinded to the vaccine received by each set of mice to ensure against bias. Mice were sacrificed by CO2 asphyxiation when tumors become unwieldy. Experiments were terminated 70 days after tumor challenge, as planned in advance.
• Data is pooled from three experiments for GPI-GM-CSF unwashed, soluble GM-CSF, and wild-type vaccine groups. Data for these groups includes that from undepleted controls in a lymphocyte subset depletion experiment. Data for the GPI-GM-CSF washed group is pooled from two experiments, since this group was not included in the initial depletion experiment. The depletion experiment had 4 mice/group, and the other experiments had 5/group. In terms of total mouse numbers, n=14 for GPI-GM-CSF unwashed; 10 for GPI-GM-CSF washed; 14 for soluble GM-CSF unwashed; and 14 for WT. Approximate percentages of mice surviving tumor-free to day 70 after challenge were: WT, 15%; soluble GM-CSF, 50%; GPI-GM-CSF washed, 60%; GPI-GM-CSF unwashed, 85%. Thus, even though the GPI-GM-CSF washed vaccine contained over a thousand-fold less GM-CSF than the unwashed soluble, administration of cells decorated with GPI-GM-CSF was more effective. Furthermore, the GPI-GM-CSF unwashed vaccine, in which some molecules were not attached to a cell, was even more effective.
Example 7 Cloning and Expression of Human GM-CSF Fused to the Gas1 GPI Modification Signal Sequence
• Human GM-CSF is amplified by PCR from a human T cell cDNA library (Clontech) using Pfu polymerase (Stratagene). The following primers are used:

  	Upstream
  	5′GCGAATCCCGGCCGGCACCCGCCCGCTCGCCCAGCCCC
  	Downstream
  	5′CAGCCGGCCTCCTGGACTGGCTCCCAGCAGTC

• The upstream primer contains EcoR1 and Eag1 restriction sites immediately preceding the first amino acid found in the mature human GM-CSF protein. Since expression in S. cerevisiae utilizes a yeast leader sequence, cloning of the human GM-CSF begins at the N terminus of the mature protein. Each downstream primer omits the native stop codon to allow in-frame ligation to the sequence encoding the Gas1 GPI modification signal. The downstream primer contains an NgoM IV restriction site, consistent with restriction sites used in other constructs.
• PCR parameters are denaturation at 97° C for 1 minute,
• • annealing at 56° C for 1 minute, and
  • extension at 72° C for 2 minutes.
    PCR is performed for the least number of cycles yielding a visible band on agarose gel electrophoresis. After amplification, the reaction mix is allowed to cool at 4° for 10 minutes.
• The PCR product is isolated by electrophoresis through a 1% agarose gel and eluted from the excised agarose band using a commercially available kit (Qiagen). The purified hGM-CSF DNA fragment is digested with EcoR1 and NgoM IV and ligated to the (murine) pUC19 GM-CSF-GPI plasmid that has been digested with EcoR1 and NgoM IV. This replaces the murine GM-CSF with its human counterpart. The pUC19-hGM-CSF GPI plasmid is then transformed into competent AG-1 E. coli cells, 30 colonies are picked for mini-culture, and plasmid clones are isolated and purified using commercially available kits (Qiagen). Positive clones are identified by restriction enzyme test digest and agarose gel electrophoresis. Positive E. coli colonies are grown overnight in maxi-culture and their plasmids purified using Qiagen maxi-prep kits. Inserts are sequenced.
• To clone GM-CSF GAS1g into the pITY-4 expression vector, PCR of this construct from the pUC19 vector is performed. The primers are:

  	5′TACGGCCGGCACCCGCCCGCTCGCCCAGCCCC
  	3′TACGGCCGCCACAATGAAAATAAGATACCAT

  
  The upstream primer has an EagI site immediately preceding the first codon of the mature GM-CSF. This removes the mammalian secretion signal and allows for in-frame ligation to the yeast signal sequence. The same restriction site can be used as for the mouse construct because it is absent in the human sequence. The downstream primer appends an EagI site at the 3′ end. PCR is performed using Pfu polymerase for 25 cycles. Conditions for PCR are: denaturation 90° one minute, annealing 60° one minute, extension 720 one minute. After amplification, the reaction mix is allowed to cool at 4° for 10 minutes.
• The PCR product is isolated by electrophoresis through a 1% agarose gel and eluted from the excised agarose band using a commercially available kit (Qiagen). The purified GM-CSF GAS1g DNA fragment is digested with EagI, ligated to pITY-4, and transformed into AG-1 chemically competent bacteria (Stratagene). 30 colonies are picked for mini-culture and plasmid clones are isolated and purified using commercially available kits (Qiagen). Positive clones are identified by restriction enzyme test digest and agarose gel electrophoresis. Positive E. coli colonies are grown overnight in maxi-culture and their plasmids purified using Qiagen maxi-prep kits. Inserts are sequenced.
• The GPI-human GM-CSF molecule is expressed in S. cerevesiae as described for the murine molecule in Example 2. Immunoaffinity purification is performed as described in Example 2, substituting an anti-human GM-CSF antibody for the anti-murine GM-CSF antibody. ELISA to detect and quantitate the molecule, whether in isolation or bound to an antigen bearing target, is performed using an anti-human GM-CSF monoclonal antibody, as is flow cytometry on cells decorated with the molecule.
Example 8 Cloning of GM-CSF/Influenza Hemagglutinin Chimeric Proteins
• pUC19 GMCSF-K-GAS1.1
• pUC19 GM-CSF-K-HA was cloned starting with pUC19 GM-CSF-K-Gas1.1, which we produced in our laboratory. This plasmid includes a sequence that encodes murine GM-CSF fused to a downstream glycosylphosphatidylinositol modification sequence derived from the yeast GAS 1 protein (the latter obtained from Dr. D. Wittrup, University of Illinois). A linker sequence is interposed between the GM-CSF and GAS 1 portions. To insert the linker sequence, the plasmid pUC19 GMCSF-Gas1.1, also previously produced in our lab, was digested with NgoM IV and NheI. These restriction enzymes cut at the 3′ end of the GM-CSF molecule and at the 5′ end of the Gas 1.1 sequence, respectively. The resulting plasmid was purified after electrophoresis through agarose gel using a kit manufactured by Qiagen. The following oligonucleotides were purchased:

  	5′ CCGGCACTAGTGGCGGAGGGGGCTCCGGCGGCGGGGGCAGCG
  	5′ CTAGCGCTGCCCCCGCCGCCGGCGCCCCCTCCGCCACTAGTG

  
  The synthetic oligonucleotides contain:
• • 1. 5′ overhang that anneals to NgoM IV digested plasmid DNA
  • 2. 3′ overhang that anneals to Nhe I digested plasmid DNA
  • 3. DNA sequence coding for the peptide GGGGSGGGGS where G stands for glycine and S stands for serine. This 10 amino acid sequence (G₄S)₂ is designed to insert a kink/spacer in the protein between the GMCSF and the Gas 0.1 moieties.
  • 4. SpeI site to allow confirmation of cloning of the small fragment and for further manipulations.
    The two oligonucleotides were mixed in equimolar concentrations, boiled for 2 minutes and allowed to anneal at room temperature. The oligonucelotide was ligated into the NgoM IV-Nhe I digested plasmid and the plasmid was used to transform the E. coli strain AG-1. Transformants were selected on LB plates containing 100 ug/ml ampicillin. Plasmid DNA was isolated, digested with Spe I, and electrophoresed on agarose gels to confirm the presence of the (G₄S)₂ sequence.
    pUC19 GM-CSF-K-hemagglutinin (HA)
• The plasmid pUC19 GM-CSF-K-HA was produced, which encodes a chimeric protein containing (from amino terminal to carboxy terminal): (1) murine GM-CSF; (2) the (G₄S)₂ linker described above; and (3) the HA1 domain of the H1 HA from the A/PR/8/34 influenza A isolate. The HA1 sequence used (amino acids 18 to 344 of the HA precursor) omits the N-terminal leader sequence and the downstream HA2 domain. A termination codon was added after amino acid 344.
• pUC 19 GM-CSF-K-Gas 1.1. was digested with Nhe I and Kpn L. Nhe I cuts at the 5′ end of the Gas 1.1 coding sequence and Kpn I cuts at the 3′ end of the Gas 1.1 coding sequence, respectively. The resulting plasmid with the GPI coding region removed, was purified after electrophoresis through agarose gel using a kit manufactured by Qiagen. The HA1 coding sequence was cloned by PCR from a plasmid encoding the HA gene of the A/PR/8/34 strain of influenza. The HA1 sequence used begins at amino acid 18, the start of the mature protein, i.e. lacking the secretion signal sequence. The 3′ end corresponds to amino acid 344, eliminating the transmembrane region and substituting a termination codon. Primers for PCR of the HA1 sequence were as follows:

  	Upstream HA1 Primer
  	5′ ATGCTAGCGACACAATATGTATAGGC
  	Downstream HA1 Primer
  	5′ ATGGTACCCGGCCGTTATCATCTGGATTGAATGGACGG

• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR was performed for 20 cycles using vent polymerase.
• Following PCR, the product was electrophoresed through a 1.0% agarose gel and the HA1 cDNA was extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified HA1 DNA fragment was digested with Nhe I and Kpn I. To make the fusion protein, the purified Nhe 1-Kpn I HA fragment was ligated into the pUC 19 GM-CSF-K-Gas1.1 vector that had been digested with Nhe I and Kpn I to remove the Gas1.1 coding region. The DNA was used to transform E. coli AG1 and transformants selected on LB-ampicillin plates. Plasmid DNA from individual colonies was isolated and digested with restriction enzymes. Restriction digests identified a pUC19 GM-CSF-K-HA plasmid.
• The pUC19 GM-CSF-K-HA plasmid was purified according to the manufacturer's instructions using a kit purchased from Qiagen.
Example 9 Cloning of GM-CSF-K-HA into Yeast Expression Vector
• PCR of pUC19 GM-CSF-K-HA was used to isolate a DNA fragment encoding GM-CSF-K-HA for cloning into a yeast expression vector. The PCR product contains Eag I cloning sites for in frame insertion into the yeast expression vector.

  	Upstream Primer
  	5′ TACGGCCGGCACCCACCCGCTCACCC
  	Downstream Primer
  	5′ ATGGTACCCGGCCGTTATCATCTGGATTGAATGGACGG

• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR was performed for 20 cycles using vent polymerase.
• Following PCR, the product was electrophoresed through a 1.0% agarose gel and the GM-CSF-K-HA gene was extracted from the gel using a Qiagen kit according to the manufacturers instructions. The purified DNA fragment was digested with Fag I and ligated to the yeast expression vector ITK that had been digested with Eag I. The ITK vector is designed for (1) replication in E. coli and (2) expression of genes in the yeast Saccharomyces cerevisiae after stable integration using homologous recombination. The vector contains:
• • 1. Sequences for replication of the plasmid in E. coli
  • 2. Yeast Gal promoter for expression of heterologous genes in yeast grown in media containing galactose.
  • 3. PrePro—Synthetic DNA sequence, optimized for secretion and signal sequence cleavage of distal genes in yeast.
  • 4. Unique Eag I site for cloning genes to be expressed.
  • 5. Alpha terminator—DNA sequence for efficient termination of proximal genes.
  • 6. Delta sequence that allows for stable integration of the plasmid by recombination with endogenous delta sequences in the yeast chromosome.
  • 7. Antibiotic resistance gene allowing for selection in E. coli with kanamycin and selection in yeast with G418.
• This plasmid was used to transform E. coli strain AG-1. Transformants were selected by growth on LB plates containing 100 ug/ml kanamycin. Individual colonies were grown in LB media containing kanamycin and plasmids were purified. Restriction digests determined orientation of inserts. The resulting plasmid ITK GM-CSF-K-HA was purified using a kit purchased from Qiagen according to the manufacturer's instructions.
Example 10 Expression of GM-CSF-K-HA in Yeast
• The purified plasmid was linearized with Mfe 1 and used to transform the yeast strain Saccharomyces cerevisiae WDHY131 using lithium acetate (LiAc). A 10 ml culture of S. cerevisiae grown to saturation at 30° in YPD media (per liter/20 g Bactotryptone; 20 g dextrose: 10 g yeast extract) was used to inoculate 100 ml of YPD. The culture was grown at 300 with shaking for 3 hours. The yeast were harvested by centrifugation at 11,000×g for 2 minutes and resuspended in 25 ml of sterile water. The yeast were centrifuged as above and resuspended in 1.0 ml of 100 mM lithium acetate and transferred to a 1.5 ml microfuge tube. The yeast were pelleted by centrifugation at 12,000×g for 15 seconds and the supernatant removed. The cells were resuspended in 0.5 ml of 100 mM LiAc. 50 uL of cell suspension was added to individual microfuge tubes and centrifuged as above. Supernatant was removed.
• Transformation mix added to the yeast pellet consisted of: 240 uL PEG (50% w/v); 36 uL 1.0 M LiAc; 5 uL single stranded DNA (10 mg/ml) and 1 ug of linearized ITK GM-CSF-K-HA in 75 uL of water. The mixture was vortexed to resuspend the cell pellet and incubated at 30° for 30 minutes. The cells were then shocked at 42° for 15 minutes, centrifuged to pellet cells and resuspended in 0.5 ml of YPD. Yeast were incubated in YPD media for 3 hours and plated on YPD plates containing 2 mg/ml G418. Plates were grown at 30° for 3 days until individual colonies appeared. To screen for expression of GM-CSF-K-HA, individual colonies were grown in 1 ml of YPD media at 300 for 2 days. The cells were centrifuged at 8,000×g for 2 minutes and the YPD media removed and replaced with 1 ml of YPG media (per liter/20 g Bactotryptone; 20 g galactose; 10 g yeast extract) for induction from the gal promoter. Yeast were grown in YPG media for 2 days. At this time, an aliquot was removed and cells were pelleted. The supernatant was tested for GM-CSF expression using an ELISA kit purchased from Endogen. Protocol was according to the manufacturer. A high-expressing yeast clone secreting the chimeric protein GM-CSF-K-HA was identified. Based on standard curve of soluble GMCSF, expression level was approximately 2.4 mg/L of GM-CSF moiety.
Example 11 Production of pUC 19 HA (hemagglutinin)-K-GM-CSF
• The plasmid pUC19 HA-K-GM-CSF was also produced, which encodes a chimeric protein containing (from amino terminal to carboxy terminal): (1) an HA1 domain (2) K, the (G₄S)₂ linker described above, and (3) murine GM-CSF, The HA1 begins at the amino terminus of the mature protein, amino acid 18, eliminating the leader sequence. The 3′ end terminates at amino acid 344. The (G₄S)₂ has been added to supply a flexible linker. The GM-CSF begins at amino acid 18 of the GM-CSF protein, corresponding to the first amino acid of the mature protein.
• The HA-K sequence was first cloned by PCR of the HA1 coding sequence from a plasmid encoding the HA gene of the A/PR/8134 strain of influenza.

  Upstream Primer
  5′ CTGAATTCCGGCCGGACACAATATGTATAGGC
  Downstream Primer
  5′ ATGGTACCGCTGCCCCCGCCGCCGGAGCCCCCTCCGCCACTTCTGGA
  TTGAATGGACGGAAT

  
  The oligonucleotides for PCR generate a nucleic acid with:
• 1. A 5′ EcoRI site at the amino terminus of the mature HA
• 2. The (G₄S)₂ linker at the carboxy terminus of the HA1 domain (amino acid 344 of the HA precursor)
• 3. A Kpn I site distal to the end of the (G₄S)₂ sequence
• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR was performed for 20 cycles using vent polymerase.
• Following PCR, the product was electrophoresed through a 1.0% agarose gel and the HA1-K DNA was extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified HA-K DNA fragment was digested with EcoRI and Kpn I and the fragment was cloned into pUC19 that had been digested with EcoRI and KpnI. The plasmid was used to transform E. coli AG-1 to amp^r. Individual colonies were picked and grown in LB-amp. The identity of plasmids with the correct insert was determined by restriction mapping. The resulting plasmid termed pUC19 HA-K was purified using a Qiagen kit according to the manufacturer's instructions.

  	Upstream Primer
  	5′ ACGGTACCGCACCCACCCGCTCACCCATC
  	Downstream Primer
  	5′ TAGGATCCCGGCCGTCATTTTTGGACTGGTTTTTTGCACG

  
  The PCR primers generate a GM-CSF fragment with
• 1. 5′ KpnI site that allows in frame translation from the (G₄S)₂ portion of the HA-K molecule to the start of the mature GM-CSF molecule at amino acid 18.
• 2. A termination codon at the 3′ end of the GM-CSF
• 3. 3′ BamHI site
• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR was performed for 20 cycles using vent polymerase.
• Following PCR, the product was electrophoresed through a 1.0% agarose gel and the GM-CSF gene was extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified fragment was digested with Kpn I and BamHI and the fragment was ligated into pUC19 HA-K plasmid that had been digested with KpnI and BamHI. The plasmid was used to transform E. coli AG-1 to amp^r. Individual colonies were picked and grown in LB-amp. The identity of plasmids with the correct insert was determined by restriction mapping. The resulting plasmid termed pUC19 HA-K-GM-CSF was purified using a Qiagen kit according to the manufacturer's instructions.
Example 12 Cloning of HA-K-GM-CSF into Yeast Expression Vector
• PCR of pUC19 HA-K-GM-CSF was used to generate a DNA fragment encoding HA-K-GM-CSF for cloning into a yeast expression vector. The PCR product contains Eag I cloning sites for in-frame insertion into the yeast expression vector.

  	Upstream Primer
  	5′ CTGAATTCCGGCCGGACACAATATGTATAGGC
  	Downstream Primer
  	5′ TAGGATCCCGGCCGTCATTTTTGGACTGGTTTTTTGCACG

• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR was performed for 20 cycles using vent polymerase.
• Following PCR, the product was electrophoresed through a 1.0% agarose gel and the HA-K-GM-CSF gene was extracted from the gel using a Qiagen kit according to the manufacturers instructions. The purified DNA fragment was digested with Eag I and ligated to the yeast expression vector ITK, that had been digested with Eag I. The ITK vector is designed for (1) replication in E. coli and (2) expression of genes in the yeast Saccharomyces cerevisiae after stable integration using homologous recombination. The vector contains:
• • 1. Sequences for replication of the plasmid in E. coli
  • 2. Yeast Gal promoter for expression of heterologous genes in media containing galactose.
  • 3. PrePro—Synthetic DNA sequence, optimized for secretion and signal sequence cleavage of distal genes in yeast.
  • 4. Unique Eag I site for cloning genes to be expressed.
  • 5. Alpha terminator—DNA sequence for efficient termination of proximal genes.
  • 6. Delta sequence that allows for stable integration of the plasmid by recombination with endogenous delta sequences in the yeast chromosome.
  • 7. Antibiotic resistance gene allowing for selection in E. coli with kanamycin and selection in yeast with G418.
• This plasmid was used to transform E. coli strain AG-1. Transformants were selected by growth on LB plates containing 100 ug/ml kanamycin. Individual colonies were grown in LB media containing kanamycin and plasmids were purified. Restriction digests determined orientation of inserts. The resulting plasmid ITK HA-K-GM-CSF was purified using a kit purchased from Qiagen according to the manufacturer's instructions.
• The purified plasmid was linearized with Mfe 1 and used to transform the yeast strain Saccharomyces cerevisiae WDHY131 using lithium acetate (LiAc). A 10 ml culture of S. cerevisiae grown to saturation at 30° C. in YPD media (per liter/20 g Bactotryptone; 20 g dextrose; 10 g yeast extract) was used to inoculate 100 ml of YPD. The culture was grown at 30° C. with shaking for 3 hours. The yeast were harvested by centrifugation at 11,000×g for 2 minutes and resuspended in 25 ml of sterile water. The yeast were centrifuged as above and resuspended in 1.0 ml of 100 mM lithium acetate and transferred to a 1.5 ml microfuge tube. The yeast were pelleted by centrifugation at 12,000×g for 15 seconds and the supernatant removed. The cells were resuspended in 0.5 ml of 100 mM LiAc. 50 uL of cell suspension was added to individual microfuge tubes and centrifuged as above. Supernatant was removed. Transformation mix added to the yeast pellet consisted of: 240 uL PEG (50% w/v); 36 uL 1.0 M LiAc; 5 uL single stranded DNA (10 mg/ml) and 1 ug of linearized ITK HA-K-GM-CSF in 75 uL of water. The mixture was vortexed to resuspend the cell pellet and incubated at 300 for 30 minutes. The cells were then shocked at 42° C. for 15 minutes, centrifuged to pellet cells and resuspended in 0.5 ml of YPD. Yeast were incubated in YPD media for 3 hours and plated on YPD plates containing 2 mg/ml G418. Plates were grown at 30° C. for 3 days until individual colonies appeared. To screen for expression of HA-K-GM-CSF, individual colonies were grown in 1 ml of YPD media at 30° C. for 2 days. The cells were centrifuged at 8,000×g for 2 minutes and the YPD media removed and replaced with 1 ml of YPG media (per liter/20 g Bactotryptone; 20 g galactose; 10 g yeast extract) for induction from the gal promoter. Yeast were grown in YPG media for 2 days. At this time, an aliquot was removed and cells were pelleted. The supernatant was tested for GM-CSF expression using an ELISA kit purchased from Endogen. The protocol was according to the manufacturer.
• A colony expressing high levels of the chimeric protein was identified. Based on standard curve of soluble GMCSF, expression level is approximately 2.0 mg/L of soluble material. There is no decrease in expression levels in the absence of G418.
Example 13 Scale Up Purification of GM-CSF-K-HA
• For scaled-up purification of the chimeric protein, yeast were inoculated into 500 ml of YPD and grown for three days at 30° C. Cells were pelleted by centrifugation at 12,000×g for 2 minutes and transferred to an equal volume of YPG for an additional three days of growth. The cells were then pelleted by centrifugation at 12,000×g for 2 minutes and the supernatant collected. The soluble material was applied to an immunoaffinity column of anti-murine GMCSF monoclonal antibody (Endogen) linked to cyanogen bromide-activated Sepharose 4B (Sigma). Coupling of the monoclonal to the Sepharose was performed according to the manufacturer. Efficiency of coupling was monitored using OD₂₈₀ and of binding of GMCSF to immobolized antibody was tested using soluble, commercially available material.
• Soluble yeast-derived material was applied to the column and allowed to flow by gravity. The column was washed with: (a) 20 volumes of 0.15M NaCl, 25 mM Tris pH 7.4 (TN) (b) 5 volumes of 50 mM Tris pH 8.0 (c) 20 volumes TN. Bound material was then eluted with 10 volumes of 0.15M NaCl, 25 mM Tris pH 2.5. Eluted material was neutralized with 1/200 volume of 1.5M Tris pH8.8. The purified material was concentrated using a Microsep 3K centrifugal devise (Pall Gelman Laboratory). Yields of chimeric protein were determined by ELISA (Endogen) according to the manufacturer's instructions.
• Purified GM-CSF-K-HA
• Purified GM-CSF-K-HA was analyzed by western blot. Approximately lug of GM-K-HA per lane was electrophoresed along with soluble GMCSF. For western blot, gels were transferred to Protran BA83 (Schleicher and Schuell), blocked with TBS (Tris Buffered Saline) containing 0.05% Tween 20 and 2% Nonfat Dry Milk. The blot was incubated with primary antibody (rat monoclonal anti-murine GMCSF, Endogen) at 1:5000 dilution in blocking buffer for 2 hours at room temperature. The blot was washed with TBS-0.05% Tween 20. Secondary antibody, alkaline phosphatase conjugated anti-rat IgG (Sigma) was incubated at 1:10,000 for 1 hour at room temperature.
Example 14 Decoration of Cells with GM-K-HA
• Purified GM-CSF-K-HA was used to decorate CMS 5 murine fibrosarcoma cells. CMS 5 cells were grown in DMEM, 10% FBS, Penicillin-streptomycin, harvested by trypsinization and washed 3 times with RPMI 1640 (Gibco). Cells were diluted to 1×10⁶/ml in RPMI 1640 and 0.9 ml were aliquoted to siliconized tubes. Cells were incubated for 2 hours at 37° C. with shaking and then washed 3 times with PBS containing 2% FBS. Primary antibody, rat anti-murine GMCSF monoclonal, was incubated for one hour at 4° C. Cells were washed as above, treated with FITC labeled anti-rat antibody (Sigma), and incubated for one hour at 4° C. After additional washing, the cells were analyzed by flow cytometry, which confirmed the presence of GM-CSF-K-HA on the surface of the tumor cells.
Example 15 Quantitation of GM-CSF-K-HA on the Cell Surface of CMS 5 Cells After Decoration
• CMS 5 cells were harvested and washed as described above. 1×10⁶ cells in 1 ml of RPMI 1640 were incubated with 1 ug of purified GM-K-HA. After incubation for 15 min, 30 min, 1 hour, or 2 hours at 4° C., room temperature, or 37° C., the cells were washed 3 times with PBS containing 2% FBS. The cell pellet was lysed with 50 microliters of PBS containing 0.15% deoxycholate and the detergent subsequently diluted by the addition of 200 microliters of PBS. The material was serially diluted with PBS and tested by ELISA (Endogen). Based on the amount of GM-CSF detected in the cell lysates, it was possible to quantitate the average number of GM-CSF molecules associated with each cell. For example, after a 15 min incubation at 4° C., 58,700 molecules were present per cell. After a 15 min incubation at room temperature, 25,700 molecules were present per cell. After a 15 min incubation at 37° C., 17,200 molecules were present per cell.
Example 16 Effective Immunization with Tumor Cells Admixed with GM-CSF/Hemagglutinin Fusion Polypeptides
• CMS-5 murine fibrosarcoma cells were grown to 70% confluence in DMEM, 10% FBS, Penicillin-streptomycin, harvested by trypsinization, and washed 3 times with RPMI 1640. Viability was determined by trypan blue staining of an aliquot and the cells were then resuspended at a concentration of 4×10⁶ cells/ml and 1 ml aliquots dispensed into siliconized microfuge tubes. The cells were incubated with 1 ug (microgram) murine GM-CSF-K-HA or 10 ng (nanograms) HA-K-murine GM-CSF per 10⁶ cells for 3 hours at 37° C. Cells were then washed 3 times with RPMI 1640 and resuspended at 4×10⁶ cells/ml in RPMI 1640. An aliquot of the cells was removed and the amount of cell-associated GM-CSF measured by ELISA as described above. There were approximately 20,240 and 18,000 molecules/cell in the GM-CSF-K-HA and HA-K-GM-CSF groups, respectively. Cells for a control vaccine, to be administered without a molecule of the invention (or any other immunomodulator), were prepared in parallel.
• The cells were irradiated at 3500 rads from a ¹³⁷Cs source. 8 week-old female Balb/c mice (which are syngeneic for CMS-5) were anesthetized by metofane inhalation and vaccinated subcutaneously in the left inguinal fold with 1×10⁶ cells in 0.25 ml. Each mouse received cells from only one vaccine type. Seven days later, wild-type CMS-5 cells at 70% confluence were harvested and washed 3 times in HBSS. Viability was determined by trypan blue staining of an aliquot and cells were adjusted to 4×10⁶/ml in HBSS. The previously vaccinated mice were then injected subcutaneously behind the neck, under metofane anesthesia, with 2×10⁶ live, wild-type CMS-5 cells in 0.5 ml HBSS. The groups receiving the HA-K-GM-CSF and control vaccines each consisted of 5 mice, whereas the group receiving the GM-CSF-K-HA vaccine consisted of 4 mice because 1 mouse failed to awaken from anesthesia.
• Tumor development was assessed daily by palpation and visual inspection. The observer was blinded to the vaccine received by each set of mice to ensure against bias. Mice were sacrificed by CO2 asphyxiation when tumors become unwieldy. All mice that had received the control vaccine developed tumors within 18 days after challenge with live tumor cells. In contrast, 100% of mice that had received the GM-CSF-K-HA vaccine and 60% of mice that had received the HA-K-GM-CSF vaccine remained tumor-free at the end of the experiment, 40 days after challenge. Thus, immunization with a composition comprising tumor cells and a molecule of the invention confers significantly longer tumor-free survival than immunization with a composition comprising tumor cells but not comprising a molecule of the invention.
Example 17 Cloning of Human GM-CSF-K-HA
• pUC19 human GM-CSF-K-HA (hGM-CSF-K-HA) is cloned starting with pUC19 GM-CSF-K-HA. pUC19 GM-CSF-K-HA. is digested with EcoRI and NgoM IV. EcoRI cuts at the 5′ end of the murine GM-CSF coding sequence and Ngo M IV cuts at the 3′ end of the murine GM-CSF molecule. The resulting plasmid with the murine GM-CSF coding region removed is purified after electrophoresis through agarose gel using a kit manufactured by Qiagen. The human GM-CSF coding segment is generated by PCR from a commercially available human cDNA library (Clontech). The human sequence begins at amino acid 18, the start of the mature protein, i.e. lacking the secretory signal sequence. The 3′ end corresponds to amino acid 144, eliminating the endogenous termination codon.

  	Upstream hGM-CSF Primer
  	5′ GCGAATTCCGGCCGGCACCCGCCCGCTCGCCCAGC
  	Downstream hGM-CSF Primer
  	5′ TAGCCGGCCTCCTGGACTGGCTCCCAGCA

• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR is performed for 20 cycles using vent polymerase.
• Following PCR, the product is electrophoresed through a 1.0% agarose gel and the hGM-CSF gene is extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified hGM-CSF DNA fragment is digested with Eco RI and NgoM IV and ligated into the pUC 19 murine GM-CSF-K-HA vector that has been digested with EcoRI and NgoM IV to remove the murine GM-CSF sequence. The DNA is used to transform E. coli AG1 and transformants are selected on LB-ampicillin plates. Plasmid DNA from individual colonies is isolated and digested with restriction enzymes to identify clone harboring a pUC19 hGM-CSF-K-HA plasmid.
• The pUC19 hGM-CSF-K-HA plasmid is purified according to the manufacturer's instructions using a kit purchased from Qiagen. PCR of pUC19 hGM-CSF-K-HA is used to generate a DNA fragment encoding hGM-CSF-K-HA for cloning into a yeast expression vector. The PCR product contains Eag I cloning sites for in frame insertion into the yeast expression vector.

  	Upstream Primer
  	5′ GCGAATTCCGGCCGGCACCCGCCCGCTCGCCCAGC
  	Downstream Primer
  	5′ ATGGTACCCGGCCGTTATCATCTGGATTGAATGGACGG

• Conditions for PCR were:

  	Denaturation	900	one minute
  	Annealing	600	one minute
  	Extension	720	one minute

  
  PCR is performed for 20 cycles using vent polymerase.
• Following PCR the product is electrophoresed through a 1.0% agarose gel and the hGM-CSF-K-HA gene is extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified DNA fragment is digested with Eag I and ligated to the yeast expression vector ITK that has been digested with Eag I. The ITK vector is designed for (1) replication in E. coli and (2) expression of genes in the yeast Saccharomyces cerevisiae after stable integration using homologous recombination. The vector contains:
• • 1. Sequences for replication of the plasmid in E. coli
  • 2. Yeast Gal promoter for expression of heterologous genes in yeast grown in media containing galactose.
  • 3. PrePro—Synthetic DNA sequence, optimized for secretion and signal sequence cleavage of distal genes in yeast.
  • 4. Unique Eag I site for cloning genes to be expressed.
  • 5. Alpha terminator—DNA sequence for efficient termination of proximal genes.
  • 6. Delta sequence that allows for stable integration of the plasmid by recombination with endogenous delta sequences in the yeast chromosome.
  • 7. Antibiotic resistance gene allowing for selection in E. coli with kanamycin and selection in yeast with G418.
• This plasmid is used to transform E. coli strain AG-1. Transformants are selected by growth on LB plates containing 100 ug/ml kanamycin. Individual colonies are grown in LB media containing kanamycin and plasmids are purified. Restriction digests determine orientation of inserts. The resulting plasmid ITK hGM-CSF-K-HA is purified using a kit purchased from Qiagen according to the manufacturer's instructions.
• The purified plasmid is linearized with Mfe 1 and used to transform the yeast strain Saccharomyces cerevisiae WDHY131 using lithium acetate (LiAc). A 10 ml culture of S. cerevisiae grown to saturation at 30° in YPD media (per liter/20 g Bactotryptone; 20 g dextrose; 10 g yeast extract) is used to inoculate 100 ml of YPD. The culture is grown at 30° with shaking for 3 hours. The yeast are harvested by centrifugation at 11,000×g for 2 minutes and resuspended in 25 ml of sterile water. The yeast are centrifuged as above and resuspended in 1.0 ml of 100 mM lithium acetate and transferred to a 1.5 ml microfuge tube. The yeast are pelleted by centrifugation at 12,000×g for 15 seconds and the supernatant removed. The cells are resuspended in 0.5 ml of 100 mM LiAc. 50 uL of cell suspension is added to individual microfuge tubes and centrifuged as above. Supernatant is removed. Transformation mix added to the yeast pellet consists of: 240 uL PEG (50% w/v); 36 uL 1.0 M LiAc; 5 uL single stranded DNA (10 mg/ml) and 1 ug of linearized ITK hGM-CSF-K-HA in 75 uL of water. The mixture is vortexed to resuspend the cell pellet and incubated at 30° for 30 minutes. The cells are then shocked at 42° for 15 minutes, centrifuged to pellet, and resuspended in 0.5 ml of YPD. Yeast are incubated in YPD media for 3 hours and plated on YPD plates containing 2 mg/ml G418. Plates are grown at 30° for 3 days until individual colonies appear.
• To screen for expression of hGM-CSF-K-HA, individual colonies are grown in 1 ml of YPD media at 30° for 2 days. The cells are centrifuged at 8,000×g for 2 minutes and the YPD media removed and replaced with 1 ml of YPG media (per liter/20 g Bactotryptone; 20 g galactose; 10 g yeast extract) for induction from the gal promoter. Yeast are grown in YPG media for 2 day. An aliquot is then removed and the cells are pelleted. The supernatant is tested for hGM-CSF expression using an ELISA kit purchased from Endogen. Protocol is according to the manufacturer.
Example 18 Reduction of Metastases in a Mouse Model
• B16F10 murine melanoma cells were harvested and washed three times in PBS. Cells were then suspended at 5×10⁵ viable cells/ml in PBS, with viability determined by staining an aliquot of cells with Trypan blue. 100 ul of this suspension was injected into the tail veins of 8-10 week old female C57BL/6 mice. On day 1 or day 3 after tumor challenge, mice were immunized with 1×10⁶ irradiated B16F10 cells subcutaneously in the left inguinal fold. Groups (3 mice each) received either cells alone, cells mixed with 1 ug soluble recombinant murine GM-CSF (Serologicals Corp.), or cells mixed with 1 ug of a multifunctional molecule of the invention comprising murine GM-CSF at the N terminus, a (Gly₄Ser)₂ flexible linker, and the HA1 domain of influenza A/PR/8/34 hemagglutinin at the C terminus. The latter composition comprised both free and cell-bound multifunctional molecule.
• Mice were sacrificed on day 12, the thoracic cavity opened with dissecting scissors, and the lungs removed en bloc by tracheal transection. Metastases were enumerated with a hand lens. In the mice immunized 1 day after challenge, the average number of metastases/mouse was as follows:

  	Cells alone:	30.00
  	Cells + GM-CSF:	14.33
  	Cells + multifunctional molecule:	0.67

• In the mice immunized 3 days after challenge, the average number of metastases/mouse was as follows:

  	Cells alone:	36.33
  	Cells + GM-CSF:	10.33
  	Cells + multifunctional molecule:	1.00

• Thus, administration of the composition comprising a multifunctional molecule of the invention was able to effectively reduce metastases and treat disease.
Example 19 GM-CSF-HA1-Mediated Protection Against Tumor Challenge In Vivo
• As an allogeneic tumor vaccine model, C57BL/6 mice (haplotype b) were immunized with C3H (haplotype k)-derived K1735 melanoma cells, followed by challenge with C57BL/6-derived B16F10 melanoma cells. K1735 cells were grown to 70% confluence in DMEM with 10% FBS and penicillin-streptomycin, harvested by trypsinization, and washed 3 times with RPMI 1640. Viability was determined by trypan blue staining of an aliquot and the cells were then resuspended at a concentration of 4×10⁶ cells/ml for K1735. One ml aliquots were then dispensed into siliconized microfuge tubes. The cells were incubated with 1 ug mGM-CSF-HA1 (a fusion polypeptide consisting of murine GM-CSF at the N terminus, a (Gly₄Ser)₂ linker, and the HA1 domain of influenza AIPR/8/34) per 10⁶ cells for 2 hours at 4° C. An aliquot of the cells was removed for measurement of cell-associated GM-CSF by ELISA. Mean cell-associated GM-CSF across two experiments was approximately 60,000. Cells that were not admixed with any polypeptide and, in one experiment, cells mixed with 1 ug soluble murine GM-CSF (Serologicals Corp.) were prepared in parallel as control vaccines.
• The cells were irradiated at 3500 rads from a ¹³⁷CS source. 8 week-old female C57BL/6 mice were anesthetized by metofane inhalation and vaccinated subcutaneously in the left inguinal fold with or 1×10⁶ cells in 0.25 ml RPMI, along with a total of 1 ug GM-CSF-HA1 (including bound and free fusion polypeptide). Each mouse received cells from only one vaccine type. Seven days later, B16F10 cells, as appropriate, at 70% confluence were harvested and washed 3 times in HBSS. Viability was determined by trypan blue staining of an aliquot and cells were adjusted in HBSS to 1×10⁵/ml. The previously vaccinated mice were then challenged subcutaneously behind the neck, under metofane anesthesia, with 0.5 ml of the B16F10 cell suspension.
• Tumor development was assessed daily by palpation and visual inspection. “Onset” was defined as the first day on which a tumor mass was both palpable and visible. The observer was blinded to the vaccine received by each set of mice to ensure against bias. Mice were sacrificed by CO2 asphyxiation when tumors become unwieldy. Experiments were terminated 70 days after tumor challenge, as planned in advance.
• In pooled results from two experiments, 70 days after challenge, 7/10 mice that had been vaccinated with cells admixed with fusion polypeptide remained tumor-free. In contrast, 10/10 mice that had been vaccinated with cells alone developed tumors, as did 4/5 mice vaccinated with cells admixed with soluble murine GM-CSF.
• Other Embodiments
• The foregoing examples demonstrate experiments performed and contemplated by the present inventors in making and carrying out the invention. It is believed that these examples include a disclosure of techniques which serve to both apprise the art of the practice of the invention and to demonstrate its usefulness. It will be appreciated by those of skill in the art that the techniques and embodiments disclosed herein are preferred embodiments only that in general numerous equivalent methods and techniques may be employed to achieve the same result.
• All of the references identified hereinabove, are hereby expressly incorporated herein by reference to the extent that they describe, set forth, provide a basis for or enable compositions and/or methods which may be important to the practice of one or more embodiments of the present inventions.
• Appendix I
• 4: BC025704 Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5, clone MGC:34418 IMAGE:5223581, mRNA, complete cds
  gi|19344005|gb|BC025704.1|[19344005]
• 5: BC025713 Homo sapiens, T-cell receptor interacting molecule, clone MGC:34314 IMAGE:5227396, mRNA, complete cds
  gi|19343996|gb|BC025713.1|[19343996]
• 6: BC025722 Homo sapiens, adenosine A2b receptor, clone MGC:34640 IMAGE:5198898, mRNA, complete cds
  gi|19343938|gb|BC025722.1|[19343938]
• 7: BC025717 Homo sapiens, chemokine (C-C motif) receptor-like 2, clone MGC:34104 IMAGE:5228561, mRNA, complete cds
  gi|19343936|gb|BC025717.1|[19343936]
• 8: BC025695 Homo sapiens, endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 4, clone MGC:34227 IMAGE:5209267, mRNA, complete cds
  gi|19343926|gb|BC025695.1|[19343926]
• 9: BC025727 Homo sapiens, Similar to T cell receptor alpha locus, clone MGC:34712 IMAGE:5201547, mRNA, complete cds
  gi|19343616|gb|BC025727.1|[19343616]
• 10: BC025691 Homo sapiens, interleukin 2 receptor, beta, clone MGC:34584 IMAGE:5207833, mRNA, complete cds
  gi|19343610|gb|BC025691.1|[19343610]
• 11: AF474992 Homo sapiens G protein-coupled receptor SNSR6 gene, complete cds
  gi|19338917|gb|AF474992.1|[19338917]
• 12: AF474991 Homo sapiens G protein-coupled receptor SNSR5 gene, complete cds
  gi|19338915|gb|AF474991.1|[19338915]
• 13: AF474990 Homo sapiens G protein-coupled receptor SNSR4 gene, complete cds
  gi|19338913|gb|AF474990.1|[19338913]
• 14: AF474989 Homo sapiens G protein-coupled receptor SNSR3 gene, complete cds
  gi|19338911|gb|AF474989.1|[19338911]
• 15: AF474988 Homo sapiens G protein-coupled receptor SNSR2 gene, complete cds
  gi|19338909|gb|AF474988.1|[19338909]
• 71: AF453877 Homo sapiens neuronal nicotinic receptor beta 4 subunit precursor, gene, exon 1 and partial cds
  gi|18042122|gb|AF453877.1|[18042122]
• 73: U62556 Homo sapiens chemokine receptor-like protein (TER1) gene, complete cds
  gi|1468978|gb|U62556.1|HSU62556[1468978]
• 74: AF449218 Homo sapiens 43 kDa acetylcholine receptor-associated protein (RAPSN) mRNA, complete cds
  gi|19310212|gb|AF449218.1|[19310212]
• 84: AJ437349 Homo sapiens partial mRNA for T-cell receptor beta chain (V14-D-J-C) (TCRB gene), clone 11
  gi|19262919|emb|AJ437349.1|HSA437349[19262919]
• 85: AJ011371 Homo sapiens mRNA for serotonin 4 receptor, splice variant h5-HT4(e)
  gi|3646277|emb|AJ011371.1|HSAJ1371[3646277]
• 88: BC025294 Homo sapiens, Similar to toll-like receptor 4, clone IMAGE:4868078, mRNA
  gi|19263693|gb|BC025294.1|[19263693]
• 89: BM875542 ij54d02.y1 Human insulinoma Homo sapiens cDNA clone IMAGE:5634842 5′ similar to TR:O00559 O00559 RECEPTOR-BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS;, mRNA sequence
  gi|19243208|gb|BM875542.1|BM875542[19243208]
• 99: AY059419 Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL1) mRNA, KIR3DL1*011 allele, partial cds
  gi|19224338|gb|AY059419.1|[19224338]
• 100: AY059418 Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*010 allele, partial cds
  gi|19224336|gb|AY059418.1|[19224336]
• 101: AY059417 Homo sapiens killer-cell immunoglobulin-like receptor KIR3DL1/2v mRNA, partial cds
  gi|19224334|gb|AY059417.1|[19224334]
• 102: AY059420 Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*012 allele, partial cds
  gi|19224332|gb|AY059420.1|[19224332]
• 103: AC079385 Homo sapiens 12q BAC RP11-482D24 (Roswell Park Cancer Institute Human BAC Library) complete sequence
  gi|14670063|gb|AC079385.18|[14670063]
• 104: AC078889 Homo sapiens 12q BAC RP11-33512 (Roswell Park Cancer Institute Human BAC Library) complete sequence
  gi|11072039|gb|AC078889.20|[11072039]
• 105: AC010168 Homo sapiens 12 p12-31.7-32.2 BAC RP11-174G6 (Rosewell Park Cancer Institute Human Bac Library) complete sequence
  gi|6855156|gb|AC010168.61[6855156]
• 106: U14188 Homo sapiens LERK-4 (EPLG4) mRNA, complete cds
  gi|642834|gb|U14188.1|HSU14188[642834]
• 107: U14187 Homo sapiens LERK-3 (EPLG3) mRNA, complete cds
  gi|642832|gb|U14187.1|HSU14187[642832]
• 108: U15637 Homo sapiens CD40 binding protein (CD40BP) mRNA, complete cds
  gi|595910|gb|U15637.1|HSU15637[595910]
• 109; AF262304 Homo sapiens clone 6 CC chemokine receptor 3-like mRNA, partial sequence, alternatively spliced
  gi|19171650|gb|AF262304.1|[19171650]
• 110: AF262303 Homo sapiens clone 6 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171648|gb|AF262303.1|[19171648]
• 111: AF262302 Homo sapiens clone 5 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171646|gb|AF262302.1|[19171646]
• 112: AF262301 Homo sapiens clone 4 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171644|gb|AF262301.1|[19171644]
• 113: AF262300 Homo sapiens clone 2 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171642|gb|AF262300.1|[19171642]
• 114: AF262299 Homo sapiens clone 1 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171640|gb|AF262299.1|[19171640]
• 118: AF247361 Homo sapiens CC chemokine receptor 3 (CCR3) gene, complete cds
  gi|19110542|gb|AF247361.1|[19110542]
• 122: AF416619 Homo sapiens prolactin receptor short isoform 1a (PRLR) mRNA, complete cds, alternatively spliced
  gi|16506717|gb|AF416619.1|[16506717]
• 123: AF416618 Homo sapiens prolactin receptor short isoform 1b (PRLR) mRNA, complete cds, alternatively spliced
  gi|16506715|gb|AF416618.1|[16506715]
• 125: AJ303165 Homo sapiens partial gene for putative transmembrane receptor
  gi|13162199|emb|AJ303165.1|HSA303165[13162199]
• 126: NM_—017451 Homo sapiens BA11-associated protein 2 (BAIAP2) transcript variant 2, mRNA
  gi|9257198|ref|NM_—017451.1|[9257198]
• 127: NM_—017450 Homo sapiens BA11-associated protein 2 (BAIAP2) transcript variant 1, mRNA
  gi|9257196|ref|NM_—017450.1|[9257196]
• 128: NM_—006340 Homo sapiens BA11-associated protein 2 (BAIAP2) transcript variant 3, mRNA
  gi|5453564|ref|NM_—006340.1|[5453564]
• 131: AF350881 Homo sapiens channel kinase 2 (CHAK2) mRNA, complete cds
  gi|18860923|gb|AF350881.2|[18860923]
• 132: AF022044 Homo sapiens natural killer cell receptor KIR3D51 variant mRNA, complete cds
  gi|2760894|gb|AF022044.1|[2760894]
• 133: AF034773 Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 3, complete cds
  gi|2739181|gb|AF034773.1|[2739181]
• 134: AF034772 Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 2, complete cds
  gi|2739179|gb|AF034772.1|[2739179]
• 135: AF034771 Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 1, complete cds
  gi|2739177|gb|AF034771.1|[2739177]
• 136: AF022047 Homo sapiens natural killer cell inhibitory receptor KIR2D53 variant mRNA, complete cds
  gi|2738966|gb|AF022047.1|[2738966]
• 137: AF022046 Homo sapiens natural killer cell inhibitory receptor KIR2D51 variant mRNA, complete cds
  gi|2738964|gb|AF022046.1|[2738964]
• 138: AF022045 Homo sapiens natural killer cell receptor KIR2DL1 variant mRNA, complete cds
  gi|2738962|gb|AF022045.1|[2738962]
• 139: U56255 Homo sapiens CW-1 mRNA, complete cds
  gi|1399688|gb|U56255.1|HSU56255[1399688]
• 140: AJ422056 Homo sapiens partial GRM5 gene for metabotrophic glutamate receptor, exon 1A
  gi|19069804|emb|AJ422056.1|HSA422056[19069804]
• 141: AY028912 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 7 and complete cds, alternatively spliced
  gi|19067944|gb|AY028912.1|AY028906S7[19067944]
• 142: AY028911 Homo sapiens ectodysplasin A receptor associated death domain (ED.hD)T ene, exon 6
  gi|19067943|gb|AY028911.1|AY028906S6[19067943]
• 143: AY028910 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 5
  gi|19067942|gb|AY028910.1|AY028906S5[19067942]
• 144: AY028909 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 4
  gi|19067941|gb|AY028909.1|AY028906S4[19067941]
• 145: AY028908 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 3
  gi|19067940|gb|AY028908.1|AY028906S3[19067940]
• 146: AY028907 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 2
  gi|19067939|gb|AY028907.1|AY028906S2[19067939]
• 147: AY028906 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 1
  gi|9067938|gb|AY028906.1|AY028906S1[19067938]
• 148: AH010677 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, complete cds, alternatively spliced
  gi|19067937|gb|AH010677.1|SEG_AY028906S[19067937]
• 149: AY028913 Homo sapiens ectodysplasia A receptor associated death domain A (EDARADD) mRNA, complete cds; alternatively spliced
  gi|19067935|gb|AY028913.1|[19067935]
• 150: BM735809 06E08 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens glycine receptor, beta, mRNA sequence
  gi|19057142|gb|BM735809.1|BM735809[19057142]
• 151: BM735756 06A09 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens glycine receptor, beta subunit, mRNA sequence
  gi|19057089|gb|BM735756.1|BM735756[19057089]
• 152: BM735711 10E11 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens protein tyrosine phosphatase, receptor-type, Z polypeptide 1, mRNA sequence
  gi|19057044|gb|BM735711.1|BM735711[19057044]
• 155: AC007165 Homo sapiens BAC clone RP11-451C2 from 2, complete sequence
  gi|19033999|gb|AC007165.4|[19033999]
• 156: AF245699 Homo sapiens type 1 angiotensin II receptor (AGTR1) gene, complete cds
  gi|7862074|gb|AF245699.1|[7862074]
• 157: BC024229 Homo sapiens, prostaglandin E receptor 3 (subtype EP3), clone MGC:27302 IMAGE:4660371, mRNA, complete cds
  gi|18999476|gb|BC024229.1|[18999476]
• 176: AJ417555 Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 4053
  gi|18958228|emb|AJ417555.1|HSA417555[18958228]
• 177: AJ417554 Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 3321
  gi|18958226|emb|AJ417554.1|HSA417554[18958226]
• 179: NM_—003877 Homo sapiens STAT induced STAT inhibitor-2 (STAT12), mRNA
  gi|18921206|ref|NM_—003877.2|[18921206]
• 180: NM_—017662 Homo sapiens transient receptor potential cation channel, subfamily M, member 6(TRPM6), mRNA
  gi|18921092|ref|NM_—017662.3|[18921092]
• 191: NM_—016148 Homo sapiens SH3 and multiple ankyrin repeat domains 1 (SHANK1), mRNA
  gi|11968151|ref|NM_—016148.1|[11968151]
• 193: NM_—017729 Homo sapiens epidermal growth factor receptor pathway substrate 8 related protein 1 (EPS8R1), mRNA
  gi|8923231|ref|NM_—017729.1|[8923231]
• 195: M13824 Homo sapiens T cell receptor gamma chain variable region (TCRG) gene, partial cds
  gi|339169|gb|M13824.1|HUMTCGXL[339169]
• 196: M12960 Homo sapiens T-cell receptor gamma-chain J1, partial cds
  gi|339144|gb|M12960.1|HUMTCGJB[339144]
• 197: M13823 Homo sapiens T cell receptor gamma chain (TCRG) gene, partial cds
  gi|292736|gb|M13823.1|HUMTCGXK[292736]
• 198: L12398 Homo sapiens dopamine receptor D4 (DRD4) mRNA, complete cds
  gi|291945|gb|L12398.1|HUMD4C[291945]
• 199: M86383 Homo sapiens nicotinic acetylcholine receptor alpha 3 subunit precursor, mRNA, complete cds
  gi|177897|gb|M86383.1|HUMA3NARSP[177897]
• 202: NM_—012245 Homo sapiens SKI-interacting protein (SNW1), mRNA
  gi|18860912|ref|NM_—012245.2|[18860912]
• 203: NM_—006750 Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basiccomponent 2) (SNTB2), transcript variant 1, mRNA
  gi|18860911|ref|NM_—006750.2|[18860911]
• 204: NM_—130845 Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basic component 2) (SNTB2), transcript variant 2, mRNA
  gi|18860909|ref|NM_—130845.1|[18860909]
• 205: NM_—002846 Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
  gi|18860905|ref|NM_—002846.2|[18860905]
• 206: NM_—002845 Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
  gi|18860903|ref|NM_—002845.2|[18860903]
• 207: NM_—002844 Homo sapiens protein tyrosine phosphatase, receptor type, K (PTPRK), mRNA
  gi|18860901|ref|NM_—002844.2|[18860901]
• 208: NM_—002843 Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
  gi|18860899|ref|NM_—002843.2|[18860899]
• 209: NM_—002841 Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
  gi|18860897|ref|NM_—002841.2|[18860897]
• 210: NM_—130440 Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript variant 2, mRNA
  gi|18860895|ref|NM_—130440.1|[18860895]
• 211: NM_—130393 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 4, mRNA
  gi|18860893|ref|NM_—130393.1|[18860893]
• 212: NM_—130392 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 3, mRNA
  gi|18860891|ref|NM_—130392.1|[18860891]
• 213: NM_—130391 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 2, mRNA
  gi|18860889|ref|NM_—130391.1|[18860889]
• 214: NM_—003682 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 4, mRNA
  gi|18860876|ref|NM_—003682.2|[18860876]
• 215: NM_—130476 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 8, mRNA
  gi|18860874|ref|NM_—130476.1|[18860874]
• 216: NM_—130475 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 7,
  mRNA
  gi|18860872|ref|NM_—130475.1|[18860872]
• 217: NM_—002840 Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript variant 1, mRNA
  gi|18860871|ref|NM_—002840.2|[18860871]
• 218: NM_—130474 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 6, mRNA
  gi|18860869|ref|NM_—130474.1|[18860869]
• 219: NM_—130473 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 5, mRNA
  gi|18860867|ref|NM_—130473.1|[18860867]
• 220: NM_—130472 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 3, mRNA
  gi|18860865|ref|NM_—130472.1|[18860865]
• 221: NM_—130471 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 2, mRNA
  gi|18860863|ref|NM_—130471.1|[18860863]
• 222: NM_—130470 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 1, mRNA
  gi|18860861|ref|NM_—130470.1|[18860861]
• 223: NM_—006504 Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript variant 1, mRNA
  gi|18860861|ref|NM_—006504.2|[18860860]
• 224: NM_—130435 Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript variant 2, mRNA
  gi|18860858|ref|NM_—130435.1|[18860858]
• 225: AJ431177 Homo sapiens mRNA for WIRE protein
  gi|18857713|emb|AJ431177.1|HSA431177[18857713]
• 226: NM_—006474 Homo sapiens lung type-I cell membrane-associated glycoprotein (T1A-2), mRNA
  gi|18767663|ref|NM_—006474.2|[18767663]
• 228: NM_—006794 Homo sapiens G protein-coupled receptor 75 (GPR75), mRNA
  gi|5803024|ref|NM_—006794.1|[5803024]
• 229: NM_—002842 Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
  gi|4506312|ref|NM_—002842.1|[4506312]
• 230: NM_—002839 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 1, mRNA
  gi|4506308|ref|NM_—002839.1|[4506308]
• 231: BC024145 Homo sapiens, TNF receptor-associated factor 1, clone MGC:10353 IMAGE:3832475, mRNA, complete cds
  gi|18848176|gb|BC024145.1|[18848176]
• 232: AF469756 Homo sapiens clone S9 interleukin-1 receptor type I (IL1R1) gene, partial sequence
  gi|18846656|gb|AF469756.1|[18846656]
• 233: AF469755 Homo sapiens clone S8 interleukin-1 receptor type I (IL1R1) gene, partial sequence
  gi|18846655|gb|AF469755.1|[18846655]
• 234: AF469754 Homo sapiens clone S7 interleukin-1 receptor type I (IL1R1) gene, partial
  sequence
  gi|18845036|gb|AF469754.1|[18845036]
• 237: AF416711 Homo sapiens Fc-gamma receptor IIc5 mRNA, partial cds
  gi|18765992|gb|AF416711.1|[18765992]
• 238: NM_—023068 Homo sapiens sialoadhesin (SN), mRNA
  gi|18765743|ref|NM_—023068.2|[18765743]
• 239: NM_—004782 Homo sapiens synaptosomal-associated protein, 29 kD (SNAP29), mRNA
  gi|18765736|ref|NM_—004782.2|[18765736]
• 240: NM_—130798 Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant 2, mRNA
  gi|18765730|ref|NM_—130798.1|[18765730]
• 241: NM_—003825 Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant 1, mRNA
  gi|18765728|ref|NM_—003825.2|[18765728]
• 245: AF439409 Homo sapiens G-protein-coupled receptor kinase 7 (GRK7) mRNA, GRK7-S allele, complete cds
  gi|17933258|gb|AF439409.1|[17933258]
• 246: NM_—032211 Homo sapiens lysyl oxidase-like 4 (LOXL4), mRNA
  gi|16933522|ref|NM_—032211.4|[16933522]
• 247: AF411122 Homo sapiens importin 4 mRNA, complete cds
  gi|18700634|gb|AF411122.1|[18700634]
• 289: NM_—130441 Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 11 (CLECSF11), mRNA
  gi|18466805|ref|NM_—130441.1|[18466805]
• 290: NM_—030876 Homo sapiens olfactory receptor, family 5, subfamily V, member 1 (OR5V1), mRNA
  gi|14495550|ref|NM_—030876.2|[14495550]
• 291: NM_—032732 Homo sapiens hypothetical protein MGC10763 (IL17RL), mRNA
  gi|14249349|ref|NM_—032732.1|[14249349]
• 292: NM_—030959 Homo sapiens olfactory receptor, family 12, subfamily D, member 3 (OR12D3), mRNA
  gi|13624334|ref|NM_—030959.1|[13624334]
• 294: NM_—018844 Homo sapiens B-cell receptor-associated protein BAP29 (BAP29), mRNA
  gi|9994198|ref|NM_—018844.1|[9994198]
• 295: NM_—002825 Homo sapiens pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) (PTN), mRNA
  gi|18656935|ref|NM_—002825.2|[18656935]
• 299: NM_—016372 Homo sapiens seven transmembrane domain orphan receptor (TPRA40), mRNA
  gi|7705964|ref|NM_—016372.1|[7705964]
• 300: NM_—014288 Homo sapiens integrin beta 3 binding protein (beta3-endonexin) (ITGB3BP), mRNA
  gi|7657205|ref|NM_—014288.1|[7657205]
• 301: L43588 Homo sapiens T cell antigen receptor mRNA, partial cds
  gi|18654191|gb|L43588.1|HUMTCARF[18654191]
• 318: U77589 Homo sapiens MHC class II HLA-DQ-alpha chain (HLA-DQA1) mRNA, HLA-DQA1*0104 allele, complete cds
  gi|1916744|gb|U77589.1|HSU77589[1916744]
• 319: AF410465 Homo sapiens importin 9 mRNA, complete cds
  gi|15529702|gb|AF410465.1|[15529702]
• 320: AF332759 Homo sapiens partially duplicated CHRNA7 gene, hybrid intron A/4 and partial exon 5
  gi|13345792|gb|AF332759.1|[13345792]
• 321: AF332758 Homo sapiens alpha-7 nicotinic cholinergic receptor subunit (CHRNA7) gene, partial intron 4 and partial cds
  gi|13345790|gb|AF332758.1|[13345790]
• 322: NM_—003744 Homo sapiens numb homolog (Drosophila) (NUMB), mRNA
  gi|18644887|ref|NM_—003744.2|[18644887]
• 323: NM_—003681 Homo sapiens pyridoxal (pyridoxine, vitamin B6) kinase (PDXK), mRNA
  gi|18644884|ref|NM_—003681.2|[18644884]
• 324: NM_—080706 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 3, mRNA
  gi|18375670|ref|NM_—080706.1|[18375670]
• 325: NM_—080705 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 4, mRNA
  gi|18375668|ref|NM_—080705.1|[18375668]
• 326: NM_—080704 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 1, mRNA
  gi|18375666|ref|NM_—080704.1|[18375666]
• 327: NM_—018727 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 2, mRNA
  gi|18375664|ref|NM_—018727.3|[18375664]
• 328: NM_—080819
  Homo sapiens G protein-coupled receptor 78 (GPR78), mRNA
  gi|18201873|ref|NM_—080819.1|[18201873]
• 329: NM_—080738
  Homo sapiens EDAR-associated death domain (EDARADD), mRNA
  gi|18152768|ref|NM_—080738.1|[18152768]
• 330: NM_—080491 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 1, mRNA
  gi|18105041|ref|NM_—080491.1|[18105041]
• 331: NM_—012296 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 2, mRNA
  gi|18105040|ref|NM_—012296.2|[18105040]
• 332: NM_—032027 Homo sapiens beta-amyloid binding protein precursor (BBP), mRNA
  gi|17738309|ref|NM_—032027.2|[17738309]
• 333: NM_—057159 Homo sapiens endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 2 (EDG2), transcript variant 2, mRNA
  gi|16950637|ref|NM_—057159.1|[16950637]
• 334: NM_—001401 Homo sapiens endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 2 (EDG2), transcript variant 1, mRNA
  gi|16950635|ref|NM_—001401.2|[16950635]
• 335: NM_—007070 Homo sapiens FKBP-associated protein (FAP48), transcript variant 2, mRNA
  gi|16933538|ref|NM_—007070.2|[16933538]
• 336: NM_—053274 Homo sapiens FKBP-associated protein (FAP48), transcript variant 1, mRNA
  gi|16933536|ref|NM_—053274.1|[16933536]
• 337: NM_—003726 Homo sapiens src family associated phosphoprotein 1 (SCAP1), mRNA
  gi|16753209|ref|NM_—003726.2|[16753209]
• 338: NM_—033632 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 1, mRNA
  gi|16117780|ref|NM_—033632.1|[16117780]
• 339: NM_—018315 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 2, mRNA
  gi|16117778|ref|NM_—018315.2|[16117778]
• 340: NM_—021203 Homo sapiens APMCF1 protein (APMCF1), mRNA
  gi|14917112|ref|NM_—021203.2|[14917112]
• 341: NM_—002927 Homo sapiens regulator of G-protein signalling 13 (RGS13), mRNA
  gi|14589857|ref|NM_—002927.2|[14589857]
• 344: NM_—020167 Homo sapiens neuromedin U receptor 2 (NMU2R), mRNA
  gi|9910461|ref|NM_—020167.1|[9910461]
• 346: AF190052 Homo sapiens interleukin 1 receptor type I (IL1R1) gene, exon 1C sequence
  gi|9719300|gb|AF190052.1|[9719300]
• 347: NM_—018965 Homo sapiens triggering receptor expressed on myeloid cells 2 (TREM2), mRNA
  gi|9507202|ref|NM_—018965.1|[9507202]
• 348: NM_—018643 Homo sapiens triggering receptor expressed on myeloid cells 1 (TREM1), mRNA
  gi|8924261|ref|NM_—018643.1|[8924261]
• 349: NM_—018647 Homo sapiens tumor necrosis factor receptor superfamily, member 19 (TNFRSF19), mRNA
  gi|8924251|ref|NM_—018647.1|[8924251]
• 350: NM_—018695 Homo sapiens erbb2 interacting protein (ERBB2IP), mRNA
  gi|8923908|ref|NM_—018695.1|[8923908]
• 351: NM_—017636 Homo sapiens transient receptor potential cation channel, subfamily M, member 4(TRPM4), mRNA
  gi|8923048|ref|NM_—017636.1|[8923048]
• 353: NM_—016559 Homo sapiens PXR2b protein (PXR2b), mRNA
  gi|7706670|ref|NM_—016559.1|[7706670]
• 354: NM_—016382 Homo sapiens natural killer cell receptor 2B4 (CD244), mRNA
  gi|7706528|ref|NM_—016382.1|[7706528]
• 357: NM_—015986 Homo sapiens cytokine receptor-like factor 3 (CRLF3), mRNA
  gi|7705331|ref|NM_—015986.1|[7705331]
• 358: NM_—014815 Homo sapiens KIAA0130 gene product (KIAA0130), mRNA
  gi|7661929|ref|NM_—014815.1|[7661929]
• 359: NM_—014053 Homo sapiens FLVCR protein (FLVCR), mRNA
  gi|7661707|ref|NM_—014053.1|[7661707]
• 360: NM_—014478 Homo sapiens calcitonin gene-related peptide-receptor component protein
  (CGRP-RCP), mRNA
  gi|7656976|ref|NM_—014478.1|[7656976]
• 361: NM_—012470 Homo sapiens transportin-SR (TRN-SR), mRNA
  gi|6912733|ref|NM_—012470.1|[6912733]
• 362: NM_—007357 Homo sapiens low density lipoprotein receptor defect C complementing (LDLC), mRNA
  gi|6678675|ref|NM_—007357.1|[6678675]
• 366: NM_—005162 Homo sapiens angiotensin receptor-like 2 (AGTRL2), mRNA
  gi|6031157|ref|NM_—005162.2|[6031157]
• 367: NM_—005501 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant b, mRNA
  gi|6006010|ref|NM_—005501.1|[6006010]
• 370: NM_—007053 Homo sapiens natural killer cell receptor, immunoglobulin superfamily member (BY55), mRNA
  gi|5901909|ref|NM_—007053.1|[5901909]
• 371: NM_—006653 Homo sapiens suc1-associated neurotrophic factor target 2 (FGFR signalling adaptor) (SNT-2), mRNA
  gi|5730058|ref|NM_—006653.1|[5730058]
• 374: NM_—005761 Homo sapiens plexin C1 (PLXNC1), mRNA
  gi|5032222|ref|NM_—005761.1|[5032222]
• 375: NM_—005866 Homo sapiens sigma receptor (SR31747 binding protein 1) (SR-BP1), mRNA
  gi|5032116|ref|NM_—005866.1|[5032116]
• 377: NM_—005506 Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) (CD36L2), mRNA
  gi|5031630|ref|NM_—005506.1|[5031630]
• 379: NM_—004799 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 3, mRNA
  gi|4759059|ref|NM_—004799.1|[4759059]
• 380: NM_—004292 Homo sapiens ras inhibitor (RIN1), mRNA
  gi|4759039|ref|NM_—004292.1|[4759039]
• 381: NM_—004828 Homo sapiens lymphocyte antigen 95 (activating NK-receptor; NK-p44) (LY95), mRNA
  gi|4758693|ref|NM_—004828.1|[4758693]
• 382: NM_—004767 Homo sapiens endothelin type b receptor-like protein 2 (ET(B)R-LP-2), mRNA
  gi|4758309|ref|NM_—004767.1|[4758309]
• 383: NM_—004440 Homo sapiens EphA7 (EPHA7), mRNA
  gi|4758281|ref|NM_—004440.1|[4758281]
• 384: NM_—003999 Homo sapiens oncostatin M receptor (OSMR), mRNA
  gi|4557039|ref|NM_—003999.1|[4557039]
• 386: NM_—003305 Homo sapiens transient receptor potential cation channel, subfamily C, member 3(TRPC3), mRNA
  gi|4507686|ref|NM_—003305.1|[4507686]
• 388: NM_—003626 Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 (PPFIA1), mRNA
  gi|4505982|ref|NM_—003626.1|[4505982]
• 389: NM_—003876 Homo sapiens putative receptor protein (PMI), mRNA
  gi|4505900|ref|NM_—003876.1|[4505900]
• 390: NM_—003559 Homo sapiens phosphatidylinositol-4-phosphate 5-kinase, type II, beta (PIP5K2B), mRNA
  gi|4505818|ref|NM_—003559.1|[4505818]
• 391: NM_—003629 Homo sapiens phosphoinositide-3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) (PIK3R3), mRNA
  gi|4505804|ref|NM_—003629.1|[4505804]
• 392: NM_—003676 Homo sapiens degenerative spermatocyte homolog, lipid desaturase (Drosophila) (DEGS), mRNA
  gi|4505192|ref|NM_—003676.1|[4505192]
• 393: NM_—002270 Homo sapiens karyopherin (importin) beta 2 (KPNB2), mRNA
  gi|4504906|ref|NM_—002270.1|[4504906]
• 394: NM_—002204 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant a, mRNA
  gi|4504746|ref|NM_—002204.1|[4504746]
• 395: NM_—001560 Homo sapiens interleukin 13 receptor, alpha 1 (IL13RA1), mRNA
  gi|4504646|ref|NM_—001560.1|[4504646]
• 396: NM_—000842 Homo sapiens glutamate receptor, metabotropic 5 (GRM5), mRNA
  gi|4504142|ref|NM_—000842.1|[4504142]
• 397: NM_—001883 Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), mRNA
  gi|4503044|ref|NM_—001883.1|[4503044]
• 398: NM_—001873 Homo sapiens carboxypeptidase E (CPE), mRNA
  gi|4503008|ref|NM_—001873.1|[4503008]
• 400: L29395 Homo sapiens v-erbB-related protein gene, partial cds
  gi|459807|gb|L29395.1|HUMERBB[459807]
• 401: L08584 Homo sapiens T cell receptor beta chain (TCRB) mRNA, partial cds
  gi|307497|gb|L08584.1|HUMTCVB7A[307497]
• 403: NM_—015638 Homo sapiens chromosome 20 open reading frame 188 (C20orf188), mRNA
  gi|18158415|ref|NM_—015638.1|[18158415]
• 405: NM_—054032 Homo sapiens G protein-coupled receptor MRGX4 (MRGX4), mRNA
  gi|16876454|ref|NM_—054032.1|[16876454]
• 406: NM_—054031 Homo sapiens G protein-coupled receptor MRGX3 (MRGX3), mRNA
  gi|16876452|ref|NM_—054031.1|[16876452]
• 407: NM_—054030 Homo sapiens G protein-coupled receptor MRGX2 (MRGX2), mRNA
  gi|16876450|ref|NM_—054030.1|[16876450]
• 408: NM_—052931 Homo sapiens activating NK receptor (KALI), mRNA
  gi|16418406|ref|NM_—052931.1|[16418406]
• 409: NM_—032871 Homo sapiens tumor necrosis factor receptor superfamily, member 19-like (TNFRSF19L), mRNA
  gi|14249611|ref|NM_—032871.1|[14249611]
• 410: NM_—032553 Homo sapiens putative purinergic receptor (FKSG79), mRNA
  gi|14211848|ref|NM_—032553.1|[14211848]
• 411: NM_—025179 Homo sapiens plexin A2 (PLXNA2), mRNA
  gi|13378152|ref|NM_—025179.1|[13378152]
• 413: NM_—021249 Homo sapiens sorting nexin 6 (SNX6), mRNA
  gi|13027619|ref|NM_—021249.1|[13027619]
• 414: NM_—014045 Homo sapiens DKFZP564C1940 protein (DKFZP564C1940), mRNA
  gi|13027587|ref|NM_—014045.1|[13027587]
• 415: NM_—080923 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 4, mRNA
  gi|18641365|ref|NM_—080923.1|[18641365]
• 416: NM_—080922 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 3, mRNA
  gi|18641363|ref|NM_—080922.1|[18641363]
• 417: NM_—080921 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 2, mRNA
  gi|18641361|ref|NM_—080921.1|[18641361]
• 418: NM_—130386 Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant I, mRNA
  gi|18641359|ref|NM_—130386.1|[18641359]
• 419: NM_—030781 Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant II, mRNA
  gi|18641357|ref|NM_—030781.2|[18641357]
• 420: NM_—002838 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 1, mRNA
  gi|18641346|ref|NM_—002838.2|[18641346]
• 421: NM_—130770 Homo sapiens 5-hydroxytryptamine receptor 3 subunit C (HTR3C), mRNA gi|18640739|ref|NM_—130770.1|[18640739]
• 430: BD010218 Novel hemopoietin receptor protein, NR12
  gi|18638591|dbj|BD010218.1|[18638591]
• 431: BD010217 Novel hemopoietin receptor protein, NR12
  gi|18638590|dbj|BD010217.1|[18638590]
• 432: BD010216 Novel hemopoietin receptor protein, NR12
  gi|18638589|dbj|BD010216.1|[18638589]
• 433: BD010215 Novel hemopoietin receptor protein, NR12
  gi|18638588|dbj|BD010215.1|[18638588]
• 434: BD010214 Novel hemopoietin receptor protein, NR12
  gi|18638587|dbj|BD010214.1|[18638587]
• 435: BD010125 Peptide leukotriene receptor
  gi|18638498|dbj|BD010125.1|[18638498]
• 436: BD010114 Novel receptor and gene encoding the same
  gi|18638487|dbj|BD010114.1|[18638487]
• 437: BD010057 Novel G protein coupled receptor protein and its DNA
  gi|18638430|dbj|BD010057.1|[18638430]
• 438: BD010056 Novel G protein coupled receptor protein and its DNA
  gi|18638429|dbj|BD010056.1|[18638429]
• 439: BD010055 Novel G protein coupled receptor protein and its DNA
  gi|18638428|dbj|BD010055.1|[18638428]
• 440: BD010054 Novel G protein coupled receptor protein and its DNA
  gi|18638427|dbj|BD010054.1|[18638427]
• 441: BD010053 Novel G protein coupled receptor protein and its DNA
  gi|18638426|dbj|BD010053.1|[18638426]
• 442: BD010052 Novel G protein coupled receptor protein and its DNA
  gi|18638425|dbj|BD010052.1|[18638425]
• 443: BD010051 Novel G protein coupled receptor protein and its DNA
  gi|18638424|dbj|BD010051.1|[18638424]
• 444: BD010050 Novel G protein coupled receptor protein and its DNA
  gi|18638423|dbj|BD010050.1[18638423]
• 445: BD010049 Novel G protein coupled receptor protein and its DNA
  gi|18638422|dbj|BD010049.1|[18638422]
• 446: BD010046 Novel G protein coupled receptor protein and its DNA
  gi|18638419|dbj|BD010046.1|[18638419]
• 447: BD010035 Novel G protein coupled receptor protein and its DNA
  gi|18638408|dbj|BD010035.1|[18638408]
• 448: BD010034 Novel G protein coupled receptor protein and its DNA
  gi|18638407|dbj|BD010034.1|[18638407]
• 449: BD010028 Novel G protein coupled receptor protein and its DNA
  gi|18638401|dbj|BD010028.1|[18638401]
• 450: BD010022 Novel G protein coupled receptor protein and its DNA
  gi|18638395|dbj|BD010022.1|[18638395]
• 451: BD009263 GABAA receptor subunit epsilon-related protein
  gi|18637636|dbj|BD009263.1|[18637636]
• 452: BD009262 GABAA receptor subunit epsilon-related protein
  gi|18637635|dbj|BD009262.1|[18637635]
• 453: BD009261 GABAA receptor subunit epsilon-related protein
  gi|18637634|dbj|BD009261.1|[18637634]
• 454: BD009260 GABAA receptor subunit epsilon-related protein
  gi|18637633|dbj|BD009260.1|[18637633]
• 455: BD006753 Human G protein chemokine receptor HDGNR10
  gi|18635124|dbj|BD006753.1|[18635124]
• 460: E51301 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633577|dbj|E51301.1|[18633577]
• 461: E51300 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633576|dbj|E51300.1|[18633576]
• 462: E51299 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633575|dbj|E51299.1|[18633575]
• 463: E51298 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633574|dbj|E51298.1|[18633574]
• 464: E51297 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633573|dbj|E51297.1|[18633573]
• 465: E51296 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633572|dbj|E51296.1|[18633572]
• 466: E50838 Novel G protein-coupled receptor
  gi|18633543|dbj|E50838.1|[18633543]
• 467: E50837 Novel G protein-coupled receptor
  gi|18633542|dbj|E50837.1|[18633542]
• 468: E50836 Novel G protein-coupled receptor
  gi|18633541|dbj|E50836.1|[18633541]
• 469: E50835 Novel G protein-coupled receptor
  gi|18633540|dbj|E50835.1|[18633540]
• 470: E50834 Novel G protein-coupled receptor
  gi|18633539|dbj|E50834.1|[18633539]
• 471: E50833 Novel G protein-coupled receptor
  gi|18633538|dbj|E50833.1|[18633538]
• 490: BD003056 Novel G protein-coupled receptor protein and DNA thereof
  gi|18631017|dbj|BD003056.1|[18631017]
• 491: E55122 Novel G protein-coupled receptor and the G protein-coupled receptor gene gb|18629753|dbj|E55122.1|[18629753]
• 492: E55121 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629752|dbj|E55121.1|[18629752]
• 493: E55120 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629751|dbj|E55120.1|[18629751]
• 494: E55119 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629750|dbj|E55119.1|[18629750]
• 495: E55118 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629749|dbj|E55118.1|[18629749]
• 496: E55117 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629748|dbj|E55117.1|[18629748]
• 497: E49128 Novel G protein-conjugated receptor protein
  gi|18629265|dbj|E49128.1|[18629265]
• 498: E49127 Novel G protein-conjugated receptor protein
  gi|18629264|dbj|E49127.1|[18629264]
• 499: E49126 Novel G protein-conjugated receptor protein
  gi|18629263|dbj|E49126.1|[18629263]
• 500: E49125 Novel G protein-conjugated receptor protein
  gi|18629262|dbj|E49125.1|[18629262]
• 501: D21847
  Human mRNA for T cell receptor alpha chain TcHST2Va7, V segment, J segment and C region
  gi|431140|dbj|D21847.1|HUMTCHST24[431140]
• 502: D21846
  Human mRNA for T cell receptor beta chain HPBL3xVb20, V segment, D segment, J segment and C region
  gi|431139|dbj|D21846.1|HUMHPBL3X3[431139]
• 503: D21845
  Human mRNA for T cell receptor alpha chain HPBL3xVa7, V segment, J segment and C region
  gi|431138|dbj|D521845.1|HUMHPBL3X2[431138]
• 504: D21844
  Human mRNA for T cell receptor alpha chain HPBL(−)Va7, V segment, J segment and
  C region
  gi|431137|dbj|D521844.1|HUMCHPBL1[431137]
• 505: D13083
  Human mRNA for T-cell receptor beta-chain V region, partial cds, clone WBDM19C
  gi|407766|dbj|D13083.1|HUMVB73B[407766]
• 506: D13085
  Human mRNA for T-cell receptor beta-chain V region, partial cds, clone WBDM28A
  gi|407764|dbj|D513085.1|HUMVB69B[407764]
• 507: D13088
  Human TCRBV2.3a mRNA for T-cell receptor beta-chain V region, partial cds
  gi|407762|dbj|D13088.1|HUMVB23A[407762]
• 508: D13087
  Human TCRBV2.1c mRNA for T-cell receptor beta-chain V region, partial cds
  gi|407760|dbj|D13087.1|HUMVB21C[407760]
• 509: D13082
  Human mRNA for T-cell receptor beta-chain V region, partial cds, clone WBDM17A
  gi|407758|dbj|D13082.1|HUMVB21AA[407758]
• 510: D13086
  Human TCRBV20.1a mRNA for T-cell receptor beta-chain V region, partial cds
  gi|407756|dbj|D13086.1HUMVB201A[407756]
• 511: D13084
  Human TCRBV12.5a mRNA for T-cell receptor beta-chain V region, partial cds
  gi|407754|dbj|D513084.1|HUMVB125A[407754]
• 512: D13073
  Human TCRAVN1 mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407752|dbj|D13073.1|HUMVAN1[407752]
• 513: D13079
  Human TCRAV8.1a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407750|dbj|D13079.1|HUMVA81A[407750]
• 514: D13069
  Human TCRAV5.1a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407748|dbj|D13069.1HUMVA51A[407748]
• 515: D13078
  Human TCRAV2.5a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407746|dbj|D13078.1|HUMVA25A[407746]
• 516: D13072
  Human mRNA for T-cell receptor alpha-chain V-J-C, partial cds, clone WADM13D
  gi|407744|dbj|D13072.1|HUMVA221AJ[407744]
• 517: D13076
  Human TCRAV21.1a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407742|dbj|D13076.1|HUMVA211A[407742]
• 518: D13071
  Human mRNA for T-cell receptor alpha-chain V region, partial cds, clone WADM11H
  gi|407740|dbj|D13071.1|HUMVA171A[407740]
• 519: D13074
  Human TCRAV14.1a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407738|dbj|D13074.1|HUMVA141A[407738]
• 520: D13070
  Human TCRAV1.3a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407736|dbj|D13070.1|HUMVA13A[407736]
• 521: D13077
  Human TCRAV1.2a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407734|dbj|D13077.1|HUMVA12A[407734]
• 522: D13075
  Human TCRAV10.1a mRNA for T-cell receptor alpha-chain V region, partial cds
  gi|407732|dbj|D13075.1|HUMVA101A[407732]
• 523: D13081
  Human mRNA for T-cell receptor alpha-chain J segment, partial cds, clone WADM36G
  gi|407730|dbj|D13081.1|HUMJAAC17[407730]
• 524: D13080
  Human mRNA for T-cell receptor alpha-chain J segment, partial cds, clone WADM36A
  gi|407728|dbj|D13080.1|HUMJAAB19[407728]
• 525: D16584
  Homo sapiens mRNA for T cell receptor beta chain, N-terminal
  gi|391732|dbj|D16584.1|HUMTCRB17[391732]
• 526: D16586
  Homo sapiens mRNA for T cell receptor alpha chain, N-terminal
  gi|391731|dbj|D16586.1|HUMTCRB17[391731]
• 527: D16585
  Homo sapiens mRNA for T cell receptor alpha chain, N-terminal
  gi|391730|dbj|D16585.1|HUMTCRA32[391730]
• 528: NM_—003268
  Homo sapiens toll-like receptor 5 (TLR5), mRNA
  gi|19718736|ref|NM_—003268.3|[19718736]
• 529: NM_—003265
  Homo sapiens toll-like receptor 3 (TLR3), mRNA
  gi|19718735|ref|NM_—003265.2|[19718735]
• 530: NM_—003264
  Homo sapiens toll-like receptor 2 (TLR2), mRNA
  gi|19718733|ref|NM_—003264.2|[19718733]
• 531: NM_—003263
  Homo sapiens toll-like receptor 1 (TLR1), mRNA
  gi|19718732|ref|NM_—003263.2|[19718732]
• 534: NM_—020350
  Homo sapiens angiotensin II, type I receptor-associated protein (ATRAP), mRNA
  gi|19705427|ref|NM_—020350.2|[19705427]
• 535: AY081843
  Homo sapiens GnRH receptor II 5TM mRNA, complete cds
  gi|19697895|gb|AY081843.1|[19697895]
• 539: NM_—016511
  Homo sapiens C-type lectin-like receptor-1 (LOC51267), mRNA
  gi|7706062|ref|NM_—016511.1|[7706062]
• 540: NM_—016509
  Homo sapiens C-type lectin-like receptor-2 (LOC51266), mRNA
  gi|7706060|ref|NM_—016509.1|[7706060]
• 546: AL713657
  Homo sapiens mRNA; cDNA DKFZp547G1215 (from clone DKFZp547G1215)
  gi|19584339|emb|AL713657.1|HSM802985[19584339]
• 547: AJ438313
  Homo sapiens partial mRNA for KIT protein
  gi|19571549|emb|AJ438313.1|HSA438313[19571549]
• 575: AF390036
  Homo sapiens FCRLd mRNA, partial cds
  gi|16611715|gb|AF390036.1|[16611715]
• 576: AF329495
  Homo sapiens FCRLe mRNA, complete cds
  gi|16506270|gb|AF329495.1|[16506270]
• 577: AF329494
  Homo sapiens FCRLc1 mRNA, complete cds
  gi|16506268|gb|AF329494.1|[16506268]
• 578: AF329493
  Homo sapiens FCRLb mRNA, complete cds
  gi|16506266|gb|AF329493.1|[16506266]
• 579: AF329491
  Homo sapiens FCRLc2 mRNA, complete cds
  gi|16506262|gb|AF329491.1|[16506262]
• 580: AF329489
  Homo sapiens FCRLa mRNA, complete cds
  gi|16506258|gb|AF329489.1|[16506258]
• 582: AB060695
  Homo sapiens TLR5 mRNA for Toll-like receptor 5, complete cds
  gi|13810567|dbj|AB060695.1|[13810567]
• 583: AJ276429
  Homo sapiens mRNA for 19A protein
  gi|12619176|emb|AJ276429.2|HSA276429[12619176]
• 584: AL136801
  Homo sapiens mRNA; cDNA DKFZp434K0220 (from clone DKFZp434K0220); complete cds
  gi|12053114|emb|AL136801.1|HSM801769[12053114]
• 585: AL136652
  Homo sapiens mRNA; cDNA DKFZp56401762 (from clone DKFZp56401762); complete cds
  gi|12052829|emb|AL136652.1|HSM801622[12052829]
• 587: AB012911
  Homo sapiens mRNA for Frizzled-6, complete cds
  gi|3062802|dbj|AB012911.1|[3062802]
• 589: AY071862
  Homo sapiens crinkled (CR) mRNA, complete cds
  gi|19568064|gb|AY071862.1|[19568064]
• 596: NM_—133169
  Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 2, mRNA
  gi|19557667|ref|NM_—133169.1|[19557667]
• 597: NM_—133168
  Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 3, mRNA
  gi|19557663|ref|NM_—133168.1|[19557663]
• 598: NM_—130771
  Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 1, mRNA
  gi|19557659|ref|NM_—130771.1|[19557659]
• 599: AF426461
  Homo sapiens FREB mRNA, complete cds
  gi|18056674|gb|AF426461.1|[18056674]
• 600: AF428134
  Homo sapiens T-cell receptor beta-chain (TCRVb13.1-Jb1.5) mRNA, partial cds
  gi|16566700|gb|AF428134.1|[16566700]
• 601: AF428133
  Homo sapiens T-cell receptor beta-chain (TCRVb13.1-Jb1.2) mRNA, partial cds
  gi|16566697|gb|AF428133.1|[16566697]
• 602: AF428132
  Homo sapiens T-cell receptor beta-chain (TCRVb8.1-Jb2.3) mRNA, partial cds
  gi|16566694|gb|AF428132.1|[16566694]
• 603: AF428131
  Homo sapiens T-cell receptor beta-chain (TCRVb8.2-Jb2.7) mRNA, partial cds
  gi|16566691|gb|AF428131.1|[16566691]
• 604: AF428130
  Homo sapiens T-cell receptor beta-chain (TCRVb8.1-Jb2.3) mRNA, partial cds
  gi|16566688|gb|AF428130.1|[16566688]
• 605: AF428129
  Homo sapiens T-cell receptor beta-chain (TCRVb7.1-Jb1.2) mRNA, partial cds
  gi|16566685|gb|AF428129.1|[16566685]
• 606: AF428128
  Homo sapiens T-cell receptor beta-chain (TCRVb7.2-Jb1.6) mRNA, partial cds
  gi|16566682|gb|AF428128.1|[16566682]
• 607: AF428127
  Homo sapiens T-cell receptor beta-chain (TCRVb7.1-Jb1.2) mRNA, partial cds
  gi|16566679|gb|AF428127.1|[16566679]
• 608: AF428126
  Homo sapiens T-cell receptor beta-chain (TCRVb7.2-Jb1.2) mRNA, partial cds
  gi|16566676|gb|AF428126.1|[16566676]
• 609: AF428125
  Homo sapiens T-cell receptor beta-chain (TCRVb7.1-Jb1.5) mRNA, partial cds
  gi|16566673|gb|AF428125.1|[16566673]
• 611: AF242456
  Homo sapiens interleukin 13 receptor alpha 1-binding protein-1 mRNA, complete cds
  gi|19548138|gb|AF242456.1|[19548138]
• 616: S57283
  Homo sapiens endothelin ET-B receptor mRNA, complete cds
  gi|298321|gb|S57283.1|[298321]
• 617: L14854
  Homo sapiens T cell receptor TCR-beta D38 (TCRB) mRNA, partial cds
  gi|292794|gb|L14854.1|HUMTCRD38[292794]
• 618: NM_—024080
  Homo sapiens transient receptor potential cation channel, subfamily M, member 8
  (TRPM8), mRNA
  gi|13129071|ref|NM_—024080.1|[13129071]
• 619: AY069961
  Homo sapiens lymphocyte effector toxicity activation ligand (LETAL) mRNA, complete cds
  gi|19525539|gb|AY069961.1|[19525539]
• 620: U43901
  Homo sapiens 37 kD laminin receptor precursor/p40 ribosome associated protein (LAMR1) gene, complete cds; and E2 small nuclear RNA gene, complete sequence
  gi|19483807|gb|U43901.2|HSU43901[19483807]
• 621: NM_—021044
  Homo sapiens desert hedgehog homolog (Drosophila) (DHH), mRNA
  gi|19482157|ref|NM_—021044.1|[19482157]
• 622: AC078860
  Homo sapiens 12q BAC RP11-186F10 (Roswell Park Cancer Institute Human BAC Library) complete sequence
  gi|13491193|gb|AC078860.19|[13491193]
• 623: AC003683
  Homo sapiens x BAC RP1-147H15 (Roswell Park Cancer Institute Human BAC Library)
  complete sequence
  gi|13489135|gb|AC003683.2|[13489135]
• 624: AC007397
  Homo sapiens 12 p13 BAC RPCI11-439G16 (Roswell Park Cancer Institute Human BAC Library) complete sequence
  gi|5685879|gb|AC007397.21|[5685879]
• 625: AC007784
  Homo sapiens 12 p13 BAC RPCI11-1092P21 (Roswell Park Cancer Library Human BAC Library) complete sequence
  gi|5597031|gb|AC007784.7|[5597031]
• 627: AF451730
  Homo sapiens isolate R5255 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401669|gb|AF451730.1|[19401669]
• 628: AF451729
  Homo sapiens isolate Q5252 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401667|gb|AF451729.1|[19401667]
• 629: AF451728
  Homo sapiens isolate P5739 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401665|gb|AF451728.1|[19401665]
• 630: AF451727
  Homo sapiens isolate P5742 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401663|gb|AF451727.1|[19401663]
• 631: AF451726
  Homo sapiens isolate P5738 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401661|gb|AF451726.1|[19401661]
• 632: AF451725
  Homo sapiens isolate 0581 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401658|gb|AF451725.1|[19401658]
• 633: AF451724
  Homo sapiens isolate N₅₀₅ T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401656|gb|AF451724.1|[19401656]
• 634: AF451723
  Homo sapiens isolate N₅₀₄ T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401653|gb|AF451723.1|[19401653]
• 635: AF451722
  Homo sapiens isolate P5729 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401650|gb|AF451722.1|[19401650]
• 636: AF451721
  Homo sapiens isolate P5728 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401647|gb|AF451721.1|[19401647]
• 637: AF451720
  Homo sapiens isolate 0268 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401645|gb|AF451720.1|[19401645]
• 638: AF451719
  Homo sapiens isolate 038 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401642|gb|AF451719.1|[19401642]
• 639: AF451718
  Homo sapiens isolate 037 T cell receptor delta chain (TRD@) mRNA, partial cds
  gi|19401640|gb|AF451718.1|[19401640]
• 640: AF449218
  Homo sapiens 43 kDa acetylcholine receptor-associated protein (RAPSN) mRNA, complete cds
  gi|19310212|gb|AF449218.1|[19310212]
• 644: BC025704
  Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily B (with TM and
  ITIM domains), member 5, clone MGC:34418 IMAGE:5223581, mRNA, complete cds
  gi|19344005|gb|BC025704.1|[19344005]
• 645: BC025713
  Homo sapiens, T-cell receptor interacting molecule, clone MGC:34314 IMAGE:5227396, mRNA, complete cds
  gi|19343996|gb|BC025713.1|[19343996]
• 646: BC025722
  Homo sapiens, adenosine A2b receptor, clone MGC:34640 IMAGE:5198898, mRNA, complete cds
  gi|19343938|gb|BC025722.1|[19343938]
• 647: BC025717
  Homo sapiens, chemokine (C-C motif) receptor-like 2, clone MGC:34104 IMAGE:5228561, mRNA, complete cds
  gi|19343936|gb|BC025717.1|[19343936]
• 648: BC025695
  Homo sapiens, endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 4, clone MGC:34227 IMAGE:5209267, mRNA, complete cds
  gi|19343926|gb|BC025695.1|[19343926]
• 650: BC025691
  Homo sapiens, interleukin 2 receptor, beta, clone MGC:34584 IMAGE:5207833, mRNA,
  complete cds
  gi|19343610|gb|BC025691.1|[19343610]
• 651: AF474992
  Homo sapiens G protein-coupled receptor SNSR6 gene, complete cds
  gi|19338917|gb|AF474992.1|[19338917]
• 652: AF474991
  Homo sapiens G protein-coupled receptor SNSR5 gene, complete cds
  gi|19338915|gb|AF474991.1|[19338915]
• 653: AF474990
  Homo sapiens G protein-coupled receptor SNSR4 gene, complete cds
  gi|19338913|gb|AF474990.1|[19338913]
• 654: AF474989
  Homo sapiens G protein-coupled receptor SNSR3 gene, complete cds
  gi|19338911|gb|AF474989.1|[19338911]
• 655: AF474988
  Homo sapiens G protein-coupled receptor SNSR2 gene, complete cds
  gi|19338909|gb|AF474988.1|[19338909]
• 656: AF474987
  Homo sapiens G protein-coupled receptor SNSR1 gene, complete cds
  gi|19338907|gb|AF474987.1|[19338907]
• 695: AF453877
  Homo sapiens neuronal nicotinic receptor beta 4 subunit precursor, gene, exon 1
  and partial cds
  gi|18042122|gb|AF453877.1|[18042122]
• 697: U62556
  Homo sapiens chemokine receptor-like protein (TER1) gene, complete cds
  gi|1468978|gb|U62556.1|HSU62556[1468978]
• 698: AJ011371
  Homo sapiens mRNA for serotonin 4 receptor, splice variant h5-HT4(e)
  gi|3646277|emb|AJ011371.1|HSAJ1371[3646277]
• 712: AY059419
  Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL1) mRNA, KIR3DL1*011 allele, partial cds
  gi|19224338|gb|AY059419.1|[19224338]
• 713: AY059418
  Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*010 allele, partial cds
  gi|19224336|gb|AY059418.1|[19224336]
• 714: AY059417
  Homo sapiens killer-cell immunoglobulin-like receptor KIR3DL1/2v mRNA, partial
  cds
  gi|19224334|gb|AY059417.1|[19224334]
• 715: AY059420
  Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*012 allele, partial cds
  gi|19224332|gb|AY059420.1|[19224332]
• 716: AC079385
  Homo sapiens 12q BAC RP11-482D24 (Roswell Park Cancer Institute Human BAC Library) complete sequence
  gi|14670063|gb|AC079385.18|[14670063]
• 717: AC078889
  Homo sapiens 12q BAC RP11-335112 (Roswell Park Cancer Institute Human BAC Library) complete sequence
  gi|11072039|gb|AC078889.20|[11072039]
• 718: AC010168
  Homo sapiens 12 p12-31.7-32.2 BAC RP11-174G6 (Rosewell Park Cancer Institute Human Bac Library) complete sequence
  gi|6855156|gb|AC010168.6|[6855156]
• 719: U14188
  Homo sapiens LERK-4 (EPLG4) mRNA, complete cds
  gi|642834|gb|U14188.1|HSU14188[642834]
• 720: U14187
  Homo sapiens LERK-3 (EPLG3) mRNA, complete cds
  gi|642832|gb|U14187.1|HSU14187[642832]
• 721: U15637
  Homo sapiens CD40 binding protein (CD40BP) mRNA, complete cds
  gi|595910 gb|U15637.1|HSU15637[595910]
• 722: AF262304
  Homo sapiens clone 7 CC chemokine receptor 3-like mRNA, partial sequence, alternatively spliced
  gi|19171650|gb|AF262304.1|[19171650]
• 723: AF262303
  Homo sapiens clone 6 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171648|gb|AF262303.1|[19171648]
• 724: AF262302
  Homo sapiens clone 5 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171646|gb|AF262302.1|[19171646]
• 725: AF262301
  Homo sapiens clone 4 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171644|gb|AF262301.1|[19171644]
• 726: AF262300
  Homo sapiens clone 2 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171642|gb|AF262300.1|[19171642]
• 727: AF262299
  Homo sapiens clone 1 CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|19171640|gb|AF262299.1|[19171640]
• 729: AF247361
  Homo sapiens CC chemokine receptor 3 (CCR3) gene, complete cds
  gi|19110542|gb|AF247361.1|[19110542]
• 730: AF247360
  Homo sapiens CC chemokine receptor 3 (CCR3) gene, promoter region and partial sequence
  gi|1911054|gb|AF247360.1|[19110541]
• 731: AF247359
  Homo sapiens CC chemokine receptor 3 (CCR3) gene, promoter region and partial sequence
  gi|19110540|gb|AF247359.1|[19110540]
• 733: AF416619
  Homo sapiens prolactin receptor short isoform 1a (PRLR) mRNA, complete cds, alternatively spliced
  gi|16506717|gb|AF416619.1|[16506717]
• 734: AF416618
  Homo sapiens prolactin receptor short isoform 1b (PRLR) mRNA, complete cds, alternatively spliced
  gi|16506715|gb|AF416618.1[16506715]
• 736: AJ303165
  Homo sapiens partial gene for putative transmembrane receptor
  gi|13162199|emb|AJ303165.1|HSA303165[13162199]
• 738: AF350881
  Homo sapiens channel kinase 2 (CHAK2) mRNA, complete cds
  gi|18860923|gb|AF350881.2|[18860923]
• 739: AF022044
  Homo sapiens natural killer cell receptor KIR3D51 variant mRNA, complete cds
  gi|2760894|gb|AF022044.1|[2760894]
• 740: AF034773
  Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 3, complete cds
  gi|2739181|gb|AF034773.1|[2739181]
• 741: AF034772
  Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 2,
  complete cds
  gi|2739179|gb|AF034772.1([2739179]
• 742: AF034771
  Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 1, complete cds
  gi|2739177|gb|AF034771.1|[2739177]
• 743: AF022047
  Homo sapiens natural killer cell inhibitory receptor KIR2D53 variant mRNA, complete cds
  gi|2738966|gb|AF022047.1|[2738966]
• 744: AF022046
  Homo sapiens natural killer cell inhibitory receptor KIR2D51 variant mRNA, complete cds
  gi|2738964|gb|AF022046.1|[2738964]
• 745: AF022045
  Homo sapiens natural killer cell receptor KIR2DL1 variant mRNA, complete cds
  gi|2738962|gb|AF022045.1|[2738962]
• 746: U56255
  Homo sapiens CW-1 mRNA, complete cds
  gi|1399688|gb|U56255.1|HSU56255[1399688]
• 747: AJ422056
  Homo sapiens partial GRM5 gene for metabotrophic glutamate receptor, exon 1A
  gi|19069804|emb|AJ422056.1|HSA422056[19069804]
• 748: AY028912
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 7 and complete cds, alternatively spliced
  gi|19067944|gb|AY028912.1|AY028906S7[19067944]
• 749: AY028911
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 6
  gi|19067943|gb|AY028911.1|AY028906S6[19067943]
• 750: AY028910
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 5
  gi|19067942|gb|AY028910.1|AY028906S5[19067942]
• 751: AY028909
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 4
  gi|1906794|gb|AY028909.1|AY028906S4[19067941]
• 752: AY028908
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 3
  gi|19067940|gb|AY028908.1|AY028906S3[19067940]
• 753: AY028907
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 2
  gi|19067939|gb|AY028907.1|AY028906S2[19067939]
• 754: AY028906
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 1
  gi|19067938|gb|AY028906.1|AY028906S1[19067938]
• 755: AH010677
  Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, complete cds, alternatively spliced
  gi|19067937|gb|AH010677.1|SEG_AY028906S[19067937]
• 756: AY028913
  Homo sapiens ectodysplasia A receptor associated death domain A (EDARADD) mRNA,
  complete cds; alternatively spliced
  gi|9067935|gb|AY028913.1|[19067935]
• 757: BM735809
  06E08 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens
  glycine receptor, beta, mRNA sequence
  gi|19057142|gb|BM735809.1|BM735809[19057142]
• 758: BM735756
  06A09 Canine Brain cDNA Library Canis familiaris cDNA 5; similar to Homo sapiens
  glycine receptor, beta subunit, mRNA sequence
  gi|19057089|gb|BM735756.1|BM735756[19057089]
• 759: BM735711
  10E11 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens
  protein tyrosine phosphatase, receptor-type, Z polypeptide 1, mRNA sequence
  gi|19057044|gb|BM735711.1|BM735711[19057044]
• 762: AC007165
  Homo sapiens BAC clone RP11-451C2 from 2, complete sequence
  gi|19033999|gb|AC007165.4|[19033999]
• 763: AF245699
  Homo sapiens type 1 angiotensin II receptor (AGTR1) gene, complete cds
  gi|7862074|gb|AF245699.1|[7862074]
• 764: BC024229
  Homo sapiens, prostaglandin E receptor 3 (subtype EP3), clone MGC:27302 IMAGE:4660371, mRNA, complete cds
  gi|18999476|gb|BC024229.1|[18999476]
• 783: AJ417555
  Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 4053
  gi|18958228|emb|AJ417555.1|HSA417555[18958228]
• 784: AJ417554
  Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 3321
  gi|18958226|emb|AJ417554.1|HSA417554[18958226]
• 786: NM_—003877
  Homo sapiens STAT induced STAT inhibitor-2 (STAT12), mRNA
  gi|18921206|ref|NM_—003877.2|[18921206]
• 787: NM_—017662
  Homo sapiens transient receptor potential cation channel, subfamily M, member 6
  (TRPM6), mRNA
  gi|18921092|ref|NM_—017662.3|[18921092]
• 788: NM_—133181
  Homo sapiens epidermal growth factor receptor pathway substrate 8 related protein 3 (EPS8R3), mRNA
  gi|18874727|ref|NM_—133181.1|[18874727]
• 802: M13823
  Homo sapiens T cell receptor gamma chain (TCRG) gene, partial cds
  gi|292736|gb|M13823.1|HUMTCGXK[292736]
• 803: L12398
  Homo sapiens dopamine receptor D4 (DRD4) mRNA, complete cds
  gi|291945|gb|L12398.1|HUMD4C[291945]
• 804: M86383
  Homo sapiens nicotinic acetylcholine receptor alpha 3 subunit precursor, mRNA,
  complete cds
  gi|177897|gb|M86383.1|HUMA3NARSP[177897]
• 805: NG_—000019
  Homo sapiens chorionic gonadotropin beta region (CGB@) on chromosome 19
  gi|18860921|ref|NG_—000019.2|[18860921]
• 807: NM_—012245
  Homo sapiens SKI-interacting protein (SNW1), mRNA
  gi|18860912|ref|NM_—012245.2|[18860912]
• 808: NM_—006750
  Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basic
  component 2) (SNTB2), transcript variant 1, mRNA
  gi|18860911|ref|NM_—006750.2|[18860911]
• 809: NM_—130845
  Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basic
  component 2) (SNTB2), transcript variant 2, mRNA
  gi|18860909|ref|NM_—130845.1|[18860909]
• 810: NM_—002846
  Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
  gi|18860905|ref|NM_—002846.2|[18860905]
• 811: NM_—002845
  Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
  gi|18860903|ref|NM_—002845.2|[18860903]
• 812: NM_—002844
  Homo sapiens protein tyrosine phosphatase, receptor type, K (PTPRK), mRNA
  gi|18860901|ref|NM_—002844.2|[18860901]
• 813: NM_—002843
  Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
  gi|18860899|ref|NM_—002843.2|[18860899]
• 814: NM_—002841
  Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
  gi|18860897|ref|NM_—002841.2|[18860897]
• 815: NM_—130440
  Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
  variant 2, mRNA
  gi|18860895|ref|NM_—130440.1|[18860895]
• 816: NM_—130393
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 4, mRNA
  gi|18860893|ref|NM_—130393.1|[18860893]
• 817: NM_—130392
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 3, mRNA
  gi|18860891|ref|NM_—130392.1|[18860891]
• 818: NM_—130391
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 2, mRNA
  gi|18860889|ref|NM_—130391.1|[18860889]
• 819: NM_—003682
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 4, mRNA
  gi|18860876|ref|NM_—003682.2|[18860876]
• 820: NM_—130476
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 8, mRNA
  gi|18860874|ref|NM_—130476.1|[18860874]
• 821: NM_—130475
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 7, mRNA
  gi|18860872|ref|NM_—130475.1|[18860872]
• 822: NM_—002840
  Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
  variant 1, mRNA
  gi|18860871|ref|NM_—002840.2|[18860871]
• 823: NM_—130474
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 6, mRNA
  gi|18860869|ref|NM_—130474.2|[18860869]
• 824: NM_—130473
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 5, mRNA
  gi|18860867|ref|NM_—130473.1|[18860867]
• 825: NM_—130472
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 3, mRNA
  gi|18860865|ref|NM_—130472.1|[18860865]
• 826: NM_—130471
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 2, mRNA
  gi|18860863|ref|NM_—130471.1|[18860863]
• 827: NM_—130470
  Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 1, mRNA
  gi|18860861|ref|NM_—130470.1|[18860861]
• 828: NM_—006504
  Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
  variant 1, mRNA
  gi|18860860|ref|NM_—006504.2|[18860860]
• 829: NM_—130435
  Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
  variant 2, mRNA
  gi|18860858|ref|NM_—130435.1|[18860858]
• 830: AJ431177
  Homo sapiens mRNA for WIRE protein
  gi|18857713|emb|AJ431177.1|HSA431177[18857713]
• 831: NM_—006474
  Homo sapiens lung type-I cell membrane-associated glycoprotein (T1A-2), mRNA
  gi|18767663|ref|NM_—006474.2|[18767663]
• 833: NM_—006794
  Homo sapiens G protein-coupled receptor 75 (GPR75), mRNA
  gi|5803024|ref|NM_—006794.1|[5803024]
• 834: NM_—002842
  Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
  gi|4506312|ref|NM_—002842.1|[4506312]
• 835: NM_—002839
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 1, mRNA
  gi|4506308|ref|NM_—002839.1|[4506308]
• 836: BC024145
  Homo sapiens, TNF receptor-associated factor 1, clone MGC:10353 IMAGE:3832475, mRNA, complete cds
  gi|18848176|gb|BC024145.1|[18848176]
• 837: AF469756
  Homo sapiens clone S9 interleukin-1 receptor type I (IL1R1) gene, partial sequence
  gi|18846656|gb|AF469756.1|[18846656]
• 838: AF469755
  Homo sapiens clone S8 interleukin-1 receptor type I (IL1R1) gene, partial sequence
  gi|18846655|gb|AF469755.1|[18846655]
• 839: AF469754
  Homo sapiens clone S7 interleukin-1 receptor type I (IL1R1) gene, partial sequence
  gi|18845036|gb|AF469754.1|[18845036]
• 841: BM565570
  ih27b03.x1 Human insulinoma Homo sapiens cDNA clone IMAGE: 3′ similar to SW:FCEG_HUMAN P30273 HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR GAMMA-SUBUNIT
  PRECURSOR; mRNA sequence
  gi|18825852|gb|BM565570.1|BM565570[18825852]
• 842: AF416711
  Homo sapiens Fc-gamma receptor IIc5 mRNA, partial cds
  gi|18765992|gb|AF416711.1|[18765992]
• 843: NM_—023068
  Homo sapiens sialoadhesin (SN), mRNA
  gi|18765743|ref|NM_—023068.2|[18765743]
• 844: NM_—004782
  Homo sapiens synaptosomal-associated protein, 29 kD (SNAP29), mRNA
  gi|18765736|ref|NM_—004782.2|[18765736]
• 845: NM_—130798
  Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant
  2, mRNA
  gi|18765730|ref|NM_—130798.1|[18765730]
• 846: NM_—003825
  Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant
  1, mRNA
  gi|18765728|ref|NM_—003825.2|[18765728]
• 850: AF439409
  Homo sapiens G-protein-coupled receptor kinase 7 (GRK7) mRNA, GRK7-S allele,
  complete cds
  gi|17933258|gb|AF439409.1|[17933258]
• 851: NM_—032211
  Homo sapiens lysyl oxidase-like 4 (LOXL4), mRNA
  gi|16933522|ref|NM_—032211.4|[16933522]
• 852: AF411122
  Homo sapiens importin 4 mRNA, complete cds
  gi|18700634|gb|AF411122.1|[18700634]
• 894: NM_—130441
  Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
  superfamily member 11 (CLECSF11), mRNA
  gi|18466805|ref|NM_—130441.1|[18466805]
• 895: NM_—030876
  Homo sapiens olfactory receptor, family 5, subfamily V, member 1 (OR5V1), mRNA
  gi|14495550|ref|NM_—030876.2|[14495550]
• 896: NM_—032732
  Homo sapiens hypothetical protein MGC10763 (IL17RL), mRNA
  gi|14249349|ref|NM_—032732.1|[14249349]
• 897: NM_—030959
  Homo sapiens olfactory receptor, family 12, subfamily D, member 3 (OR12D3), mRNA
  gi|13624334|ref|NM_—030959.1|[13624334]
• 898: NM_—018842
  Homo sapiens insulin receptor tyrosine kinase substrate (LOC55971), mRNA
  gi|10047119|ref|NM_—018842.1|[10047119]
• 899: NM_—018844
  Homo sapiens B-cell receptor-associated protein BAP29 (BAP29), mRNA
  gi|9994198|ref|NM_—018844.1|[9994198]
• 900: NM_—002825
  Homo sapiens pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) (PTN), mRNA
  gi|18656935|ref|NM_—002825.2|[18656935]
• 904: NM_—016372
  Homo sapiens seven transmembrane domain orphan receptor (TPRA40), mRNA
  gi|7705964|ref|NM_—016372.1|[7705964]
• 905: NM_—014288
  Homo sapiens integrin beta 3 binding protein (beta3-endonexin) (ITGB3BP), mRNA
  gi|7657205|ref|NM_—014288.1|[7657205]
• 906: L43588
  Homo sapiens T cell antigen receptor mRNA, partial cds
  gi|18654191|gb|L43588.1|HUMTCARF[18654191]
• 907: AB050954
  Homo sapiens irs-2 gene for insulin receptor substrate-2, partial cds
  gi|18652856|dbj|AB050954.1|[18652856]
• 923: U77589
  Homo sapiens MHC class II HLA-DQ-alpha chain (HLA-DQA1) mRNA, HLA-DQA1*0104 allele, complete cds
  gi|1916744|gb|U77589.1|HSU77589[1916744]
• 924: AF410465
  Homo sapiens importin 9 mRNA, complete cds
  gi|15529702|gb|AF410465.1|[15529702]
• 925: AF332759
  Homo sapiens partially duplicated CHRNA7 gene, hybrid intron A/4 and partial exon 5
  gi|13345792|gb|AF332759.1|[13345792]
• 926: AF332758
  Homo sapiens alpha-7 nicotinic cholinergic receptor subunit (CHRNA7) gene, partial intron 4 and partial cds
  gi|13345790|gb|AF332750.1|[13345790]
• 927: NM_—003744
  Homo sapiens numb homolog (Drosophila) (NUMB), mRNA
  gi|18644887|ref|NM_—003744.2|[18644887]
• 928: NM_—003681
  Homo sapiens pyridoxal (pyridoxine, vitamin B6) kinase (PDXK), mRNA
  gi|18644884|ref|NM_—003681.2|[18644884]
• 929: NM_—080706
  Homo sapiens transient receptor potential cation channel, subfamily V, member 1
  (TRPV1), transcript variant 3, mRNA
  gi|18375670|ref|NM_—080706.1|[18375670]
• 930: NM_—080705
  Homo sapiens transient receptor potential cation channel, subfamily V, member 1
  (TRPV1), transcript variant 4, mRNA
  gi|18375668|ref|NM_—080705.1|[18375668]
• 931: NM_—080704
  Homo sapiens transient receptor potential cation channel, subfamily V, member 1
  (TRPV1), transcript variant 1, mRNA
  gi|18375666|ref|NM_—080704.1|[18375666]
• 932: NM_—018727
  Homo sapiens transient receptor potential cation channel, subfamily V, member 1
  (TRPV1), transcript variant 2, mRNA
  gi|18375664|ref|NM_—018727.3|[18375664]
• 933: NM_—080819
  Homo sapiens G protein-coupled receptor 78 (GPR78), mRNA
  gi|18201873|ref|NM_—080819.1|[18201873]
• 934: NM_—080738
  Homo sapiens EDAR-associated death domain (EDARADD), mRNA
  gi|18152768|ref|NM_—080738.1|[18152768]
• 935: NM_—080491 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 1, mRNA gi|18105041|ref|NM_—080491.1|[18105041]
• 936: NM_—012296 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 2, mRNA gi|18105040|ref|NM_—012296.2|[18105040]
• 937: NM_—032027 Homo sapiens beta-amyloid binding protein precursor (BBP), mRNA gi|17738309|ref|NM_—032027.2|[17738309]
• 938: NM_—057159 Homo sapiens endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 (EDG2), transcript variant 2, mRNA
  gi|16950637|ref|NM_—057159.1|[16950637]
• 939: NM_—001401 Homo sapiens endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 (EDG2), transcript variant 1, mRNA
  gi|16950635|ref|NM_—001401.2|[16950635]
• 940: NM_—007070 Homo sapiens FKBP-associated protein (FAP48), transcript variant 2, mRNA gi|16933538|ref|NM_—007070.2|[16933538]
• 941: NM_—053274 Homo sapiens FKBP-associated protein (FAP48), transcript variant 1, mRNA gi|16933536|ref|NM_—053274.1|[16933536]
• 942: NM_—003726 Homo sapiens src family associated phosphoprotein 1 (SCAP1), mRNA gi|16753209|ref|NM_—003726.2|[16753209]
• 943: NM_—033632 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 1, mRNA
  gi|16117780|ref|NM_—033632.1|[16117780]
• 944: NM_—018315 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 2, mRNA
  gi|16117778|ref|NM_—018315.2|[16117778]
• 945: NM_—021203 Homo sapiens APMCF1 protein (APMCF1), mRNA
  gi|14917112|ref|NM_—021203.2|[14917112]
• 946: NM_—002927 Homo sapiens regulator of G-protein signalling 13 (RGS13), mRNA gi|14589857|ref|NM_—002927.2|[14589857]
• 949: NM_—020167 Homo sapiens neuromedin U receptor 2 (NMU2R), mRNA
  gi|9910461|ref|NM_—020167.1|[9910461]
• 950: NM_—020149 Homo sapiens Meis1, myeloid ecotropic viral integration site 1 homolog 2 (mouse) (MEIS2), mRNA
  gi|9910355|ref|NM_—020149.1|[9910355]
• 951: AF190052 Homo sapiens interleukin 1 receptor type I (IL1R1) gene, exon 1C sequence gi|9719300|gb|AF190052.1|[9719300]
• 952: NM_—018965 Homo sapiens triggering receptor expressed on myeloid cells 2 (TREM2), mRNA gi|9507202|ref|NM_—018965.1|[9507202]
• 953: NM_—018643 Homo sapiens triggering receptor expressed on myeloid cells 1 (TREM1), mRNA gi|8924261|ref|NM_—018643.1|[8924261]
• 954: NM_—018647 Homo sapiens tumor necrosis factor receptor superfamily, member 19 (TNFRSF19), mRNA gi|8924251|ref|NM_—018647.1|[8924251]
• 955: NM_—018695 Homo sapiens erbb2 interacting protein (ERBB2IP), mRNA
  gi|8923908|ref|NM_—018695.1|[8923908]
• 956: NM_—017636 Homo sapiens transient receptor potential cation channel, subfamily M, member 4(TRPM4), mRNA gi|8923048|ref|NM_—017636.1|[8923048]
• 958: NM_—016559 Homo sapiens PXR2b protein (PXR2b), mRNA
  gi|7706670|ref|NM_—016559.1|[7706670]
• 959: NM_—016382 Homo sapiens natural killer cell receptor 2B4 (CD244), mRNA
  gi|7706528|ref|NM_—016382.1|[7706528]
• 962: NM_—015986 Homo sapiens cytokine receptor-like factor 3 (CRLF3), mRNA
  gi|7705331|ref|NM_—015986.1|[7705331]
• 963: NM_—014815 Homo sapiens KIAA0130 gene product (KIAA0130), mRNA
  gi|7661929|ref|NM_—014815.1|[7661929]
• 964: NM_—014053 Homo sapiens FLVCR protein (FLVCR), mRNA
  gi|7661707|ref|NM_—014053.1|[7661707]
• 965: NM_—014478 Homo sapiens calcitonin gene-related peptide-receptor component protein (CGRP-RCP), mRNA gi|7656976|ref|NM_—014478.1|[7656976]
• 966: NM_—012470
  Homo sapiens transportin-SR (TRN-SR), mRNA
  gi|6912733|ref|NM_—012470.1|[6912733]
• 967: NM_—007357 Homo sapiens low density lipoprotein receptor defect C complementing (LDLC), mRNA gi|6678675|ref|NM_—007357.1|[6678675]
• 969: NM_—007324 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 1, mRNA gi|6552338|ref|NM_—007324.1|[6552338]
• 970: NM_—007323 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 2, mRNA gi|6552336|ref|NM_—007323.1|[6552336]
• 971: NM_—005162 Homo sapiens angiotensin receptor-like 2 (AGTRL2), mRNA
  gi|6031157|ref|NM_—005162.21[6031157]
• 972: NM_—005501 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant b, mRNA
  gi|6006010|ref|NM_—005501.1|[6006010]
• 975: NM_—007053 Homo sapiens natural killer cell receptor, immunoglobulin superfamily member (BY55), mRNA gi|5901909|ref|NM_—007053.1|[5901909]
• 978: NM_—006254 Homo sapiens protein kinase C, delta (PRKCD), mRNA
  gi|5453969|ref|NM_—006254.1|[5453969]
• 979: NM_—005761 Homo sapiens plexin C1 (PLXNC1), mRNA
  gi|5032222|ref|NM_—005761.1|[5032222]
• 980: NM_—005866 Homo sapiens sigma receptor (SR31747 binding protein 1) (SR-BP1), mRNA gi|5032116|ref|NM_—005866.1|[5032116]
• 982: NM_—005506 Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) (CD36L2), mRNA gi|5031630|ref|NM_—005506.1|[5031630]
• 984: NM_—004799 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 3, mRNA gi|4759059|ref|NM_—004799.1|[4759059]
• 985: NM_—004292 Homo sapiens ras inhibitor (RIN1), mRNA
  gi|4759039|ref|NM_—004292.1|[4759039]
• 986: NM_—004828 Homo sapiens lymphocyte antigen 95 (activating NK-receptor; NK-p44) (LY95), mRNA gi|4758693|ref|NM_—004828.1|[4758693]
• 987: NM_—004767 Homo sapiens endothelin type b receptor-like protein 2 (ET(B)R-LP-2), mRNA gi|4758309|ref|NM_—004767.1|[4758309]
• 988: NM_—004440 Homo sapiens EphA7 (EPHA7), mRNA
  gi|4758281|ref|NM_—004440.1|[4758281]
• 989: NM_—003999 Homo sapiens oncostatin M receptor (OSMR), mRNA
  gi|4557039|ref|NM_—003999.1|[4557039]
• 990: NM_—003904 Homo sapiens zinc finger protein 259 (ZNF259), mRNA
  gi|4508020|ref|NM_—003904.1|[4508020]
• 991: NM_—003305 Homo sapiens transient receptor potential cation channel, subfamily C, member 3(TRPC3), mRNA gi|4507686|ref|NM_—003305.1|[4507686]
• 992: NM_—003804 Homo sapiens receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1), mRNA gi|4506538|ref|NM_—003804.1|[4506538]
• 993: NM_—003626 Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 (PPFIA1), mRNA
  gi|4505982|ref|NM_—003626.1|[4505982]
• 994: NM_—003876 Homo sapiens putative receptor protein (PMI), mRNA
  gi|4505900|ref|NM_—003876.1|[4505900]
• 995: NM_—003559 Homo sapiens phosphatidylinositol-4-phosphate 5-kinase, type II, beta (PIP5K2B), mRNA gi|4505818|ref|NM_—003559.1|[4505818]
• 996: NM_—003629 Homo sapiens phosphoinositide-3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) (PIK3R3), mRNA gi|4505804|ref|NM_—003629.1|[4505804]
• 997: NM_—003676 Homo sapiens degenerative spermatocyte homolog, lipid desaturase (Drosophila) (DEGS), mRNA gi|4505192|ref|NM_—003676.1|[4505192]
• 998: NM_—002270 Homo sapiens karyopherin (importin) beta 2 (KPNB2), mRNA
  gi|4504906|ref|NM_—002270.1|[4504906]
• 999: NM_—002204 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant a, mRNA
  gi|4504746|ref|NM_—002204.1|[4504746]
• 1000: NM_—001560 Homo sapiens interleukin 13 receptor, alpha 1 (IL13RA1), mRNA
  gi|4504646|ref|NM_—001560.1|[4504646]
  sapiens AND receptor NOT similar NOT non-receptor NOT nuclear NOT receptor-associated NOT “thyroid hormone” NOT “steroid receptor”
• 779: NM_—000842
  Homo sapiens glutamate receptor, metabotropic 5 (GRM5), mRNA
  gi|4504142|ref|NM_—000842.1|[4504142]
• 780: NM_—001883
  Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), mRNA
  gi|4503044|ref|NM_—001883.1|[4503044]
• 781: NM_—001873
  Homo sapiens carboxypeptidase E (CPE), mRNA
  gi|4503008|ref|NM_—001873.1|[4503008]
• 783: L29395
  Homo sapiens v-erbB-related protein gene, partial cds
  gi|459807|gb|L29395.1|HUMERBB[459807]
• 784: L08584
  Homo sapiens T cell receptor beta chain (TCRB) mRNA, partial cds
  gi|307497|gb|L08584.1|HUMTCVB7A[307497]
• 786: NM_—015638
  Homo sapiens chromosome 20 open reading frame 188 (C20orf188), mRNA
  gi|18158415|ref|NM_—015638.1|[18158415]
• 787: NM_—058167
  Homo sapiens ubiquitin conjugating enzyme 6 (Ubc6p), mRNA
  gi|17157996|ref|NM_—058167.1|[17157996]
• 788: NM_—054032
  Homo sapiens G protein-coupled receptor MRGX4 (MRGX4), mRNA
  gi|16876454|ref|NM_—054032.1|[16876454]
• 789: NM_—054031
  Homo sapiens G protein-coupled receptor MRGX3 (MRGX3), mRNA
  gi|16876452|ref|NM_—054031.1|[16876452]
• 790: NM_—054030
  Homo sapiens G protein-coupled receptor MRGX2 (MRGX2), mRNA
  gi|16876450|ref|NM_—054030.1|[16876450]
• 791: NM_—052931
  Homo sapiens activating NK receptor (KALI), mRNA
  gi|16418406|ref|NM_—052931.1|[16418406]
• 792: NM_—032871
  Homo sapiens tumor necrosis factor receptor superfamily, member 19-like (TNFRSF19L), mRNA
  gi|14249611|ref|NM_—032871.1|[14249611]
• 793: NM_—032553
  Homo sapiens putative purinergic receptor (FKSG79), mRNA
  gi|14211848|ref|NM_—032553.1|[14211848]
• 794: NM_—025179
  Homo sapiens plexin A2 (PLXNA2), mRNA
  gi|13378152|ref|NM_—025179.1|[13378152]
• 795: NM_—024419
  Homo sapiens Phosphatidylglycerophosphate Synthase (PGS1), mRNA
  gi|13259369|ref|NM_—024419.1|[13259369]
• 796: NM_—021249
  Homo sapiens sorting nexin 6 (SNX6), mRNA
  gi|13027619|ref|NM_—021249.1|[13027619]
• 797: NM_—014045
  Homo sapiens DKFZP564C1940 protein (DKFZP564C1940), mRNA
  gi|13027587|ref|NM_—014045.1|[13027587]
• 798: NM_—080923
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 4, mRNA
  gi|18641365|ref|NM_—080923.1|[18641365]
• 799: NM_—080922
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 3, mRNA
  gi|18641363|ref|NM_—080922.1|[18641363]
• 800: NM_—080921
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 2, mRNA
  gi|18641361|ref|NM_—080921.1|[18641361]
• 801: NM_—130386
  Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant I, mRNA
  gi|18641359|ref|NM_—130386.1|[18641359]
• 802: NM_—030781
  Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant II, mRNA
  gi|18641357|ref|NM_—030781.2|[18641357]
• 803: NM_—002838
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 1, mRNA
  gi|18641346|ref|NM_—002838.2|[18641346]
• 804: NM_—130770
  Homo sapiens 5-hydroxytryptamine receptor 3 subunit C (HTR3C), mRNA
  gi|18640739|ref|NM_—130770.1|[18640739]
• 813: BD010218
  Novel hemopoietin receptor protein, NR12
  gi|18638591|dbj|BD010218.1|[18638591]
• 814: BD010217
  Novel hemopoietin receptor protein, NR12
  gi|18638590|dbj|BD010217.1|[18638590]
• 815: BD010216
  Novel hemopoietin receptor protein, NR12
  gi|18638589|dbj|BD010216.1|[18638589]
• 816: BD010215
  Novel hemopoietin receptor protein, NR12
  gi|18638588|dbj|BD010215.1|[18638588]
• 817: BD010214
  Novel hemopoietin receptor protein, NR12
  gi|18638587|dbj|BD010214.1|[18638587]
• 818: BD010125
  Peptide leukotrien receptor
  gi|18638498|dbj|BD010125.1|[18638498]
• 819: BD010114
  Novel receptor and gene encoding the same
  gi|18638487|dbj|BD010114.1|[18638487]
• 820: BD010057
  Novel G protein coupled receptor protein and its DNA
  gi|18638430|dbj|BD010057.1|[18638430]
• 821: BD010056
  Novel G protein coupled receptor protein and its DNA
  gi|18638429|dbj|BD010056.1|[18638429]
• 822: BD010055
  Novel G protein coupled receptor protein and its DNA
  gi|18638428|dbj|BD010055.1|[18638428]
• 823: BD010054
  Novel G protein coupled receptor protein and its DNA
  gi|18638427|dbj|BD010054.1|[18638427]
• 824: BD010053
  Novel G protein coupled receptor protein and its DNA
  gi|18638426|dbj|BD010053.1|[18638426]
• 825: BD010052
  Novel G protein coupled receptor protein and its DNA
  gi|18638425|dbj|BD010052.1|[18638425]
• 826: BD010051
  Novel G protein coupled receptor protein and its DNA
  gi|18638424|dbj|BD010051.1|[18638424]
• 827: BD010050
  Novel G protein coupled receptor protein and its DNA
  gi|18638423|dbj|BD010050.1|[18638423]
• 828: BD010049
  Novel G protein coupled receptor protein and its DNA
  gi|18638422|dbj|BD010049.1|[18638422]
• 829: BD010046
  Novel G protein coupled receptor protein and its DNA
  gi|18638419|dbj|BD010046.1|[18638419]
• 830: BD010035
  Novel G protein coupled receptor protein and its DNA
  gi|18638408|dbj|BD010035.1|[18638408]
• 831: BD010034
  Novel G protein coupled receptor protein and its DNA
  gi|18638407|dbj|BD010034.1|[18638407]
• 832: BD010028
  Novel G protein coupled receptor protein and its DNA
  gi|18638401|dbj|BD010028.1|[18638401]
• 833: BD010022
  Novel G protein coupled receptor protein and its DNA
  gi|18638395|dbj|BD010022.1|[18638395]
• 834: BD009263
  GABAA receptor subunit epsilon-related protein
  gi|18637636|dbj|BD009263.1|[18637636]
• 835: BD009262
  GABAA receptor subunit epsilon-related protein
  gi|18637635|dbj|BD009262.1|[18637635]
• 836: BD009261
  GABAA receptor subunit epsilon-related protein
  gi|18637634|dbj|BD009261.1|[18637634]
• 837: BD009260
  GABAA receptor subunit epsilon-related protein
  gi|18637633|dbj|BD009260.1|[18637633]
• 838: BD006753
  Human G protein chemokine receptor HDGNR10
  gi|18635124|dbj|BD006753.1|[18635124]
• 843: E51301
  Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633577|dbj|E51301.1|[18633577]
• 844: E51300
  Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633576|dbj|E51300.1|[18633576]
• 845: E51299
  Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633575|dbj|E51299.1|[18633575]
• 846: E51298
  Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633574|dbj|E51298.1|[18633574]
• 847: E51297
  Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633573|dbj|E51297.1|[18633573]
• 848: E51296
  Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
  gi|18633572|dbj|E51296.1|[18633572]
• 849: E50838
  Novel G protein-coupled receptor
  gi|18633543|dbj|E50838.1|[18633543]
• 850: E50837
  Novel G protein-coupled receptor
  gi|18633542|dbj|E50837.1|[18633542]
• 851: E50836
  Novel G protein-coupled receptor
  gi|18633541|dbj|E50836.1|[18633541]
• 852: E50835
  Novel G protein-coupled receptor
  gi|18633540|dbj|E50835.1|[18633540]
• 853: E50834
  Novel G protein-coupled receptor
  gi|18633539|dbj|E50834.1|[18633539]
• 854: E50833
  Novel G protein-coupled receptor
  gi|18633538|dbj|E50833.1|[18633538]
• 873: BD003056
  Novel G protein-coupled receptor protein and DNA thereof
  gi|18631017|dbj|BD003056.1|[18631017]
• 874: E55122
  Novel G protein-coupled receptor and the G protein-coupled receptor gene
  gi|18629753|dbj|E55122.1|[18629753]
• 875: E55121
  Novel G protein-coupled receptor and the G protein-coupled receptor gene
  gi|18629752|dbj|E55121.1|[18629752]
• 876: E55120
  Novel G protein-coupled receptor and the G protein-coupled receptor gene
  gi|18629751|dbj|E55120.1|[18629751]
• 877: E55119
  Novel G protein-coupled receptor and the G protein-coupled receptor gene
  gi|18629750|dbj|E55119.1|[18629750]
• 878: E55118
  Novel G protein-coupled receptor and the G protein-coupled receptor gene
  gi|18629749|dbj|E55118.1|[18629749]
• 879: E55117
  Novel G protein-coupled receptor and the G protein-coupled receptor gene
  gi|18629748|dbj|E55117.1|[18629748]
• 880: E49128
  Novel G protein-conjugated receptor protein
  gi|18629265|dbj|E49128.1|[18629265]
• 881: E49127
  Novel G protein-conjugated receptor protein
  gi|18629264|dbj|E49127.1|[18629264]
• 882: E49126
  Novel G protein-conjugated receptor protein
  gi|18629263|dbj|E49126.1|[18629263]
• 883: E49125
  Novel G protein-conjugated receptor protein
  gi|18629262|dbj|E49125.1|[18629262]
• 884: E49124
  Novel G protein-conjugated receptor protein
  gi|18629261|dbj|E49124.1|[18629261]
• 885: E49123
  Novel G protein-conjugated receptor protein
  gi|18629260|dbj|E49123.1|[18629260]
• 887: E58499
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628416|dbj|E58499.1|[18628416]
• 888: E58495
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628412|dbj|E58495.1|[18628412]
• 889: E58494
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628411|dbj|E58494.1|[18628411]
• 890: E58488
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628405|dbj|E58488.1|[18628405]
• 891: E58485
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628402|dbj|E58485.1|[18628402]
• 892: E58484
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628401|dbj|E58484.1|[18628401]
• 893: E58479
  Novel G protein-coupled receptor protein, DNA and utilization thereof
  gi|18628396|dbj|E58479.1|[18628396]
• 902: E43451
  Novel protein G-coupled receptor protein and DNA thereof
  gi|18627717|dbj|E43451.1|[18627717]
• 903: E43450
  Novel protein G-coupled receptor protein and DNA thereof
  gi|18627716|dbj|E43450.1|[18627716]
• 904: E41270
  Novel G protein-conjugate receptor protein and its DNA
  gi|18627502|dbj|E41270.1|[18627502]
• 905: E41269
  Novel G protein-conjugate receptor protein and its DNA
  gi|18627501|dbj|E41269.1|[18627501]
• 906: E41268
  Novel G protein-conjugate receptor protein and its DNA
  gi|18627500|dbj|E41268.1|[18627500]
• 907: E40003
  Novel G protein-conjugate receptor protein and its DNA
  gi|18627119|dbj|E40003.1|[18627119]
• 908: E40000
  Novel G protein-conjugate receptor protein and its DNA
  gi|18627116|dbj|E40000.1|[18627116]
• 909: E39999
  Novel G protein-conjugate receptor protein and its DNA
  gi|18627115|dbj|E39999.1|[18627115]
• 910: E39824
  Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
  gi|18627105|dbj|E39824.1|[18627105]
• 911: E39817
  Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
  gi|18627098|dbj|E39817.1|[18627098]
• 912: E39816
  Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
  gi|18627097|dbj|E39816.1|[18627097]
• 913: E39815
  Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
  gi|18627096|dbj|E39815.1|[18627096]
• 929: E34464
  Novel Toll-like receptor and gene thereof
  gi|18624350|dbj|E34464.1|[18624350]
• 930: E33807
  Human splice mutant CXCR4B of CXCR4 chemokine receptor
  gi|18624164|dbj|E33807.1|[18624164]
• 931: E33806
  Human splice mutant CXCR4B of CXCR4 chemokine receptor
  gi|18624163|dbj|E33806.1)[18624163]
• 941: E63757
  Human nurse cell receptor gene
  gi|18622844|dbj|E63757.1|[18622844]
• 942: E63756
  Human nurse cell receptor gene
  gi|18622843|dbj|E63756.1|[18622843]
• 943: E63754
  Human nurse cell receptor gene
  gi|18622841|dbj|E63754.1|[18622841]
• 944: E49275
  Novel G protein-conjugated receptor protein and DNA thereof
  gi|18622037|dbj|E49275.1|[18622037]
• 945: E44151
  Novel G protein-coupled receptor protein and DNA thereof
  gi|18622012|dbj|E44151.1|[18622012]
• 946: E44032
  Novel G protein-coupled receptor protein and DNA and ligand of the same
  gi|18621998|dbj|E44032.1|[18621998]
• 947: AX350990
  Sequence 24 from Patent WO0190358
  gi|18616366|emb|AX350990.1|[18616366]
• 948: AX350988
  Sequence 22 from Patent WO0190358
  gi|18616364|emb|AX350988.1|[18616364]
• 949: AX350984
  Sequence 18 from Patent WO0190358
  gi|18616360|emb|AX350984.1|[18616360]
• 950: AX350982
  Sequence 16 from Patent WO0190358
  gi|18616358|emb|AX350982.1|[18616358]
• 951: AX350981
  Sequence 15 from Patent WO0190358
  gi|18616357|emb|AX350981.1|[18616357]
• 952: AX350979
  Sequence 13 from Patent WO0190358
  gi|18616355|emb|AX350979.1|[18616355]
• 953: AX350975
  Sequence 9 from Patent WO0190358-
  gi|18616351|emb|AX350975.1|[18616351]
• 954: AX350973
  Sequence 7 from Patent WO0190358
  gi|18616349|emb|AX350973.1|[18616349]
• 955: AX350969
  Sequence 3 from Patent WO0190358
  gi|18616345|emb|AX350969.1|[18616345]
• 956: AX350967
  Sequence 1 from Patent WO0190358
  gi|18616343|emb|AX350967.1|[18616343]
• 957: NM_—005608
  Homo sapiens protein tyrosine phosphatase, receptor type, C-associated protein
  (PTPRCAP), mRNA
  gi|5032004|ref|NM_—005608.1|[5032004]
• 958: XM_—012097
  Homo sapiens olfactory receptor, family 6, subfamily A, member 1 (OR6A1), mRNA
  gi|18605332|ref|XM_—012097.3|[18605332]
• 959: XM_—090173
  Homo sapiens olfactory receptor, family 5, subfamily L, member 2 (OR5L2), mRNA
  gi|1860518|ref|XM_—090173.1|[18605181]
• 960: XM_—055369
  Homo sapiens pro-oncosis receptor inducing membrane injury gene (PORIMIN), mRNA
  gi|18604484|ref|XM_—055369.2|[18604484]
• 961: XM_—041961
  Homo sapiens PYK2 N-terminal domain-interacting receptor 1 (NIR1), mRNA
  gi|18604126|ref|XM_—041961.2|[18604126]
• 962: XM_—040037
  Homo sapiens adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA
  gi|18604053|ref|XM_—040037.3|[18604053]
• 963: XM_—045532
  Homo sapiens olfactory receptor, family 51, subfamily E, member 2 (OR51E2), mRNA
  gi|18603788|ref|XM_—045532.2|[18603788]
• 964: XM_—091465
  Homo sapiens olfactory receptor, family 4, subfamily D, member 1 (OR4D1), mRNA
  gi|18603196|ref|XM_—091465.1|[18603196]
• 965: XM_—036784
  Homo sapiens phosphatidylserine receptor (KIAA0585), mRNA
  gi|18603024|ref|XM_—036784.3|[18603024]
• 966: XM_—036728
  Homo sapiens ryanodine receptor 3 (RYR3), mRNA
  gi|18602746|ref|XM_—036728.3|[18602746]
• 967: XM_—084025
  Homo sapiens complement component 5 receptor 1 (C5a ligand) (C5R1), mRNA
  gi|18601827|ref|XM_—084025.1|[18601827]
• 968: XM_—009107
  Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 (KDELR1), mRNA
  gi|18601740|ref|XM_—009107.6|[18601740]
• 969: XM_—027883
  Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
  interacting protein (liprin), alpha 3 (PPFIA3), mRNA
  gi|18601690|ref|XM_—027883.2|[18601690]
• 970: XM_—027904
  Homo sapiens Fc fragment of IgG, receptor, transporter, alpha (FCGRT), mRNA
  gi|18601656|ref|XM_—027904.4|[18601656]
• 971: XM_—049229
  Homo sapiens dopamine receptor interacting protein (DRIP78), mRNA
  gi|18601498|ref|XM_—049229.3|[18601498]
• 972: XM_—040709
  Homo sapiens prostaglandin F2 receptor negative regulator (PTGFRN), mRNA
  gi|186011300ref|XM_—040709.2|[18601130]
• 973: XM_—003091
  Homo sapiens G protein-coupled receptor 105 (GPR105), mRNA
  gi|18600688|ref|XM_—003091.5|[18600688]
• 975: XM_—010533
  Homo sapiens interleukin 12 receptor, beta 2 (IL12RB2), mRNA
  gi|18600602|ref |XM_—010533.4|[18600602]
• 976: NT_—006318
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18600353|ref|NT_—006318.7|Hs4_—6475[18600353]
• 977: XM_—039145
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 3 (CHRNA3), mRNA
  gi|18597785|ref|XM_—039145.3|[18597785]
• 978: XM_—039151
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 4 (CHRNB4), mRNA
  gi|18597777|ref|XM_—039151.2|[18597777]
• 979: XM_—007392
  Homo sapiens G protein-coupled receptor 65 (GPR65), mRNA
  gi|8597722|ref|XM_—007392.4|[18597722]
• 980: XM_—007315
  Homo sapiens receptor-interacting serine-threonine kinase 3 (RIPK3), mRNA
  gi|18597625|ref|XM_—007315.2|[18597625]
• 981: NT_—024675
  Homo sapiens chromosome 15 working draft sequence segment
  gi|18597616|ref|NT_—024675.7|Hs15_—24831[18597616]
• 982: XM_—051711
  Homo sapiens prostaglandin D2 receptor (DP) (PTGDR), mRNA
  gi|18597012|ref|XM_—051711.2|[18597012]
• 983: XM_—007337
  Homo sapiens kinectin 1 (kinesin receptor) (KTN1), mRNA
  gi|18596970|ref|XM_—007337.7|[18596970]
• 984: XM_—096782
  Homo sapiens putative leukocyte platelet-activating factor receptor (HUMNPIIY20), mRNA
  gi|18596920|ref|XM_—096782.1|[18596920]
• 985: XM_—055898
  Homo sapiens nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), mRNA
  gi|18596422|ref|XM_—055898.3|[18596422]
• 986: XM_—018505
  Homo sapiens G protein-coupled receptor 23 (GPR23), mRNA
  gi|18594906|ref|XM_—018505.3|[18594906]
• 987: XM_—096288
  Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA
  gi|18594854|ref|XM_—096288.1|[18594854]
• 988: XM_—096154
  Homo sapiens angiotensin receptor-like 2 (AGTRL2), mRNA
  gi|18593950|ref|XM_—096154.1|[18593950]
• 989: XM_—015620
  Homo sapiens nogo receptor (NOGOR), mRNA
  gi|18593698|ref|XM_—015620.5|[18593698]
• 990: XM_—048563
  Homo sapiens interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2), mRNA
  gi|18593096|ref|XM_—048563.2|[18593096]
• 991: XM_—086754
  Homo sapiens coxsackie virus and adenovirus receptor (CXADR), mRNA
  gi|18592977|ref|XM_—086754.1|[18592977]
• 992: XM_—056242
  Homo sapiens protein C receptor, endothelial (EPCR) (PROCR), mRNA
  gi|18592822|ref|XM_—056242.3|[18592822]
• 993: XM_—097415
  Homo sapiens leukocyte receptor cluster (LRC) member 8 (LENG8), mRNA
  gi|18591238|ref|XM_—097415.1|[18591238]
• 994: XM_—044314
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4 (ILT7), mRNA
  gi|18591234|ref|XM_—044314.4|[18591234]
• 995: XM_—092068
  Homo sapiens olfactory receptor, family 7, subfamily C, member 1 (OR7C1), mRNA
  gi|18591224|ref|XM_—092068.1|[18591224]
• 996: XM_—084042
  Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 2 (EMR2), mRNA
  gi|18591222|ref|XM_—084042.1|[18591222]
• 997: XM_—012893
  Homo sapiens endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 4 (EDG4), mRNA
  gi|18591032|ref|XM_—012893.5|[18591032]
• 998: XM_—103288
  Homo sapiens polycythemia rubra vera 1; cell surface receptor (PRV1), mRNA
  gi|18590882|ref|XM_—103288.1|[18590882]
• 999: XM_—046103
  Homo sapiens protein tyrosine phosphatase, receptor type, S (PTPRS), mRNA
  gi|18590850|ref|XM_—046103.3|[18590850]
• 1000: XM_—047633
  Homo sapiens thromboxane A2 receptor (TBXA2R), mRNA
  gi|18590817|ref|XM_—047633.2|[18590817]
• 1001: XM_—030637
  Homo sapiens G protein-coupled receptor kinase 7 (GPRK7), mRNA
  gi|18590749|ref|XM_—030637.3|[18590749]
• 1002: XM_—086017
  Homo sapiens plasminogen activator, urokinase receptor (PLAUR), mRNA
  gi|18590707|ref|XM_—086017.1|[18590707]
• 1003: XM_—029455
  Homo sapiens ryanodine receptor 1 (skeletal) (RYR1), mRNA
  gi|18590460|ref|XM_—029455.2|[18590460]
• 1004: XM_—085976
  Homo sapiens leukocyte receptor cluster (LRC) member 3 (LENG3), mRNA
  gi|18590428|ref|XM_—085976.1|[18590428]
• 1005: XM_—084028
  Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1), mRNA
  gi|18590419|ref|XM_—084028.1|[18590419]
• 1006: XM_—097304
  Homo sapiens leukocyte receptor cluster (LRC) member 1 (LENG1), mRNA
  gi|18590235|ref|XM_—097304.1|[18590235]
• 1007: XM_—050582
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM, domains), member 3 (LILRB3), mRNA
  gi|18590233|ref|XM_—050582.3|[18590233]
• 1008: XM_—041258
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), mRNA
  gi|18590231|ref|XM_—041258.3|[18590231]
• 1009: XM_—050236
  Homo sapiens leukocyte receptor cluster (LRC) member 4 (LENG4), mRNA
  gi|18590224|ref|XM_—050236.3|[18590224]
• 1010: XM_—048346
  Homo sapiens insulin receptor (INSR), mRNA
  gi|18590185|ref|XM_—048346.3|[18590185]
• 1011: XM_—044591
  Homo sapiens G protein-coupled receptor 108 (GPR108), mRNA
  gi|18590160|ref|XM_—044591.3|[18590160]
• 1012: XM_—085864
  Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 (EDG8), mRNA
  gi|18589990|ref|XM_—085864.1|[18589990]
• 1013: XM_—044320
  Homo sapiens poliovirus receptor-related 2 (herpesvirus entry mediator B) (PVRL2), mRNA
  gi|18589873|ref|XM_—044320.4|[18589873]
• 1014: XM_—012671
  Homo sapiens olfactory receptor, family 1, subfamily E, member 2 (OR1E2), mRNA
  gi|18588331|ref|XM_—012671.5|[18588331]
• 1015: XM_—085745
  Homo sapiens somatostatin receptor 2 (SSTR2), mRNA
  gi|18588314|ref|XM_—085745.1|[18588314]
• 1016: XM_—008646
  Homo sapiens cytokine receptor-like factor 3 (CRLF3), mRNA
  gi|18588105|ref|XM_—008646.5|[18588105]
• 1017: XM_—008509
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), mRNA
  gi|18587692|ref|XM_—008509.6|[18587692]
• 1018: XM_—030851
  Homo sapiens G protein-coupled receptor kinase-interactor 1 (GIT1), mRNA
  gi|18587652|ref|XM_—030851.2|[18587652]
• 1019: XM_—048233
  Homo sapiens autocrine motility factor receptor (AMFR), mRNA
  gi|18585872|ref|XM_—048233.3|[18585872]
• 1020: NT_—010280
  Homo sapiens chromosome 15 working draft sequence segment
  gi|18584150|ref|NT_—010280.8|Hs15_—10437[18584150]
• 1021: XM_—039208
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 3 (GABRG3), mRNA
  gi|18584141|ref|XM_—039208.5|[18584141]
• 1022: XM_—030709
  Homo sapiens transient receptor potential cation channel, subfamily M, member 7
  (TRPM7), mRNA
  gi|18583756|ref|XM_—030709.3|[18583756]
• 1023: XM_—085103
  Homo sapiens G protein-coupled receptor (G2A), mRNA
  gi|18583332|ref|XM_—085103.1|[18583332]
• 1024: XM_—040854
  Homo sapiens bradykinin receptor B2 (BDKRB2), mRNA
  gi|18582977|ref|XM_—040854.2|[18582977]
• 1025: XM_—007275
  Homo sapiens bradykinin receptor B1 (BDKRB1), mRNA
  gi|18582976|ref|XM_—007275.4|[18582976]
• 1027: XM_—083897
  Homo sapiens Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor) (EBI2), mRNA
  gi|18581588|ref|XM_—083897.1|[18581588]
• 1029: XM_—062656
  Homo sapiens C-type lectin-like receptor (CLEC-6), mRNA
  gi|18580484|ref|XM_—062656.2|[18580484]
• 1031: XM_—084785
  Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
  interacting protein (liprin), alpha 2 (PPFIA2), mRNA
  gi|18579245|ref|XM_—084785.1|[18579245]
• 1032: XM_—043322
  Homo sapiens peroxisome receptor 1 (PXR1), mRNA
  gi|18579222|ref|XM_—043322.3|[18579222]
• 1033: XM_—090117
  Homo sapiens olfactory receptor, family 8, subfamily G, member 2 (OR8G2), mRNA
  gi|18578560|ref|XM_—090117.1|[18578560]
• 1034: XM_—090109
  Homo sapiens olfactory receptor, family 8, subfamily G, member 1 (OR8G1), mRNA
  gi|18578546|ref|XM_—090109.1[18578546]
• 1035: XM_—035095
  Homo sapiens cortical thymocyte receptor (X. laevis CTX) like (CTXL), mRNA
  gi|18578508|ref|XM_—035095.4|[18578508]
• 1036: XM_—084690
  Homo sapiens olfactory receptor, family 8, subfamily B, member 8 (OR8B8), mRNA
  gi|18578501|ref|XM_—084690.1|[18578501]
• 1037: XM_—012064
  Homo sapiens glutamate receptor, ionotropic, kainate 4 (GRIK4), mRNA
  gi|18578454|ref|XM_—012064.6|[18578454]
• 1039: XM_—031348
  Homo sapiens glutamate receptor, metabotropic 5 (GRM5), mRNA
  gi|18577875|ref|XM_—031348.2|[18577875]
• 1040: XM_—089965
  Homo sapiens olfactory receptor, family 10, subfamily A, member 3 (OR10A3), mRNA
  gi|18577828|ref|XM_—089965.1|[18577828]
• 1041: NT_—030791
  Homo sapiens chromosome 11 working draft sequence segment
  gi|18577645|ref|NT_—030791.2|Hs11_—31047[18577645]
• 1042: XM_—006549
  Homo sapiens G protein-coupled receptor 48 (GPR48), mRNA
  gi|18577644|ref|XM_—006549.5|[18577644]
• 1043: XM_—054215
  Homo sapiens purinergic receptor P2Y, G-protein coupled, 2 (P2RY2), mRNA
  gi|18577261|ref|XM_—054215.4|[18577261]
• 1044: XM_—038024
  Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
  gi|18577179|ref|XM_—038024.4|[18577179]
• 1045: XM_—049296
  Homo sapiens GDNF family receptor alpha 1 (GFRA1), mRNA
  gi|18576832|ref|XM_—049296.4|[18576832]
• 1046: XM_—005781
  Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), mRNA
  gi|18576581|ref|XM_—005781.5|[18576581]
• 1047: XM_—011904
  Homo sapiens cubilin (intrinsic factor-cobalamin receptor) (CUBN), mRNA
  gi|18576082|ref|XM_—011904.6|[18576082]
• 1048: XM_—005969
  Homo sapiens G protein-coupled receptor kinase 5 (GPRK5), mRNA
  gi|18575440|ref|XM_—005969.6|[18575440]
• 1049: XM_—089569
  Homo sapiens VPS10 domain receptor protein SORCS1 (SORCS1), mRNA
  gi|18574995|ref|XM_—089569.1|[18574995]
• 1050: XM_—005830
  Homo sapiens mannose receptor, C type 1 (MRC1), mRNA
  gi|18574297|ref|XM_—005830.7|[18574297]
• 1051: XM_—005747
  Homo sapiens tachykinin receptor 2 (TACR2), mRNA
  gi|18574167|ref |XM_—005747.5|[18574167]
• 1052: XM_—043613
  Homo sapiens glutamate receptor, ionotropic, delta 1 (GRID1), mRNA
  gi|18574031|ref|XM_—043613.4|[18574031]
• 1053: XM_—028830
  Homo sapiens transient receptor potential cation channel, subfamily M, member 6
  (TRPM6), mRNA
  gi|18573768|ref|XM_—028830.3|[18573768]
• 1054: XM_—095961
  Homo sapiens olfactory receptor, family 2, subfamily K, member 2 (OR2K2), mRNA
  gi|18573486|ref|XM_—095961.1|[18573486]
• 1055: XM_—096286
  Homo sapiens receptor tyrosine kinase-like orphan receptor 2 (ROR2), mRNA
  gi|18573067|ref|XM_—096286.1|[18573067]
• 1056: XM_—095815
  Homo sapiens olfactory receptor, family 1, subfamily J, member 5 (OR1J5), mRNA
  gi|18572435|ref|XM_—095815.1|[18572435]
• 1057: XM_—095814
  Homo sapiens olfactory receptor, family 1, subfamily J, member 4 (OR1J4), mRNA
  gi|18572433|ref|XM_—095814.1|[18572433]
• 1059: XM_—011695
  Homo sapiens leptin receptor overlapping transcript-like 1 (LEPROTL1), mRNA
  gi|18570296|ref|XM_—011695.3|[18570296]
• 1061: XM_—088035
  Homo sapiens transient receptor potential cation channel, subfamily V, member 6
  (TRPV6), mRNA
  gi|18565882|ref|XM_—088035.1|[18565882]
• 1062: XM_—004696
  Homo sapiens EphB6 (EPHB6), mRNA
  gi|18565881|ref|XM_—004696.5|[18565881]
• 1063: XM_—096245
  Homo sapiens olfactory receptor, family 2, subfamily H, member 3 (OR2H3), mRNA
  gi|18564780|ref|XM_—096245.1|[18564780]
• 1064: XM_—084200
  Homo sapiens olfactory receptor, family 11, subfamily A, member 1 (OR11A1), mRNA
  gi|18563692|ref|XM_—084200.1|[18563692]
• 1065: XM_—084190
  Homo sapiens olfactory receptor, family 2, subfamily A, member 4 (OR2A4), mRNA
  gi|18563106|ref|XM_—084190.1|[18563106]
• 1066: XM_—004341
  Homo sapiens opioid receptor, mu 1 (OPRM1), mRNA
  gi|18562969|ref|XM_—004341.6|[18562969]
• 1067: XM_—084185
  Homo sapiens dopamine receptor D1 (DRD1), mRNA
  gi|18561988|ref|XM_—084185.1|[18561988]
• 1069: XM_—049570
  Homo sapiens dioxin receptor repressor (AHRR), mRNA
  gi|18560847|ref|XM_—049570.4|[18560847]
• 1070: XM_—084176
  Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA
  gi|18560787|ref|XM_—084176.1|[18560787]
• 1071: NT_—029289
  Homo sapiens chromosome 5 working draft sequence segment
  gi|18560495|ref|NT_—029289.4|Hs5_—29448[18560495]
• 1072: XR_—000069
  Homo sapiens neuropeptide Y receptor Y6 (psuedogene) (NPY6R), misc RNA
  gi|18560235|ref|XR_—000069.1|[18560235]
• 1073: NT_—025716
  Homo sapiens chromosome 5 working draft sequence segment
  gi|18560224|ref|NT_—025716.6|Hs5_—25872[18560224]
• 1074: XM_—094306
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 1 (GABRA1), mRNA
  gi|18560222|ref|XM_—094306.1|[18560222]
• 1075: XM_—096226
  Homo sapiens interleukin 7 receptor (IL7R), mRNA
  gi|18560176|ref|XM_—096226.1|[18560176]
• 1076: XM_—031131
  Homo sapiens leukemia inhibitory factor receptor (LIFR), mRNA
  gi|18559952|ref|XM_—031131.2|[18559952]
• 1077: XM_—011222
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), mRNA
  gi|18559788|ref|XM_—011222.6|[18559788]
• 1078: XM_—003519
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1), mRNA
  gi|18558473|ref|XM_—003519.3|[18558473]
• 1079: XM_—038446
  Homo sapiens melatonin receptor 1A (MTNR1A), mRNA
  gi|18558343|ref|XM_—038446.2|[18558343]
• 1080: XM_—084160
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 2 (GABRA2), mRNA
  gi|18558328|ref|XM_—084160.1|[18558328]
• 1081: XM_—011169
  Homo sapiens neuropeptide Y receptor Y2 (NPY2R), mRNA
  gi|18558281|ref|XM_—011169.3|[18558281]
• 1082: XM_—044120
  Homo sapiens fibroblast growth factor receptor 3 (achondroplasia, thanatophoric
  dwarfism) (FGFR3), mRNA
  gi|18558241|ref|XM_—044120.2|[18558241]
• 1083: NT_—030654
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18557828|ref|NT_—030654.2|Hs4_—30910[18557828]
• 1084: NT_—030650
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18557822|ref|NT_—030650.2|Hs4_—30906[18557822]
• 1085: XM_—011173
  Homo sapiens glutamate receptor, ionotropic, delta 2 (GRID2), mRNA
  gi|18557816|ref|XM_—011173.4|[18557816]
• 1086: NT_—029955
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18557687|ref|NT_—029955.3|Hs4_—30210[18557687]
• 1087: NT_—025693
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18557505|ref|NT_—025693.3|Hs4_—25849[18557505]
• 1088: NM_—019841
  Homo sapiens transient receptor potential nation channel, subfamily V, member 5
  (TRPV5), mRNA
  gi|17505199|ref|NM_—019841.2|[17505199]
• 1089: NT_—030778
  Homo sapiens chromosome 10 working draft sequence segment
  gi|17489667|ref|NT_—030778.1|Hs10_—31034[17489667]
• 1090: NT_—010591
  Homo sapiens chromosome 16 working draft sequence segment
  gi|17487829|ref|NT_—010591.6|Hs16_—10748[17487829]
• 1091: NT_—030889
  Homo sapiens chromosome X working draft sequence segment
  gi|17486981|ref|NT_—030889.1|HsX_—31145[17486981]
• 1092: XM_—066104
  Homo sapiens G protein-coupled receptor 73-like 1 (GPR73L1), mA
  gi|17484462|ref|XM_—066104.1|[17484462]
• 1093: XM_—056414
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), mRNA
  gi|17483039|ref|XM_—056414.2|[17483039]
• 1094: XM_—053166
  Homo sapiens somatostatin receptor-interacting protein (SSTRIP), mRNA
  gi|17482811|ref|XM_—053166.3|[17482811]
• 1096: XM_—008489
  Homo sapiens acetyl LDL receptor; SREC=scavenger receptor expressed by endothelial cells (SREC), mRNA
  gi|17481055|ref|XM_—008489.7|[17481055]
• 1097: XM_—044091
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 7 (CHRNA7), mRNA
  gi|17477913|ref|XM_—044091.2|[17477913]
• 1098: NT_—010258
  Homo sapiens chromosome 15 working draft sequence segment
  gi|17477780|ref|NT_—010258.7|Hs15_—10415[17477780]
• 1099: XM_—038336
  Homo sapiens neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), mRNA
  gi|17477779|ref|XM_—038336.2|[17477779]
• 1101: XM_—027181
  Homo sapiens transient receptor potential cation channel, subfamily V, member 4
  (TRPV4), mRNA
  gi|17475007|ref|XM_—027181.2|[17475007]
• 1102: XM_—047362
  Homo sapiens Glutamate receptor interacting protein (GRIP1), mRNA
  gi|17474492|ref|XM_—047362.3|[17474492]
• 1104: XM_—006372
  Homo sapiens aryl hydrocarbon receptor interacting protein (AIP), mRNA
  gi|17472888|ref|XM_—006372.4|[17472888]
• 1105: XM_—004893
  Homo sapiens receptor (calcitonin) activity modifying protein 3 (RAMP3), mRNA
  gi|17464777|ref|XM_—004893.4|[17464777]
• 1107: XM_—004559
  Homo sapiens discoidin domain receptor family, member 1 (DDR1), mRNA
  gi|17464405|ref|XM_—004559.5|[17464405]
• 1108: XM_—004237
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R), mRNA
  gi|17463326|ref|XM_—004237.4|[17463326]
• 1109: XM_—051214
  Homo sapiens type 1 tumor necrosis factor receptor shedding aminopeptidase regulator (ARTS-1), mRNA
  gi|17462792|ref|XM_—051214.2|[17462792]
• 1110: XM_—059645
  Homo sapiens neuropeptide Y receptor Y1 (NPY1R), mRNA
  gi|17462720|ref|XM_—059645.1|[17462720]
• 1111: XM_—044493
  Homo sapiens cholecystokinin B receptor (CCKBR), mRNA
  gi|17461537|ref|XM_—044493.2|[17461537]
• 1112: XM_—048562
  Homo sapiens interferon (alpha, beta and omega) receptor 1 (IFNAR1), mRNA
  gi|17460140|ref|XM_—048562.3|[17460140]
• 1113: XM_—040307
  Homo sapiens low density lipoprotein receptor defect B complementing (LDLB), mRNA
  gi|17459160|ref|XM_—040307.2|[17459160]
• 1114: XM_—046949
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C),
  mRNA
  gi|17457940|ref|XM_—046949.3|[17457940]
• 1115: XM_—050937
  Homo sapiens galanin receptor 1 (GALR1), mRNA
  gi|17457665|ref|XM_—050937.2|[17457665]
• 1116: XM_—058224
  Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
  gi|17457059|ref|XM_—058224.1|[17457059]
• 1117: XM_—059877
  Homo sapiens scavenger receptor cysteine rich domain containing, group B (4 domains) (SRCRB4D), mRNA
  gi|17452620|ref|XM_—059877.1|[17452620]
• 1118: XM_—030074
  Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), mRNA
  gi|17451624|ref|XM_—030074.2|[17451624]
• 1119: XM_—036899
  Homo sapiens paired immunoglobulin-like receptor alpha (PILR(ALPHA)), mRNA
  gi|17450024|ref|XM_—036899.2|[17450024]
• 1120: XM_—040292
  Homo sapiens glutamate receptor, ionotropic, AMPA 1 (GRIA1), mRNA
  gi|17447971|ref|XM_—040292.3|[17447971]
• 1121: XM_—003913
  Homo sapiens integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2), mRNA
  gi|17447767|ref|XM_—003913.5|[17447767]
• 1122: XM_—052621
  Homo sapiens VPS10 domain receptor protein (SORCS2), mRNA
  gi|17447359|ref|XM_—052621.2|[17447359]
• 1123: XM_—011186
  Homo sapiens platelet-derived growth factor receptor, alpha polypeptide (PDGFRA), mRNA
  gi|17446713|ref|XM_—011186.5|[17446713]
• 1124: XM_—037260
  Homo sapiens coagulation factor II (thrombin) receptor (F2R), mRNA
  gi|17446698|ref|XM_—037260.3|[17446698]
• 1125: XM_—068231
  Homo sapiens G protein-coupled receptor 78 (GPR78), mRNA
  gi|17446518|ref|XM_—068231.1|[17446518]
• 1126: XM_—003896
  Homo sapiens growth hormone receptor (GHR), mRNA
  gi|17446516|ref|XM_—003896.5|[17446516]
• 1127: XM_—003883
  Homo sapiens prolactin receptor (PRLR), mRNA
  gi|17446302|ref|XM_—003883.4|[17446302]
• 1128: XM_—003423
  Homo sapiens toll-like receptor 6 (TLR6), mRNA
  gi|17443462|ref|XM_—003423.5|[17443462]
• 1129: XM_—050674
  Homo sapiens kinase insert domain receptor (a type III receptor tyrosine kinase)
  (KDR), mRNA
  gi|17443063|ref|XM_—050674.2|[17443063]
• 1130: XM_—016537
  Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
  e receptor (LRP8), mRNA
  gi|17438001|ref|XM_—016537.4|[17438001]
• 1131: XM_—050512
  Homo sapiens activin A receptor, type I (ACVR1), mRNA
  gi|17437640|ref|XM_—050512.3|[17437640]
• 1132: XM_—011248
  Homo sapiens adrenergic, alpha-1B-, receptor (ADRA1B), mRNA
  gi|17437111|ref|XM_—011248.5|[17437111]
• 1133: XM_—057299
  Homo sapiens very large G protein-coupled receptor 1 (VLGR1), mRNA
  gi|17436651|ref|XM_—057299.2|[17436651]
• 1134: XM_—042825
  Homo sapiens luteinizing hormone/choriogonadotropin receptor (LHCGR), mRNA
  gi|17433844|ref|XM_—042825.3|[17433844]
• 1135: XM_—039993
  Homo sapiens fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1), mRNA
  gi|16188964|ref|XM_—039993.2|[16188964]
• 1136: XM_—028642
  Homo sapiens integrin, alpha 5 (fibronectin receptor, alpha polypeptide) (ITGA5), mRNA
  gi|16186750|ref|XM_—028642.2|[16186750]
• 1137: XM_—057337
  Homo sapiens cholinergic receptor, muscarinic 1 (CHRM1), mRNA
  gi|16184321|ref|XM_—057337.1|[16184321]
• 1138: XM_—006447
  Homo sapiens interleukin 10 receptor, alpha (IL10RA), mRNA
  gi|16183626|ref|XM_—006447.5|[16183626]
• 1139: XM_—057984
  Homo sapiens G protein-coupled receptor 51 (GPR51), mRNA
  gi|16181083|ref|XM_—057984.1|[16181083]
• 1140: XM_—057452
  Homo sapiens toll-like receptor 4 (TLR4), mRNA
  gi|16179752|ref|XM_—057452.1|[16179752]
• 1141: XM_—051505
  Homo sapiens opioid receptor, kappa 1 (OPRK1), mRNA
  gi|16179331|ref|XM_—051505.2|[16179331]
• 1142: XM_—027651
  Homo sapiens tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B),
  mRNA
  gi|16178146|ref|XM_—027651.2|[16178146]
• 1144: XM_—028141
  Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), mRNA
  gi|16176785|ref|XM_—028141.2|[16176785]
• 1145: XM_—004872
  Homo sapiens atrophin-1 interacting protein 1; activin receptor interacting protein 1 (KIAA0705), mRNA
  gi|16175845|ref|XM_—004872.6|[16175845]
• 1146: XM_—057372
  Homo sapiens tumor necrosis factor receptor superfamily, member 5 (TNFRSF5), mRNA
  gi|16174074|ref|XM_—057372.1|[16174074]
• 1147: XM_—056391
  Homo sapiens BAFF receptor (BAFFR), mRNA
  gi|16168558|ref|XM_—056391.1|[16168558]
• 1148: XM_—054949
  Homo sapiens transient receptor potential cation channel, subfamily V, member 2
  (TRPV2), mRNA
  gi|16165271|ref|XM_—054949.1|[16165271]
• 1149: XM_—009219
  Homo sapiens endothelial differentiation, G-protein-coupled receptor 6 (EDG6),
  mRNA
  gi|16163259|ref|XM_—009219.5|[16163259]
• 1150: XM_—057188
  Homo sapiens transient receptor potential cation channel, subfamily M, member 4
  (TRPM4), mRNA
  gi|16162857|ref|XM_—057188.1|[16162857]
• 1151: XM_—033762
  Homo sapiens growth factor receptor-bound protein 10 (GRB10), mRNA
  gi|16162156|ref|XM_—033762.2|[16162156]
• 1152: XM_—037256
  Homo sapiens protein tyrosine phosphatase, receptor type, N polypeptide 2 (PTPRN2), mRNA
  gi|16162004|ref|XM_—037256.2|[16162004]
• 1153: XM_—007662
  Homo sapiens transient receptor potential cation channel, subfamily M, member 1
  (TRPM1), mRNA
  gi|16161643|ref|XM_—007662.6|[16161643]
• 1154: XM_—011327
  Homo sapiens hepatitis A virus cellular receptor 1 (HAVCR-1), mRNA
  gi|16159892|ref|XM_—011327.4|[16159892]
• 1155: XM_—034331
  Homo sapiens endothelin receptor type A (EDNRA), mRNA
  gi|16158485|ref|XM_—034331.2|[16158485]
• 1156: XM_—002212
  Homo sapiens follicle stimulating hormone receptor (FSHR), mRNA
  gi|16158251|ref|XM_—002212.4|[16158251]
• 1157: XM_—003736
  Homo sapiens G protein-coupled receptor kinase 6 (GPRK6), mRNA
  gi|16157601|ref|XM_—003736.4|[16157601]
• 1158: XM_—038350
  Homo sapiens platelet-derived growth factor receptor, beta polypeptide (PDGFRB),
  mRNA
  gi|16157449|ref|XM_—038350.21[16157449]
• 1159: XM_—003789
  Homo sapiens colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R), mRNA
  gi|16157447|ref|XM_—003789.4|[16157447]
• 1160: XM_—054659
  Homo sapiens olfactory receptor, family 3, subfamily A, member 3 (OR3A3), mRNA
  gi|15314104|ref|XM_—054659.1|[15314104]
• 1161: XM_—054658
  Homo sapiens olfactory receptor, family 1, subfamily E, member 1 (OR1E1), mRNA
  gi|15314100|ref|XM_—054658.1|[15314100]
• 1162: XM_—006275
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 1 (MS4A2), mRNA
  gi|15311761|ref|XM_—006275.4|[15311761]
• 1163: XM_—012695
  Homo sapiens growth factor receptor-bound protein 7 (GRB7), mRNA
  gi|15310219|ref|XM_—012695.4|[15310219]
• 1164: XM_—045812
  Homo sapiens G protein-coupled receptor 72 (GPR72), mRNA
  gi|15308293|ref|XM_—045812.2|[15308293]
• 1165: XM_—033995
  Homo sapiens histamine H4 receptor (HRH4), mRNA
  gi|15305825|ref|XM_—033995.2|[15305825]
• 1166: XM_—036978
  Homo sapiens tumor necrosis factor receptor superfamily, member 11a, activator
  of NFKB (TNFRSF11A), mRNA
  gi|15305343|ref|XM_—036978.2|[15305343]
• 1167: XM_—015355
  Homo sapiens protein tyrosine phosphatase, receptor type, R (PTPRR), mRNA
  gi|15304370|ref|XM_—015355.2|[15304370]
• 1168: XM_—006738
  Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1 (CD36L1), mRNA
  gi|15303296|ref|XM_—006738.5|[15303296]
• 1169: XM_—049255
  Homo sapiens Fc fragment of IgE, low affinity II, receptor for (CD23A) (FCER2),
  mRNA
  gi|15302967|ref|XM_—049255.2|[15302967]
• 1170: XM_—008930
  Homo sapiens coagulation factor II (thrombin) receptor-like 3 (F2RL3), mRNA
  gi|15302724|ref|XM_—008930.4|[15302724]
• 1171: NT_—029418
  Homo sapiens chromosome 12 working draft sequence segment
  gi|15302021|ref|NT_—029418.1|Hs12_—29577[15302021]
• 1173: XM_—054004
  Homo sapiens glutamate receptor, metabotropic 1 (GRM1), mRNA
  gi|15299786|ref|XM_—054004.1|[15299786]
• 1174: XM_—046588
  Homo sapiens G protein-coupled receptor slt (SLT), mRNA
  gi|15299770|ref|XM_—046588.2|[15299770]
• 1175: XM_—032592
  Homo sapiens VPS10 domain receptor protein SORCS 3 (SORCS3), mRNA
  gi|15299687|ref|XM_—032592.2|[15299687]
• 1176: XM_—054157
  Homo sapiens G protein-coupled receptor 35 (GPR35), mRNA
  gi|15298180|ref|XM_—054157.1|[15298180]
• 1177: XM_—042907
  Homo sapiens bone morphogenetic protein receptor, type IB (BMPR1B), mRNA
  gi|15296528|ref|XM_—042907.2|[15296528]
• 1178: XM_—033031
  Homo sapiens peroxisome proliferative activated receptor, gamma, coactivator 1
  (PPARGC1), mRNA
  gi|15295682|ref|XM_—033031.2|[15295682]
• 1179: XM_—003708
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, pi (GABRP), mRNA
  gi|15294866|ref|XM_—003708.5|[15294866]
• 1180: XM_—008189
  Homo sapiens CMRF35 leukocyte immunoglobulin-like receptor (CMRF35), mRNA
  gi|14785569|ref|XM_—008189.4|[14785569]
• 1182: XM_—033305
  Homo sapiens lymphotoxin beta receptor (TNFR superfamily, member 3) (LTBR), mRNA
  gi|14784387|ref|XM_—033305.1|[14784387]
• 1183: XM_—004350
  Homo sapiens cannabinoid receptor 1 (brain) (CNR1), mRNA
  gi|14783266|ref|XM_—004350.4|[14783266]
• 1184: XM_—004285
  Homo sapiens peroxisome proliferative activated receptor, delta (PPARD), mRNA
  gi|14782955|ref|XM_—004285.4|[14782955]
• 1185: XM_—042636
  Homo sapiens inositol 1,4,5-triphosphate receptor, type 3 (ITPR3), mRNA
  gi|14782869|ref|XM_—042636.1|[14782869]
• 1187: XM_—050142
  Homo sapiens integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) (ITGAM), mRNA
  gi|14779440|ref|XM_—050142.1|[14779440]
• 1188: XM_—037826
  Homo sapiens adrenergic, beta, receptor kinase 2 (ADRBK2), mRNA
  gi|14777914|ref|XM_—037826.1|[14777914]
• 1189: XM_—036497
  Homo sapiens olfactory receptor, family 1, subfamily F, member 2 (OR1F2), mRNA
  gi|14777865|ref|XM_—036497.1|[14777865]
• 1190: XM_—036891
  Homo sapiens purinergic receptor P2X-like 1, orphan receptor (P2RXL1), mRNA
  gi|14777537|ref|XM_—036891.1|[14777537]
• 1191: XM_—007986
  Homo sapiens apolipoprotein B48 receptor (APOB48R), mRNA
  gi|14777420|ref|XM_—007986.4|[14777420]
• 1192: XM_—047456
  Homo sapiens melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) (MC1R), mRNA
  gi|14776693|ref|XM_—047456.1|[14776693]
• 1193: XM_—030214
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A),
  mRNA
  gi|14776459|ref|XM_—030214.1|[14776459]
• 1194: XM_—049959
  Homo sapiens chemokine (C-C motif) receptor 7 (CCR7), mRNA
  gi|14775963|ref|XM_—049959.1|[14775963]
• 1196: XM_—048049
  Homo sapiens G protein-coupled receptor 56 (GPR56), mRNA
  gi|14775189|ref|XM_—048049.1|[14775189]
• 1197: XM_—046488
  Homo sapiens glucagon receptor (GCGR), mRNA
  gi|14775175|ref|XM_—046488.1|[14775175]
• 1198: XM_—040635
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1), mRNA
  gi|14774341|ref|XM_—040635.1|[14774341]
• 1199: XM_—018451
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) (CHRNB1), mRNA
  gi|14773487|ref|XM_—018451.2|[14773487]
• 1201: XM_—008432
• Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), mRNA
• gi|14773206|ref|XM_—008432.4|[14773206]
• 1202: XM_—047339
  Homo sapiens opiate receptor-like 1 (OPRL1), mRNA
  gi|14772199|ref|XM_—047339.1|[14772199]
• 1203: XM_—006349
  Homo sapiens angiotensin receptor-like 1 (AGTRL1), mRNA
  gi|14771894|ref|XM_—006349.2|[14771894]
• 1204: XM_—046182
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 3 (P2RX3), mRNA
  gi|14771633|ref|XM_—046182.1|[14771633]
• 1205: XM_—006312
  Homo sapiens sortilin-related receptor, L (DLR class) A repeats-containing (SORL1), mRNA
  gi|14771251|ref|XM_—006312.4|[14771251]
• 1206: XM_—012936
  Homo sapiens protein tyrosine phosphatase, receptor type, T (PTPRT), mRNA
  gi|14770881|ref|XM_—012936.3|[14770881]
• 1207: XM_—040842
  Homo sapiens cullin 5 (CUL5), mRNA
  gi|14770334|ref|XM_—040842.1|[14770334]
• 1208: XM_—045103
  Homo sapiens G protein coupled receptor interacting protein, complement-c1q tumor necrosis factor-related (ZSIG37), mRNA
  gi|14770190|ref|XM_—045103.1|[14770190]
• 1209: XM_—040699
  Homo sapiens transient receptor potential cation channel, subfamily C, member 6
  (TRPC6), mRNA
  gi|14770156|ref|XM_—040699.1|[14770156]
• 1210: XM_—040922
  Homo sapiens interleukin 13 receptor, alpha 2 (IL13RA2), mRNA
  gi|14769890|ref|XM_—040922.1|[14769890]
• 1211: XM_—028854
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 4 (CHRNA4), mRNA
  gi|14769881|ref|XM_—028854.1|[14769881]
• 1212: XM_—028783
  Homo sapiens opioid growth factor receptor (OGFR), mRNA
  gi|14769761|ref|XM_—028783.1|[14769761]
• 1213: XM_—050577
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7 (ILT11), mRNA
  gi|14769454|ref|XM_—050577.1|[14769454]
• 1215: XM_—045929
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 4 (P2RX4), mRNA
  gi|14768232|ref|XM_—045929.1|[14768232]
• 1216: XM_—006929
  Homo sapiens complement component 3a receptor 1 (C3AR1), mRNA
  gi|14765892|ref|XM_—006929.2|[14765892]
• 1217: XM_—030897
  Homo sapiens angiotensin receptor 2 (AGTR2), mRNA
  gi|14765825|ref|XM_—030897.1|[14765825]
• 1218: XM_—037563
  Homo sapiens G protein-coupled receptor 54 (GPR54), mRNA
  gi|14765555|ref|XM_—037563.1|[14765555]
• 1219: XM_—045549
  Homo sapiens FGF receptor activating protein 1 (FRAG1), mRNA
  gi|4765112|ref|XM_—045549.1|[14765112]
• 1220: XM_—045706
  Homo sapiens toll-like receptor 8 (TLR8), mRNA
  gi|14764423|ref|XM_—045706.1|[14764423]
• 1221: XM_—013100
  Homo sapiens G protein-coupled receptor 34 (GPR34), mRNA
  gi|14764061|ref|XM_—013100.3|[14764061]
• 1222: XM_—012862
  Homo sapiens cargo selection protein (mannose 6 phosphate receptor binding protein) (TIP47), mRNA
  gi|14764025|ref|XM_—012862.3|[14764025]
• 1223: XM_—035037
  Homo sapiens low density lipoprotein receptor-related protein 4 (LRP4), mRNA
  gi|14763920|ref|XM_—035037.1|[14763920]
• 1224: XM_—050707
  Homo sapiens activin A receptor type II-like 1 (ACVRL1), mRNA
  gi|14763806|ref|XM_—050707.1|[14763806]
• 1225: XM_—036573
  Homo sapiens low density lipoprotein receptor-related protein 3 (LRP3), mRNA
  gi|14763070|ref|XM_—036573.1|[14763070]
• 1226: XM_—012843
  Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
  gi|14762603|ref|XM_—012843.3|[14762603]
• 1227: XM_—006789
  Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA
  gi|14762249|ref|XM_—006789.4|[14762249]
• 1229: XM_—034808
  Homo sapiens interleukin 1 receptor accessory protein-like 2 (IL1RAPL2), mRNA
  gi|14760985|ref|XM_—034808.1|[14760985]
• 1230: XM_—006747
  Homo sapiens inositol 1,4,5-triphosphate receptor, type 2 (ITPR2), mRNA
  gi|14760648|ref|XM_—006747.4|[14760648]
• 1231: XM_—015921
  Homo sapiens putative chemokine receptor; GTP-binding protein (HM74), mRNA
  gi|14760439|ref|XM_—015921.2|[14760439]
• 1232: XM_—009008
  Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 1 (EMR1), mRNA
  gi|14759169|ref|XM_—009008.4|[14759169]
• 1233: XM_—028274
  Homo sapiens prostaglandin 12 (prostacyclin) receptor (IP) (PTGIR), mRNA
  gi|14758807|ref|XM_—028274.1|[14758807]
• 1234: XM_—007123
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A), mRNA
  gi|14757796|ref|XM_—007123.4|[14757796]
• 1235: XM_—049518
  Homo sapiens intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
  (ICAM1), mRNA
  gi|14756651|ref|XM_—049518.1|[14756651]
• 1236: XM_—049496
  Homo sapiens purinergic receptor P2Y, G-protein coupled, 11 (P2RY11), mRNA
  gi|14756601|ref|XM_—049496.1|[14756601]
• 1237: XM_—007577
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 5 (CHRNA5), mRNA
  gi|14756537|ref|XM_—007577.2|[14756537]
• 1238: XM_—006636
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B),
  mRNA
  gi|14756111|ref|XM_—006636.4|[14756111]
• 1239: XM_—044309
  Homo sapiens poliovirus receptor (PVR), mRNA
  gi|14755769|ref|XM_—044309.1|[14755769]
• 1240: XM_—004134
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1E (HTR1E), mRNA
  gi|14755675|ref|XM_—004134.4|[14755675]
• 1241: XM_—033838
  Homo sapiens chemokine (C-C motif) receptor 6 (CCR6), mRNA
  gi|14755122|ref|XM_—033838.1|[14755122]
• 1242: XM_—031082
  Homo sapiens formyl peptide receptor-like 1 (FPRL1), mRNA
  gi|14754918|ref|XM_—031082.1|[14754918]
• 1243: XM_—028205
  Homo sapiens glucagon-like peptide 1 receptor (GLP1R), mRNA
  gi|14754205|ref|XM_—028205.1|[14754205]
• 1244: XM_—051710
  Homo sapiens prostaglandin E receptor 2 (subtype EP2), 53 kD (PTGER2), mRNA
  gi|14753577|ref|XM_—051710.1|[14753577]
• 1245: XM_—048918
  Homo sapiens met proto-oncogene (hepatocyte growth factor receptor) (MET), mRNA
  gi|14753543|ref|XM_—048918.1|[14753543]
• 1246: XM_—045352
  Homo sapiens receptor-interacting serine-threonine kinase 2 (RIPK2), mRNA
  gi|14751723|ref|XM_—045352.1|[14751723]
• 1247: XM_—049463
  Homo sapiens fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2,
  Pfeiffer syndrome) (FGFR1), mRNA
  gi|14750712|ref|XM_—049463.1|[14750712]
• 1248: XM_—033240
  Homo sapiens leukotriene b4 receptor (chemokine receptor-like 1) (LTB4R), mRNA
  gi|14750696|ref|XM_—033240.1|[14750696]
• 1249: XM_—046720
  Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 1 (GABRR1), mRNA
  gi|14750531|ref|XM_—046720.1|[14750531]
• 1250: XM_—050434
  Homo sapiens interferon gamma receptor 1 (IFNGR1), mRNA
  gi|14750131|ref|XM_—050434.1|[14750131]
• 1251: XM_—035832
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 3 (CHRNB3), mRNA
  gi|14749978|ref|XM_—035832.1|[14749978]
• 1252: XM_—034142
  Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor) (CD36), mRNA
  gi|14749875|ref|XM_—034142.1|[14749875]
• 1253: XM_—030066
  Homo sapiens growth hormone releasing hormone receptor (GHRHR), mRNA
  gi|14749610|ref|XM_—030066.1|[14749610]
• 1254: XM_—007383
  Homo sapiens G protein-coupled receptor 68 (GPR68), mRNA
  gi|14748827|ref|XM_—007383.2|[14748827]
• 1255: XM_—004117
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B), mRNA
  gi|14747779|ref|XM_—004117.2|[14747779]
• 1256: XM_—036123
  Homo sapiens transient receptor potential cation channel, subfamily M, member 3
  (TRPM3), mRNA
  gi|14743665|ref|XM_—036123.1|[14743665]
• 1257: XM_—011817
  Homo sapiens muscle, skeletal, receptor tyrosine kinase (MUSK), mRNA
  gi|14742818|ref|XM_—011817.3|[14742818]
• 1258: XM_—044653
  Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), mRNA
  gi|14741797|ref|XM_—044653.1|[14741797]
• 1259: XM_—033529
  Homo sapiens G protein-coupled receptor 85 (GPR85), mRNA
  gi|14741568|ref|XM_—033529.1|[14741568]
• 1260: XM_—011916
  Homo sapiens pancreatic polypeptide receptor 1 (PPYR1), mRNA
  gi|14740172|ref|XM_—011916.2|[14740172]
• 1261: XM_—005486
  Homo sapiens neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), mRNA
  gi|14740022|ref|XM_—005486.4|[14740022]
• 1262: XM_—042740
  Homo sapiens region containing Sulfonylurea receptor; KIAA1674 (LOC142781), mRNA
  gi|14739341|ref|XM_—042740.1|[14739341]
• 1263: XM_—045386
  Homo sapiens very low density lipoprotein receptor (VLDLR), mRNA
  gi|14736403|ref|XM_—045386.1|[14736403]
• 1264: XM_—004002
  Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), mRNA
  gi|14734503|ref|XM_—004002.4|[14734503]
• 1265: XM_—034451
  Homo sapiens olfactory receptor, family 7, subfamily A, member 120 (OR7E120), mRNA
  gi|14733406|ref|XM_—034451.1|[14733406]
• 1266: XM_—029284
  Homo sapiens cholecystokinin A receptor (CCKAR), mRNA
  gi|14733138|ref|XM_—029284.1|[14733138]
• 1267: XM_—052171
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 4 (HTR4), mRNA
  gi|14732310|ref|XM_—052171.1|[14732310]
• 1268: XM_—042695
  Homo sapiens fibroblast growth factor receptor-like 1 (FGFRL1), mRNA
  gi|14728655|ref|XM_—042695.1|[14728655]
• 1269: XM_—041933
  Homo sapiens Ig superfamily receptor LNIR (LNIR), mRNA
  gi|14723974|ref|XM_—041933.1|[14723974]
• 1270: XM_—032738
  Homo sapiens glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man
  syndrome) (GLRA1), mRNA
  gi|14722750|ref|XM_—032738.1|[14722750]
• 1271: XM_—032682
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 6 (GABRA6), mRNA
  gi|14722636|ref|XM_—032682.1|[14722636]
• 1272: XM_—017228
  Homo sapiens low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) (LRP1), mRNA
  gi|13654580|ref|XM_—017228.1|[13654580]
• 1273: XM_—008538
  Homo sapiens aryl hydrocarbon receptor interacting protein-like 1 (AIPL1), mRNA
  gi|13653245|ref|XM_—008538.3|[13653245]
• 1274: XM_—007046
  Homo sapiens vitamin D (1,25-dihydroxyvitamin D3) receptor (VDR), mRNA
  gi|13653215|ref|XM_—007046.3|[13653215]
• 1275: XM_—007751
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), mRNA
  gi|13653090|ref|XM_—007751.3|[13653090]
• 1276: XM_—007719
  Homo sapiens paired basic amino acid cleaving enzyme (furin, membrane associated
  receptor protein) (PACE), mRNA
  gi|1365250|ref|XM_—007719.2|[13652501]
• 1277: XM_—010296
  Homo sapiens transient receptor potential cation channel, subfamily C, member 5
  (TRPC5), mRNA
  gi|13652451|ref|XM_—010296.2|[13652451]
• 1278: XM_—006950
  Homo sapiens tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A),
  mRNA
  gi|13652420|ref|XM_—006950.3|[13652420]
• 1279: XM_—008206
  Homo sapiens receptor (calcitonin) activity modifying protein 2 (RAMP2), mRNA
  gi|13652390|ref|XM_—008206.3|[13652390]
• 1280: XM_—013114
  Homo sapiens interleukin 1 receptor accessory protein-like 1 (IL1RAPL1), mRNA
  gi|13652318|ref|XM_—013114.2|[13652318]
• 1281: XM_—015989
  Homo sapiens interleukin 9 receptor (IL9R), mRNA
  gi|13652206|ref|XM_—015989.1|[13652206]
• 1282: XM_—006934
  Homo sapiens arginine vasopressin receptor 1A (AVPR1A), mRNA
  gi|13652044|ref|XM_—006934.3|[13652044]
• 1283: XM_—012441
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 5 (GABRA5), mRNA
  gi|13651536|ref|XM_—012441.2|[13651536]
• 1284: XM_—008193
  Homo sapiens putative receptor protein (PMI), mRNA
  gi|13650873|ref|XM_—008193.2|[13650873]
• 1285: XM_—009108
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2D (GRIN2D),
  mRNA
  gi|13650682|ref|XM_—009108.3|[13650682]
• 1286: XM_—015505
  Homo sapiens AXL receptor tyrosine kinase (AXL), mRNA
  gi|13650099|ref|XM_—015505.1|[13650099]
• 1287: XM_—006145
  Homo sapiens dopamine receptor D4 (DRD4), mRNA
  gi|13647063|ref|XM_—006145.2|[13647063]
• 1288: XM_—009803
  Homo sapiens transient receptor potential cation channel, subfamily M, member 2
  (TRPM2), mRNA
  gi|13646881|ref|XM_—009803.3|[13646881]
• 1289: XM_—004030
  Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA
  gi|13645597|ref|XM_—004030.2|[13645597]
• 1290: XM_—011703
  Homo sapiens tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A),
  mRNA
  gi|13644652|ref|XM_—011703.2|[13644652]
• 1291: XM_—003986
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 2 (GABRG2), mRNA
  gi|13643024|ref|XM_—003986.2|[13643024]
• 1292: XM_—004253
  Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 2 (GABRR2), mRNA
  gi|13642452|ref|XM_—004253.2|[13642452]
• 1293: XM_—006233
  Homo sapiens glutamate receptor, ionotrophic, AMPA 4 (GRIA4), mRNA
  gi|13639643|ref|XM_—006233.3|[13639643]
• 1294: XM_—005384
  Homo sapiens RAR-related orphan receptor B (RORB), mRNA
  gi|13639481|ref|XM_—005384.3|[13639481]
• 1295: XM_—004988
  Homo sapiens aryl hydrocarbon receptor (AHR), mRNA
  gi|13631520|ref|XM_—004988.2|[13631520]
• 1296: XM_—011364
  Homo sapiens lymphocyte antigen 95 (activating NK-receptor; NK-p44) (LY95), mRNA
  gi|3630600|ref|XM_—011364.2|[13630600]
• 1297: XM_—009612
  Homo sapiens neurotensin receptor 1 (high affinity) (NTSR1), mRNA
  gi|13630500|ref|XM_—009612.2|[13630500]
• 1298: XM_—003417
  Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) (CD36L2), mRNA
  gi|13630130|ref|XM_—003417.3|[13630130]
• 1299: XM_—007817
  Homo sapiens tumor necrosis factor receptor superfamily, member 17 (TNFRSF17),
  mRNA
  gi|13627219|ref|XM_—007817.3|[13627219]
• 1300: XM_—012949
  Homo sapiens complement component 1, q subcomponent, receptor 1 (C1QR1), mRNA
  gi|12742414|ref|XM_—012949.1|[12742414]
• 1301: XM_—009594
  Homo sapiens somatostatin receptor 4 (SSTR4), mRNA
  gi|12742412|ref|XM_—009594.2|[12742412]
• 1302: XM_—008512
  Homo sapiens vanilloid receptor subtype 1 (VR1), mRNA
  gi|12740624|ref|XM_—008512.2|[12740624]
• 1303: XM_—006931
  Homo sapiens oxidised low density lipoprotein (lectin-like) receptor 1 (OLR1),
  mRNA
  gi|12737735|ref|XM_—006931.2|[12737735]
• 1304: XM_—006933
  Homo sapiens C-type lectin-like receptor-1 (LOC51267), mRNA
  gi|12737731|ref|XM_—006933.2|[12737731]
• 1305: XM_—004438
  Homo sapiens interleukin 20 receptor, alpha (IL20RA), mRNA
  gi|12732139|ref|XM_—004438.2|[12732139]
• 1306: XM_—003692
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1A (HTR1A), mRNA
  gi|12731011|ref|XM_—003692.2|[12731011]
• 1307: XM_—010228
  Homo sapiens G protein-coupled receptor 50 (GPR50), mRNA
  gi|12719157|ref|XM_—010228.2|[12719157]
• 1308: XM_—009082
  Homo sapiens low density lipoprotein receptor (familial hypercholesterolemia) (LDLR), mRNA
  gi|1525992|ref|XM_—009082.1|[11525992]
• 1309: XM_—006296
  Homo sapiens cholinergic receptor, muscarinic 4 (CHRM4), mRNA
  gi|11437838|ref|XM_—006296.1|[11437838]
• 1310: NT_—009784
  Homo sapiens chromosome 12 working draft sequence segment
  gi|11436706|ref|NT_—009784.1|Hs12_—9941[11436706] ¹³¹I: XM_—003386
  Homo sapiens gonadotropin-releasing hormone receptor (GNRHR), mRNA
  gi|11435615|ref|XM_—003386.1|[11435615]
• 1312: NT_—024131
  Homo sapiens chromosome 10 working draft sequence segment
  gi|11430625|ref|NT_—024131.1|Hs10_—24287[11430625]
• 1313: XM_—009373
  Homo sapiens formyl peptide receptor-like 2 (FPRL2), mRNA
  gi|11426996|ref|XM_—009373.1|[11426996]
• 1314: XM_—008520
  Homo sapiens cholinergic receptor, nicotinic, epsilon polypeptide (CHRNE), mRNA
  gi|11426945|ref|XM_—008520.1|[11426945]
• 1315: XM_—009140
  Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA
  gi|11425489|ref|XM_—009140.1|[11425489]
• 1316: XM_—008279
  Homo sapiens adenosine A2b receptor (ADORA2B), mRNA
  gi|11425432|ref|XM_—008279.1|[11425432]
• 1317: XM_—010321
  Homo sapiens glycine receptor, alpha 2 (GLRA2), mRNA
  gi|11421007|ref|XM_—010321.1|[11421007]
• 1318: XM_—004808
  Homo sapiens taste receptor, type 2, member 4 (TAS2R4), mRNA
  gi|11420322|ref|XM_—004808.1|[11420322]
• 1319: XM_—004807
  Homo sapiens taste receptor, type 2, member 5 (TAS2R5), mRNA
  gi|11420320|ref|XM_—004807.1|[11420320]
• 1320: XM_—011092
  Homo sapiens glycine receptor, alpha 3 (GLRA3), mRNA
  gi|18556859|ref|XM_—011092.4|[18556859]
• 1321: XM_—003324
  Homo sapiens transient receptor potential cation channel, subfamily C, member 3
  (TRPC3), mRNA
  gi|18556760|ref|XM_—003324.5|[18556760]
• 1322: XM_—011068
  Homo sapiens macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
  (MST1R), mRNA
  gi|18556611|ref|XM_—011068.4|[18556611]
• 1323: XM_—011064
  Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
  gi|18556526|ref|XM_—011064.7|[18556526]
• 1324: XM_—003207
  Homo sapiens glutamate receptor, metabotropic 2 (GRM2), mRNA
  gi|18556346|ref|XM_—003207.5|[18556346]
• 1325: XM_—036436
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP), mRNA
  gi|18555803|ref|XM_—036436.4|[18555803]
• 1326: XM_—031246
  Homo sapiens roundabout, axon guidance receptor, homolog 2 (Drosophila) (ROBO2),
  mRNA
  gi|18555796|ref|XM_—031246.2|[18555796]
• 1327: XM_—003226
  Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA
  gi|18555693|ref|XM_—003226.7|[18555693]
• 1328: NT_—005824
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18555677|ref|NT_—005824.7|Hs3_—5981[18555677]
• 1329: XM_—093692
  Homo sapiens RYK receptor-like tyrosine kinase (RYK), mRNA
  gi|18555675|ref|XM_—093692.1|[18555675]
• 1332: NT_—005564
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18555104|ref|NT_—005564.8|Hs3_—5721[18555104]
• 1333: XM_—010943
  Homo sapiens inositol 1,4,5-triphosphate receptor, type 1 (ITPR1), mRNA
  gi|18554594|ref|XM_—010943.7|[18554594]
• 1334: XM_—052730
  Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA
  gi|18553906|ref|XM_—052730.3|[18553906]
• 1335: XM_—032666
  Homo sapiens calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) (CASR), mRNA
  gi|18553576|ref|XM_—032666.3|[18553576]
• 1336: XM_—002686
  Homo sapiens interleukin 1 receptor, type I (IL1R1), mRNA
  gi|18553052|ref|XM_—002686.6|[18553052]
• 1337: XM_—002596
  Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
  gi|18552617|ref|XM_—002596.6|[18552617]
• 1338: XM_—087110
  Homo sapiens macrophage receptor with collagenous structure (MARCO), mRNA
  gi|18552038|ref|XM_—087110.1|[18552038]
• 1340: XM_—087047
  Homo sapiens G protein-coupled receptor 66 (GPR66), mRNA
  gi|18551251|ref|XM_—087047.1|[18551251]
• 1341: XM_—086954
  Homo sapiens G protein-coupled receptor 45 (GPR45), mRNA
  gi|18549982|ref|XM_—086954.1|[18549982]
• 1342: XM_—029434
  Homo sapiens toll-like receptor 5 (TLR5), mRNA
  gi|18549454|ref|XM_—029434.2|[18549454]
• 1344: XM_—089355
  Homo sapiens LDL receptor adaptor protein (ARH), mRNA
  gi|18549097|ref|XM_—089355.1|[18549097]
• 1346: XM_—086483
  Homo sapiens Fc fragment of IgG, low affinity IIa, receptor for (CD32) (FCGR2A),
  mRNA
  gi|18548731|ref|XM_—086483.1|[18548731]
• 1347: XM_—046751
  Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
  interacting protein (liprin), alpha 4 (PPFIA4), mRNA
  gi|18548679|ref|XM_—046751.3|[18548679]
• 1348: XM_—001821
  Homo sapiens glutamate receptor, ionotropic, kainate 3 (GRIK3), mRNA
  gi|18548332|ref|XM_—001821.7|[18548332]
• 1349: XM_—002205
  Homo sapiens colony stimulating factor 3 receptor (granulocyte) (CSF3R), mRNA
  gi|18548330|ref|XM_—002205.2|[18548330]
• 1350: XM_—033690
  Homo sapiens protein tyrosine phosphatase, receptor type, U (PTPRU), mRNA
  gi|18548204|ref|XM_—033690.2|[18548204]
• 1351: XM_—001795
  Homo sapiens lamin B receptor (LBR), mRNA
  gi|18548051|ref|XM_—001795.6|[18548051]
• 1352: XM_—058179
  Homo sapiens natural killer cell receptor 2B4 (CD244), mRNA
  gi|18547600|ref|XM_—058179.3|[18547600]
• 1353: XM_—086356
  Homo sapiens cannabinoid receptor 2 (macrophage) (CNR2), mRNA
  gi|18547399|ref|XM_—086356.1|[18547399]
• 1354: XM_—001499
  Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1), mRNA
  gi|18547249|ref|XM_—001499.1|[18547249]
• 1355: NT_—031737
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18547126|ref|NT_—031737.1|Hs1_—31908[18547126]
• 1356: XM_—010608
  Homo sapiens G-protein coupled receptor 88 (GPR88), mRNA
  gi|18547116|ref|XM_—010608.6|[18547116]
• 1357: XM_—089029
  Homo sapiens olfactory receptor, family 2, subfamily L, member 2 (OR2L2), mRNA
  gi|18547000|ref|XM_—089029.1|[18547000]
• 1358: XM_—089028
  Homo sapiens olfactory receptor, family 2, subfamily L, member 1 (OR2L1), mRNA
  gi|18546996|ref|XM_—089028.1|[18546996]
• 1359: XM_—089016
  Homo sapiens olfactory receptor, family 1, subfamily C, member 1 (OR1C1), mRNA
  gi|18546895|ref|XM_—089016.1|[18546895]
• 1360: XM_—001289
  Homo sapiens xenotropic and polytropic retrovirus receptor (XPR1), mRNA
  gi|18546688|ref|XM_—001289.7|[18546688]
• 1361: XM_—049849
  Homo sapiens tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14), mRNA
  gi|18546661|ref|XM_—049849.3|[18546661]
• 1362: XM_—001667
  Homo sapiens natural killer cell receptor, immunoglobulin superfamily member (BY55), mRNA
  gi|18546631|ref|XM_—001667.5|[18546631]
• 1364: XM_—086285
  Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6),
  mRNA
  gi|18546477|ref|XM_—086285.1|[18546477]
• 1365: XM_—016748
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), mRNA
  gi|18546353|ref|XM_—016748.4|[18546353]
• 1366: XM_—088942
  Homo sapiens olfactory receptor, family 2, subfamily M, member 4 (OR2M4), mRNA
  gi|18546222|ref|XM_—088942.1|[18546222]
• 1367: XM_—086242
  Homo sapiens receptor tyrosine kinase-like orphan receptor 1 (ROR1), mRNA
  gi|18546174|ref|XM_—086242.1|[18546174]
• 1368: XM_—086232
  Homo sapiens G protein-coupled receptor 61 (GPR61), mRNA
  gi|18546070|ref|XM_—086232.1|[18546070]
• 1369: XM_—042739
  Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog,
  Drosophila) (CELSR2), mRNA
  gi|18546045|ref|XM_—042739.2|[18546045]
• 1370: XM_—002008
  Homo sapiens complement component (3d/Epstein Barr virus) receptor 2 (CR2), mRNA
  gi|18545768|ref|XM_—002008.6|[18545768]
• 1371: XM_—052013
  Homo sapiens polymeric immunoglobulin receptor (PIGR), mRNA
  gi|18545758|ref|XM_—052013.2|[18545758]
• 1372: XM_—001320
  Homo sapiens low density lipoprotein receptor defect C complementing (LDLC), mRNA
  gi|18545223|ref|XM_—001320.4|[18545223]
• 1373: NT_—030585
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18544898|ref|NT_—030585.2|Hs1_—30841[18544898]
• 1374: XM_—084053
  Homo sapiens complement component (3b/4b) receptor 1, including Knops blood group system (CR1), mRNA
  gi|18544845|ref|XM_—084053.1|[18544845]
• 1376: XM_—039685
  Homo sapiens putative G-protein coupled receptor (SH120), mRNA
  gi|17488963|ref|XM_—039685.3|[17488963]
• 1377: XM_—001687
  Homo sapiens adenosine A1 receptor (ADORA1), mRNA
  gi|17488879|ref|XM_—001687.5|[17488879]
• 1378: XM_—002700
  Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 2 like (COX7A2L), mRNA
  gi|17462137|ref|XM_—002700.3|[17462137]
• 1379: XM_—002673
  Homo sapiens calcitonin receptor-like (CALCRL), mRNA
  gi|17447546|ref|XM_—002673.5|[17447546]
• 1380: XM_—001924
  Homo sapiens transforming growth factor, beta receptor III (betaglycan, 300 kD)
  (TGFBR3), mRNA
  gi|17446897|ref|XM_—001924.6|[17446897]
• 1381: XM_—001744
  Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), mRNA
  gi|17444362|ref|XM_—001744.6|[17444362]
• 1382: XM_—054837
  Homo sapiens tumor necrosis factor receptor superfamily, member 1B, (TNFRSF1B),
  mRNA
  gi|17444359|ref|XM_—054837.2|[17444359]
• 1383: XM_—037011
  Homo sapiens T-cell receptor interacting molecule (TRIM), mRNA
  gi|17438759|ref|XM_—037011.2|[17438759]
• 1384: NT_—022773
  Homo sapiens chromosome 4 working draft sequence segment
  gi|17438611|ref|NT_—022773.6|Hs4_—22929[17438611]
• 1385: XM_—051522
  Homo sapiens G protein-coupled receptor (RDC1), mRNA
  gi|17437231|ref|XM_—051522.2|[17437231]
• 1386: NT_—029249
  Homo sapiens chromosome 2 working draft sequence segment
  gi|17436701|ref|NT_—029249.2|Hs2_—29408[17436701]
• 1387: XM_—050043
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 4 (GABRA4), mRNA
  gi|17436698|ref|XM_—050043.2|[17436698]
• 1388: XM_—001857
  Homo sapiens platelet-activating factor receptor (PTAFR), mRNA
  gi|17435918|ref|XM_—001857.3|[17435918]
• 1389: XM_—001630
  Homo sapiens prostaglandin F receptor (FP) (PTGFR), mRNA
  gi|17434349|ref|XM_—001630.5|[17434349]
• 1390: XM_—058183
  Homo sapiens activating NK receptor (KALI), mRNA
  gi|16165765|ref|XM_—058183.1|[16165765]
• 1391: XM_—003177
  Homo sapiens oxytocin receptor (OXTR), mRNA
  gi|16164840|ref|XM_—003177.5|[16164840]
• 1392: XM_—001778
  Homo sapiens ryanodine receptor 2 (cardiac) (RYR2), mRNA
  gi|16161568|ref|XM_—001778.6|[16161568]
• 1393: XM_—039118
  Homo sapiens phospholipase A2 receptor 1, 180 kD (PLA2R1), mRNA
  gi|16160858|ref|XM_—039118.2|[16160858]
• 1394: NT_—005791
  Homo sapiens chromosome 3 working draft sequence segment
  gi|16159942|ref|NT_—005791.5|Hs3_—5948[16159942]
• 1395: NT_—029941
  Homo sapiens chromosome 3 working draft sequence segment
  gi|16158541|ref|NT_—029941.1|Hs3_—30196[16158541]
• 1396: XM_—056760
  Homo sapiens tumor necrosis factor receptor superfamily, member 9 (TNFRSF9), mRNA
  gi|16158007|ref|XM_—056760.1|[16158007]
• 1397: XM_—010871
  Homo sapiens adrenergic, alpha-2B-, receptor (ADRA2B), mRNA
  gi|16157882|ref|XM_—010871.5|[16157882]
• 1398: XM_—055737
  Homo sapiens interleukin 6 receptor (IL6R), mRNA
  gi|16157271|ref|XM_—055737.1|[16157271]
• 1399: XM_—043563
  Homo sapiens insulin receptor-related receptor (INSRR), mRNA
  gi|15299156|ref|XM_—043563.2|[15299156]
• 1400: XM_—001466
  Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), mRNA
  gi|15299050|ref|XM_—001466.5|[15299050]
• 1401: XM_—002888
  Homo sapiens activin A receptor, type IIB (ACVR2B), mRNA
  gi|15298060|ref|XM_—002888.3|[15298060]
• 1402: XM_—049427
  Homo sapiens interleukin 5 receptor, alpha (IL5RA), mRNA
  gi|15297287|ref|XM_—049427.2|[15297287]
• 1404: XM_—047502
  Homo sapiens chemokine (C-X3-C) receptor 1 (CX3CR1), mRNA
  gi|15295593|ref|XM_—047502.2|[15295593]
• 1405: XM_—041048
  Homo sapiens chemokine (C-C motif) receptor 8 (CCR8), mRNA
  gi|15295589|ref|XM_—041048.2|[15295589]
• 1406: XM_—052155
  Homo sapiens adenosine A3 receptor (ADORA3), mRNA
  gi|14739381|ref|XM_—052155.1|[14739381]
• 1407: XM_—002926
  Homo sapiens chemokine (C-C motif) receptor-like 2 (CCRL2), mRNA
  gi|14736663|ref|XM_—002926.3|[14736663]
• 1408: XM_—030397
  Homo sapiens chemokine (C-C motif) receptor 5 (CCR5), mRNA
  gi|14736645|ref|XM_—030397.1|[14736645]
• 1409: XM_—040605
  Homo sapiens interleukin 17B receptor (IL17BR), mRNA
  gi|14735848|ref|XM_—040605.1|[14735848]
• 1410: XM_—033199
  Homo sapiens growth hormone secretagogue receptor (GHSR), mRNA
  gi|14735283|ref|XM_—003199.4|[14735283]
• 1411: XM_—041399
  Homo sapiens glutamate receptor, metabotropic 7 (GRM7), mRNA
  gi|14734683|ref|XM_—041399.1|[14734683]
• 1412: XM_—039011
  Homo sapiens integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (ITGA4), mRNA
  gi|14733147|ref|XM_—039011.1|[14733147]
• 1413: XM_—033709
  Homo sapiens opioid receptor, delta 1 (OPRD1), mRNA
  gi|14732044|ref|XM_—033709.1|[14732044]
• 1414: XM_—033469
  Homo sapiens transforming growth factor, beta receptor II (70-80 kD) (TGFBR2), mRNA
  gi|14732004|ref|XM_—033469.1|[14732004]
• 1415: XM_—017782
  Homo sapiens ectodysplasin 1, anhidrotic receptor (EDAR), mRNA
  gi|14731094|ref|XM_—017782.2|[14731094]
• 1416: XM_—002475
  Homo sapiens insulin receptor substrate 1 (IRS1), mRNA
  gi|14730385|ref|XM_—002475.4|[14730385]
• 1417: XM_—051470
  Homo sapiens angiotensin receptor 1 (AGTR1), mRNA
  gi|14729512|ref|XM_—051470.1|[14729512]
• 1418: XM_—001542
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1D (HTR1D), mRNA
  gi|14726872|ref|XM_—001542.4|[14726872]
• 1419: XM_—052382
  Homo sapiens histamine receptor H1 (HRH1), mRNA
  gi|14726259|ref|XM_—052382.1|[14726259]
• 1420: XM_—032349
  Homo sapiens interleukin 22 receptor (IL22R), mRNA
  gi|14725224|ref|XM_—032349.1|[14725224]
• 1421: XM_—002792
  Homo sapiens APMCF1 protein (APMCF1), mRNA
  gi|14720925|ref|XM_—002792.4|[14720925]
• 1422: XM_—045070
  Homo sapiens immunoglobulin superfamily receptor translocation associated 2 (IRTA2), mRNA
  gi|14720460|ref|XM_—045070.1|[14720460]
• 1423: XM_—045067
  Homo sapiens immunoglobulin superfamily receptor translocation associated 1 (IRTA1), mRNA
  gi|14720452|ref|XM_—045067.1|[14720452]
• 1425: XM_—002685
  Homo sapiens interleukin 1 receptor-like 2 (IL1RL2), mRNA
  gi|12728885|ref|XM_—002685.2|[12728885]
• 1426: XM_—002624
  Homo sapiens G protein-coupled receptor 75 (GPR75), mRNA
  gi|11430331|ref|XM_—002624.1|[11430331]
• 1427: XM_—001907
  Homo sapiens G protein-coupled receptor 25 (GPR25), mRNA
  gi|11425714|ref|XM_—001907.1|[11425714]
• 1428: XM_—001543
  Homo sapiens G protein-coupled receptor 52 (GPR52), mRNA
  gi|11423045|ref|XM_—001543.1|[11423045]
• 1429: NM_—016113
  Homo sapiens transient receptor potential cation channel, subfamily V, member 2
  (TRPV2), mRNA
  gi|7706766|ref|NM_—016113.1|[7706766]
• 1430: NM_—002837
  Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA
  gi|18491009|ref|NM_—002837.2|[18491009]
• 1431: NM_—017625
  Homo sapiens intelectin (ITLN), mRNA
  gi|8923027|ref|NM_—017625.1|[8923027]
• 1432: NM_—000651
  Homo sapiens complement component (3b/4b) receptor 1, including Knops blood group system (CR1), transcript variant S, mRNA
  gi|18490997|ref|NM_—000651.2|[18490997]
• 1433: NM_—000573
  Homo sapiens complement component (3b/4b) receptor 1, including Knops blood group system (CR1), transcript variant F, mRNA
  gi|18490996|ref|NM_—000573.2|[18490996]
• 1435: BC022501
  Homo sapiens, neurotensin receptor 2, clone MGC:26447 IMAGE:4792730, mRNA, complete cds
  gi|18490911|gb|BC022501.1)[18490911]
• 1436: BC022447
  Homo sapiens, angiotensin receptor 1, clone MGC:25987 IMAGE:4799755, mRNA, complete cds
  gi|18490885|gb|BC022447.1|[18490885]
• 1437: BC022317
  Homo sapiens, T cell receptor delta diversity 3, clone MGC:22624 IMAGE:4732634, mRNA, complete cds
  gi|18490613|gb|BC022317.1|[18490613]
• 1438: BC022304
  Homo sapiens, receptor (calcitonin) activity modifying protein 3, clone MGC:22548 IMAGE:4717934, mRNA, complete cds
  gi|18490610|gb|BC022304.1|[18490610]
• 1439: BC022496
  Homo sapiens, glutamate receptor, metabotropic 3, clone MGC:26392 IMAGE:4792430,
  mRNA, complete cds
  gi|18490393|gb|BC022496.1|[18490393]
• 1440: BC022511
  Homo sapiens, endothelin receptor type A, clone MGC:26548 IMAGE:4812050, mRNA,
  complete cds
  gi|18490297|gb|BC022511.1|[18490297]
• 1441: BC022502
  Homo sapiens, glycine receptor, beta, clone IMAGE:4792516, mRNA
  gi|18490294|gb|BC022502.1|[18490294]
• 1442: BC022449
  Homo sapiens, gamma-aminobutyric acid (GABA) A receptor, beta 1, clone MGC:25991
  IMAGE:4797401, mRNA, complete cds
  gi|18490266|gb|BC022449.1|[18490266]
• 1443: BC022295
  Homo sapiens, oxidised low density lipoprotein (lectin-like) receptor 1, clone
  MGC:22491 IMAGE:4722086, mRNA, complete cds
  gi|18490152|gb|BC022295.1|[18490152]
• 1444: BC022279
  Homo sapiens, CMRF35 leukocyte immunoglobulin-like receptor, clone MGC:22395 IMAGE:4692025, mRNA, complete cds
  gi|18490142|gb|BC022279.1|[18490142]
• 1448: AH011463
  Homo sapiens chromosome 7 map 7q22
  gi|18483169|gb|AH011463.1|SEG_AF461188S[18483169]
• 1449: AF453828
  Homo sapiens G protein-coupled receptor affecting testicular descent (GREAT) mRNA, complete cds
  gi|18483167|gb|AF453828.1|[18483167]
• 1450: AY072912
  Homo sapiens coxsackie-adenovirus-receptor isoform CAR4/7 (CXADR) mRNA, complete
  cds; alternatively spliced
  gi|18482481|gb|AY072912.1|[18482481]
• 1451: AY072911
  Homo sapiens coxsackie-adenovirus-receptor isoform CAR3/7 (CXADR) mRNA, complete
  cds; alternatively spliced
  gi|18482479|gb|AY072911.1|[18482479]
• 1452: AY072910
  Homo sapiens soluble coxsackie-adenovirus-receptor isoform CAR2/7 (CXADR) mRNA,
  complete cds; alternatively spliced
  gi|18482477|gb|AY072910.1|[18482477]
• 1453: NM_—020399
  Homo sapiens PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10 (PIST), mRNA
  gi|9966876|ref|NM_—020399.1|[9966876]
• 1454: NM_—017935
  Homo sapiens hypothetical protein FLJ20706 (BANK), mRNA
  gi|8923635|ref|NM_—017935.1|[8923635]
• 1455: NM_—002438
  Homo sapiens mannose receptor, C type 1 (MRC1), mRNA
  gi|4505244|ref|NM_—002438.1|[4505244]
• 1456: AF321913
  Homo sapiens histamine H3 receptor isoform 4 (HRH3) mRNA, complete cds, alternatively spliced
  gi|18461386|gb|AF321913.1|[18461386]
• 1457: AF321912
  Homo sapiens histamine H3 receptor isoform 3 (HRH3) mRNA, complete cds, alternatively spliced
  gi|18461384|gb|AF321912.1|[18461384]
• 1458: AF321911
  Homo sapiens histamine H3 receptor isoform 2 (HRH3) mRNA, complete cds, alternatively spliced
  gi|18461382|gb|AF321911.1|[18461382]
• 1459: AF321910
  Homo sapiens histamine H3 receptor isoform 1 (HRH3) mRNA, complete cds, alternatively spliced
  gi|18461380|gb|AF321910.1|[18461380]
• 1460: NM_—080841
  Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
  variant 3, mRNA
  gi|18450370|ref|NM_—080841.1|[18450370]
• 1461: NM_—080840
  Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
  variant 2, mRNA
  gi|18450368|ref|NM_—080840.1|[18450368]
• 1462: NM_—002836
  Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
  variant 1, mRNA
  gi|18450367|ref|NM_—002836.2|[18450367]
• 1463: NM_—023915
  Homo sapiens G protein-coupled receptor 87 (GPR87), mRNA
  gi|13236505|ref|NM_—023915.1|[13236505]
• 1464: NM_—003029
  Homo sapiens SHC (Src homology 2 domain containing) transforming protein 1 (SHC1), mRNA
  gi|10835030|ref|NM_—003029.1|[10835030]
• 1465: NM_—018490
  Homo sapiens G protein-coupled receptor 48 (GPR48), mRNA
  gi|8923700|ref|NM_—018490.1|[8923700]
• 1466: NM_—006065
  Homo sapiens signal-regulatory protein beta 1 (SIRPB1), mRNA
  gi|5174678|ref|NM_—006065.1|[5174678]
• 1467: NM_—003667
  Homo sapiens G protein-coupled receptor 49 (GPR49), mRNA
  gi|4504378|ref|NM_—003667.1|[4504378]
• 1468: NM_—080816
  Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 2, mRNA
  gi|18426908|ref|NM_—080816.1|[18426908]
• 1469: NM_—018556
  Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 1, mRNA
  gi|18426907|ref|NM_—018556.2|[18426907]
• 1470: NM_—080914
  Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant 3, mRNA
  gi|18426876|ref|NM_—080914.1|[18426876]
• 1471: NM_—080913
  Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant 2, mRNA
  gi|18426874|ref|NM_—080913.1|[18426874]
• 1472: NM_—080912
  Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant H2′, mRNA
  gi|18426872|ref|NM_—080912.1|[18426872]
• 1473: NM_—001181
  Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant 1, mRNA
  gi|18426871|ref|NM_—001181.2|[18426871]
• 1474: NM_—001671
  Homo sapiens asialoglycoprotein receptor 1 (ASGR1), mRNA
  gi|18426870|ref|NM_—001671.2|[18426870]
• 1475: NM_—014978
  Homo sapiens VPS10 domain receptor protein SORCS 3 (SORCS3), mRNA
  gi|18379345|ref|NM_—014978.1|[18379345]
• 1476: NM_—021625
  Homo sapiens transient receptor potential cation channel, subfamily V, member 4
  (TRPV4), mRNA
  gi|13699862|ref|NM_—021625.2|[13699862]
• 1477: NM_—020960
  Homo sapiens G protein-coupled receptor 107 (GPR107), mRNA
  gi|13470087|ref|NM_—020960.1|[13470087]
• 1478: NM_—021634
  Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 7 (LGR7),
  mRNA
  gi|11056007|ref|NM_—021634.1|[11056007]
• 1479: NM_—016179
  Homo sapiens transient receptor potential cation channel, subfamily C, member 4
  (TRPC4), mRNA
  gi|7706746|ref|NM_—016179.1|[7706746]
• 1480: NM_—004621
  Homo sapiens transient receptor potential cation channel, subfamily C, member 6
  (TRPC6), mRNA
  gi|5730101|ref|NM_—004621.21[5730101]
• 1481: NM_—003304
  Homo sapiens transient receptor potential cation channel, subfamily C, member 1
  (TRPC1), mRNA
  gi|4507684|ref|NM_—003304.1|[4507684]
• 1485: NM_—016235
  Homo sapiens G protein-coupled receptor, family C, group 1, member B (GPRC5B),
  mRNA
  gi|7706450|ref|NM_—016235.1|[7706450]
• 1487: AF024642
  Homo sapiens luteinizing hormone receptor gene, exon 1 and partial cds
  gi|2655113|gb|AF024642.1|AF024642[2655113]
• 1488: NM_—007128
  Homo sapiens pre-B lymphocyte gene 1 (VPREB1), mRNA
  gi|18379350|ref|NM_—007128.2|[18379350]
• 1489: NM_—020777
  Homo sapiens VPS10 domain receptor protein (SORCS2), mRNA
  gi|18379343|ref|NM_—020777.1|[18379343]
• 1490: NM_—052918
  Homo sapiens VPS10 domain receptor protein SORCS 1 (SORCS1), mRNA
  gi|8379341|ref|NM_—052918.2|[18379341]
• 1491: AF391164
  Homo sapiens osteoclast-associated receptor hOSCAR-M3 (OSCAR) mRNA, complete cds
  gi|18376830|gb|AF391164.1|AF391164[18376830]
• 1492: AF391163
  Homo sapiens osteoclast-associated receptor hOSCAR-M2 (OSCAR) mRNA, complete cds
  gi|18376828|gb|AF391163.1|AF391163[18376828]
• 1493: AF391162
  Homo sapiens osteoclast-associated receptor hOSCAR-M1 (OSCAR) mRNA, complete cds
  gi|18376826|gb|AF391162.1|AF391162[18376826]
• 1494: AJ421783
  Homo sapiens mRNA for short transient receptor potential channel 7 (TRP7 gene)
  gi|18376628|emb|AJ421783.1|HSA421783[18376628]
• 1497: AF410902
  Homo sapiens neurotrophin receptor tyrosine kinase type 2 (NTRK2) gene, promoter
  region and partial cds; alternatively spliced
  gi|18369868|gb|AF410902.1|AF410902[18369868]
• 1498: AF410901
  Homo sapiens neurotrophin receptor tyrosine kinase type 2 truncated isoform (NTRK2) mRNA, complete cds; alternatively spliced
  gi|18369866|gb|AF410901.1|AF410901[18369866]
• 1499: AF410900
  Homo sapiens neurotrophin receptor tyrosine kinase type 2 truncated isoform (NTRK2) mRNA, complete cds; alternatively spliced
  gi|18369864|gb|AF410900.1|AF410900[18369864]
• 1500: AF410899
  Homo sapiens neurotrophin receptor tyrosine kinase type 2 (NTRK2) mRNA, complete
  cds; alternatively spliced
  gi|18369862|gb|AF410899.1|AF410899[18369862]
• 1501: AF410898
  Homo sapiens clone DKFZp547L014 neurotrophin receptor tyrosine kinase type 2 truncated isoform (NTRK2) mRNA, partial cds; alternatively spliced
  gi|18369860|gb|AF410898.1|AF410898[18369860]
• 1502: AY071830
  Homo sapiens interleukin 9 receptor (IL9R) gene, complete cds
  gi|18071671|gb|AY071830.1|[18071671]
• 1503: AF421362
  Homo sapiens transient receptor potential channel 4 zeta splice variant (TRPC4)
  mRNA, complete cds; alternatively spliced
  gi|16517177|gb|AF421362.1|AF421362[16517177]
• 1504: AF421361
  Homo sapiens transient receptor potential channel 4 eta splice variant (TRPC4)
  mRNA, complete cds; alternatively spliced
  gi|16517175|gb|AF421361.1|AF421361[16517175]
• 1505: AF421360
  Homo sapiens transient receptor potential channel 4 epsilon splice variant (TRPC4) mRNA, complete cds; alternatively spliced
  gi|16517173|gb|AF421360.1|AF421360[16517173]
• 1506: AF421359
  Homo sapiens transient receptor potential channel 4 beta splice variant (TRPC4)
  mRNA, complete cds; alternatively spliced
  gi|16517171|gb|AF421359.1|AF421359[16517171]
• 1507: AF421358
  Homo sapiens transient receptor potential channel 4 alpha splice variant (TRPC4)
  mRNA, complete cds; alternatively spliced
  gi|16517169|gb|AF421358.1|AF421358[16517169]
• 1508: AF359246
  Homo sapiens fibroblast growth factor receptor 4 variant mRNA, complete cds
  gi|13991617|gb|AF359246.1|AF359246[13991617]
• 1509: NM_—022349
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), mRNA
  gi|11641258|ref|NM_—022349.1|[11641258]
• 1510: NM_—006055
  Homo sapiens LanC lantibiotic synthetase component C-like 1 (bacterial) (LANCL1), mRNA
  gi|5174444|ref|NM_—006055.1|[5174444]
• 1511: NM_—005716
  Homo sapiens regulator of G-protein signalling 19 interacting protein 1 (RGS19IP1), mRNA
  gi|5031714|ref|NM_—005716.1|[5031714]
• 1512: NM_—003307
  Homo sapiens transient receptor potential cation channel, subfamily M, member 2
  (TRPM2), mRNA
  gi|4507688|ref|NM_—003307.1|[4507688]
• 1513: NM_—003807
  Homo sapiens tumor necrosis factor (ligand) superfamily, member 14 (TNFSF14), mRNA
  gi|4507600|ref|NM_—003807.1|[4507600]
• 1514: NM_—002984
  Homo sapiens small inducible cytokine A4 (SCYA4), mRNA
  gi|4506844|ref|NM_—002984.1|[4506844]
• 1515: NM_—021181
  Homo sapiens 19A24 protein (CRACC), mRNA
  gi|12711663|ref|NM_—021181.2|[12711663]
• 1516: BC021892
  Homo sapiens, CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II), clone MGC:9392 IMAGE:3872778, mRNA, complete cds
  gi|18257311|gb|BC021892.1|BC021892[18257311]
• 1517: AF459285
  Homo sapiens 5-hydroxytryptamine receptor 3 subunit C (HTR3C) mRNA, complete cds
  gi|18251965|gb|AF459285.1|AF459285[18251965]
• 1518: BC021553
  Homo sapiens, G protein coupled receptor interacting protein, complement-c1q tumor necrosis factor-related, clone MGC:31795 IMAGE:4622952, mRNA, complete cds
  gi|18204860|gb|BC021553.1|BC021553[18204860]
• 1519: BC021195
  Homo sapiens, dopamine receptor D2, clone MGC:10521 IMAGE:3939741, mRNA, complete cds
  gi|18203702|gb|BC021195.1|BC021195[18203702]
• 1520: BC020752
  Homo sapiens, Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor), clone MGC:22599 IMAGE:4722289, mRNA, complete cds
  gi|18089130|gb|BC020752.1|BC020752[18089130]
• 1521: BC020614
  Homo sapiens, G protein-coupled receptor 84, clone MGC:22224 IMAGE:4279185, mRNA, complete cds
  gi|18089044|gb|BC020614.1|BC020614[18089044]
• 1522: BC021104
  Homo sapiens, apelin; peptide ligand for APJ receptor, clone MGC:31846 IMAGE:4586949, mRNA, complete cds
  gi|18088893|gb|BC021104.1|BC021104[18088893]
• 1523: BC020805
  Homo sapiens, leukocyte receptor cluster (LRC) member 5, clone MGC:23828 IMAGE:4277870, mRNA, complete cds
  gi|18088780|gb|BC020805.1|BC020805[18088780]
• 1524: BC020742
  Homo sapiens, complement component 3a receptor 1, clone MGC:22570 IMAGE:4690283,
  mRNA, complete cds
  gi|18088764|gb|BC020742.1|BC020742[18088764]
• 1525: BC020815
  Homo sapiens, putative receptor protein, clone MGC:23860 IMAGE:4296149, mRNA, complete cds
  gi|18088747|gb|BC020815.1|BC020815[18088747]
• 1526: BC020768
  Homo sapiens, olfactory receptor, family 51, subfamily E, member 2, clone MGC:22638 IMAGE:4249775, mRNA, complete cds
  gi|18088468|gb|BC020768.1|BC020768[18088468]
• 1527: BC020739
  Homo sapiens, interleukin 13 receptor, alpha 2, clone MGC:22566 IMAGE:4807603,
  mRNA, complete cds
  gi|18088440|gb|BC020739.1|BC020739[18088440]
• 1528: BC020678
  Homo sapiens, G protein-coupled receptor 34, clone MGC:22389 IMAGE:4770479, mRNA, complete cds
  gi|18088371|gb|BC020678.1|BC020678[18088371]
• 1529: BC020669
  Homo sapiens, advanced glycosylation end product-specific receptor, clone MGC:22357 IMAGE:4718076, mRNA, complete cds
  gi|18088362|gb|BC020669.1|BC020669[18088362]
• 1530: BC020968
  Homo sapiens, chemokine (C-X-C motif), receptor 4 (fusin), clone MGC:9199 IMAGE:3846345, mRNA, complete cds
  gi|18088082|gb|BC020968.1|BC020968[18088082]
• 1531: BC019610
  Homo sapiens, somatostatin receptor 2, clone MGC:24950 IMAGE:3875163, mRNA, complete cds
  gi|18043108|gb|BC019610.1|BC019610[18043108]
• 1532: BC020079
  Homo sapiens, lamin B receptor, clone MGC:9041 IMAGE:3925138, mRNA, complete cds
  gi|18042833|gb|BC020079.1|BC020079[18042833]
• 1715: NM_—001364
  Homo sapiens discs, large homolog 2, chapsyn-110 (Drosophila) (DLG2), mRNA
  gi|4557526|ref|NM_—001364.1|[4557526]
• 1716: NM_—080744
  Homo sapiens scavenger receptor cysteine rich domain containing, group B (4 domains) (SRCRB4D), mRNA
  gi|18152778|ref|NM_—080744.1|[18152778]
• 1717: AB063170
  Homo sapiens mRNA for BANK, complete cds
  gi|17646091|dbj|AB063170.1|AB063170[17646091]
• 1718: NM_—022760
  Homo sapiens chromosome 20 open reading frame 81 (C20orf81), mRNA
  gi|16163672|ref|NM_—022760.2|[16163672]
• 1719: NM_—032554
  Homo sapiens G protein-coupled receptor 81 (GPR81), mRNA
  gi|14211850|ref|NM_—032554.1|[14211850]
• 1720: AB054004
  Homo sapiens DR5 gene for death receptor 5, promoter and partial cds
  gi|13429873|dbj|AB054004.1|AB054004[13429873]
• 1721: NM_—000668
  Homo sapiens alcohol dehydrogenase IB (class I), beta polypeptide (ADH1B), mRNA
  gi|11496887|ref|NM_—000668.2|[11496887]
• 1722: NM_—018697
  Homo sapiens LanC lantibiotic synthetase component C-like 2 (bacterial) (LANCL2), mRNA
  gi|8923910|ref|NM_—018697.1|[8923910]
• 1723: NM_—016610
  Homo sapiens toll-like receptor 8 (TLR8), mRNA
  gi|7706147|ref|NM_—016610.1|[7706147]
• 1725: NM_—015833
  Homo sapiens adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) (ADARB1),
  transcript variant DRABA2b, mRNA
  gi|7669476|ref|NM_—015833.1|[7669476]
• 1727: NM_—007184
  Homo sapiens nischarin (NISCH), mRNA
  gi|6005787|ref|NM_—007184.1|[6005787]
• 1728: NM_—000139
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 1 (MS4A2), mRNA
  gi|4503676|ref|NM_—000139.1|[4503676]
• 1730: NM_—080681
  Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 2, mRNA
  gi|18201918|ref|NM_—080681.1|[18201918]
• 1731: NM_—080680
  Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 1, mRNA
  gi|18201916|ref|NM_—080680.1|[18201916]
• 1732: NM_—080679
  Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 3, mRNA
  gi|18201914|ref|NM_—080679.1|[18201914]
• 1733: NM_—006115
  Homo sapiens preferentially expressed antigen in melanoma (PRAME), mRNA
  gi|18201906|ref|NM_—006115.2|[18201906]
• 1734: NM_—020526
  Homo sapiens EphA8 (EPHA8), mRNA
  gi|18201903|ref|NM_—020526.2|[18201903]
• 1735: NM_—080818
  Homo sapiens G protein-coupled receptor 80 (GPR80), mRNA
  gi|18201871|ref|NM_—080818.1[18201871]
• 1736: NM_—080817
  Homo sapiens G protein-coupled receptor 82 (GPR82), mRNA
  gi|18201869|ref|NM_—080817.1|[18201869]
• 1737: AF400075
  Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1) gene, complete cds
  gi|15021772|gb|AF400075.1|AF400075[15021772]
• 1738: NM_—024021
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 4 (MS4A4A), mRNA
  gi|13430865|ref|NM_—024021.1|[13430865]
• 1739: A1B066218
  Homo sapiens RYR1 gene for ryanodine receptor type1, partial cds, clone: 4-101
  gi|18181961|dbj|AB066218.1|AB066218[18181961]
• 1740: AB066217
  Homo sapiens RYR1 gene for ryanodine receptor type1, partial cds, clone: 4-96
  gi|18181959|dbj|AB066217.1|AB066217[18181959]
• 1741: NM_—021950
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of
  IgE, high affinity I, receptor for; beta polypeptide) (MS4A1), mRNA
  gi|11386186|ref|NM_—021950.1|[11386186]
• 1742: NM_—012323
  Homo sapiens v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) (MAFF), mRNA
  gi|6912489|ref|NM_—012323.1|[6912489]
• 1743: AJ298292
  Homo sapiens mRNA for histamine receptor H4 (HRH4 gene)
  gi|18152452|emb|AJ298292.1|HSA298292[18152452]
• 1744: AB070621
  Homo sapiens HTR4 gene for 5-hydroxytryptamine 4 receptor, promoter and exon 1
  gi|18149171|dbj|AB070621.1|AB070621[18149171]
• 1745: AB070620
  Homo sapiens HTR4 mRNA for 5-hydroxytryptamine 4 receptor, partial cds
  gi|18149169|dbj|AB070620.1|AB070620[18149169]
• 1746: AB050774
  Homo sapiens N27C7-4 gene, complete cds
  gi|8147104|dbj|AB050774.1|AB050774[18147104]
• 1747: AB048946
  Homo sapiens PrRPR gene for prolactin releasing peptide receptor, complete cds
  gi|18147078|dbj|AB048946.1|AB048946[18147078]
• 1748: NM_—030760
  Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 (EDG8), mRNA
  gi|18141314|ref|NM_—030760.2|[18141314]
• 1749: NM_—032556
  Homo sapiens interleukin-1 HY2 (IL1HY2), mRNA
  gi|18141307|ref|NM_—032556.2|[18141307]
• 1750: AF459634
  Homo sapiens immunoglobulin superfamily receptor translocation associated 5 mRNA, complete cds
  gi|18140080|gb|AF459634.1|AF459634[18140080]
• 1751: AF459633
  Homo sapiens immunoglobulin superfamily receptor translocation associated 4 mRNA, complete cds
  gi|18140078|gb|AF459633.1|AF459633[18140078]
• 1752: AY046529
  Homo sapiens melanocortin 1 receptor mutant V122M (MC1R) gene, complete cds
  gi|1813824|gb|AY046529.1|[18138241]
• 1753: AY046528
  Homo sapiens melanocortin 1 receptor mutant 140T (MC1R) gene, complete cds
  gi|18138239|gb|AY046528.1|[18138239]
• 1754: AX338549
  Sequence 1 from Patent WO0185790
  gi|18128949|emb|AX338549.1|AX338549[18128949]
• 1755: NM_—001745
  Homo sapiens calcium modulating ligand (CAMLG), mRNA
  gi|18105008|ref|NM_—001745.2|[18105008]
• 1756: NM_—001128
  Homo sapiens adaptor-related protein complex 1, gamma 1 subunit (AP1G1), mRNA
  gi|18104997|ref|NM_—001128.2|[18104997]
• 1757: NM_—080545
  Homo sapiens adaptor-related protein complex 1, gamma 2 subunit (AP1G2), transcript variant 2, mRNA
  gi|18104995|ref|NM_—080545.1|[18104995]
• 1758: NM_—003917
  Homo sapiens adaptor-related protein complex 1, gamma 2 subunit (AP1G2), transcript variant 1, mRNA
  gi|18104994|ref|NM_—003917.2|[18104994]
• 1759: AF459027
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 3 mRNA, complete cds
  gi|18092654|gb|AF459027.1|AF459027[18092654]
• 1760: AY069943
  Homo sapiens TCP11b protein mRNA, complete cds
  gi|18091790|gb|AY069943.1|[18091790]
• 1761: AY063126
  Homo sapiens Fc alpha/mu receptor mRNA, partial cds; alternatively spliced
  gi|18032043|gb|AY063126.1[18032043]
• 1762: AY063125
  Homo sapiens Fc alpha/mu receptor mRNA, complete cds; alternatively spliced
  gi|18032041|gb|AY063125.1|[18032041]
• 1763: AF395264
  Homo sapiens clone EIII48 bpVNTR55 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063763|gb|AF395264.1|AF395264[17063763]
• 1764: AF395263
  Homo sapiens clone EIII48 bpVNTR54 dopamine receptor D4 (DRD4) gene, partial cds
  gi|1706376|gb|AF395263.1|AF395263[17063761]
• 1765: AF395262
  Homo sapiens clone EIII48 bpVNTR53 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063759|gb|AF395262.1|AF395262[17063759]
• 1766: AF395261
  Homo sapiens clone EIII48 bpVNTR52 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063757|gb|AF395261.1|AF395261[17063757]
• 1767: AF395260
  Homo sapiens clone EIII48 bpVNTR51 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063755|gb|AF395260.1|AF395260[17063755]
• 1768: AF395259
  Homo sapiens clone EIII48 bpVNTR50 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063753|gb|AF395259.1|AF395259[17063753]
• 1769: AF395258
  Homo sapiens clone EIII48 bpVNTR49 dopamine receptor D4 (DRD4) gene, partial cds
  gi|1706375|gb|AF395258.1|AF395258[17063751]
• 1770: AF395257
  Homo sapiens clone EIII48 bpVNTR48 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063749|gb|AF395257.1|AF395257[17063749]
• 1771: AF395256
  Homo sapiens clone EIII48 bpVNTR47 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063747|gb|AF395256.1|AF395256[17063747]
• 1772: AF395255
  Homo sapiens clone EIII48 bpVNTR46 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063745|gb|AF395255.1|AF395255[17063745]
• 1773: AF395254
  Homo sapiens clone EIII48 bpVNTR45 dopamine receptor D4 (DRD4) gene, partial cds
  gi|7063743|gb|AF395254.1|AF395254[17063743]
• 1774: AF395253
  Homo sapiens clone EIII48 bpVNTR44 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063741|gb|AF395253.1|AF395253[17063741]
• 1775: AF395252
  Homo sapiens clone EIII48 bpVNTR43 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063739|gb|AF395252.1|AF395252[17063739]
• 1776: AF395251
  Homo sapiens clone EIII48 bpVNTR42 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063737|gb|AF395251.1|AF395251[17063737]
• 1777: AF395250
  Homo sapiens clone EIII48 bpVNTR41 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063735|gb|AF395250.1|AF395250[17063735]
• 1778: AF395249
  Homo sapiens clone EIII48 bpVNTR40 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063733|gb|AF395249.1|AF395249[17063733]
• 1779: AF395248
  Homo sapiens clone EIII48 bpVNTR39 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063731|gb|AF395248.1|AF395248[17063731]
• 1780: AF395247
  Homo sapiens clone EIII48 bpVNTR38 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063729|gb|AF395247.1|AF395247[17063729]
• 1781: AF395246
  Homo sapiens clone EIII48 bpVNTR37 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063727|gb|AF395246.1|AF395246[17063727]
• 1782: AF395245
  Homo sapiens clone EIII48 bpVNTR36 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063725|gb|AF395245.1|AF395245[17063725]
• 1783: AF395244
  Homo sapiens clone EIII48 bpVNTR35 dopamine receptor D4 (DRD4) gene, partial cds
  gi|7063723|gb|AF395244.1|AF395244[17063723]
• 1784: AF395243
  Homo sapiens clone EIII48 bpVNTR34 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063721|gb|AF395243.1|AF395243[17063721]
• 1785: AF395242
  Homo sapiens clone EIII48 bpVNTR33 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063719|gb|AF395242.1|AF395242[17063719]
• 1786: AF395241
  Homo sapiens clone EIII48 bpVNTR32 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063717|gb|AF395241.1|AF395241[17063717]
• 1787: AF395240
  Homo sapiens clone EIII48 bpVNTR31 dopamine receptor D4 (DRD4) gene, partial cds
  gi|7063715|gb|AF395240.1|AF395240[17063715]
• 1788: AF395239
  Homo sapiens clone EIII48 bpVNTR30 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063713|gb|AF395239.1|AF395239[17063713]
• 1789: AF395238
  Homo sapiens clone EIII48 bpVNTR29 dopamine receptor D4 (DRD4) gene, partial cds
  gi|1706371|gb|AF395238.1|AF395238[17063711]
• 1790: AF395237
  Homo sapiens clone EIII48 bpVNTR28 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063709|gb|AF395237.1|AF395237[17063709]
• 1791: AF395236
  Homo sapiens clone EIII48 bpVNTR27 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063707|gb|AF395236.1|AF395236[17063707]
• 1792: AF395235
  Homo sapiens clone EIII48 bpVNTR26 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063705|gb|AF395235.1|AF395235[17063705]
• 1793: AF395234
  Homo sapiens clone EIII48 bpVNTR25 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063703|gb|AF395234.1|AF395234[17063703]
• 1794: AF395233
  Homo sapiens clone EIII48 bpVNTR24 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063701|gb|AF395233.1|AF395233[17063701]
• 1795: AF395232
  Homo sapiens clone EIII48 bpVNTR23 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063699|gb|AF395232.1|AF395232[17063699]
• 1796: AF395231
  Homo sapiens clone EIII48 bpVNTR22 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063697|gb|AF395231.1|AF395231[17063697]
• 1797: AF395230
  Homo sapiens clone EIII48 bpVNTR21 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063695|gb|AF395230.1|AF395230[17063695]
• 1798: AF395229
  Homo sapiens clone EIII48 bpVNTR20 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063693|gb|AF395229.1|AF395229[17063693]
• 1799: AF395228
  Homo sapiens clone EIII48 bpVNTR19 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063691|gb|AF395228.1|AF395228[17063691]
• 1800: AF395227
  Homo sapiens clone EIII48 bpVNTR18 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063689|gb|AF395227.1|AF395227[170636891]
• 1801: AF395226
  Homo sapiens clone EIII48 bpVNTR17 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063687|gb|AF395226.1|AF395226[17063687]
• 1802: AF395225
  Homo sapiens clone EIII48 bpVNTR16 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063685|gb|AF395225.1|AF395225[17063685]
• 1803: AF395224
  Homo sapiens clone EIII48 bpVNTR15 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063683|gb|AF395224.1|AF395224[17063683]
• 1804: AF395223
  Homo sapiens clone EIII48 bpVNTR14 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063681|gb|AF395223.1|AF395223[17063681]
• 1805: AF395222
  Homo sapiens clone EIII48 bpVNTR13 dopamine receptor D4 (DRD4) gene, partial cds
  gi|7063679|gb|AF395222.1|AF395222[17063679]
• 1806: AF395221
  Homo sapiens clone EIII48 bpVNTR12 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063677|gb|AF395221.1|AF395221[17063677]
• 1807: AF395220
  Homo sapiens clone EIII48 bpVNTR11 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063675|gb|AF395220.1|AF395220[17063675]
• 1808: AF395219
  Homo sapiens clone EIII48 bpVNTR10 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063673|gb|AF395219.1|AF395219[17063673]
• 1809: AF395218
  Homo sapiens clone EIII48 bpVNTR9 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063671|gb|AF395218.1|AF395218[17063671]
• 1810: AF395217
  Homo sapiens clone EIII48 bpVNTR8 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063669|gb|AF395217.1|AF395217[17063669]
• 1811: AF395216
  Homo sapiens clone EIII48 bpVNTR7 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063667|gb|AF395216.1|AF395216[17063667]
• 1812: AF395215
  Homo sapiens clone EIII48 bpVNTR6 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063665|gb|AF395215.1|AF395215[17063665]
• 1813: AF395214
  Homo sapiens clone EIII48 bpVNTR5 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063663|gb|AF395214.1|AF395214[17063663]
• 1814: AF395213
  Homo sapiens clone EIII48 bpVNTR4 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063661|gb|AF395213.1|AF395213[17063661]
• 1815: AF395212
  Homo sapiens clone EIII48 bpVNTR3 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063659|gb|AF395212.1|AF395212[17063659]
• 1816: AF395211
  Homo sapiens clone EIII48 bpVNTR2 dopamine receptor D4 (DRD4) gene, partial cds
  gi|17063657|gb|AF395211.1|AF395211[17063657]
• 1817: AF395210
  Homo sapiens clone EIII48 bpVNTR1 dopamine receptor D4 (DRD4) gene, partial cds
  gi|7063655|gb|AF395210.1|AF395210[17063655]
• 1818: AF258342
  Homo sapiens biogenic amine receptor-like protein mRNA, complete cds
  gi|15428321|gb|AF258342.1|AF258342[15428321]
• 1819: AJ278982
  Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
  h5-HT4(n)
  gi|12274905|emb|AJ278982.1|HSA278982[12274905]
• 1820: AJ278981
  Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
  h5-HT4(g)
  gi|12274903|emb|AJ278981.1|HSA278981[12274903]
• 1821: AJ278980
  Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
  h5-HT4(b)
  gi|12274901|emb|AJ278980.1|HSA278980[12274901]
• 1822: AJ278979
  Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
  h5-HT4(a)
  gi|12274899|emb|AJ278979.1|HSA278979[12274899]
• 1823: NM_—014555
  Homo sapiens transient receptor potential cation channel, subfamily M, member 5
  (TRPM5), mA
  gi|11225265|ref|NM_—014555.1|[11225265]
• 1824: AF200627
  Homo sapiens putative catecholamine receptor gene, complete cds
  gi|10441576|gb|AF200627.1|AF200627[10441576]
• 1825: AF257789
  Homo sapiens urokinase-type plasminogen activator receptor mRNA, partial cds
  gi|8050814|gb|AF257789.1|AF257789[8050814]
• 1826: NM_—002335
  Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5), mRNA
  gi|4505018|ref|NM_—002335.1|[4505018]
• 1827: Y00508
  H. sapiens M1 gene for muscarinic acetylcholine receptor
  gi|297405|emb|Y00508.1|HSMIMAR[297405]
• 1828: AF457599
  Homo sapiens killer cell immunoglobulin-like receptor (KIR3DL1) gene, KIR3DL1-NKB1-like allele, promoter region and exon 1
  gi|18087432|gb|AF457599.1|AF457599[18087432]
• 1829: AF457598
  Homo sapiens killer cell immunoglobulin-like receptor (KIR3DL1) gene, KIR3DL1-NKB1-like allele, promoter region and exon 1
  gi|18087431|gb|AF457598.1|AF457598[18087431]
• 1830: AF457597
  Homo sapiens killer cell immunoglobulin-like receptor (KIR3DL1) gene, KIR3DL1-NKAT3-like allele, promoter region and exon 1
  gi|18087430|gb|AF457597.1|AF457597[18087430]
• 1831: AJ312755
  Homo sapiens mRNA for scavenger receptor cysteine-rich protein SRCRB-S4D, (SRCRB-S4D gene)
  gi|18073905|emb|AJ312755.1|HSA312755[18073905]
• 1832: AF331842
  Homo sapiens SPPR-2 mRNA, complete cds, alternatively spliced
  gi|18033260|gb|AF331842.1|AF331842[18033260]
• 1833: AF331841
  Homo sapiens SPPR-1 mRNA, complete cds, alternatively spliced
  gi|18033258|gb|AF331841.1|AF331841[18033258]
• 1834: AF331840
  Homo sapiens SPPR mRNA, complete cds, alternatively spliced
  gi|18033256|gb|AF331840.1|AF331840[18033256]
• 1835: AF284756
  Homo sapiens VPS10 domain receptor S or CS mRNA, complete cds
  gi|18032274|gb|AF284756.1|AF284756[18032274]
• 1836: AF328684
  Homo sapiens Fc-epsilon receptor III mRNA, complete cds
  gi|8028292|gb|AF328684.1|AF328684[18028292]
• 1837: AY029413
  Homo sapiens interleukin-1 receptor antagonist-like FIL1 theta (FIL1-theta) mRNA, complete cds
  gi|18025343|gb|AY029413.1|[18025343]
• 1838: AF126470
  Homo sapiens KOR-3D (KOR-3) mRNA, complete cds
  gi|18000078|gb|AF126470.1|AF126470[18000078]
• 1839: AF435925
  Homo sapiens very large G protein-coupled receptor 1b (VLGR1) mRNA, complete cds
  gi|16904207|gb|AF435925.1|AF435925[16904207]
• 1840: G67431
  D7S3125 GRB10 Homo sapiens STS genomic, sequence tagged site
  gi|12025489|gb|G67431.1|G67431[12025489]
• 1841: AF260136
  Homo sapiens NK cell receptor D (NKG2-D) mRNA, NKG2-D*03 allele, complete cds
  gi|9295444|gb|AF260136.1|AF260136[9295444]
• 1842: AF260135
  Homo sapiens NK cell receptor D (NKG2-D) mRNA, NKG2-D*02 allele, complete cds
  gi|9295442|gb|AF260135.1|AF260135[9295442]
• 1843: AF260134
  Homo sapiens NK cell receptor C (NKG2-C) mRNA, NKG2-C*02 allele, complete cds
  gi|9295440|gb|AF260134.1|AF260134[9295440]
• 1844: NM_—015891
  Homo sapiens pre-mRNA splicing factor 17 (PRP17), mRNA
  gi|7706656|ref|NM_—015891.1|[7706656]
• 1845: L12397
  Homo sapiens Dopamine D4 receptor (DRD4) gene, partial cds
  gi|291947|gb|L12397.1|HUMD4G[291947]
• 1846: NM_—019888
  Homo sapiens melanocortin 3 receptor (MC3R), mRNA
  gi|17986278|ref|NM_—019888.2|[17986278]
• 1847: NM_—000795
  Homo sapiens dopamine receptor D2 (DRD2), transcript variant 1, mRNA
  gi|17986271|ref|NM_—000795.2|[17986271]
• 1848: NM_—016574
  Homo sapiens dopamine receptor D2 (DRD2), transcript variant 2, mRNA
  gi|17986269|ref|NM_—016574.2|[17986269]
• 1849: AY070269
  Homo sapiens hypocretin receptor 1 (HCRTR1) gene, complete cds
  gi|17979217|gb|AY070269.1|[17979217]
• 1850: NM_—052945
  Homo sapiens BAFF receptor (BAFFR), mRNA
  gi|17978517|ref|NM_—052945.2|[17978517]
• 1851: NM_—054026
  Homo sapiens CCR4—NOT transcription complex, subunit 7 (CNOT7), transcript variant 2, mRNA
  gi|17978499|ref|NM_—054026.1|[17978499]
• 1852: NM_—013354
  Homo sapiens CCR4—NOT transcription complex, subunit 7 (CNOT7), transcript variant 1, mRNA
  gi|17978498|ref|NM_—013354.3|[17978498]
• 1853: NM_—004444
  Homo sapiens EphB4 (EPHB4), mRNA
  gi|17975769|ref|NM_—004444.2|[17975769]
• 1854: NM_—004443
  Homo sapiens EphB3 (EPHB3), mRNA
  gi|17975767|ref|NM_—004443.2|[17975767]
• 1855: NM_—004442
  Homo sapiens EphB2 (EPHB2), transcript variant 1, mRNA
  gi|17975766|ref|NM_—004442.2|[17975766]
• 1856: NM_—017449
  Homo sapiens EphB2 (EPHB2), transcript variant 2, mRNA
  gi|17975764|ref|NM_—017449.1|[17975764]
• 1857: BC019278
  Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:3816 IMAGE:2905275, mRNA, complete cds
  gi|17939468|gb|BC019278.1|BC019278[17939468]
• 1858: NM_—080387
  Homo sapiens C-type lectin-like receptor (CLEC-6), mRNA
  gi|17933769|ref|NM_—080387.1|[17933769]
• 1859: NM_—007200
  Homo sapiens A kinase (PRKA) anchor protein 13 (AKAP13), mRNA
  gi|17933491|ref|NM_—007200.1|[17933491]
• 1861: AF373878
  Homo sapiens herpesvirus entry mediator (TNFRSF14) mRNA, TNFRSF14-V241I allele,
  complete cds
  gi|17901872|gb|AF373878.1|AF373878[17901872]
• 1862: AF373877
  Homo sapiens herpesvirus entry mediator (TNFRSF14) mRNA, TNFRSF14-R17K allele,
  complete cds
  gi|17901869|gb|AF373877.1|AF373877[17901869]
• 1863: AF373876
  Homo sapiens nectin-1 (PVRL1) gene, PVRL1-R199W allele, partial cds
  gi|17901866|gb|AF373876.1|AF373876[17901866]
• 1864: AY065844
  Homo sapiens truncated receptor tyrosine kinase TrkC mRNA, partial cds
  gi|17887448|gb|AY065844.1|[17887448]
• 1865: AY062295
  Homo sapiens prolactin receptor (PRLR) mRNA, partial cds; alternatively spliced
  gi|7887307|gb|AY062295.1|[17887307]
• 1866: NM_—078474
  Homo sapiens BBP-like protein 2 (BLP2), transcript variant 1, mRNA
  gi|17865799|ref|NM_—078474.1|[17865799]
• 1867: NM_—025141
  Homo sapiens BBP-like protein 2 (BLP2), transcript variant 2, mRNA
  gi|17865798|ref|NM_—025141.2|[17865798]
• 1868: NM_—078473
  Homo sapiens BBP-like protein 1 (BLP1), transcript variant 1, mRNA
  gi|17865796|ref|NM_—078473.1|[17865796]
• 1869: NM_—020749
  Homo sapiens AT2 receptor-interacting protein 1 (ATIP1), mRNA
  gi|17865631|ref|NM_—020749.1|[17865631]
• 1870: NM_—002088
  Homo sapiens glutamate receptor, ionotropic, kainate 5 (GRIK5), mRNA
  gi|17864085|ref|NM_—002088.2|[17864085]
• 1871: AY064474
  Homo sapiens interleukin 21 receptor (IL21R) gene, complete cds
  gi|17863086|gb|AY064474.1|[17863086]
• 1872: AY036093
  Homo sapiens lysyl oxidase-like 4 mRNA, complete cds
  gi|1786137|gb|AY036093.1|[17861371]
• 1873: AF369653
  Homo sapiens corticotropin releasing hormone receptor variant 1 g (CRHR1) mRNA,
  partial cds, alternatively spliced
  gi|17834100|gb|AF369653.1|AF369653[17834100]
• 1874: AF369652
  Homo sapiens corticotropin releasing hormone receptor variant lf (CRHR1) mRNA,
  partial cds, alternatively spliced
  gi|17834097|gb|AF369652.1|AF369652[17834097]
• 1875: AF369651
  Homo sapiens corticotropin releasing hormone receptor variant le (CRHRL) mRNA,
  partial cds, alternatively spliced
  gi|17834094|gb|AF369651.1|AF369651[17834094]
• 1876: NM_—001239
  Homo sapiens cyclin H(CCNH), mRNA
  gi|17738313|ref|NM_—001239.2|[17738313]
• 1877: NM_—014286
  Homo sapiens frequenin homolog (Drosophila) (FREQ), mRNA
  gi|17738307|ref|NM_—014286.2|[17738307]
• 1878: NM_—006650
  Homo sapiens complexin 2 (CPLX2), mRNA
  gi|17738306|ref|NM_—006650.2|[17738306]
• 1879: NM_—006651
  Homo sapiens complexin 1 (CPLX1), mRNA
  gi|17738305|ref|NM_—006651.2|[17738305]
• 1880: AF416558
  Homo sapiens N-methyl-D-aspartate receptor 3A (GRIN3A) mRNA, complete cds
  gi|17530176|gb|AF416558.1|AF416558[17530176]
• 1882: BC018926
  Homo sapiens, vanilloid receptor-like protein, clone MGC:12549 IMAGE:4298484, mRNA, complete cds
  gi|17511937|gb|BC018926.1|BC018926[17511937]
• 1883: BC018778
  Homo sapiens, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1, clone MGC:32075 IMAGE:4870476, mRNA, complete cds
  gi|17511855|gb|BC018778.1|BC018778[17511855]
• 1884: NM_—004625
  Homo sapiens wingless-type MMTV integration site family, member 7A (WNT7A), mRNA
  gi|17505190|ref|NM_—004625.2|[17505190]
• 1885: L78805
  Homo sapiens G protein-coupled receptor gene, partial cds
  gi|17466993|gb|L78805.1|HUMGPCRE[17466993]
• 1886: NM_—003602
  Homo sapiens FK506 binding protein 6 (36 kD) (FKBP6), mRNA
  gi|17149848|ref|NM_—003602.2|[17149848]
• 1887: NM_—000801
  Homo sapiens FK506 binding protein 1A (12 kD) (FKBP1A), transcript variant 12B,
  mRNA
  gi|17149837|ref|NM_—000801.2|[17149837]
• 1888: NM_—054014
  Homo sapiens FK506 binding protein 1A (12 kD) (FKBP1A), transcript variant 12A,
  mRNA
  gi|17149835|ref|NM_—054014.1|[17149835]
• 1889: AF411044
  Homo sapiens DnaJ protein Tid-1 mRNA, complete cds
  gi|17066574|gb|AF411044.1|AF411044[17066574]
• 1890: NM_—003728
  Homo sapiens unc-5 homolog B (C. elegans) (UNC5C), mRNA
  gi|16933524|ref|NM_—003728.2|[16933524]
• 1891: NM_—005633
  Homo sapiens son of sevenless homolog 1 (Drosophila) (SOS1), mRNA
  gi|15529995|ref|NM_—005633.2|[15529995]
• 1892: AJ308539
  Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV7BJ2S4 gene)
  gi|4787781|emb|AJ308539.1|HSA308539[14787781]
• 1893: AJ308538
  Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV14BJ1S1 gene)
  gi|14787779|emb|AJ308538.1|HSA308538[14787779]
• 1894: AJ308537
  Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV17BJ2S7 gene)
  gi|14787777|emb|AJ308537.1|HSA308537[14787777]
• 1895: AJ308536
  Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV23BJ2S2 gene)
  gi|14787775|emb|AJ308536.1|HSA308536[14787775]
• 1896: AJ308535
  Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV12BJ1S5 gene)
  gi|14787773|emb|AJ308535.1|HSA308535[14787773]
• 1897: AJ308534
  Homo sapiens partial mRNA for T-cell receptor beta chain, V-D-J region (TCRBV1BJ2S1 gene)
  gi|14787771|emb|AJ308534.1|HSA308534[14787771]
• 1898: AJ308533
  Homo sapiens partial mRNA for T-cell receptor beta chain, V-D-J region (TCRBV25BJ2S7 gene)
  gi|14787769|emb|AJ308533.1|HSA308533[14787769]
• 1899: AJ308532
  Homo sapiens partial mRNA for T-cell receptor beta chain, V-D-J region (TCRBV22BJ2S7 gene)
  gi|14787767|emb|AJ308532.1|HSA308532[14787767]
• 1900: NM_—014459
  Homo sapiens protocadherin 17 (PCDH17), mRNA
  gi|14589926|ref|NM_—014459.2|[14589926]
• 1901: NM_—032961
  Homo sapiens protocadherin 10 (PCDH10), transcript variant 1, mRNA
  gi|14589915|ref|NM_—032961.1|[14589915]
• 1902: NM_—020815
  Homo sapiens protocadherin 10 (PCDH10), transcript variant 2, mRNA
  gi|14589913|ref|NM_—020815.1|[14589913]
• 1903: NM_—032966
  Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein (BLR1), transcript
  variant 2, mRNA
  gi|145
• 2001: AF011513
  Homo sapiens isolate MwCCR5-1553 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305143|gb|AF011513.1|AF011513[2305143]
• 2002: AF011512
  Homo sapiens isolate MwCCR5-107 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305141|gb|AF011512.1|AF011512[2305141]
• 2003: AF011511
  Homo sapiens isolate KeCCR5-3b CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305139|gb|AF011511.1|AF011511[2305139]
• 2004: AF011510
  Homo sapiens isolate KeCCR5-3a CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305137|gb|AF011510.1|AF011510[2305137]
• 2005: AF011509
  Homo sapiens isolate KeCCR5-116 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305135|gb|AF011509.1|AF011509[2305135]
• 2006: AF011508
  Homo sapiens isolate KeCCR5-111 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305133|gb|AF011508.1|AF011508[2305133]
• 2007: AF011507
  Homo sapiens isolate InCCR5-72a CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305131|gb|AF011507.1|AF011507[2305131]
• 2008: AF011506
  Homo sapiens isolate InCCR5-71b CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305129|gb|AF011506.1|AF011506[2305129]
• 2009: AF011505
  Homo sapiens isolate InCCR5-71a CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305127|gb|AF0115050.1|AF011505[2305127]
• 2010: AF011504
  Homo sapiens isolate InCCR5-46 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305125|gb|AF011504.1|AF011504[2305125]
• 2011: AF011503
  Homo sapiens isolate InCCR5-467 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305123|gb|AF011503.1|AF011503[2305123]
• 2012: AF011502
  Homo sapiens isolate InCCR5-463 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305121|gb|AF011502.1|AF011502[2305121]
• 2013: AF011501
  Homo sapiens isolate InCCR5-45c CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305119|gb|AF011501.1|AF011501[2305119]
• 2014: AF011500
  Homo sapiens isolate HtCCR5-104 CCR5 receptor (CCR5) mRNA, partial cds
  gi|2305117|gb|AF011500.1|AF011500[2305117]
• 2015: U77732
  Homo sapiens glycine receptor alpha 1 subunit gene, partial cds
  gi|1718390|gb|U77732.1|HSU77732[1718390]
• 2016: NM_—033519
  Homo sapiens olfactory receptor sdolf (sdolf), mRNA
  gi|15723373|ref|NM_—033519.1|[15723373]
• 2017: NM_—032192
  Homo sapiens hypothetical protein FLJ20940 (FLJ20940), mRNA
  gi|14149882|ref|NM_—032192.1|[14149882]
• 2018: NM_—032152
  Homo sapiens PRAM-1 protein (PRAM-1), mRNA
  gi|14149826|ref|NM_—032152.1|[14149826]
• 2019: NM_—032142
  Homo sapiens hypothetical protein FLJ10352 (FLJ10352), mRNA
  gi|14149808|ref|NM_—032142.1|[14149808]
• 2020: NM_—004801
  Homo sapiens neurexin 1 (NRXN1), mRNA
  gi|14149612|ref|NM_—004801.1|[14149612]
• 2021: NM_—031936
  Homo sapiens G protein-coupled receptor 61 (GPR61), mRNA
  gi|13994319|ref|NM_—031936.1|[13994319]
• 2022: NM_—030901
  Homo sapiens olfactory receptor, family 7, subfamily A, member 17 (OR7A17), mRNA
  gi|13775161|ref|NM_—030901.1|[13775161]
• 2023: NM_—024681
  Homo sapiens hypothetical protein FLJ12242 (FLJ12242), mRNA
  gi|13489098|ref|NM_—024681.1|[13489098]
• 2024: NM_—022571
  Homo sapiens putative leukocyte platelet-activating factor receptor (HUMNPIIY20), mRNA
  gi|12007653|ref|NM_—022571.1|[12007653]
• 2025: NM_—022065
  Homo sapiens hypothetical protein FLJ21877 (FLJ21877), mRNA
  gi|11545774|ref|NM_—022065.1|[11545774]
• 2026: NM_—020806
  Homo sapiens gephyrin (GPHN), mRNA
  gi|10880982|ref|NM_—020806.1|[10880982]
• 2027: NM_—021258
  Homo sapiens interleukin 22 receptor (IL22R), mRNA
  gi|10864066|ref|NM_—021258.1|[10864066]
• 2029: NM_—020400
  Homo sapiens G protein-coupled receptor 92 (GPR92), mRNA
  gi|9966878|ref|NM_—020400.1|[9966878]
• 2030: NM_—000888
  Homo sapiens integrin, beta 6 (ITGB6), mRNA
  gi|9966771|ref|NM_—000888.31[9966771]
• 2032: NM_—018113
  Homo sapiens lipocalin-interacting membrane receptor (LIMR), mRNA
  gi|8922462|ref|NM_—018113.1|[8922462]
• 2033: NM_—018423
  Homo sapiens hypothetical protein DKFZp761P1010 (DKFZp761P1010), mRNA
  gi|8922178|ref|NM_—018423.1|[8922178]
• 2034: AF257182
  Homo sapiens G-protein-coupled receptor 48 (GPR48) mRNA, complete cds
  gi|7739736|gb|AF257182.1|AF257182[7739736]
• 2035: NM_—016442
  Homo sapiens type 1 tumor necrosis factor receptor shedding aminopeptidase regulator (ARTS-1), mRNA
  gi|7706544|ref|NM_—016442.1|[7706544]
• 2036: NM_—015364
  Homo sapiens MD-2 protein (MD-2), mRNA
  gi|7702503|ref|NM_—015364.1|[7702503]
• 2037: NM_—014380
  Homo sapiens nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), mRNA
  gi|7657043|ref|NM_—014380.1|[7657043]
• 2038: NM_—013308
  Homo sapiens platelet activating receptor homolog (H963), mRNA
  gi|7019400|ref|NM_—013308.1|[7019400]
• 2039: NM_—013333
  Homo sapiens EH domain-binding mitotic phosphoprotein (EPSIN), mRNA
  gi|7019368|ref|NM_—013333.1|[7019368]
• 2040: NM_—007369
  Homo sapiens G-protein coupled receptor (RE2), mRNA
  gi|6677700|ref|NM_—007369.1|[6677700]
• 2041: NM_—002673
  Homo sapiens plexin B1 (PLXNB1), mRNA
  gi|6631105|ref|NM_—002673.1|[6631105]
• 2042: NM_—007115
  Homo sapiens tumor necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA
  gi|6005905|ref|NM_—007115.1|[6005905]
• 2044: NM_—007223
  Homo sapiens putative G protein coupled receptor (GPR), mRNA
  gi|6005771|ref|NM_—007223.1|[6005771]
• 2045: NM_—006748
  Homo sapiens Src-like-adaptor (SLA), mRNA
  gi|5803170|ref|NM_—006748.1|[5803170]
• 2046: NM_—006681
  Homo sapiens neuromedin U (NMU), mRNA
  gi|5729946|ref|NM_—006681.1|[5729946]
• 2047: NM_—006068
  Homo sapiens toll-like receptor 6 (TLR6), mRNA
  gi|5174720|ref|NM_—006068.1|[5174720]
• 2048: NM_—006018
  Homo sapiens putative chemokine receptor; GTP-binding protein (HM74), mRNA
  gi|5174460|ref|NM_—006018.1|[5174460]
• 2049: NM_—006098
  Homo sapiens guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 (GNB2L1), mRNA
  gi|5174446|ref|NM_—006098.1|[5174446]
• 2050: NM_—005879
  Homo sapiens TRAF interacting protein (TRIP), mRNA
  gi|5032194|ref|NM_—005879.1|[5032194]
• 2051: NM_—005843
  Homo sapiens signal transducing adaptor molecule (SH3 domain and ITAM motif) 2
  (STAM2), mRNA
  gi|5032126|ref|NM_—005843.1|[5032126]
• 2052: NM_—005505
  Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1 (CD36L1), mRNA
  gi|5031628|ref|NM_—005505.1|[5031628]
• 2053: NM_—005795
  Homo sapiens calcitonin receptor-like (CALCRL), mRNA
  gi|5031620|ref|NM_—005795.1|[5031620]
• 2054: NM_—005400
  Homo sapiens protein kinase C, epsilon (PRKCE), mRNA
  gi|4885562|ref|NM_—005400.1|[4885562]
• 2057: NM_—004488
  Homo sapiens glycoprotein V (platelet) (GP5), mRNA
  gi|4758459|ref|NM_—004488.1|[4758459]
• 2058: NM_—004122
  Homo sapiens growth hormone secretagogue receptor (GHSR), mRNA
  gi|4758433|ref|NM_—004122.1|[4758433]
• 2059: NM_—004438
  Homo sapiens EphA4 (EPHA4), mRNA
  gi|4758279|ref|NM_—004438.1|[4758279]
• 2060: NM_—004198
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 6 (CHRNA6), mRNA
  gi|4757981|ref|NM_—004198.1|[4757981]
• 2061: NM_—004054
  Homo sapiens complement component 3a receptor 1 (C3AR1). mRNA
  gi|4757887|ref|NM_—004054.1|[4757887]
• 2062: NM_—003955
  Homo sapiens STAT induced STAT inhibitor 3 (SSI-3), mRNA
  gi|4507234|ref|NM_—003955.1|[4507234]
• 2063: NM_—003693
  Homo sapiens acetyl LDL receptor; SREC=scavenger receptor expressed by endothelial cells (SREC), mRNA
  gi|4507202|ref|NM_—003693.1|[4507202]
• 2064: NM_—003625
  Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
  interacting protein (liprin), alpha 2 (PPFIA2), mRNA
  gi|4505984|ref|NM_—003625.1|[4505984]
• 2065: NM_—000286
  Homo sapiens peroxisomal biogenesis factor 12 (PEX12), mRNA
  gi|4505720|ref|NM_—000286.1|[4505720]
• 2066: NM_—002563
  Homo sapiens purinergic receptor P2Y, G-protein coupled, 1 (P2RY1), mRNA
  gi|4505556|ref|NM_—002563.1|[4505556]
• 2067: NM_—000913
  Homo sapiens opiate receptor-like 1 (OPRL1), mRNA
  gi|4505512|ref|NM_—000913.1|[4505512]
• 2068: NM_—002333
  Homo sapiens low density lipoprotein receptor-related protein 3 (LRP3), mRNA
  gi|4505014|ref|NM_—002333.1|[4505014]
• 2069: NM_—001957
  Homo sapiens endothelin receptor type A (EDNRA), mRNA
  gi|4503464|ref|NM_—001957.1|[4503464]
• 2070: L34726
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100206|gb|L34726.1|HUMTCRBZ[1100206]
• 2071: L34725
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100204|gb|L34725.1|HUMTCRBY[1100204]
• 2072: L34724
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100202|gb|L34724.1|HUMTCRBU[1100202]
• 2073: L34723
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100200|gb|L34723.1|HUMTCRBT[1100200]
• 2074: L34722
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100198|gb|L34722.1|HUMTCRBS[1100198]
• 2075: L34721
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7). partial cds
  gi|1100196|gb|L34721.1|HUMTCRBQ[1100196]
• 2076: L34719
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100192|gb|L34719.1|H1MTCRBO[1100192]
• 2077: L34737
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR2, 7), partial cds
  gi|1100188|gb|L34737.1|HUMTCRBAO[1100188]
• 2078: L34736
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR2, 7), partial cds
  gi|1100186|gb|L34736.1|HUMTCRBAN[1100186]
• 2079: L34735
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100184|gb|L34735.1|HUMTCRBAM[1100184]
• 2080: L34733
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1001179|gb|L34733.1|HUMTCRBAK[1100179]
• 2081: L34732
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29: B7, 44; DR 2, 7), partial cds
  gi|1100177|gb|L34732.1|HUMTCRBAJ[1100177]
• 2082: L34731
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100175|gb|L34731.1|HUMTCRBAI[1100175]
• 2083: L34730
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100173|gb|L34730.1|HUMTCRBAH[1100173]
• 2084: L34728
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100169|gb|L34728.1|HUMTCRBAF[1100169]
• 2085: L34727
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100167|gb|L34727.1|HUMTCRBAE[1100167]
• 2086: L34703
  Homo sapiens T-cell receptor alpha chain (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1,
  3), complete cds
  gi|110065|gb|L34703.1|HUMTCRAZ[1100165]
• 2087: L34702
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100163|gb|L34702.1|HUMTCRAY[1100163]
• 2088: L34701
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100161|gb|L34701.1|HUMTCRAV[1100161]
• 2089: L34700
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1001159|gb|L34700.1|HUMTCRAU[1100159]
• 2090: L34699
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; C7; DR 1, 3),
  partial cds
  gi|1001157|gb|L34699.1|HUMTCRAT[1100157]
• 2091: L34698
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), complete cds
  gi|1100155|gb|L34698.1|HUMTCRAQ[1100155]
• 2092: L34695
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR2, 7), partial cds
  gi|1001153|gb|L34695.1|HUMTCRAP[1100153]
• 2093: L34694
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; C7; DR 1, 3),
  partial cds
  gi|1100151|gb|L34694.1|HUMTCRAO[1100151]
• 2094: L34738
  Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; C7; DR 1, 3),
  partial cds
  gi|1100149|gb|L34738.1|HUMTCRAAX[1100149]
• 2095: L34718
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100147|gb|L34718.1|HUMTCRAAW[1100147]
• 2096: L34717
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|100145|gb|L34717.1|HUMTCRAAV[1100145]
• 2097: L34716
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|100143|gb|L34716.1|HUMTCRAAU[1100143]
• 2098: L34715
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100141|gb|L34715.1|HUMTCRAAT[1100141]
• 2099: L34714
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
  gi|1100139|gb|L34714.1|HUMTCRAAT[1100139]
• 2100: L34713
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100137|gb|L34713.1|HUMTCRAAR[1100137]
• 2101: L34712
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100135|gb|L34712.1|HUMTCRAAQ[1100135]
• 2102: L34711
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100133|gb|L34711.1|HUMTCRAAP[1100133]
• 2103: L34710
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100131|gb|L34710.1|HUMTCRAAO[1100131]
• 2104: L34709
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100129|gb|L34709.1|HUMTCRAAN[1100129]
• 2105: L34708
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR1, 3), partial cds
  gi|1100127|gb|L34708.1|HUMTCRAAM[1100127]
• 2106: L34707
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100125|gb|L34707.1|HUMTCRAAL[1100125]
• 2107: L34706
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100123|gb|L34706.1HUMTCRAAK[1100123]
• 2108: L34705
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100121|gb|L34705.1|HUMTCRAAJ[1100121]
• 2109: L34704
  Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
  gi|1100119|gb|L34704.1|HUMTCRAAI[1100119]
• 2110: L29037
  Human T-cell antigen receptor mRNA
  gi|517066|gb|L29037.1|HUMTCRBW[517066]
• 2111: L29038
  Human T-cell antigen receptor mRNA
  gi|456432|gb|L29038.1|HUMTCRBX[456432]
• 2112: L29036
  Human T-cell antigen receptor mRNA
  gi|456431|gb|L29036.1|HUMTCRAX[456431]
• 2113: L29035
  Human T-cell antigen receptor mRNA
  gi|456430|gb|L29035.1|HUMTCRAW[456430]
• 2114: AF106913
  Homo sapiens CRL3 protein (CRL3) mRNA, complete cds
  gi|7221662|gb|AF106913.1|AF106913[17221662]
• 2115: AB055881
  Homo sapiens NKp30 mRNA for natural killer cell receptor, complete cds
  gi|17221621|dbj|AB055881.1|AB055881[17221621]
• 2116: AJ417149
  Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 21
  gi|17154680|emb|AJ417149.1|HSA417149[17154680]
• 2117: AJ417148
  Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 17
  gi|17148484|emb|AJ417148.1|HSA417148[17148484]
• 2118: NM_—054021
  Homo sapiens G protein-coupled receptor 101 (GPR101), mRNA
  gi|16876434|ref|NM_—054021.1|[16876434]
• 2119: NM_—052939
  Homo sapiens Fc receptor-like protein 3 (FCRH3), mRNA
  gi|16418420|ref|NM_—052939.1|[16418420]
• 2120: NM_—052938
  Homo sapiens Fc receptor-like protein 1 (FCRH1), mRNA
  gi|16418418|ref|NM_—052938.1|[16418418]
• 2121: NM_—003823
  Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68E, mRNA
  gi|14790166|ref|NM_—003823.2|[14790166]
• 2122: NM_—006470
  Homo sapiens tripartite motif-containing 16 (TRIM16), mRNA
  gi|14577927|ref|NM_—006470.2|[14577927]
• 2123: NM_—031918
  Homo sapiens Kruppel-like factor 16 (KLF16), mRNA
  gi|13994286|ref|NM_—031918.1|[13994286]
• 2124: NM_—023945
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 5 (MS4A5), mRNA
  gi|12965204|ref|NM_—023945.1|[12965204]
• 2125: NM_—018485
  Homo sapiens G protein-coupled receptor C5L2 (LOC55868), mRNA
  gi|8923872|ref|NM_—018485.1|[8923872]
• 2126: NM_—016562
  Homo sapiens toll-like receptor 7 (TLR7), mRNA
  gi|7706092|ref|NM_—016562.1|[7706092]
• 2130: NM_—006138
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) (MS4A3), mRNA
  gi|5453608|ref|NM_—006138.1|[5453608]
• 2131: AF447176
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 20 and complete cds
  gi|17432420|gb|AF447176.1|F447157S11[17432420]
• 2132: AF447175
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 19
  gi|17432419|gb|AF447175.1|F447157S10[17432419]
• 2133: AF447174
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 18
  gi|17432418|gb|AF447174.1|F447157S09[17432418]
• 2134: AF447173
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 17
  gi|17432417|gb|AF447173.1|F447157S08[17432417]
• 2135: AF447171
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 15 and 16
  gi|17432416|gb|AF447171.1|F447157S07[17432416]
• 2136: AF447170
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 14
  gi|174324155gb|AF447170.1|F447157S06[17432415]
• 2137: AF447167
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 11, 12, and 13
  gi|17432414|gb|AF447167.1|F447157S05[17432414]
• 2138: AF447164
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 8, 9, and 10
  gi|17432413|gb|AF447164.1|F447157S04[17432413]
• 2139: AF447162
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 6 and 7
  gi|17432412|gb|AF447162.1|F447157S03[17432412]
• 2140: AF447158
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 2, 3, 4, and 5
  gi|17432411|gb|AF447158.1F447157S02[17432411]
• 2141: AF447157
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 1
  gi|17432410|gb|AF447157.1|F447157S01[17432410]
• 2142: AH011239
  Homo sapiens protein tyrosine kinase-7 (PTK7) gene, complete cds
  gi|17432409|gb|AH011239.1|SEG_F447157S[17432409]
• 2143: AF374231
  Homo sapiens corticotropin releasing hormone receptor variant 1 h mRNA, partial
  cds, alternatively spliced
  gi|17432316|gb|AF374231.1|AF374231[17432316]
• 2145: AY013309
  Homo sapiens clone FM1-3.3.12A immunoglobulin heavy chain variable region gene,
  partial cdc
  gi|17220530|gb|AY013309.1|[17220530]
• 2146: AY013308
  Homo sapiens clone FL1-2.4.2G immunoglobulin heavy chain variable region gene,
  partial cds
  gi|17220528|gb|AY013308.1|[17220528]
• 2147: AY013307
  Homo sapiens clone FL1-2.4.12A immunoglobulin heavy chain variable region gene,
  partial cds
  gi|17220526|gb|AY013307.1|[17220526]
• 2148: AY013306
  Homo sapiens clone FL3-3.4.4G immunoglobulin heavy chain variable region gene,
  partial cds
  gi|17220524|gb|AY013306.1|[17220524]
• 2149: AB062787
  Homo sapiens mRNA for triggering receptor TREM-2V, complete cds
  gi|17425161|dbj|AB062787.1|AB062787[17425161]
• 2150: NM_—003392
  Homo sapiens wingless-type MMTV integration site family, member 5A (WNT5A), mRNA
  gi|17402917|ref|NM_—003392.2|[17402917]
• 2152: AJ421518
  Homo sapiens mRNA for tumor necrosis factor-stimulated gene 6 (TSG-6) protein,
  G431 allele
  gi|17402491|emb|A1|AJ421518.1|HSA421518[17402491]
• 2153: NM_—053049
  Homo sapiens stresscopin (SPC), mRNA
  gi|16596691|ref|NM_—053049.1|[16596691]
• 2154: AF430697
  Homo sapiens T cell receptor beta variable region, Vbeta 13S3-KRGAYETQYF-Jbeta
  2.5 mRNA, partial cds
  gi|16566919|gb|AF430697.1|AF430697[16566919]
• 2155: AF430696
  Homo sapiens T cell receptor beta variable region, Vbeta 13S2A1T-SEVRETQYF-Jbeta
  2.5 mRNA, partial cds
  gi|16566916|gb|AF430696.1|AF430696[16566916]
• 2156: AF430695
  Homo sapiens T cell receptor beta variable region, Vbeta 13S3-EKVTGGETQYF-Jbeta
  2.5 mRNA, partial cds
  gi|16566913|gb|AF430695.1|AF430695[16566913]
• 2157: AF430694
  Homo sapiens T cell receptor beta variable region, Vbeta
  13S2A1T-QGRTSVIETQYF-Jbeta 2.5 mRNA, partial cds
  gi|16566910|gb|AF430694.1|AF430694[16566910]
• 2158: AF430693
  Homo sapiens T cell receptor beta variable region, Vbeta
  13S2A1T-RSDRRKTRYF-Jbeta2.5 mRNA, partial cds
  gi|16566907|gb|AF430693.1|AF430693[16566907]
• 2159: AF430692
  Homo sapiens T cell receptor beta variable region, Vbeta 13S3-GRGAQETQYF-Jbeta
  2.5 mRNA, partial cds
  gi|16566904|gb|AF430692.1|AF430692[16566904]
• 2160: AF430691
  Homo sapiens T cell receptor beta variable region, Vbeta 13S2A1T-GGQTYF-Jbeta 2.5 mRNA, partial cds
  gi|1656690|gb|AF430691.1|AF430691[16566901]
• 2161: AF430690
  Homo sapiens T cell receptor beta variable region, Vbeta 1S1A1N1-SGLTPNTGELFF-Jbeta 2.2 mRNA, partial cds
  gi|16566898|gb|AF430690.1|AF430690[16566898]
• 2162: AF430689
  Homo sapiens T cell receptor beta variable region, Vbeta 13S6A1N1-TSPVPIGTDTQYF-Jbeta 2.3 mRNA, partial cds
  gi|16566895|gb|AF430689.1|AF430689[16566895]
• 2163: AF430688
  Homo sapiens T cell receptor beta variable region, Vbeta 13S3-MFGGSTGELFF-Jbeta
  2.2 mRNA, partial cds
  gi|16566892|gb|AF430688.1|AF430688[16566892]
• 2164: AF430687
  Homo sapiens T cell receptor beta variable region, Vbeta 13S3-AQGKGTQYF-Jbeta 2.5 mRNA, partial cds
  gi|16566889|gb|AF430687.1|AF430687[16566889]
• 2165: AF430686
  Homo sapiens T cell receptor beta variable region, Vbeta 13 S3-EQGLLSTDTQYF-Jbeta 2.3 mRNA, partial cds
  gi|16566886|gb|AF430686.1|AF430686[16566886]
• 2166: AF430685
  Homo sapiens T cell receptor beta variable region, Vbeta 13S5-ETPGQGAGELFF-Jbeta
  2.2 mRNA, partial cds
  gi|16566883|gb|AF430685.1|AF430685[16566883]
• 2167: AF430684
  Homo sapiens T cell receptor beta variable region, Vbeta 13S5-RLAGASYNEQYF-Jbeta
  2.1 mRNA, partial cds
  gi|16566880|gb|AF430684.1|AF430684[16566880]
• 2168: AF430683
  Homo sapiens T cell receptor beta variable region, Vbeta 13S5-DTAGSTDTQYF-Jbeta
  2.3 mRNA, partial cds
  gi|16566877|gb|AF430683.1|AF430683[16566877]
• 2169: AF430682
  Homo sapiens T cell receptor beta variable region, Vbeta 13S5-EVASGTDTQYF-Jbeta
  2.3 mRNA, partial cds
  gi|16566874|gb|AF430682.1|AF430682[16566874]
• 2170: AF430681
  Homo sapiens T cell receptor beta variable region, Vbeta S6A3N2T-ASSGGYEQYF-Jbeta 2.7 mRNA, partial cds
  gi|16566871|gb|AF430681.1|AF430681[16566871]
• 2171: AF430680
  Homo sapiens T cell receptor beta variable region, Vbeta 5 S3A1T/S1A1T-RRSDTQYF-Jbeta 2.3 mRNA, partial cds
  gi|16566868|gb|AF430680.1|AF430680[16566868]
• 2172: AF430679
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-FGGEDTDTQYF-Jbeta 2.3 mRNA, partial cds
  gi|16566865|gb|AF430679.1|AF430679[16566865]
• 2173: AF430678
  Homo sapiens T cell receptor beta variable region, Vbeta 5 S2-FGTRGNEQFF-Jbeta
  2.7 mRNA, partial cds
  gi|16566862|gb|AF430678.1|AF430678[16566862]
• 2174: AF430677
  Homo sapiens T cell receptor beta variable region, Vbeta 5-FQGARETQYF-Jbeta 2.5
  mRNA, partial cds
  gi|16566859|gb|AF430677.1|AF430677[16566859]
• 2175: AF430676
  Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-FTGTGIYGYTF-Jbeta 1.2 mRNA, partial cds
  gi|16566856|gb|AF430676.1|AF430676[16566856]
• 2176: AF430675
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-APLTGDSGNTIYF-Jbeta 1.3 mRNA, partial cds
  gi|16566853|gb|AF430675.1|AF430675[16566853]
• 2177: AF430674
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1TSDLSGANVLTF-Jbeta
  2.6 mRNA, partial cds
  gi|16566850|gb|AF430674.1|AF430674[16566850]
• 2178: AF430673
  Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-GQGKGTF-Jbeta
  1.2 mRNA, partial cds
  gi|16566847|gb|AF430673.1|AF430673[16566847]
• 2179: AF430672
  Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-YTGGVWRNQYF-Jbeta 2.5 mRNA, partial cds
  gi|16566844|gb|AF430672.1|AF430672[16566844]
• 2180: AF430671
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2-FSGGAHTQYF-Jbeta 2.3 mRNA, partial cds
  gi|16566841|gb|AF430671.1|AF430671[16566841]
• 2181: AF430670
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2/S6A3N2T-SGQGKTEAFF-Jbeta 1.1 mRNA, partial cds
  gi|16566838|gb|AF430670.1|AF430670[16566838]
• 2182: AF430669
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-FSKGVTEAFF-Jbeta
  1.1 mRNA, partial cds
  gi|16566835|gb|AF430669.1|AF430669[16566835]
• 2183: AF430668
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2-SSPTGRSGNTIYF-Jbeta
  1.3 mRNA, partial cds
  gi|16566832|gb|AF430668.1|AF430668[16566832]
• 2184: AF430667
  Homo sapiens T cell receptor beta variable region, Vbeta 5S4A2T-PLLGQGRDEQFF-Jbeta 2.1 mRNA, partial cds
  gi|16566829|gb|AF430667.1|AF430667[16566829]
• 2185: AF430666
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-FDFPGELFF-Jbeta
  2.2 mRNA, partial cds
  gi|16566827|gb|AF430666.1|AF430666[16566827]
• 2186: AF430665
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-DPSGGYNEQFF-Jbeta 2.1 mRNA, partial cds
  gi|16566824|gb|AF430665.1|AF430665[16566824]
• 2187: AF430664
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-DATGNLNEQYF-Jbeta 2.7 mRNA, partial cds
  gi|16566821|gb|AF430664.1|AF430664[16566821]
• 2188: AF430663
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-SGQVTGELFF-Jbeta
  2.2 mRNA, partial cds
  gi|16566818|gb|AF430663.1|AF430663[16566818]
• 2189: AF430662
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-AWWGAGYEGYF-Jbeta 2.7 mRNA, partial cds
  gi|16566815|gb|AF430662.1|AF430662[16566815]
• 2190: AF430661
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-RRLAGVYNEQFF-Jbeta 2.1 mRNA, partial cds
  gi|16566812|gb|AF430661.1|AF430661[16566812]
• 2191: AF430660
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-EFQAPYGYTF-Jbeta 1.2 mRNA, partial cds
  gi|6566809|gb|AF430660.1|AF430660[16566809]
• 2192: AF430659
  Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-TGTESPDTQYF-Jbeta 2.3 mRNA, partial cds
  gi|16566806|gb|AF430659.1|AF430659[16566806]
• 2193: AF430658
  Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-TFGTPTYNEQFF-Jbeta 2.1 mRNA, partial cds
  gi|16566803|gb|AF430658.1|AF430658[16566803]
• 2194: AF430657
  Homo sapiens T cell receptor beta variable region, Vbeta 5-SGPSTDTQYF-Jbeta 2.3
  mRNA, partial cds
  gi|16566800|gb|AP430657.1|AF430657[16566800]
• 2195: AF430656
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2-NPGGNYGYTF-Jbeta 1.2 mRNA, partial cds
  gi|16566797|gb|AF430656.1|AF430656[16566797]
• 2196: AF430655
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-VIGTYEQYF-Jbeta
  2.7 mRNA, partial cds
  gi|6566794|gb|AF430655.1|AF430655[16566794]
• 2197: AF430654
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2-AGGETQYF-J beta
  2.5
  mRNA, partial cds
  gi|16566791|gb|AF430654.1|AF430654[16566791]
• 2198: AF430653
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-VSGRGSYEQYF-Jbeta 2.7 mRNA, partial cds
  gi|16566788|gb|AF430653.1|AF430653[16566788]
• 2199: AF430652
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2-VRSEAFF-JBeta 1.1
  mRNA, partial cds
  gi|16566785|gb|AF430652.1|AF430653[16566785]
• 2200: AF430651
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-RTRTGETNTGELFF-JBeta2.2 mRNA, partial cds
  gi|16566782|gb|AF430651.1|AF430651[16566782]
• 2201: AF430650
  Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-GAGPSGELFF-JBeta 2.2 mRNA, partial cds
  gi|16566779|gb|AF430650.1|AF430650[16566779]
• 2202: AF430649
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-GGGTGELFF-Jbeta2.2 mRNA, partial cds
  gi|16566776(gb|AF430649.1|AF430649[16566776]
• 2203: AF430648
  Homo sapiens T cell receptor beta variable region, Vbeta 5S1AT-PGQGAYEQYF-2.7 mRNA, partial cds
  gi|16566773|gb|AF430648.1|AF430648[16566773]
• 2204: AF430647
  Homo sapiens T cell receptor beta variable region, Vbeta 5S2-RPDSGYTF-Jeta1.2 mRNA, partial cds
  gi|6566770|gb|AF430647.1|AF430647[16566770]
• 2205: AF411117
  Homo sapiens G protein-coupled receptor (GPR103) mRNA, complete cds
  gi|16566346|gb|AF411117.1|AF411117[16566346]
• 2206: AF411116
  Homo sapiens G protein-coupled receptor (GPR102) gene, complete cds
  gi|16566343|gb|AF411116.1|AF411116[16566343]
• 2207: AF411115
  Homo sapiens G protein-coupled receptor (GPR101) gene, complete cds
  gi|16566340|gb|AF411115.1|AF411115[16566340]
• 2208: AF411114
  Homo sapiens G protein-coupled receptor (GPR95) mRNA, complete cds
  gi|16566337|gb|AF411114.1|AF411114[16566337]
• 2209: AF411113
  Homo sapiens G protein-coupled receptor (GPR94) gene, complete cds
  gi|16566334|gb|AF411113.1|AF411113[16566334]
• 2210: AF411112
  Homo sapiens G protein-coupled receptor (GPR93) gene, complete cds
  gi|16566331|gb|AF411112.1|AF411112[16566331]
• 2211: AF411111
  Homo sapiens G protein-coupled receptor (GPR82) gene, complete cds
  gi|16566328|gb|AF411111.1|AF411111[16566328]
• 2212: AF411110
  Homo sapiens G protein-coupled receptor (GPR81) gene, complete cds
  gi|16566325|gb|AF411110.1|AF411110[16566325]
• 2213: AF411109
  Homo sapiens G protein-coupled receptor (GPR80) gene, complete cds
  gi|16566322|gb|AF411109.1|AF411109[16566322]
• 2215: AF411107
  Homo sapiens G protein-coupled receptor (GPR78) mRNA, complete cds
  gi|1656631B|gb|AF411107.1|AF411107[16566318]
• 2216: AF406692
  Homo sapiens G protein-coupled receptor GPR86 mRNA, complete cds
  gi|5487985|gb|AF406692.1|AF406692[15487985]
• 2217: NM_—019035
  Homo sapiens protocadherin 18 (PCDH18), mRNA
  gi|14589928|ref|NM_—019035.1|[14589928]
• 2218: AF214012
  Homo sapiens prolactin receptor gene, exon 11 and partial sequence
  gi|14328908|gb|AF214012.1|AF214012[14328908]
• 2219: NM_—030943
  Homo sapiens amnionless protein (AMN), mRNA
  gi|13569914|ref|NM_—030943.1|[13569914]
• 2220: NM_—023922
  Homo sapiens taste receptor, type 2, member 14 (TAS2R14), mRNA
  gi|12965181|ref|NM_—023922.1|[12965181]
• 2221: NM_—023921
  Homo sapiens taste receptor, type 2, member 10 (TAS2R10), mRNA
  gi|12965179|ref|NM_—023921.1|[12965179]
• 2222: NM_—023920
  Homo sapiens taste receptor, type 2, member 13 (TAS2R13), mRNA
  gi|12965177|ref|NM_—023920.1|[12965177]
• 2223: NM_—023919
  Homo sapiens taste receptor, type 2, member 7 (TAS2R7), mRNA
  gi|12965175|ref|NM_—023919.1|[12965175]
• 2224: NM_—023918
  Homo sapiens taste receptor, type 2, member 8 (TAS2R8), mRNA
  gi|12965173|ref|NM_—023918.1|[12965173]
• 2225: NM_—023917
  Homo sapiens taste receptor, type 2, member 9 (TAS2R9), mRNA
  gi|12965171|ref|NM_—023917.1|[12965171]
• 2226: AF206696
  Homo sapiens interleukin-1 epsilon (IL1E) mRNA, complete cds
  gi|11493847|gb|AF206696.1|AF206696[11493847]
• 2227: AF230377
  Homo sapiens interleukin-1 delta mRNA, complete cds
  gi|9651788|gb|AF230377.1|AF230377[9651788]
• 2228: BC018284
  Homo sapiens, triggering receptor expressed on myeloid cells 2, clone IMAGE:4151400, mRNA
  gi|17390669|gb|BC018284.1|BC018284[17390669]
• 2229: BC018130
  Homo sapiens, coagulation factor II (thrombin) receptor-like 1, clone MGC:9298
  IMAGE:3895653, mRNA, complete cds
  gi|17390291|gb|BC018130.1|BC018130[17390291]
• 2230: BC017898
  Homo sapiens, Purinergic receptor P2Y, G protein-coupled, 12, clone MGC:23802 IMAGE:4251263, mRNA, complete cds
  gi|17389766|gb|BC017898.1|BC017898[17389766]
• 2231: BC017865
  Homo sapiens, Fc fragment of IgG, low affinity 111a, receptor for (CD16), clone
  MGC:22630 IMAGE:4690249, mRNA, complete cds
  gi|17389687|gb|BC017865.1|BC017865[17389687]
• 2232: BC017852
  Homo sapiens, tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain, clone IMAGE:4700855, mRNA
  gi|17389657|gb|BC017852.1|BC017852[17389657]
• 2233: BC017784
  Homo sapiens, killer cell lectin-like receptor subfamily C, member 4, clone MGC:22279 IMAGE:4619154, mRNA, complete cds
  gi|17389488|gb|BC017784.1|BC017784[17389488]
• 2234: BC017773
  Homo sapiens, triggering receptor expressed on myeloid cells 1, clone MGC:22242
  IMAGE:4692680, mRNA, complete cds
  gi|17389458|gb|BC017773.1|BC017773[17389458]
• 2235: BC017730
  Homo sapiens, tumor necrosis factor receptor superfamily, member 21, clone MGC:21476 IMAGE:3847246, mRNA, complete cds
  gi|17389378|gb|BC017730.1|BC017730[17389378]
• 2237: AJ252246
  Homo sapiens mRNA for kainate receptor subunit (GRIK2 gene)
  gi|17384623|emb|AJ252246.1|HSA252246[17384623]
• 2238: AJ249210
  Homo sapiens mRNA for glutamate/kainate receptor subtype GluR7 (GRIK3 gene)
  gi|17384612|emb|AJ249210.1|HSA249210[17384612]
• 2239: AJ249209
  Homo sapiens mRNA for glutamate/kainate receptor subunit KA2a (GRIK5 gene)
  gi|17384610|emb|AJ249209.1|HSA249209[17384610]
• 2240: AJ249208
  Homo sapiens mRNA for glutamate receptor subunit GluR5 (GRIK1 gene)
  gi|17384608|emb|AJ249208.1|HSA249208[17384608]
• 2241: AJ415410
  Homo sapiens partial IGVK1-O14 gene for immunoglobulin kappa chain variable region, donor MF, cell24
  gi|17384019|emb|AJ415410.2|HSA415410[17384019]
• 2242: AJ415291
  Homo sapiens partial IGVH3-33 gene for immunoglobulin heavy chain variable region, donor TG, cell46
  gi|17384018|emb|AJ415291.2|HSA415291[17384018]
• 2243: AJ414840
  Homo sapiens partial IGVKA30 gene for immunoglobulin kappa chain variable region, donor MF, cell2
  gi|17384017|emb|AJ414840.2|HSA414840[17384017]
• 2244: NM_—000623
  Homo sapiens bradykinin receptor B2 (BDKRB2), mRNA
  gi|17352499|ref|NM_—000623.2|[17352499]
• 2246: AJ347709
  Homo sapiens mRNA for FKBP-associated protein
  gi|15620770|emb|AJ347709.1|HSA347709[15620770]
• 2247: AF356518
  Homo sapiens junctional adhesion molecule 3 precursor, mRNA, complete cds
  gi|13448824|gb|AF356518.1|AF356518[13448824]
• 2248: NM_—021201
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), mRNA
  gi|11139298|ref|NM_—021201.1|[11139298]
• 2249: NM_—015344
  Homo sapiens leptin receptor overlapping transcript-like 1 (LEPROTL1), mRNA
  gi|7662509|ref|NM_—015344.1|[7662509]
• 2250: AF411850
  Homo sapiens C-type lectin-like receptor CLEC-6 mRNA, complete cds
  gi|17226267|gb|AF411850.1|AF411850[17226267]
• 2251: AF325460
  Homo sapiens dendritic lectin b isoform (CLECSF11) mRNA, complete cds, alternatively spliced
  gi|17225338|gb|AF325460.1|AF325460[17225338]
• 2252: AF325459
  Homo sapiens dendritic lectin (CLECSF11) mRNA, complete cds, alternatively spliced
  gi|17225336|gb|AF325459.1|AF325459[17225336]
• 2253: AF293357
  Homo sapiens AT2 receptor-interacting protein 1 mRNA, complete cds
  gi|17224595|gb|AF293357.1|AF293357[17224595]
• 2254: AF283988
  Homo sapiens leukocyte immunoglobulin-like receptor-5 (LILRB5) mRNA, LILRB5-v1
  allele, complete cds
  gi|17224473|gb|AF283988.1|AF283988[17224473]
• 2255: AF283987
  Homo sapiens leukocyte immunoglobulin-like receptor-2 (LILRB2) mRNA, LILRB2-v2
  allele, complete cds
  gi|17224471|gb|AF283987.1|AF283987[17224471]
• 2256: AF283986
  Homo sapiens leukocyte immunoglobulin-like receptor-2 (LILRB2) mRNA, LILRB2-v1
  allele, complete cds
  gi|17224469|gb|AF283986.1|AF283986[17224469]
• 2257: AF283985
  Homo sapiens leukocyte immunoglobulin-like receptor-1 (LILRB1) mRNA, LILRB1-v2
  allele, complete cds
  gi|17224467|gb|AF283985.1|AF283985[17224467]
• 2258: AF283984
  Homo sapiens leukocyte immunoglobulin-like receptor-1 (LILRB1) mRNA, LILRB1-v1
  allele, complete cds
  gi|17224465|gb|AF283984.1|AF283984[17224465]
• 2259: NM_—057170
  Homo sapiens G protein-coupled receptor kinase-interactor 2 (GIT2), transcript
  variant 2, mRNA
  gi|17149831|ref|NM_—057170.1|[17149831]
• 2260: NM_—057169
  Homo sapiens G protein-coupled receptor kinase-interactor 2 (GIT2), transcript
  variant 1, mRNA
  gi|17149829|ref|NM_—057169.1|[17149829]
• 2261: AJ417151
  Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 25
  gi|17148488|emb|AJ417151.1|HSA417151[17148488]
• 2262: AJ417150
  Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 27
  gi|17148486|emb|AJ417150.1|HSA417150[17148486]
• 2263: NM_—014776
  Homo sapiens G protein-coupled receptor kinase-interactor 2 (GIT2), transcript
  variant 3, mRNA
  gi|7661943|ref|NM_—014776.1|[7661943]
• 2264: AJ239326
  Homo sapiens chromosome 21 clone cosmid LLNLc116 32E2 map 21q22.3, *** SEQUENCING IN PROGRESS ***, 4 ordered pieces
  gi|6982097|emb|AJ239326.3|HSS171M[6982097]
• 2265: NM_—000675
  Homo sapiens adenosine A2a receptor (ADORA2A), mRNA
  gi|17136146|ref|NM_—000675.3|[17136146]
• 2266: AF035374
  Homo sapiens Cys-rich protein (RAMP) mRNA, complete cds
  gi|2665702|gb|AF035374.1|AF035374[2665702]
• 2267: AF282269
  Homo sapiens G protein-coupled receptor kinase 7 mRNA, complete cds
  gi|17026317|gb|AF282269.1|AF282269[17026317]
• 2268: AF437510
  Homo sapiens T-cell receptor beta-chain mRNA, partial cds
  gi|16974744|gb|AF437510.1|AF437510[16974744]
• 2269: AX286800
  Sequence 35 from Patent WO0178796
  gi|17048833|emb|AX286800.1|AX286800[17048833]
• 2270: AX286799
  Sequence 34 from Patent WO0178796
  gi|17048832|emb|AX286799.1|AX286799[17048832]
• 2271: AB005145
  Homo sapiens CL-P1 mRNA for collectin placenta 1, complete cds
  gi|17026100|dbj|AB005145.1|AB005145[17026100]
• 2272: SEG_HUMIL3RA
  Homo sapiens gene for interleukin 3 receptor alpha subunit
  gi|1345401|dbj||SEG_HUMIL3RA[1345401]
• 2273: L34720
  Homo sapiens T-cell receptor beta (TCRB) mRNA, partial cds
  gi|1100194|gb|L34720.1|HUMTCRBP[1100194]
• 2274: L34734
  Homo sapiens T-cell receptor beta (TCRB) mRNA, complete cds
  gi|1100181|gb|L34734.1|HUMTCRBAL[1100181]
• 2275: L34729
  Homo sapiens T-cell receptor beta (TCRB) mRNA, partial cds
  gi|110017|gb|L34729.1|HUMTCRBAG[1100171]
• 2276: D49412
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 11
  gi|684969|dbj|D49412.1|HUMIL3RA11[684969]
• 2277: D49410
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 12 and partial
  cds
  gi|684968|dbj|D49410.1|HUMIL3RA12[684968]
• 2278: D49408
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 10
  gi|684967|dbj|D49408.1|HUMIL3RA10[684967]
• 2279: D49409
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 6
  gi|684966|dbj|D549409.1|HUMIL3RA06[684966]
• 2280: D49407
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 4
  gi|684965|dbj|D549407.1|HUMIL3RA04[684965]
• 2281: D49406
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 2
  gi|684964|dbj|D549406.1|HUMIL3RA02[684964]
• 2282: D49404
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 7
  gi|684963|dbj|D549404.1|HUMIL3RA07[684963]
• 2283: D49403
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 5
  gi|684962|dbj|D549403.1|HUMIL3RA05[684962]
• 2284: D49402
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 3
  gi|684961|dbj|D549402.1|HUMIL3RA03[684961]
• 2285: D49401
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 1
  gi|684960|dbj|D549401.1|HUMIL3RA01[684960]
• 2286: D49411
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 9
  gi|684959|dbj|D549411.1|HUMIL3RA09[684959]
• 2287: D49405
  Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 8
  gi|684958|dbj|D49405.1|HUMIL3RA08[684958]
• 2288: SEG_HUMGRAS
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit
  gi|522101|dbj||SEG_HUMGRAS[522101]
• 2289: D26625
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 10
  gi|467508|dbj|D526625.1|HUMGRAS10[467508]
• 2290: D26624
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 9
  gi|467507|dbj|D526624.1|HUMGRAS09[467507]
• 2291: D26623
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 8
  gi|467506|dbj|D526623.1|HUMGRAS08[467506]
• 2292: D26622
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 7
  gi|467505|dbj|D526622.1|HUMGRAS07[467505]
• 2293: D26621
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 6
  gi|467504|dbj|D526621.1|HUMGRAS06[467504]
• 2294: D26628
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 13 and partial cds
  gi|456594|dbj|D526628.1|HUMGRAS13[456594]
• 2295: D26627
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 12
  gi|456593|dbj|D526627.1|HUMGRAS12[456593]
• 2296: D26626
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 11
  gi|456592|dbj|D526626.1|HUMGRAS11[456592]
• 2297: D26620
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 5
  gi|456591|dbj|D526620.1|HUMGRAS05[456591]
• 2298: D26619
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 4
  gi|456590|dbj|D526619.1|HUMGRAS04[456590]
• 2299: D26618
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 3
  gi|456589|dbj|D526618.1|HUMGRAS03[456589]
• 2300: D26617
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 2
  gi|456588|dbj|D526617.1|HUMGRAS02[456588]
• 2301: D26616
  Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
  receptor alpha subunit, exon 1
  gi|456587|dbj|D526616.1|HUMGRAS01[456587]
• 2307; AF324499
  Homo sapiens olfactory-like receptor mRNA, complete cds
  gi|17016397|gb|AF324499.1|AF324499[17016397]
• 2308: AF308814
  Homo sapiens olfactory receptor-like protein (JCG10) mRNA, partial cds
  gi|17016395|gb|AF308814.1|AF308814[17016395]
• 2309: AF238488
  Homo sapiens olfactory-like receptor JCG8 (JCG8) mRNA, complete cds
  gi|17016318|gb|AF238488.1JAF238488[17016318]
• 2310: AF238487
  Homo sapiens olfactory-like receptor PJCG2 (PJCG2) mRNA, partial cds
  gi|17016316|gb|AF238487.1|AF238487[17016316]
• 2311: AF220494
  Homo sapiens olfactory receptor-like protein JCG4 (JCG4) mRNA, partial cds
  gi|17016314|gb|AF220494.1|AF220494[17016314]
• 2312: AF220493
  Homo sapiens olfactory receptor-like protein PJCG1 (PJCG1) mRNA, partial cds
  gi|17016312|gb|AF220493.1|AF220493[17016312]
• 2313: AF209507
  Homo sapiens olfactory receptor-like protein mRNA, complete sequence
  gi|17016311|gb|AF209507.1|AF209507[17016311]
• 2314: AF403014
  Homo sapiens type II gonadotropin-releasing hormone receptor gene, partial cds
  gi|16589055|gb|AF403014.1|AF403014[16589055]
• 2316: AF403012
  Homo sapiens ribonucleoprotein RBM8 gene, complete cds
  gi|1658905|gb|AF403012.1|AF403012[16589051]
• 2317: AY011601
  Homo sapiens cannabinoid receptor 1 (CNR1) gene, partial cds
  gi|12699807|gb|AY011601.1|[12699807]
• 2318: AY011231
  Homo sapiens adenosine A3 receptor (ADORA3) gene, partial cds
  gi|12699245|gb|AY011231.1|[12699245]
• 2319: AF400602
  Homo sapiens beta-glucan receptor isoform H (BGR) mRNA, complete cds, alternatively spliced
  gi|15986713|gb|AF400602.1|AF400602[15986713]
• 2320: AF400601
  Homo sapiens beta-glucan receptor isoform G (BGR) mRNA, complete cds, alternatively spliced
  gi|15986711|gb|AF400601.1|AF400601[15986711]
• 2321: AF400600
  Homo sapiens beta-glucan receptor isoform F (BGR) mRNA, complete cds, alternatively spliced
  gi|15986709|gb|AF400600.1|AF400600[15986709]
• 2322: AF400599
  Homo sapiens beta-glucan receptor isoform E (BGR) mRNA, complete cds, alternatively spliced
  gi|15986707|gb|AF400599.1|AF400599[15986707]
• 2323: AF400598
  Homo sapiens beta-glucan receptor isoform D (BGR) mRNA, complete cds, alternatively spliced
  gi|15986705|gb|AF400598.1|AF400598[15986705]
• 2324: AF400597
  Homo sapiens beta-glucan receptor isoform C (BGR) mRNA, complete cds, alternatively spliced
  gi|15986703|gb|AF400597.1|AF400597[15986703]
• 2325: AF400596
  Homo sapiens beta-glucan receptor isoform B (BGR) mRNA, complete cds, alternatively spliced
  gi|15986701|gb|AF400596.1|AF400596[15986701]
• 2326: AF400595
  Homo sapiens beta-glucan receptor isoform A (BGR) mRNA, complete cds, alternatively spliced
  gi|15986699|gb|AF400595.1|AF400595[15986699]
• 2329: AF162669
  Homo sapiens olfactory receptor-like protein JCG2 (JCG2) gene, complete cds
  gi|12002783|gb|AF162669.1|AF162669[12002783]
• 2330: NM_—004895
  Homo sapiens cold autoinflammatory syndrome 1 (CIAS1), mRNA
  gi|4757727|ref|NM_—004895.1|[4757727]
• 2331: AF409103
  Homo sapiens T-cell receptor VB3 CDR3 region mRNA, partial cds
  gi|15425973|gb|AF409103.1|AF409103[15425973]
• 2332: NM_—033181
  Homo sapiens cannabinoid receptor 1 (brain) (CNR1), transcript variant 3, mRNA
  gi|15208647|ref|NM_—033181.1|[15208647]
• 2333: AF373846
  Homo sapiens BAFF receptor mRNA, complete cds
  gi|15208474|gb|AF373846.1|AF373846[15208474]
• 2334: AF361108
  Homo sapiens CRHF2 receptor beta-isoform mRNA, partial sequence, aberrantly spliced
  gi|14586959|gb|AF361108.1|AF361108[14586959]
• 2335: NM_—005755
  Homo sapiens Epstein-Barr virus induced gene 3 (EBI3), mRNA
  gi|14577916|ref|NM_—005755.2|[14577916]
• 2336: AF369794
  Homo sapiens B cell crosslinked IgM-activating sequence protein (BXMAS1) mRNA,
  complete cds
  gi|14278718|gb|AF369794.2|AF369794[14278718]
• 2337: AF376725
  Homo sapiens lung seven transmembrane receptor 1 (LUSTR1) mRNA, complete cds
  gi|14248996|gb|AF376725.1|AF376725[14248996]
• 2343: AF352324
  Homo sapiens killer cell Ig-like receptor KIR3DL7 (KIRC1) mRNA, complete cds
  gi|13560903|gb|AF352324.1|AF352324[13560903]
• 2344: AJ249131
  Homo sapiens partiel mPR gene for progesterone membrane binding protein
  gi|6688178|emb|AJ249131.1|HSA249131[6688178]
• 2345: S73474
  Homo sapiens folate receptor alpha isoform mRNA, partial cds
  gi|688233|gb|S73474.1|S73490S2[688233]
• 2346: S73490
  Homo sapiens folate receptor alpha isoform mRNA, partial cds
  gi|688232|gb|S73490.1|S73490S1[688232]
• 2347: S69142
  Homo sapiens T-cell receptor alpha-chain (TcR V alpha) mRNA, partial cds
  gi|545977|gb|S69142.1|S69142[545977]
• 2348: S67401
  Homo sapiens T-cell receptor beta chain VDJ region (TCR Vbeta 7.1 Jbeta 2.3) mRNA, partial cds
  gi|455870gb|S67401.1|S67401[455870]
• 2349: S62797
  Homo sapiens T cell receptor beta chain VDJ region (TcrVbeta 6) mRNA, TcrVbeta
  6.7a allele, partial cds
  gi|385951|gb|S62797.1|S62797[385951]
• 2350: AF310685
  Homo sapiens ADP-glucose receptor gene, complete cds
  gi|16973448|gb|AF310685.1|AF310685[16973448]
• 2351: NM_—057160
  Homo sapiens artemin (ARTN), transcript variant 3, mRNA
  gi|16950644|ref|NM_—057160.1|[16950644]
• 2352: NM_—057091
  Homo sapiens artemin (ARTN), transcript variant 2, mRNA
  gi|16950642|ref|NM_—057091.1|[16950642]
• 2353: NM_—057090
  Homo sapiens artemin (ARTN), transcript variant 4, mRNA
  gi|16950640|ref|NM_—057090.1|[16950640]
• 2354: NM_—003976
  Homo sapiens artemin (ARTN), transcript variant 1, mRNA
  gi|16950639|ref|NM_—003976.2|[16950639]
• 2355: NM_—053032
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 8, mRNA
  gi|16950624|ref|NM_—053032.1|[16950624]
• 2356: NM_—053031
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 7, mRNA
  gi|16950622|ref|NM_—053031.1|[16950622]
• 2357: NM_—053030
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 5, mRNA
  gi|16950620|ref|NM_—053030.1|[16950620]
• 2358: NM_—053029
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 4, mRNA
  gi|16950618|ref|NM_—053029.1|[16950618]
• 2359: NM_—053028
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 3B, mRNA
  gi|16950616|ref|NM_—053028.1|[16950616]
• 2360: NM_—053027
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 3A, mRNA
  gi|16950614|ref|NM_—053027.1|[16950614]
• 2361: NM_—053026
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 2, mRNA
  gi|16950612|ref|NM_—053026.1|[16950612]
• 2362: NM_—053025
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 1, mRNA
  gi|16950610|ref|NM_—053025.1|[16950610]
• 2363: NM_—005965
  Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 6, mRNA
  gi|16950600|ref|NM_—005965.2|[16950600]
• 2364: AF106202
  Homo sapiens endothelial cell protein C receptor precursor (EPCR) gene, promoter
  region and complete cds
  gi|16950557|gb|AF106202.2|AF106202[16950557]
• 2365: AY033942
  Homo sapiens prostate-specific G protein-coupled receptor (PSGR) mRNA, complete
  cds
  gi|16943640|gb|AY033942.1|[16943640]
• 2366: AF369708
  Homo sapiens prostate-specific G-protein coupled receptor mRNA, complete cds
  gi|13752563|gb|AF369708.1|AF369708[13752563]
• 2368: AJ276204
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-8
  gi|9968287|emb|AJ276204.1|HSA276204[9968287]
• 2369: AJ276203
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-7
  gi|9968285|emb|AJ276203.1|HSA276203[9968285]
• 2370: AJ276202
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-6
  gi|9968266|emb|AJ276202.1|HSA276202[9968266]
• 2371: AJ276201
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-5
  gi|9968264|emb|AJ276201.1|HSA276201[9968264]
• 2372: AJ276200
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-4
  gi|9968262|emb|AJ276200.1|HSA276200[9968262]
• 2373: AJ276199
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-3
  gi|9968260|emb|AJ276199.1|HSA276199[9968260]
• 2374: AJ276198
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-2
  gi|9968258|emb|AJ276198.1|HSA276198[9968258]
• 2375: AJ276197
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-1
  gi|9968256|emb|AJ276197.1|HSA276197[9968256]
• 2376: AJ276196
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Gel-C
  gi|9968254|emb|AJ276196.1|HSA276196[9968254]
• 2377: AJ276195
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-11
  gi|9968252|emb|AJ276195.1|HSA276195[9968252]
• 2378: AJ276194
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-10
  gi|9968250|emb|AJ276194.1|HSA276194[9968250]
• 2379: AJ276193
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-9
  gi|9968248|emb|AJ276193.1|HSA276193[9968248]
• 2380: AJ276192
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-8
  gi|9968246|emb|AJ276192.1|HSA276192[9968246]
• 2381: AJ276191
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-7
  gi|9968244|emb|AJ276191.1|HSA276191[9968244]
• 2382: AJ276190
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-6
  gi|9968242|emb|AJ276190.1|HSA276190[9968242]
• 2383: AJ276189
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-5
  gi|9968240|emb|AJ276189.1|HSA276189[9968240]
• 2384: AJ276188
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-4
  gi|9968238|emb|AJ276188.1|HSA276188[9968238]
• 2385: AJ276187
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-3
  gi|9968236|emb|AJ276187.1|HSA276187[9968236]
• 2386: AJ276186
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-2
  gi|9968234|emb|AJ276186.1|HSA276186[9968234]
• 2387: AJ276185
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-1
  gi|9968232|emb|AJ276185.1|HSA276185[9968232]
• 2388: AJ276184
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Gel-A2
  gi|9968230|emb|AJ276184.1|HSA276184[9968230]
• 2389: AJ276183
  Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Gel-A1
  gi|9968228|emb|AJ276183.1|HSA276183[9968228]
• 2390: NM_—005086
  Homo sapiens sarcospan (Kras oncogene-associated gene) (SSPN), mRNA
  gi|16933560|ref|NM_—005086.3|[16933560]
• 2391: NM_—018153
  Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 3, mRNA
  gi|16933552|ref|NM_—018153.2|[16933552]
• 2392: NM_—053034
  Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 2, mRNA
  gi|16933550|ref|NM_—053034.1|[16933550]
• 2393: NM_—005929
  Homo sapiens antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 (MFI2), transcript variant 1, mRNA
  gi|16933549|ref|NM_—005929.3|[16933549]
• 2394: NM_—033316
  Homo sapiens antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 (MFI2), transcript variant 2, mRNA
  gi|16933548|ref|NM_—033316.2|[16933548]
• 2395: AF361473
  Homo sapiens magic roundabout mRNA, complete cds
  gi|16930357|gb|AF361473.1|AF361473[16930357]
• 2396: NM_—032208
  Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 1, mRNA
  gi|14149903|ref|NM_—032208.1|[14149903]
• 2397: NM_—007346
  Homo sapiens opioid growth factor receptor (OGFR), mRNA
  gi|6671492|ref|NM_—007346.1|[6671492]
• 2398: BC017412
  Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2, clone MGC:27265 IMAGE:4618777, mRNA, complete cds
  gi|16924270|gb|BC017412.1|BC017412[16924270]
• 2401: AF435588
  Homo sapiens melatonin receptor Me11a (MTNR1A) mRNA, partial cds
  gi|16904202|gb|AF435588.1|AF435588[16904202]
• 2402: AF421380
  Homo sapiens anthrax toxin receptor mRNA, complete cds
  gi|16566412|gb|AF421380.1|AF421380[16566412]
• 2403: AF291815
  Homo sapiens NK cell receptor (CS1) mRNA, complete cds
  gi|113021809 gb|AF291815.1|AF291815[13021809]
• 2404: AF117899
  Homo sapiens LDLR-FUT fusion protein (LDLR-FUT) mRNA, complete cds
  gi|6739499|gb|AF117899.1|AF117899[6739499]
• 2405: AF054013
  Homo sapiens lipoxin A4 receptor mRNA, complete cds
  gi|3047268|gb|AF054013.1|AF054013[3047268]
• 2406: AF013250
  Homo sapiens leukocyte-associated Ig-like receptor-2 (LAIR-2) mRNA, complete cds
  gi|2352942|gb|AF013250.1|AF013250[2352942]
• 2407: AF013249
  Homo sapiens leukocyte-associated Ig-like receptor-1 (LAIR-1) mRNA, complete cds
  gi|2352940gb|AF013249.1|AF013249[2352940]
• 2409: AF326353
  Homo sapiens Src-like adapter protein-2 mRNA, complete cds
  gi|16797891|gb|AF326353.1|AF326353[16797891]
• 2411: BC017065
  Homo sapiens, tumor necrosis factor receptor superfamily, member 6b, decoy, clone MGC:9587 IMAGE:3886635, mRNA, complete cds
  gi|16877637|gb|BC017065.1|BC017065[16877637]
• 2412: BC016938
  Homo sapiens, neuromedin U receptor 2, clone MGC:21396 IMAGE:3852151, mRNA, complete cds
  gi|16877376|gb|BC016938.1|BC016938[16877376]
• 2413: BC016860
  Homo sapiens, G protein-coupled receptor, family C, group 5, member C, clone MGC:17384 IMAGE:3904655, mRNA, complete cds
  gi|16877192|gb|BC016860.1|BC016860[16877192]
• 2414: BC016692
  Homo sapiens, progesterone receptor membrane component 2, clone MGC:22407 IMAGE:4067832, mRNA, complete cds
  gi|16876813|gb|BC016692.1|BC016692[16876813]
• 2415: AY026949
  Homo sapiens stresscopin mRNA, complete cds
  gi|15026913|gb|AY026949.1|[15026913]
• 2416: AF285092
  Homo sapiens Bcl-2-like protein 10 mRNA, complete cds
  gi|9837265|gb|AF285092.1|AF285092[9837265]
• 2417: D78579
  Homo sapiens NOR-1 mRNA for neuron derived orphan receptor, complete cds
  gi|1651190|dbj|D78579.1|D78579[1651190]
• 2418: D38044
  Homo sapiens gene for Ah-receptor, partial cds, exons 7-9
  gi|532672|dbj|D538044.1|HUMAHRA[532672]
• 2419: NM_—053278
  Homo sapiens G protein-coupled receptor 102 (GPR102), mRNA
  gi|16751916|ref|NM_—053278.1|[16751916]
• 2420: NM_—030916
  Homo sapiens Ig superfamily receptor LNIR (LNIR), mRNA
  gi|16716338|ref|NM_—030916.1|[16716338]
• 2421: AF403479
  Homo sapiens EWS/FLI1 activated transcript 2 protein mRNA, complete cds
  gi|16611777|gb|AF403479.1|AF403479[16611777]
• 2422: NM_—053036
  Homo sapiens G protein-coupled receptor 74 (GPR74), mRNA
  gi|16604257|gb|BC053036.1|BC016004[16604257]
• 2431: BC016004
  Homo sapiens, macrophage receptor with collagenous structure, clone MGC:27263 IMAGE:4618447, mRNA, complete cds
  gi|16359078|gb|BC016004.1|BC016004[16359078]
• 2432: BC013827
  Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:17122
  IMAGE:3446816, mRNA, complete cds
  gi|16307601|gb|BC013827.1|BC013827[16307601]
• 2433: BC001590
  Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:2012 IMAGE:2987965, mRNA, complete cds
  gi|16306788|gb|BC001590.1|BC001590[16306788]
• 2434: BC001492
  Homo sapiens, ciliary neurotrophic factor receptor, clone MGC:1774 IMAGE:3510004, mRNA, complete cds
  gi|16306633|gb|BC001492.1|BC001492[16306633]
• 2435: BC015768
  Homo sapiens, interleukin 13 receptor, alpha 1, clone MGC:23204 IMAGE:4868206,
  mRNA, complete cds
  gi|16041774|gb|BC015768.1|BC015768[16041774]
• 2436: BC015731
  Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily B (with TM and
  ITIM domains), member 1, clone MGC:22968 IMAGE:4878915, mRNA, complete cds
  gi|16041710|gb|BC015731.1|BC015731[16041710]
• 2437: BC015542
  Homo sapiens, poliovirus receptor, clone MGC:9603 IMAGE:3902226, mRNA, complete
  cds
  gi|15930222|gb|BC015542.1|BC015542[15930222]
• 2439: BC015195
  Homo sapiens, Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, clone MGC:14717 IMAGE:4251469, mRNA, complete cds
  gi|15929529|gb|BC015195.1|BC015195[15929529]
• 2440: BC014972
  Homo sapiens, interleukin 2 receptor, gamma (severe combined immunodeficiency),
  clone MGC:23116 IMAGE:4878734, mRNA, complete cds
  gi|15929027|gb|BC014972.1|BC014972[15929027]
• 2441: BC014962
  Homo sapiens, GDNF family receptor alpha 1, clone MGC:23045 IMAGE:4874042, mRNA,
  complete cds
  gi|15929001|gb|BC014962.1|BC014962[15929001]
• 2442: BC014960
  Homo sapiens, low density lipoprotein receptor defect C complementing, clone MGC:23019 IMAGE:4876271, mRNA, complete cds
  gi|15928995|gb|BC014960.1|BC014960[15928995]
• 2443: BC013816
  Homo sapiens, platelet-activating factor receptor, clone MGC:17210 IMAGE:4343214, mRNA, complete cds
  gi|15489458|gb|BC013816.1|BC013816[15489458]
• 2444: BC013780
  Homo sapiens, adenosine A2a receptor, clone MGC:21342 IMAGE:4385637, mRNA, complete cds
  gi|15489369|gb|BC013780.1|BC013780[15489369]
• 2445: NM_—032551
  Homo sapiens G protein-coupled receptor 54 (GPR54), mRNA
  gi|14211846|ref|NM_—032551.1|[14211846]
• 2446: AF329490
  Homo sapiens IFGP2 mRNA, complete cds
  gi|16506260|gb|AF329490.1|AF329490[16506260]
• 2447: AF329488
  Homo sapiens IFGP1 mRNA, complete cds
  gi|16506256|gb|AF329488.1|AF329488[16506256]
• 2448: NM_—000798
  Homo sapiens dopamine receptor D5 (DRD5), mRNA
  gi|16445405|ref|NM_—000798.2|[16445405]
• 2449: NM_—000794
  Homo sapiens dopamine receptor D1 (DRD1), mRNA
  gi|16445404|ref|NM_—000794.2|[16445404]
• 2450: NM_—000796
  Homo sapiens dopamine receptor D3 (DRD3), transcript variant a, mRNA
  gi|16445403|ref|NM_—000796.2|[16445403]
• 2451: NM_—033663
  Homo sapiens dopamine receptor D3 (DRD3), transcript variant e, mRNA
  gi|16445401|ref|NM_—033663.1|[16445401]
• 2452: NM_—033660
  Homo sapiens dopamine receptor D3 (DRD3), transcript variant d, mRNA
  gi|16445399|ref|NM_—033660.1|[16445399]
• 2453: NM_—033659
  Homo sapiens dopamine receptor D3 (DRD3), transcript variant c, mRNA
  gi|16445397|ref|NM_—033659.1|[16445397]
• 2454: NM_—033658
  Homo sapiens dopamine receptor D3 (DRD3), transcript variant b, mRNA
  gi|16445395|ref|NM_—033658.1|[16445395]
• 2455: AJ298918
  Homo sapiens t(8;22) (p11;q11) translocation breakpoint, BCR/FGFR gene
  gi|16444915|emb|AJ298918.1|HSA298918[16444915]
• 2456: AJ298917
  Homo sapiens partial mRNA for FGFR1/BCR chimaeric fusion peptide
  gi|16444913|emb|AJ298917.1|HSA298917[16444913]
• 2457: AJ298916
  Homo sapiens partial mRNA for BCR/FGFR1 chimaeric fusion protein
  gi|16444911|emb|AJ298916.1|HSA298916[16444911]
• 2458: AF325925
  Homo sapiens tandem motif downstream of INSRR gene, allele 2
  gi|13374363|gb|AF325925.1|AF325925[13374363]
• 2459: AF325924
  Homo sapiens tandem motif downstream of INSRR gene, allele 1
  gi|13374362|gb|AF325924.1|AF325924[13374362]
• 2460: NM_—014879
  Homo sapiens G protein-coupled receptor 105 (GPR105), mRNA
  gi|7661847|ref|NM_—014879.1|[7661847]
• 2461: NM_—000797
  Homo sapiens dopamine receptor D4 (DRD4), mRNA
  gi|4503388|ref|NM_—000797.1|[4503388]
• 2462: NM_—052962
  Homo sapiens class II cytokine receptor (IL22RA2), mRNA
  gi|16418458|ref|NM_—052962.1|[16418458]
• 2463: NM_—052932
  Homo sapiens pro-oncosis receptor inducing membrane injury gene (PORIMIN), mRNA
  gi|16418408|ref|NM_—052932.1|[16418408]
• 2464: NM_—052887
  Homo sapiens Toll-interleukin 1 receptor (TIR) domain-containing adapter protein
  (TIRAP), mRNA
  gi|16418398|ref|NM_—052887.1|[16418398]
• 2465: NM_—018835
  Homo sapiens olfactory receptor, family 1, subfamily K, member 1 (OR1K1), mRNA
  gi|9256536|ref|NM_—018835.1|[9256536]
• 2466: BC016141
  Homo sapiens, interleukin 1 receptor accessory protein, clone IMAGE:3920152, mRNA
  gi|16359373|gb|BC016141.1|BC016141[16359373]
• 2467: AF177765
  Homo sapiens toll-like receptor 4 (TLR4) gene, TLR4A allele, complete cds
  gi|6175872|gb|AF177765.1|AF177765[6175872]
• 2468: U11813
  Homo sapiens hepatocyte growth factor receptor precursor, mRNA, partial cds; alternatively spliced
  gi|530799|gb|U11813.1|HSU11813[530799]
• 2469: BC009540
  Homo sapiens, G protein-coupled receptor 87, clone MGC:10065 IMAGE:3894333, mRNA, complete cds
  gi|16306940 gb|BC009540.1|BC009540[16306940]
• 2474: AJ313162
  Homo sapiens mRNA for soluble cytokine class II receptor, long isoform (CRF2-S1
  gene)
  gi|16304592|emb|AJ313162.1|HSA313162[16304592]
• 2475: AJ313161
  Homo sapiens mRNA for soluble cytokine class II receptor, short isoform (CRF2-S1
  gene)
  gi|16304590|emb|AJ313161.1|HSA313161[16304590]
• 2476: AY048757
  Homo sapiens ATP-binding cassette transporter G1 (ABCG1) mRNA, complete cds, alternatively spliced
  gi|16304310|gb|AY048757.1|[16304310]
• 2501: AJ313161
  Homo sapiens mRNA for soluble cytokine class II receptor, short isoform (CRF2-S1 gene)
  gi|16304590|emb|AJ313161.1|HSA313161[16304590]
• 2502: AY048757
  Homo sapiens ATP-binding cassette transporter G1 (ABCG1) mRNA, complete cds, alternatively spliced
  gi|16304310|gb|AY048757.1|[16304310]
• 2626: NM_—012068
  Homo sapiens activating transcription factor 5 (ATF5), mRNA
  gi|12597624|ref|NM_—012068.2|[12597624]
• 2627: AF055084
  Homo sapiens very large G-protein coupled receptor-1 (VLGR1) mRNA, complete cds
  gi|5902965|gb|AF055084.1|AF055084[5902965]
• 2629: AJ414821
  Homo sapiens partial IGVKL12 gene for immunoglobulin kappa chain variable region, donor TG, cell84
  gi|16215495|emb|AJ414821.2|HSA414821[16215495]
• 2630: AY056048
  Homo sapiens receptor protein tyrosine kinase variant EphB4v1 (EPHB4) mRNA, complete cds, alternatively spliced
  gi|16209619|gb|AY056048.1|[16209619]
• 2631: AY056047
  Homo sapiens receptor protein tyrosine kinase EphB4 (EPHB4) gene, complete cds,
  alternatively spliced
  gi|16209617|gb|AY056047.1|[16209617]
• 2632: AY052490
  Homo sapiens NK cell receptor (KIR2DL4) mRNA, KIR2DL4-10A allele, partial cds
  gi|16209550|gb|AY052498.1|[16209550]
• 2633: AY052497
  Homo sapiens NK cell receptor (KIR2DL4) mRNA, KIR2DL4-9A allele, partial cds
  gi|16209510|gb|AY052497.1|[16209510]
• 2634: AY052496
  Homo sapiens truncated NK cell receptor (KIR2DL4) mRNA, KIR2DL4-9A allele, partial cds
  gi|16209507|gb|AY052496.1|[16209507]
• 2635: AF267245
  Homo sapiens killer cell lectin-like receptor KLRF1-S3 (KLRF1) mRNA, complete cds., alternatively spliced
  gi|16151842|gb|AF267245.1|AF267245[16151842]
• 2636: AF267244
  Homo sapiens killer cell lectin-like receptor KLRF1-S2 (KLRF1) mRNA, complete cds., alternatively spliced
  gi|16151840|gb|AF267244.1|AF267244[16151840]
• 2637: NM_—033637
  Homo sapiens beta-transducin repeat containing (BTRC), transcript variant 1, mRNA
  gi|16117782|ref|NM_—033637.1|[16117782]
• 3563: NM_—033050
  Homo sapiens G protein-coupled receptor 91 (GPR91), mRNA
  gi|14780893|ref|NM_—033050.1|[14780893]
• 3564: NM_—023914
  Homo sapiens G protein-coupled receptor 86 (GPR86), mRNA
  gi|13194202|ref|NM_—023914.1|[13194202]
• 3565: NM_—020402
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 10 (CHRNA10), mRNA
  gi|11138122|ref|NM_—020402.2|[11138122]
• 3566: NM_—020370
  Homo sapiens G protein-coupled receptor 84 (GPR84), mRNA
  gi|9966838|ref|NM_—020370.1|[9966838]
• 3567: NM_—012301
  Homo sapiens atrophin-1 interacting protein 1; activin receptor interacting protein 1 (KIAA0705), mRNA
  gi|6912461|ref|NM_—012301.1|[6912461]
• 3568: AF208541
  Homo sapiens V1-vascular vasopressin receptor AVPRLA gene, promoter region and
  partial cds
  gi|658112|gb|AF208541.1|AF208541[6581121]
• 3569: NM_—005756
  Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA
  gi|5031732|ref|NM_—005756.1|[5031732]
• 3570: NM_—003939
  Homo sapiens beta-transducin repeat containing (BTRC), transcript variant 2, mRNA
  gi|4502476|ref|NM_—003939.1|[4502476]
• 3571: AH003597
  Homo sapiens A3 adenosine receptor (ADORA3) gene
  gi|1387984|gb|AH003597.1|SEG_HUMADOR0[1387984]
• 3572: L77730
  Homo sapiens A3 adenosine receptor (ADORA3) gene, exon 2
  gi|387983|gb|L77730.1[HUMADOR02[1387983]
• 3573: L77729
  Homo sapiens A3 adenosine receptor (ADORA3) gene, exon 1
  gi|1387982|gb|L77729.1|HUMADOR01[1387982]
• 3574: AF000381
  Homo sapiens folate binding protein mRNA, partial cds
  gi|16041647|gb|AF000381.2|AF000381[16041647]
• 3583: AY054974
  Homo sapiens RAE-1-like transcript 4 mRNA, complete cds
  gi|15990603|gb|AY054974.1|[15990603]
• 3584: AF421855
  Homo sapiens interleukin 4 receptor (IL4R) gene, complete cds
  gi|15987825|gb|AF421855.1|AF421855[15987825]
• 3585: AF359241
  Homo sapiens soluble truncated fibroblast growth factor receptor 4 (FGFR4) mRNA,
  complete cds
  gi|3877134|gb|AF359241.1|AF359241[13877134]
• 3586: NM_—022148
  Homo sapiens cytokine receptor-like factor 2 (CRLF2), mRNA
  gi|13375623|ref|NM_—022148.1|[13375623]
• 3587: AF179770
  Homo sapiens olfactory receptor (HSA8) gene, partial cds
  gi|7211542|gb|AF179770.1|AF179770[7211542]
• 3590: AF179767
  Homo sapiens olfactory receptor (HSA5) gene, partial cds
  gi|7211538|gb|AF179767.1|AF179767[7211538]
• 3591: AF179766
  Homo sapiens olfactory receptor (HSA3) gene, partial cds
  gi|7211536|gb|AF179766.1|AF179766[7211536]
• 3596: AF179761
  Homo sapiens olfactory receptor (HSA12) gene, partial cds
  gi|7211530|gb|AF179761.1|AF179761[7211530]
• 3597: AF179760
  Homo sapiens olfactory receptor (HSA10) gene, partial cds
  gi|7211528|gb|AF179760.1|AF179760[7211528]
• 3598: AF179759
  Homo sapiens olfactory receptor (HSA1) gene, partial cds
  gi|7211526|gb|AF179759.1|AF179759[7211526]
• 3599: D86962
  Human mRNA for KIAA0207 gene, complete cds
  gi|1503997|dbj|D86962.1D86962[1503997]
• 3600: D13626
  Human mRNA for KIAA0001 gene, complete cds
  gi|285994|dbj|D13626.1|HUMRSC338[285994]
• 3601: AY026770
  Homo sapiens lectin-like receptor 1B (DECTIN1) mRNA, complete cds, alternatively
  spliced
  gi|15967098|gb|AY026770.2|[15967098]
• 3602: AY026769
  Homo sapiens lectin-like receptor 1 (DECTIN1) mRNA, complete cds
  gi|15967096|gb|AY026769.2|[15967096]
• 3605: AJ344142
  Homo sapiens mRNA for putative MCP-1 chemokine receptor (CCR11 gene)
  gi|15919090|emb|AJ344142.1|HSA344142[15919090]
• 3606: AY029770
  Homo sapiens CCK-B/gastrin receptor variant mRNA, complete cds, alternatively spliced
  gi|15911832|gb|AY029770.1|[15911832]
• 3607: NM_—002821
  Homo sapiens PTK7 protein tyrosine kinase 7 (PTK7), mRNA
  gi|15826839|ref|NM_—002821.2|[15826839]
• 3608: AF303576
  Homo sapiens G protein-coupled receptor 75 (GPR75) gene, exon 1
  gi|15824419|gb|AF303576.1|AF303576[15824419]
• 3609: AB032427
  Homo sapiens VRL-2 mRNA for vanilloid receptor like channel-2, complete cds
  gi|15822824|dbj|AB032427.1|AB032427[15822824]
• 3610: AY008280
  Homo sapiens histamine receptor H4 (H4) mRNA, complete cds
  gi|15822540|gb|AY008280.1|[15822540]
• 3611: U40271
  Homo sapiens transmembrane receptor precursor (PTK7) mRNA, complete cds
  gi|15808058|gb|U40271.2|HSU40271[15808058]
• 3612: NM_—000575
  Homo sapiens interleukin 1, alpha (IL1A), mRNA
  gi|13236493|ref|NM_—000575.1|[13236493]
• 3615: NM_—014312
  Homo sapiens cortical thymocyte receptor (X. laevis CTX) like (CTXL), mRNA
  gi|7657000|ref|NM_—014312.1|[7657000]
• 3616: AB032738
  Homo sapiens gene for chemokine receptor CXCR3, partial cds
  gi|7209698|dbj|AB032738.1|AB032738[7209698]
• 3617: AB032737
  Homo sapiens gene for chemokine receptor CXCR3, partial cds
  gi|7209696|dbj|AB032737.1|AB032737[7209696]
• 3618: AB032736
  Homo sapiens gene for chemokine receptor CXCR3, partial cds
  gi|7209694|dbj|AB032736.1|AB032736[7209694]
• 3619: AB032735
  Homo sapiens gene for chemokine receptor CXCR3, partial cds
  gi|7209692|dbj|AB032735.1|AB032735[7209692]
• 3620: AB032734
  Homo sapiens CXCR2 gene for IL-8 receptor type B, partial cds
  gi|7209690|dbj|AB032734.1|AB032734[7209690]
• 3621: AB032733
  Homo sapiens CXCR2 gene for IL-8 receptor type B, partial cds
  gi|7209688|dbj|AB032733.1|AB032733[7209688]
• 3622: AB032732
  Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
  gi|7209686|dbj|AB032732.1|AB032732[7209686]
• 3623: AB032731
  Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
  gi|7209684|dbj|AB032731.1|AB032731[7209684]
• 3624: AB032730
  Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
  gi|7209682|dbj|AB032730.1|AB032730[7209682]
• 3625: AB032729
  Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
  gi|7209680|dbj|AB032729.1|AB032729[7209680]
• 3626: AB032728
  Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
  gi|7209678|dbj|AB032728.1|A]B032728[7209678]
• 3628: AB030952
  Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
  gi|6683135|dbj|AB030952.1|AB030952[6683135]
• 3629: AB030951
  Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
  gi|6683133|dbj|AB030951.1|AB030951[6683133]
• 3630: AB030950
  Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
  gi|6683131|dbj|AB030950.1|AB030950[6683131]
• 3631: AB030949
  Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
  gi|6683129|dbj|AB030949.1|AB030949[6683129]
• 3632: AB023892
  Homo sapiens gene for b-chemokine receptor CCR4, complete cds
  gi|6467142|dbj|AB023892.1|AB023892[6467142]
• 3633: AB023891
  Homo sapiens gene for b-chemokine receptor CCR4, complete cds
  gi|6467140|dbj|AB023891.1|AB023891[6467140]
• 3634: AB023890
  Homo sapiens gene for b-chemokine receptor CCR4, complete cds
  gi|6467138|dbj|AB023890.1|AB023890[6467138]
• 3635: AB023889
  Homo sapiens gene for b-chemokine receptor CCR4, complete cds
  gi|6467136|dbj|AB023889.1|AB023889[6467136]
• 3636: AB023888
  Homo sapiens gene for b-chemokine receptor CCR4, complete cds
  gi|6467134|dbj|AB023888.1|AB023888[6467134]
• 3637: AB023887
  Homo sapiens gene for b-chemokine receptor CCR3, complete cds
  gi|6467132|dbj|AB023887.1|AB023887[6467132]
• 3638: AH008153
  Homo sapiens IL-1RI gene, complete sequence
  gi|5823144|gb|AH008153.1|SEG_HSAIL1R[5823144]
• 3639: AF146427
  Homo sapiens interleukin-1 receptor type I (IL1R1) gene, exon 1c
  gi|5823143|gb|AF146427.1|HSAIL1R2[5823143]
• 3640: AF146426
  Homo sapiens interleukin-1 receptor type I (IL1R1) gene, exon 1b and intron 1b
  gi|5823142|gb|AF146426.1|HSAIL1R1[5823142]
• 3641: NM_—006691
  Homo sapiens extracellular link domain-containing 1 (XLKD1), mRNA
  gi|5729910|ref|NM_—006691.1|[5729910]
• 3642: Z99761
  Homo sapiens gonadotrophin-releasing hormone receptor gene exon 2
  gi|5514748|emb|Z99761.2|HSGRHRX2[5514748]
• 3643: Z99760
  Homo sapiens gonadotropin-releasing hormone receptor gene exon 1 variant 1
  gi|5514747|emb|Z99760.2|HSGRHRX1[5514747]
• 3644: NM_—001250
  Homo sapiens tumor necrosis factor receptor superfamily, member 5 (TNFRSF5), mRNA
  gi|4507580|ref|NM_—001250.1|[4507580]
• 3645: NM_—000406
  Homo sapiens gonadotropin-releasing hormone receptor (GNRHR), mRNA
  gi|4504058|ref|NM_—000406.1|[4504058]
• 3646: Z99995
  Homo sapiens partial gonadotropin releasing hormone receptor gene
  gi|3334762|emb|Z99995.1|HSZ99995[3334762]
• 3647: G16069
  928H1R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 928H1 right arm, sequence tagged site
  gi|1825444|gb|G16069.1|G16069[1825444]
• 3648: G16077
  817D6L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 817D6 left arm, sequence tagged site
  gi|1592357|gb|G16077.1|G16077[1592357]
• 3649: G16076
  807B6L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 807B6 left arm, sequence tagged site
  gi|1592356|gb|G16076.1|G16076[1592356]
• 3650: G16075
  940H12L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 940H12 left arm, sequence tagged site
  gi|1592355|gb|G16075.1|G16075[1592355]
• 3651: G16074
  706A2L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 706A2 left arm, sequence tagged site
  gi|1592354|gb|G16074.1G16074[1592354]
• 3652: G16073
  967A10L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 967A10 left arm, sequence tagged site
  gi|1592353|gb|G16073.1|G16073[1592353]
• 3653: G16072
  816C10L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 816C10 left arm, sequence tagged site
  gi|1592352|gb|G16072.1G16072[1592352]
• 3654: G16071
  765B8R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 765B8 right arm, sequence tagged site
  gi|1592351|gb|G16071.1G16071[1592351]
• 3655: G16070
  622F2R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 622F2 right arm, sequence tagged site
  gi|1592350|gb|G16070.1|G16070[1592350]
• 3656: G16068
  868H11L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 868H11 left arm, sequence tagged site
  gi|1592349|gb|G16068.1|G16068[1592349]
• 3657: G16067
  662F2L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 662F2 left arm, sequence tagged site
  gi|1592348|gb|G16067.1|G16067[1592348]
• 3658: G16066
  918D7R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 918D7 right arm, sequence tagged site
  gi|1592347|gb|G16066.1|G16066[1592347]
• 3659: G16065
  758C4R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 758C4 right arm, sequence tagged site
  gi|1592346|gb|G16065.1|G16065[1592346]
• 3660: G16064
  677D7L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 677D7 left arm, sequence tagged site
  gi|1592345|gb|G16064.1|G16064[1592345]
• 3663: L11238
  Homo sapiens platelet membrane glycoprotein V mRNA; complete cds
  gi|388759|gb|L11238.1|HUMGLYCOPR[388759]
• 3665: AF406652
  Homo sapiens MyD88 adapter-like protein mRNA, complete cds
  gi|15528826|gb|AF406652.1|AF406652[15528826]
• 4053: NM_—022059
  Homo sapiens chemokine (C-X-C motif) ligand 16 (CXCL16), mRNA
  gi|11545764|ref|NM_—022059.1|[11545764]
• 4054: NM_—030956
  Homo sapiens toll-like receptor 10 (TLR10), mRNA
  gi|13569929|ref|NM_—030956.1|[13569929]
• 4055: NM_—033358
  Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
  variant E, mRNA
  gi|15718711|ref|NM_—033358.1|[15718711]
• 4056: NM_—033357
  Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
  variant D, mRNA
  gi|15718709|ref|NM_—033357.1|[15718709]
• 4057: NM_—033356
  Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
  variant C, mRNA
  gi|15718707|ref|NM_—033356.1|[15718707]
• 4058: NM_—033355
  Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
  variant B, mRNA
  gi|15718705|ref|NM_—033355.1|[15718705]
• 4059: NM_—001228
  Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
  variant A, mRNA
  gi|15718703|ref|NM_—001228.2|[15718703]
• 4061: NM_—000024
  Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA
  gi|15718673|ref|NM_—000024.3|[15718673]
• 4062: NM_—000683
  Homo sapiens adrenergic, alpha-2C—, receptor (ADRA2C), mRNA
  gi|15718672|ref|NM_—000683.2|[15718672]
• 4063: NM_—000682
  Homo sapiens adrenergic, alpha-2B-, receptor (ADRA2B), mRNA
  gi|5718671|ref|NM_—000682.2|[15718671]
• 4064: NM_—000681
  Homo sapiens adrenergic, alpha-2A-, receptor (ADRA2A), mRNA
  gi|15718669|ref|NM_—000681.2|[15718669]
• 4065: NM_—006179
  Homo sapiens neurotrophin 5 (neurotrophin 4/5) (NTF5), mRNA
  gi|15718666|ref|NM_—006179.2|[15718666]
• 4066: L26458
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432477|gb|L26458.1|HUMEBSH[432477]
• 4067: L26457
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432476|gb|L26457.1|HUMEBSG[432476]
• 4068: L26456
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432475|gb|L26456.1|HUMEBSF[432475]
• 4069: L26455
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432474|gb|L26455.1|HUMEBSE[432474]
• 4070: L26454
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432473|gb|L26454.1|HUMEBSD[432473]
• 4071: L26453
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432472|gb|L26453.1|HUMEBSC[432472]
• 4072: L26452
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432471|gb|L26452.1|HUMEBSB[432471]
• 4073: L26451
  Homo sapiens T-cell receptor mRNA, partial sequence
  gi|432470|gb|L26451.1|HUMEBSA[432470]
• 4074: AH009839
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  partial cds, alternatively spliced
  gi|15706245|gb|AH009839.2|[15706245]
• 4075: AJ301610
  Homo sapiens mRNA for GluR6 kainate receptor (GRIK2 gene), isoform-b
  gi|15485591|emb|AJ301610.1|HSA301610[15485591]
• 4076: AJ301609
  Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 10, and 13
  gi|15485589|emb|AJ301609.1|HSA301609[15485589]
• 4077: AJ301608
  Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 11, and 14
  gi|15485587|emb|AJ301608.1|HSA301608[15485587]
• 4078: AF196774
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 8 and partial cds, alternatively spliced
  gi|10312084|gb|AF196774.1|AH009839S8[10312084]
• 4079: AF196773
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 7
  gi|10312083|gb|AF196773.1|AH009839S7[10312083]
• 4080: AF196772
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 6
  gi|10312082|gb|AF196772.1|AH009839S6[10312082]
• 4081: AF252867
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 6A and partial cds, alternatively spliced
  gi|10312081|gb|AF252867.1|AH009839S5[10312081]
• 4082: AF196771
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 5
  gi|10312080|gb|AF196771.1|AH009839S4[10312080]
• 4083: AF196770
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 4
  gi|10312079|gb|AF196770.1|AH009839S3[10312079]
• 4084: AF196769
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 3
  gi|10312078|gb|AF196769.1|AH009839S2[10312078]
• 4085: AF196768
  Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
  exon 2
  gi|10312077|gb|AF196768.1|AH009839S1[10312077]
• 4086: AF399937
  Homo sapiens melanin-concentrating hormone receptor MCH-R2 mRNA, complete cds
  gi|15667842|gb|AF399937.1|AF399937[15667842]
• 4087: NM_—032405
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant D,
  mRNA
  gi|14602456|ref|NM_—032405.1|[14602456]
• 4088: NM_—032404
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant C,
  mRNA
  gi|14602454|ref|NM_—032404.1|[14602454]
• 4089: NM_—032401
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant B,
  mRNA
  gi|14602452|ref|NM_—032401.1|[14602452]
• 4090: NM_—024022
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant A,
  mRNA
  gi|13173470|ref|NM_—024022.1|[13173470]
• 4091: AY046418
  Homo sapiens brain immunoglobulin receptor precursor, mRNA, complete cds
  gi|15636797|gb|AY046418.1|[15636797]
• 4092: AF069333
  Homo sapiens insulin-like growth factor II receptor (IGF2R) gene, partial cds
  gi|15628184|gb|AF069333.2|AF069333115628184]
• 4093: AY029541
  Homo sapiens putative G protein-coupled receptor mRNA, complete cds
  gi|15626067|gb|AY029541.1|[15626067]
• 4094: AF117819
  Homo sapiens bradykinin B1 receptor mRNA, partial cds and 3′-untranslated region
  gi|4325046|gb|AF117819.1|AF117819[4325046]
• 4095: NM_—004624
  Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA
  gi|15619005|ref|NM_—004624.2|[15619005]
• 4096: AY042216
  Homo sapiens G protein-coupled receptor (MRGX4) gene, complete cds
  gi|15546067|gb|AY042216.1|[15546067]
• 4097: AY042215
  Homo sapiens G protein-coupled receptor (MRGX3) gene, complete cds
  gi|15546065|gb|AY042215.1|[15546065]
• 4098: AY042214
  Homo sapiens G protein-coupled receptor (MRGX2) gene, complete cds
  gi|15546063|gb|AY042214.1|[15546063]
• 4099: AY042213
  Homo sapiens G protein-coupled receptor (MRGX1) gene, complete cds
  gi|1554606|gb|AY042213.1|[15546061]
• 4100: Y11395
  Homo sapiens mRNA for lanthionine synthetase C-like protein 1 (LANCL1 gene)
  gi|2894085|emb|Y11395.1|HSRNAP40[2894085]
• 4101: BC014108
  Homo sapiens, Fc fragment of IgE, low affinity II, receptor for (CD23A), clone
  MGC:20696 IMAGE:4309266, mRNA, complete cds
  gi|15559484|gb|BC014108.1|BC014108[15559484]
• 4102: AF306329
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
  gene, exon 6 and complete cds
  gi|15558964|gb|AF306329.1|AF306325S5[15558964]
• 4103: AF306328
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
  gene, exon 5
  gi|15558963|gb|AF306328.1|AF306325S4[15558963]
• 4104: AF306327
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
  gene, exons 3, 4, and 4a, alternatively spliced
  gi|15558962|gb|AF306327.1|AF306325S3[15558962]
• 4105: AF306326
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
  gene, exon 2
  gi|15558961|gb|AF306326.1|AF306325S2[15558961]
• 4106: AF306325
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
  gene, exon 1
  gi|15558960|gb|AF306325.1|AF306325S1[15558960]
• 4107: AH011061
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
  gene, complete cds
  gi|15558959|gb|AH011061.1|SEG_AF306325S[15558959]
• 4108: AJ316282
  Homo sapiens partial TCRB gene for T cell receptor beta chain, allele TCRBV1J2S3, isolate P15SF, clone 9
  gi|15558855|emb|AJ316282.1|HSA316282[15558855]
• 4109: AJ316281
  Homo sapiens partial TCRB gene for T cell receptor beta chain, allele TCRBV1J2S3, patient P22SF, clone 3
  gi|5558853|emb|AJ316281.1|HSA316281[15558853]
• 4110: AJ316280
  Homo sapiens partial TCRB gene for T cell receptor beta chain, allele TCRBV1J2S3, patient P14SF, clone 1
  gi|15558851|emb|AJ316280.1|HSA316280[15558851]
• 4111: NM_—001954
  Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 2, mRNA
  gi|7669486|ref|NM_—001954.21[7669486]
• 4112: NM_—013994
  Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 3, mRNA
  gi|7669484|ref|NM_—013994.1|[7669484]
• 4113: NM_—013993
  Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 1, mRNA
  gi|7669482|ref|NM_—013993.1|[7669482]
• 4114: AF325356
  Homo sapiens histamine receptor H4 (AXOR35) mRNA, complete cds
  gi|15553202|gb|AF325356.1|AF325356[15553202]
• 4115: AF349574
  Homo sapiens interleukin 12 receptor beta 2 (IL12RB2) gene, partial sequence
  gi|15088551|gb|AF349574.1|AF349574[15088551]
• 4116: NM_—014395
  Homo sapiens dual adaptor of phosphotyrosine and 3-phosphoinositides (DAPP1), mRNA
  gi|7657006|ref|NM_—014395.1|[7657006]
• 4117: AY043466
  Homo sapiens Fc receptor-like protein 3 (FCRH3) mRNA, complete cds
  gi|15528834|gb|AY043466.1|[15528834]
• 4118: AY043465
  Homo sapiens Fc receptor-like protein 2 (FCRH2) mRNA, complete cds
  gi|15528832|gb|AY043465.1|[15528832]
• 4119: AY043464
  Homo sapiens Fc receptor-like protein 1 (FCRH1) mRNA, complete cds
  gi|15528830|gb|AY043464.1|[15528830]
• 4120: AJ344350
  Homo sapiens partial IGDH3-9 gene segment, isolate case6-cell520
  gi|15528515|emb|AJ344350.1|HSA344350[15528515]
• 4121: AJ344349
  Homo sapiens partial IGDH3-9 gene segment, isolate case5-cell49
  gi|15528514|emb|AJ344349.1|HSA344349[15528514]
• 4122: AJ344348
  Homo sapiens partial IGDH6-25 gene segment, isolate case4-cell89
  gi|15528513|emb|AJ344348.1|HSA344348[15528513]
• 4125: NM_—033135
  Homo sapiens spinal cord-derived growth factor-B (SCDGF-B), transcript variant
  2, mRNA
  gi|15451920|ref|NM_—033135.1|[15451920]
• 4126: NM_—025208
  Homo sapiens spinal cord-derived growth factor-B (SCDGF-B), transcript variant
  1, mRNA
  gi|15451919|ref|NM_—025208.2|[15451919]
• 4127: NM_—033346
  Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 2, mRNA
  gi|15451917|ref|NM_—033346.1|[15451917]
• 4128: NM_—001204
  Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 1, mRNA
  gi|15451915|ref|NM_—001204.3|[15451915]
• 4129: NM_—003933
  Homo sapiens BA11-associated protein 3 (BAIAP3), mRNA
  gi|15451913|ref|NM_—003933.3|[15451913]
• 4130: NM_—002006
  Homo sapiens fibroblast growth factor 2 (basic) (FGF2), mRNA
  gi|15451897|ref|NM_—002006.2|[15451897]
• 4131: NM_—000647
  Homo sapiens chemokine (C-C motif) receptor 2 (CCR2), transcript variant A, mRNA
  gi|15451896|ref|NM_—000647.2|[15451896]
• 4132: NM_—004631
  Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
  e receptor (LRP8), transcript variant 1, mRNA
  gi|15451869|ref|NM_—004631.2|[15451869]
• 4133: NM_—033300
  Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
  e receptor (LRP8), transcript variant 2, mRNA
  gi|15451867|ref|NM_—033300.1|[15451867]
• 4134: NM_—017522
  Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
  e receptor (LRP8), transcript variant 3, mRNA
  gi|15451865|ref|NM_—017522.2|[15451865]
• 4135: NM_—033337
  Homo sapiens caveolin 3 (CAV3), transcript variant 1, mRNA
  gi|15451859|ref|NM_—033337.1|[15451859]
• 4136: NM_—001234
  Homo sapiens caveolin 3 (CAV3), transcript variant 2, mRNA
  gi|15451858|ref|NM_—001234.3|[15451858]
• 4137: NM_—002609
  Homo sapiens platelet-derived growth factor receptor, beta polypeptide (PDGFRB),
  mRNA
  gi|15451788|ref|NM_—002609.2|[15451788]
• 4138: NM_—006206
  Homo sapiens platelet-derived growth factor receptor, alpha polypeptide (PDGFRA), mRNA
  gi|15451787|ref|NM_—006206.2|[15451787]
• 4139: NM_—000679
  Homo sapiens adrenergic, alpha-1B-, receptor (ADRA1B), mRNA
  gi|15451783|ref|NM_—000679.2|[15451783]
• 4140: AY026771
  Homo sapiens lectin-like receptor 1C (DECTIN1) mRNA, complete cds, alternatively
  spliced
  gi|14278822|gb|AY026771.1|[14278822]
• 4142: NM_—000648
  Homo sapiens chemokine (C-C motif) receptor 2 (CCR2), transcript variant B, mRNA
  gi|4757937|ref|NM_—000648.1|[4757937]
• 4143: AB041403
  Homo sapiens HTR1A gene for serotonin receptor 1A, complete cds
  gi|7592996|dbj|AB041403.1|AB041403[7592996]
• 4144: NM_—015722
  Homo sapiens calcyon; D1 dopamine receptor-interacting protein (CALCYON), mRNA
  gi|9257200|ref|NM_—015722.2|[9257200]
• 4145: AY044429
  Homo sapiens class II cytokine receptor (IL22RA2) mRNA, complete cds
  gi|15419022|gb|AY044429.1|[15419022]
• 4148: AJ306388
  Homo sapiens mRNA for NTB-A receptor (KALI b gene)
  gi|15384842|emb|AJ306388.1|HSA306388[15384842]
• 4149: AJ277141
  Homo sapiens mRNA for activating NK receptor (KALI gene)
  gi|15384840|emb|AJ277141.1|HSA277141[15384840]
• 4150: NM_—033199
  Homo sapiens stresscopin-related peptide (SRP), mRNA
  gi|15082239|ref|NM_—033199.1|[15082239]
• 4151: AB052684
  Homo sapiens mRNA for G1-coupled ADP receptor HORK3, complete cds
  gi|14422409|dbj|AB052684.1|AB052684[14422409]
• 4152: AF227732
  Homo sapiens nicotinic acetylcholine receptor alpha 9 subunit mRNA, partial cds
  gi|7407124|gb|AF227732.1|AF227732[7407124]
• 4153: NM_—005849
  Homo sapiens immunoglobulin superfamily, member 6 (IGSF6), mRNA
  gi|5031672|ref|NM_—005849.1|[5031672]
• 4154: AF317654
  Homo sapiens G protein-coupled receptor (GPR63) gene, complete cds
  gi|15321723|gb|AF317654.2|AF317654[15321723]
• 4155: AF399637
  Homo sapiens clone OR5B16 olfactory receptor gene, partial cds
  gi|15293858|gb|AF399637.1|AF399637[15293858]
• 4156: AF399636
  Homo sapiens clone OR5B2 olfactory receptor gene, partial cds
  gi|15293856|gb|AF399636.1|AF399636[15293856]
• 4157: AF399635
  Homo sapiens clone OR5AU1 olfactory receptor gene, partial cds
  gi|15293854|gb|AF399635.1|AF399635[15293854]
• 4158: AF399634
  Homo sapiens clone OR10A3 olfactory receptor gene, partial cds
  gi|15293852|gb|AF399634.1|AF399634[15293852]
• 4159: AF399633
  Homo sapiens clone OR13H1 olfactory receptor gene, partial cds
  gi|15293850|gb|AF399633.1|AF399633[15293850]
• 4160: AF399632
  Homo sapiens clone OR2B3 olfactory receptor gene, partial cds
  gi|15293848|gb|AF399632.1|AF399632[15293848]
• 4161: AF399631
  Homo sapiens clone OR2H2 olfactory receptor gene, partial cds
  gi|15293846|gb|AF399631.1|AF399631[15293846]
• 4162: AF399630
  Homo sapiens clone OR2J3 olfactory receptor gene, partial cds
  gi|15293844|gb|AF399630.1|AF399630[15293844]
• 4163: AF399629
  Homo sapiens clone OR2Y1 olfactory receptor gene, partial cds
  gi|15293842|gb|AF399629.1|AF399629[15293842]
• 4164: AF399628
  Homo sapiens clone OR2W1 olfactory receptor gene, partial cds
  gi|15293840 gb|AF399628.1|AF399628[15293840]
• 4165: AF399627
  Homo sapiens clone OR10C2 olfactory receptor gene, partial cds
  gi|5293838|gb|AF399627.1|AF399627[15293838]
• 4166: AF399626
  Homo sapiens clone OR10A7 olfactory receptor gene, partial cds
  gi|15293836|gb|AF399626.1|AF399626[15293836]
• 4167: AF399625
  Homo sapiens clone OR10A4 olfactory receptor gene, partial cds
  gi|15293834|gb|AF399625.1|AF399625[15293834]
• 4168: AF399624
  Homo sapiens clone OR10A1 olfactory receptor gene, partial cds
  gi|15293832|gb|AF399624.1|AF399624[15293832]
• 4169: AF399623
  Homo sapiens clone OR10A5 olfactory receptor gene, partial cds
  gi|15293830 gb|AF399623.1|AF399623[15293830]
• 4170: AF399622
  Homo sapiens clone OR1K1 olfactory receptor gene, partial cds
  gi|15293828|gb|AF399622.1|AF399622[15293828]
• 4171: AF399621
  Homo sapiens clone OR3A4 olfactory receptor gene, partial cds
  gi|5293826|gb|AF399621.1|AF399621[15293826]
• 4172: AF399620
  Homo sapiens clone OR3A3 olfactory receptor gene, partial cds
  gi|15293824|gb|AF399620.1|AF399620[15293824]
• 4173: AF399619
  Homo sapiens clone OR2Z2 olfactory receptor gene, partial cds
  gi|5293822|gb|AF399619.1|AF399619[15293822]
• 4174: AF399618
  Homo sapiens clone OR2AG1 olfactory receptor gene, partial cds
  gi|15293820|gb|AF399618.1|AF399618[15293820]
• 4175: AF399617
  Homo sapiens clone OR2M4 olfactory receptor gene, partial cds
  gi|5293818|gb|AF399617.1|AF399617[15293818]
• 4176: AF399616
  Homo sapiens clone OR2M2 olfactory receptor gene, partial cds
  gi|15293816|gb|AF399616.1|AF399616[15293816]
• 4177: AF399615
  Homo sapiens clone OR2M2 olfactory receptor gene, partial cds
  gi|15293814|gb|AF399615.1|AF399615[15293814]
• 4178: AF399614
  Homo sapiens clone OR2V2 olfactory receptor gene, partial cds
  gi|15293812|gb|AF399614.1|AF399614[15293812]
• 4179: AF399613
  Homo sapiens clone OR2T1 olfactory receptor gene, partial cds
  gi|15293810|gb|AF399613.1|AF399613[15293810]
• 4180: AF399612
  Homo sapiens clone OR2T3 olfactory receptor gene, partial cds
  gi|15293808|gb|AF399612.1|AF399612[15293808]
• 4181: AF399611
  Homo sapiens clone OR11H1 olfactory receptor gene, partial cds
  gi|5293806|gb|AF399611.1|AF399611[15293806]
• 4182: AF399610
  Homo sapiens clone OR11G2 olfactory receptor gene, partial cds
  gi|15293804|gb|AF399610.1|AF399610[15293804]
• 4183: AF399609
  Homo sapiens clone OR6Q1 olfactory receptor gene, partial cds
  gi|15293802|gb|AF399609.1|AF399609[15293802]
• 4184: AF399608
  Homo sapiens clone OR6N1 olfactory receptor gene, partial cds
  gi|5293800|gb|AF399608.1|AF399608[15293800]
• 4185: AF399607
  Homo sapiens clone OR6W1 olfactory receptor gene, partial cds
  gi|15293798|gb|AF399607.1|AF399607[15293798]
• 4186: AF399606
  Homo sapiens clone OR6M1 olfactory receptor gene, partial cds
  gi|15293796|gb|AF399606.1|AF399606[15293796]
• 4187: AF399605
  Homo sapiens clone OR6B1 olfactory receptor gene, partial cds
  gi|5293794|gb|AF399605.1|AF399605[15293794]
• 4188: AF399604
  Homo sapiens clone OR6F1 olfactory receptor gene, partial cds
  gi|15293792|gb|AF399604.1|AF399604[15293792]
• 4189: AF399603
  Homo sapiens clone OR13J1 olfactory receptor gene, partial cds
  gi|15293790|gb|AF399603.1|AF399603[15293790]
• 4190: AF399602
  Homo sapiens clone OR13C4 olfactory receptor gene, partial cds
  gi|15293788|gb|AF399602.1|AF399602[15293788]
• 4191: AF399601
  Homo sapiens clone OR2S2 olfactory receptor gene, partial cds
  gi|15293786|gb|AF399601.1|AF399601[15293786]
• 4192: AF399600
  Homo sapiens clone OR13C7 olfactory receptor gene, partial cds
  gi|15293784|gb|AF399600.1|AF399600[15293784]
• 4193: AF399599
  Homo sapiens clone OR13C8 olfactory receptor gene, partial cds
  gi|15293782|gb|AF399599.1|AF399599[15293782]
• 4194: AF399598
  Homo sapiens clone OR2A7 olfactory receptor gene, partial cds
  gi|15293780|gb|AF399598.1|AF399598[15293780]
• 4195: AF399597
  Homo sapiens clone OR2A1 olfactory receptor gene, partial cds
  gi|15293778|gb|AF399597.1|AF399597[15293778]
• 4196: AF399596
  Homo sapiens clone OR2A6 olfactory receptor gene, partial cds
  gi|15293776|gb|AF399596.1|AF399596[15293776]
• 4197: AF399595
  Homo sapiens clone OR2A5 olfactory receptor gene, partial cds
  gi|15293774|gb|AF399595.1|AF399595[15293774]
• 4198: AF399594
  Homo sapiens clone OR2F1 olfactory receptor gene, partial cds
  gi|15293772|gb|AF399594.1|AF399594[15293772]
• 4199: AF399593
  Homo sapiens clone OR10V1 olfactory receptor gene, partial cds
  gi|15293770|gb|AF399593.1|AF399593[15293770]
• 4200: AF399592
  Homo sapiens clone OR2D3 olfactory receptor gene, partial cds
  gi|15293768|gb|AF399592.1|AF399592[15293768]
• 4201: AF399591
  Homo sapiens clone OR2D2 olfactory receptor gene, partial cds
  gi|15293766|gb|AF399591.1|AF399591[15293766]
• 4202: AF399590
  Homo sapiens clone OR5AY1 olfactory receptor gene, partial cds
  gi|15293764|gb|AF399590.1|AF399590[15293764]
• 4203: AF399589
  Homo sapiens clone OR5AX1 olfactory receptor gene, partial cds
  gi|15293762|gb|AF399589.1|AF399589[15293762]
• 4204: AF399588
  Homo sapiens clone OR10J6 olfactory receptor gene, partial cds
  gi|15293760|gb|AF399588.1|AF399588[15293760]
• 4205: AF399587
  Homo sapiens clone OR10J1 olfactory receptor gene, partial cds
  gi|15293758|gb|AF399587.1|AF399587[15293758]
• 4206: AF399586
  Homo sapiens clone OR10H4 olfactory receptor gene, partial cds
  gi|15293756|gb|AF399586.1|AF399586[15293756]
• 4207: AF399585
  Homo sapiens clone OR10H2 olfactory receptor gene, partial cds
  gi|15293754|gb|AF399585.1|AF399585[15293754]
• 4208: AF399584
  Homo sapiens clone OR10H1 olfactory receptor gene, partial cds
  gi|15293752|gb|AF399584.1|AF399584[15293752]
• 4209: AF399583
  Homo sapiens clone OR10H5 olfactory receptor gene, partial cds
  gi|15293750|gb|AF399583.1|AF399583[15293750]
• 4210: AF399582
  Homo sapiens clone OR10R2 olfactory receptor gene, partial cds
  gi|15293748|gb|AF399582.1|AF399582[15293748]
• 4211: AF399581
  Homo sapiens clone OR4E2 olfactory receptor gene, partial cds
  gi|15293746|gb|AF399581.1|AF399581[15293746]
• 4212: AF399580
  Homo sapiens clone OR4X2 olfactory receptor gene, partial cds
  gi|15293744|gb|AF399580.1|AF399580[15293744]
• 4213: AF399579
  Homo sapiens clone OR4B1 olfactory receptor gene, partial cds
  gi|5293742|gb|AF399579.1|AF399579[15293742]
• 4214: AF399578
  Homo sapiens clone OR4A15 olfactory receptor gene, partial cds
  gi|15293740|gb|AF399578.1|AF399578[15293740]
• 4215: AF399577
  Homo sapiens clone OR4A4 olfactory receptor gene, partial cds
  gi|15293738|gb|AF399577.1|AF399577[15293738]
• 4216: AF399576
  Homo sapiens clone OR4C12 olfactory receptor gene, partial cds
  gi|15293736|gb|AF399576.1|AF399576[15293736]
• 4217: AF399575
  Homo sapiens clone OR4C13 olfactory receptor gene, partial cds
  gi|15293734|gb|AF399575.1|AF399575[15293734]
• 4218: AF399574
  Homo sapiens clone OR4F4 olfactory receptor gene, partial cds
  gi|15293732|gb|AF399574.1|AF399574[15293732]
• 4219: AF399573
  Homo sapiens clone OR4F15 olfactory receptor gene, partial cds
  gi|15293730|gb|AF399573.1|AF399573[15293730]
• 4220: AF399572
  Homo sapiens clone OR4K14 olfactory receptor gene, partial cds
  gi|5293728|gb|AF399572.1|AF399572[15293728]
• 4221: AF399571
  Homo sapiens clone OR4K3 olfactory receptor gene, partial cds
  gi|15293726|gb|AF399571.1|AF399571[15293726]
• 4222: AF399570
  Homo sapiens clone OR4K1 olfactory receptor gene, partial cds
  gi|15293724|gb|AF399570.1|AF399570[15293724]
• 4223: AF399569
  Homo sapiens clone OR4D6 olfactory receptor gene, partial cds
  gi|15293722|gb|AF399569.1|AF399569[15293722]
• 4224: AF399568
  Homo sapiens clone OR4D2 olfactory receptor gene, partial cds
  gi|15293720|gb|AF399568.1|AF399568[15293720]
• 4225: AF399567
  Homo sapiens clone OR4D1 olfactory receptor gene, partial cds
  gi|15293718|gb|AF399567.1|AF399567[15293718]
• 4226: AF399566
  Homo sapiens clone OR10G3 olfactory receptor gene, partial cds
  gi|15293716|gb|AF399566.1|AF399566[15293716]
• 4227: AF399565
  Homo sapiens clone OR10S1 olfactory receptor gene, partial cds
  gi|15293714|gb|AF399565.1|AF399565[15293714]
• 4228: AF399564
  Homo sapiens clone OR1L8 olfactory receptor gene, partial cds
  gi|5293712|gb|AF399564.1|AF399564[15293712]
• 4229: AF399563
  Homo sapiens clone OR1L6 olfactory receptor gene, partial cds
  gi|15293710|gb|AF399563.1|AF399563[15293710]
• 4230: AF399562
  Homo sapiens clone OR1L4 olfactory receptor gene, partial cds
  gi|15293708|gb|AF399562.1|AF399562[15293708]
• 4231: AF399561
  Homo sapiens clone ORIQI olfactory receptor gene, partial cds
  gi|15293706|gb|AF399561.1|AF399561[15293706]
• 4232: AF399560
  Homo sapiens clone OR1C1 olfactory receptor gene, partial cds
  gi|15293704|gb|AF399560.1|AF399560[15293704]
• 4233: AF399559
  Homo sapiens clone OR1F1 olfactory receptor gene, partial cds
  gi|15293702|gb|AF399559.1|AF399559[15293702]
• 4234: AF399558
  Homo sapiens clone OR1F2 olfactory receptor gene, partial cds
  gi|15293700|gb|AF399558.1|AF399558[15293700]
• 4235: AF399557
  Homo sapiens clone OR1S2 olfactory receptor gene, partial cds
  gi|15293698|gb|AF399557.1|AF399557[15293698]
• 4236: AF399556
  Homo sapiens clone OR1A2 olfactory receptor gene, partial cds
  gi|15293696|gb|AF399556.1|AF399556[15293696]
• 4237: AF399555
  Homo sapiens clone OR1A1 olfactory receptor gene, partial cds
  gi|15293694|gb|AF399555.1|AF399555[15293694]
• 4238: AF399554
  Homo sapiens clone OR1J1 olfactory receptor gene, partial cds
  gi|15293692|gb|AF399554.1|AF399554[15293692]
• 4239: AF399553
  Homo sapiens clone OR1J4 olfactory receptor gene, partial cds
  gi|5293690|gb|AF399553.1|AF399553[15293690]
• 4240: AF399552
  Homo sapiens clone OR1J2 olfactory receptor gene, partial cds
  gi|15293688|gb|AF399552.1|AF399552[15293688]
• 4241: AF399551
  Homo sapiens clone OR1E2 olfactory receptor gene, partial cds
  gi|15293686|gb|AF399551.1|AF399551[15293686]
• 4242: AF399550
  Homo sapiens clone OR1E1 olfactory receptor gene, partial cds
  gi|15293684|gb|AF399550.1|AF399550[15293684]
• 4243: AF399549
  Homo sapiens clone OR1M1 olfactory receptor gene, partial cds
  gi|15293682|gb|AF399549.1|AF399549[15293682]
• 4244: AF399548
  Homo sapiens clone OR1I1 olfactory receptor gene, partial cds
  gi|5293680|gb|AF399548.1|AF399548[15293680]
• 4245: AF399547
  Homo sapiens clone OR1N3 olfactory receptor gene, partial cds
  gi|15293678|gb|AF399547.1|AF399547[15293678]
• 4246: AF399546
  Homo sapiens clone OR7C1 olfactory receptor gene, partial cds
  gi|15293676|gb|AF399546.1|AF399546[15293676]
• 4247: AF399545
  Homo sapiens clone OR7C2 olfactory receptor gene, partial cds
  gi|15293674|gb|AF399545.1|AF399545[15293674]
• 4248: AF399544
  Homo sapiens clone OR7A2 olfactory receptor gene, partial cds
  gi|15293672|gb|AF399544.1|AF399544[15293672]
• 4249: AF399543
  Homo sapiens clone OR7A5 olfactory receptor gene, partial cds
  gi|15293670|gb|AF399543.1|AF399543[15293670]
• 4250: AF399542
  Homo sapiens clone OR7A10 olfactory receptor gene, partial cds
  gi|15293668|gb|AF399542.1|AF399542[15293668]
• 4251: AF399541
  Homo sapiens clone OR7A17 olfactory receptor gene, partial cds
  gi|15293666|gb|AF399541.1|AF399541[15293666]
• 4252: AF399540
  Homo sapiens clone OR7G3 olfactory receptor gene, partial cds
  gi|15293664|gb|AF399540.1|AF399540[15293664]
• 4253: AF399539
  Homo sapiens clone OR7G2 olfactory receptor gene, partial cds
  gi|15293662|gb|AF399539.1|AF399539[15293662]
• 4254: AF399538
  Homo sapiens clone OR7G1 olfactory receptor gene, partial cds
  gi|15293660|gb|AF399538.1|AF399538[15293660]
• 4255: AF399537
  Homo sapiens clone OR7D2 olfactory receptor gene, partial cds
  gi|15293658|gb|AF399537.1|AF399537[15293658]
• 4256: AF399536
  Homo sapiens clone OR1N2 olfactory receptor gene, partial cds
  gi|15293656|gb|AF399536.1|AF399536[15293656]
• 4257: AF399535
  Homo sapiens clone OR1D2 olfactory receptor gene, partial cds
  gi|15293654|gb|AF399535.1|AF399535[15293654]
• 4258: AF399534
  Homo sapiens clone OR1D4 olfactory receptor gene, partial cds
  gi|15293652|gb|AF399534.1|AF399534[15293652]
• 4259: AF399533
  Homo sapiens clone OR1D5 olfactory receptor gene, partial cds
  gi|15293650|gb|AF399533.1|AF399533[15293650]
• 4260: AF399532
  Homo sapiens clone OR9Q1 olfactory receptor gene, partial cds
  gi|15293648|gb|AF399532.1|AF399532[15293648]
• 4261: AF399531
  Homo sapiens clone OR9I1 olfactory receptor gene, partial cds
  gi|15293646|gb|AF399531.1|AF399531[15293646]
• 4262: AF399530
  Homo sapiens clone OR9G4 olfactory receptor gene, partial cds
  gi|15293644|gb|AF399530.1|AF399530[15293644]
• 4263: AF399529
  Homo sapiens clone OR5A2 olfactory receptor gene, partial cds
  gi|15293642|gb|AF399529.1|AF399529[15293642]
• 4264: AF399528
  Homo sapiens clone OR5A1 olfactory receptor gene, partial cds
  gi|15293640|gb|AF399528.1|AF399528[15293640]
• 4265: AF399527
  Homo sapiens clone OR5F1 olfactory receptor gene, partial cds
  gi|15293638|gb|AF399527.1|AF399527[15293638]
• 4266: AF399526
  Homo sapiens clone OR5L2 olfactory receptor gene, partial cds
  gi|15293636|gb|AF399526.1|AF399526[15293636]
• 4267: AF399525
  Homo sapiens clone OR5D18 olfactory receptor gene, partial cds
  gi|15293634|gb|AF399525.1|AF399525[15293634]
• 4268: AF399524
  Homo sapiens clone OR5D16 olfactory receptor gene, partial cds
  gi|15293632|gb|AF399524.1|AF399524[15293632]
• 4269: AF399523
  Homo sapiens clone OR5D14 olfactory receptor gene, partial cds
  gi|15293630|gb|AF399523.1|AF399523[15293630]
• 4270: AF399522
  Homo sapiens clone OR5M1 olfactory receptor gene, partial cds
  gi|15293628|gb|AF399522.1|AF399522[15293628]
• 4271: AF399521
  Homo sapiens clone OR5M11 olfactory receptor gene, partial cds
  gi|15293626|gb|AF399521.1|AF399521[15293626]
• 4272: AF399520
  Homo sapiens clone OR5 MB olfactory receptor gene, partial cds
  gi|15293624|gb|AF399520.1|AF399520[15293624]
• 4273: AF399519
  Homo sapiens clone OR5M9 olfactory receptor gene, partial cds
  gi|15293622|gb|AF399519.1|AF399519[15293622]
• 4274: AF399518
  Homo sapiens clone OR5M3 olfactory receptor gene, partial cds
  gi|15293620|gb|AF399518.1|AF399518[15293620]
• 4275: AF399517
  Homo sapiens clone OR8K1 olfactory receptor gene, partial cds
  gi|15293618|gb|AF399517.1|AF399517[15293618]
• 4276: AF399516
  Homo sapiens clone OR8J3 olfactory receptor gene, partial cds
  gi|15293616|gb|AF399516.1|AF399516[15293616]
• 4277: AF399515
  Homo sapiens clone OR8J1 olfactory receptor gene, partial cds
  gi|15293614|gb|AF399515.1|AF399515[15293614]
• 4278: AF399514
  Homo sapiens clone OR5C1 olfactory receptor gene, partial cds
  gi|15293612|gb|AF399514.1|AF399514[15293612]
• 4279: AF399513
  Homo sapiens clone OR8I2 olfactory receptor gene, partial cds
  gi|15293610|gb|AF399513.1|AF399513[15293610]
• 4280: AF399512
  Homo sapiens clone OR8A1 olfactory receptor gene, partial cds
  gi|15293608|gb|AF399512.1|AF399512[15293608]
• 4281: AF399511
  Homo sapiens clone OR8B12 olfactory receptor gene, partial cds
  gi|15293606|gb|AF399511.1|AF399511[15293606]
• 4282: AF399510
  Homo sapiens clone OR8B8 olfactory receptor gene, partial cds
  gi|15293604|gb|AF399510.1|AF399510[15293604]
• 4283: AF399509
  Homo sapiens clone OR8B4 olfactory receptor gene, partial cds
  gi|15293602|gb|AF399509.1|AF399509[15293602]
• 4284: AF399508
  Homo sapiens clone OR8B2 olfactory receptor gene, partial cds
  gi|15293600|gb|AF399508.1|AF399508[15293600]
• 4285: AF399507
  Homo sapiens clone OR8G1 olfactory receptor gene, partial cds
  gi|15293598|gb|AF399507.1|AF399507[15293598]
• 4286: AF399506
  Homo sapiens clone OR6C1 olfactory receptor gene, partial cds
  gi|15293596|gb|AF399506.1|AF399506[15293596]
• 4287: AF399505
  Homo sapiens clone OR52B2 olfactory receptor gene, partial cds
  gi|15293594|gb|AF399505.1|AF399505[15293594]
• 4288: AF399504
  Homo sapiens clone OR52E6 olfactory receptor gene, partial cds
  gi|15293592|gb|AF399504.1|AF399504[15293592]
• 4289: AF399503
  Homo sapiens clone OR51B2 olfactory receptor gene, partial cds
  gi|15293590|gb|AF399503.1|AF399503[15293590]
• 4290: AF244813
  Homo sapiens platelet-derived growth factor C mRNA, complete cds
  gi|8886883|gb|AF244813.1|AF244813[8886883]
• 4291: AF169650
  Homo sapiens high mobility group 1 protein (HMG1) gene, exon 5
  gi|14522864|gb|AF169650.1|AF169650[14522864]
• 4451: AF330055
  Homo sapiens neuropeptide NPVF receptor mRNA, complete cds
  gi|15281399|gb|AF330055.1|AF330055[15281399]
• 4452: AF330053
  Homo sapiens neuropeptide NPFF receptor mRNA, complete cds
  gi|15281395|gb|AF330053.1|AF330053[15281395]
• 4453: AF402318
  Homo sapiens differentiation-related DIF14 long form (DIF14) mRNA, complete cds,
  alternatively spliced
  gi|15278166|gb|AF402318.1|AF402318[15278166]
• 4454: AF397453
  Homo sapiens Fc receptor-like protein 5 (FCRH5) mRNA, complete cds
  gi|15277745|gb|AF397453.1|AF397453[15277745]
• 4455: AF397452
  Homo sapiens Fc receptor-like protein 4 (FCRH4) mRNA, complete cds
  gi|15277740|gb|AF397452.1|AF397452[15277740]
• 4456: AF400441
  Homo sapiens neurotrophic tyrosine kinase receptor type 2 (NTRK2) mRNA, complete
  cds
  gi|15217076|gb|AF400441.1|AF400441[15217076]
• 4462: NM_—020535
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5 (KIR2DL5), mRNA
  gi|11968153|ref|NM_—020535.1|[11968153]
• 4463: AP000511
  Homo sapiens genomic DNA, chromosome 6p21.3, HLA Class I region, section 10/20
  gi|5926698|dbj|AP000511.1|AP000511[5926698]
• 4465: L20295
  Homo sapiens vasoactive intestinal peptide receptor mRNA, partial cds
  gi|403461|gb|L20295.1|HUMVAIPR[403461]
• 4466: AY040568
  Homo sapiens interleukin 22-binding protein CRF2-10S (IL22BP) mRNA, complete cds, alternatively spliced
  gi|5212829|gb|AY040568.1|[15212829]
• 4467: AY040567
  Homo sapiens interleukin 22-binding protein CRF2-10L (IL22BP) mRNA, complete cds, alternatively spliced
  gi|15212827|gb|AY040567.1|[15212827]
• 4468: AY040566
  Homo sapiens interleukin 22-binding protein CRF2-10 (IL22BP) mRNA, complete cds
  gi|15212825|gb|AY040566.1|[15212825]
• 4471: AX193708
  Sequence 30 from Patent WO0136467
  gi|15211557|emb|AX193708.1|AX193708[15211557]
• 4472: AX193705
  Sequence 27 from Patent WO0136467
  gi|15211554|emb|AX193705.1|AX193705[15211554]
• 4473: AX193702
  Sequence 24 from Patent WO0136467
  gi|15211551|emb|AX193702.1|AX193702[15211551]
• 4474: AX193682
  Sequence 4 from Patent WO0136467
  gi|15211548|emb|AX193682.1|AX193682[15211548]
• 4475: AX193679
  Sequence 1 from Patent WO0136467
  gi|15211545|emb|AX193679.1|AX193679[15211545]
• 4476: NM_—005675
  Homo sapiens DiGeorge syndrome critical region gene 6 (DGCR6), mRNA
  gi|15208653|ref|NM_—005675.2|[15208653]
• 4477: NM_—016083
  Homo sapiens cannabinoid receptor 1 (brain) (CNR1), transcript variant 2, mRNA
  gi|15208646|ref|NM_—016083.2|[15208646]
• 4478: NM_—016205
  Homo sapiens platelet derived growth factor C (PDGFC), mRNA
  gi|9994186|ref|NM_—016205.1|[9994186]
• 4479: AF159056
  Homo sapiens T-cell gamma receptor locus, complete sequence
  gi|5566238|gb|AF159056.1|AF159056[5566238]
• 4480: NM_—006207
  Homo sapiens platelet-derived growth factor receptor-like (PDGFRL), mRNA
  gi|5453871|ref|NM_—006207.1|[5453871]
• 4481: NM_—004986
  Homo sapiens kinectin 1 (kinesin receptor) (KTN1), mRNA
  gi|4826813|ref|NM_—004986.1|[4826813]
• 4482: NM_—001840
  Homo sapiens cannabinoid receptor 1 (brain) (CNR1), transcript variant 1, mRNA
  gi|4502926|ref|NM_—001840.1|[4502926]
• 4483: NM_—033223
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 3 (GABRG3), mRNA
  gi|15193297|ref|NM_—033223.1|[15193297]
• 4484: AY008283
  Homo sapiens porimin mRNA, complete cds
  gi|15192138|gb|AY008283.1|[15192138]
• 4485: NM_—015906
  Homo sapiens tripartite motif-containing 33 (TRIM33), transcript variant alpha,
  mRNA
  gi|14971412|ref|NM_—015906.2|[14971412]
• 4486: NM_—033020
  Homo sapiens tripartite motif-containing 33 (TRIM33), transcript variant beta,
  mRNA
  gi|14971410|ref|NM_—033020.1|[14971410]
• 4487: AH006431
  Homo sapiens glycine receptor alpha 2 subunit, complete cds
  gi|3598700|gb|AH006431.1|SEG_HSGLRA2G[3598700]
• 4488: AF053495
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 9 and complete
  cds
  gi|3598699|gb|AF053495.1|HSGLRA2G9[3598699]
• 4489: AF053494
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 8
  gi|3598698|gb|AF053494.1|HSGLRA2G8[3598698]
• 4490: AF053493
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 7
  gi|3598697|gb|AF053493.1|HSGLRA2G7[3598697]
• 4491: AF053492
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 6
  gi|3598696|gb|AF053492.1|HSGLRA2G6[3598696]
• 4492: AF053491
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 5
  gi|3598695|gb|AF053491.1|HSGLRA2G5[3598695]
• 4493: AF053490
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 4
  gi|3598694|gb|AF053490.1|HSGLRA2G4[3598694]
• 4494: AF053489
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exons 3a and 3b
  gi|3598693|gb|AF053489.1|HSGLRA2G3[3598693]
• 4495: AF053488
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 2
  gi|3598692|gb|AF053488.1|HSGLRA2G2[3598692]
• 4496: AF053487
  Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 1
  gi|3598691|gb|AF053487.1|HSGLRA2G1[3598691]
• 4499: AF344654
  Homo sapiens growth hormone receptor variant gene, partial cds
  gi|15186845|gb|AF344654.1|[15186845]
• 4501: AF179680
  Homo sapiens apelin gene, complete cds
  gi|6708145|gb|AF179680.1|AF179680[6708145]
• 4502: AJ296652
  Homo sapiens HRH3 gene for histamine h3 receptor, exons 1-3
  gi|15149878|emb|AJ296652.1|HSA296652[15149878]
• 4503: NM_—006707
  Homo sapiens butyrophilin-like 3 (BTNL3), mRNA
  gi|5729747|ref|NM_—006707.1|[5729747]
• 4504: NM_—002009
  Homo sapiens fibroblast growth factor 7 (keratinocyte growth factor) (FGF7), mRNA
  gi|15147344|ref|NM_—002009.2|[15147344]
• 4505: AF190501
  Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6)
  mRNA, partial cds
  gi|10441731|gb|AF190501.1|AF190501[10441731]
• 4506: AF190500
  Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 7 (LGR7)
  mRNA, complete cds
  gi|10441729|gb|AF190500.1|AF190500[10441729]
• 4507: NM_—016543
  Homo sapiens sialic acid binding Ig-like lectin 7 (SIGLEC7), mRNA
  gi|7706570|ref|NM_—016543.1|[7706570]
• 4508: NM_—014385
  Homo sapiens sialic acid binding Ig-like lectin 7 (SIGLEC7), mRNA
  gi|7657569|ref|NM_—014385.1|[7657569]
• 4509: AC005153
  Homo sapiens PAC clone RP4-537P9 from 7p11.2-p12, complete sequence
  gi|3242766|gb|AC005153.1|AC005153[3242766]
• 4528: AJ309020
  Homo sapiens mRNA for G protein-coupled receptor (AXOR12 gene)
  gi|14330412|emb|AJ309020.1|HSA309020[14330412]
• 4529: AJ243297
  Homo sapiens partial RET gene, exons 2 to 20
  gi|5419752|emb|AJ243297.1|HSA243297[5419752]
• 4530: X57019
  H. sapiens mRNA for tyrosine kinase receptor
  gi|37592|emb|X57019.1|HSUF025[37592]
• 4585: AF166361
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 9 and complete cds
  gi|10086249|gb|AF166361.1|AF165901S9[10086249]
• 4586: AF166360
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 8
  gi|10086248|gb|AF166360.1|AF165901S8[10086248]
• 4587: AF166359
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 7
  gi|10086247|gb|AF166359.1|AF165901S7[10086247]
• 4588: AF165906
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 6
  gi|10086246|gb|AF165906.1|AF165901S6[10086246]
• 4589: AF165905
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 5
  gi|10086245|gb|AF165905.1|AF165901S5[10086245]
• 4590: AF165904
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 4
  gi|10086244|gb|AF165904.1|AF165901S4[10086244]
• 4591: AF165903
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 3
  gi|0086243|gb|AF165903.1|AF165901S3[10086243]
• 4592: AF165902
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 2
  gi|10086242|gb|AF165902.1|AF165901S2[10086242]
• 4593: AF165901
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 1
  gi|10086241|gb|AF165901.1|AF165901S1[10086241]
• 4594: AH009803
  Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, complete cds
  gi|10086240|gb|AH009803.1|SEG_AF165901S[10086240]
• 4595: AF167332
  Homo sapiens glutamate receptor subunit 3 flip and flop isoforms (GRIA3) gene,
  exon 16 and partial cds, alternatively spliced
  gi|9738978|gb|AF167332.1|F166362S15[9738978]
• 4596: AF166375
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 15
  gi|9738977|gb|AF166375.1|F166362S14[9738977]
• 4597: AF166374
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 14
  gi|9738976|gb|AF166374.1|F166362S13[9738976]
• 4598: AF166373
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 13
  gi|9738975|gb|AF166373.1F166362S12[9738975]
• 4599: AF166372
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 12
  gi|9738974|gb|AF166372.1|F166362S11[9738974]
• 4600: AF166371
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 11
  gi|9738973|gb|AF166371.1|F166362S10[9738973]
• 4601: AF166370
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 10
  gi|9738972|gb|AF166370.1|F166362S09[9738972]
• 4602: AF166369
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 9
  gi|9738971|gb|AF166369.1F166362S08[9738971]
• 4603: AF166368
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 8
  gi|9738970|gb|AF166368.1|F166362S07[9738970]
• 4604: AF166367
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 7
  gi|9738969|gb|AF166367.1|F166362S06[9738969]
• 4605: AF166366
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 6
  gi|9738968|gb|AF166366.1|F166362S05[9738968]
• 4606: AF166365
  Homo sapiens glutamate receptor subunit 3 flip and flop isoforms (GRIA3) gene,
  exon 4 and partial cds
  gi|9738967|gb|AF166365.1|F166362S04[9738967]
• 4607: AF166364
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 3
  gi|9738966|gb|AF166364.1|F166362S03[9738966]
• 4608: AF166363
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 2
  gi|9738965|gb|AF166363.1|F166362S02[9738965]
• 4609: AF166362
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 1
  gi|9738964|gb|AF166362.1|F166362S01[9738964]
• 4610: AH009704
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, partial cds; and glutamate receptor subunit 3 (GRIA3) gene, partial cds, alternatively spliced
  gi|9738963|gb|AH009704.1|SEG_F166362S[9738963]
• 4611: AF272389
  Homo sapiens natural killer cell immunoglobulin-like receptor (KIR2D55) mRNA, partial cds
  gi|15080894|gb|AF272389.1|AF272389[15080894]
• 4612: BC011847
  Homo sapiens, fibroblast growth factor receptor 4, clone MGC:20292 IMAGE:4121396, mRNA, complete cds
  gi|15080147|gb|BC011847.1|BC011847[15080147]
• 4613: BC011787
  Homo sapiens, nogo receptor, clone MGC:19831 IMAGE:4040540, mRNA, complete cds
  gi|15080004|gb|BC011787.1|BC011787[15080004]
• 4614: AF353942
  Homo sapiens lantibiotic synthetase C-like protein 2 (LANCL2) mRNA, complete cds
  gi|15077638|gb|AF353942.1|AF353942[15077638]
• 4615: AF343725
  Homo sapiens G-protein-coupled receptor GPR54 (GPR54) mRNA, complete cds
  gi|15077535|gb|AF343725.1|AF343725[15077535]
• 4617: AJ272063
  Homo sapiens mRNA for vanilloid receptor 1 (VR1 gene)
  gi|15028818|emb|AJ272063.2|HSA272063[15028818]
• 4618: AF133266
  Homo sapiens cysteinyl leukotriene receptor mRNA, complete cds
  gi|5359717|gb|AF133266.1|AF133266[5359717]
• 4619: NM_—033130
  Homo sapiens sialic acid binding Ig-like lectin 10 (SIGLEC10), mRNA
  gi|15055512|ref|NM_—033130.1|[15055512]
• 4620: NM_—033180
  Homo sapiens olfactory receptor, family 51, subfamily B, member 2 (OR51B2), mRNA
  gi|15042966|ref|NM_—033180.1|[15042966]
• 4621: NM_—033179
  Homo sapiens olfactory receptor, family 51, subfamily B, member 4 (OR51B4), mRNA
  gi|15042964|ref|NM_—033179.1|[15042964]
• 4622: AF380193
  Homo sapiens trace amine receptor 5 (TA5) gene, complete cds
  gi|14600089|gb|AF380193.1|AF380193[14600089]
• 4623: AF380192
  Homo sapiens trace amine receptor 4 (TA4) gene, complete cds
  gi|14600087|gb|AF380192.1|AF380192[14600087]
• 4624: AF380189
  Homo sapiens trace amine receptor 3 (TA3) gene, complete cds
  gi|14600081|gb|AF380189.1|AF380189[14600081]
• 4625: AF380185
  Homo sapiens trace amine receptor 1 (TA1) gene, complete cds
  gi|14600073|gb|AF380185.1|AF380185[14600073]
• 4626: AF313468
  Homo sapiens dendritic cell-associated C-type lectin-1 mRNA, complete cds
  gi|13649707|gb|AF313468.1|AF313468[13649707]
• 4627: NM_—007096
  Homo sapiens clathrin, light polypeptide (Lca) (CLTA), transcript variant brain-specific, mRNA
  gi|6005992|ref|NM_—007096.1|[6005992]
• 4628: NM_—001833
  Homo sapiens clathrin, light polypeptide (Lca) (CLTA), transcript variant nonbrain, mRNA
  gi|4502898|ref|NM_—001833.1|[4502898]
• 4629: NM_—005292
  Homo sapiens G protein-coupled receptor 18 (GPR18), mRNA
  gi|15029527|ref|NM_—005292.1|[15029527]
• 4630: NM_—012276
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4 (ILT7), mRNA
  gi|15029521|ref|NM_—012276.1|[15029521]
• 4631: AJ299451
  Homo sapiens mRNA for glutamate receptor 7 (GRIK3 gene)
  gi|5028906|emb|AJ299451.1|HSA299451[15028906]
• 4632: AY033606
  Homo sapiens fused in glioblastoma mRNA, complete cds
  gi|14289128|gb|AY033606.1|[14289128]
• 4633: AF190696
  Homo sapiens bile salt export pump (ABCB11) gene, promoter region and partial sequence
  gi|14280234|gb|AF190696.1|AF190696[14280234]
• 4634: NM_—018558
  Homo sapiens gamma-aminobutyric acid (GABA) receptor, theta (GABRQ), mRNA
  gi|8924257|ref|NM_—018558.1|[8924257]
• 4635: NM_—014452
  Homo sapiens tumor necrosis factor receptor superfamily, member 21 (TNFRSF21),
  mRNA
  gi|7657038|ref|NM_—014452.1|[7657038]
• 4637: AF320560
  Homo sapiens stresscopin-related protein mRNA, complete cds
  gi|14029393|gb|AF320560.1|AF320560[14029393]
• 4638: NM_—007368
  Homo sapiens RAS p21 protein activator (GTPase activating protein) 3 (Ins(1,3,4,5)P4-binding protein) (GAP1IP4BP), mRNA
  gi|12545409|ref|NM_—007368.1|[12545409]
• 4639: NM_—016109
  Homo sapiens angiopoietin-like 4 (ANGPTL4), mRNA
  gi|7705828|ref|NM_—016109.1|[7705828]
• 4640: NM_—006667
  Homo sapiens progesterone receptor membrane component 1 (PGRMC1), mRNA
  gi|6857798|ref|NM_—006667.2|[6857798]
• 4641: NM_—006320
  Homo sapiens progesterone receptor membrane component 2 (PGRMC2), mRNA
  gi|5453915|ref|NM_—006320.1|[5453915]
• 4662: AF319553
  Homo sapiens TNFRSF19L mRNA, complete cds
  gi|15011026|gb|AF319553.1|AF319553[15011026]
• 4663: AF395806
  Homo sapiens adrenergic receptor alpha-1a (ADRA1A) mRNA, complete cds
  gi|15004693|gb|AF395806.1|AF395806[15004693]
• 4664: AF388194
  Homo sapiens PML/RARA fusion mRNA, partial sequence
  gi|15004544|gb|AF388194.1|AF388194[15004544]
• 4665: AF388193
  Homo sapiens PML/RARA fusion mRNA, partial sequence
  gi|15004543|gb|AF388193.1|AF388193[15004543]
• 4666: AF334818
  Homo sapiens sodium-dependent neutral amino acid transporter type 2 truncated isoform (ASCT2) mRNA, partial cds
  gi|15004316|gb|AF334818.1|AF334818[15004316]
• 4667: NM_—022788
  Homo sapiens Purinergic receptor P2Y, G protein-coupled, 12 (P2RY12), mRNA
  gi|12232482|ref|NM_—022788.1|[12232482]
• 4668: NM_—016523
  Homo sapiens killer cell lectin-like receptor subfamily F, member 1 (KLRF1), mRNA
  gi|7705573|ref|NM_—016523.1|[7705573]
• 4669: NM_—002558
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1), mRNA
  gi|4505544|ref|NM_—002558.1|[4505544]
• 4670: AF391809
  Homo sapiens coagulation factor II (thrombin) receptor (F2R) gene, complete cds
  gi|14971463|gb|AF391809.2|AF391809[14971463]
• 4671: NM_—016930
  Homo sapiens syntaxin 18 (STX18), mRNA
  gi|8394375|ref|NM_—016930.1|[8394375]
• 4672: NM_—032957
  Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant 1, mRNA
  gi|14790173|ref|NM_—032957.1|[14790173]
• 4673: NM_—032945
  Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68C, mRNA
  gi|14790169|ref|NM_—032945.1|[14790169]
• 4674: NM_—015647
  Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant 3, mRNA
  gi|14790156|ref|NM_—015647.2|[14790156]
• 4675: NM_—005409
  Homo sapiens small inducible cytokine subfamily B (Cys-X-Cys), member 11 (SCYB11), mRNA
  gi|14790145|ref|NM_—005409.3|[14790145]
• 4676: NM_—001305
  Homo sapiens claudin 4 (CLDN4), mRNA
  gi|14790131|ref|NM_—001305.2|[14790131]
• 4677: NM_—004346
  Homo sapiens caspase 3, apoptosis-related cysteine protease (CASP3), transcript
  variant alpha, mRNA
  gi|14790118|ref|NM_—004346.2|[14790118]
• 4678: NM_—032991
  Homo sapiens caspase 3, apoptosis-related cysteine protease (CASP3), transcript
  variant beta, mRNA
  gi|14790114|ref|NM_—032991.1|[14790114]
• 4679: NM_—033057
  Homo sapiens olfactory receptor, family 2, subfamily B, member 2 (OR2B2), mRNA
  gi|14780899|ref|NM_—033057.1|[14780899]
• 4680: NM_—020137
  Homo sapiens GRIP-associated protein 1 (GRASP1), mRNA
  gi|14719405|ref|NM_—020137.1|[14719405]
• 4681: NM_—032503
  Homo sapiens G protein-coupled receptor slt (SLT), mRNA
  gi|14210483|ref|NM_—032503.1|[14210483]
• 4682: AF260738
  Homo sapiens platelet-derived growth factor C (PDGFC) mRNA, complete cds
  gi|14009503|gb|AF260738.1|AF260738[14009503]
• 4683: AF326275
  Homo sapiens melanocortin 1 receptor (MC1R) gene, complete cds
  gi|12658397|gb|AF326275.1|AF326275[12658397]
• 4684: NM_—016434
  Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant 2, mRNA
  gi|7706540|ref|NM_—016434.1|[7706540]
• 4685: NM_—013314
  Homo sapiens B-cell linker (BLNK), mRNA
  gi|7019534|ref|NM_—013314.1|[7019534]
• 4686: NM_—005817
  Homo sapiens cargo selection protein (mannose 6 phosphate receptor binding protein) (TIP47), mRNA
  gi|5032182|ref|NM_—005817.1|[5032182]
• 4687: NM_—003110
  Homo sapiens Sp2 transcription factor (SP2), mRNA
  gi|4507166|ref|NM_—003110.1|[4507166]
• 4688: NM_—002704
  Homo sapiens pro-platelet basic protein (includes platelet basic protein, beta-thromboglobulin, connective tissue-activating peptide III, neutrophil-activating peptide-2) (PPBP), mRNA
  gi|4505980|ref|NM_—002704.1|[4505980]
• 4689: AF064083
  Homo sapiens T-cell receptor beta chain variable region (TCRBV28) mRNA, TCRBV28*S2 allele, partial cds
  gi|3859856|gb|AF064083.1|AF064083[3859856]
• 4690: BC010641
  Homo sapiens, gamma-aminobutyric acid (GABA) A receptor, beta 3, clone MGC:9051
  IMAGE:3871111, mRNA, complete cds
  gi|14714964|gb|BC010641.1|BC010641[14714964]
• 4691: BC010574
  Homo sapiens, glutamate receptor, ionotropic, AMPA2 (alpha 2), clone MGC:17079
  IMAGE:4215347, mRNA, complete cds
  gi|14714845|gb|BC010574.1|BC010574[14714845]
• 4692: BC010536
  Homo sapiens, coxsackie virus and adenovirus receptor, clone MGC:17118 IMAGE:3456544, mRNA, complete cds
  gi|14714774|gb|BC010536.1|BC010536[14714774]
• 4693: BC010423
  Homo sapiens, Ig superfamily receptor LNIR, clone MGC:15117 IMAGE:3610849, mRNA,
  complete cds
  gi|14714573|gb|BC010423.1|BC010423[14714573]
• 4694: BC010418
  Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:16557
  IMAGE:4079845, mRNA, complete cds
  gi|14714563|gb|BC010418.1|BC010418[14714563]
• 4695: NM_—020168
  Homo sapiens p21(CDKN1A)-activated kinase 6 (PAK6), mRNA
  gi|14670348|ref|NM_—020168.2|[14670348]
• 4696: BC010140
  Homo sapiens, tumor necrosis factor receptor superfamily, member 1A, clone MGC:19588 IMAGE:4131360, mRNA, complete cds
  gi|14603367|gb|BC010140.1|BC010140[14603367]
• 4697: BC010054
  Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:19795
  IMAGE:3845335, mRNA, complete cds
  gi|14603183|gb|BC010054.1|BC010054[14603183]
• 4698: BC009974
  Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:16607
  IMAGE:4110990, mRNA, complete cds
  gi|14602973|gb|BC009974.1|BC009974[14602973]
• 4699: BC009960
  Homo sapiens, interleukin 13 receptor, alpha 1, clone MGC:15228 IMAGE:4300487, mRNA, complete cds
  gi|14602931|gb|BC009960.1|BC009960[14602931]
• 4701: BC009877
  Homo sapiens, purinergic receptor P2Y, G-protein coupled, 11, clone MGC:16468 IMAGE:3953307, mRNA, complete cds
  gi|14602717|gb|BC009877.1|BC009877[14602717]
• 4702: BC009861
  Homo sapiens, super conserved receptor expressed in brain 3, clone MGC:16375 IMAGE:3936037, mRNA, complete cds
  gi|14602675|gb|BC009861.1|BC009861[14602675]
• 4703: BC009748
  Homo sapiens, dopamine receptor D5, clone MGC:10601 IMAGE:3928370, mRNA, complete cds
  gi|14602484|gb|BC009748.1|BC009748[14602484]
• 4705: BC009391
  Homo sapiens, pyrimidinergic receptor P2Y, G-protein coupled, 6, clone MGC:15335
  IMAGE:4128941, mRNA, complete cds
  gi|14424757|gb|BC009391.1|BC009391[14424757]
• 4707: BC009237
  Homo sapiens, thyroid stimulating hormone receptor, clone MGC:2216 IMAGE:2989823, mRNA, complete cds
  gi|14328043|gb|3BC009237.1|BC009237[14328043]
• 4708: BC008982
  Homo sapiens, complement component 5 receptor 1 (C5a ligand), clone MGC:17119 IMAGE:4177114, mRNA, complete cds
  gi|14290435|gb|BC008982.1|BC008982[14290435]
• 4709: BC008867
  Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:16750
  IMAGE:4130936, mRNA, complete cds
  gi|14250793|gb|BC008867.1|BC008867[14250793]
• 4710: BC008786
  Homo sapiens, integrin, alpha 5 (fibronectin receptor, alpha polypeptide), clone
  MGC:3697 IMAGE:3629647, mRNA, complete cds
  gi|14250643|gb|BC008786.1|BC008786[14250643]
• 4711: BC008770
  Homo sapiens, G protein-coupled receptor 56, clone MGC:1409 IMAGE:3139174, mRNA,
  complete cds
  gi|14250619|gb|BC008770.1|BC008770[14250619]
• 4712: BC008734
  Homo sapiens, Fc fragment of IgG, receptor, transporter, alpha, clone MGC:1506
  IMAGE:3163446, mRNA, complete cds
  gi|14250560|gb|BC008734.1|BC008734[14250560]
• 4714: BC008716
  Homo sapiens, discoidin domain receptor family, member 1, clone MGC:8681 IMAGE:2964574, mRNA, complete cds
  gi|14250529|gb|BC008716.1|BC008716[14250529]
• 4715: BC008406
  Homo sapiens, CD36 antigen (collagen type I receptor, thrombospondin receptor),
  clone MGC:14530 IMAGE:4244251, mRNA, complete cds
  gi|14250019|gb|BC008406.1|BC008406[14250019]
• 4716: NM_—032571
  Homo sapiens EGF-like module-containing mucin-like receptor EMR3 (EMR3), mRNA
  gi|14211882|ref|NM_—032571.1|[14211882]
• 4717: AF345568
  Homo sapiens putative chemokine receptor (FKSG80) mRNA, complete cds
  gi|13517963|gb|AF345568.1|AF345568[13517963]
• 4718: AF345567
  Homo sapiens putative purinergic receptor (FKSG79) mRNA, complete cds
  gi|13517961|gb|AF345567.1|AF345567[13517961]
• 4719: AF345566
  Homo sapiens putative G-protein-coupled receptor FKSG78 (FKSG78) mRNA, complete
  cds
  gi|3517959|gb|AF345566.1|AF345566[13517959]
• 4720: AF345565
  Homo sapiens putative G-protein-coupled receptor FKSG77 (FKSG77) mRNA, complete
  cds
  gi|13517957|gb|AF345565.1|AF345565[13517957]
• 4722: NM_—013447
  Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 2 (EMR2), mRNA
  gi|7305024|ref|NM_—013447.1|[7305024]
• 4724: BC007720
  Homo sapiens, 5-hydroxytryptamine (serotonin) receptor 1D, clone MGC:12645 IMAGE:4299633, mRNA, complete cds
  gi|14043458|gb|BC007720.1|BC007720[14043458]
• 4725: BC007713
  Homo sapiens, protein tyrosine phosphatase, receptor type, N, clone MGC:12646 IMAGE:4130827, mRNA, complete cds
  gi|14043446|gb|BC007713.1|BC007713[14043446]
• 4727: BC007566
  Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:15516 IMAGE:3028104, mRNA, complete cds
  gi|14043156|gb|BC007566.1|BC007566[14043156]
• 4728: BC007408
  Homo sapiens, low density lipoprotein receptor-related protein 3, clone MGC:2428
  IMAGE:3009711, mRNA, complete cds
  gi|13938518|gb|BC007408.1|BC007408[13938518]
• 4729: BC006196
  Homo sapiens, tumor necrosis factor receptor superfamily, member 9, clone MGC:2172 IMAGE:2924109, mRNA, complete cds
  gi|13623200|gb|BC006196.1|BC006196[13623200]
• 4730: BC005912
  Homo sapiens, Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, clone MGC:14507 IMAGE:4294467, mRNA, complete cds
  gi|13543505|gb|BC005912.1|BC005912[13543505]
• 4731: BC005818
  Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:11117 IMAGE:3833411, mRNA, complete cds
  gi|13543306|gb|BC005818.1|BC005818[13543306]
• 4732: BC005391
  Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:12521
  IMAGE:3997019, mRNA, complete cds
  gi|13529268|gb|BC005391.1|BC005391[13529268]
• 4733: BC005333
  Homo sapiens, interferon gamma receptor 1, clone MGC:12420 IMAGE:3950528, mRNA,
  complete cds
  gi|13529118|gb|BC005333.1|BC005333[13529118]
• 4734: BC005315
  Homo sapiens, formyl peptide receptor 1, clone MGC:12392 IMAGE:3829614, mRNA, complete cds
  gi|13529064|gb|BC005315.1|BC005315[13529064]
• 4735: BC005268
  Homo sapiens, putative receptor protein, clone MGC:12310 IMAGE:4051155, mRNA, complete cds
  gi|13528953|gb|BC005268.1|BC005268[13528953]
• 4737: BC004555
  Homo sapiens, G protein-coupled receptor, clone MGC:10314 IMAGE:4054377, mRNA,
  complete cds
  gi|13528716|gb|BC004555.1|BC004555[13528716]
• 4738: BC004553
  Homo sapiens, receptor-interacting serine-threonine kinase 2, clone MGC:10684 IMAGE:4026156, mRNA, complete cds
  gi|13528713|gb|BC004553.1|BC004553[13528713]
• 4739: BC004545
  Homo sapiens, leukotriene b4 receptor (chemokine receptor-like 1), clone MGC:10388 IMAGE:3946189, mRNA, complete cds
  gi|13528695|gb|BC004545.1|BC004545[13528695]
• 4740: BC004899
  Homo sapiens, sigma receptor (SR31747 binding protein 1), clone MGC:3851 IMAGE:3529352, mRNA, complete cds
  gi|13436169|gb|BC004899.1|BC004899[13436169]
• 4741: BC004348
  Homo sapiens, interleukin 21 receptor, clone MGC:10967 IMAGE:3634520, mRNA, complete cds
  gi|13279298|gb|BC004348.1|BC004348[13279298]
• 4742: BC003684
  Homo sapiens, coxsackie virus and adenovirus receptor, clone MGC:5086 IMAGE:3463613, mRNA, complete cds
  gi|13277551|gb|BC003684.1|BC003684[13277551]
• 4743: BC003624
  Homo sapiens, interferon gamma receptor 2 (interferon gamma transducer 1), clone
  MGC:2193 IMAGE:2967074, mRNA, complete cds
  gi|13177681|gb|BC003624.1|BC003624[13177681]
• 4744: BC003187
  Homo sapiens, putative G-protein coupled receptor, clone MGC:688 IMAGE:3537949, mRNA, complete cds
  gi|13112026|gb|BC003187.1|BC003187[13112026]
• 4745: BC003142
  Homo sapiens, vesicle-associated soluble NSF attachment protein receptor (v-SNARE; homolog of S. cerevisiae VTI1), clone MGC:3767 IMAGE:2958320, mRNA, complete cds
  gi|13111940|gb|BC003142.1|BC003142[13111940]
• 4746: BC003110
  Homo sapiens, interleukin 11 receptor, alpha, clone MGC:2146 IMAGE:3502059, mRNA, complete cds
  gi|13111884|gb|BC003110.1|BC003110[13111884]
• 4747: BC003091
  Homo sapiens, poliovirus receptor-related 2 (herpesvirus entry mediator B), clone MGC:1349 IMAGE:3503222, mRNA, complete cds
  gi|13111848|gb|BC003091.1|BC003091[13111848]
• 4748: BC000181
  Homo sapiens, putative G protein-coupled receptor, clone MGC:5003 IMAGE:3048193,
  mRNA, complete cds
  gi|13111815|gb|BC000181.2|BC000181[13111815]
• 4751: BC003005
  Homo sapiens, unactive progesterone receptor, 23 kD, clone MGC:4004 IMAGE:2821965, mRNA, complete cds
  gi|12804292|gb|BC003005.1|BC003005[12804292]
• 4752: BC002996
  Homo sapiens, cholinergic receptor, nicotinic, alpha polypeptide 3, clone MGC:3862 IMAGE:2822768, mRNA, complete cds
  gi|12804274|gb|BC002996.1|BC002996[12804274]
• 4753: BC002947
  Homo sapiens, folate receptor 1 (adult), clone MGC:10473 IMAGE:3956659, mRNA, complete cds
  gi|12804178|gb|BC002947.1|BC002947[12804178]
• 4754: BC002819
  Homo sapiens, putative receptor protein, clone MGC:3676 IMAGE:3636199, mRNA, complete cds
  gi|12803944|gb|BC002819.1|BC002819[12803944]
• 4755: BC002794
  Homo sapiens, tumor necrosis factor receptor superfamily, member 14 (herpesvirus
  entry mediator), clone MGC:3753 IMAGE:3614650, mRNA, complete cds
  gi|12803894|gb|BC002794.1|BC002794[12803894]
• 4756: BC002793
  Homo sapiens, interferon (alpha, beta and omega) receptor 2, clone MGC:3873 IMAGE:3626374, mRNA, complete cds
  gi|12803892|gb|BC002793.1|BC002793[12803892]
• 4757: BC002788
  Homo sapiens, plasminogen activator, urokinase receptor, clone MGC:3905 IMAGE:3617894, mRNA, complete cds
  gi|12803884|gb|BC002788.1|BC002788[12803884]
• 4758: BC002635
  Homo sapiens, colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage), clone MGC:3848 IMAGE:3606186, mRNA, complete cds
  gi|12803600|gb|BC002635.1|BC002635[12803600]
• 4759: BC002537
  Homo sapiens, fibroblast growth factor receptor-like 1, clone IMAGE:3140874, mRNA
  gi|12803426|gb|BC002537.1|BC002537[12803426]
• 4760: BC002464
  Homo sapiens, coagulation factor II (thrombin) receptor, clone MGC:1197 IMAGE:3343051, mRNA, complete cds
  gi|12803296|gb|BC002464.1|BC002464[12803296]
• 4761: BC002443
  Homo sapiens, putative T1/ST2 receptor binding protein, clone MGC:1270 IMAGE:3346273, mRNA, complete cds
  gi|12803256|gb|BC002443.1|BC002443[12803256]
• 4762: BC002354
  Homo sapiens, 5-hydroxytryptamine (serotonin) receptor 3A, clone MGC:8469 IMAGE:2821710, mRNA, complete cds
  gi|12803100|gb|BC002354.1|BC002354[12803100]
• 4763: BC001379
  Homo sapiens, G protein-coupled receptor kinase-interactor 2, clone MGC:760 IMAGE:3051069, mRNA, complete cds
  gi|12655058|gb|BC001379.1|BC001379[12655058]
• 4764: BC001281
  Homo sapiens, tumor necrosis factor receptor superfamily, member lob, clone MGC:5144 IMAGE:3458466, mRNA, complete cds
  gi|12654874|gb|BC001281.1|BC001281[12654874]
• 4766: BC001188
  Homo sapiens, transferrin receptor (p90, CD71), clone MGC:3151 IMAGE:3354176, mRNA, complete cds
  gi|12654696|gb|BC001188.1|BC001188[12654696]
• 4769: BC001110
  Homo sapiens, benzodiazapine receptor (peripheral), clone MGC:1184 IMAGE:2989070, mRNA, complete cds
  gi|12654552|gb|BC001110.1|BC001110[12654552]
• 4770: BC000740
  Homo sapiens, cholecystokinin B receptor, clone MGC:2199 IMAGE:3504160, mRNA, complete cds
  gi|12653894|gb|BC000740.1|BC000740[12653894]
• 4772: BC000571
  Homo sapiens, pyrimidinergic receptor P2Y, G-protein coupled, 6, clone MGC:2067
  IMAGE:3162734, mRNA, complete cds
  gi|12653590|gb|BC000571.1|BC000571[12653590]
• 4773: BC000548
  Homo sapiens, receptor (calcitonin) activity modifying protein 1, clone MGC:1996
  IMAGE:3163522, mRNA, complete cds
  gi|12653550|gb|BC000548.1|BC000548[12653550]
• 4774: BC000513
  Homo sapiens, cholinergic receptor, nicotinic, alpha polypeptide 3, clone MGC:8545 IMAGE:2822768, mRNA, complete cds
  gi|12653482|gb|BC000513.1|BC000513[12653482]
• 4776: BC000254
  Homo sapiens, activin A receptor, type IB, clone MGC:2177 IMAGE:3352720, mRNA,
  complete cds
  gi|12652986|gb|BC000254.1|BC000254[12652986]
• 4780: AF037351
  Homo sapiens macrophage scavenger receptor type III (SR-A) mRNA, complete cds
  gi|3004959|gb|AF037351.1|AF037351[3004959]
• 4781: BC009277
  Homo sapiens, G protein-coupled receptor kinase 6, clone IMAGE:4053197, mRNA
  gi|14627273|gb1BC009277.1|BC009277[14627273]
• 4782: AF369786
  Homo sapiens growth hormone secretagogue receptor gene, complete cds, alternatively spliced
  gi|14625865|gb|AF369786.1|AF369786[14625865]
• 4784: U35877
  Homo sapiens (−) genotype B2 bradykinin receptor gene, exon 1
  gi|1353393|gb|U35877.1|HSU35877[1353393]
• 4785: U35876
  Homo sapiens (+) genotype B2 bradykinin receptor gene, exon 1
  gi|1353392|gb|U35876.1|HSU35876[1353392]
• 4786: NM_—005656
  Homo sapiens transmembrane protease, serine 2 (TMPRSS2), mRNA
  gi|14602458|ref|NM_—005656.2|[14602458]
• 4787: NM_—004167
  Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 15 (SCYA15),
  transcript variant 2, mRNA
  gi|14602450|ref|NM_—004167.2|[14602450]
• 4788: NM_—032965
  Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 15 (SCYA15),
  transcript variant 3, mRNA
  gi|14602448|ref|NM_—032965.1|[14602448]
• 4789: NM_—032964
  Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 15 (SCYA15),
  transcript variant 1, mRNA
  gi|14602446|ref|NM_—032964.1|[14602446]
• 4790: AJ312373
  Homo sapiens mRNA for DECTIN-1 receptor, splice variant 2
  gi|14599395|emb|AJ312373.1|HSA312373[14599395]
• 4791: AJ312372
  Homo sapiens mRNA for DECTIN-1 receptor, splice variant 1
  gi|14599393|emb|AJ312372.1|HSA312372[14599393]
• 4792: AJ307885
  Homo sapiens mRNA for T-cell receptor beta chain, clone 83
  gi|14595016|emb|AJ307885.1|HSA307885[14595016]
• 4793: NM_—001987
  Homo sapiens ets variant gene 6 (TEL oncogene) (ETV6), mRNA
  gi|14589947|ref|NM_—001987.2|[14589947]
• 4794: NM_—020403
  Homo sapiens protocadherin 9 (PCDH9), mRNA
  gi|14589940|ref|NM_—020403.2|[14589940]
• 4795: NM_—022843
  Homo sapiens protocadherin 20 (PCDH20), mRNA
  gi|14589938|ref|NM_—022843.1|[14589938]
• 4797: NM_—020164
  Homo sapiens aspartate beta-hydroxylase (ASPH), transcript variant 5, mRNA
  gi|14589858|ref|NM_—020164.2|[14589858]
• 4798: AF361107
  Homo sapiens CRHF2 receptor beta-isoform mRNA, partial sequence, aberrantly spliced
  gi|14586958|gb|AF361107.1|AF361107[14586958]
• 4799: AF361106
  Homo sapiens CRHF2 receptor beta-isoform mRNA, partial sequence, aberrantly spliced
  gi|14586957|gb|AF361106.1|AF361106[14586957]
• 4800: AF284768
  Homo sapiens laminin receptor-like protein LAMRL5 mRNA, complete cds
  gi|14583013|gb|AF284768.1|AF284768[14583013]
• 4801: AF343090
  Homo sapiens HSF-27 protein mRNA, complete cds
  gi|14582809|gb|AF343090.1|AF343090[14582809]
• 4802: AF286696
  Homo sapiens olfactory receptor sdolf mRNA, complete cds
  gi|14582606|gb|AF286696.1|AF286696[14582606]
• 4803: AF279673
  Homo sapiens vanilloid receptor-like protein 2 (VRL2) mRNA, complete cds
  gi|14582397|gb|AF279673.1|AF279673[14582397]
• 4804: AF279611
  Homo sapiens cysteinyl leukotriene receptor type 2 (CYSLT2) gene, complete cds
  gi|14582393|gb|AF2796711.1|AF279611[14582393]
• 4806: NM_—005111
  Homo sapiens crystallin, zeta (quinone reductase)-like 1 (CRYZL1), mRNA
  gi|14577924|ref|NM_—005111.2|[14577924]
• 4807: NM_—000592
  Homo sapiens complement component 4B (C4B), mRNA
  gi|14577920|ref|NM_—000592.3|[14577920]
• 4809: NM_—016557
  Homo sapiens orphan seven-transmembrane receptor, chemokine related (VSHK1), mRNA
  gi|7706768|ref|NM_—016557.1|[7706768]
• 4810: NM_—006850
  Homo sapiens interleukin 24 (IL24), mRNA
  gi|5803085|ref|NM_—006850.1|[5803085]
• 4811: NM_—000029
  Homo sapiens angiotensinogen (serine (or cysteine) proteinase inhibitor, clade A
  (alpha-1 antiproteinase, antitrypsin), member 8) (AGT), mRNA
  gi|4557286|ref|NM_—000029.1|[4557286]
• 4812: AF385591
  Homo sapiens m5 muscarinic cholinergic receptor (CHRM5) mRNA, complete cds
  gi|14573544|gb|AF385591.1|AF385591[14573544]
• 4813: AF385590
  Homo sapiens m4 muscarinic cholinergic receptor (CHRM4) mRNA, complete cds
  gi|14573542|gb|AF385590.1|AF385590[14573542]
• 4814: AF385589
  Homo sapiens m3 muscarinic cholinergic receptor (CHRM3) mRNA, partial cds
  gi|14573540|gb|AF385589.1|AF385589[14573540]
• 4815: AF385588
  Homo sapiens m2 muscarinic cholinergic receptor (CHRM2) mRNA, complete cds
  gi|14573538|gb|AF385588.1|AF385588[14573538]
• 4816: AF385587
  Homo sapiens ml muscarinic cholinergic receptor (CHRM1) mRNA, complete cds
  gi|14573536|gb|AF385587.1|AF385587[14573536]
• 4817: AF385585
  Homo sapiens nicotinic cholinergic receptor alpha 7 (CHRNA7) mRNA, complete cds
  gi|14573533|gb|AF385585.1|AF385585[14573533]
• 4818: AF385584
  Homo sapiens nicotinic cholinergic receptor alpha 3 (CHRNA3) mRNA, partial cds
  gi|4573531|gb|AF385584.1|AF385584[14573531]
• 4819: AF361943
  Homo sapiens urocortin III (UCNIII) gene, complete cds
  gi|14571921|gb|AF361943.1|AF361943[14571921]
• 4825: NM_—031282
  Homo sapiens immunoglobulin superfamily receptor translocation associated 1 (IRTA1), mRNA
  gi|14550415|ref|NM_—031282.1|[14550415]
• 4826: NM_—031281
  Homo sapiens immunoglobulin superfamily receptor translocation associated 2 (IRTA2), mRNA
  gi|14550413|ref|NM_—031281.1|[14550413]
• 4827: NM_—020404
  Homo sapiens tumor endothelial marker 1 precursor (TEM1), mRNA
  gi|9966884|ref|NM_—020404.1|[9966884]
• 4830: AF338733
  Homo sapiens thymic stromal lymphopoietin protein receptor TSLPR mRNA, complete
  cds
  gi|14335439|gb|AF338733.1|AF338733[14335439]
• 4831: AF338732
  Homo sapiens thymic stromal lymphopoietin protein TSLP mRNA, complete cds
  gi|14335437|gb|AF338732.1|AF338732[14335437]
• 4832: AJ272324
  Homo sapiens mRNA for PRAM-1 protein
  gi|11558108|emb|AJ272324.1|HSA272324[11558108]
• 4833: AF281043
  Homo sapiens high mobility group 1 protein (HMG1) gene, promoter and partial cds
  gi|14522873|gb|AF281043.1|AF281043[14522873]
• 4834: NM_—024298
  Homo sapiens malignant cell expression-enhanced gene/tumor progression-enhance (LENG4), mRNA
  gi|13236521|ref|NM_—024298.1|[13236521]
• 4835: AB051580
  Homo sapiens gene for IgG receptor IIIB, complete cds
  gi|11344590|dbj|AB051580.1|AB051580[11344590]
• 4836: NM_—006134
  Homo sapiens chromosome 21 open reading frame 4 (C21orf4), mRNA
  gi|8659558|ref|NM_—006134.2|[8659558]
• 4837: NM_—015927
  Homo sapiens transforming growth factor beta 1 induced transcript 1 (TGFB1I1),
  mRNA
  gi|7706249|ref|NM_—015927.1|[7706249]
• 4838: NM_—000956
  Homo sapiens prostaglandin E receptor 2 (subtype EP2), 53 kD (PTGER2), mRNA
  gi|4506254|ref|NM_—000956.1|[4506254]
• 4839: AF019381
  Homo sapiens corticotropin releasing hormone receptor type 2 gamma isoform (CRH2R) mRNA, complete cds
  gi|2738888|gb|AF019381.1|AF019381[2738888]
• 4840: AB043702
  Homo sapiens FZD5 mRNA for seven-transmembrane receptor Frizzled-5, complete cds
  gi|14495150|dbj|AB043702.1|AB043702[14495150]
• 4841: AF384819
  Homo sapiens coagulation factor II receptor-like 3 (F2RL3) gene, complete cds
  gi|14488403|gb|AF384819.2|AF384819[14488403]
• 4842: AF343666
  Homo sapiens translocation associated fusion protein IRTA1/IGA1 (IRTA1/IGHA1) mRNA, complete cds
  gi|13591717|gb|AF343666.1|AF343666[13591717]
• 4843: AF343665
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2d (IRTA2) mRNA, partial cds, alternatively spliced
  gi|13591715|gb|AF343665.1|AF343665[13591715]
• 4844: AF343664
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2c (IRTA2) mRNA, complete cds, alternatively spliced
  gi|13591713|gb|AF343664.1|AF343664[13591713]
• 4845: AF343663
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2b (IRTA2) mRNA, complete cds, alternatively spliced
  gi|13591711|gb|AF343663.1|AF343663[13591711]
• 4846: AF343662
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2a (IRTA2) mRNA, complete cds, alternatively spliced
  gi|13591709|gb|AF343662.1|AF343662[13591709]
• 4847: AF343661
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 1a (IRTA1) mRNA, complete cds, alternatively spliced
  gi|13591707|gb|AF343661.1|AF343661[13591707]
• 4848: AF343660
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 1b (IRTA1) mRNA, complete cds, alternatively spliced
  gi|13591705|gb|AF343660.1|AF343660[13591705]
• 4849: AF343659
  Homo sapiens immunoglobulin superfamily receptor translocation associated protein 1c (IRTA1) mRNA, complete cds, alternatively spliced
  gi|13591703|gb|AF343659.1|AF343659[13591703]
• 4850: AF321237
  Homo sapiens chromosome 11p15.4 clone RPC11-610i20 P2-containing olfactory receptor gene cluster, complete sequence
  gi|12007433|gb|AF321237.1|AF321237[12007433]
• 4851: NM_—005567
  Homo sapiens lectin, galactoside-binding, soluble, 3 binding protein (LGALS3BP),
  mRNA
  gi|6006016|ref|NM_—005567.21[6006016]
• 4852: AF351620
  Homo sapiens lipocalin-1 interacting membrane receptor (LIMR) gene, complete cds
  gi|14485746|gb|AF351620.1|AF351620[14485746]
• 4853: AF366519
• 4890: AB063174
  Homo sapiens SLC-1 mRNA for somatostatin receptor-like protein, complete cds
  gi|14475646|dbj|AB063174.1|AB063174[14475646]
• 4891: AF238470
  Homo sapiens natural killer cell receptor NKG2F gene, partial cds
  gi|11023178|gb|AF238470.1|AF238470[11023178]
• 4892: AF238469
  Homo sapiens natural killer cell receptor NKG2E gene, partial cds
  gi|11023176|gb|AF238469.1|AF238469[11023176]
• 4893: AF238468
  Homo sapiens natural killer cell receptor NKG2C gene, partial cds
  gi|11023174|gb|AF238468.1|AF238468[11023174]
• 4894: AE000662
  Homo sapiens T-cell receptor alpha delta locus from bases 1000498 to 1071650 (section 5 of 5) of the Complete Nucleotide Sequence
  gi|2358068|gb|AE000662.1|HUAE000662[2358068]
• 4895: AE000661
  Homo sapiens T-cell receptor alpha delta locus from bases 752679 to 1000555 (section 4 of 5) of the Complete Nucleotide Sequence
  gi|2358060|gb|AE000661.1|HUAE000661[2358060]
• 4896: AE000660
  Homo sapiens T-cell receptor alpha delta locus from bases 501613 to 752736 (section 3 of 5) of the Complete Nucleotide Sequence
  gi|2358042|gb|AE000660.1|HUAE000660[2358042]
• 4897: AE000659
  Homo sapiens T-cell receptor alpha delta locus from bases 250472 to 501670 (section 2 of 5) of the Complete Nucleotide Sequence
  gi|2358025|gb|AE000659.1|HUAE000659[2358025]
• 4898: AE000658
  Homo sapiens T-cell receptor alpha delta locus from bases 1 to 250529 (section 1 of 5) of the Complete Nucleotide Sequence
  gi|2358019|gb|AE000658.1|HUAE000658[2358019]
• 4899: AF364129
  Homo sapiens tandem repeat region 76.3 kb upstream of BMPR1A exon 1
  gi|14423333|gb|AF364129.1|AF364129[14423333]
• 4900: AF364128
  Homo sapiens tandem repeat region 49.4 kb upstream of BMPR1A exon 1
  gi|14423332|gb|AF364128.1|AF364128[14423332]
• 4901: AF261083
  Homo sapiens polymeric immunoglobulin receptor (PIGR) gene, partial cds
  gi|8099662|gb|AF261083.1|AF261083[8099662]
• 4902: AF243129
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 67 and partial cds
  gi|14388671|gb|AF243129.1|F243081S49[14388671]
• 4903: AF243128
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 66
  gi|14388670 gb|AF243128.1|F243081S48[14388670]
• 4904: AF243127
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 65
  gi|14388669|gb|AF243127.1|F243081S47[14388669]
• 4905: AF243126
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 63 and
  gi|14388668|gb|AF243126.1|F243081S46[14388668]
• 4906: AF243125
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 61 and
  gi|14388667|gb|AF243125.1|F243081S45[14388667]
• 4907: AF243124
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 60
  gi|14388666|gb|AF243124.1|F243081S44[14388666]
• 4908: AF243123
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 59
  gi|14388665|gb|AF243123.1|F243081S43[14388665]
• 4909: AF243122
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 58
  gi|14388664|gb|AF243122.1|F243081S42[14388664]
• 4910: AF243121
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 57
  gi|14388663|gb|AF243121.1|F243081S41[14388663]
• 4911: AF243120
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 56
  gi|14388662|gb|AF243120.1|F243081S40[14388662]
• 4912: AF243119
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 55
  gi|4388661|gb|AF243119.1F243081S39[14388661]
• 4913: AF243118
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 54
  gi|14388660|gb|AF243118.1F243081S38[14388660]
• 4914: AF243117
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 52 and
  gi|14388659|gb|AF243117.1|F243081S37[14388659]
• 4915: AF243116
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 51
  gi|14388658|gb|AF243116.1|F243081S36[14388658]
• 4916: AF243115
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 49 and
  gi|14388657|gb|AF243115.1|F243081S35[14388657]
• 4917: AF243114
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 48
  gi|14388656|gb|AF243114.1|F243081S34[14388656]
• 4918: AF243113
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 47
  gi|14388655|gb|AF243113.1F243081S33[14388655]
• 4919: AF243112
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 46
  gi|14388654|gb|AF243112.1F243081S32[14388654]
• 4920: AF243111
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 45
  gi|4388653|gb|AF243111.1F243081S31[14388653]
• 4921: AF243110
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 44
  gi|14388652|gb|AF243110.1|F243081S30[14388652]
• 4922: AF243109
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 42 and
  gi|14388651|gb|AF243109.1|F243081S29[14388651]
• 4923: AF243108
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 41
  gi|14388650|gb|AF243108.1|F243081S28[14388650]
• 4924: AF243107
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 40
  gi|14388649|gb|AF243107.1F243081S27[14388649]
• 4925: AF243106
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 39
  gi|4388648|gb|AF243106.1F243081S26[14388648]
• 4926: AF243105
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 37 and
  gi|14388647|gb|AF243105.1|F243081S25[14388647]
• 4927: AF243104
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 35 and
  gi|14388646|gb|AF243104.1|F243081S24[14388646]
• 4928: AF243103
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 34
  gi|14388645|gb|AF243103.1F243081S23[14388645]
• 4929: AF243102
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 33
  gi|14388644|gb|AF243102.1F243081S22[14388644]
• 4930: AF243101
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 32
  gi|14388643|gb|AF243101.1F243081S21[14388643]
• 4931: AF243100
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 31
  gi|14388642|gb|AF243100.1F243081S20[14388642]
• 4932: AF243099
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 30
  gi|1438864|gb|AF243099.1F243081S19[14388641]
• 4933: AF243098
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 29
  gi|14388640|gb|AF243098.1F243081S18[14388640]
• 4934: AF243097
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 28
  gi|14388639|gb|AF243097.1F243081S17[14388639]
• 4935: AF243096
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 27
  gi|14388638|gb|AF243096.1F243081S16[14388638]
• 4936: AF243095
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 26
  gi|14388637|gb|AF243095.1|F243081S15[14388637]
• 4937: AF243094
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 23, 24, and 25
  gi|14388636|gb|AF243094.1|F243081S14[14388636]
• 4938: AF243093
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 22
  gi|14388635|gb|AF243093.1|F243081S13[14388635]
• 4939: AF243092
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 20 and
  gi|14388634|gb|AF243092.1|F243081S12[14388634]
• 4940: AF243091
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 18 and
  gi|4388633|gb|AF243091.1|F243081S11[14388633]
• 4941: AF243090
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 16 and
  gi|14388632|gb|AF243090.1|F243081S10[14388632]
• 4942: AF243089
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 15
  gi|14388631|gb|AF243089.1|F243081S09[14388631]
• 4943: AF243088
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 14
  gi|14388630|gb|AF243088.1|F243081S08[14388630]
• 4944: AF243087
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 11, 12, and 13
  gi|14388629|gb|AF243087.1|F243081S07[14388629]
• 4945: AF243086
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 9 and
  gi|14388628|gb|AF243086.1|F243081S06[14388628]
• 4946: AF243085
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 8
  gi|14388627|gb|AF243085.1|F243081S05[14388627]
• 4947: AF243084
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 7
  gi|14388626|gb|AF243084.1|F243081S04[14388626]
• 4948: AF243083
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 5 and 6
  gi|14388625|gb|AF243083.1|F243081S03[14388625]
• 4949: AF243082
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 3 and partial cds
  gi|14388624|gb|AF243082.1|F243081S02[14388624]
• 4950: AF243081
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 1 and 2
  gi|14388623|gb|AF243081.1|F243081S01[14388623]
• 4951: AH010855
  Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) and intrinsic factor-vitamin B12 receptor (CUBN) genes, partial cds
  gi|14388622|gb|AH010855.1|SEG_F243081S[14388622]
• 4952: AY029596
  Homo sapiens melanin-concentrating hormone 2 receptor mRNA, complete cds
  gi|14388165|gb|AY029596.1|[14388165]
• 4953: AF233349
  Homo sapiens neuronal phosphoprotein DARPP-32 mRNA, partial cds
  gi|7243754|gb|AF233349.1|AF233349[7243754]
• 4954: AF208690
  Homo sapiens clone 24 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851353|gb|AF208690.1|AF208690[6851353]
• 4955: AF208689
  Homo sapiens clone 22 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851351|gb|AF208689.1|AF208689[6851351]
• 4956: AF208688
  Homo sapiens clone 3 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851349|gb|AF208688.1|AF208688[6851349]
• 4957: AF208687
  Homo sapiens clone 25 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851347|gb|AF208687.1|AF208687[6851347]
• 4958: AF208686
  Homo sapiens clone 23 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851345|gb|AF208686.1|AF208686[6851345]
• 4959: AF208685
  Homo sapiens clone 21 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851343|gb|AF208685.1|AF208685[6851343]
• 4960: AF208684
  Homo sapiens clone 6 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851341|gb|AF208684.1|AF208684[6851341]
• 4961: AF208683
  Homo sapiens clone 1 p70 killer cell inhibitory receptor mRNA, partial cds
  gi|6851339|gb|AF208683.1|AF208683[6851339]
• 4962: AB052639
  Homo sapiens mRNA for IL-XR, complete cds
  gi|14349288|dbj|AB052639.1|AB052639[14349288]
• 4963: AF366364
  Homo sapiens interleukin-1 receptor type 1 (IL1R1) gene, exon 1A, partial sequence
  gi|1434887|gb|AF366364.1|AF366364[14348871]
• 4967: AF260728
  Homo sapiens lipocalin-interacting protein mRNA, complete cds
  gi|14335227|gb|AF260728.1|AF260728[14335227]
• 4968: AJ308526
  Homo sapiens partial GRIK3 gene for glutamate receptor 7, exon 18
  gi|14329723|emb|AJ308526.1|HSA308526[14329723]
• 4969: AJ308525
  Homo sapiens partial GRIK3 gene for glutamate receptor 7, exon 16
  gi|14329720|emb|AJ308525.1|HSA308525[14329720]
• 4970: AF165124
  Homo sapiens chromosome 5q31.1-q33.1 clone BAC djn082c10 containing GABRG2 gene,
  complete sequence
  gi|5738137|gb|AF165124.1|AF165124[5738137]
• 4971: AF353733
  Homo sapiens leukocyte immunoglobulin-like receptor A3 (LILRA3) gene, exon 3 and
  partial cds
  gi|4280086|gb|AF353733.1|AF353733[14280086]
• 4972: AF236083
  Homo sapiens G-protein-coupled receptor 74 (GPR74) mRNA, complete cds
  gi|14279164|gb|AF236083.1|AF236083[14279164]
• 4973: AF375468
  Homo sapiens endothelial protein C receptor (PROCR) gene, complete cds
  gi|1427871|gb|AF375468.2|AF375468[14278711]
• 4974: AF374726
  Homo sapiens coagulation factor II receptor-like 2 (F2RL2) gene, complete cds
  gi|14278710|gb|AF374726.2|AF374726[14278710]
• 4975: AF378542
  Homo sapiens bradykinin receptor B2 (BDKRB2) gene, complete cds
  gi|14278705|gb|AF378542.2|AF378542[14278705]
• 4976: AB051065
  Homo sapiens hot7t175 mRNA for G protein-coupled receptor, complete cds
  gi|14041797|dbj|AB051065.1|AB051065[14041797]
• 4977: AF347063
  Homo sapiens G protein-coupled receptor MCH2 mRNA, complete cds
  gi|13604341|gb|AF347063.1|AF347063[13604341]
• 4978: AJ278250
  Homo sapiens HRH3 gene for histamine H3 receptor, exons 1-3
  gi|14270360|emb|AJ278250.1|HSA278250[14270360]
• 4979: AF297616
  Homo sapiens natural killer cell receptor 2B4 gene, partial cds
  gi|14268841|gb|AF297616.1|AF297616[14268841]
• 4980: AJ271068
  Homo sapiens mRNA for transient receptor potential channel 6, variant delta377-431 (TRP6 gene)
  gi|9716912|emb|AJ271068.1|HSA271068[9716912]
• 4981: AJ271067
  Homo sapiens mRNA for transient receptor potential channel 6, variant delta316-431 (TRP6 gene)
  gi|9716910|emb|AJ271067.1|HSA271067[9716910]
• 4982: AJ271066
  Homo sapiens mRNA for transient receptor potential channel 6 (TRP6 gene)
  gi|9716908|emb|AJ271066.1|HSA271066[9716908]
• 4983: X91852
  H. sapiens P2Y4 gene
  gi|1124904|emb|X91852.1|HSP2Y4[1124904]
• 4984: NM_—032565
  Homo sapiens emopamil binding related protein, delta8-delta7 sterol isomerase related protein (EBRP), mRNA
  gi|4211872|ref|NM_—032565.1|[14211872]
• 4986: AY029539
  Homo sapiens soluble nectin1 gamma mRNA, complete cds
  gi|1419622|gb|AY029539.1|[14196221]
• 4987: NM_—006986
  Homo sapiens melanoma antigen, family D, 1 (MAGED1), mRNA
  gi|14195633|ref|NM_—006986.2|[14195633]
• 4988: AF351784
  Homo sapiens dopamine receptor interacting protein mRNA, partial cds
  gi|14194056|gb|AF351784.1|AF351784[14194056]
• 4989: AF336376
  Homo sapiens platelet-derived growth factor D (PDGFD) mRNA, complete cds
  gi|14193795|gb|AF336376.1|AF336376[14193795]
• 4992: AH010778
  Homo sapiens CHRNA3 gene, partial sequence
  gi|14190789|gb|AH010778.1|SEG_AY027913S[14190789]
• 4995: AH010779
  Homo sapiens CHRNB4 gene, partial sequence
  gi|14190786|gb|AH010779.1|SEG_AY027915S[14190786]
• 4996: AF310234
  Homo sapiens sialic acid binding immunoglobulin-like lectin 8 (SIGLEC8) mRNA, complete cds, alternatively spliced
  gi|14164614|gb|AF310234.1|AF310234[14164614]
• 4997: AF310233
  Homo sapiens sialic acid binding immunoglobulin-like lectin 10 (SIGLEC10) mRNA,
  complete cds
  gi|14164612|gb|AF310233.1|AF310233[14164612]
• 4998: AB060151
  Homo sapiens slt mRNA for G protein-coupled receptor, complete cds
  gi|14164382|dbj|AB060151.1|AB060151[14164382]
• 4999: AF239764
  Homo sapiens EGF-like module-containing mucin-like receptor EMR3 mRNA, complete
  cds
  gi|13183148|gb|AF239764.1|AF239764[13183148]
• 5000: AF199235
  Homo sapiens nicotinic acetylcholine receptor subunit alpha 10 mRNA, complete cds
  gi|11128455|gb|AF199235.2|AF199235[11128455]
• 5001: AF054176
  Homo sapiens angiotensin/vasopressin receptor AII/AVP mRNA, complete cds
  gi|3341995|gb|AF054176.1|AF054176[3341995]
• 5002: AF369213
  Homo sapiens fibroblast growth factor receptor 3 IIIc isoform (FGFR3) mRNA, partial cds
  gi|14161391|gb|AF369213.1|AF369213[14161391]
• 5003: AF369212
  Homo sapiens fibroblast growth factor receptor 3 IIIc isoform (FGFR3) mRNA, partial cds
  gi|14161389|gb|AF369212.1|AF369212[14161389]
• 5004: AF369211
  Homo sapiens fibroblast growth factor receptor 3 IIIc isoform (FGFR3) mRNA, partial cds
  gi|14161387|gb|AF369211.1|AF369211[14161387]
• 5005: AF274714
  Homo sapiens oxysterol-binding protein-related protein (ORP1) mRNA, complete cds
  gi|13183326|gb|AF274714.1|AF274714[13183326]
• 5034: NM_—005959
  Homo sapiens melatonin receptor 1B (MTNR1B), mRNA
  gi|14141172|ref|NM_—005959.2|[14141172]
• 5035: NM_—005958
  Homo sapiens melatonin receptor 1A (MTNR1A), mRNA
  gi|14141171|ref|NM_—005958.2|[14141171]
• 5036: AF366903
  Homo sapiens MER receptor tyrosine kinase gene, exon 1 and partial cds
  gi|14133725|gb|AF366903.1|AF366903[14133725]
• 5037: NM_—002226
  Homo sapiens jagged 2 (JAG2), mRNA
  gi|4504800|ref|NM_—002226.1|[4504800]
• 5039: NM_—009585
  Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 2, mRNA
  gi|14043067|ref|NM_—009585.2|[14043067]
• 5040: NM_—032049
  Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 5, mRNA
  gi|14043065|ref|NM_—032049.1|[14043065]
• 5041: NM_—031850
  Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 4, mRNA
  gi|14043063|ref|NM_—031850.1|[14043063]
• 5042: NM_—004835
  Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 3, mRNA
  gi|14043061|ref|NM_—004835.2|[14043061]
• 5043: NM_—000685
  Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 1, mRNA
  gi|14043060|ref|NM_—000685.3|[14043060]
• 5044: NM_—003965
  Homo sapiens chemokine (C-C motif) receptor-like 2 (CCRL2), mRNA
  gi|14043058|ref|NM_—003965.2|[14043058]
• 5045: AJ298334
  Homo sapiens mRNA for P2Y11 receptor (P2Y11 gene)
  gi|12964589|emb|AJ298334.1|HSA298334[12964589]
• 5046: NM_—000323
  Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 1, mRNA
  gi|10862704|ref|NM_—000323.1|[10862704]
• 5047: NM_—020975
  Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 2, mRNA
  gi|10862702|ref|NM_—020975.1|[10862702]
• 5048: NM_—020630
  Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 4, mRNA
  gi|10862700|ref|NM_—020630.1|[10862700]
• 5049: NM_—020629
  Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 3, mRNA
  gi|10862698|ref|NM_—020629.1|[10862698]
• 5050: NM_—002342
  Homo sapiens lymphotoxin beta receptor (TNFR superfamily, member 3) (LTBR), mRNA
  gi|4505038|ref|NM_—002342.1|[4505038]
• 5051: AY032736
  Homo sapiens alpha-2A adrenergic receptor (ADR2AR) gene, complete cds
  gi|14029162|gb|AY032736.1|[14029162]
• 5052: AF322014
  Homo sapiens growth hormone receptor gene, partial sequence
  gi|14028657|gb|AF322014.1|AF322014S1[14028657]
• 5053: AF283321
  Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5) gene, exons 10 through 23 and complete cds
  gi|14028617|gb|AF283321.1|AF283320S2[14028617]
• 5054: AF283320
  Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5) gene, exons 1 through 9
  gi|14028616|gb|AF283320.1|AF283320S1[14028616]
• 5055: AH010745
  Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5) gene, complete cds
  gi|14028615|gb|AH010745.1|SEG_AF283320S[14028615]
• 5056: NM_—017934
  Homo sapiens pleckstrin homology domain interacting protein (PHIP), mRNA
  gi|8923633|ref|NM_—017934.1|[8923633]
• 5057: AF203386
  Homo sapiens beta-2 adrenergic receptor (ADRB2) gene, complete cds
  gi|6636495|gb|AF203386.1|AF203386[6636495]
• 5058: AF202305
  Homo sapiens beta-2 andrenergic receptor gene, complete cds
  gi|6573152|gb|AF202305.1|AF202305[6573152]
• 5059: AF169225
  Homo sapiens beta-2-adrenergic receptor gene, complete cds
  gi|5714687|gb|AF169225.1|AF169225[5714687]
• 5060: AF063657
  Homo sapiens vascular endothelial growth factor receptor (FLT1) mRNA, complete
  cds
  gi|3132830|gb|AF063657.1|AF063657[3132830]
• 5061: AF022049
  Homo sapiens natural killer cell inhibitory receptor KIR3DL1 variant mRNA, complete cds
  gi|2760898|gb|AF022049.1|AF022049[2760898]
• 5062: AF022048
  Homo sapiens natural killer cell inhibitory receptor KIR2DL3 variant mRNA, complete cds
  gi|2760896|gb|AF022048.1|AF022048[2760896]
• 5066: AF361880
  Homo sapiens neurokinin-2 receptor gene, partial cds
  gi|1400294|gb|AF361880.1|AF361880[14010294]
• 5068: AF209923
  Homo sapiens orphan G-protein coupled receptor (GPRC5D) mRNA, complete cds
  gi|8118039|gb|AF209923.1|AF209923[8118039]
• 5069: AF207989
  Homo sapiens orphan G-protein coupled receptor (GPRC5C) mRNA, complete cds
  gi|8118031|gb|AF207989.1|AF207989[8118031]
• 5070: AB018076
  Homo sapiens hedgehog gene, exon 3 and complete cds
  gi|13990993|dbj|AB018076.2|AB010092S3[13990993]
• 5071: SEG_AB010092S
  Homo sapiens hedgehog gene
  gi|13990992|dbj|SEG_AB010092S[13990992]
• 5072: NM_—018980
  Homo sapiens taste receptor, type 2, member 5 (TAS2R5), mRNA
  gi|9507172|ref|NM_—018980.1|[9507172]
• 5073: NM_—016945
  Homo sapiens taste receptor, type 2, member 16 (TAS2R16), mRNA
  gi|8394394|ref|NM_—016945.1|[8394394]
• 5074: AB018075
  Homo sapiens hedgehog gene, exon 2
  gi|3702725|dbj|AB018075.1|AB010092S2[3702725]
• 5075: AB010092
  Homo sapiens hedgehog gene, exon 1
  gi|2810977|dbj|AB010092.1|AB010092S1[2810977]
• 5076: AF130867
  Homo sapiens smoothened mRNA, partial cds
  gi|4732138|gb|AF130867.1|AF130867[4732138]
• 5077: AF363791
  Homo sapiens histamine receptor H3S(HRH3) mRNA, complete cds
  gi|13937081|gb|AF363791.1|AF363791[13937081]
• 5078: AF363452
  Homo sapiens NK cell type I receptor protein 2B4 (CD244) mRNA, partial cds, alternatively spliced
  gi|13937022|gb|AF363452.1|AF363452[13937022]
• 5079: AY029486
  Homo sapiens G protein gamma subunit 13 mRNA, complete cds
  gi|13936268|gb|AY029486.1|[13936268]
• 5080: AF224497
  Homo sapiens CC chemokine receptor 3 (CCR3) gene, exon 2 and partial cds
  gi|13924486|gb|AF224497.1|AF224496S2[13924486]
• 5081: AF224496
  Homo sapiens CC chemokine receptor 3 (CCR3) gene, exon 1
  gi|13924485|gb|AF224496.1|AF224496S1[13924485]
• 5082: AH010691
  Homo sapiens CC chemokine receptor 3 (CCR3) gene, partial cds
  gi|13924484|gb|AH010691.1|SEG_AF224496S[13924484]
• 5083: AF224495
  Homo sapiens CC chemokine receptor 3 (CCR3) mRNA, partial cds
  gi|13924481|gb|AF224495.1|AF224495[13924481]
• 5084: AF251120
  Homo sapiens interleukin-1-related protein short isoform mRNA, complete cds; alternatively spliced
  gi|10185739|gb|AF251120.1|AF251120[10185739]
• 5085: AF251119
  Homo sapiens interleukin-1-related protein long isoform mRNA, complete cds; alternatively spliced
  gi|10185737|gb|AF251119.1|AF251119[10185737]
• 5086: AF251118
  Homo sapiens interleukin-1-related protein long isoform a mRNA, complete cds; alternatively spliced
  gi|10185735|gb|AF251118.1|AF251118[10185735]
• 5087: AF103013
  Homo sapiens JME clone 4 KIR3DL1-like natural killer cell receptor mRNA, complete cds
  gi|3983423|gb|AF103013.1|AF103013[3983423]
• 5088: AF103012
  Homo sapiens JME clone 3 KIR3DL1-like natural killer cell receptor mRNA, complete cds
  gi|3983421|gb|AF103012.1|AF103012[3983421]
• 5089: AF103011
  Homo sapiens JME clone 2 KIR3DL1-like natural killer cell receptor mRNA, complete cds
  gi|3983419|gb|AF103011.1|AF103011[3983419]
• 5090: AF103010
  Homo sapiens JME clone 1 KIR3DL1-like natural killer cell receptor mRNA, complete cds
  gi|3983417|gb|AF103010.1|AF103010[3983417]
• 5091: AF353183
  Homo sapiens discoidin domain receptor DDR1e (DDR1) mRNA, partial cds, alternatively spliced
  gi|13898644|gb|AF353183.1|AF353183[13898644]
• 5092: AF353182
  Homo sapiens discoidin domain receptor DDR1d (DDR1) mRNA, partial cds, alternatively spliced
  gi|13898642|gb|AF353182.1|AF353182[13898642]
• 5096: AF014112
  Homo sapiens phenol UDP-glucuronosyltransferase (UGT1A6) gene, partial cds
  gi|2645490|gb|AF014112.1|AF014112[2645490]
• 5097: AJ293654
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ARSPRV allele
  gi|12054061|emb|AJ293654.1|HSA293654[12054061]
• 5098: AJ293653
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ACSPRV allele
  gi|12054059|emb|AJ293653.1|HSA293653[12054059]
• 5099: AJ293652
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ACSSRI allele
  gi|12054057|emb|AJ293652.1|HSA293652[12054057]
• 5100: AJ293651
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ECLPRV allele
  gi|12054055|emb|AJ293651.1|HSA293651[12054055]
• 5101: AJ293650
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ECSPRV allele
  gi|12054053|emb|AJ293650.1|HSA293650[12054053]
• 5102: AJ293649
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ECSSRV allele
  gi|12054051|emb|AJ293649.1|HSA293649[12054051]
• 5103: AJ293648
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ECSPQV allele
  gi|12054049|emb|AJ293648.1|HSA293648[12054049]
• 5104: AJ293647
  Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
  ECSSQV allele
  gi|12054047|emb|AJ293647.1|HSA293647[12054047]
• 5105: AF329449
  Homo sapiens histamine receptor H4 mRNA, complete cds
  gi|13876643|gb|AF329449.1|AF329449[13876643]
• 5106: AF276893
  Homo sapiens p21-activated protein kinase 6 (PAK6) mRNA, complete cds
  gi|9082305|gb|AF276893.1|AF276893[9082305]
• 5107: AY029324
  Homo sapiens mRNA sequence
  gi|13752242|gb|AY029324.1|[13752242]
• 5108: AF307337
  Homo sapiens ALPP, ALPPL2, ALPI, XCE, CHRND, and CHRNG genes, complete sequence
  gi|10732831|gb|AF307337.1|AF307337[10732831]
• 5109: Z75190
  H. sapiens mRNA for apolipoprotein E receptor 2
  gi|1834533|emb|Z75190.1|HSZ75190[1834533]
• 5110: NM_—004523
  Homo sapiens kinesin-like 1 (KNSL1), mRNA
  gi|13699823|ref|NM_—004523.2|[13699823]
• 5111: NM_—006646
  Homo sapiens WAS protein family, member 3 (WASF3), mRNA
  gi|13699802|ref|NM_—006646.2|[13699802]
• 5112: NM_—030667
  Homo sapiens protein tyrosine phosphatase, receptor type, O (PTPRO), transcript
  variant 1, mRNA
  gi|13677213|ref|NM_—030667.1|[13677213]
• 5113: NM_—002848
  Homo sapiens protein tyrosine phosphatase, receptor type, O (PTPRO), transcript
  variant 2, mRNA
  gi|13677212|ref|NM_—002848.2|[13677212]
• 5114: NM_—006990
  Homo sapiens WAS protein family, member 2 (WASF2), mRNA
  gi|11386182|ref|NM_—006990.1|[11386182]
• 5115: AF250309
  Homo sapiens putative cytokine receptor CRL4 precusor mRNA, complete cds
  gi|13649476|gb|AF250309.1|AF250309[13649476]
• 5116: AY029180
  Homo sapiens soluble urokinase plasminogen activator receptor precursor (SUPAR)
  mRNA, complete cds
  gi|13641308|gb|AY029180.1|[13641308]
• 5117: AF346711
  Homo sapiens G-protein couple receptor (GPR48) gene, exons 3 through 18, and complete cds
  gi|13569576|gb|AF346711.1|AF346709S3[13569576]
• 5118: AF346710
  Homo sapiens G-protein couple receptor (GPR48) gene, exon 2
  gi|13569575|gb|AF346710.1|AF346709S2[13569575]
• 5119: AF346709
  Homo sapiens G-protein couple receptor (GPR48) gene, exon 1
  gi|13569574|gb|AF346709.1|AF346709S1[13569574]
• 5120: AH010608
  Homo sapiens G-protein couple receptor (GPR48) gene, complete cds
  gi|13569573|gb|AH010608.1|SEG_AF346709S[13569573]
• 5121: AF251059
  Homo sapiens FGF receptor 4b mRNA, complete cds
  gi|13625179|gb|AF251059.1|AF251059[13625179]
• 5122: AF251055
  Homo sapiens 5-HT receptor mRNA, complete cds
  gi|1362517|gb|AF251055.1|AF251055[13625171]
• 5123: NM_—030905
  Homo sapiens olfactory receptor, family 2, subfamily J, member 2 (OR2J2), mRNA
  gi|13624330|ref|NM_—030905.1|[13624330]
• 5124: NM_—012377
  Homo sapiens olfactory receptor, family 7, subfamily C, member 2 (OR7C2), mRNA
  gi|13624324|ref|NM_—012377.1|[13624324]
• 5125: AB043703
  Homo sapiens FZD8 mRNA for seven-transmembrane receptor Frizzled-8, complete cds
  gi|13623798|dbj|AB043703.1|AB043703[13623798]
• 5126: AB051851
  Homo sapiens DR3 gene for death receptor 3, complete cds, mutant DR3 sequnce
  gi|13537362|dbj|AB051851.1|AB051851[13537362]
• 5127: AB051850
  Homo sapiens DR3 gene for death receptor 3, complete cds
  gi|13537360|dbj|AB051850.1|AB051850[13537360]
• 5128: AF349939
  Homo sapiens prolactin receptor isoform delta S1 precursor, mRNA, complete cds
  gi|13605397|gb|AF349939.1|AF349939[13605397]
• 5130: AF346629
  Homo sapiens channel-kinase 1 (CHAK1) mRNA, complete cds
  gi|13562152|gb|AP346629.2|AF346629[13562152]
• 5131: NM_—012373
  Homo sapiens olfactory receptor, family 3, subfamily A, member 3 (OR3A3), mRNA
  gi|13562103|ref|NM_—012373.1|[13562103]
• 5132: AF056979
  Homo sapiens clone YAN1 interferon-gamma receptor mRNA, complete cds
  gi|13562048|gb|AF056979.1|AF056979[13562048]
• 5133: NM_—017506
  Homo sapiens olfactory receptor family 7, subfamily C, member 1 (OR7C1), mRNA
  gi|9506798|ref|NM_—017506.1|[9506798]
• 5134: AF222689
  Homo sapiens protein arginine N-methyltransferase 1 (HRMT1L2) gene, complete cds, alternatively spliced
  gi|7453574|gb|AF222689.1|AF222689[7453574]
• 5135: NM_—005137
  Homo sapiens DiGeorge syndrome critical region gene 2 (DGCR2), mRNA
  gi|4826693|ref|NM_—005137.1|[4826693]
• 5136: AC002533
  Homo sapiens clone SCb-24C13 from 7q31.3, complete sequence
  gi|2388587|gb|AC002533.1|AC002533[2388587]
• 5139: AF263617
  Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00901 allele, complete cds
  gi|13560454|gb|AF263617.1|AF263617[13560454]
• 5140: AF262974
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00801 allele, complete cds
  gi|13560452|gb|AF262974.1|AF262974[13560452]
• 5141: AF262973
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00701 allele, complete cds
  gi|13560450|gb|AF262973.1|AF262973[13560450]
• 5142: AF262972
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00601 allele, partial cds
  gi|13560448|gb|AF262972.1|AF262972[13560448]
• 5143: AF262971
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00501 allele, partial cds
  gi|13560446|gb|AF262971.1|AF262971[13560446]
• 5144: AF262970
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00402 allele, partial cds
  gi|13560444|gb|AF262970.1|AF262970[13560444]
• 5145: AF262969
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00401 allele, partial cds
  gi|13560442|gb|AF262969.1|AF262969[13560442]
• 5146: AF262968
  Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00102 allele, partial cds
  gi|13560440|gb|AF262968.1|AF262968[13560440]
• 5147: AF262967
  Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00801 allele, complete cds
  gi|13560438|gb|AF262967.1|AF262967[13560438]
• 5148: AF262966
  Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00601 allele, partial cds
  gi|13560436|gb|AF262966.1|AF262966[13560436]
• 5149: AF262965
  Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00701 allele, partial cds
  gi|13560434|gb|AF262965.1|AF262965[13560434]
• 5150: AF348491
  Homo sapiens chemokine receptor CXCR4 mRNA, complete cds
  gi|13549089|gb|AF348491.1|AF348491[13549089]
• 5151: AF295368
  Homo sapiens G-protein coupled receptor GPR86 (GPR86) mRNA, complete cds
  gi|12711484|gb|AF295368.1|AF295368[12711484]
• 5152: AF237763
  Homo sapiens orphan G protein-coupled receptor 87 (GPR87) mRNA, complete cds
  gi|12711472|gb|AF237763.1|AF237763[12711472]
• 5153: AF237762
  Homo sapiens orphan G protein-coupled receptor 84 (GPR84) mRNA, complete cds
  gi|12711470|gb|AF237762.1|AF237762[12711470]
• 5154: NM_—004248
  Homo sapiens G protein-coupled receptor 10 (GPR10), mRNA
  gi|4758473|ref|NM_—004248.1|[4758473]
• 5155: AC000099
  Homo sapiens chromosome 7 map 7q31.3 cosmid g0771a003, complete sequence
  gi|1764159|emb|AC99.1|HSAC000099[1764159]
• 5156: NM_—030784
  Homo sapiens brain expressed G-protein-coupled receptor PSP24 beta (PSP24B), mRNA
  gi|13540556|ref|NM_—030784.1|[13540556]
• 5157: NM_—030774
  Homo sapiens prostate specific G-protein coupled receptor (PSGR), mRNA
  gi|13540538|ref|NM_—030774.1|[13540538]
• 5158: NM_—030764
  Homo sapiens SH2 domain-containing phosphatase anchor protein 1 (SPAP1), mRNA
  gi|13540524|ref|NM_—030764.1)[13540524]
• 5160: AJ249921
  Homo sapiens intergenic region between apoE and apoCI genes
  gi|6006507|emb|AJ249921.1|HSA249921[6006507]
• 5161: AF050737
  Homo sapiens dopamine D2 receptor (DRD2) gene, complete cds
  gi|382049|gb|AF050737.1|AF050737[3820491]
• 5162: NM_—004987
  Homo sapiens LIM and senescent cell antigen-like domains 1 (LIMS1), mRNA
  gi|13518025|ref|NM_—004987.2|[13518025]
• 5163: AF348078
  Homo sapiens G-protein coupled receptor 91 (GPR91) mRNA, complete cds
  gi|13517982|gb|AF348078.1|AF348078[13517982]
• 5164: AJ276125
  Homo sapiens mRNA for inhibitory NK receptor (kir3d gene)
  gi|13516222|emb|AJ276125.1|HSA276125[13516222]
• 5165: AF246999
  Homo sapiens TRADEbeta mRNA, complete cds
  gi|13506909|gb|AF246999.1|AF246999[13506909]
• 5166: AF246998
  Homo sapiens TRADEalpha mRNA, complete cds
  gi|13506907|gb|AF246998.1|AF246998[13506907]
• 5167: AF263450
  Homo sapiens dopamine D3 receptor (DRD3) gene, exon 2 and partial cds
  gi|13506728|gb|AF263450.1|AF148807S2[13506728]
• 5168: AF148807
  Homo sapiens dopamine D3 receptor (DRD3) gene, exon 1
  gi|13506727|gb|AF148807.1|AF148807S1[13506727]
• 5169: AH010591
  Homo sapiens dopamine D3 receptor (DRD3) gene, partial cds
  gi|13506726|gb|AH010591.1|SEG_AF148807S[13506726]
• 5170: Y18388
  Homo sapiens CD163 gene, exon 1 and joined CDS
  gi|5107944|emb|Y18388.1|HSA118388[5107944]
• 5171: NM_—002183
  Homo sapiens interleukin 3 receptor, alpha (low affinity) (IL3RA), mRNA
  gi|13324709|ref|NM_—002183.1|[13324709]
• 5172: AF142570
  Homo sapiens cytokine receptor CRL2 precusor (CRL2) mRNA, complete cds
  gi|11055018|gb|AF142570.1|AF142570[11055018]
• 5173: NM_—006140
  Homo sapiens colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (CSF2RA), mRNA
  gi|5453626|ref|NM_—006140.1|[5453626]
• 5174: NM_—002186
  Homo sapiens interleukin 9 receptor (IL9R), mRNA
  gi|4504684|ref|NM_—002186.1|[4504684]
• 5175: AF296673
  Homo sapiens toll-like receptor 10 mRNA, complete cds
  gi|13447752|gb|AF296673.1|AF296673[13447752]
• 5176: AF284095
  Homo sapiens alpha-2A adrenergic receptor mRNA, complete cds
  gi|13447750|gb|AF284095.1|AF284095[13447750]
• 5177: AF279689
  Homo sapiens fibroblast growth factor receptor 5 (FGFR5) mRNA, complete cds
  gi|13447748|gb|AF279689.1|AF279689[13447748]
• 5178: NM_—000861
  Homo sapiens histamine receptor H1 (HRH1), mRNA
  gi|13435403|ref|NM_—000861.2|[13435403]
• 5179: NM_—001514
  Homo sapiens general transcription factor IIB (GTF2B), mRNA
  gi|13435384|ref|NM_—001514.2|[13435384]
• 5180: NM_—022845
  Homo sapiens core-binding factor, beta subunit (CBFB), transcript variant 1, mRNA
  gi|13124880|ref|NM_—022845.1|[13124880]
• 5181: AF213460
  Homo sapiens ephrin receptor EPHA3 secreted form (EPHA3) mRNA, complete cds
  gi|12003436|gb|AF213460.1|AF213460[12003436]
• 5182: AF213459
  Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds
  gi|12003434|gb|AF213459.1|AF213459[12003434]
• 5183: NM_—019599
  Homo sapiens taste receptor, type 2, member 1 (TAS2R1), mRNA
  gi|9625042|ref|NM_—019599.1|[9625042]
• 5184: NM_—017579
  Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 3,
  mRNA
  gi|8923739|ref|NM_—017579.1|[8923739]
• 5185: AJ306481
  Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
  alpha-5 subunit, exon 1 and joined CDS
  gi|13400975|emb|AJ306481.1|HSA306481[13400975]
• 5186: AJ306454
  Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
  beta-4 subunit, exon 1 and joined CDS
  gi|13400963|emb|AJ306454.1|HSA306454[13400963]
• 5187: NM_—024317
  Homo sapiens immunoglobulin-like transcript 10 (ILT10), mRNA
  gi|13399319|ref|NM_—024317.1|[13399319]
• 5188: NM_—020070
  Homo sapiens immunoglobulin lambda-like polypeptide 1 (IGLL1), mRNA
  gi|13399297|ref|NM_—020070.1|[13399297]
• 5189: NM_—002383
  Homo sapiens MYC-associated zinc finger protein (purine-binding transcription factor) (MAZ), mRNA
  gi|13399295|ref|NM_—002383.1|[13399295]
• 5190: AJ306486
  Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
  alpha-5 subunit, exon 6
  gi|13399189|emb|AJ306486.1|HSA306486[13399189]
• 5191: AJ306485
  Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
  alpha-5 subunit, exon 5
  gi|13399188|emb|AJ306485.1|HSA306485[13399188]
• 5192: AJ306484
  Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
  alpha-5 subunit, exon 4
  gi|13399187|emb|AJ306484.1|HSA306484[13399187]
• 5193: AJ306483
  Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
  alpha-5 subunit, exon 3
  gi|13399186|emb|AJ306483.1|HSA306483[13399186]
• 5194: AJ306482
  Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
  alpha-5 subunit, exon 2
  gi|13399185|emb|AJ306482.1|HSA306482[13399185]
• 5195: AJ306459
  Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
  beta-4 subunit, exon 6
  gi|13399184|emb|AJ306459.1|HSA306459[13399184]
• 5196: AJ306458
  Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
  beta-4 subunit, exon 5
  gi|13399183|emb|AJ306458.1|HSA306458[13399183]
• 5197: AJ306457
  Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
  beta-4 subunit, exon 4
  gi|13399182|emb|AJ306457.1|HSA306457[13399182]
• 5198: AJ306456
  Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
  beta-4 subunit, exon 3
  gi|13399181|emb|AJ306456.1|HSA306456[13399181]
• 5199: AJ306455
  Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
  beta-4 subunit, exon 2
  gi|13399180|emb|AJ306455.1|HSA306455[13399180]
• 5200: AJ291675
  Homo sapiens mRNA for putative GDNF family receptor alpha 4, secreted isoform c
  (GFRA4 gene)
  gi|12038960|emb|AJ291675.1|HSA291675[12038960]
• 5201: AJ291674
  Homo sapiens mRNA for putative GDNF family receptor alpha 4, GPI anchored isoform b (GFRA4 gene)
  gi|12038958|emb|AJ291674.1|HSA291674[12038958]
• 5202: AJ291673
  Homo sapiens mRNA for GDNF family receptor alpha 4, GPI anchored isoform (GFRA4 gene)
  gi|12038956|emb|AJ291673.1|HSA291673[12038956]
• 5203: AF245704
  Homo sapiens toll-like receptor 9 (TLR9) mRNA, complete cds
  gi|8575528|gb|AF245704.1|AF245704[8575528]
• 5204: AF245703
  Homo sapiens toll-like receptor 8 (TLR8) mRNA, complete cds
  gi|8575526|gb|AF245703.1|AF245703[8575526]
• 5205: AF245702
  Homo sapiens toll-like receptor 7 (TLR7) mRNA, complete cds
  gi|8575524|gb|AF245702.1|AF245702[8575524]
• 5206: NM_—016944
  Homo sapiens taste receptor, type 2, member 4 (TAS2R4), mRNA
  gi|8394401|ref|NM_—016944.1|[8394401]
• 5207: NM_—016943
  Homo sapiens taste receptor, type 2, member 3 (TAS2R3), mRNA
  gi|8394397|ref|NM_—016943.1|[8394397]
• 5209: AF307776
  Homo sapiens beta-1 adrenergic receptor gene, 5′ UTR and partial cds
  gi|11837864|gb|AF307776.1|AF307776[11837864]
• 5210: AB026043
  Homo sapiens mRNA for MS4A7, complete cds
  gi|11559249|dbj|AB026043.1|AB026043[11559249]
• 5211: AB013104
  Homo sapiens mRNA for MS4A6, complete cds
  gi|11559215|dbj|AB013104.1|AB013104[11559215]
• 5212: AB013103
  Homo sapiens mRNA for MS4A5, complete cds
  gi|11559213|dbj|AB013103.1|AB013103[11559213]
• 5213: AB013102
  Homo sapiens mRNA for MS4A4, complete cds
  gi|11559211|dbj|AB013102.1|AB013102[11559211]
• 5215: NM_—003789
  Homo sapiens TNFRSF1A-associated via death domain (TRADD), mRNA
  gi|13378136|ref|NM_—003789.1|[13378136]
• 5216: NM_—025218
  Homo sapiens UL16-binding protein 1 (ULBP1), mRNA
  gi|13376825|ref|NM_—025218.1|[13376825]
• 5217: NM_—025217
  Homo sapiens UL16-binding protein 2 (ULBP2), mRNA
  gi|13376823|ref|NM_—025217.1|[13376823]
• 5218: NM_—024518
  Homo sapiens UL16-binding protein 3 (ULBP3), mRNA
  gi|13375655|ref|NM_—024518.1|[13375655]
• 5220: AB052103
  Homo sapiens SRCL mRNA for scavenger receptor with C-type lectin type II, complete cds
  gi|13365552|dbj|AB052103.1|AB052103[13365552]
• 5221: AB038518
  Homo sapiens SRCL mRNA for scavenger receptor with C-type lectin type I, complete cds
  gi|13365514|dbj|AB038518.1|AB038518[13365514]
• 5222: NM_—021708
  Homo sapiens leukocyte-associated Ig-like receptor 1 (LAIR1), transcript variant
  d, mRNA
  gi|11231178|ref|NM_—021708.1|[11231178]
• 5223: NM_—021706
  Homo sapiens leukocyte-associated Ig-like receptor 1 (LAIR1), transcript variant
  b, mRNA
  gi|11231176|ref|NM_—021706.1|[11231176]
• 5224: NM_—002287
  Homo sapiens leukocyte-associated Ig-like receptor 1 (LAIR1), transcript variant
  a, mRNA
  gi|11231175|ref|NM_—002287.2|[11231175]
• 5225: AB038237
  Homo sapiens mRNA for G protein-coupled receptor C5L2, complete cds
  gi|7707800|dbj|AB038237.1|AB038237[7707800]
• 5226: S82756
  Homo sapiens T cell receptor (Vbeta8.2-N1DbetaN2-Jbeta1.6) mRNA, partial cds
  gi|1835847|gb|S82756.1|S82756[1835847]
• 5227: S82754
  Homo sapiens T cell receptor mRNA, partial cds
  gi|1835843|gb|S82754.1|S82754[1835843]
• 5233: NM_—024318
  Homo sapiens immunoglobulin-like transcript 8 (ILT8), mRNA
  gi|13324689|ref|NM_—024318.1|[13324689]
• 5234: AF178982
  Homo sapiens putative G protein-coupled receptor GPCR1 precursor, mRNA, complete
  cds
  gi|13324450|gb|AF178982.1|AF178982[13324450]
• 5236: NM_—021956
  Homo sapiens glutamate receptor, ionotropic, kainate 2 (GRIK2), mRNA
  gi|11386136|ref|NM_—021956.1|[11386136]
• 5237: NM_—018724
  Homo sapiens interleukin 20 (IL20), mRNA
  gi|11036633|ref|NM_—018724.1|[11036633]
• 5238: AJ295846
  Homo sapiens mRNA for endosialin protein
  gi|13277300|emb|AJ295846.1|HSA295846[13277300]
• 5242: AF310249
  Homo sapiens peroxisome proliferator activated receptor gamma 2 gene, upstream
  sequence
  gi|13274397|gb|AF310249.1|AF310249[13274397]
• 5243: AF321815
  Homo sapiens G-protein coupled receptor SP1999 mRNA, complete cds
  gi|12656597|gb|AF321815.1|AF321815[12656597]
• 5244: AL136818
  Homo sapiens mRNA; cDNA DKFZp434F1726 (from clone DKFZp434F1726)
  gi|12053146|emb|AL136818.1|HSM801786[12053146]
• 5245: AF285440
  Homo sapiens clone KIR2D54v1 killer-cell Ig-like receptor mRNA, complete cds
  gi|11385699|gb|AF285440.1|AF285440[11385699]
• 5246: AF285439
  Homo sapiens clone KIR2D52v2 killer-cell Ig-like receptor mRNA, complete cds
  gi|11385697|gb|AF285439.1|AF285439[11385697]
• 5247: AF285438
  Homo sapiens clone KIR2D52v1 killer-cell Ig-like receptor mRNA, partial cds
  gi|11385695|gb|AF285438.1|AF285438[11385695]
• 5248: AF285437
  Homo sapiens clone KIR2DS1v2 killer-cell Ig-like receptor mRNA, partial cds
  gi|11385693|gb|AF285437.1|AF285437[11385693]
• 5249: AF285436
  Homo sapiens clone KIR2DL4v4 killer-cell Ig-like receptor mRNA, complete cds
  gi|11385691|gb|AF285436.1|AF285436[11385691]
• 5250: AF285435
  Homo sapiens clone KIR2DL3v2 killer-cell Ig-like receptor mRNA, partial cds
  gi|11385689|gb|AF285435.1|AF285435[11385689]
• 5251: AF285434
  Homo sapiens clone KIR2DL2v2 killer-cell Ig-like receptor mRNA, partial cds
  gi|11385687|gb|AF285434.1|AF285434[11385687]
• 5252: AF285433
  Homo sapiens clone KIR2DL2v1 killer-cell Ig-like receptor mRNA, partial cds
  gi|11385685|gb|AF285433.1|AF285433[11385685]
• 5253: AF285432
  Homo sapiens clone KIR2DL1v3 killer-cell Ig-like receptor mRNA, partial cds
  gi|11385683|gb|AF285432.1|AF285432[11385683]
• 5254: AF285431
  Homo sapiens clone KIR2DL1v2 killer-cell Ig-like receptor mRNA, complete cds
  gi|11385681|gb|AF285431.1|AF285431[11385681]
• 5255: AJ245872
  Homo sapiens mRNA for putative truncated metabotropic glutamatereceptor 6 form
  b, partial (tr-mGluR6 b)
  gi|6688173|emb|AJ245872.1|HSA245872[6688173]
• 5256: AJ245871
  Homo sapiens mRNA for putative truncated metabotropic glutamatereceptor 6 form
  a, partial (tr-mGluR6 a)
  gi|6688171|emb|AJ245871.1|HSA245871[6688171]
• 5258: AL050262
  Homo sapiens mRNA; cDNA DKFZp56410682 (from clone DKFZp56410682); complete cds
  gi|4886482|emb|AL050262.1|HSM800268[4886482]
• 5259: AF308820
  Homo sapiens adrenocorticotropin receptor gene, upstream sequence
  gi|13272368|gb|AF308820.1|AF308820[13272368]
• 5260: NM_—014432
  Homo sapiens interleukin 20 receptor, alpha (IL20RA), mRNA
  gi|7657690|ref|NM_—014432.1|[7657690]
• 5261: NM_—004967
  Homo sapiens integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein
  II) (IBSP), mRNA
  gi|13259536|ref|NM_—004967.2|[13259536]
• 5270: AF348323
  Homo sapiens nociceptin receptor (ORL1) mRNA, complete cds
  gi|13022242|gb|AF348323.1|AF348323[13022242]
• 5272: S79217
  Homo sapiens Ca(2+)-sensing receptor mRNA, partial cds
  gi|1050985|gb|S79217.1|S79217[1050985]
• 5273: S78723
  Homo sapiens serotonin 5-HT2A receptor (5-HT2A R) gene, partial cds
  gi|1042173|gb|S78723.1|S78723[1042173]
• 5274: S78505
  Homo sapiens prolactin receptor mRNA, partial cds
  gi|999114|gb|S78505.1S78505[999114]
• 5277: S77555
  Homo sapiens corticotropin receptor/ACTH receptor gene, partial cds
  gi|957294|gb|S77555.1|S77555[957294]
• 5278: NM_—024012
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 5A (HTR5A), mRNA
  gi|13236496|ref|NM_—024012.1|[13236496]
• 5279: NM_—021904
  Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
  variant 3, mRNA
  gi|11497613|ref|NM_—021904.1|[11497613]
• 5280: NM_—021903
  Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
  variant 2, mRNA
  gi|11497611|ref|NM_—021903.1|[11497611]
• 5281: NM_—001470
  Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
  variant 1, mRNA
  gi|10835014|ref|NM_—001470.1|[10835014]
• 5282: NM_—007329
  Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 2,
  mRNA
  gi|6633800|ref|NM_—007329.1|[6633800]
• 5283: S71404
  Homo sapiens interleukin-9 receptor mRNA, partial cds
  gi|551356|gb|S71404.1|S71404[551356]
• 5356: NM_—023031
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  13, mRNA
  gi|13186272|ref|NM_—023031.1|[13186272]
• 5357: NM_—023030
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  12, mRNA
  gi|13186270|ref|NM_—023030.1|[13186270]
• 5358: NM_—023028
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  10, mRNA
  gi|13186268|ref|NM_—023028.1|[13186268]
• 5359: NM_—022976
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  9, mRNA
  gi|13186266|ref|NM_—022976.1|[13186266]
• 5360: NM_—022975
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  8, mRNA
  gi|13186264|ref|NM_—022975.1|[13186264]
• 5361: NM_—022974
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  7, mRNA
  gi|13186262|ref|NM_—022974.1|[13186262]
• 5362: NM_—022973
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  6, mRNA
  gi|13186260|ref|NM_—022973.1|[13186260]
• 5363: NM_—022972
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  5, mRNA
  gi|13186258|ref|NM_—022972.1|[13186258]
• 5364: NM_—022971
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  4, mRNA
  gi|13186256|ref|NM_—022971.1|[13186256]
• 5365: NM_—022970
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  3, mRNA
  gi|13186254|ref|NM_—022970.1|[13186254]
• 5366: NM_—022969
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  2, mRNA
  gi|13186252|ref|NM_—022969.1|[13186252]
• 5367: NM_—023029
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  11, mRNA
  gi|13186242|ref|NM_—023029.1|[13186242]
• 5368: NM_—000141
  Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
  1, mRNA
  gi|13186239|ref|NM_—000141.2|[13186239]
• 5369: AF312678
  Homo sapiens FGF homologous factor receptor (FHFR) mRNA, complete cds
  gi|13183617|gb|AF312678.1|AF312678[13183617]
• 5370: AF243385
  Homo sapiens beta-2 syntrophin mRNA, complete cds, alternatively spliced
  gi|13183299|gb|AF243385.1|AF243385[13183299]
• 5371: M97191
  Homo sapiens Sp3 protein mRNA, partial cds
  gi|13162672|gb|M97191.2|HUMSP3A[13162672]
• 5474: NM_—024075
  Homo sapiens LENG5 protein (LENG5), mRNA
  gi|13129061|ref|NM_—024075.1|[13129061]
• 5475: AF304379
  Homo sapiens ULBP3 protein mRNA, complete cds
  gi|13128926|gb|AF304379.1|AF304379[13128926]
• 5476: AF304378
  Homo sapiens ULBP2 protein mRNA, complete cds
  gi|13128924|gb|AF304378.1|AF304378[13128924]
• 5477: AF304377
  Homo sapiens ULBP1 protein mRNA, complete cds
  gi|13128922|gb|AF304377.1|AF304377[13128922]
• 5481: AF000549
  AF000549 Human Homo sapiens genomic clone P1 clone DMPC-HFF#1-1075-D9, genomic
  survey sequence
  gi|2232072|gb|AF000549.1|AF000549[2232072]
• 5482: NM_—001755
  Homo sapiens core-binding factor, beta subunit (CBFB), transcript variant 2, mRNA
  gi|13124872|ref|NM_—001755.1|[13124872]
• 5483: AF172398
  Homo sapiens junctional adhesion molecule-1 mRNA, complete cds
  gi|13124448|gb|AF172398.2|AF172398[13124448]
• 5484: AF317655
  Homo sapiens G protein-coupled receptor (GPR77) gene, complete cds
  gi|13122466|gb|AF317655.1|AF317655[13122466]
• 5485: AF317653
  Homo sapiens G protein-coupled receptor (GPR62) gene, complete cds
  gi|13122462|gb|AF317653.1|AF317653[13122462]
• 5486: AF317652
  Homo sapiens G protein-coupled receptor (GPR61) mRNA, complete cds
  gi|13122460|gb|AF317652.1|AF317652[13122460]
• 5487: NM_—022036
  Homo sapiens G protein-coupled receptor, family C, group 5, member C (GPRC5C),
  transcript variant 1, mRNA
  gi|13112058|ref|NM_—022036.1|[13112058]
• 5488: NM_—018653
  Homo sapiens G protein-coupled receptor, family C, group 5, member C (GPRC5C),
  transcript variant 2, mRNA
  gi|13112056|ref|NM_—018653.2|[13112056]
• 5489: NM_—000707
  Homo sapiens arginine vasopressin receptor 1B (AVPR1B), mRNA
  gi|13112055|ref|NM_—000707.2|[13112055]
• 5490: NM_—000706
  Homo sapiens arginine vasopressin receptor 1A (AVPR1A), mRNA
  gi|13112054|ref|NM_—000706.2|[13112054]
• 5491: NM_—021923
  Homo sapiens fibroblast growth factor receptor-like 1 (FGFRL1), mRNA
  gi|13112053|ref|NM_—021923.2|[13112053]
• 5492: NM_—002011
  Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 1,
  mRNA
  gi|13112051|ref|NM_—002011.2|[13112051]
• 5493: NM_—022963
  Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 2,
  mRNA
  gi|13112049|ref|NM_—022963.1|[13112049]
• 5494: NM_—022965
  Homo sapiens fibroblast growth factor receptor 3 (achondroplasia, thanatophoric
  dwarfism) (FGFR3), transcript variant 2, mRNA
  gi|13112047|ref|NM_—022965.1|[13112047]
• 5495: NM_—000142
  Homo sapiens fibroblast growth factor receptor 3 (achondroplasia, thanatophoric
  dwarfism) (FGFR3), transcript variant 1, mRNA
  gi|13112046|ref|NM_—000142.2|[13112046]
• 5496: NM_—022336
  Homo sapiens ectodysplasin 1, anhidrotic receptor (EDAR), mRNA
  gi|11641230|ref|NM_—022336.1|[11641230]
• 5497: NM_—018654
  Homo sapiens G protein-coupled receptor, family C, group 5, member D (GPRC5D),
  mRNA
  gi|8923704|ref|NM_—018654.1|[8923704]
• 5498: AF312230
  Homo sapiens histamine receptor H4 subtype mRNA, complete cds
  gi|13094918|gb|AF312230.1|AF312230[13094918]
• 5504: AY016370
  Homo sapiens hnRNPA1 pseudogene, complete sequence; and CC chemokine receptor 8
  (CCR8) and CX3C chemokine receptor 1 (CX3CR1) genes, complete cds
  gi|13027668|gb|AY016370.1|[13027668]
• 5505: E32517
  Scavenger receptor-like protein
  gi|13026764|dbj|E32517.1E32517[13026764]
• 5506: E32511
  Scavenger receptor-like protein
  gi|13026758|dbj|E32511.1|E32511[13026758]
• 5507: E32510
  Scavenger receptor-like protein
  gi|3026757|dbj|E32510.1|E32510[13026757]
• 5508: E32509
  Scavenger receptor-like protein
  gi|13026756|dbj|E32509.1|E32509[13026756]
• 5509: E32504
  Scavenger receptor-like protein
  gi|13026751|dbj|E32504.1|E32504[13026751]
• 5510: E32503
  Scavenger receptor-like protein
  gi|13026750|dbj|E32503.1|E32503[13026750]
• 5511: E60222
  Melatonin receptor expressing cell and utilization thereof
  gi|13025812|dbj|E60222.1|E60222[13025812]
• 5512: E36078
  cDNA clone HNEAA81 encoding human seven-pass transmembrane receptor
  gi|13022480|dbj|E36078.1|E36078[13022480]
• 5522: AJ309545
  Homo sapiens mRNA for T-cell receptor alpha chain, clone 57LSK10 (Va2, Ja45)
  gi|13016702|emb|AJ309545.1|HSA309545[13016702]
• 5523: AF323176
  Homo sapiens death receptor-interacting protein mRNA, complete cds
  gi|12964787|gb|AF323176.1|AF323176[12964787]
• 5524: AF329496
  Homo sapiens immunoglobulin kappa light chain gene, partial cds
  gi|12963392|gb|AF329496.1|AF329496[12963392]
• 5529: NM_—015717
  Homo sapiens Langerhans cell specific c-type lectin (LANGERIN), mRNA
  gi|7657290|ref|NM_—015717.1|[7657290]
• 5530: NM_—012329
  Homo sapiens monocyte to macrophage differentiation-associated (MMD), mRNA
  gi|6912507|ref|NM_—012329.1|[6912507]
• 5571: AH009956
  Homo sapiens chromosome 12 clone pacHRARg map 12q13
  gi|12746591|gb|AH009956.2|SEG_AF311283S[12746591]
• 5573: AF230330
  Homo sapiens angiopoietin-related protein 5 (ARP5) mRNA, complete cds
  gi|12743935|gb|AF230330.1|AF230330[12743935]
• 5574: AF316895
  Homo sapiens alpha 2B adrenergic receptor (ADRA2B) gene, complete cds
  gi|12698669|gb|AF316895.1|AF316895[12698669]
• 5575: NM_—021905
  Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
  variant 4, mRNA
  gi|11497615|ref|NM_—021905.1|[11497615]
• 5578: NM_—016730
  Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 3, mRNA
  gi|9257214|ref|NM_—016730.1|[9257214]
• 5579: NM_—016729
  Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 4, mRNA
  gi|9257212|ref|NM_—016729.1|[9257212]
• 5580: NM_—016725
  Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 1, mRNA
  gi|9257206|ref|NM_—016725.1|[9257206]
• 5581: NM_—016724
  Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 7, mRNA
  gi|9257204|ref|NM_—016724.1|[9257204]
• 5582: NM_—004406
  Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 1,
  mRNA
  gi|4758169|ref|NM_—004406.1|[4758169]
• 5583: L27609
  Homo sapiens T-cell receptor beta gene, partial cds
  gi|457265|gb|L27609.1|HUMTCRBD[457265]
• 5584: U65905
  U65905 Human Homo sapiens genomic, genomic survey sequence
  gi|1743863|gb|U65905.1|U65905[1743863]
• 5585: U65904
  U65904 Human Homo sapiens genomic, genomic survey sequence
  gi|1743862|gb|U65904.1|U65904[1743862]
• 5586: U65903
  U65903 Human Homo sapiens genomic, genomic survey sequence
  gi|1743861|gb|U65903.1|U65903[1743861]
• 5587: NM_—016731
  Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 8, mRNA
  gi|12719454|ref|NM_—016731.2|[12719454]
• 5588: AF316870
  Homo sapiens T cell receptor beta chain variable region mRNA, partial cds
  gi|12711595|gb|AF316870.1|AF316870[12711595]
• 5589: AX074315
  Sequence 29 from Patent WO0104310
  gi|12710501|emb|AX074315.1|AX074315[12710501]
• 5590: AX074314
  Sequence 28 from Patent WO0104310
  gi|12710500|emb|AX074314.1|AX074314[12710500]
• 5591: NM_—022113
  Homo sapiens kinesin family member 13A (KIF13A), mRNA
  gi|11545828|ref|NM_—022113.1|[11545828]
• 5592: AF283296
  Homo sapiens interleukin-15 receptor alpha gene, 5′ regulatory region and exon
  1, partial sequence
  gi|9965299|gb|AF283296.1|AF283296[9965299]
• 5593: NM_—014688
  Homo sapiens related to the N terminus of tre (RNTRE), mRNA
  gi|7661863|ref|NM_—014688.1|[7661863]
• 5594: NM_—000916
  Homo sapiens oxytocin receptor (OXTR), mRNA
  gi|12707575|ref|NM_—000916.2|[12707575]
• 5595: NM_—000915
  Homo sapiens oxytocin, prepro-(neurophysin I) (OXT), mRNA
  gi|12707574|ref|NM_—000915.2|[12707574]
• 5596: NM_—004961
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 1, mRNA
  gi|12707559|ref|NM_—004961.2|[12707559]
• 5597: NM_—021990
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 4, mRNA
  gi|12707557|ref|NM_—021990.1|[12707557]
• 5598: NM_—021987
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 3, mRNA
  gi|12707555|ref|NM_—021987.1|[12707555]
• 5599: NM_—021984
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 2, mRNA
  gi|12707553|ref|NM_—021984.1|[12707553]
• 5600: AY011291
  Homo sapiens beta-2 adrenergic receptor (ADRB2) gene, partial cds
  gi|12699005|gb|AY011291.1|[12699005]
• 5601: AF316894
  Homo sapiens alpha 2A adrenergic receptor (ADRA2A) gene, complete cds
  gi|12698667|gb|AF316894.1|AF316894[12698667]
• 5602: AJ300340
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 1 and joined complete CDS
  gi|11878410|emb|AJ300340.1|HSA300340[11878410]
• 5603: AF063605
  Homo sapiens brain my047 protein mRNA, complete cds
  gi|4071360|gb|AF063605.1|AF063605[4071360]
• 5604: AF319440
  Homo sapiens SH2 domain-containing phosphatase anchor protein 1c (SPAP1) mRNA,
  complete cds, alternatively spliced
  gi|12667355|gb|AF319440.1|AF319440[12667355]
• 5605: AF319439
  Homo sapiens SH2 domain-containing phosphatase anchor protein 1b (SPAP1) mRNA,
  complete cds, alternatively spliced
  gi|12667353|gb|AF319439.1|AF319439[12667353]
• 5606: AF319438
  Homo sapiens SH2 domain-containing phosphatase anchor protein 1a (SPAP1) mRNA,
  complete cds, alternatively spliced
  gi|12667351|gb|AF319438.1|AF319438[12667351]
• 5607: NM_—021912
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 2, mRNA
  gi|12548787|ref|NM_—021912.1|[12548787]
• 5608: NM_—021911
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), transcript variant 1, mRNA
  gi|12548784|ref|NM_—021911.1|[12548784]
• 5609: NM_—000814
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 1, mRNA
  gi|12548782|ref|NM_—000814.2|[12548782]
• 5610: NM_—000812
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1), mRNA
  gi|12548775|ref|NM_—000812.2|[12548775]
• 5611: NM_—006786
  Homo sapiens urotensin 2 (UTS2), transcript variant 2, mRNA
  gi|12056480|ref|NM_—006786.2|[12056480]
• 5612: NM_—021995
  Homo sapiens urotensin 2 (UTS2), transcript variant 1, mRNA
  gi|12056478|ref|NM_—021995.1|[12056478]
• 5613: AJ300444
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 105
  gi|1863669|emb|AJ300444.1|HSA300444[11863669]
• 5614: AJ300443
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 104
  gi|11863668|emb|AJ300443.1|HSA300443[11863668]
• 5615: AJ300442
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 103
  gi|11863667|emb|AJ300442.1|HSA300442[11863667]
• 5616: AJ300441
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 102
  gi|11863666|emb|AJ300441.1|HSA300441[11863666]
• 5617: AJ300440
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 101
  gi|11863665|emb|AJ300440.1|HSA300440[11863665]
• 5618: AJ300439
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 100
  gi|11863664|emb|AJ300439.1|HSA300439[11863664]
• 5619: AJ300438
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 99
  gi|11863663|emb|AJ300438.1|HSA300438[11863663]
• 5620: AJ300437
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 98
  gi|11863662|emb|AJ300437.1|HSA300437[11863662]
• 5621: AJ300436
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 97
  gi|11863661|emb|AJ300436.1|HSA300436[11863661]
• 5622: AJ300435
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 96
  gi|11863660|emb|AJ300435.1|HSA300435[11863660]
• 5623: AJ300434
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 95
  gi|11863659|emb|AJ300434.1|HSA300434[11863659]
• 5624: AJ300433
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 94
  gi|11863658|emb|AJ300433.1|HSA300433[11863658]
• 5625: AJ300432
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 93
  gi|11863657|emb|AJ300432.1|HSA300432[11863657]
• 5626: AJ300431
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 92
  gi|11863656|emb|AJ300431.1|HSA300431[11863656]
• 5627: AJ300430
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 91
  gi|11863655|emb|AJ300430.1|HSA300430[11863655]
• 5628: AJ300429
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 90
  gi|11863654|emb|AJ300429.1|HSA300429[11863654]
• 5629: AJ300428
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 89
  gi|11863653|emb|AJ300428.1|HSA300428[11863653]
• 5630: AJ300427
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 88
  gi|11863652|emb|AJ300427.1|HSA300427[11863652]
• 5631: AJ300426
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 87
  gi|11863651|emb|AJ300426.1|HSA300426[11863651]
• 5632: AJ300425
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 86
  gi|11863650|emb|AJ300425.1|HSA300425[11863650]
• 5633: AJ300424
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 85
  gi|11863649|emb|AJ300424.1|HSA300424[11863649]
• 5634: AJ300423
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 84
  gi|11863648|emb|AJ300423.1|HSA300423[11863648]
• 5635: AJ300422
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 83
  gi|11863647|emb|AJ300422.1|HSA300422[11863647]
• 5636: AJ300421
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 82
  gi|11863646|emb|AJ300421.1|HSA300421[11863646]
• 5637: AJ300420
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 81
  gi|11863645|emb|AJ300420.1|HSA300420[11863645]
• 5638: AJ300419
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 80
  gi|11863644|emb|AJ300419.1|HSA300419[11863644]
• 5639: AJ300418
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 79
  gi|11863643|emb|AJ300418.1|HSA300418[11863643]
• 5640: AJ300417
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 78
  gi|11863642|emb|AJ300417.1|HSA300417[11863642]
• 5641: AJ300416
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 77
  gi|11863641|emb|AJ300416.1|HSA300416[11863641]
• 5642: AJ300415
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 76
  gi|1863640|emb|AJ300415.1|HSA300415[11863640]
• 5643: AJ300414
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 75
  gi|11863639|emb|AJ300414.1|HSA300414[11863639]
• 5644: AJ300413
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 74
  gi|11863638|emb|AJ300413.1|HSA300413[11863638]
• 5645: AJ300412
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 73
  gi|11863637|emb|AJ300412.1|HSA300412[11863637]
• 5646: AJ300411
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 72
  gi|11863636|emb|AJ300411.1|HSA300411[11863636]
• 5647: AJ300410
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 71
  gi|11863635|emb|AJ300410.1|HSA300410[11863635]
• 5648: AJ300409
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 70
  gi|11863634|emb|AJ300409.1|HSA300409[11863634]
• 5649: AJ300408
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 69
  gi|11863633|emb|AJ300408.1|HSA300408[11863633]
• 5650: AJ300407
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 68
  gi|11863632|emb|AJ300407.1|HSA300407[11863632]
• 5651: AJ300406
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 67
  gi|11863631|emb|AJ300406.1|HSA300406[11863631]
• 5652: AJ300405
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 66
  gi|11863630|emb|AJ300405.1|HSA300405[11863630]
• 5653: AJ300404
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 65
  gi|11863629|emb|AJ300404.1|HSA300404[11863629]
• 5654: AJ300403
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 64
  gi|11863628|emb|AJ300403.1|HSA300403[11863628]
• 5655: AJ300402
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 63
  gi|11863627|emb|AJ300402.1|HSA300402[11863627]
• 5656: AJ300401
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 62
  gi|11863626|emb|AJ300401.1|HSA300401[11863626]
• 5657: AJ300400
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 61
  gi|11863625|emb|AJ300400.1|HSA300400[11863625]
• 5658: AJ300399
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 60
  gi|11863624|emb|AJ300399.1|HSA300399[11863624]
• 5659: AJ300398
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 59
  gi|11863623|emb|AJ300398.1|HSA300398[11863623]
• 5660: AJ300397
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 58
  gi|11863622|emb|AJ300397.1|HSA300397[11863622]
• 5661: AJ300396
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 57
  gi|11863621|emb|AJ300396.1|HSA300396[11863621]
• 5662: AJ300395
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 56
  gi|11863620|emb|AJ300395.1|HSA300395[11863620]
• 5663: AJ300394
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 55
  gi|11863619|emb|AJ300394.1|HSA300394[11863619]
• 5664: AJ300393
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 54
  gi|11863618|emb|AJ300393.1|HSA300393[11863618]
• 5665: AJ300392
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 53
  gi|11863617|emb|AJ300392.1|HSA300392[11863617]
• 5666: AJ300391
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 52
  gi|11863616|emb|AJ300391.1|HSA300391[11863616]
• 5667: AJ300390
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 51
  gi|11863615|emb|AJ300390.1|HSA300390[11863615]
• 5668: AJ300389
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 50
  gi|11863614|emb|AJ300389.1|HSA300389[11863614]
• 5669: AJ300388
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 49
  gi|11863613|emb|AJ300388.1|HSA300388[11863613]
• 5670: AJ300387
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 48
  gi|11863612|emb|AJ300387.1|HSA300387[11863612]
• 5671: AJ300386
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 47
  gi|11863611|emb|AJ300386.1|HSA300386[11863611]
• 5672: AJ300385
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 46
  gi|11863610|emb|AJ300385.1|HSA300385[11863610]
• 5673: AJ300384
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 45
  gi|11863609|emb|AJ300384.1HSA300384[11863609]
• 5674: AJ300383
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 44
  gi|11863608|emb|AJ300383.1|HSA300383[11863608]
• 5675: AJ300382
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 43
  gi|11863607|emb|AJ300382.1|HSA300382[11863607]
• 5676: AJ300381
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 42
  gi|11863606|emb|AJ300381.1|HSA300381[11863606]
• 5677: AJ300380
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 41
  gi|11863605|emb|AJ300380.1|HSA300380[11863605]
• 5678: AJ300379
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 40
  gi|11863604|emb|AJ300379.1|HSA300379[11863604]
• 5679: AJ300378
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 39
  gi|1863603|emb|AJ300378.1|HSA300378[11863603]
• 5680: AJ300377
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 38
  gi|11863602|emb|AJ300377.1|HSA300377[11863602]
• 5681: AJ300376
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 37
  gi|1863601|emb|AJ300376.1|HSA300376[11863601]
• 5682: AJ300375
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 36
  gi|1863600|emb|AJ300375.1|HSA300375[11863600]
• 5683: AJ300374
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 35
  gi|11863599|emb|AJ300374.1|HSA300374[11863599]
• 5684: AJ300373
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 34
  gi|11863598|emb|AJ300373.1|HSA300373[11863598]
• 5685: AJ300372
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 33
  gi|11863597|emb|AJ300372.1|HSA300372[11863597]
• 5686: AJ300371
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 32
  gi|11863596|emb|AJ300371.1|HSA300371[11863596]
• 5687: AJ300370
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 31
  gi|11863595|emb|AJ300370.1|HSA300370[11863595]
• 5688: AJ300369
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 30
  gi|11863594|emb|AJ300369.1|HSA300369[11863594]
• 5689: AJ300368
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 29
  gi|11863593|emb|AJ300368.1|HSA300368[11863593]
• 5690: AJ300367
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 28
  gi|11863592|emb|AJ300367.1|HSA300367[11863592]
• 5691: AJ300366
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 27
  gi|11863591|emb|AJ300366.1|HSA300366[11863591]
• 5692: AJ300365
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 26
  gi|11863590|emb|AJ300365.1|HSA300365[11863590]
• 5693: AJ300364
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 25
  gi|11863589|emb|AJ300364.1|HSA300364[11863589]
• 5694: AJ300363
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 24
  gi|11863588|emb|AJ300363.1|HSA300363[11863588]
• 5695: AJ300362
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 23
  gi|11863587|emb|AJ300362.1|HSA300362[11863587]
• 5696: AJ300361
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 22
  gi|11863586|emb|AJ300361.1|HSA300361[11863586]
• 5697: AJ300360
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 21
  gi|11863585|emb|AJ300360.1|HSA300360[11863585]
• 5698: AJ300359
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 20
  gi|11863584|emb|AJ300359.1|HSA300359[11863584]
• 5699: AJ300358
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 19
  gi|11863583|emb|AJ300358.1|HSA300358[11863583]
• 5700: AJ300357
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 18
  gi|11863582|emb|AJ300357.1|HSA300357[11863582]
• 5701: AJ300356
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 17
  gi|11863581|emb|AJ300356.1|HSA300356[11863581]
• 5702: AJ300355
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 16
  gi|11863580|emb|AJ300355.1|HSA300355[11863580]
• 5703: AJ300354
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 15
  gi|11863579|emb|AJ300354.1|HSA300354[11863579]
• 5704: AJ300353
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 14
  gi|11863578|emb|AJ300353.1|HSA300353[11863578]
• 5705: AJ300352
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 13
  gi|11863577|emb|AJ300352.1|HSA300352[11863577]
• 5706: AJ300351
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 12
  gi|11863576|emb|AJ300351.1|HSA300351[11863576]
• 5707: AJ300350
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 11
  gi|11863575|emb|AJ300350.1|HSA300350[11863575]
• 5708: AJ300349
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 10
  gi|11863574|emb|AJ300349.1|HSA300349[11863574]
• 5709: AJ300348
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 9
  gi|11863573|emb|AJ300348.1|HSA300348[11863573]
• 5710: AJ300347
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 8
  gi|11863572|emb|AJ300347.1|HSA300347[11863572]
• 5711: AJ300346
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 7
  gi|11863571|emb|AJ300346.1|HSA300346[11863571]
• 5712: AJ300345
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 6
  gi|11863570|emb|AJ300345.1|HSA300345[11863570]
• 5713: AJ300344
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 5
  gi|11863569|emb|AJ300344.1|HSA300344[11863569]
• 5714: AJ300343
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 4
  gi|11863568|emb|AJ300343.1|HSA300343[11863568]
• 5715: AJ300342
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 3
  gi|11863567|emb|AJ300342.1|HSA300342[11863567]
• 5716: AJ300341
  Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 2
  gi|11863566|emb|AJ300341.1|HSA300341[11863566]
• 5717: NM_—000832
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-1, mRNA
  gi|11496970|ref|NM_—000832.4|[11496970]
• 5718: NM_—021709
  Homo sapiens CD27-binding (Siva) protein (SIVA), transcript variant 2, mRNA
• 5719: NM_—006427
  Homo sapiens CD27-binding (Siva) protein (SIVA), transcript variant 1, mRNA
  gi|11277467|ref|NM_—006427.2|[11277467]
• 5720: NM_—016232
  Homo sapiens interleukin 1 receptor-like 1 (IL1RL1), mRNA
  gi|11136631|ref|NM_—016232.2|[11136631]
• 5721: AF202091
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 7 and complete cds
  gi|11055242|gb|AF202091.1|F202078S14[11055242]
• 5722: AF202090
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 6
  gi|11055241|gb|AF202090.1|F202078S13[11055241]
• 5723: AF202089
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 5
  gi|110552400gb|AF202089.1|F202078S12[11055240]
• 5724: AF202088
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 4
  gi|11055239|gb|AF202088.1|F202078S11[11055239]
• 5725: AF202087
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 3
  gi|11055238|gb|AF202087.1|F202078S10[11055238]
• 5726: AF202086
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 2
  gi|11055237|gb|AF202086.1|F202078S09[11055237]
• 5727: AF202085
  Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 1
  gi|11055236|gb|AF202085.1|F202078S08[11055236]
• 5728: AF202084
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 7 and complete cds
  gi|11055235|gb|AF202084.1|F202078S07[11055235]
• 5729: AF202083
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 6
  gi|11055234|gb|AF202083.1|F202078S06[11055234]
• 5730: AF202082
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 5
  gi|11055233|gb|AF202082.1|F202078S05[11055233]
• 5731: AF202081
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 4
  gi|11055232|gb|AF202081.1|F202078S04[11055232]
• 5732: AF202080
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 3
  gi|11055231|gb|AF202080.1|F202078S03[11055231]
• 5733: AF202079
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 2
  gi|110552300gb|AF202079.1|F202078S02[11055230]
• 5734: AF202078
  Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 1
  gi|11055229|gb|AF202078.1|F202078S01[11055229]
• 5735: AH009943
  Homo sapiens hypocretin receptor-1 (HCRTR1) and hypocretin receptor-2 (HCRTR2)
  genes, complete cds
  gi|11055228|gb|AH009943.1|SEG_F202078S[11055228]
• 5736: NM_—021602
  Homo sapiens CD79B antigen (immunoglobulin-associated beta) (CD79B), transcript
  variant 2, mRNA
  gi|11038675|ref|NM_—021602.1|[11038675]
• 5737: NM_—000626
  Homo sapiens CD79B antigen (immunoglobulin-associated beta) (CD79B), transcript
  variant 1, mRNA
  gi|11038673|ref|NM_—000626.1|[11038673]
• 5738: NM_—021601
  Homo sapiens CD79A antigen (immunoglobulin-associated alpha) (CD79A), transcript
  variant 2, mRNA
  gi|11038671|ref|NM_—021601.1|[11038671]
• 5739: NM_—007327
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-3, mRNA
  gi|11038636|ref|NM_—007327.1|[11038636]
• 5740: NM_—021569
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-2, mRNA
  gi|11038634|ref|NM_—021569.1|[11038634]
• 5743: NM_—021270
  Homo sapiens leukocyte-associated Ig-like receptor 2 (LAIR2), transcript variant
  2, mRNA
  gi|10947102|ref|NM_—021270.1|[10947102]
• 5744: NM_—002288
  Homo sapiens leukocyte-associated Ig-like receptor 2 (LAIR2), transcript variant
  1, mRNA
  gi|10947100|ref|NM_—002288.2|[10947100]
• 5745: NM_—004041
  Homo sapiens arrestin, beta 1 (ARRB1), transcript variant 1, mRNA
  gi|10880135|ref|NM_—004041.2|[10880135]
• 5746: NM_—020251
  Homo sapiens arrestin, beta 1 (ARRB1), transcript variant 2, mRNA
  gi|10880133|ref|NM_—020251.1|[10880133]
• 5747: NM_—000872
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) (HTR7), transcript variant a, mRNA
  gi|10880132|ref|NM_—000872.2|[10880132]
• 5748: NM_—019860
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) (HTR7), transcript variant b, mRNA
  gi|10880130|ref|NM_—019860.1|[10880130]
• 5749: NM_—019859
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) (HTR7), transcript variant d, mRNA
  gi|10880128|ref|NM_—019859.1|[10880128]
• 5750: NM_—004302
  Homo sapiens activin A receptor, type IB (ACVR1B), transcript variant 1, mRNA
  gi|10862695|ref|NM_—004302.2|[10862695]
• 5751: NM_—020328
  Homo sapiens activin A receptor, type IB (ACVR1B), transcript variant 3, mRNA
  gi|10862693|ref|NM_—020328.1|[10862693]
• 5752: NM_—020327
  Homo sapiens activin A receptor, type IB (ACVR1B), transcript variant 2, mRNA
  gi|10862691|ref|NM_—020327.1|[10862691]
• 5753: NM_—020525
  Homo sapiens interleukin 22 (IL22), mRNA
  gi|10092624|ref|NM_—020525.1|[10092624]
• 5754: NM_—000407
  Homo sapiens glycoprotein Ib (platelet), beta polypeptide (GP1BB), mRNA
  gi|9945387|ref|NM_—000407.31[9945387]
• 5755: NM_—018971
  Homo sapiens G protein-coupled receptor 27 (GPR27), mRNA
  gi|9506746|ref|NM_—018971.1|[9506746]
• 5756: NM_—017455
  Homo sapiens stromal cell derived factor receptor 1 (SDFR1), transcript variant
  alpha, mRNA
  gi|9257239|ref|NM_—017455.1|[9257239]
• 5757: NM_—002197
  Homo sapiens aconitase 1, soluble (ACO1), mRNA
  gi|8659554|ref|NM_—002197.1|[8659554]
• 5758: NM_—005242
  Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA
  gi|8051581|ref|NM_—005242.2|[8051581]
• 5759: NM_—016388
  Homo sapiens T-cell receptor interacting molecule (TRIM), mRNA
  gi|7706744|ref|NM_—016388.1|[7706744]
• 5760: NM_—016334
  Homo sapiens putative G-protein coupled receptor (SH120), mRNA
  gi|7706703|ref|NM_—016334.1|[7706703]
• 5761: NM_—016318
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 2 (P2RX2), mRNA
  gi|7706628|ref|NM_—016318.1|[7706628]
• 5762: NM_—016602
  Homo sapiens G protein-coupled receptor 2 (GPR2), mRNA
  gi|7705315|ref|NM_—016602.1|[7705315]
• 5763: NM_—013964
  Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-alpha, mRNA
  gi|7669525|ref|NM_—013964.1|[7669525]
• 5764: NM_—013962
  Homo sapiens neuregulin 1 (NRG1), transcript variant GGF2, mRNA
  gi|7669523|ref|NM_—013962.1|[7669523]
• 5765: NM_—013961
  Homo sapiens neuregulin 1 (NRG1), transcript variant GGF, mRNA
  gi|7669521|ref|NM_—013961.1|[7669521]
• 5766: NM_—013960
  Homo sapiens neuregulin 1 (NRG1), transcript variant ndf43, mRNA
  gi|7669519|ref|NM_—013960.1|[7669519]
• 5767: NM_—013959
  Homo sapiens neuregulin 1 (NRG1), transcript variant SMDF, mRNA
  gi|7669517|ref|NM_—013959.1|[7669517]
• 5768: NM_—013958
  Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta3, mRNA
  gi|7669515|ref|NM_—013958.1|[7669515]
• 5769: NM_—013957
  Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta2, mRNA
  gi|7669513|ref|NM_—013957.1|[7669513]
• 5770: NM_—013956
  Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta1, mRNA
  gi|7669511|ref|NM_—013956.1|[7669511]
• 5771: NM_—007334
  Homo sapiens killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 2, mRNA
  gi|7669498|ref|NM_—007334.1|[7669498]
• 5772: NM_—002262
  Homo sapiens killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 1, mRNA
  gi|7669497|ref|NM_—002262.21[7669497]
• 5773: NM_—007319
  Homo sapiens presenilin 1 (Alzheimer disease 3) (PSEN1), transcript variant I-374., mRNA
  gi|7549814|ref|NM_—007319.1|[7549814]
• 5774: NM_—007318
  Homo sapiens presenilin 1 (Alzheimer disease 3) (PSEN1), transcript variant I-463, mRNA
  gi|7549812|ref|NM_—007318.1|[7549812]
• 5775: NM_—007333
  Homo sapiens killer cell lectin-like receptor subfamily C, member 3 (KLRC3), transcript variant NKG2-H, mRNA
  gi|7262385|ref|NM_—007333.1|[7262385]
• 5776: NM_—007328
  Homo sapiens killer cell lectin-like receptor subfamily C, member 1 (KLRC1), transcript variant NKG2-B, mRNA
  gi|7262383|ref|NM_—007328.1|[7262383]
• 5777: NM_—002259
  Homo sapiens killer cell lectin-like receptor subfamily C, member 1 (KLRC1), transcript variant NKG2-A, mRNA
  gi|7262382|ref|NM_—002259.2|[7262382]
• 5778: NM_—006350
  Homo sapiens follistatin (FST), transcript variant FST317, mRNA
  gi|7242223|ref|NM_—006350.2|[7242223]
• 5779: NM_—013409
  Homo sapiens follistatin (FST), transcript variant FST344, mRNA
  gi|7242221|ref|NM_—013409.1|[7242221]
• 5780: NM_—012486
  Homo sapiens presenilin 2 (Alzheimer disease 4) (PSEN2), transcript variant 2,
  mRNA
  gi|7108359|ref|NM_—012486.1|[7108359]
• 5781: NM_—012485
  Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 2, mRNA
  gi|7108350|ref|NM_—012485.1|[7108350]
• 5782: NM_—012484
  Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 1, mRNA
  gi|7108348|ref|NM_—012484.1|[7108348]
• 5783: NM_—012428
  Homo sapiens stromal cell derived factor receptor 1 (SDFR1), transcript variant
  beta, mRNA
  gi|6912645|ref|NM_—012428.1|[6912645]
• 5784: NM_—012226
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 2 (P2RX2), mRNA
  gi|6912565|ref|NM_—012226.1|[6912565]
• 5785: NM_—012369
  Homo sapiens olfactory receptor, family 2, subfamily F, member 1 (OR2F1), mRNA
  gi|6912557|ref|NM_—012369.1|[6912557]
• 5786: NM_—007325
  Homo sapiens glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant
  flip, mRNA
  gi|6598324|ref|NM_—007325.1|[6598324]
• 5787: NM_—000632
  Homo sapiens integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) (ITGAM), mRNA
  gi|6006013|ref|NM_—000632.21[6006013]
• 5788: NM_—007097
  Homo sapiens clathrin, light polypeptide (Lcb) (CLTB), mRNA
  gi|6005994|ref|NM_—007097.1|[6005994]
• 5789: NM_—000655
  Homo sapiens selectin L (lymphocyte adhesion molecule 1) (SELL), mRNA
  gi|5713320|ref|NM_—000655.2|[5713320]
• 5790: NM_—005751
  Homo sapiens A kinase (PRKA) anchor protein (yotiao) 9 (AKAP9), mRNA
  gi|5032230|ref|NM_—005751.1|[5032230]
• 5791: NM_—005691
  Homo sapiens ATP-binding cassette, sub-family C(CFTR/MRP), member 9 (ABCC9), transcript variant SUR2A, mRNA
  gi|5032134|ref|NM_—005691.1|[5032134]
• 5792: NM_—005534
  Homo sapiens interferon gamma receptor 2 (interferon gamma transducer 1) (IFNCR2), mRNA
  gi|5031782|ref|NM_—005534.1|[5031782]
• 5793: NM_—005682
  Homo sapiens G protein-coupled receptor 56 (GPR56), mRNA
  gi|5031724|ref|NM_—005682.1|[5031724]
• 5794: NM_—005446
  Homo sapiens purinergic receptor P2X-like 1, orphan receptor (P2RXL1), mRNA
  gi|4885534|ref|NM_—005446.1|[4885534]
• 5795: NM_—004958
  Homo sapiens FK506 binding protein 12-rapamycin associated protein 1 (FRAP1), mRNA
  gi|4826729|ref|NM_—004958.1|[4826729]
• 5796: NM_—004495
  Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-gamma, mRNA
  gi|4758525|ref|NM_—004495.1|[4758525]
• 5797: NM_—003995
  Homo sapiens natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) (NPR2), mRNA
  gi|4580421|ref|NM_—003995.2|[4580421]
• 5798: NM_—003994
  Homo sapiens KIT ligand (KITLG), mRNA
  gi|4580419|ref|NM_—003994.2|[4580419]
• 5799: NM_—000115
  Homo sapiens endothelin receptor type B (EDNRB), transcript variant 1, mRNA
  gi|4557546|ref|NM_—000115.1|[4557546]
• 5800: NM_—000734
  Homo sapiens CD3Z antigen, zeta polypeptide (TiT3 complex) (CD3Z), mRNA
  gi|4557430|ref|NM_—000734.1|[4557430]
• 5801: NM_—003856
  Homo sapiens interleukin 1 receptor-like 1 (IL1RL1), mRNA
  gi|4507244|ref|NM_—003856.1|[4507244]
• 5802: NM_—002980
  Homo sapiens secretin receptor (SCTR), mRNA
  gi|4506824|ref|NM_—002980.1|[4506824]
• 5803: NM_—000447
  Homo sapiens presenilin 2 (Alzheimer disease 4) (PSEN2), transcript variant 1,
  mRNA
  gi|4506164|ref|NM_—000447.1|[4506164]
• 5804: NM_—000021
  Homo sapiens presenilin 1 (Alzheimer disease 3) (PSEN1), transcript variant I-467, mRNA
  gi|4506162|ref|NM_—000021.1|[4506162]
• 5805: NM_—000907
  Homo sapiens natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) (NPR2), mRNA
  gi|4505436|ref|NM_—000907.1|[4505436]
• 5806: NM_—000899
  Homo sapiens KIT ligand (KITLG), mRNA
  gi|4505174|ref|NM_—000899.1|[4505174]
• 5807: NM_—002353
  Homo sapiens tumor-associated calcium signal transducer 2 (TACSTD2), mRNA
  gi|4505056|ref|NM_—002353.1|[4505056]
• 5808: NM_—002261
  Homo sapiens killer cell lectin-like receptor subfamily C, member 3 (KLRC3), transcript variant NKG2-E, mRNA
  gi|4504884|ref|NM_—002261.1|[4504884]
• 5809: NM_—000836
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2D (GRIN2D),
  mRNA
  gi|4504130|ref|NM_—000836.1|[4504130]
• 5810: NM_—000828
  Homo sapiens glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant
  flop, mRNA
  gi|4504114|ref|NM_—000828.1|[4504114]
• 5811: NM_—000813
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), transcript variant 2, mRNA
  gi|4503864|ref|NM_—000813.1|[4503864]
• 5812: NM_—003991
  Homo sapiens endothelin receptor type B (EDNRB), transcript variant 2, mRNA
  gi|4503466|ref|NM_—003991.1|[4503466]
• 5813: NM_—001337
  Homo sapiens chemokine (C-X3-C) receptor 1 (CX3CR1), mRNA
  gi|4503170|ref|NM_—001337.1|[4503170]
• 5814: NM_—001834
  Homo sapiens clathrin, light polypeptide (Lcb) (CLTB), transcript variant nonbrain, mRNA
  gi|4502900|ref|NM_—001834.1|[4502900]
• 5815: NM_—001783
  Homo sapiens CD79A antigen (immunoglobulin-associated alpha) (CD79A), transcript
  variant 1, mRNA
  gi|4502684|ref|NM_—001783.1|[4502684]
• 5816: AF277897
  Homo sapiens truncated epidermal growth factor receptor (EGFR) mRNA, partial cds; alternatively spliced
  gi|12658300|gb|AF277897.1|AF277897[12658300]
• 5817: AF192403
  Homo sapiens ETL protein (ETL) mRNA, complete cds
  gi|11225482|gb|AF192403.1|AF192403[11225482]
• 5818: AF259263
  Homo sapiens toll-like receptor 9 form B (TLR9) mRNA, complete cds; alternatively spliced
  gi|8099653|gb|AF259263.1|AF259263[8099653]
• 5819: AF259262
  Homo sapiens toll-like receptor 9 form A (TLR9) mRNA, complete cds; alternatively spliced
  gi|8099651|gb|AF259262.1|AF259262[8099651]
• 5820: AF246971
  Homo sapiens Toll-like receptor 8 (TLR8) mRNA, complete cds
  gi|7576932|gb|AF246971.1|AF246971[7576932]
• 5821: AF240467
  Homo sapiens toll-like receptor 7 (TLR7) mRNA, complete cds
  gi|7330280|gb|AF240467.1|AF240467[7330280]
• 5822: AF230073
  Homo sapiens sialoadhesin mRNA, complete cds
  gi|12656129|gb|AF230073.1|AF230073[12656129]
• 5823: BC000783
  Homo sapiens, calcitonin gene-related peptide-receptor component protein, clone
  MGC:804, mRNA, complete cds
  gi|12653974|gb|BC000783.1|BC000783[12653974]
• 5824: NM_—016184
  Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
  superfamily member 6 (CLECSF6), mRNA
  gi|7705337|ref|NM_—016184.1|[7705337]
• 5825: AF242540
  Homo sapiens NK cell type I receptor protein 2B4 (2B4) mRNA, complete cds, alternatively spliced
  gi|12642415|gb|AF242540.1|AF242540[12642415]
• 5826: NM_—020979
  Homo sapiens adaptor protein with pleckstrin homology and src homology 2 domains
  (APS), mRNA
  gi|10280625|ref|NM_—020979.1|[10280625]
• 5827: NM_—018557
  Homo sapiens low density lipoprotein-related protein 1B (deleted in tumors) (LRP1B), mRNA
  gi|9055269|ref|NM_—018557.1|[9055269]
• 5828: NM_—012452
  Homo sapiens transmembrane activator and CAML interactor (TACI), mRNA
  gi|6912693|ref|NM_—012452.1|[6912693]
• 5829: NM_—005338
  Homo sapiens huntingtin interacting protein 1 (HIP1), mRNA
  gi|12545385|ref|NM_—005338.3|[12545385]
• 5830: AF321238
  Homo sapiens T-cell receptor variable beta-chain 15 mRNA, partial cds
  gi|2484115|gb|AF321238.1|AF321238[12484115]
• 5831: AF125253
  Homo sapiens truncated epidermal growth factor receptor precursor (EGFR) mRNA,
  complete cds
  gi|1200221|gb|AF125253.1|AF125253[12002211]
• 5832: NM_—014211
  Homo sapiens gamma aminobutyric acid (GABA) A receptor, pi (GABRP), mRNA
  gi|7657105|ref|NM_—014211.1|[7657105]
• 5833: AF283463
  Homo sapiens Nogo receptor mRNA, complete cds
  gi|12407652|gb|AF283463.1|AF283463[12407652]
• 5834: AF224266
  Homo sapiens four alpha helix cytokine (ZCYTO10) mRNA, ZCYTO10-1 allele,
  complete cds
  gi|7109206|gb|AF224266.1|AF224266[7109206]
• 5837: AB045370
  Homo sapiens mRNA for histamine H4 receptor HH4R, complete cds
  gi|12248411|dbj|AB045370.1|AB045370[12248411]
• 5838: AB045369
  Homo sapiens mRNA for histamine H3 receptor HH3R, complete cds
  gi|12248409|dbj|AB045369.1|AB045369[12248409]
• 5840: NM_—016363
  Homo sapiens glycoprotein VI (platelet) (GP6), mRNA
  gi|7705956|ref|NM_—016363.1|[7705956]
• 5841: NM_—022139
  Homo sapiens GDNF family receptor alpha 4 (GFRA4), mRNA
  gi|11545874|ref|NM_—022139.1|[11545874]
• 5842: NM_—004403
  Homo sapiens deafness, autosomal dominant 5 (DFNA5), mRNA
  gi|4758153|ref|NM_—004403.1|[4758153]
• 5847: AF308156
  Homo sapiens HERV-E LTR/leader long terminal repeat, complete sequence; and endothelin B receptor mRNA, partial cds
  gi|12239519|gb|AF308156.1|AF308156[12239519]
• 5850: NM_—022789
  Homo sapiens interleukin 17E (IL17E), mRNA
  gi|12232484|ref|NM_—022789.1|[12232484]
• 5851: AX054991
  Sequence 3 from Patent WO0073451
  gi|12228357|emb|AX054991.1|AX054991[12228357]
• 5852: AX054989
  Sequence 1 from Patent WO0073451
  gi|12228355|emb|AX054989.1|AX054989[12228355]
• 5853: AJ278581
  Homo sapiens DREV gene and IGSF6 gene for immunoglobulin superfamily 6 protein
  gi|12053852|emb|AJ278581.1|HSA278581[12053852]
• 5854: AJ302556
  Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line OLGA olfactory receptor
  gi|12140483|emb|AJ302556.1|HSA302556[12140483]
• 5855: AJ302555
  Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line SA olfactory receptor
  gi|12140479|emb|AJ302555.1|HSA302555[12140479]
• 5856: AJ302554
  Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line KR3598 olfactory receptor
  gi|12140476|emb|AJ302554.1|HSA302554[12140476]
• 5857: AJ302553
  Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line BM19.7 olfactory receptor
  gi|12140472|emb|AJ302553.1|HSA302553[12140472]
• 5858: AJ302552
  Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line BM28.7 olfactory receptor
  gi|12140468|emb|AJ302552.1|HSA302552[12140468]
• 5859: AF209481
  Homo sapiens probable mannose binding C-type lectin DC-SIGNR gene, exons 3-8, and complete cds
  gi|12084794|gb|AF209481.2|AF209480S2[12084794]
• 5860: AH009824
  Homo sapiens chromosome 19 probable mannose binding C-type lectin DC-SIGNR (abc)
  gene, complete cds
  gi|12084793|gb|AH009824.2|SEG_AF209480S[12084793]
• 5861: AF313449
  Homo sapiens P2Y12 platelet ADP receptor mRNA, complete cds
  gi|1208390|gb|AF313449.1|AF313449[12083901]
• 5884: AH009659
  Homo sapiens RON gene, partial sequence
  gi|9621821|gb|AH009659.1|SEG_HSRONPO[9621821]
• 5885: NM_—002351
  Homo sapiens SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) (SH2D1A), mRNA
  gi|4506922|ref|NM_—002351.1|[4506922]
• 5886: NM_—000171
  Homo sapiens glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man
  syndrome) (GLRA1), mRNA
  gi|4504018|ref|NM_—000171.1|[4504018]
• 5887: NM_—000569
  Homo sapiens Fc fragment of IgG, low affinity 111a, receptor for (CD16) (FCGR3A), mRNA
  gi|12056966|ref|NM_—000569.2|[12056966]
• 5888: NM_—000802
  Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 2, mRNA
  gi|12056965|ref|NM_—000802.2|[12056965]
• 5889: NM_—003979
  Homo sapiens retinoic acid induced 3 (RA13), mRNA
  gi|12056470|ref|NM_—003979.2|[12056470]
• 5900: AJ302633
  Homo sapiens 6M1-02P*02 gene for olfactory receptor, cell line BM28.7
  gi|12054481|emb|AJ302633.1|HSA302633[12054481]
• 5910: AJ302623
  Homo sapiens 6M1-18*02 gene for olfactory receptor, cell line KR3598
  gi|12054470|emb|AJ302623.1|HSA302623[12054470]
• 5911: AJ302622
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line AMAI
  gi|12054468|emb|AJ302622.1|HSA302622[12054468]
• 5912: AJ302621
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line OLGA
  gi|12054466|emb|AJ302621.1|HSA302621[12054466]
• 5913: AJ302620
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line YAR
  gi|12054464|emb|AJ302620.1|HSA302620[12054464]
• 5914: AJ302619
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line SA
  gi|2054462|emb|AJ302619.1|HSA302619[12054462]
• 5915: AJ302618
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line WT51
  gi|12054460|emb|AJ302618.1|HSA302618[12054460]
• 5916: AJ302617
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line H2LCL
  gi|12054458|emb|AJ302617.1|HSA302617[12054458]
• 5917: AJ302616
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line LG2
  gi|2054456|emb|AJ302616.1|HSA302616[12054456]
• 5918: AJ302615
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line BM19.7
  gi|12054454|emb|AJ302615.1|HSA302615[12054454]
• 5919: AJ302614
  Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line BM28.7
  gi|12054452|emb|AJ302614.1|HSA302614[12054452]
• 5920: AJ302613
  Homo sapiens 6M1-16*03 gene for olfactory receptor, cell line AMAI
  gi|12054450|emb|AJ302613.1|HSA302613[12054450]
• 5921: AJ302612
  Homo sapiens 6M1-16*03 gene for olfactory receptor, cell line BM19.7
  gi|12054448|emb|AJ302612.1|HSA302612[12054448]
• 5922: AJ302611
  Homo sapiens 6M1-16*02 gene for olfactory receptor, cell line BM28.7
  gi|12054446|emb|AJ302611.1|HSA302611[12054446]
• 5923: AJ302610
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line OLGA
  gi|12054444|emb|AJ302610.1|HSA302610[12054444]
• 5924: AJ302609
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line YAR
  gi|12054442|emb|AJ302609.1|HSA302609[12054442]
• 5925: AJ302608
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line SA
  gi|12054440|emb|AJ302608.1|HSA302608[12054440]
• 5926: AJ302607
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line WT51
  gi|12054438|emb|AJ302607.1|HSA302607[12054438]
• 5927: AJ302606
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line H2LCL
  gi|12054436|emb|AJ302606.1|HSA302606[12054436]
• 5928: AJ302605
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line KR3598
  gi|12054434|emb|AJ302605.1|HSA302605[12054434]
• 5929: AJ302604
  Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line LG2
  gi|2054432|emb|AJ302604.1|HSA302604[12054432]
• 5930: AJ302603
  Homo sapiens 6M1-15*03 gene for olfactory receptor, cell line AMAI
  gi|12054430|emb|AJ302603.1|HSA302603[12054430]
• 5931: AJ302602
  Homo sapiens 6M1-15*02 gene for olfactory receptor, cell line WT51
  gi|12054428|emb|AJ302602.1|HSA302602[12054428]
• 5932: AJ302601
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line OLGA
  gi|12054426|emb|AJ302601.1|HSA302601[12054426]
• 5933: AJ302600
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line YAR
  gi|12054424|emb|AJ302600.1|HSA302600[12054424]
• 5934: AJ302599
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line SA
  gi|12054422|emb|AJ302599.1|HSA302599[12054422]
• 5935: AJ302598
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line H2LCL
  gi|12054420|emb|AJ302598.1|HSA302598[12054420]
• 5936: AJ302597
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line KR3598
  gi|12054418|emb|AJ302597.1|HSA302597[12054418]
• 5937: AJ302596
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line LG2
  gi|12054416|emb|AJ302596.1|HSA302596[12054416]
• 5938: AJ302595
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line BM19.7
  gi|12054414|emb|AJ302595.1|HSA302595[12054414]
• 5939: AJ302594
  Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line BM28.7
  gi|12054412|emb|AJ302594.1|HSA302594[12054412]
• 5940: AJ302593
  Homo sapiens 6M1-10*02 gene for olfactory receptor, cell line KR3598
  gi|12054410|emb|AJ302593.1|HSA302593[12054410]
• 5941: AJ302592
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line AMAI
  gi|12054408|emb|AJ302592.1|HSA302592[12054408]
• 5942: AJ302591
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line OLGA
  gi|12054406|emb|AJ302591.1|HSA302591[12054406]
• 5943: AJ302590
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line YAR
  gi|12054404|emb|AJ302590.1|HSA302590[12054404]
• 5944: AJ302589
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line SA
  gi|12054402|emb|AJ302589.1|HSA302589[12054402]
• 5945: AJ302588
  Homo sapiens 6M-10*01 gene for olfactory receptor, cell line WT51
  gi|12054400|emb|AJ302588.1|HSA302588[12054400]
• 5946: AJ302587
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line H2LCL
  gi|12054398|emb|AJ302587.1|HSA302587[12054398]
• 5947: AJ302586
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line LG2
  gi|12054396|emb|AJ302586.1|HSA302586[12054396]
• 5948: AJ302585
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line BM19.7
  gi|12054394|emb|AJ302585.1|HSA302585[12054394]
• 5949: AJ302584
  Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line BM28.7
  gi|12054392|emb|AJ302584.1|HSA302584[12054392]
• 5950: AJ302583
  Homo sapiens 6M1-6*03 gene for olfactory receptor, cell line WT51
  gi|12054390|emb|AJ302583.1|HSA302583[12054390]
• 5951: AJ302582
  Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line OLGA
  gi|12054388|emb|AJ302582.1|HSA302582[12054388]
• 5952: AJ302581
  Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line KR3598
  gi|12054386|emb|AJ3025810.1HSA302581[12054386]
• 5953: AJ302580
  Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line SA
  gi|12054384|emb|AJ302580.1|HSA302580[12054384]
• 5954: AJ302579
  Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line AMAI
  gi|12054382|emb|AJ302579.1|HSA302579[12054382]
• 5955: AJ302578
  Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line BM28.7
  gi|12054380|emb|AJ302578.1|HSA302578[12054380]
• 5956: AJ302577
  Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line BM19.7
  gi|112054378|emb|AJ302577.1|HSA302577[12054378]
• 5957: AJ302576
  Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line OLGA
  gi|12054376|emb|AJ302576.1|HSA302576[12054376]
• 5958: AJ302575
  Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line YAR
  gi|2054374|emb|AJ302575.1|HSA302575[12054374]
• 5959: AJ302574
  Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line SA
  gi|12054372|emb|AJ302574.1|HSA302574[12054372]
• 5960: AJ302573
  Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line H2LCL
  gi|12054370|emb|AJ302573.1|HSA302573[12054370]
• 5961: AJ302572
  Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line KR3598
  gi|12054368|emb|AJ302572.1|HSA302572[12054368]
• 5962: AJ302571
  Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line LG2
  gi|12054366|emb|AJ302571.1|HSA302571[12054366]
• 5963: AJ302570
  Homo sapiens 6M1-4P*05 gene for olfactory receptor, cell line BM19.7
  gi|12054364|emb|AJ302570.1|HSA302570[12054364]
• 5964: AJ302569
  Homo sapiens 6M1-4P*05 gene for olfactory receptor, cell line BM28.7
  gi|12054362|emb|AJ302569.1|HSA302569[12054362]
• 5965: AJ302568
  Homo sapiens 6M1-4P*04 gene for olfactory receptor, cell line AMAI
  gi|12054360|emb|AJ302568.1|HSA302568[12054360]
• 5966: AJ302567
  Homo sapiens 6M1-4P*03 gene for olfactory receptor, cell line WT51
  gi|12054358|emb|AJ302567.1|HSA302567[12054358]
• 5967: AJ302566
  Homo sapiens 6M1-4P*02 gene for olfactory receptor, cell line OLGA
  gi|2054356|emb|AJ302566.1|HSA302566[12054356]
• 5968: AJ302565
  Homo sapiens 6M1-4P*02 gene for olfactory receptor, cell line KR3598
  gi|12054354|emb|AJ302565.1|HSA302565[12054354]
• 5975: AJ302558
  Homo sapiens 6M1-3*04 gene for olfactory receptor, cell line AMAI
  gi|12054346|emb|AJ302558.1|HSA302558[12054346]
• 5976: AJ302557
  Homo sapiens 6M1-3*03 gene for olfactory receptor, cell line WT51
  gi|12054344|emb|AJ302557.1|HSA302557[12054344]
• 5977: AJ302551
  Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line OLGA
  gi|12054342|emb|AJ302551.1|HSA302551[12054342]
• 5978: AJ302550
  Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line YAR
  gi|12054340|emb|AJ302550.1|HSA302550[12054340]
• 5979: AJ302549
  Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line SA
  gi|12054338|emb|AJ302549.1|HSA302549[12054338]
• 5980: AJ302548
  Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line H2LCL
  gi|12054336|emb|AJ302548.1|HSA302548[12054336]
• 5981: AJ302547
  Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line LG2
  gi|2054334|emb|AJ302547.1|HSA302547[12054334]
• 5982: AJ302546
  Homo sapiens 6M1-1*02 gene for olfactory receptor, cell line BM19.7
  gi|12054332|emb|AJ302546.1|HSA302546[12054332]
• 5983: AJ302545
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line KR3598
  gi|12054330|emb|AJ302545.1|HSA302545[12054330]
• 5984: AJ302544
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line YAR
  gi|12054328|emb|AJ302544.1|HSA302544[12054328]
• 5985: AJ302543
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line OLGA
  gi|12054326|emb|AJ302543.1|HSA302543[12054326]
• 5986: AJ302542
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line SA
  gi|12054324|emb|AJ302542.1|HSA302542[12054324]
• 5987: AJ302541
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line AMAI
  gi|12054322|emb|AJ302541.1|HSA302541[12054322]
• 5988: AJ302540
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line WT51
  gi|12054320|emb|AJ302540.1|HSA302540[12054320]
• 5989: AJ302539
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line H2LCL
  gi|12054318|emb|AJ302539.1|HSA302539[12054318]
• 5990: AJ302538
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line BM28.7
  gi|12054316|emb|AJ302538.1|HSA302538[12054316]
• 5991: AJ302537
  Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line LG2
  gi|12054314|emb|AJ302537.1|HSA302537[12054314]
• 5993: AJ131724
  Homo sapiens mRNA for serotonin receptor 5-HT4 (splice variant h5-HT4(b))
  gi|12053629|emb|AJ131724.1|HSA131724[12053629]
• 5994: AF305200
  Homo sapiens interleukin 17E (IL17E) mRNA, complete cds
  gi|11878209|gb|AF305200.1|AF305200[11878209]
• 5995: AH003378
  Homo sapiens ciliary neurotrophic factor alpha receptor gene
  gi|608655|gb|AH003378.1|SEG_HUMCNFAR0[608655]
• 5996: L38025
  Homo sapiens ciliary neurotrophic factor alpha receptor gene, exons 8-10, complete cds
  gi|608654|gb|L38025.1|HUMCNFAR06[608654]
• 5997: L38024
  Homo sapiens ciliary neurotrophic factor alpha receptor gene, exons 5-7
  gi|608653|gb|L38024.1|HUMCNFAR05[608653]
• 5998: L38023
  Homo sapiens ciliary neurotrophic factor alpha receptor gene, exon 4
  gi|608652|gb|L38023.1|HUMCNFAR04[608652]
• 5999: L38022
  Homo sapiens ciliary neurotrophic factor alpha receptor gene, exon 3
  gi|608651|gb|L380220.1HUMCNFAR03[608651]
• 6000: L38021
  Homo Sapiens ciliary neurutrophic factor alpha receptor gene, exon 2
  gi|608650|gb|L38021.1|HUMCNFAR02[608650]
• 6001: L38020
  Homo sapiens ciliary neurotrophic factor alpha receptor gene, exon 1
  gi|608649|gb|L380200.1HUMCNFAR01[608649]
• 6050: NM_—012152
  Homo sapiens endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 7 (EDG7), mRNA
  gi|6912347|ref|NM_—012152.1|[6912347]
• 6051: NM_—007360
  Homo sapiens DNA segment on chromosome 12 (unique) 2489 expressed sequence (D12S2489E), mRNA
  gi|6679051|ref|NM_—007360.1|[6679051]
• 6054: AF263029
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 14
  and complete cds
  gi|12043771|gb|AF263029.1|F263016S14[12043771]
• 6055: AF263028
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 13
  gi|12043770|gb|AF263028.1|F263016S13[12043770]
• 6056: AF263027
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 12
  gi|12043769|gb|AF263027.1|F263016S12[12043769]
• 6057: AF263026
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 11----
  gi|12043768|gb|AF263026.1|F263016S11[12043768]
• 6058: AF263025
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 10
  gi|12043767|gb|AF263025.1|F263016S10[12043767]
• 6059: AF263024
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 9
  gi|12043766|gb|AF263024.1|F263016S09[12043766]
• 6060: AF263023
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 8
  gi|12043765|gb|AF263023.1|F263016S08[12043765]
• 6061: AF263022
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 7
  gi|12043764|gb|AF263022.1|F263016S07[12043764]
• 6062: AF263021
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 6
  gi|12043763|gb|AF263021.1F263016S06[12043763]
• 6063: AF263020
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 5
  gi|12043762|gb|AF263020.1|F263016S05[12043762]
• 6064: AF263019
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon
  gi|12043761|gb|AF263019.1|F263016S04[12043761]
• 6065: AF263018
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 3
  gi|12043760|gb|AF263018.1|F263016S03[12043760]
• 6066: AF263017
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 2
  gi|12043759|gb|AF263017.1|F263016S02[12043759]
• 6067: AF263016
  Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 1
  gi|12043758|gb|AF263016.1|F263016S01[12043758]
• 6068: AH010208
  Homo sapiens chromosome 12 map 12q15
  gi|12043757|gb|AH010208.1|SEG_F263016S[12043757]
• 6069: AF310676
  Homo sapiens E3 ubiquitin ligase SMURF2 mRNA, complete cds
  gi|112018150gb|AF310676.1|AF310676[12018150]
• 6070: AF310250
  Homo sapiens IRS-1 PH domain binding protein PHIP mRNA, complete cds
  gi|12007333|gb|AF310250.1|AF310250[12007333]
• 6071: AF276292
  Homo sapiens killer cell immunoglobulin-like receptor KIR2DL4 mRNA, complete cds
  gi|12006296|gb|AF276292.1|AF276292[12006296]
• 6072: AF272157
  Homo sapiens killer cell immunoglobulin-like receptor precursor (KIR2DLX) gene,
  complete cds
  gi|12006228|gb|AF272157.1|AF272157[12006228]
• 6073: AF271608
  Homo sapiens clone 3 killer cell immunoglobulin-like receptor KIR2DLX (KIR2DLX)
  mRNA, complete cds
  gi|12006190|gb|AF271608.1|AF271608[12006190]
• 6074: AF271607
  Homo sapiens clone 13 killer cell immunoglobulin-like receptor KIR2DLX (KIR2DLX)
  mRNA, complete cds
  gi|2006188|gb|AF271607.1|AF271607[12006188]
• 6075: AF223941
  Homo sapiens complement receptor 2 (CR2) gene, promoter region and partial sequence
  gi|12004993|gb|AF223941.1|AF223941[12004993]
• 6076: AF196176
  Homo sapiens capsaicin receptor variant mRNA, complete cds
  gi|12003147|gb|AF196176.1|AF196176[12003147]
• 6077: AF196175
  Homo sapiens capsaicin receptor mRNA, complete cds
  gi|12003145|gb|AF196175.1|AF196175[12003145]
• 6078: AF125539
  Homo sapiens epidermal growth factor receptor (EGFR) gene, alternative exons, exons 16 and 17 and partial cds, alternatively spliced
  gi|12002219|gb|AF125539.1|AF125538S2[12002219]
• 6079: AF125538
  Homo sapiens epidermal growth factor receptor (EGFR) gene, exon 15
  gi|2002218|gb|AF125538.1|AF125538S1[12002218]
• 6080: AH010139
  Homo sapiens epidermal growth factor receptor (EGFR) gene, partial cds, alternatively spliced
  gi|12002217|gb|AH010139.1|SEG_AF125538S[12002217]
• 6081: AF308571
  Homo sapiens hepatointestinal leukotriene B4 receptor mRNA, complete cds
  gi|11878227|gb|AF308571.1|AF308571[11878227]
• 6082: AF275260
  Homo sapiens SRPSOX (SRPSOX) mRNA, complete cds
  gi|11139543|gb|AF275260.1|AF275260[11139543]
• 6083: NM_—007161
  Homo sapiens DNA segment on chromosome 6 (unique) 49 expressed sequence, NK cell
  triggering receptor, p30 (D6S49E), mRNA
  gi|6005740|ref|NM_—007161.1|[6005740]
• 6090: AF289204
  Homo sapiens odorant receptor HOR3′beta4 and odorant receptor HOR3′beta5 genes,
  complete cds
  gi|1991862|gb|AF289204.1|AF289203S2[11991862]
• 6091: AF289203
  Homo sapiens odorant receptor HOR3′beta1, odorant receptor HOR3′beta2, and odorant receptor HOR3′beta3 genes, complete cds
  gi|11991861|gb|AF289203.1|AF289203S1[11991861]
• 6092: AH010109
  Homo sapiens odorant receptor HOR3′beta1, odorant receptor HOR3′beta4, odorant
  receptor HOR3′beta2, odorant receptor HOR3′beta5, and odorant receptor HOR3′beta3 genes, complete cds
  gi|11991860|gb|AH010109.1|SEG_AF289203S[11991860]
• 6093: AF217689
  Homo sapiens nociceptin receptor ORL1 (ORL1) gene, exons 1b and 2, and partial
  cds, alternatively spliced
  gi|11991833|gb|AF217689.1|AF217688S2[11991833]
• 6094: AF217688
  Homo sapiens G alpha interacting protein (GAIP) gene, partial cds, alternatively
  spliced; and nociceptin receptor ORL1 (ORL1) gene, exon 1a
  gi|11991832|gb|AF217688.1|AF217688S1[11991832]
• 6095: AH010108
  Homo sapiens G alpha interacting protein (GAIP) and nociceptin receptor ORL1 (ORL1) genes, partial cds
  gi|1199183|gb|AH010108.1|SEG_AF217688S[11991831]
• 6096: AB045011
  Homo sapiens hmGluR2 gene for metabotropic glutamate receptor type 2, complete
  cds
  gi|11990938|dbj|AB045011.1|AB045011[11990938]
• 6097: AF281074
  Homo sapiens neuropilin 2 (NRP2) gene, complete cds, alternatively spliced
  gi|11934947|gb|AF281074.1|AF281074[11934947]
• 6098: AJ400846
  Homo sapiens mRNA for immunoglobulin-like cell surface receptor FDFACT1, activating counterpart allele 1
  gi|11932154|emb|AJ400846.1|HSA400846[11932154]
• 6099: AJ400845
  Homo sapiens mRNA for immunoglobulin-like cell surface receptor FDFACT2, activating counterpart allele 2
  gi|11932151|emb|AJ400845.1|HSA400845[11932151]
• 6100: AB024327
  Homo sapiens pt-wd mRNA for WD-40 repeat protein, complete cds
  gi|4519416|dbj|AB024327.1|AB024327[4519416]
• 6102: AF280547
  Homo sapiens neuropilin-1 soluble isoform 11 (NRP1) mRNA, complete cds, alternatively spliced
  gi|11907931|gb|AF280547.1|AF280547[11907931]
• 6103: AF280546
  Homo sapiens neuropilin-2 soluble isoform 9 (NRP2) mRNA, complete cds, alternatively spliced
  gi|11907929|gb|AF280546.1|AF280546[11907929]
• 6104: AF280545
  Homo sapiens neuropilin-2b(5) (NRP2) mRNA, complete cds, alternatively spliced
  gi|11907927|gb|AF280545.1|AF280545[11907927]
• 6105: AF280544
  Homo sapiens neuropilin-2b(O) (NRP2) mRNA, complete cds, alternatively spliced
  gi|11907925|gb|AF280544.1|AF280544[11907925]
• 6106: AF268899
  Homo sapiens neuropeptide FF receptor 2 (NPFF2) mRNA, complete cds
  gi|11907914|gb|AF268899.1|AF268899[11907914]
• 6107: AF268898
  Homo sapiens neuropeptide FF receptor 1 (NPFF1) mRNA, complete cds
  gi|11907912|gb|AF268898.1|AF268898[11907912]
• 6111: Y19228
  Homo sapiens partial GIR gene for glucocorticoid induced receptor, exons and joined CDS
  gi|11878425|emb|Y19228.1|HSY19228[11878425]
• 6118: Y19231
  Homo sapiens partial GIR gene for glucocorticoid induced receptor, exon 4
  gi|11877264|emb|Y19231.1|HSY19231[11877264]
• 6119: Y19230
  Homo sapiens partial GIR gene for glucocorticoid induced receptor, exon 3
  gi|11877263|emb|Y19230.1|HSY19230[11877263]
• 6120: Y19229
  Homo sapiens partial GIR gene for glucocorticoid induced receptor, exon 2
  gi|11877262|emb|Y19229.1|HSY19229[11877262]
• 6121: AX047952
  Sequence 19 from Patent WO0070045
  gi|11876875|emb|AX047952.1|AX047952[11876875]
• 6122: AX047940
  Sequence 7 from Patent WO0070045
  gi|11876863|emb|AX047940.1|AX047940[11876863]
• 6123: AX047936
  Sequence 3 from Patent WO0070045
  gi|11876859|emb|AX047936.1|AX047936[11876859]
• 6124: AJ272207
  Homo sapiens mRNA for putative G protein-coupled receptor 92 (GPR92 gene)
  gi|9843745|emb|AJ272207.1|HSA272207[9843745]
• 6125: AF311306
  Homo sapiens prostate specific G-protein coupled receptor gene, complete cds
  gi|11875777|gb|AF311306.1|AF311306[11875777]
• 6126: NM_—022146
  Homo sapiens neuropeptide FF 1; RFamide-related peptide receptor (OT7T022), mRNA
  gi|11545886|ref|NM_—022146.1|[11545886]
• 6127: NM_—004885
  Homo sapiens neuropeptide G protein-coupled receptor; neuropeptide FF 2 (NPGPR),
  mRNA
  gi|4758819|ref|NM_—004885.1|[4758819]
• 6128: NM_—002958
  Homo sapiens RYK receptor-like tyrosine kinase (RYK), mRNA
  gi|11863158|ref|NM_—002958.1|[11863158]
• 6129: AF217485
  Homo sapiens KIR3D51 gene, partial sequence; and killer cell Ig-like receptor KIR2DL5.1 (KIR2DL5.1) gene, complete cds
  gi|1761705|gb|AF217485.1|AF217485[11761705]
• 6130: NM_—005856
  Homo sapiens receptor (calcitonin) activity modifying protein 3 (RAMP3), mRNA
  gi|5032022|ref|NM_—005856.1|[5032022]
• 6131: NM_—005854
  Homo sapiens receptor (calcitonin) activity modifying protein 2 (RAMP2), mRNA
  gi|5032020|ref|NM_—005854.1|[5032020]
• 6132: NM_—005855
  Homo sapiens receptor (calcitonin) activity modifying protein 1 (RAMP1), mRNA
  gi|5032018|ref|NM_—005855.1|[5032018]
• 6133: NM_—000025
  Homo sapiens adrenergic, beta-3-, receptor (ADRB3), mRNA
  gi|4557266|ref|NM_—000025.1|[4557266]
• 6134: AF245390
  Homo sapiens GREB1c (GREB1) mRNA, complete cds, alternatively spliced
  gi|11611737|gb|AF245390.1|AF245390[11611737]
• 6135: AF245389
  Homo sapiens GREB1b (GREB1) mRNA, complete cds, alternatively spliced
  gi|11611735|gb|AF245389.1|AF245389[11611735]
• 6136: AF245388
  Homo sapiens GREB1a (GREB1) mRNA, partial cds, alternatively spliced
  gi|11611733|gb|AF245388.1|AF245388[11611733]
• 6137: AF292402
  Homo sapiens neuromedin U receptor-type 2 mRNA, complete cds
  gi|9944989|gb|AF292402.1|AF292402[9944989]
• 6138: NM_—002855
  Homo sapiens poliovirus receptor-related 1 (herpesvirus entry mediator C; nectin) (PVRL1), mRNA
  gi|11602905|ref|NM_—002855.2|[11602905]
• 6143: AH010043
  Homo sapiens
  gi|1155957|gb|AH010043.1|SEG_AF260138S[11559571]
• 6144: AF260137
  Homo sapiens killer-cell immunoglobulin-like receptor KIR2DL5.3 (KIR2DL5) gene,
  exon 1 and partial cds
  gi|11559569|gb|AF260137.1|AF260137[11559569]
• 6145: X76400
  Homo sapiens mRNA for nectin 1 (PRR1 gene)
  gi|11558774|emb|X76400.2|HSPRR[11558774]
• 6147: NM_—022159
  Homo sapiens ETL protein (ETL), mRNA
  gi|11545907|ref|NM_—022159.1|[11545907]
• 6148: NM_—022150
  Homo sapiens RFamide-related peptide precursor (RFRP), mRNA
  gi|11545893|ref|NM_—022150.1|[11545893]
• 6149: NM_—022049
  Homo sapiens G-protein coupled receptor 88 (GPR88), mRNA
  gi|11545752|ref|NM_—022049.1|[11545752]
• 6219: AF281308
  Homo sapiens alpha 2A adrenergic receptor (ADRA2A) gene, complete cds
  gi|9652209|gb|AF281308.1|AF281308[9652209]
• 6241: AF217487
  Homo sapiens killer cell Ig-like receptor KIR2DL5.3 (KIR2DL5.3) mRNA, complete
  cds
  gi|11528059|gb|AF217487.1|AF217487[11528059]
• 6242: NM_—003553
  Homo sapiens olfactory receptor, family 1, subfamily E, member 1 (OR1E1), mRNA
  gi|11496274|ref|NM_—003553.1|[11496274]
• 6243: AF208054
  Homo sapiens non-inhibitory killer-cell Ig-like receptor KIR (KIR2D55) mRNA, complete cds
  gi|11493968|gb|AF208054.1|AF208054[11493968]
• 6244: NM_—018690
  Homo sapiens apolipoprotein B48 receptor (APOB48R), mRNA
  gi|8922078|ref|NM_—018690.1|[8922078]
• 6245: AB044934
  Homo sapiens H4R mRNA for histamine H4 receptor, complete cds
  gi|10241846|dbj|AB044934.1|AB044934[10241846]
• 6246: NM_—003555
  Homo sapiens olfactory receptor, family 1, subfamily G, member 1 (OR1G1), mRNA
  gi|11415033|ref|NM_—003555.1|[11415033]
• 6247: NM_—003552
  Homo sapiens olfactory receptor, family 1, subfamily D, member 4 (OR1D4), mRNA
  gi|11415031|ref|NM_—003552.1|[11415031]
• 6248: NM_—003554
  Homo sapiens olfactory receptor, family 1, subfamily E, member 2 (OR1E2), mRNA
  gi|11386152|ref|NM_—003554.1|[11386152]
• 6390: AF264014
  Homo sapiens scavenger receptor cysteine-rich type 1 protein M160 precursor, mRNA, complete cds, alternatively spliced
  gi|9652086|gb|AF264014.1|AF264014[9652086]
• 6391: AF169007
  Homo sapiens beta-1-adrenergic receptor (ADRB1) gene, complete cds
  gi|5833816|gb|AF169007.1|AF169007[5833816]
• 6392: AF169006
  Homo sapiens beta-1-adrenergic receptor (ADRB1) gene, complete cds
  gi|5833814|gb|AF169006.1|AF169006[5833814]
• 6393: AF159854
  Homo sapiens cytokine signaling suppressor (SOCS3) mRNA, complete cds
  gi|5353755|gb|AF159854.1|AF159854[5353755]
• 6394: AF032124
  Homo sapiens RET proto-oncogene (RET) gene, 5′ flanking region and partial cds
  gi|2795879|gb|AF032124.1|AF032124[2795879]
• 6395: NM_—002644
  Homo sapiens polymeric immunoglobulin receptor (PIGR), mRNA
  gi|11342673|ref|NM_—002644.1|[11342673]
• 6396: AJ249248
  Homo sapiens mRNA for putative G protein-coupled Receptor
  gi|5834594|emb|AJ249248.1|HSA249248[5834594]
• 6397: AJ277028
  Homo sapiens mRNA for vanilloid receptor 1 (VR1 gene)
  gi|8977865|emb|AJ277028.1|HSA277028[8977865]
• 6398: AF072872
  Homo sapiens frizzled 1 mRNA, complete cds
  gi|5305406|gb|AF072872.1|AF072872[5305406]
• 6399: AF073727
  Homo sapiens EH domain-binding mitotic phosphoprotein (EPSIN) mRNA, complete cds
  gi|5051635|gb|AF073727.1|AF073727[5051635]
• 6400: NM_—002551
  Homo sapiens olfactory receptor, family 3, subfamily A, member 2 (OR3A2), mRNA
  gi|11321568|ref|NM_—002551.1|[11321568]
• 6401: NM_—000870
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 4 (HTR4), mRNA
  gi|11321562|ref|NM_—000870.1|[11321562]
• 6419: AB042411
  Homo sapiens strg gene for striatum-specific G potein-coupled receptor, complete
  cds
  gi|11275369|dbj|AB042411.1|AB042411[11275369]
• 6420: AB042410
  Homo sapiens strg mRNA for striatum-specific G protein-coupled receptor, complete cds
  gi|1275367|dbj|AB042410.1|AB042410[11275367]
• 6434: AJ289159
  Homo sapiens CD30 gene for cytokine receptor CD30, exons 1-8
  gi|11230634|emb|AJ289159.1|HSA289159[11230634]
• 6435: AF279762
  Homo sapiens ROR2 (ROR2) gene, exon 9 and partial cds
  gi|11228720|gb|AF279762.1|AF279755S8[11228720]
• 6436: AF279761
  Homo sapiens ROR2 (ROR2) gene, exon 8
  gi|11228719|gb|AF279761.1|AF279755S7[11228719]
• 6437: AF279760
  Homo sapiens ROR2 (ROR2) gene, exon 7
  gi|11228718|gb|AF279760.1|AF279755S6[11228718]
• 6438: AF279759
  Homo sapiens ROR2 (ROR2) gene, exon 6
  gi|11228717|gb|AF279759.1|AF279755S5[11228717]
• 6439: AF279758
  Homo sapiens ROR2 (ROR2) gene, exon 5
  gi|11228716|gb|AF279758.1|AF279755S4[11228716]
• 6440: AF279757
  Homo sapiens ROR2 (ROR2) gene, exon 4
  gi|11228715|gb|AF279757.1|AF279755S3[11228715]
• 6441: AF279756
  Homo sapiens ROR2 (ROR2) gene, exon 3
  gi|11228714|gb|AF279756.1|AF279755S2[11228714]
• 6442: AF279755
  Homo sapiens ROR2 (ROR2) gene, exon 2
  gi|11228713|gb|AF279755.1|AF279755S1[11228713]
• 6443: AH010002
  Homo sapiens ROR2 (ROR2) gene, partial cds
  gi|11228712|gb|AH010002.1|SEG AF279755S[11228712]
• 6444: AF260529
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 19 and partial cds
  gi|11228705|gb|AF260529.1|F260514S16[11228705]
• 6445: AF260528
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exons 17 and 18
  gi|11228704|gb|AF260528.1|F260514S15[11228704]
• 6446: AF260527
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 16
  gi|11228703|gb|AF260527.1|F260514S14[11228703]
• 6447: AF260526
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 15
  gi|11228702|gb|AF260526.1|F260514S13[11228702]
• 6448: AF260525
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 14
  gi|11228701|gb|AF260525.1|F260514S12[11228701]
• 6449: AF260524
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exons 12 and 13
  gi|11228700|gb|AF260524.1|F260514S11[11228700]
• 6450: AF260523
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 11
  gi|11228699|gb|AF260523.1|F260514S10[11228699]
• 6451: AF260522
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 10
  gi|11228698|gb|AF260522.1|F260514S09[11228698]
• 6452: AF260521
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 9
• 6453: AF260520
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 8
  gi|11228696|gb|AF260520.1|F260514S07[11228696]
• 6454: AF260519
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 7
  gi|11228695|gb|AF260519.1|F260514S06[11228695]
• 6455: AF260518
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 6
  gi|11228694|gb|AF260518.1|F260514S05[11228694]
• 6456: AF260517
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 5
  gi|11228693|gb|AF260517.1|F260514S04[11228693]
• 6457: AF260516
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 4
  gi|11228692|gb|AF260516.1|F260514S03[11228692]
• 6458: AF260515
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 3
  gi|11228691|gb|AF260515.1|F260514S02[11228691]
• 6459: AF260514
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 2
  gi|11228690|gb|AF260514.1|F260514S01[11228690]
• 6460: AH010001
  Homo sapiens MER receptor tyrosine kinase (MERTK) gene, partial cds
  gi|11228689|gb|AH010001.1|SEG_F260514S[11228689]
• 6461: AF175406
  Homo sapiens transient receptor potential 4 (TRP4) mRNA, complete cds
  gi|5802614|gb|AF175406.1|AF175406[5802614]
• 6462: NM_—017416
  Homo sapiens interleukin 1 receptor accessory protein-like 2 (IL1RAPL2), mRNA
  gi|11225606|ref|NM_—017416.1|[11225606]
• 6463: AJ295237
  Homo sapiens mRNA for neuronal nicotinic acetylcholine receptor subunit alpha 10
  (NACHR alpha 10 gene)
  gi|11182127|emb|AJ295237.1|HSA295237[11182127]
• 6464: NM_—004720
  Homo sapiens endothelial differentiation, lysophosphatidic acid
  G-protein-coupled receptor, 4 (EDG4), mRNA
  gi|11038657|ref|NM_—004720.3|[11038657]
• 6465: AF298770
  Homo sapiens Smac/DIABLO-S protein mRNA, complete cds
  gi|107196531|gb|AF298770.1|AF298770[10719653]
• 6562: NM_—005226
  Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 (EDG3), mRNA
  gi|4885194|ref|NM_—005226.1|[4885194]
• 6563: NM_—021803
  Homo sapiens interleukin 21 (IL21), mRNA
  gi|11141874|ref|NM_—021803.1|[11141874]
• 6564: NM_—021798
  Homo sapiens interleukin 21 receptor (IL21R), mRNA
  gi|11141868|ref|NM_—021798.1|[11141868]
• 6565: AF307973
  Homo sapiens histamine H4 receptor mRNA, complete cds
  gi|11141732|gb|AF307973.1|AF307973[11141732]
• 6566: X06026
  Homo sapiens partial CD3G gene, exon 1 (and joined CDS)
  gi|36809|emb|X06026.1|HSTCR3G1[36809]
• 6567: AF200220
  Homo sapiens FcRn alpha chain (FCGRT) gene, exons 5, 6, 7, and complete cds
  gi|11138512|gb|AF200220.1|AF200219S2[11138512]
• 6568: AF200219
  Homo sapiens FcRn alpha chain (FCGRT) gene, exons 1 through 4
  gi|11138511|gb|AF200219.1|AF200219S1[1113851l]
• 6569: AH009974
  Homo sapiens FcRn alpha chain (FCGRT) gene, exons 1 through 4
  gi|11138510|gb|AH009974.1|SEG_AF200219S[11138510]
• 6570: NM_—017581
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 9 (CHRNA9), mRNA
  gi|8923741|ref|NM_—017581.1|[8923741]
• 6571: AB040290
  Homo sapiens RFRP mRNA for RFamide-related peptide precursor, complete cds
  gi|11125707|dbj|AB040290.1|AB040290[11125707]
• 6572: AB040104
  Homo sapiens OT7T022 mRNA for RFamide-related peptide receptor, complete cds
  gi|11125701|dbj|AB040104.1|AB040104[11125701]
• 6598: AF308542
  Homo sapiens clone ST1L_G11 immunoglobulin heavy chain mRNA, partial cds
  gi|11119124|gb|AF308542.1|AF308542[11119124]
• 6599: AJ271338
  Homo sapiens IL1L1 gene for interleukin-1 like protein 1, exons 1-6
  gi|6729586|emb|AJ271338.1|HSA271338[6729586]
• 6600: AJ242738
  Homo sapiens mRNA for interleukin-1-like protein 1 (IL1L1 gene) transcript 2
  gi|6165335|emb|AJ242738.1|HSA242738[6165335]
• 6601: AJ242737
  Homo sapiens mRNA for interleukin-1-like protein-1 (IL1L gene), transcript 1
  gi|6165333|emb|AJ242737.1|HSA242737[6165333]
• 6602: NM_—005508
  Homo sapiens chemokine (C-C motif) receptor 4 (CCR4), mRNA
  gi|5031626|ref|NM_—005508.1|[5031626]
• 6603: NM_—005283
  Homo sapiens chemokine (C motif) XC receptor 1 (CCXCR1), mRNA
  gi|4885338|ref|NM_—005283.1|[4885338]
• 6604: AJ238419
  Homo sapiens mRNA for HIV-specific T-cell receptor beta chain, clone R1, partial
  gi|4691321|emb|AJ238419.1|HSA238419[4691321]
• 6605: AJ238418
  Homo sapiens mRNA for HIV-specific T-cell receptor beta chain, clone MA, partial
  gi|4691319|emb|AJ238418.1|HSA238418[4691319]
• 6606: AJ238417
  Homo sapiens mRNA for HIV-specific T-cell receptor beta chain, clone HA, partial
  gi|4691317|emb|AJ238417.1|HSA238417[4691317]
• 6607: AJ238416
  Homo sapiens mRNA for HIV-specific T-cell receptor alpha chain, clone R1, partial
  gi|4691315|emb|AJ238416.1|HSA238416[4691315]
• 6608: AJ238415
  Homo sapiens mRNA for HIV-specific T-cell receptor alpha chain, clone MA, partial
  gi|4691313|emb|AJ238415.1|HSA238415[4691313]
• 6609: AJ238414
  Homo sapiens mRNA for HIV-specific T-cell receptor alpha chain, clone HA, partial
  gi|4691311|emb|AJ238414.1|HSA238414[4691311]
• 6610: AF074042
  AF074042 Human Homo sapiens genomic clone pTWB15.69 T7, genomic survey sequence
  gi|3342086|gb|AF074042.1|AF074042[3342086]
• 6611: AF074041
  AF074041 Human Homo sapiens genomic clone pTWB15.69 SP6, genomic survey sequence
  gi|3342085|gb|AF074041.1|AF074041[3342085]
• 6612: AF074040
  AF074040 Human Homo sapiens genomic clone pTWB15.53 T7, genomic survey sequence
  gi|3342084|gb|AF074040.1|AF074040[3342084]
• 6613: AF074039
  AF074039 Human Homo sapiens genomic clone pTWB15.53 SP6, genomic survey sequence
  gi|3342083|gb|AF074039.1|AF074039[3342083]
• 6614: AF074038
  AF074038 Human Homo sapiens genomic clone pTWB15.43 T7, genomic survey sequence
  gi|3342082|gb|AF074038.1|AF074038[3342082]
• 6615: AF074037
  AF074037 Human Homo sapiens genomic clone pTWB15.43 SP6, genomic survey sequence
  gi|3342081|gb|AF074037.1|AF074037[3342081]
• 6616: AF074036
  AF074036 Human Homo sapiens genomic clone pTWB15.42, genomic survey sequence
  gi|3342080|gb|AF074036.1|AF074036[3342080]
• 6617: AF074034
  AF074034 Human Homo sapiens genomic clone pTWB15.32 T7, genomic survey sequence
  gi|3342079|gb|AF074034.1|AF074034[3342079]
• 6618: AF074033
  AF074033 Human Homo sapiens genomic clone pTWB15.32 SP6, genomic survey sequence
  gi|3342078|gb|AF074033.1|AF074033[3342078]
• 6619: AF074032
  AF074032 Human Homo sapiens genomic clone pTWB15.31 T7, genomic survey sequence
  gi|3342077|gb|AF074032.1|AF074032[3342077]
• 6620: AF074031
  AF074031 Human Homo sapiens genomic clone pTWB15.31 SP6, genomic survey sequence
  gi|3342076|gb|AF074031.1|AF074031[3342076]
• 6621: AF074030
  AF074030 Human Homo sapiens genomic clone pTWB15.28 T7, genomic survey sequence
  gi|3342075|gb|AF074030.1|AF074030[3342075]
• 6622: AF074028
  AF074028 Human Homo sapiens genomic clone pTWB15.21, genomic survey sequence
  gi|3342074|gb|AF074028.1|AF074028[3342074]
• 6623: AF074027
  AF074027 Human Homo sapiens genomic clone pTWB15.12, genomic survey sequence
  gi|3342073|gb|AF074027.1|AF074027[3342073]
• 6624: AF074026
  AF074026 Human Homo sapiens genomic clone pTWB15.09, genomic survey sequence
  gi|3342072|gb|AF074026.1|AF074026[3342072]
• 6625: AF074025
  AF074025 Human Homo sapiens genomic clone pTWB15.08, genomic survey sequence
  gi|3342071|gb|AF074025.1|AF074025[3342071]
• 6626: AF074024
  AF074024 Human Homo sapiens genomic clone pTWB15.07, genomic survey sequence
  gi|3342070|gb|AF074024.1|AF074024[3342070]
• 6627: AF074023
  AF074023 Human Homo sapiens genomic clone pTWB15.04, genomic survey sequence
  gi|3342069|gb|AF074023.1|AF074023[3342069]
• 6628: AF074022
  AF074022 Human Homo sapiens genomic clone pTWB15.04 SP6, genomic survey sequence
  gi|3342068|gb|AF074022.1|AF074022[3342068]
• 6629: NM_—000450
  Homo sapiens selectin E (endothelial adhesion molecule 1) (SELE), mRNA
  gi|4506870|ref|NM_—000450.1|[4506870]
• 6630: AF254069
  Homo sapiens interleukin 21 (IL21) mRNA, complete cds
  gi|11093535|gb|AF254069.1|AF254069[11093535]
• 6631: AF254067
  Homo sapiens interleukin 21 receptor (IL21R) mRNA, complete cds
  gi|1093531|gb|AF254067.1|AF254067[11093531]
• 6632: AF251510
  Homo sapiens leukocyte-associated Ig-like receptor 1D isoform mRNA, complete cds
  gi|1090865|gb|AF251510.2|AF251510[11090865]
• 6633: AF251509
  Homo sapiens leukocyte-associated Ig-like receptor 1C isoform mRNA, complete cds
  gi|11090859|gb|AF251509.2|AF251509[11090859]
• 6634: AB3043943
  Homo sapiens GPVI gene for platelet glycoprotein VI, partial cds
  gi|9955915|dbj|AB043943.1|AB043943[9955915]
• 6635: AB043821
  Homo sapiens GPVI mRNA for platelet glycoprotein VI-3, complete cds
  gi|9955913|dbj|AB3043821.1|AB043821[9955913]
• 6636: AB043820
  Homo sapiens GPVI mRNA for platelet glycoprotein VI-2, complete cds
  gi|9955911|dbj|AB043820.1|AB043820[9955911]
• 6637: AB043819
  Homo sapiens GPVI mRNA for platelet glycoprotein VI-1, complete cds
  gi|9955909|dbj|AB043819.1|AB043819[9955909]
• 6638: NM_—000527
  Homo sapiens low density lipoprotein receptor (familial hypercholesterolemia) (LDLR), mRNA
  gi|8051613|ref|NM_—000527.2|[8051613]
• 6639: NM_—012407
  Homo sapiens protein kinase C, alpha binding protein (PRKCABP), mRNA
  gi|7110696|ref|NM_—012407.1|[7110696]
• 6640: NM_—005232
  Homo sapiens EphA1 (EPHA1), mRNA
  gi|4885208|ref|NM_—005232.1|[4885208]
• 6641: NM_—000214
  Homo sapiens jagged 1 (Alagille syndrome) (JAG1), mRNA
  gi|4557678|ref|NM_—000214.1|[4557678]
• 6642: NM_—000875
  Homo sapiens insulin-like growth factor 1 receptor (IGF1R), mRNA
  gi|11068002|ref|NM_—000875.2|[11068002]
• 6643: AF298812
  Homo sapiens X-linked ectodysplasin-A2 receptor (XEDAR) mRNA, complete cds
  gi|11066914|gb|AF298812.1|AF298812[11066914]
• 6644: AF197929
  Homo sapiens short form lysophosphatidic acid receptor EDG4 (EDG4) mRNA, complete cds
  gi|11066253|gb|AF197929.1|AF197929[11066253]
• 6645: NM_—021642
  Homo sapiens Fc fragment of IgG, low affinity IIa, receptor for (CD32) (FCGR2A),
  mRNA
  gi|11056051|ref|NM_—021642.1|[11056051]
• 6646: AF280400
  Homo sapiens alpha 2C adrenergic receptor variant (ADRA2C) gene, complete cds
  gi|11055420|gb|AF280400.1|AF280400[11055420]
• 6647: AF280399
  Homo sapiens alpha 2C adrenergic receptor (ADRA2C) gene, complete cds
  gi|11055418|gb|AF280399.1|AF280399[11055418]
• 6648: AF263523
  Homo sapiens vanilloid receptor-related osmotically activated channel (VROAC) mRNA, complete cds
  gi|11055321|gb|AF263523.1|AF263523[11055321]
• 6649: NM_—001117
  Homo sapiens adenylate cyclase activating polypeptide 1 (pituitary) (ADCYAP1),
  mRNA
  gi|10947062|ref|NM_—001117.2|[10947062]
• 6650: NM_—002355
  Homo sapiens mannose-6-phosphate receptor (cation dependent) (M6PR), mRNA
  gi|10947032|ref|NM_—002355.2|[10947032]
• 6651: NM_—000541
  Homo sapiens S-antigen; retina and pineal gland (arrestin) (SAG), mRNA
  gi|10880124|ref|NM_—000541.2|[10880124]
• 6652: NM_—021130
  Homo sapiens peptidylprolyl isomerase A (cyclophilin A) (PPIA), mRNA
  gi|10863926|ref|NM_—021130.1|[10863926]
• 6653: NM_—001106
  Homo sapiens activin A receptor, type IIB (ACVR2B), mRNA
  gi|10862697|ref|NM_—001106.2|[10862697]
• 6654: NM_—001616
  Homo sapiens activin A receptor, type II (ACVR2), mRNA
  gi|10862696|ref|NM_—001616.2|[10862696]
• 6655: NM_—001105
  Homo sapiens activin A receptor, type I (ACVR1), mRNA
  gi|10862690|ref|NM_—001105.2|[10862690]
• 6656: NM_—001136
  Homo sapiens advanced glycosylation end product-specific receptor (AGER), mRNA
  gi|10835202|ref|NM_—001136.1|[10835202]
• 6657: NM_—000866
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1F (HTR1F), mRNA
  gi|10835196|ref|NM_—000866.1|[10835196]
• 6658: NM_—000629
  Homo sapiens interferon (alpha, beta and omega) receptor 1 (IFNAR1), mRNA
  gi|10835182|ref|NM_—000629.1|[10835182]
• 6659: NM_—000621
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A), mRNA
  gi|10835174|ref|NM_—000621.1|[10835174]
• 6660: NM_—000610
  Homo sapiens CD44 antigen (homing function and Indian blood group system) (CD44), mRNA
  gi|10835162|ref|NM_—000610.1|[10835162]
• 6661: NM_—000585
  Homo sapiens interleukin 15 (IL15), mRNA
  gi|10835152|ref|NM_—000585.1|[10835152]
• 6662: NM_—000586
  Homo sapiens interleukin 2 (IL2), mRNA
  gi|10835148|ref|NM_—000586.1|[10835148]
• 6663: NM_—000577
  Homo sapiens interleukin 1 receptor antagonist (IL1RN), mRNA
  gi|10835146|ref|NM_—000577.1|[10835146]
• 6664: NM_—000576
  Homo sapiens interleukin 1, beta (IL1B), mRNA
  gi|10835144|ref|NM_—000576.1|[10835144]
• 6665: NM_—000570
  Homo sapiens Fc fragment of IgG, low affinity 111b, receptor for (CD16) (FCGR3B), mRNA
  gi|10835138|ref|NM_—000570.1|[10835138]
• 6666: NM_—000566
  Homo sapiens Fc fragment of IgG, high affinity Ia, receptor for (CD64) (FCGR1A),
  mRNA
  gi|10835132|ref|NM_—000566.1|[10835132]
• 6667: NM_—000564
  Homo sapiens interleukin 5 receptor, alpha (IL5RA), mRNA
  gi|10835130|ref|NM_—000564.1|[10835130]
• 6668: NM_—000525
  Homo sapiens potassium inwardly-rectifying channel, subfamily J, member 11
  gi|10835116|ref|NM_—000525.1|[10835116]
• 6669: NM_—003841
  Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain (TNFRSF10C), mRNA
  gi|10835042|ref|NM_—003841.1|[10835042]
• 6672: NM_—001307
  Homo sapiens claudin 7 (CLDN7), mRNA
  gi|10835007|ref|NM_—001307.1[10835007]
• 6673: NM_—000640
  Homo sapiens interleukin 13 receptor, alpha 2 (IL13RA2), mRNA
  gi|10834991|ref|NM_—000640.1|[10834991]
• 6674: NM_—001993
  Homo sapiens coagulation factor III (thromboplastin, tissue factor) (F3), mRNA
  gi|10518499|ref|NM_—001993.2|[10518499]
• 6675: NM_—013252
  Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
  superfamily member 5 (CLECSF5), mRNA
  gi|10281668|ref|NM_—013252.1|[10281668]
• 6676: NM_—020547
  Homo sapiens anti-Mullerian hormone receptor, type II (AMHR2), mRNA
  gi|10198655|ref|NM_—020547.1|[10198655]
• 6677: NM_—018970
  Homo sapiens G protein-coupled receptor 85 (GPR85), mRNA
  gi|10190654|ref|NM_—018970.2|[10190654]
• 6678: NM_—014292
  Homo sapiens chromobox homolog 6 (CBX6), mRNA
  gi|10140848|ref|NM_—014292.1|[10140848]
• 6679: NM_—019897
  Homo sapiens olfactory receptor, family 2, subfamily S, member 2 (OR2S2), mRNA
  gi|10092668|ref|NM_—019897.1|[10092668]
• 6680: NM_—014499
  Homo sapiens putative purinergic receptor (P2Y10), mRNA
  gi|10092632|ref|NM_—014499.1|[10092632]
• 6681: NM_—017572
  Homo sapiens G protein-coupled receptor kinase 7 (GPRK7), mRNA
  gi|9994196|ref|NM_—017572.1|[9994196]
• 6682: NM_—020406
  Homo sapiens polycythemia rubra vera 1; cell surface receptor (PRV1), mRNA
  gi|9966888|ref|NM_—020406.1|[9966888]
• 6683: NM_—020377
  Homo sapiens cysteinyl leukotriene CysLT2 receptor; cDNA: PSEC0146 from clone PLACE1006979 (LOC57105), mRNA
  gi|9966850|ref|NM_—020377.1|[9966850]
• 6686: NM_—002295
  Homo sapiens laminin receptor 1 (67 kD, ribosomal protein SA) (LAMR1), mRNA
  gi|9845501|ref|NM_—002295.2|[9845501]
• 6687: NM_—019839
  Homo sapiens seven transmembrane receptor BLTR2; leukotriene B4 receptor BLT2 (BLTR2), mRNA
  gi|9789896|ref|NM_—019839.1|[9789896]
• 6688: NM_—018969
  Homo sapiens super conserved receptor expressed in brain 3 (SREB3), mRNA
  gi|9507142|ref|NM_—018969.1|[9507142]
• 6689: NM_—018949
  Homo sapiens G protein-coupled receptor 14 (GPR14), mRNA
  gi|9506744|ref|NM_—018949.1|[9506744]
• 6690: NM_—000804
  Homo sapiens folate receptor 3 (gamma) (FOLR3), mRNA
  gi|9257219|ref|NM_—000804.2|[9257219]
• 6691: NM_—000803
  Homo sapiens folate receptor 2 (fetal) (FOLR2), mRNA
  gi|9257218|ref|NM_—000803.2|[9257218]
• 6692: NM_—017526
  Homo sapiens leptin receptor gene-related protein (HSOBRGRP), mRNA
  gi|8923784|ref|NM_—017526.1|[8923784]
• 6693: NM_—017532
  Homo sapiens p65 protein (HSAJ2425), mRNA
  gi|8923776|ref|NM_—017532.1|[8923776]
• 6694: NM_—017442
  Homo sapiens toll-like receptor 9 (TLR9), mRNA
  gi|8394455|ref|NM_—017442.1|[8394455]
• 6695: NM_—016946
  Homo sapiens junctional adhesion molecule (JAM), mRNA
  gi|8393637|ref|NM_—016946.1|[8393637]
• 6697: NM_—013280
  Homo sapiens fibronectin leucine rich transmembrane protein 1 (FLRT1), mRNA
  gi|8051591|ref|NM_—013280.2|[8051591]
• 6698: NM_—013431
  Homo sapiens killer cell lectin-like receptor subfamily C, member 4 (KLRC4), mRNA
  gi|7710123|ref|NM_—013431.1|[7710123]
• 6699: NM_—016568
  Homo sapiens G-protein coupled receptor SALPR; somatostatin and angiotensin-like
  peptide receptor (LOC51289), mRNA
  gi|7706102|ref|NM_—016568.1|[7706102]
• 6700: NM_—015863
  Homo sapiens surfactant protein B (LOC51041), mRNA
  gi|7705659|ref|NM_—015863.1|[7705659]
• 6702: NM_—015868
  Homo sapiens NK-receptor (KIR-023 GB), mRNA
  gi|7705567|ref|NM_—015868.1|[7705567]
• 6703: NM_—016540
  Homo sapiens G protein-coupled receptor 72 (GPR72), mRNA
  gi|7705384|ref|NM_—016540.1|[7705384]
• 6704: NM_—001059
  Homo sapiens tachykinin receptor 3 (TACR3), mRNA
  gi|7669547|ref|NM_—001059.1|[7669547]
• 6705: NM_—014030
  Homo sapiens G protein-coupled receptor kinase-interactor 1 (GIT1), mRNA
  gi|7661711|ref|NM_—014030.1|[7661711]
• 6706: NM_—014521
  Homo sapiens SH3-domain binding protein 4 (SH3BP4), mRNA
  gi|7657561|ref|NM_—014521.1|[7657561]
• 6707: NM_—014285
  Homo sapiens homolog of Yeast RRP4 (ribosomal RNA processing 4), 3′-5′-exoribonuclease (RRP4), mRNA
  gi|7657527|ref|NM_—014285.1|[7657527]
• 6708: NM_—014566
  Homo sapiens olfactory receptor, family 1, subfamily D, member 5 (OR1D5), mRNA
  gi|7657422|ref|NM_—014566.1|[7657422]
• 6709: NM_—014565
  Homo sapiens olfactory receptor, family 1, subfamily A, member 1 (OR1A1), mRNA
  gi|7657420|ref|NM_—014565.1|[7657420]
• 6710: NM_—014221
  Homo sapiens mature T-cell proliferation 1 (MTCP1), mRNA
  gi|7657348|ref|NM_—014221.1|[7657348]
• 6711: NM_—014387
  Homo sapiens linker for activation of T cells (LAT), mRNA
  gi|7657292|ref|NM_—014387.1|[7657292]
• 6712: NM_—014514
  Homo sapiens killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 (KIR3D51), mRNA
  gi|7657280|ref|NM_—014514.1|[7657280]
• 6713: NM_—014513
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 (KIR2D55), mRNA
  gi|7657278|ref|NM_—014513.1|[7657278]
• 6714: NM_—014512
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 (KIR2D51), mRNA
  gi|7657276|ref|NM_—014512.1|[7657276]
• 6715: NM_—014511
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 (KIR2DL3), mRNA
  gi|7657274|ref|NM_—014511.1|[7657274]
• 6716: NM_—014219
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 (KIR2DL2), mRNA
  gi|7657272|ref|NM_—014219.1|[7657272]
• 6717: NM_—014218
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 (KIR2DL1), mRNA
  gi|7657270|ref|NM_—014218.1|[7657270]
• 6718: NM_—014271
  Homo sapiens interleukin 1 receptor accessory protein-like 1 (IL1RAPL1), mRNA
  gi|7657231|ref|NM_—014271.1|[7657231]
• 6719: NM_—014339
  Homo sapiens interleukin 17 receptor (IL17R), mRNA
  gi|7657229|ref|NM_—014339.1|[7657229]
• 6720: NM_—014619
  Homo sapiens glutamate receptor, ionotropic, kainate 4 (GRIK4), mRNA
  gi|7657143|ref|NM_—014619.1|[7657143]
• 6721: NM_—014626
  Homo sapiens G protein-coupled receptor 58 (GPR58), mRNA
  gi|7657141|ref|NM_—014626.1|[7657141]
• 6722: NM_—014627
  Homo sapiens G protein-coupled receptor 57 (GPR57), mRNA
  gi|7657139|ref|NM_—014627.1|[7657139]
• 6723: NM_—014373
  Homo sapiens putative G protein-coupled receptor (GPCR150), mRNA
  gi|7657135|ref|NM_—014373.1|[7657135]
• 6724: NM_—005529
  Homo sapiens heparan sulfate proteoglycan 2 (perlecan) (HSPG2), mRNA
  gi|7427516|ref|NM_—005529.2|[7427516]
• 6727: NM_—005415
  Homo sapiens solute carrier family 20 (phosphate transporter), member 1 (SLC20A1), mRNA
  gi|7382462|ref|NM_—005415.2|[7382462]
• 6728: NM_—005199
  Homo sapiens cholinergic receptor, nicotinic, gamma polypeptide (CHRNG), mRNA
  gi|7382453|ref|NM_—005199.3|[7382453]
• 6729: NM_—013940
  Homo sapiens olfactory receptor, family 10, subfamily H, member 1 (OR10H1), mRNA
  gi|7363438|ref|NM_—013940.1|[7363438]
• 6730: NM_—013440
  Homo sapiens paired immunoglobulin-like receptor beta (PILR(BETA)), mRNA
  gi|7305386|ref|NM_—013440.1|[7305386]
• 6731: NM_—013439
  Homo sapiens paired immunoglobulin-like receptor alpha (PILR(ALPHA)), mRNA
  gi|7305384|ref|NM_—013439.1|[7305384]
• 6732: NM_—002260
  Homo sapiens killer cell lectin-like receptor subfamily C, member 2 (KLRC2), mRNA
  gi|7108353|ref|NM_—002260.2|[7108353]
• 6733: NM_—012125
  Homo sapiens cholinergic receptor, muscarinic 5 (CHRM5), mRNA
  gi|7108335|ref|NM_—012125.1|[7108335]
• 6734: NM_—013378
  Homo sapiens pre-B lymphocyte gene 3 (VPREB3), mRNA
  gi|7019566|ref|NM_—013378.1|[7019566]
• 6735: NM_—013261
  Homo sapiens peroxisome proliferative activated receptor, gamma, coactivator (PPARGC1), mRNA
  gi|7019498|ref|NM_—013261.1|[7019498]
• 6736: NM_—013269
  Homo sapiens lectin-like NK cell receptor (LLT1), mRNA
  gi|7019446|ref|NM_—013269.1|[7019446]
• 6737: NM_—013289
  Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1), mRNA
  gi|7019440|ref|NM_—013289.1|[7019440]
• 6738: NM_—013281
  Homo sapiens fibronectin leucine rich transmembrane protein 3 (FLRT3), mRNA
  gi|7019382|ref|NM_—013281.1|[7019382]
• 6739: NM_—013231
  Homo sapiens fibronectin leucine rich transmembrane protein 2 (FLRT2), mRNA
  gi|7019380|ref|NM_—013231.1|[7019380]
• 6740: NM_—012410
  Homo sapiens type I transmembrane receptor (seizure-related protein) (PSK-1), mRNA
  gi|6912611|ref|NM_—012410.1|[6912611]
• 6741: NM_—012391
  Homo sapiens prostate epithelium-specific Ets transcription factor (PDEF), mRNA
  gi|6912579|ref|NM_—012391.1|[6912579]
• 6742: NM_—012375
  Homo sapiens olfactory receptor, family 52, subfamily A, member 1 (OR52A1), mRNA
  gi|6912559|ref|NM_—012375.1|[6912559]
• 6743: NM_—012368
  Homo sapiens olfactory receptor, family 2, subfamily C, member 1 (OR2C1), mRNA
  gi|6912555|ref|NM_—012368.1|[6912555]
• 6744: NM_—012360
  Homo sapiens olfactory receptor, family 1, subfamily F, member 8 (OR1F8), mRNA
  gi|6912553|ref|NM_—012360.1|[6912553]
• 6745: NM_—012352
  Homo sapiens olfactory receptor, family 1, subfamily A, member 2 (OR1A2), mRNA
  gi|6912551|ref|NM_—012352.1|[6912551]
• 6746: NM_—012351
  Homo sapiens olfactory receptor, family 10, subfamily J, member 1 (OR10J1), mRNA
  gi|6912549|ref|NM_—012351.1|[6912549]
• 6747: NM_—012344
  Homo sapiens neurotensin receptor 2 (NTSR2), mRNA
  gi|6912537|ref|NM_—012344.1|[6912537]
• 6748: NM_—012314
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 (KIR2D54), mRNA
  gi|6912475|ref|NM_—012314.1|[6912475]
• 6749: NM_—012313
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2D53), mRNA
  gi|6912473|ref|NM_—012313.1|[6912473]
• 6750: NM_—012312
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 (KIR2D52), mRNA
  gi|6912471|ref|NM_—012312.1|[6912471]
• 6751: NM_—012211
  Homo sapiens integrin, alpha 11 (ITGA11), mRNA
  gi|6912435|ref|NM_—012211.1|[6912435]
• 6752: NM_—012275
  Homo sapiens interleukin-1 receptor antagonist homolog 1 (IL1HY1), mRNA
  gi|6912431|ref|NM_—012275.1|[6912431]
• 6753: NM_—004525
  Homo sapiens low density lipoprotein-related protein 2 (LRP2), mRNA
  gi|6806918|ref|NM_—004525.1|[6806918]
• 6754: NM_—004304
  Homo sapiens anaplastic lymphoma kinase (Ki-1) (ALK), mRNA
  gi|6715586|ref|NM_—004304.2|[6715586]
• 6755: NM_—000686
  Homo sapiens angiotensin receptor 2 (AGTR2), mRNA
  gi|6715584|ref|NM_—000686.2|[6715584]
• 6756: NM_—007366
  Homo sapiens phospholipase A2 receptor 1, 180 kD (PLA2R1), mRNA
  gi|6679370|ref|NM_—007366.1|[6679370]
• 6757: NM_—005385
  Homo sapiens natural killer-tumor recognition sequence (NKTR), mRNA
  gi|6631099|ref|NM_—005385.2|[6631099]
• 6758: NM_—005266
  Homo sapiens gap junction protein, alpha 5, 40 kD (connexin 40) (GJA5), mRNA
  gi|6631082|ref|NM_—005266.2|[6631082]
• 6759: NM_—000827
  Homo sapiens glutamate receptor, ionotropic, AMPA 1 (GRIA1), mRNA
  gi|6552333|ref|NM_—000827.21[6552333]
• 6760: NM_—001619
  Homo sapiens adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA
  gi|6138971|ref|NM_—001619.2|[6138971]
• 6761: NM_—000810
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 5 (GABRA5), mRNA
  gi|6031207|ref|NM_—000810.2|[6031207]
• 6762: NM_—003006
  Homo sapiens selectin P ligand (SELPLG), mRNA
  gi|6031197|ref|NM_—003006.2|[6031197]
• 6763: NM_—001480
  Homo sapiens galanin receptor 1 (GALR1), mRNA
  gi|6031165|ref|NM_—001480.21[6031165]
• 6764: NM_—001992
  Homo sapiens coagulation factor II (thrombin) receptor (F2R), mRNA
  gi|6031164|ref|NM_—001992.2|[6031164]
• 6765: NM_—000677
  Homo sapiens adenosine A3 receptor (ADORA3), mRNA
  gi|6031156|ref|NM_—000677.21[6031156]
• 6766: NM_—001526
  Homo sapiens hypocretin (orexin) receptor 2 (HCRTR2), mRNA
  gi|6006037|ref|NM_—001526.2|[6006037]
• 6767: NM_—000885
  Homo sapiens integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (ITGA4), mRNA
  gi|6006032|ref|NM_—000885.2|[6006032]
• 6768: NM_—002377
  Homo sapiens MAS1 oncogene (MAS1), mRNA
  gi|6006022|ref|NM_—002377.21[6006022]
• 6769: NM_—000887
  Homo sapiens integrin, alpha X (antigen CD11C (p150), alpha polypeptide) (ITGAX), mRNA
  gi|6006014|ref|NM_—000887.2|[6006014]
• 6770: NM_—000419
  Homo sapiens integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex,
  antigen CD41B) (ITGA2B), mRNA
  gi|6006009|ref|NM_—000419.2|[6006009]
• 6771: NM_—002203
  Homo sapiens integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2), mRNA
  gi|6006008|ref|NM_—002203.21[6006008]
• 6772: NM_—000843
  Homo sapiens glutamate receptor, metabotropic 6 (GRM6), mRNA
  gi|6006006|ref|NM_—000843.2|[6006006]
• 6773: NM_—000838
  Homo sapiens glutamate receptor, metabotropic 1 (GRM1), mRNA
  gi|6006005|ref|NM_—000838.2|[6006005]
• 6774: NM_—000835
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C),
  mRNA
  gi|6006004|ref|NM_—000835.2|[6006004]
• 6775: NM_—000834
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B),
  mRNA
  gi|6006003|ref|NM_—000834.2|[6006003]
• 6776: NM_—000833
  Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A),
  mRNA
  gi|6006002|ref|NM_—000833.2|[6006002]
• 6777: NM_—007155
  Homo sapiens zona pellucida glycoprotein 3A (sperm receptor) (ZP3A), mRNA
  gi|6005983|ref|NM_—007155.1|[6005983]
• 6778: NM_—007124
  Homo sapiens utrophin (homologous to dystrophin) (UTRN), mRNA
  gi|6005937|ref|NM_—007124.1|[6005937]
• 6779: NM_—007114
  Homo sapiens TATA element modulatory factor 1 (TMF1), mRNA
  gi|6005903|ref|NM_—007114.1|[6005903]
• 6780: NM_—007273
  Homo sapiens B-cell associated protein (REA), mRNA
  gi|6005853|ref|NM_—007273.1|[6005853]
• 6781: NM_—007160
  Homo sapiens olfactory receptor, family 2, subfamily H, mer-er 3 (OR2H3), mRNA
  gi|6005821|ref|NM_—007160.1|[6005821]
• 6782: NM_—007227
  Homo sapiens G protein-coupled receptor 45 (GPR45), mRNA
  gi|6005769|ref|NM_—007227.1|[6005769]
• 6783: NM_—006934
  Homo sapiens solute carrier family 6 (neurotransmitter transporter, glycine), member 9 (SLC6A9), mRNA
  gi|5902093|ref|NM_—006934.1|[5902093]
• 6785: NM_—007011
  Homo sapiens putative transmembrane protein (HS1-2), mRNA
  gi|5901977|ref|NM_—007011.1|[5901977]
• 6786: NM_—007045
  Homo sapiens FGFR1 oncogene partner (FOP), mRNA
  gi|5901953|ref|NM_—007045.1|[5901953]
• 6787: NM_—006889
  Homo sapiens CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) (CD86), mRNA
  gi|5901919|ref|NM_—006889.1|[5901919]
• 6788: NM_—006749
  Homo sapiens solute carrier family 20 (phosphate transporter), member 2 (SLC20A2), mRNA
  gi|5803172|ref|NM_—006749.1|[5803172]
• 6789: NM_—006770
  Homo sapiens macrophage receptor with collagenous structure (MARCO), mRNA
  gi|5803079|ref|NM_—006770.1|[5803079]
• 6790: NM_—006840
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 (LILRB5), mRNA
  gi|5803069|ref|NM_—006840.1|[5803069]
• 6791: NM_—006866
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 (LILRA2), mRNA
  gi|5803067|ref|NM_—006866.1|[5803067]
• 6792: NM_—006863
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 (LILRA1), mRNA
  gi|5803065|ref|NM_—006863.1|[583065]
• 6793: NM_—006847
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 (LILRB4), mRNA
  gi|5803063|ref|NM_—006847.1|[5803063]
• 6794: NM_—006865
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 (LILRA3), mRNA
  gi|5803061|ref|NM_—006865.1|[5803061]
• 6795: NM_—006864
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), mRNA
  gi|5803059|ref|NM_—006864.1|[5803059]
• 6796: NM_—006738
  Homo sapiens lymphoid blast crisis oncogene (LBC), mRNA
  gi|5803057|ref|NM_—006738.1|[5803057]
• 6797: NM_—006737
  Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), mRNA
  gi|5803051|ref|NM_—006737.1|[5803051]
• 6799: NM_—006564
  Homo sapiens G protein-coupled receptor (TYMSTR), mRNA
  gi|5730105|ref|NM_—006564.1|[5730105]
• 6800: NM_—001561
  Homo sapiens tumor necrosis factor receptor superfamily, member 9 (TNFRSF9), mRNA
  gi|5730094|ref|NM_—001561.2|[5730094]
• 6801: NM_—006664
  Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 27 (SCYA27),
  mRNA
  gi|5730034|ref|NM_—006664.1|[5730034]
• 6802: NM_—006583
  Homo sapiens retinal pigment epithelium-derived rhodopsin homolog (RRH), mRNA
  gi|5730018|ref|NM_—006583.1|[5730018]
• 6803: NM_—006505
  Homo sapiens poliovirus receptor (PVR), mRNA
  gi|5729994ref|NM_—006505.1|[5729994]
• 6804: NM_—006637
  Homo sapiens olfactory receptor, family 5, subfamily I, member 1 (OR5I1), mRNA
  gi|5729959|ref|NM_—006637.1|[5729959]
• 6805: NM_—006669
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 (LILRB1), mRNA
  gi|5729926|ref|NM_—006669.1|[5729926]
• 6806: NM_—006611
  Homo sapiens killer cell lectin-like receptor subfamily A, member 1 (KLRA1), mRNA
  gi|5729898|ref|NM_—006611.1|[5729898]
• 6807: NM_—006496
  Homo sapiens guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 (GNA13), mRNA
  gi|5729849|ref|NM_—006496.1|[5729849]
• 6808: NM_—006529
  Homo sapiens glycine receptor, alpha 3 (GLRA3), mRNA
  gi|5729843|ref|NM_—006529.1|[5729843]
• 6809: NM_—006639
  Homo sapiens cysteinyl leukotriene receptor 1 (CYSLT1), mRNA
  gi|5729797|ref|NM_—006639.1|[5729797]
• 6810: NM_—006293
  Homo sapiens TYRO3 protein tyrosine kinase (TYRO3), mRNA
  gi|5454141|ref|NM_—006293.1|[5454141]
• 6813: NM_—006238
  Homo sapiens peroxisome proliferative activated receptor, delta (PPARD), mRNA
  gi|5453939|ref|NM_—006238.1|[5453939]
• 6814: NM_—006189
  Homo sapiens olfactory marker protein (OMP), mRNA
  gi|5453827|ref|NM_—006189.1|[5453827]
• 6815: NM_—006182
  Homo sapiens discoidin domain receptor family, member 2 (DDR2), mRNA
  gi|5453813|ref|NM_—006182.1|[5453813]
• 6816: NM_—006180
  Homo sapiens neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), mRNA
  gi|5453811|ref|NM_—006180.1|[5453811]
• 6817: NM_—006403
  Homo sapiens enhancer of filamentation 1 (cas-like docking; Crk-associated substrate related) (HEF1), mRNA
  gi|5453679|ref|NM_—006403.1|[5453679]
• 6818: NM_—006143
  Homo sapiens G protein-coupled receptor 19 (GPR19), mRNA
  gi|5453665|ref|NM_—006143.1|[5453665]
• 6819: NM_—006404
  Homo sapiens protein C receptor, endothelial (EPCR) (PROCR), mRNA
  gi|5453645|ref|NM_—006404.1|[5453645]
• 6820: NM_—006419
  Homo sapiens small inducible cytokine B subfamily (Cys-X-Cys motif), member (B-cell chemoattractant) (SCYB13), mRNA
  gi|5453576|ref|NM_—006419.1|[5453576]
• 6821: NM_—005954
  Homo sapiens metallothionein 3 (growth inhibitory factor (neurotrophic)) (MT3),
  mRNA
  gi|5174761|ref|NM_—005954.1|[5174761]
• 6822: NM_—006006
  Homo sapiens zinc finger protein 145 (Kruppel-like, expressed in promyelocytic
  leukemia) (ZNF145), mRNA
  gi|5174752|ref|NM_—006006.1|[5174752]
• 6823: NM_—006072
  Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 26 (SCYA26),
  mRNA
  gi|5174670|ref|NM_—006072.1|[5174670]
• 6824: NM_—005972
  Homo sapiens pancreatic polypeptide receptor 1 (PPYR1), mRNA
  gi|5174638|ref|NM_—005972.1|[5174638]
• 6825: NM_—005913
  Homo sapiens melanocortin 5 receptor (MC5R), mRNA
  gi|5174534|ref|NM_—005913.1|[5174534]
• 6826: NM_—005912
  Homo sapiens melanocortin 4 receptor (MC4R), mRNA
  gi|5174532|ref|NM_—005912.1|[5174532]
• 6827: NM_—006028
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3B (HTR3B), mRNA
  gi|5174468|ref|NM_—006028.1|[5174468]
• 6828: NM_—005628
  Homo sapiens solute carrier family 1 (neutral amino acid transporter), member 5
  (SLC1A5), mRNA
  gi|5032092|ref|NM_—005628.1|[5032092]
• 6829: NM_—005767
  Homo sapiens purinergic receptor (family A group 5) (P2Y5), mRNA
  gi|5031968|ref|NM_—005767.1|[5031968]
• 6830: NM_—005592
  Homo sapiens muscle, skeletal, receptor tyrosine kinase (MUSK), mRNA
  gi|5031926|ref|NM_—005592.1|[5031926]
• 6831: NM_—005874
  Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), mRNA
  gi|5031910|ref|NM_—005874.1|[5031910]
• 6832: NM_—005810
  Homo sapiens killer cell lectin-like receptor subfamily G, member 1 (KLRG1), mRNA
  gi|5031900|ref|NM_—005810.1|[5031900]
• 6833: NM_—005544
  Homo sapiens insulin receptor substrate 1 (IRS1), mRNA
  gi|5031804|ref|NM_—005544.1|[5031804]
• 6834: NM_—005535
  Homo sapiens interleukin 12 receptor, beta 1 (IL12RB1), mRNA
  gi|5031784|ref|NM_—005535.1|[5031784]
• 6835: NM_—005683
  Homo sapiens G protein-coupled receptor 55 (GPR55), mRNA
  gi|5031722|ref|NM_—005683.1|[5031722]
• 6836: NM_—005684
  Homo sapiens G protein-coupled receptor 52 (GPR52), mRNA
  gi|5031720|ref|NM_—005684.1|[5031720]
• 6837: NM_—001621
  Homo sapiens aryl hydrocarbon receptor (AHR), mRNA
  gi|5016091|ref|NM_—001621.2|[5016091]
• 6838: NM_—005429
  Homo sapiens vascular endothelial growth factor C (VEGFC), mRNA
  gi|4885652|ref|NM_—005429.1|[4885652]
• 6839: NM_—005424
  Homo sapiens tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (TIE), mRNA
  gi|4885630|ref|NM_—005424.1|[4885630]
• 6840: NM_—005408
  Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 13 (SCYA13),
  mRNA
  gi|4885586|ref|NM_—005408.1|[4885586]
• 6841: NM_—005328
  Homo sapiens hyaluronan synthase 2 (HAS2), mRNA
  gi|4885390|ref|NM_—005328.1|[4885390]
• 6842: NM_—005314
  Homo sapiens gastrin-releasing peptide receptor (GRPR), mRNA
  gi|4885360|ref|NM_—005314.1|[4885360]
• 6843: NM_—005311
  Homo sapiens growth factor receptor-bound protein 10 (GRB10), mRNA
  gi|4885352|ref|NM_—005311.1|[4885352]
• 6844: NM_—005308
  Homo sapiens G protein-coupled receptor kinase 5 (GPRK5), mRNA
  gi|4885348|ref|NM_—005308.1|[4885348]
• 6845: NM_—005286
  Homo sapiens G protein-coupled receptor 8 (GPR8), mRNA
  gi|4885344|ref|NM_—005286.1|[4885344]
• 6846: NM_—005285
  Homo sapiens G protein-coupled receptor 7 (GPR7), mRNA
  gi|4885342|ref|NM_—005285.1|[4885342]
• 6847: NM_—005284
  Homo sapiens G protein-coupled receptor 6 (GPR6), mRNA
  gi|4885340|ref|NM_—005284.1|[4885340]
• 6848: NM_—005458
  Homo sapiens G protein-coupled receptor 51 (GPR51), mRNA
  gi|4885336|ref|NM_—005458.1|[4885336]
• 6849: NM_—005282
  Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA
  gi|4885334|ref|NM_—005282.1|[4885334]
• 6850: NM_—005306
  Homo sapiens G protein-coupled receptor 43 (GPR43), mRNA
  gi|4885332|ref|NM_—005306.1|[4885332]
• 6851: NM_—005305
  Homo sapiens G protein-coupled receptor 42 (GPR42), mRNA
  gi|4885330|ref|NM_—005305.1|[4885330]
• 6852: NM_—005304
  Homo sapiens G protein-coupled receptor 41 (GPR41), mRNA
  gi|4885328|ref|NM_—005304.1|[4885328]
• 6853: NM_—005303
  Homo sapiens G protein-coupled receptor 40 (GPR40), mRNA
  gi|4885326|ref|NM_—005303.1|[4885326]
• 6854: NM_—005281
  Homo sapiens G protein-coupled receptor 3 (GPR3), mRNA
  gi|4885324|ref|NM_—005281.1|[4885324]
• 6855: NM_—005302
  Homo sapiens G protein-coupled receptor 37 (endothelin receptor type B-like) (GPR37), mRNA
  gi|4885322|ref|NM_—005302.1|[4885322]
• 6856: NM_—005301
  Homo sapiens G protein-coupled receptor 35 (GPR35), mRNA
  gi|4885320|ref|NM_—005301.1|[4885320]
• 6857: NM_—005300
  Homo sapiens G protein-coupled receptor 34 (GPR34), mRNA
  gi|4885318|ref|NM_—005300.1|[4885318]
• 6858: NM_—005299
  Homo sapiens G protein-coupled receptor 31 (GPR31), mRNA
  gi|4885316|ref|NM_—005299.1|[4885316]
• 6859: NM_—005298
  Homo sapiens G protein-coupled receptor 25 (GPR25), mRNA
  gi|4885314|ref|NM_—005298.1|[4885314]
• 6860: NM_—005297
  Homo sapiens G protein-coupled receptor 24 (GPR24), mRNA
  gi|4885312|ref|NM_—005297.1|[4885312]
• 6861: NM_—005296
  Homo sapiens G protein-coupled receptor 23 (GPR23), mRNA
  gi|4885310|ref|NM_—005296.1|[4885310]
• 6862: NM_—005295
  Homo sapiens G protein-coupled receptor 22 (GPR22), mRNA
  gi|4885308|ref|NM_—005295.1|[4885308]
• 6863: NM_—005294
  Homo sapiens G protein-coupled receptor 21 (GPR21), mRNA
  gi|4885306|ref|NM_—005294.1|[4885306]
• 6864: NM_—005293
  Homo sapiens G protein-coupled receptor 20 (GPR20), mRNA
  gi|4885304|ref|NM_—005293.1|[4885304]
• 6865: NM_—005279
  Homo sapiens G protein-coupled receptor 1 (GPR1), mRNA
  gi|4885302|ref|NM_—005279.1|[4885302]
• 6866: NM_—005291
  Homo sapiens G protein-coupled receptor 17 (GPR17), mRNA
  gi|4885300|ref|NM_—005291.1|[4885300]
• 6867: NM_—005290
  Homo sapiens G protein-coupled receptor 15 (GPR15), mRNA
  gi|4885298|ref|NM_—005290.1|[4885298]
• 6868: NM_—005288
  Homo sapiens G protein-coupled receptor 12 (GPR12), mRNA
  gi|4885294|ref|NM_—005288.1|[4885294]
• 6869: NM_—005264
  Homo sapiens GDNF family receptor alpha 1 (GFRA1), mRNA
  gi|4885268|ref|NM_—005264.1|[4885268]
• 6870: NM_—005246
  Homo sapiens fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) (FER),
  mRNA
  gi|4885230|ref|NM_—005246.1|[4885230]
• 6871: NM_—005233
  Homo sapiens EphA3 (EPHA3), mRNA
  gi|4885210|ref|NM_—005233.1|[4885210]
• 6872: NM_—005227
  Homo sapiens ephrin-A4 (EFNA4), mRNA
  gi|4885196|ref|NM_—005227.1|[4885196]
• 6873: NM_—005211
  Homo sapiens colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R), mRNA
  gi|4885158|ref|NM_—005211.1|[4885158]
• 6875: NM_—005161
  Homo sapiens angiotensin receptor-like 1 (AGTRL1), mRNA
  gi|4885056|ref|NM_—005161.1|[4885056]
• 6876: NM_—005092
  Homo sapiens tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18), mRNA
  gi|4827033|ref|NM_—005092.1|[4827033]
• 6877: NM_—005118
  Homo sapiens tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15), mRNA
  gi|4827031|ref|NM_—005118.1|[4827031]
• 6878: NM_—005048
  Homo sapiens parathyroid hormone receptor 2 (PTHR2), mRNA
  gi|4826953|ref|NM_—005048.1|[4826953]
• 6879: NM_—004963
  Homo sapiens guanylate cyclase 2C (heat stable enterotoxin receptor) (GUCY2C),
  mRNA
  gi|4826751|ref|NM_—004963.1|[4826751]
• 6880: NM_—005145
  Homo sapiens guanine nucleotide binding protein (G protein), gamma 7 (GNG7), mRNA
  gi|4826745|ref|NM_—005145.1|[4826745]
• 6881: NM_—004952
  Homo sapiens ephrin-A3 (EFNA3), mRNA
  gi|4826707|ref|NM_—004952.1|[4826707]
• 6882: NM_—004736
  Homo sapiens xenotropic and polytropic retrovirus receptor (XPR1), mRNA
  gi|4759333|ref|NM_—004736.1|[4759333]
• 6883: NM_—004664
  Homo sapiens Vertebrate LIN7 homolog 1, Tax interaction protein 33 (VELI1), mRNA
  gi|4759305|ref|NM_—004664.1|[4759305]
• 6884: NM_—004195
  Homo sapiens tumor necrosis factor receptor superfamily, member 18 (TNFRSF18),
  mRNA
  gi|4759245|ref|NM_—004195.1|[4759245]
• 6885: NM_—004612
  Homo sapiens transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53 kD) (TGFBR1), mRNA
  gi|4759225|ref|NM_—004612.1|[4759225]
• 6887: NM_—004154
  Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 6 (P2RY6), mRNA
  gi|4758863|ref|NM_—004154.1|[4758863]
• 6888: NM_—004244
  Homo sapiens CD163 antigen (CD163), mRNA
  gi|4758721|ref|NM_—004244.1|[4758721]
• 6889: NM_—002332
  Homo sapiens low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) (LRP1), mRNA
  gi|4758685|ref|NM_—002332.1|[4758685]
• 6890: NM_—004514
  Homo sapiens interleukin enhancer binding factor 1 (ILF1), mRNA
  gi|4758599|ref|NM_—004514.1|[4758599]
• 6891: NM_—004633
  Homo sapiens interleukin 1 receptor, type II (IL1R2), mRNA
  gi|4758597|ref|NM_—004633.1|[4758597]
• 6892: NM_—004512
  Homo sapiens interleukin 11 receptor, alpha (IL11RA), mRNA
  gi|4758593|ref|NM_—004512.1|[4758593]
• 6894: NM_—000826
  Homo sapiens glutamate receptor, ionotropic, AMPA 2 (GRIA2), mRNA
  gi|4758479|ref|NM_—000826.1|[4758479]
• 6896: NM_—004224
  Homo sapiens G protein-coupled receptor 50 (GPR50), mRNA
  gi|4758467|ref|NM_—004224.1|[4758467]
• 6898: NM_—004246
  Homo sapiens glucagon-like peptide 2 receptor (GLP2R), mRNA
  gi|4758437|ref|NM_—004246.1|[4758437]
• 6899: NM_—004293
  Homo sapiens guanine deaminase (GDA), mRNA
  gi|4758425|ref|NM_—004293.1|[4758425]
• 6900: NM_—002030
  Homo sapiens formyl peptide receptor-like 2 (FPRL2), mRNA
  gi|4758401|ref|NM_—002030.2|[4758401]
• 6901: NM_—004469
  Homo sapiens c-fos induced growth factor (vascular endothelial growth factor D)
  (FIGF), mRNA
  gi|4758377|ref|NM_—004469.1|[4758377]
• 6902: NM_—004107
  Homo sapiens Fc fragment of IgG, receptor, transporter, alpha (FCGRT), mRNA
  gi|4758345|ref|NM_—004107.1|[4758345]
• 6903: NM_—004101
  Homo sapiens coagulation factor II (thrombin) receptor-like 2 (F2RL2), mRNA
  gi|4758325|ref|NM_—004101.1|[4758325]
• 6904: NM_—004447
  Homo sapiens epidermal growth factor receptor pathway substrate 8 (EPS8), mRNA
  gi|4758295|ref|NM_—004447.1|[4758295]
• 6905: NM_—004431
  Homo sapiens EphA2 (EPHA2), mRNA
  gi|4758277|ref|NM_—004431.1|[4758277]
• 6906: NM_—004093
  Homo sapiens ephrin-B2 (EFNB2), mRNA
  gi|4758249|ref|NM_—004093.1|[4758249]
• 6907: NM_—004429
  Homo sapiens ephrin-B1 (EFNB1), mRNA
  gi|4758247|ref|NM_—004429.1|[4758247]
• 6908: NM_—004428
  Homo sapiens ephrin-A1 (EFNA1), mRNA
  gi|4758245|ref|NM_—004428.1|[4758245]
• 6909: NM_—004393
  Homo sapiens dystroglycan 1 (dystrophin-associated glycoprotein 1) (DAG1), mRNA
  gi|4758115|ref|NM_—004393.1|[4758115]
• 6910: NM_—004383
  Homo sapiens c-src tyrosine kinase (CSK), mRNA
  gi|4758077|ref|NM_—004383.1|[4758077]
• 6911: NM_—004778
  Homo sapiens G protein-coupled receptor 44 (GPR44), mRNA
  gi|4758069|ref|NM_—004778.1|[4758069]
• 6912: NM_—004382
  Homo sapiens corticotropin releasing hormone receptor 1 (CRHR1), mRNA
  gi|4758059|ref|NM_—004382.1|[4758059]
• 6913: NM_—004072
  Homo sapiens chemokine-like receptor 1 (CMKLR1), mRNA
  gi|4758013|ref|NM_—004072.1|[4758013]
• 6914: NM_—004329
  Homo sapiens bone morphogenetic protein receptor, type IA (BMPR1A), mRNA
  gi|4757853|ref|NM_—004329.1|[4757853]
• 6915: NM_—004313
  Homo sapiens arrestin, beta 2 (ARRB2), mRNA
  gi|4757779|ref|NM_—004313.1|[4757779]
• 6916: NM_—004039
  Homo sapiens annexin A2 (ANXA2), mRNA
  gi|4757755|ref|NM_—004039.1|[4757755]
• 6917: NM_—000806
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 1 (GABRA1), mRNA
  gi|4585862|ref|NM_—000806.2|[4585862]
• 6918: NM_—002529
  Homo sapiens neurotrophic tyrosine kinase, receptor, type 1 (NTRK1), mRNA
  gi|4585711|ref|NM_—002529.2|[4585711]
• 6919: NM_—000395
  Homo sapiens colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) (CSF2RB), mRNA
  gi|4559407|ref|NM_—000395.1|[4559407]
• 6920: NM_—000211
  Homo sapiens integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit) (ITGB2), mRNA
  gi|4557885|ref|NM_—000211.1|[4557885]
• 6921: NM_—000208
  Homo sapiens insulin receptor (INSR), mRNA
  gi|4557883|ref|NM_—000208.1|[4557883]
• 6922: NM_—000206
  Homo sapiens interleukin 2 receptor, gamma (severe combined immunodeficiency) (IL2RG), mRNA
  gi|4557881|ref|NM_—000206.1|[4557881]
• 6923: NM_—000416
  Homo sapiens interferon gamma receptor 1 (IFNGR1), mRNA
  gi|4557879|ref|NM_—000416.1|[4557879]
• 6924: NM_—000201
  Homo sapiens intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
  (ICAM1), mRNA
  gi|4557877|ref|NM_—000201.1|[4557877]
• 6925: NM_—000459
  Homo sapiens TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) (TEK), mRNA
  gi|4557868|ref|NM_—000459.1|[4557868]
• 6926: NM_—001053
  Homo sapiens somatostatin receptor 5 (SSTR5), mRNA
  gi|4557864|ref|NM_—001053.1|[4557864]
• 6927: NM_—001052
  Homo sapiens somatostatin receptor 4 (SSTR4), mRNA
  gi|4557862|ref|NM_—001052.1|[4557862]
• 6928: NM_—001051
  Homo sapiens somatostatin receptor 3 (SSTR3), mRNA
  gi|4557860|ref|NM_—001051.1|[4557860]
• 6929: NM_—001050
  Homo sapiens somatostatin receptor 2 (SSTR2), mRNA
  gi|4557858|ref|NM_—001050.1|[4557858]
• 6930: NM_—001049
  Homo sapiens somatostatin receptor 1 (SSTR1), mRNA
  gi|4557856|ref|NM_—001049.1|[4557856]
• 6931: NM_—000245
  Homo sapiens met proto-oncogene (hepatocyte growth factor receptor) (MET), mRNA
  gi|4557746|ref|NM_—000245.1|[4557746]
• 6932: NM_—000242
  Homo sapiens mannose-binding lectin (protein C) 2, soluble (opsonic defect) (MBL2), mRNA
  gi|4557738|ref|NM_—000242.1|[4557738]
• 6933: NM_—000237
  Homo sapiens lipoprotein lipase (LPL), mRNA
  gi|4557726|ref|NM_—000237.1|[4557726]
• 6934: NM_—000236
  Homo sapiens lipase, hepatic (LIPC), mRNA
  gi|4557722|ref|NM_—000236.1|[4557722]
• 6935: NM_—000233
  Homo sapiens luteinizing hormone/choriogonadotropin receptor (LHCGR), mRNA
  gi|4557716|ref|NM_—000233.1|[4557716]
• 6936: NM_—000222
  Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), mRNA
  gi|4557694|ref|NM_—000222.1|[4557694]
• 6937: NM_—000212
  Homo sapiens integrin, beta 3 (platelet glycoprotein 111a, antigen CD61) (ITGB3), mRNA
  gi|4557676|ref|NM_—000212.1|[4557676]
• 6939: NM_—000418
  Homo sapiens interleukin 4 receptor (IL4R), mRNA
  gi|4557668|ref|NM_—000418.1|[4557668]
• 6940: NM_—000417
  Homo sapiens interleukin 2 receptor, alpha (IL2RA), mRNA
  gi|4557666|ref|NM_—000417.1|[4557666]
• 6941: NM_—001551
  Homo sapiens immunoglobulin (CD79A) binding protein 1 (IGBP1), mRNA
  gi|4557662|ref|NM_—001551.1|[4557662]
• 6942: NM_—000859
  Homo sapiens 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGCR), mRNA
  gi|4557642|ref|NM_—000859.1|[4557642]
• 6943: NM_—001525
  Homo sapiens hypocretin (orexin) receptor 1 (HCRTR1), mRNA
  gi|4557636|ref|NM_—001525.1|[4557636]
• 6944: NM_—001510
  Homo sapiens glutamate receptor, ionotropic, delta 2 (GRID2), mRNA
  gi|4557632|ref|NM_—001510.1|[4557632]
• 6945: NM_—000829
  Homo sapiens glutamate receptor, ionotrophic, AMPA 4 (GRIA4), mRNA
  gi|4557630|ref|NM_—000829.1|[4557630]
• 6946: NM_—001496
  Homo sapiens GDNF family receptor alpha 3 (GFRA3), mRNA
  gi|4557622|ref|NM_—001496.1|[4557622]
• 6947: NM_—000820
  Homo sapiens growth arrest-specific 6 (GAS6), mRNA
  gi|4557616|ref|NM_—000820.1|[4557616]
• 6948: NM_—000155
  Homo sapiens galactose-1-phosphate uridylyltransferase (GALT), mRNA
  gi|4557614|ref|NM_—000155.1|[4557614]
• 6949: NM_—000816
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 2 (GABRG2), mRNA
  gi|4557610|ref|NM_—000816.1|[4557611]
• 6950: NM_—000815
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, delta (GABRD), mRNA
  gi|4557608|ref|NM_—000815.1|[4557608]
• 6951: NM_—000811
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 6 (GABRA6), mRNA
  gi|4557606|ref|NM_—000811.1|[4557606]
• 6952: NM_—000809
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 4 (GABRA4), mRNA
  gi|4557604|ref|NM_—000809.1|[4557604]
• 6953: NM_—000808
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 3 (GABRA3), mRNA
  gi|4557602|ref|NM_—000808.1|[4557602]
• 6954: NM_—000807
  Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 2 (GABRA2), mRNA
  gi|4557600|ref|NM_—000807.1|[4557600]
• 6955: NM_—000121
  Homo sapiens erythropoietin receptor (EPOR), mRNA
  gi|4557561|ref|NM_—000121.2|[4557561]
• 6956: NM_—000118
  Homo sapiens endoglin (Osler-Rendu-Weber syndrome 1) (ENG), mRNA
  gi|4557554|ref|NM_—000118.1|[4557554]
• 6957: NM_—000114
  Homo sapiens endothelin 3 (EDN3), mRNA
  gi|4557544|ref|NM_—000114.1|[4557544]
• 6958: NM_—001365
  Homo sapiens discs, large (Drosophila) homolog 4 (DLG4), mRNA
  gi|4557528|ref|NM_—001365.1|[4557528]
• 6959: NM_—000080
  Homo sapiens cholinergic receptor, nicotinic, epsilon polypeptide (CHRNE), mRNA
  gi|4557462|ref|NM_—000080.1|[4557462]
• 6960: NM_—000751
  Homo sapiens cholinergic receptor, nicotinic, delta polypeptide (CHRND), mRNA
  gi|4557460|ref|NM_—000751.1|[4557460]
• 6961: NM_—000747
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) (CHRNB1), mRNA
  gi|4557458|ref|NM_—000747.1|[4557458) b6Y2: NM_—000079
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) (CHRNA1), mRNA
  gi|4557456|ref|NM_—000079.1|[4557456]
• 6963: NM_—000074
  Homo sapiens tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) (TNFSF5), mRNA
  gi|4557432|ref|NM_—000074.1|[4557432]
• 6964: NM_—000073
  Homo sapiens CD3G antigen, gamma polypeptide (TiT3 complex) (CD3G), mRNA
  gi|4557428|ref|NM_—000073.1|[4557428]
• 6965: NM_—000072
  Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor) (CD36), mRNA
  gi|4557418|ref|NM_—000072.1|[4557418]
• 6966: NM_—000388
  Homo sapiens calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) (CASR), mRNA
  gi|4557410|ref|NM_—000388.1|[4557410]
• 6967: NM_—000069
  Homo sapiens calcium channel, voltage-dependent, L type, alpha 1S subunit (CACNA1S), mRNA
  gi|4557400|ref|NM_—000069.1|[4557400]
• 6968: NM_—000041
  Homo sapiens apolipoprotein E (APOE), mRNA
  gi|4557324|ref|NM_—000041.1|[4557324]
• 6969: NM_—000684
  Homo sapiens adrenergic, beta-1-, receptor (ADRB1), mRNA
  gi|4557264|ref|NM_—000684.1|[4557264]
• 6970: NM_—001116
  Homo sapiens adenylate cyclase 9 (ADCY9), mRNA
  gi|4557258|ref|NM_—001116.1|[4557258]
• 6971: NM_—001115
  Homo sapiens adenylate cyclase 8 (brain) (ADCY8), mRNA
  gi|4557256|ref|NM_—001115.1|[4557256]
• 6972: NM_—004001
  Homo sapiens Fc fragment of IgG, low affinity IIb, receptor for (CD32) (FCGR2B),
  mRNA
  gi|4557021|ref|NM_—004001.1|[4557021]
• 6975: NM_—003931
  Homo sapiens WAS protein family, member 1 (WASF1), mRNA
  gi|4507912|ref|NM_—003931.1|[4507912]
• 6976: NM_—003383
  Homo sapiens very low density lipoprotein receptor (VLDLR), mRNA
  gi|4507900|ref|NM_—003383.1|[4507900]
• 6977: NM_—003382
  Homo sapiens vasoactive intestinal peptide receptor 2 (VIPR2), mRNA
  gi|4507898|ref|NM_—003382.1|[4507898]
• 6978: NM_—000376
  Homo sapiens vitamin D (1,25-dihydroxyvitamin D3) receptor (VDR), mRNA
  gi|4507882|ref|NM_—000376.1|[4507882]
• 6979: NM_—003329
  Homo sapiens thioredoxin (TXN), mRNA
  gi|4507744|ref|NM_—003329.1|[4507744]
• 6980: NM_—000369
  Homo sapiens thyroid stimulating hormone receptor (TSHR), mRNA
  gi|4507700|ref|NM_—000369.1|[4507700]
• 6981: NM_—003301
  Homo sapiens thyrotropin-releasing hormone receptor (TRHR), rRNA
  gi|4507680|ref|NM_—003301.1|[4507680]
• 6982: NM_—001244
  Homo sapiens tumor necrosis factor (ligand) superfamily, member 8 (TNFSF8), mRNA
  gi|4507606|ref|NM_—001244.1|[4507606]
• 6983: NM_—003809
  Homo sapiens tumor necrosis factor (ligand) superfamily, member 12 (TNFSF12), mRNA
  gi|4507596|ref|NM_—003809.1|[4507596]
• 6984: NM_—001243
  Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), mRNA
  gi|4507588|ref|NM_—001243.1|[4507588]
• 6985: NM_—001242
  Homo sapiens tumor necrosis factor receptor superfamily, member 7 (TNFRSF7), mRNA
  gi|4507586|ref|NM_—001242.1|[4507586]
• 6986: NM_—000043
  Homo sapiens tumor necrosis factor receptor superfamily, member 6 (TNFRSF6), mRNA
  gi|4507582|ref|NM_—000043.1|[4507582]
• 6987: NM_—003327
  Homo sapiens tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), mRNA
  gi|4507578|ref|NM_—003327.1|[4507578]
• 6988: NM_—001065
  Homo sapiens tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A),
  mRNA
  gi|4507574|ref|NM_—001065.1|[4507574]
• 6989: NM_—001192
  Homo sapiens tumor necrosis factor receptor superfamily, member 17 (TNFRSF17),
  mRNA
  gi|4507572|ref|NM_—001192.1|[4507572]
• 6990: NM_—003820
  Homo sapiens tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14), mRNA
  gi|4507570|ref|NM_—003820.1|[4507570]
• 6991: NM_—003790
  Homo sapiens tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein) (TNFRSF12), mRNA
  gi|4507568|ref|NM_—003790.1|[4507568]
• 6992: NM_—002546
  Homo sapiens tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (TNFRSF11B), mRNA
  gi|4507566|ref|NM_—002546.1|[4507566]
• 6993: NM_—003839
  Homo sapiens tumor necrosis factor receptor superfamily, member lla, activator
  of NFKB (TNFRSF11A), mRNA
  gi|4507564|ref|NM_—003839.1|[4507564]
• 6994: NM_—003840
  Homo sapiens tumor necrosis factor receptor superfamily, member 10d, decoy with
  truncated death domain (TNFRSF10D), mRNA
  gi|4507562|ref|NM_—003840.1|[4507562]
• 6995: NM_—003842
  Homo sapiens tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B),
  mRNA
  gi|4507560|ref|NM_—003842.1|[4507560]
• 6996: NM_—003844
  Homo sapiens tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A),
  mRNA
  gi|4507558|ref|NM_—003844.1|[4507558]
• 6997: NM_—003692
  Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA
  gi|4507548|ref|NM_—003692.1|[4507548]
• 6998: NM_—003273
  Homo sapiens transmembrane 7 superfamily member 2 (TM7SF2), mRNA
  gi|4507546|ref|NM_—003273.1|[4507546]
• 6999: NM_—003272
  Homo sapiens transmembrane 7 superfamily member 1 (upregulated in kidney) (TM7SF1), mRNA
  gi|4507544|ref|NM_—003272.1|[4507544]
• 7000: NM_—000460
  Homo sapiens thrombopoietin (myeloproliferative leukemia virus oncogene ligand,
  megakaryocyte growth and development factor) (THPO), mRNA
  gi|4507492|ref|NM_—000460.1|[4507492]
• 7001: NM_—003844
  Homo sapiens tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A),
  mRNA
  gi|4507558|ref|NM_—003844.1|[4507558]
• 7002: NM_—003692
  Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA
  gi|4507548|ref|NM_—003692.1|[4507548]
• 7003: NM_—003273
  Homo sapiens transmembrane 7 superfamily member 2 (TM7SF2), mRNA
  gi|4507546|ref|NM_—003273.1|[4507546]
• 7004: NM_—003272
  Homo sapiens transmembrane 7 superfamily member 1 (upregulated in kidney) (TM7SF1), mRNA
  gi|4507544|ref|NM_—003272.1|[4507544]
• 7005: NM_—000460
  Homo sapiens thrombopoietin (myeloproliferative leukemia virus oncogene ligand,
  megakaryocyte growth and development factor) (THPO), mRNA
  gi|4507492|ref|NM_—000460.1|[4507492]
• 7006: NM_—000361
  Homo sapiens thrombomodulin (THBD), mRNA
  gi|4507482|ref|NM_—000361.1|[4507482]
• 7007: NM_—003243
  Homo sapiens transforming growth factor, beta receptor III (betaglycan, 300 kD)
  (TGFBR3), mRNA
  gi|4507470|ref|NM_—003243.1|[4507470]
• 7008: NM_—003234
  Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA
  gi|4507456|ref|NM_—003234.1|[4507456]
• 7009: NM_—003608
  Homo sapiens G protein-coupled receptor 65 (GPR65), mRNA
  gi|4507420|ref|NM_—003608.1|[4507420]
• 7010: NM_—001060
  Homo sapiens thromboxane A2 receptor (TBXA2R), mRNA
  gi|4507380|ref|NM_—001060.1|[4507380]
• 7012: NM_—001057
  Homo sapiens tachykinin receptor 2 (TACR2), mRNA
  gi|4507344|ref|NM_—001057.1|[4507344]
• 7013: NM_—003177
  Homo sapiens spleen tyrosine kinase (SYK), mRNA
  gi|4507328|ref|NM_—003177.1|[4507328]
• 7015: NM_—003070
  Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2), mRNA
  gi|4507068|ref|NM_—003070.1|[4507068]
• 7016: NM_—003045
  Homo sapiens solute carrier family 7 (cationic amino acid transporter, y+system), member 1 (SLC7A1), mRNA
  gi|4507046|ref|NM_—003045.1|[4507046]
• 7017: NM_—003037
  Homo sapiens signaling lymphocytic activation molecule (SLAM), mRNA
  gi|4506968|ref|NM_—003037.1|[4506968]
• 7019: NM_—001036
  Homo sapiens ryanodine receptor 3 (RYR3), mRNA
  gi|4506758|ref|NM_—001036.1|[4506758]
• 7020: NM_—001035
  Homo sapiens ryanodine receptor 2 (cardiac) (RYR2), mRNA
  gi|4506756|ref|NM_—001035.1|[4506756]
• 7023: NM_—002921
  Homo sapiens retinal G protein coupled receptor (RGR), mRNA
  gi|4506502|ref|NM_—002921.1|[4506502]
• 7026: NM_—002852
  Homo sapiens pentaxin-related gene, rapidly induced by IL-1 beta (PTX3), mRNA
  gi|4506332|ref|NM_—002852.1|[4506332]
• 7027: NM_—002851
  Homo sapiens protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1), mRNA
  gi|4506328|ref|NM_—002851.1|[4506328]
• 7028: NM_—000316
  Homo sapiens parathyroid hormone receptor 1 (PTHR1), mRNA
  gi|4506270|ref|NM_—000316.1|[4506270]
• 7029: NM_—000960
  Homo sapiens prostaglandin 12 (prostacyclin) receptor (IP) (PTGIR), mRNA
  gi|4506262|ref|NM_—000960.1|[4506262]
• 7030: NM_—000959
  Homo sapiens prostaglandin F receptor (FP) (PTGFR), mRNA
  gi|4506260|ref|NM_—000959.1|[4506260]
• 7031: NM_—000958
  Homo sapiens prostaglandin E receptor 4 (subtype EP4) (PTGER4), mRNA
  gi|4506258|ref|NM_—000958.1|[4506258]
• 7032: NM_—000957
  Homo sapiens prostaglandin E receptor 3 (subtype EP3) (PTGER3), mRNA
  gi|4506256|ref|NM_—000957.1|[4506256]
• 7033: NM_—000955
  Homo sapiens prostaglandin E receptor 1 (subtype EP1), 42 kD (PTGER1), mRNA
  gi|4506252|ref|NM_—000955.1|[4506252]
• 7034: NM_—000952
  Homo sapiens platelet-activating factor receptor (PTAFR), mRNA
  gi|4506240|ref|NM_—000952.1|[4506240]
• 7035: NM_—002769
  Homo sapiens protease, serine, 1 (trypsin 1) (PRSS1), mRNA
  gi|4506144|ref|NM_—002769.1|[4506144]
• 7036: NM_—000949
  Homo sapiens prolactin receptor (PRLR), mRNA
  gi|4506106|ref|NM_—000949.1|[4506106]
• 7037: NM_—002745
  Homo sapiens mitogen-activated protein kinase 1 (MAPK1), mRNA
  gi|4506086|ref|NM_—002745.1|[4506086]
• 7038: NM_—002702
  Homo sapiens POU domain, class 6, transcription factor 1 (POU6F1), mRNA
  gi|4505968|ref|NM_—002702.1|[4505968]
• 7039: NM_—003967
  Homo sapiens putative neurotransmitter receptor (PNR), mRNA
  gi|4505924|ref|NM_—003967.1|[4505924]
• 7040: NM_—002659
  Homo sapiens plasminogen activator, urokinase receptor (PLAUR), mRNA
  gi|4505864|ref|NM_—002659.1|[4505864]
• 7041: NM_—000926
  Homo sapiens progesterone receptor (PGR), mRNA
  gi|4505766|ref|NM_—000926.1|[4505766]
• 7042: NM_—000288
  Homo sapiens peroxisomal biogenesis factor 7 (PEX7), mRNA
  gi|4505730|ref|NM_—000288.1|[4505730]
• 7043: NM_—000287
  Homo sapiens peroxisomal biogenesis factor 6 (PEX6), mRNA
  gi|4505728|ref|NM_—000287.1|[4505728]
• 7044: NM_—002618
  Homo sapiens peroxisome biogenesis factor 13 (PEX13), mRNA
  gi|4505722|ref|NM_—002618.1|[4505722]
• 7045: NM_—002591
  Homo sapiens phosphoenolpyruvate carboxykinase 1 (soluble) (PCK1), mRNA
  gi|4505638|ref|NM_—002591.1|[4505638]
• 7046: NM_—002586
  Homo sapiens pre-B-cell leukemia transcription factor 2 (PBX2), mRNA
  gi|4505624|ref|NM_—002586.1|[4505624]
• 7047: NM_—002569
  Homo sapiens paired basic amino acid cleaving enzyme (furin, membrane associated
  receptor protein) (PACE), mRNA
  gi|4505578|ref|NM_—002569.11 4505578]
• 7048: NM_—002565
  Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 4 (P2RY4), mRNA
  gi|4505560|ref|NM_—002565.1)[4505560]
• 7049: NM_—002566
  Homo sapiens purinergic receptor P2Y, G-protein coupled, 11 (P2RY11), mRNA
  gi|4505554|ref|NM_—002566.1|[4505554]
• 7050: NM_—002562
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 7 (P2RX7), mRNA
  gi|4505552|ref|NM_—002562.1|[4505552]
• 7051: NM_—002561
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), mRNA
  gi|4505550|ref|NM_—002561.1|[4505550]
• 7052: NM_—002560
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 4 (P2RX4), mRNA
  gi|4505548|ref|NM_—002560.1|[4505548]
• 7053: NM_—002559
  Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 3 (P2RX3), mRNA
  gi|4505546|ref|NM_—002559.1|[4505546]
• 7054: NM_—002556
  Homo sapiens oxysterol binding protein (OSBP), mRNA
  gi|4505530|ref|NM_—002556.1|[4505530]
• 7055: NM_—003696
  Homo sapiens olfactory receptor, family 6, subfamily A, member 1 (OR6A1), mRNA
  gi|4505520|ref|NM_—003696.1|[4505520]
• 7056: NM_—002550
  Homo sapiens olfactory receptor, family 3, subfamily A, member 1 (OR3A1), mRNA
  gi|4505518|ref|NM_—002550.1|[4505518]
• 7057: NM_—002548
  Homo sapiens olfactory receptor, family 1, subfamily D, member 2 (OR1D2), mRNA
  gi|4505516|ref|NM_—002548.1|[4505516]
• 7058: NM_—000914
  Homo sapiens opioid receptor, mu 1 (OPRM1), mRNA
  gi|4505514|ref|NM_—000914.1|[4505514]
• 7059: NM_—000912
  Homo sapiens opioid receptor, kappa 1 (OPRK1), mRNA
  gi|4505510|ref|NM_—000912.1|[4505510]
• 7060: NM_—000911
  Homo sapiens opioid receptor, delta 1 (OPRD1), mRNA
  gi|4505508|ref|NM_—000911.1|[4505508]
• 7061: NM_—002543
  Homo sapiens oxidised low density lipoprotein (lectin-like) receptor 1 (OLR1),
  mRNA
  gi|4505500|ref|NM_—002543.1|[4505500]
• 7062: NM_—003485
  Homo sapiens G protein-coupled receptor 68 (GPR68), mRNA
  gi|4505496|ref|NM_—003485.1|[4505496]
• 7063: NM_—002531
  Homo sapiens neurotensin receptor 1 (high affinity) (NTSR1), mRNA
  gi|4505476|ref|NM_—002531.1|[4505476]
• 7064: NM_—002530
  Homo sapiens neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), mRNA
  gi|4505474|ref|NM_—002530.1|[4505474]
• 7065: NM_—003580
  Homo sapiens neutral sphingomyelinase (N-SMase) activation associated factor (NSMAF), mRNA
  gi|4505464|ref|NM_—003580.1|[4505464]
• 7066: NM_—003872
  Homo sapiens neuropilin 2 (NRP2), mRNA
  gi|4505458|ref|NM_—003872.1|[4505458]
• 7067: NM_—003873
  Homo sapiens neuropilin 1 (NRP1), mRNA
  gi|4505456|ref|NM_—003873.1|[4505456]
• 7068: NM_—000910
  Homo sapiens neuropeptide Y receptor Y2 (NPY2R), mRNA
  gi|4505446|ref|NM_—000910.1|[4505446]
• 7069: NM_—000909
  Homo sapiens neuropeptide Y receptor Y1 (NPY1R), mRNA
  gi|4505444|ref|NM_—000909.1|[4505444]
• 7070: NM_—000908
  Homo sapiens natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) (NPR3), mRNA
  gi|4505440|ref|NM_—000908.1|[4505440]
• 7071: NM_—000906
  Homo sapiens natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) (NPR1), mRNA
  gi|4505434|ref|NM_—000906.1|[4505434]
• 7072: NM_—002511
  Homo sapiens neuromedin B receptor (NMBR), mRNA
  gi|4505406|ref|NM_—002511.1|[4505406]
• 7073: NM_—003954
  Homo sapiens mitogen-activated protein kinase kinase kinase 14 (MAP3K14), mRNA
  gi|4505396|ref|NM_—003954.1|[4505396]
• 7074: NM_—002507
  Homo sapiens nerve growth factor receptor (TNFR superfamily, member 16) (NGFR),
  mRNA
  gi|4505392|ref|NM_—002507.1|[4505392]
• 7075: NM_—002447
  Homo sapiens macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
  (MST1R), mRNA
  gi|4505264|ref|NM_—002447.1|[4505264]
• 7076: NM_—002445
  Homo sapiens macrophage scavenger receptor 1 (MSR1), mRNA
  gi|4505258|ref|NM_—002445.1|[4505258]
• 7077: NM_—000529
  Homo sapiens melanocortin 2 receptor (adrenocorticotropic hormone) (MC2R), mRNA
  gi|4505126|ref|NM_—000529.1|[4505126]
• 7078: NM_—002386
  Homo sapiens melanocortin I receptor (alpha melanocyte stimulating hormone receptor) (MC1R), mRNA
  gi|4505124|ref|NM_—002386.1[4505124]
• 7079: NM_—002349
  Homo sapiens lymphocyte antigen 75 (LY75), mRNA
  gi|4505052|ref|NM_—002349.1|[4505052]
• 7080: NM_—002344
  Homo sapiens leukocyte tyrosine kinase (LTK), mRNA
  gi|4505044|ref|NM_—002344.1|[4505044]
• 7081: NM_—000752
  Homo sapiens leukotriene b4 receptor (chemokine receptor-like 1) (LTB4R), mRNA
  gi|4505032|ref|NM_—000752.1[4505032]
• 7082: NM_—002336
  Homo sapiens low density lipoprotein receptor-related protein 6 (LRP6), mRNA
  gi|4505016|ref|NM_—002336.1|[4505016]
• 7083: NM_—002319
  Homo sapiens leucine-rich neuronal protein (LRN), mRNA
  gi|4505012|ref|NM_—002319.1|[4505012]
• 7084: NM_—002303
  Homo sapiens leptin receptor (LEPR), mRNA
  gi|4504978|ref|NM_—002303.1|[4504978]
• 7085: NM_—002291
  Homo sapiens laminin, beta 1 (LAMB1), mRNA
  gi|4504950|ref|NM_—002291.1[4504950]
• 7086: NM_—002258
  Homo sapiens killer cell lectin-like receptor subfamily B, member 1 (KLRB1), mRNA
  gi|4504878|ref|NM_—002258.1|[4504878]
• 7087: NM_—002255
  Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), mRNA
  gi|4504870|ref|NM_—002255.1|[4504870]
• 7088: NM_—002227
  Homo sapiens Janus kinase 1 (a protein tyrosine kinase) (JAK1), mRNA
  gi|4504802|ref|NM_—002227.1|[4504802]
• 7091: NM_—002210
  Homo sapiens integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen
  CD51) (ITGAV), mRNA
  gi|4504762|ref|NM_—002210.1|[4504762]
• 7092: NM_—002205
  Homo sapiens integrin, alpha 5 (fibronectin receptor, alpha polypeptide) (ITGA5), mRNA
  gi|4504750|ref|NM_—002205.1|[4504750]
• 7094: NM_—001565
  Homo sapiens small inducible cytokine subfamily B (Cys-X-Cys), member 10 (SCYB10), mRNA
  gi|4504700|ref|NM_—001565.1|[4504700]
• 7095: NM_—001557
  Homo sapiens interleukin 8 receptor, beta (IL8RB), mRNA
  gi|4504682|ref|NM_—001557.1|[4504682]
• 7096: NM_—000634
  Homo sapiens interleukin 8 receptor, alpha (IL8RA), mRNA
  gi|4504680|ref|NM_—000634.1|[4504680]
• 7097: NM_—002185
  Homo sapiens interleukin 7 receptor (IL7R), mRNA
  gi|4504678|ref|NM_—002185.1|[4504678]
• 7098: NM_—002184
  Homo sapiens interleukin 6 signal transducer (gp130, oncostatin M receptor) (IL6ST), mRNA
  gi|4504674|ref|NM_—002184.1|[4504674]
• 7099: NM_—000565
  Homo sapiens interleukin 6 receptor (IL6R), mRNA
  gi|4504672|ref|NM_—000565.1|[4504672]
• 7100: NM_—000878
  Homo sapiens interleukin 2 receptor, beta (IL2RB), mRNA
  gi|4504664|ref|NM_—000878.1|[4504664]
• 7101: NM_—003854
  Homo sapiens interleukin 1 receptor-like 2 (IL1RL2), mRNA
  gi|4504662|ref|NM_—003854.1|[4504662]
• 7102: NM_—000877
  Homo sapiens interleukin 1 receptor, type I (IL1R1), mRNA
  gi|4504658|ref|NM_—000877.1|[4504658]
• 7103: NM_—003853
  Homo sapiens interleukin 18 receptor accessory protein (IL18RAP), mRNA
  gi|4504656|ref|NM_—003853.1|[4504656]
• 7104: NM_—002189
  Homo sapiens interleukin 15 receptor, alpha (IL15RA), mRNA
  gi|4504648|ref|NM_—002189.1|[4504648]
• 7105: NM_—001559
  Homo sapiens interleukin 12 receptor, beta 2 (IL12RB2), mRNA
  gi|4504642|ref|NM_—001559.1|[4504642]
• 7106: NM_—001558
  Homo sapiens interleukin 10 receptor, alpha (IL10RA), mRNA
  gi|4504632|ref|NM_—001558.1|[4504632]
• 7107: NM_—000876
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R), mRNA
  gi|4504610|ref|NM_—000876.1|[4504610]
• 7108: NM_—000871
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 6 (HTR6), mRNA
  gi|4504544|ref|NM_—000871.1|[4504544]
• 7109: NM_—000869
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3A (HTR3A), mRNA
  gi|4504542|ref|NM_—000869.1|[4504542]
• 7110: NM_—000868
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2C (HTR2C), mRNA
  gi|4504540|ref|NM_—000868.1|[4504540]
• 7111: NM_—000867
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2B (HTR2B), mRNA
  gi|4504538|ref|NM_—000867.1|[4504538]
• 7112: NM_—000865
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1E (HTR1E), mRNA
  gi|4504536|ref|NM_—000865.1|[4504536]
• 7113: NM_—000863
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B), mRNA
  gi|4504532|ref|NM_—000863.1|[4504532]
• 7114: NM_—000524
  Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1A (HTR1A), mRNA
  gi|4504530|ref|NM_—000524.1|[4504530]
• 7115: NM_—000186
  Homo sapiens H factor 1 (complement) (HF1), mRNA
  gi|4504374|ref|NM_—000186.1|[4504374]
• 7116: NM_—001523
  Homo sapiens hyaluronan synthase 1 (HAS1), mRNA
  gi|4504338|ref|NM_—001523.1|[4504338]
• 7117: NM_—000845
  Homo sapiens glutamate receptor, metabotropic 8 (GRM8), mRNA
  gi|4504148|ref|NM_—000845.1|[4504148]
• 7118: NM_—000844
  Homo sapiens glutamate receptor, metabotropic 7 (GRM7), mRNA
  gi|4504146|ref|NM_—000844.1|[4504146]
• 7119: NM_—000841
  Homo sapiens glutamate receptor, metabotropic 4 (GRM4), mRNA
  gi|4504140|ref|NM_—000841.1|[4504140]
• 7120: NM_—000840
  Homo sapiens glutamate receptor, metabotropic 3 (GRM3), mRNA
  gi|4504138|ref|NM_—000840.1|[4504138]
• 7121: NM_—000831
  Homo sapiens glutamate receptor, ionotropic, kainate 3 (GRIK3), mRNA
  gi|4504118|ref|NM_—000831.1|[4504118]
• 7122: NM_—000830
  Homo sapiens glutamate receptor, ionotropic, kainate 1 (GRIK1), mRNA
  gi|4504116|ref|NM_—000830.1|[4504116]
• 7123: NM_—002086
  Homo sapiens growth factor receptor-bound protein 2 (GRB2), mRNA
  gi|4504110|ref|NM_—002086.1|[4504110]
• 7124: NM_—002082
  Homo sapiens G protein-coupled receptor kinase 6 (GPRK6), mRNA
  gi|4504100|ref|NM_—002082.1|[4504100]
• 7125: NM_—001504
  Homo sapiens G protein-coupled receptor 9 (GPR9), mRNA
  gi|4504098|ref|NM_—001504.1|[4504098]
• 7126: NM_—001508
  Homo sapiens G protein-coupled receptor 39 (GPR39), mRNA
  gi|4504096|ref|NM_—001508.1|[4504096]
• 7127: NM_—001507
  Homo sapiens G protein-coupled receptor 38 (GPR38), mRNA
  gi|4504094|ref|NM_—001507.1|[4504094]
• 7128: NM_—001506
  Homo sapiens G protein-coupled receptor 32 (GPR32), mRNA
  gi|4504092|ref|NM_—001506.1|[4504092]
• 7129: NM_—001505
  Homo sapiens G protein-coupled receptor 30 (GPR30), mRNA
  gi|4504090|ref|NM_—001505.1|[4504090]
• 7130: NM_—000173
  Homo sapiens glycoprotein Ib (platelet), alpha polypeptide (GP1BA) mRNA
  gi|4504070|ref|NM_—000173.1|[4504070]
• 7131: NM_—000824
  Homo sapiens glycine receptor, beta (GLRB), mRNA
  gi|4504022|ref|NM_—000824.1|[4504022]
• 7132: NM_—002063
  Homo sapiens glycine receptor, alpha 2 (GLRA2), mRNA
  gi|4504020|ref|NM_—002063.1|[4504020]
• 7133: NM_—000164
  Homo sapiens gastric inhibitory polypeptide receptor (GIPR), mRNA
  gi|4503998|ref|NM_—000164.1|[4503998]
• 7134: NM_—000823
  Homo sapiens growth hormone releasing hormone receptor (GHRHR), mRNA
  gi|4503996|ref|NM_—000823.1|[4503996]
• 7135: NM_—000163
  Homo sapiens growth hormone receptor (GHR), mRNA
  gi|4503992|ref|NM_—000163.1|[4503992]
• 7136: NM_—000160
  Homo sapiens glucagon receptor (GCGR), mRNA
  gi|4503946|ref|NM_—000160.1|[4503946]
• 7137: NM_—003614
  Homo sapiens galanin receptor 3 (GALR3), mRNA
  gi|4503906|ref|NM_—003614.1|[4503906]
• 7138: NM_—002043
  Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 2 (GABRR2), mRNA
  gi|4503870|ref|NM_—002043.1|[4503870]
• 7139: NM_—002042
  Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 1 (GABRR1), mRNA
  gi|4503868|ref|NM_—002042.1|[4503868]
• 7140: NM_—002036
  Homo sapiens Duffy blood group (FY), mRNA
  gi|4503818|ref|NM_—002036.1|[4503818]
• 7141: NM_—001462
  Homo sapiens formyl peptide receptor-like 1 (FPRL1), mRNA
  gi|4503780|ref|NM_—001462.1|[4503780]
• 7142: NM_—002029
  Homo sapiens formyl peptide receptor 1 (FPR1), mRNA
  gi|4503778|ref|NM_—002029.1|[4503778]
• 7143: NM_—001461
  Homo sapiens flavin containing monooxygenase 5 (FMO5), mRNA
  gi|4503760|ref|NM_—001461.1|[4503760]
• 7144: NM_—002020
  Homo sapiens fms-related tyrosine kinase 4 (FLT4), mRNA
  gi|4503752|ref|NM_—002020.1|[4503752]
• 7145: NM_—001459
  Homo sapiens fms-related tyrosine kinase 3 ligand (FLT3LG), mRNA
  gi|4503750|ref|NM_—001459.1|[4503750]
• 7146: NM_—002019
  Homo sapiens fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1), mRNA
  gi|4503748|ref|NM_—002019.1|[4503748]
• 7147: NM_—002002
  Homo sapiens Fc fragment of IgE, low affinity II, receptor for (CD23A) (FCER2),
  mRNA
  gi|4503678|ref|NM_—002002.1|[4503678]
• 7148: NM_—002001
  Homo sapiens Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A), mRNA
  gi|4503674|ref|NM_—002001.1|[4503674]
• 7149: NM_—003950
  Homo sapiens coagulation factor II (thrombin) receptor-like 3 (F2RL3), mRNA
  gi|4503638|ref|NM_—003950.1|[4503638]
• 7150: NM_—001981
  Homo sapiens epidermal growth factor receptor pathway substrate 15 (EPS15), mRNA
  gi|4503592|ref|NM_—001981.1|[4503592]
• 7151: NM_—001974
  Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 1 (EMR1), mRNA
  gi|4503564|ref|NM_—001974.1|[4503564]
• 7152: NM_—001423
  Homo sapiens epithelial membrane protein 1 (EMP1), mRNA
  gi|4503558|ref|NM_—001423.1|[4503558]
• 7153: NM_—003757
  Homo sapiens eukaryotic translation initiation factor 3, subunit 2 (beta, 36 kD)
  (EIF3S2), mRNA
  gi|4503512|ref|NM_—003757.1|[4503512]
• 7154: NM_—001406
  Homo sapiens ephrin-B3 (EFNB3), mRNA
  gi|4503488|ref|NM_—001406.1|[4503488]
• 7155: NM_—001962
  Homo sapiens ephrin-A5 (EFNA5), mRNA
  gi|4503486|ref|NM_—001962.1|[4503486]
• 7156: NM_—001405
  Homo sapiens ephrin-A2 (EFNA2), mRNA
  gi|4503484|ref|NM_—001405.1|[4503484]
• 7157: NM_—003775
  Homo sapiens endothelial differentiation, G-protein-coupled receptor 6 (EDG6),
  mRNA
  gi|4503458|ref|NM_—003775.1|[4503458]
• 7158: NM_—001945
  Homo sapiens diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) (DTR), mRNA
  gi|4503412|ref|NM_—001945.1|[4503412]
• 7159: NM_—001360
  Homo sapiens 7-dehydrocholesterol reductase (DHCR7), mRNA
  gi|4503320|ref|NM_—001360.1|[4503320]
• 7160: NM_—003467
  Homo sapiens chemokine (C-X-C motif), receptor 4 (fusin) (CXCR4), mRNA
  gi|4503174|ref|NM_—003467.1|[4503174]
• 7161: NM_—001338
  Homo sapiens coxsackie virus and adenovirus receptor (CXADR), mRNA
  gi|4503172|ref|NM_—001338.1|[4503172]
• 7162: NM_—003478
  Homo sapiens cullin 5 (CUL5), mRNA
  gi|4503166|ref|NM_—003478.1|[4503166]
• 7163: NM_—001330
  Homo sapiens cardiotrophin 1 (CTF1), mRNA
  gi|4503120|ref|NM_—001330.1|[4503120]
• 7164: NM_—000760
  Homo sapiens colony stimulating factor 3 receptor (granulocyte) (CSF3R), mRNA
  gi|4503080|ref|NM_—000760.1|[4503080]
• 7165: NM_—003805
  Homo sapiens CASP2 and RIPK1 domain containing adaptor with death domain (CRADD), mRNA
  gi|4503030|ref|NM_—003805.1|[4503030]
• 7166: NM_—001877
  Homo sapiens complement component (3d/Epstein Barr virus) receptor 2 (CR2), mRNA
  gi|4503026|ref|NM_—001877.1|[4503026]
• 7167: NM_—001842
  Homo sapiens ciliary neurotrophic factor receptor (CNTFR), mRNA
  gi|4502930|ref|NM_—001842.1|[4502930]
• 7168: NM_—001281
  Homo sapiens cytoskeleton-associated protein 1 (CKAP1), mRNA
  gi|4502848|ref|NM_—001281.1|[4502848]
• 7169: NM_—000750
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 4 (CHRNB4), mRNA
  gi|4502836|ref|NM_—000750.1|[4502836]
• 7170: NM_—000749
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 3 (CHRNB3), mRNA
  gi|4502834|ref|NM_—000749.1|[4502834]
• 7171: NM_—000748
  Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) (CHRNB2), mRNA
  gi|4502832|ref|NM_—000748.1|[4502832]
• 7172: NM_—000746
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 7 (CHRNA7),
  gi|4502830|ref|NM_—000746.1|[4502830]
• 7173: NM_—000745
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 5 (CHRNA5), mRNA
  gi|4502828|ref|NM_—000745.1|[4502828]
• 7174: NM_—000744
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 4 (CHRNA4), mRNA
  gi|4502826|ref|NM_—000744.1|[4502826]
• 7175: NM_—000742
  Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) (CHRNA2), mRNA
  gi|4502822|ref|NM_—000742.1|[4502822]
• 7176: NM_—000741
  Homo sapiens cholinergic receptor, muscarinic 4 (CHRM4), mRNA
  gi|4502820|ref|NM_—000741.1|[4502820]
• 7177: NM_—000740
  Homo sapiens cholinergic receptor, muscarinic 3 (CHRM3), mRNA
  gi|4502818|ref|NM_—000740.1|[4502818]
• 7178: NM_—000739
  Homo sapiens cholinergic receptor, muscarinic 2 (CHRM2), mRNA
  gi|4502816|ref|NM_—000739.1|[4502816]
• 7179: NM_—000738
  Homo sapiens cholinergic receptor, muscarinic 1 (CHRM1), mRNA
  gi|4502814|ref|NM_—000738.1|[4502814]
• 7181: NM_—001768
  Homo sapiens CD8 antigen, alpha polypeptide (p32) (CD8A), mRNA
  gi|4502688|ref|NM_—001768.1|[4502688]
• 7182: NM_—001781
  Homo sapiens CD69 antigen (p60, early T-cell activation antigen) (CD69), mRNA
  gi|4502680|ref|NM_—001781.1|[4502680]
• 7183: NM_—001779
  Homo sapiens CD58 antigen, (lymphocyte function-associated antigen 3) (CD58), mRNA
  gi|4502676|ref|NM_—001779.1|[4502676]
• 7184: NM_—000733
  Homo sapiens CD3E antigen, epsilon polypeptide (TiT3 complex) (CD3E), mRNA
  gi|4502670|ref|NM_—000733.1|[4502670]
• 7185: NM_—000732
  Homo sapiens CD3D antigen, delta polypeptide (TiT3 complex) (CD3D), mRNA
  gi|4502668|ref|NM_—000732.1|[4502668]
• 7186: NM_—001775
  Homo sapiens CD38 antigen (p45) (CD38), mRNA
  gi|4502664|ref|NM_—001775.1|[4502664]
• 7187: NM_—001767
  Homo sapiens CD2 antigen (p50), sheep red blood cell receptor (CD2), mRNA
  gi|4502652|ref|NM_—001767.1|[4502652]
• 7188: NM_—001837
  Homo sapiens chemokine (C-C motif) receptor 3 (CCR3), mRNA
  gi|4502636|ref|NM_—001837.1|[4502636]
• 7189: NM_—000731
  Homo sapiens cholecystokinin B receptor (CCKBR), mRNA
  gi|4502608|ref|NM_—000731.1|[4502608]
• 7190: NM_—000730
  Homo sapiens cholecystokinin A receptor (CCKAR), mRNA
  gi|4502606|ref|NM_—000730.1|[4502606]
• 7191: NM_—001742
  Homo sapiens calcitonin receptor (CALCR), mRNA
  gi|4502546|ref|NM_—001742.1|[4502546]
• 7192: NM_—001737
  Homo sapiens complement component 9 (C9), mRNA
  gi|4502510|ref|NM_—001737.1|[4502510]
• 7193: NM_—001736
  Homo sapiens complement component 5 receptor 1 (C5a ligand) (C5R1), mRNA
  gi|4502508|ref|NM_—001736.1|[4502508]
• 7194: NM_—001732
  Homo sapiens butyrophilin, subfamily 1, member A1 (BTN1A1), mRNA
  gi|4502474|ref|NM_—001732.1|[4502474]
• 7195: NM_—001729
  Homo sapiens betacellulin (BTC), mRNA
  gi|4502460|ref|NM_—001729.1|[4502460]
• 7196: NM_—001727
  Homo sapiens bombesin-like receptor 3 (BRS3), mRNA
  gi|4502454|ref|NM_—001727.1|[4502454]
• 7197: NM_—001203
  Homo sapiens bone morphogenetic protein receptor, type IB (BMPR1B), mRNA
  gi|4502430|ref|NM_—001203.1|[4502430]
• 7198: NM_—000710
  Homo sapiens bradykinin receptor B1 (BDKRB1), mRNA
  gi|4502390|ref|NM_—000710.1|[4502390]
• 7199: NM_—003921
  Homo sapiens B-cell CLL/lymphoma 10 (BCL10), mRNA
  gi|4502378|ref|NM_—003921.1|[4502378]
• 7200: NM_—001168
  Homo sapiens baculoviral IAP repeat-containing 5 (survivin) (BIRC5), mRNA
  gi|4502144|ref|NM_—001168.1|[4502144]
• 7201: NM_—001150
  Homo sapiens alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase
  M, microsomal aminopeptidase, CD13, p150) (ANPEP), mRNA
  gi|4502094|ref|NM_—001150.1|[4502094]
• 7202: NM_—001146
  Homo sapiens angiopoietin 1 (ANGPT1), mRNA
  gi|4502086|ref|NM_—001146.1|[4502086]
• 7203: NM_—000676
  Homo sapiens adenosine A2b receptor (ADORA2B), mRNA
  gi|4501950|ref|NM_—000676.1|[4501950]
• 7204: NM_—000674
  Homo sapiens adenosine A1 receptor (ADORA1), mRNA
  gi|4501946|ref|NM_—000674.1-|[4501946]
• 7205: NM_—001118
  Homo sapiens adenylate cyclase activating polypeptide 1 (pituitary) receptor type I (ADCYAP1R1), mRNA
  gi|4501922|ref|NM_—001118.1|[4501922]
• 7206: AF287270
  Homo sapiens mucolipin (MCOLN1) gene, complete cds
  gi|9844925|gb|AF287270.1|AF287270[9844925]
• 7207: AF287269
  Homo sapiens mucolipin (MCOLN1) mRNA, complete cds
  gi|9844923|gb|AF287269.1|AF287269[9844923]
• 7208: AF307080
  Homo sapiens lectomedin-3 (LEC3) mRNA, complete cds
  gi|11037015|gb|AF307080.1|AF307080[11037015]
• 7209: AF307079
  Homo sapiens lectomedin-2 (LEC2) mRNA, complete cds
  gi|1037013|gb|AF307079.1|AF307079[11037013]
• 7216: AF265242
  Homo sapiens type-I T cell cytokine receptor mRNA, complete cds
  gi|103679|gb|AF265242.1|AF265242[11036791]
• 7217: AF018284
  Homo sapiens P2Y1 receptor (P2YR1) mRNA, partial cds
  gi|2738815|gb|AF018284.1|AF018284[2738815]
• 7218: AF017307
  Homo sapiens Ets-related transcription factor (ERT) mRNA, complete cds
  gi|2338755|gb|AF017307.1|AF017307[2338755]
• 7219: AF106912
  Homo sapiens CRL1 protein (CRL1) mRNA, complete cds
  gi|1022746|gb|AF106912.1|AF106912[11022746]
• 7220: AB042033
  Homo sapiens FCER1B gene for high affinity IgE receptor beta subunit, 5′ flanking sequence and partial cds
  gi|11022658|dbj|AB042033.1|AB042033[11022658]
• 7221: AB019000
  Homo sapiens mRNA for G-protein coupled receptor, complete cds
  gi|11022652|dbj|AB019000.1|AB019000[11022652]
• 7222: AH007076
  Homo sapiens chromosome 13 map 13q34
  gi|3955190|gb|AH007076.1|SEG_HSGRKIN[3955190]
• 7223: AF019765
  Homo sapiens G protein-coupled receptor kinase 1 and G protein-coupled receptor
  kinase 1b (GRK1) gene, alternatively spliced, alternative exon 6, exon 7, and partial cds
  gi|3955189|gb|AF019765.1|HSGRKIN2[3955189]
• 7224: AF019764
  Homo sapiens G protein-coupled receptor kinase 1 and G protein-coupled receptor
  kinase 1b (GRK1) gene, alternatively spliced, exon 6, alternative exon 6, and partial cds
  gi|3955188|gb|AF019764.1|HSGRKIN1[3955188]
• 7225: AF035819
  Homo sapiens macrophage receptor MARCO mRNA, complete cds
  gi|3002790|gb|AF035819.1|AF035819[3002790]
• 7227: AF253318
  Homo sapiens GFR receptor alpha 4 protein (GFRA4) mRNA, complete cds
  gi|10998399|gb|AF253318.1|AF253318[10998399]
• 7228: AF077186
  Homo sapiens neuronal nicotinic acetylcholine receptor beta 2 (CHRNB2) gene, complete cds
  gi|10947140|gb|AF077186.2|[10947140]
• 7229: AF272363
  Homo sapiens neuromedin U receptor 2 (NMUR2) mRNA, complete cds
  gi|10946202|gb|AF272363.1|AF272363[10946202]
• 7230: AF272362
  Homo sapiens neuromedin U receptor 1 (NMUR1) mRNA, complete cds
  gi|10946200|gb|AF272362.1|AF272362[10946200]
• 7231: AJ277437
  Homo sapiens mRNA for fibroblast growth factor receptor-like protein 1, (FGFRL1 gene)
  gi|10944886|emb|AJ277437.1|HSA277437[10944886]
• 7232: G64264
  Alk4/3′ Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
  gi|9802476|gb|G64264.1|G64264[9802476]
• 7233: G64261
  AMHR2/ex1-2 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
  gi|9802473|gb|G64261.1|G64261[9802473]
• 7234: G64251
  Alk4/ex1 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
  gi|9802463|gb|G64251.1|G64251[9802463]
• 7235: G64250
  Alk1/ex10 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
  gi|9802462|gb|G64250.1|G64250[9802462]
• 7236: G64249
  Alk1/ex2 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
  gi|9802461|gb|G64249.1|G64249[9802461]
• 7237: AF301005
  Homo sapiens gamma-aminobutyric acid receptor GABA-B1e mRNA, complete cds
  gi|10863757|gb|AF301005.1|AF301005[10863757]
• 7238: AF269133
  Homo sapiens novel interleukin receptor (NILR) mRNA, complete cds
  gi|10801191|gb|AF269133.1|AF269133[10801190]
• 7239: AF127670
  Homo sapiens hyaluronic acid receptor (HAR) mRNA, complete cds
  gi|10800121|gb|AF127670.2|AF127670[10800121]
• 7241: AF284436
  Homo sapiens TIGIRR-1 mRNA, complete cds
  gi|10644689|gb|AF284436.1|AF284436[10644689]
• 7242: AF284435
  Homo sapiens TIGIRR-2 mRNA, complete cds
  gi|10644687|gb|AF284435.1|AF284435[10644687]
• 7243: AF284434
  Homo sapiens IL-1Rrp2 mRNA, complete cds
  gi|10644685|gb|AF284434.1|AF284434[10644685]
• 7244: M35198
  Homo sapiens integrin beta-subunit mRNA, complete cds
  gi|9961228|gb|M35198.3|HUMINTB6A[9961228]
• 7245: AF302903
  Homo sapiens vomeronasal receptor 1 (VNR19I1) mRNA, complete cds
  gi|10732801|gb|AF302903.1|AF302903[10732801]
• 7246: AF286095
  Homo sapiens IL-22 receptor (IL22R) mRNA, complete cds
  gi|10719607|gb|AF286095.1|AF286095[10719607]
• 7248: AF239668
  Homo sapiens CCK-B/gastrin receptor mRNA, complete cds; alternatively spliced
  gi|7677459|gb|AF239668.1|AF239668[7677459]
• 7249: AF029759
  Homo sapiens mutant G protein-coupled receptor STRL33 (STRL33) gene, STRL33-3K allele, complete cds
  gi|10716827|gb|AF029759.1|AF029759[10716827]
• 7250: AB041644
  Homo sapiens gene for cysteinyl leukotriene receptor like receptor, complete cds
  gi|10716135|dbj|AB041644.1|AB041644[10716135]
• 7251: AF237381
  Homo sapiens CCR3 gene and exon 3
  gi|10643653|gb|AF237381.1|AF237380S2[10643653]
• 7252: AF237380
  Homo sapiens CCR3 gene, promotor and exon 1
  gi|10643652|gb|AF237380.1|AF237380S1[10643652]
• 7253: AH009867
  Homo sapiens
  gi|10643651|gb|AH009867.1|SEG_AF237380S[10643651]
• 7254: AF233516
  Homo sapiens PD-1-ligand precursor, mRNA, complete cds
  gi|10567621|gb|AF233516.1|AF233516[10567621]
• 7255: AJ297688
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 1 and joined CDS
  gi|0445329|emb|AJ297688.1|HSA297688[10445329]
• 7256: AJ297701
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exons 16-gi|10443220|emb|AJ297701.1|HSA297701[10443220]
• 7257: AJ297700
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 15
  gi|10443219|emb|AJ297700.1|HSA297700[10443219]
• 7258: AJ297699
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 14
  gi|10443218|emb|AJ297699.1|HSA297699[10443218]
• 7259: AJ297698
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 13
  gi|0443217|emb|AJ297698.1HSA297698[10443217]
• 7260: AJ297697
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 12
  gi|10443216|emb|AJ297697.1|HSA297697[10443216]
• 7261: AJ297696
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 11
  gi|10443215|emb|AJ297696.1|HSA297696[10443215]
• 7262: AJ297695
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 10
  gi|10443214|emb|AJ297695.1|HSA297695[10443214]
• 7263: AJ297694
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 9
  gi|10443213|emb|AJ297694.1|HSA297694[10443213]
• 7264: AJ297693
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 8
  gi|10443212|emb|AJ297693.1|HSA297693[10443212]
• 7265: AJ297692
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exons 6-7
  gi|0443211|emb|AJ297692.1|HSA297692[10443211]
• 7266: AJ297691
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 5
  gi|0443210|emb|AJ297691.1|HSA297691[10443210]
• 7267: AT2976910
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 4
  gi|10443209|emb|AJ297690.1|HSA297690[10443209]
• 7268: AJ297689
  Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exons 2-3
  gi|10443208|emb|AJ297689.1|HSA297689[10443208]
• 7269: AJ276452
  Homo sapiens partial pIgR gene for polymeric immunoglobulin receptor, partial intron 1 and partial exon 2
  gi|10303247|emb|AJ276452.1|HSA276452[10303247]
• 7271: AF254664
  Homo sapiens cysteinyl leukotriene receptor CYSLT2 gene, complete cds
  gi|10442007|gb|AF254664.1|AF254664[10442007]
• 7273: AC005330
  Homo sapiens chromosome 19, cosmid R34047 and overlapping PCR product, complete
  sequence
  gi|10305189|gb|AC005330.2|AC005330[10305189]
• 7517: AF176039
  Homo sapiens high mobility group protein-R mRNA, complete cds
  gi|5834272|gb|AF176039.1|AF176039[5834272]
• 7518: AB041228
  Homo sapiens mRNA for G protein-coupled receptor TGR-1, complete cds
  gi|10257380|dbj|AB041228.1|AB041228[10257380]
• 7519: AF282262
  Homo sapiens GHRH receptor splice variant 4 mRNA, complete cds
  gi|10242297|gb|AF282262.1|AF282262[10242297]
• 7520: AF282261
  Homo sapiens GHRH receptor splice variant 3 mRNA, complete cds
  gi|10242295|gb|AF282261.1|AF282261[10242295]
• 7521: AF282260
  Homo sapiens GHRH receptor splice variant 2 mRNA, complete cds
  gi|10242293|gb|AF282260.1|AF282260[10242293]
• 7522: AF282259
  Homo sapiens GHRH receptor splice variant 1 mRNA, complete cds
  gi|10242291|gb|AF282259.1|AF282259[10242291]
• 7523: X80389
  H. sapiens platelet-derived growth factor alpha receptor DNA
  gi|10241726|emb|X80389.2|HSPDGFAD[10241726]
• 7524: AF177761
  Homo sapiens herstatin (HER-2) mRNA, alternatively spliced, complete cds
  gi|10181232|gb|AF177761.2|AF177761[10181232]
• 7525: AF005058
  Homo sapiens chemokine receptor (CXCR-4) gene, complete cds
  gi|2735718|gb|AF005058.1|AF005058[2735718]
• 7526: AF264716
  Homo sapiens complement receptor type 1 (CR1) gene, CR1*SCR25-HUM1 allele, partial cds
  gi|10185787|gb|AF264716.1|AF264716[10185787]
• 7527: AF264715
  Homo sapiens complement receptor type 1 (CR1) gene, CR1*SCR25-HUM2 allele, partial cds
  gi|10185785|gb|AF264715.1|AF264715[10185785]
• 7528: AF250237
  Homo sapiens orphan G protein-coupled receptor 85 (GPR85) mRNA, complete cds
  gi|10181092|gb|AF250237.2|AF250237[10181092]
• 7533: AF189277
  Homo sapiens leukocyte immunoglobulin-like receptor 1 (LIR1) gene, complete cds
  gi|9954209|gb|AF189277.1|AF189277[9954209]
• 7534: AB010994
  Homo sapiens hedgehog gene, exon 3 and complete cds
  gi|10047225|dbj|AB010994.2|AB010581S3[10047225]
• 7535: AB010993
  Homo sapiens hedgehog gene, exon 2
  gi|10047224|dbj|AB010993.2|AB010581S2[10047224]
• 7536: AB010581
  Homo sapiens hedgehog gene, exon 1
  gi|10047223|dbj|AB010581.2|AB010581S1[10047223]
• 7537: SEG_AB010581S
  Homo sapiens hedgehog gene
  gi|0047222|dbj|SEG_AB010581S[10047222]
• 7538: AX015117
  Sequence 8 from Patent WO9952943
  gi|10041220|emb|AX015117.1|AX015117[10041220]
• 7539: AX015116
  Sequence 7 from Patent WO9952943
  gi|10041219|emb|AX015116.1|AX015116[10041219]
• 7540: AX015115
  Sequence 6 from Patent WO9952943
  gi|10041218|emb|AX015115.1|AX015115[10041218]
• 7541: AX015114
  Sequence 5 from Patent WO9952943
  gi|10041217|emb|AX015114.1|AX015114[10041217]
• 7542: AX015113
  Sequence 4 from Patent WO9952943
  gi|10041216|emb|AX015113.1|AX015113[10041216]
• 7543: AX015112
  Sequence 3 from Patent WO9952943
  gi|10041215|emb|AX015112.1|AX015112[10041215]
• 7544: AX015111
  Sequence 2 from Patent WO9952943
  gi|10041214|emb|AX015111.1|AX015111[10041214]
• 7545: AX015110
  Sequence 1 from Patent WO9952943
  gi|10041213|emb|AX015110.1|AX015110[10041213]
• 7546: AF042080
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  mRNA, complete cds
  gi|2801556|gb|AF042080.1|AF042080[2801556]
• 7547: AF255342
  Homo sapiens putative pheromone receptor V1RL1 long form (V1RL1) mRNA, complete
  cds
  gi|9988584|gb|AF255342.1|AF255342[9988584]
• 7548: AF254747
  Homo sapiens ROR2 protein (ROR2) gene, exon 2
  gi|9664303|gb|AF254747.1|AF254747S1[9664303]
• 7550: AJ295613
  Homo sapiens partial GHR gene for growth hormone receptor, exon 2
  gi|9968301|emb|AJ295613.1|HSA295613[9968301]
• 7551: AJ278681
  Homo sapiens partial GHR gene for growth hormone receptor, exons 8-10
  gi|9968297|emb|AJ278681.1|HSA278681[9968297]
• 7553: AF217963
  Homo sapiens NRAGE mRNA, complete cds
  gi|9963809|gb|AF217963.1|AF217963[9963809]
• 7554: AF169970
  Homo sapiens complement receptor 1 (CR1) gene, CR1*SCR25-HUM5 allele, exon 29 and partial cds
  gi|9956947|gb|AF169970.1|AF169970[9956947]
• 7555: AF169969
  Homo sapiens complement receptor 1 (CR1) gene, CR1*SCR25-HUM4 allele, exon 29 and partial cds
  gi|9956945|gb|AF169969.1|AF169969[9956945]
• 7556: AB044402
  Homo sapiens mRNA for LTB4 receptor JULF2, complete cds
  gi|9081802|dbj|AB044402.1|AB044402[9081802]
• 7557: U96190
  Homo sapiens p58 NK cell inhibitory receptor NKR-K7 mRNA, partial cds
  gi|2088618|gb|U96190.1|HSU96190[2088618]
• 7558: U96189
  Homo sapiens p58 NK cell inhibitory receptor NKR-K6 mRNA, partial cds
  gi|2088616|gb|U96189.1|HSU96189[2088616]
• 7559: U96188
  Homo sapiens p50 cell activatory receptor NKR-K1 mRNA, partial cds
  gi|2088614|gb|U96188.1|HSU96188[2088614]
• 7560: AF251841
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 29, 30, and complete cds
  gi|9944844|gb|AF251841.1|F251818S24[9944844]
• 7561: AF251840
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 27 and
  gi|9944843|gb|AF251840.1F251818S23[9944843]
• 7562: AF251839
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 26
  gi|99448421|gb|AF251839.1|F251818S22[9944842]
• 7563: AF251838
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 25
  gi|9944841|gb|AF251838.1|F251818S21[9944841]
• 7564: AF251837
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 23 and
  gi|9944840|gb|AF251837.1F251818S20[9944840]
• 7565: AF251836
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 22
  gi|9944839|gb|AF251836.1|F251818S19[9944839]
• 7566: AF251835
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 20 and
  gi|9944838|gb|AF251835.1|F251818S18[9944838]
• 7567: AF251834
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 19
  gi|9944837|gb|AF251834.1F251818S17[9944837]
• 7568: AF251833
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 18
  gi|9944836|gb|AF251833.1|F251818S16[9944836]
• 7569: AF251832
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 17
  gi|9944835|gb|AF251832.1|F251818S15[9944835]
• 7570: AF251831
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 16
  gi|9944834|gb|AF251831.1|F251818S14[9944834]
• 7571: AF251830
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 15
  gi|9944833|gb|AF251830.1|F251818S13[9944833]
• 7572: AF251829
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 14
  gi|9944832|gb|AF251829.1|F251818S12[9944832]
• 7573: AF251828
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 13
  gi|9944831|gb|AF251828.1|F251818S11[9944831]
• 7574: AF251827
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 11 and
  gi|9944830|gb|AF251827.1|F251818S10[9944830]
• 7575: AF251826
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 9 and
  gi|9944829|gb|AF251826.1|F251818S09[9944829]
• 7576: AF251825
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 8
  gi|9944828|gb|AF251825.1|F251818S08[9944828]
• 7577: AF251824
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 7
  gi|9944827|gb|AF251824.1F251818S07[9944827]
• 7578: AF251823
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 6
  gi|9944826|gb|AF251823.1|F251818S06[9944826]
• 7579: AF251822
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 5
  gi|9944825|gb|AF251822.1|F251818S05[9944825]
• 7580: AF251821
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 4
  gi|9944824|gb|AF251821.1|F251818S04[9944824]
• 7581: AF251820
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 3
  gi|9944823|gb|AF251820.1|F251818S03[9944823]
• 7582: AF251819
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 2
  gi|9944822|gb|AF251819.1|F251818S02[9944822]
• 7583: AF251818
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, promoter region and exon 1
  gi|9944821|gb|AF251818.1|F251818S01[9944821]
• 7584: AH009773
  Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, complete cds
  gi|9944820|gb|AH009773.1|SEG_F251818S[9944820]
• 7585: AF189768
  Homo sapiens leukocyte immunoglobulin-like receptor 5 (LIR5) gene, complete cds
  gi|9930102|gb|AF189768.1|AF189768[9930102]
• 7600: AJ245377
  Homo sapiens mRNA for 2B4 NK receptor homologue (h2B4 gene)
  gi|9621661|emb|AJ245377.1|HSA245377[9621661]
• 7601: X07206
  H. sapiens TRGV10 gene, allele V10*A1
  gi|1848182|emb|X07206.1|HSTRGV10[1848182]
• 7603: AF246974
  Homo sapiens toll-like receptor 9 (TLR9) mRNA, partial cds, alternatively spliced
  gi|9887086|gb|AF246974.1|AF246974[9887086]
• 7604: AF246973
  Homo sapiens toll-like receptor 9 (TLR9) mRNA, partial cds, alternatively spliced
  gi|9887084|gb|AF246973.1|AF246973[9887084]
• 7605: AF246972
  Homo sapiens toll-like receptor 9 (TLR9) mRNA, partial cds
  gi|9887082|gb|AF246972.1|AF246972[9887082]
• 7606: AF215826
  Homo sapiens killer-cell Ig-like receptor KIR2DL4v1 (KIR2DL4) gene, KIR2DL4v1 allele, exon 3 and partial cds
  gi|9886965|gb|AF215826.1|AF215826[9886965]
• 7607: AF215825
  Homo sapiens killer-cell Ig-like receptor KIR3DL1v (KIR3DL1) gene, KIR3DL1v allele, exon 3 and partial cds
  gi|9886963|gb|AF215825.1|AF215825[9886963]
• 7608: AB008193
  Homo sapiens genes for leukotriene B4 receptor BLT2, leukotriene B4 receptor BLT1, complete cds
  gi|9229835|gb|AF008193.1|AF008193[9229835]
• 7609: AB029892
  Homo sapiens hBLT2 mRNA for Leukotriene B4 receptor BLT2, complete cds
  gi|9186899|dbj|AB029892.1|AB029892[9186899]
• 7610: AF211978
  Homo sapiens LENG11 mRNA, partial sequence
  gi|9885308|gb|AF211978.1|AF211978[9885308]
• 7611: AF211977
  Homo sapiens LENG10 mRNA, partial sequence
  gi|9885307|gb|AF211977.1|AF211977[9885307]
• 7612: AF211976
  Homo sapiens LENG9 mRNA, partial sequence
  gi|9885306|gb|AF211976.1|AF211976[9885306]
• 7613: AF211975
  Homo sapiens LENG8 mRNA, variant C, partial sequence
  gi|9885305|gb|AF211975.1|AF211975[9885305]
• 7614: AF211974
  Homo sapiens LENG8 mRNA, variant B, partial sequence
  gi|9885304|gb |AF211974.1|AF211974[9885304]
• 7615: AF211973
  Homo sapiens LENG8 mRNA, variant A, partial sequence
  gi|9885303|gb|AF211973.1|AF211973[9885303]
• 7616: AF211972
  Homo sapiens LENG7 mRNA, partial sequence
  gi|9885302|gb|AF211972.1|AF211972[9885302]
• 7617: AF211971
  Homo sapiens LENG6 mRNA, partial sequence
  gi|9885301|gb|AF211971.1|AF211971[9885301]
• 7618: AF211970
  Homo sapiens LENG5 mRNA, partial sequence
  gi|9885300|gb|AF211970.1|AF211970[9885300]
• 7619: AF211969
  Homo sapiens LENG4 mRNA, partial sequence
  gi|9885299|gb|AF211969.1|AF211969[9885299]
• 7620: AF211968
  Homo sapiens LENG3 mRNA, partial sequence
  gi|9885298|gb|AF211968.1|AF211968[9885298]
• 7621: AF211967
  Homo sapiens LENG2 mRNA, partial sequence
  gi|9885297|gb|AF211967.1|AF211967[9885297]
• 7622: AF211966
  Homo sapiens LENG1 protein (LENG1) mRNA, partial cds
  gi|9885295|gb|AF211966.1|AF211966[9885295]
• 7624: AF262016
  Homo sapiens adrenergic receptor alpha-2A gene, complete cds
  gi|986478|gb|AF262016.2|AF262016[9864781]
• 7626: AF242865
  Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, exon 7 and complete cds
  gi|9858570|gb|AF242865.1|AF242862S4[9858570]
• 7627: AF242864
  Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, exons 2 through 6
  gi|9858569|gb|AF242864.1|AF242862S3[9858569]
• 7629: AF242862
  Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, exon 1
  gi|9858567|gb|AF242862.1|AF242862S1[9858567]
• 7630: AH009718
  Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, complete cds
  gi|9858566|gb|AH009718.1|SEG_AF242862S[9858566]
• 7631: AF257210
  Homo sapiens G-protein coupled receptor HLWAR77 mRNA, complete cds
  gi|9309468|gb|AF257210.1|AF257210[9309468]
• 7632: AF292403
  Homo sapiens type B natriuretic peptide receptor gene, promoter region and partial cds
  gi|9858187|gb|AF292403.1|AF292403[9858187]
• 7633: AF288571
  Homo sapiens lymphoid enhancer factor-1 (LEF1) mRNA, complete cds
  gi|9858157|gb|AF288571.1|AF288571[9858157]
• 7634: AF146747
  Homo sapiens cell surface receptor (PRV1) mRNA, complete cds
  gi|9857660|gb|AF146747.1|AF146747[9857660]
• 7862: AF233092
  Homo sapiens lysophosphatidic acid G protein-coupled receptor 4 (EDG4) mRNA, complete cds
  gi|7243675|gb|AF233092.1|AF233092[7243675]
• 7863: AF269144
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 10 and complete
  cds
  gi|9802369|gb|AF269144.1|F269135S10[9802369]
• 7864: AF269143
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 9
  gi|9802368|gb|AF2691430.1F269135S09[9802368]
• 7865: AF269142
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 8
  gi|9802367|gb|AF269142.1|F269135S08[9802367]
• 7866: AF269141
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 7
  gi|9802366|gb|AF269141.1F269135S07[9802366]
• 7867: AF269140
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 6
  gi|9802365|gb|AF269140.1|F269135S06[9802365]
• 7868: AF269139
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 5
  gi|9802364|gb|AF269139.1|F269135S05[9802364]
• 7869: AF269138
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 4
  gi|9802363|gb|AF269138.1F269135S04[9802363]
• 7870: AF269137
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 3
  gi|9802362|gb|AF269137.1|F269135S03[9802362]
• 7871: AF269136
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 2
  gi|980236|gb|AF269136.1|F269135S02[9802361]
• 7872: AF269135
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 1
  gi|9802360|gb|AF269135.1|F269135S01[9802360]
• 7873: AH009710
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, complete cds
  gi|9802359|gb|AH009710.1|SEG_F269135S[9802359]
• 7874: AF211942
  Homo sapiens haplotype 1089 olfactory receptor (OR2H3) gene, partial cds
  gi|9798923|gb|AF211942.1|AF211942[9798923]
• 7875: AF211941
  Homo sapiens haplotype 1037 olfactory receptor (OR2H3) gene, partial cds
  gi|9798921|gb|AF211941.1|AF211941[9798921]
• 7876: AF211940
  Homo sapiens haplotype 1012 olfactory receptor (OR2H3) gene, partial cds
  gi|9798919|gb|AF211940.1|AF211940[9798919]
• 7877: AF211939
  Homo sapiens haplotype 1013 olfactory receptor (OR2H3) gene, partial cds
  gi|9798917|gb|AF211939.1|AF211939[9798917]
• 7878: AJ272029
  Homo sapiens partial CD30 gene for cytokine receptor CD30 and promoter region
  gi|9798449|emb|AJ272029.1|HSA272029[9798449]
• 7880: AF101726
  Homo sapiens vasopressin receptor subtype 1b mRNA, complete cds
  gi|4336681|gb|AF101726.1|AF101726[4336681]
• 7881: AF101725
  Homo sapiens vasopressin receptor subtype 1a mRNA, complete cds
  gi|4336679|gb|AF101725.1|AF101725[4336679]
• 7882: AF101728
  Homo sapiens truncated vasopressin receptor type 2 mRNA, complete cds
  gi|4323606|gb|AF101728.1|AF101728[4323606]
• 7883: AF101727
  Homo sapiens vasopressin receptor type 2 mRNA, complete cds
  gi|4323604|gb|AF101727.1|AF101727[4323604]
• 7884: AF064078
  Homo sapiens insulin receptor-related receptor (INSRR) mRNA, partial cds
  gi|3152883|gb|AF064078.1|AF064078[3152883]
• 7885: S82307
  Homo sapiens p65 mRNA, partial cds
  gi|1839613|gb|S82307.1|S82307[1839613]
• 7886: S83176
  Homo sapiens calcium-sensing receptor long isoform (CASR) mRNA, partial cds
  gi|1836093|gb|S83176.1|S83176[1836093]
• 7887: S82755
  Homo sapiens T cell receptor mRNA, partial cds
  gi|1835845|gb|S82755.1|S82755[1835845]
• 7888: S82612
  Homo sapiens 5-hydroxytryptamine type 3AS receptor subunit mRNA, complete cds
  gi|1699437|gb|S82612.1|S82612[1699437]
• 7891: AF238374
  Homo sapiens mutant fibroblast growth factor receptor 3 (FGFR3) mRNA, partial cds
  gi|9719331|gb|AF2383740.1|AF238374[9719331]
• 7894: AJ400843
  Homo sapiens partial mRNA for immunoglobulin-like cell surface receptor FDF03-M14, soluble alternative form
  gi|9715838|emb|AJ400843.1|HSA400843[9715838]
• 7895: AJ400842
  Homo sapiens partial mRNA for immunoglobulin-like cell surface receptor FDF03-dtm, soluble form
  gi|9715835|emb|AJ400842.1|HSA400842[9715835]
• 7896: AJ400841
  Homo sapiens mRNA for immunoglobulin-like cell surface receptor FDF03
  gi|9715833|emb|AJ400841.1|HSA400841[9715833]
• 8061: AJ005205
  Homo sapiens 5HT3 gene for serotonin 3 receptor
  gi|7019744|emb|AJ005205.2|HSA005205[7019744]
• 8062: AB038269
  Homo sapiens mRNA for cysteinyl leukotriene CysLT2 receptor, complete cds; cDNA:
  PSEC0146 from clone PLACE1006979
  gi|9663957|dbj|AB038269.1|AB038269[9663957]
• 8063: AJ278476
  Homo sapiens partial mRNA for transport-secretion protein 2.2, (TTS-2.2 gene)
  gi|9663152|emb|AJ278476.1|HSA278476[9663152]
• 8064: AJ278475
  Homo sapiens partial mRNA for transport-secretion protein 2.1 (TTS-2.1 gene)
  gi|9663150|emb|AJ278475.1|HSA278475[9663150]
• 8065: AF282693
  Homo sapiens inflammation-related G protein-coupled receptor EX33 (EX33) mRNA,
  complete cds
  gi|9652260|gb|AF282693.1|AF282693[9652260]
• 8066: AF254409
  Homo sapiens scavenger receptor class B type III SR-BIII mRNA, partial cds
  gi|9651987|gb|AF254409.1|AF254409[9651987]
• 8067: AF236117
  Homo sapiens G-protein coupled receptor EDG-7 mRNA, complete cds
  gi|9651838|gb|AF236117.1|AF236117[9651838]
• 8068: AF287008
  Homo sapiens triggering receptor expressed on monocytes 1 (TREML) mRNA, complete
  cds
  gi|9624485|gb|AF287008.1|AF287008[9624485]
• 8069: AF172171
  Homo sapiens toll-like receptor 4 (TLR4) gene, exon 4 and complete cds
  gi|9622356|gb|AF172171.1|HSTLR3[9622356]
• 8070: AF172170
  Homo sapiens toll-like receptor 4 (TLR4) genie, exons 2 and 3
  gi|9622355|gb|AF172170.1|HSTLR2[9622355]
• 8071: AF172169
  Homo sapiens toll-like receptor 4 (TLR4) gene, exon 1
  gi|9622354|gb|AF172169.1|HSTLR1[9622354]
• 8072: AH009665
  Homo sapiens toll-like receptor 4 (TLR4) gene, complete cds
  gi|9622353|gb|AH009665.1|SEG_HSTLR[9622353]
• 8073: AF165312
  Homo sapiens pre-T-cell receptor alpha chain (PTA) mRNA, alternatively spliced,
  complete cds
  gi|9621867|gb|AF165312.1|AF165312[9621867]
• 8074: AJ245375
  Homo sapiens mRNA for PP35 act (h2B4 gene)
  gi|9621657|emb|AJ245375.1|HSA245375[9621657]
• 8075: AF277230
  Homo sapiens seven transmembrane receptor BLTR2 (BLTR2) mRNA, complete cds
  gi|8896158|gb|AF277230.1|AF277230[8896158]
• 8076: AF114491
  Homo sapiens EGF-like module EMR2 (EMR2) mRNA, complete cds
  gi|6650688|gb|AF114491.1|AF114491[6650688]
• 8077: AF107259
  Homo sapiens chromosome 21q22.1 cosmid clone ICRFcA0552D2, complete sequence, containing part of the glutamate receptor gene GLUR5
  gi|4154320|gb|AF107259.1|AF107259[4154320]
• 8078: AF107257
  Homo sapiens chromosome 21q22.1 PAC L12209, complete sequence
  gi|4106881|gb|AF107257.1|AF107257[4106881]
• 8079: AZ081535
  p133B6#4 RPCI-6 Homo sapiens genomic, genomic survey sequence
  gi|9587541|gb|AZ081535.1|AZ081535[9587541]
• 8081: AF285168
  Homo sapiens GABA-A receptor beta 1 subunit (GABRB1) gene, promoter and partial
  cds
  gi|9502261|gb|AF285168.1|AF285168[9502261]
• 8126: AC018755
  Homo sapiens chromosome 19, BAC BC330783 (CIT-HSPC_—470E3), complete sequence
  gi|9454515|gb|AC018755.3|AC018755[9454515]
• 8159: AF246303
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 9 and complete cds
  gi|7417394|gb|AF246303.1|AF246296S8[7417394]
• 8160: AF246302
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exons 7 and 8
  gi|7417393|gb|AF246302.1|AF246296S7[7417393]
• 8161: AF246301
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 6
  gi|7417392|gb|AF246301.1|AF246296S6[7417392]
• 8162: AF246300
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 5
  gi|741739|gb|AF246300.1|AF246296S5[7417391]
• 8163: AF246299
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 4
  gi|7417390|gb|AF246299.1|AF246296S4[7417390]
• 8164: AF246298
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 3
  gi|7417389|gb|AF246298.1|AF246296S3[7417389]
• 8165: AF246297
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 2
  gi|7417388|gb|AF246297.1|AF246296S2[7417388]
• 8166: AF246296
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, promoter and exon 1
  gi|7417387|gb|AF246296.1|AF246296S1[7417387]
• 8167: AH009223
  Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, complete cds
  gi|7417386|gb|AH009223.1|SEG_AF246296S[7417386]
• 8168: U94888
  Homo sapiens CC-chemokine-binding receptor JAB61 mRNA, complete cds
  gi|2213808|gb|U94888.1|HSU94888[2213808]
• 8169: AB040434
  Homo sapiens mRNA for hTROY, complete cds
  gi|9392329|dbj|AB040434.1|AB040434[9392329]
• 8170: AJ272427
  Homo sapiens mRNA for frizzled homolog 3 (FZD3 gene)
  gi|7649448|emb|AJ272427.1|HSA272427[7649448]
• 8173: U88356
  Homo sapiens receptor tyrosine kinase ErbB-3 (c-erbB-3) gene, exons 12, 13, 14, and partial cds
  gi|9294704|gb|U88356.1|HSCERBR3[9294704]
• 8174: U88355
  Homo sapiens receptor tyrosine kinase ErbB-3 (c-erbB-3) gene, exon 10 and partial cds
  gi|9294703|gb|U88355.1|HSCERBR2[9294703]
• 8175: U88354
  Homo sapiens receptor tyrosine kinase ErbB-3 (c-erbB-3) gene, exons 8 and 9
  gi|9294702|gb|U88354.1|HSCERBR1[9294702]
• 8176: AB037533
  Homo sapiens HTR1F gene for 5-hydroxytryptamine (serotonin) receptor 1F, partial
  cds
  gi|6815236|dbj|AB037533.1|AB037533[6815236]
• 8177: AB037513
  Homo sapiens HTR2A gene for 5-hydroxytryptamine (serotonin) receptor 2A, partial
  cds
  gi|6815196|dbj|AB037513.1|AB037513[6815196]
• 8178: AF180301
  Homo sapiens corticotropin-releasing factor receptor variant id (CRHR1) mRNA, alternative splice product, complete cds
  gi|5815472|gb|AF180301.1|AF180301[5815472]
• 8181: AF208111
  Homo sapiens truncated IL-17 receptor homolog precursor (EVI27) mRNA, complete
  cds
  gi|9246434|gb|AF208111.1|AF208111[9246434]
• 8182: AF208110
  Homo sapiens IL-17 receptor homolog precursor (EVI27) mRNA, complete cds
  gi|9246432|gb|AF208110.1|AF208110[9246432]
• 8183: M15222
  Homo sapiens T-cell receptor (TCRB) mRNA, partial cds
  gi|338893|gb|M15222.1|HUMTCBVO[338893]
• 8189: AF263279
  Homo sapiens CD164 mRNA, complete cds
  gi|9230740|gb|AF263279.1|AF263279[9230740]
• 8192: AF242874
  Homo sapiens neuromedin U receptor 2 (NMU2R) mRNA, complete cds
  gi|9082155|gb|AF242874.1|AF242874[9082155]
• 8193: AF160477
  Homo sapiens Ig superfamily receptor LNIR precursor, mRNA, complete cds
  gi|9049507|gb|AF160477.1|AF160477[9049507]
• 8194: AF058290
  Homo sapiens imidazoline receptor antisera-selected protein mRNA, partial cds
  gi|3493224|gb|AF058290.1|AF058290[3493224]
• 8195: AF082516
  Homo sapiens I-1 receptor candidate protein mRNA, complete cds
  gi|3462806|gb|AF082516.1|AF082516[3462806]
• 8211: X06031
  Homo sapiens partial T-cell receptor CD3-gamma gene, exon 6
  gi|36818|emb|X06031.1|HSTCR3G6[36818]
• 8212: X06030
  Homo sapiens partial T-cell receptor CD3-gamma gene, exon 5
  gi|36816|emb|X06030.1|HSTCR3G5[36816]
• 8213: X06029
  Homo sapiens partial T-cell receptor CD3-gamma gene exon 4
  gi|36814|emb|X06029.1|HSTCR3G4[36814]
• 8214: X06027
  Homo sapiens partial CD3G gene, exon 2 (and joined mature peptide)
  gi|36811|emb|X06027.1|HSTCR3G2[36811]
• 8216: Z30426
  H. sapiens gene for early lymphocyte activation antigen CD69, exon 1
  gi|525242|emb|Z30426.1|HSLACD691[525242]
• 8302: AJ278605
  Homo sapiens BLT-2R gene for leukotriene B4 receptor 2
  gi|8919627|emb|AJ278605.1|HSA278605[8919627]
• 8444: AF246925
  Homo sapiens haplotype 28 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|880984|gb|AF246925.1|AF246925[8809841]
• 8445: AF246924
  Homo sapiens haplotype 27 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809840|gb|AF246924.1|AF246924[8809840]
• 8446: AF246923
  Homo sapiens haplotype 26 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809839|gb|AF246923.1|AF246923[8809839]
• 8447: AF246922
  Homo sapiens haplotype 24 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809838|gb|AF246922.1|AF246922[8809838]
• 8448: AF246921
  Homo sapiens haplotype 23 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809837|gb|AF246921.1|AF246921[8809837]
• 8449: AF246920
  Homo sapiens haplotype 22 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809836|gb|AF246920.1|AF246920[8809836]
• 8450: AF246919
  Homo sapiens haplotype 21 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809835|gb|AF246919.1|AF246919[8809835]
• 8451: AF246918
  Homo sapiens haplotype 20 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809834|gb|AF246918.1|AF246918[8809834]
• 8452: AF246917
  Homo sapiens haplotype 19 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809833|gb|AF246917.1|AF246917[8809833]
• 8452: AF246917
• 8453: AF246916
  Homo sapiens haplotype 18 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809832|gb|AF246916.1|AF246916[8809832]
• 8454: AF246915
  Homo sapiens haplotype 17 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809831|gb|AF246915.1|AF246915[8809831]
• 8455: AF246914
  Homo sapiens haplotype 16 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809830|gb|AF246914.1|AF246914[8809830]
• 8456: AF246913
  Homo sapiens haplotype 15 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809829|gb|AF246913.1|AF246913[8809829]
• 8457: AF246912
  Homo sapiens haplotype 14 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809828|gb|AF246912.1|AF246912[8809828]
• 8458: AF246911
  Homo sapiens haplotype 13 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809827|gb|AF246911.1|AF246911[8809827]
• 8459: AF246910
  Homo sapiens haplotype 12 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809826|gb|AF246910.1|AF246910[8809826]
• 8460: AF246909
  Homo sapiens haplotype 11 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809825|gb|AF246909.1|AF246909[8809825]
• 8461: AF246908
  Homo sapiens haplotype 10 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809824|gb|AF246908.1|AF246908[8809824]
• 8462: AF246907
  Homo sapiens haplotype 9 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809823|gb|AF246907.1|AF246907[8809823]
• 8463: AF246906
  Homo sapiens haplotype 8 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809822|gb|AF246906.1|AF246906[8809822]
• 8464: AF246905
  Homo sapiens haplotype 7 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809821|gb|AF246905.1|AF246905[8809821]
• 8465: AF246904
  Homo sapiens haplotype 6 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809820|gb|AF246904.1|AF246904[8809820]
• 8466: AF246903
  Homo sapiens haplotype 5 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809819|gb|AF246903.1|AF246903[8809819]
• 8467: AF246902
  Homo sapiens haplotype 4 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809818|gb|AF246902.1|AF246902[8809818]
• 8468: AF246901
  Homo sapiens haplotype 1 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809817|gb|AF246901.1|AF246901[8809817]
• 8469: AF246900
  Homo sapiens haplotype 2 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809816|gb|AF246900.1|AF246900[8809816]
• 8470: AF246899
  Homo sapiens haplotype 3 CC chemokine receptor 5 (CCR5) gene, partial sequence
  gi|8809815|gb|AF246899.1|AF246899[8809815]
• 8471: AF210633
  Homo sapiens growth hormone receptor (GHR) gene, GHR-d3 allele, partial sequence
  gi|8809760|gb|AF210633.1|AF210633[8809760]
• 8472: M22057
  Homo sapiens T-cell receptor epsilon (CD3E) gene, exon 5 and partial cds
  gi|339220|gb|M22057.1|HUMTCR3E[339220]
• 8476: AF212311
  Homo sapiens interleukin 20 (IL20) mRNA, complete cds
  gi|8705219|gb|AF2123110.1|AF212311[8705219]
• 8477: AF141334
  Homo sapiens placenta apolipoprotein B48 receptor type 2 (APOB48R) mRNA, complete cds
  gi|8699629|gb|AF141334.1|AF141334[8699629]
• 8478: AF277379
  Homo sapiens vitamin D receptor-interacting protein complex component DRIP100 (DRIP100) mRNA, complete cds
  gi|8699627|gb|AF277379.1|AF277379[8699627]
• 8480: AJ251962
  Homo sapiens partial TGF-beta III receptor gene
  gi|6634455|emb|AJ251962.1|HSA251962[6634455]
• 8481: AJ251961
  Homo sapiens partial mRNA for betaglycan (TBR III gene)
  gi|6634453|emb|AJ251961.1|HSA251961[6634453]
• 8483: AF062039
  Homo sapiens integrin alpha-2 subunit (ITGA2) gene, ITGA2-1 allele, partial cds
  gi|8574452|gb|AF062039.1|AF062039[8574452]
• 8485: AF141333
  Homo sapiens apolipoprotein B48 receptor (APOB48R) gene, complete cds
  gi|8547065|gb|AF141333.1|AF141333[8547065]
• 8486: AF141332
  Homo sapiens apolipoprotein B48 receptor (APOB48R) mRNA, complete cds
  gi|8547063|gb|AF141332.1|AF141332[8547063]
• 8488: X56253
  Homo sapiens partial MPR46 gene for 46 kd mannose 6-phosphate receptor, exon 1 and join mRNA
  gi|34727|emb|X56253.1|HSMPR461[34727]
• 8489: AF155912
  Homo sapiens growth hormone receptor (GHR) gene, exon 3 and partial cds
  gi|8037572|gb|AF155912.1|AF155912[8037572]
• 8490: AF263744
  Homo sapiens erbb2-interacting protein ERBIN mRNA, complete cds
  gi|8572220|gb|AF263744.1|AF263744[8572220]
• 8501: X56254
  Homo sapiens partial MPR46 gene for 46 kd mannose 6-phosphate receptor, exon 2 join CDS
  gi|34729|emb|X56254.1|HSMPR462[34729]
• 8503: AB040801
  Homo sapiens mRNA for SREB3, complete cds
  gi|8467969|dbj|AB040801.1|AB040801[8467969]
• 8504: AB040800
  Homo sapiens mRNA for SREB2, complete cds
  gi|8467967|dbj|AB040800.1|AB040800[8467967]
• 8505: AB040799
  Homo sapiens mRNA for SREB1, complete cds
  gi|8467965|dbj|AB040799.1|AB040799[8467965]
• 8506: AF187064
  Homo sapiens p75NTR-associated cell death executor (NADE) mRNA, complete cds
  gi|8452893|gb|AF187064.1|AF187064[8452893]
• 8507: AF045606
  Homo sapiens C21orf4 mRNA, complete cds
  gi|8277249|gb|AF045606.2|AF045606[8277249]
• 8508: AF204920
  Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b variant, exon 5
  gi|8248132|gb|AF204920.1|AF204918S3[8248132]
• 8509: AF204919
  Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b variant, exon 4
  gi|8248131|gb|AF204919.1|AF204918S2[8248131]
• 8510: AF204918
  Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b variant, exons 4
  and 3
  gi|8248130|gb|AF204918.1|AF204918S1[8248130]
• 8511: AH009422
  Homo sapiens
  gi|8248129|gb|AH009422.1|SEG_AF204918S[8248129]
• 8512: AF204917
  Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48a variant, exon 5
  gi|8248128|gb|AF204917.1|AF204915S3[8248128]
• 8513: AF204916
  Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48a variant, exon 4
  gi|8248127|gb|AF204916.1|AF204915S2[8248127]
• 8514: AF204915
  Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48a variant, exons 2
  and 3
  gi|8248126|gb|AF204915.1|AF204915S1[8248126]
• 8515: AH009421
  Homo sapiens
  gi|8248125|gb|AH009421.1|SEG_AF204915S[8248125]
• 8516: AF204914
  Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44b variant, exon 5
  gi|8248124|gb|AF204914.1|AF204912S3[8248124]
• 8517: AF204913
  Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44b variant, exon 4
  gi|8248123|gb|AF204913.1|AF204912S2[8248123]
• 8518: AF204912
  Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44b variant, exons 2
  and 3
  gi|8248122|gb|AF204912.1|AF204912S1[8248122]
• 8519: AH009420
  Homo sapiens
  gi|8248121|gb|AH009420.1|SEG_AF204912S[8248121]
• 8520: AF204911
  Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44a variant, exon
  5
  gi|8248120|gb|AF204911.1|AF204909S3[8248120]
• 8521: AF204910
  Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44a variant, exon 4
  gi|8248119|gb|AF204910.1|AF204909S2[8248119]
• 8522: AF204909
  Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44a variant, exons
  2
  and 3
  gi|8248118|gb|AF204909.1|AF204909S1[8248118]
• 8523: AH009419
  Homo sapiens
  gi|8248117|gb|AH009419.1|SEG_AF204909S[8248117]
• 8524: AF204905
  Homo sapiens killer cell Ig-like receptor (KIR2DL5) gene, KIR2DL5.2 variant, partial sequence
  gi|8248112|gb|AF204905.1|AF204905[8248112]
• 8525: AF204904
  Homo sapiens killer cell Ig-like receptor (KIR2DL5) gene, KIR2DL5.1 variant, partial cds
  gi|8248110|gb|AF204904.1|AF204904[8248110]
• 8607: AF212842
  Homo sapiens immunoglobulin-like transcript 11 protein (ILT11) mRNA, partial cds
  gi|8163785|gb|AF212842.1|AF212842[8163785]
• 8608: AF208237
  Homo sapiens 7-transmembrane G-protein coupled receptor 2 (GPR2) mRNA, complete
  cds
  gi|8118034|gb|AF208237.1|AF208237[8118034]
• 8609: AF204903
  Homo sapiens killer-cell immunoglobulin-like receptor KIR2DL5.1 (KIR2DL5) mRNA,
  complete cds
  gi|8117976|gb|AF204903.1|AF204903[8117976]
• 8610: AP001716
  Homo sapiens genomic DNA, chromosome 21q, section 60/105
  gi|7768717|dbj|AP001716.1|AP001716[7768717]
• 8611: AP001705
  Homo sapiens genomic DNA, chromosome 21q, section 49/105
  gi|7768711|dbj|AP001705.1|AP001705[7768711]
• 8612: AP001670
  Homo sapiens genomic DNA, chromosome 21q, section 14/105
  gi|7768690|dbj|AP001670.1|AP001670[7768690]
• 8613: AP001717
  Homo sapiens genomic DNA, chromosome 21q, section 61/105
  gi|7768678|dbj|AP001717.1|AP001717[7768678]
• 8616: AJ012074
  Homo sapiens VPAC1 receptor gene, 5′ end and promoter region
  gi|3758828|emb|AJ012074.1|HSA012074[3758828]
• 8617: AF039906
  Homo sapiens cosmid D16B8, chromosome 21 3′ of IFNGR2
  gi|2914756|gb|AF039906.1|AF039906[2914756]
• 8619: S77335
  Homo sapiens growth hormone receptor gene, partial cds
  gi|999143|gb|S77335.1|S77335[999143]
• 8621: S75765
  Homo sapiens delta CCK-B gene, partial cds
  gi|913754|gb|S75765.1|S75765[913754]
• 8624: S78717
  Homo sapiens ryanodine receptor (RYR1) gene, partial cds
  gi|244183|gb|S78717.1|S78717[244183]
• 8625: X15266
  Homo sapiens gene for muscarinic acetylcholine receptor HM3
  gi|32323|emb|X15266.1|HSACM3[32323]
• 8626: X15265
  Homo sapiens gene for muscarinic acetylcholine receptor M4
  gi|32321|emb|X15265.1|HSACM4[32321]
• 8627: AF220542
  Homo sapiens FCRN protein gene, complete cds
  gi|8101614|gb|AF220542.1|AF220542[8101614]
• 8629: AF073924
  Homo sapiens putative taste receptor HTR2 mRNA, partial cds
  gi|8100088|gb|AF073924.1|AF073924[8100088]
• 8630: D88437
  Homo sapiens mRNA for G-protein coupled receptor SALPR, complete cds
  gi|7340885|dbj|D88437.1|D88437[7340885]
• 8631: AB032369
  Homo sapiens MIST mRNA, partial cds
  gi|8099156|dbj|AB032369.1|AB032369[8099156]
• 8632: AF167555
  Homo sapiens TAJ-alpha mRNA, complete cds
  gi|8071643|gb|AF167555.1|AF167555[8071643]
• 8633: AF002982
  Homo sapiens killer cell receptor (KIR103) mRNA, allele ASD2, complete cds
  gi|2443483|gb|AF002982.1|AF002982[2443483]
• 8634: AF002981
  Homo sapiens killer cell receptor (KIR103) mRNA, allele ASD1, complete cds
  gi|2443481|gb|AF002981.1|AF002981[2443481]
• 8635: AF002980
  Homo sapiens killer cell receptor (KIR103) mRNA, allele AS, complete cds
  gi|2443479|gb|AF002980.1|AF002980[2443479]
• 8636: AF002979
  Homo sapiens killer cell receptor (KIR103) mRNA, allele LP, complete cds
  gi|2443477|gb|AF002979.1|AF002979[2443477]
• 8637: AH005453
  Homo sapiens chromosome 19 clone 4 map 19q13.4
  gi|2228790|gb|AH005453.1|SEG_HSKIR[2228790]
• 8638: AF003123
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 8 and complete cds
  gi|2228789|gb|AF003123.1|HSKIR8[2228789]
• 8639: AF003122
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 7
  gi|2228788|gb|AF003122.1|HSKIR7[2228788]
• 8640: AF003121
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 6
  gi|2228787|gb|AF003121.1|HSKIR6[2228787]
• 8641: AF003120
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 5
  gi|2228786|gb|AF003120.1|HSKIR5[2228786]
• 8642: AF003119
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 4
  gi|2228785|gb|AF003119.1|HSKIR4[2228785]
• 8643: AF003118
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 3
  gi|2228784|gb|AF003118.1|HSKIR3[2228784]
• 8644: AF003117
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 2
  gi|2228783|gb|AF003117.1|HSKIR2[2228783]
• 8645: AF003116
  Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 1
  gi|2228782|gb|AF003116.1|HSKIR1[2228782]
• 8646: AF196329
  Homo sapiens triggering receptor expressed on monocytes 1 mRNA, complete cds
  gi|8050526|gb|AF196329.1|AF196329[8050526]
• 8647: AF167342
  Homo sapiens membrane interleukin 1 receptor accessory protein (IL1RAP) gene, exon 12 and complete cds, alternatively spliced
  gi|8050498|gb|AF167342.1|F167333S10[8050498]
• 8648: AF167341
  Homo sapiens membrane interleukin 1 receptor accessory protein (IL1RAP) gene, exons 10 and 11
  gi|8050497|gb|AF167341.1|F167333S09[8050497]
• 8649: AF167340
  Homo sapiens soluble interleukin 1 receptor accessory protein (IL1RAP) gene, exon 8, alternative exons 9 and complete cds, alternatively spliced
  gi|8050496|gb|AF167340.1|F167333S08[8050496]
• 8650: AF167339
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 7
  gi|8050495|gb|AF167339.1|F167333S07[8050495]
• 8651: AF167338
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 6
  gi|8050494|gb|AF167338.1|F167333S06[8050494]
• 8652: AF167337
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 5
  gi|8050493|gb|AF167337.1|F167333S05[8050493]
• 8653: AF167336
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 4
  gi|8050492|gb|AF167336.1F167333S04[8050492]
• 8654: AF167335
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 3
  gi|8050491|gb|AF167335.1|F167333S03[8050491]
• 8655: AF167334
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 2
  gi|8050490|gb|AF167334.1|F167333S02[8050490]
• 8656: AF167333
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 1
  gi|8050489|gb|AF167333.1|F167333S01[8050489]
• 8657: AH009309
  Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, complete cds, alternatively spliced
  gi|8050488|gb|AH009309.1|SEG_F167333S[8050488]
• 8658: AF167343
  Homo sapiens soluble interleukin-1 receptor accessory protein (IL1RAP) mRNA, complete cds
  gi|8050486|gb|AF167343.1|AF167343[8050486]
• 8659: AF213457
  Homo sapiens triggering receptor expressed on myeloid cells 2 mRNA, complete cds
  gi|7800156|gb|AF213457.1|AF213457[7800156]
• 8661: AF233281
  Homo sapiens CC chemokine receptor (CCBP2) gene, complete cds
  gi|7274391|gb|AF233281.1|AF233281[7274391]
• 8662: AF189259
  Homo sapiens GABA-A receptor theta subunit (THETA) mRNA, complete cds
  gi|7861735|gb|AF189259.1|AF189259[7861735]
• 8663: AF176832
  Homo sapiens low density lipoprotein receptor related protein-deleted in tumor
  (LRPDIT) mRNA, complete cds
  gi|7861732|gb|AF176832.1|AF176832[7861732]
• 8664: AH001455
  Homo sapiens protooncogene protein (c-erb-2) gene, partial cds
  gi|182164|gb|AH001455.1|SEG_HUMERB2[182164]
• 8665: M11767
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 7 and partial cds
  gi|182163|gb|M11767.1|HUMERB27[182163]
• 8666: M11766
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 6
  gi|182162|gb|M11766.1|HUMERB26[182162]
• 8667: M11765
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 5
  gi|118216|gb|M11765.1|HUMERB25[182161]
• 8668: M11764
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 4
  gi|182160|gb|M11764.1|HUMERB24[182160]
• 8669: M11763
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 3
  gi|182159|gb|M11763.1|HUMERB23[182159]
• 8670: M11762
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 2
  gi|182158|gb|M11762.1|HUMERB22[182158]
• 8671: M11761
  Homo sapiens protooncogene protein (c-erb-2) gene, exon 1
  gi|182157|gb|M11761.1|HUMERB21[182157]
• 8674: AC068948
  Homo sapiens chromosome 19, cosmid R28371 (LLNL-R_—244D7), complete sequence
  gi|7798735|gb|AC068948.1|AC068948[7798735]
• 8675: AF060231
  Homo sapiens herpesvirus entry protein C (HVEC) mRNA, complete cds
  gi|3242792|gb|AF060231.1|AF060231[3242792]
• 8676: Z24459
  H. sapiens MTCP1 gene, exons 2A to 7 (and joined mRNA)
  gi|2252491|emb|Z24459.1|HSMTCP12A[2252491]
• 8677: AB006200
  Homo sapiens gene for parathyroid hormone/parathyroid hormone-related protein receptor, exon1, partial sequence
  gi|7770088|dbj|AB006200.1|AB006200[7770088]
• 8693: AB023493
  Homo sapiens mRNA for preproapelin, complete cds
  gi|6009585|dbj|AB023493.1|AB023493[6009585]
• 8697: M55336
  Homo sapiens oncogene tyrosine protein kinase receptor (trk2) mRNA, partial cds
  gi|339913|gb|M55336.1|HUMTRK2[339913]
• 8701: AB028741
  Homo sapiens mRNA for syntaxin 18, complete cds
  gi|7707423|dbj|AB028741.1|AB028741[7707423]
• 8702: U27478
  Homo sapiens angiotensin II type 2 receptor (AT2) gene, partial cds
  gi|1143833|gb|U27478.1|HSU27478[1143833]
• 8707: M81774
  Homo sapiens T-cell receptor alpha (TCRB) mRNA, partial cds
  gi|186224|gb|M81774.1|HUMIGTCACA[186224]
• 8708: S70782
  Homo sapiens alpha adrenergic receptor subtype alpha 1a mRNA, complete cds
  gi|547219|gb|S70782.1|S70782[547219]
• 8709: S70057
  Homo sapiens cholecystokinin B receptor mRNA, complete cds
  gi|546748|gb|S70057.1|S70057[546748]
• 8711: S70123
  Homo sapiens low density lipoprotein receptor mRNA, partial cds
  gi|546107|gb|S70123.1|S70123[546107]
• 8712: S56143
  Homo sapiens A1 adenosine receptor mRNA, complete cds
  gi|298327|gb|S56143.1|S56143[298327]
• 8715: S57793
  Homo sapiens luteinizing hormone receptor mRNA, complete cds
  gi|236050|gb|S57793.1|S57793[236050]
• 8722: AF202640
  Homo sapiens orphan G-protein coupled receptor (GPRC5B) mRNA, complete cds
  gi|7682556|gb|AF202640.1|AF202640[7682556]
• 8723: AF211154
  AF211154 Clontech HL1008b Homo sapiens cDNA, mRNA sequence
  gi|7677996|gb|AF211154.1|AF211154[7677996]
• 8724: AF211153
  AF211153 Clontech HL1008b Homo sapiens cDNA, mRNA sequence
  gi|7677995|gb|AF211153.1|AF211153[7677995]
• 8729: AF145440
  Homo sapiens CC chemokine receptor 9B (CCR9) mRNA, alternatively spliced, complete cds
  gi|7673010|gb|AF145440.1|AF145440[7673010]
• 8730: AF145439
  Homo sapiens CC chemokine receptor 9A (CCR9) mRNA, alternatively spliced, complete cds
  gi|7673008|gb|AF145439.1|AF145439[7673008]
• 8731: AF129170
  Homo sapiens apolipoprotein E receptor 2 gene, exon 6b and partial cds, alternatively spliced
  gi|7672339|gb|AF129170.1|AF129169S2[7672339]
• 8732: AF129169
  Homo sapiens apolipoprotein E receptor 2 gene, exon 6a and partial cds, alternatively spliced
  gi|7672338|gb|AF129169.1|AF129169S1[7672338]
• 8733: AH009264
  Homo sapiens apolipoprotein E receptor 2 and apolipoprotein E receptor 2 genes,
  partial cds
  gi|7672337|gb|AH009264.1|SEG_AF129169S[7672337]
• 8812: AB039723
  Homo sapiens FZD3 mRNA for WNT receptor frizzled-3, complete cds
  gi|7670051|dbj|AB039723.1|AB039723[7670051]
• 8813: AL353940
  Homo sapiens mRNA; cDNA DKFZp761P1010 (from clone DKFZp761P1010)
  gi|7669978|emb|AL353940.1|HSM802647[7669978]
• 8814: AC067969
  Homo sapiens chromosome 19, cosmid R26839 (LLNL-R_—228D1), complete sequence
  gi|7656699|gb|AC067969.1|AC067969[7656699]
• 8815: AF236081
  Homo sapiens orphan G-protein coupled receptor GPR72 (GPR72) mRNA, complete cds
  gi|7248881|gb|AF236081.1|AF236081[7248881]
• 8819: AC004416
  Homo sapiens BAC clone CTB-13N12 from 7q31.2, complete sequence
  gi|2979585|gb|AC004416.1|AC004416[2979585]
• 8820: AF056020
  Homo sapiens chemokine receptor CCR5 (CCR5) gene, CCR5-delta32 allele, partial
  cds
  gi|7648496|gb|AF056020.1|AF056020[7648496]
• 8821: AF056019
  Homo sapiens mutant chemokine receptor CCR5 (CCR5) gene, CCR5-delta32 allele, partial cds
  gi|7648494|gb|AF056019.1|AF056019[7648494]
• 8822: AF052244
  Homo sapiens mutant chemokine receptor CCR5 (CCR5) gene, CCR5-delta32 allele, partial cds
  gi|7648492|gb|AF052244.1|AF052244[7648492]
• 8824: AF068288
  Homo sapiens HDCME31P mRNA, complete cds
  gi|7643783|gb|AF068288.1|AF068288[7643783]
• 8825: AF186022
  Homo sapiens B lymphocyte adapter protein BAM32 (BAM32) mRNA, complete cds
  gi|6503077|gb|AF186022.1|AF186022[6503077]
• 8826: AB002168
  Homo sapiens gene for vitamin D receptor, exon 9 and complete cds
  gi|5736651|dbj|AB002168.1|AB00215S12[5736651]
• 8827: AB002167
  Homo sapiens gene for vitamin D receptor, exon 8
  gi|5736591|dbj|AB002167.1|AB00215S11[5736591]
• 8828: AB002166
  Homo sapiens gene for vitamin D receptor, exon 7
  gi|5736588|dbj|AB002166.1|AB00215S10[5736588]
• 8829: AB002165
  Homo sapiens gene for vitamin D receptor, exon 6
  gi|5736585|dbj|AB002165.1|AB00215S09[5736585]
• 8830: AB002164
  Homo sapiens gene for vitamin D receptor, exon 5
  gi|5736582|dbj|AB002164.1|AB00215S08[5736582]
• 8831: AB002163
  Homo sapiens gene for vitamin D receptor, exon 4
  gi|5736579|dbj|AB002163.1|AB00215S07[5736579]
• 8832: AB002162
  Homo sapiens gene for vitamin D receptor, exon 3
  gi|5736575|dbj|AB002162.1|AB00215S06[5736575]
• 8833: AB002161
  Homo sapiens gene for vitamin D receptor, exon 2
  gi|5736571|dbj|AB002161.1|AB00215S05[5736571]
• 8834: AB002160
  Homo sapiens gene for vitamin D receptor, exon 1c, 5′ non-coding region
  gi|5736566|dbj|AB002160.1|AB00215S04[5736566]
• 8835: AB002159
  Homo sapiens gene for vitamin D receptor, exon 1b, 5′ non-coding region
  gi|5736562|dbj|AB002159.1|AB00215S03[5736562]
• 8839: AB005647
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 22 and complete cds
  gi|5139788|dbj|AB005647.1|AB00562S23[5139788]
• 8840: AB005646
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 21
  gi|5139787|dbj|AB005646.1|AB00562S22[5139787]
• 8841: AB005645
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 20
  gi|5139786|dbj|AB005645.1|AB00562S21[5139786]
• 8842: AB005644
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 19
  gi|5139785|dbj|AB005644.1|AB00562S20[5139785]
• 8843: AB005643
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 18
  gi|5139784|dbj|AB005643.1|AB00562S19[5139784]
• 8844: AB005642
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 17
  gi|5139783|dbj|AB005642.1|AB00562S18[5139783]
• 8845: AB005641
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 16
  gi|5139782|dbj|AB005641.1|AB00562S17[5139782]
• 8846: AB005640
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 15
  gi|5139781|dbj||AB005640.1|AB00562S16[5139781]
• 8847: AB005639
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 14
  gi|5139780|dbj|AB005639.1|AB00562S15[5139780]
• 8848: AB005638
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 13
  gi|5139779|dbj|AB005638.1|AB00562S14[5139779]
• 8849: AB005637
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 12
  gi|5139778|dbj|AB005637.1|AB00562S13[5139778]
• 8850: AB005636
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 11
  gi|5139777|dbj|AB005636.1|AB00562S12[1L39777]
• 8851: AB005635
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 10
  gi|5139776|dbj|AB005635.1|AB00562S11[5139776]
• 8852: AB005634
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 9
  gi|5139775|dbj|AB005634.1|AB00562S10[5139775]
• 8853: AB005633
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 8
  gi|5139774|dbj|AB005633.1|AB00562S09[5139774]
• 8854: AB005632
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 7
  gi|5139773|dbj|AB005632.1|AB00562S08[5139773]
• 8855: AB005631
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 6
  gi|5139772|dbj|AB005631.1|AB00562S07[5139772]
• 8856: AB005630
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 5
  gi|5139771|dbj|AB005630.1|AB00562S06[5139771]
• 8857: AB005629
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 4
  gi|5139770|dbj|AB005629.1|AB00562S05[5139770]
• 8858: AB005628
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 3
  gi|5139769|dbj|AB005628.1|AB00562S04[5139769]
• 8859: AB005627
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 2
  gi|5139768|dbj|AB005627.1|AB00562S03[5139768]
• 8860: AB005626
  Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 1
  gi|5139767|dbj|AB005626.1|AB00562S02[5139767]
• 8862: AF030335
  Homo sapiens purinergic P2Y11 receptor (P2Y11) mRNA, complete cds
  gi|2674119|gb|AF030335.1|AF030335[2674119]
• 8863: AF003522
  Homo sapiens Delta mRNA, complete cds
  gi|2197068|gb|AF003522.1|AF003522[2197068]
• 8864: AF003521
  Homo sapiens Jagged 2 mRNA, complete cds
  gi|2197066|gb|AF003521.1|AF003521[2197066]
• 8865: AF068292
  Homo sapiens HDCMA39P mRNA, partial cds
  gi|7634778|gb|AF068292.1|AF068292[7634778]
• 8868: AH007819
  Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, complete cds
  gi|5442455|gb|AH007819.2|SEG_HSHTR2B[5442455]
• 8869: AF156158
  Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, exon 1
  gi|5442454|gb|AF156158.2|HSHTR2B1[5442454]
• 8870: AF156160
  Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, exon 3 and complete
  cds
  gi|5070703|gb|AF156160.1|HSHTR2B3[5070703]
• 8871: AF156159
  Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, exon 2
  gi|5070702|gb|AF156159.1|HSHTR2B2[5070702]
• 8872: AB041713
  Homo sapiens fp gene for prostaglandin F2alpha receptor, exon 1 and 2, partial
  cds
  gi|7619988|dbj|AB041713.1|AB041713[7619988]
• 8873: AF041811
  Homo sapiens ETS related protein-growth factor receptor tyrosine kinase fusion
  proteins (ETV6-NTRK3 fusion) mRNA, partial cds
  gi|6274523|gb|AF041811.2|AF041811[6274523]
• 8874: AF172453
  Homo sapiens opioid growth factor receptor mRNA, complete cds
  gi|7595306|gb|AF172453.1|AF172453[7595306]
• 8875: AF172452
  Homo sapiens opioid growth factor receptor mRNA, complete cds
  gi|7595304|gb|AF172452.1|AF172452[7595304]
• 8876: AF172451
  Homo sapiens opioid growth factor receptor mRNA, complete cds
  gi|7595302|gb|AF172451.1|AF172451[7595302]
• 8877: AF172450
  Homo sapiens opioid growth factor receptor mRNA, complete cds
  gi|7595300|gb|AF172450.1|AF172450[7595300]
• 8878: AF172449
  Homo sapiens clone 127 opioid growth factor receptor mRNA, complete cds
  gi|7595298|gb|AF172449.1|AF172449[7595298]
• 8879: D49394
  Homo sapiens mRNA for serotonin 5-HT3 receptor, complete cds
  gi|681913|dbj|D49394.1|HUMS5HT3RA[681913]
• 8880: AB041395
  Homo sapiens CHRM3 gene for muscarinic acetylcholine receptor m3, complete cds
  gi|7592980|dbj|AB041395.1|AB041395[7592980]
• 8881: AB041391
  Homo sapiens CHRM2 gene for muscarinic acetylcholine receptor m2, partial cds
  gi|7592971|dbj|AB041391.1|AB041391[7592971]
• 8882: AB041384
  Homo sapiens gene for histamine H2 receptor, complete cds
  gi|7592957|dbj|AB041384.1|AB041384[7592957]
• 8883: AB041380
  Homo sapiens gene for histamine H1 receptor, complete cds
  gi|7592949|dbj|AB041380.1|AB041380[7592949]
• 8884: AB041373
  Homo sapiens HTR1E gene for 5-hydroxytryptamine (serotonin) receptor 1E, partial
  cds
  gi|7592934|dbj|AB041373.1|AB041373[7592934]
• 8885: AB041370
  Homo sapiens HTR1B gene for 5-hydroxytryptamine (serotonin) receptor 1B, complete cds
  gi|7592928|dbj|AB041370.1|AB041370[7592928]
• 8887: AB033598
  Homo sapiens gene for melatonin 1b receptor, exon 2 and complete cds
  gi|7209599|dbj|AB033598.1|AB033597S2[7209599]
• 8888: AB033597
  Homo sapiens gene for melatonin 1b receptor, exon 1
  gi|7209598|dbj|AB033597.1|AB033597S1[7209598]
• 8889: SEG_AB033597S
  Homo sapiens gene for melatonin 1b receptor
  gi|7209597|dbj|SEG_AB033597S[7209597]
• 8890: D85606
  Homo sapiens gene for cholecystokinin type-A receptor, complete cds
  gi|7008026|dbj|D85606.1D85606[7008026]
• 8891: SEG_AB019480S
  Homo sapiens NTRK1 gene for TRKA
  gi|6492387|dbj|SEG_AB019480S[6492387]
• 8892: AB019485
  Homo sapiens NTRK1 gene for TRKA, exon 8-14
  gi|6492386|dbj|AB019485.2|AB019480S6[6492386]
• 8893: SEG_AB029932S
  Homo sapiens hMel1a gene for melatonin 1a receptor
  gi|6045084|dbj|SEG_AB029932S[6045084]
• 8894: AB029933
  Homo sapiens hMel1a gene for melatonin 1a receptor, exon 2 and complete cds
  gi|6045083|dbj|AB029933.1|AB029932S2[6045083]
• 8895: AB029932
  Homo sapiens hMel1a gene for melatonin 1a receptor, exon 1
  gi|6045082|dbj|AL029932.1|AB029932S1[6045082]
• 8896: AB026584
  Homo sapiens gene for endothelial protein C receptor, complete cds
  gi|5837963|dbj|AB026584.2|AB026584[5837963]
• 8897: AB017444
  Homo sapiens gene for lectin-like oxidized LDL receptor, exon 6
  gi|5821166|dbj|AB017444.1|AB017444[5821166]
• 8898: AB017443
  Homo sapiens gene for lectin-like oxidized LDL receptor, exon 5
  gi|5821165|dbj|AB017443.1|AB017443[5821165]
• 8899: AB017442
  Homo sapiens gene for lectin-like oxidized LDL receptor, exon 4
  gi|5821164|dbj|AB017442.1|AB017442[5821164]
• 8900: AB017441
  Homo sapiens gene for lectin-like oxidized LDL receptor, exon 3
  gi|5821163|dbj|AB017441.1|AB017441[5821163]
• 8901: AB017440
  Homo sapiens gene for lectin-like oxidized LDL receptor, exon 2
  gi|5821162|dbj|AB017440.1|AB017440[5821162]
• 8902: AB017439
  Homo sapiens gene for lectin-like oxidized LDL receptor, exon 1
  gi|5821161|dbj|AB017439.1|AB017439[5821161]
• 8903: AB019488
  Homo sapiens NTRK1 gene for TRKA, exon 17 and complete cds
  gi|3869111|dbj|AB019488.1|AB019480S9[3869111]
• 8904: AB019487
  Homo sapiens NTRK1 gene for TRKA, exon 16
  gi|3869110|dbj|AB019487.1|AB019480S8[3869110]
• 8905: AB019486
  Homo sapiens NTRK1 gene for TRKA, exon 15
  gi|3869109|dbj|AB019486.1|AB019480S7[3869109]
• 8906: AB019484
  Homo sapiens NTRK1 gene for TRKA, exon 7
  gi|3869107|dbj|AB019484.1|AB019480S5[3869107]
• 8907: AB019483
  Homo sapiens NTRK1 gene for TRKA, exon 5 and 6
  gi|3869106|dbj|AB019483.1|AB3019480S4[3869106]
• 8908: AB019482
  Homo sapiens NTRK1 gene for TRKA, exon 4
  gi|3869105|dbj|AB019482.1|AB019480S3[3869105]
• 8909: AB019481
  Homo sapiens NTRK1 gene for TRKA, exon 2,3
  gi|3869104|dbj|AB019481.1|AB019480S2[3869104]
• 8910: AB019480
  Homo sapiens NTRK1 gene for TRKA, exon 1
  gi|3869103|dbj|AB019480.1|AB019480S1[3869103]
• 8911: SEG_AB01471S
  Homo sapiens DR5 gene
  gi|3721877|dbj|SEG_AB01471S[3721877]
• 8912: AB014718
  Homo sapiens DR5 gene, exon 9 and complete cds
  gi|3721876|dbj|AB014718.1|AB01471S9[3721876]
• 8913: AB014717
  Homo sapiens DR5 gene, exon 8
  gi|3721875|dbj|AB014717.1|AB301471S8[3721875]
• 8914: AB014716
  Homo sapiens DR5 gene, exon 7
  gi|3721874|dbj|AB014716.1|AB01471S7[3721874]
• 8915: AB014715
  Homo sapiens DR5 gene, exon 6
  gi|3721873|dbj|AB014715.1|AB01471S6[3721873]
• 8916: AB3014714
  Homo sapiens DR5 gene, exon 5
  gi|3721872|dbj|AB014714.1|AB01471S5[3721872]
• 8917: AB014713
  Homo sapiens DR5 gene, exon 4
  gi|3721871|dbj|AB014713.1|AB01471S4[3721871]
• 8918: AB014712
  Homo sapiens DR5 gene, exon 3
  gi|3721870|dbj|AB014712.1|AB01471S3[3721870]
• 8919: AB014711
  Homo sapiens DR5 gene, exon 2
  gi|3721869|dbj|AB014711.1|AB01471S2[3721869]
• 8920: AB014710
  Homo sapiens DR5 gene, exon 1, partial sequence
  gi|3721868|dbj|AB014710.1|AB01471S1[3721868]
• 8921: SEG_AB01047S
  Homo sapiens gene for natriuretic peptide A type receptor
  gi|3297985|dbj|SEG_AB01047S[3297985]
• 8922: AB010491
  Homo sapiens gene for natriuretic peptide A type receptor, exon 22 and complete
  cds
  gi|3297984|dbj|AB010491.1|AB01047S22[3297984]
• 8923: AB010490
  Homo sapiens gene for natriuretic peptide A type receptor, exon 21
  gi|3297983|dbj|AB010490.1|AB01047S21[3297983]
• 8924: AB010489
  Homo sapiens gene for natriuretic peptide A type receptor, exon 20
  gi|3297982|dbj|AB010489.1|AB01047S20[3297982]
• 8925: AB010488
  Homo sapiens gene for natriuretic peptide A type receptor, exon 19
  gi|3297981|dbj|AB010488.1|AB01047S19[3297981]
• 8926: AB010487
  Homo sapiens gene for natriuretic peptide A type receptor, exon 18
  gi|3297980|dbj|AB010487.1|AB01047S18[3297980]
• 8927: AB010486
  Homo sapiens gene for natriuretic peptide A type receptor, exon 17
  gi|3297979|dbj|AB010486.1|AB01047S17[3297979]
• 8928: AB010485
  Homo sapiens gene for natriuretic peptide A type receptor, exon 16
  gi|3297978|dbj|AB010485.1|AB01047S16[3297978]
• 8929: AB010484
  Homo sapiens gene for natriuretic peptide A type receptor, exon 15
  gi|3297977|dbj|AB010484.1|AB01047S15[3297977]
• 8930: AB010483
  Homo sapiens gene for natriuretic peptide A type receptor, exon 14
  gi|3297976|dbj|AB010483.1|AB01047S14[3297976]
• 8931: AB010482
  Homo sapiens gene for natriuretic peptide A type receptor, exon 13
  gi|3297975|dbj|AB010482.1|AB01047S13[3297975]
• 8932: AB010481
  Homo sapiens gene for natriuretic peptide A type receptor, exon 12
  gi|3297974|dbj|AB010481.1|AB01047S12[3297974]
• 8933: AB010480
  Homo sapiens gene for natriuretic peptide A type receptor, exon 11
  gi|3297973|dbj|AB010480.1|AB01047S11[3297973]
• 8934: AB010479
  Homo sapiens gene for natriuretic peptide A type receptor, exon 10
  gi|3297972|dbj|AB010479.1|AB01047S10[3297972]
• 8935: AB010478
  Homo sapiens gene for natriuretic peptide A type receptor, exon 9
  gi|3297971|dbj|AB010478.1|AB01047S09[3297971]
• 8936: AB010477
  Homo sapiens gene for natriuretic peptide A type receptor, exon 8
  gi|3297970|dbj|AB010477.1|AB01047S08[3297970]
• 8937: AB010476
  Homo sapiens gene for natriuretic peptide A type receptor, exon 7
  gi|3297969|dbj|AB010476.1|AB01047S07[3297969]
• 8938: AB010475
  Homo sapiens gene for natriuretic peptide A type receptor, exon 6
  gi|3297968|dbj|AB010475.1|AB01047S06[3297968]
• 8939: AB010474
  Homo sapiens gene for natriuretic peptide A type receptor, exon 5
  gi|3297967|dbj|AB010474.1|AB01047S05[3297967]
• 8940: AB010473
  Homo sapiens gene for natriuretic peptide A type receptor, exon 4
  gi|3297966|dbj|AB010473.1|AB01047S04[3297966]
• 8941: AB010472
  Homo sapiens gene for natriuretic peptide A type receptor, exon 3
  gi|3297965|dbj|AB010472.1|AB01047S03[3297965]
• 8942: AB010471
  Homo sapiens gene for natriuretic peptide A type receptor, exon 2
  gi|3297964|dbj|AB010471.1|AB01047S02[3297964]
• 8943: AB010470
  Homo sapiens gene for natriuretic peptide A type receptor, exon 1, partial sequence
  gi|3297963|dbj|AB010470.1|AB01047S01[3297963]
• 8944: AB008681
  Homo sapiens gene for activin receptor type IIB, complete cds
  gi|2760152|dbj|AB008681.1|AB008681[2760152]
• 8945: SEG_AB005521S
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma
  gi|2605496|dbj|SEG_AB005521S[2605496]
• 8946: AB005526
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, eoxn 6 and complete cds
  gi|2605495|dbj|AB005526.1|AB005521S6[2605495]
• 8947: AB005525
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 5
  gi|2605494|dbj|AB005525.1|AB005521S5[2605494]
• 8948: AB005524
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 4
  gi|2605493|dbj|AB005524.1|AB005521S4[2605493]
• 8949: AB005523
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 3
  gi|2605492|dbj|AB005523.1|AB005521S3[2605492]
• 8950: AB005522
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 2
  gi|2605491|dbj|AB005522.1|AB005521S2[2605491]
• 8951: AB005521
  Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 1
  gi|2605490|dbj|AB005521.1|AB005521S1[2605490]
• 8954: AB002059
  Homo sapiens DNA for Human P2XM, complete cds
  gi|2350848|dbj|AB002059.1|AB002059[2350848]
• 8955: SEG_D86389S
• 8955: D86407
  Homo sapiens DNA for apoER2
  gi|2344801|dbj||SEG_D86389S[2344801]
• 8956: D86407
  Homo sapiens DNA for apoER2, complete cds, and exon 19
  gi|2344800|dbj|D86407.1|D86389S19[2344800]
• 8957: D86406
  Homo sapiens DNA for apoER2, exon 18
  gi|2344799|dbj|D86406.1|D86389S18[2344799]
• 8958: D86405
  Homo sapiens DNA for apoER2, exon 17
  gi|2344798|dbj|D86405.1|D86389S17[2344798]
• 8959: D86404
  Homo sapiens DNA for apoER2, exon 16
  gi|2344797|dbj|D586404.1|D8.6389S16[2344797]
• 8960: D86403
  Homo sapiens DNA for apoER2, exon 15
  gi|2344796|dbj|D86403.1|D86389S15[2344796]
• 8961: D86402
  Homo sapiens DNA for apoER2, exon 14
  gi|2344795|dbj|D586402.1D86389S14[2344795]
• 8962: D86401
  Homo sapiens DNA for apoER2, exon 13
  gi|2344794|dbj|D586401.1|D86389S13[2344794]
• 8963: D86400
  Homo sapiens DNA apoER2, exon 12
  gi|2344793|dbj|D86400.1|D86389S12[2344793]
• 8964: D86399
  Homo sapiens DNA for apoER2, exon 11
  gi|2344792|dbj|D586399.1|D86389S11[2344792]
• 8965: D86398
  Homo sapiens DNA for apoER2, exon 10
  gi|2344791|dbj|D586398.1|D86389S10[2344791]
• 8966: D86397
  Homo sapiens DNA for apoER2, exon 9
  gi|2344790|dbj|D586397.1|D86389S09[2344790]
• 8967: D86396
  Homo sapiens DNA for apoER2, exon 8
  gi|2344789|dbj|D86396.1|D86389S08[2344789]
• 8968: D86395
  Homo sapiens DNA for apoER2, exon 7
  gi|2344788|dbj|D586395.1|D86389S07[2344788]
• 8969: D86394
  Homo sapiens DNA for apoER2, exon 6
  gi|2344787|dbj|D86394.1|D86389S06[2344787]
• 8970: D86393
  Homo sapiens DNA for apoER2, exon 5
  gi|2344786|dbj|D86393.1|D86389S05[2344786]
• 8971: D86392
  Homo sapiens DNA for apoER2, exon 4
  gi|2344785|dbj|D86392.1|D86389S04[2344785]
• 8972: D86391
  Homo sapiens DNA for apoER2, exon 3
  gi|2344784|dbj|D586391.1|D86389S03[2344784]
• 8973: D86390
  Homo sapiens DNA for apoER2, exon 2
  gi|2344783|dbj|D86390.1|D86389S02[2344783]
• 8974: D86389
  Homo sapiens DNA for apoER2, exon 1
  gi|2344782|dbj|D86389.1|D86389S01[2344782]
• 8975: D86096
  Human DNA for prostaglandin EP3 receptor subtype, complete cds
  gi|2114186|dbj|D86096.1|D86087S10[2114186]
• 8976: D86095
  Human DNA for prostaglandin E receptor EP3 subtype, exon 9
  gi|2114185|dbj|D86095.1|D86087S09[2114185]
• 8977: D86094
  Human DNA for prostaglandin E receptor EP3 subtype, exon 8
  gi|2114184|dbj|D86094.1|D86087S08[2114184]
• 8978: D86093
  Human DNA for prostaglandin E receptor EP3 subtype, exon 7
  gi|2114183|dbj|D586093.1|D86087S07[2114183]
• 8979: D86092
  Human DNA for prostaglandin E receptor EP3 subtype, exon 6
  gi|2114182|dbj|D586092.1|D86087S06[2114182]
• 8980: D86091
  Human DNA for prostaglandin E receptor EP3 subtype, exon 5
  gi|2114181|dbj|D86091.1|D86087S05[2114181]
• 8981: D86090
  Human DNA for prostaglandin E receptor EP3 subtype, exon 4
  gi|21141800 dbj|D86090.1|D86087S04[2114180]
• 8982: D86089
  Human DNA for prostaglandin E receptor EP3 subtype, exon 3
  gi|2114179|dbj|D86089.1|D86087S03[2114179]
• 8983: D86088
  Human DNA for prostaglandin E receptor EP3 subtype, exon 2
  gi|2114178|dbj|D86088.1|D86087S02[2114178]
• 8984: D86087
  Human DNA for prostaglandin E receptor EP3 subtype, exon 1
  gi|2114177|dbj|D586087.1|D86087S01[2114177]
• 8985: SEG_D49555S
  Homo sapiens DNA for gastric inhibitory polypeptide receptor
  gi|1805368|dbj||SEG_D49555S[1805368]
• 8986: D85376
  Human DNA for thyrotropin-releasing hormone receptor, exon 3 and copmplete cds
  gi|1616933|dbj|D585376.1|D85375S2[1616933]
• 8987: D85375
  Human DNA for thyrotropin-releasing hormon receptor, exon 1, 2
  gi|1616932|dbj|D585375.1D85375S1[1616932]
• 8988: D49559
  Human DNA for gastric inhibitory polypeptide receptor, exon 13 and 14, complete
  cds
  gi|1088442|dbj|D549559.1|D49555S5[1088442]
• 8989: D49558
  Human DNA for gastric inhibitory polypeptide receptor, exon 5, 6, 7, 8, 9, 10,
  11 and 12
  gi|1088441|dbj|D549558.1|D49555S4[1088441]
• 8990: D49557
  Human DNA for gastric inhibitory polypeptide receptor, exon 3 and 4
  gi|1088440|dbj|D549557.1D49555S3[1088440]
• 8991: D49556
  Homo sapiens DNA for gastric inhibitory polypeptide receptor, exon 2
  gi|1088439|dbj|D549556.1D49555S2[1088439]
• 8992: D49555
  Homo sapiens DNA for gastric inhibitory polypeptide receptor, exon 1
  gi|1088438|dbj|D549555.1|D49555S1[1088438]
• 8993: D64016
  Human gene for vascular endothelial growth factor receptor, promoter and exon 1
  gi|1088437|dbj|D564016.1|HUMES[1088437]
• 8994: D38128
  Homo sapiens IP gene for prostacyclin receptor, exon 3
  gi|1019364|dbj|D538128.1|HUMIP2[1019364]
• 8995: D38127
  Human IP gene for prostacyclin receptor, exon 1 and exon 2
  gi|1019362|dbj|D538127.1|HUMIP1[1019362]
• 8996: D37965
  Human mRNA for PDGF receptor beta-like tumor suppressor (PRLTS), complete cds
  gi|807818|dbj|D537965.1|HUMPRLTS[807818]
• 8997: D50017
  Human DNA for alpha-platelet-derived growth factor receptor, exon 23
  gi|767797|dbj|D550017.1|D50001S17[767797]
• 8998: D50016
  Human DNA for alpha-platelet-derived growth factor receptor, exon 22
  gi|767796|dbj|D550016.1|D50001S16[767796]
• 8999: DS0015
  Human DNA for alpha-platelet-derived growth factor receptor, exon 20 and 21
  gi|767795|dbj|D50015.1|D50001S15[767795]
• 9000: D50014
  Human DNA for alpha-platelet-derived growth factor receptor, exon 19
  gi|767794|dbj|D550014.1|D50001S14[767794]
• 9001: D50013
  Human DNA for alpha-platelet-derived growth factor receptor, exon 18
  gi|767793|dbj|D550013.1|D50001S13[767793]
• 9002: D50012
  Human DNA for alpha-platelet-derived growth factor receptor, exon 17
  gi|767792|dbj|D550012.1D50001S12[767792]
• 9003: D50011
  Human DNA for alpha-platelet-derived growth factor receptor, exon 16
  gi|767791|dbj|D550011.1|D50001S11[767791]
• 9004: D50010
  Human DNA for alpha-platelet-derived growth factor receptor, exon 15
  gi|767790|dbj|D550010.1|D50001S10[767790]
• 9005: D50009
  Human DNA for alpha-platelet-derived growth factor receptor, exon 14
  gi|767789|dbj|D550009.1|D50001S09[767789]
• 9006: D50008
  Human DNA for alpha-platelet-derived growth factor receptor, exon 13
  gi|767788|dbj|D550008.1|D50001S08[767788]
• 9007: D50007
  Human DNA for alpha-platelet-derived growth factor receptor, exon 11 and 12
  gi|767787|dbj|D550007.1|D50001S07[767787]
• 9008: D50006
  Human DNA for alpha-platelet-derived growth factor receptor, exon 6-10
  gi|767786|dbj|D550006.1|D50001S06[767786]
• 9009: D50005
  Human DNA for alpha-platelet-derived growth factor receptor, exon 5
  gi|767785|dbj|D550005.1|D50001S05[767785]
• 9010: D50004
  Human DNA for alpha-platelet-derived growth factor receptor, exon 4
  gi|767784|dbj|D550004.1D50001S04[767784]
• 9011: D50003
  Human DNA for alpha-platelet-derived growth factor receptor, exon 3
  gi|767783|dbj|D550003.1|D50001S03[767783]
• 9012: D50002
  Human DNA for alpha-platelet-derived growth factor receptor, exon 2
  gi|767781|dbj|D550002.1D50001S02[767781]
• 9013: D50001
  Human DNA for alpha-platelet-derived growth factor receptor, exon 1
  gi|767780|dbj|D550001.1|D50001S01[767780]
• 9014: D31793
  Human CD40 ligand (CD40L) gene, 5′ flanking region and exon 1
  gi|662386|dbj|D531793.1|HUMCD40L1[662386]
• 9015: D28768
  Homo sapiens leukocyte DNA for Ah receptor, exon 1
  gi|567941|dbj|D528768.1|HUMAHRP[567941]
• 9016: D28769
  Human HOX12 and RAGE genes, complete cds
  gi|561657|dbj|D528769.1|HUMHOXRAGE[561657]
• 9017: D31708
  Human DNA for Ah-receptor, exon 1
  gi|538228|dbj|D531708.1|HUMAHR[538228]
• 9019: D26535
  Human gene for dihydrolipoamide succinyltransferase, complete cds (exon 1-15)
  gi|537349|dbj|D26535.1|HUMDS[537349]
• 9020: SEG_HUMTA2R
  Homo sapiens gene for thromboxane A2 receptor
  gi|488600|dbj|SEGHUMTA2R[488600]
• 9021: D15056
  Homo sapiens gene for thromboxane A2 receptor, exon 3
  gi|441173|dbj|D515056.1|HUMTA2R4[441173]
• 9022: D15055
  Homo sapiens gene for thromboxane A2 receptor, exon 2
  gi|441172|dbj|D515055.1|HUMTA2R3[441172]
• 9023: D15054
  Homo sapiens gene for thromboxane A2 receptor, exon 1b (promoter region II)
  gi|441171|dbj|D515054.1|HUMTA2R2[441171]
• 9024: D15053
  Homo sapiens gene for thromboxane A2 receptor, exon 1 (promoter region I)
  gi|441170|dbj|D515053.1|HUMTA2R1[441170]
• 9025: D21219
  Human CCKBR gene for cholecystokinin-B receptor/gastrin receptor, exon 2-5, partial cds
  gi|416225|dbj|D521219.1|HUMCCKBR2[416225]
• 9026: D21218
  Human CCKBR gene for cholecystokinin-B receptor/gastrin receptor, exon 1
  gi|416224|dbj|D21218.1|HUMCCKBR1[416224]
• 9027: D16532
  Human gene for very low density lipoprotein receptor, exon 19
  gi|407219|dbj|D16532.1|HUMVLDLR19[407219]
• 9028: D16531
  Human gene for very low density lipoprotein receptor, exon 18
  gi|407218|dbj|D16531.1|HUMVLDLR18[407218]
• 9029: D16530
  Huma gene for very low density lipoprotein receptor, exon 17
  gi|407217|dbj|D16530.1|HUMVLDLR17[407217]
• 9030: D16529
  Human gene for very low density lipoprotein receptor, exon 16
  gi|407216|dbj|D516529.1|HUMVLDLR16[407216]
• 9031: D16528
  Human gene for very low density lipoprotein receptor, exon 15
  gi|407215|dbj|D516528.1|HUMVLDLR15[407215]
• 9032: D16527
  Human gene for very low density lipoprotein receptor, exon 14
  gi|407214|dbj|D516527.1|HUMVLDLR14[407214]
• 9033: D16526
  Human gene for very low density lipoprotein receptor, exon 13
  gi|407213|dbj|D516526.1|HUMVLDLR13[407213]
• 9034: D16525
  Human gene for very low density lipoprotein receptor, exon 12
  gi|407212|dbj|D516525.1|HUMVLDLR12[407212]
• 9035: D16524
  Human gene for very low density lipoprotein receptor, exon 11
  gi|407211|dbj|D516524.1|HUMVLDLR11[407211]
• 9036: D16523
  Human gene for very low density lipoprotein receptor, exon 10
  gi|407210|dbj|D516523.1|HUMVLDLR10[407210]
• 9037: D16522
  Human gene for very low density lipoprotein receptor, exon 9
  gi|407209|dbj|D516522.1|HUMVLDLR09[407209]
• 9038: D16520
  Human gene for very low density lipoprotein receptor, exon 8
  gi|407208|dbj|D516520.1|HUMVLDLR08[407208]
• 9039: D16518
  Human gene for very low density lipoprotein receptor, exon 7
  gi|407207|dbj|D516518.1|HUMVLDLR07[407207]
• 9040: D16516
  Human gene for very low density lipoprotein receptor, exon 6
  gi|407206|dbj|D516516.1|HUMVLDLR06[407206]
• 9041: D16514
  Human gene for very low density lipoprotein receptor, exon 5
  gi|407205|dbj|D516514.1|HUMVLDLR05[407205]
• 9042: D16512
  Human gene for very low density lipoprotein receptor, exon 4
  gi|407204|dbj|D516512.1|HUMVLDLR04[407204]
• 9043: D16510
  Human gene for very low density lipoprotein receptor, exon 3
  gi|407203|dbj|D516510.1|HUMVLDLR03[407203]
• 9044: D16508
  Human gene for very low density lipoprotein receptor, exon 2
  gi|407202|dbj|D516508.1|HUMVLDLR02[407202]
• 9045: D16495
  Human gene for very low density lipoprotein receptor, 5′flanking and exon 1
  gi|407201|dbj|D516495.1|HUMVLDLR01[407201]
• 9046: D13168
  Human gene for endothelin-B receptor (hET-BR), exon 7
  gi|285924|dbj|D513168.1|HUMHETBR7[285924]
• 9047: D13167
  Human gene for endothelin-B receptor (hET-BR), exon 6
  gi|285923|dbj|D513167.1|HUMHETBR6[285923]
• 9048: D13166
  Human gene for endothelin-B receptor (hET-BR), exon 5
  gi|285922|dbj|D513166.1|HUMHETBR5[285922]
• 9049: D13165
  Human gene for endothelin-B receptor (hET-BR), exon 4
  gi|285921|dbj|D513165.1|HUMHETBR4[285921]
• 9050: D13164
  Human gene for endothelin-B receptor (hET-BR), exon 3
  gi|285920|dbj|D513164.1|HUMHETBR3[285920]
• 9051: D13163
  Human gene for endothelin-B receptor (hET-BR), exon 2
  gi|285919|dbj|D13163.1|HUMHETBR2[285919]
• 9052: D13162
  Human gene for endothelin-B receptor (hET-BR), exon 1
  gi|285918|dbj|D13162.1|HUMHETBR1[285918]
• 9053: D10604
  Human midkine gene, complete cds
  gi|219928|dbj|D10604.1|HUMMK[219928]
• 9054: D11151
  Human DNA for endothelin-A receptor, exon 8 and 3′ flanking region
  gi|219628|dbj|D511151.1|HUMETAR8[219628]
• 9055: D11150
  Human DNA for endothelin-A receptor, exon 7
  gi|219627|dbj|D511150.1|HUMETAR7[219627]
• 9056: D11149
  Human DNA for endothelin-A receptor, exon 6
  gi|219626|dbj|D511149.1|HUMETAR6[219626]
• 9057: D11148
  Human DNA for endothelin-A receptor, exon 5
  gi|219625|dbj|D511148.1|HUMETAR5[219625]
• 9058: D11147
  Human DNA for endothelin-A receptor, exon 4
  gi|219624|dbj|D511147.1|HUMETAR4[219624]
• 9059: D11146
  Human DNA for endothelin-A receptor, exon 3
  gi|219623|dbj|D511146.1|HUMETAR3[219623]
• 9060: D11145
  Human DNA for endothelin-A receptor, exon 2
  gi|219622|dbj|D511145.1|HUMETAR2[219622]
• 9061: D11144
  Human DNA for endothelin-A receptor, 5′ flanking region and exon 1
  gi|219621|dbj|D511144.1|HUMETAR1[219621]
• 9063: AF215981
  Homo sapiens CC chemokine receptor 10 (CCR10) mRNA, complete cds
  gi|7546844|gb|AF215981.1|AF215981[7546844]
• 9066: AF065440
  Homo sapiens low density lipoprotein receptor-related protein II (LRP2) gene, exon 1 and partial cds
  gi|7534311|gb|AF065440.2|AF065440[7534311]
• 9068: AF228458
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 10 and partial
  cds
  gi|7530451|gb|AF228458.1|AF228450S9[7530451]
• 9069: AF228457
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 9
  gi|7530450|gb|AF228457.1|AF228450S8[7530450]
• 9070: AF228456
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 8
  gi|7530449|gb|AF228456.1|AF228450S7[7530449]
• 9071: AF228455
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 7
  gi|7530448|gb|AF228455.1|AF228450S6[7530448]
• 9072: AF228454
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 6
  gi|7530447|gb|AF228454.1|AF228450S5[7530447]
• 9073: AF228453
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 5
  gi|7530446|gb|AF228453.1|AF228450S4[7530446]
• 9074: AF228452
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 4
  gi|7530445|gb|AF228452.1|AF228450S3[7530445]
• 9075: AF228451
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 3
  gi|7530444|gb|AF228451.1|AF228450S2[7530444]
• 9076: AF228450
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 2
  gi|7530443|gb|AF228450.1|AF228450S1[7530443]
• 9077: AH009226
  Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, partial cds
  gi|7530442|gb|AH009226.1|SEG_AF228450S[7530442]
• 9078: AJ272208
  Homo sapiens mRNA for IL-1 receptor accessory protein-like 2 (IL1RAPL-2 gene)
  gi|7530096|emb|AJ272208.1|HSA272208[7530096]
• 9081: AF056085
  Homo sapiens GABA-B receptor mRNA, complete cds
  gi|3719225|gb|AF056085.1|AF056085[3719225]
• 9083: AF161081
  Homo sapiens activating receptor PILRbeta mRNA, complete cds
  gi|5817856|gb|AF161081.1|AF161081[5817856]
• 9084: AF161080
  Homo sapiens inhibitory receptor PILRalpha mRNA, complete cds
  gi|5817854|gb|AF161080.1|AF161080[5817854]
• 9085: AF228449
  Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) gene, exon 10 and partial cds
  gi|7417243|gb|AF228449.1|AF228447S3[7417243]
• 9086: AF228448
  Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) gene, exon 8 and partial cds
  gi|7417242|gb|AF228448.1|AF228447S2[7417242]
• 9087: AF228447
  Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) gene, exons 5, 6, and partial cds
  gi|7417241|gb|AF228447.1|AF228447S1[7417241]
• 9088: AH009221
  Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5), gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5), and gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) genes, partial cds
  gi|7417240|gb|AH009221.1|SEG_AF228447S[7417240]
• 9089: AF198052
  Homo sapiens EVH1 domain binding protein mRNA, complete cds
  gi|7416992|gb|AF198052.1|AF198052[7416992]
• 9091: AF159278
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 17
  gi|7406946|gb|AF159278.1F159262S17[7406946]
• 9092: AF159277
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 16 and complete cds, alternatively spliced
  gi|7406945|gb|AF159277.1|F159262S16[7406945]
• 9093: AF159276
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 15
  gi|7406944|gb|AF159276.1|F159262S15[7406944]
• 9094: AF159275
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 14
  gi|7406943|gb|AF159275.1|F159262S14[7406943]
• 9095: AF159274
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 13
  gi|7406942|gb|AF159274.1|F159262S13[7406942]
• 9096: AF159273
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 12
  gi|7406941|gb|AF159273.1F159262S12[7406941]
• 9097: AF159272
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 11
  gi|7406940|gb|AF159272.1|F159262S11[7406940]
• 9098: AF159271
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 10
  gi|7406939|gb|AF159271.1|F159262S10[7406939]
• 9099: AF159270
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 9
  gi|7406938|gb|AF159270.1|F159262S09[7406938]
• 9100: AF159269
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 8
  gi|7406937|gb|AF159269.1F159262S08[7406937]
• 9101: AF159268
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 7
  gi|7406936|gb|AF159268.1|F159262S07[7406936]
• 9102: AF159267
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 6
  gi|7406935|gb|AF159267.1|F159262S06[7406935]
• 9103: AF159266
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 5
  gi|7406934|gb|AF159266.1|F159262S05[7406934]
• 9104: AF159265
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 4
  gi|7406933|gb|AF159265.1|F159262S04[7406933]
• 9105: AF159264
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 3
  gi|7406932|gb|AF159264.1F159262S03[7406932]
• 9106: AF159263
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 2
  gi|7406931|gb|AF159263.1|F159262S02[7406931]
• 9107: AF159262
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 1
  gi|7406930|gb|AF159262.1|F159262S01[7406930]
• 9108: AH009217
  Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, complete cds, alternatively spliced
  gi|7406929|gb|AH009217.1|SEG_F159262S[7406929]
• 9109: AF176812
  Homo sapiens dopamine receptor D2longer mRNA, complete cds
  gi|7381415|gb|AF176812.1|AF176812[7381415]
• 9112: AF193507
  Homo sapiens chemokine receptor (CCR11) gene, complete cds
  gi|736334|gb|AF193507.1|AF193507[7363341]
• 9113: AF105239
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 9
  and complete cds
  gi|7363319|gb|AF105239.1|KIR3DL9[7363319]
• 9114: AF105238
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 8
  gi|7363318|gb|AF105238.1|KIR3DL8[7363318]
• 9115: AF105237
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 7
  gi|7363317|gb|AF105237.1|KIR3DL7[7363317]
• 9116: AF105236
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 6
  gi|7363316|gb|AF105236.1|KIR3DL6[7363316]
• 9117: AF105235
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 5
  gi|7363315|gb|AF105235.1|KIR3DL5[7363315]
• 9118: AF105234
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 4
  gi|7363314|gb|AF105234.1|KIR3DL4[7363314]
• 9119: AF105233
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 3
  gi|7363313|gb|AF105233.1|KIR3DL3[7363313]
• 9120: AF105232
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 2
  gi|7363312|gb|AF105232.1|KIR3DL2[7363312]
• 9121: AF105231
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 1
  gi|736331|gb|AF105231.1|KIR3DL1[7363311]
• 9122: AH009212
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, complete
  cds
  gi|7363310|gb|AH009212.1|SEG_KIR3DL[7363310]
• 9123: AF104856
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 9
  and complete cds
  gi|7363308|gb|AF104856.1|HSKCIRV9[7363308]
• 9124: AF104855
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 8
  gi|7363307|gb|AF104855.1|HSKCIRV8[7363307]
• 9125: AF104854
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 7
  gi|7363306|gb|AF104854.1|HSKCIRV7[7363306]
• 9126: AF104853
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 6
  gi|7363305|gb|AF104853.1|HSKCIRV6[7363305]
• 9127: AF104852
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 5
  gi|7363304|gb|AF104852.1|HSKCIRV5[7363304]
• 9128: AF104851
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 4
  gi|7363303|gb|AF104851.1|HSKCIRV4[7363303]
• 9129: AF104850
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 3
  gi|7363302|gb|AF104850.1|HSKCIRV3[7363302]
• 9130: AF104849
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 2
  gi|7363301|gb|AF104849.1|HSKCIRV2[7363301]
• 9131: AF104848
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon
  1
  gi|7363300|gb|AF104848.1|HSKCIRV1[7363300]
• 9132: AH009211
  Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, complete cds
  gi|7363299|gb|AH009211.1|SEG_HSKCIRV[7363299]
• 9136: AF130742
  AF130742 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
  gi|7330628|gb|AF130742.1|AF130742[7330628]
• 9137: AF130741
  AF130741 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
  gi|7330627|gb|AF130741.1|AF130741[7330627]
• 9138: AF130740
  AF130740 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
  gi|7330626|gb|AF130740.1|AF130740[7330626]
• 9139: AF130739
  AF130739 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
  gi|7330625|gb|AF130739.1|AF130739[7330625]
• 9140: AF130738
  AF130738 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
  gi|7330624|gb|AF130738.1|AF130738[7330624]
• 9141: AF130737
  AF130737 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
  gi|7330623|gb|AF130737.1|AF130737[7330623]
• 9142: AF130743
  AF130743 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
• 9143: AB032593
  Homo sapiens mRNA for PXR2b, complete cds
  gi|7328930|dbj|AB3032593.1|AB032593[7328930]
• 9144: AB032592
  Homo sapiens mRNA for PXR2a, complete cds
  gi|7328928|dbj|AB032592.1|AB032592[7328928]
• 9145: AF110640
  Homo sapiens orphan seven-transmembrane receptor (VSHK1) mRNA, complete cds
  gi|7328551|gb|AF110640.1|AF110640[7328551]
• 9147: AF181286
  Homo sapiens mutant dystrophin mRNA, partial cds
  gi|7321332|gb|AF181286.1|AF181286[7321332]
• 9148: AF181285
  Homo sapiens X-linked interleukin-1 receptor accessory protein-like 2 (IL1RAPL2)
  mRNA, partial cds
  gi|7321330|gb|AF181285.1|AF181285[7321330]
• 9149: AF181284
  Homo sapiens X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL1)
  mRNA, complete cds
  gi|7321328|gb|AF181284.1|AF181284[7321328]
• 9150: G64286
  34 Human Homo sapiens STS cDNA, sequence tagged site
  gi|7274484|gb|G64286.1G64286[7274484]
• 9151: AF145712
  Homo sapiens soluble neuropilin-1 mRNA, complete cds
  gi|7271464|gb|AF145712.1|AF145712[7271464]
• 9180: AB031325
  Homo sapiens gene for calcium-sensing receptor, exons, promoter region
  gi|7023984|dbj|AB031325.1|AB031325[7023984]
• 9183: AF112461
  Homo sapiens G protein-coupled receptor 57 (GPR57) gene, complete cds
  gi|6739495|gb|AF112461.1|AF112461[6739495]
• 9184: AF112460
  Homo sapiens G protein-coupled receptor 58 (GPR58) gene, complete cds
  gi|6739493|gb|AF112460.1|AF112460[6739493]
• 9185: AF184174
  Homo sapiens somatostatin receptor 2 (SSTR2) gene, complete cds, alternatively
  spliced
  gi|7229402|gb|AF184174.1|AF184174[7229402]
• 9227: AF175207
  Homo sapiens lectin-like receptor F1, splice variant 1 KLRF1-s1 (KLRF1) mRNA, complete cds
  gi|7188568|gb|AF175207.1|AF175207[7188568]
• 9228: AF175206
  Homo sapiens lectin-like receptor F1 (KLRF1) mRNA, complete cds
  gi|7188566|gb|AF175206.1|AF175206[7188566]
• 9229: AJ271348
  Homo sapiens partial DRD3 gene for dopamine D3 receptor, exon 1
  gi|7159738|emb|AJ271348.2|HSA271348[7159738]
• 9236: AF180814
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 10 and complete cds
  gi|7157949|gb|AF180814.1|HSPEX7NB9[7157949]
• 9237: AF180813
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 9
  gi|7157948|gb|AF180813.1|HSPEX7NB8[7157948]
• 9238: AF180812
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 8
  gi|7157947|gb|AF180812.1|HSPEX7NB7[7157947]
• 9239: AF180811
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 7
  gi|7157946|gb|AF180811.1|HSPEX7NB6[7157946]
• 9240: AF180810
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 6
  gi|7157945|gb|AF180810.1|HSPEX7NB5[7157945]
• 9241: AF180809
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exons 4 and 5
  gi|7157944|gb|AF180809.1|HSPEX7NB4[7157944]
• 9242: AF180808
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 3
  gi|7157943|gb|AF180808.1|HSPEX7NB3[7157943]
• 9243: AF180807
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 2
  gi|7157942|gb|AF180807.1|HSPEX7NB2[7157942]
• 9244: AF180806
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, 5′ region and exon 1
  gi|715794|gb|AF180806.1|HSPEX7NB1[7157941]
• 9245: AH009157
  Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, complete cds
  gi|7157940|gb|AH009157.1|SEG_HSPEX7NB[7157940]
• 9246: AF087930
  Homo sapiens olfactory receptor 17-228 (OR3A2) gene, complete cds
  gi|714464|gb|AF087930.1|AF087930[7144641]
• 9248: AF087928
  Homo sapiens olfactory receptor 17-209 (OR1G1) gene, complete cds
  gi|7144638|gb|AF087928.1|AF087928[7144638]
• 9250: AF087926
  Homo sapiens olfactory receptor 17-201 (OR3A3) gene, complete cds
  gi|7144635|gb|AF087926.1|AF087926[7144635]
• 9251: AF087925
  Homo sapiens olfactory receptor 17-93 (OR1E2) gene, complete cds
  gi|7144633|gb|AF087925.1|AF087925[7144633]
• 9252: AF087924
  Homo sapiens olfactory receptor 17-40 (OR3A1) gene, complete cds
  gi|7144631|gb|AF087924.1|AF087924[7144631]
• 9253: AF087923
  Homo sapiens olfactory receptor 17-31 (OR1D5) gene, complete cds
  gi|7144629|gb|AF087923.1|AF087923[7144629]
• 9254: AF087922
  Homo sapiens olfactory receptor 17-30 (OR1D4) gene, complete cds
  gi|7144627|gb|AF087922.1|AF087922[7144627]
• 9258: AF087918
  Homo sapiens olfactory receptor 17-7 (OR1A1) gene, complete cds
  gi|7144622|gb|AF087918.1|AF087918[7144622]
• 9259: AF087917
  Homo sapiens olfactory receptor 17-4 (OR1D2) gene, complete cds
  gi|7144620|gb|AF087917.1|AF087917[7144620]
• 9260: AF087916
  Homo sapiens olfactory receptor 17-2 (OR1E1) gene, complete cds
  gi|7144618|gb|AF087916.1|AF087916[7144618]
• 9262: AC010582
  Homo sapiens chromosome 14 clone CTD-2547F10, complete sequence
  gi|6721135|gb|AC010582.6|AC010582[6721135]
• 9263: AC010072
  Homo sapiens chromosome 14q31 clone CTD-217314 containing TSHR gene, partial cds; and unknown gene, complete sequence
  gi|6453843|gb|AC010072.5|AC010072[6453843]
• 9264: AF155225
  Homo sapiens olfactory receptor 17-6 (OR1A2) gene, complete cds
  gi|5081803|gb|AF155225.1|AF155225[5081803]
• 9265: AC007262
  Homo sapiens chromosome 14 clone containing gene for thyroid stimulating hormone
  receptor, partial CDS, complete sequence
  gi|4883585|gb|AC007262.4|AC007262[4883585]
• 9266: AC002085
  Homo sapiens Chromosome 17 p13 Cosmid Clone cos26, complete sequence
  gi|4835805|gb|AC002085.2|AC002085[4835805]
• 9267: AC006531
  Homo sapiens chromosome 16 clone 113K5, complete sequence
  gi|4235137|gb|AC006531.1|AC006531[4235137]
• 9268: AC004164
  Homo sapiens chromosome 19, cosmid R26450, complete sequence
  gi|2905827|gb|AC004164.1|AC004164[2905827]
• 9269: AF200949
  Homo sapiens C-type lectin-like receptor-1 mRNA, complete cds
  gi|7110215|gb|AF200949.1|AF200949[7110215]
• 9277: AF124841
  Homo sapiens C-type lectin-like receptor-2 mRNA, complete cds
  gi|7109730|gb|AF124841.1|AF124841[7109730]
• 9278: AF210818
  Homo sapiens SWAP-70 mRNA, complete cds
  gi|6691098|gb|AF210818.1|AF210818[6691098]
• 9281: AF134838
  Homo sapiens endocytic receptor Endo180 (ENDO180) mRNA, complete cds
  gi|4835877|gb|AF134838.1|AF134838[4835877]
• 9282: U89326
  Homo sapiens bone morphogenetic protein receptor type I ALK-6 mRNA, complete cds
  gi|3377788|gb|U89326.1|HSU89326[3377788]
• 9283: AJ003080
  Homo sapiens mRNA for serotonin receptor (short isoform)
  gi|3115225|emb|AJ003080.1|HSAJ3080[3115225]
• 9284: AJ003079
  Homo sapiens mRNA for 5-hydroxytryptamine3 receptor
  gi|3115223|emb|AJ003079.1|HSAJ3079[3115223]
• 9285: AJ003078
  Homo sapiens mRNA for 5-HT3 serotonin receptor (long isoform)
  gi|3115221|emb|AJ003078.1|HSAJ3078[3115221]
• 9286: AC024126
  Homo sapiens chromosome 11 clone cosmid f-o-8180 map 11q13, *** SEQUENCING IN PROGRESS ***, 2 ordered pieces
  gi|7025812|gb|AC024126.1|AC024126[7025812]
• 9287: AC024124
  Homo sapiens chromosome 11 clone cosmid b-o-7185 map 11q13, *** SEQUENCING IN PROGRESS ***, 4 ordered pieces
  gi|7025810|gb|AC024124.1|AC024124[7025810]
• 9288: AC024123
  Homo sapiens chromosome 11 clone bac67-m-5 map 11q13, *** SEQUENCING IN PROGRESS ***, 3 ordered pieces
  gi|7025809|gb|AC024123.1|AC024123[7025809]
• 9289: AF226728
  Homo sapiens somatostatin receptor-interacting protein splice variant b (SSTRIP)
  mRNA, complete cds
  gi|7025450|gb|AF226728.1|AF226728[7025450]
• 9290: AL157442
  Homo sapiens mRNA; cDNA DKFZp586P1424 (from clone DKFZp586P1424); partial cds
  gi|7018558|emb|AL157442.1|HSM802508[7018558]
• 9291: AF217796
  Homo sapiens SCG10 like-protein, helicase-like protein NHL, M68, and ADP-ribosylation factor related protein 1 (ARFRP1) genes, complete cds
  gi|7012928|gb|AF217796.1|AF217796[7012928]
• 9293: AL137719
  Homo sapiens mRNA; cDNA DKFZp434K1831 (from clone DKFZp434K1831); partial cds
  gi|6808155|emb|AL137719.1|HSM802224[6808155]
• 9294: AL137432
  Homo sapiens mRNA; cDNA DKFZp761E1824 (from clone DKFZp761E1824); partial cds
  gi|6807990|emb|AL137432.1|HSM802135[6807990]
• 9295: AL137375
  Homo sapiens mRNA; cDNA DKFZp43411926 (from clone DKFZp43411926); partial cds
  gi|6807903|emb|AL137375.1|HSM802063[6807903]
• 9296: AL137288
  Homo sapiens mRNA; cDNA DKFZp434F1516 (from clone DKFZp434F1S16); partial cds
  gi|6807745|emb|AL137288.1|HSM801953[6807745]
• 9297: AL137651
  Homo sapiens mRNA; cDNA DKFZp43400213 (from clone DKFZp43400213); partial cds
  gi|6807717|emb|AL137651.1|HSM801924[6807717]
• 9298: AL133666
  Homo sapiens mRNA; cDNA DKFZp434C1418 (from clone DKFZp434C1418); partial cds
  gi|6599298|emb|AL133666.1|HSM801500[6599298]
• 9299: AL133097
  Homo sapiens mRNA; cDNA DKFZp434N1928 (from clone DKFZp434N1928)
  gi|6453551|emb|AL133097.1|HSM801374[6453551]
• 9300: AL133058
  Homo sapiens mRNA; cDNA DKFZp434K0615 (from clone DKFZp434K0615); partial cds
  gi|6453479|emb|AL133058.1|HSM801329[6453479]
• 9301: AL133030
  Homo sapiens mRNA; cDNA DKFZp434H177 (from clone DKFZp434H177); partial cds
  gi|6453431|emb|AL133030.1|HSM801297[6453431]
• 9304: AL117432
  Homo sapiens mRNA; cDNA DKFZp434E066 (from clone DKFZp434E066); partial cds
  gi|5911868|emb|AL117432.1|HSM800941[5911868]
• 9305: AL096753
  Homo sapiens mRNA; cDNA DKFZp434C192 (from clone DKFZp434C192); partial cds
  gi|5419889|emb|AL096753.1|HSM800719[5419889]
• 9306: AL080164
  Homo sapiens mRNA; cDNA DKFZp564C1940 (from clone DKFZp564C1940); partial cds
  gi|5262628|emb|AL080164.1|HSM800683[5262628]
• 9307: AL050071
  Homo sapiens mRNA; cDNA DKFZp566B0846 (from clone DKFZp566B0846); partial cds
  gi|4884302|emb|AL050071.1|HSM800396[4884302]
• 9308: AL049924
  Homo sapiens mRNA; cDNA DKFZp564G1182 (from clone DKFZp564G1182); partial cds
  gi|4884170|emb|AL049924.1|HSM800265[4884170]
• 9309: X68559
  Homo sapiens partial FGFR-4 gene for acidic fibroblast growth factor
  gi|556841|emb|X68559.1|HSFGRF[556841]
• 9310: AF228312
  Homo sapiens T-cell receptor zeta chain precursor, mRNA, partial cds
  gi|6984206|gb|AF228312.1|AF228312[6984206]
• 9311: AF199028
  Homo sapiens B7-like protein (GL50) mRNA, complete cds
  gi|6983943|gb|AF199028.1|AF199028[6983943]
• 9315: AF225903
  Homo sapiens D1 dopamine receptor interacting protein calcyon mRNA, complete cds
  gi|6980075|gb|AF225903.1|AF225903[6980075]
• 9316: AF222340
  Homo sapiens type 1 tumor necrosis factor receptor shedding aminopeptidase regulator mRNA, complete cds
  gi|6979942|gb|AF222340.1|AF222340[6979942]
• 9317: AF201349
  Homo sapiens glutamate receptor C gene, partial cds
  gi|6690029|gb|AF201349.1|AF201349[6690029]
• 9318: AF201343
  Homo sapiens glutamate receptor B flop isoform and glutamate receptor B flip isoform genes, partial cds
  gi|6690023|gb|AF201343.1|AF201343[6690023]
• 9319: AJ271729
  Homo sapiens mRNA for glucose-regulated protein (HSPA5 gene)
  gi|6900103|emb|AJ271729.1|HSA271729[6900103]
• 9320: AF217794
  Homo sapiens M68E mRNA, alternatively spliced, complete cds
  gi|6969262|gb|AF217794.1|AF217794[6969262]
• 9321: AF217793
  Homo sapiens M68C mRNA, alternatively spliced, complete cds
  gi|6969260|gb|AF217793.1|AF217793[6969260]
• 9322: AF152238
  Homo sapiens V1b vasopressin receptor (VPR3) gene, complete cds
  gi|6969252|gb|AF152238.1|AF152238[6969252]
• 9325: X89271
  H. sapiens mRNA for HG11 orphan receptor
  gi|6911643|emb|X89271.1|HSHG11ORP[6911643]
• 9328: AJ240085
  Homo sapiens mRNA for T-cell receptor interacting molecule protein, splice variant (TRIM gene)
  gi|6911580|emb|AJ240085.1|HSA240085[6911580]
• 9330: AJ271684
  Homo sapiens mRNA for myeloid DAP12-associating lectin (MDL-1 gene)
  gi|6900101|emb|AJ271684.1|HSA271684[6900101]
• 9331: AJ243213
  Homo sapiens partial 5-HT4 receptor gene, exons 2 to 5
  gi|6900061|emb|AJ243213.1|HSA243213[6900061]
• 9332: AC003075
  Human PAC clone RP4-658N5 from 7p21, complete sequence
  gi|2588637|gb|AC003075.1|AC003075[2588637]
• 9333: AC003078
  Human BAC clone GS1-117010 from 7q21-q22, complete sequence
  gi|258863|gb|AC003078.1|AC003078[2588631]
• 9334: AC002381
  Human BAC clone CTB-20D2 from 7q22, complete sequence
  gi|2275186|gb|AC002381.1|AC002381[2275186]
• 9335: AC005155
  Homo sapiens PAC clone RP5-877J2 from 7 p14-p15, complete sequence
  gi|3242760|gb|AC005155.1|AC005155[3242760]
• 9338: D50678
  Human mRNA for apolipoprotein E receptor 2, complete cds
  gi|1321643|dbj|D50678.1|D50678[1321643]
• 9339: D31770
  Human osteosarcoma mRNA for activin typeII A receptor, complete cds
  gi|1321631|dbj|D31770.1|HUMACTRIIA[1321631]
• 9340: D50516
  Human mRNA for type II receptor for bone morphogenetic protein-4, complete cds
  gi|807712|dbj|D50516.1|HUMBMP4A[807712]
• 9341: D31661
  Human mRNA for tyrosine kinase, complete cds
  gi|495677|dbj|D31661.1|HUMERKA[495677]
• 9342: D17516
  Homo sapiens mRNA for PACAP receptor, complete cds
  gi|457562|dbj|D17516.1|HUMPACAPR[457562]
• 9343: D16105
  Human mRNA for leukocyte tyrosine kinase, complete cds
  gi|440854|dbj|D516105.1|HUMLTKLP2[440854]
• 9344: D16494
  Human mRNA for very low density lipoprotein receptor, complete cds
  gi|391735|dbj|D516494.1|HUMVLDLRB[391735]
• 9345: D16493
  Human mRNA for very low density lipoprotein receptor, complete cds
  gi|391733|dbj|D516493.1|HUMVLDLRA[391733]
• 9346: G63891
  GRM7 Human Homo sapiens STS genomic 3′, sequence tagged site
  gi|6842052|gb|G63891.1|G63891[6842052]
• 9347: G63890
  GRM4 Human Homo sapiens STS genomic 5′, sequence tagged site
  gi|6842051|gb|G63890.1|G63890[6842051]
• 9471: AF148806
  Homo sapiens dopamine receptor D2 (DRD2) gene, 5′-flanking region and exon 1
  gi|6759904|gb|AF148806.1|AF148806[6759904]
• 9473: AF189251
  Homo sapiens cytomegalovirus partial fusion receptor mRNA, partial cds
  gi|6760349|gb|AF189251.1|AF189251[6760349]
• 9474: AF202063
  Homo sapiens fibroblast growth factor receptor 4, soluble-form splice variant (FGFR4) mRNA, complete cds
  gi|6739817|gb|AF202063.1|AF202063[6739817]
• 9475: AF201951
  Homo sapiens high affinity immunoglobulin epsilon receptor beta subunit mRNA, complete cds
  gi|6563299|gb|AF201951.1|AF201951[6563299]
• 9476: AB037108
  Homo sapiens mRNA for seven transmembrane domain orphan receptor, complete cds
  gi|6729335|dbj|AB037108.1|AB037108[6729335]
• 9478: AF209721
  Homo sapiens IgG Fc receptor locus, partial sequence
  gi|6715394|gb|AF209721.1|AF209721[6715394]
• 9480: AJ238323
  Homo sapiens mRNA for NK inhibitory receptor (IRC2)
  gi|6707798|emb|AJ238323.1|HSA238323[6707798]
• 9481: AB036432
  Homo sapiens RAGE mRNA for advanced glycation endproducts receptor, complete cds
  gi|6691625|dbj|AB036432.1|AB036432[6691625]
• 9482: AF192548
  Homo sapiens tumor necrosis factor receptor-like protein ZTNFR9 (ZTNFR9) mRNA,
  complete cds
  gi|6319129|gb|AF192548.1|AF192548[6319129]
• 9483: AF184971
  Homo sapiens class II cytokine receptor ZCYTOR7 (ZCYTOR7) mRNA, complete cds
  gi|6013324|gb|AF184971.1|AF184971[6013324]
• 9484: AJ012288
  Homo sapiens mRNA for GABA-BR1
  gi|4186035|emb|AJ012288.1|HSA012288[4186035]
• 9485: AB035073
  Homo sapiens mRNA for platelet glycoprotein VI, complete cds
  gi|6691622|dbj|AB035073.1|AB035073[6691622]
• 9486: AF217403
  Homo sapiens low density lipoprotein receptor (LDLR) gene, partial cds
  gi|6691160|gb|AF217403.1|AF217403[6691160]
• 9487: AF200465
  Homo sapiens coxsackievirus and adenovirus receptor (CXADR) gene, complete cds;
  and ANA gene, partial cds
  gi|6690789|gb|AF200465.1|AF200465[6690789]
• 9509: AJ243342
  Homo sapiens mRNA for nicotinic acetylcholine receptor alpha 9 subunit (NACHRA9 gene)
  gi|6688135|emb|AJ243342.1|HSA243342[6688135]
• 9510: AJ223183
  Homo sapiens mRNA for DORA protein
  gi|3925598|emb|AJ223183.1|HSAJ3183[3925598]
• 9512: AF006265
  Homo sapiens cancer associated surface antigen (RCAS1) mRNA, complete cds
  gi|2213933|gb|AF006265.1|AF006265[2213933]
• 9513: AF159570
  Homo sapiens regulator of G-protein signalling 5 (RGS5) mRNA, complete cds
  gi|5230675|gb|AF159570.1|AF159570[5230675]
• 9515: D29952
  Human DNA for alpha1A/D adrenergic receptor, complete cds
  gi|914933|dbj|D29952.1|HUMA1ADAR[914933]
• 9516: NM_—004441
  Homo sapiens EphB1 (EPHB1) mRNA
  gi|4758283|ref|NM_—004441.1|[4758283]
• 9532: AF133299
  Homo sapiens lectin-like NK cell receptor LLT1 (LLT1) mRNA, complete cds
  gi|6651064|gb|AF133299.1|AF133299[6651064]
• 9533: AF110265
  Homo sapiens epidermal growth factor receptor substrate EPS15R mRNA, complete cds
  gi|6650598|gb|AF110265.1|AF110265[6650598]
• 9535: AF061779
  Homo sapiens cosmid 25, complete sequence
  gi|6650204|gb|AF061779.1|AF061779[6650204]
• 9537: AF118224
  Homo sapiens matriptase mRNA, complete cds
  gi|6647301|gb|AF118224.2|AF118224[6647301]
• 9538: AF125809
  Homo sapiens neurotrophic receptor tyrosine kinase-ETS related protein fusion protein (NTRK3-ETV6 fusion) mRNA, partial cds
  gi|6635288|gb|AF125809.1|AF125809[6635288]
• 9539: AF125808
  Homo sapiens ETS related protein-neurotrophic receptor tyrosine kinase fusion protein (ETV6-NTRK3 fusion) mRNA, partial cds
  gi|6635286|gb|AF125808.1|AF125808[6635286]
• 9540: AJ000542
  Homo sapiens partial p58 gene for NK receptor
  gi|6624934|emb|AJ000542.2|HSP58NKRC[6624934]
• 9541: AF190826
  Homo sapiens P2X2A receptor (P2X2) gene, complete cds
  gi|6606329|gb|AF190826.1|AF190826[6606329]
• 9542: AF190825
  Homo sapiens P2X2D receptor (P2X2) mRNA, complete cds
  gi|6606327|gb|AF190825.1|AF190825[6606327]
• 9543: AF190824
  Homo sapiens P2X2C receptor (P2X2) mRNA, complete cds
  gi|6606325|gb|AF190824.1|AF190824[6606325]
• 9544: AF190823
  Homo sapiens P2X2B receptor (P2X2) mRNA, complete cds
  gi|6606323|gb|AF190823.1|AF190823[6606323]
• 9545: AF190822
  Homo sapiens P2X2A receptor (P2X2) mRNA, complete cds
  gi|660632|gb|AF190822.1|AF190822[6606321]
• 9546: AH008809
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, complete cds
  gi|6606289|gb|AH008809.1|SEG_AF159616S[6606289]
• 9547: AF159621
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 6 and complete
  cds
  gi|6606288|gb|AF159621.1|AF159616S6[6606288]
• 9548: AF159620
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 5
  gi|6606287|gb|AF159620.1|AF159616S5[6606287]
• 9549: AF159619
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 4
  gi|6606286|gb|AF159619.1|AF159616S4[6606286]
• 9550: AF159618
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 3
  gi|6606285|gb|AF159618.1|AF159616S3[6606285]
• 9551: AF159617
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 2
  gi|6606284|gb|AF159617.1|AF159616S2[6606284]
• 9552: AF159616
  Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 1
  gi|6606283|gb|AF159616.1|AF159616S1[6606283]
• 9553: AH008808
  Homo sapiens PPAR gamma coactivator (PPAR gamma coactivator) gene, complete cds
  gi|6606153|gb|AH008808.1|SEG_F108193S[6606153]
• 9554: AF108205
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 13 and complete cds
  gi|6606152|gb|AF108205.1|F108193S13[6606152]
• 9555: AF108204
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 12
  gi|6606151|gb|AF108204.1|F108193S12[6606151]
• 9556: AF108203
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 11
  gi|6606150|gb|AF108203.1|F108193S11[6606150]
• 9557: AF108202
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 10
  gi|6606149|gb|AF108202.1|F108193S10[6606149]
• 9558: AF108201
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 9
  gi|6606148|gb|AF108201.1|F108193S09[6606148]
• 9559: AF108200
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 8
  gi|6606147|gb|AF108200.1|F108193S08[6606147]
• 9560: AF108199
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 7
  gi|6606146|gb|AF108199.1|F108193S07[6606146]
• 9561: AF108198
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 6
  gi|6606145|gb|AF108198.1|F108193S06[6606145]
• 9562: AF108197
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 5
  gi|6606144|gb|AF108197.1|F108193S05[6606144]
• 9563: AF108196
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 4
  gi|6606143|gb|AF108196.1F108193S04[6606143]
• 9564: AF108195
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 3
  gi|6606142|gb|AF108195.1|F108193S03[6606142]
• 9565: AF108194
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 2
  gi|6606141|gb|AF108194.1|F108193S02[6606141]
• 9566: AF108193
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 1
  gi|6606140|gb|AF108193.1|F108193S01[6606140]
• 9567: AC005009
  Homo sapiens BAC clone GS1-67A24 from 7q21.q21.2, complete sequence
  gi|4156150|gb|AC005009.1|AC005009[4156150]
• 9568: AF047487
  Homo sapiens Nck-2 (NCK2) mRNA, complete cds
  gi|3930216|gb|AF047487.1|AF047487[3930216]
• 9569: AC004822
  Homo sapiens PAC clone RP1-170D19 from Xq23, complete sequence
  gi|3845420|gb|AC004822.1|AC004822[3845420]
• 9570: AC002543
  Homo sapiens BAC clone CTA-300C3 from 7q31.2, complete sequence
  gi|3645947|gb|AC002543.1|AC002543[3645947]
• 9571: AC002081
  Homo sapiens BAC clone CTA-331C24 from 7q21, complete sequence
  gi|2078453|gb|AC002081.1|AC002081[2078453]
• 9572: AF106698
  Homo sapiens PPAR gamma coactivator-1 (PPARGC1) mRNA, complete cds
  gi|6594644|gb|AF106698.1|AF106698[6594644]
• 9574: AH002552
  Homo sapiens CHRNG gene, complete sequence; and acetylcholine receptor gamma-subunit (ACHR) gene, partial cds
  gi|6579185|gb|AH002552.2|SEG_HUMACHRG[6579185]
• 9575: L29197
  Homo sapiens acetylcholine receptor gamma-subunit (ACHR) gene, exons 10 and 11
  gi|457433|gb|L29197.1|HUMACHRG7[457433]
• 9576: M11811
  Homo sapiens acetylcholine receptor gamma-subunit (ACHR) gene, exon 12 and partial cds
  gi|177984|gb|M11811.1|HUMACHRG8[177984]
• 9580: AF119666
  Homo sapiens insulin receptor tyrosine kinase substrate mRNA, complete cds
  gi|6563257|gb|AF119666.1|AF119666[6563257]
• 9581: AF109683
  Homo sapiens leukocyte-associated Ig-like receptor 1b mRNA, complete cds
  gi|6563041|gb|AF109683.1|AF109683[6563041]
• 9582: AH008758
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, complete cds
  gi|6561205|gb|AH008758.1|SEG_HSILGFR[6561205]
• 9583: AF109291
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 48 and complete cds
  gi|6561204|gb|AF109291.1|HSILGFR48[6561204]
• 9584: AF109290
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 47
  gi|6561203|gb|AF109290.1|HSILGFR47[6561203]
• 9585: AF109289
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 46
  gi|6561202|gb|AF109289.1|HSILGFR46[6561202]
• 9586: AF109288
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 45
  gi|656120|gb|AF109288.1|HSILGFR45[6561201]
• 9587: AF109287
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 44
  gi|6561200|gb|AF109287.1|HSILGFR44[6561200]
• 9588: AF109286
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 43
  gi|6561199|gb|AF109286.1|HSILGFR43[6561199]
• 9589: AF109285
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 42
  gi|6561198|gb|AF109285.1|HSILGFR42[6561198]
• 9590: AF109284
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 41
  gi|6561197|gb|AF109284.1|HSILGFR41[6561197]
• 9591: AF109283
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 40
  gi|6561196|gb|AF109283.1|HSILGFR40[6561196]
• 9592: AF109282
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 39
  gi|6561195|gb|AF109282.1|HSILGFR39[6561195]
• 9593: AF109281
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 38
  gi|6561194|gb|AF109281.1|HSILGFR38[6561194]
• 9594: AF109280
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 37
  gi|6561193|gb|AF109280.1|HSILGFR37[6561193]
• 9595: AF109279
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 36
  gi|6561192|gb|AF109279.1|HSILGFR36[6561192]
• 9596: AF109278
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 35
  gi|6561191|gb|AF109278.1|HSILGFR35[6561191]
• 9597: AF109277
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 34
  gi|6561190|gb|AF109277.1|HSILGFR34[6561190]
• 9598: AF109276
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 33
  gi|6561189|gb|AF109276.1|HSILGFR33[6561189]
• 9599: AF109275
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 32
  gi|6561188|gb|AF109275.1|HSILGFR32[6561188]
• 9600: AF109274
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 31
  gi|6561187|gb|AF109274.1|HSILGFR31[6561187]
• 9601: AF109273
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 30
  gi|6561186|gb|AF109273.1|HSILGFR30[6561186]
• 9602: AF109272
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 29
  gi|6561185|gb|AF109272.1|HSILGFR29[6561185]
• 9603: AF109271
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 28
  gi|6561184|gb|AF109271.1|HSILGFR28[6561184]
• 9604: AF109270
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 27
  gi|6561183|gb|AF109270.1|HSILGFR27[6561183]
• 9605: AF109269
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 26
  gi|6561182|gb|AF109269.1|HSILGFR26[6561182]
• 9606: AF109268
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 25
  gi|6561181|gb|AF109268.1|HSILGFR25[6561181]
• 9607: AF109267
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 24
  gi|6561180gb|AF109267.1|HSILGFR24[6561180]
• 9608: AF109266
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 23
  gi|6561179|gb|AF109266.1|HSILGFR23[6561179]
• 9609: AF109265
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 22
  gi|6561178|gb|AF109265.1|HSILGFR22[6561178]
• 9610: AF109264
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 21
  gi|6561177|gb|AF109264.1|HSILGFR21[6561177]
• 9611: AF109263
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 20
  gi|6561176|gb|AF109263.1|HSILGFR20[6561176]
• 9612: AF109262
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 19
  gi|6561175|gb|AF109262.1|HSILGFR19[6561175]
• 9613: AF109261
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 18
  gi|6561174|gb|AF109261.1|HSILGFR18[6561174]
• 9614: AF109260
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 17
  gi|6561173|gb|AF109260.1|HSILGFR17[6561173]
• 9615: AF109259
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 16
  gi|6561172|gb|AF109259.1|HSILGFR16[6561172]
• 9616: AF109258
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 15
  gi|6561171|gb|AF109258.1|HSILGFR15[6561171]
• 9617: AF109257
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 14
  gi|6561170gb|AF109257.1|HSILGFR14[6561170]
• 9618: AF109256
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 13
  gi|6561169|gb|AF109256.1|HSILGFR13[6561169]
• 9619: AF109255
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 12
  gi|6561168|gb|AF109255.1|HSILGFR1 2[6561168]
• 9620: AF109254
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 11
  gi|6561167|gb|AF109254.1|HSILGFR11[6561167]
• 9621: AF109253
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 10
  gi|6561166|gb|AF109253.1|HSILGFR10[6561166]
• 9622: AF109252
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 9
  gi|6561165|gb|AF109252.1|HSILGFR09[6561165]
• 9623: AF109251
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 8
  gi|6561164|gb|AF109251.1|HSILGFR08[6561164]
• 9624: AF109250
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 7
  gi|6561163|gb|AF109250.1|HSILGFR07[6561163]
• 9625: AF109249
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 6
  gi|6561162|gb|AF109249.1|HSILGFR06[6561162]
• 9626: AF109248
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 5
  gi|6561161|gb|AF109248.1HSILGFR05[6561161]
• 9627: AF109247
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 4
  gi|6561160gb|AF109247.1|HSILGFR04[6561160]
• 9628: AF109246
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 3
  gi|6561159|gb|AF109246.1|HSILGFR03[6561159]
• 9629: AF109245
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 2
  gi|6561158|gb|AF109245.1|HSILGFR02[6561158]
• 9630: AF109244
  Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 1
  gi|6561157|gb|AF109244.1|HSILGFR01[6561157]
• 9631: AF178684
  Homo sapiens class I cytokine receptor (zcytor5) mRNA, complete cds
  gi|5853247|gb|AF178684.1|AF178684[5853247]
• 9632: AQ917583
  hxa18 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552294|gb|AQ917583.1|AQ917583[6552294]
• 9633: AQ917582
  hxa17 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552293|gb|AQ917582.1|AQ917582[6552293]
• 9634: AQ917581
  hxa16 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552292|gb|AQ917581.1|AQ917581[6552292]
• 9635: AQ917580
  hxa15 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552291|gb|AQ917580.1|AQ917580[6552291]
• 9636: AQ917579
  hxa14 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552290|gb|AQ917579.1|AQ917579[6552290]
• 9637: AQ917578
  hxa13 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552289|gb|AQ917578.1|AQ917578[6552289]
• 9638: AQ917577
  hxa12 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552288|gb|AQ917577.1|AQ917577[6552288]
• 9639: AQ917576
  Hxa11 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552287|gb|AQ917576.1|AQ917576[6552287]
• 9640: AQ917575
  hxa10 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552286|gb|AQ917575.1|AQ917575[6552286]
• 9641: AQ917574
  hxa9 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552285|gb|AQ917574.1|AQ917574[6552285]
• 9642: AQ917573
  hxa8 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552284|gb|AQ917573.1|AQ917573[6552284]
• 9643: AQ917572
  hxa7 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552283|gb|AQ917572.1|AQ917572[6552283]
• 9644: AQ917571
  hxa6 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552282|gb|AQ917571.1|AQ917571[6552282]
• 9645: AQ917570
  hxa5 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552281|gb|AQ917570.1|AQ917570[6552281]
• 9646: AQ917569
  hxa4 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552280|gb|AQ917569.1|AQ917569[6552280]
• 9647: AQ917568
  hxa3 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552279|gb|AQ917568.1|AQ917568[6552279]
• 9648: AQ917567
  hxa2 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552278|gb|AQ917567.1|AQ917567[6552278]
• 9649: AQ917566
  hxa1 Bac Human I Homo sapiens genomic, genomic survey sequence
  gi|6552277|gb|AQ917566.1|AQ917566[6552277]
• 9650: AH008470
  Homo sapiens somatostatin receptor subtype 2 gene, partial cds
  gi|6531649|gb|AH008470.1|SEG_AF182397S[6531649]
• 9652: AF182397
  Homo sapiens somatostatin receptor subtype 2 gene, promoter region and patial
  cds
  gi|6531647|gb|AF182397.1|AF182397S1[6531647]
• 9654: AF068757
  Homo sapiens somatostatin receptor subtype 3 (SSTR3) gene, 5′ flanking region and partial cds
  gi|6523784|gb|AF068757.1|AF068757[6523784]
• 9656: AF166329
  Homo sapiens intermediate prolactin receptor isoform mRNA, complete cds
  gi|5734139|gb|AF166329.1|AF166329[5734139]
• 9658: AJ251595
  Homo sapiens mRNA for transmembrane glycoprotein (CD44 gene)
  gi|6491738|emb|AJ251595.1|HSA251595[6491738]
• 9659: AF100772
  Homo sapiens tenascin-M1 (TNM1) mRNA, complete cds
  gi|6165844|gb|AF100772.1|AF100772[6165844]
• 9660: AF100634
  Homo sapiens Duffy antigen/Receptor for chemokines (DARC) gene, DARC-Fya allele,
  partial cds
  gi|6048958|gb|AF100634.1|AF100634[6048958]
• 9661: AH008438
  Homo sapiens outer membrane receptor Tom20 (TOM20) gene, complete cds
  gi|6469611|gb|AH008438.1|SEG_HS20TOM[6469611]
• 9662: AF019638
  Homo sapiens nedasin s-form mRNA, complete cds
  gi|6469319|gb|AF019638.1|AF019638[6469319]
• 9663: AB3010445
  Homo sapiens mRNA for CC chemokine ILC, complete cds
  gi|6469037|dbj|AB010445.1|AB010445[6469037]
• 9664: AF119330
  Synthetic construct from Homo sapiens dopamine receptor D4-7 mRNA, partial cds
  gi|4325159|gb|AF119330.1|AF119330[4325159]
• 9665: AF119329
  Synthetic construct from Homo sapiens dopamine receptor D4-4 mRNA, partial cds
  gi|4325157|gb|AF119329.1|AF119329[4325157]
• 9666: AF119328
  Synthetic construct from Homo sapiens dopamine receptor D4-2 mRNA, partial cds
  gi|4325155|gb|AF119328.1|AF119328[4325155]
• 9667: AL021940
  Homo sapiens DNA sequence from PAC 117P20 on chromosome 1q24. Contains the LNHR
  (SELL) gene coding for Lymph Node Homing Receptor (L-Selectin precursor, LAM-1
  Leukocyte Adhesion Molecule, Leukocyte surface antigen Leu-8, TQ1, GP90-MEL, LECAM1 Leukocyte-Endothelial Cell Adhesion Molecule 1, CD62L). Contains the SELE
  gene coding for E-Selectin precursor (CD62E, ELAM-1 Endothelial Leukocyte Adhesion Molecule 1, LECAM-2 Leukocyte-Endothelial Cell Adhesion Molecule 2).
  Contains an unknown gene with homology to predicted yeast. plant and worm proteins. Contains ESTs and STSs, complete sequence
  gi|3115962|emb|AL021940.1|HS117P20[3115962]
• 9668: AF152113
  Homo sapiens perforin gene, IL-2 responsive enhancer sequence
  gi|6467393|gb|AF152113.1|AF152113[6467393]
• 9669: AB022178
  Homo sapiens mRNA for calcitonin receptor, complete cds, isolate from bone marrow osteoclast
  gi|6456431|dbj|AB022178.1|AB022178[6456431]
• 9670: AB022177
  Homo sapiens mRNA for calcitonin receptor, complete cds, isolate from breast carcinoma
  gi|6456429|dbj|AB022177.1|AB022177[6456429]
• 9671: AJ251004
  Homo sapiens ITGB4 gene for integrin beta 4, exons 1-2 and joined CDS
  gi|6453379|emb|AJ251004.1|HSA251004[6453379]
• 9672: AJ133822
  Homo sapiens mRNA for receptor for Advanced Glycation End Product, secreted isoform (RAGEsec gene)
  gi|4877290|emb|AJ133822.1|HSA133822[4877290]
• 9673: Y18994
  Homo sapiens GABRR3 gene, partial
  gi|6434194|emb|Y18994.1|HSP18994[6434194]
• 9676: AF177766
  Homo sapiens human toll-like receptor 4 (TLR4) gene, TLR4B allele, partial cds
  gi|6403466|gb|AF177766.1|AF177766[6403466]
• 9677: AH008297
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, complete
  cds
  gi|6090614|gb|AH008297.1|SEG_HSDRA2S[6090614]
• 9678: AF083854
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 40
  and complete cds
  gi|6090613|gb|AF083854.1|HSDRA2S38[6090613]
• 9679: AF083853
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 39
  gi|6090612|gb|AF083853.1|HSDRA2S37[6090612]
• 9680: AF083852
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 38
  gi|6090611|gb|AF083852.1|HSDRA2S36[6090611]
• 9681: AF083851
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 37
  gi|6090610gb|AF083851.1|HSDRA2S35[6090610]
• 9682: AF083850
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 36
  gi|6090609|gb|AF083850.1|HSDRA2S34[6090609]
• 9683: AF083849
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exons 34
  and 35
  gi|6090608|gb|AF083849.1|HSDRA2S33[6090608]
• 9684: AF083848
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 33
  gi|6090607|gb|AF083848.1|HSDRA2S32[6090607]
• 9685: AF083847
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 32
  gi|6090606|gb|AF083847.1|HSDRA2S31[6090606]
• 9686: AF083846
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 31
  gi|6090605|gb|AF083846.1|HSDRA2S30[6090605]
• 9687: AF083845
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 30
  gi|6090604|gb|AF083845.1|HSDRA2S29[6090604]
• 9688: AF083844
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 29
  gi|6090603|gb|AF083844.1|HSDRA2S28[6090603]
• 9689: AF083843
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 28
  gi|6090602|gb|AF083843.1|HSDRA2S27[6090602]
• 9690: AF083842
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 27
  gi|6090601|gb|AF083842.1|HSDRA2S26[6090601]
• 9691: AF083841
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 26
  gi|6090600|gb|AF083841.1|HSDRA2S25[6090600]
• 9692: AF083840
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 25
  gi|6090599|gb|AF083840.1|HSDRA2S24[6090599]
• 9693: AF083839
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 24
  gi|6090598|gb|AF083839.1|HSDRA2S23[6090598]
• 9694: AF083838
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 23
  gi|6090597|gb|AF083838.1|HSDRA2S22[6090597]
• 9695: AF083837
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 22
  gi|6090596|gb|AF083837.1|HSDRA2S21[6090596]
• 9696: AF083836
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 21
  gi|6090595|gb|AF083836.1|HSDRA2S20[6090595]
• 9697: AF083835
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 20
  gi|6090594|gb|AF083835.1|HSDRA2S19[6090594]
• 9698: AF083834
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 19
  gi|6090593|gb|AF083834.1|HSDRA2S18[6090593]
• 9699: AF083833
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exons 17
  and 18
  gi|6090592|gb|AF083833.1|HSDRA2S17[6090592]
• 9700: AF083832
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 16
  gi|6090591|gb|AF083832.1|HSDRA2S16[6090591]
• 9701: AF083831
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 15
  gi|6090590|gb|AF083831.1|HSDRA2S15[6090590]
• 9702: AF083830
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 14
  gi|6090589|gb|AF083830.1|HSDRA2S14[6090589]
• 9703: AF083829
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 13
  gi|6090588|gb|AF083829.1|HSDRA2S13[6090588]
• 9704: AF083828
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 12
  gi|6090587|gb|AF083828.1|HSDRA2S12[6090587]
• 9705: AF083827
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 11
  gi|6090586|gb|AF083827.1|HSDRA2S11[6090586]
• 9706: AF083826
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 10
  gi|6090585|gb|AF083826.1|HSDRA2S10[6090585]
• 9707: AF083825
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 9
  gi|6090584|gb|AF083825.1|HSDRA2S09[6090584]
• 9708: AF083824
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 8
  gi|6090583|gb|AF083824.1|HSDRA2S08[6090583]
• 9709: AF083823
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 7
  gi|6090582|gb|AF083823.1|HSDRA2S07[6090582]
• 9710: AF083822
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 6
  gi|6090581|gb|AF083822.1|HSDRA2S06[6090581]
• 9711: AF083821
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 5
  gi|6090580|gb|AF083821.1|HSDRA2S05[6090580]
• 9712: AF083820
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 4
  gi|6090579|gb|AF083820.1|HSDRA2S04[6090579]
• 9713: AF083819
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 3
  gi|60905781|gb|AF083819.1|HSDRA2S03[6090578]
• 9714: AF083818
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 2
  gi|6090577|gb|AF083818.1|HSDRA2S02[6090577]
• 9715: AF083817
  Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 1
  gi|6090576|gb|AF083817.1|HSDRA2S01[6090576]
• 9716: U68492
  Homo sapiens 5-hydroxytryptamine 7 receptor isoform B gene, alternatively spliced, partial cds
  gi|1857150|gb|U68492.1|HS5HTSEV01[1857150]
• 9717: AB032417
  Homo sapiens FZD4 mRNA for WNT receptor Frizzled-4, complete cds
  gi|6277265|dbj|AB032417.1|AB032417[6277265]
• 9718: AF191093
  Homo sapiens P2X4 purinoceptor gene, complete cds
  gi|6274470|gb|AF191093.1|AF191093[6274470]
• 9719: AJ130713
  Homo sapiens mRNA for QA79 membrane protein, splice product airm-1
  gi|5541875|emb|AJ130713.1|HSA130713[5541875]
• 9720: AJ130712
  Homo sapiens mRNA for QA79 membrane protein, splice product airm-3
  gi|5541873|emb|AJ130712.1|HSA130712[5541873]
• 9721: AJ130711
  Homo sapiens mRNA for QA79 membrane protein, splice product airm-2
  gi|5541871|emb|AJ130711.1|HSA130711[5541871]
• 9722: AJ130710
  Homo sapiens mRNA for QA79 membrane protein, allelic variant airm-1b
  gi|5541869|emb|AJ130710.1|HSA130710[5541869]
• 9723: AJ007395
  Homo sapiens mRNA for QA79 membrane protein
  gi|5295849|emb|AJ007395.1|HSA7395[5295849]
• 9724: X95097
  Homo sapiens mRNA for VIP receptor 2
  gi|4837717|emb|X95097.2|HSVIP2R[4837717]
• 9725: Y18423
  Homo sapiens VIP2R gene, exons 1-2 (and joined CDS)
  gi|4753150|emb|Y18423.1|HA18423[4753150]
• 9726: Y18431
  Homo sapiens VIP2R gene, exon 13
  gi|4741409|emb|Y18431.1|HA18431[4741409]
• 9727: Y18430
  Homo sapiens VIP2R gene, exons 9-12
  gi|4741408|emb|Y18430.1|HA18430[4741408]
• 9728: Y18429
  Homo sapiens VIP2R gene, exon 8
  gi|4741407|emb|Y18429.1|HA18429[4741407]
• 9729: Y18428
  Homo sapiens VIP2R gene, exon 7
  gi|4741406|emb|Y18428.1|HA18428[4741406]
• 9730: Y18427
  Homo sapiens VIP2R gene, exon 6
  gi|4741405|emb|Y18427.1|HA18427[4741405]
• 9731: Y18426
  Homo sapiens VIPR2 gene exon 5
  gi|4741404|emb|Y18426.1|HA18426[4741404]
• 9732: Y18425
  Homo sapiens VIPR2 gene exon 4
  gi|4741403|emb|Y18425.1|HA18425[4741403]
• 9733: Y18424
  Homo sapiens VIPR2 gene exon 3
  gi|4741402|emb|Y18424.1|HA18424[4741402]
• 9734: X57250
  H. sapiens C5aR mRNA for C5 anaphylatoxin receptor
  gi|29569|emb|X57250.1|HSC5AR[29569]
• 9735: AF200348
  Homo sapiens melanoma-associated antigen MG50 mRNA, partial cds
  gi|6273398|gb|AF200348.1|AF200348[6273398]
• 9736: AH008357
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 1
  gi|6224699|gb|AH008357.1|SEG_HSCXADR[6224699]
• 9737: AF169366
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 7 and complete cds
  gi|6224698|gb|AF169366.1|HSCXADR7[6224698]
• 9738: AF169365
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 6
  gi|6224697|gb|AF169365.1|HSCXADR6[6224697]
• 9739: AF169364
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 5
  gi|6224696|gb|AF169364.1|HSCXADR5[6224696]
• 9740: AF169363
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 4
  gi|6224695|gb|AF169363.1|HSCXADR4[6224695]
• 9741: AF169362
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 3
  gi|6224694|gb|AF169362.1|HSCXADR3[6224694]
• 9742: AF169361
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 2
  gi|6224693|gb|AF169361.1|HSCXADR2[6224693]
• 9743: AF169360
  Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 1
  gi|6224692|gb|AF169360.1|HSCXADR1[6224692]
• 9744: AF181862
  Homo sapiens G protein-coupled receptor mRNA, complete cds
  gi|6175912|gb|AF181862.1|AF181862[6175912]
• 9745: AF178632
  Homo sapiens FEM-1-like death receptor binding protein mRNA, complete cds
  gi|6175868|gb|AF178632.1|AF178632[6175868]
• 9755: X80763
  Homo sapiens gene for 5-hydroxytrptamine 2C receptor, exons 1 to 4
  gi|602872|emb|X80763.1|HS5HT2C[602872]
• 9756: X68149
  Homo sapiens BLR1 gene for Burkitt's lymphoma receptor 1
  gi|29459|emb|X68149.1|HSBLR1A[29459]
• 9757: AF187320
  Homo sapiens transferrin receptor (TFRC) gene, complete cds
  gi|6164847|gb|AF187320.1|AF187320[6164847]
• 9758: AF154673
  Homo sapiens olfactory receptor HPFH1OR (HPFH1OR) gene, complete cds
  gi|5764388|gb|AF154673.1|AF154673[5764388]
• 9760: AF169255
  Homo sapiens 5-hydroxytryptamine 3 receptor B subunit (5-HTR3B) mRNA, complete
  cds
  gi|6103620|gb|AF169255.1|AF169255[6103620]
• 9762: AJ133107
  Homo sapiens CD163 gene, exon 17
  gi|5102659|emb|AJ133107.1|HSA133107[5102659]
• 9763: Y18403
  Homo sapiens CD163 gene, exon 16
  gi|5102656|emb|Y18403.1|HSA118403[5102656]
• 9764: Y18402
  Homo sapiens CD163 gene, exon 15
  gi|5102655|emb|Y18402.1|HSA118402[5102655]
• 9765: Y18401
  Homo sapiens CD163 gene, exon 14
  gi|5102654|emb|Y18401.1|HSA118401[5102654]
• 9766: Y18400
  Homo sapiens CD163 gene, exon 13
  gi|5102653|emb|Y18400.1|HSA118400[5102653]
• 9767: Y18399
  Homo sapiens CD163 gene, exon 12
  gi|5102652|emb|Y18399.1|HSA118399[5102652]
• 9768: Y18398
  Homo sapiens CD163 gene, exon 11
  gi|5102651|emb|Y18398.1|HSA118398[5102651]
• 9769: Y18397
  Homo sapiens CD163 gene, exon 10
  gi|5102650|emb|Y18397.1|HSA118397[5102650]
• 9770: Y18396
  Homo sapiens CD163 gene, exon 9
  gi|5102649|emb|Y18396.1|HSA118396[5102649]
• 9771: Y18395
  Homo sapiens CD163 gene, exon 8
  gi|5102648|emb|Y18395.1|HSA118395[5102648]
• 9772: Y18394
  Homo sapiens CD163 gene, exon 7
  gi|5102647|emb|Y18394.1|HSA118394[5102647]
• 9773: Y18393
  Homo sapiens CD163 gene, exon 6
  gi|5102646|emb|Y18393.1|HSA118393[5102646]
• 9774: Y18392
  Homo sapiens CD163 gene, exon 5
  gi|5102645|emb|Y18392.1|HSA118392[5102645]
• 9775: Y18391
  Homo sapiens CD163 gene, exon 4
  gi|5102644|emb|Y18391.1|HSA118391[5102644]
• 9776: Y18390
  Homo sapiens CD163 gene, exon 3
  gi|5102643|emb|Y18390.1|HSA118390[5102643]
• 9777: Y18389
  Homo sapiens CD163 gene, exon 2
  gi|5102642|emb|Y18389.1|HSA118389[5102642]
• 9791: AF095725
  Homo sapiens PAC LLNLP704E02527Q3 olfactory receptor 17-1 (OR17-1), olfactory receptor 17-2 (OR17-2), olfactory receptor 17-201 (OR17-201), and olfactory receptor 17-93 (OR17-93) genes, complete cds
  gi|6090622|gb|AF095725.1|AF095725[6090622]
• 9792: AH007997
  Homo sapiens prostaglandin E2 receptor EP2 subtype (PTGER2) gene, complete cds
  gi|5524234|gb|AH007997.1|SEG_HSPTGER2G[5524234]
• 9793: AF134202
  Homo sapiens prostaglandin E2 receptor EP2 subtype (PTGER2) gene, alternatively
  spliced exons and complete cds
  gi|5524233|gb|AF134202.1|HSPTGER2G2[5524233]
• 9794: AF134201
  Homo sapiens prostaglandin E2 receptor EP2 subtype (PTGER2) gene, exon 1
  gi|5524232|gb|AF134201.1|HSPTGER2G1[5524232]
• 9797: AF139768
  Homo sapiens type II transmembrane protein MDL-1 (MDL1) mRNA, complete cds
  gi|6049175|gb|AF139768.1|AF139768[6049175]
• 9799: X75318
  H. sapiens ITIH1 gene (exon 22) and ITIH3 gene (exon 1 and joining features)
  gi|575256|emb|X75318.1|HSITIH[575256]
• 9800: AJ245822
  Homo sapiens mRNA for type I transmembrane receptor (psk-3 gene)
  gi|6018463|emb|AJ245822.1|HSA245822[6018463]
• 9801: AJ245820
  Homo sapiens mRNA for type I transmembrane receptor (psk-1 gene)
  gi|6018459|emb|AJ245820.1|HSA245820[6018459]
• 9802: L46722
  Homo sapiens BTG1 binding factor 1 (CAF1) mRNA, complete cds
  gi|6016011|gb|L46722.1|L46722[6016011]
• 9803: X87831
  Homo sapiens mRNA for partial OCT/plexin-A2 protein
  gi|6010214|emb|X87831.2|HSOCTPROT[6010214]
• 9804: AJ000994
  Homo sapiens DNA for p58 NK receptor gene
  gi|2764562|emb|AJ000994.1|HSP58NK[2764562]
• 9805: X84761
  H. sapiens LHCGR gene, exon 9
  gi|1225992|emb|X84761.1|HSLHCGRX9[1225992]
• 9806: X84760
  H. sapiens LHCGR gene, exon 8
  gi|1225991|emb|X84760.1|HSLHCGRX8[1225991]
• 9807: X84759
  H. sapiens LHCGR gene, exon 7
  gi|1225990|emb|X84759.1|HSLHCGRX7[1225990]
• 9808: X84758
  H. sapiens LHCGR gene, exon 6
  gi|1225989|emb|X84758.1|HSLHCGRX6[1225989]
• 9809: X84757
  H. sapiens LHCGR gene, exon 5
  gi|1225988|emb|X84757.1|HSLHCGRX5[1225988]
• 9810: X84756
  H. sapiens LHCGR gene, exon 4
  gi|1225987|emb|X84756.1|HSLHCGRX4[1225987]
• 9811: X84754
  H. sapiens LHCGR gene, exon 2
  gi|1225985|emb|X84754.1|HSLHCGRX2[1225985]
• 9812: X84753
  H. sapiens LHCGR gene, exon 1
  gi|1225983|emb|X84753.1|HSLHCGRX1[1225983]
• 9813: X84763
  H. sapiens LHCGR gene, exon 11
  gi|1225982|emb|X84763.1|HSLHCGR111[1225982]
• 9814: X84762
  H. sapiens LHCGR gene, exon 10
  gi|1225981|emb|X84762.1|HSLHCGR10[1225981]
• 9815: AF140631
  Homo sapiens G-protein coupled receptor 14 (GPR14) gene, complete cds
  gi|5902615|gb|AF140631.1|AF140631[5902615]
• 9816: AF140630
  Homo sapiens urotensin-II mRNA, complete cds
  gi|5902613|gb|AF140630.1|AF140630[5902613]
• 9817: AF040752
  Homo sapiens G protein-coupled receptor kinase 6, splice variant C (GRK6) mRNA,
  complete cds
  gi|3005017|gb|AF040752.1|AF040752[3005017]
• 9818: AF040751
  Homo sapiens G protein-coupled receptor kinase 6, splice variant B (GRK6) mRNA,
  complete cds
  gi|3005015|gb|AF040751.1|AF040751[3005015]
• 9819: AF040753
  Homo sapiens G protein-coupled receptor kinase 6 (GRK6) gene, partial cds
  gi|3004990|gb|AF040753.1|AF040753[3004990]
• 9820: X87832
  Homo sapiens mRNA for partial NOV/plexin-A1 protein
  gi|6010216|emb|X87832.2|HSNOVPROT[6010216]
• 9821: X87904
  Homo sapiens mRNA for semaphorin receptor (plexin-B1/SEP gene)
  gi|6010210|emb|X87904.2|HSRNASEP[6010210]
• 9822: AJ011415
  Homo sapiens mRNA for plexin-B1 plasma membrane receptor, splice variant R (plexin-B1/SEP gene)
  gi|5918166|emb|AJ011415.1|HSA011415[5918166]
• 9823: AJ011414
  Homo sapiens mRNA for plexin-B1 plasma membrane receptor, truncated splice variant (plexin-B1/SEP gene)
  gi|5918164|emb|AJ011414.1|HSA011414[5918164]
• 9824: X07019
  Homo sapiens partial TRDC gene for T-cell receptor delta chain, exon 1
  gi|29766|emb|X07019.1|HSCD1G[29766]
• 9825: X54559
  Homo sapiens mRNA for met proto-oncogene
  gi|34557|emb|X54559.1|HSMETPRO[34557]
• 9826: AF186380
  Homo sapiens calcium-mobilizing lysophosphatidic acid receptor LP-A3/Edg-7 mRNA,
  complete cds
  gi|6003655|gb|AF186380.1|AF186380[6003655]
• 9827: AF147204
  Homo sapiens chemokine receptor CXCR4-Lo (CXCR4) mRNA, alternatively spliced, complete cds
  gi|6002763|gb|AF147204.1|AF147204[6002763]
• 9828: AF029213
  Homo sapiens IL-1 receptor accessory protein mRNA, complete cds
  gi|2599126|gb|AF029213.1|AF029213[2599126]
• 9829: Z24462
  H. sapiens MTCP-1 gene
  gi|406858|emb|Z24462.1|HSMTCP1B[406858]
• 9830: Z24455
  H. sapiens MTCP-1 gene
  gi|406857|emb|Z24455.1|HSMTCP1A[406857]
• 9832: AF124598
  Homo sapiens coxsackie and adenovirus receptor protein (HCAR2) mRNA, partial cds
  gi|4884701|gb|AF124598.1|AF124598[4884701]
• 9833: AF124145
  Homo sapiens autocrine motility factor receptor (AMFR) mRNA, complete cds
  gi|5931954|gb|AF124145.1|AF124145[5931954]
• 9835: AF118637
  Homo sapiens feline leukemia virus subgroup C receptor FLVCR(C10) mRNA, complete cds
  gi|5565871|gb|AF118637.1|AF118637[5565871]
• 9836: AF127138
  Homo sapiens lysophosphatidic acid G protein-coupled receptor (EDG7) mRNA, complete cds
  gi|5922724|gb|AF127138.1|AF127138[5922724]
• 9837: AF104939
  Homo sapiens lectomedin-1 gamma (LEC1) mRNA, complete cds
  gi|5880493|gb|AF104939.1|AF104939[5880493]
• 9838: AF104266
  Homo sapiens lectomedin-1 alpha (LEC1) mRNA, complete cds
  gi|5880489|gb|AF104266.1|AF104266[5880489]
• 9839: X51646
  Homo sapiens DRD2 gene for dopamine receptor D2
  gi|30868|emb|X51646.1|HSDOPD2GE[30868]
• 9840: X51645
  Homo sapiens mRNA for dopamine receptor D2 (DRD2 gene)
  gi|30867|emb|X51645.1|HSDOPD2[30867]
• 9841: AB010447
  Homo sapiens mRNA for CC chemokine eotaxin3, complete cds
  gi|5921130|dbj|AB010447.1|AB010447[5921130]
• 9844: AF137378
  Homo sapiens integrin alpha 11 subunit precursor (ITGA11) mRNA, complete cds
  gi|5915661|gb|AF137378.2|AF137378[5915661]
• 9845: AJ243212
  Homo sapiens mRNA for DMBT1 protein 8 kb transcript variant 2 (DMBT1/8 kb.2)
  gi|5912463|emb|AJ243212.1|HSA243212[5912463]
• 9846: AJ243874
  Homo sapiens mRNA for oligophrenin-4 (OPHN4 gene)
  gi|5911829|emb|AJ243874.1|HSA243874[5911829]
• 9847: AF091352
  Homo sapiens vascular permeability factor 148 mRNA, complete cds
  gi|5901560|gb|AF091352.1|AF091352[5901560]
• 9848: AF159456
  Homo sapiens gp-340 variant protein (DMBT1) mRNA, complete cds
  gi|5733597|gb|AF159456.1|AF159456[5733597]
• 9948: AB023486
  Homo sapiens gene for histamine H2 receptor, promoter region and complete cds
  gi|5881575|dbj|AB023486.1|AB023486[5881575]
• 9949: AF104938
  Homo sapiens lectomedin-1 beta (LEC1) mRNA, complete cds
  gi|588049|gb|AF104938.1|AF104938[5880491]
• 9950: U81379
  Homo sapiens interleukin-13 receptor mRNA, complete cds
  gi|5870850|gb|U81379.3|HSU81379[5870850]
• 9951: AH008056
  Homo sapiens galanin receptor (GALR3) gene, complete cds
  gi|5870844|gb|AH008056.2|SEG_HSGALR3S[5870844]
• 9952: AF129514
  Homo sapiens galanin receptor (GALR3) gene, exon 2 and complete cds
  gi|5870843|gb|AF129514.2|HSGALR3S2[5870843]
• 9953: AF129513
  Homo sapiens galanin receptor (GALR3) gene, exon 1
  gi|5870842|gb|AF129513.2|HSGALR3S1[5870842]
• 9954: AF101472
  Homo sapiens G protein-coupled receptor 75 (GPR75) gene, complete cds
  gi|4558866|gb|AF101472.1|AF101472[4558866]
• 9955: AF072693
  Homo sapiens G protein-coupled receptor 75 (GPR75) mRNA, complete cds
  gi|4406084|gb|AF072693.1|AF072693[4406084]
• 9957: AJ246000
  Homo sapiens mRNA for leucocyte adhesion receptor, L-selectin
  gi|5852071|emb|AJ246000.1|HSA246000[5852071]
• 9959: AJ224864
  Homo sapiens mRNA for IRC1 protein
  gi|5834585|emb|AJ224864.1|HSA224864[5834585]
• 9960: AJ132948
  Homo sapiens mRNA for rfg7 protein, partial
  gi|5834581|emb|AJ132948.1|HSA132948[5834581]
• 9961: AB027464
  Homo sapiens FZD10 mRNA for Frizzled-10, complete cds
  gi|5834487|dbj|AB027464.1|AB027464[5834487]
• 9963: AJ133532
  Homo sapiens mRNA for dendritic cell immunoreceptor
  gi|5823973|emb|AJ133532.1|HSA133532[5823973]
• 9964: AJ223153
  Homo sapiens mRNA for activating NK-A1 receptor
  gi|5823969|emb|AJ223153.1|HSAJ3153[5823969]
• 9965: AB025257
  Homo sapiens FCER1B gene for high affinity IgE receptor beta chain, promoter region, partial sequence
  gi|5821396|dbj|AB025257.1|AB025257[5821396]
• 9970: Y16434
  Homo sapiens mRNA for T-cell receptor beta, clone PPN82
  gi|2879843|emb|Y16434.1|HSTCRB82[2879843]
• 9971: Y16433
  Homo sapiens mRNA for T-cell receptor alpha, clone PPN82
  gi|2879842|emb|Y16433.1|HSTCRA82[2879842]
• 9972: AF144648
  Homo sapiens GABA-A receptor theta (theta) mRNA, complete cds
  gi|5764186|gb|AF144648.1|AF144648[5764186]
• 9973: AF151104
  Homo sapiens T-cell receptor gamma gene sequence
  gi|5758137|gb|AF151104.1|AF151104[5758137]
• 9974: AF039686
  Homo sapiens G-protein coupled receptor GPR34 (GPR34) mRNA, complete cds
  gi|5757633|gb|AF039686.1|AF039686[5757633]
• 9975: AF000548
  Homo sapiens P1 clone DMPC-HFF#1-1075-D9, repeat region
  gi|223207|gb|AF000548.1|HSAF000548[2232071]
• 9976: X83701
  Homo sapiens IGF2R gene (subclone pE3UP)
  gi|929648|emb|X83701.1|HSIGF2RX3[929648]
• 9977: X83700
  Home sapiens IGF2R gene (subclone pEX2)
  gi|929646|emb|X83700.1|HSIGF2RX2[929646]
• 9978: X83702
  Homo sapiens IGF2R gene (subclone pEX3)
  gi|929644|emb|X83702.1|HSIGF2R1 3[929644]
• 9979: G16210
  967A10R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 967A10, sequence tagged site
  gi|1592382|gb|G16210.1|G16210[1592382]
• 9980: AH008077
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, complete cds
  gi|5737745|gb|AH008077.1|SEG_HSEDAR[5737745]
• 9981: AF130996
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 12 and complete
  cds
  gi|5737744|gb|AF130996.1|HSEDAR8[5737744]
• 9982: AF130995
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 11
  gi|5737743|gb|AF130995.1|HSEDAR7[5737743]
• 9983: AF130994
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 10
  gi|5737742|gb|AF130994.1|HSEDAR6[5737742]
• 9984: AF130993
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exons 7, 8, and 9
  gi|573774|gb|AF130993.1|HSEDAR5[5737741]
• 9985: AF130992
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 6
  gi|5737740|gb|AF130992.1|HSEDAR4[5737740]
• 9986: AF130991
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 5
  gi|5737739|gb|AF130991.1|HSEDAR3[5737739]
• 9987: AF130990
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exons 2, 3, and 4
  gi|5737738|gb|AF130990.1|HSEDAR2[5737738]
• 9988: AF130989
  Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 1
  gi|5737737|gb|AF130989.1|HSEDAR1[5737737]
• 9989: AF130988
  Homo sapiens ectodysplasin-A receptor protein (EDAR) mRNA, complete cds
  gi|5737735|gb|AF130988.1|AF130988[5737735]
• 9990: AF033111
  Homo sapiens Siva-2 mRNA, complete cds
  gi|5737690|gb|AF033111.1|AF033111[5737690]
• 9992: AJ238044
  Homo sapiens mRNA for bradykinin B1 receptor (BLBKR gene)
  gi|5139485|emb|AJ238044.1|HSA238044[5139485]
• 9993: X95425
  H. sapiens mRNA for EHK-1 receptor tyrosine kinase
  gi|1177465|emb|X95425.1|HSEHK1[1177465]
• 9995: AF135562
  Homo sapiens p58 killer cell inhibitory receptor KIR-K78 (KIR-K78) mRNA, partial
  cds
  gi|5730925|gb|AF135562.1|AF135562[5730925]
• 9996: AF135561
  Homo sapiens p58 killer cell inhibitory receptor KIR-K65 (KIR-K65) mRNA, partial
  cds
  gi|5730923|gb|AF135561.1(AF135561[5730923]
• 9997: AF135560
  Homo sapiens p58 killer cell inhibitory receptor KIR-K64 (KIR-K64) mRNA, partial
  cds
  gi|5730921|gb|AF135560.1|AF135560[5730921]
• 9998: AF135559
  Homo sapiens p58 killer cell inhibitory receptor KIR-K61 (KIR-K61) mRNA, partial
  cds
  gi|5730919|gb|AF135559.1|AF135559[5730919]
• 9999: AF135558
  Homo sapiens p58 killer cell inhibitory receptor KIR-K39 (KIR-K39) mRNA, partial
  cds
  gi|5730917|gb|AF135558.1|AF135558[5730917]
• 10000: AF135557
  Homo sapiens p58 killer cell inhibitory receptor KIR-K36 (KIR-K36) mRNA, partial
  cds
  gi|5730915|gb|AF135557.1|AF135557[5730915]
• 10001: AF135556
  Homo sapiens p58 killer cell inhibitory receptor KIR-K15 (KIR-K15) mRNA, partial
  cds
  gi|5730913|gb|AF135556.1|AF135556[5730913]
• 10002: AF135555
  Homo sapiens p58 killer cell inhibitory receptor KIR-K9 (KIR-K9) mRNA, partial
  cds
  gi|5730911|gb|AF135555.1|AF135555[5730911]
• 10003: AF135554
  Homo sapiens p58 killer cell inhibitory receptor KIR-K3 (KIR-K3) mRNA, partial
  cds
  gi|5730909|gb|AF135554.1|AF135554[5730909]
• 10004: AF135567
  Homo sapiens p58 killer cell inhibitory receptor KIR-K7c mRNA, alternatively spliced, partial cds
  gi|5730907|gb|AF135567.1|AF135567[5730907]
• 10005: AF135566
  Homo sapiens p58 killer cell inhibitory receptor KIR-K7b mRNA, alternatively spliced, partial cds
  gi|5730905|gb|AF135566.1|AF135566[5730905]
• 10006: AF135565
  Homo sapiens p58 killer cell inhibitory receptor KIR-K7a mRNA, alternatively spliced, partial cds
  gi|5730903|gb|AF135565.1|AF135565[5730903]
• 10007: AF135564
  Homo sapiens p50 killer cell activating receptor KAR-K1d mRNA, alternatively spliced, partial cds
  gi|5730901|gb|AF135564.1|AF135564[5730901]
• 10008: AF135563
  Homo sapiens p50 killer cell activating receptor KAR-K1a mRNA, alternatively spliced, partial cds
  gi|5730899|gb|AF135563.1|AF135563[5730899]
• 10009: AF172932
  Homo sapiens MIS type II receptor (MISRII) mRNA, complete cds
  gi|5726642|gb|AF172932.1|AF172932[5726642]
• 10010: AF162790
  Homo sapiens Fc gamma receptor III-A gene, partial cds
  gi|5726469|gb|AF162790.1|AF162790[5726469]
• 10012: AF161921
  Homo sapiens clone G7 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712813|gb|AF161921.1|[5712813]
• 10013: AF161920
  Homo sapiens clone G6 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712812|gb|AF161920.1|[5712812]
• 10014: AF161919
  Homo sapiens clone F4 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712811|gb|AF161919.1|[5712811]
• 10015: AF161918
  Homo sapiens clone F3 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712810|gb|AF161918.1|[5712810]
• 10016: AF161917
  Homo sapiens clone F1.1 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712809|gb|AF161917.1|[5712809]
• 10017: AF161916
  Homo sapiens clone H-JM-2 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712808|gb|AF161916.1|[5712808]
• 10018: AF161915
  Homo sapiens clone JM-1 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712807|gb|AF161915.1|[5712807]
• 10019: AF161914
  Homo sapiens clone 9/8.2 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712806|gb|AF161914.1|[5712806]
• 10020: AF161913
  Homo sapiens clone 6-53 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712805|gb|AF161913.1|[5712805]
• 10021: AF161912
  Homo sapiens clone 5-53 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712804|gb|AF161912.1|[5712804]
• 10022: AF161911
  Homo sapiens clone 4-55 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712803|gb|AF161911.1|[5712803]
• 10023: AF161910
  Homo sapiens clone 4-53 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712802|gb|AF161910.1|[5712802]
• 10024: AF161909
  Homo sapiens clone 3-55 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
  gi|5712801|gb|AF161909.1|[5712801]
• 10025: E17202
  Human cDNA for JEG18 complete cds
  gi|5711885|dbj|E17202.1|E17202[5711885]
• 10026: E17201
  Human mRNA for JEG18 complete cds
  gi|5711884|dbj|E17201.1|E17201[5711884]
• 10027: E16188
  cDNA encoding G protein-coupled receptor
  gi|5710871|dbj|E16188.1|E16188[5710871]
• 10028: E16187
  Partial sequence of cDNA encoding G protein-coupled receptor
  gi|5710870|dbj|E16187.1|E16187[5710870]
• 10029: E16186
  Partial sequence of cDNA encoding G protein-coupled receptor
  gi|5710869|dbj|E16186.1|E16186[5710869]
• 10030: E16000
  EST sequence containing human G protein-coupling receptor gene
  gi|5710683|dbj|E6000.1|E16000[5710683]
• 10031: E15999
  EST sequence containing human G protein-coupling receptor gene
  gi|5710682|dbj|E15999.1|E15999[5710682]
• 10032: E15998
  cDNA encoding G protein-coupling receptor protein
  gi|5710681|dbj|E15998.1|E15998[5710681]
• 10033: E15997
  cDNA encoding human G protein-coupling receptor protein
  gi|5710680|dbj|E15997.1|E15997[5710680]
• 10034: E15919
  cDNA encoding prostaglandin EP3-6 receptor
  gi|5710602|dbj|E15919.1|E15919[5710602]
• 10035: E15918
  cDNA encoding prostaglandin EP3-5 receptor
  gi|5710601|dbj|E15918.1|E15918[5710601]
• 10037: E15242
  Human mRNA for endothelin B receptor, complete cds
  gi|5709925|dbj|E15242.1|E15242[5709925]
• 10038: E14946
  Human mRNA for adrenaline beta 3 receptor
  gi|5709629|dbj|E14946.1|E14946[5709629]
• 10039: E14587
  Human mRNA isoform fragment for Vitamin D receptor
  gi|5709270|dbj|E14587.1|E14587[5709270]
• 10040: E14586
  Human mRNA isoform fragment for Vitamin D receptor
  gi|5709269|dbj|E14586.1|E14586[5709269]
• 10041: E14585
  Human mRNA isoform for Vitamin D receptor
  gi|5709268|dbj|E14585.1|E14585[5709268]
• 10042: E14219
  Partial sequence of human cDNA encoding a G protein-coupled receptor, 63A2full
  gi|5708902|dbj|E14219.1|E14219[5708902]
• 10043: E14218
  Partial sequence of human cDNA encoding a G protein-coupled receptor, 63A2full
  gi|5708901|dbj|E14218.1|E14218[5708901]
• 10044: E14217
  Human mRNA for a G protein-coupled receptor, 63A2full, complete cds
  gi|5708900|dbj|E14217.1|E14217[5708900]
• 10046: X83699
  Homo sapiens IGF2R gene (subclone pEX1-P)
  gi|1006660|emb|X83699.1|HSIGF2RX1[1006660]
• 10048: AF007790
  Homo sapiens ICERE-1 mRNA, complete cds
  gi|5670325|gb|AF007790.2|AF007790[5670325]
• 10054: AF036718
  Homo sapiens FGFR signalling adaptor SNT-2 mRNA, complete cds
  gi|2708629|gb|AF036718.1|AF036718[2708629]
• 10056: AF099033
  Homo sapiens gamma-aminobutyric acid type B receptor 2 (GABABR2) mRNA, complete
  cds
  gi|5639666|gb|AF099033.1|AF099033[5639666]
• 10057: AF009221
  Homo sapiens leucocyte immunoglobulin-like receptor-1 mRNA, complete cds
  gi|2267169|gb|AF009221.1|AF009221[2267169]
• 10058: AF009220
  Homo sapiens leucocyte immunoglobulin-like receptor-1 mRNA, complete cds
  gi|2267167|gb|AF009220.1|AF009220[2267167]
• 10059: AF067864
  Homo sapiens transferrin receptor 2 alpha (TFR2) mRNA, complete cds
  gi|5596369|gb|AF067864.1|AF067864[5596369]
• 10061: AF040257
  Homo sapiens TNF receptor homolog mRNA, partial cds
  gi|3170220|gb|AF040257.1|AF040257[3170220]
• 10062: AF026245
  Homo sapiens yotiao mRNA, complete cds
  gi|2623067|gb|AF026245.1|AF026245[2623067]
• 10064: AF163302
  Homo sapiens somatostatin receptor interacting protein splice variant a (SSTRIP)
  mRNA, complete cds
  gi|5533304|gb|AF163302.1|AF163302[5533304]
• 10065: AF153500
  Homo sapiens mu opioid receptor (MOR1) gene, partial cds
  gi|5524612|gb|AF153500.1|AF153500[5524612]
• 10066: AH007996
  Homo sapiens NK receptor Ly-49L gene, complete cds
  gi|5524171|gb|AH007996.1|SEG_HSLY49L[5524171]
• 10067: AF126038
  Homo sapiens NK receptor Ly-49L gene, pseudoexon 7
  gi|5524170|gb|AF126038.1|HSLY49L3[5524170]
• 10068: AF126037
  Homo sapiens NK receptor Ly-49L gene, exon 5, pseudoexon 6, and complete cds
  gi|5524169|gb|AF126037.1|HSLY49L2[5524169]
• 10069: AF126036
  Homo sapiens NK receptor Ly-49L gene, exons 1 through 4
  gi|5524168|gb|AF126036.1|HSLY49L1[5524168]
• 10070: AF081675
  Homo sapiens ITIM-containing receptor MAFA-L mRNA, complete cds
  gi|3421400|gb|AF081675.1|AF081675[3421400]
• 10071: AF145782
  Homo sapiens 2B4 type I transmembrane protein mRNA, complete cds
  gi|5059179|gb|AF145782.1|AF145782[5059179]
• 10072: AH007960
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, complete cds
  gi|5453121|gb|AH007960.1|SEG_HSEPHAI[5453121]
• 10073: AF101171
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 18 and complete cds
  gi|5453120|gb|AF101171.1|HSEPHA17[5453120]
• 10074: AF101170
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 17
  gi|5453119|gb|AF101170.1|HSEPHA16[5453119]
• 10075: AF101169
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exons 12 through 16
  gi|5453118|gb|AF101169.1|HSEPHA15[5453118]
• 10076: AF101168
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exons 4 through 11
  gi|5453117|gb|AF101168.1|HSEPHA14[5453117]
• 10077: AF101167
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 3
  gi|5453116|gb|AF101167.1|HSEPHA13[5453116]
• 10078: AF101166
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 2
  gi|5453115|gb|AF101166.1|HSEPHA12[5453115]
• 10079: AF101165
  Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 1
  gi|5453114|gb|AF101165.1|HSEPHA11[5453114]
• 10080: AF107761
  Homo sapiens NK cell receptor (2B4) mRNA, complete cds
  gi|5442467|gb|AF107761.2|AF107761[5442467]
• 10081: AF109127
  Homo sapiens stromal cell-derived receptor-1 alpha mRNA, complete cds
  gi|5442037|gb|AF109127.1|AF109127[5442037]
• 10082: AF109126
  Homo sapiens stromal cell-derived receptor-1 beta mRNA, complete cds
  gi|5442035|gb|AF109126.1|AF109126[5442035]
• 10084: Y17131
  Homo sapiens FGFR2 gene, exon 7 and exon 8 (partial)
  gi|3077606|emb|Y17131.1|HSY17131[3077606]
• 10085: X57829
  H. sapiens serotonin 5-HT1a receptor gene
  gi|36428|emb|X57829.1|HSSERR51[36428]
• 10086: AF100762
  Homo sapiens thyroid receptor interactor trip15 mRNA, complete cds
  gi|5410309|gb|AF100762.1|TRIP15[5410309]
• 10087: AF109388
  Homo sapiens P2X2B receptor mRNA, complete cds
  gi|5381338|gb|AF109388.1|AF109388[5381338]
• 10088: AF109387
  Homo sapiens P2X2A receptor mRNA, complete cds
  gi|5381336|gb|AF109387.1|AF109387[5381336]
• 10089: AF118108
  Homo sapiens lymphatic endothelium-specific hyaluronan receptor LYVE-1 mRNA, complete cds
  gi|5359672|gb|AF118108.1|AF118108[5359672]
• 10090: AF119711
  Homo sapiens cysLT1 LTD4 receptor (CYSLT1) mRNA, complete cds
  gi|5353886|gb|AF119711.1|AF119711[5353886]
• 10091: X72861
  H. sapiens gene for beta-3-adrenergic receptor
  gi|298094|emb|X72861.1|HSB3A[298094]
• 10092: AF103906
  Homo sapiens vanilloid receptor-like protein (VRL) mRNA, complete cds
  gi|5305597|gb|AF103906.1|AF103906[5305597]
• 10093: AF072873
  Homo sapiens frizzled 6 mRNA, complete cds
  gi|5305408|gb|AF072873.1|AF072873[5305408]
• 10095: AF153437
  Homo sapiens haplotype val92met/A942G melanocortin 1 receptor (MC1R) gene, complete cds
  gi|5257473|gb|AF153437.1|AF153437[5257473]
• 10096: AF153436
  Homo sapiens haplotype A942G melanocortin 1 receptor (MC1R) gene, complete cds
  gi|5257472|gb|AF153436.1|AF153436[5257472]
• 10097: AF153435
  Homo sapiens haplotype arg67gln/arg163gln melanocortin 1 receptor (MC1R) gene,
  complete cds
  gi|525747|gb|AF153435.1|AF153435[5257471]
• 10098: AF153434
  Homo sapiens haplotype arg163gln melanocortin 1 receptor (MC1R) gene, complete
  cds
  gi|5257470|gb|AF153434.1|AF153434[5257470]
• 10099: AF153433
  Homo sapiens haplotype arg151cys melanocortin 1 receptor (MC1R) gene, complete
  cds
  gi|5257469|gb|AF153433.1|AF153433[5257469]
• 10100: AF153432
  Homo sapiens haplotype asp84glu melanocortin 1 receptor (MC1R) gene, complete cds
  gi|5257468|gb|AF153432.1|AF153432[5257468]
• 10101: AF153431
  Homo sapiens melanocortin 1 receptor (MC1R) gene, complete cds
  gi|5257467|gb|AF153431.1|AF153431[5257467]
• 10103: AH007879
  Homo sapiens macrophage receptor (MARCO) gene, complete cds
  gi|5231091|gb|AH007879.1|SEG_HSMARCO[5231091]
• 10104: AF128186
  Homo sapiens macrophage receptor (MARCO) gene, exon 17 and complete cds
  gi|5231090gb|AF128186.1|HSMARCO15[5231090]
• 10105: AF128185
  Homo sapiens macrophage receptor (MARCO) gene, exon 16
  gi|5231089|gb|AF128185.1|HSMARCO14[5231089]
• 10106: AP128184
  Homo sapiens macrophage receptor (MARCO) gene, exon 15
  gi|5231088|gb|AF128184.1|HSMARCO13[5231088]
• 10107: AF128183
  Homo sapiens macrophage receptor (MARCO) gene, exon 14
  gi|5231087|gb|AF128183.1|HSMARCO12[5231087]
• 10108: AF128182
  Homo sapiens macrophage receptor (MARCO) gene, exon 13
  gi|5231086|gb|AF128182.1|HSMARCO11[5231086]
• 10109: AF128181
  Homo sapiens macrophage receptor (MARCO) gene, exons 11 and 12
  gi|5231085|gb|AF128181.1|HSMARCO10[5231085]
• 10110: AF128180
  Homo sapiens macrophage receptor (MARCO) gene, exons 9 and 10
  gi|5231084|gb|AF128180.1|HSMARCO09[5231084]
• 10111: AF128179
  Homo sapiens macrophage receptor (MARCO) gene, exon 8
  gi|5231083|gb|AF128179.1|HSMARCO08[5231083]
• 10112: AF128178
  Homo sapiens macrophage receptor (MARCO) gene, exon 7
  gi|5231082|gb|AF128178.1|HSMARCO07[5231082]
• 10113: AF128177
  Homo sapiens macrophage receptor (MARCO) gene, exon 6
  gi|5231081|gb|AF128177.1|HSMARCO06[5231081]
• 10114: AF128176
  Homo sapiens macrophage receptor (MARCO) gene, exon 5
  gi|5231080|gb|AF128176.1|HSMARCO05[5231080]
• 10115: AF128175
  Homo sapiens macrophage receptor (MARCO) gene, exon 4
  gi|5231079|gb|AF128175.1|HSMARCO04[5231079]
• 10116: AF128174
  Homo sapiens macrophage receptor (MARCO) gene, exon 3
  gi|5231078|gb|AF128174.1|HSMARCO03[5231078]
• 10117: AF128173
  Homo sapiens macrophage receptor (MARCO) gene, exon 2
  gi|5231077|gb|AF128173.1|HSMARCO02[5231077]
• 10118: AF128172
  Homo sapiens macrophage receptor (MARCO) gene, exon 1
  gi|5231076|gb|AF128172.1|HSMARCO01[5231076]
• 10140: D50855
  Human mRNA for Ca-sensing receptor, complete cds
  gi|904209|dbj|D50855.1|HUMCASR[904209]
• 10141: D49783
  Human gene for histamine H2 receptor, complete cds
  gi|728495|dbj|D49783.1|HUMHH2R[728495]
• 10142: D16826
  Human gene for fourth somatostatin receptor subtype
  gi|693907|dbj|D16826.1|HUMSSTR4[693907]
• 10143: D29984
  Human mRNA for monocyte chemoattractant protein 1 receptor (MCP-1 receptor), complete cds
  gi|531246|dbj|D529984.1|HUMMCP1R[531246]
• 10144: D14436
  Human gene for histamine H1-receptor, complete cds
  gi|506335|dbj|D514436.1|HUMHH1RE[506335]
• 10145: D16827
  Human gene for fifth somatostatin receptor subtype
  gi|487683|dbj|D516827.1|HUMSSTR5[487683]
• 10146: D14717
  Human mRNA for large erk kinase
  gi|285916|dbj|D514717.1|HUMERK[285916]
• 10147: AF073515
  Homo sapiens cytokine type 1 receptor CRLP-1 precursor, mRNA, complete cds
  gi|5106394|gb|AF073515.1|AF073515[5106394]
• 10148: AH007696
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, partial cds; fibroblast growth factor receptor 2 Ksam IV secreted isoform (FGFR2) gene, complete cds; fibroblast growth factor receptor (FGFR2) gene, alternative splice
  products, partial cds; and fibroblast growth factor receptor 2 (FGFR2) gene, partial cds
  gi|4808621|gb|AH007696.1|SEG_HSFGFR2A[4808621]
• 10149: AF097354
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 20, alternative splice products and partial cds
  gi|4808620|gb|AF097354.1|HSFGFR2A19[4808620]
• 10150: AF097353
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 19, alternative splice products and partial cds
  gi|4808619|gb|AF097353.1|HSFGFR2A18[4808619]
• 10151: AF097352
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 18
  gi|4808618|gb|AF097352.1|HSFGFR2A17[4808618]
• 10152: AF097351
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 17
  gi|4808617|gb|AF097351.1|HSFGFR2A16[4808617]
• 10153: AF097350
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 16
  gi|4808616|gb|AF097350.1|HSFGFR2A15[4808616]
• 10154: AF097349
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 15
  gi|4808615|gb|AF097349.1|HSFGFR2A14[4808615]
• 10155: AF097348
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 14
  gi|4808614|gb|AF097348.1|HSFGFR2A13[4808614]
• 10156: AF097347
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 13
  gi|4808613|gb|AF097347.1|HSFGFR2A12[4808613]
• 10157: AF097346
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 12
  gi|4808612|gb|AF097346.1|HSFGFR2A11[4808612]
• 10158: AF097345
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exons 11 and 11′
  gi|4808611|gb|AF097345.1|HSFGFR2A10[4808611]
• 10159: AF097344
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 10
  gi|4808610|gb|AF097344.1|HSFGFR2A09[4808610]
• 10160: AF097343
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 9
  gi|4808609|gb|AF097343.1|HSFGFR2A08[4808609]
• 10161: AF097342
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 8
  gi|4808608|gb|AF097342.1|HSFGFR2A07[4808608]
• 10162: AF097341
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exons 6 and 7, alternative splice products and partial cds
  gi|4808607|gb|AF097341.1|HSFGFR2A06[4808607]
• 10163: AF097340
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 5, alternative splice products and partial cds
  gi|4808606|gb|AF097340.1|HSFGFR2A05[4808606]
• 10164: AF097339
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 4
  gi|4808605|gb|AF097339.1|HSFGFR2A04[4808605]
• 10165: AF097338
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 3
  gi|4808604|gb|AF097338.1|HSFGFR2A03[4808604]
• 10166: AF097337
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 2
  gi|4808603|gb|AF097337.1|HSFGFR2A02[4808603]
• 10167: AF097336
  Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 1
  gi|4808602|gb|AF097336.1|HSFGFR2A01[4808602]
• 10168: U58146
  Homo sapiens alternatively spliced interleukin-6 receptor beta chain mRNA, partial cds
  gi|2253597|gb|U58146.1|HSU58146[2253597]
• 10169: AF134395
  Homo sapiens CARD-like apoptotic protein (CLAP) mRNA, complete cds
  gi|5070371|gb|AF134395.1|AF134395[5070371]
• 10170: AF015044
  Homo sapiens EH-binding protein mRNA, partial cds
  gi|4102712|gb|AF015044.1|AF015044[4102712]
• 10171: AF015043
  Homo sapiens EH-binding protein mRNA, partial cds
  gi|4102710|gb|AF015043.1|AF015043[4102710]
• 10172: AF145207
  Homo sapiens CCR9 chemokine receptor (CCR9) mRNA, partial cds
  gi|5052417|gb|AF145207.1|AF145207[5052417]
• 10173: AB018549
  Homo sapiens MD-2 mRNA, complete cds
  gi|5051739|dbj|AB018549.1|AB018549[5051739]
• 10174: AH007443
  Homo sapiens chromosome 19 clone cosmid R31931 map 19q13.4
  gi|4322573|gb|AH007443.1|SEG_HSCD89S[4322573]
• 10175: AF091544
  Homo sapiens myeloid FcalphaRI (CD89) gene, 3′ sequence
  gi|4322572|gb|AF091544.1|HSCD89S2[4322572]
• 10177: AF152962
  Homo sapiens somatostatin receptor type 5 (SSTR5) gene, promoter region and partial cds
  gi|5031446|gb|AF152962.1|AF152962[5031446]
• 10178: AF140538
  Homo sapiens histamine H3 receptor mRNA, complete cds
  gi|5031290|gb|AF140538.1|AF140538[5031290]
• 10179: AJ238896
  Homo sapiens partial RAGE gene, exons 9 to 11
  gi|4867820|emb|AJ238896.1|HSA238896[4867820]
• 10180: AF039904
  Homo sapiens cosmid D56B10, chromosome 21 5′ of IFNAR1
  gi|2853622|gb|AF039904.1|AF039904[2853622]
• 10181: AF039905
  Homo sapiens cosmid Q95D4, chromosome 21 5′ of IFNAR2
  gi|2766549|gb|AF039905.1|AF039905[2766549]
• 10182: AF039907
  Homo sapiens cosmid Q50G2, chromosome 21 3′ of IFNAR1
  gi|2754858|gb|AF039907.1|AF039907[2754858]
• 10183: AB020807
  Homo sapiens mRNA for TLR6, complete cds
  gi|5006247|dbj|AB020807.1|AB020807[5006247]
• 10184: AF144308
  Homo sapiens putative G protein-coupled receptor (DL1R) mRNA, complete cds
  gi|4959876|gb|AF144308.1|AF144308[4959876]
• 10185: AF107262
  Homo sapiens central cannabinoid receptor (CB1K5) mRNA, complete cds
  gi|4959366|gb|AF107262.1|AF107262[4959366]
• 10263: AH007742
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, complete cds
  gi|4927249|gb|AH007742.1|SEG_HSCHRNB[4927249]
• 10264: AF140765
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, exon 6 and complete cds
  gi|4927248|gb|AF140765.1|HSCHRNB6[4927248]
• 10265: AF140764
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, exon 5
  gi|4927247|gb|AF140764.1|HSCHRNB5[4927247]
• 10266: AF140763
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, exon 4
  gi|4927246|gb|AF140763.1|HSCHRNB4[4927246]
• 10267: AF140762
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, exon 3
  gi|4927245|gb|AF140762.1|HSCHRNB3[4927245]
• 10268: AF140761
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, exon 2
  gi|49272441gb|AF140761.1|HSCHRNB2[4927244]
• 10269: AF140760
  Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
  gene, exon 1
  gi|4927243|gb|AF140760.1|HSCHRNB1[4927243]
• 10270: U19261
  Homo sapiens Epstein-Barr virus-induced protein mRNA, complete cds
  gi|675461|gb|U19261.1|HSU19261[675461]
• 10272: AF105261
  Homo sapiens natural killer cell receptor 2B4 mRNA, complete cds
  gi|4894519|gb|AF105261.1|AF105261[4894519]
• 10273: AH007727
  Homo sapiens prolactin receptor gene, complete cds
  gi|4886767|gb|AH007727.1|SEG_HSPLR[4886767]
• 10274: AF091870
  Homo sapiens prolactin receptor gene, alternatively spliced, exon 10 and complete cds
  gi|4886766|gb|AF091870.1|HSPLR12[4886766]
• 10275: AF091869
  Homo sapiens prolactin receptor gene, exon 9
  gi|4886765|gb|AF091869.1|HSPLR11[4886765]
• 10276: AF091868
  Homo sapiens prolactin receptor gene, exon 8
  gi|4886764|gb|AF091868.1|HSPLR10[4886764]
• 10277: AF091867
  Homo sapiens prolactin receptor gene, exon 7
  gi|4886763|gb|AF091867.1|HSPLR09[4886763]
• 10278: AF091866
  Homo sapiens prolactin receptor gene, exon 6
  gi|4886762|gb|AF091866.1|HSPLR08[4886762]
• 10279: AF091865
  Homo sapiens prolactin receptor gene, exon 5
  gi|4886761|gb|AF091865.1|HSPLR07[4886761]
• 10280: AF091864
  Homo sapiens prolactin receptor gene, exon 4
  gi|4886760|gb|AF091864.1|HSPLR06[4886760]
• 10281: AF091863
  Homo sapiens prolactin receptor gene, exon 3
  gi|4886759|gb|AF091863.1|HSPLR05[4886759]
• 10282: AF091862
  Homo sapiens prolactin receptor gene, exon 2
  gi|4886758|gb|AF091862.1|HSPLR04[4886758]
• 10283: AF091859
  Homo sapiens prolactin receptor gene, promoter region and alternative exons 1
  gi|4886757|gb|AF091859.1|HSPLR01[4886757]
• 10284: AJ132337
  Homo sapiens mRNA for chemokine receptor CCR9
  gi|4886431|emb|AJ132337.1|HSA132337[4886431]
• 10285: AF120152
  Mus musculus cytokine receptor-like molecule 9 (Creme9) mRNA, complete cds
  gi|4884628|gb|AF120152.1|AF120152[4884628]
• 10286: AF120151
  Homo sapiens cytokine receptor-like molecule 9 (CREME9) mRNA, complete cds
  gi|4884626|gb|AF120151.1|AF120151[4884626]
• 10287: D13814
  Homo sapiens mRNA for angiotensin II type 1b receptor, complete cds
  gi|471120|dbj|D13814.1|HUMAGRT1B[471120]
• 10288: AJ236922
  Homo sapiens mRNA for metabotropic glutamate receptor 8c
  gi|4456479|emb|AJ236922.1|HSA236922[4456479]
• 10289: AJ236921
  Homo sapiens mRNA for metabotropic glutamate receptor 8b
  gi|4456477|emb|AJ236921.1HSA236921[4456477]
• 10478: AF106858
  Homo sapiens G-protein-coupled receptor (GPR56) mRNA, complete cds
  gi|4836764|gb|AF106858.1|AF106858[4836764]
• 10479: AF095784
  Homo sapiens GABA-B receptor R2 (GABBR2) mRNA, complete cds
  gi|4836217|gb|AF095784.1|AF095784[4836217]
• 10500: AJ006520
  Homo sapiens mRNA for m1 muscarinic acetylcholine receptor protein, partial
  gi|3292964|emb|AJ006520.1|HSA6520[3292964]
• 10693: AF110907
  Homo sapiens TNF-receptor associated factor-3 (TRAF-3) gene, exons 1a and 1b, complete sequence
  gi|4761208|gb|AF110907.1|AF110907[4761208]
• 10694: AJ002425
  Homo sapiens mRNA for p65 protein
  gi|4753767|emb|AJ002425.2|HSAJ2425[4753767]
• 10697: Y15220
  Homo sapiens mRNA for chemokine IP-9
  gi|4225953|emb|Y15220.1|HSCHIP9RN[4225953]
• 10698: AJ005282
  Homo sapiens mRNA for NPR-B1
  gi|3059110|emb|AJ005282.1|HSAJ5282[3059110]
• 10699: AJ012188
  Homo sapiens mRNA for GABAB receptor, subunit 2
  gi|3776097|emb|AJ012188.1|HSA012188[3776097]
• 10700: AJ012187
  Homo sapiens mRNA for GABAB receptor, subunit 1c,
  gi|3776095|emb|AJ012187.1|HSA012187[3776095]
• 10701: AJ012186
  Homo sapiens mRNA for GABAB receptor, subunit 1b
  gi|3776093|emb|AJ012186.1|HSA012186[3776093]
• 10702: AJ012185
  Homo sapiens mRNA for GABAB-receptor, subunit 1a
  gi|3776072|emb|AJ012185.1|HSA012185[3776072]
• 10704: AF129112
  Homo sapiens vanilloid receptor-like protein 1 (VRL-1) mRNA, complete cds
  gi|4589140|gb|AF129112.1|AF129112[4589140]
• 10705: AF068265
  Homo sapiens monocyte chemoattractant protein 1 receptor (CCR2) gene promoter and mRNA, partial sequence
  gi|4587865|gb|AF068265.1|AF068265[4587865]
• 10706: AB020625
  Homo sapiens mRNA for butyrophilin like receptor, complete cds
  gi|4587208|dbj|AB020625.1|AB020625[4587208]
• 10709: AH007576
  Homo sapiens killer cell inhibitory receptor G9P gene, complete cds
  gi|4581764|gb|AH007576.1|SEG_HSKIRG9P[4581764]
• 10710: AF110035
  Homo sapiens killer cell inhibitory receptor G9P gene, complete cds
  gi|4581763|gb|AF110035.1|HSKIRG9P4[4581763]
• 10711: AF110034
  Homo sapiens killer cell inhibitory receptor G9P gene, partial sequence
  gi|4581762|gb|AF110034.1|HSKIRG9P3[4581762]
• 10712: AF110033
  Homo sapiens killer cell inhibitory receptor G9P gene, partial sequence
  gi|4581761|gb|AF110033.1HSKIRG9P2[4581761]
• 10713: AF110032
  Homo sapiens killer cell inhibitory receptor G9P gene, partial sequence
  gi|4581760|gb|AF110032.1|HSKIRG9 P1[4581760]
• 10714: AF114165
  Homo sapiens endothelin receptor B delta 3 mRNA, complete cds
  gi|4580923|gb|AF114165.1|AF114165[4580923]
• 10717: AF105999
  Homo sapiens acetylcholine receptor epsilon subunit (CHRNE) gene, complete cds
  gi|4580858|gb|AF105999.1|AF105999[4580858]
• 10718: AH007573
  Homo sapiens killer inhibitory receptor 1 (KIR1) gene, complete cds; and kill inhibitory receptor 2 (KIR2) gene, partial cds
  gi|4580703|gb|AH007573.1|SEG_HS2KIR[4580703]
• 10720: AF134316
  Homo sapiens killer inhibitory receptor 4-1-2 (KIR412) gene, exon 5 and partial
  cds
  gi|4580701|gb|AF134316.1|SEG_HS2KIR7[4580701]
• 10721: AF134315
  Homo sapiens killer inhibitory receptor 4-1-2 (KIR412) gene, exon 4
  gi|4580700|gb|AF134315.1|SEG_HS2KIR6[4580700]
• 10723: AF134313
  Homo sapiens killer inhibitory receptor 4-1-2 (KIR412) gene, exon 2 and pseudoexon 3
  gi|4580698|gb|AF134313.1|SEG_HS2KIR4[4580698]
• 10724: AF134312
  Homo sapiens killer inhibitory receptor 4-1-1 (KIR411) gene, exons 7, 8 and 9
  and partial cds; killer inhibitory receptor 4-1-2 (KIR412) gene, exon 1
  gi|4580697|gb|AF134312.1|SEG_HS2KIR3[4580697]
• 10725: AF134311
  Homo sapiens killer inhibitory receptor 4-1-1 (KIR411) gene, exon 6
  gi|4580696|gb|AF134311.1|SEG_HS2KIR2[4580696]
• 10727: AH007572
  Homo sapiens killer inhibitory receptor (KIR) gene, partial cds
  gi|4580693|gb|AH007572.1|SEG_HSKIRP[4580693]
• 10728: AF133900
  Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exons 7, 8, and 9
  and partial cds
  gi|4580692|gb|AF133900.1|HSKIRP5[4580692]
• 10729: AF133899
  Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exon 6
  gi|4580691|gb|AF133899.1|HSKIRP4[4580691]
• 10730: AF133898
  Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exon 5
  gi|4580690|gb|AF133898.1|HSKIRP3[4580690]
• 10731: AF133897
  Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exon 4
  gi|4580689|gb|AF133897.1|HSKIRP2[4580689]
• 10732: AF133896
  Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, pseudoexon 3
  gi|4580688|gb|AF133896.1|HSKIRP1[4580688]
• 10733: AF133901
  Homo sapiens killer inhibitory receptor 2-2-1 (KIR221) and killer inhibitory receptor 2-2-2 (KIR222) genes, partial cds
  gi|4580682|gb|AF133901.1|AF133901[4580682]
• 10736: AF069755
  Homo sapiens orphan G protein-coupled receptor HG20 (HG20) mRNA, complete cds
  gi|4091932|gb|AF069755.1|AF069755[4091932]
• 10738: AC007229
  Homo sapiens chromosome 19, cosmid R34187, complete sequence
  gi|4567173|gb|AC007229.1|AC007229[4567173]
• 10740: AF125303
  Homo sapiens glucocorticoid-induced TNFR-related protein ligand (TNFSF18) mRNA,
  complete cds
  gi|4558500|gb|AF125303.1|AF125303[4558500]
• 10742: AF058762
  Homo sapiens galanin receptor subtype 2 (GALNR2) gene, complete cds
  gi|3170598|gb|AF058762.1|AF058762[3170598]
• 10743: AF096786
  Homo sapiens chromosome 2 G protein-coupled receptor (GPR55) gene, complete cds
  gi|4545136|gb|AF096786.1|AF096786[4545136]
• 10745: AF096784
  Homo sapiens chromosome 1 G protein-coupled receptor (GPR52) gene, complete cds
  gi|4545133|gb|AF096784.1|AF096784[4545133]
• 10746: AF119815
  Homo sapiens G-protein coupled receptor (NPGPR) mRNA, complete cds
  gi|4530468|gb|AF119815.1|AF119815[4530468]
• 10749: AF098664
  Homo sapiens olfactory receptor-like protein (OR2C1) gene, complete cds
  gi|3982606|gb|AF098664.1|AF098664[3982606]
• 10752: AF090131
  Homo sapiens clone b312C2EN9 LDL receptor-related protein 6 gene, partial cds,
  and CpG island sequence
  gi|4494988|gb|AF090131.1|AF090131[4494988]
• 10778: X95583
  H. sapiens mRNA for monocyte chemotactic protein-1 (MCP-1) receptor
  gi|4468944|emb|X95583.1|HSMCP1REC[4468944]
• 10791: AJ131757
  Homo sapiens olr1 gene
  gi|4468343|emb|AJ131757.1|HSA131757[4468343]
• 10792: X58674
  H. sapiens RNA for receptor for C5a anaphylatoxin
  gi|29568|emb|X58674.1|HSC5ANAPL[29568]
• 10793: U51134
  Homo sapiens calcitonin gene-related peptide receptor component protein mRNA, complete cds
  gi|4097252|gb|U51134.1|HSU51134[4097252]
• 10794: Y13464
  Homo sapiens mRNA for cholecystokinin B receptor
  gi|3287189|emb|Y13464.1|HSY13464[3287189]
• 10795: Z66558
  H. sapiens FAS/Apo1 gene (Del B1 mutation; partial)
  gi|150414|embo Z66558.1|HSFASAPOC[1150414]
• 10796: Z66557
  H. sapiens of FAS/Apo1 gene (partial)
  gi|150413|emb|Z66557.1|HSFASAPOB[1150413]
• 10797: Z66556
  H. sapiens FASExo8Del mRNA
  gi|11150412emb|Z66556.1|HSFASAPOA[1150412]
• 10825: AF118266
  Homo sapiens orphan G protein-coupled receptor GPR45 (GPR45) gene, complete cds
  gi|4455062|gb|AF118266.1|AF118266[4455062]
• 10826: AF118265
  Homo sapiens orphan G protein-coupled receptor GPR44 (GPR44) gene, complete cds
  gi|4455060|gb|AF118265.1|AF118265[4455060]
• 10827: Y18046
  Homo sapiens mRNA for FOP (FGFR1 oncogene partner)
  gi|4454262|emb|Y18046.1|HSAY18046[4454262]
• 10828: AJ006276
  Homo sapiens mRNA for transient receptor potential protein TRP6
  gi|4454260|emb|AJ006276.1|HSAJ6276[4454260]
• 10829: M13918
  Homo sapiens fibronectin receptor alpha-subunit precursor (ITGA5) mRNA, partial
  cds
  gi|4464190|gb|M13918.2|HUMFNRAS[4464190]
• 10831: D13515
  Homo sapiens mRNA for key subunit of N-methyl-D-aspartate receptor, complete cds
  gi|219919|dbj|D13515.1|HUMMARR[219919]
• 10832: D10583
  Homo sapiens mRNA for IgE receptor beta subunit, complete cds
  gi|219881|dbj|D10583.1|HUMIGERB[219881]
• 10834: AH007490
  Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, partial cds
  gi|4416260|gb|AH007490.1|SEG_HSGLVR1G[4416260]
• 10835: AF102063
  Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exon 11 and complete cds
  gi|4416259|gb|AF102063.1|HSGLVR1G5[4416259]
• 10836: AF102062
  Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exons 7 through 10
  gi|4416258|gb|AF102062.1|HSGLVR1G4[4416258]
• 10837: AF102061
  Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exon 6
  gi|4416257|gb|AF102061.1|HSGLVR1G3[4416257]
• 10838: AF102060
  Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exon 5
  gi|4416256|gb|AF102060.1|HSGLVR1G2[4416256]
• 10839: AF102059
  Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exons 1 through 4
  gi|4416255|gb|AF102059.1|HSGLVR1G1[4416255]
• 10840: AF098798
  Homo sapiens unknown mRNA
  gi|4416073|gb|AF098798.1|AF098798[4416073]
• 10841: AF118670
  Homo sapiens orphan G protein-coupled receptor (GPR34) gene, complete cds
  gi|4325085|gb|AF118670.1|AF118670[4325085]
• 10842: AF053072
  Homo sapiens GABA subunit A receptor alpha 6 precursor, gene, partial cds
  gi|4405812|gb|AF053072.1|AF053072[4405812]
• 10843: AF052539
  Homo sapiens chemokine receptor 5 (CCR5) gene, CCR5—CYS allele, complete cds
  gi|4337455|gb|AF052539.1|AF052539[4337455]
• 10844: AF117713
  Homo sapiens AITR ligand (TL6) mRNA, complete cds
  gi|4378801|gb|AF117713.1|AF117713[4378801]
• 10845: AF117297
  Homo sapiens TNF receptor superfamily activation-inducible protein mRNA, complete cds
  gi|4378799|gb|AF117297.1|AF117297[4378799]
• 10974: Z29585
  H. sapiens gene for high affinity IgE receptor alpha chain
  gi|452350|emb|Z29585.1|HSHAIGER[452350]
• 10975: AF050154
  Homo sapiens clone F19374 APO E-C2 gene cluster, complete sequence
  gi|4105701|gb|AF050154.1|AF050154[4105701]
• 10981: X97881
  H. sapiens mRNA for G protein coupled receptor kinase, GRK4D
  gi|1770427|emb|X97881.1|HSGRK4D[1770427]
• 10982: X97880
  H. sapiens mRNA for G protein coupled receptor kinase, GRK4C
  gi|1770425|emb|X97880.1|HSGRK4C[1770425]
• 10983: X97879
  H. sapiens mRNA for G protein coupled receptor kinase, GRK4B
  gi|1770423|emb|X97879.1|HSGRK4B[1770423]
• 10984: AJ007787
  Homo sapiens CHRNA3 gene, exon 6, partial
  gi|4164387|emb|AJ007787.1|HSA7787[4164387]
• 10985: AJ007786
  Homo sapiens CHRNA3 gene, exon 5
  gi|4164386|emb|AJ007786.1|HSA7786[4164386]
• 10986: AJ007785
  Homo sapiens CHRNA3 gene, exon 4
  gi|4164383|emb|AJ007785.1|HSA7785[4164383]
• 10987: AJ007784
  Homo sapiens CHRNA3 gene, exons 2 to 3
  gi|4164382|emb|AJ007784.1|HSA7784[4164382]
• 10988: AJ007783
  Homo sapiens CHRNA3 gene, exon 1 and joined CDS
  gi|4164380|emb|AJ007783.1|HSA7783[4164380]
• 10989: AJ001939
  Homo sapiens CHRNB2 gene, exon 6
  gi|3766463|emb|AJ001939.1|HSAJ1939[3766463]
• 10990: AJ001938
  Homo sapiens CHRNB2 gene, exon 5
  gi|3766454|emb|AJ001938.1|HSAJ1938[3766454]
• 10991: AJ001937
  Homo sapiens CHRNB2 gene, exon 4
  gi|3766453|emb|AJ001937.1|HSAJ1937[3766453]
• 10992: AJ001936
  Homo sapiens CHRNB2 gene, exon 2 and exon 3
  gi|3766452|emb|AJ001936.1|HSAJ1936[3766452]
• 10993: AJ001935
  Homo sapiens CHRNB2 gene, exon 1 (and joined CDS)
  gi|3766450|emb|AJ001935.1|HSAJ1935[3766450]
• 10998: AJ003147
  Homo sapiens complete genomic sequence between D16S3070 and D16S3275, containing
  Familial Mediterranean Fever gene disease
  gi|2808656|emb|AJ003147.1|HSAJ03147[2808656]
• 11000: AJ225029
  Homo sapiens mRNA for GABA-B R1b receptor
  gi|3892873|emb|AJ225029.1|HSA225029[3892873]
• 11004: AJ003147
  Homo sapiens complete genomic sequence between D16S3070 and D16S3275, containing
  Familial Mediterranean Fever gene disease
  gi|2808656|emb|AJ003147.1|HSAJ03147[2808656]
• 11006: AJ225029
  Homo sapiens mRNA for GABA-B R1b receptor
  gi|3892873|emb|AJ225029.1|HSA225029[3892873]
• 11007: AJ225028
  Homo sapiens mRNA for GABA-B R1a receptor
  gi|3892593|emb|AJ225028.1|HSA225028[3892593]
• 11092: AJ132194
  Homo sapiens olfr89 gene
  gi|4160227|emb|AJ132194.1|HSA132194[4160227]
• 11093: AJ012753
  Homo sapiens RAGE gene (partial), exon 2
  gi|4034482|emb|AJ012753.1|HSA012753[4034482]
• 11094: AJ012332
  Homo sapiens IL-1R gene cluster PAC contig, centromeric STS, sequence tagged site
  gi|4128031|emb|AJ012332.1|HSA012332[4128031]
• 11095: AJ012331
  Homo sapiens IL-1R gene cluster PAC contig, telomeric STS, sequence tagged site
  gi|4128030|emb|AJ012331.1|HSA012331[4128030]
• 11097: AJ011701
  Homo sapiens TRHR gene promoter and exons 1-2, partial
  gi|4128016|emb|AJ011701.1|HSA011701[4128016]
• 11098: AJ010191
  Homo sapiens gababr1 receptor gene, exon 18
  gi|3980509|emb|AJ010191.1|HSA010191[3980509]
• 11099: AJ010190
  Homo sapiens gababr1 receptor gene, exon 17
  gi|3980507|emb|AJ010190.1|HSA010190[3980507]
• 11100: AJ010189
  Homo sapiens gababr1 receptor gene, exon 16
  gi|3980504|emb|AJ010189.1|HSA010189[3980504]
• 11101: AJ010188
  Homo sapiens gababr1 receptor gene, exon 15
  gi|3980502|emb|AJ010188.1|HSA010188[3980502]
• 11102: AJ010187
  Homo sapiens gababr1 receptor gene, exon 14
  gi|3980500|emb|AJ010187.1|HSA010187[3980500]
• 11103: AJ010186
  Homo sapiens gababr1 receptor gene, exon 13
  gi|3980498|emb|AJ010186.1|HSA010186[3980498]
• 11104: AJ010185
  Homo sapiens gababr1 receptor gene, exon 12
  gi|3980496|emb|AJ010185.1|HSA010185[3980496]
• 11105: AJ010184
  Homo sapiens gababr1 receptor gene, exon 11
  gi|3980494|emb|AJ010184.1|HSA010184[3980494]
• 11106: AJ010183
  Homo sapiens gababr1 receptor gene, exon 10
  gi|3980492|emb|AJ010183.1|HSA010183[3980492]
• 11107: AJ010182
  Homo sapiens gababr1 receptor gene, exon 9
  gi|3980490|emb|AJ010182.1|HSA010182[3980490]
• 11108: AJ010181
  Homo sapiens gababr1 receptor gene, exon 8
  gi|3980488|emb|AJ010181.1|HSA010181[3980488]
• 11109: AJ010180
  Homo sapiens gababr1 receptor gene, exon 7
  gi|3980486|emb|AJ010180.1|HSA010180[3980486]
• 11110: AJ010179
  Homo sapiens gababr1 receptor gene, exon 6
  gi|3980484|emb|AJ010179.1|HSA010179[3980484]
• 11111: AJ010178
  Homo sapiens gababr1 receptor gene, exon 5
  gi|3980482|emb|AJ010178.1|HSA010178[3980482]
• 11112: AJ010177
  Homo sapiens gababr1 receptor gene, exon 4
  gi|3980481|emb|AJ010177.1|HSA010177[3980481]
• 11113: AJ010176
  Homo sapiens gababr1 receptor gene, exon 3
  gi|3980480|emb|AJ010176.1|HSA010176[3980480]
• 11114: AJ010175
  Homo sapiens gababr1 receptor gene, exon 2
  gi|3980479|emb|AJ010175.1|HSA010175[3980479]
• 11115: AJ010174
  Homo sapiens gababr1 receptor gene, exon 1
  gi|3980477|emb|AJ010174.1|HSA010174[3980477]
• 11116: AJ010173
  Homo sapiens gababr1 receptor gene, exon 1a4
  gi|3980475|emb|AJ010173.1|HSA010173[3980475]
• 11117: AJ010172
  Homo sapiens gababr1 receptor gene, exon 1a3
  gi|3980472|emb|AJ010172.1|HSA010172[3980472]
• 11118: AJ010171
  Homo sapiens gababr1 receptor gene, exon 1a2
  gi|3980469|emb|AJ010171.1|HSA10171[3980469]
• 11119: AJ010170
  Homo sapiens gababr1 receptor gene, exon 1a1
  gi|3980465|emb|AJ010170.1|HSA10170[3980465]
• 11121: AF061022
  Homo sapiens CTH gene, complete cds
  gi|4335930|gb|AF061022.1|AF061022[4335930]
• 11122: AF052041
  Homo sapiens olfactory receptor gene cluster, complete sequence
  gi|4335873|gb|AF052041.1|AF052041[4335873]
• 11124: AC006953
  Homo sapiens chromosome 19, cosmid R28316, complete sequence
  gi|4335701|gb|AC006953.1|AC006953[4335701]
• 11125: AF105367
  Homo sapiens glucagon-like peptide-2 receptor precursor (GLP2R) mRNA, complete
  cds
  gi|4324490|gb|AF105367.1|AF105367[4324490]
• 11434: AH007439
  Homo sapiens chromosome X
  gi|4322454|gb|AH007439.1|SEG_HSIL2RGIN[4322454]
• 11435: AF085452
  Homo sapiens interleukin-2 receptor gamma chain (IL2RG) gene, intron 5, partial
  sequence
  gi|4322453|gb|AF085452.1|HSIL2RGIN2[4322453]
• 11436: AF085451
  Homo sapiens interleukin-2 receptor gamma chain (IL2RG) gene, intron 4, partial
  sequence
  gi|4322452|gb|AF085451.1|HSIL2RGIN1[4322452]
• 11437: AF065213
  Homo sapiens advanced glycosylation end product-specific receptor (RAGE) gene,
  intron 3, partial sequence
  gi|4321945|gb|AF065213.1|AF065213[4321945]
• 11438: AF065212
  Homo sapiens patient M1 advanced glycosylation end product-specific receptor (RAGE) gene, exon 3 and partial cds
  gi|4321943|gb|AF065212.1|AF065212[4321943]
• 11439: AF065211
  Homo sapiens patient M21 advanced glycosylation end product-specific receptor (RAGE) gene, exon 3 and partial cds
  gi|4321941|gb|AF065211.1|AF065211[4321941]
• 11440: AF065210
  Homo sapiens patient M20 advanced glycosylation end product-specific receptor (RAGE) gene, exon 3 and partial cds
  gi|4321939|gb|AF0652101.1|AF065210[4321939]
• 11441: AF051305
  Homo sapiens beta chemokine receptor (CCR1) gene, promoter region and exon 1
  gi|4321648|gb|AF051305.1|AF051305[4321648]
• 11442: U87223
  Homo sapiens contactin associated protein (Caspr) mRNA, complete cds
  gi|1857707|gb|U87223.1|HSU87223[1857707]
• 11443: AF022386
  Homo sapiens p53-regulated DNA damage-inducible cell death receptor (killer) mRNA, complete cds
  gi|2460427|gb|AF022386.1|AF022386[2460427]
• 11444: AF011368
  Homo sapiens CEV14 mRNA, partial cds
  gi|2618824|gb|AF011368.1|AF011368[2618824]
• 11445: AF016267
  Homo sapiens TRAIL receptor 3 mRNA, complete cds
  gi|2529564|gb|AF016267.1|AF016267[2529564]
• 11446: AF020502
  Homo sapiens cytotoxic TRAIL receptor-3 (TRAIL-R3) mRNA, complete cds
  gi|2443819|gb|AF020502.1|AF020502[2443819]
• 11447: AF020501
  Homo sapiens cytotoxic TRAIL receptor-2 (DR5) mRNA, complete cds
  gi|2443817|gb|AF020501.1|AF020501[2443817]
• 11454: AF075460
  Homo sapiens type 1-like ryanodine receptor mRNA, partial cds
  gi|3328200|gb|AF075460.1|AF075460[3328200]
• 11455: AF054830
  Homo sapiens interleukin-1 type I receptor mRNA, partial sequence
  gi|3003026|gb|AF054830.1|AF054830[3003026]
• 11456: AF099082
  Homo sapiens xenotropic and polytropic murine retrovirus receptor (XPR1) mRNA,
  complete cds
  gi|4176765|gb|AF099082.1|AF099082[4176765]
• 11501: AF089744
  Homo sapiens xenotropic and polytropic murine leukemia virus receptor (X3) mRNA,
  complete cds
  gi|4154282|gb|AF089744.1|AF089744[4154282]
• 11502: AF001095
  Homo sapiens receptor for advanced glycation end products (RAGE) gene, promoter
  region and exon 1
  gi|3093415|gb|AF001095.1|AF001095[3093415]
• 11503: AF101784
  Homo sapiens b-TRCP variant E3RS-IkappaB mRNA, partial cds
  gi|4165135|gb|AF101784.1|AF101784[4165135]
• 11504: AF080586
  Homo sapiens galanin receptor type 2 (GALR2) mRNA, complete cds
  gi|4165080|gb|AF080586.1|AF080586[4165080]
• 11505: U71374
  Homo sapiens HsPex13p mRNA, complete cds
  gi|3738269|gb|U71374.1|HSU71374[3738269]
• 11506: AF111116
  Homo sapiens silencer of death domains (SODD) mRNA, complete cds
  gi|4160013|gb|AF111116.1|AF111116[4160013]
• 11507: AF110314
  Homo sapiens herpesvirus immunoglobulin-like receptor HIgR mRNA, complete cds
  gi|4154345|gb|AF110314.1|AF110314[4154345]
• 11518: AF069543
  Homo sapiens IL-3/IL-5/GM-CSFR receptor beta chain promoter and exon 1 sequence
  gi|4071316|gb|AF069543.1|AF069543[4071316]
• 11519: U81262
  Homo sapiens LERK5 (LERK5) mRNA, complete cds
  gi|1809333|gb|U81262.1|HSU81262[1809333]
• 11520: AF097358
  Homo sapiens mast cell function-associated antigen homolog (MAFA) mRNA, complete
  cds
  gi|4139191|gb|AF097358.1|AF097358[4139191]
• 11521: AF029761
  Homo sapiens decoy receptor 2 mRNA, complete cds
  gi|4106963|gb|AF029761.1|AF029761[4106963]
• 11522: AF074483
  Homo sapiens GABA-B receptor 2 mRNA, complete cds
  gi|4107511|gb|AF074483.1|AF074483[4107511]
• 11523: AC006293
  Homo sapiens chromosome 19, cosmid F15658, complete sequence
  gi|4106979|gb|AC006293.1|AC006293[4106979]
• 11524: AF104419
  Homo sapiens decoy receptor 3 (DcR3) mRNA, complete cds
  gi|4106877|gb|AF104419.1|AF104419[4106877]
• 11525: AF046059
  Homo sapiens cytokine receptor related protein 4 (CYTOR4) mRNA, complete cds
  gi|4105471|gb|AF046059.1|AF046059[4105471]
• 11526: AF041262
  Homo sapiens immunoglobulin-like transcript 8 mRNA, complete cds
  gi|4104892|gb|AF041262.1|AF041262[4104892]
• 11527: AF041261
  Homo sapiens immunoglobulin-like transcript 7 mRNA, complete cds
  gi|4104890|gb|AF041261.1|AF041261[4104890]
• 11528: AH007196
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 6
  gi|4104446|gb|AH007196.1|SEG_HSTGFRBI[4104446]
• 11529: AF035670
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 9, and
  complete cds
  gi|4104445|gb|AF035670.1|HSTGFRBI9[4104445]
• 11530: AF035669
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 8
  gi|4104444|gb|AF035669.1|HSTGFRBI8[4104444]
• 11531: AF035668
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 7
  gi|4104443|gb|AF035668.1|HSTGFRBI7[4104443]
• 11532: AF035667
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 6
  gi|4104442|gb|AF035667.1|HSTGFRBI6[4104442]
• 11533: AF035666
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 5
  gi|4104441|gb|AF035666.1|HSTGFRBI5[4104441]
• 11534: AF035665
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 4
  gi|4104440|gb|AF035665.1|HSTGFRBI4[4104440]
• 11535: AF035664
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 3
  gi|4104439|gb|AF035664.1|HSTGFRBI3[4104439]
• 11536: AF035663
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 2
  gi|4104438|gb|AF035663.1|HSTGFRBI2[4104438]
• 11537: AF035662
  Homo sapiens transforming growth factor-beta type I receptor gene, exon 1
  gi|4104437|gb|AF035662.1|HSTGFRBI1[4104437]
• 11538: AF037332
  Homo sapiens Eph-like receptor tyrosine kinase hEphB1b (EphB1) mRNA, complete cds
  gi|4104412|gb|AF037332.1|AF037332[4104412]
• 11539: AF037331
  Homo sapiens Eph-like receptor tyrosine kinase hEphB1 (EphB1) mRNA, complete cds
  gi|4104410|gb|AF037331.1|AF037331[4104410]
• 11543: AH007119
  Homo sapiens killer cell inhibitory receptor KIRC1 gene, complete cds
  gi|3776473|gb|AH007119.1|SEG_HSKIRCI[3776473]
• 11544: AF072410
  Homo sapiens killer cell inhibitory receptor KIRC1 gene, exons 6, 7 and 8 and complete cds
  gi|3776472|gb|AF072410.1|HSKIRCI4[3776472]
• 11545: AF072409
  Homo sapiens killer cell inhibitory receptor KIRCI gene, exon 5
  gi|3776471|gb|AF072409.1|HSKIRCI3[3776471]
• 11546: AF072408
  Homo sapiens killer cell inhibitor receptor KIRCI gene, exons 2, 3, and 4
  gi|3776470|gb|AF072408.1|HSKIRCI2[3776470]
• 11547: AF072407
  Homo sapiens killer cell inhibitory receptor KIRCI gene, exon 1
  gi|3776469|gb|AF072407.1|HSKIRCI1[3776469]
• 11548: AH007118
  Homo sapiens immunoglobulin-like transcript 10 protein gene, complete cds
  gi|3776467|gb|AH007118.1|SEG_HSILTX[3776467]
• 11549: AF072101
  Homo sapiens immunoglobulin-like transcript 10 protein gene, exons 7 and 8
  and
  complete cds
  gi|3776466|gb|AF072101.1|HSILTX2[3776466]
• 11550: AF072100
  Homo sapiens immunoglobulin-like transcript 10 protein gene, exons 1 through
  gi|3776465|gb|AF072100.1|HSILTX1[3776465]
• 11551: AF072099
  Homo sapiens immunoglobulin-like transcript 3 protein variant 1 gene, complete
  cds
  gi|3776463|gb|AF072099.1|AF072099[3776463]
• 11553: AF106941
  Homo sapiens beta-arrestin 2 mRNA, complete cds
  gi|4092782|gb|AF106941.1|AF106941[4092782]
• 11554: AF104304
  Homo sapiens Smad anchor for receptor activation (SARA) mRNA, complete cds
  gi|4092766|gb|AF104304.1|AF104304[4092766]
• 11555: AF034780
  Homo sapiens lysosphingolipid receptor Edg5 mRNA, complete cds
  gi|4090955|gb|AF034780.1|AF034780[4090955]
• 11556: AF109401
  Homo sapiens neurotrophic factor artemin precursor (ARTN) mRNA, complete cds
  gi|4071352|gb|AF109401.1|AF109401[4071352]
• 11557: AF099148
  Homo sapiens GABA-B1a receptor mRNA, complete cds
  gi|4063891|gb|AF099148.1|AF099148[4063891]
• 11558: AF095448
  Homo sapiens putative G protein-coupled receptor (RAIG1) mRNA, complete cds
  gi|4063889|gb|AF095448.1|AF095448[4063889]
• 11559: L34689
  Homo sapiens somatostatin receptor isoform 2 (SSTR2) gene, partial cds
  gi|598233|gb|L34689.1|HUMSOREC2X[598233]
• 11560: AF100161
  Homo sapiens folate receptor type gamma′ gene, partial cds
  gi|4063392|gb|AF100161.1|AF100161[4063392]
• 11561: AF082076
  Homo sapiens luteinizing hormone receptor (LHR) gene, partial cds
  gi|4063365|gb|AF082076.1|AF082076[4063365]
• 11562: AC006132
  Homo sapiens chromosome 19, cosmid R28204, complete sequence
  gi|3970930|gb|AC006132.1|AC006132[3970930]
• 11563: AH007081
  Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, complete cds
  gi|4050003|gb|AH007081.1|SEG_HSOLR[4050003]
• 11564: AF079167
  Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exons 4, 5, and 6, and complete cds
  gi|4050002|gb|AF079167.1|HSOLR4[4050002]
• 11565: AF079166
  Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exon 3
  gi|4050001|gb|AF079166.1|HSOLR3[4050001]
• 11566: AF079165
  Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exon 2
  gi|4050000|gb|AF079165.1|HSOLR2[4050000]
• 11567: AF079164
  Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exon 1
  gi|4049999|gb|AF079164.1|HSOLR1[4049999]
• 11568: AF099083
  Homo sapiens growth hormone secretagogue receptor gene, 5′ flanking region and
  partial cds
  gi|4039145|gb|AF099083.1|AF099083[4039145]
• 11569: AF058390
  Homo sapiens neurotrophin 3 receptor truncated isoform (NTRK3) mRNA, partial cds
  gi|4027932|gb|AF058390.1|AF058390[4027932]
• 11570: AF058389
  Homo sapiens neurotrophin 3 receptor (NTRK3) mRNA, partial cds
  gi|4027930|gb|AF058389.1|AF058389[4027930]
• 11877: AF029839
  Homo sapiens alpha 7 neuronal nicotinic receptor mRNA sequence
  gi|3757794|gb|AF029839.1|AF029839[3757794]
• 11878: AF029838
  Homo sapiens alpha 7 neuronal nicotinic receptor mRNA sequence
  gi|3757793|gb|AF029838.1|AF029838[3757793]
• 11880: AH007062
  Homo sapiens galanin receptor (GALNR), complete cds
  gi|3064074|gb|AH007062.1|SEG_HSGALNRS[3064074]
• 11881: U90660
  Homo sapiens galanin receptor (GALNR) gene, exon 3 and complete cds
  gi|3064073|gb|U90660.1|HSGALNRS3[3064073]
• 11882: U90659
  Homo sapiens galanin receptor (GALNR) gene, exon 2
  gi|3064072|gb|U90659.1|HSGALNRS2[3064072]
• 11883: U90658
  Homo sapiens galanin receptor (GALNR) gene, exon 1
  gi|3064071|gb|U90658.1|HSGALNRS1[3064071]
• 11884: AF041474
  Homo sapiens BAF53a (BAF53a) mRNA, complete cds
  gi|4001802|gb|AF041474.1|AF041474[4001802]
• 11886: AF097942
  Homo sapiens monocyte antigen CD14 precursor (CD14) mRNA, complete cds
  gi|3983126|gb|AF097942.1|AF097942[3983126]
• 11887: AH007044
  Homo sapiens growth factor receptor (GRB10) gene, alternative splice products,
  complete cds
  gi|3982774|gb|AH007044.1|SEG_HSGRB[3982774]
• 11904: AF084941
  Homo sapiens pre-T cell receptor alpha chain 1 precursor, gene, complete cds
  gi|3978459|gb|AF084941.1|AF084941[3978459]
• 11905: AH007043
  Homo sapiens interleukin-7 receptor precursor (IL7R), complete cds
  gi|3978161|gb|AH007043.1|SEG_HSIL7R[3978161]
• 11906: AF043129
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exons 7 and 8 and complete cds
  gi|3978160|gb|AF043129.1|HSIL7R7[3978160]
• 11907: AF043128
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 6
  gi|3978159|gb|AF043128.1|HSIL7R6[3978159]
• 11908: AF043127
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 5
  gi|3978158|gb|AF043127.1|HSIL7R5[3978158]
• 11909: AF043126
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 4
  gi|3978157|gb|AF043126.1|HSIL7R4[3978157]
• 11910: AF043125
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 3
  gi|3978156|gb|AF043125.1|HSIL7R3[3978156]
• 11911: AF043124
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 2
  gi|3978155|gb|AF043124.1|HSIL7R2[3978155]
• 11912: AF043123
  Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 1
  gi|3978154|gb|AF043123.1|HSIL7R1[3978154]
• 11913: AH007033
  Homo sapiens prostanoid FP receptor (PTGFR), partial cds
  gi|3941539|gb|AH007033.1|SEG_HSPTF2AGR[3941539]
• 11914: AF068679
  Homo sapiens prostanoid FF receptor gene, exon and partial cds
  gi|3941538|gb|AF068679.1|HSPTF2AGR4[3941538]
• 11915: AF068678
  Homo sapiens prostanoid FP receptor (PTGFR) gene, exon
  gi|3941537|gb|AF068678.1|HSPTF2AGR3[3941537]
• 11916: AF068677
  Homo sapiens prostanoid FP receptor (PTGFR) gene, exon and partial 5′UTR
  gi|3941536|gb|AF068677.1|HSPTF2AGR2[3941536]
• 11917: AF068676
  Homo sapiens prostanoid FP receptor (PTGFR) gene, exon
  gi|3941535|gb|AF068676.1|HSPTF2AGR1[3941535]
• 11918: AF035776
  Homo sapiens oxidized low-density lipoprotein receptor mRNA, complete cds
  gi|3941299|gb|AF035776.1|AF035776[3941299]
• 11920: AF091501
  Homo sapiens receptor protein patched 2 (PTCH2) mRNA, complete cds
  gi|3929234|gb|AF091501.1|AF091501[3929234]
• 11953: X98174
  H. sapiens mRNA for MACH-alpha-3 protein
  gi|3928273|emb|X98174.1|HSMACHA3[3928273]
• 11955: X68990
  Homo sapiens CR2 mRNA for complement receptor
  gi|3928195|emb|X68990.1|HSCR2AA[3928195]
• 11956: X63128
  H. sapiens mRNA for activin receptor
  gi|3928172|emb|X63128.1|HSACTREC[3928172]
• 11958: AF074397
  Homo sapiens anti-mullerian hormone type II receptor (AMHR2) gene, promoter region and partial cds
  gi|3916231|gb|AF074397.1|AF074397[3916231]
• 11959: U72648
  Homo sapiens alpha2-C4-adrenergic receptor gene, complete cds
  gi|3914602|gb|U72648.1|HSU72648[3914602]
• 11960: Y10148
  H. sapiens mRNA for NTR2 receptor
  gi|3901027|emb|Y10148.1|HSNTR2REC[3901027]
• 11961: Y12476
  Homo sapiens putative GPR37 gene (exon 1 and joined CDS)
  gi|2570029|emb|Y12476.1|HSY12476[2570029]
• 11962: AJ000479
  Homo sapiens mRNA for putative G-protein coupled receptor, EDG6
  gi|3805931|emb|AJ000479.1|HSEDG4[3805931]
• 11963: Y12477
  Homo sapiens putative GPR37 gene, exon 2
  gi|2570031|emb|Y12477.1|HSY12477[2570031]
• 11964: X04329
  Homo sapiens mRNA fragment for receptor-like furin
  gi|31479|emb|X04329.1|HSFUR1[31479]
• 11965: AH007002
  Homo sapiens chromosome 1 map 1q12-q13
  gi|3892221|gb|AH007002.1|SEG_HSM1MUSR[3892221]
• 11966: AF091493
  Homo sapiens M1 muscarinic receptor gene, exons 2 and 3
  gi|3892220|gb|AF091493.1|HSM1MUSR2[3892220]
• 11967: AF091492
  Homo sapiens M1 muscarinic receptor gene, promoter region and exon 1
  gi|3892219|gb|AF091492.1|HSM1MUSR1[3892219]
• 12129: AF077820
  Homo sapiens LDL receptor member LR3 mRNA, complete cds
  gi|3831747|gb|AF077820.1|AF077820[3831747]
• 12130: AF055992
  Homo sapiens Duffy antigen/chemokine receptor (FY) gene, FY*X allele,
  complete cds
  gi|3659623|gb|AF055992.1|AF055992[3659623]
• 12131: U58675
  Homo sapiens Chromosome 17 p13 Cosmid Clone cos39, complete sequence
  gi|3849817|gb|U58675.1|U58675[3849817]
• 12132: AF077346
  Homo sapiens interleukin-18 receptor accessory protein-like mRNA, complete cds
  gi|3851059|gb|AF077346.1|AF077346[3851059]
• 12136: Z17227
  Homo sapiens mRNA for transmebrane receptor protein
  gi|393378|emb|Z17227.1|HSTRECP[393378]
• 12137: AF082742
  Homo sapiens CC chemokine receptor 5 (CCR5) gene, promoter region and partial sequence
  gi|3561057|gb|AF082742.1|AF082742[3561057]
• 12139: Z34897
  H. sapiens mRNA for H1 histamine receptor
  gi|510295|emb|Z34897.1|HSHISTR1[510295]
• 12140: X76786
  H. sapiens histamine H1 receptor gene
  gi|442517|emb|X76786.1|HSHISH1[442517]
• 12141: AC005933
  Homo sapiens chromosome 19, cosmid F15472, complete sequence
  gi|3845348|gb|AC005933.1|AC005933[3845348]
• 12142: AF094755
  Homo sapiens glycine receptor beta subunit precursor (GLRB), variant B mRNA, complete cds
  gi|3834636|gb|AF094755.1|AF094755[3834636]
• 12143: AF094754
  Homo sapiens glycine receptor beta subunit precursor (GLRB), variant A mRNA, complete cds
  gi|3834634|gb|AF094754.1|AF094754[3834634]
• 12144: AF091512
  Homo sapiens familial Mediterranean fever locus genomic sequence
  gi|3834584|gb|AF091512.1|AF091512[3834584]
• 12145: AF065876
  Homo sapiens olfactory receptor (OR2D2) gene, partial cds
  gi|3831618|gb|AF065876.1|AF065876[3831618]
• 12147: AF065874
  Homo sapiens olfactory receptor (OR10A1) gene, partial cds
  gi|3831615|gb|AF065874.1|AF065874[3831615]
• 12151: AF065870
  Homo sapiens olfactory receptor (OR6A1) gene, complete cds
  gi|38316100gb|AF065870.1|AF065870[3831610]
• 12158: AF065863
  Homo sapiens olfactory receptor (OR5F1) gene, partial cds
  gi|3831602|gb|AF065863.1|AF065863[3831602]
• 12160: AF065861
  Homo sapiens olfactory receptor (OR5D4) gene, partial cds
  gi|3831599|gb|AF065861.1|AF06S861[3831599]
• 12161: AF065860
  Homo sapiens olfactory receptor (OR5D3) gene, partial cds
  gi|3831597|gb|AF065860.1|AF065860[3831597]
• 12170: AH006968
  Homo sapiens
  gi|2828129|gb|AH006968.1|SEG_HSCRFR[2828129]
• 12171: AF039523
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 14 and complete cds
  gi|2828128|gb|AF039523.1|HSCRFR14[2828128]
• 12172: AF039522
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 13
  gi|2828127|gb|AF039522.1|HSCRFR13[2828127]
• 12173: AF039521
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 12
  gi|2828126|gb|AF039521.1|HSCRFR12[2828126]
• 12174: AF039520
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 11
  gi|2828125|gb|AF039520.1|HSCRFR11[2828125]
• 12175: AF039519
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 10
  gi|2828124|gb|AF039519.1|HSCRFR10[2828124]
• 12176: AF039518
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 9
  gi|2828123|gb|AF039518.1|HSCRFR09[2828123]
• 12177: AF039517
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 8
  gi|2828122|gb|AF039517.1|HSCRFR08[2828122]
• 12178: AF039516
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 7
  gi|2828121|gb|AF039516.1|HSCRFR07[2828121]
• 12179: AF039515
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 6
  gi|28281201gb|AF039515.1|HSCRFR06[2828120]
• 12180: AF039514
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 5
  gi|2828119|gb|AF039514.1|HSCRFR05[2828119]
• 12181: AF039513
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 4
  gi|2828118|gb|AF039513.1|HSCRFR04[2828118]
• 12182: AF039512
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 3
  gi|2828117|gb|AF039512.1|HSCRFR03[2828117]
• 12183: AF039511
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 2
  gi|2828116|gb|AF039511.1|HSCRFR02[2828116]
• 12184: AF039510
  Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 1
  gi|2828115|gb|AF039510.1|HSCRFR01[2828115]
• 12185: AF030186
  Homo sapiens glypican-4 (GPC4) mRNA, complete cds
  gi|3831546|gb|AF030186.1|AF030186[3831546]
• 12206: AJ006353
  Homo sapiens mRNA for ephrin-A4 protein, soluble form
  gi|3821236|emb|AJ006353.1|HSA6353[3821236]
• 12212: AF055634
  Homo sapiens transmembrane receptor UNC5C (UNC5C) mRNA, complete cds
  gi|3789764|gb|AF055634.1|AF055634[3789764]
• 12227: AH006936
  Homo sapiens activin receptor type IIB (ACVR2B), complete cds
  gi|3769442|gb|AH006936.1|SEG_HSACVR2B[3769442]
• 12228: AF060202
  Homo sapiens activin receptor type IIB (ACVR2B) gene, exon 11 and complete cds
  gi|3769441|gb|AF060202.1|HSACVR2B4[3769441]
• 12229: AF060201
  Homo sapiens activin receptor type IIB (ACVR2B) gene, exons 8, 9, and 10
  gi|3769440|gb|AF060201.1|HSACVR2B3[3769440]
• 12230: AF060200
  Homo sapiens activin receptor type IIB (ACVR2B) gene, exons 2 through 7
  gi|3769439|gb|AF060200.1|HSACVR2B2[3769439]
• 12231: AF060199
  Homo sapiens activin receptor type IIB (ACVR2B) gene, exon 1
  gi|3769438|gb|AF060199.1|HSACVR2B[3769438]
• 12232: AF037646
  Homo sapiens alpha-7 neuronal nicotinic acetylcholine receptor precursor RNA, partial sequence
  gi|3757808|gb|AF037646.1|AF037646[3757808]
• 12233: AF036903
  Homo sapiens alpha-7 neuronal nicotinic acetylcholine receptor mRNA, alternatively spliced, partial sequence
  gi|3757807|gb|AF036903.1|AF036903[3757807]
• 12234: AH006931
  Homo sapiens lipoprotein receptor-related protein (LRP1) gene, complete cds
  gi|3493575|gb|AH006931.1|SEG_HSLRPSS[3493575]
• 12235: AF058427
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 80 through 89 and complete cds
  gi|3493574|gb|AF058427.1|HSLRPSS61[3493574]
• 12236: AF058426
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 78 and 79
  gi|3493573|gb|AF058426.1|HSLRPSS59[3493573]
• 12237: AF058425
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 77
  gi|3493572|gb|AF058425.1|HSLRPSS57[3493572]
• 12238: AF058424
• Homo sapiens lipoprotein receptor-related protein (LRP1), exon 76
• gi|3493571|gb|AF058424.1|HSLRPSS55[3493571]
• 12239: AF058423
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 71 through 75
  gi|3493570|gb|AF058423.1|HSLRPSS53[3493570]
• 12240: AF058422
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 61 through 70
  gi|3493569|gb|AF058422.1|HSLRPSS51[3493569]
• 12241: AF058421
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 59 and 60
  gi|3493568|gb|AF058421.1|HSLRPSS49[3493568]
• 12242: AF058420
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 56, 57, and
  gi|3493567|gb|AF058420.1|HSLRPSS47[3493567]
• 12243: AF058419
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 45 through 55
  gi|3493566|gb|AF058419.1|HSLRPSS45[3493566]
• 12244: AF058418
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 43 and 44
  gi|3493565|gb|AF058418.1|HSLRPSS43[3493565]
• 12245: AF058417
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 42
  gi|3493564|gb|AF058417.1|HSLRPSS41[3493564]
• 12246: AF058416
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 39, 40, and
  gi|3493563|gb|AF058416.1|HSLRPSS39[3493563]
• 12247: AF058415
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 36, 37, and
  gi|3493562|gb|AF058415.1|HSLRPSS37[3493562]
• 12248: AF058414
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 27 through 34
  gi|3493561|gb|AF058414.1|HSLRPSS35[3493561]
• 12249: AF058413
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 25 and 26
  gi|3493560|gb|AF058413.1|HSLRPSS33[3493560]
• 12250: AF058412
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 23 and 24
  gi|3493559|gb|AF058412.1|HSLRPSS31[3493559]
• 12251: AF058411
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 21 and 22
  gi|3493558|gb|AF058411.1|HSLRPSS29[3493558]
• 12252: AF058410
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 20
  gi|3493557|gb|AF058410.1|HSLRPSS27[3493557]
• 12253: AF058409
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 18 and 19
  gi|3493556|gb|AF058409.1|HSLRPSS25[3493556]
• 12254: AF058408
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 16 and 17
  gi|3493555|gb|AF058408.1|HSLRPSS23[3493555]
• 12255: AF058407
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 14 and 15
  gi|3493554|gb|AF058407.1|HSLRPSS21[3493554]
• 12256: AF058406
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 13
  gi|3493553|gb|AF058406.1|HSLRPSS19[3493553]
• 12257: AF058405
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 12
  gi|3493552|gb|AF058405.1|HSLRPSS17[3493552]
• 12258: AF058404
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 11
  gi|3493551|gb|AF058404.1|HSLRPSS15[3493551]
• 12259: AF058403
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 9 and 10
  gi|3493550|gb|AF058403.1|HSLRPSS13[3493550]
• 12260: AF058402
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 7 and 8
  gi|493549|gb|AF058402.1|HSLRPSS11[3493549r
• 12261: AF058401
  Homo sapiens lipoprotein receptor-related protein (LRP1), exons 5 and 6
  gi|3493548|gb|AF058401.1|HSLRPSS09[3493548]
• 12262: AF058400
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 4
  gi|3493547|gb|AF058400.1|HSLRPSS07[3493547]
• 12263: AF058399
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 3
  gi|3493546|gb|AF058399.1|HSLRPSS05[3493546]
• 12264: AF058398
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 2
  gi|3493545|gb|AF058398.1|HSLRPSS03[3493545]
• 12265: AF058397
  Homo sapiens lipoprotein receptor-related protein (LRP1), exon 1
  gi|3493544|gb|AF058397.1|HSLRPSS01[3493544]
• 12267: Y11044
  Homo sapiens mRNA for GABA-BR1a (hGB1a) receptor
  gi|2826760|emb|Y11044.1|HSGTHLA1[2826760]
• 12277: AF073019
  Homo sapiens clone 21 T cell signal transduction molecule SAP mRNA, complete cds
  gi|3695070|gb|AF073019.1|AF073019[3695070]
• 12278: AF072930
  Homo sapiens clone 14 T cell signal transduction molecule SAP mRNA, complete cds
  gi|3695068|gb|AF072930.1|AF072930[3695068]
• 12279: Y12670
  Homo sapiens mRNA for leptin receptor gene-related protein
  gi|2266637|emb|Y12670.1|HSOBRGRP[2266637]
• 12280: AF091890
  Homo sapiens G-protein coupled receptor RE2 mRNA, complete cds
  gi|3659902|gb|AF091890.1|AF091890[3659902]
• 12281: Y09586
  Homo sapiens mRNA for serotonin 4 receptor (h5-HT4(a)), splice variant
  gi|2584764|emb|Y09586.1|HS5HT4SAR[2584764]
• 12282: X77777
  H. sapiens intestinal VIP receptor related protein mRNA
  gi|456352|emb|X77777.1|HSVIPRRP[456352]
• 12283: AJ001383
  Homo sapiens activating NK-receptor (NK-p46) mRNA
  gi|3647278|emb|AJ001383.1|HSJ001383[3647278]
• 12284: AJ224901
  Homo sapiens mRNA for ZNF198 protein
  gi|3647276|emb|AJ224901.1|HSAJ4901[3647276]
• 12285: AJ006123
  Homo sapiens mRNA for NK receptor (NKp46), isoform d
  gi|3647272|emb|AJ006123.1|HSA6123[3647272]
• 12286: AJ006122
  Homo sapiens mRNA for NK receptor (NKp46) isoform c
  gi|3647270|emb|AJ006122.1|HSA6122[3647270]
• 12287: AJ006121
  Homo sapiens mRNA for NK receptor (NKp46), isoform b
  gi|3647268|emb|AJ006121.1|HSA6121[3647268]
• 12289: X99906
  Homo sapiens mRNA for alpha endosulfine
  gi|2764973|emb|X99906.1|HSALPEND[2764973]
• 12292: U52064
  Kaposi's sarcoma-associated herpes-like virus ORF73 homolog gene, complete cds
  gi|1633571|gb|U52064.1|KSU52064[1633571]
• 12293: U29343
  Homo sapiens hyaluronan receptor (RHAMM) mRNA, complete cds
  gi|2959555|gb|U29343.1|HSU29343[2959555]
• 12294: AF035771
  Homo sapiens Na+/H+ exchanger regulatory factor 2 (NHERF-2) mRNA, complete cds
  gi|2665825|gb|AF035771.1|AF035771[2665825]
• 12296: AF023849
  Homo sapiens TNF receptor-related receptor for TRAIL mRNA, complete cds
  gi|2653844|gb|AF023849.1|AF023849[2653844]
• 12297: AH006710
  Homo sapiens interferon-gamma receptor alpha chain (interferon-gamma receptor alpha chain gene), complete cds
  gi|2078444|gb|AH006710.1|SEG_HSINFGRA[2078444]
• 12298: U19247
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 7 and complete cds
  gi|632541|gb|U19247.1|HSINFGRA7[632541]
• 12299: U19246
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 6
  gi|632540|gb|U19246.1|HSINFGRA6[632540]
• 12300: U19245
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 5
  gi|632539|gb|U19245.1|HSINFGRA5[632539]
• 12301: U19244
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 4
  gi|632538|gb|U19244.1|HSINFGRA4[632538]
• 12302: U19243
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 3
  gi|632537|gb|U19243.1|HSINFGRA3[632537]
• 12303: U19242
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 2
  gi|632536|gb|U19242.1|HSINFGRA2[632536]
• 12304: U19241
  Homo sapiens interferon-gamma receptor alpha chain gene, exon 1
  gi|632535|gb|U19241.1|HSINFGRA1[632535]
• 12305: AF027957
  Homo sapiens G protein-coupled receptor (GPR35) gene, complete cds
  gi|2739108|gb|AF027957.1|AF027957[2739108]
• 12306: AF027956
  Homo sapiens G protein-coupled receptor (GPR30) gene, complete cds
  gi|2739106|gb|AF027956.1|AF027956[2739106]
• 12307: AF016709
  Homo sapiens ATP receptor subunit (P2X5) mRNA, complete cds
  gi|2731560|gb|AF016709.1|AF016709[2731560]
• 12308: AF035824
  Homo sapiens vesicle soluble NSF attachment protein receptor (VTI1) mRNA, complete cds
  gi|2687399|gb|AF035824.1|AF035824[2687399]
• 12309: U96845
  Homo sapiens natual killer cell group 2-F (NKG2-F) mRNA, complete cds
  gi|2673988|gb|U96845.1|HSU96845[2673988]
• 12310: AF022139
  Homo sapiens lysosphingolipid receptor (EDG3) mRNA, partial cds
  gi|2668611|gb|AF022139.1|AF022139[2668611]
• 12311: AF022137
  Homo sapiens G protein-coupled receptor (EDG1) mRNA, partial cds
  gi|2668607|gb|AF022137.1|AF022137[2668607]
• 12312: AF031556
  Homo sapiens clone 17.30 immunoglobulin-like transcript 5 mRNA, complete cds
  gi|2665646|gb|AF031556.1|AF031556[2665646]
• 12313: AF031555
  Homo sapiens clone 17.23 immunoglobulin-like transcript 5 mRNA, complete cds
  gi|2665644|gb|AF031555.1|AF031555[2665644]
• 12314: AF031554
  Homo sapiens clone 17.18 immunoglobulin-like transcript 5 mRNA, complete cds
  gi|2665642|gb|AF031554.1|AF031554[2665642]
• 12315: AF031553
  Homo sapiens clone DC.1 immunoglobulin-like transcript 5 mRNA, complete cds
  gi|2665640|gb|AF031553.1|AF031553[2665640]
• 12316: AF009644
  Homo sapiens clone 41 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662447|gb|AF009644.1|AF009644[2662447]
• 12317: AF009643
  Homo sapiens clone 6 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662445|gb|AF009643.1|AF009643[2662445]
• 12318: AF009642
  Homo sapiens clone 40 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662443|gb|AF009642.1|AF009642[2662443]
• 12319: AF009641
  Homo sapiens clone 36 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662441|gb|AF009641.1|AF009641[2662441]
• 12320: AF009640
  Homo sapiens clone 33 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662439|gb|AF009640.1|AF009640[2662439]
• 12321: AF009639
  Homo sapiens clone 31 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662437|gb|AF009639.1|AF009639[2662437]
• 12322: AF009638
  Homo sapiens clone 22 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662435|gb|AF009638.1|AF009638[2662435]
• 12323: AF009637
  Homo sapiens clone 19 immunoglobulin-like transcript 5 protein mRNA, complete cds
  gi|2662433|gb|AF009637.1|AF009637[2662433]
• 12324: AF009636
  Homo sapiens clone 17.8 immunoglobulin-like transcript 5 protein mRNA, complete
  cds
  gi|2662431|gb|AF009636.1|AF009636[2662431]
• 12325: AF009635
  Homo sapiens clone 17.7 immunoglobulin-like transcript 5 protein mRNA, complete
  cds
  gi|2662429|gb|AF009635.1|AF009635[2662429]
• 12326: AF009634
  Homo sapiens clone 17.6 immunoglobulin-like transcript 5 protein mRNA, complete
  cds
  gi|2662427|gb|AF009634.1|AF009634[2662427]
• 12327: AF009633
  Homo sapiens clone 17.11 immunoglobulin-like transcript 5 protein mRNA, complete
  cds
  gi|2662425|gb|AF009633.1|AF009633[2662425]
• 12328: AF009632
  Homo sapiens clone 17.10 immunoglobulin-like transcript 5 protein mRNA, complete
  cds
  gi|2662423|gb|AF009632.1|AF009632[2662423]
• 12329: AF014924
  Homo sapiens immunoglobulin-like transcript 6a (ILT6a) mRNA, complete cds
  gi|2661224|gb|AF014924.1|AF014924[2661224]
• 12330: AF014923
  Homo sapiens immunoglobulin-like transcript 6 (ILT6) mRNA, complete cds
  gi|2661222|gb|AF014923.1|AF014923[2661222]
• 12331: AF011566
  Homo sapiens clone 17 immunoglobulin-like transcript 4 mRNA, complete cds
  gi|2660709|gb|AF011566.1|AF011566[2660709]
• 12332: AF011565
  Homo sapiens clone 26 immunoglobulin-like transcript 4 mRNA, complete cds
  gi|2660707|gb|AF011565.1|AF011565[2660707]
• 12333: AF009007
  Homo sapiens immunoglobulin-like transcript 2c mRNA, complete cds
  gi|2660705|gb|AF009007.1|AF009007[2660705]
• 12334: AF009006
  Homo sapiens immunoglobulin-like transcript 2b mRNA, complete cds
  gi|2660703|gb|AF009006.1|AF009006[2660703]
• 12335: AF009005
  Homo sapiens immunoglobulin-like transcript 2a mRNA, complete cds
  gi|2660701|gb|AF009005.1|AF009005[2660701]
• 12336: AH006705
  Homo sapiens mu opioid receptor (OPRM1) and mu opioid receptor (OPRM1)s, partial
  cds
  gi|2655104|gb|AH006705.1|SEG_HSOPRMI[2655104]
• 12338: AF024516
  Homo sapiens mu opioid receptor (OPRM1) gene, partial cds, exons 2 and 3, complete IVS2
  gi|2655102|gb|AF024516.1|HSOPRMI2[2655102]
• 12339: AF024515
  Homo sapiens mu opioid receptor (OPRM1) gene, partial cds, exon 1
  gi|2655101|gb|AF024515.1|HSOPRMI1[2655101]
• 12410: AF030625
  Homo sapiens SCCL vasopressin subtype 1a receptor mRNA, complete cds
  gi|2623229|gb|AF030625.1|AF030625[2623229]
• 12411: AF002986
  Homo sapiens platelet activating receptor homolog (H963) mRNA, complete cds
  gi|2580587|gb|AF002986.1|AF002986[2580587]
• 12412: AF023614
  Homo sapiens transmembrane activator and CAML interactor (TACI) mRNA, complete
  cds
  gi|2554947|gb|AF023614.1|AF023614[2554947]
• 12413: AF022860
  Homo sapiens neuropilin-2(a17) mRNA, complete cds
  gi|2547131|gb|AF022860.1|AF022860[2547131]
• 12414: AF022859
  Homo sapiens neuropilin-2(a0) mRNA, complete cds
  gi|2547129|gb|AF022859.1|AF022859[2547129]
• 12415: AF016849
  Homo sapiens apoptosis inducing receptor TRAIL-R2 (TRAILR2) mRNA, complete cds
  gi|2465585|gb|AF016849.1|AF016849[2465585]
• 12416: AF013171
  Homo sapiens TNF-related ligand TRANCE mRNA, partial cds
  gi|2411499|gb|AF013171.1|AF013171[2411499]
• 12417: AF018956
  Homo sapiens neuropilin mRNA, complete cds
  gi|2407640|gb|AF018956.1|AF018956[2407640]
• 12419: AF015257
  Homo sapiens flow-induced endothelial G protein-coupled receptor (FEG-1) mRNA,
  complete cds
  gi|2353152|gb|AF015257.1|AF015257[2353152]
• 12420: U75285
  Homo sapiens apoptosis inhibitor survivin gene, complete cds
  gi|2315862|gb|U75285.1|HSU75285[2315862]
• 12421: AF012270
  Homo sapiens visual pigment-like receptor peropsin (Rrh) mRNA, complete cds
  gi|2387009|gb|AF012270.1|AF012270[2307009]
• 12422: AH006692
  Homo sapiens chromosome 19 clone PAC clone 72N6 map 19q13.42
  gi|2290633|gb|AH006692.1|SEG_HSNKAT2A[2290633]
• 12423: U97180
  Homo sapiens NKAT-2a like protein (KIR) gene, exons 8 and 9 and complete cds
  gi|2290632|gb|U97180.1|HSNKAT2A8[2290632]
• 12424: U97179
  Homo sapiens NKAT-2a like protein (KIR) gene, exon 7
  gi|2290631|gb|U97179.1|HSNKAT2A7[2290631]
• 12425: U97178
  Homo sapiens NKAT-2a like protein (KIR) gene, exon 6
  gi|2290630|gb|U97178.1|HSNKAT2A6[2290630]
• 12426: U97177
  KIR Homo sapiens NKAT-2a like protein (KIR) gene, exon 5
  gi|2290629|gb|U97177.1|HSNKAT2A5[2290629]
• 12427: U97176
  Homo sapiens NKAT-2a like protein (KIR) gene, exon 4
  gi|2290628|gb|U97176.1|HSNKAT2A4[2290628]
• 12429: U97174
  KIR Homo sapiens NKAT-2a like protein (KIR) gene, exon 2
  gi|2290626|gb|U97174.1|HSNKAT2A2[2290626]
• 12430: U97173
  Homo sapiens NKAT-2a like protein (KIR) gene, exon 1
  gi|2290625|gb|U97173.1|HSNKAT2A1[2290625]
• 12431: U97075
  Homo sapiens FLICE-like inhibitory protein short form mRNA, complete cds
  gi|2253680|gb|U97075.1|U97075[2253680]
• 12432: U97074
  Homo sapiens FLICE-like inhibitory protein long form mRNA, complete cds
  gi|2253678|gb|U97074.1|U97074[2253678]
• 12688: L76380
  Homo sapiens (clone HSNME29) CGRP type 1 receptor mRNA, complete cds
  gi|1321593|gb|L76380.1|HUMCGRPB[1321593]
• 12689: L49241
  Homo sapiens fibroblast growth factor 2 (FGFR2) Ser354Cys mutant gene, exon IIIc
  gi|1129116|gb|L49241.1|HUMFGF354C[1129116]
• 12690: L49240
  Homo sapiens fibroblast growth factor 2 (FGFR2) Ala344Gly mutant gene, exon IIIc
  gi|1129114|gb|L49240.1|HUMFGF344G[1129114]
• 12691: L49239
  Homo sapiens fibroblast growth factor 2 (FGFR2) Cys342Tyr mutant gene, exon IIIc
  gi|1129112|gb|L49239.1|HUMFGF342Y[1129112]
• 12692: L49238
  Homo sapiens fibroblast growth factor 2 (FGFR2) Cys342Ser mutant gene, exon IIIc
  gi|1129110|gb|L49238.1|HUMFGF342S[1129110]
• 12693: L49242
  Homo sapiens fibroblast growth factor 2 (FGFR2) Gly338Arg mutant gene, exon IIIc
  gi|1129108|gb|L49242.1|HUMFGF338R[1129108]
• 12694: L49237
  Homo sapiens fibroblast growth factor 2 (FGFR2) Gln289Pro mutant gene, exon IIIu
  gi|1129106|gb|L49237.1|HUMFGF289P[1129106]
• 12842: L38734
  Homo sapiens hepatoma transmembrane kinase ligand (HTK ligand) mRNA, complete cds
  gi|769675|gb|L38734.1|HUMHTK[769675]
• 12843: L40764
  Homo sapiens vasoactive intestinal polypeptide receptor 2 (VIPR2) mRNA, complete
  cds
  gi|712836|gb|L40764.1|HUMVIPR2A[712836]
• 12844: AF068181
  Homo sapiens B cell linker protein BLNK-s mRNA, alternatively spliced, complete
  cds
  gi|3406750|gb|AF068181.1|AF068181[3406750]
• 12845: AF068180
  Homo sapiens B cell linker protein BLNK mRNA, alternatively spliced, complete cds
  gi|3406748|gb|AF068180.1|AF068180[3406748]
• 12846: AF064801
  Homo sapiens multiple membrane spanning receptor TRC8 (TRC8) mRNA, complete cds
  gi|3395786|gb|AF064801.1|AF064801[3395786]
• 12847: AH006513
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene
  gi|3342791|gb|AH006513.1|SEG_HSGLRA3S[3342791]
• 12848: AF017724
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 10n, and complete cds
  gi|3342790|gb|AF017724.1|HSGLRA3S10[3342790]
• 12849: AF017723
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 9n
  gi|3342789|gb|AF017723.1|HSGLRA3S09[3342789]
• 12850: AF017722
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 8
  gi|3342788|gb|AF017722.1|HSGLRA3S08[3342788]
• 12851: AF017721
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 7
  gi|3342787|gb|AF017721.1|HSGLRA3S07[3342787]
• 12852: AF017720
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 6
  gi|3342786|gb|AF017720.1|HSGLRA3S06[3342786]
• 12853: AF017719
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 5
  gi|3342785|gb|AF017719.1|HSGLRA3S05[3342785]
• 12854: AF017718
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 4
  gi|3342784|gb|AF017718.1|HSGLRA3S04[3342784]
• 12855: AF017717
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 3
  gi|3342783|gb|AF017717.1|HSGLRA3S03[3342783]
• 12856: AF017716
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 2
  gi|3342782|gb|AF017716.1|HSGLRA3S02[3342782]
• 12857: AF017715
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 1
  gi|3342781|gb|AF017715.1|HSGLRA3S01[3342781]
• 12858: AF018157
  Homo sapiens glycine receptor alpha 3 subunit (GLRA3) mRNA, alternatively spliced, partial cds
  gi|3342237|gb|AF018157.1|AF018157[3342237]
• 12861: AF045764
  Homo sapiens orphan G protein-coupled receptor (GPR32) gene, complete cds
  gi|3282838|gb|AF045764.1|AF045764[3282838]
• 12864: AF053004
  Homo sapiens class I cytokine receptor (WSX1) mRNA, complete cds
  gi|31532400gb|AF053004.1|AF053004[3153240]
• 12865: AF055872
  Homo sapiens Apo3/DR3 ligand (APO3L) mRNA, complete cds
  gi|3108230|gb|AF055872.1|AF055872[3108230]
• 12866: AF057140
  Homo sapiens cargo selection protein TIP47 (TIP47) mRNA, complete cds
  gi|3095185|gb|AF057140.1|AF057140[3095185]
• 12870: AF028785
  Homo sapiens phosphatidylinositol 3-kinase p55 gamma regulatory subunit mRNA, complete cds
  gi|3046405|gb|AF028785.1|AF028785[3046405]
• 12872: AF027826
  Homo sapiens putative seven pass transmembrane protein (TM7SF1) mRNA, complete
  cds
  gi|2992627|gb|AF027826.1|AF027826[2992627]
• 12883: AF040630
  Homo sapiens galanin receptor GalR2 mRNA, complete cds
  gi|2921759|gb|AF040630.1|AF040630[2921759]
• 12904: U86281
  Homo sapiens olfactory receptor (OR7-141) gene, partial cds
  gi|2921715|gb|U86281.1|U86281[2921715]
• 12905: U86280
  Homo sapiens olfactory receptor (OR7-140) gene, partial cds
  gi|2921713|gb|U86280.1|U86280[2921713]
• 12906: U86279
  Homo sapiens olfactory receptor (OR7-139) gene, partial cds
  gi|2921711|gb|U86279.1|U86279[2921711]
• 12907: U86278
  Homo sapiens olfactory receptor (OR7-138) gene, partial cds
  gi|2921709|gb|U86278.1|U86278[2921709]
• 12911: U86274
  Homo sapiens olfactory receptor (OR5-85) gene, partial cds
  gi|2921704|gb|U86274.1|U86274[2921704]
• 12915: U86270
  Homo sapiens olfactory receptor (OR5-40) gene, partial cds
  gi|2921699|gb|U86270.1|U86270[2921699]
• 12921: U86264
  Homo sapiens olfactory receptor (OR3-145) gene, partial cds
  gi|2921692|gb|U86264.1|U86264[2921692]
• 12927: AH006491
  Homo sapiens GPI-linked anchor protein (GFRA1), complete cds
  gi|2921544|gb|AH006491.1|SEG_HSGFRA1G[2921544]
• 12928: AF038420
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 11 and complete cds
  gi|2921543|gb|AF038420.1|HSGFRA1G11[2921543]
• 12929: AF038419
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 10
  gi|2921542|gb|AF038419.1|HSGFRA1G1002921542]
• 12930: AF038418
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 9
  gi|2921541|gb|AF038418.1|HSGFRA1G 9[2921541]
• 12931: AF038417
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 8
  gi|2921540|gb|AF038417.1|HSGFRA1G 8[2921540]
• 12932: AF038416
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 7
  gi|2921539|gb|AF038416.1|HSGFRA1G 7[2921539]
• 12933: AF038415
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 6
  gi|2921538|gb|AF038415.1|HSGFRA1G 6[2921538]
• 12934: AF038414
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 5
  gi|2921537|gb|AF038414.1|HSGFRA1G 5[2921537]
• 12935: AF038413
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 4
  gi|2921536|gb|AF038413.1|HSGFRA1G 4[2921536]
• 12936: AF038412
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 3
  gi|2921535|gb|AF038412.1|HSGFRA1G 3[2921535]
• 12937: AF038411
  Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 2
  gi|2921534|gb|AF038411.1|HSGFRA1G 2[2921534]
• 12938: AF036906
  Homo sapiens linker for activation of T cells (LAT) mRNA, alternatively spliced
  form, complete cds
  gi|2828025|gb|AF036906.1|AF036906[2828025]
• 12939: AF036905
  Homo sapiens linker for activation of T cells (LAT) mRNA, complete cds
  gi|2828023|gb|AF036905.1|AF036905[2828023]
• 12940: AF043724
  Homo sapiens hepatitis A virus cellular receptor 1 (hHAVcr-1) mRNA, complete cds
  gi|2827453|gb|AF043724.1|AF043724[2827453]
• 12954: U86239
  Homo sapiens olfactory receptor (OR16-90) gene, partial cds
  gi|2921659|gb|U86239.1|U86239[2921659]
• 12955: U86238
  Homo sapiens olfactory receptor (OR16-89) gene, partial cds
  gi|2921657|gb|U86238.1|U86238[2921657]
• 12956: U86237
  Homo sapiens olfactory receptor (OR16-88) gene, partial cds
  gi|2921655|gb|U86237.1U86237[2921655]
• 12957: U86236
  Homo sapiens olfactory receptor (OR16-37) gene, partial cds
  gi|2921653|gb|U86236.1|U86236[2921653]
• 12958: U86235
  Homo sapiens olfactory receptor (OR16-36) gene, partial cds
  gi|2921651|gb|U86235.1|U86235[2921651]
• 12959: U86234
  Homo sapiens olfactory receptor (OR16-35) gene, partial cds
  gi|2921649|gb|U86234.1|U86234[2921649]
• 12971: U86222
  Homo sapiens olfactory receptor (OR13-66) gene, partial cds
  gi|2921636|gb|U86222.1|U86222[2921636]
• 12977: U86216
  Homo sapiens olfactory receptor (OR1-26) gene, partial cds
  gi|2921629|gb|U86216.1U86216[2921629]
• 12978: U86215
  Homo sapiens olfactory receptor (OR1-25) gene, partial cds
  gi|2921627|gb|U86215.1|U86215[2921627]
• 12979: AF016261
  Homo sapiens interleukin-1 receptor accessory protein (IL1RAP) gene, partial cds
  gi|2911297|gb|AF016261.1|AF016261[2911297]
• 12980: AF041245
  Homo sapiens orexin receptor-2 mRNA, complete cds
  gi|2897127|gb|AF041245.1|AF041245[2897127]
• 12981: AF041243
  Homo sapiens orexin receptor-1 mRNA, complete cds
  gi|2897123|gb|AF041243.1|AF041243[2897123]
• 12982: U97123
  Homo sapiens chemokine receptor mRNA, complete cds
  gi|2897070|gb|U97123.1|HSU97123[2897070]
• 12983: AF009014
  Homo sapiens glutamate receptor delta-2 subunit (GLURD2) mRNA, complete cds
  gi|2853314|gb|AF009014.1|AF009014[2853314]
• 12984: AF036581
  Homo sapiens tumor necrosis factor superfamily member LIGHT mRNA, complete cds
  gi|2815623|gb|AF036581.1|AF036581[2815623]
• 12985: AF040991
  Homo sapiens roundabout 2 (robo2) mRNA, partial cds
  gi|2804785|gb|AF040991.1|AF040991[2804785]
• 12986: AF040990
  Homo sapiens roundabout 1 (robo1) mRNA, complete cds
  gi|2804783|gb|AF040990.1|AF040990[2804783]
• 12987: AF026070
  Homo sapiens death receptor 3 beta (DR3) mRNA, complete cds
  gi|2570830|gb|AF026070.1|AF026070[2570830]
• 12988: AF021818
  Homo sapiens putative neurotransmitter receptor mRNA, complete cds
  gi|2465431|gb|AF021818.1|AF021818[2465431]
• 12990: L48211
  Homo Sapiens angiotensin II receptor gene, complete cds
  gi|1160612|gb|L48211.1|HUMAIR[1160612]
• 12992: L47169
  Homo sapiens neuropeptide Y receptor gene, exon, promoter C
  gi|976208|gb|L47169.1|HUMNPYAC[976208]
• 12993: L47168
  Homo sapiens neuropeptide Y receptor gene, exon, promoter B
  gi|976207|gb|L47168.1|HUMNPYAB[976207]
• 12994: L47167
  Homo sapiens neuropeptide Y receptor gene, exon, promoter A
  gi|976206|gb|L47167.1|HUMNPYAA[976206]
• 12995: L37086
  Homo sapiens FK-506 binding protein (fkbp12.6) gene, complete cds
  gi|965467|gb|L37086.1|HUMFK506B[965467]
• 12996: L36566
  Human helodermin-preferring VIP receptor (VIP2/PACAP receptor) mRNA, complete cds
  gi|550477|gb|L36566.1|HUMHVP[550477]
• 12997: L25647
  Homo sapiens fibroblast growth factor receptor gene (located in the central MHC)
  signal peptide and consecutive exon
  gi|457233|gb|L25647.1|HUMFGFRZ[457233]
• 12998: M85247
  H. sapiens dopamine D1A receptor gene, complete exon 1, and exon 2, 5′ end
  gi|181652|gb|M85247.1|HUMDOPAM[181652]
• 12999: L21195
  Human serotonin 5-HT7 receptor mRNA, complete cds
  gi|413865|gb|L21195.1|HLJMSHTR[413865]
• 13000: L22647
  Human prostaglandin receptor ep1 subtype mRNA, complete cds
  gi|410208|gb|L22647.1|HUMG[410208]
• 13001: L10822
  Human gastrin receptor gene, complete cds
  gi|406075|gb|L10822.1|HUMGARE[406075]
• 13002: L19546
  Human (IL2RG) gene, complete cds with repeats
  gi|349631|gb|L19546.1|HUMIL2RGA[349631]
• 13003: M95667
  Homo sapiens c-erb B2/neu protein (ERBB2) gene, partial cds
  gi|182168|gb|M95667.1|HUMERBB2[182168]
• 13004: AF087138
  Homo sapiens sulfonylurea receptor 1 (SUR1) mRNA, complete cds
  gi|3643189|gb|AF087138.1|AF087138[3643189]
• 13005: AF042782
  Homo sapiens galanin receptor type. 2 (GALR2) gene, complete cds
  gi|3642913|gb|AF042782.1|AF042782[3642913]
• 13007: AF064548
  Homo sapiens low-density lipoprotein receptor-related protein 5 (LRP5) mRNA,
  complete cds
  gi|3641526|gb|AF064548.1|AF064548[3641526]
• 13008: AF073799
  Homo sapiens galanin receptor GALR3 mRNA, complete cds
  gi|3608409|gb|AF073799.1|AF073799[3608409]
• 13009: D10202
  Homo sapiens mRNA for platelet-activating factor receptor, complete cds
  gi|219975|dbj|D10202.1|HUMPAFRE[219975]
• 13010: AB017498
  Homo sapiens LRP5 mRNA for Lipoprotein Receptor Related Protein 5, complete cds
  gi|3582144|dbj|AB017498.1|AB017498[3582144]
• 13011: AJ011041
  Homo sapiens CHRM2 gene, satellite
  gi|3581973|emb|AJ011041.1|HSA011041[3581973]
• 13012: AH006427
  Homo sapiens chromosome 12 map 12q13-14
  gi|3561040|gb|AH006427.1|SEG_HOMOVDR[3561040]
• 13013: AF080456
  Homo sapiens vitamin D receptor gene, exon if
  gi|3561039|gb|AF080456.1|HOMOVDR3[3561039]
• 13014: AF080455
  Homo sapiens vitamin D receptor gene, exon le
  gi|3561038|gb|AF080455.1|HOMOVDR2[3561038]
• 13015: AF080454
  Homo sapiens vitamin D receptor gene, exon id
  gi|3561037|gb|AF080454.1|HOMOVDR1[3561037]
• 13025: AJ001689
  Homo sapiens NKG2D gene, exon 10
  gi|2980867|emb|AJ001689.1|HSAJ1689[2980867]
• 13026: AJ001688
  Homo sapiens NKG2D gene, exons 6-9
  gi|2980866|emb|AJ001688.1|HSAJ1688[2980866]
• 13027: AJ001687
  Homo sapiens NKG2D gene, exons 2-5 and joined mRNA and CDS
  gi|2980864|emb|AJ001687.1|HSAJ1687[2980864]
• 13028: AJ001686
  Homo sapiens NKG2F gene
  gi|2980862|emb|AJ001686.1|HSAJ1686[2980862]
• 13029: AJ001685
  Homo sapiens NKG2E gene
  gi|2980860|emb|AJ001685.1|HSAJ1685[2980860]
• 13030: AJ001684
  Homo sapiens NKG2C gene
  gi|2980858|emb|AJ001684.1|HSAJ1684[2980858]
• 13031: AJ001683
  Homo sapiens NKG2F mRNA
  gi|2980856|emb|AJ001683.1|HSAJ1683[2980856]
• 13032: Y12546
  H. sapiens mRNA for P2Y-like G-protein coupled receptor
  gi|2687818|emb|Y12546.1|HSP2YLG[2687818]
• 13033: AF015525
  Homo sapiens putative chemokine receptor (CRAM-B) mRNA, complete cds
  gi|3550069|gb|AF015525.1|AF015525[3550069]
• 13034: AF015524
  Homo sapiens putative chemokine receptor (CRAM-A) mRNA, complete cds
  gi|3550066|gb|AF015524.1|AF015524[3550066]
• 13035: AF068868
  Homo sapiens TNFR-related death receptor-6 (DR6) mRNA, complete cds
  gi|3549262|gb|AF068868.1|AF068868[3549262]
• 13036: AF052572
  Homo sapiens chemokine receptor CXCR4 gene, promoter region and complete cds
  gi|3549254|gb|AF052572.1|AF052572[3549254]
• 13037: AC005625
  Homo sapiens chromosome 19, cosmid R27328, complete sequence
  gi|3549153|gb|AC005625.1|AC005625[3549153]
• 13038: AF051152
  Homo sapiens Toll/interleukin-1 receptor-like protein 4 (TIL4) mRNA, complete cds
  gi|3132527|gb|AF051152.1|AF051152[3132527]
• 13039: AF051151
  Homo sapiens Toll/interleukin-1 receptor-like protein 3 (TIL3) mRNA, complete cds
  gi|3132525|gb|AF051151.1|AF051151[3132525]
• 13040: AC005601
  Homo sapiens chromosome 5, BAC clone 343g16 (LBNL H180), complete sequence
  gi|3522917|gb|AC005601.1|AC005601[3522917]
• 13042: U88540
  Homo sapiens Toll-like receptor 1 (TLR1) mRNA, complete cds
  gi|2459617|gb|U88540.1|HSU88540[2459617]
• 13066: Z94155
  H. sapiens mRNA for P2Y-like G-protein coupled receptor (partial)
  gi|2695875|emb|Z94155.1|HSZ94155[2695875]
• 13067: Z94154
  H. sapiens mRNA for P2Y-like G-protein coupled receptor
  gi|2695873|emb|Z94154.1|HSZ94154[2695873]
• 13068: AF074264
  Homo sapiens LDL receptor-related protein 6 (LRP6) mRNA, complete cds
  gi|3462526|gb|AF074264.1|AF074264[3462526]
• 13069: AF021233
  Homo sapiens TRAIL-R4-B (TRAIL-R4) mRNA, complete cds
  gi|3452184|gb|AF021233.1|AF021233[3452184]
• 13070: AF021232
  Homo sapiens TRAIL-R4-A (TRAIL-R4) mRNA, complete cds
  gi|3452182|gb|AF021232.1|AF021232[3452182]
• 13072: X98765
  H. sapiens gene encoding secretory component of polymeric immunoglobulin receptor
  gi|2546984|emb|X98765.1|HSSC[2546984]
• 13103: U50062
  Homo sapiens RIP protein kinase mRNA, complete cds
  gi|3426026|gb|U50062.1|HSU50062[3426026]
• 13104: AF078925
  Homo sapiens P2X1 receptor gene, partial cds
  gi|3421366|gb|AF078925.1|AF078925[3421366]
• 13106: AF061785
  Homo sapiens gamma-aminobutyric acid receptor A5 subunit (GABRA5) gene, three alternative first exons and exons 2-3, partial cds
  gi|3420025|gb|AF061785.1|AF061785[3420025]
• 13110: AB009462
  Homo sapiens hLRp105 mRNA for LDL receptor related protein 105, complete cds
  gi|3413957|dbj|AB009462.1|AB009462[3413957]
• 13111: AF075590
  Homo sapiens MCF-7 peripheral-type benzodiazepine receptor (PBR) mRNA, partial
  cds
  gi|3411164|gb|AF075590.1|AF075590[3411164]
• 13112: AF075589
  Homo sapiens MDA-MB-231 peripheral-type benzodiazepine receptor (PBR) mRNA, partial cds
  gi|3411162|gb|AF075589.1|AF075589[3411162]
• 13113: L39064
  Homo sapiens interleukin 9 receptor precursor (IL9R) gene, complete cds
  gi|632992|gb|L39064.1|HUMIL9RA[632992]
• 13114: AJ224878
  Homo sapiens mRNA for T-cell receptor interacting molecule (TRIM) protein
  gi|3402215|emb|AJ224878.1|HSAJ4878[3402215]
• 13115: AF080214
  Homo sapiens protease-activated receptor 4 mRNA, complete cds
  gi|3396080|gb|AF080214.1|AF080214[3396080]
• 13116: AF075005
  Homo sapiens full length insert cDNA YH98E06
  gi|3377544|gb|AF075005.1|HUMYH98E06[3377544]
• 13133: AF062006
  Homo sapiens orphan G protein-coupled receptor HG38 mRNA, complete cds
  gi|3366801|gb|AF062006.1|AF062006[3366801]
• 13134: Y12815
  H. sapiens mRNA for chemokine receptor D6
  gi|2204204|emb|Y12815.1|HSY12815[2204204]
• 13135: AC005338
  Homo sapiens chromosome 19, cosmid R31646, complete sequence
  gi|3355457|gb|AC005338.1|AC005338[3355457]
• 13137: AF078530
  Homo sapiens receptor interacting protein 2 (RIP2) mRNA, complete cds
  gi|3342909|gb|AF078530.1|AF078530[3342909]
• 13138: AF077526
  Homo sapiens parathyroid hormone-related protein receptor gene, partial cds
  gi|3342553|gb|AF077526.1|AF077526[3342553]
• 13139: AH006311
  Homo sapiens chromosome 11 gastrin\cholecystokinin brain receptor (CCKBR), partial cds
  gi|3342089|gb|AH006311.1|SEG_HSCCKBR[3342089]
• 13140: AF074029
  Homo sapiens gastrincholecystokinin brain receptor (CCKBR) gene, exons 4 and and partial cds
  gi|3342088|gb|AF074029.1|HSCCKBR2[3342088]
• 13141: AF074035
  Homo sapiens gastrincholecystokinin brain receptor (CCKBR) gene, exons 2 and 3
  gi|3342087|gb|AF074035.1|HSCCKBR1[3342087]
• 13142: U44132
  Homo sapiens lung cancer suppressor region LCR11.1 satellite DNA
  gi|1174163|gb|U44132.1|HSU44132[1174163]
• 13143: Y14930
  Homo sapiens TCRAV28 gene, allele A4, partial
  gi|2664276|emb|Y14930.1|HSY14930[2664276]
• 13144: Y14931
  Homo sapiens TCRAV28 gene, allele A5, partial
  gi|2661832|emb|Y14931.1|HSY14931[2661832]
• 13145: Y14929
  Homo sapiens TCRAV28 gene, allele A3, partial
  gi|2661828|emb|Y14929.1|HSY14929[2661828]
• 13146: AF074087
  Homo sapiens killer cell inhibitory receptor short form (KIR2D52) mRNA, alternatively spliced, partial cds
  gi|3328178|gb|AF074087.1|AF074087[3328178]
• 13147: Y12507
  H. sapiens mRNA for serotonin receptor 5-HT4D, splice variant
  gi|3326990|emb|Y12507.1|HSY12507[3326990]
• 13148: Y12506
  H. sapiens mRNA for serotonin receptor 5-HT4C, splice variant
  gi|3326988|emb|Y12506.1|HSY12506[3326988]
• 13151: D85242
  Homo sapiens mRNA for NOR-1 3′-variant, partial cds
  gi|3168581|dbj|D85242.1D85242[3168581]
• 13152: D85241
  Homo sapiens mRNA for NOR-1beta, partial cds
  gi|3168579|dbj|D85241.1|D85241[3168579]
• 13153: AF034633
  Homo sapiens orphan G protein-coupled receptor (GPR39) mRNA, complete cds
  gi|2654160|gb|AF034633.1|AF034633[2654160]
• 13154: AF034632
  Homo sapiens orphan G protein-coupled receptor (GPR38) gene, complete cds
  gi|2654158|gb|AF034632.1|AF034632[2654158]
• 13155: AF054633
  Homo sapiens thrombin receptor gene, exon 1 and partial cds
  gi|3309036|gb|AF054633.1|AF054633[3309036]
• 13156: AF073792
  Homo sapiens CGRP-receptor component protein mRNA, complete cds
  gi|3300101|gb|AF073792.1|AF073792[3300101]
• 13157: AF007575
  Homo sapiens ES/130-related protein mRNA, partial cds
• 13158: AF055917
  Homo sapiens protease-activated receptor 4 mRNA, complete cds
  gi|329332|gb|AF055917.1|AF055917[3293321]
• 13160: AC005255
  Homo sapiens chromosome 19, CIT-HSP-146e8, complete sequence
  gi|3289998|gb|AC005255.1|AC005255[3289998]
• 13165: AB012724
  Homo sapiens gene for endothelin-A receptor, cis_element region
  gi|3273319|dbj|AB012724.1|AB012724[3273319]
• 13166: AB015745
  Homo sapiens mRNA for human prolactin-releasing peptide receptor, complete cds
  gi|3273224|dbj|AB015745.1|AB015745[3273224]
• 13167: AF020498
  Homo sapiens P2X1 purinoceptor (P2X) mRNA, complete cds
  gi|3258622|gb|AF020498.1|AF020498[3258622]
• 13170: AF051767
  Homo sapiens GDNF family receptor alpha 3 (GFRA3) mRNA, complete cds
  gi|2961631|gb|AF051767.1|AF051767[2961631]
• 13171: AH006188
  Homo sapiens GABA-A receptor pi subunit (GABRP), partial cds
  gi|3252851|gb|AH006188.1|SEG_HSGABRP[3252851]
• 13172: AF009702
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 10 and complete cds
  gi|3252850|gb|AF009702.1|HSGABRP10[3252850]
• 13173: AF009701
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 9
  gi|3252849|gb|AF009701.1|HSGABRP09[3252849]
• 13174: AF009700
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 8
  gi|3252848|gb|AF009700.1|HSGABRP08[3252848]
• 13175: AF009699
• Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 7
• gi|3252847|gb|AF009699.1|HSGABRP07[3252847]
• 13176: AF009698
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 6
  gi|3252846|gb|AF009698.1|HSGABRP06[3252846]
• 13177: AF009697
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 5
  gi|3252845|gb|AF009697.1|HSGABRP05[3252845]
• 13178: AF009696
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 4
  gi|3252844|gb|AF009696.1|HSGABRP04[3252844]
• 13179: AF009695
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 3
  gi|3252843|gb|AF009695.1|HSGABRP03[3252843]
• 13180: AF009694
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 2
  gi|3252842|gb|AF009694.1|HSGABRP02[3252842]
• 13181: AF009693
  Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 1
  gi|3252841|gb|AF009693.1|HSGABRP01[3252841]
• 13182: E13909
  cDNA encoding human MCP-1 receptor protein
  gi|3252676|dbj|E13909.1|E13909[3252676]
• 13183: E13892
  cDNA encoding human novel G protein-coupling receptor protein
  gi|3252659|dbj|E13892.1|E13892[3252659]
• 13184: E13385
  cDNA encoding human MIP-1 alpha/RANTES receptor
  gi|13252190|dbj|E13385.1|E13385[3252190]
• 13185: E13006
  cDNA encoding human G-protein coupling receptor protein
  gi|3251830|dbj|E13006.1|E13006[3251830]
• 13186: E13005
  cDNA encoding human G-protein-coupling receptor protein
  gi|3251829|dbj|E13005.1|E13005[3251829]
• 13187: E12979
  cDNA encoding human interleukin-6 receptor
  gi|3251803|dbj|E12979.1|E12979[3251803]
• 13188: E12916
  Human cDNA encoding a denatured low-density lipoprotein receptor
  gi|3251747|dbj|E12916.1|E12916[3251747]
• 13189: E12845
  cDNA encoding melatonin receptor
  gi|3251677|dbj|E12845.1|E12845[3251677]
• 13190: E12752
  A novel human Corticotropin Releasing Factor 2 (CRF2) receptor mRNA, complete cds
  gi|3251584|dbj|E12752.1|E12752[3251584]
• 13191: E12750
  A novel human Corticotropin Releasing Factor 2 (CRF2) receptor mRNA, complete cds
  gi|3251582|dbj|E12750.1|E12750[3251582]
• 13192: E12703
  cDNA encoding asialoglycoprotein receptor L-H2, AGPR L-H2
  gi|3251535|dbj|E12703.1|E12703[3251535]
• 13193: E12702
  cDNA encoding asialoglycoprotein receptor H1, AGPR H1
  gi|3251534|dbj|E12702.1|E12702[3251534]
• 13197: E12658
  cDNA encoding galanin receptor
  gi|3251490|dbj|E12658.1|E12658[3251490]
• 13198: E12487
  Human cDNA encoding a G protein-coupled receptor
  gi|3251320|dbj|E12487.1|E12487[3251320]
• 13199: E12484
  Human cDNA encoding a G protein-coupled receptor
  gi|3251317|dbj|E12484.1|E12484[3251317]
• 13200: E12354
  cDNA encoding receptor of luteinizing hormone-releasing hormone, LH-RH receptor
  gi|3251188|dbj|E12354.1|E12354[3251188]
• 13201: E12281
  cDNA encoding human growth hormone-releasing hormone receptor
  gi|3251115|dbj|E12281.1|E12281[3251115]
• 13202: E12186
  A novel ligand for receptor type tyrosine kinase
  gi|3251020|dbj|E12186.1|E12186[3251020]
• 13203: E12185
  cDNA encoding a receptor type tyrosine kinase
  gi|3251019|dbj|E12185.1|E12185[3251019]
• 13204: AF009962
  Homo sapiens CC-chemokine receptor (CCR-5) gene, delta-32 allele, complete cds
  gi|3243092|gb|AF009962.1|AF009962[3243092]
• 13205: AF050525
  Homo sapiens proteinase activated receptor-3 (PAR-3) gene, 5′ regulatory sequence
  gi|3241996|gb|AF050525.1|AF050525[3241996]
• 13206: U33328
  Homo sapiens killer cell Ig-like receptor variant (KIR3DL1) mRNA, complete cds
  gi|995756|gb|U33328.1|HSU33328[995756]
• 13207: U31416
  Homo sapiens killer cell Ig-like receptor (KIR3DL1) mRNA, complete cds
  gi|973405|gb|U31416.1|HSU31416[973405]
• 13208: U50748
  Homo sapiens leptin receptor short form (db) mRNA, complete cds
  gi|3236285|gb|U50748.1|HSU50748[3236285]
• 13215: Y14838
  Homo sapiens ChemR23 gene
  gi|3219597|emb|Y14838.1|HSCHEMR23[3219597]
• 13216: Y12505
  H. sapiens mRNA for serotonin receptor 5-HT4B, splice variant
  gi|2661756|emb|Y12505.1|HSY12505[2661756]
• 13217: Y08756
  H. sapiens mRNA for serotonin receptor 5-HT4
  gi|2661732|emb|Y08756.1|HS5HT4AR[2661732]
• 13218: X85785
  H. sapiens DARC gene
  gi|929624|emb|X85785.1|HSDARC[929624]
• 13219: AH006173
  Homo sapiens Type II integral membrane protein (NKG2-F), complete cds
  gi|2674028|gb|AH006173.1|SEG_HSNKG2F0[2674028]
• 13220: AF001298
  Homo sapiens type II integral membrane protein (NKG2-D) gene, exons 9-13
  gi|2674027|gb|AF001298.1|HSNKG2F02[2674027]
• 13221: AF001297
  Homo sapiens type II integral membrane protein (NKG2-D) gene, exons 5-8
  gi|2674026|gb|AF001297.1|HSNKG2F01[2674026]
• 13222: AF048704
  Homo sapiens lamin B receptor homolog TM7SF2 gene, complete cds
  gi|3211743|gb|AF048704.1|AF048704[3211743]
• 13223: AF023676
  Homo sapiens lamin B receptor homolog TM7SF2 (TM7SF2) mRNA, complete cds
  gi|3211721|gb|AF023676.1|AF023676[3211721]
• 13224: AJ001016
  Homo sapiens mRNA encoding RAMP3
  gi|3171913|emb|AJ001016.1|HSRAMP3[3171913]
• 13236: Y13584
  Homo sapiens mRNA for serotin receptor 4, short splice variant
  gi|3183985|emb|Y13584.1|HSY13584[3183985]
• 13237: AF030339
  Homo sapiens receptor for viral semaphorin protein (VESPR) mRNA, complete cds
  gi|3176761|gb|AF030339.1|AF030339[3176761]
• 13239: AC004782
  Homo sapiens chromosome 5, BAC clone 205e20 (LBNL H170), complete sequence
  gi|3172145|gb|AC004782.1|AC004782[3172145]
• 13240: AF009662
  Homo sapiens T cell receptor beta locus, TCRBV13S1 to TCRBV6S9 region
  gi|2275573|gb|AF009662.1|HSTCRBB27[2275573]
• 13241: AJ001015
  Homo sapiens mRNA encoding RAMP2
  gi|3171911|emb|AJ001015.1|HSRAMP2[3171911]
• 13242: AJ001014
  Homo sapiens mRNA encoding RAMP1
  gi|3171909|emb|AJ001014.1|HSRAMP1[3171909]
• 13243: AF011333
  Homo sapiens DEC-205 mRNA, complete cds
  gi|3165456|gb|AF011333.1|AF011333[3165456]
• 13244: AJ001902
  Homo sapiens mRNA for TRIP6 (thyroid receptor interacting protein)
  gi|2558591|emb|AJ001902.1|HSTRIP6[2558591]
• 13245: AF002216
  AF002216 AP20 melanoma mRNA Homo sapiens cDNA, mRNA sequence
  gi|2895065|gb|AF002216.1|AF002216[2895065]
• 13246: AF002215
  AF002215 AP20 melanoma mRNA Homo sapiens cDNA, mRNA sequence
  gi|2895064|gb|AF002215.1|AF002215[2895064]
• 13247: AF002214
  AF002214 AP20 melanoma mRNA Homo sapiens cDNA, mRNA sequence
  gi|2895063|gb|AF002214.1|AF002214[2895063]
• 13248: AC002411
  Arabidopsis thaliana chromosome 1 BAC F20D22 sequence, complete sequence
  gi|2570223|gb|AC002411.1|F20D22[2570223]
• 13249: AF058927
  Homo sapiens clone hvRNA92 vRNA sequence
  gi|3138979|gb|AF058927.1|AF058927[3138979]
• 13250: AF058926
  Homo sapiens clone hvRNA82 vRNA sequence
  gi|3138978|gb|AF058926.1|AF058926[3138978]
• 13252: AC004699
  Homo sapiens chromosome 19, cosmid R31973, complete sequence
  gi|3138892|gb|AC004699.1|AC004699[3138892]
• 13253: Y13472
  Homo sapiens mRNA for FIM protein
  gi|3135791|emb|Y13472.1|HSRIMP[3135791]
• 13254: AF015452
  Homo sapiens Usurpin-gamma mRNA, complete cds
  gi|3133284|gb|AF015452.1|AF015452[3133284]
• 13255: AF015451
  Homo sapiens Usurpin-beta mRNA, complete cds
  gi|3133282|gb|AF015451.1|AF015451[3133282]
• 13256: AF015450
  Homo sapiens Usurpin-alpha mRNA, complete cds
  gi|3133280|gb|AF015450.1|AF015450[3133280]
• 13257: AF063658
  Homo sapiens vascular endothelial growth factor receptor 2 (KDR) mRNA, complete
  cds
  gi|3132832|gb|AF063658.1|AF063658[3132832]
• 13258: AJ224869
  Homo sapiens CXCR4 gene encoding receptor CXCR4
  gi|3059119|emb|AJ224869.1|HSA224869[3059119]
• 13259: AH006106
  Homo sapiens apoptosis signaling receptor FAS (FAS) and apoptosis signaling receptor FAS (FAS)s, partial cds
  gi|3128402|gb|AH006106.1|SEG_HSASRFAS[3128402]
• 13260: AF061979
  Homo sapiens apoptosis signaling receptor FAS (FAS) gene, exon 7 and partial cds
  gi|3128401|gb|AF061979.1|HSASRFAS2[3128401]
• 13261: AF061978
  Homo sapiens apoptosis signaling receptor FAS (FAS) gene, exons 6 and 7 and partial cds
  gi|3128400|gb|AF061978.1|HSASRFAS1[3128400]
• 13262: AH006105
  Homo sapiens sulfonylurea receptor type (SUR2) gene, alternative splice products, complete cds
  gi|3127174|gb|AH006105.1|SEG_HSSUR2G[3127174]
• 13263: AF061324
  Homo sapiens sulfonylurea receptor 2B (SUR2) gene, alternatively spliced product, exon 38b and complete cds
  gi|3127173|gb|AF061324.1|HSSUR2G71[3127173]
• 13264: AF061323
  Homo sapiens sulfonylurea receptor 2A (SUR2) gene, alternatively spliced product, exon 38a and complete cds
  gi|3127172|gb|AF061323.1|HSSUR2G69[3127172]
• 13265: AF061322
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 37
  gi|3127171|gb|AF061322.1|HSSUR2G67[3127171]
• 13266: AF061321
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 36
  gi|3127170|gb|AF061321.1HSSUR2G65[3127170]
• 13267: AF061320
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 35
  gi|3127169|gb|AF061320.1|HSSUR2G63[3127169]
• 13268: AF061319
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 34
  gi|3127168|gb|AF061319.1|HSSUR2G61[3127168]
• 13269: AF061318
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 33
  gi|3127167|gb|AF061318.1|HSSUR2G59[3127167]
• 13270: AF061317
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 32
  gi|3127166|gb|AF061317.1|HSSUR2G57[3127166]
• 13271: AF061316
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 31
  gi|3127165|gb|AF061316.1|HSSUR2G55[3127165]
• 13272: AF061315
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 30
  gi|3127164|gb|AF061315.1|HSSUR2G53[3127164]
• 13273: AF061314
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 29
  gi|3127163|gb|AF061314.1|HSSUR2G51[3127163]
• 13274: AF061313
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 28
  gi|3127162|gb|AF061313.1|HSSUR2G49[3127162]
• 13275: AF061312
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 27
  gi|3127161|gb|AF061312.1|HSSUR2G47[3127161]
• 13276: AF061311
  Homo sapiens sulfonylurea receptor (SUR2) gene, exons 25 and 26
  gi|3127160|gb|AF061311.1|HSSUR2G45[3127160]
• 13277: AF061310
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 24
  gi|3127159|gb|AF061310.1|HSSUR2G43[3127159]
• 13278: AF061309
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 23
  gi|3127158|gb|AF061309.1|HSSUR2G41[3127158]
• 13279: AF061308
  Homo sapiens sulfonylurea receptor (SUR2) gene, exons 21 and 22
  gi|3127157|gb|AF061308.1|HSSUR2G39[3127157]
• 13280: AF061307
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 20
  gi|3127156|gb|AF061307.1|HSSUR2G37[3127156]
• 13281: AF061306
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 19
  gi|3127155|gb|AF061306.1|HSSUR2G35[3127155]
• 13282: AF061305
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 18
  gi|3127154|gb|AF061305.1|HSSUR2G33[3127154]
• 13283: AF061304
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 17
  gi|3127153|gb|AF061304.1|HSSUR2G31[3127153]
• 13284: AF061303
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 16
  gi|3127152|gb|AF061303.1|HSSUR2G29[3127152]
• 13285: AF061302
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 15
  gi|3127151|gb|AF061302.1|HSSUR2G27[3127151]
• 13286: AF061301
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 14
  gi|3127150|gb|AF061301.1|HSSUR2G25[3127150]
• 13287: AF061300
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 13
  gi|3127149|gb|AF061300.1|HSSUR2G23[3127149]
• 13288: AF061299
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 12
  gi|3127148|gb|AF061299.1|HSSUR2G21[3127148]
• 13289: AF061298
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 11
  gi|3127147|gb|AF061298.1|HSSUR2G19[3127147]
• 13290: AF061297
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 10
  gi|3127146|gb|AF061297.1|HSSUR2G17[3127146]
• 13291: AF061296
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 9
  gi|3127145|gb|AF061296.1|HSSUR2G15[3127145]
• 13292: AF061295
  Homo sapiens sulfonylurea receptor (SUR2) gene, exons 7 and 8
  gi|3127144|gb|AF061295.1|HSSUR2G13[3127144]
• 13293: AF061294
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 6
  gi|3127143|gb|AF061294.1|HSSUR2G11[3127143]
• 13294: AF061293
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 5
  gi|3127142|gb|AF061293.1|HSSUR2G09[3127142]
• 13295: AF061292
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 4
  gi|3127141|gb|AF061292.1|HSSUR2G07[3127141]
• 13296: AF061291
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 3
  gi|3127140|gb|AF061291.1|HSSUR2G05[3127140]
• 13297: AF061290
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 2
  gi|3127139|gb|AF061290.1|HSSUR2G03[3127139]
• 13298: AF061289
  Homo sapiens sulfonylurea receptor (SUR2) gene, exon 1
  gi|3127138|gb|AF061289.1|HSSUR2G01[3127138]
• 13299: U77783
  Homo sapiens N-methyl-D-aspartate receptor 2D subunit precursor (NMDAR2D) mRNA,
  complete cds
  gi|2444025|gb|U77783.1|HSU77783[2444025]
• 13300: AJ001515
  Homo sapiens mRNA for ryanodine receptor 3, complete CDS
  gi|3123583|emb|AJ001515.1|HSRYR3[3123583]
• 13302: AJ002512
  Homo sapiens mRNA for ryanodine receptor 3, partial
  gi|2582750|emb|AJ002512.1|HSAJ2512[2582750]
• 13303: AJ002511
  Homo sapiens mRNA for ryanodine receptor 2, partial
  gi|2582748|emb|AJ002511.1HSAJ2511[2582748]
• 13315: Z81148
  H. sapiens mRNA for gonadotropin-releasing hormone receptor, splice variant
  gi|1628389|emb|Z81148.1|HSGTRHSV[1628389]
• 13316: U71092
  Homo sapiens somatostatin receptor-like protein (GPR24) gene, complete cds
  gi|1737178|gb|U71092.1|HSU71092[1737178]
• 13317: AH006056
  Homo sapiens chromosome 10 clone BAC 73106 map 10q25-q26
  gi|3068782|gb|AH006056.1|SEG_HSGFRA1H[3068782]
• 13318: AF058999
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 11 and complete cds
  gi|3068781|gb|AF058999.1|HSGFRA1H10[3068781]
• 13319: AF058998
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 10
  gi|3068780|gb|AF058998.1|HSGFRA1H09[3068780]
• 13320: AF058997
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 9
  gi|3068779|gb|AF058997.1|HSGFRA1H08[3068779]
• 13321: AF058996
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 8
  gi|3068778|gb|AF058996.1|HSGFRA1H07[3068778]
• 13322: AF058995
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 7
  gi|3068777|gb|AF058995.1|HSGFRA1H06[3068777]
• 13323: AF058994
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 6
  gi|3068776|gb|AF058994.1|HSGFRA1H05[3068776]
• 13324: AF058993
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 5
  gi|3068775|gb|AF058993.1|HSGFRA1H04[3068775]
• 13325: AF058992
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 4
  gi|3068774|gb|AF058992.1|HSGFRA1H03[3068774]
• 13326: AF058991
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 3
  gi|3068773|gb|AF058991.1|HSGFRA1H02[3068773]
• 13327: AF058990
  Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
  gene, exon 2
  gi|3068772|gb|AF058990.1|HSGFRA1H01[3068772]
• 13328: AF044197
  Homo sapiens B lymphocyte chemoattractant BLC mRNA, complete cds
  gi|2911375|gb|AF044197.1|AF044197[2911375]
• 13329: Y16280
  Homo sapiens mRNA for G protein-coupled receptor ETBR-LP-2
  gi|3059117|emb|Y16280.1|HSETBRLP2[3059117]
• 13330: U16260
  Neisseria gonorrheae lactoferrin receptor precursor (lbpA) gene, complete cds
  gi|915277|gb|U16260.1|NGU16260[915277]
• 13331: AF057177
  Homo sapiens T-cell receptor gamma V1 gene region
  gi|3047019|gb|AF057177.1|AF057177[3047019]
• 13333: AF057168
  Homo sapiens type II interleukin-1 receptor antagonist (IL-1ra3) gene, partial
  cds
  gi|3046605|gb|AF057168.1|AF057168[3046605]
• 13334: L06155
  Homo sapiens melanocortin receptor gene, complete cds
  gi|188673|gb|L06155.1|HUMMR[188673]
• 13335: L27490
  Homo sapiens prostanoid EP3-I receptor mRNA, complete cds
  gi|440313|gb|L27490.1|HUMPEIRB[440313]
• 13336: L27489
  Homo sapiens prostanoid EP3-III receptor mRNA, complete cds
  gi|44031|gb|L27489.1|HUMPEIRA[440311]
• 13337: L27488
  Homo sapiens prostanoid EP3-II receptor mRNA, complete cds
  gi|440309|gb|L27488.1|HUMPEIR[440309]
• 13338: AF009664
  Homo sapiens T cell receptor beta locus, 3′ trypsinogen repeats
  gi|2275594|gb|AF009664.1|HSTCRB1H[2275594]
• 13339: AF009660
  Homo sapiens T cell receptor beta locus, TCRBV7S3A2 to TCRBV12S2 region
  gi|2275560|gb|AF009660.1|HSTCRBK17[2275560]
• 13340: AB006537
  Homo sapiens mRNA for interleukin 1 receptor accessory protein, complete cds
  gi|3041772|dbj|AB006537.1|AB006537[3041772]
• 13341: AF016098
  Homo sapiens vascular endothelial cell growth factor 165 receptor 2 (VEGF165R2)
  mRNA, complete cds
  gi|2978561|gb|AF016098.1|AF016098[2978561]
• 13342: AF016050
  Homo sapiens vascular endothelial cell growth factor 165 receptor/neuropilin (VEGF165) mRNA, complete cds
  gi|2978559|gb|AF016050.1|AF016050[2978559]
• 13343: U90941
  Homo sapiens cell-type natural killer cells Fc gamma receptor RIIc4 (Fc-gammaRIIC) mRNA, complete cds
  gi|214963|gb|U90941.1|HSU90941[2149631]
• 13344: U90940
  Homo sapiens cell-type natural killer cells Fc gamma receptor IIc3 (Fc-gammaRIIC) mRNA, complete cds
  gi|2149629|gb|U90940.1|HSU90940[2149629]
• 13345: U90939
  Homo sapiens cell-type natural killer cells Fc gamma receptor IIc2 (Fc-gammaRIIC) mRNA, complete cds
  gi|2149627|gb|U90939.1|HSU90939[2149627]
• 13346: U90938
  Homo sapiens cell-type natural killer cells Fc gamma receptor IIc1 (Fc-gammaRIIC) mRNA, complete cds
  gi|2149625|gb|U90938.1|HSU90938[2149625]
• 13348: Y14739
  Homo sapiens CXCR4 gene
  gi|3021393|emb|Y14739.1|HSCXCR4[3021393]
• 13349: Y07683
  H. sapiens mRNA for P2X3 purinoceptor
  gi|2370146|emb|Y07683.1|HSP2X3PC[2370146]
• 13350: AF027390
  Homo sapiens 7q telomere, complete sequence
  gi|3004858|gb|AF027390.1|AF027390[3004858]
• 13351: U04357
  Homo sapiens arginine vasopressin receptor type 11, V2 antidiuretic hormone receptor (AVPR2) gene, complete cds
  gi|3004498|gb|U04357.1|HSU04357[3004498]
• 13352: AH006005
  Homo sapiens TGF-beta type I receptor (TGFBR1), complete cds
  gi|3003037|gb|AH006005.1|SEG_HSTGFBR1G[3003037]
• 13353: AF054598
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 9 and complete cds
  gi|3003036|gb|AF054598.1|HSTGFBR1G9[3003036]
• 13354: AF054597
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 8
  gi|3003035|gb|AF054597.1|HSTGFBR1G8[3003035]
• 13355: AF054596
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 7
  gi|3003034|gb|AF054596.1|HSTGFBR1G7[3003034]
• 13356: AF054595
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 6
  gi|3003033|gb|AF054595.1|HSTGFBR1G6[3003033]
• 13357: AF054594
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 5
  gi|3003032|gb|AF054594.1|HSTGFBR1G5[3003032]
• 13358: AF054593
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 4
  gi|3003031|gb|AF054593.1|HSTGFBR1G4[3003031]
• 13359: AF054592
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 3
  gi|3003030|gb|AF054592.1|HSTGFBR1G3[3003030]
• 13360: AF054591
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 2
  gi|3003029|gb|AF054591.1|HSTGFBR1G2[3003029]
• 13361: AF054590
  Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 1
  gi|3003028|gb|AF054590.1|HSTGFBR1G1[3003028]
• 13362: L12406
  Homo sapiens chemoattractant receptor (fMLP) gene sequence
  gi|348164|gb|L12406.1|HUMCR[348164]
• 13363: AC004510
  Homo sapiens chromosome 19, cosmid R30385, complete sequence
  gi|12996651|gb|AC004510.1|AC004510[29969551]
• 13364: U84721
  Homo sapiens interferon gamma receptor 1 gene, microsatellite sequence
  gi|2982188|gb|U84721.1|HSU84721[2982188]
• 13365: AF013261
  Homo sapiens alpha 1A adrenergic receptor isoform 4 mRNA, complete cds
  gi|2978555|gb|AF013261.1|AF013261[2978555]
• 13369: AF014794
  Homo sapiens TNF related TRAIL receptor (TRAIL-R3) mRNA, complete cds
  gi|2957263|gb|AF014794.1|AF014794[2957263]
• 13372: AC003658
  Homo sapiens Xp22 BAC GS-607H18 (Genome Systems Human BAC library) complete sequence
  gi|2935592|gb|AC003658.1|AC003658[2935592]
• 13375: AH005897
  Homo sapiens type I sigma receptor, complete cds
  gi|2914739|gb|AH005897.1|SEG_HSTIRG[2914739]
• 13376: AF001977
  Homo sapiens type I sigma receptor gene, exon 4 and complete cds
  gi|2914738|gb|AF001977.1|HSTIRG3[2914738]
• 13377: AF001976
  Homo sapiens type I sigma receptor gene, exons 1, 2 and 3
  gi|2914737|gb|AF001976.1|HSTIRG2[2914737]
• 13486: U78192
  Homo sapiens Edg-2 receptor mRNA, complete cds
  gi|1688304|gb|U78192.1|HSU78192[1688304]
• 13488: AF044492
  Homo sapiens olfactory receptor-like protein (OLFR42A) gene, allele 9092.1, partial cds
  gi|2828698|gb|AF044492.1|AF044492[2828698]
• 13489: AF044491
  Homo sapiens olfactory receptor-like protein (OLFR42A) gene, allele 9004.14, partial cds
  gi|2828696|gb|AF044491.1|AF044491[2828696]
• 13490: AF042078
  Homo sapiens olfactory receptor-like protein (OLFR42A) gene, OLFR42A-9026.2 allele, partial cds
  gi|282868|gb|AF042078.1|AF042078[2828681]
• 13491: AB010710
  Homo sapiens mRNA for lectin-like oxidized LDL receptor, complete cds
  gi|2828355|dbj|AB010710.1|AB010710[2828355]
• 13492: AF041462
  Homo sapiens I-FLICE isoform 5 mRNA, complete cds
  gi|2827297|gb|AF041462.1|AF041462[2827297]
• 13493: AF041461
  Homo sapiens I-FLICE isoform 4 mRNA, complete cds
  gi|2827295|gb|AF041461.1|AF041461[2827295]
• 13494: AF041460
  Homo sapiens I-FLICE isoform 3 mRNA, complete cds
  gi|2827293|gb|AF041460.1|AF041460[2827293]
• 13495: AF041459
  Homo sapiens I-FLICE isoform 2 mRNA, complete cds
  gi|2827291|gb|AF041459.1|AF041459[2827291]
• 13496: AF041458
  Homo sapiens I-FLICE mRNA, complete cds
  gi|2827289|gb|AF041458.1|AF041458[2827289]
• 13497: Z73157
  H. sapiens mRNA for C3a anaphylatoxin receptor
  gi|2826756|emb|Z73157.1|HSC3AAREC[2826756]
• 13498: U58917
  Homo sapiens IL-17 receptor mRNA, complete cds
  gi|2826475|gb|U58917.1|HSU58917[2826475]
• 13524: Y16282
  Homo sapiens mRNA for nicotinic acetylcholine receptor alpha6 subunit precursor
  gi|2815224|emb|Y16282.1|HSY16282[2815224]
• 13525: Y16281
  Homo sapiens mRNA for nicotinic acetylcholine receptor alpha2 subunit precursor
  gi|2815222|emb|Y16281.1|HSY16281[2815222]
• 13526: X98858
  H. sapiens mRNA for HLA-C specific activatory NK receptor
  gi|1419593|emb|X98858.1|HSNKREC[1419593]
• 13527: M76676
  Homo sapiens leukocyte platelet-activating factor receptor mRNA, complete cds
  gi|2810988|gb|M76676.1|HUMNPIIY20[2810988]
• 13528: Y08420
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha7 subunit precursor
  gi|2808623|emb|Y08420.1|HSNACHRA7[2808623]
• 13529: Y08419
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha5 subunit precursor
  gi|1702913|emb|Y08419.1|HSNACHRA5[1702913]
• 13530: Y08421
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha4 subunit precursor
  gi|1702911|emb|Y08421.1|HSNACHRA4[1702911]
• 13531: Y08417
  H. sapiens mRNA for nicotinic acetylcholine receptor beta3 subunit precursor
  gi|1702909|emb|Y08417.1|HSNACHR3B[1702909]
• 13532: Y08416
  H. sapiens mRNA for nicotinic acetylcholine receptor beta4 subunit precursor
  gi|1702919|emb|Y08416.1|HSNACHRB4[1702919]
• 13533: Y08415
  H. sapiens mRNA for nicotinic acetylcholine receptor beta2 subunit precursor
  gi|1702917|emb|Y08415.1|HSNACHRB2[1702917]
• 13534: Y08418
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha3 subunit precursor
  gi|1702907|emb|Y08418.1|HSNACHR3A[1702907]
• 13536: AF042077
  Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9079.6 allele, partial cds
  gi|2801710|gb|AF042077.1|AF042077[2801710]
• 13537: AF042076
  Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9108.1 allele, partial cds
  gi|2801708|gb|AF042076.1|AF042076[2801708]
• 13538: AF042075
  Homo sapiens olfactory receptor-like protein (OLFR 428) gene, OLFR 42B-9110 allele, partial cds
  gi|2801706|gb|AF042075.1|AF042075[2801706]
• 13539: AF042074
  Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9079.3 allele, partial cds
  gi|2801704|gb|AF042074.1|AF042074[2801704]
• 13540: AF042073
  Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9049 allele, partial cds
  gi|2801702|gb|AF042073.1|AF042073[2801702]
• 13600: Y10530
  H. sapiens gene encoding putative olfactory receptor (clone htpcr2)
  gi|2792017|emb|Y10530.1|HSHTPCR2[2792017]
• 13601: Y10529
  H. sapiens mRNA for putative olfactory receptor (clone ht2)
  gi|2792015|emb|Y10529.1|HSHT2[2792015]
• 13614: Z26876
  H. sapiens gene for ribosomal protein L38
  gi|407422|emb|Z26876.1|HSRPL38[407422]
• 13615: Z50150
  H. sapiens mRNA for tyrosine kinase activator protein 1 (TKA-1)
  gi|1246762|emb|Z50150.1|HSTKA1MR[1246762]
• 13616: Y13055
  Homo sapiens mRNA for NKG2-CII activating NK receptor
  gi|2765292|emb|Y13055.1|HSNKG2CII[2765292]
• 13617: Y13054
  Homo sapiens mRNA for NK receptor, clone GR #29
  gi|2765290|emb|Y13054.1|HSNKREC29[2765290]
• 13618: Y10437
  H. sapiens mRNA for serotonin receptor 4
  gi|2765076|emb|Y10437.1|HSSERR4[2765076]
• 13619: AJ002105
  Homo sapiens mRNA for NK receptor, clone library TG14#13
  gi|2764706|emb|AJ002105.1|HSAJ2105[2764706]
• 13620: AJ002104
  Homo sapiens mRNA for NK receptor, clone library TG14#6
  gi|2764704|emb|AJ002104.1|HSAJ2104[2764704]
• 13621: AJ002103
  Homo sapiens mRNA for NK receptor, clone library TG14#35
  gi|2764702|emb|AJ002103.1|HSAJ2103[2764702]
• 13622: AJ002102
  Homo sapiens mRNA for NK receptor, clone library TG14#8
  gi|2764700|emb|AJ002102.1|HSAJ2102[2764700]
• 13623: AJ000001
  Homo sapiens mRNA for CD94-B NK receptor
  gi|2764393|emb|AJ000001.1|HSCD94B[2764393]
• 13624: Y10141
  H. sapiens DAT1 gene, partial, VNTR
  gi|1752665|emb|Y10141.1|HSDAT1[1752665]
• 13625: Z97213
  Homo sapiens mRNA for T-cell receptor
  gi|2239129|emb|Z97213.1|HSTCRBV2S[2239129]
• 13627: AF026263
  Homo sapiens muscarinic receptor (CHRM5) mRNA, complete cds
  gi|2605721|gb|AF026263.1|AF026263[2605721]
• 13628: AF026261
  Homo sapiens histamine H1 receptor mRNA, complete cds
  gi|2605717|gb|AF026261.1|AF026261[2605717]
• 13629: AF026260
  Homo sapiens vitamin D receptor (VDR) mRNA, complete cds
  gi|2605715|gb|AF026260.1|AF026260[2605715]
• 13630: AH005786
  Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
  gi|2739498|gb|AH005786.1|SEG_HSCCR5AB[2739498]
• 13631: AF031237
  Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
  gi|2739497|gb|AF031237.1|HSCCR5AB3[2739497]
• 13633: AH005782
  Homo sapiens chromosome X map Xq28
  gi|2735348|gb|AH005782.1|SEG_HSGABRE[2735348]
• 13634: AF037334
  Homo sapiens Eph-like receptor tyrosine kinase hEphB1d (EphB1) mRNA, complete cds
  gi|2739209|gb|AF037334.1|AF037334[2739209]
• 13635: AF037333
  Homo sapiens Eph-like receptor tyrosine kinase hEphB1c (EphB1) mRNA, complete cds
  gi|2739207|gb|AF037333.1|AF037333[2739207]
• 13636: AF011406
  Homo sapiens corticotropin releasing hormone receptor type 2 beta isoform (CRH2R) mRNA, complete cds
  gi|2738557|gb|AF011406.1|AF011406[2738557]
• 13637: U59632
  Homo sapiens H5 mRNA, partial cds; and platelet glycoprotein Ib beta chain mRNA,
  complete cds
  gi|1809264|gb|U59632.1|HSU59632[1809264]
• 13638: D86864
  Homo sapiens mRNA for acetyl LDL receptor, complete cds
  gi|2723468|dbj|D586864.1|D86864[2723468]
• 13639: AF027208
  Homo sapiens AC133 antigen mRNA, complete cds
  gi|2688948|gb|AF027208.1|AF027208[2688948]
• 13640: AB001025
  Homo sapiens mRNA for brain ryanodine receptor, complete cds
  gi|2696014|dbj|AB001025.1|AB001025[2696014]
• 13641: D00017
  Homo sapiens mRNA for lipocortin II, complete cds
  gi|219909|dbj|D00017.1|HUMLIC[219909]
• 13642: Y08236
  H. sapiens LRP gene, polymorphisms in intron 24
  gi|2125808|emb|Y08236.1|HSLRPIN24[2125808]
• 13644: AF025998
  Homo sapiens atrial natriuretic peptide clearance receptor (ANPRC) mRNA, complete cds
  gi|2570851|gb|AF025998.1|AF025998[2570851]
• 13645: AD000671
  Homo sapiens DNA from chromosome 19-cosmid f24109 containing HRX2, genomic sequence
  gi|1905893|gb|AD000671.1|AD000671[1905893]
• 13646: Z49119
  H. sapiens mRNA for serotonin 6 receptor (5-HT6; partial)
  gi|984128|emb|Z49119.1|HS5HT6[984128]
• 13647: Z48150
  H. sapiens 5-HT4 mRNA for serotonin 4 receptor (5-HT4)
  gi|984126|emb|Z48150.1|HS5HT4[984126]
• 13648: Y15743
  Homo sapiens RET proto-oncogene, exon 13 containing two mutations
  gi|2665353|emb|Y15743.1|HSRET13[2665353]
• 13649: AF000575
  Homo sapiens clone 16 immunoglobulin-like transcript 5 mRNA, complete cds
  gi|2264428|gb|AF000575.1|AF000575[2264428]
• 13650: AF000574
  Homo sapiens clone 1 immunoglobulin-like transcript 4 mRNA, complete cds
  gi|2264426|gb|AF000574.1|AF000574[2264426]
• 13651: Z26652
  H. sapiens FLT3 mRNA for FLT3 receptor tyrosine kinase
  gi|406322|emb|Z26652.1|HSFLT3RTK[406322]
• 13653: X82208
  H. sapiens mRNA for beta-centractin (ATCC# HHCPJ76)
  gi|563887|emb|X82208.1|HSBCENTR[563887]
• 13654: AF035261
  Homo sapiens thyroid stimulating hormone receptor (TSHR) mRNA, partial cds
  gi|2654195|gb|AF035261.1|HSTSHR[2654195]
• 13655: AF032388
  Homo sapiens vasopressin receptor type 2 mRNA, alternatively spliced, complete
  cds
  gi|2654030|gb|AF032388.1|AF032388[2654030]
• 13656: AF025534
  Homo sapiens leucocyte immunoglobulin-like receptor-8 (LIR-8) mRNA, complete cds
  gi|2653874|gb|AF025534.1|AF025534[2653874]
• 13657: AF025533
  Homo sapiens leucocyte immunoglobulin-like receptor-3 (LIR-3) mRNA, complete cds
  gi|2653872|gb|AF025533.1|AF025533[2653872]
• 13658: AF025532
  Homo sapiens leucocyte immunoglobulin-like receptor-5 (LIR-5) mRNA, complete cds
  gi|2653870|gb|AF025532.1|AF025532[2653870]
• 13659: AF025531
  Homo sapiens leucocyte immunoglobulin-like receptor-7 (LIR-7) mRNA, complete cds
  gi|2653868|gb|AF025531.1|AF025531[2653868]
• 13660: AF025530
  Homo sapiens leucocyte immunoglobulin-like receptor-6a (LIR-6) mRNA, complete cds
  gi|2653866|gb|AF025530.1|AF025530[2653866]
• 13661: AF025529
  Homo sapiens leucocyte immunoglobulin-like receptor-6b (LIR-6) mRNA, complete cds
  gi|2653864|gb|AF025529.1|AF025529[2653864]
• 13662: AF025528
  Homo sapiens leucocyte immunoglobulin-like receptor-2 (LIR-2) mRNA, complete cds
  gi|2653862|gb|AF025528.1|AF025528[2653862]
• 13663: AF025527
  Homo sapiens leucocyte immunoglobulin-like receptor-4 (LIR-4) mRNA, complete cds
  gi|2653860|gb|AF025527.1|AF025527[2653860]
• 13664: Y13583
  Homo sapiens mRNA for G-protein coupled receptor
  gi|2652933|emb|Y13583.1|HSGPCP[2652933]
• 13665: Y13367
  H. sapiens mRNA for phosphoinositide 3-kinase
  gi|2143259|emb|Y13367.1|HSPHOSI3K[2143259]
• 13666: X82207
  H. sapiens mRNA for beta-centractin (PC3)
  gi|563885|emb|X82207.1|HSBCENT[563885]
• 13667: AF033854
  Homo sapiens lymphocyte inhibitor of TRAIL (LIT) mRNA, complete cds
  gi|2645841|gb|AF033854.1|AF033854[2645841]
• 13668: X81882
  H. sapiens mRNA for for vasopressin activated calcium mobilizing receptor-like protein
  gi|1628414|emb|X81882.1|HSVACM1[1628414]
• 13669: AF024690
  Homo sapiens putative G protein-coupled receptor (GPR43) gene, complete cds
  gi|2612951|gb|AF024690.1|AF024690[2612951]
• 13670: AF024689
  Homo sapiens putative G protein-coupled receptor (GPR42) gene, complete cds
  gi|2612949|gb|AF024689.1|AF024689[2612949]
• 13671: AF024688
  Homo sapiens putative G protein-coupled receptor (GPR41) gene, complete cds
  gi|2612947|gb|AF024688.1|AF024688[2612947]
• 13672: AF024687
  Homo sapiens putative G protein-coupled receptor (GPR40) gene, complete cds
  gi|2612945|gb|AF024687.1|AF024687[2612945]
• 13673: D87513
  Homo sapiens mRNA for Grb7 protein, partial cds
  gi|1526534|dbj|D587513.1|D87513[1526534]
• 13674: D49919
  Homo sapiens mRNA for C-C chemokine receptor type 2, complete cds
  gi|2626807|dbj|D549919.1|D49919[2626807]
• 13675: AF030512
  Homo sapiens small cell vasopressin subtype 1b receptor mRNA, complete cds
  gi|2613124|gb|AF030512.1|AF030512[2613124]
• 13676: Y12852
  Homo sapiens P2X7 gene, exon 2 and 3
  gi|2612788|emb|Y12852.1|HSP2X7E23[2612788]
• 13677: Y12851
  Homo sapiens P2X7 gene, exon 1 and joined CDS
  gi|2597926|emb|Y12851.1|HSP2X7EX1[2597926]
• 13678: Y12854
  Homo sapiens P2X7 gene, exon 9-11
  gi|2612787|emb|Y12854.1|HSP2X7911[2612787]
• 13679: Y12853
  Homo sapiens P2X7 gene, exon 4-8
  gi|2612786|emb|Y12853.1|HSP2X748[2612786]
• 13680: Y12855
  Homo sapiens P2X7 gene, exon 12 and 13
  gi|2612785|emb|Y12855.1|HSP2X7123[2612785]
• 13681: AB005520
  Homo sapiens ppar gamma2 gene for peroxisome proliferator activated-receptor gamma, partial cds and 5′ flanking
  gi|2605488|dbj|AB005520.1|AB005520[2605488]
• 13682: Y09765
  Homo sapiens mRNA for putative GABA receptor epsilon subunit
  gi|2285960|emb|Y09765.1|HSY09765[2285960]
• 13683: Y09764
  Homo sapiens GABRE gene, exon 2-8
  gi|2285959|emb|Y09764.1|HSY09764[2285959]
• 13684: Y09763
  Homo sapiens GABRE gene, exon 1 (and joined CDS)
  gi|2285957|emb|Y09763.1|HSY09763[2285957]
• 13685: AF026535
  Homo sapiens chemokine receptor (CCR3) mRNA, complete cds
  gi|2582565|gb|AF026535.1|AF026535[2582565]
• 13686: AF026071
  Homo sapiens soluble death receptor 3 beta (DR3) mRNA, complete cds
  gi|2570832|gb|AF026071.1|AF026071[2570832]
• 13687: AF022956
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570532|gb|AF022956.1|AF022956[2570532]
• 13688: AF022955
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570530|gb|AF022955.1|AF022955[2570530]
• 13689: AF022954
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570528|gb|AF022954.1|AF022954[2570528]
• 13690: AF022953
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570526|gb|AF022953.1|AF022953[2570526]
• 13691: AF014958
  Homo sapiens chemokine receptor X (CKRX) mRNA, complete cds
  gi|2305263|gb|AF014958.1|AF014958[2305263]
• 13692: AB000712
  Homo sapiens hCPE-R mRNA for CPE-receptor, complete cds
  gi|2570124|dbj|AB000712.1|AB000712[2570124]
• 13693: X94609
  H. sapiens mRNA for activatory NK receptor/KKA3 p50.3
  gi|1495414|emb|X94609.1HSANKRMR[1495414]
• 13694: AF025375
  Homo sapiens chemokine receptor-4 (CXCR4) mRNA, complete cds
  gi|2565335|gb|AF025375.1|AF025375[2565335]
• 13695: AF000380
  Homo sapiens folate binding protein mRNA, complete cds
  gi|2565193|gb|AF000380.1|HSAF000380[2565193]
• 13696: U35875
  Homo sapiens B2 bradykinin receptor mRNA, 5′ sequence
  gi|1353391|gb|U35875.1|HSU35875[1353391]
• 13697: AF010193
  Homo sapiens MAD-related gene SMAD7 (SMAD7) mRNA, complete cds
  gi|2252821|gb|AF010193.1|AF010193[2252821]
• 13698: X94634
  H. sapiens CD97 gene exon 7
  gi|1165087|emb|X94634.1|HSX94634[1165087]
• 13699: X94633
  H. sapiens CD97 gene exon 4
  gi|1165086|emb|X94633.1|HSX94633[1165086]
• 13700: X94632
  H. sapiens CD97 gene exon 3
  gi|1165085|emb|X94632.1|HSX94632[1165085]
• 13702: AF007892
  Homo sapiens P2Y6 receptor, long splice variant mRNA, complete cds
  gi|2258421|gb|AF007892.1|[2258421]
• 13703: AF007891
  Homo sapiens P2Y6 receptor, short splice variant mRNA, complete cds
  gi|2258419|gb|AF007891.1|[2258419]
• 13704: AF022383
  Homo sapiens complexin I mRNA, complete cds
  gi|2465458|gb|AF022383.1|AF022383[2465458]
• 13709: X89860
  H. sapiens mRNA for T-cell receptor alpha chain
  gi|927420|emb|X89860.1|HSNP7TCR2[927420]
• 13710: Y08456
  H. sapiens ChemR1 gene
  gi|2465081|emb|Y08456.1|HSCHEMR1[2465081]
• 13711: U95025
  Homo sapiens metabotropic glutamate receptor 8 (GRM8) mRNA, complete cds
  gi|2435409|gb|U95025.1|HSU95025[2435409]
• 13712: AF021799
  Homo sapiens interleukin 17 receptor-like mRNA sequence
  gi|2460201|gb|AF021799.1|AF021799[2460201]
• 13714: U73443
  Homo sapiens 5HT3 serotonin receptor gene, partial cds
  gi|2459549|gb|U73443.1|MMU73443[2459549]
• 13715: AB000520
  Homo sapiens mRNA for APS, complete cds
  gi|2447035|dbj|AB000520.1|AB000520[2447035]
• 13716: X98172
  H. sapiens mRNA for MACH-alpha-1 protein
  gi|1403318|emb|X98172.1|HSMACHA1[1403318]
• 13728: AH005567
  Homo sapiens chromosome 4 map 4q13
  gi|2290767|gb|AH005567.1|SEG_HSGNRHR[2290767]
• 13729: AF001952
  Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 3 and complete cds
  gi|2290766|gb|AF001952.1|HSGNRHR3[2290766]
• 13730: AF001951
  Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 2
  gi|2290765|gb|AF001951.1|HSGNRHR2[2290765]
• 13731: AF001950
  Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 1
  gi|2290764|gb|AF001950.1|HSGNRHR1[2290764]
• 13733: AF020201
  Homo sapiens Jagged 2 mRNA, complete cds
  gi|2432001|gb|AF020201.1|AF020201([2432001]
• 13734: Y14442
  Homo sapiens mRNA for olfactory receptor protein, partial
  gi|2370144|emb|Y14442.1|HSOLFMF[2370144]
• 13736: AF017061
  Homo sapiens vasopressin-activated calcium mobilizing putative receptor protein
  (VACM-1) mRNA, complete cds
  gi|2394273|gb|AF017061.1|AF017061[2394273]
• 13737: AF017262
  Homo sapiens putative G protein-coupled receptor mRNA, complete cds
  gi|2388705|gb|AF017262.1|AF017262[2388705]
• 13738: AF016917
  Homo sapiens GABA-A receptor delta subunit (GABRD) mRNA, complete cds
  gi|2388692|gb|AF016917.1|AF016917[2388692]
• 13739: Y13248
  Homo sapiens mRNA for orphan chemokine receptor TYMSTR
  gi|2370179|emb|Y13248.1|HSY13248[2370179]
• 13740: D83492
  Homo sapiens mRNA for Eph-family protein, complete cds
  gi|2281007|dbj|D83492.1|D83492[2281007]
• 13741: AB002058
  Homo sapiens mRNA for HUMAN P2XM, complete cds
  gi|2350846|dbj|AB002058.1|AB002058[2350846]
• 13742: AF015251
  Homo sapiens breast cancer-related unknown protein mRNA, partial cds
  gi|2345090|gb|AF015251.1|AF015251[2345090]
• 13743: AF004231
  Homo sapiens monocyte/macrophage Ig-related receptor MIR-10 (MIR cl-10) mRNA, complete cds
  gi|2343110|gb|AF004231.1|AF004231[2343110]
• 13744: AF004230
  Homo sapiens monocyte/macrophage Ig-related receptor MIR-7 (MIR cl-7) mRNA, complete cds
  gi|2343108|gb|AF004230.1|AF004230[2343108]
• 13745: X90563
  H. sapiens mRNA for peroxisome proliferactor activated receptor gamma
  gi|1480099|emb|X90563.1|HSPPARGAM[1480099]
• 13746: AF012629
  Homo sapiens antagonist decoy receptor for TRAIL/Apo-2L (TRID) mRNA, complete cds
  gi|2338430|gb|AF012629.1|AF012629[2338430]
• 13747: AF012628
  Homo sapiens death domain containing receptor for TRAIL/Apo-2L (DR5) mRNA, complete cds
  gi|2338428|gb|AF012628.1|AF012628[2338428]
• 13748: AF012536
  Homo sapiens decoy receptor 1 (DcR1) mRNA, complete cds
  gi|2338421|gb|AF012536.1|AF012536[2338421]
• 13749: AF012535
  Homo sapiens death receptor 5 (DR5) mRNA, complete cds
  gi|2338419|gb|AF012535.1|AF012535[2338419]
• 13750: AF012903
  Homo sapiens P2X4 ATP-gated cation channel protein mRNA, partial cds
  gi|2331043|gb|AF012903.1|AF012903[2331043]
• 13751: X69316
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 21
  gi|34105|emb|X69316.1|HSKITPO16[34105]
• 13752: X69315
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 18, 19, 20
  gi|34104|emb|X69315.1|HSKITPO15[34104]
• 13753: X69314
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 17
  gi|34103|emb|X69314.1|HSKITPO14[34103]
• 13754: X69313
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 16
  gi|34102|emb|X69313.1|HSKITPO13[34102]
• 13755: X69312
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 15
  gi|34101|emb|X69312.1|HSKITPO12[34101]
• 13756: X69311
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 14
  gi|34100|emb|X69311.1|HSKITPO11[34100]
• 13757: X69310
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 10, 11, 12, 13
  gi|34099|emb|X69310.1|HSKITPO10[34099]
• 13758: X69309
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 9
  gi|34098|emb|X69309.1|HSKITPO09[34098]
• 13759: X69308
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 8
  gi|34097|emb|X69308.1|HSKITPO08[34097]
• 13760: X69307
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 7
  gi|34096|emb|X69307.1|HSKITPO07[34096]
• 13761: X69306
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 6
  gi|34095|emboX69306.1|HSKITPO06[34095]
• 13762: X69305
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 5
  gi|34094|emb|X69305.1|HSKITPO05[34094]
• 13763: AF005419
  Homo sapiens P2Y5-like receptor gene, complete cds
  gi|2240034|gb|AF005419.1|AF005419[2240034]
• 13764: L42324
  Homo sapiens (clone GPCR W) G protein-linked receptor gene (GPCR) gene, 5′ end
  of cds
  gi|066730|gb|L42324.1|HUMFRCG[1066730]
• 13766: AF015910
  Homo sapiens unknown protein mRNA, partial cds
  gi|2286201|gb|AF015910.1|AF015910[2286201]
• 13767: X99250
  H. sapiens mRNA for endothelin-B receptor splice variant
  gi|2285955|emb|X99250.1|HSX99250[2285955]
• 13768: AF007545
  Homo sapiens SIV/HIV receptor Bonzo (Bonzo) mRNA, complete cds
  gi|225342|gb|AF007545.1|AF007545[2253421]
• 13769: Z79783
  H. sapiens G protein-coupled receptor CKR-L2
  gi|2281709|emb|Z79783.1|HSCKRL2[2281709]
• 13778: Z49994
  H. sapiens partial gene for proteinase-activated receptor 2 (1289 BP)
  gi|1008086|emb|Z49994.1|HSPAR2B[1008086]
• 13779: AF007555
  Homo sapiens IAR/receptor-like protein-tyrosine phosphatase precursor mRNA, complete cds
  gi|2262074|gb|AF007555.1|AF007555[2262074]
• 13780: AF008556
  Homo sapiens interleukin-2 receptor mRNA, alternatively spliced, partial cds
  gi|2266932|gb|AF008556.1|AF008556[2266932]
• 13891: Y10152
  H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (94 bp deletion)
  gi|1785640|emb|Y10152.1|HSCRF294[1785640]
• 13892: Y10153
  H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (227 bp insertion)
  gi|1785639|emb|Y10153.1|HSCRF2227[1785639]
• 13893: Y10151
  H. sapiens mRNA for CRF2 receptor, beta isoform, partial
  gi|1785637|emb|Y10151.1|HSCRF2[1785637]
• 13894: M17325
  Homo sapiens T-cell receptor gamma-chain constant region (TCRGC1) mRNA, partial
  cds
  gi|2072752|gb|M17325.1|HUMTCGCJ[2072752]
• 13895: M17324
  Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
  cds
  gi|207275|gb|M17324.1|HUMTCGCI[2072751]
• 13896: M17323
  Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
  cds
  gi|2072750|gb|M17323.1|HUMTCGCH[2072750]
• 13897: AF004327
  Homo sapiens angiopoietin-2 mRNA, complete cds
  gi|2257932|gb|AF004327.1|AF004327[2257932]
• 13898: AF004021
  Homo sapiens prostaglandin F2 alpha receptor mRNA, complete cds
  gi|2257849|gb|AF004021.1|AF004021[2257849]
• 13899: AF006464
  Homo sapiens muscle specific tyrosine kinase receptor (MUSK) mRNA, complete cds
  gi|225331|gb|AF006464.1|AF006464[2253311]
• 13900: AF005637
  Homo sapiens endothelin A receptor gene, 5′ flanking region and exon 1
  gi|2253289|gb|AF005637.1|AF005637[2253289]
• 13902: Z24461
  H. sapiens MTCP-1 gene
  gi|406866|emb|Z24461.1|HSMTCP1I[406866]
• 13903: Z24463
  H. sapiens MTCP-1 gene
  gi|406865|emb|Z24463.1|HSMTCP1H[406865]
• 13904: Z24457
  H. sapiens of TCRA gene MTCP-1 gene
  gi|406860|emb|Z24457.1|HSMTCP1D[406860]
• 13905: Z24456
  H. sapiens of MTCP-1 gene MTCP-1 gene
  gi|406859|emb|Z24456.1|HSMTCP1C[406859]
• 13906: U45984
  Homo sapiens CCR6 chemokine receptor (CMKBR6) gene, complete cds
  gi|2246432|gb|U45984.1|HSU45984[2246432]
• 13908: AF005900
  Homo sapiens alpha2B-adrenergic receptor (alpha2C2AR) gene, complete cds
  gi|2245627|gb|AF005900.1|AF005900[2245627]
• 13909: AF005210
  Homo sapiens CC chemokine receptor CCR8 (CMKBR8) mRNA, partial cds
  gi|2245579|gb|AF005210.1|AF005210[2245579]
• 13524: Y16282
  Homo sapiens mRNA for nicotinic acetylcholine receptor alpha6 subunit precursor
  gi|2815224|emb|Y16282.1|HSY16282[2815224]
• 13525: Y16281
  Homo sapiens mRNA for nicotinic acetylcholine receptor alpha2 subunit precursor
  gi|2815222|emb|Y16281.1|HSY16281[2815222]
• 13526: X98858
  H. sapiens mRNA for HLA-C specific activatory NK receptor
  gi|1419593|emb|X98858.1|HSNKREC[1419593]
• 13527: M76676
  Homo sapiens leukocyte platelet-activating factor receptor mRNA, complete cds
  gi|2810988|gb|M76676.1|HUMNPIIY20[2810988]
• 13528: Y08420
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha7 subunit precursor
  gi|2808623|emb|Y08420.1|HSNACHRA7[2808623]
• 13529: Y08419
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha5 subunit precursor
  gi|1702913|emb|Y08419.1|HSNACHRA5[1702913]
• 13530: Y08421
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha4 subunit precursor
  gi|1702911|emb|Y08421.1|HSNACHRA4[1702911]
• 13531: Y08417
  H. sapiens mRNA for nicotinic acetylcholine receptor beta3 subunit precursor
  gi|1702909|emb|Y08417.1|HSNACHR3B[1702909]
• 13532: Y08416
  H. sapiens mRNA for nicotinic acetylcholine receptor beta4 subunit precursor
  gi|1702919|emb|Y08416.1|HSNACHRB4[1702919]
• 13533: Y08415
  H. sapiens mRNA for nicotinic acetylcholine receptor beta2 subunit precursor
  gi|1702917|emb|Y08415.1|HSNACHRB2[1702917]
• 13534: Y08418
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha3 subunit precursor
  gi|1702907|emb|Y08418.1|HSNACHR3A[1702907]
• 13535: AF001985
  Homo sapiens CD38 gene, 5′ upstream sequence
  gi|2804672|gb|AF001985.1|AF001985[2804672]
• 13536: AF042077
  Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9079.6 allele, partial cds
  gi|2801710|gb|AF042077.1|AF042077[2801710]
• 13537: AF042076
  Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9108.1 allele, partial cds
  gi|2801708|gb|AF042076.1|AF042076[2801708]
• 13538: AF042075
  Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9110 allele, partial cds
  gi|2801706|gb|AF042075.1|AF042075[2801706]
• 13539: AF042074
  Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9079.3 allele, partial cds
  gi|2801704|gb|AF042074.1|AF042074[2801704]
• 13540: AF042073
  Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9049 allele, partial cds
  gi|2801702|gb|AF042073.1|AF042073[2801702]
• 13600: Y10530
  H. sapiens gene encoding putative olfactory receptor (clone htpcr2)
  gi|2792017|emb|Y10530.1|HSHTPCR2[2792017]
• 13601: Y10529
  H. sapiens mRNA for putative olfactory receptor (clone ht2)
  gi|2792015|emb|Y10529.1|HSHT2[2792015]
• 13614: Z26876
  H. sapiens gene for ribosomal protein L38
  gi|407422|emb|Z26876.1|HSRPL38[407422]
• 13615: Z50150
  H. sapiens mRNA for tyrosine kinase activator protein 1 (TKA-1)
  gi|1246762|emb|Z50150.1|HSTKA1MR[1246762]
• 13616: Y13055
  Homo sapiens mRNA for NKG2-CII activating NK receptor
  gi|2765292|emb|Y13055.1|HSNKG2CII[2765292]
• 13617: Y13054
  Homo sapiens mRNA for NK receptor, clone GR #29
  gi|2765290|emb|Y13054.1|HSNKREC29[2765290]
• 13618: Y10437
  H. sapiens mRNA for serotonin receptor 4
  gi|2765076|emb|Y10437.1|HSSERR4[2765076]
• 13619: AJ002105
  Homo sapiens mRNA for NK receptor, clone library TG14#13
  gi|2764706|emb|AJ002105.1|HSAJ2105[2764706]
• 13620: AJ002104
  Homo sapiens mRNA for NK receptor, clone library TG14#6
  gi|2764704|emb|AJ002104.1|HSAJ2104[2764704]
• 13621: AJ002103
  Homo sapiens mRNA for NK receptor, clone library TG14#35
  gi|2764702|emb|AJ002103.1|HSAJ2103[2764702]
• 13622: AJ002102
  Homo sapiens mRNA for NK receptor, clone library TG14#8
  gi|2764700|emb|AJ002102.1|HSAJ2102[2764700]
• 13623: AJ000001
  Homo sapiens mRNA for CD94-B NK receptor
  gi|2764393|emb|AJ000001.1|HSCD94B[2764393]
• 13624: Y10141
  H. sapiens DAT1 gene, partial, VNTR
  gi|1752665|emb|Y10141.1|HSDAT1[1752665]
• 13625: Z97213
  Homo sapiens mRNA for T-cell receptor
  gi|2239129|emb|Z97213.1|HSTCRBV2S[2239129]
• 13627: AF026263
  Homo sapiens muscarinic receptor (CHRM5) mRNA, complete cds
  gi|2605721|gb|AF026263.1|AF026263[2605721]
• 13628: AF026261
  Homo sapiens histamine H1 receptor mRNA, complete cds
  gi|2605717|gb|AF026261.1|AF026261[2605717]
• 13629: AF026260
  Homo sapiens vitamin D receptor (VDR) mRNA, complete cds
  gi|2605715|gb|AF026260.1|AF026260[2605715]
• 13630: AH005786
  Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
  gi|2739498|gb|AH005786.1|SEG_HSCCR5AB[2739498]
• 13631: AF031237
  Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
  gi|2739497|gb|AF031237.1|HSCCR5AB3[2739497]
• 13633: AH005782
  Homo sapiens chromosome X map Xq28
  gi|2735348|gb|AH005782.1|SEG_HSGABRE[2735348]
• 13634: AF037334
  Homo sapiens Eph-like receptor tyrosine kinase hEphB1d (EphB1) mRNA, complete cds
  gi|2739209|gb|AF037334.1|AF037334[2739209]
• 13635: AF037333
  Homo sapiens Eph-like receptor tyrosine kinase hEphB1c (EphB1) mRNA, complete cds
  gi|2739207|gb|AF037333.1|AF037333[2739207]
• 13636: AF011406
  Homo sapiens corticotropin releasing hormone receptor type 2 beta isoform (CRH2R) mRNA, complete cds
  gi|2738557|gb|AF011406.1|AF011406[2738557]
• 13637: U59632
  Homo sapiens H5 mRNA, partial cds; and platelet glycoprotein Ib beta chain mRNA,
  complete cds
  gi|1809264|gb|U59632.1|HSU59632[1809264]
• 13638: D86864
  Homo sapiens mRNA for acetyl LDL receptor, complete cds
  gi|2723468|dbj|D86864.1|D86864[2723468]
• 13639: AF027208
  Homo sapiens AC133 antigen mRNA, complete cds
  gi|2688948|gb|AF027208.1|AF027208[2688948]
• 13640: AB001025
  Homo sapiens mRNA for brain ryanodine receptor, complete cds
  gi|2696014|dbj|AB001025.1|AB001025[2696014]
• 13641: D00017
  Homo sapiens mRNA for lipocortin II, complete cds
  gi|219909|dbj|D00017.1|HUMLIC[219909]
• 13644: AF025998
  Homo sapiens atrial natriuretic peptide clearance receptor (ANPRC) mRNA, complete cds
  gi|257085|gb|AF025998.1|AF025998[2570851]
• 13645: AD000671
  Homo sapiens DNA from chromosome 19-cosmid f24109 containing HRX2, genomic sequence
  gi|1905893|gb|AD000671.1|AD000671[1905893]
• 13646: Z49119
  H. sapiens mRNA for serotonin 6 receptor (5-HT6; partial)
  gi|984128|emb|Z49119.1|HS5HT6[984128]
• 13647: Z48150
  H. sapiens 5-HT4 mRNA for serotonin 4 receptor (5-HT4)
  gi|984126|emb|Z48150.1|HS5HT4[984126]
• 13648: Y15743
  Homo sapiens RET proto-oncogene, exon 13 containing two mutations
  gi|2665353|emb|Y15743.1|HSRET13[2665353]
• 13649: AF000575
  Homo sapiens clone 16 immunoglobulin-like transcript 5 mRNA, complete cds
  gi|2264428|gb|AF000575.1|AF000575[2264428]
• 13650: AF000574
  Homo sapiens clone 1 immunoglobulin-like transcript 4 mRNA, complete cds
  gi|2264426|gb|AF000574.1|AF000574[2264426]
• 13651: Z26652
  H. sapiens FLT3 mRNA for FLT3 receptor tyrosine kinase
  gi|406322|emb|Z26652.1|HSFLT3RTK[406322]
• 13653: X82208
  H. sapiens mRNA for beta-centractin (ATCC# HHCPJ76)
  gi|563887|emb|X82208.1|HSBCENTR[563887]
• 13654: AF035261
  Homo sapiens thyroid stimulating hormone receptor (TSHR) mRNA, partial cds
  gi|2654195|gb|AF035261.1|HSTSHR[2654195]
• 13655: AF032388
  Homo sapiens vasopressin receptor type 2 mRNA, alternatively spliced, complete
  cds
  gi|2654030|gb|AF032388.1|AF032388[2654030]
• 13656: AF025534
  Homo sapiens leucocyte immunoglobulin-like receptor-8 (LIR-8) mRNA, complete cds
  gi|2653874|gb|AF025534.1|AF025534[2653874]
• 13657: AF025533
  Homo sapiens leucocyte immunoglobulin-like receptor-3 (LIR-3) mRNA, complete cds
  gi|2653872|gb|AF025533.1|AF025533[2653872]
• 13658: AF025532
  Homo sapiens leucocyte immunoglobulin-like receptor-5 (LIR-5) mRNA, complete cds
  gi|2653870|gb|AF025532.1|AF025532[2653870]
• 13659: AF025531
  Homo sapiens leucocyte immunoglobulin-like receptor-7 (LIR-7) mRNA, complete cds
  gi|2653868|gb|AF025531.1|AF025531[2653868]
• 13660: AF025530
  Homo sapiens leucocyte immunoglobulin-like receptor-6a (LIR-6) mRNA, complete cds
  gi|2653866|gb|AF025530.1|AF025530[2653866]
• 13661: AF025529
  Homo sapiens leucocyte immunoglobulin-like receptor-6b (LIR-6) mRNA, complete cds
  gi|2653864|gb|AF025529.1|AF025529[2653864]
• 13662: AF025528
  Homo sapiens leucocyte immunoglobulin-like receptor-2 (LIR-2) mRNA, complete cds
  gi|2653862|gb|AF025528.1|AF025528[2653862]
• 13663: AF025527
  Homo sapiens leucocyte immunoglobulin-like receptor-4 (LIR-4) mRNA, complete cds
  gi|2653860|gb|AF025527.1|AF025527[2653860]
• 13664: Y13583
  Homo sapiens mRNA for G-protein coupled receptor
  gi|255233|emb|Y13583.1|HSGPCP[2652933]
• 13665: Y13367
  H. sapiens mRNA for phosphoinositide 3-kinase
  gi|2143259|emb|Y13367.1|HSPHOSI3K[2143259]
• 13666: X82207
  H. sapiens mRNA for beta-centractin (PC3)
  gi|563885|emb|X82207.1|HSBCENT[563885]
• 13667: AF033854
  Homo sapiens lymphocyte inhibitor of TRAIL (LIT) mRNA, complete cds
  gi|2645841|gb|AF033854.1|AF033854[2645841]
• 13668: X81882
  H. sapiens mRNA for for vasopressin activated calcium mobilizing receptor-like protein
  gi|1628414|emb|X81882.1|HSVACM1[1628414]
• 13669: AF024690
  Homo sapiens putative G protein-coupled receptor (GPR43) gene, complete cds
  gi|2612951|gb|AF024690.1|AF024690[2612951]
• 13670: AF024689
  Homo sapiens putative G protein-coupled receptor (GPR42) gene, complete cds
  gi|2612949|gb|AF024689.1|AF024689[2612949]
• 13671: AF024688
  Homo sapiens putative G protein-coupled receptor (GPR41) gene, complete cds
  gi|2612947|gb|AF024688.1|AF024688[2612947]
• 13672: AF024687
  Homo sapiens putative G protein-coupled receptor (GPR40) gene, complete cds
  gi|2612945|gb|AF024687.1|AF024687[2612945]
• 13673: D87513
  Homo sapiens mRNA for Grb7 protein, partial cds
  gi|1526534|dbj|D87513.1|D87513[1526534]
• 13674: D49919
  Homo sapiens mRNA for C-C chemokine receptor type 2, complete cds
  gi|2626807|dbj|D49919.1|D49919[2626807]
• 13675: AF030512
  Homo sapiens small cell vasopressin subtype 1b receptor mRNA, complete cds
  gi|2613124|gb|AF030512.1|AF030512[2613124]
• 13676: Y12852
  Homo sapiens P2X7 gene, exon 2 and 3
  gi|2612788|emb|Y12852.1|HSP2X7E23[2612788]
• 13677: Y12851
  Homo sapiens P2X7 gene, exon 1 and joined CDS
  gi|2597926|emb|Y12851.1|HSP2X7EX1[2597926]
• 13678: Y12854
  Homo sapiens P2X7 gene, exon 9-11
  gi|2612787|emb|Y12854.1|HSP2X7911[2612787]
• 13679: Y12853
  Homo sapiens P2X7 gene, exon 4-8
  gi|2612786|emb|Y12853.1|HSP2X748[2612786]
• 13680: Y12855
  Homo sapiens P2X7 gene, exon 12 and 13
  gi|2612785|emb|Y112855.1|HSP2X7123[2612785]
• 13681: AB005520
  Homo sapiens ppar gamma2 gene for peroxisome proliferator activated-receptor gamma, partial cds and 5′ flanking
  gi|2605488|dbj|AB005520.1|AB005520[2605488]
• 13682: Y09765
  Homo sapiens mRNA for putative GABA receptor epsilon subunit
  gi|2285960|emb|Y09765.1|HSY09765[2285960]
• 13683: Y09764
  Homo sapiens GABRE gene, exon 2-8
  gi|2285959|emb|Y09764.1|HSY09764[2285959]
• 13684: Y09763
  Homo sapiens GABRE gene, exon 1 (and joined CDS)
  gi|2285957|emb|Y09763.1|HSY09763[2285957]
• 13685: AF026535
  Homo sapiens chemokine receptor (CCR3) mRNA, complete cds
  gi|2582565|gb|AF026535.1|AF026535[2582565]
• 13686: AF026071
  Homo sapiens soluble death receptor 3 beta (DR3) mRNA, complete cds
  gi|2570832|gb|AF026071.1|AF026071[2570832]
• 13687: AF022956
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570532|gb|AF022956.1|AF022956[2570532]
• 13688: AF022955
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570530|gb|AF022955.1|AF022955[2570530]
• 13689: AF022954
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570528|gb|AF022954.1|AF022954[2570528]
• 13690: AF022953
  Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
  gi|2570526|gb|AF022953.1|AF022953[2570526]
• 13691: AF014958
  Homo sapiens chemokine receptor X (CKRX) mRNA, complete cds
  gi|2305263|gb|AF014958.1|AF014958[2305263]
• 13692: AB000712
  Homo sapiens hCPE-R mRNA for CPE-receptor, complete cds
  gi|2570124|dbj|AB000712.1|AB000712[2570124]
• 13693: X94609
  H. sapiens mRNA for activatory NK receptor/KKA3 p50.3
  gi|1495414|emb|X94609.1|HSANKRMR[1495414]
• 13694: AF025375
  Homo sapiens chemokine receptor-4 (CXCR4) mRNA, complete cds
  gi|2565335|gb|AF025375.1|AF025375[2565335]
• 13695: AF000380
  Homo sapiens folate binding protein mRNA, complete cds
  gi|2565193|gb|AF000380.1|HSAF000380[2565193]
• 13696: U35875
  Homo sapiens B2 bradykinin receptor mRNA, 5′ sequence
  gi|135339|gb|U35875.1|HSU35875[1353391]
• 13697: AF010193
  Homo sapiens MAD-related gene SMAD7 (SMAD7) mRNA, complete cds
  gi|225282|gb|AF010193.1|AF010193[2252821]
• 13698: X94634
  H. sapiens CD97 gene exon 7
  gi|1165087|emb|X94634.1|HSX94634[1165087]
• 13699: X94633
  H. sapiens CD97 gene exon 4
  gi|1165086|emb|X94633.1|HSX94633[1165086]
• 13700: X94632
  H. sapiens CD97 gene exon 3
  gi|1165085|emb|X94632.1|HSX94632[1165085]
• 13702: AF007892
  Homo sapiens P2Y6 receptor, long splice variant mRNA, complete cds
  gi|225842|gb|AF007892.1|[2258421]
• 13703: AF007891
  Homo sapiens P2Y6 receptor, short splice variant mRNA, complete cds
  gi|2258419|gb|AF007891.1|[2258419]
• 13704: AF022383
  Homo sapiens complexin I mRNA, complete cds
  gi|2465458|gb|AF022383.1|AF022383[2465458]
• 13709: X89860
  H. sapiens mRNA for T-cell receptor alpha chain
  gi|927420|emb|X89860.1|HSNP7TCR2[927420]
• 13710: Y08456
  H. sapiens ChemR1 gene
  gi|2465081|emb|Y08456.1|HSCHEMR1[2465081]
• 13711: U95025
  Homo sapiens metabotropic glutamate receptor 8 (GRM8) mRNA, complete cds
  gi|2435409|gb|U95025.1|HsU95025[2435409]
• 13712: AF021799
  Homo sapiens interleukin 17 receptor-like mRNA sequence
  gi|2460201|gb|AF021799.1|AF021799[2460201]
• 13714: U73443
  Homo sapiens 5HT3 serotonin receptor gene, partial cds
  gi|2459549|gb|U73443.1|MMU73443[2459549]
• 13715: AB000520
  Homo sapiens mRNA for APS, complete cds
  gi|2447035|dbj|AB3000520.1|AB3000520[2447035]
• 13716: X98172
  H. sapiens mRNA for MACH-alpha-1 protein
  gi|1403318|emb|X98172.1|HSMACHA1[1403318]
• 13727: X92883
  H. sapiens mRNA for T cell receptor alpha (clone XPHC46IV)
  gi|1061141|emb|X92883.1|HSPHC46A1[1061141]
• 13728: AH005567
  Homo sapiens chromosome 4 map 4q13
  gi|2290767|gb|AH005567.1|SEG_HSGNRHR[2290767]
• 13729: AF001952
  Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 3 and complete cds
  gi|2290766|gb|AF001952.1|HSGNRHR3[2290766]
• 13730: AF001951
  Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 2
  gi|2290765|gb|AF001951.1|HSGNRHR2[2290765]
• 13731: AF001950
  Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 1
  gi|2290764|gb|AF001951.1|HSGNRHR1[2290764]
• 13732: AF017263
  Homo sapiens putative G protein-coupled receptor gene, partial intron sequence
  gi|2435439|gb|AF017263.1|AF017263[2435439]
• 13733: AF020201
  Homo sapiens Jagged 2 mRNA, complete cds
  gi|2432001|gb|AF020201.1|AF020201[2432001]
• 13734: Y14442
  Homo sapiens mRNA for olfactory receptor protein, partial
  gi|2370144|emb|Y14442.1|HSOLFMF[2370144]
• 13735: AF017264
  Homo sapiens putative G protein-coupled receptor gene, intronic sequence
  gi|2407224|gb|AF017264.1|AF017264[2407224]
• 13736: AF017061
  Homo sapiens vasopressin-activated calcium mobilizing putative receptor protein
  (VACM-1) mRNA, complete cds
  gi|2394273|gb|AF01706.1|AF017061[2394273]
• 13737: AF017262
  Homo sapiens putative G protein-coupled receptor mRNA, complete cds
  gi|2388705|gb|AF017262.1|AF017262[2388705]
• 13738: AF016917
  Homo sapiens GABA-A receptor delta subunit (GABRD) mRNA, complete cds
  gi|2388692|gb|AF016917.1|AF016917[2388692]
• 13739: Y13248
  Homo sapiens mRNA for orphan chemokine receptor TYMSTR
  gi|2370179|emb|Y13248.1|HSY13248[2370179]
• 13740: D83492
  Homo sapiens mRNA for Eph-family protein, complete cds
  gi|2281007|dbj|D83492.1|D83492[2281007]
• 13741: AB002058
  Homo sapiens mRNA for HUMAN P2XM, complete cds
  gi|2350846|dbj|AB002058.1|AB002058[2350846]
• 13742: AF015251
  Homo sapiens breast cancer-related unknown protein mRNA, partial cds
  gi|2345090|gb|AF015251.1|AF015251[2345090]
• 13743: AF004231
  Homo sapiens monocyte/macrophage Ig-related receptor MIR-10 (MIR cl-10) mRNA, complete cds
  gi|2343110|gb|AF004231.1|AF004231[2343110]
• 13744: AF004230
  Homo sapiens monocyte/macrophage Ig-related receptor MIR-7 (MIR cl-7) mRNA, complete cds
  gi|2343108|gb|AF004230.1|AF004230[2343108]
• 13745: X90563
  H. sapiens mRNA for peroxisome proliferactor activated receptor gamma
  gi|1480099|emb|X90563.1|HSPPARGAM[1480099]
• 13746: AF012629
  Homo sapiens antagonist decoy receptor for TRAIL/Apo-2L (TRID) mRNA, complete cds
  gi|2338430|gb|AF012629.1|AF012629[2338430]
• 13747: AF012628
  Homo sapiens death domain containing receptor for TRAIL/Apo-2L (DR5) mRNA, complete cds
  gi|2338428|gb|AF012628.1|AF012628[2338428]
• 13748: AF012536
  Homo sapiens decoy receptor 1 (DcR1) mRNA, complete cds
  gi|2338421|gb|AF012536.1|AF012536[2338421]
• 13749: AF012535
  Homo sapiens death receptor 5 (DR5) mRNA, complete cds
  gi|2338419|gb|AF012535.1|AF012535[2338419]
• 13750: AF012903
  Homo sapiens P2X4 ATP-gated cation channel protein mRNA, partial cds
  gi|2331043|gb|AF012903.1|AF012903[2331043]
• 13751: X69316
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 21
  gi|34105|emb|X69316.1|HSKITPO16[34105]
• 13752: X69315
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 18, 19, 20
  gi|34104|emb|X69315.1|HSKITPO15[34104]
• 13753: X69314
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 17
  gi|34103|emb|X69314.1|HSKITPO14[34103]
• 13754: X69313
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 16
  gi|34102|emb|X69313.1|HSKITPO13[34102]
• 13755: X69312
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 15
  gi|34101|emb|X69312.1|HSKITPO12[34101]
• 13756: X69311
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 14
  gi|34100|emb|X69311.1|HSKITPO11[34100]
• 13757: X69310
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 10, 11, 12, 13
  gi|34099|emb|X69310.1|HSKITPO10[34099]
• 13758: X69309
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 9
  gi|34098|emb|X69309.1|HSKITPO09[34098]
• 13759: X69308
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 9
  gi|34097|emb|X69308.1|HSKITPO08[34097]
• 13760: X69307
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 8
  gi|34096|emb|X69307.1|HSKITPO07[34096]
• 13761: X69306
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 7
  gi|34095|emb|X69306.1|HSKITPO06[34095]
• 13762: X69305
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 5
  gi|34094|emb|X69305.1|HSKITPO05[34094]
• 13763: AF005419
  Homo sapiens P2Y5-like receptor gene, complete cds
  gi|2240034|gb|AF005419.1|AF005419[2240034]
• 13764: L42324
  Homo sapiens (clone GPCR W) G protein-linked receptor gene (GPCR) gene, 5′ end
  of cds
  gi|1066730|gb|L42324.1|HUMFRCG[1066730]
• 13766: AF015910
  Homo sapiens unknown protein mRNA, partial cds
  gi|2286201|gb|AF015910.1|AF015910[2286201]
• 13767: X99250
  H. sapiens mRNA for endothelin-B receptor splice variant
  gi|2285955|emb|X99250.1|HSX99250[2285955]
• 13768: AF007545
  Homo sapiens SIV/HIV receptor Bonzo (Bonzo) mRNA, complete cds
  gi|225342|gb|AF007545.1|AF007545[2253421]
• 13769: Z79783
  H. sapiens G protein-coupled receptor CKR-L2
  gi|2281709|emb|Z79783.1|HSCKRL2[2281709]
• 13778: Z49994
  H. sapiens partial gene for proteinase-activated receptor 2 (1289 BP)
  gi|1008086|emb|Z49994.1|HSPAR2B[1008086]
• 13779: AF007555
  Homo sapiens IAR/receptor-like protein-tyrosine phosphatase precursor mRNA, complete cds
  gi|2262074|gb|AF007555.1|AF007555[2262074]
• 13780: AF008556
  Homo sapiens interleukin-2 receptor mRNA, alternatively spliced, partial cds
  gi|2266932|gb|AF008556.1|AF008556[2266932]
• 13891: Y10152
  H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (94 bp deletion)
  gi|1785640|emb|Y10152.1|HSCRF294[1785640]
• 13892: Y10153
  H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (227 bp insertion)
  gi|1785639|emb|Y10153.1|HSCRF2227[1785639]
• 13893: Y10151
  H. sapiens mRNA for CRF2 receptor, beta isoform, partial
  gi|1785637|emb|Y10151.1|HSCRF2[1785637]
• 13894: M17325
  Homo sapiens T-cell receptor gamma-chain constant region (TCRGC1) mRNA, partial
  cds
  gi|2072752|gb|M17325.1|HUMTCGCJ[2072752]
• 13895: M17324
  Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
  cds
  gi|2072751|gb|M17324.1|HUMTCGCI[2072751]
• 13896: M17323
  Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
  cds
  gi|2072750|gb|M17323.1|HUMTCGCH[2072750]
• 13897: AF004327
  Homo sapiens angiopoietin-2 mRNA, complete cds
  gi|2257932|gb|AF004327.1|AF004327[2257932]
• 13898: AF004021
  Homo sapiens prostaglandin F2 alpha receptor mRNA, complete cds
  gi|2257849|gb|AF004021.1|AF004021[2257849]
• 13899: AF006464
  Homo sapiens muscle specific tyrosine kinase receptor (MUSK) mRNA, complete cds
  gi|2253311|gb|AF006464.1|AF006464[2253311]
• 13900: AF005637
  Homo sapiens endothelin A receptor gene, 5′ flanking region and exon 1
  gi|2253289|gb|AF005637.1|AF005637[2253289]
• 13902: Z24461
  H. sapiens MTCP-1 gene
  gi|406866|emb|Z24461.1|HSMTCP1I[406866]
• 13903: Z24463
  H. sapiens MTCP-1 gene
  gi|406865|emb|Z24463.1|HSMTCP1H[406865]
• 13904: Z24457
  H. sapiens of TCRA gene MTCP-1 gene
  gi|406860|emb|Z24457.1|HSMTCP1D[406860]
• 13905: Z24456
  H. sapiens of MTCP-1 gene MTCP-1 gene
  gi|406859|emb|Z24456.1|HSMTCP1C[406859]
• 13906: U45984
  Homo sapiens CCR6 chemokine receptor (CMKBR6) gene, complete cds
  gi|2246432|gb|U45984.1|HSU45984[2246432]
• 13908: AF005900
  Homo sapiens alpha2B-adrenergic receptor (alpha2C2AR) gene, complete cds
  gi|2245627|gb|AF005900.1|AF005900[2245627]
• 13909: AF005210
  Homo sapiens CC chemokine receptor CCR8 (CMKBR8) mRNA, partial cds
  gi|2245579|gb|AF005210.1|AF005210[2245579]
• 14010: Y13758
  Homo sapiens mRNA for transient receptor potential related channel 3 protein
  gi|2225936|emb|Y13758.1|HSY13758[2225936]
• 14012: AF000546
  Homo sapiens purinergic receptor P2Y5 mRNA, complete cds
  gi|2232068|gb|AF000546.1|HSAF000546[2232068]
• 14013: U45983
  Homo sapiens CCR8 chemokine receptor (CMKBR8) gene, complete cds
  gi|2231165|gb|U45983.1|HSU45983[2231165]
• 14015: X63819
  H. sapiens mRNA for Lipoxin A4 receptor
  gi|31460|emb|X63819.1|HSLIPA4R[31460]
• 14016: X15274
  H. sapiens TRGV9 gene, allele V9*A2
  gi|1848091|emb|X15274.1|HSTRGV9F[1848091]
• 14020: X80282
  H. sapiens gene for oxytocin receptor
  gi|609014|emb|X80282.1|HSOXYTOC[609014]
• 14021: X81086
  H. sapiens PCaR1 gene
  gi|599819|emb|X81086.1|HSPCAR1[599819]
• 14023: X65857
  H. sapiens HGMP07E gene for olfactory receptor
  gi|425220|emb|X65857.1|HSHGM07EG[425220]
• 14024: X65858
  H. sapiens gene for high affinity IL-8 receptor
  gi|312046|emb|X65858.1|HSHAIL8G[312046]
• 14026: Z69640
  H. sapiens fgfr2 gene (exon 5)
  gi|200062|emb|Z69640.1|HSFGFR2UB[1200062]
• 14027: Z69641
  H. sapiens fgfr2 gene
  gi|1120006|emb|Z69641.1|HSFGFR2UA[1200061]
• 14029: Z70243
  H. sapiens enhancer region for interleukin-2 receptor alpha chain
  gi|1769435|emb|Z70243.1|HSENHREG1[1769435]
• 14030: Z38109
  H. sapiens DNA for CD69, exon 1
  gi|793837|emb|Z38109.1|HSCD69X1[793837]
• 14031: AC002306
  Homo sapiens DNA from chromosome 19-cosmid R33799, genomic sequence, complete sequence
  gi|2213634|gb|AC002306.1|AC002306[2213634]
• 14032: AF002256
  Homo sapiens killer cell inhibitory receptor homolog cl-9 mRNA, complete cds
  gi|2197058|gb|AF002256.1|AF002256[2197058]
• 14033: AF002255
  Homo sapiens killer cell inhibitory receptor cl-17 mRNA, complete cds
  gi|2197056|gb|AF002255.1|AF002255[2197056]
• 14034: D89079
  Homo sapiens mRNA for leukotriene b4 receptor, complete cds
  gi|2196450|dbj|D589079.1|D89079[2196450]
• 14035: D89078
  Homo sapiens mRNA for leukotriene b4 receptor, complete cds
  gi|2196448|dbj|D89078.1|D89078[2196448]
• 14036: AB004662
  Homo sapiens mRNA for adenosine A1-receptor, complete cds
  gi|2196442|dbj|AB004662.1|AB004662[2196442]
• 14037: Y07909
  H. sapiens mRNA for Progression Associated Protein
  gi|1542882|emb|Y07909.1|HSPAPR[1542882]
• 14038: L17411
  Human complement receptor type 1 (alleles S and F) gene, exon 40
  gi|1199855|gb|L17411.1|HUMCR1SF34[1199855]
• 14039: L17425
  Human complement receptor type 1 (allele S) gene, exon 11
  gi|451301|gb|L17425.1|HUMCR1SF10[451301]
• 14040: L17418
  Human complement receptor type 1 (alleles S and F) gene, exon 47 and complete cds's
  gi|306678|gb|L17418.1|HUMCR1SF41[306678]
• 14041: L17417
  Human complement receptor type 1 (alleles S and F) gene, exon 46
  gi|306677|gb|L17417.1|HUMCR1SF40[306677]
• 14042: L17416
  Human complement receptor type 1 (alleles S and F) gene, exon 45
  gi|306676|gb|L17416.1|HUMCR1SF39[306676]
• 14043: L17415
  Human complement receptor type 1 (alleles S and F) gene, exon 44
  gi|306675|gb|L17415.1|HUMCR1SF38[306675]
• 14044: L17414
  Human complement receptor type 1 (alleles S and F) gene, exon 43
  gi|306674|gb|L17414.1|HUMCR1SF37[306674]
• 14045: L17413
  Human complement receptor type 1 (alleles S and F) gene, exon 42
  gi|306673|gb|L17413.1|HUMCR1SF36[306673]
• 14046: L17412
  Human complement receptor type 1 (alleles S and F) gene, exon 41
  gi|306672|gb|L17412.1|HUMCR1SF35[306672]
• 14047: L17410
  Human complement receptor type 1 (alleles S and F) gene, exons 38 and 39
  gi|306670|gb|L17410.1|HUMCR1SF33[306670]
• 14048: L17408
  Human complement receptor type 1 (alleles S and F) gene, exon 37
  gi|306669|gb|L17408.1|HUMCR1SF32[306669]
• 14049: L17407
  Human complement receptor type 1 (alleles S and F) gene, exon 36
  gi|306668|gb|L17407.1|HUMCR1SF31[306668]
• 14050: L17406
  Human complement receptor type 1 (alleles S and F) gene, exon 35
  gi|306667|gb|L17406.1|HUMCR1SF30[306667]
• 14051: L17405
  Human complement receptor type 1 (alleles S and F) gene, exon 34
  gi|306666|gb|L17405.1|HUMCR1SF29[306666]
• 14052: L17404
  Human complement receptor type 1 (alleles S and F) gene, exon 33
  gi|306665|gb|L17404.1|HUMCR1SF28[306665]
• 14053: L17403
  Human complement receptor type 1 (alleles S and F) gene, exon 32
  gi|306664|gb|L17403.1|HUMCR1SF27[306664]
• 14054: L17402
  Human complement receptor type 1 (alleles S and F) gene, exons 30 and 31
  gi|306663|gb|L17402.1|HUMCR1SF26[306663]
• 14055: L17401
  Human complement receptor type 1 (alleles S and F) gene, exon 29
  gi|306662|gb|L17401.1|HUMCR1SF25[306662]
• 14056: L17400
  Human complement receptor type 1 (alleles S and F) gene, exon 28
  gi|306661|gb|L17400.1|HUMCR1SF24[306661]
• 14057: L17398
  Human complement receptor type 1 (alleles S and F) gene, exons 26 and 27
  gi|306660|gb|L17398.1|HUMCR1SF23[306660]
• 14058: L17397
  Human complement receptor type 1 (alleles S and F) gene, exon 25
  gi|306659|gb|L17397.1|HUMCR1SF22[306659]
• 14059: L17396
  Human complement receptor type 1 (alleles S and F) gene, exon 24
  gi|306658|gb|L17396.1|HUMCR1SF21[306658]
• 14060: L17395
  Human complement receptor type 1 (alleles S and F) gene, exons 22 and 23
  gi|306657|gb|L17395.1|HUMCR1SF20[306657]
• 14061: L17394
  Human complement receptor type 1 (alleles S and F) gene, exon 21
  gi|306656|gb|L17394.1|HUMCR1SF19[306656]
• 14062: L17393
  Human complement receptor type 1 (alleles S and F) gene, exon 20
  gi|306655|gb|L17393.1|HUMCR1SF18[306655]
• 14063: L17392
  Human complement receptor type 1 (alleles S and F) gene, exon 19
  gi|306654|gb|L17392.1|HUMCR1SF17[306654]
• 14064: L17391
  Human complement receptor type 1 (alleles S and F) gene, exon 18
  gi|306653|gb|L17391.1|HUMCR1SF16[306653]
• 14065: L17430
  Human complement receptor type 1 (allele S) gene, exon 17
  gi|306652|gb|L17430.1|HUMCR1SF15[306652]
• 14066: L17429
  Human complement receptor type 1 (allele S) gene, exon 16
  gi|306651|gb|L17429.1|HUMCR1SF14[306651]
• 14067: L17428
  Human complement receptor type 1 (allele S) gene, exons 14 and 15
  gi|306650|gb|L17428.1|HUMCR1SF13[306650]
• 14068: L17427
  Human complement receptor type 1 (allele S) gene, exon 13
  gi|306649|gb|L17427.1|HUMCR1SF12[306649]
• 14069: L17426
  Human complement receptor type 1 (allele S) gene, exon 12
  gi|306648|gb|L17426.1|HUMCR1SF11[306648]
• 14070: L17424
  Human complement receptor type 1 (allele S) gene, exon 10
  gi|306646|gb|L17424.1|HUMCR1SF09[306646]
• 14071: L17423
  Human complement receptor type 1 (alleles S and F) gene, exon 9
  gi|306645|gb|L17423.1|HUMCR1SF08[306645]
• 14072: L17422
  Human complement receptor type 1 (alleles S and F) gene, exon 8
  gi|306644|gb|L17422.1|HUMCR1SF07[306644]
• 14073: L17421
  Human complement receptor type 1 (alleles S and F) gene, exons 6 and 7
  gi|306643|gb|L17421.1|HUMCR1SF06[306643]
• 14074: L17420
  Human complement receptor type 1 (alleles S and F) gene, exon 5
  gi|306642|gb|L17420.1|HUMCR1SF05[306642]
• 14075: L17419
  Human complement receptor type 1 (alleles S and F) gene, exon 4
  gi|306641|gb|L17419.1|HUMCR1SF04[306641]
• 14076: L17409
  Human complement receptor type 1 (alleles S and F) gene, exon 3
  gi|306640|gb|L17409.1|HUMCR1SF03[306640]
• 14077: L17399
  Human complement receptor type 1 (alleles S and F) gene, exon 2
  gi|306639|gb|L17399.1|HUMCR1SF02[306639]
• 14078: L17390
  Human complement receptor type 1 (alleles S and F) gene, enhancer and exon 1
  gi|306638|gb|L17390.1|HUMCR1SF01[306638]
• 14081: M14764
  Human nerve growth factor receptor mRNA, complete cds
  gi|189204|gb|M14764.1|HUMNGFR[189204]
• 14082: M11025
  Human asialoglycoprotein receptor H2 mRNA, complete cds
  gi|179080|gb|M11025.1|HUMASGPR2[179080]
• 14083: L31772
  Human alpha-1a/d adrenergic receptor mRNA, complete cds
  gi|666894|gb|L31772.1|HUMA1DA[666894]
• 14084: L31774
  Human alpha-1c-adrenergic receptor mRNA, complete cds
  gi|666892|gb|L31774.1|HUMA1ARA[666892]
• 14085: L31773
  Human alpha-1B-adrenergic receptor mRNA, complete cds
  gi|666890|gb|L31773.1|HUMA1AR[666890]
• 14093: L07868
  Homo sapiens receptor tyrosine kinase (ERBB4) gene, complete cds
  gi|337359|gb|L07868.1|HUMRETYKIN[337359]
• 14094: L19593
  Homo sapiens interleukin 8 receptor beta (IL8RB) mRNA, complete cds
  gi|559053|gb|L19593.1|HUMIL8RB[559053]
• 14095: L19591
  Homo sapiens interleukin 8 receptor alpha (IL8RA) mRNA, complete cds
  gi|559049|gb|L19591.1|HUMIL8RAA[559049]
• 14096: M69229
  Human insulin-like growth factor I receptor gene, promoter region and 5′ end
  gi|184837|gb|M69229.1|HUMIGFR1PR[184837]
• 14097: L03840
  Human fibroblast growth factor receptor 4 (FGFR4) mRNA, complete cds
  gi|182570|gb|L03840.1|HUMFGFR4X[182570]
• 14098: L13268
  Homo sapiens N-methyl-d-aspartate receptor (NR1-3) mRNA, 3′ end
  gi|292286|gb|L13268.1|HUMMARB[292286]
• 14099: L13266
  Homo sapiens N-methyl-d-aspartate receptor (NR1-1) mRNA, complete cds
  gi|292282|gb|L13266.1|HUMMAR[292282]
• 14100: Y13426
  Homo sapiens TCRDV2 gene, partial
  gi|2181879|emb|Y13426.1|HSTCRDV2[2181879]
• 14101: Y08768
  H. sapiens mRNA for IL-13 receptor
  gi|1877211|emb|Y08768.1|HSIL13[1877211]
• 14102: Y08110
  H. sapiens mRNA for mosaic protein LR11
  gi|1552323|emb|Y08110.1|HSLR11[1552323]
• 14103: E08844
  Histamine H1 receptor gene
  gi|2176948|dbj|E08844.1|E08844[2176948]
• 14104: E08843
  cDNA encoding Histamine H1 receptor
  gi|2176947|dbj|E08843.1|E08843[2176947]
• 14106: E07873
  cDNA encoding cholecystokinin B/gastrin receptor
  gi|2176006|dbj|E07873.1|E07873[2176006]
• 14107: E07650
  cDNA encoding endothelin receptor, ETB-receptor
  gi|2175785|dbj|E07650.1|E07650[2175785]
• 14108: E07649
  cDNA encoding endothelin receptor, ETA-receptor
  gi|2175784|dbj|E07649.1|E07649[2175784]
• 14109: E07358
  cDNA encoding adrenaline alpha2CII receptor
  gi|2175498|dbj|E07358.1|E07358[2175498]
• 14110: E07278
  cDNA encoding human cholecystokinin (CCK) receptor
  gi|2175419|dbj|E07278.1|E07278[2175419]
• 14111: E06799
  DNA encoding human Interleukin-5 receptor
  gi|2174981|dbj|E06799.1|E06799[2174981]
• 14112: E06798
  DNA encoding human Interleukin-5 receptor
  gi|2174980|dbj|E06798.1|E06798[2174980]
• 14113: E06797
  DNA encoding human Interleukin-5 receptor
  gi|2174979|dbj|E06797.1|E06797[2174979]
• 14114: E06796
  DNA encoding human Interleukin-5 receptor
  gi|2174978|dbj|E06796.1|E06796[2174978]
• 14115: E05678
  cDNA encoding human LH-hCG (luteinizing hormone-human choriogonadotropic hormone) receptor
  gi|2173865|dbj|E05678.1|E05678[2173865]
• 14116: E05211
  DNA encoding human scavenger receptor II
  gi|2173401|dbj|E05211.1|E05211[2173401]
• 14117: E05210
  DNA encoding human scavenger receptor I
  gi|2173400|dbj|E05210.1|E05210[2173400]
• 14118: E05109
  cDNA encoding human oxytocin receptor
  gi|2173303|dbj|E05109.1|E05109[2173303]
• 14189: E04823
  cDNA encoding interleukin 6 receptor
  gi|2173019|dbj|E04823.1|E04823[2173019]
• 14190: E03879
  cDNA encoding platelet activating factor receptor
  gi|2172093|dbj|E03879.1|E03879[2172093]
• 14191: E03829
  cDNA encoding human thromboxane receptor
  gi|2172043|dbj|E03829.1|E03829[2172043]
• 14192: E03378
  DNA encoding N-terminal fragment of human growth hormone receptor
  gi|2171595|dbj|E03378.1|E03378[2171595]
• 14193: E03377
  DNA encoding C-terminal fragment of human growth hormone receptor
  gi|2171594|dbj|E03377.1|E03377[2171594]
• 14194: E03335
  Human b-FGF receptor gene
  gi|2171552|dbj|E03335.1|E03335[2171552]
• 14195: E03268
  cDNA sequence coding for human scavenger receptor, type II
  gi|2171485|dbj|E03268.1|E03268[2171485]
• 14196: E03267
  cDNA sequence coding for human scavenger receptor, type I
  gi|2171484|dbj|E03267.1|E03267[2171484]
• 14197: E02673
  cDNA encoding human B cell stimulating factor 2 receptor protein
  gi|2170901|dbj|E02673.1|E02673[2170901]
• 14198: E02541
  cDNA encoding human Interleukin-2 receptor L chain
  gi|2170771|dbj|E02541.1|E02541[2170771]
• 14199: E02151
  Terminal sequence of constant region of T cell receptor beta chain (c beta-1)
  gi|2170389|dbj|E02151.1|E02151[2170389]
• 14200: E01646
  cDNA encoding Fc epsilon receptor
  gi|2169899|dbj|E01646.1|E01646[2169899]
• 14201: E01052
  DNA encoding human mature TNF
  gi|2169311|dbj|E01052.1|E01052[2169311]
• 14202: E00999
  cDNA encoding human insulin receptor
  gi|2169258|dbj|E00999.1|E00999[2169258]
• 14203: E00990
  cDNA encoding alpha chain of T-cell receptor
  gi|2169251|dbj|E00990.1|E00990[2169251]
• 14204: E00727
  cDNA encoding human IL-2 receptor
  gi|2169004|dbj|E00727.1|E00727[2169004]
• 14205: E00723
  cDNA encoding human interleukin-2 receptor
  gi|2169000|dbj|E00723.1|E00723[2169000]
• 14206: E00685
  cDNA encoding human T-cell antigen receptor protein
  gi|2168964|dbj|E00685.1|E00685[2168964]
• 14207: D31833
  Human mRNA for vasopressin V1b receptor, complete cds
  gi|563981|dbj|D31833.1|HUMVV1BR[563981]
• 14208: D16845
  Human mRNA for thyrotropin-releasing hormone receptor, complete cds
  gi|577631|dbj|D16845.1|HUMTRHR1[577631]
• 14209: D28131
  Human mRNA for TGF-beta receptor type IIB, partial sequence
  gi|456708|dbj|D28131.1|HUMTGFBRII[456708]
• 14211: D17517
  Human sky mRNA for Sky, complete cds
  gi|624880|dbj|D17517.1|HUMSKY[624880]
• 14214: D30780
  Human mRNA for phospholipase A2 receptor, partial cds
  gi|565645|dbj|D30780.1|HUMPLA21R[565645]
• 14215: D38299
  Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 2 isoform, complete
  cds
  gi|1389574|dbj|D38299.1|HUMPEREFC[1389574]
• 14216: D38298
  Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 1b isoform, complete
  cds
  gi|1389573|dbj|D38298.1|HUMPEREEB[1389573]
• 14217: D38301
  Homo sapiens mRNA for prostaglandin E receptor EP3 subtype 3 isoform, complete
  cds
  gi|1389572|dbj|D38301.1|HUMPERECE[1389572]
• 14218: D38300
  Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 4 isoform, complete
  cds
  gi|1389571|dbj|D38300.1|HUMPEREBD[1389571]
• 14219: D38297
  Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 1a isoform, complete
  cds
  gi|1389570|dbj|D38297.1|HUMPEREA[1389570]
• 14220: D28538
  Human mRNA for metabotropic glutamate receptor subtype 5a, complete cds
  gi|1140805|dbj|D28538.1|HUMMGRS5A[1408051]
• 14221: D14872
  Human DNA for fibroblast growth factor receptor 2 (K-sam-II) exon C3, partial sequence
  gi|511927|dbj|D14872.1|HUMKSAMC3[511927]
• 14222: D50582
  Human gene for inward rectifier K channel, complete cds
  gi|1088444|dbj|D50582.1|HUMIRKCB[1088444]
• 14223: D26070
  Human mRNA for type 1 inositol 1,4,5-trisphosphate receptor, complete cds
  gi|559322|dbj|D26070.1|HUMINSP3R1[559322]
• 14232: D26156
  Human mRNA for transcriptional activator hSNF2b, complete cds
  gi|505087|dbj|D26156.1|HUMHSNF2B[505087]
• 14233: D26155
  Human mRNA for transcriptional activator hSNF2a, complete cds
  gi|505086|dbj|D26155.1|HUMHSNF2A[505086]
• 14234: D26351
  Human mRNA for type 3 inositol 1,4,5-trisphosphate receptor, complete cds
  gi|450470|dbj|D26351.1|HUMHT3I[450470]
• 14235: D26350
  Human mRNA for type 2 inositol 1,4,5-trisphosphate receptor, complete cds
  gi|450468|dbj|D26350.1|HUMHT2I[450468]
• 14236: D25418
  Human mRNA for prostacyclin receptor, complete cds
  gi|467509|dbj|D25418.1|HUMHPR[467509]
• 14237: D10924
  Human mRNA for HM89
  gi|219868|dbj|D10924.1|HUMHM89[219868]
• 14238: D10923
  Human mRNA for HM74
  gi|219866|dbj|D10923.1|HUMHM74[219866]
• 14239: D10922
  Human mRNA for FMLP-related receptor (HM63)
  gi|219864|dbj|D10922.1|HUMHM63[219864]
• 14240: D10925
  Human mRNA for HM145
  gi|219862|dbj|D10925.1|HUMHM145[219862]
• 14241: D28481
  Human mRNA for histamine H1 receptor, complete cds
  gi|457654|dbj|D28481.1|HUMHH1R[457654]
• 14242: D10995
  Human gene for serotonin 1B receptor, complete cds
  gi|219678|dbj|D10995.1|HUMHGCR[219678]
• 14243: D38449
  Human mRNA for G protein-coupled receptor, complete cds
  gi|556519|dbj|D30449.1|HUMGPCRAA[556519]
• 14243: D38449
• 14245: D37827
  Homo sapiens mRNA for large erk/cek5 tyrosine kinase, partial cds
  gi|1060894|dbj|D37827.1|HUMERK1P[1060894]
• 14246: D13305
  Human mRNA for brain cholecystokinin receptor
  gi|436039|dbj|D13305.1|HUMBRACHRE[436039]
• 14247: D32201
  Human mRNA for alpha 1C adrenergic receptor isoform 3, complete cds
  gi|927210|dbj|D32201.1|HUMAICAR3[927210]
• 14248: D16354
  Human mRNA for Ah receptor, complete cds
  gi|464179|dbj|D16354.1|HUMAHRE[464179]
• 14249: D25235
  Human mRNA for alpha1C adrenergic receptor, complete cds
  gi|433200|dbj|D25235.1|HUMACAR[433200]
• 14250: D13538
  Human alpha2CII-adrenergic receptor gene, complete cds
  gi|219405|dbj|D13538.1|HUMA2CIIA[219405]
• 14251: D32202
  Human mRNA for alpha 1C adrenergic receptor isoform 2, complete cds
  gi|927208|dbj|D32202.1|HUMA1CAR2[927208]
• 14253: D86519
  Human mRNA for neuropeptide y/peptide YY Y6 receptor, complete cds
  gi|1731789|dbj|D86519.1|D86519[1731789]
• 14254: D50683
  Homo sapiens mRNA for TGF-betaIIR alpha, complete cds
  gi|1827474|dbj|D50683.1|D50683[1827474]
• 14255: D50682
  Homo sapiens mRNA for TGF-betaIIR beta, partial cds
  gi|1827472|dbj|D50682.1|D50682[1827472]
• 14256: D28472
  Human mRNA for prostaglandin E receptor EP4 subtype, complete cds
  gi|1486234|dbj|D28472.1|D28472[1486234]
• 14257: D29634
  Human lung mRNA for receptor for prostacyclin, complete cds
  gi|577629|dbj|D29634.1|D29634[577629]
• 14258: D28539
  Human mRNA for metabotropic glutamate receptor subtype 5b, complete cds
  gi|1408053|dbj|D28539.1|HUMMGRS5B[1408053]
• 14259: Y09479
  H. sapiens mRNA for G protein-coupled receptor Edg-2
  gi|1679601|emb|Y09479.1|HSEDG2[1679601]
• 14260: U97197
  Homo sapiens asialoglycoprotein receptor (ASGPR) mRNA, complete cds
  gi|2121249|gb|U97197.1|HSU97197[2121249]
• 14261: X81892
  H. sapiens mA for HE6 Tm7 receptor
  gi|2117160|emb|X81892.1|HSHE6[2117160]
• 14262: Y07619
  H. sapiens mRNA for peroxisome proliferator-activated receptor alpha
  gi|1514594|emb|Y07619.1|HSPPARAGE[1514594]
• 14263: D16815
  Homo sapiens mRNA for EAR-1r, complete cds
  gi|2116671|dbj|D16815.1|D16815[2116671]
• 14264: X95876
  H. sapiens mRNA for G-protein coupled receptor
  gi|1552845|emb|X95876.1|HSGPCRIN8[1552845]
• 14265: AF000545
  Homo sapiens putative purinergic receptor P2Y10 gene, complete cds
  gi|2104786|gb|AF000545.1|HSAF000545[2104786]
• 14267: U95626
  Homo sapiens ccr2b (ccr2), ccr2a (ccr2), ccr5 (ccr5) and ccr6 (ccr6) genes, complete cds, and lactoferrin (lactoferrin) gene, partial cds, complete sequence
  gi|2104517|gb|U95626.1|HSU95626[2104517]
• 14268: U77352
  Homo sapiens MAP kinase-activating death domain protein (MADD) mRNA, complete cds
  gi|2102697|gb|U77352.1|HSU77352[2102697]
• 14269: D86098
  Homo sapiens mRNA for prostaglandin EP3 receptor subtype isoform, complete cds
  gi|2102646|dbj|D86098.1|D86098[2102646]
• 14270: D86097
  Homo sapiens mRNA for prostaglandin EP3 receptor subtype isoform, complete cds
  gi|2102644|dbj|D86097.1|D86097[2102644]
• 14271: X98510
  H. sapiens mRNA for G protein-coupled receptor
  gi|1894788|emb|X98510.1|HSX98510[1894788]
• 14272: D89675
  Homo sapiens mRNA for bone morphogenetic protein type IB receptor, complete cds
  gi|2055308|dbj|D89675.1|D89675[2055308]
• 14273: D43772
  Human squamous cell carcinoma of esophagus mRNA for GRB-7 SH2 domain protein, complete cds
  gi|601890|dbj|D43772.1|HUMGRB7[601890]
• 14274: X89677
  H. sapiens RA for TPCR92 protein
  gi|902337|emb|X89677.1|HSTPCR92P[902337]
• 14275: X89676
  H. sapiens mRNA for TPCR86 protein
  gi|902335|emb|X89676.1|HSTPCR86P[902335]
• 14276: X89675
  H. sapiens mRNA for TPCR85 protein
  gi|902333|emb|X89675.1|HSTPCR85P[902333]
• 14277: X89674
  H. sapiens mRNA for TPCR27 protein
  gi|902331|emb|X89674.1|HSTPCR27P[902331]
• 14278: X89673
  H. sapiens mRNA for TPCR26 protein
  gi|902329|emb|X89673.1|HSTPCR26P[902329]
• 14279: X89672
  H. sapiens mRNA for TPCR25 protein
  gi|902327|emb|X89672.1|HSTPCR25P[902327]
• 14280: X89671
  H. sapiens mRNA for TPCR24 protein
  gi|902325|emb|X89671.1|HSTPCR24P[902325]
• 14281: X89670
  H. sapiens mRNA for TPCR16 protein
  gi|902323|emb|X89670.1|HSTPCR16P[902323]
• 14282: X89669
  H. sapiens mRNA for TPCR120 protein
  gi|902321|emb|X89669.1|HSTPCR120[902321]
• 14283: X89668
  H. sapiens mRNA for TPCR110 protein
  gi|902319|emb|X89668.1|HSTPCR110[902319]
• 14284: X89667
  H. sapiens mRNA for TPCR106 protein
  gi|902317|emb|X89667.1|HSTPCR106[902317]
• 14285: X89666
  H. sapiens mRNA for TPCR100 protein
  gi|902315|emb|X89666.1|HSTPCR100[902315]
• 14291: X73617
  H. sapiens mRNA for T-cell receptor delta
  gi|402624|emb|X73617.1|HSTCRDE[402624]
• 14292: Z79612
  H. sapiens DNA for muscle nicotinic acetylcholine receptor gene promotor, clone
  DBLambda20
  gi|1922318|emb|Z79612.1|HSMNAR3[1922318]
• 14293: Z79611
  H. sapiens DNA for muscle nicotinic acetylcholine receptor gene promotor, clone
  DBLambda23
  gi|1922317|emb|Z79611.1|HSMNAR2[1922317]
• 14294: Z79610
  H. sapiens DNA for muscle nicotinic acetylcholine receptor gene promotor, clone
  ICRFc105F02104
  gi|1922316|emb|Z79610.1|HSMNAR1[1922316]
• 14295: Y09852
  H. sapiens FGFR3 gene, partial
  gi|1922307|emb|Y09852.1|HSFGFR312[1922307]
• 14309: Z46223
  H. sapiens DNA for immunoglobulin G Fc receptor IIIB
  gi|559446|emb|Z46223.1|HSIGGRE3B[559446]
• 14310: Z46222
  H. sapiens DNA for immunoglobulin G Fc receptor 111A
  gi|559445|emb|Z46222.1|HSIGGRE3A[559445]
• 14311: Y09561
  H. sapiens mRNA for P2X7 receptor
  gi|1854511|emb|Y09561.1|HSP2X7[1854511]
• 14312: Y09328
  H. sapiens mRNA for IL13 receptor alpha-1 chain
  gi|1885307|emb|Y09328.1|HSIL13RA1[1885307]
• 14313: Y07593
  H. sapiens mRNA for 46 kDa coxsackievirus and adenovirus receptor (CAR) protein
  gi|1881446|emb|Y07593.1|HS46 KDA[1881446]
• 14314: X07205
  H. sapiens TRGV9 gene, allele V9*A1
  gi|1848089|emb|X07205.1|HSTRGV9[1848089]
• 14315: X15272
  H. sapiens TRGV4F gene
  gi|1841921|emb|X15272.1|HSTRGV4F[1841921]
• 14316: Y11227
  H. sapiens TRGV11 gene
  gi|1848086|emb|Y11227.1|HSTRGV11G[1848086]
• 14317: X74798
  H. sapiens TRGV10 gene, allele V10*A2
  gi|1848083|emb|X74798.1|HSTRGV[1848083]
• 14321: X80878
  H. sapiens R kappa B mRNA
  gi|695578|emb|X80878.1|HSTRGV[695578]
• 14324: X70070
  H. sapiens mRNA for neurotensin receptor
  gi|35020|emb|X70070.1|HSNEURA[35020]
• 14325: X94552
  H. sapiens mRNA for metabotropic glutamate receptor type 7
  gi|1370110|emb|X94552.1|HSMGLU7[1370110]
• 14326: X89105
  H. sapiens krag-like mRNA
  gi|939922|emb|X89105.1|HSKRAGGEN[939922]
• 14327: X92562
  H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (539 bp)
  gi|1296655|emb|X92562.1|HSIGAFCR5[1296655]
• 14328: X92561
  H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (585 bp)
  gi|1296654|emb|X92561.1|HSIGAFCR4[1296654]
• 14329: X92560
  H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (807 bp)
  gi|1296653|emb|X92560.1|HSIGAFCR3[1296653]
• 14330: X92559
  H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (771 bp)
  gi|1296652|emb|X92559.1|HSIGAFCR2[1296652]
• 14331: X92558
  H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (837 bp)
  gi|1296651|emb|X92558.1|HSIGAFCR1[1296651]
• 14332: Z50197
  H. sapiens FGFR2, Bek gene (partial; mutation C)
  gi|929635|emb|Z50197.1|HSFGFR2XC[929635]
• 14333: Z50196
  H. sapiens FGFR2, Bek gene (partial; mutation B)
  gi|929634|emb|Z50196.1|HSFGFR2XB[929634]
• 14334: Z50201
  H. sapiens FGFR2 gene (partial; mutation A)
  gi|929633|emb|Z50201.1|HSFGFR2XA[929633]
• 14335: X72304
  H. sapiens mRNA for corticotrophin releasing factor receptor
  gi|436118|emb|X72304.1|HSCRFA[436118]
• 14336: X86169
  H. sapiens B2-bradykinin receptor gene, exon 2, C allele
  gi|1220165|emb|X86169.1|HSB2BRX2C[1220165]
• 14342: X03131
  H. sapiens interleukin 2 receptor gene 5′ flanking region and exon 1 (and joined
  CDS)
  gi|33818|emb|X03131.1|HSIL2RG1[33818]
• 14343: X57740
  H. sapiens rearranged T-cell receptor gamma chain gene, V3RS-J1 (hybrid joint)
  gi|505478|emb|X57740.1|HSTCRHJD[505478]
• 14344: X01719
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 7 and
  8)
  gi|28278|emb|X01719.1|HSACHG5[28278]
• 14345: X01715
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit precursor
  (exons 1 and 2)
  gi|28268|emb|X01715.1|HSACHG1[28268]
• 14535: Z30429
  H. sapiens gene for early lymphocyte activation antigen CD69, exon 4
  gi|534947|emb|Z30429.1|HSLACD694[534947]
• 14536: X89744
  H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 4
  gi|1279462|emb|X89744.1|HSCHRNA44[1279462]
• 14537: X87765
  H. sapiens CD89 gene, exon TM/C
  gi|963045|emb|X87765.1|HSCD89EX5[963045]
• 14538: X87766
  H. sapiens CD89 gene, exon EC2
  gi|963044|emb|X87766.1|HSCD89EX4[963044]
• 14539: X87769
  H. sapiens CD89 gene, exon EC1
  gi|963043|emb|X87769.1|HSCD89EX3[963043]
• 14540: X87768
  H. sapiens CD89 gene, exon S2
  gi|963042|emb|X87768.1|HSCD89EX2[963042]
• 14541: X87767
  H. sapiens CD89 gene, exon S1
  gi|963041|emb|X87767.1|HSCD89EX1[963041]
• 14542: AH004970
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene
  gi|995299|gb|AH004970.1|SEG_HUMIFNAMO[995299]
• 14543: L42243
  Homo sapiens (clone 51H8) alternatively spliced interferon receptor (IFNAR2) gene, exon 9 and complete cds's
  gi|995298|gb|L42243.1|HUMIFNAM08[995298]
• 14544: L41944
  Homo sapiens interferon receptor ifnar2-1 (splice variant IFNAR2-1) mRNA, complete cds
  gi|995296|gb|L41944.1|HUMIFNAL[995296]
• 14545: L41943
  Homo sapiens interferon receptor ifnar2-3 (splice variant IFNAR2-3) mRNA, complete cds
  gi|995294|gb|L41943.1|HUMIFNAK[995294]
• 14546: L41942
  Homo sapiens interferon receptor ifnar2-2 (splice variant IFNAR2-2) mRNA, complete cds
  gi|995292|gb|L41942.1|HUMIFNAJ[995292]
• 14547: L42242
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 8
  gi|994722|gb|L42242.1|HUMIFNAM07[994722]
• 14548: L42241
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 7
  gi|994721|gb|L42241.1|HUMIFNAM06[994721]
• 14549: L42323
  Homo sapiens (clone 20D3) interferon receptor (IFNAR2) gene, exon 6
  gi|994720|gb|L42323.1|HUMIFNAM05[994720]
• 14550: L42240
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 5
  gi|994719|gb|L42240.1|HUMIFNAM04[994719]
• 14551: L42239
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exons 3-4
  gi|994718|gb|L42239.1|HUMIFNAM03[994718]
• 14552: L42238
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 2
  gi|994717|gb|L42238.1|HUMIFNAM02[994717]
• 14553: L42237
  Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 1
  gi|994716|gb|L42237.1|HUMIFNAM01[994716]
• 14557: X94647
  H. sapiens CD97 gene exon 20
  gi|1165083|emb|X94647.1|HSX94647[1165083]
• 14558: X94630
  H. sapiens CD97 gene exon 1 (and joined CDS)
  gi|1165073|emb|X94630.1|HSX94630[1165073]
• 14560: X91747
  H. sapiens gene for FSH receptor (exon 10)
  gi|1009412|emb|X91747.1|HSFSHRX10[1009412]
• 14561: X74979
  H. sapiens TRK E mRNA
  gi|400462|emb|X74979.1|HSTRKE[400462]
• 14562: Y10100
  H. sapiens ACTH receptor promoter & exon 1
  gi|1743254|emb|Y10100.11HSACTHPRO[1743254]
• 14563: Y09028
  H. sapiens NTRK1 gene, exon 1 (and joined mRNA)
  gi|1785644|emb|Y09028.1|HSNTRK11[1785644]
• 14564: Y07684
  H. sapiens mRNA for P2X4 purinoceptor
  gi|1781008|emb|Y07684.1|HSP2X4PC[1781008]
• 14565: X95712
  H. sapiens mRNA for receptor protein tyrosine phosphatase
  gi|1666422|emb|X95712.1|HSRPTYRPH[1666422]
• 14568: X97232
  H. sapiens mRNA for NK receptor, clone library D97.10
  gi|1770483|emb|X97232.1|HSNKRD9[1770483]
• 14569: X97233
  H. sapiens mRNA for NK receptor, clone library C97.12#5
  gi|1770481|emb|X97233.1|HSNKRC9[1770481]
• 14570: X97231
  H. sapiens mRNA for NK receptor, clone library 59C/K3
  gi|1770479|emb|X97231.1|HSNKR59[1770479]
• 14571: X97230
  H. sapiens mRNA for NK receptor, clone library 4M1#6
  gi|1770477|emb|X97230.1|HSNKR4M[1770477]
• 14572: X97229
  H. sapiens mRNA for NK receptor, clone library 15.212
  gi|1770475|emb|X97229.1|HSNKR15[1770475]
• 14573: X99481
  H. sapiens mRNA for NK receptor, clone GR #19
  gi|1770473|emb|X99481.1|HSNKGR19[1770473]
• 14574: X99480
  H. sapiens mRNA for NK receptor, clone NK3.3 #27
  gi|1770471|emb|X99480.1|HSNK3327[1770471]
• 14575: X99479
  H. sapiens mRNA for NK receptor, clone 12.11C
  gi|1770469|emb|X99479.1|HSNK1211C[1770469]
• 14576: X98118
  H. sapiens GRK4A gene
  gi|1770421|emb|X98118.1|HSGRK4AGE[1770421]
• 14589: X83864
  H. sapiens EDG-3 gene
  gi|1770395|emb|X83864.1|HSEDG3[1770395]
• 14590: Z48923
  H. sapiens mRNA for BMPR-II
  gi|1009409|emb|Z48923.1|HSBMPRII[1009409]
• 14592: X84939
  H. sapiens mRNA for fibroblast growth factor receptor-3
  gi|695548|emb|X84939.1|HSFGFR3EX[695548]
• 14593: X89604
  H. sapiens mRNA for metallothionein-III
  gi|914850|emb|X89604.1|HSMTIII[914850]
• 14594: Z70276
  H. sapiens mRNA for fibroblast growth factor 12 (partial)
  gi|1749790|emb|Z70276.1|HSFGF12CR[1749790]
• 14595: Z70275
  H. sapiens mRNA for fibroblast growth factor 11 (partial)
  gi|1749788|emb|Z70275.1|HSFGF11CR[1749788]
• 14596: Y09392
  H. sapiens mRNA for WSL-LR, WSL-S1 and WSL-S2 proteins
  gi|1669690|emb|Y09392.1|HSWSL1[1669690]
• 14597: X99031
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 14
  gi|1480251|emb|X99031.1|HSDRTK14[1480251]
• 14598: X99029
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 11
  gi|1480247|emb|X99029.1|HSDRTK11[1480247]
• 14599: Y08162
  H. sapiens mRNA for heptahelix receptor
  gi|1707499|emb|Y08162.1|HSHHR[1707499]
• 14600: X98194
  H. sapiens gene encoding serotonin receptor, 5-HT7, exon 3
  gi|1707470|emb|X98194.1|HS5HT73[1707470]
• 14601: X99025
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exons 6 & 7
  gi|1480257|emb|X99025.1|HSDRTK6[1480257]
• 14615: X98147
  H. sapiens gene encoding serotonin receptor, 5-HT7, exon 2
  gi|1707469|emb|X98147.1|HS5HT72[1707469]
• 14616: X98193
  H. sapiens gene encoding serotonin receptor, 5-HT7, exon 1 (and joined CDS)
  gi|1707467|emb|X98193.1|HS5HT71[1707467]
• 14617: X90753
  H. sapiens mRNA for alternatively spliced IgA Fc receptor (CD89)
  gi|951268|emb|X90753.1|HSIGAFCGN[951268]
• 14618: X70812
  H. sapiens gene for beta 3 adrenergic receptor
  gi|312398|emb|X70812.1|HSBARED[312398]
• 14619: Z22971
  H. sapiens mRNA for M130 antigen extracellular variant
  gi|312147|emb|Z22971.1|HSM130AE[312147]
• 14620: Z22970
  H. sapiens mRNA for M130 antigen cytoplasmic variant 2
  gi|312145|emb|Z22970.1|HSM130AC2[312145]
• 14621: Z22969
  H. sapiens mRNA for M130 antigen cytoplasmic variant 1
  gi|312143|emb|Z22969.1|HSM130AC1[312143]
• 14622: Z22968
  H. sapiens mRNA for M130 antigen
  gi|312141|emb|Z22968.1|HSM130A[312141]
• 14623: X69680
  H. sapiens mRNA for bradykinin receptor
  gi|288798|emb|X69680.1|HSBKR[288798]
• 14624: Z79784
  H. sapiens G protein-coupled receptor CKR-L3
  gi|1668737|emb|Z79784.1|HSCKRL3[1668737]
• 14625: Z79782
  H. sapiens G protein-coupled receptor CKR-L1
  gi|1668735|emb|Z79782.1|HSCKRL1[1668735]
• 14626: X94374
  H. sapiens mRNA for HLA class I inhibitory NK receptor (AMC5)
  gi|1495480|emb|X94374.1|HSNKRAMC5[1495480]
• 14627: X94373
  H. sapiens mRNA for HLA class I inhibitory NK receptor (1.1)
  gi|1495478|emb|X94373.1|HSNKR11[1495478]
• 14628: X93596
  H. sapiens mRNA for HLA specific NK receptor
  gi|1495476|emb|X93596.1|HSNKI8[1495476]
• 14629: X93595
  H. sapiens mRNA for NK receptor (clone 17.1C)
  gi|1495474|emb|X93595.1|HSNKI7[1495474]
• 14630: X94262
  H. sapiens mRNA for HLA-Bw4 specific inhibitory NK cell receptor
  gi|1495472|emb|X94262.1|HSNKCRMR[1495472]
• 14631: X89772
  H. sapiens mRNA for interferon alpha/beta receptor (long form)
  gi|1620400|emb|X89772.1|HSRNAIABR[1620400]
• 14632: X69516
  H. sapiens gene for folate receptor
  gi|288876|emb|X69516.1|HSFOLA[288876]
• 14633: X97671
  H. sapiens mRNA for erythropoietin receptor
  gi|1310666|emb|X97671.1|HSERYTHR[1310666]
• 14639: X97874
  H. sapiens EP4 prostaglandin receptor gene, exon III
  gi|1359732|emb|X97874.1|HSEP4EX3[1359732]
• 14640: X97873
  H. sapiens EP4 prostaglandin receptor gene, exons I & II (and joined CDS)
  gi|1359730|emb|X97873.1|HSEP4EX12[1359730]
• 14646: X99404
  H. sapiens mRNA for early response gene, Berg36
  gi|1480242|emb|X99404.1|HSBERG36[1480242]
• 14647: Z49205
  H. sapiens mRNA for purinergic receptor
  gi|798835|emb|Z49205.1|HSATPRMR[798835]
• 14650: X89066
  H. sapiens mRNA for TRPC1 protein
  gi|1370118|emb|X89066.1|HSTRPC1GN[1370118]
• 14671: Y08218
  H. sapiens mRNA for ryanodine receptor 2
  gi|1561613|emb|Y08218.1|HSRYAN2[1561613]
• 14678: X96586
  H. sapiens mRNA for FAN protein
  gi|1556398|emb|X96586.1|HSFAN[1556398]
• 14679: Z48226
  H. sapiens partial gene for receptor-type protein tyrosine phosphatase IA-2
  gi|667014|emb|Z48226.1|HSPTPAIA2[667014]
• 14680: X91665
  H. sapiens B2-bradykinin receptor gene (allele BE-R33)
  gi|121615|emb|X91665.1|HSB2BER33[1216151]
• 14681: L05424
  Human cell surface glycoprotein CD44 (CD44) gene, 3′ end of long tailed isoform
  gi|337956|gb|L05424.1|HUMSCG19[337956]
• 14682: L05423
  Human cell surface glycoprotein CD44 (CD44) gene, exon 18, 3′ end of short tailed isoform
  gi|337955|gb|L05423.1|HUMSCG18[337955]
• 14683: L05422
  Human cell surface glycoprotein CD44 (CD44) gene, exon 17
  gi|337954|gb|L05422.1|HUMSCG17[337954]
• 14684: L05421
  Human cell surface glycoprotein CD44 (CD44) gene, exon 16
  gi|337953|gb|L05421.1|HUMSCG16[337953]
• 14685: L05420
  Human cell surface glycoprotein CD44 (CD44) gene, exon 15
  gi|337952|gb|L05420.1|HUMSCG1S[337952]
• 14686: L05419
  Human cell surface glycoprotein CD44 (CD44) gene, exon 14
  gi|337951|gb|L05419.1|HUMSCG14[337951]
• 14687: L05418
  Human cell surface glycoprotein CD44 (CD44) gene, exon 13
  gi|337950|gb|L05418.1|HUMSCG13[337950]
• 14688: L05417
  Human cell surface glycoprotein CD44 (CD44) gene, exon 12
  gi|337949|gb|L05417.1|HUMSCG12[337949]
• 14689: L05416
  Human cell surface glycoprotein CD44 (CD44) gene, exon 11
  gi|337948|gb|L05416.1|HUMSCG11[337948]
• 14690: L05415
  Human cell surface glycoprotein CD44 (CD44) gene, exon 10
  gi|337947|gb|L05415.1|HUMSCG10[337947]
• 14691: L05414
  Human cell surface glycoprotein CD44 (CD44) gene, exon 9
  gi|337946|gb|L05414.1|HUMSCG09[337946]
• 14692: L05413
  Human cell surface glycoprotein CD44 (CD44) gene, exon 8
  gi|337945|gb|L05413.1|HUMSCG08[337945]
• 14693: L05412
  Human cell surface glycoprotein CD44 (CD44) gene, exon 7
  gi|337944|gb|L05412.1|HUMSCG07[337944]
• 14694: L05411
  Human cell surface glycoprotein CD44 (CD44) gene, exon 6
  gi|337943|gb|L05411.1|HUMSCG06[337943]
• 14695: L05410
  Human cell surface glycoprotein CD44 (CD44) gene, exon 5
  gi|337942|gb|L05410.1|HUMSCG05[337942]
• 14696: L05409
  Human cell surface glycoprotein CD44 (CD44) gene, exon 4
  gi|33794|gb|L05409.1|HUMSCG04[337941]
• 14697: L05408
  Human cell surface glycoprotein CD44 (CD44) gene, exon 3
  gi|337940|gb|L05408.1|HUMSCG03[337940]
• 14698: L05407
  Human cell surface glycoprotein CD44 (CD44) gene, exon 2
  gi|337939|gb|L05407.1|HUMSCG02[337939]
• 14699: M69214
  Human hyaluronate receptor (CD44) gene, exon 1
  gi|180127|gb|M69215.1|HUMSCG01[180127]
• 14700: X91492
  H. sapiens ChemR13 gene
  gi|1262810|emb|X91492.1|HSCCCKR4G[1262810]
• 14701: X91742
  H. sapiens gene for FSH receptor (exon 5)
  gi|1051149|emb|X91742.1|HSFSHRX5[1051149]
• 14702: X91746
  H. sapiens gene for FSH receptor (exon 9)
  gi|1009420|emb|X91746.1|HSFSHRX9[1009420]
• 14703: X91745
  H. sapiens gene for FSH receptor (exon 8)
  gi|1009419|emb|X91745.1|HSFSHRX8[1009419]
• 14704: X91744
  H. sapiens gene for FSH receptor (exon 7)
  gi|1009418|emb|X91744.1|HSFSHRX7[1009418]
• 14705: X91743
  H. sapiens gene for FSH receptor (exon 6)
  gi|1009417|emb|X91743.1|HSFSHRX6[1009417]
• 14706: X91741
  H. sapiens gene for FSH receptor (exon 4)
  gi|1009415|emb|X91741.1|HSFSHRX4[1009415]
• 14707: X91740
  H. sapiens gene for FSH receptor (exon 3)
  gi|1009414|emb|X91740.1|HSFSHRX3[1009414]
• 14708: X91739
  H. sapiens gene for FSH receptor (exon 2)
  gi|1009413|emb|X91739.1|HSFSHRX2[1009413]
• 14709: X91738
  H. sapiens gene for FSH receptor (exon 1)
  gi|1009411|emb|X91738.1|HSFSHRX1[1009411]
• 14710: A34990
  H. sapiens TSH receptor
  gi|1568335|emb|A34990.1|A34990[1568335]
• 14729: A23337
  H. sapiens mRNA for 5-HT2 receptor
  gi|1566776|emb|A23337.1|A23337[1566776]
• 14730: X95095
  H. sapiens mRNA for PDGFRalpha protein
  gi|1403334|emb|X95095.1|HSPDGFRAL[1403334]
• 14731: X91875
  H. sapiens IGF2R gene exon & intron 1
  gi|1017421|emb|X91875.1|HSIGF2R1[1017421]
• 14733: L40636
  Homo sapiens (clone FBK III 16) protein tyrosine kinase (NET PTK) mRNA, complete
  cds
  gi|1100111|gb|L40636.1|HUMEPHT2R[1100111]
• 14734: X55077
  H. sapiens mRNA fragment for alpha-2 macroglobulin receptor
  gi|24762|emb|X55077.1|HSA2MR[24762]
• 14735: X98330
  H. sapiens mRNA for ryanodine receptor 2
  gi|1526977|emb|X98330.1|HSRR2[1526977]
• 14737: X80038
  H. sapiens PRR2 mRNA
  gi|1524087|emb|X80038.1|HSPRR2[1524087]
• 14738: Z15017
  H. sapiens mRNA for glycoprotein 39 (gp39)
  gi|38483|emb|Z15017.1|HSGP39MR[38483]
• 14740: Z36748
  H. sapiens mRNA for serotonin receptor
  gi|558382|emb|Z36748.1|HSSERRC[558382]
• 14741: X97198
  H. sapiens mRNA for receptor phosphate PCP-2
  gi|1502342|emb|X97198.1|HSRECPCP2[1502342]
• 14742: X81870
  H. sapiens DNA for macrophage stimulating protein receptor
  gi|1491705|emb|X81870.1|HSDNAMSPR[1491705]
• 14743: Z11168
  H. sapiens 5HT1A receptor region
  gi|1033027|emb|Z11168.1|HS5HT1A[1033027]
• 14744: M75105
  Human neurokinin-2 receptor (TAC2R) gene, exon 5
  gi|189219|gb|M75105.1|HUMNK25[189219]
• 14745: M75104
  Human neurokinin-2 receptor (NK-2) gene, exon 4
  gi|189218|gb|M75104.1|HUMNK24[189218]
• 14746: M75103
  Human neurokinin-2 receptor (NK-2) gene, exon 3
  gi|189217|gb|M75103.1|HUMNK23[189217]
• 14747: M75102
  Human neurokinin-2 receptor (NK-2) gene, exon 2
  gi|189216|gb|M75102.1|HUMNK22[189216]
• 14748: M75101
  Human neurokinin-2 receptor (TAC2R) gene, exon 1
  gi|189215|gb|M75101.1|HUMNK21[189215]
• 14750: X76981
  H. sapiens mRNA for adenosin receptor A3
  gi|440547|emb|X76981.1|HSRADRA3[440547]
• 14751: X95302
  H. sapiens mRNA for IL13 receptor
  gi|1483349|emb|X95302.1|HSIL13REC[1483349]
• 14752: X51469
  H. sapiens cell receptor gamma-chain J1-C1 DNA fragment (Raji cell line)
  gi|1480294|emb|X51469.1|HSRAJI[1480294]
• 14753: X99027
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 9
  gi|1480259|emb|X99027.1|HSDRTK9[1480259]
• 14754: X99026
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 8
  gi|1480258|emb|X99026.1|HSDRTK8[1480258]
• 14755: X99024
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 5
  gi|1480256|emb|X99024.1|HSDRTK5[1480256]
• 14756: X99023
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 4
  gi|1480255|emb|X99023.1|HSDRTK4[1480255]
• 14757: X99034
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 17
  gi|1480254|emb|X99034.1|HSDRTK17[1480254]
• 14758: X99033
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 16
  gi|1480253|emb|X99033.1|HSDRTK16[1480253]
• 14759: X99032
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 15
  gi|1480252|emb|X99032.1|HSDRTK15[1480252]
• 14760: X98208
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exons 1, 2, 3 and joined CDS
  gi|1480249|emb|X98208.1|HSDRTK123[1480249]
• 14761: X99030
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exons 12 & 13
  gi|1480248|emb|X99030.1|HSDRTK12[1480248]
• 14762: X99028
  H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 10
  gi|1480246|emb|X99028.1|HSDRTK10[1480246]
• 14763: X51470
  H. sapiens T-cell receptor gamma-chain J1-C1 DNA fragment (D-PLL cell line)
  gi|1480245|emb|X51470.1|HSDPLL[1480245]
• 14764: L76631
  Homo sapiens metabotropic glutamate receptor 1 beta (mGluR1beta) mRNA, complete
  cds
  gi|1477389|gb|L76631.1|HUMMGLUB[1477389]
• 14765: L76627
  Homo sapiens metabotropic glutamate receptor 1 alpha (mGluR1alpha) mRNA, complete cds
  gi|1477387|gb|L76627.1|HUMMGLUB[1477387]
• 14766: L57508
  Homo sapiens Cak receptor kinase mRNA, complete cds
  gi|1160924|gb|L57508.1|HUMCAKA[1160924]
• 14767: L38019
  Homo sapiens (clone HUM-IP3R1) inositol 1,4,5-trisphosphate receptor type 1 mRNA, complete cds
  gi|1464750|gb|L38019.1|HUMITR[1464750]
• 14768: X77748
  H. sapiens mRNA for metabotropic glutamate receptor type 3
  gi|1171563|emb|X77748.1|HSMGLUR3[1171563]
• 14769: M26016
  Human CR2/CD21/C3d/Epstein-Barr virus receptor gene, exon IC
  gi|181935|gb|M26016.1|HUMEBUR13[181935]
• 14770: X63717
  H. sapiens mRNA for APO-1 cell surface antigen
  gi|28741|emb|X63717.1|HSAPO1[28741]
• 14771: L03718
  Human G protein-coupled receptor (kinase-like) gene, complete cds
  gi|183598|gb|L03718.1|HUMGPRKLG[183598]
• 14773: X99269
  H. sapiens NPYY1 gene
  gi|1430810|emb|X99269.1|HSNPYY1[1430810]
• 14774: X95536
  H. sapiens earl gene
  gi|418937|emb|X95536.1|HSREOR[1418937]
• 14775: X63745
  H. sapiens ERD2.2 mRNA for KDEL receptor
  gi|31217|emb|X63745.1|HSERD22[31217]
• 14777: X98133
  H. sapiens gene encoding histamine H2 receptor
  gi|1359758|emb|X98133.1|HSH2R[1359758]
• 14778: X89893
  H. sapiens mRNA for NK receptor (183 ActI)
  gi|1103680|emb|X89893.1|HSNKRECT2[1103680]
• 14779: X89892
  H. sapiens mRNA for NK receptor (Eb6 ActI)
  gi|1103678|emb|X89892.1|HSNKRECT1[1103678]
• 14780: X98178
  H. sapiens mRNA for MACH-beta-4 protein
  gi|1403330|emb|X98178.1|HSMACHB4[1403330]
• 14781: X98177
  H. sapiens mRNA for MACH-beta-3 protein
  gi|1403328|emb|X98177.1|HSMACHB3[1403328]
• 14782: X98175
  H. sapiens mRNA for MACH-beta-2 protein
  gi|1403326|emb|X98175.1|HSMACHB2[1403326]
• 14783: X98176
  H. sapiens mRNA for MACH-beta-1 protein
  gi|1403324|emb|X98176.1|HSMACHB1[1403324]
• 14784: X98173
  H. sapiens mRNA for MACH-alpha-2 protein
  gi|1403320|emb|X98173.1|HSMACHA2[1403320]
• 14785: X67594
  H. sapiens mRNA for MSH receptor
  gi|1405733|emb|X67594.1|HSMSHRECA[1405733]
• 14786: X96597
  H. sapiens gene encoding G protein coupled receptor
  gi|1296631|emb|X96597.1|HSGPCRE[1296631]
• 14789: M88714
  Human bradykinin receptor (BK-2) mRNA, complete cds
  gi|1387999|gb|M88714.1|HUMBK2A[1387999]
• 14790: AH003589
  Homo sapiens sulfonylurea receptor (SUR1) gene
  gi|1374918|gb|AH003589.1|SEG_HUMSUR1G[1374918]
• 14791: L78243
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 39
  gi|1374917|gb|L78243.1|HUMSUR1G38[1374917]
• 14792: L78242
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 38
  gi|1374916|gb|L78242.1|HUMSUR1G37[1374916]
• 14793: L78241
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 37
  gi|1374915|gb|L78241.1|HUMSUR1G36[1374915]
• 14794: L78240
  Homo sapiens sulfonylurea receptor (SUR1) gene, exons 34, 35, and 36
  gi|1374914|gb|L78240.1|HUMSUR1G35[1374914]
• 14795: L78239
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 33
  gi|1374913|gb|L78239.1|HUMSUR1G34[1374913]
• 14796: L78238
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 32
  gi|1374912|gb|L78238.1|HUMSUR1G33[1374912]
• 14797: L78237
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 31
  gi|1374911|gb|L78237.1|HUSUR1G32[1374911]
• 14798: L78236
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 30
  gi|1374910|gb|L78236.1|HUMSUR1G31[1374910]
• 14799: L78235
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 29
  gi|1374909|gb|L78235.1|HUMSUR1G30[1374909]
• 14800: L78234
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 28
  gi|1374908|gb|L78234.1|HUMSUR1G29[1374908]
• 14801: L78233
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 27
  gi|1374907|gb|L78233.1|HUMSUR1G28[1374907]
• 14802: L78232
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 26
  gi|1374906|gb|L78232.1|HUMSUR1G27[1374906]
• 14803: L78231
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 25
  gi|1374905|gb|L78231.1|HUMSUR1G28[1374905]
• 14804: L78230
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 24
  gi|1374904|gb|L78230.1|HUMSUR1G25[1374904]
• 14805: L78229
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 23
  gi|1374903|gb|L78229.1|HUMSUR1G24[1374903]
• 14806: L78228
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 22
  gi|1374902|gb|L78228.1|HUMSUR1G23[1374902]
• 14807: L78227
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 21
  gi|1374901|gb|L78227.1|HUMSUR1G22[1374901]
• 14808: L78226
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 20
  gi|1374900|gb|L78226.1|HUMSUR1G21[1374900]
• 14809: L78254
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 19
  gi|1374899|gb|L78254.1|HUMSUR1G20[1374899]
• 14810: L78225
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 18
  gi|1374898|gb|L78225.1|HUMSUR1G19[1374898]
• 14811: L78224
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 17 (alternative)
  gi|1374897|gb|L78224.1|HUMSUR1G18[1374897]
• 14812: L78223
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 17
  gi|1374896|gb|L78223.1|HUMSUR1G17[1374896]
• 14813: L78222
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 16
  gi|1374895|gb|L78222.1|HUMSUR1G16[1374895]
• 14814: L78221
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 15
  gi|1374894|gb|L78221.1|HUMSUR1G15[1374894]
• 14815: L78220
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 14
  gi|1374893|gb|L78220.1|HUMSUR1G14[1374893]
• 14816: L78219
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 13
  gi|1374892|gb|L78219.1|HUMSUR1G13[1374892]
• 14817: L78218
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 12
  gi|1374891|gb|L78218.1|HUMSUR1G12[1374891]
• 14818: L78217
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 11
  gi|1374890|gb|L78217.1|HUMSUR1G11[1374890]
• 14819: L78216
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 10
  gi|1374889|gb|L78216.1|HUMSUR1G10[1374889]
• 14820: L78215
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 9
  gi|1374888|gb|L78215.1|HUMSUR1G09[1374888]
• 14821: L78214
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 8
  gi|1374887|gb|L78214.1|HUMSUR1G08[1374887]
• 14822: L78213
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 7
  gi|1374886|gb|L78213.1|HUMSUR1G07[1374886]
• 14823: L78255
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 6
  gi|1374885|gb|L78255.1|HUMSUR1G06[1374885]
• 14824: L78212
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 5
  gi|1374884|gb|L78212.1|HUMSUR1G05[1374884]
• 14825: L78211
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 4
  gi|1374883|gb|L78211.1|HUMSUR1G04[1374883]
• 14826: L78210
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 3
  gi|1374882|gb|L78210.1|HUMSUR1G03[1374882]
• 14827: L78209
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 2
  gi|137488|gb|L78209.1|HUMSUR1G02[1374881]
• 14828: L78208
  Homo sapiens sulfonylurea receptor (SUR1) gene, exon 1
  gi|1374880|gb|L78208.1|HUMSUR1G01[1374880]
• 14829: L78207
  Homo sapiens sulfonylurea receptor (SUR1) mRNA, complete cds
  gi|1374674|gb|L78207.1|HUMSUR1RNA[1374674]
• 14830: X80818
  H. sapiens mRNA for metabotropic glutamate receptor type 4
  gi|1160182|emb|X80818.1|HSMGLUR4[1160182]
• 14831: X89068
  H. sapiens mRNA for TRPC3 protein
  gi|1019789|emb|X89068.1|HSTRPC3GN[1019789]
• 14832: X85740
  H. sapiens mRNA for C-C chemokine receptor-4
  gi|1370103|emb|X85740.1|HSCCCR3[1370103]
• 14833: X72924
  H. sapiens STS in the vicinity of the ADRA2C gene, sequence tagged site
  gi|458814|emb|X72924.1|HSADRASTS[458814]
• 14834: A27282
  H. sapiens TGR-CL3C
  gi|1247129|emb|A27282.1|A27282[1247129]
• 14835: A27278
  H. sapiens TGR-CL5
  gi|1247127|emb|A27278.1|A27278[1247127]
• 14836: A27276
  H. sapiens TGR-CL1
  gi|1247125|emb|A27276.1|A27276[1247125]
• 14837: A27270
  H. sapiens TGR-CL10C
  gi|1247123|emb|A27270.1|A27270[1247123]
• 14838: A10542
  H. sapiens low affinity Fc-epsilon-receptor
  gi|489152|emb|A10542.1|A10542[489152]
• 14839: X84700
  H. sapiens mRNA for leucocyte antigen CD97
  gi|840770|emb|X84700.1|HSCD97[840770]
• 14841: X56794
  H. sapiens CD44R mRNA
  gi|29798|emb|X56794.1|HSCD441[29798]
• 14842: Z22924
  H. sapiens of CD36 gene, partial CDS
  gi|397604|emb|Z22924.1|HSCD36AA[397604]
• 14843: X81121
  H. sapiens mRNA for central cannabinoid receptor, short isoform
  gi|736238|emb|X81121.1|HSCB1A[736238]
• 14844: X74328
  H. sapiens mRNA for CB2 (peripheral) cannabinoid receptor
  gi|407806|emb|X74328.1|HSCB2CANR[407806]
• 14852: X81120
  H. sapiens mRNA for central cannabinoid receptor
  gi|736236|emb|X81120.1|HSCANN6[736236]
• 14853: X82466
  H. sapiens mRNA for calcitonin receptor
  gi|565026|emb|X82466.1|HSCALRECR[565026]
• 14854: X69920
  H. sapiens mRNA for calcitonin receptor
  gi|474931|emb|X69920.1|HSCALRE[474931]
• 14855: Z22672
  H. sapiens cacnl1a3 gene encoding skeletal muscle dhp-receptor alpha 1 subunit
  gi|297467|emb|Z22672.1|HSCACN1A[297467]
• 14856: Z35761
  H. sapiens TEL/ABL fusion protien
  gi|601903|emb|Z35761.1|HSBREAKP3[601903]
• 14862: X62515
  H. sapiens mRNA for basement membrane heparan sulfate proteoglycan
  gi|29469|emb|X62515.1|HSBMHSP[29469]
• 14887: X70811
  H. sapiens mRNA for beta 3 adrenergic receptor
  gi|312396|emb|X70811.1|HSBARE[312396]
• 14888: X69117
  H. sapiens mRNA for beta-adrenergic kinase 2
  gi|312394|emb|X69117.1|HSBADRK2[312394]
• 14889: X61157
  H. sapiens mRNA for beta-adrenergic receptor kinase
  gi|288307|emb|X61157.1|HSBARK[288307]
• 14891: X77584
  H. sapiens mRNA for ATL-derived factor/thiredoxin
  gi|453963|emb|X77584.1|HSATLRED[453963]
• 14894: X70297
  H. sapiens mRNA for neuronal nicotinic acetylcholine receptor alpha-7 subunit
  gi|496606|emb|X70297.1|HSARA7A[496606]
• 14901: Z11162
  H. sapiens gene for angiotensin II
  gi|28709|emb|Z11162.1|HSANTENII[28709]
• 14902: X91162
  H. sapiens anti-mullerian hormone type II receptor exon 9
  gi|1107682|emb|X91162.1|HSAMREXO9[1107682]
• 14903: X91164
  H. sapiens anti-mullerian hormone type II receptor exon 11
  gi|1107681|emb|X91164.1|HSAMREX11[1107681]
• 14904: X91163
  H. sapiens anti-mullerian hormone type II receptor exon 10
  gi|1107680|emb|X91163.1|HSAMREX10[1107680]
• 14905: X91161
  H. sapiens anti-mullerian hormone type II receptor exon 8
  gi|1107679|emb|X91161.1|HSAMREX08[1107679]
• 14906: X91160
  H. sapiens anti-mullerian hormone type II receptor exon 7
  gi|1107678|emb|X91160.1|HSAMREX07[1107678]
• 14907: X91159
  H. sapiens anti-mullerian hormone type II receptor exon 6
  gi|1107677|emb|X91159.1|HSAMREX06[1107677]
• 14908: X91158
  H. sapiens anti-mullerian hormone type II receptor exon 5
  gi|1107676|emb|X91158.1|HSAMREX05[1107676]
• 14909: X91157
  H. sapiens anti-mullerian hormone type II receptor exon 4
  gi|1107675|emb|X91157.1|HSAMREX04[1107675]
• 14910: X91165
  H. sapiens anti-mullerian hormone type II receptor exon 3
  gi|1107674|emb|X91165.1|HSAMREX03[1107674]
• 14911: X91166
  H. sapiens anti-mullerian hormone type II receptor exon 2
  gi|1107673|emb|X91166.1|HSAMREX02[1107673]
• 14912: X65699
  H. sapiens mRNA for angiotensin II receptor
  gi|510983|emb|X65699.1|HSANGII[510983]
• 14913: X91156
  H. sapiens anti-mullerian hormone type II receptor exon 1
  gi|1107671|emb|X91156.1|HSAMREX01[1107671]
• 14914: Z22533
  H. sapiens ALK-1 mRNA
  gi|402196|emb|Z22533.1|HSALK1A[402196]
• 14915: Z22536
  Homo sapiens ALK-4 mRNA, complete CDS
  gi|402188|emb|Z22536.1|HSALK4A[402188]
• 14916: Z22535
  H. sapiens ALK-3 mRNA
  gi|402186|emb|Z22535.1|HSALK3A[402186]
• 14917: Z22534
  H. sapiens ALK-2 mRNA
  gi|402184|emb|Z22534.1|HSALK2A[402184]
• 14918: X59684
  H. sapiens DNA for alpha2-1.8 adrenergic receptor gene
  gi|28635|emb|X59684.1|HSALPH218[28635]
• 14919: Z11687
  H. sapiens mRNA for antidiuretic hormone receptor
  gi|28417|emb|Z11687.1|HSADHRMR[28417]
• 14920: X77533
  H. sapiens mRNA for activin type II receptor
  gi|825619|emb|X77533.1|HSACTIIRE[825619]
• 14921: X62381
  H. sapiens mRNA for activin receptor
  gi|28347|emb|X62381.1|HSACTR[28347]
• 14922: X65633
  H. sapiens ACTH-R gene for adrenocorticotropic hormone receptor
  gi|28343|emb|X65633.1|HSACTHR[28343]
• 14923: X55019
  H. sapiens mRNA for acetylcholine receptor delta subunit
  gi|297401|emb|X55019.1|HSACHRG[297401]
• 14924: X02508
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha subunit exons 8,
  9 and 3′ flanking region
  gi|28306|emb|X02508.1|HSACHR8[28306]
• 14925: X02507
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha subunit exon 7
  gi|28304|emb|X02507.1|HSACHR7[28304]
• 14926: X02506
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exon 6
  gi|28302|emb|X02506.1|HSACHR6[28302]
• 14927: X83956
  H. sapiens ACCA gene
  gi|1061125|emb|X83956.1|HSACCAGEN[1061125]
• 14928: X66403
  H. sapiens mRNA for acetylcholine receptor (epsilon subunit)
  gi|560152|emb|X66403.1|HSACETR[560152]
• 14929: X02505
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha subunit exon 5
  gi|28300|emb|X02505.1|HSACHR5[28300]
• 14930: X02504
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exon 4
  gi|28298|emb|X02504.1|HSACHR4[28298]
• 14931: X02503
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exons 2 and 3
  gi|28293|emb|X02503.1|HSACHR2[28293]
• 14932: X02502
  H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exon
  gi|28291|emb|X02502.1|HSACHR[28291]
• 14933: X04759
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 12)
  gi|28288|emb|X04759.1|HSACHG8[28288]
• 14934: X01721
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exons and 11)
  gi|28286|emb|X01721.1|HSACHG7[28286]
• 14935: X01720
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 9)
  gi|28283|emb|X01720.1|HSACHG6[28283]
• 14936: X01718
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 6)
  gi|28276|emb|X01718.1|HSACHG4[28276]
• 14937: X01717
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 5)
  gi|28274|emb|X01717.1|HSACHG3[28274]
• 14938: X01716
  H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 3 and
  4)
  gi|28271|emb|X01716.1|HSACHG2[28271]
• 14939: X77018
  H. sapiens mRNA for anti-acetylcholine receptor monoclonal autoantibody V lambda
  region
  gi|441251|emb|X77018.1|HSAARMA2[441251]
• 14941: X68487
  H. sapiens mRNA for A2b adenosine receptor
  gi|400453|emb|X68487.1|HSA2BREC[400453]
• 14942: X68486
  H. sapiens mRNA for A2a adenosine receptor
  gi|400451|emb|X68486.1|HSA2AREC[400451]
• 14943: X68485
  H. sapiens mRNA for A1 adenosine receptor
  gi|400449|emb|X68485.1|HSA1ADREC[400449]
• 14948: X87197
  H. sapiens mRNA for 6.3 gene
  gi|854083|emb|X87197.1|HS63MRNAG[854083]
• 14949: X81412
  H. sapiens DNA for 5-HT5A exon2
  gi|541777|emb|X81412.1|HS5HT5A2[541777]
• 14950: X81411
  H. sapiens DNA for 5-HT5A exon1
  gi|541776|emb|X81411.1|HS5HT5A1[541776]
• 14952: X77307
  H. sapiens mRNA for 5-HT2B serotonin receptor
  gi|475197|emb|X77307.1|HS5HT2BSR[475197]
• 14968: X75299
  H. sapiens HIVR mRNA for vasoactive intestinal peptide (VIP) receptor
  gi|407461|emb|X75299.1|HSVIPRE[407461]
• 14969: X94216
  H. sapiens mRNA for VEGF-C protein
  gi|1177488|emb|X94216.1|HSVEGFC[1177488]
• 14971: X67482
  H. sapiens mRNA for 1,25-dihydroxyvitamin D-3 receptor
  gi|37653|emb|X67482.1|HSVD3R[37653]
• 14976: Z46797
  H. sapiens gene for urokinase receptor (partial)
  gi|732804|emb|Z46797.1|HSUPAR5[732804]
• 14977: X74039
  H. sapiens mRNA for urokinase plasminogen activator receptor
  gi|456192|emb|X74039.1|HSUPAR[456192]
• 14984: X51675
  H. sapiens urokinase plasminogen activator surface receptor (UPAR) mRNA
  gi|37604|emb|X51675.1|HSUPARAA[37604]
• 14985: X76498
  H. sapiens gene for uterine bombesin receptor
  gi|468753|emb|X76498.1|HSUBR[468753]
• 14986: X66029
  H. sapiens mRNA for tyrosine kinase receptor
  gi|37596|emb|X66029.1|HSUFOR[37596]
• 14987: X66030
  Homo sapiens partial ufo gene encoding tyrosine kinase receptor
  gi|37594|emb|X66030.1|HSUFOD[37594]
• 14998: X72089
  H. sapiens mRNA for TRH receptor
  gi|440155|emb|X72089.1|HSTRHREC[440155]
• 15005: X72018
  H. sapiens hTGR 1 mRNA
  gi|1200088|emb|X72018.1|HSTGR1[1200088]
• 15006: X69178
  H. sapiens mRNA for thyrotropin receptor, partial
  gi|288212|emb|X69178.1|HSTHREC[288212]
• 15007: X69177
  H. sapiens mRNA for thyrotropin receptor, partial
  gi|288211|emb|X69177.1|HSTHRE[288211]
• 15246: X65181
  H. sapiens gene for substance P receptor (exon 5)
  gi|36640|emb|X65181.1|HSSUBP5G[36640]
• 15247: X65180
  H. sapiens gene for substance P receptor (exon 4)
  gi|36639|emb|X65180.1|HSSUBP4G[36639]
• 15248: X65179
  H. sapiens gene for substance P receptor (exon 3)
  gi|36638|emb|X65179.1|HSSUBP3G[36638]
• 15249: X65177
  H. sapiens gene for substance P receptor (exon 1)
  gi|36636|emb|X65177.1|HSSUBP1G[36636]
• 15253: X62156
  H. sapiens mRNA for soluble interleukin-5 receptor
  gi|36465|emb|X62156.1|HSSILRS[36465]
• 15254: X57830
  H. sapiens serotonin 5-HT2 receptor mRNA
  gi|36430|emb|X57830.1|HSSERR52[36430]
• 15255: Z11166
  H. sapiens S31 gene for serotonin receptor
  gi|36264|emb|Z11166.1|HSS31G[36264]
• 15256: X91869
  H. sapiens mRNA for ryanodine receptor
  gi|1022320|emb|X91869.1|HSRYR2[1022320]
• 15257: X74269
  H. sapiens RYR3 mRNA for ryanodine receptor type 3 (partial)
  gi|405718|emb|X74269.1|HSRYR3MR[405718]
• 15258: X74270
  H. sapiens RYR3 gene for ryanodine receptor type 3 (partial)
  gi|405716|emb|X74270.1|HSRYR3G[405716]
• 15261: Z27409
  H. sapiens mRNA for receptor tyrosine kinase eph (partial)
  gi|482916|emb|Z27409.1|HSRTKEPH[482916]
• 15262: X74764
  H. sapiens mRNA for receptor protein tyrosine kinase
  gi|433337|emb|X74764.1|HSRPTK[433337]
• 15265: X59155
  H. sapiens retroviral receptor mRNA
  gi|36160|emb|X59155.1|HSRRMRNA[36160]
• 15267: X70040
  H. sapiens RON mRNA for tyrosine kinase
  gi|36109|emb|X70040.1|HSRON[36109]
• 15268: X75071
  H. sapiens mRNA for human thyrotropin-releasing hormone receptor
  gi|404157|emb|X75071.1|HSRNAHTRH[404157]
• 15269: X86446
  H. sapiens mRNA for 55.11 binding protein
  gi|1008088|emb|X86446.1|HSRNA5511[1008088]
• 15270: Z29093
  H. sapiens EDDR1 gene for receptor tyrosine kinase
  gi|732799|emb|Z29093.1|HSRETYK1[732799]
• 15274: X64123
  H. sapiens PVR gene for poliovirus receptor (exon 8)
  gi|35819|emb|X64123.1|HSPVR8G[35819]
• 15275: X64122
  H. sapiens PVR gene for poliovirus receptor (exon 7)
  gi|35818|emb|X64122.1|HSPVR7G[35818]
• 15276: X64121
  H. sapiens PVR gene for poliovirus receptor (exon 6)
  gi|35817|emb|X64121.1|HSPVR6G[35817]
• 15277: X64120
  H. sapiens PVR gene for poliovirus receptor (exon 5)
  gi|35816|emb|X64120.1|HSPVR5G[35816]
• 15278: X64119
  H. sapiens PVR gene for poliovirus receptor (exon 4)
  gi|35815|emb|X64119.1|HSPVR4G[35815]
• 15279: X64118
  H. sapiens PVR gene for poliovirus receptor (exon 3)
  gi|35814|emb|X64118.1|HSPVR3G[35814]
• 15280: X64117
  H. sapiens PVR gene for poliovirus receptor (exon 2)
  gi|35813|emb|X64117.1|HSPVR2G[35813]
• 15281: X64116
  H. sapiens PVR gene for poliovirus receptor (exon 1)
  gi|35809|emb|X64116.1|HSPVR1G[35809]
• 15283: X75208
  H. sapiens HEK2 mRNA for protein tyrosine kinase receptor
  gi|406867|emb|X75208.1|HSPTKR[406867]
• 15284: X65178
  H. sapiens gene for substance P receptor (exon 2)
  gi|35653|emb|X65178.1|HSPREC2G[35653]
• 15285: X94226
  H. sapiens poliovirus receptor gene
  gi|1185121|emb|X94226.1|HSPOLR[1185121]
• 15288: X73079
  Homo sapiens encoding Polymeric immunoglobulin receptor
  gi|456345|emb|X73079.1|HSPIR[456345]
• 15291: X68596
  H. sapiens mRNA for parathyroid hormone receptor
  gi|396812|emb|X68596.1|HSPHR[396812]
• 15302: X76079
  H. sapiens mRNA for platelet derived growth factor alpha receptor
  gi|433494|emb|X76079.1|HSPDGF[433494]
• 15311: Z49993
  H. sapiens partial gene for proteinase-activated receptor 2 (292 BP)
  gi|1008084|emb|Z49993.1|HSPAR2A[1008084]
• 15321: X80022
  H. sapiens p75 TNF receptor, exon 2
  gi|666045|emb|X80022.1|HSP75NFR2[666045]
• 15322: X80021
  H. sapiens p75 TNF receptor, exon 1
  gi|666044|emb|X80021.1|HSP75NFR1[666044]
• 15323: X69810
  H. sapiens gene for p55 tumor necrosis factor receptor, exon 1
  gi|288493|emb|X69810.1|HSP55TNF[288493]
• 15324: X83688
  H. sapiens mRNA for ATP receptor
  gi|1166437|emb|X83688.1|HSP2XRCPR[1166437]
• 15325: X77130
  H. sapiens mRNA for ORL1 receptor
  gi|471316|emb|X77130.1|HSORL1[471316]
• 15327: X71635
  H. sapiens mRNA for neuropeptide Y-like receptor
  gi|297099|emb|X71635.1|HSNPYRLA[297099]
• 15328: X71445
  H. sapiens partial NTRK1 gene, involved in oncogenic rearrangements
  gi|296536|emb|X71445.1|HSNTRK1[296536]
• 15329: X66945
  H. sapiens N-sam mRNA for fibroblast growth factor receptor
  gi|35109|emb|X66945.1|HSNSAMTK[35109]
• 15330: X75918
  H. sapiens mRNA for NOT
  gi|415822|emb|X75918.1|HSNOT[415822]
• 15331: Z32774
  H. sapiens gene for N-methyl-D-aspartate receptor R1 exons 6-21
  gi|807894|emb|Z32774.1|HSNMDAR1C[807894]
• 15332: Z32773
  H. sapiens gene for N-methyl-D-aspartate receptor R1 exons 3, 4, 5
  gi|807893|emb|Z32773.1|HSNMDAR1B[807893]
• 15333: Z32772
  H. sapiens gene for N-methyl-D-aspartate receptor R1, exon1, exon2
  gi|807892|emb|Z32772.1|HSNMDAR1A[807892]
• 15334: X68275
  H. sapiens mRNA for nicotinic receptor beta 4 subunit
  gi|35054|emb|X68275.1|HSNICRB[35054]
• 15335: X65176
  H. sapiens gene for neuromedin K receptor (exon 5)
  gi|35027|emb|X65176.1|HSNEURK5[35027]
• 15336: X65175
  H. sapiens gene for neuromedin K receptor (exon 4)
  gi|35026|emb|X65175.1|HSNEURK4[35026]
• 15337: X65174
  H. sapiens gene for neuromedin K receptor (exon 3)
  gi|35025|emb|X65174.1|HSNEURK3[35025]
• 15338: X65173
  H. sapiens gene for neuromedin K receptor (exon 2)
  gi|35024|emb|X65173.1|HSNEURK2[35024]
• 15339: X65172
  H. sapiens gene for neuromedin K receptor (exon 1)
  gi|35022|emb|X65172.1|HSNEURK1[35022]
• 15340: X87629
  H. sapiens mRNA for nicotinic acetylcholine receptor alpha4 subunit
  gi|854158|emb|X87629.1|HSNACRA4G[854158]
• 15341: X70108
  H. sapiens gene for nicotinic acetylcholine receptor alpha subunit, partial
  gi|312470|emb|X70108.1|HSNACHRA[312470]
• 15342: X67513
  H. sapiens mRNA for neuronal nAChR beta-3 subunit
  gi|34987|emb|X67513.1|HSNACHRB3[34987]
• 15343: X53559
  H. sapiens Hachr alpha-3 mRNA for mature neuronal nicotinic acetylcholine receptor alpha-3 subunit
  gi|34985|emb|X53559.1|HSNACHRA3[34985]
• 15344: X63131
  H. sapiens My1 (PML) mRNA
  gi|34813|emb|X63131.1|HSMY1[34813]
• 15345: X65634
  H. sapiens MSH-R gene for melanocyte stimulating hormone receptor
  gi|34790|emb|X65634.1HSMSHR[34790]
• 15346: X64878
  H. sapiens mRNA for oxytocin receptor
  gi|34764|emb|X64878.1|HSMRNAOXY[34764]
• 15347: X84709
  H. sapiens mRNA for mediator of receptor-induced toxicity
  gi|791037|emb|X84709.1|HSMRINTX[791037]
• 15348: X55635
  H. sapiens mRNA for macrophage mannose receptor
  gi|34702|emb|X55635.1|HSMMR[34702]
• 15349: Z25470
  H. sapiens melanocortin 5 receptor gene, complete CDS
  gi|939924|emb|Z25470.1|HSMELRECA[939924]
• 15350: X68829
  H. sapiens mRNA for MDR15 protein
  gi|840783|emb|X68829.1|HSMDCR[840783]
• 15351: X61615
  H. sapiens mRNA for leukemia inhibitory factor (LIF) receptor
  gi|34365|emb|X61615.1|HSLIFR[34365]
• 15374: X86128
  H. sapiens mRNA for ood T lymphocyte
  gi|1197254|emb|X86128.1|HSLAB2725[1197254]
• 15375: Z30428
  H. sapiens gene for early lymphocyte activation antigen CD69, exon 5
  gi|536775|emb|Z30428.1|HSLACD695[536775]
• 15376: Z30430
  H. sapiens gene for early lymphocyte activation antigen CD69, exon 2
  gi|535122|emb|Z30430.1|HSLACD692[535122]
• 15398: X69304
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 4
  gi|34093|emb|X69304.1HSKITPO04[34093]
• 15399: X69303
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 3
  gi|34092|emb|X69303.1|HSKITPO03[34092]
• 15400: X69302
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 2
  gi|34091|emb|X69302.1|HSKITPO02[34091]
• 15401: X69301
  H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 1
  gi|34089|emb|X69301.1|HSKITPO01[34089]
• 15405: X03138
  H. sapiens interleukin 2 receptor gene exon 8 and 3′ untranslated region
  gi|33830|emb|X03138.1|HSIL2RG8[33830]
• 15406: X03137
  H. sapiens interleukin 2 receptor gene exon 7
  gi|33829|emb|X03137.1|HSIL2RG7[33829]
• 15407: X03136
  H. sapiens interleukin 2 receptor gene exon 6
  gi|33827|emb|X03136.1|HSIL2RG6[33827]
• 15408: X03135
  H. sapiens interleukin 2 receptor gene exon 5
  gi|33825|emb|X03135.1|HSIL2RG5[33825]
• 15409: X03134
  H. sapiens interleukin 2 receptor gene exon 4
  gi|33823|emb|X03134.1|HSIL2RG4[33823]
• 15410: X03133
  H. sapiens interleukin 2 receptor gene exon 3
  gi|33822|emb|X03133.1|HSIL2RG3[33822]
• 15411: X03132
  H. sapiens interleukin 2 receptor gene exon 2
  gi|33820|emb|X03132.1|HSIL2RG2[33820]
• 15412: X84348
  H. sapiens mRNA for intracellular IL-1 receptor antagonist type II
  gi|1008970|emb|X84348.1|HSIL1RAII[1008970]
• 15413: Z46595
  H. sapiens mRNA for interleukin 11 receptor isoform (incomplete)
  gi|995655|emb|Z46595.1|HSIL11RR[995655]
• 15414: Z38102
  H. sapiens mRNA for interleukin-11 receptor
  gi|995653|emb|Z38102.1|HSIL11RM[995653]
• 15415: Z46596
  H. sapiens gene for interleukin 11 receptor
  gi|995652|emb|Z46596.1|HSIL11RGN[995652]
• 15416: X59770
  H. sapiens IL-1R2 mRNA for type II interleukin-1 receptor, (cell line CB23)
  gi|33796|emb|X59770.1|HSIL1R211[33796]
• 15421: X77722
  H. sapiens mRNA for interferon alpha/beta receptor
  gi|488363|emb|X77722.1|HSIFNABR[488363]
• 15423: X53296
  H. sapiens mRNA for IRAP
  gi|32578|emb|X53296.1|HSI1RAP[32578]
• 15424: X52015
  H. sapiens mRNA for interleukin-1 receptor antagonist
  gi|32576|emb|X52015.1|HSI1RA[32576]
• 15425: X64993
  H. sapiens mRNA HTPCRX19 for olfactory receptor
  gi|32523|emb|X64993.1|HSHTPRX19[32523]
• 15426: X64992
  H. sapiens mRNA HTPCRX18 for olfactory receptor
  gi|32522|emb|X64992.1|HSHTPRX18[32522]
• 15427: X64991
  H. sapiens mRNA HTPCRX17 for olfactory receptor
  gi|32521|emb|X64991.1|HSHTPRX17[32521]
• 15428: X64990
  H. sapiens mRNA HTPCRX16 for olfactory receptor
  gi|32520|emb|X64990.1|HSHTPRX16[32520]
• 15429: X64989
  H. sapiens mRNA HTPCRX15 for olfactory receptor
  gi|32519|emb|X64989.1|HSHTPRX15[32519]
• 15430: X64988
  H. sapiens mRNA HTPCRX14 for olfactory receptor
  gi|32518|emb|X64988.1|HSHTPRX14[32518]
• 15431: X64987
  H. sapiens mRNA HTPCRX13 for olfactory receptor
  gi|32517|emb|X64987.1|HSHTPRX13[32517]
• 15432: X64986
  H. sapiens mRNA HTPCRX12 for olfactory receptor
  gi|32516|emb|X64986.1|HSHTPRX12[32516]
• 15433: X64985
  H. sapiens mRNA HTPCRX11 for olfactory receptor
  gi|32515|emb|X64985.1|HSHTPRX11[32515]
• 15434: X64984
  H. sapiens mRNA HTPCRX10 for olfactory receptor
  gi|32514|emb|X64984.1|HSHTPRX10[32514]
• 15435: X64983
  H. sapiens mRNA HTPCRX09 for olfactory receptor
  gi|32513|emb|X64983.1|HSHTPRX09[32513]
• 15436: X64982
  H. sapiens mRNA HTPCRX06 for olfactory receptor
  gi|32512|emb|X64982.1|HSHTPRX06[32512]
• 15437: X64981
  H. sapiens mRNA HTPCRX03 for olfactory receptor
  gi|32511|emb|X64981.1|HSHTPRX03[32511]
• 15438: X64980
  H. sapiens mRNA HTPCRX02 for olfactory receptor
  gi|32510|emb|X64Y80.1|HSHTPRX02[32510]
• 15439: X64979
  H. sapiens mRNA HTPCRX01 for olfactory receptor
  gi|32509|emb|X64979.1|HSHTPRX01[32509]
• 15440: X64974
  H. sapiens mRNA HTPCRH02 for olfactory receptor
  gi|32508|emb|X64974.1|HSHTPRH02[32508]
• 15441: X64978
  H. sapiens mRNA HTPCRH07 for olfactory receptor
  gi|32507|emb|X64978.1|HSHTPRH07[32507]
• 15442: X64977
  H. sapiens mRNA HTPCRH06 for olfactory receptor
  gi|32506|emb|X64977.1|HSHTPRH06[32506]
• 15443: X64976
  H. sapiens mRNA HTPCRH04 for olfactory receptor
  gi|32505|emb|X64976.1|HSHTPRH04[32505]
• 15444: X64975
  H. sapiens mRNA HTPCRH03 for olfactory receptor
  gi|32504|emb|X64975.1|HSHTPRH03[32504]
• 15445: X58288
  H. sapiens hR-PTPu gene for protein tyrosine phosphatase
  gi|32455|emb|X58288.1|HSHRPTPU[32455]
• 15449: X64995
  H. sapiens HGMP07J gene for olfactory receptor
  gi|32092|emb|X64995.1|HSHGMP07J[32092]
• 15450: X64994
  H. sapiens HGMP07I gene for olfactory receptor
  gi|32085|emb|X64994.1|HSHGM071[32085]
• 15451: X17653
  H. sapiens hFcRII-C isoform mRNA for IgG Fc receptor hFcRII
  gi|32076|emb|X17653.1|HSHFCRIIC[32076]
• 15452: X17652
  H. sapiens hFcRII-B isoform mRNA for IgG Fc receptor hFcRII
  gi|32073|emb|X17652.1|HSHFCRIIB[32073]
• 15453: X53364
  H. sapiens HePTP mRNA for tyrosine phosphatase
  gi|32066|emb|X53364.1|HSHEPTP[32066]
• 15454: X64830
  H. sapiens mRNA for GLU-R2 glutamate receptor subunit, ‘flop’ exon
  gi|31911|emb|X64830.1|HSGRSFLOP[31911]
• 15455: X64829
  H. sapiens mRNA for GLU-R2 glutamate receptor subunit, ‘flip’ exon
  gi|31910|emb|X64829.1|HSGRSFLIP[31910]
• 15456: X75897
  H. sapiens mRNA for G-protein coupled kinase 4
  gi|483764|emb|X75897.1|HSGRK4[483764]
• 15460: X52009
  H. sapiens alpha-1 strychnine binding subunit of inhibitory glycine receptor mRNA
  gi|3185|emb|X52009.1|HSGLYRA2[31850]
• 15461: X52008
  H. sapiens alpha-2 strychnine binding subunit of inhibitory glycine receptor mRNA
  gi|31848|emb|X52008.1|HSGLYRA1[31848]
• 15462: X82068
  H. sapiens mRNA for glutamate receptor subunit GluRC
  gi|558587|emb|X82068.1|HSGLURC[558587]
• 15463: X58633
  H. sapiens mRNA for glutamate receptor GLUR1
  gi|414892|emb|X58633.1|HSGLUR1[414892]
• 15464: X81832
  H. sapiens mRNA for glucose-dependant insulinotropic polypeptide receptor gene
  gi|11030050 emb|X81832.1|HSGDIPR[1030050]
• 15465: X61656
  H. sapiens mRNA for growth factor receptor tyrosine kinase
  gi|31717|emb|X61656.1|HSGFRTK[31717]
• 15466: X55037
  H. sapiens GATA-3 mRNA
  gi|31661|emb|X55037.1|HSGATA3[31661]
• 15467: X63670
  H. sapiens DNA sequence for polymorphism at the GABA receptor B3
  gi|31638|emb|X63670.1|HSGABRB3[31638]
• 15472: Z34260
  H. sapiens DNA for follicle stimulating hormone (FSH) receptor
  gi|1052701|emb|Z34260.1|HSFSHX1[1052701]
• 15473: X68044
  H. sapiens mRNA for follicle-stimulating hormone receptor
  gi|31473|emb|X68044.1|HSFSTHR[31473]
• 15474: Z46619
  H. sapiens mRNA for immunoglobulin kappa chain (fsa10)
  gi|575235|emb|Z46619.1|HSFSA10KA[575235]
• 15475: Z46615
  H. sapiens DNA for immunoglobulin kappa chain (fsa10glk)
  gi|575234|emb|Z46615.1|HSFSA10GL[575234]
• 15476: Z32633
  H. sapiens FRGAMMA′ mRNA for folate receptor (817 bp)
  gi|474060|emb|Z32633.1|HSFRGAM2[474060]
• 15477: Z32564
  H. sapiens FRGAMMA mRNA (819 bp) for folate receptor
  gi|473235|emb|Z32564.1|HSFRGAM1[473235]
• 15478: X69878
  H. sapiens Flt4 mRNA for transmembrane tyrosine kinase
  gi|297049|emb|X69878.1|HSFLT4X[297049]
• 15479: X68203
  H. sapiens mRNA for FLT4, class III receptor tyrosine kinase
  gi|31433|emb|X68203.1|HSFLT4[31433]
• 15480: X62573
  H. sapiens RNA for Fc receptor, TC9
  gi|31339|emb|X62573.1|HSFCTC6[31339]
• 15481: X66187
  H. sapiens FceRI mRNA, partial CDS
  gi|396463|emb|X66187.1|HSFCERIGB[396463]
• 15482: X62572
  H. sapiens RNA for Fc receptor, PC23
  gi|31328|emb|X62572.1|HSFCPC23[31328]
• 15483: Z46618
  H. sapiens mRNA for immunoglobulin lambda chain (f29)
  gi|575230|emb|Z46618.1|HSF29LAM[575230]
• 15484: Z46634
  H. sapiens mRNA for immunoglobulin kappa chain (f29)
  gi|575228|emb|Z46634.1|HSF29KAP[575228]
• 15485: X61950
  H. sapiens mRNA for endothelin-1 receptor
  gi|288312|emb|X61950.1|HSET1R[288312]
• 15486: X83863
  H. sapiens mRNA for prostaglandin E receptor (EP3f)
  gi|633219|emb|X83863.1|HSEP3F[633219]
• 15487: X83862
  H. sapiens mRNA for prostaglandin E receptor (EP3e)
  gi|633217|emb|X83862.1|HSEP3E[633217]
• 15488: X83861
  H. sapiens mRNA for prostaglandin E receptor (EP3d)
  gi|633215|emb|X83861.1|HSEP3D[633215]
• 15489: X83860
  H. sapiens mRNA for prostaglandin E receptor (EP3c)
  gi|633213|emb|X83860.1|HSEP3C[633213]
• 15490: X83859
  H. sapiens mRNA for prostaglandin E receptor (EP3b)
  gi|633211|emb|X83859.1|HSEP3B[633211]
• 15491: X83858
  H. sapiens mRNA for prostaglandin E receptor (EP3a2)
  gi|633209|emb|X83858.1|HSEP3A2[633209]
• 15492: X83857
  H. sapiens mRNA for prostaglandin E receptor (EP3a1)
  gi|633207|emb|X83857.1HSEP3A1[633207]
• 15493: X83868
  H. sapiens mRNA for EP2 prostaglandin receptor
  gi|633205|emb|X83868.1|HSEP2PR[633205]
• 15494: X81479
  H. sapiens mRNA for EMR1 hormone receptor
  gi|784993|emb|X81479.1|HSEMR1[784993]
• 15518: Z28613
  H. sapiens (dhpa215) cacnl2a gene for dihydropyridine receptor alpha-2 subunit
  gi|472953|emb|Z28613.1|HSDPRA25[472953]
• 15519: Z28609
  H. sapiens (dhpa22hd) cacnl2a gene for dihydropyridine receptor alpha 2-subunit
  gi|472952|emb|Z28609.1|HSDPRA24[472952]
• 15520: Z28605
  H. sapiens (dhpa23) cacnl2a gene for dihydropyridine receptor alpha2 subunit
  gi|472951|emb|Z28605.1|HSDPRA23[472951]
• 15521: Z28602
  H. sapiens (dhpa21hb) cacnl2a gene for dihydropyridine receptor alpha 2-subunit
  gi|472950|emb|Z28602.1|HSDPRA22[472950]
• 15522: Z28599
  H. sapiens (a225eh) cacnl2a gene for dihydropyridine receptor alpha2 subunit
  gi|472949|emb|Z28599.1|HSDPRA21[472949]
• 15526: X55758
  H. sapiens dopamine D1 receptor gene
  gi|288931|emb|X55758.1|HSDOPD1[288931]
• 15529: Z23025
  H. sapiens cacnl1a3 gene encoding skeletal muscle DHP-receptor alpha 1 subunit (exon)
  gi|312285|emb|Z23025.1|HSDHPRA1S[312285]
• 15530: X84076
  H. sapiens mRNA for DGCR2
  gi|80902|emb|X84076.1|HSDGCR2[809021]
• 15532: X63523
  H. sapiens mRNA DAUD16 3′-region
  gi|30449|emb|X63523.1|HSDAUDI63[30449]
• 15533: X66171
  H. sapiens CMRF35 mRNA, complete CDS
  gi|396169|emb|X66171.1|HSCMRF35A[396169]
• 15534: Z23141
  H. sapiens CHRNA7 mRNA, 3′ end
  gi|457736|emb|Z23141.1|HSCHRNA7A[457736]
• 15550: X56777
  H. sapiens mRNA for ZP3 gene
  gi|297790|emb|X56777.1|HSZP3G[297790]
• 15551: X77155
  H. sapiens genomic DNA (YAC end 63 with high affinity Fc-receptor for IgG)
  gi|450533|emb|X77155.1|HSYACFC[450533]
• 15582: M31165
  Human tumor necrosis factor-inducible (TSG-6) mRNA fragment, adhesion receptor
  CD44 putative CDS
  gi|339994|gb|M31165.1|HUMTSG6A[339994]
• 15594: A31613
  H. sapiens beta-adrenergic receptor gene
  gi|1247565|emb|A31613.1|A31613[1247565]
• 15595: A29216
  H. sapiens DNA for bFGF receptor from patent WO9111459
  gi|1247528|emb|A29216.1|A29216[1247528]
• 15596: A29103
  H. sapiens mRNA for TNF-binding polypeptide from patent EP0393438
  gi|1247517|emb|A29103.1|A29103[1247517]
• 15597: A28489
  H. sapiens mRNA for IL-2R-beta-chain from patent EP0395853
  gi|1247509|emb|A28489.1|A28489[1247509]
• 15598: A28003
  H. sapiens HEK gene
  gi|1247486|emb|A28003.1|A28003[1247486]
• 15599: A27284
  H. sapiens TGR-CLH
  gi|1247482|emb|A27284.1|A27284[1247482]
• 15600: A27280
  H. sapiens TGR-CL3
  gi|1247480|emb|A27280.1|A27280[1247480]
• 15601: A27274
  H. sapiens TGR-CL11/TGR-C15
  gi|1247478|emb|A27274.1|A27274[1247478]
• 15602: A27272
  H. sapiens TGR-CL11
  gi|1247476|emb|A27272.1|A27272[1247476]
• 15603: A27268
  H. sapiens TGR-CL10
  gi|1247474|emb|A27268.1|A27268[1247474]
• 15604: A27266
  H. sapiens TGR-CL7
  gi|1247472|emb|A27266.1|A27266[1247472]
• 15605: A27264
  H. sapiens TGR-CL6
  gi|1247470|emb|A27264.1|A27264[1247470]
• 15606: A27262
  H. sapiens TGR-CL5bis
  gi|1247468|emb|A27262.1|A27262[1247468]
• 15607: A27260
  H. sapiens TGR-CL4
  gi|1247466|emb|A27260.1|A27260[1247466]
• 15608: A27258
  H. sapiens TGR-CL1bis
  gi|1247464|emb|A27258.1|A27258[1247464]
• 15609: A19671
  H. sapiens DNA for D3 receptor fragment
  gi|579581|emb|A19671.1|A19671[579581]
• 15610: A19670
  H. sapiens DNA for D3 receptor fragment
  gi|579580|emb|A19670.1|A19670[579580]
• 15611: A19667
  H. sapiens gene for dopaminergic receptor D-3
  gi|579578|emb|A19667.1|A19667[579578]
• 15612: A09781
  H. sapiens (clone 18-4-3) mRNA interferon-gamma receptor segment
  gi|412192|emb|A09781.1|A09781[412192]
• 15613: A09779
  H. sapiens (clone 15-21-1) mRNA for interferon-gamma receptor segment binding interferon-gamma
  gi|412190|emb|A09779.1|A09779[412190]
• 15614: A07799
  H. sapiens IL-2R-beta mRNA for interleukin-2 beta-chain
  gi|1247399|emb|A07799.1|A07799[1247399]
• 15615: A07801
  H. sapiens IL-2R-beta mRNA for interleukin-2 beta-chain
  gi|490067|emb|A07801.1|A07801[490067]
• 15616: A07795
  H. sapiens IL-2R-beta mRNA for interleukin-2 receptor beta-chain
  gi|412175|emb|A07795.1|A07795[412175]
• 15617: L11573
  Human surfactant protein B mRNA, complete cds
  gi|1220354|gb|L11573.1|HUMPSPBQ[1220354]
• 15618: L40625
  Homo sapiens sulfonylurea receptor (SUR) mRNA, 3′ end of cds
  gi|784881|gb|L40625.1|HUMSUR[784881]
• 15620: L34579
  Homo sapiens (clone HCl) angiotensin II type-2 receptor (AGTR2) gene, complete
  cds
  gi|510700|gb|L34579.1|HUMAIRS[510700]
• 15621: X97058
  H. sapiens mRNA for P2Y6 receptor
  gi|1296659|emb|X97058.1|HSP2Y6[1296659]
• 15622: X96588
  H. sapiens mRNA for H-RYK receptor tyrosine kinase
  gi|1296649|emb|X96588.1|HSHRYKG[1296649]
• 15623: X80391
  H. sapiens OR17-40 gene
  gi|516319|emb|X80391.1|HSOR1740[516319]
• 15624: L41690
  Homo sapiens TNF receptor-1 associated protein (TRADD) mRNA, 3′ end of cds
  gi|808914|gb|L41690.1|HUMTRADD[808914]
• 15630: X89746
  H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 6
  gi|1279464|emb|X89746.1|HSCHRNA46[1279464]
• 15631: X89745
  H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 5
  gi|1279463|emb|X89745.1|HSCHRNA45[1279463]
• 15632: X89743
  H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 3
  gi|1279461|emb|X89743.1|HSCHRNA43[1279461]
• 15633: X89742
  H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 2
  gi|1279460|emb|X89742.1|HSCHRNA42[1279460]
• 15634: X89741
  H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 1
  gi|1279458|emb|X89741.1|HSCHRNA41[1279458]
• 15644: M21574
  Human platelet-derived growth factor receptor alpha (PDGFRA) mRNA, complete cds
  gi|189733|gb|M21574.1|HUMPDGFRAA[189733]
• 15645: X94635
  H. sapiens CD97 gene exon 8
  gi|4379070|emb|X94635.1|HSX94635[4379070]
• 15646: X94638
  H. sapiens CD97 gene exon 11
  gi|165091|emb|X94638.1|HSX94638[1165091]
• 15647: X94637
  H. sapiens CD97 gene exon 10
  gi|1165090|emb|X94637.1|HSX94637[1165090]
• 15648: X94636
  H. sapiens CD97 gene exon 9
  gi|1165089|emb|X94636.1|HSX94636[1165089]
• 15649: X94631
  H. sapiens CD97 gene exon 2
  gi|1165084|emb|X94631.1|HSX94631[1165084]
• 15650: X94646
  H. sapiens CD97 gene exon 19
  gi|1165082|emb|X94646.1|HSX94646[1165082]
• 15651: X94645
  H. sapiens CD97 gene exon 18
  gi|1165081|emb|X94645.1|HSX94645[1165081]
• 15652: X94644
  H. sapiens CD97 gene exon 17
  gi|1165080|emb|X94644.1|HSX94644[1165080]
• 15653: X94643
  H. sapiens CD97 gene exon 16
  gi|1165079|emb|X94643.1|HSX94643[1165079]
• 15654: X94642
  H. sapiens CD97 gene exon 15
  gi|1165078|emb|X94642.1|HSX94642[1165078]
• 15655: X94641
  H. sapiens CD97 gene exon 14
  gi|1165077|emb|X94641.1|HSX94641[1165077]
• 15656: X94640
  H. sapiens CD97 gene exon 13
  gi|1165076|emb|X94640.1|HSX94640[1165076]
• 15657: X94639
  H. sapiens CD97 gene exon 12
  gi|1165075|emb|X94639.1|HSX94639[1165075]
• 15658: L40949
  Homo sapiens (clone AT7-5eu) opioid-receptor-like protein mRNA, 5′ end
  gi|725265|gb|L40949.1|HUMOPRLP[725265]
• 15659: X57282
  H. sapiens mRNA for soluble erythropoietin receptor
  gi|36426|emb|X57282.1|HSSER[36426]
• 15660: Z66526
  H. sapiens pancreatic polypeptide receptor PP1 gene
  gi|1107699|emb|Z66526.1|HSPP1GN[1107699]
• 15661: X89013
  H. sapiens gene for anti-mullerian hormone type II receptor
  gi|1212943|emb|X89013.1|HSDNAAMHI[1212943]
• 15662: X86163
  H. sapiens mRNA for B2-bradykinin receptor, 3′
  gi|1220163|emb|X86163.1|HSB2BRRNA[1220163]
• 15663: X86165
  H. sapiens mRNA for B2-bradykinin receptor, R14 allele
  gi|1220160|emb|X86165.1|HSB2BRR14[1220160]
• 15664: X86164
  H. sapiens mRNA for B2-bradykinin receptor, C14 allele
  gi|1220155|emb|X86164.1|HSB2BRC14[1220155]
• 15665: L08187
  Human cytokine receptor (EBI3) mRNA, complete cds
  gi|632973|gb|L08187.1|HUMEBI3X[632973]
• 15666: L41147
  Homo sapiens 5-HT6 serotonin receptor mRNA, complete cds
  gi|1162923|gb|L41147.1|HUM5HSR[1162923]
• 15698: X84755
  H. sapiens LHCGR gene, exon 3
  gi|1225986|emb|X84755.1|HSLHCGRX3[1225986]
• 15699: L25829
  Human platelet-derived growth factor alpha-receptor (PDGFRA) mRNA, exons 13-gi|1220351|gb|L25829.1|HUMPDGFRAX[1220351]
• 15700: L07746
  Human cholecystokinin B receptor (CCK-B) mRNA, complete cds
  gi|1220298|gb|L07746.1|HUMCCKBR[1220298]
• 15701: X86172
  H. sapiens B2-bradykinin receptor gene, exon 3, allele R48
  gi|220162|emb|X86172.1|HSB2BRR48[1220162]
• 15702: X86180
  H. sapiens B2-bradykinin receptor gene, promoter region and exon 1
  gi|1220159|emb|X86180.1|HSB2BRPX1[1220159]
• 15703: X86173
  H. sapiens B2-bradykinin receptor gene, promotor region and exon 1
  gi|220158|emb|X86173.1|HSB2BREX11[1220158]
• 15704: X86162
  H. sapiens B2-bradykinin receptor gene, 3′
  gi|1220157|emb|X86162.1|HSB2BRDNA[1220157]
• 15705: X86171
  H. sapiens B2-bradykinin receptor gene, exon 3, BE3-R43 allele
  gi|1220154|emb|X86171.1|HSB2BRBE3[1220154]
• 15706: X86170
  H. sapiens B2-bradykinin receptor gene, exon 2, T allele
  gi|1220153|emb|X86170.1|HSB2BRAXT[1220153]
• 15707: X86168
  H. sapiens B2-bradykinin receptor gene, exon 1, 3T allele
  gi|1220152|emb|X86168.1|HSB2BR3T[1220152]
• 15708: X86167
  H. sapiens B2-bradykinin receptor gene, exon 1, 3G allele
  gi|1220151|emb|X86167.1|HSB2BR3G[1220151]
• 15709: X86166
  H. sapiens B2-bradykinin receptor gene, exon 1, 2G allele
  gi|1220150|emb|X86166.1|HSB2BR2G[1220150]
• 15710: Z69891
  H. sapiens mRNA (clone ICRFp507G10101)
  gi|1213610|emb|Z69891.1|HSBRN3B2[1213610]
• 15711: L18983
  Homo sapiens tyrosine phosphatase (IA-2/PTP) mRNA, complete cds
  gi|662362|gb|L18983.1|HUMTYROPHO[662362]
• 15712: L76224
  Homo sapiens NMDA receptor mRNA, complete cds
  gi|1196448|gb|L76224.1|HUMNMRE[1196448]
• 15715: M73481
  Human gastrin releasing peptide receptor (GRPR) mRNA, complete cds
  gi|183649|gb|M73481.1|HUMGRPR[183649]
• 15717: M30625
  Human dopamine D2 receptor, mRNA, complete cds
  gi|181431|gb|M30625.1|HUMD2A[181431]
• 15718: J02960
  Human beta-2-adrenergic receptor gene, complete cds
  gi|178203|gb|J02960.1|HUMADRBRA[178203]
• 15719: M15169
  Human beta-2-adrenergic receptor mRNA, complete cds
• 15720: L18973
  Human acetylcholine receptor mRNA, partial cds
  gi|441143|gb|L18973.1|HUMACETYL[441143]
• 15723: M73969
  Human interleukin-8 receptor type B (IL8RB) mRNA, complete cds
  gi|186516|gb|M73969.1|HUMINTLEU8[186516]
• 15752: L35233
  Homo sapiens autocrine motility factor receptor (AMFR) mRNA, complete cds
  gi|521220|gb|L35233.1|HUMNGP78A[521220]
• 15754: U35399
  Human G protein-coupled receptor mRNA, complete cds
  gi|1015420|gb|U35399.1|HSU35399[1015420]
• 15755: L35318
  Human rearranged metabotropic glutamate receptor type II (GLUR2) mRNA, complete
  cds
  gi|999415|gb|L35318.1|HUMGLUR2A[999415]
• 15756: M11730
  Human tyrosine kinase-type receptor (HER2) mRNA, complete cds
  gi|183986|gb|M11730.1|HUMHER2A[183986]
• 15759: U33017
  Human signaling lymphocytic activation molecule (SLAM) mRNA, complete cds
  gi|984968|gb|U33017.1|HSU33017[984968]
• 15761: L47220
  Homo sapiens inositol triphosphate receptor type 1 gene fragment
  gi|976275|gb|L47220.1|HUMITRT1F[976275]
• 15762: M37722
  Human shorter form basic fibroblast growth factor (bFGF) receptor mRNA, complete
  cds
  gi|179413|gb|M37722.1|HUMBFGFS[179413]
• 15765: L09753
  Homo sapiens CD30 ligand mRNA, complete cds
  gi|349277|gb|L09753.1|HUMCD30[349277]
• 15767: L36645
  Homo sapiens receptor protein-tyrosine kinase (HEK8) mRNA, complete cds
  gi|551613|gb|L36645.1|HUMRPTKC[551613]
• 15768: L36644
  Homo sapiens receptor protein-tyrosine kinase (HEK7) mRNA, 3′ end
  gi|551611|gb|L36644.1|HUMRPTKB[551611]
• 15769: L36643
  Homo sapiens receptor protein-tyrosine kinase (HEK5) mRNA, 3′ end
  gi|551609|gb|L36643.1|HUMRPTKA[551609]
• 15770: L36642
  Homo sapiens receptor protein-tyrosine kinase (HEK11) mRNA, complete cds
  gi|551607|gb|L36642.1|HUMRPTK[551607]
• 15771: L31581
  Human G protein-coupled receptor (EBI 1) mRNA, complete cds
  gi|468319|gb|L31581.1|HUMEBI1CDN[468319]
• 15772: L29301
  Homo sapiens opioid receptor mRNA, complete cds
  gi|459831|gb|L29301.1|HUMOPIOIDA[459831]
• 15773: L32831
  Homo sapiens G protein-coupled receptor (GPR3) gene, complete cds
  gi|602311|gb|L32831.1|HUMGPCRD[602311]
• 15774: L32830
  Homo sapiens G protein-coupled receptor (GPR3) gene, exon
  gi|602310|gb|L32830.1|HUMGPCRC[602310]
• 15775: M88461
  Human neuropeptide Y peptide YY receptor mRNA, complete cds
  gi|189155|gb|M88461.1|HUMNEYPEPY[189155]
• 15779: M73747
  Homo sapiens thyroid stimulating hormone receptor (TSHR) mRNA, complete cds
  gi|903759|gb|M73747.1|HUMTSHR[903759]
• 15780: M73746
  Homo sapiens lutropin/choriogonadotropin receptor (LHCGR) mRNA, complete cds
  gi|903745|gb|M73746.1|HUMLHCGR[903745]
• 15781: M90103
  Human (clones 18, 23, 27, 24) c-myeloproliferative leukemia virus type K (c-mpl-K) mRNA, complete cds
  gi|184262|gb|M90103.1|HSHMPLK[184262]
• 15782: M90102
  Human (clones 15, 39, 41) c-myeloproliferative leukemia virus type P (c-mpl-P)
  mRNA, complete cds
  gi|184260|gb|M90102.1|HSHMPLP[184260]
• 15796: M98512
  Human NFG genomic fragment
  gi|292359|gb|M98512.1|HUMNF1FRAG[292359]
• 15797: M98511
  Human NFE genomic fragment
  gi|292358|gb|M98511.1|HUMNF1FRAE[292358]
• 15798: M98510
  Human NFC genomic fragment
  gi|292357|gb|M98510.1|HUMNF1FRAC[292357]
• 15799: M98508
  Human NFA genomic fragment
  gi|292355|gb|M98508.1|HUMNF1FRAA[292355]
• 15801: L32662
  Human prostaglandin E2 receptor EP3 subtype isoform IV mRNA, complete cds
  gi|484163|gb|L32662.1|HUMEP3IV[484163]
• 15802: L32661
  Human prostaglandin E2 receptor EP3 subtype isoform III mRNA, 3′ end
  gi|48416|gb|L32661.1|HUMEP3III[484161]
• 15803: L32660
  Human prostaglandin E2 receptor EP3 subtype isoform II mRNA, partial cds
  gi|484159|gb|L32660.1|HUMEP3II[484159]
• 15822: L07594
  Human transforming growth factor-beta type III receptor (TGF-beta) mRNA, complete cds
  gi|818001|gb|L07594.1|HUMTGFB3C[818001]
• 15823: M83181
  Human serotonin receptor gene, complete cds
  gi|8080000gb|M83181.1|HUMHTRB[808000]
• 15824: M33602
  Human T-cell leukemia t(10:14) (q24:q11) chromosomal translocation
  gi|339907|gb|M33602.1|HUMTRANSX[339907]
• 15828: L37112
  Homo sapiens vasopressin V3 receptor mRNA, complete cds
  gi|791151|gb|L37112.1|HUMVVR[791151]
• 15829: L35901
  Human nicotinic acetylcholine receptor alpha 4 subunit (nAChR) mRNA, complete cds
  gi|755647|gb|L35901.1|HUMNACHR4A[755647]
• 15830: U13666
  Human G protein-coupled receptor (GPR1) gene, complete cds
  gi|577412|gb|U13666.1|HSU13666[577412]
• 15831: L35903
  Human dopamine D3 receptor gene, exon 6
  gi|532478|gb|L35903.1|UMDOPD30S2[532478]
• 15832: L35902
  Human dopamine D3 receptor gene, exon 5
  gi|532477|gb|L35902.1|UMDOPD30S1[532477]
• 15833: L37362
  Homo sapiens (clone d2-115) kappa opioid receptor (OPRK1) mRNA, complete cds
  gi|722617|gb|L37362.1|HUMOPRK1B[722617]
• 15834: L35545
  Homo sapiens endothelial cell protein C/APC receptor (EPCR) mRNA, complete cds
  gi|565267|gb|L35545.1|HUMECPC[565267]
• 15835: L36130
  Homo sapiens kappa opiate receptor mRNA, partial cds
  gi|598184|gb|L36130.1|HUMKOR[598184]
• 15836: L36150
  Homo sapiens G protein-coupled receptor (GPR6) gene, complete cds
  gi|598156|gb|L361500.1HUMGPR6A[598156]
• 15837: L36148
  Homo sapiens G protein-coupled receptor (GPR4) gene, complete cds
  gi|598152|gb|L36148.1|HUMGPR4A[598152]
• 15839: L36149
  Homo sapiens G protein-coupled receptor (GPR5) gene, complete cds
  gi|598154|gb|L36149.1|HUMGPR5A[598154]
• 15840: M64749
  Human homologue of the canine orphan receptor (RDC1) mRNA, 5′ end
  gi|292418|gb|M64749.1|HUMRDC1A[292418]
• 15841: L35848
  Homo sapiens IgE receptor beta chain (HTm4) mRNA, complete cds
  gi|561638|gb|L35848.1|HUMIERB[561638]
• 16011: L22431
  Human very low density lipoprotein receptor, complete cds
  gi|437386|gb|L22431.1|HUMVLDLRX[437386]
• 16012: M90366
  Human zona pellucida glycoprotein 2 (ZP2) mRNA, complete cds
  gi|292939|gb|M90366.1|HUMZP2GP[292939]
• 16015: M76125
  Human tyrosine kinase receptor (axl) mRNA, complete cds
  gi|292869|gb|M76125.1|HUMTYRKINR[292869]
• 16016: L04489
  Homo sapiens (clone NCD18) tumor necrosis factor receptor related protein mRNA,
  complete exon and repeat region
  gi|340022|gb|L04489.1|HUMTUMNEC[340022]
• 16017: M31163
  Human tumor necrosis factor-inducible (TSG-12) mRNA fragment
  gi|339990|gb|M31163.1|HUMTSG12A[339990]
• 16019: M75866
  Human tumor necrosis factor receptor 1 (TNFR1) gene, complete cds
  gi|339748|gb|M75866.1|HUMTNFR103[339748]
• 16020: M75865
  Human tumor necrosis factor receptor 1 (TNFR1) gene, exons 2-5
  gi|339747|gb|M75865.1|HUMTNFR102[339747]
• 16021: M75864
  Human tumor necrosis factor receptor 1 (TNFR1) gene, exon 1
  gi|339746|gb|M75864.1|HUMTNFR101[339746]
• 16026: M85079
  Human TGF-beta type II receptor mRNA, complete cds
  gi|339569|gb|M85079.1|HUMTGFBIIR[339569]
• 16027: L06139
  Homo sapiens receptor protein-tyrosine kinase (TEK) mRNA, complete cds
  gi|292823|gb|L06139.1|HUMTEKRPTK[292823]
• 16204: L29349
  Homo sapiens granulocyte-macrophage colony-stimulating factor receptor alpha-subunit 3 (GM-CSF-RA3) mRNA, complete cds
  gi|460284|gb|L29349.1|HUMGMCSA[460284]
• 16205: L29348
  Homo sapiens granulocyte-macrophage colony-stimulating factor receptor alpha-subunit soluble isoform 2 (GM-CSF-RAS2) mRNA, complete cds
  gi|460282|gb|L29348.1|HUMGMCS[460282]
• 16270: M74290
  Human substance P receptor protein mRNA
  gi|338612|gb|M74290.1|HUMSUBPRA[338612]
• 16271: M96738
  Human somatostatin receptor subtype 3 (SSTR3) gene, complete cds
  gi|338498|gb|M96738.1|HUMSSTR3X[338498]
• 16272: L13033
  Homo sapiens somatostatin receptor isoform 2 gene, alternatively spliced exon
  gi|292515|gb|L13033.1|HUMSSTR23X[292515]
• 16273: L07833
  Homo sapiens somatostatin receptor (SSTR4) gene, complete cds
  gi|307429|gb|L07833.1|HUMSOMATA[307429]
• 16274: L10126
  Human serine/threonine kinase receptor-2-3 (SKR2-3) mRNA, complete cds
  gi|558102|gb|L10126.1|HUMSKR23A[558102]
• 16275: L10125
  Human serine/threonine kinase receptor-2-2 (SKR2-2) mRNA, complete cds
  gi|558101|gb|L10125.1|HUMSKR22A[558101]
• 16276: J04132
  Human T cell receptor zeta-chain mRNA, complete cds
  gi|623041|gb|J04132.1|HUMTCRZCN[623041]
• 16277: M93221
  Human macrophage mannose receptor (MRC1) gene, exon 30
  gi|187332|gb|M93221.1|HUMMANR30[187332]
• 16278: M93220
  Human macrophage mannose receptor (MRC1) gene, exon 29
  gi|187331|gb|M93220.1|HUMMANR29[187331]
• 16279: M93219
  Human macrophage mannose receptor (MRC1) gene, exon 28
  gi|187330|gb|M93219.1|HUMMANR28[187330]
• 16280: M93218
  Human macrophage mannose receptor (MRC1) gene, exon 27
  gi|187329|gb|M93218.1|HUMMANR27[187329]
• 16281: M93217
  Human macrophage mannose receptor (MRC1) gene, exon 26
  gi|187328|gb|M93217.1|HUMMANR26[187328]
• 16282: M93216
  Human macrophage mannose receptor (MRC1) gene, exon 25
  gi|187327|gb|M93216.1|HUMMANR25[187327]
• 16283: M93215
  Human macrophage mannose receptor (MRC1) gene, exon 24
  gi|187326|gb|M93215.1|HUMMANR24[187326]
• 16284: M93214
  Human macrophage mannose receptor (MRC1) gene, exon 23
  gi|187325|gb|M93214.1|HUMMANR23[187325]
• 16285: M93213
  Human macrophage mannose receptor (MRC1) gene, exon 22
  gi|187324|gb|M93213.1|HUMMANR22[187324]
• 16286: M93212
  Human macrophage mannose receptor (MRC1) gene, exon 21
  gi|187323|gb|M93212.1|HUMMANR21[187323]
• 16287: M93211
  Human macrophage mannose receptor (MRC1) gene, exon 20
  gi|187322|gb|M93211.1|HUMMANR20[187322]
• 16288: M93210
  Human macrophage mannose receptor (MRC1) gene, exon 19
  gi|187321|gb|M93210.1|HUMMANR19[187321]
• 16289: M93209
  Human macrophage mannose receptor (MRC1) gene, exon 18
  gi|187320|gb|M93209.1|HUMMANR18[187320]
• 16290: M93208
  Human macrophage mannose receptor (MRC1) gene, exon 17
  gi|187319|gb|M93208.1|HUMMANR17[187319]
• 16291: M93207
  Human macrophage mannose receptor (MRC1) gene, exon 16
  gi|187318|gb|M93207.1|HUMMANR16[187318]
• 16292: M93206
  Human macrophage mannose receptor (MRC1) gene, exon 15
  gi|187317|gb|M93206.1|HUMMANR15[187317]
• 16293: M93205
  Human macrophage mannose receptor (MRC1) gene, exon 14
  gi|187316|gb|M93205.1|HUMMANR14[187316]
• 16294: M93204
  Human macrophage mannose receptor (MRC1) gene, exon 13
  gi|187315|gb|M93204.1|HUMMANR13[187315]
• 16295: M93203
  Human macrophage mannose receptor (MRC1) gene, exon 12
  gi|187314|gb|M93203.1|HUMMANR12[187314]
• 16296: M93202
  Human macrophage mannose receptor (MRC1) gene, exon 11
  gi|187313|gb|M93202.1|HUMMANR11[187313]
• 16297: M93201
  Human macrophage mannose receptor (MRC1) gene, exon 10
  gi|187312|gb|M93201.1|HUMMANR10[187312]
• 16298: M93200
  Human macrophage mannose receptor (MRC1) gene, exon 9
  gi|187311|gb|M93200.1|HUMMANR09[187311]
• 16299: M93199
  Human macrophage mannose receptor (MRC1) gene, exon 8
  gi|187310|gb|M93199.1|HUMMANR08[187310]
• 16300: M93198
  Human macrophage mannose receptor (MRC1) gene, exon 7
  gi|187309|gb|M93198.1|HUMMANR07[187309]
• 16301: M93197
  Human macrophage mannose receptor (MRC1) gene, exon 6
  gi|187308|gb|M93197.1|HUMMANR06[187308]
• 16302: M93196
  Human macrophage mannose receptor (MRC1) gene, exon 5
  gi|187307|gb|M93196.1|HUMMANR05[187307]
• 16303: M93195
  Human macrophage mannose receptor (MRC1) gene, exon 4
  gi|187306|gb|M93195.1|HUMMANR04[187306]
• 16304: M93194
  Human macrophage mannose receptor (MRC1) gene, exon 3
  gi|187305|gb|M93194.1HUMMANR03[187305]
• 16305: M93193
  Human macrophage mannose receptor (MRC1) gene, exon 2
  gi|187304|gb|M93193.1HUMMANR02[187304]
• 16306: M93192
  Human macrophage mannose receptor (MRC1) gene, exon 1
  gi|87303|gb|M93192.1|HUMMANR01[187303]
• 16307: L05198
  Homo sapiens insulin receptor substrate 1 (IRS1) gene, repeat polymorphism
  gi|307396|gb|L05198.1|HUMIRS1RPT[307396]
• 16308: M15365
  Human low density lipoprotein receptor mutant gene recombination site
  gi|187107|gb|M15365.1|HUMLDLRM[187107]
• 16309: M80637
  Human keratinocyte growth factor receptor gene, exon K
  gi|186758|gb|M80637.1|HUMKKGFRA[186758]
• 16310: M81778
  Human serotonin 5-HT1C receptor mRNA, complete cds
  gi|338027|gb|M81778.1|HUMSER5R[338027]
• 16311: M81590
  Homo sapiens serotonin 1D receptor (5-HT1D-) mRNA, complete cds
  gi|338025|gb|M81590.1|HUMSER1DRB[338025]
• 16312: M81589
  Homo sapiens serotonin 1D receptor (5-HT1D) mRNA, complete cds
  gi|338023|gb|M81589.1|HUMSER1DRA[338023]
• 16313: M91455
  Human ryanodine receptor (RYR1) gene, exons 17 and 18
  gi|337723|gb|M91455.1|HUMRYR1[337723]
• 16316: M97639
  Human transmembrane receptor (ror2) mRNA, complete cds
  gi|337466|gb|M97639.1|HUMROR2A[337466]
• 16317: M97675
  Human transmembrane receptor (ror1) mRNA, complete cds
  gi|337464|gb|M97675.1|HUMROR1A[337464]
• 16318: M74721
  Human B-cell antigen receptor (MB-1) mRNA, complete cds
  gi|337419|gb|M74721.1|HUMRIGMAMB[337419]
• 16319: M89796
  Human high affinity IgE receptor beta chain gene, complete cds
  gi|337417|gb|M89796.1|HUMRIGBCHA[337417]
• 16329: L09247
  Human receptor-type protein tyrosine phosphatase gamma (PTPRG) mRNA, complete cds
  gi|292410|gb|L09247.1|HUMPTPRG[292410]
• 16330: M93426
  Human protein tyrosine phosphatase zeta-polypeptide (PTPRZ) mRNA, complete cds
  gi|190743|gb|M93426.1|HUMPTPRZ[190743]
• 16331: M88177
  Human platelet activating factor receptor (PTAFR) gene, complete cds
  gi|190697|gb|M88177.1|HUMPTAFR[190697]
• 16332: L16862
  Homo sapiens G protein-coupled receptor kinase (GRK6) mRNA, complete cds
  gi|388766|gb|L16862.1|HUMPROCRKI[388766]
• 16333: M86528
  Human neurotrophin-4 (NT-4) gene, complete cds
  gi|190264|gb|M86528.1|HUMPPNT4P[190264]
• 16334: L07334
  Human platelet-activating factor receptor mRNA, complete cds
  gi|1190014gb|L07334.1|HUMPLACTFR[190014]
• 16335: L26976
  Human prostalandin receptor (PGE-2) mRNA, complete cds
  gi|473428|gb|L26976.1|HUMPGE2REP[473428]
• 16336: M88107
  Human formyl peptide receptor (FPR2) mRNA, complete cds
  gi|189862|gb|M88107.1|HUMPFPR2A[189862]
• 16337: M76674
  Human platelet activating factor receptor (PAFR) mRNA, complete cds
  gi|456293|gb|M76674.1|HUMPAFRX[456293]
• 16338: M80436
  Human platelet activating factor receptor mRNA, complete cds
  gi|189537|gb|M80436.1|HUMPAFR[189537]
• 16339: L26079
  Homo sapiens (clone hSR4-1) kappa opioid receptor (OPRK1) gene, complete exon
  gi|416143|gb|L26079.1|HUMOPRK1A[416143]
• 16340: L07615
  Human neuropeptide Y receptor Y1 (NPYY1) mRNA, exon 2-3 and complete cds
  gi|189284|gb|L07615.1|HUMNPYY1A2[189284]
• 16341: L07614
  Human neuropeptide Y receptor Y1 (NPYY1) mA, exon 1
  gi|189283|gb|L07614.1|PYY1A1[189283]
• 16342: M37981
  Human alpha-3 neuronal nicotinic acetylcholine receptor subunit mRNA, complete
  cds
  gi|189252|gb|M37981.1|HUMNNAR[189252]
• 16343: M73482
  Human neuromedin B receptor (NMB-R) mRNA, complete cds
  gi|18924|gb|M73482.1|HUMNMBR[189241]
• 16344: M76675
  Human neurokinin 1 receptor (NKIR) mRNA, complete cds
  gi|189231|gb|M76675.1|HUMNKIRX[189231]
• 16345: M81797
  Human NK-1 receptor mRNA, complete cds
  gi|189213|gb|M81797.1|HUMNK1A[189213]
• 16346: M32315
  Human tumor necrosis factor receptor mRNA, complete cds
  • Human tumor necrosis factor receptor mRNA, complete cds
    gi|189185|gb|M32315.1|HUMNFR[189185]
• 16347: M84755
  Human neuropeptide y receptor mRNA, complete cds
  gi|189153|gb|M84755.1|HUMNEUYREC[189153]
• 16348: M83246
  Human monocyte activation antigen (Mo3) mRNA, complete cds
  gi|188623|gb|M83246.1|HUMMO3A[188623]
• 16350: L27080
  Human melanocortin 5 receptor (MC5R) gene, complete cds
  gi|435599|gb|L27080.1|HUMMC5R[435599]
• 16351: M28219
  Homo sapiens low density lipoprotein receptor (FH 10 mutant causing familial hypercholesterolemia) mRNA, 3′ end
  gi|619785|gb|M28219.1|HUMLDLRFMT[619785]
• 16352: M12626
  Human low density lipoprotein receptor gene, FH381 (deletion mutant) allele
  gi|187103|gb|M12626.1|HUMLDLRFH[187103]
• 16353: M93189
  Human acetylated low density lipoprotein (ACLDL) receptor (LDLR) gene, promoter
  and exon 1
  gi|187100|gb|M93189.1|HUMLDLRAC[187100]
• 16354: M87772
  Human secreted fibroblast growth factor receptor (K-sam-IV) mRNA, complete cds
  gi|186783|gb|M87772.1|HUMKSAMIV[186783]
• 16355: M87771
  Human secreted fibroblast growth factor receptor (K-sam-III) mRNA, complete cds
• 16356: M87770
  Human fibroblast growth factor receptor (K-sam) mRNA, complete cds
  gi|186779|gb|M87770.1|HUMKSAMI[186779]
• 16357: L04947
  Homo sapiens (clones BT3.081.8, BT3.129.5 and BT4.169) receptor tyrosine kinase
  (KDR) mRNA, 31 end cds
  gi|186674|gb|L04947.1|HUMKDRZ[186674]
• 16358: M32972
  Human insulin receptor (INSR) gene, exon 22, clones lambda-hINSR-(1-13)
  gi|186462|gb|M32972.1|HUMINSR22[186462]
• 16359: M32842
  Human insulin receptor (INSR) gene, exon 21, clones lambda-hINSR-(1-13)
  gi|8646|gb|M32842.1|HUMINSR21[186461]
• 16360: M32841
  Human insulin receptor (INSR) gene, exon 20, clones lambda-hINSR-(1-13)
  gi|186460|gb|M32841.1|HUMINSR20[186460]
• 16361: M32840
  Human insulin receptor (INSR) gene, exon 19, clones lambda-hINSR-(1-13)
  gi|186459|gb|M32840.1|HUMINSR19[186459]
• 16362: M32839
  Human insulin receptor (INSR) gene, exon 18, clones lambda-hINSR-(1-13)
  gi|186458|gb|M32839.1|HUMINSR18[186458]
• 16363: M32838
  Human insulin receptor (hINSR) gene, exon 17, clones lambda-hINSR-(1-13)
  gi|186457|gb|M32838.1|HUMINSR17[186457]
• 16364: M32837
  Human insulin receptor (INSR) gene, exon 16, clones lambda-hINSR-(1-13)
  gi|186456|gb|M32837.1|HUMINSR16[186456]
• 16365: M32836
  Human insulin receptor (INSR) gene, exon 15, clones lambda-hINSR-(1-13)
  gi|186455|gb|M32836.1|HUMINSR15[186455]
• 16366: M32835
  Human insulin receptor (INSR) gene, exon 14, clones lambda-hINSR-(1-13)
  gi|186454|gb|M32835.1|HUMINSR14[186454]
• 16367: M32834
  Human insulin receptor (INSR) gene, exon 13, clones lambda-hINSR-(1-13)
  gi|186453|gb|M32834.1|HUMINSR13[186453]
• 16368: M32833
  Human insulin receptor (INSR) gene, exon 12, clones lambda-hINSR-(1-13)
  gi|186452|gb|M32833.1|HUMINSR12[186452]
• 16369: M32832
  Human insulin receptor (INSR) gene, exon 11, clones lambda-hINSR-(1-13)
  gi|186451|gb|M32832.1|HUMINSR11[186451]
• 16370: M32831
  Human insulin receptor (INSR) gene, exon 10, clones lambda-hINSR-(1-13)
  gi|186450|gb|M32831.1|HUMINSR10[186450]
• 16371: M32830
  Human insulin receptor (hINSR) gene, exon 9, clones lambda-hINSR-(1-13)
  gi|186449|gb|M32830.1|HUMINSR09[186449]
• 16372: M32829
  Human insulin receptor (INSR) gene, exon 8, clones lambda-hINSR-(1-13)
  gi|186448|gb|M32829.1|HUMINSR08[186448]
• 16373: M32828
  Human insulin receptor (INSR) gene, exon 7, clones lambda-hINSR-(1-13)
  gi|186447|gb|M32828.1|HUMINSR07[186447]
• 16374: M32827
  Human insulin receptor (INSR) gene, exon 6, clones lambda-hINSR-(1-13)
  gi|186446|gb|M32827.1|HUMINSR06[186446]
• 16375: M32826
  Human insulin receptor (INSR) gene, exon 5, clones lambda-hINSR-(1-13)
  gi|186445|gb|M32826.1|HUMINSR05[186445]
• 16376: M32825
  Human insulin receptor (INSR) gene, exon 4, clones lambda-hINSR-(1-13)
  gi|186444|gb|M32825.1|HUMINSR04[186444]
• 16377: M32824
  Human insulin receptor (INSR) gene, exon 3, clones lambda-hINSR-(1-13)
  gi|186443|gb|M32824.1|HUMINSR03[186443]
• 16378: M32823
  Human insulin receptor (INSR) gene, exon 2, clones lambda-hINSR-(1-13)
  gi|186442|gb|M32823.1|HUMINSR02[186442]
• 16379: M23100
  Human insulin receptor (INSR) gene, exon 1, clones lambda-hINSR-(1-13)
  gi|186441|gb|M23100.1|HUMINSR01[186441]
• 16380: J05043
  Human insulin receptor (1R) gene, exon 1
  gi|186556|gb|J05043.1|HUMIRSRE[186556]
• 16381: M24555
  Human insulin receptor (INSR) mRNA, partial cds
  gi|186480|gb|M24555.1|HUMINSRZ[186480]
• 16382: L07782
  Human insulin receptor gene, last exon
  gi|186475|gb|L07782.1|HUMINSRE[186475]
• 16383: J03466
  Human insulin receptor gene, exon 1, clone p-lambda EA2
  gi|186469|gb|J03466.1|HUMINSRB[186469]
• 16384: L19592
  Homo sapiens interleukin 8 receptor alpha (IL8RA) gene, complete cds
  gi|559051|gb|L19592.1|HUMIL8RAB[559051]
• 16385: M15864
  Human interleukin-2 receptor alpha (IL2R-alpha) gene, exon 1 and promoter region
  gi|186375|gb|M15864.1|HUMILA2R1A[186375]
• 16387: M68932
  Human IL-8 receptor mRNA, complete cds
  gi|186369|gb|M68932.1|HUMIL8RA[186369]
• 16388: L12183
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 8 and complete cds
  gi|307056|gb|L12183.1|HUMIL2RG08[307056]
• 16389: L12182
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 7
  gi|307055|gb|L12182.1|HUMIL2RG07[3070155]
• 16390: L12181
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 6
  gi|307054|gb|L12181.1|HUMIL2RG06[307054]
• 16391: L12180
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 5
  gi|307053|gb|L12180.1|HUMIL2RG05[307053]
• 16392: L12179
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 4
  gi|307052|gb|L12179.1|HUMIL2RG04[307052]
• 16393: L12177
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 3
  gi|307051|gb|L12177.1|HUMIL2RG03[307051]
• 16394: L12176
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 2
  gi|307050|gb|L12176.1|HUMIL2RG02[307050]
• 16395: L12178
  Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 1 and promoter region
  gi|307049|gb|L12178.1|HUMIL2RG01[307049]
• 16396: M96652
  Human interleukin 5 receptor alpha-subunit (IL5R) mRNA, complete cds
  gi|186344|gb|M96652.1|HUMILSRB[186344]
• 16397: M96651
  Human interleukin 5 receptor alpha-subunit (IL5R) mRNA, complete cds
  gi|186342|gb|M96651.1|HUMIL5RA[186342]
• 16398: M74782
  Human interleukin 3 receptor (hIL-3Ra) mRNA, complete cds
  gi|186330|gb|M74782.1|HUMIL3B[186330]
• 16405: M84967
  Human acrosin-trypsin inhibitor (HUSI-II) gene
  gi|553347|gb|M84967.1|HUMHUSIIIA[553347]
• 16406: M84747
  Human interleukin 9 receptor mRNA, complete cds
  gi|184508|gb|M84747.1|HUMI9R[184508]
• 16407: M75128
  Human serotonin 1Db receptor (HTR1D) gene, complete cds
  gi|184459|gb|M75128.1|HUMHTR1DB[184459]
• 16408: M64799
  Human histamine H2 receptor gene, complete cds
  gi|184087|gb|M64799.1|HUMHISH2R[184087]
• 16409: M83941
  Human receptor tyrosine kinase (HEK) mRNA, complete cds
  gi|183931|gb|M83941.1|HUMHEK[183931]
• 16410: L20814
  Human glutamate receptor 2 (HBGR2) mRNA, complete cds
  gi|493133|gb|L20814.1|HUMHBGR2A[493133]
• 16412: L09237
  growth hormone releasing hormone receptor, human, G-protein coupled receptor, secretin family
  gi|337134|gb|L09237.1|HUMGRFREC1[337134]
• 16413: L15388
  Human G protein-coupled receptor kinase (GRK5) mRNA, complete cds
  gi|306804|gb|L15388.1|HUMGRK5A[306804]
• 16415: L08176
  Human Epstein-Barr virus induced G-protein coupled receptor mRNA, complete cds
  gi|183484|gb|L08176.1|HUMGPCRA[183484]
• 16416: M64752
  Human glutamate receptor subunit (GluH1) mRNA, complete cds
  gi|183280|gb|M64752.1|HUMGLURS[183280]
• 16417: L34075
  Human FKBP-rapamycin associated protein (FRAP) mRNA, complete cds
  gi|508481|gb|L34075.1|HUMFRAPX[508481]
• 16418: L08485
  Human GABA-benzodiazepine receptor alpha-5-subunit (GABRA5) mRNA, complete cds
  gi|182915|gb|L08485.1|HUMGABRA5Y[182915]
• 16419: M93435
  Human gamma-aminobutyric acid receptor A5 subunit (GABRA5) gene
  gi|182914|gb|M93435.1|HUMGABRASX[182914]
• 16421: M76673
  Human RMLP-related receptor I (RMLP R I) mRNA, complete cds
  gi|182668|gb|M76673.1|HUMFMLPY[182668]
• 16422: M76672
  Human FMLP-related receptor II (FMLP R II) mRNA, complete cds
  gi|182666|gb|M76672.1|HUMFMLPX[182666]
• 16423: M64347
  Human novel growth factor receptor mRNA, 3′ cds
  gi|182564|gb|M64347.1|HUMFGFLR[182564]
• 16424: M74921
  Human endothelin receptor mRNA, complete cds
  gi|182275|gb|M74921.1|HUMETSR[182275]
• 16427: M96995
  Homo sapiens epidermal growth factor receptor-binding protein GRB2 (EGFRBP-GRB2) mRNA sequence
  gi|181975|gb|M96995.1|HUMEGFGRBA[181975]
• 16428: L06622
  Homo sapiens endothelin receptor type A (EDNRA) mRNA, complete cds
  gi|181956|gb|L06622.1|HUMEDNRA[181956]
• 16434: M26317
  Homo sapiens (clone lambda-6.11) complement receptor 2 (CR2) allele, mRNA fragment
  gi|541647|gb|M26317.1|HUMCR2ALLE[541647]
• 16435: M25785
  Homo sapiens transmembrane glycoprotein (c-fms) gene, exon 1, and platelet-derived growth factor receptor (PDGF) gene, 3′UTR
  gi|349453|gb|M25785.1|HUMCFMS01[349453]
• 16436: M91555
  Human Fc gamma receptor type I (CD64) gene, exon 6
  gi|180160|gb|M91555.1|HUMCD6406[180160]
• 16437: M91554
  Human Fc gamma receptor type I (CD64) gene, exon 5
  gi|180159|gb|M91554.1|HUMCD6405[180159]
• 16438: M91553
  Human Fc gamma receptor type I (CD64) gene, exon 4
  gi|180158|gb|M91553.1|HUMCD6404[180158]
• 16439: M91552
  Human Fc gamma receptor type I (CD64) gene, exon 3
  gi|180157|gb|M91552.1|HUMCD6403[180157]
• 16440: M91551
  Human Fc gamma receptor type I (CD64) gene, exon 2
  gi|180156|gb|M91551.1|HUMCD6402[180156]
• 16441: M91550
  Human Fc gamma receptor type I (CD64) gene, exon 1
  gi|180155|gb|M91550.1|HUMCD6401[180155]
• 16442: M63928
  Homo sapiens T cell activation antigen (CD27) mRNA, complete cds
  gi|180084|gb|M63928.1|HUMCD27A[180084]
• 16443: M95293
  Homo sapiens integrin beta subunit (CD18) gene, exon 1
  gi|180022|gb|M95293.1|HUMCD18EX[180022]
• 16444: M76724
  Human leukocyte adhesion receptor alpha subunit (CD11b) gene, 5′ end
  gi|180018|gb|M76724.1|HUMCD11B[180018]
• 16447: L09230
  Human C-C chemokine receptor type 1 (C-C CKR-1) mRNA, complete cds
  gi|179984|gb|L09230.1|HUMCCCKR1A[179984]
• 16448: M81886
  Human glutamate receptor type 1 (HBGR1) mRNA, complete cds
  gi|17944|gb|M81886.1|HUMBGR1A[179441]
• 16449: M80776
  Human beta-adrenergic receptor kinase 1 mRNA, complete cds
  gi|179334|gb|M80776.1|HUMBARK1A[179334]
• 16450: L25259
  Human CTLA4 counter-receptor (B7-2) mRNA, complete cds
  gi|416368|gb|L25259.1|HUMB72A[416368]
• 16451: M93394
  Human angiotensin 11 type-1 receptor (AT1) mRNA, complete cds
  gi|178680|gb|M93394.1|HUMANTIIR[178680]
• 16452: M83712
  H. sapiens nicotinic receptor alpha 5 subunit mRNA, complete cds
  gi|177925|gb|M83712.1|HUMA5NICRC[177925]
• 16453: M97370
  Human adenosine receptor (A2) gene, complete cds
  gi|177891|gb|M97370.1|HUMA2XXX[177891]
• 16454: M92826
  Human serotonin receptor (5-HTR1E) gene, complete cds
  gi|177777|gb|M92826.1|HUM5HTR1E[177777]
• 16455: M86841
  Human serotonin receptor type 2 (5HT2) mRNA, complete cds
  gi|177775|gb|M86841.1|HUM5HT2A[177775]
• 16456: M91467
  Human serotonin receptor (5HT1E) mRNA, complete cds
  gi|177773|gb|M91467.1|HUM5HT1E[177773]
• 16457: M81830
  Human somatostatin receptor isoform 2 (SSTR2) gene, complete cds
  gi|307435|gb|M81830.1|HUMSRI2A[307435]
• 16458: M81829
  Human somatostatin receptor isoform 1 gene, complete cds
  gi|307433|gb|M81829.1|HUMSRI1A[307433]
• 16463: L20470
  Human very low density lipoprotein receptor mRNA, complete cds
  gi|409425|gb|L20470.1|HUMVLDLR[409425]
• 16464: L20316
  Human glucagon receptor mRNA, complete cds
  gi|405189|gb|L20316.1|HUMGLUCREC[405189]
• 16465: M24853
  Homo sapiens (clone H12) low affinity IgG receptor CD16 (FcGRIII) mRNA, 3′ end
  gi|184849|gb|M24853.1|HUMIGGRLA[184849]
• 16466: M80635
  Human fibroblast growth factor receptor-2 (FGFR2) gene, exon B
  gi|182572|gb|M80635.1|HUMFGFRA[182572]
• 16467: L31848
  Homo sapiens serine/threonine kinase receptor 2 (SKR2) gene, 3 alternative splices, 3′ ends
  gi|576680|gb|L31848.1|HUMSKR2[576680]
• 16472: M29066
  Human dopamine D2 receptor (DRD2) mRNA, complete cds
  gi|181828|gb|M29066.1|HUMDRD2A[181828]
• 16473: M85289
  Human heparan sulfate proteoglycan (HSPG2) mRNA, complete cds
  gi|184426|gb|M85289.1|HUMHSPG2B[184426]
• 16474: L02931
  Human hepatocyte growth factor heavy chain (HGF) gene mRNA, complete cds
  gi|184033|gb|L02931.1|HUMHGFX[184033]
• 16475: L19058
  Human glutamate receptor (GLUR5) mRNA, complete cds
  gi|455447|gb|L19058.1|HUMGLUR5X[455447]
• 16476: L20859
  Human leukemia virus receptor 1 (GLVR1) mRNA, complete cds
  gi|306769|gb|L20859.1|HUMGLVR1X[306769]
• 16477: M82919
  Human gamma amino butyric acid (GABAA) receptor beta-3 subunit mRNA, complete cds
  gi|182924|gb|M82919.1|HUMGABRB3A[182924]
• 16478: M86868
  Human gamma amino butyric acid (GABA rho2) gene mRNA, complete cds
  gi|182912|gb|M86868.1|HUMGABARHO[182912]
• 16479: L14061
  Human N-formyl receptor-like 2 protein (FPRL2) gene, complete cds
  gi|292034|gb|L14061.1|HUMFRPL2[292034]
• 16480: M95489
  H. sapiens follicle stimulating hormone receptor mRNA, complete cds
  gi|182772|gb|M95489.1|HUMFSHREC[182772]
• 16481: M84562
  Human formyl peptide receptor-like receptor (FPRL1) mRNA, complete cds
  gi|182741|gb|M84562.1|HUMFPRL1A[182741]
• 16482: M97193
  Homo sapiens fibroblast growth factor receptor 2 IIIb (FGFR2) mRNA, complete cds
  gi|182566|gb|M97193.1|HUMFGFR2A[182566]
• 16483: M23562
  Human IgE Fc-epsilon-RIIa gene, exon 2, and Fc-epsilon-RIIb gene, exon 1
  gi|182444|gb|M23562.1|HUMFCEIIA[182444]
• 16484: M76595
  Human erythropoietin receptor mRNA sequence derived from DNA, 5′ end
  gi|182147|gb|M76595.1|HUMEPR[182147]
• 16485: M77244
  H. sapiens erythropoietin receptor (EPOR) gene, 5′ end
  gi|182133|gb|M77244.1|HUMEPOR[182133]
• 16486: M24736
  Human endothelial leukocyte adhesion molecule 1 (ELAM-1) mRNA, complete cds
  gi|537523|gb|M24736.1|HUMELAM1A[537523]
• 16487: L37361
  Homo sapiens (clone hELK-L) ELK receptor tyrosine kinase ligand (EFL-3) mRNA, complete cds
  gi|567005|gb|L37361.1|HUMEFL3[567005]
• 16488: L37360
  Homo sapiens (clone hEHK1-L) EHK1 receptor tyrosine kinase ligand (EFL-2) mRNA,
  complete cds
  gi|567003|gb|L37360.1|HUMEFL2[567003]
• 16489: K03193
  Human aberrant (short) epidermal growth factor receptor mRNA, complete cds
  gi|181984|gb|K03193.1|HUMEGFRS[181984]
• 16490: M11234
  Human epidermal growth factor receptor (EGFR) gene, exon 1
  gi|181981|gb|M11234.1|HUMEGFRG[181981]
• 16491: L06623
  Homo sapiens endothelin receptor type B (EDNRB) mRNA, complete cds
  gi|9181958|gb|L06623.1|HUMEDNRB[181958]
• 16494: M67439
  Human D5 dopamine receptor (DRD5) gene, complete cds
  gi|181830|gb|M67439.1|HUMDRD5A[181830]
• 16495: M77250
  Human dopamine D2 receptor gene, intron 6/exon 7 boundary
  gi|181825|gb|M77250.1|HUMDRD24[181825]
• 16496: M77249
  Human dopamine D2 receptor gene; exon 3
  gi|181824|gb|M77249.1|HUMDRD23[181824]
• 16497: M77247
  Human dopamine D2 receptor gene, exon 2
  gi|181823|gb|M77247.1|HUMDRD22[181823]
• 16498: M77248
  Human dopamine D2 receptor gene, exon 1
  gi|181822|gb|M77248.1|HUMDRD21[181822]
• 16499: M33210
  Human colony stimulating factor 1 receptor (CSF1R) gene, exon 5
  gi|532591|gb|M33210.1|HUMCSF1R03[532591]
• 16500: M33209
  Human colony stimulating factor 1 receptor (CSF1R) gene, exon 4
  gi|532590|gb|M33209.1|HUMCSF1R02[532590]
• 16501: M33208
  Human colony stimulating factor 1 receptor (CSF1R) gene, exon 2
  gi|532589|gb|M33208.1|HUMCSF1R01[532589]
• 16502: M83328
  Human cell surface glycoprotein CD44 mRNA, (variant F) exons 1, 2, 3, and 5
  gi|180135|gb|M83328.1|HUMCD44J[180135]
• 16503: M83327
  Human cell surface glycoprotein CD44 mRNA, (variant E) exons 1, 2, 3, and 4
  gi|180134|gb|M83327.1|HUMCD441[180134]
• 16504: M83326
  Human cell surface glycoprotein CD44 mRNA, (variant D) exon 1, 2, and 3
  gi|180133|gb|M83326.1|HUMCD44H[180133]
• 16505: M83325
  Human cell surface glycoprotein CD44 mRNA, (variant C) exons 1 and 2
  gi|180132|gb|M83325.1|HUMCD44G[180132]
• 16506: M83324
  Human cell surface glycoprotein CD44 mRNA, (variant B) exon 1
  gi|180131|gb|M83324.1|HUMCD44F[180131]
• 16507: M83554
  H. sapiens lymphocyte activation antigen CD30 mRNA, complete cds
  gi|180095|gb|M83554.1|HUMCD30A[180095]
• 16512: M97759
  Human adenosine A2b receptor (ADORA2) mRNA, complete cds
  gi|178149|gb|M97759.1|HUMADORA1[178149]
• 16513: M80333
  Human m5 muscarinic acetylcholine receptor gene, complete cds
  gi|177987|gb|M80333.1|HUMACHRM[177987]
• 16527: L34339
  Human galanin receptor mRNA, complete cds
  gi|559047|gb|L34339.1|HUMGALAREC[559047]
• 16528: L17033
  Human heparin-binding epidermal growth factor gene sequence
  gi|348176|gb|L17033.1|HUMHBEGFF[348176]
• 16529: L17032
  Human heparin-binding epidermal growth factor gene sequence
  gi|348175|gb|L17032.1|HUMHBEGFE[348175]
• 16530: L17031
  Human heparin-binding epidermal growth factor gene, 3′ end
  gi|348173|gb|L17031.1|HUMHBEGFD[348173]
• 16531: L17030
  Human heparin-binding epidermal growth factor gene, partial cds
  gi|348171|gb|L17030.1|HUMHBEGFC[348171]
• 16532: L17029
  Human heparin-binding epidermal growth factor gene, partial cds
  gi|348169|gb|L17029.1|HUMHBEGFB[348169]
• 16533: L17028
  Human heparin-binding epidermal growth factor gene, 5′ end
  gi|348168|gb|L17028.1|HUMHBEGFA[348168]
• 16534: L13288
  Human vasoactive intestial peptide receptor mRNA, complete cds
  gi|292903|gb|L13288.1|HUMVIPR[292903]
• 16545: M31164
  Human tumor necrosis factor-inducible (TSG-37) mRNA fragment
  gi|339993|gb|M31164.1|HUMTSG37A[339993]
• 16547: L04270
  Homo sapiens (clone CD18) tumor necrosis factor receptor 2 related protein mRNA,
  complete cds
  gi|339761|gb|L04270.1|HUMTNFRRP[339761]
• 16548: M58286
  Homo sapiens tumor necrosis factor receptor mRNA, complete cds
  gi|339753|gb|M58286.1|HUMTNFRB[339753]
• 16562: L07062
  Human somatostatin receptor 3 (SSTR3) gene
  gi|348713|gb|L07062.1|HUMSSTR3Y[348713]
• 16563: L07061
  Human somatostatin receptor 4 (SSTR4) gene
  gi|348712|gb|L07061.1|HUMSSTR4Z[348712]
• 16564: M73489
  Human heat-stable enterotoxin receptor mRNA, complete cds
  gi|338501|gb|M73489.1|HUMSTAR[338501]
• 16565: L04962
  Homo sapiens serotonin receptor (HTR1F) gene, complete cds
  gi|338464|gb|L04962.1|HUMSRCPT1F[338464]
• 16566: M84426
  Homo sapiens substance P receptor (short form) mRNA, complete cds
  gi|338435|gb|M84426.1|HUMSPRSHOR[338435]
• 16567: M84425
  Homo sapiens substance P receptor (long form) mRNA, complete cds
  gi|338427|gb|M84425.1|HUMSPRLONG[338427]
• 16568: M97190
  Human Sp2 protein mRNA, complete cds
  gi|338300|gb|M97190.1|HUMSP2A[338300]
• 16569: L05521
  Human somatostatin receptor subtype 2 gene related dinucleotide repeat
  gi|292502|gb|L05521.1|HUMSOMREPB[292502]
• 16570: L05520
  Human somatostatin receptor subtype 1 gene related dinucleotide repeat
  gi|292501|gb|L05520.1|HUMSOMREPA[292501]
• 16570: L14856
  Human somatostatin receptor gene, complete cds
  gi|292499|gb|L14856.1|HUMSOMAT[292499]
• 16572: L02911
  Human novel serine kinase receptor mRNA, complete cds
  gi|338218|gb|L02911.1|HUMSKRN[338218]
• 16573: L05597
  Human serotonin receptor gene, complete cds
  gi|307419|gb|L05597.1|HUMSEROTON[307419]
• 16576: L10918
  Homo sapiens macrophage inflammatory protein-1-alpha/RANTES receptor mRNA, complete cds
  gi|292416|gb|L10918.1|HUMRANTES[292416]
• 16577: L28824
  Homo sapiens protein tyrosine kinase (Syk) mRNA, complete cds
  gi|479012|gb|L28824.1|HUMPTK[479012]
• 16578: L04308
  Human parathyroid hormone receptor mRNA, complete cds
  gi|190721|gb|L04308.1|HUMPTHR[190721]
• 16579: L02932
  Human peroxisome proliferator activated receptor mRNA, complete cds
  gi|307340|gb|L02932.1|HUMPPAR[307340]
• 16580: L07592
  Human peroxisome proliferator activated receptor mRNA, complete cds
  gi|190229|gb|L07592.1|HUMPPARA[190229]
• 16581: L29016
  Homo sapiens prostanoid IP receptor, complete cds
  gi|495042|gb|L29016.1|HUMPIR[495042]
• 16582: L25124
  Homo sapiens prostaglandin E2 receptor mRNA, complete cds
  gi|435049|gb|L25124.1|HUMPGE2R[435049]
• 16583: L28175
  Homo sapiens prostaglandin E2 receptor EP2 subtype mRNA, complete cds
  gi|452495|gb|L28175.1|HUMPERE[452495]
• 16584: M84986
  Human DNA sequence from 5-hydroxytryptamine 1B receptor region
  gi|189401|gb|M84986.1|HUMORFZ[189401]
• 16585: M84605
  Human putative opioid receptor mRNA, complete cds
  gi|189391|gb|M84605.1|HUMOPIODRE[189391]
• 16587: M89473
  Human neurokinin 3 receptor (NK3R) mRNA, complete cds
  gi|189223|gb|M89473.1|HUMNK3R[189223]
• 16588: L12214
  Human N-formyl receptor gene
  gi|189182|gb|L12214.1|HUMNFORECB[189182]
• 16589: L12213
  Human N-formyl receptor gene
  gi|189181|gb|L12213.1|HUMNFORECA[189181]
• 16590: L13267
  Homo sapiens N-methyl-d-aspartate receptor (NR1-2) mRNA, 3′ end
  gi|292284|gb|L13267.1|HUMMARA[292284]
• 16591: M80634
  Human keratinocyte growth factor receptor mRNA, complete cds
  gi|186740|gb|M80634.1|HUMKGFRA[186740]
• 16592: M80638
  Human keratinocyte growth factor receptor and fibroblast growth factor receptor-2 gene, exon
  gi|186737|gb|M80638.1|HUMKFGFRB[186737]
• 16593: M80636
  Human keratinocyte growth factor receptor and fibroblast growth factor receptor-2 gene, exon
  gi|186736|gb|M80636.1|HUMKFGFRA[186736]
• 16594: M59911
  Human integrin alpha-3 chain mRNA, complete cds
  gi|186496|gb|M59911.1|HUMINTA3A[186496]
• 16595: M75914
  Human interleukin 5 receptor alpha mRNA, complete cds
  gi|186387|gb|M75914.1|HUMILSRAA[186387]
• 16596: M73724
  Human insulin-like growth factor-I receptor gene, exon 1
  gi|186383|gb|M73724.1|HUMILGFIR[186383]
• 16597: M94582
  Human interleukin 8 receptor B mRNA, complete cds
  gi|186377|gb|M94582.1|HUMILEU8R[186377]
• 16599: M24559
  Human poly-Ig receptor transmembrane secretory component mRNA, 3′ end
  gi|514365|gb|M24559.1|HUMIGRPOLY[514365]
• 16600: L03418
  Human Fc-gamma receptor I A1 mRNA, complete cds
  gi|184840|gb|L03418.1|HUMIGGFCIA[184840]
• 16601: M73780
  Human integrin beta-8 subunit mRNA, complete cds
  gi|184520|gb|M73780.1|HUMIBBSUA[184520]
• 16602: L09732
  Homo sapiens 5-hydroxytryptamine 1D receptor gene, complete cds
  gi|184467|gb|L09732.1|HUMHTRD1A[184467]
• 16603: M83180
  Human serotonin receptor gene, complete cds
  gi|184463|gb|M83180.1|HUMHTRA[184463]
• 16605: M63889
  Human heparin-binding growth factor receptor (HBGF-R-alpha-a3) mRNA, complete cds
  gi|183882|gb|M63889.1|HUMHBGFC[183882]
• 16606: L22607
  Homo sapiens A3 adenosine receptor mRNA, complete cds
  gi|413863|gb|L22607.1|HUMHAAR[413863]
• 16607: M82819
  Human DNA sequence
  gi|183778|gb|M82819.1|HUMHAIGGR[183778]
• 16608: L13436
  Homo sapiens guanylate cyclase mRNA, complete mature peptide
  gi|292071|gb|L13436.1|HUMGUANCYC[292071]
• 16609: L08177
  Human EBV induced G-protein coupled receptor (EBI2) mRNA, complete cds
  gi|292056|gb|L08177.1|HUMGPCRB[292056]
• 16610: L07949
  Homo sapiens GnRH receptor mRNA, complete cds
  gi|292052|gb|L07949.1|HUMGNRHR[292052]
• 16611: L03380
  Human gonadotropin-releasing hormone receptor mRNA, complete cds
  gi|18342|gb|L03380.1|HUMGNRHREC[183421]
• 16612: M73832
  Human GM-CSF receptor (GM-CSF receptor) mRNA, complete cds
  gi|306773|gb|M73832.1|HUMGMCSFRA[306773]
• 16613: M64445
  Human GM-CSF receptor mRNA, complete cds
  gi|183361|gb|M64445.1|HUMGMCSF[183361]
• 16614: L24751
  Homo sapiens glucagon receptor gene, partial cds
  gi|404723|gb|L24751.1|HUMGLCGNR[404723]
• 16615: L01406
  Human growth hormone-releasing hormone receptor mRNA, complete cds
  gi|183172|gb|L01406.1|HUMGHRHREC[183172]
• 16616: L08109
  Human low-affinity Fc-gamma receptor IIC gene, exons 4-7
  gi|183090|gb|L08109.1|HUMGFCIIC[183090]
• 16617: L08108
  Human low-affinity Fc-receptor IIB gene, exons 4-7
  gi|183089|gb|L08108.1|HUMGFCIIB[183089]
• 16618: L08107
  Human low-affinity Fc-gamma receptor IIA gene, exons 4-7
  gi|183088|gb|L08107.1|HUMGFCIIA[183088]
• 16619: M69106
  Human Gata3 enhancer-binding protein mRNA, complete cds
  gi|182999|gb|M69106.1|HUMGATA3BP[182999]
• 16620: M59216
  Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exon 9
  gi|182921|gb|M59216.1|HUMGABRB15[182921]
• 16621: M59215
  Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exons 6, 7 and
  8
  gi|182920|gb|M59215.1|HUMGABRB14[182920]
• 16622: M59214
  Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exon 5
  gi|182919|gb|M59214.1|HUMGABRB13[182919]
• 16623: M59213
  Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exon 4
  gi|182918|gb|M5923.13|HUMGABRB12[182918]
• 16624: M59212
  Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exons 1, 2 and
  3
  gi|182917|gb|M59212.1|HUMGABRB11[182917]
• 16625: M11067
  Human c-fms proto-oncogene, exon 2, partial cds
  gi|182674|gb|M11067.1|HUMFMSB[182674]
• 16626: M91647
  Human high-affinity Fc IgG receptor gamma polypeptide (FcgammaRI) gene
  gi|182486|gb|M91647.1|HUMFCIGGHC[182486]
• 16627: M91646
  Human high-affinity Fc IgG receptor gamma polypeptide (FcgammaRI) gene
  gi|182485(gb|M91646.1|HUMFCIGGHB[182485]
• 16628: M91645
  Human high-affinity Fc IgG receptor gamma polypeptide (FcgammaRI) gene
  gi|182484|gb|M91645.1|HUMFCIGGHA[182484]
• 16629: L03420
  Human Fc-gamma receptor I B2 mRNA, complete cds
  gi|182461|gb|L03420.1|HUMFCGR1BB[182461]
• 16630: L03419
  Human Fc-gamma receptor I B1 mRNA, complete cds
  gi|182460|gb|L03419.1|HUMFCGR1B[182460]
• 16632: L08603
  Human melanocortin 4 receptor gene, complete cds
  gi|291977|gb|L08603.1|HUMEL4REC[182460]
• 16633: M93111
  Human endothelial cell-derived thrombin receptor cDNA, 5′ additional sequence
  gi|181945 gb|M93111.1|HUMECTR[181945]
• 16635: M94915
  Human dinucleotide repeat polymorphism gene
  gi|181836|gb|M94915.1|HUMDRP[181836]
• 16636: L12116
  Homo sapiens dinucleotide polymorphism in the G-protein coupled receptor gene (d20s32e)
  gi|181631|gb|L12116.1|HUMDNP[181631]
• 16637: M25945
  Human DNA sequence, C-beta locus
  gi|181627|gb|M25945.1|HUMDNAZ[181627]
• 16639: L22303
  Human dopamine receptor D2 gene, repeat polymorphism
  gi|441061|gb|L22303.1|HUMD2RP[441061]
• 16640: L23333
  Human corticotropin releasing factor receptor mRNA, complete cds
  gi|408691|gb|L23333.1|HUMCRFRB[408691]
• 16641: L23332
  Human corticotropin releasing factor receptor mRNA, complete cds
  gi|408689|gb|L23332.1|HUMCRFRA[408689]
• 16642: M73238
  Human ciliary neurotrophic factor receptor (CNTFR) mRNA, complete cds
  gi|180710|gb|M73238.1|HUMCNTFR[180710]
• 16643: M63835
  Human IgG Fc receptor I gene, exon 6 and complete cds
  gi|80277|gb|M63835.1|HUMCFCGRI6[180277]
• 16644: M63834
  Human IgG Fc receptor I gene, exon 5
  gi|180276|gb|M63834.1|HUMCFCGRI5[180276]
• 16645: M63833
  Human IgG Fc receptor I gene, exon 4
  gi|180275|gb|M63833.1|HUMCFCGRI4[180275]
• 16646: M63832
  Human IgG Fc receptor I gene, exon 3
  gi|180274|gb|M63832.1|HUMCFCGRI3[180274]
• 16647: M63831
  Human IgG Fc receptor I gene, exon 2
  gi|180273|gb|M63831.1|HUMCFCGRI2[180273]
• 16648: M63830
  Human IgG Fc receptor I gene, exon 1
  gi|180272|gb|M63830.1|HUMCFCGRI1[180272]
• 16649: L13605
  Human cholecystokinin A receptor mRNA, complete cds
  gi|306490|gb|L13605.1|HUMCCKAR[306490]
• 16650: L08112
  Human brain cholecystokinin-B/gastrin receptor mRNA, complete cds
  gi|306488|gb|L08112.1|HUMCCBGR[306488]
• 16651: L04473
  Human cholecystokinin receptor mRNA, complete cds
  gi|179997|gb|L04473.1|HUMCCKR[179997]
• 16652: L00587
  Human calcitonin receptor mRNA, complete cds
  gi|179879|gb|L00587.1|HUMCALREC[179879]
• 16653: L08893
  Human bombesin receptor subtype-3 mRNA, complete cds
  gi|291876|gb|L08893.1|HUMBOMB3S[291876]
• 16654: L27594
  Homo sapiens bradykinin B2 receptor gene sequence
  gi|508475|gb|L27594.1|HUMBB2R[508475]
• 16656: M28639
  Human autoimmune thyroid disease-related antigen mRNA
  gi|291864|gb|M28639.1|HUMATDRAGA[291864]
• 16657: M91464
  Human angiotensinogen II type-1A receptor gene, complete cds
  gi|179121|gb|M91464.1|HUMAT1A[179121]
• 16658: M87290
  Human angiotensin II type 1 receptor mRNA, complete cds
  gi|178682|gb|M87290.1|HUMANTIR[178682]
• 16659: M26228
  Human anti-angiotensinogen mRNA, partial cds
  gi|178641|gb|M26228.1|HUMANGA[178641]
• 16661: M99590
  Homo sapiens (clone pmt2-huma1b) alpha-1B adrenergic receptor gene sequence
  gi|17821|gb|M99590.1|HUMADRENB[178211]
• 16663: M93415
  Human activin type II receptor mRNA, complete cds
  gi|178049|gb|M93415.1|HUMACTIIA[178049]
• 16664: M74954
  Human alpha-5-beta-1 fibronectin receptor
  gi|177940|gb|M74954.1|HUMABFIREC[177940]
• 16665: L25827
  Human a7 nicotinic acetylcholine receptor mRNA
  gi|438616|gb|L25827.1|HUMA7NAR[438616]
• 16666: M76446
  Human alpha-A1-adrenergic receptor mRNA, complete cds
  gi|177806|gb|M76446.1|HUMA1AADR[177806]
• 16667: M89955
  Human 5-HT1D-type serotonin receptor gene, complete cds
  gi|177771|gb|M89955.1|HUM5HT1DA[177771]
• 16668: M89478
  Human 5-HT1B serotonin receptor gene
  gi|177770|gb|M89478.1|HUM5HT1BSR[177770]
• 16669: L36162
  Homo sapiens (clone TH3L) receptor tyrosine kinase tire ITT (DTD) mRNA
  gi|537326|gb|L36162.1|HUM3RTK[537326]
• 16670: L05666
  Homo sapiens NMDA receptor subunit (NR1) mRNA, complete cds
  gi|307302|gb|L05666.1|HUMNMDAREC[307302]
• 16671: L14865
  Human somatostatin receptor (SST) gene, complete cds
  gi|431094|gb|L14865.1|HUMSST28A[431094]
• 16672: L24894
  Human myelin protein zero (PO) gene, exon 1
  gi|454413|gb|L24894.1|HUMAAC01[454413]
• 16673: L24893
  Human myelin protein zero (PO) gene, exons 2, 3, 4, 5, and 6
  gi|454412|gb|L24893.1|HUMAAC02[454412]
• 16674: L25119
  Human Mu opiate receptor (MOR1) mRNA, complete cds
  gi|452072|gb|L25119.1|HUMMOR1X[452072]
• 16676: L24804
  Human (p23) mRNA, complete cds
  gi|438651|gb|L24804.1|HUMPRA[438651]
• 16677: L21954
  Human peripheral benzodiazepine receptor gene, exon 4
  gi|483405|gb|L21954.1|HSPBR4[483405]
• 16678: L21953
  Human peripheral benzodiazepine receptor gene, exon 3
  gi|483404|gb|L21953.1|HSPBR3[483404]
• 16679: L21952
  Human peripheral benzodiazepine receptor gene, exon 2
  gi|483403|gb|L21952.1|HSPBR2[483403]
• 16680: L21951
  Human peripheral benzodiazepine receptor gene, exon 1
  gi|483402|gb|L21951.1|HSPBR1[483402]
• 16681: L21950
  Human peripheral benzodiazepine receptor related mRNA sequence
  gi|483401|gb|L21950.1|HUMBENZA[483401]
• 16682: L20817
  Homo sapiens tyrosine protein kinase (CAK) gene, complete cds
  gi|306474|gb|L20817.1|HUMCAK[306474]
• 16683: L20852
  Human leukemia virus receptor 2 (GLVR2) mRNA, complete cds
  gi|306771|gb|L20852.1|HUMGLVR2X[306771]
• 16684: L24470
  Homo sapiens prostanoid FP receptor mRNA, complete cds
  gi|456563|gb|L24470.1|HUMPF2AR[456563]
• 16685: L22214
  Human adenosine A1 receptor (ADORA1) mRNA exons 1-6, complete cds
  gi|347520|gb|L22214.1|HUMADORA1X[347520]
• 16687: L23503
  Human glucagon-like peptide-1 receptor (GLP-1) mRNA, complete cds
  gi|402480|gb|L23503.1|HUMGLP1R[402480]
• 16689: L10820
  Human N-formyl peptide receptor (FPR1) gene, complete cds and Alu repeats
  gi|182739|gb|L10820.1|HUMFPR1A[182739]
• 16690: M99293
  Homo sapiens seven transmembrane segment receptor mRNA, complete cds
  gi|292516|gb|M99293.1|HUMSTSR[292516]
• 16691: L01639
  Human (clone HSY3RR) neuropeptide Y receptor (NPYR) mRNA, complete cds
  gi|189313|gb|L01639.1|HUMNYRECA[189313]
• 16692: L20463
  Human A3 adenosine receptor mRNA, complete cds
  gi|349448|gb|L20463.1|HUMA3ADENR[349448]
• 16693: L19872
  Human AH-receptor mRNA, complete cds
  gi|41614|gb|L19872.1|HUMAHREC[416141]
• 16694: L17075
  Human TGF-b superfamily receptor type I mRNA, complete cds
  gi|425147|gb|L17075.1|HUMTGFBRS[425147]
• 16695: L14075
  Homo sapiens immunoglobulin receptor alpha chain gene, complete cds
  gi|410211|gb|L14075.1|HUMIGERA[410211]
• 16696: L11695
  Human activin receptor-like kinase (ALK-5) mRNA, complete cds
  gi|431034|gb|L11695.1|HUMALK5A[431034]
• 16697: L22206
• Human vasopressin receptor V2 gene, complete cds
• gi|347522|gb|L22206.1|HUMV2R[347522]
• 16698: M91211
  Human receptor for advanced glycosylation end products (RAGE) mRNA, partial cds
  gi|190845|gb|M91211.1|HUMRAGE[190845]
• 16699: L20469
  Human truncated dopamine D3 receptor mRNA, complete cds
  gi|306688|gb|L20469.1|HUMD3DR[306688]
• 16701: L11315
  Homo sapiens receptor tyrosine kinase mRNA, complete cds
  gi|403386|gb|L11315.1|HUMRTK[403386]
• 16702: L19315
  Human cholecystokinin A receptor mRNA, complete cds
  gi|306595|gb|L19315.1|HUMCHOLREC[306595]
• 16724: L15310
  Homo sapiens glucagon-like peptide-1 receptor gene
  gi|292051|gb|L15310.1|HUMGLP1RGA[292051]
• 16725: M99624
  Human epidermal growth factor receptor-related gene, 5′ end
  gi|178251|gb|M99624.1|HUMAGGCRB[178251]-892-Appendix II
• 1: NM_—017882
  Homo sapiens ceroid-lipofuscinosis, neuronal 6, late infantile, variant (CLN6),
  mRNA
  gi|8923531|ref|NM_—017882.1|[8923531]
• 2: BI480800
  H2RPE-0436 Human Retinal Pigment Epithelium (2) Homo sapiens cDNA 5′ similar to
  glycoprotein (transmembrane) nmb (GPNMB), mRNA sequence
  gi|18998609|gb|BI480800.1|BI480800[18998609]
• 4: AC096780
  Tcc118, complete sequence
  gi|18958727|gb|AC096780.1|[18958727]
• 5: AC113243
  Tcc1a22, complete sequence
  gi|18958719|gb|AC113243.1|[18958719]
• 6: AF347029
  Homo sapiens transmembrane protein (C60RF33) mRNA, complete cds
  gi|18873730|gb|AF347029.1|[18873730]
• 8: NM_—001183
  Homo sapiens ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit
  1 (ATP6S1), mRNA
  gi|17136147|ref|NM_—001183.2|[17136147]
• 13: NM_—005765
  Homo sapiens ATPase, H+ transporting, lysosomal (vacuolar proton pump) membrane
  sector associated protein M8-9 (ATP6M8-9), mRNA
  gi|15011917|ref|NM_—005765.2|[15011917]
• 14: AB028140
  Homo sapiens mRNA for spinesin, complete cds
  gi|12248916|dbj|AB028140.1|[12248916]
• 15: NM_—002846
  Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
  gi|18860905|ref|NM_—002846.2|[18860905]
• 16: NM_—002845
  Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
  gi|18860903|ref|NM_—002845.2|[18860903]
• 17: NM_—002844
  Homo sapiens protein tyrosine phosphatase, receptor type, K (PTPRK), mRNA
  gi|18860901|ref|NM_—002844.2|[18860901]
• 18: NM_—002843
  Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
  gi|18860899|ref|NM_—002843.2|[18860899]
• 19: NM_—002841
  Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
  gi|18860897|ref|NM_—002841.2|[18860897]
• 20: NM_—130440
  Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
  variant 2, mRNA
  gi|18860895|ref|NM_—130440.1|[18860895]
• 21: NM_—130393
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 4, mRNA
  gi|18860893|ref|NM_—130393.1|[18860893]
• 22: NM_—130392
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 3, mRNA
  gi|18860891|ref|NM_—130392.1|[18860891]
• 23: NM_—130391
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 2, mRNA
  gi|18860889|ref|NM_—130391.1|[18860889]
• 24: NM_—002840
  Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
  variant 1, mRNA
  gi|18860871|ref|NM_—002840.2|[18860871]
• 25: NM_—006504
  Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
  variant 1, mRNA
  gi|18860860|ref|NM_—006504.2|[18860860]
• 26: NM_—130435
  Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
  variant 2, mRNA
  gi|18860858|ref|NM_—130435.1|[18860858]
• 27: NM_—002842
  Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
  gi|4506312|ref|NM_—002842.1|[4506312]
• 28: NM_—002839
  Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
  variant 1, mRNA
  gi|4506308|ref|NM_—002839.1|[4506308]
• 29: BC024191
  Homo sapiens, Similar to transmembrane protein HTMP10, clone IMAGE:4799785, mRNA
  gi|18848306|gb|BC024191.1[18848306]
• 30: NM_—023068
  Homo sapiens sialoadhesin (SN), mRNA
  gi|18765743|ref|NM_—023068.2|[18765743]
• 31: NM_—032646
  Homo sapiens tweety homolog 2 (Drosophila) (TTYH2), mRNA
  gi|17939343|ref|NM_—032646.4|[17939343]
• 32: NM_—022006
  Homo sapiens FXYD domain-containing ion transport regulator 7 (FXYD7), mRNA
  gi|11612658|ref|NM_—022006.1|[11612658]
• 33: NM_—022003
  Homo sapiens FXYD domain-containing ion transport regulator 6 (FXYD6), mRNA
  gi|11612654|ref|NM_—022003.1|[11612654]
• 34: NM_—002127
  Homo sapiens HLA-G histocompatibility antigen, class I, G (HLA-G), mRNA
  gi|18765718|ref|NM_—002127.2|[18765718]
• 35: NM_—005516
  Homo sapiens major histocompatibility complex, class I, E (HLA-E), mRNA
  gi|18765717|ref|NM_—005516.2|[18765717]
• 36: NM_—002121
  Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1),
  mRNA
  gi|18765716|ref|NM_—002121.3|[18765716]
• 37: NM_—006120
  Homo sapiens major histocompatibility complex, class II, DM alpha (HLA-DMA), mRNA
  gi|18765714|ref|NM_—006120.2|[18765714]
• 38: NM_—002116
  Homo sapiens major histocompatibility complex, class I, A (HLA-A), mRNA
  gi|18765713|ref|NM_—002116.3|[18765713]
• 39: NM_—130797
  Homo sapiens dipeptidylpeptidase VI (DPP6), transcript variant 1, mRNA
  gi|18765697|ref|NM_—130797.1|[18765697]
• 40: NM_—001936
  Homo sapiens dipeptidylpeptidase VI (DPP6), transcript variant 2, mRNA
  gi|18765695|ref|NM_—001936.2|[18765695]
• 41: NM_—018593
  Homo sapiens solute carrier family 16 (monocarboxylic acid transporters), member
  10 (SLC16A10), mRNA
  gi|18699729|ref|NM_—018593.2|[18699729]
• 42: BM510040
  ig97b09.x1 HR85 islet Homo sapiens cDNA clone IMAGE: 3′ similar to TR:O60478 O60478 PUTATIVE SEVEN PASS TRANSMEMBRANE PROTEIN.;, mRNA sequence
  gi|18681183|gb|BM510040.1|BM510040[18681183]
• 43: BM509858
  ig94h01.y1 HR85 islet Homo sapiens cDNA clone IMAGE: 5′ similar to SW:MTRP_HUMAN
  Q15012 GOLGI 4-TRANSMEMBRANE SPANNING TRANSPORTER MTP; mRNA sequence
  gi|18681001|gb|BM509858.1|BM509858[18681001]
• 44: BM509717
  ig93b05.y1 HR85 islet Homo sapiens cDNA clone IMAGE: 5′ similar to SW:MTRP_HUMAN
  Q15012 GOLGI 4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
  gi|18680860|gb|BM509717.1|BM509717[18680860]
• 45: BM508064
  ij38f06.x1 Human insulinoma Homo sapiens cDNA clone IMAGE:5633410 3′ similar to
  TR:P97544 P97544 ER TRANSMEMBRANE PROTEIN.;, mRNA sequence
  gi|18679207|gb|BM508064.1|BM508064[18679207]
• 46: NM_—033543
  Homo sapiens hypothetical protein R29124_—1 (R29124_—1), mRNA
  gi|16117774|ref|NM_—033543.1|[16117774]
• 47: NM_—032732
  Homo sapiens hypothetical protein MGC10763 (IL17RL), mRNA
  gi|14249349|ref|NM_—032732.1|[14249349]
• 48: NM_—018676
  Homo sapiens TMTSP for transmembrane molecule with thrombospondin module (LOC55901), mRNA
  gi|8923893|ref|NM_—018676.1|[8923893]
• 49: NM_—016372
  Homo sapiens seven transmembrane domain orphan receptor (TPRA40), mRNA
  gi|7705964|ref|NM_—016372.1|[7705964]
• 50: L47337
  Homo sapiens transmembrane protein (TMC) mRNA, complete cds
  gi|18654193|gb|L47337.1|HUMTMC[18654193]
• 56: Y13567
  Homo sapiens HLA-B*07022 gene exon 1-5
  gi|4007617|emb|Y13567.1|HSY13567[4007617]
• 57: NM_—032027
  Homo sapiens beta-amyloid binding protein precursor (BBP), mRNA
  gi|17738309|ref|NM_—032027.2|[17738309]
• 58: NM_—030913
  Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (SEMA6C), mRNA
  gi|16306551|ref|NM_—030913.2|[16306551]
• 59: NM_—021203
  Homo sapiens APMCF1 protein (APMCF1), mRNA
  gi|14917112|ref|NM_—021203.2|[14917112]
• 60: NM_—006854
  Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), mRNA
  gi|8051609|ref|NM_—006854.21[8051609]
• 61: NM_—014394
  Homo sapiens growth hormone inducible transmembrane protein (GHITM), mRNA
  gi|7657479|ref|NM_—014394.1|[7657479]
• 62: NM_—014399
  Homo sapiens tetraspan NET-6 protein (NET-6), mRNA
  gi|7657372|ref|NM_—014399.1|[7657372]
• 63: NM_—014478
  Homo sapiens calcitonin gene-related peptide-receptor component protein (CGRP-RCP), mRNA
  gi|7656976|ref|NM_—014478.1|[7656976]
• 64: NM_—007324
  Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 1,
  mRNA
  gi|6552338|ref|NM_—007324.1|[6552338]
• 65: NM_—007323
  Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 2,
  mRNA
  gi|6552336|ref|NM_—007323.1|[6552336]
• 66: NM_—006876
  Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (B3GNT6), mRNA
  gi|5802983|ref|NM_—006876.1|[5802983]
• 67: NM_—006675
  Homo sapiens tetraspan transmembrane 4 super family (NET-5), mRNA
  gi|5729940|ref|NM_—006675.1|[5729940]
• 68: NM_—006405
  Homo sapiens transmembrane 9 superfamily member 1 (TM9SF1), mRNA
  gi|5453741|ref|NM_—006405.1|[5453741]
• 69: NM_—005761
  Homo sapiens plexin C1 (PLXNC1), mRNA
  gi|5032222|ref|NM_—005761.1|[5032222]
• 70: NM_—005814
  Homo sapiens glycoprotein A33 (transmembrane) (GPA33), mRNA
  gi|5031560|ref|NM_—005814.1|[5031560]
• 71: NM_—004799
  Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 3,
  mRNA
  gi|4759059|ref|NM_—004799.1|[4759059]
• 72: NM_—003764
  Homo sapiens syntaxin 11 (STX11), mRNA
  gi|4507286|ref|NM_—003764.1|[4507286]
• 73: NM_—003622
  Homo sapiens PTPRF interacting protein, binding protein 1 (liprin beta 1) (PPFIBP1), mRNA
  gi|4505986|ref|NM_—003622.1|[4505986]
• 74: NM_—003626
  Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
  interacting protein (liprin), alpha 1 (PPFIA1), mRNA
  gi|4505982|ref|NM_—003626.1|[4505982]
• 75: NM_—033266
  Homo sapiens ER to nucleus signalling 2 (ERN2), mRNA
  gi|15149481|ref|NM_—033266.1|[15149481]
• 76: NM_—030780
  Homo sapiens folate transporter/carrier (LOC81034), mRNA
  gi|13540550|ref|NM_—030780.1|[13540550]
• 77: NM_—025179
  Homo sapiens plexin A2 (PLXNA2), mRNA
  gi|13378152|ref|NM_—025179.1|[13378152]
• 78: NM_—022097
  Homo sapiens hepatocellular carcinoma antigen gene 520 (LOC63928), mRNA
  gi|11545810|ref|NM_—022097.1|[11545810]
• 79: NM_—019111
  Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA
  gi|18641378|ref|NM_—019111.2|[18641378]
• 80: NM_—002120
  Homo sapiens major histocompatibility complex, class II, DO beta (HLA-DOB), mRNA
  gi|18641377|ref|NM_—002120.2|[18641377]
• 81: NM_—002118
  Homo sapiens major histocompatibility complex, class II, DM beta (HLA-DMB), mRNA
  gi|18641376|ref|NM_—002118.3|[18641376]
• 82: NM_—002125
  Homo sapiens major histocompatibility complex, class II, DR beta 5 (HLA-DRB5),
  mRNA
  gi|18641374|ref|NM_—002125.2|[18641374]
• 83: NM_—021983
  Homo sapiens major histocompatibility complex, class II, DR beta 4 (HLA-DRB4),
  mRNA
  gi|18641372|ref|NM_—021983.3|[18641372]
• 84: NM_—022555
  Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3),
  mRNA
  gi|18641371|ref|NM_—022555.3|[18641371]
• 85: NM_—080923
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 4, mRNA
  gi|18641365|ref|NM_—080923.1|[18641365]
• 86: NM_—080922
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 3, mRNA
  gi|18641363|ref|NM_—080922.1|[18641363]
• 87: NM_—080921
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 2, mRNA
  gi|18641361|ref|NM_—080921.1|[18641361]
• 88: NM_—130778
  Homo sapiens collagen, type XVII, alpha 1 (COL17A1), transcript variant short,
  mRNA
  gi|18641355|ref|NM_—130778.1|[18641355]
• 89: NM_—000494
  Homo sapiens collagen, type XVII, alpha 1 (COL17A1), transcript variant long, mRNA
  gi|18641353|ref|NM_—000494.2|[18641353]
• 90: NM_—002838
  Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
  variant 1, mRNA
  gi|18641346|ref|NM_—002838.2|[18641346]
• 91: NM_—030950
  Homo sapiens ret finger protein (RFP), transcript variant beta, mRNA
  gi|18641280|ref|NM_—030950.2[18641280]
• 92: NM_—130785
  Homo sapiens TPTE and PTEN homologous inositol lipid phosphatase (TPIP), mRNA
  gi|18640755|ref|NM_—130785.1|[18640755]
• 93: AB057445
  Homo sapiens hTAT1 mRNA for aromatic amino acid transporter, complete cds
  gi|18640046|dbj|AB057445.1|[18640046]
• 94: NM_—006510
  Homo sapiens ret finger protein (RFP), transcript variant alpha, mRNA
  gi|17105396|ref|NM_—006510.3|[17105396]
• 95: NM_—033554
  Homo sapiens major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1),
  mRNA
  gi|15809045|ref|NM_—033554.1|[15809045]
• 96: NM_—005608
  Homo sapiens protein tyrosine phosphatase, receptor type, C-associated protein
  (PTPRCAP), mRNA
  gi|5032004|ref|NM_—005608.1|[5032004]
• 97: BM491907
  pgp2n.pk007.m20 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk007.m20 5′ similar to gb|AAH17476.1|AAH17476 (BC017476) sema domain, immunoglobulin domain (Ig), transmembrane domain TM) and
  short cytoplasmic domain, (semaphorin) 4C [Homo sapiens], mRNA sequence
  gi|18612838|gb|BM491907.1|BM491907[18612838]
• 98: BM491823
  pgp2n.pk007.i6 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk007.i6 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18612754|gb|BM491823.1|BM491823[18612754]
• 99: BM491746
  pgp2n.pk107.f14 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk007.f14 5′ similar to ref|XP_—044533.2 (XM_—044533) sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4B [Homo sapiens], mRNA sequence
  gi|18612677|gb|BM491746.1|BM491746[18612677]
• 100: BM491722
  pgp2n.pk007.d9 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk007.d9 5′ similar to ref|XP_—032285.1 (XM_—032285) similar to putative transmembrane protein; homolog of yeast Golgi membrane protein Yif1p (Yip1p-interacting factor) [Homo sapiens], mRNA sequence
  gi|18612653|gb|BM491722.1|BM491722[18612653]
• 101: BM491453
  pgp2n.pk006.h11 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk006.h11 5′ similar to ref|XP 058189.1 (XM_—058189) similar to Similar to transmembrane 4 superfamily member 1 (H. sapiens) [Homo sapiens] gb|AAH14339.1|AAH14339 (BC014339) Similar to transmembrane 4 superfamily member 1 [Homo sapiens], mRNA sequence
  gi|18612384|gb|BM491453.1|BM491453[18612384]
• 102: BM490974
  pgp2n.pk005.a11 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk005.a11 5′ similar to ref|XP_—008022.1 (XM_—008022) chromosome 16 open reading frame 5 [Homo sapiens]
  gi|AAG35583.1|AF195661_—1 (AF195661) transmembrane protein I1 [Homo sapiens]
  gi|AAH02882.1|AAH02882 (BC002882) chromosome 16 open reading frame 5 [Homo sapiens], mRNA sequence
  gi|18611905|gb|BM490974.1|BM490974[18611905]
• 103: BM490515
  pgp2n.pk003.k2 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk003.k2 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18611446|gb|BM490515.1|BM490515[18611446]
• 104: BM490496
  pgp2n.pk003.j21 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk003.j21 5′ similar to ref|XP_—015557.1 (XM_—015557) transmembrane gamma-carboxyglutamic acid protein 3 [Homo sapiens],
  mRNA sequence
  gi|18611427|gb|BM490496.1|BM490496[18611427]
• 105: BM490381
  pgp2n.pk003.e10 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
  Gallus gallus cDNA clone pgp2n.pk003.e10 5′ similar to ref|NP_—057641.1 (NM_—016557) orphan seven-transmembrane receptor, chemokine related [Homo sapiens] ref|XP_—016022.11 (XM_—016022) orphan seven-transmembrane receptor, chemokine related [Homo sapiens] sp|Q9NPB9|CKRB_HUMAN C-C CHEMOKINE RECEPTOR TYPE, mRNA sequence
  gi|18611312|gb|BM490381.1|BM490381[18611312]
• 106: BM489618
  pgm2n.pk011.h5 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk011.h5 5′ similar to ref|NP_—114131.1 (NM_—031925) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gb|AAK16442.1|AF327923_—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
  gi|18610549|gb|BM489618.1|BM489618[18610549]
• 107: BM489501
  pgm2n.pk011.b24 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk011.b24 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18610432|gb|BM489501.1|BM489501[18610432]
• 108: BM489487
  pgm2n.pk011.a8 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk011.a8 5′ similar to gb|AAC64943.1 (AF084481) transmembrane protein [Homo sapiens], mRNA
  sequence
  gi|18610418|gb|BM489487.1|BM489487[18610418]
• 109: BM489466
  pgm2n.pk010.p5 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.p5 5′ similar to dbj|AK056595.1|AK056595 Homo sapiens cDNA FLJ32033 fis, clone NTONG2000265, weakly similar to Probable transmembrane protein of fission yeast,
  mRNA sequence
  gi|18610397|gb|BM489466.1|BM489466[18610397]
• 110: BM489443
  pgm2n.pk010.o4 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.o4 5′ similar to ref|XP_—008022.1 (XM_—008022) chromosome 16 open reading frame 5 [Homo sapiens] gb|AAG35583.1|AF195661_—1 (AF195661) transmembrane protein I1 [Homo sapiens] gb|AAH02882.1|AAH02882 (BC002882) chromosome 16 open reading frame 5 [Homo sapiens], mRNA sequence
  gi|18610374|gb|BM489443.1|BM489443[18610374]
• 111: BM489432
  pgm2n.pk010.o15 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.o15 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.11 (AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18610363|gb|BM489432.1|BM489432[18610363]
• 112: BM489389
  pgm2n.pk010.m15 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.m15 5′ similar to ref|XP_—028438.1 (XM_—028438) CGI-101 protein [Homo sapiens]
  gi|AAF99603.1|AF242523_—1 (AF242523) hypothetical transmembrane protein SBB153 [Homo sapiens] gb|AAG43049.1|AF132289_—1 (AF132289) F-LAN-1 [Homo sapiens]
  gi|AAH10890.1|AAH10890 (BC010890), mRNA sequence
  gi|18610320|gb|BM489389.1|BM489389[18610320]
• 113: BM489272
  pgm2n.pk010.g4 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.g4 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18610203|gb|BM489272.1|BM489272[18610203]
• 114: BM489267
  pgm2n.pk010.g2 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.g2 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens), mRNA sequence
  gi|18610198|gb|BM489267.1|BM489267[18610198]
• 115: BM488196
  pgm2n.pk006.n2 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk006.n2 5′ similar to ref|NP_—114434.1 (NM_—032045) kringle-containing transmembrane protein;
  kringle-coding gene marking the eye and the nose [Homo sapiens] dbj|BAB40969.11
  (AB059618) kringle-containing transmembrane protein [Homo sapiens), mRNA sequence
  gi|18609127|gb|BM488196.1|BM488196[18609127]
• 116: BM488072
  pgm2n.pk006.h15 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk006.h15 5′ similar to ref|XP_—044533.2 (XM_—044533) sema domain, immunoglobulin domain (Ig),
  transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B [Homo sapiens], mRNA sequence
  gi|18609003|gb|BM488072.1|BM488072[18609003]
• 117: BM487945
  pgm2n.pk006.h16 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk006.b16 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18608876|gb|BM487945.1|BM487945[18608876]
• 118: BM487175
  pgm2n.pk003.m18 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk003.m18 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18608105|gb|BM487175.1|BM487175[18608105]
• 119: BM487035
  pgm2n.pk003.f7 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk003.f7 5′ similar to emb|CAC88191.1 (AL136141) bA138E2.2 (novel protein (lung seven transmembrane receptor 1 (LUSTR1), KIAA1623, FLJ22591, MGC15440)) [Homo sapiens), mRNA sequence
  gi|18607965|gb|BM487035.1|BM487035[18607965]
• 120: BM486914
  pgm2n.pk003.a11 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk003.a11 5′ similar to ref|NP_—055070.1 (NM_—014255) transmembrane protein 4; putative type II
  membrane protein [Homo sapiens] dbj|BAA76498.11 (AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18607844|gb|BM486914.1|BM486914[18607844]
• 121: NT_—009151
  Homo sapiens chromosome 11 working draft sequence segment
  gi|18604868|ref|NT_—009151.8|Hs11_—9308[18604868]
• 122: NT_—010823
  Homo sapiens chromosome 17 working draft sequence segment
  gi|18604211|ref|NT_—010823.8|Hs17_—10980[18604211]
• 123: XM_—008517
  Homo sapiens similar to transmembrane 4 superfamily member 5 (H. sapiens) (LOC147059), mRNA
  gi|18604159|ref|XM_—008517.4|[18604159]
• 124: NT_—009482
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18601829|ref|NT_—009482.8|Hs129639[18601829]
• 125: NT_—009458
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18601539|ref|NT_—009458.7|Hs12_—9615[18601539]
• 126: NT_—005428
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18600405|ref|NT_—005428.7|Hs25585[18600405]
• 127: XM_—087234
  Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4F (SEMA4F), mRNA
  gi|18600294|ref|XM_—087234.1|[18600294]
• 128: NT_—030593
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18599598|ref|NT_—030593.2|Hs2_—30849[18599598]
• 129: XM_—092364
  Homo sapiens similar to seven transmembrane receptor (LOC165082), mRNA
  gi|18599578|ref|XM_—092364.1|[18599578]
• 130: NT_—025667
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18599563|ref|NT_—025667.2|Hs325823[18599563]
• 131: NT_—010478
  Homo sapiens chromosome 16 working draft sequence segment
  gi|18598685|ref|NT_—010478.8|Hs16_—10635[18598685]
• 132: NT_—010422
  Homo sapiens chromosome 16 working draft sequence segment
  gi|18598469|ref|NT_—010422.8|Hs16_—10579[18598469]
• 133: NT_—030136
  Homo sapiens chromosome 14 working draft sequence segment
  gi|18597657|ref|NT_—030136.3|Hs1430391[18597657]
• 134: XM_—090902
  Homo sapiens similar to transmembrane 9 superfamily member 1 (H. sapiens) (LOC161426), mRNA
  gi|18597655|ref|XM_—090902.1|[18597655]
• 135: XM_—085169
  Homo sapiens similar to seven transmembrane receptor BLTR2; leukotriene B4 receptor BLT2 (H. sapiens) (LOC145549), mRNA
  gi|18597626|ref|XM_—085169.1|[18597626]
• 136: NT_—026437
  Homo sapiens chromosome 14 working draft sequence segment
  gi|18597566|ref|NT_—026437.6|Hs14_—26604[18597566]
• 137: XM_—085149
  Homo sapiens similar to fibronectin leucine rich transmembrane protein 2 (H. sapiens) (LOC145535), mRNA
  gi|18597448|ref|XM_—085149.1|[18597448]
• 138: NT_—025892
  Homo sapiens chromosome 14 working draft sequence segment
  gi|18597282|ref|NT_—025892.7|Hs14_—26048[18597282]
• 139: NT_—019583
  Homo sapiens chromosome 14 working draft sequence segment
  gi|18596851|ref|NT_—019583.8|Hs14_—19739[18596851]
• 140: XM_—093204
  Homo sapiens similar to G protein-coupled receptor 64; G protein-coupled receptor, epididymis-specific (seven transmembrane family) (LOC170247), mRNA
  gi|18596481|ref|XM_—093204.1|[18596481]
• 141: NT_—025319
  Homo sapiens chromosome X working draft sequence segment
  gi|18596220|ref|NT_—025319.8|HsX_—25475[18596220]
• 142: NT_—011719
  Homo sapiens chromosome X working draft sequence segment
  gi|18595448|ref|NT_—011719.6|HsX_—11876[18595448]
• 143: XM_—093073
  Homo sapiens similar to TRANSMEMBRANE 9 SUPERFAMILY PROTEIN MEMBER 2 PRECURSOR
  (LOC170048), mRNA
  gi|18595444|ref|XM_—093073.1|[18595444]
• 144: XM_—060026
  Homo sapiens similar to transmembrane 9 superfamily member 2; 76 kDa membrane protein; transmembrane protein 9 superfamily member 2 (LOC139375), mRNA
  gi|18595426|ref|XM_—060026.2|[18595426]
• 145: NT_—011687
  Homo sapiens chromosome X working draft sequence segment
  gi|18595291|ref|NT_—011687.8|HsX_—11844[18595291]
• 146: NT_—011657
  Homo sapiens chromosome X working draft sequence segment
  gi|18595178|ref|NT_—011657.8|HsX_—11814[18595178]
• 147: XM_—032382
  Homo sapiens transmembrane 4 superfamily member 2 (TM4SF2), mRNA
  gi|18595108|ref|XM_—032382.3|[18595108]
• 148: XM_—055073
  Homo sapiens similar to transmembrane phosphatase with tensin homology (H. sapiens) (LOC150132), mRNA
  gi|18593511|ref|XM_—055073.3|[18593511]
• 149: XM_—009671
  Homo sapiens transmembrane, prostate androgen induced RNA (TMEPAI), mRNA
  gi|18591987|ref|XM_—009671.7|[18591987]
• 150: NT_—011296
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18591133|ref|NT_—011296.8|Hs19_—11453[18591133]
• 151: NT_—011295
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18591086|ref|NT_—011295.5|Hs19_—11452[18591086]
• 152: NT_—011294
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18591029|ref|NT_—011294.7|Hs19_—11451[18591029]
• 153: NT_—011255
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18590680|ref|NT_—011255.8|HS19 11412[18590680]
• 154: NT_—011233
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18590500|ref|NT_—011233.8|Hs19_—11390[18590500]
• 155: XM_—032285
  Homo sapiens similar to putative transmembrane protein; homolog of yeast Golgi
  membrane protein Yif1p (Yip1p-interacting factor) (LOC90522), mRNA
  gi|18590452|ref|XM_—032285.2|[18590452]
• 156: NT_—011151
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18590324|ref|NT_—011151.8|Hs19_—11308[18590324]
• 157: NT_—011109
  Homo sapiens chromosome 19 working draft sequence segment
  gi|18589940|ref|NT_—011109.8|Hs19_—11266[18589940]
• 158: NT_—030157
  Homo sapiens chromosome 17 working draft sequence segment
  gi|18588299|ref|NT_—030157.3|Hs1730412[18588299]
• 159: XM_—096100
  Homo sapiens transmembrane activator and CAML interactor (TACI), mRNA
  gi|18588295|ref|XM_—096100.1|[18588295]
• 160: NT_—010672
  Homo sapiens chromosome 17 working draft sequence segment
  gi|18586808|ref|NT_—010672.8|Hs17_—10829[18586808]
• 161: NT_—024776
  Homo sapiens chromosome 16 working draft sequence segment
  gi|8585964|ref|NT_—024776.4|Hs16_—24932[18585964]
• 162: NT_—015360
  Homo sapiens chromosome 16 working draft sequence segment
  gi|18585813|ref|NT_—015360.8|Hs16_—15516[18585813]
• 163: NT_—010552
  Homo sapiens chromosome 16 working draft sequence segment
  gi|18585429|ref|NT_—010552.8|Hs16_—10709[18585429]
• 164: NT_—010356
  Homo sapiens chromosome 15 working draft sequence segment
  gi|18584698|ref|NT_—010356.8|Hs15_—10513[18584698]
• 165: NT_—010351
  Homo sapiens chromosome 15 working draft sequence segment
  gi|18584556|ref|NT_—010351.8|Hs15_—10508[18584556]
• 166: NT_—010224
  Homo sapiens chromosome 15 working draft sequence segment
  gi|18583998|ref|NT_—010224.7|Hs15_—10381[18583998]
• 167: XM_—083914
  Homo sapiens transmembrane 6 superfamily member 1 (TM6SF1), mRNA
  gi|18583986|ref|XM_—083914.1|[18583986]
• 168: XM_—083903
  Homo sapiens transmembrane 9 superfamily member 1 (TM9SF1), mRNA
  gi|18583350|ref|XM_—083903.1|[18583350]
• 169: NT_—010036
  Homo sapiens chromosome 14 working draft sequence segment
  gi|18583080|ref|NT_—010036.8|Hs14_—10193[18583080]
• 170: XM_—028295
  Homo sapiens calponin like transmembrane domain protein (calmin), mRNA
  gi|18582992|ref|XM_—028295.3|[18582992]
• 171: NT_—029430
  Homo sapiens chromosome 13 working draft sequence segment
  gi|18582622|ref|NT_—029430.4|Hs13_—29589[18582622]
• 172: NT_—009967
  Homo sapiens chromosome 13 working draft sequence segment
  gi|18582005|ref|NT_—009967.8|Hs13_—10124[18582005]
• 173: NT_—009952
  Homo sapiens chromosome 13 working draft sequence segment
  gi|18581926|ref|NT_—009952.8|Hs13_—10109[18581926]
• 174: NT_—009917
  Homo sapiens chromosome 13 working draft sequence segment
  gi|18581517(ref|NT_—009917.8|Hs13_—10074[18581517]
• 175: XM_—084974
  Homo sapiens transmembrane phosphatase with tensin homology (TPTE), mRNA
  gi|18581435|ref|XM_—084974.1|[18581435]
• 176: NT_—009910
  Homo sapiens chromosome 13 working draft sequence segment
  gi|18581383|ref|NT_—009910.8|Hs13_—10067[18581383]
• 177: NT_—009711
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18580591|ref|NT_—009711.8|Hs12_—9868[18580591]
• 178: NT_—009540
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18579972|ref|NT_—009540.8|Hs129697[18579972]
• 179: NT_—009487
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18579817|ref|NT_—009487.8|Hs12_—9644[18579817]
• 180: XM_—084852
  Homo sapiens similar to transmembrane protein induced by tumor necrosis factor
  alpha (LOC144404), mRNA
  gi|18579801|ref|XM_—084852.1|[18579801]
• 181: NT_—009471
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18579778|ref|NT_—009471.8|Hs12_—9628[18579778]
• 182: XM_—084845
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC144383), mRNA
  gi|18579688|ref|XM_—084845.1|[18579688]
• 183: XM_—006748
  Homo sapiens seven transmembrane protein TM7SF3 (TM7SF3), mRNA
  gi|18579647|ref|XM_—006748.5|[18579647]
• 184: NT_—030809
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18579377|ref|NT_—030809.2|Hs12_—31065[18579377]
• 185: NT_—024394
  Homo sapiens chromosome 12 working draft sequence segment
  gi|18579035|ref|NT_—024394.7|Hs12_—24550[18579035]
• 186: NT_—009237
  Homo sapiens chromosome 11 working draft sequence segment
  gi|18578641|ref|NT_—009237.8|Hs11_—9394[18578641]
• 187: NT_—009215
  Homo sapiens chromosome 11 working draft sequence segment
  gi|18578584|ref|NT_—009215.8|Hs11_—9372[18578584]
• 188: NT_—008992
  Homo sapiens chromosome 11 working draft sequence segment
  gi|18578338|ref|NT_—008992.7|Hs11_—9149[18578338]
• 189: XM_—055266
  Homo sapiens putative transmembrane protein; homolog of yeast Golgi membrane protein Yif1p (Yip1p-interacting factor) (54TM), mRNA
  gi|18578177|ref|XM_—055266.2|[18578177]
• 190: XM_—045525
  Homo sapiens transmembrane 7 superfamily member 2 (TM7SF2), mRNA
  gi|18578063|ref|XM_—045525.4|[18578063]
• 191: XM_—006111
  Homo sapiens fibronectin leucine rich transmembrane protein 1 (FLRT1), mRNA
  gi|18578050|ref|XM_—006111.5|[18578050]
• 192: NT_—008804
  Homo sapiens chromosome 10 working draft sequence segment
  gi|18576536|ref|NT_—008804.8|Hs10_—8961[18576536]
• 193: XM_—084484
  Homo sapiens similar to sema domain, immunoglobulin domain (Ig), transmembrane
  domain (TM) and short cytoplasmic domain, (semaphorin) 4G; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4G (LOC143288), mRNA
  gi|18576428|ref|XM_—084484.1|[18576428]
• 194: NT_—008609
  Homo sapiens chromosome 10 working draft sequence segment
  gi|18575857|ref|NT_—008609.8|Hs10_—8766[18575857]
• 195: NT_—029394
  Homo sapiens chromosome 10 working draft sequence segment
  gi|185745771 ref|NT029394.3|Hs10_—29553[18574577]
• 196: NT_—024089
  Homo sapiens chromosome 10 working draft sequence segment
  gi|8574182|ref|NT_—024089.8|Hs10_—24245[18574182]
• 197: NT_—024064
  Homo sapiens chromosome 10 working draft sequence segment
  gi|18574077|ref|NT_—024064.8|Hs10_—24220[18574077]
• 198: XM_—084331
  Homo sapiens similar to growth hormone inducible transmembrane protein (H. sapiens) (LOC170427), mRNA
  gi|18574063|ref|XM_—084331.1|[18574063]
• 199: XM_—043589
  Homo sapiens growth hormone inducible transmembrane protein (GHITM), mRNA
  gi|8574061|ref|XM_—043589.3|[18574061]
• 200: NT_—008554
  Homo sapiens chromosome 9 working draft sequence segment
  gi|8573734|ref|NT_—008554.8|HS9_—8711[18573734]
• 201: XM_—071188
  Homo sapiens similar to mucin 1, transmembrane (LOC138940), mRNA
  gi|18573702|ref|XM_—071188.2|[18573702]
• 202: NT_—008476
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18573649|ref|NT_—008476.8|HS9_—8633[18573649]
• 203: NT_—008421
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18573390|ref|NT_—008421.8|Hs9_—8578[18573390]
• 204: NT_—031831
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18572946|ref|NT_—031831.1|Hs9_—32002[18572946]
• 205: NT_—031830
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18572933|ref|NT_—031830.1|HS9_—32001[18572933]
• 206: NT_—029366
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18572447|ref|NT_—029366.4|Hs9_—29525[18572447]
• 207: NT_—027082
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18572282|ref|NT_—027082.5|Hs9_—27242[18572282]
• 208: NT_—024010
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18572162|ref|NT_—024010.7|Hs9_—24166[18572162]
• 209: XM_—108898
  Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4D (SEMA4D), mRNA
  gi|18572160|ref|XM_—108898.1|[18572160]
• 210: NT_—023967
  Homo sapiens chromosome 9 working draft sequence segment
  gi|18571929|ref|NT_—023967.8|Hs924123[18571929]
• 211: XM_—095756
  Homo sapiens similar to transmembrane protein 2 (H. sapiens) (LOC169529), mRNA
  gi|18571901|ref|XM_—095756.1|[18571901]
• 212: NT_—008253
  Homo sapiens chromosome 8 working draft sequence segment
  gi|18571429|ref|NT_—008253.8|Hs88410[18571429]
• 213: NT_—008079
  Homo sapiens chromosome 8 working draft sequence segment
  gi|18570812|ref|NT_—008079.8|Hs8_—8236[18570812]
• 214: NT_—007997
  Homo sapiens chromosome 8 working draft sequence segment
  gi|8570417|ref|NT_—007997.8|Hs88154[18570417]
• 215: XM_—095564
  Homo sapiens similar to transmembrane trafficking protein (LOC169193), mRNA
  gi|18570401|ref|XM_—095564.1|[18570401]
• 216: NT_—007978
  Homo sapiens chromosome 8 working draft sequence segment
  gi|18570256|ref|NT_—007978.8|Hs8_—8135[18570256]
• 217: NT_—030735
  Homo sapiens chromosome 8 working draft sequence segment
  gi|18569963|ref|NT_—030735.2|Hs8_—30991[18569963]
• 218: NT_—007905
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18568542|ref|NT_—007905.8Hs7_—8062[18568542]
• 219: NT_—007902
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18568515|ref|NT_—007902.8|Hs78059[18568515]
• 220: AF132746
  Homo sapiens transmembrane protein mRNA, complete cds
  gi|18568116|gb|AF132746.1|[18568116]
• 221: NT_—007867
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18568101|ref|NT_—007867.8|Hs78024[18568101]
• 222: NT_—007751
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18567173|ref|NT_—007751.8|Hs7_—7908[18567173]
• 223: NT_—031815
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18566709|ref|NT_—031815.1|Hs731986[18566709]
• 224: NT_—031811
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18566667|ref|NT_—031811.1Hs731982[18566667]
• 225: XM_—095132
  Homo sapiens similar to dM538M10.1 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein similar to human HS6M1-21) (LOC154958), mRNA
  gi|18566661|ref|XM_—095132.1|[18566661]
• 226: NT_—031807
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18566613|ref|NT_—031807.1|Hs7_—31978[18566613]
• 227: NT_—030004
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18566403|ref|NT_—030004.3|Hs7_—30259[18566403]
• 228: NT_—027064
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18566143|ref|NT_—027064.5|Hs7_—27224[18566143]
• 229: NT_—017168
  Homo sapiens chromosome 7 working draft sequence segment
  gi|18565551|ref|NT_—017168.8|Hs7_—17324[18565551]
• 230: NT_—007592
  Homo sapiens chromosome 6 working draft sequence segment
  gi|18565438|ref|NT_—007592.8|Hs6_—7749[18565438]
• 231: XM_—094938
  Homo sapiens similar to 573K1.2 (mm17M1-3 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor LIKE) protein)) (LOC168233), mRNA
  gi|18565395|ref|XM_—094938.1|[18565395]
• 232: XM_—094903
  Homo sapiens similar to 573K1.15 (mm17M1-6 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor LIKE) protein)) (LOC168189), mRNA
  gi|18565249|ref|XM_—094903.1|[18565249]
• 233: XM_—094939
  Homo sapiens similar to dM538M10.7 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein) (LOC154634), mRNA
  gi|18565093|ref|XM_—094939.1|[18565093]
• 234: NT_—007402
  Homo sapiens chromosome 6 working draft sequence segment
  gi|18564193|ref|NT_—007402.8|Hs6_—7559[18564193]
• 235: XM_—069322
  Homo sapiens similar to transmembrane protein 2 (LOC135381), mRNA
  gi|18564165|ref|XM_—069322.2|[18564165]
• 236: XM_—087914
  Homo sapiens similar to dJ402H5.1 (novel 7 transmembrane receptor of the rhodopsin family) (LOC154354), mRNA
  gi|18564052|ref|XM_—087914.1|[18564052]
• 237: XM_—087917
  Homo sapiens similar to embryonic seven-span transmembrane protein-like protein
  (LOC154344), mRNA
  gi|18564031|ref|XM_—087917.1|[18564031]
• 238: XM_—094741
  Homo sapiens similar to 573K1.15 (mm17M1-6 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor LIKE) protein)) (LOC167905), mRNA
  gi|18563541|ref|XM_—094741.1|[18563541]
• 239: NT_—025741
  Homo sapiens chromosome 6 working draft sequence segment
  gi|18563240|ref|NT_—025741.7|Hs6_—25897[18563240]
• 240: NT_—023451
  Homo sapiens chromosome 6 working draft sequence segment
  gi|18563080|ref|NT_—023451.8|Hs623607[18563080]
• 241: XM_—069021
  Homo sapiens similar to putative transmembrane protein PTG (L1C134801) mRNA
  gi|18563039|ref|XM_—069021.2|[18563039]
• 242: NT_—006725
  Homo sapiens chromosome 5 working draft sequence segment
  gi|18561712|ref|NT_—006725.8|Hs56882[18561712]
• 243: XM_—094515
  Homo sapiens similar to transmembrane receptor Unc5H1 (LOC167476), mRNA
  gi|18561698|ref|XM_—094515.1|[18561698]
• 244: NT_—006576
  Homo sapiens chromosome 5 working draft sequence segment
  gi|18561313|ref|NT_—006576.8|Hs56733[18561313]
• 245: XM_—004042
  Homo sapiens sema domain, seven thrombospondin repeats (type 1 and type 1-like),
  transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A (SEMA5A), mRNA
  gi|18561264|ref|XM_—004042.7|[18561264]
• 246: XM_—087665
  Homo sapiens similar to semaphorin 6A1; sema domain, transmembrane domain (TM),
  and cytoplasmic domain, 6A; semaphorin 6A-1 (LOC153420), mRNA
  gi|18560683|ref|XM_—087665.1|[18560683]
• 247: NT_—006169
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18558377|ref|NT_—006169.8|Hs4_—6326[18558377]
• 248: NT_—022836
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18557125|ref|NT_—022836.7|Hs4_—22992[18557125]
• 249: XM_—093891
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC166482), mRNA
  gi|18557119|ref|XM_—093891.1|[18557119]
• 250: AF456925
  Homo sapiens USH3 region, partial sequence
  gi|17901944|gb|AF456925.1|AF411849S2[17901944]
• 251: AF411849
  Homo sapiens USH3 region, partial sequence
  gi|17901943|gb|AF411849.1|AF411849S1]17901943]
• 252: AH011260
  Homo sapiens
  gi|17901942|gb|AH011260.1|SEG_AF411849S[17901942]
• 253: XM_—064062
  Homo sapiens similar to putative transmembrane receptor (LOC124274), mRNA
  gi|17488065|ref|XM_—064062.1|[17488065]
• 254: XM_—063875
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC123862), mRNA
  gi|17487213|ref|XM_—063875.1|[17487213]
• 255: XM_—066655
  Homo sapiens similar to G protein-coupled receptor 64; G protein-coupled receptor, epididymis-specific (seven transmembrane family) (LOC139378), mRNA
  gi|17485715|ref|XM_—066655.1|[17485715]
• 256: NT_—011519
  Homo sapiens chromosome 22 working draft sequence segment
  gi|17484914|ref|NT_—011519.9|Hs22_—11676[17484914]
• 257: NT_—011362
  Homo sapiens chromosome 20 working draft sequence segment
  gi|17484369|ref|NT_—011362.7|Hs20_—11519[17484369]
• 258: XM_—063355
  Homo sapiens similar to transmembrane 7 superfamily member 1 (upregulated in kidney); transmembrane 7 superfamily member 1 (upregulated in (LOC122791), mRNA
  gi|17476790|ref|XM_—063355.1|[17476790]
• 259: XM_—062544
  Homo sapiens similar to transmembrane protein 4; putative secreted protein ZSIG9 (LOC121255), mRNA
  gi|17474559|ref|XM_—062544.1|[17474559]
• 260: XM_—062443
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC121062), mRNA
  gi|17474137|ref|XM_—062443.1|[17474137]
• 261: XM_—070446
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC137474), mRNA
  gi|17466780|ref|XM_—070446.1|[17466780]
• 262: XM_—070130
  Homo sapiens similar to transmembrane protein 4; putative secreted protein ZSIG9
  (LOC136903), mRNA
  gi|17465836|ref|XM_—070130.1|[17465836]
• 263: XM_—069635
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC135982), mRNA
  gi|17465065|ref|XM_—069635.1|[17465065]
• 264: XM_—069633
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U); interferon-inducible (LOC135976), mRNA
  gi|17465055|ref|XM_—069633.1|[17465055]
• 265: XM_—069470
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC135637), mRNA
  gi|17464370|ref|XM_—069470.1|[17464370]
• 266: XM_—069460
  Homo sapiens similar to dM538M10.7 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein) (LOC135626), mRNA
  gi|17464346|ref|XM_—069460.1|[17464346]
• 267: XM_—064220
  Homo sapiens similar to putative transmembrane receptor (LOC124601), mRNA
  gi|17457972|ref|XM_—064220.1|[17457972]
• 268: XM_—063652
  Homo sapiens similar to leucine zipper-EF-hand containing transmembrane protein
  1; leucine zipper-EF-hand containing transmembrane protein 1 (LOC123430), mRNA
  gi|17456715|ref|XM_—063652.1|[17456715]
• 269: XM_—062703
  Homo sapiens similar to tetraspan transmembrane 4 super family (LOC121590), mRNA
  gi|17456679|ref|XM_—062703.1|[17456679]
• 270: XM_—051362
  Homo sapiens transmembrane 6 superfamily member 2 (TM6SF2), mRNA
  gi|17456138|ref|XM_—051362.2|[17456138]
• 271: NT_—011288
  Homo sapiens chromosome 19 working draft sequence segment
  gi|17455923|ref|NT_—011288.7|HS19_—11445[17455923]
• 272: XM_—031933
  Homo sapiens transmembrane protein vezatin (VEZATIN), mRNA
  gi|17454769|ref|XM_—031933.3|[17454769]
• 273: XM_—068785
  Homo sapiens similar to transmembrane receptor Unc5H1 (LOC13430i), mRNA
  gi|17446928|ref|XM_—068785.1|[17446928]
• 274: NT_—030685
  Homo sapiens chromosome 5 working draft sequence segment
  gi|17443457|ref|NT_—030685.1Hs5_—30941[17443457]
• 275: NT_—011387
  Homo sapiens chromosome 20 working draft sequence segment
  gi|16195112|ref|NT_—011387.6|Hs20_—11544[16195112]
• 276: NT_—011512
  Homo sapiens chromosome 21 working draft sequence segment
  gi|16170824|ref|NT_—011512.4|Hs21_—11669[16170824]
• 277: XM_—049793
  Homo sapiens transmembrane protease, serine 2 (TMPRSS2), mRNA
  gi|16170797|ref|XM_—049793.2|[16170797]
• 278: NT_—011520
  Homo sapiens chromosome 22 working draft sequence segment
  gi|16168698|ref|NT_—011520.8|Hs22_—11677[16168698]
• 279: NT_—030188
  Homo sapiens chromosome 21 working draft sequence segment
  gi|16166749|ref|NT_—030188.1|Hs21_—30443[16166749]
• 280: NT_—029490
  Homo sapiens chromosome 21 working draft sequence segment
  gi|16166567|ref|NT_—029490.2|Hs21_—29649[16166567]
• 281: NT_—011515
  Homo sapiens chromosome 21 working draft sequence segment
  gi|16166537|ref|NT_—011515.6|Hs21_—11672[16166537]
• 282: XM_—009794
  Homo sapiens transmembrane protein 1 (TMEM1), mRNA
  gi|16166381|ref|XM_—009794.4|[16166381]
• 283: NT_—009407
  Homo sapiens chromosome 11 working draft sequence segment
  gi|16164445|ref|NT_—009407.5|Hs11_—9564[16164445]
• 284: NT_—027220
  Homo sapiens chromosome X working draft sequence segment
  gi|16163830|ref|NT_—027220.2|HsX_—27380[16163830]
• 285: XM_—055222
  Homo sapiens region containing sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; mitochondrial ribosomal protein L32 (LOC143289), mRNA
  gi|16156787|ref|XM_—055222.1|[16156787]
• 286: XM_—008123
  Homo sapiens tryptase gamma 1 (TPSG1), mRNA
  gi|15317318|ref|XM_—008123.5|[15317318]
• 287: NT_—009738
  Homo sapiens chromosome 12 working draft sequence segment
  gi|15307319|ref|NT_—009738.5|HS12_—9895[15307319]
• 288: XM_—006991
  Homo sapiens tetraspan transmembrane 4 super family (NET-5), mRNA
  gi|15307297|ref|XM_—006991.5|[15307297]
• 289: NT_—009513
  Homo sapiens chromosome 12 working draft sequence segment
  gi|15303938|ref|NT_—009513.5|Hs12_—9670[15303938]
• 290: NT_—029317
  Homo sapiens chromosome 6 working draft sequence segment
  gi|15300889|ref|NT_—029317.1|Hs6_—29476[15300889]
• 291: XM_—040419
  Homo sapiens transmembrane trafficking protein (TMP21), mRNA
  gi|14784589|ref|XM_—040419.1|[14784589]
• 292: XM_—030300
  Homo sapiens similar to transmembrane receptor Unc5H1 (LOC90249), mRNA
  gi|14781377|ref|XM_—030300.1|[14781377]
• 293: XM_—036570
  Homo sapiens type I transmembrane protein Fn14 (FN14), mRNA
  gi|14777984|ref|XM_—036570.1|[14777984]
• 294: XM_—027469
  Homo sapiens transmembrane protein 8 (five membrane-spanning domains) (TMEM8),
  mRNA
  gi|14777199|ref|XM_—027469.1|[14777199]
• 295: XM_—009839
  Homo sapiens claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) (CLDN5), mRNA
  gi|14777026|ref|XM_—009839.4|[14777026]
• 296: NT_—025911
  Homo sapiens chromosome 17 working draft sequence segment
  gi|14776336|ref|NT_—025911.3|Hs17_—26067[14776336]
• 297: XM_—041427
  Homo sapiens transmembrane protease, serine 5 (spinesin) (TMPRSS5), mRNA
  gi|14770562|ref|XM_—041427.1|[14770562]
• 298: XM_—006940
  Homo sapiens cytoskeleton-associated protein 4 (CKAP4), mRNA
  gi|14766392|ref|XM_—006940.4|[14766392]
• 299: NT_—011598
  Homo sapiens chromosome X working draft sequence segment
  gi|14759313|ref|NT_—011598.4|HsX_—11755[14759313]
• 300: XM_—033157
  Homo sapiens transmembrane 4 superfamily member 6 (TM4SF6), mRNA
  gi|14757314|ref|XM_—033157.1|[14757314]
• 301: XM_—044358
  Homo sapiens similar to cleft lip and palate associated transmembrane protein (LOC92330), mRNA
  gi|14755905|ref|XM_—044358.1|[14755905]
• 302: XM_—004980
  Homo sapiens cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7) (CFTR), mRNA
  gi|14753226|ref|XM_—004980.4|[14753226]
• 303: XM_—002838
  Homo sapiens similar to orphan seven-transmembrane receptor, chemokine related
  (H. sapiens) (LOC154103), mRNA
  gi|14750021|ref|XM_—002838.6|[14750021]
• 304: XM_—005949
  Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4G (SEMA4G), mRNA
  gi|14747317|ref|XM_—005949.4|[14747317]
• 305: XM_—035329
  Homo sapiens similar to transmembrane trafficking protein (LOC90981), mRNA
  gi|14744677|ref|XM_—035329.1|[14744677]
• 306: XM_—038156
  Homo sapiens transmembrane protein 2 (TMEM2), mRNA
  gi|14743733|ref|XM_—038156.1|[14743733]
• 307: XM_—005346
  Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA
  gi|14738782|ref|XM_—005346.4|[14738782]
• 308: XM_—045505
  Homo sapiens transmembrane 4 superfamily member (tetraspan NET-7) (NET-7), mRNA
  gi|14738519|ref|XM_—045505.1|[14738519]
• 311: NT_—026472
  Homo sapiens chromosome 17 working draft sequence segment
  gi|13654226|ref|NT_—026472.1|Hs17_—26639[13654226]
• 312: XM_—012718
  Homo sapiens secreted and transmembrane 1 (SECTM1), mRNA
  gi|13654161|ref|XM_—012718.2|[13654161]
• 313: XM_—016506
  Homo sapiens fibronectin leucine rich transmembrane protein 2 (FLRT2), mRNA
  gi|13648109|ref|XM_—016506.1|[13648109]
• 314: XM_—005187
  Homo sapiens ankyrin-like with transmembrane domains 1 (ANKTM1), mRNA
  gi|13645787|ref|XM_—005187.3|[13645787]
• 315: NT_—025803
  Homo sapiens chromosome 8 working draft sequence segment
  gi|13642635|ref|NT_—025803.2|Hs8_—25959[13642635]
• 316: XM_—017003
  Homo sapiens interferon induced transmembrane protein 3 (1-8U) (IFITM3), mRNA
  gi|13642630|ref|XM_—017003.1|[13642630]
• 317: NT_—022761
  Homo sapiens chromosome 4 working draft sequence segment
  gi|18556805|ref|NT_—022761.8|Hs4_—22917[18556805]
• 318: XM_—093853
  Homo sapiens similar to transmembrane tryptase (LOC166415), mRNA
  gi|18556799|ref|XM_—093853.1|[18556799]
• 319: NT_—005997
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18556520|ref|NT_—005997.8|Hs3_—6154[18556520]
• 320: XM_—087464
  Homo sapiens similar to transmembrane protein 7 (LOC152408), mRNA
  gi|18556483|ref|XM_—087464.1|[18556483]
• 321: NT_—005986
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18556440|ref|NT_—005986.8|Hs3_—6143[18556440]
• 322: NT_—005678
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18555423|ref|NT_—005678.7|Hs3_—5835[18555423]
• 323: XM_—093638
  Homo sapiens similar to orphan seven transmembrane receptor (LOC166071), mRNA
  gi|18555421|ref|XM_—093638.1|[18555421]
• 324: XM_—093637
  Homo sapiens similar to orphan seven transmembrane receptor (LOC166070), mRNA
  gi|18555419|ref|XM_—093637.1|[18555419]
• 325: NT_—005654
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18555355|ref|NT_—005654.8|Hs3_—5811[18555355]
• 326: NT_—005616
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18555281|ref|NT_—005616.8|Hs3_—5773[18555281]
• 327: NT_—005543
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18555061|ref|NT_—005543.7|Hs35700[18555061]
• 328: XM_—098155
  Homo sapiens similar to seven transmembrane domain orphan receptor (H. sapiens)
  (LOC152010), mRNA
  gi|18555022|ref|XM_—098155.1|[18555022]
• 329: NT_—022531
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18554079|ref|NT_—022531.4|Hs3_—22687[18554079]
• 330: XM_—096181
  Homo sapiens transmembrane 4 superfamily member 4 (TM4SF4), mRNA
  gi|18554072|ref|XM_—096181.1|[18554072]
• 331: NT_—022412
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18553606|ref NT_—022412.6|Hs322568[18553606]
• 332: NT _—022393
  Homo sapiens chromosome 3 working draft sequence segment
  gi|18553572|ref|NT_—022393.7|Hs322549[18553572]
• 333: NT_—005423
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18553407|ref|NT_—005423.8|Hs2_—5580[18553407]
• 334: NT_—005387
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18553071|ref|NT_—005387.8|Hs2_—5544[18553071]
• 335: NT_—005289
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18552655|ref|NT_—005289.8|Hs25446[18552655]
• 336: NT_—005214
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18552351|ref|NT_—005214.8|Hs25371[18552351]
• 337: NT_—005138
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18552129|ref|NT_—005138.8|Hs25295[18552129]
• 338: NT _—022180
  Homo sapiens chromosome 2 working draft sequence segment
  gi|18550124|ref|NT_—022180.8|Hs222336[18550124]
• 339: NT_—004858
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18549451|ref|NT_—004858.8|Hs1_—5015[18549451]
• 340: XM_—053256
  Homo sapiens mucin 1, transmembrane (MUC1), mRNA
  gi|18549380|ref|XM_—053256.4|[18549380]
• 341: NT_—004836
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18549182|ref|NT_—004836.8|Hs1_—4993[18549182]
• 342: NT_—004811
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18549145|ref|NT_—004811.8|Hs14968[18549145]
• 343: XM_—041879
  Homo sapiens similar to AF1Q protein; transmembrane protein (LOC149430), mRNA
  gi|18549121|ref|XM_—041879.2|[18549121]
• 344: NT_—004668
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18548894|ref|NT_—004668.8|Hs14825[18548894]
• 345: NT_—004441
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18547758|ref|NT_—004441.8|Hs1_—4598[18547758]
• 346: NT_—004434
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18547724|ref|NT_—004434.8|Hs14591[18547724]
• 347: NT_—004391
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18547557|ref|NT_—004391.8|Hs14548[18547557]
• 348: NT_—021907
  Homo sapiens chromosome 1 working draft sequence segment
  gi|18544452|ref|NT_—021907.8|Hs1_—22063[18544452]
• 349: XM_—053163
  Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (SEMA6C), mRNA
  gi|18544383|ref|XM_—053163.4|[18544383]
• 350: NM_—016155
  Homo sapiens matrix metalloproteinase 17 (membrane-inserted) (MMP17), mRNA
  gi|18543372|ref|NM_—016155.2|[18543372]
• 351: XM_—060507
  Homo sapiens similar to putative integral membrane transporter; lysosomal associated transmembrane protein 4 beta (LOC127480), mRNA
  gi|17443784|ref|XM_—060507.1|[17443784]
• 352: XM_—060501
  Homo sapiens similar to bM332P19.3 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein (mm17M1-14)) (LOC127469), mRNA
  gi|17443690|ref|XM_—060501.1|[17443690]
• 353: XM_—060442
  Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U); interferon-inducible (LOC127360), mRNA
  gi|17441370|ref|XM_—060442.1|[17441370]
• 354: XM_—065294
  Homo sapiens similar to Transmembrane protease, serine 3 (Serine protease TADG-12) (Tumor associated differentially-expressed gene-12 protein) (LOC129566), mRNA
  gi|17439790|ref|XM_—065294.1|[17439790]
• 355: XM_—032249
  Homo sapiens sema domain, seven thrombospondin repeats (type 1 and type 1-like),
  transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B (SEMA5B), mRNA
  gi|17438489|ref|XM_—032249.3|[17438489]
• 356: XM_—058189
  Homo sapiens similar to TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 1 (TUMOR-ASSOCIATED
  ANTIGEN L6) (MEMBRANE COMPONENT, SURFACE MARKER 1) (M3S1) (LOC116441), mRNA
  gi|17437690|ref|XM_—058189.2|[17437690]
• 357: NT_—011903
  Homo sapiens chromosome Y working draft sequence segment
  gi|17433681|ref|NT_—011903.8|HsY_—12060[17433681]
• 358: XM_—034757
  Homo sapiens similar to transmembrane phosphatase with tensin homology (H. sapiens) (LOC159185), mRNA
  gi|16164045|ref|XM_—034757.2|[16164045]
• 359: XM_—003025
  Homo sapiens mucin 13, epithelial transmembrane (MUC13), mRNA
  gi|16159511|ref|XM_—003025.5|[16159511]
• 360: NT_—015169
  Homo sapiens chromosome 4 working draft sequence segment
  gi|16156888|ref|NT_—015169.5|Hs4_—15325[16156888]
• 361: NM_—002837
  Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA
  gi|18491009|ref|NM_—002837.2|[18491009]
• 362: BC022439
  Homo sapiens, interferon induced transmembrane protein 3 (1-8U), clone MGC:24755
  IMAGE:4282809, mRNA, complete cds
  gi|18490258|gb|BC022439.1|[18490258]
• 363: NM_—005031
  Homo sapiens FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant a, mRNA
  gi|11612671|ref|NM_—005031.2|[11612671]
• 364: NM_—021902
  Homo sapiens FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant b, mRNA
  gi|11612669|ref|NM_—021902.1|[11612669]
• 365: NM_—014164
  Homo sapiens FXYD domain-containing ion transport regulator 5 (FXYD5), mRNA
  gi|11612664|ref|NM_—014164.2|[11612664]
• 366: NM_—020399
  Homo sapiens PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10 (PIST), mRNA
  gi|9966876|ref|NM_—020399.1|[9966876]
• 367: BM439879
  pgr1n.pk001.i17 Normalized Chicken Reproductive Tract cDNA Library (pgr1n) Gallus gallus cDNA clone pgr1n.pk001.i17 5′ similar to gi|7657373 ref|NP_—055214.11 tetraspan NET-6 protein; transmembrane 4 superfamily protein [Homo sapiens] gi|13628481 ref|XP_—004793.31 tetraspan NET-6 protein [Homo sapiens] gi|14747013 ref|XP_—049585.11 tetraspan NET-6 protein [Homo sapiens]
  gi|14, mRNA sequence
  gi|18470654|gb|BM439879.1|BM439879[18470654]
• 368: BM439852
  pgr1n.pk001.h13 Normalized Chicken Reproductive Tract cDNA Library (pgr1n) Gallus gallus cDNA clone pgr1n.pk001.h13 5′ similar to gi|7657176 ref|NP_—055070.1|transmembrane protein 4; putative type II membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
  gi|18470627|gb|BM439852.1|BM439852[18470627]
• 369: BM439375
  pgr1c.pk001.a9 Primary Chicken Reproductive Tract cDNA Library (pgr1c) Gallus gallus cDNA clone pgr1c.pk001.a9 5′ similar to gi|13994300 ref|NP_—114131.1] transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gi|AAK16442.1|AF327923_—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
  gi|18470150|gb|BM439375.1|BM439375[18470150]
• 370: NM_—080841
  Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
  variant 3, mRNA
  gi|18450370|ref|NM_—080841.1|[18450370]
• 371: NM_—080840
  Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
  variant 2, mRNA
  gi|18450368|ref|NM_—080840.1|[18450368]
• 372: NM_—002836
  Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
  variant 1, mRNA
  gi|18450367|ref|NM_—002836.2|[18450367]
• 373: NM_—018490
  Homo sapiens G protein-coupled receptor 48 (GPR48), mRNA
  gi|8923700|ref|NM_—018490.1|[8923700]
• 374: NM_—006065
  Homo sapiens signal-regulatory protein beta 1 (SIRPB1), mRNA
  gi|5174678|ref|NM_—006065.1|[5174678]
• 375: NM_—004648
  Homo sapiens protein tyrosine phosphatase, non-receptor type substrate 1 (PTPNS1), mRNA
  gi|4758977|ref|NM_—004648.1|[4758977]
• 376: NM_—003667
  Homo sapiens G protein-coupled receptor 49 (GPR49), mRNA
  gi|4504378|ref|NM_—003667.1|[4504378]
• 377: BM427439
  pgf2n.pk006.m15 Normalized Chicken Abdominal Fat Library (pgf2n) Gallus gallus
  cDNA clone pgf2n.pk006.m15 5′ similar to gi|13994300 ref|NP_—114131.11 transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gi|AAK16442.1|AF327923_—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
  gi|18432616|gb|BM427439.1|BM427439[18432616]
• 378: BM427410
  pgf2n.pk006.k5 Normalized Chicken Abdominal Fat Library (pgf2n) Gallus gallus cDNA clone pgf2n.pk006.k5 5′ similar to gi|13994300 ref|NP_—114131.1|transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gi|AAK16442.1|AF327923_—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
  gi|18432562|gb|BM427410.1|BM427410[18432562]
• 379: BM427358
  pgf2n.pk006.i13 Normalized Chicken Abdominal Fat Library (pgf2n) Gallus gallus
  cDNA clone pgf2n.pk006.i13 5′ similar to gi|7705965 ref|NP_—057456.11 seven transmembrane domain orphan receptor [Homo sapiens] dbj|BAA89782.1|(AB037108)
  seven transmembrane domain orphan receptor [Homo sapiens], mRNA sequence
  gi|18432475|gb|BM427358.1|BM427358[18432475]
• 380: NM_—002122
  Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1),
  mRNA
  gi|18426974|ref|NM_—002122.2|[18426974]
• 381: NM_—080815
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 19, mRNA
  gi|18426960|ref|NM_—080815.1|[18426960]
• 382: NM_—080814
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 18, mRNA
  gi|18426958|ref|NM_—080814.1|[18426958]
• 383: NM_—080813
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 17, mRNA
  gi|18426956|ref|NM_—080813.1|[18426956]
• 384: NM_—080812
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 16, mRNA
  gi|18426954|ref|NM_—080812.1|[18426954]
• 385: NM_—080811
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 15, mRNA
  gi|18426952|ref|NM_—080811.1|[18426952]
• 386: NM_—080810
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 14, mRNA
  gi|18426950|ref|NM_—080810.1|[18426950]
• 387: NM_—080809
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 13, mRNA
  gi|18426948|ref|NM_—080809.1|[18426948]
• 388: NM_—080808
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 12, mRNA
  gi|18426946|ref|NM_—080808.1|[18426946]
• 389: NM_—080807
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 11, mRNA
  gi|18426944|ref|NM_—080807.1|[18426944]
• 390: NM_—080806
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 10, mRNA
  gi|18426942|ref|NM_—080806.1|[18426942]
• 391: NM_—080805
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 9, mRNA
  gi|18426940|ref|NM_—080805.1|[18426940]
• 392: NM_—080804
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 8, mRNA
  gi|18426938|ref|NM_—080804.1|[18426938]
• 393: NM_—080803
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 7, mRNA
  gi|18426936|ref|NM_—080803.1|[18426936]
• 394: NM_—080802
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 6, mRNA
  gi|18426934|ref|NM_—080802.1|[18426934]
• 395: NM_—080801
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 5, mRNA
  gi|18426932|ref|NM_—080801.1|[18426932]
• 396: NM_—080800
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 4, mRNA
  gi|18426930|ref|NM_—080800.1|[18426930]
• 397: NM_—080799
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 3, mRNA
  gi|18426928|ref|NM_—080799.1|[18426928]
• 398: NM_—080798
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 2, mRNA
  gi|18426926|ref|NM_—080798.1|[18426926]
• 399: NM_—005203
  Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 1, mRNA
  gi|18426924|ref|NM_—005203.2|[18426924]
• 400: NM_—080792
  Homo sapiens brain-immunoglobulin-like molecule with tyrosine-based activation
  motifs (BIT), mRNA
  gi|18426910|ref|NM_—080792.1|[8426910]
• 401: NM_—080816
  Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 2, mRNA
  gi|18426908|ref|NM_—080816.1|[18426908]
• 402: NM_—018556
  Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 1, mRNA
  gi|18426907|ref|NM_—018556.2|[18426907]
• 406: AF367761
  Homo sapiens transmembrane protein HTMP10 (HTMP10) mRNA, complete cds
  gi|16356924|gb|AF367761.2|[16356924]
• 409: NM_—002124
  Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1),
  mRNA
  gi|4504410|ref|NM_—002124.1|[4504410]
• 411: NM_—016235
  Homo sapiens G protein-coupled receptor, family C, group 1, member B (GPRC5B),
  mRNA
  gi|7706450|ref|NM_—016235.1|[7706450]
• 412: NM_—003105
  Homo sapiens sortilin-related receptor, L(DLR class) A repeats-containing (SORL1), mRNA
  gi|18379347|ref|NM_—003105.3|[18379347]
• 413: NM_—004843
  Homo sapiens class I cytokine receptor (WSX1), mRNA
  gi|18379338|ref|NM_—004843.2|[18379338]
• 414: AF450008
  Homo sapiens CFTR-associated ligand (CAL) mRNA, complete cds
  gi|17865153|gb|AF450008.1|AF450008[17865153]
• 415: NM_—033056
  Homo sapiens protocadherin 15 (PCDH15), mRNA
  gi|16933554|ref|NM_—033056.2|[16933554]
• 416: NM_—022349
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), mRNA
  gi|11641258|ref|NM_—022349.1|[11641258]
• 417: NM_—005438
  Homo sapiens FOS-like antigen 1 (FOSL1), mRNA
  gi|4885242|ref|NM_—005438.1|[4885242]
• 418: BC021208
  Homo sapiens, leucine zipper-EF-hand containing transmembrane protein 1, clone
  MGC:12631 IMAGE:4126510, mRNA, complete cds
  gi|18204588|gb|BC021208.1|BC021208[18204588]
• 419: BC021557
  Homo sapiens, transmembrane protein 8 (five membrane-spanning domains), clone MGC:31822 IMAGE:4899167, mRNA, complete cds
  gi|18204291|gb|BC021557.1|BC021557[18204291]
• 420: BC020870
  Homo sapiens, fibronectin leucine rich transmembrane protein 3, clone MGC:24073
  IMAGE: A 6065852, mRNA, complete cds
  gi|18088787|gb|BC020870.1|BC020870[18088787]
• 421: BC020960
  Homo sapiens, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4G, clone MGC:8849 IMAGE:3851526, mRNA, complete cds
  gi|18088075|gb|BC020960.1|BC020960[18088075]
• 422: AF444779
  Homo sapiens myocyte inner nuclear membrane protein (MYNE1) mRNA, complete cds
  gi|17227153|gb|AF444779.1|AF444779[17227153]
• 423: AF329637
  Homo sapiens mitofusin 1 mRNA, nuclear gene for mitochondrial protein, complete
  cds
  gi|12744895|gb|AF329637.1|AF329637[12744895]
• 424: NM_—019074
  Homo sapiens delta-like 4 (Drosophila) (DLL4), mRNA
  gi|9506544|ref|NM_—019074.1|[9506544]
• 425: NM_—017789
  Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4C (SEMA4C), mRNA
  gi|8923345|ref|NM_—017789.1|[8923345]
• 426: NM_—003836
  Homo sapiens delta-like 1 homolog (Drosophila) (DLK1), mRNA
  gi|4503338|ref|NM_—003836.1|[4503338]
• 427: NM_—024021
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 4 (MS4A4A), mRNA
  gi|13430865|ref|NM_—024021.1|[13430865]
• 432: NM_—021950
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of
  IgE, high affinity I, receptor for; beta polypeptide) (MS4A1), mRNA
  gi|11386186|ref|NM_—021950.1|[11386186]
• 433: AY046529
  Homo sapiens melanocortin 1 receptor mutant V122M (MC1R) gene, complete cds
  gi|18138241|gb|AY046529.1|[18138241]
• 434: AY046528
  Homo sapiens melanocortin 1 receptor mutant 140T (MC1R) gene, complete cds
  gi|18138239|gb|AY046528.1|[18138239]
• 436: AY028261
  Homo sapiens delta transmembrane LIGHT mRNA, complete cds, alternatively spliced
  gi|14278834|gb|AY028261.1|[14278834]
• 437: AF296875
  Gallus gallus fas ligand receptor soluble form mRNA, partial cds
  gi|993164|gb|AF296875.1|AF296875[9931641]
• 439: BM315073
  ig43b07.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN Q15012 GOLGI
  4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
  gi|18049418|gb|BM315073.1|BM315073[18049418]
• 440: BM314493
  ig51c05.y1 HR85 islet Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|18048838|gb|BM314493.1|BM314493[18048838]
• 441: BM313985
  ih05d09.y1 Human insulinoma Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN
  Q15012 GOLGI 4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
  gi|18048330|gb|BM313985.1|BM313985[18048330]
• 442: AF267740
  Homo sapiens transmembrane protein H4 mRNA, complete cds
  gi|18032260|gb|AF267740.1|AF267740[18032260]
• 443: AF350504
  Homo sapiens four-span transmembrane protein 4 (4SPAN4) mRNA, complete cds
  gi|18028935|gb|AF350504.1|AF350504[18028935]
• 444: AF350503
  Homo sapiens four-span transmembrane protein 3.2 (4SPAN3) mRNA, complete cds
  gi|18028933|gb|AF350503.1|AF350503[18028933]
• 445: AF350502
  Homo sapiens four-span transmembrane protein 3.1 (4SPAN3) mRNA, complete cds
  gi|1802893|gb|AF350502.1|AF350502[18028931]
• 446: AF350501
  Homo sapiens four-span transmembrane protein 2 (4SPAN2) mRNA, complete cds
  gi|18028929|gb|AF350501.1|AF350501[18028929]
• 447: AF350500
  Homo sapiens four-span transmembrane protein 1 (4SPAN1) mRNA, complete cds
  gi|18028927|gb|AF350500.1|AF350500[18028927]
• 448: NM_—078470
  Homo sapiens COX15 homolog, cytochrome c oxidase assembly protein (yeast) (COX15), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA
  gi|17921984|ref|NM_—078470.1|[17921984]
• 449: NM_—004375
  Homo sapiens COX11 homolog, cytochrome c oxidase assembly protein (yeast) (COX11), nuclear gene encoding mitochondrial protein, mRNA
  gi|17921983|ref|NM_—004375.2|[17921983]
• 450: NM_—001303
  Homo sapiens COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast) (COX10), nuclear gene encoding mitochondrial protein, mRNA
  gi|17921981|ref|NM_—001303.2|[17921981]
• 451: NM_—031999
  Mus musculus transmembrane 7 superfamily member 1 (Tm7sf1), mRNA
  gi|14269573|ref|NM_—031999.1|[14269573]
• 452: NM_—020659
  Homo sapiens tweety homolog 1 (Drosophila) (TTYH1), mRNA
  gi|10257436|ref|NM_—020659.1|[10257436]
• 453: NM_—052945
  Homo sapiens BAFF receptor (BAFFR), mRNA
  gi|17978517|ref|NM_—052945.2|[17978517]
• 454: NM_—078481
  Homo sapiens CD97 antigen (CD97), transcript variant 1, mRNA
  gi|17978490|ref|NM_—078481.1|[17978490]
• 455: NM_—001784
  Homo sapiens CD97 antigen (CD97), transcript variant 2, mRNA
  gi|17978488|ref|NM_—001784.2|[17978488]
• 456: NM_—1004444
  Homo sapiens EphB4 (EPHB4), mRNA
  gi|17975769|ref|NM_—004444.2|[17975769]
• 457: NM_—004443
  Homo sapiens EphB3 (EPHB3), mRNA
  gi|17975767|ref|NM_—004443.2|[17975767]
• 458: NM_—004442
  Homo sapiens EphB2 (EPHB2), transcript variant 1, mRNA
  gi|17975766|ref|NM_—004442.2|[17975766]
• 459: NM_—017449
  Homo sapiens EphB2 (EPHB2), transcript variant 2, mRNA
  gi|17975764|ref|NM_—017449.1|[17975764]
• 460: BM273281
  if28f09.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
  to TR:Q9Z112 Q9Z112 SEVEN TRANSMEMBRANE DOMAIN ORPHAN RECEPTOR.;, mRNA sequence
  gi|17966574|gb|BM273281.1|BM273281[17966574]
• 461: BM271899
  ig36e08.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN Q15012 GOLGI
  4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
  gi|17965175|gb|BM271899.1|BM271899[17965175]
• 462: BM271817
  ig35e06.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN Q15012 GOLGI
  4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
  gi|1796509|gb|BM271817.1|BM271817[17965091]
• 463: BM271771
  ig38h09.x1 HR85 islet Homo sapiens cDNA 3′ similar to TR:O08721 O08721 TRANSMEMBRANE RECEPTOR UNC5H1.;, mRNA sequence
  gi|17965045|gb|BM271771.1|BM271771[17965045]
• 464: BC019314
  Homo sapiens, transmembrane 4 superfamily member 7, clone MGC:4337 IMAGE:2821236, mRNA, complete cds
  gi|17939509|gb|BC019314.1|BC019314[17939509]
• 465: BM263743
  ig29h12.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:NMB_HUMAN Q14956 PUTATIVE TRANSMEMBRANE PROTEIN NMB PRECURSOR.;, mRNA sequence
  gi|17926783|gb|BM263743.1|BM263743[17926783]
• 466: NM_—004376
  Homo sapiens COX15 homolog, cytochrome c oxidase assembly protein (yeast) (COX15), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA
  gi|17921986|ref|NM_—004376.2|[17921986]
• 467: AY062295
  Homo sapiens prolactin receptor (PRLR) mRNA, partial cds; alternatively spliced
  gi|17887307|gb|AY062295.1|[17887307]
• 468: NM_—078474
  Homo sapiens BBP-like protein 2 (BLP2), transcript variant 1, mRNA
  gi|17865799|ref|NM_—078474.1|[17865799]
• 469: NM_—025141
  Homo sapiens BBP-like protein 2 (BLP2), transcript variant 2, mRNA
  gi|17865798|ref|NM_—025141.2|[17865798]
• 470: NM_—078473
  Homo sapiens BBP-like protein 1 (BLP1), transcript variant 1, mRNA
  gi|17865796|ref|NM_—078473.1|[17865796]
• 471: NM_—031940
  Homo sapiens BBP-like protein 1 (BLP1), transcript variant 2, mRNA
  gi|17865794|ref|NM_—031940.2|[17865794]
• 472: NM_—003728
  Homo sapiens unc-5 homolog B (C. elegans) (UNC5C), mRNA
  gi|16933524|ref|NM_—003728.2|[16933524]
• 473: NM_—054027
  Homo sapiens ankylosis, progressive homolog (mouse) (ANKH), transcript variant
  2, mRNA
  gi|16905506|ref|NM_—054027.1|[16905506]
• 474: NM_—019847
  Homo sapiens ankylosis, progressive homolog (mouse) (ANKH), transcript variant
  1, mRNA
  gi|16905505|ref|NM_—019847.3|[16905505]
• 475: NM_—018440
  Homo sapiens phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), mRNA
  gi|16753228|ref|NM_—018440.2|[16753228]
• 478: NM_—019894
  Homo sapiens transmembrane protease, serine 4 (TMPRSS4), mRNA
  gi|15451939|ref|NM_—019894.1|[15451939]
• 479: NM_—006577
  Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1), transcript variant 1, mRNA
  gi|15451893|ref|NM_—006577.3|[15451893]
• 480: NM_—033252
  Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1), transcript variant 2, mRNA
  gi|15451863|ref|NM_—033252.1|[15451863]
• 481: NM_—014302
  Homo sapiens Sec61 gamma (SEC61G), mRNA
  gi|14591933|ref|NM_—014302.2|[14591933]
• 482: NM_—014459
  Homo sapiens protocadherin 17 (PCDH17), mRNA
  gi|14589926|ref|NM_—014459.2|[14589926]
• 483: NM_—032961
  Homo sapiens protocadherin 10 (PCDH10), transcript variant 1, mRNA
  gi|14589915|ref|NM_—032961.1|[14589915]
• 484: NM_—020815
  Homo sapiens protocadherin 10 (PCDH10), transcript variant 2, mRNA
  gi|14589913|ref|NM_—020815.1|[14589913]
• 485: NM_—032966
  Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein (BLR1), transcript
  variant 2, mRNA
  gi|14589868|ref|NM_—032966.1|[14589868]
• 486: NM_—001716
  Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein (BLR1), transcript
  variant 1, mRNA
  gi|14589867|ref|NM_—001716.2|[14589867]
• 487: NM_—031866
  Homo sapiens trizzled homolog 8 (Drosophila) (FZD8), mRNA
  gi|13994189|ref|NM_—031866.1|[13994189]
• 488: NM_—030770
  Homo sapiens transmembrane protease, serine 5 (spinesin) (TMPRSS5), mRNA
  gi|13540534|ref|NM_—030770.1|[13540534]
• 489: NM_—001407
  Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog,
  Drosophila) (CELSR3), mRNA
  gi|13325065|ref|NM_—001407.1|[13325065]
• 490: NM_—001408
  Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog,
  Drosophila) (CELSR2), mRNA
  gi|13325063|ref|NM_—001408.1|[13325063]
• 491: NM_—005971
  Homo sapiens FXYD domain-containing ion transport regulator 3 (FXYD3), transcript variant 1, mRNA
  gi|11612675|ref|NM_—005971.2|[11612675]
• 492: NM_—021910
  Homo sapiens FXYD domain-containing ion transport regulator 3 (FXYD3), transcript variant 2, mRNA
  gi|11612673|ref|NM_—021910.1|[11612673]
• 493: NM_—021778
  Homo sapiens a disintegrin and metalloproteinase domain 28 (ADAM28), transcript
  variant 2, mRNA
  gi|11496995|ref|NM_—021778.1|[11496995]
• 494: NM_—021777
  Homo sapiens a disintegrin and metalloproteinase domain 28 (ADAM28), transcript
  variant 3, mRNA
  gi|11496993|ref|NM_—021777.1|[11496993]
• 495: NM_—021783
  Homo sapiens ectodysplasin A2 isoform receptor (XEDAR), mRNA
  gi|11140822|ref|NM_—021783.1|[11140822]
• 496: NM_—020182
  Homo sapiens transmembrane, prostate androgen induced RNA (TMEPAI), mRNA
  gi|9910497|ref|NM_—020182.1|[9910497]
• 497: NM_—003857
  Homo sapiens galanin receptor 2 (GALR2), mRNA
  gi|8051600|ref|NM_—003857.21[8051600]
• 498: NM_—015727
  Homo sapiens tachykinin receptor 1 (TACR1), transcript variant short, mRNA
  gi|7669545|ref|NM_—015727.1|[7669545]
• 499: NM_—001058
  Homo sapiens tachykinin receptor 1 (TACR1), transcript variant long, mRNA
  gi|7669544|ref|NM_—001058.2|[7669544]
• 501: NM_—014246
  Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog,
  Drosophila) (CELSR1), mRNA
  gi|7656966|ref|NM_—014246.1|[7656966]
• 502: NM_—014265
  Homo sapiens a disintegrin and metalloproteinase domain 28 (ADAM28), transcript
  variant 1, mRNA
  gi|7656862|ref|NM_—014265.1|[7656862]
• 503: NM_—007264
  Homo sapiens adrenomedullin receptor (ADMR), mRNA
  gi|6466448|ref|NM_—007264.2|[6466448]
• 504: NM_—004733
  Homo sapiens acetyl-Coenzyme A transporter (ACATN), mRNA
  gi|6042194|ref|NM_—004733.2|[6042194]
• 505: NM_—003801
  Homo sapiens GPAA1P anchor attachment protein 1 homolog (yeast) (GPAA1), mRNA
  gi|6031166|ref|NM_—003801.2|[6031166]
• 506: NM_—007197
  Homo sapiens frizzled homolog 10 (Drosophila) (FZD10), mRNA
  gi|6005761|ref|NM_—007197.1|[6005761]
• 507: NM_—001466
  Homo sapiens frizzled homolog 2 (Drosophila) (FZD2), mRNA
  gi|5922012|ref|NM_—001466.21[5922012]
• 508: NM_—006579
  Homo sapiens emopamil binding protein (sterol isomerase) (EBP), mRNA
  gi|5729809|ref|NM_—006579.1|[5729809]
• 509: NM_—006017
  Homo sapiens prominin-like 1 (mouse) (PROML1), mRNA
  gi|5174386|ref|NM_—006017.1|[5174386]
• 510: NM_—005228
  Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), mRNA
  gi|4885198|ref|NM_—005228.1|[4885198]
• 511: NM_—004617
  Homo sapiens transmembrane 4 superfamily member 4 (TM4SF4), mRNA
  gi|4759239|ref|NM_—004617.1|[4759239]
• 512: NM_—004787
  Homo sapiens slit homolog 2 (Drosophila) (SLIT2), mRNA
  gi|4759145|ref|NM_—004787.1|[4759145]
• 513: NM_—004445
  Homo sapiens EphB6 (EPHB6), mRNA
  gi|4758291|ref|NM_—004445.1|[4758291]
• 514: NM_—004338
  Homo sapiens chromosome 18 open reading frame 1 (C18orf1), mRNA
  gi|4757883|ref|NM_—004338.1|[4757883]
• 515: NM_—002982
  Homo sapiens small inducible cytokine A2 (monocyte chemotactic protein 1) (SCYA2), mRNA
  gi|4506840|ref|NM_—002982.1|[4506840]
• 516: NM_—002944
  Homo sapiens v-ros UR2 sarcoma virus oncogene homolog 1 (avian) (ROS1), mRNA
  gi|4506578|ref|NM_—002944.1|[4506578]
• 517: NM_—000264
  Homo sapiens patched homolog (Drosophila) (PTCH), mRNA
  gi|4506246|ref|NM_—000264.1|[4506246]
• 518: NM_—003508
  Homo sapiens frizzled homolog 9 (Drosophila) (FZD9), mRNA
  gi|4503834|ref|NM_—003508.1|[4503834]
• 519: NM_—003507
  Homo sapiens frizzled homolog 7 (Drosophila) (FZD7), mRNA
  gi|4503832|ref|NM_—003507.1|[4503832]
• 520: NM_—003506
  Homo sapiens frizzled homolog 6 (Drosophila) (FZD6), mRNA
  gi|4503830|ref|NM_—003506.1|[4503830]
• 521: NM_—003468
  Homo sapiens frizzled homolog 5 (Drosophila) (FZD5), mRNA
  gi|4503828|ref|NM_—003468.1|[4503828]
• 522: NM_—003505
  Homo sapiens frizzled homolog 1 (Drosophila) (FZD1), mRNA
  gi|4503824|ref|NM_—003505.1|[4503824]
• 523: NM_—001982
  Homo sapiens v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
  (ERBB3), mRNA
  gi|4503596|ref|NM_—001982.1|[4503596]
• 524: NM_—003859
  Homo sapiens dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit (DPM1), mRNA
  gi|4503362|ref|NM_—003859.1|[4503362]
• 525: NM_—003915
  Homo sapiens copine I (CPNE1), mRNA
  gi|4503012|ref|NM_—003915.1|[4503012]
• 527: NM_—052959
  Homo sapiens pannexin 3 (PANX3), mRNA
  gi|16418452|ref|NM_—052959.1|[16418452]
• 528: NM_—052859
  Homo sapiens putative endoplasmic reticulum multispan transmembrane protein (RFT1), mRNA
  gi|16418360|ref|NM_—052859.1|[16418360]
• 531: NM_—032108
  Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B (SEMA6B), mRNA
  gi|14165267|ref|NM_—032108.1|[14165267]
• 532: NM_—031925
  Homo sapiens transmembrane protein induced by tumor necrosis factor alpha (TMPIT), mRNA
  gi|13994299|ref|NM_—031925.1|[13994299]
• 533: NM_—030960
  Homo sapiens sperm acrosome associated 1 (SPACA1), mRNA
  gi|13569933|ref|NM_—030960.1|[13569933]
• 534: NM_—030755
  Homo sapiens thioredoxin domain-containing (TXNDC), mRNA
  gi|13559515|ref|NM_—030755.1|[13559515]
• 535: NM_—024734
  Homo sapiens calponin like transmembrane domain protein (calmin), mRNA
  gi|13376053|ref|NM_—024734.1|[13376053]
• 536: NM_—023003
  Homo sapiens transmembrane 6 superfamily member 1 (TM6SF1), mRNA
  gi|13194198|ref|NM_—023003.1|[13194198]
• 537: NM_—021034
  Homo sapiens interferon induced transmembrane protein 3 (1-8U) (IFITM3), mRNA
  gi|11995467|ref|NM_—021034.1|[11995467]
• 538: NM_—006435
  Homo sapiens interferon induced transmembrane protein 2 (1-8D) (IFITM2), mRNA
  gi|10835237|ref|NM_—006435.1|[0835237]
• 539: NM_—016326
  Homo sapiens chemokine-like factor 1 (CKLF1), mRNA
  gi|10092611|ref|NM_—016326.2|[10092611]
• 540: NM_—016951
  Homo sapiens chemokine-like factor 1 (CKLF1), mRNA
  gi|10092593|ref|NM_—016951.2|[10092593]
• 541: NM_—000888
  Homo sapiens integrin, beta 6 (ITGB6), mRNA
  gi|9966771|ref|NM_—000888.3|[9966771]
• 542: NM_—020241
  Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B (SEMA6B), mRNA
  gi|9910379|ref|NM_—020241.1|[9910379]
• 543: NM_—018407
  Homo sapiens putative integral membrane transporter (LC27), mRNA
  gi|8923827|ref|NM_—018407.1|[8923827]
• 544: NM_—017514
  Homo sapiens SEX gene (HSSEXGENE), mRNA
  gi|8923792|ref|NM_—017514.1|[8923792]
• 545: NM_—017893
  Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4G (SEMA4G), mRNA
  gi|8923550|ref|NM_—017893.1|[8923550]
• 546: NM_—017599
  Homo sapiens transmembrane protein vezatin (VEZATIN), mRNA
  gi|8922162|ref|NM_—017599.1|[8922162]
• 547: NM_—014254
  Homo sapiens transmembrane protein 5 (TMEM5), mRNA
  gi|7657177|ref|NM_—014254.1|[7657177]
• 548: NM_—012339
  Homo sapiens transmembrane 4 superfamily member (tetraspan NET-7) (NET-7), mRNA
  gi|6912529|ref|NM_—012339.1|[6912529]
• 549: NM_—012338
  Homo sapiens transmembrane 4 superfamily member (tetraspan NET-2) (NET-2), mRNA
  gi|6912527|ref|NM_—012338.1|[6912527]
• 550: NM_—002673
  Homo sapiens plexin B1 (PLXNB1), mRNA
  gi|6631105|ref|NM_—002673.1|[6631105]
• 551: NM_—006825
  Homo sapiens cytoskeleton-associated protein 4 (CKAP4), mRNA
  gi|5803112|ref|NM_—006825.1|[5803112]
• 552: NM_—004785
  Homo sapiens solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulatory factor 2 (SLC9A3R2), mRNA
  gi|4759141|ref|NM_—004785.1|[4759141]
• 553: NM_—004263
  Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4F (SEMA4F), mRNA
  gi|4759093|ref|NM_—004263.1|[4759093]
• 554: NM_—004800
  Homo sapiens transmembrane 9 superfamily member 2 (TM9SF2), mRNA
  gi|4758873|ref|NM_—004800.1|[4758873]
• 555: NM_—000950
  Homo sapiens proline-rich Gla (G-carboxyglutamic acid) polypeptide 1 (PRRG1), mRNA
  gi|4506134|ref|NM_—000950.1|[4506134]
• 556: NM_—003625
  Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
  interacting protein (liprin), alpha 2 (PPFIA2), mRNA
  gi|4505984|ref|NM_—003625.1|[4505984]
• 558: NM_—032518
  Homo sapiens collagen-like Alzheimer amyloid plaque component precursor (LOC84570), mRNA
  gi|14210525|ref|NM_—032518.1|[14210525]
• 559: NM_—023945
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 5 (MS4A5), mRNA
  gi|12965204|ref|NM_—023945.1|[12965204]
• 560: NM_—016158
  Homo sapiens erythrocyte transmembrane protein (LOC51145), % T
  gi|7705856|ref|NM_—016158.1|[7705856]
• 561: AK056649
  Homo sapiens cDNA FLJ32087 fis, clone OCBBF2000467, highly similar to Fibronectin leucine rich transmembrane protein 2
  gi|16552109|dbj|AK056649.1|AK056649[16552109]
• 562: AK056595
  Homo sapiens cDNA FLJ32033 fis, clone NTONG2000265, weakly similar to Probable
  transmembrane protein of fission yeast
  gi|16552042|dbj|AK056595.1|AK056595[16552042]
• 563: AK055648
  Homo sapiens cDNA FLJ31086 fis, clone IMR321000044, highly similar to Human transmembrane receptor precursor (PTK7) mRNA
  gi|16550428|dbj|AK055648.1|AK055648[16550428]
• 564: AK055208
  Homo sapiens cDNA FLJ30646 fis, clone CTONG2004716, weakly similar to Rattus norvegicus mRNA for seven transmembrane receptor
  gi|16549884|dbj|AK055208.1|AK055208[16549884]
• 565: AK054712
  Homo sapiens cDNA FLJ30150 fis, clone BRACE2000300, highly similar to TRANSMEMBRANE PROTEIN PFT27
  gi|16549313|dbj|AK054712.1|AK054712[16549313]
• 566: AK054646
  Homo sapiens cDNA FLJ30084 fis, clone BGGI12001682, highly similar to Homo sapiens transmembrane protein TENB2 (TENB2) mRNA
  gi|16549231|dbj|AK054646.1|AK054646[16549231]
• 567: NM_—019035
  Homo sapiens protocadherin 18 (PCDH18), mRNA
  gi|14589928|ref|NM_—019035.1|[14589928]
• 568: NM_—030943
  Homo sapiens amnionless protein (AMN), mRNA
  gi|13569914|ref|NM_—030943.1|[13569914]
• 570: BC018361
  Homo sapiens, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
  and short cytoplasmic domain, (semaphorin) 4F, clone MGC:21849 IMAGE:4215248, mRNA, complete cds
  gi|17390842|gb|BC018361.1|BC018361[17390842]
• 571: AF214006
  Homo sapiens TDC1 (TDC1) mRNA, complete cds
  gi|17221828|gb|AF214006.1|AF214006[17221828]
• 572: NM_—021201
  Homo sapiens membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), mRNA
  gi|11139298|ref|NM_—021201.1|[11139298]
• 573: AF289028
  Homo sapiens transmembrane protein B7-H2 ICOS ligand mRNA, complete cds
  gi|9858866|gb|AF289028.1|AF289028[9858866]
• 574: NM_—016941
  Homo sapiens delta-like 3 (Drosophila) (DLL3), mRNA
  gi|8393263|ref|NM_—016941.1|[8393263]
• 575: NM_—014450
  Homo sapiens SHP2 interacting transmembrane adaptor (SIT), mRNA
  gi|7657576|ref|NM_—014450.1|[7657576]
• 576: NM_—021259
  Homo sapiens transmembrane protein 8 (five membrane-spanning domains) (TMEM8),
  mRNA
  gi|10864068|ref|NM_—021259.1|[10864068]
• 577: NM_—002959
  Homo sapiens sortilin 1 (SORT1), mRNA
  gi|17149833|ref|NM_—002959.3|[17149833]
• 578: NM_—000675
  Homo sapiens adenosine A2a receptor (ADORA2A), mRNA
  gi|17136146|ref|NM_—000675.3|[17136146]
• 579: BM128846
  if17e06.x1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 3′ similar
  to SW:PF27_MOUSE P52875 TRANSMEMBRANE PROTEIN PFT27. [1];, mRNA sequence
  gi|17123398|gb|BM128846.1|BM128846[17123398]
• 580: BM127423
  ie95b07.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
  to TR:O60639 O60639 PUTATIVE TRANSMEMBRANE GTPASE;, mRNA sequence
  gi|17121975|gb|BM127423.1|BM127423[17121975]
• 581: AY016020
  Gallus gallus alpha globin gene cluster, complete sequence
  gi|17104478|gb|AY016020.1|[17104478]
• 582: M86631
  Homo sapiens (clone ST-18-5(9/16)) cystic fibrosis transmembrane conductance regulator (CFTR) gene, 3′ end intron 17B; complete exon 18; complete intron
  gi|180296|gb|M86631.1|HUMCFTR[180296]
• 584: BC017476
  Homo sapiens, sema domain, immunoglobulin domain (Ig), transmembrane domain TM)
  and short cytoplasmic domain, (semaphorin) 4C, clone MGC:15189 IMAGE:3528227, mRNA, complete cds
  gi|17028345|gb|BC017476.1|BC017476[17028345]
• 585: NM_—000420
  Homo sapiens Kell blood group (KEL), mRNA
  gi|17025233|ref|NM_—000420.2|[17025233]
• 586: BM090614
  ig16b09.y1 Human Fetal Pancreas 1A Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|17019580|gb|BM090614.1|BM090614[17019580]
• 587: AF217288
  Homo sapiens protocadherin-S mRNA, complete cds, alternatively spliced
  gi|15054520|gb|AF217288.1|AF217288[15054520]
• 588: AF206516
  Homo sapiens protocadherin-S mRNA, complete cds
  gi|15054518 gb|AF206516.1|AF206516[15054518]
• 589: NM_—021153
  Homo sapiens cadherin 19, type 2 (CDH19), mRNA
  gi|16306535|ref|NM_—021153.2|[16306535]
• 590: AY048509
  Homo sapiens pannexin 1 (PANX1) gene, partial cds
  gi|15808666|gb|AY048509.1|[15808666]
• 591: NG_—000012
  Homo sapiens genomic protocadherin gamma cluster (PCDHG@) on chromosome 5
  gi|14861871|ref|NG_—000012.1|[14861871]
• 592: AE006466
  Homo sapiens 16p13.3 sequence section 5 of 8
  gi|14336735|gb|AE006466.1|AE006466[14336735]
• 593: AF376725
  Homo sapiens lung seven transmembrane receptor 1 (LUSTR1) mRNA, complete cds
  gi|14248996|gb|AF376725.1|AF376725[14248996]
• 594: NM_—004776
  Homo sapiens UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5
  (B4GALT5), mRNA
  gi|13929470|ref|NM_—004776.2|[13929470]
• 595: NM_—030587
  Homo sapiens UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2
  (B4GALT2), transcript variant 1, mRNA
  gi|13929464|ref|NM_—030587.1|[13929464]
• 596: NM_—003780
  Homo sapiens UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2
  (B4GALT2), transcript variant 2, mRNA
  gi|13929463|ref|NM_—003780.2|[13929463]
• 597: NM_—002590
  Homo sapiens protocadherin 8 (PCDH8), transcript variant 1, mRNA
  gi|6631101|ref|NM_—002590.2|[6631101]
• 598: L42572
  Homo sapiens transmembrane protein (p87/89) mRNA, complete cds
  gi|1160962|gb|L42572.1|HUMP8789R[1160962]
• 599: AF106202
  Homo sapiens endothelial cell protein C receptor precursor (EPCR) gene, promoter
  region and complete cds
  gi|16950557|gb|AF106202.2|AF106202[16950557]
• 600: NM_—033207
  Homo sapiens transmembrane protein HTMP10 (HTMP10), mRNA
  gi|16945967|ref|NM_—033207.2|[16945967]
• 601: AF153440
  Mus musculus Nma (Nma) mRNA, complete cds
  gi|14328906|gb|AF153440.1|AF153440[14328906]
• 604: NM_—005086
  Homo sapiens sarcospan (Kras oncogene-associated gene) (SSPN), mRNA
  gi|16933560|ref|NM_—005086.3|[16933560]
• 605: NM_—018153
  Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 3, mRNA
  gi|16933552|ref|NM_—018153.2|[16933552]
• 606: NM_—053034
  Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 2, mRNA
  gi|16933550|ref|NM_—053034.1|[16933550]
• 607: NM_—032208
  Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 1, mRNA
  gi|14149903|ref|NM_—032208.1|[14149903]
• 608: AV225853
  AV225853 RIKEN full-length enriched, 18 days pregnant, placenta and extra embryonic tissue Mus musculus cDNA clone 3830432D01 3′ similar to X69910
  H. sapiens p63 mRNA for transmembrane protein, mRNA sequence
  gi|6177168|dbj|AV225853.1|AV225853[6177168]
• 609: AV222771
  AV222771 RIKEN full-length enriched, 18 days pregnant, placenta and extra embryonic tissue Mus musculus cDNA clone 3830404C12 3′ similar to X69910
  H. sapiens p63 mRNA for transmembrane protein, mRNA sequence
  gi|6171948|dbj|AV222771.1|AV222771[6171948]
• 611: BC017058
  Homo sapiens, Similar to seven transmembrane domain orphan receptor, clone MGC:9442 IMAGE:3904719, mRNA, complete cds
  gi|16877618|gb|BC017058.1|BC017058[16877618]
• 612: BM055437
  ie94h04.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
  to SW:CFTR_HUMAN P13569 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;, mRNA sequence
  gi|16813328|gb|BM055437.1|BM055437[16813328]
• 614: AF328788
  Homo sapiens amnionless mRNA, complete cds
  gi|13507258|gb|AF328788.1|AF328788[13507258]
• 615: NM_—052836
  Homo sapiens cadherin related 23 (CDH23), transcript variant 2, mRNA
  gi|16507963|ref|NM_—052836.1|[16507963]
• 616: NM_—022124
  Homo sapiens cadherin related 23 (CDH23), transcript variant 1, mRNA
  gi|16507961|ref|NM_—022124.2|[16507961]
• 617: NM_—004063
  Homo sapiens cadherin 17, LI cadherin (liver-intestine) (CDH17), mRNA
  gi|16507959|ref|NM_—004063.2|[16507959]
• 618: NM_—004062
  Homo sapiens cadherin 16, KSP-cadherin (CDH16), mRNA
  gi|16507958|ref|NM_—004062.2|[16507958]
• 619: NM_—004933
  Homo sapiens cadherin 15, M-cadherin (myotubule) (CDH15), mRNA
  gi|16507957|ref|NM_—004933.2|[16507957]
• 620: NM_—001257
  Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), mRNA
  gi|16507956|ref|NM_—001257.2|[16507956]
• 621: BC009704
  Homo sapiens, transmembrane 4 superfamily member 9, clone MGC:9300 IMAGE:3895933, mRNA, complete cds
  gi|16307230|gb|BC009704.1|BC009704[16307230]
• 622: BC001496
  Homo sapiens, transmembrane trafficking protein, clone MGC:1979
  IMAGE:2959718, mRNA, complete cds
  gi|16306639|gb|BC001496.1|BC001496[16306639]
• 623: BC013577
  Homo sapiens, claudin 11 (oligodendrocyte transmembrane protein), clone MGC:9232
  IMAGE:3895040, mRNA, complete cds
  gi|15488893|gb|BC013577.1|BC013577[15488893]
• 624: NM_—053002
  Homo sapiens no opposite paired repeat protein (NOPAR), mRNA
  gi|16506292|ref|NM_—053002.1|[16506292]
• 625: NM_—052995
  Homo sapiens Usher syndrome 3A (USH3A), mRNA
  gi|16506280|ref|NM_—052995.1|[16506280]
• 639: NM_—014879
  Homo sapiens G protein-coupled receptor 105 (GPR105), mRNA
  gi|7661847|ref|NM_—014879.1|[7661847]
• 640: NM_—052891
  Homo sapiens peptidoglycan recognition protein-1-alpha precursor (PGLYRPIalpha),
  mRNA
  gi|16418404|ref|NM_—052891.1|[16418404]
• 642: B1964203
  ie66b09.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
  to TR:Q99989 Q99989 TRANSMEMBRANE CHLORIDE CONDUCTOR PROTEIN;, mRNA sequence
  gi|16338608|gb|BI964203.1|BI964203[16338608]
• 643: B1963913
  ie66e08.x1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 3′ similar
  to SW:PF27_MOUSE P52875 TRANSMEMBRANE PROTEIN PFT27. [1];, mRNA sequence
  gi|16338318|gb|BI963913.1|BI963913[16338318]
• 644: AF293372
  Pan troglodytes sialic acid-binding lectin Siglec-L1 mRNA, complete cds
  gi|15824309|gb|AF293372.1|AF293372[15824309]
• 645: BC009696
  Homo sapiens, interferon induced transmembrane protein 2 (1-8D), clone MGC:9196
  IMAGE:3876542, mRNA, complete cds
  gi|16307214|gb|BC009696.1|BC009696[16307214]
• 646: NM_—031891
  Homo sapiens cadherin 20, type 2 (CDH20), mRNA
  gi|16306536|ref|NM_—031891.2|[16306536]
• 647: NM_—004361
  Homo sapiens cadherin 7, type 2 (CDH7), transcript variant b, mRNA
  gi|16306488|ref|NM_—004361.2|[16306488]
• 648: NM_—033646
  Homo sapiens cadherin 7, type 2 (CDH7), transcript variant a, mRNA
  gi|16306486|ref|NM_—033646.1|[16306486]
• 649: AF319952
  Homo sapiens tweety-like protein 2 mRNA, complete cds
  gi|16303747|gb|AF319952.1|AF319952[16303747]
• 651: NM_—005756
  Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA
  gi|5031732|ref|NM_—005756.1|[5031732]
• 652: AF416903
  Homo sapiens SH2 domain-containing phosphatase anchor protein 2c mRNA, complete
  cds, alternatively spliced
  gi|16033593|gb|AF416903.1|AF416903[16033593]
• 653: AF416902
  Homo sapiens SH2 domain-containing phosphatase anchor protein 2b mRNA, complete
  cds, alternatively spliced
  gi|16033590|gb|AF416902.1|AF416902[16033590]
• 654: AF416901
  Homo sapiens SH2 domain-containing phosphatase anchor protein 2a mRNA, complete
  cds, alternatively spliced
  gi|16033587|gb|AF416901.1|AF416901[16033587]
• 655: AF264740
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
  exon 6 and partial cds
  gi|16032983|gb|AF264740.1|AF264738S3[16032983]
• 656: AF264739
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
  exons 4 and 5
  gi|16032982|gb|AF264739.1|AF264738S2[16032982]
• 657: AF264738
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
  exons 2 and 3
  gi|16032981|gb|AF264738.1|AF264738S1[16032981]
• 658: AH011143
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
  partial cds
  gi|16032980|gb|AH011143.1|SEG_AF264738S[16032980]
• 659: NM_—033467
  Homo sapiens membrane metallo-endopeptidase-like 2 (MMEL2), mRNA
  gi|15991812|ref|NM_—033467.1|[15991812]
• 660: AF378755
  Homo sapiens tumor endothelial marker 5 precursor (TEM5) mRNA, complete cds
  gi|15987490|gb|AF378755.1|AF378755[15987490]
• 661: NM_—016227
  Homo sapiens chromosome 1 open reading frame 9 (C1orf9), mRNA
  gi|7705321|ref|NM_—016227.1|[7705321]
• 662: NM_—014283
  Homo sapiens chromosome 1 open reading frame 9 (C1orf9), mRNA
  gi|7656939|ref|NM_—014283.1|[7656939]
• 663: NM_—018475
  Homo sapiens TPA regulated locus (TPARL), mRNA
  gi|8923860|ref|NM_—018475.1|[8923860]
• 664: D83783
  Human mRNA for KIAA0192 gene, partial cds
  gi|1663693|dbj|D83783.1D83783[1663693]
• 665: D79997
  Human mRNA for KIAA0175 gene, complete cds
  gi|1136409|dbj|D79997.1|D79997[1136409]
• 666: D13626
  Human mRNA for KIAA0001 gene, complete cds
  gi|285994|dbj|D13626.1|HUMRSC338[285994]
• 679: B1793175
  ie48h08.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
  to SW:NMB_HUMAN Q14956 PUTATIVE TRANSMEMBRANE PROTEIN NMB PRECURSOR.;, mRNA sequence
  gi|15820900|gb|BI793175.1|BI793175[15820900]
• 680: U40271
  Homo sapiens transmembrane receptor precursor (PTK7) mRNA, complete cds
  gi|15808058|gb|U40271.2|HSU40271[15808058]
• 681: BC014554
  Homo sapiens, calponin like transmembrane domain protein, clone IMAGE:3837453,
  mRNA
  gi|15778950|gb|BC014554.1|BC014554[15778950]
• 682: NM_—018916
  Homo sapiens protocadherin gamma subfamily A, 3 (PCDHGA3), transcript variant 1,
  mRNA
  gi|14589879|ref|NM_—018916.3|[14589879]
• 683: NM_—032407
  Homo sapiens protocadherin gamma subfamily C, 5 (PCDHGC5), transcript variant 2,
  mRNA
  gi|14277684|ref|NM_—032407.1|[14277684]
• 684: NM_—018929
  Homo sapiens protocadherin gamma subfamily C, 5 (PCDHGC5), transcript variant 1,
  mRNA
  gi|14277683|ref|NM_—018929.2|[14277683]
• 685: NM_—032406
  Homo sapiens protocadherin gamma subfamily C, 4 (PCDHGC4), transcript variant 2,
  mRNA
  gi|14277681|ref|NM_—032406.1|[14277681]
• 686: NM_—018928
  Homo sapiens protocadherin gamma subfamily C, 4 (PCDHGC4), transcript variant 1,
  mRNA
  gi|14277680|ref|NM_—018928.2|[14277680]
• 687: NM_—032101
  Homo sapiens protocadherin gamma subfamily B, 7 (PCDHGB7), transcript variant 2,
  mRNA
  gi|14270507|ref|NM_—032101.1|[14270507]
• 688: NM_—018927
  Homo sapiens protocadherin gamma subfamily B, 7 (PCDHGB7), transcript variant 1,
  gi|14270506|ref|NM_—018927.2|[14270506]
• 689: NM_—032099
  Homo sapiens protocadherin gamma subfamily B, 5 (PCDHGB5), transcript variant 2,
  mRNA
  gi|14270504|ref|NM_—032099.1|[14270504]
• 690: NM_—018925
  Homo sapiens protocadherin gamma subfamily B, 5 (PCDHGB5), transcript variant 1,
  mRNA
  gi|14270503|ref|NM_—018925.2|[14270503]
• 691: NM_—032100
  Homo sapiens protocadherin gamma subfamily B, 6 (PCDHGB6), transcript variant 2,
  mRNA
  gi|14270501|ref|NM_—032100.2|[14270501]
• 692: NM_—018926
  Homo sapiens protocadherin gamma subfamily B, 6 (PCDHGB6), transcript variant 1,
  mRNA
  gi|14270500|ref|NM_—018926.2|[14270500]
• 693: NM_—032097
  Homo sapiens protocadherin gamma subfamily B, 3 (PCDHGB3), transcript variant 2,
  mRNA
  gi|14270495|ref|NM_—032097.1|[14270495]
• 694: NM_—018924
  Homo sapiens protocadherin gamma subfamily B, 3 (PCDHGB3), transcript variant 1,
  mRNA
  gi|14270494|ref|NM_—018924.2|[14270494]
• 695: NM_—032096
  Homo sapiens protocadherin gamma subfamily B, 2 (PCDHGB2), transcript variant 2,
  mRNA
  gi|14270492|ref|NM_—032096.1|[14270492]
• 696: NM_—018923
  Homo sapiens protocadherin gamma subfamily B, 2 (PCDHGB2), transcript variant 1,
  mRNA
  gi|14270491|ref|NM_—018923.2|[14270491]
• 697: NM_—032095
  Homo sapiens protocadherin gamma subfamily B, 1 (PCDHGB1), transcript variant 2,
  mRNA
  gi|14270489|ref|NM_—032095.1|[14270489]
• 698: NM_—018922
  Homo sapiens protocadherin gamma subfamily B, 1 (PCDHGB1), transcript variant 1,
  mRNA
  gi|14270488|ref|NM_—018922.2|[14270488]
• 699: NM_—032089
  Homo sapiens protocadherin gamma subfamily A, 9 (PCDHGA9), transcript variant 2,
  mRNA
  gi|14270486|ref|NM_—032089.1|[14270486]
• 700: NM_—018921
  Homo sapiens protocadherin gamma subfamily A, 9 (PCDHGA9), transcript variant 1,
  mRNA
  gi|14270485|ref|NM_—018921.2|[14270485]
• 701: NM_—032088
  Homo sapiens protocadherin gamma subfamily A, 8 (PCDHGA8), transcript variant 1,
  mRNA
  gi|14270483|ref|NM_—032088.1|[14270483]
• 702: NM_—014004
  Homo sapiens protocadherin gamma subfamily A, 8 (PCDHGA8), transcript variant 2,
  mRNA
  gi|14270482|ref|NM_—014004.2|[14270482]
• 703: NM_—032087
  Homo sapiens protocadherin gamma subfamily A, 7 (PCDHGA7), transcript variant 2,
  mRNA
  gi|14196476|ref|NM_—032087.1|[14196476]
• 704: NM_—018920
  Homo sapiens protocadherin gamma subfamily A, 7 (PCDHGA7), transcript variant 1,
  mRNA
  gi|14196475|ref|NM_—018920.2|[14196475]
• 705: NM_—032086
  Homo sapiens protocadherin gamma subfamily A, 6 (PCDHGA6), transcript variant 2,
  mRNA
  gi|14196473|ref|NM_—032086.1|[14196473]
• 706: NM_—018919
  Homo sapiens protocadherin gamma subfamily A, 6 (PCDHGA6), transcript variant 1,
  mRNA
  gi|14196472|ref|NM_—018919.2|[14196472]
• 707: NM_—032054
  Homo sapiens protocadherin gamma subfamily A, 5 (PCDHGA5), transcript variant 2,
  mRNA
  gi|14196470|ref|NM_—032054.1|[14196470]
• 708: NM_—018918
  Homo sapiens protocadherin gamma subfamily A, 5 (PCDHGA5), transcript variant 1,
  mRNA
  gi|14196469|ref|NM_—018918.2|[14196469]
• 709: NM_—032053
  Homo sapiens protocadherin gamma subfamily A, 4 (PCDHGA4), transcript variant 2,
  mRNA
  gi|14196467|ref|NM_—032053.1|[14196467]
• 710: NM_—018917
  Homo sapiens protocadherin gamma subfamily A, 4 (PCDHGA4), transcript variant 1,
  mRNA
  gi|14196466|ref|NM_—018917.2|[14196466]
• 711: NM_—032011
  Homo sapiens protocadherin gamma subfamily A, 3 (PCDHGA3), transcript variant 2,
  mRNA
  gi|14196464|ref|NM_—032011.1|[14196464]
• 712: NM_—032009
  Homo sapiens protocadherin gamma subfamily A, 2 (PCDHGA2), transcript variant 2,
  mRNA
  gi|14196461|ref|NM_—032009.1|[14196461]
• 713: NM_—018915
  Homo sapiens protocadherin gamma subfamily A, 2 (PCDHGA2), transcript variant 1,
  mRNA
  gi|14196460|ref|NM_—018915.2|[14196460]
• 714: NM_—031993
  Homo sapiens protocadherin gamma subfamily A, 1 (PCDHGA1), transcript variant 2,
  mRNA
  gi|14196458|ref|NM_—031993.1|[14196458]
• 715: NM_—032092
  Homo sapiens protocadherin gamma subfamily A, 11 (PCDHGA11), transcript variant
  3, mRNA
  gi|14196454|ref|NM_—032092.1|[14196454]
• 716: NM_—018912
  Homo sapiens protocadherin gamma subfamily A, 1 (PCDHGA1), transcript variant mRNA
  gi|14196453|ref|NM_—018912.2|[14196453]
• 717: NM_—032091
  Homo sapiens protocadherin gamma subfamily A, 11 (PCDHGA11), transcript variant
  2, mRNA
  gi|14196450|ref|NM_—032091.1|[14196450]
• 718: NM_—018914
  Homo sapiens protocadherin gamma subfamily A, 11 (PCDHGA11), transcript variant
  1, mRNA
  gi|14196449|ref|NM_—018914.2|[14196449]
• 719: NM_—032090
  Homo sapiens protocadherin gamma subfamily A, 10 (PCDHGA10), transcript variant
  2, mRNA
  gi|14196447|ref|NM_—032090.1|[14196447]
• 720: NM_—018913
  Homo sapiens protocadherin gamma subfamily A, 10 (PCDHGA10), transcript variant
  1, mRNA
  gi|14196446|ref|NM_—018913.2|[14196446]
• 721: NM_—031411
  Homo sapiens protocadherin alpha 1 (PCDHA1), transcript variant 3, mRNA
  gi|14165401|ref|NM_—031411.1|[14165401]
• 722: NM_—031849
  Homo sapiens protocadherin alpha 6 (PCDHA6), transcript variant 3, mRNA
  gi|14165393|ref|NM_—031849.1|[14165393]
• 723: NM_—031860
  Homo sapiens protocadherin alpha 10 (PCDHA10), transcript variant 3, mRNA
  gi|14165382|ref|NM_—031860.1|[14165382]
• 724: NM_—031442
  Homo sapiens brain cell membrane protein 1 (BCMP1), mRNA
  gi|13899272|ref|NM_—031442.1|[13899272]
• 725: NM_—007000
  Homo sapiens uroplakin 1A (UPK1A), mRNA
  gi|5902147|ref|NM_—007000.1|[5902147]
• 726: NM_—003332
  Homo sapiens TYRO protein tyrosine kinase binding protein (TYROBP), mRNA
  gi|4507754|ref|NM_—003332.1|[4507754]
• 727: AF264747
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
  exon 6 and partial cds
  gi|14279228|gb|AF264747.1|AF264744S3[14279228]
• 728: AF264746
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
  exons 4 and 5
  gi|14279227|gb|AF264746.1|AF264744S2[14279227]
• 729: AF264744
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
  exons 2 and 3
  gi|14279226|gb|AF264744.1|AF264744S1[14279226]
• 730: AH010821
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
  partial cds
  gi|14279225|gb|AH010821.1|SEG_AF264744S[14279225]
• 731: AF264743
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
  exon 6 and partial cds
  gi|14279223|gb|AF264743.1|AF264741S3[14279223]
• 732: AF264742
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
  exons 4 and 5
  gi|14279222|gb|AF264742.1|AF264741S2[14279222]
• 733: AF264741
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
  exons 2 and 3
  gi|14279221|gb|AF264741.1|AF264741S1[14279221]
• 734: AH010820
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
  partial cds
  gi|14279220|gb|AH010820.1|SEG_AF264741S[14279220]
• 735: AF264737
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
  exon 6 and partial cds
  gi|14279218|gb|AF264737.1|AF264735S3[14279218]
• 736: AF264736
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
  exons 4 and 5
  gi|14279217|gb|AF264736.1|AF264735S2[14279217]
• 737: AF264735
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
  exons 2 and 3
  gi|14279216|gb|AF264735.1|AF264735S1[14279216]
• 738: AH010819
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
  partial cds
  gi|14279215|gb|AH010819.1|SEG_AF264735S[14279215]
• 739: AF336080
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*019 allele,
  exon 6 and partial cds
  gi|13469855|gb|AF336080.1|AF336079S2[13469855]
• 740: AF336079
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*019 allele,
  exons 2 through 5
  gi|13469854|gb|AF336079.1|AF336079S1[13469854]
• 741: AH010587
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*019 allele,
  partial cds
  gi|13469853|gb|AH010587.1|SEG_AF336079S[13469853]
• 742: AF336086
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*001 allele,
  exon 6 and partial cds
  gi|13445651|gb|AF336086.1|AF336085S2[13445651]
• 743: AF336085
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*001 allele,
  exons 2 through 5
  gi|13445650 gb|AF336085.1|AF336085S1[13445650]
• 744: AH010572
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*001 allele,
  partial cds
  gi|13445649|gb|AH010572.1|SEG_AF336085S[13445649]
• 745: AF336084
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
  exon 6 and partial cds
  gi|13445647|gb|AF336084.1|AF336083S2[13445647]
• 746: AF336083
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
  exons 2 through 5
  gi|13445646|gb|AF336083.1|AF336083S1[13445646]
• 747: AH010571
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
  partial cds
  gi|13445645|gb|AH010571.1|SEG_AF336083S[13445645]
• 748: AF336070
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*009 allele,
  exon 6 and partial cds
  gi|13430213|gb|AF336070.1|AF336069S2[13430213]
• 749: AF336069
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*009 allele,
  exons 2 through 5
  gi|3430212|gb|AF336069.1|AF336069S1[13430212]
• 750: AH010569
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*009 allele,
  partial cds
  gi|13430211|gb|AH010569.1|SEG_AF336069S[13430211]
• 751: AF336068
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*008 allele,
  exon 6
  gi|13430209|gb|AF336068.1|AF336067S2[13430209]
• 752: AF336067
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*008 allele,
  exons 2 through 5 and partial cds
  gi|13430208|gb|AF336067.1|AF336067S1[13430208]
• 753: AH010568
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*008 allele,
  partial cds
  gi|13430207|gb|AH010568.1|SEG_AF336067S[13430207]
• 754: AF336082
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*012 allele,
  exon 6 and partial cds
  gi|13378046|gb|AF336082.1|AF336081S2[13378046]
• 755: AF336081
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*012 allele,
  exons 2 through 5
  gi|13378045|gb|AF336081.1|AF336081S1[13378045]
• 756: AH010562
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*012 allele,
  partial cds
  gi|13378044|gb|AH010562.1|SEG_AF336081S[13378044]
• 757: AF336078
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*018 allele,
  exon 6 and partial cds
  gi|13378042|gb|AF336078.1|AF336077S2[13378042]
• 758: AF336077
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*018 allele,
  exons 2 through 5
  gi|13378041|gb|AF336077.1|AF336077S1[13378041]
• 759: AH010561
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*018 allele,
  partial cds
  gi|13378040|gb|AH010561.1|SEG_AF336077S[13378040]
• 760: AF336076
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*016 allele,
  exon 6 and partial cds
  gi|13378038|gb|AF336076.1|AF336075S2[13378038]
• 761: AF336075
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*016 allele,
  exons 2 through 5
  gi|13378037|gb|AF336075.1|AF336075S1[13378037]
• 762: AH010560
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*016 allele,
  partial cds
  gi|13378036|gb|AH010560.1|SEG_AF336075S[13378036]
• 763: AF336074
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*011 allele,
  exon 6 and partial cds
  gi|13346205|gb|AF336074.1|AF336073S2[13346205]
• 764: AF336073
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*011 allele,
  exons 2 through 5
  gi|13346204|gb|AF336073.1|AF336073S1[13346204]
• 765: AH010546
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*011 allele,
  partial cds
  gi|13346203|gb|AH010546.1|SEG_AF336073S[13346203]
• 766: AF336064
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
  exon 6 and partial cds
  gi|13346201|gb|AF336064.1|AF336063S2[13346201]
• 767: AF336063
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
  exons 2 through 5
  gi|13346200|gb|AF336063.1|AF336063S1[13346200]
• 768: AH010545
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
  partial cds
  gi|13346199|gb|AH010545.1|SEG_AF336063S[13346199]
• 769: AF336072
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*010 allele,
  exon 6 and partial cds
  gi|13310419|gb|AF336072.1|AF336071S2[13310419]
• 770: AF336071
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*010 allele,
  exons 2 through 5
  gi|13310418|gb|AF336071.1|AF336071S1[13310418]
• 771: AH010532
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*010 allele,
  partial cds
  gi|13310417|gb|AH010532.1|SEG_AF336071S[13310417]
• 772: AF336066
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*006 allele,
  exon 6 and partial cds
  gi|13274608|gb|AF336066.1|AF336065S2[13274608]
• 773: AF336065
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*006 allele,
  exons 2 through 5
  gi|13274607|gb|AF336065.1|AF336065S1[13274607]
• 774: AH010526
  Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*006 allele,
  partial cds
  gi|13274606|gb|AH010526.1|SEG_AF336065S[13274606]
• 775: NM_—022059
  Homo sapiens chemokine (C-X-C motif) ligand 16 (CXCL16), mRNA
  gi|11545764|ref|NM_—022059.1|[11545764]
• 776: NM_—000024
  Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA
  gi|15718673|ref|NM_—000024.3|[15718673]
• 777: AF257472
  Homo sapiens transmembrane protein MT75 mRNA, complete cds
  gi|15718477|gb|AF257472.1|AF257472[15718477]
• 778: AJ301609
  Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 10, and 13
  gi|15485589|emb|AJ301609.1|HSA301609[15485589]
• 779: AJ301608
  Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 11, and 14
  gi|15485587|emb|AJ301608.1|HSA301608[15485587]
• 780: B1713761
  ie03f09.y1 HR85 islet Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15689456|gb|BI713761.1|BI713761[15689456]
• 781: B1713497
  ie03f09.x1 HR85 islet Homo sapiens cDNA 3′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15689192|gb|BI713497.1|BI713497[15689192]
• 782: B1712829
  ie09g03.y1 HR85 islet Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15688524|gb|BI712829.1|BI712829[15688524]
• 783: B1712748
  ie08g08.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:TM21_RAT Q63584 TRANSMEMBRANE PROTEIN TMP21 PRECURSOR;, mRNA sequence
  gi|15688524|gb|BI712829.1|BI712829[15688524]
• 784: B1711750
  id97b10.y1 Human insulinoma Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15687445|gb|BI711750.1|BI711750[15687445]
• 785: B1711468
  id97b10.x1 Human insulinoma Homo sapiens cDNA 3′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15687163|gb|BI711468.1|BI711468[15687163]
• 786: B1711211
  id93c12.x1 Human insulinoma Homo sapiens cDNA 3′ similar to TR:P97544 P97544 ER
  TRANSMEMBRANE PROTEIN.;, mRNA sequence
  gi|15686906|gb|BI711211.1|BI711211[15686906]
• 787: B1710795
  id92a02.y1 Human insulinoma Homo sapiens cDNA 5′ similar to SW:NMB_HUMAN Q14956
  PUTATIVE TRANSMEMBRANE PROTEIN NMB PRECURSOR.;, mRNA sequence
  gi|15686490|gb|BI710795.1|BI710795[15686490]
• 788: BC014500
  Homo sapiens, Similar to leucine zipper-EF-hand containing transmembrane protein
  1, clone MGC:23613 IMAGE:4860194, mRNA, complete cds
  gi|15680274|gb|BC014500.1|BC014500[15680274]
• 789: BC014443
  Homo sapiens, Similar to transmembrane protein vezatin, clone IMAGE:4851150, mRNA
  gi|15680188|gb|BC014443.1|BC014443[15680188]
• 790: BC014339
  Homo sapiens, Similar to transmembrane 4 superfamily member 1, clone MGC:23935
  IMAGE:3828466, mRNA, complete cds
  gi|15680043|gb|BC014339.1|BC014339[15680043]
• 791: NM_—032405
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant D,
  mRNA
  gi|14602456|ref|NM_—032405.1|[14602456]
• 792: NM_—032404
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant C,
  mRNA
  gi|14602454|ref|NM_—032404.1|[14602454]
• 793: NM_—032401
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant B,
  mRNA
  gi|14602452|ref|NM_—032401.1|[14602452]
• 794: NM_—024022
  Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant A,
  mRNA
  gi|13173470|ref|NM_—024022.1|[13173470]
• 795: AF325418
  Ovis aries cystic fibrosis transmembrane conductance regulator (CFTR) gene, intron 21
  gi|15637182|gb|AF325418.1|F325416S08[15637182]
• 796: AF325419
  Ovis aries cystic fibrosis transmembrane conductance regulator (CFTR) gene, intron 10
  gi|15637180|gb|AF325419.1|F325416S06[15637180]
• 797: AH011064
  Ovis aries
  gi|15637174|gb|AH011064.1|SEG_F325416S[15637174]
• 798: NM_—022570
  Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
  superfamily member 12 (CLECSF12), mRNA
  gi|13384603|ref|NM_—022570.2|[13384603]
• 799: AF360695
  Homo sapiens keratinocyte growth factor receptor 2 (FGFR2) gene, exons 3 through
  22 and complete cds, alternatively spliced
  gi|15620559|gb|AF360695.3|AF410480S2[15620559]
• 800: AH010989
  Homo sapiens keratinocyte growth factor receptor 2 (FGFR2) gene, complete cds,
  alternatively spliced
  gi|15620558|gb|AH010989.3|SEG_AF410480S[15620558]
• 801: AY035377
  Homo sapiens peptidoglycan recognition protein-1-beta precursor (PGLYRPIbeta) mRNA, complete cds
  gi|15590685|gb|AY035377.1|[15590685]
• 802: AY035376
  Homo sapiens peptidoglycan recognition protein-1-alpha precursor (PGLYRPIalpha)
  mRNA, complete cds
  gi|15590683|gb|AY035376.1|[15590683]
• 803: NM_—013317
  Homo sapiens lung type-I cell membrane-associated glycoprotein (T1A-2), transcript variant 1, mRNA
  gi|7019416|ref|NM_—013317.1|[7019416]
• 804: AJ318099
  Homo sapiens mRNA for putative endoplasmic reticulum multispan transmembrane protein (RFT1 gene)
  gi|15558857|emb|AJ318099.1|HSA318099[15558857]
• 807: NM_—021808
  Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9), mRNA
  gi|11141878|ref|NM_—021808.1|[11141878]
• 808: AF275150
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 20 and complete cds
  gi|9652146|gb|AF275150.1|F275131S20[9652146]
• 809: AF275149
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 19
  gi|9652145|gb|AF275149.1|F275131S19[9652145]
• 810: AF275148
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 18
  gi|9652144|gb|AF275148.1|F275131S18[9652144]
• 811: AF275147
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 17
  gi|9652143|gb|AF275147.1|F275131S17[9652143]
• 812: AF275146
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 16
  gi|9652142|gb|AF275146.1|F275131S16[9652142]
• 813: AF275145
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 15
  gi|9652141|gb|AF275145.1|F275131S15[9652141]
• 814: AF275144
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 14
  gi|9652140|gb|AF275144.1|F275131S14[9652140]
• 815: AF275143
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 13
  gi|9652139|gb|AF275143.1|F275131S13[9652139]
• 816: AF275142
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 12
  gi|9652138|gb|AF275142.1|F275131S12[9652138]
• 817: AF275141
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 11
  gi|9652137|gb|AF275141.1|F275131S11[9652137]
• 818: AF275140
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 10
  gi|9652136|gb|AF275140.1|F275131S10[9652136]
• 819: AF275139
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 9
  gi|9652135|gb|AF275139.1|F275131S09[9652135]
• 820: AF275138
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 8
  gi|9652134|gb|AF275138.1|F275131S08[9652134]
• 821: AF275137
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 7
  gi|9652133|gb|AF275137.1|F275131S07[9652133]
• 822: AF275136
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 6
  gi|9652132|gb|AF275136.1|F275131S06[9652132]
• 823: AF275135
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 5
  gi|9652131|gb|AF275135.1|F275131S05[9652131]
• 824: AF275134
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 4
  gi|9652130|gb|AF275134.1F275131S04[9652130]
• 825: AF275133
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 3
  gi|9652129|gb|AF275133.1F275131S03[9652129]
• 826: AF275132
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 2
  gi|9652128|gb|AF275132.1|F275131S02[9652128]
• 827: AF275131
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 1
  gi|9652127|gb|AF275131.1|F275131S01[9652127]
• 828: AH009676
  Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, complete cds
  gi|9652126|gb|AH009676.1|SEG_F275131S[9652126]
• 829: NM_—017417
  Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) (GALNT8), mRNA
  gi|8393411|ref|NM_—017417.1|[8393411]
• 830: NM_—033346
  Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 2, mRNA
  gi|15451917|ref|NM_—033346.1|[15451917]
• 831: NM_—001204
  Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 1, mRNA
  gi|15451915|ref|NM_—001204.3|[15451915]
• 832: NM_—003933
  Homo sapiens BAI1-associated protein 3 (BAIAP3), mRNA
  gi|15451913|ref|NM_—003933.3|[15451913]
• 833: NM_—014256
  Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3), mRNA
  gi|15451894|ref|NM_—014256.2|[15451894]-834: NM_—033274
  Homo sapiens a disintegrin and metalloproteinase domain 19 (meltrin beta) (ADAM19), transcript variant 2, mRNA
  gi|15451843|ref|NM_—033274.1|[15451843]
• 835: NM_—023038
  Homo sapiens a disintegrin and metalloproteinase domain 19 (meltrin beta) (ADAM19), transcript variant 1, mRNA
  gi|15451841|ref|NM_—023038.2|[15451841]
• 836: NM_—030765
  Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 (B3GNT4), mRNA
  gi|13540526|ref|NM_—030765.1|[13540526]
• 837: AB048207
  Homo sapiens mRNA for TIGA1, complete cds
  gi|15425668|dbj|AB048207.1|AB048207[15425668]
• 838: NM_—006005
  Homo sapiens Wolfram syndrome 1 (wolframin) (WFS1), mRNA
  gi|13376995|ref|NM_—006005.2|[13376995]
• 839: NM_—015722
  Homo sapiens calcyon; D1 dopamine receptor-interacting protein (CALCYON),
  gi|9257200|ref|NM_—015722.2|[9257200]
• 840: AY038990
  Homo sapiens ER-localized type I transmembrane adaptor precursor (CAPER) mRNA,
  complete cds
  gi|15418959|gb|AY038990.1|[15418959]
• 841: BB226825
  BB226825 RIKEN full-length enriched, adult male aorta and vein Mus musculus cDNA
  clone A530098L04 3′ similar to AF169676 Homo sapiens leucine-rich repeat transmembrane protein FLRT2 (FLRT2) mRNA, mRNA sequence
  gi|15410201|dbj|BB226825.2|BB226825[15410201]
• 843: AF059274
  Homo sapiens neuroglycan C mRNA, complete cds
  gi|3820499|gb|AF059274.1|AF059274[3820499]
• 844: BC013152
  Homo sapiens, Similar to transmembrane protein 5, clone MGC:17085 IMAGE:3919181, mRNA, complete cds
  gi|15341928|gb|BC013152.1|BC013152[15341928]
• 845: AH011005
  Homo sapiens
  gi|15341629|gb|AH011005.1|SEG_L11671S[15341629]
• 846: AF406650
  Homo sapiens putative gap junction protein pannexin 3 (PANX3) mRNA, complete cds
  gi|1534153|gb|AF406650.1|AF406650[15341531]
• 847: L11671
  Homo sapiens transmembrane glycoprotein (CD53) gene, exon 1
  gi|291896|gb|L11671.1|L11671S1[291896]
• 848: L11670
  Homo sapiens transmembrane glycoprotein (CD53) gene, exons 2 through 8
  gi|180145|gb|L11670.1|L11671S2[180145]
• 849: B1468287
  id87a04.y1 Human insulinoma Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15284396|gb|BI468287.1|BI468287[15284396]
• 850: B1468286
  id87a04.x1 Human insulinoma Homo sapiens cDNA 3′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
  gi|15284395|gb|BI468286.1|BI468286[15284395]

Claims (82)

1. A method of modulating an immune response in an animal comprising the step of administering to said animal a composition comprising

an antigen bearing target and further comprising a multifunctional molecule which comprises

a first amino acid sequence which can bind to a carbohydrate and a second amino acid sequence comprising a ligand for a cell surface polypeptide, wherein said ligand is chosen from the group: a ligand for a cytokine receptor, a ligand for CD40, a ligand for an adhesion molecule, a ligand for a defensin receptor, a ligand for a heat shock protein receptor, a ligand for a T cell costimulatory molecule, a ligand for a counterreceptor for a T cell costimulatory molecule.

2. The method of claim 1, wherein said animal is a mammal.

3. The method of claim 2, wherein said mammal is a human.

4. The method of claim 1, wherein said antigen bearing target comprises at least one of the following: a tumor antigen, a viral antigen, a bacterial antigen, a fungal antigen, a parasite antigen, a prion antigen, an antigen of an autoimmune disease.

5. The method of claim 1 wherein said antigen bearing target is a cell.

6. The method of claim 1, wherein said antigen bearing target is chosen from the group: a tumor cell, a virus, a bacterial cell, a fungal cell, a cell of a parasite, a prion, a mammalian cell, an insect cell, a polypeptide free of other cell-derived material.

7. The method of claim 5, wherein said antigen bearing target is pathogenic.

8. The method of claim 7, wherein said antigen bearing target is attenuated.

9. The method of claim 1, wherein said antigen bearing target is a cell which is substantially unable to divide.

10. The method of claim 1, wherein said multifunctional molecule is a fusion polypeptide.

11. The method of claim 10, wherein said first amino acid sequence is N-terminal to said second amino acid sequence.

12. The method of claim 10, wherein said first amino acid sequence is C-terminal to said second amino acid sequence.

13. The method of claim 5, wherein said multifunctional molecule is exogenous to said cell.

14. The method of claim 5, wherein said multifunctional molecule is endogenous to said cell and is encoded by a nucleic acid sequence comprised by the cell.

15. The method of claim 1, wherein said first amino acid sequence can bind to a sialic acid on a glycoprotein.

16. The method of claim 15, wherein said sialic acid comprises at least one of the following carbohydrate structures: N-acetylneuraminic acid, alpha-NeuNAc-[2->6]-Gal, alpha-NeuNAc-[2->6]-GalNAc, alpha-NeuNAc-[2->3]-Gal.

17. The method of claim 1, wherein said first amino acid sequence comprises a carbohydrate-binding domain of a naturally occuring lectin.

18. The method of claim 1, wherein said first amino acid sequence comprises at least about 10 contiguous amino acids of a hemagglutinin.

19. The method of claim 18, wherein said hemagglutinin is an influenza virus hemagglutinin.

20. The method of claim 19, wherein said contiguous amino acids of an influenza hemagglutinin are contiguous amino acids of an influenza hemagglutinin HA1 domain.

21. The method of claim 19, wherein said influenza virus is an influenza A virus.

22. The method of claim 21, wherein said influenza virus is of a subtype that infects humans.

23. The method of claim 21, wherein said influenza virus is of an H1 subtype.

24. The method of claim 23, wherein said influenza virus is from the strain A/PR/8/34.

25. The method of claim 24, wherein said influenza virus is of an H2 or H3 subtype.

26. The method of claim 19, wherein said influenza virus is of a subtype that does not infect humans.

27. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mammalian cell surface polypeptide.

28. The method of claim 27, wherein said ligand for a cell surface polypeptide is a ligand for a mouse cell surface polypeptide.

29. The method of claim 27, wherein said ligand for a cell surface polypeptide is a ligand for a human cell surface polypeptide.

30. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of a leukocyte.

31. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of an antigen presenting cell.

32. The method of claim 31, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of a professional antigen presenting cell.

33. The method of claim 30, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of a dendritic cell.

34. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mouse GM-CSF receptor.

35. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a mouse GM-CSF.

36. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a mouse GM-CSF.

37. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a human GM-CSF receptor.

38. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a human GM-CSF.

39. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a human GM-CSF.

40. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for an interleukin.

41. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a mouse interleukin.

42. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a human interleukin.

43. The method of claim 40, wherein said interleukin is chosen from the group: IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, IL-20, IL-21, IL-22, IL-23, IL-24, IL-25.

44. The method of claim 40, wherein said ligand for a cell surface polypeptide comprises at least about 5 contiguous amino acids of an interleukin.

45. The method of claim 44, wherein said interleukin is chosen from the group: IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, IL-20, IL-21, IL-22, IL-23, IL-24, IL-25.

46. The method of claim 40, wherein said ligand for a cell surface polypeptide comprises an interleukin.

47. The method of claim 46, wherein said interleukin is chosen from the group: IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, IL-20, IL-21, IL-22, IL-23, IL-24, IL-25.

48. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a chemokine.

49. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a mouse chemokine.

50. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a human chemokine.

51. The method of claim 48, wherein said chemokine is a C-C cytokine.

52. The method of claim 48, wherein said chemokine is a C-X-C cytokine.

53. The method of claim 48, wherein said cell surface polypeptide is chosen from the group: CXCR-1, CXCR-2, CXCR-3, CXCR-4, CCR-1, CCR-2, CCR-3, CCR-4, CCR-5, CCR-6, CCR-7, CCR-8.

54. The method of claim 48, wherein said chemokine is chosen from the group: 9E3, AMCF, beta-thromboglobulin, ENA-78, eotaxin, eotaxin-2, IP-10, KC, LIX, mig, MGSA, mob-1, NAP-2, NAP-3, NAP-4, PBSF, MGSA, mouse KC, MIP-2, MIP-1 alpha, NAP-2, ENA-78, GCP-2, ACT-2, C10, CCF18, DC-CK1, ELC, Exodus, FIC, GDCF, GDCF-2, HC-21, HCC-1, 1-309, JE, LAG-1, MARC, MCAF, MCP-1, MCP-2, MCP-3, MCP-4, MCP-5, MRP-2, RANTES SDF, TARC, ATAC, Ltn, SCM-1, neurotactin.

55. The method of claim 48, wherein said ligand for a cell surface polypeptide comprises at least about 5 contiguous amino acids of a chemokine.

56. The method of claim 55 wherein said chemokine is chosen from the group: 9E3, AMCF, beta-thromboglobulin, ENA-78, eotaxin, eotaxin-2, IP-10, KC, LIX, mig, MGSA, mob-1, NAP-2, NAP-3, NAP4, PBSF, MGSA, mouse KC, MIP-2, MIP-1 alpha, NAP-2, ENA-78, GCP-2, ACT-2, C10, CCF18, DC-CK1, ELC, Exodus, FIC, GDCF, GDCF-2, HC-21, HCC-1, 1-309, JE, LAG-1, MARC, MCAF, MCP-1, MCP-2, MCP-3, MCP-4, MCP-5, MRP-2, RANTES SDF, TARC, ATAC, Ltn, SCM-1, neurotactin.

57. The method of claim 48, wherein said ligand for a cell surface polypeptide comprises a chemokine.

58. The method of claim 57, wherein said chemokine is chosen from the group: 9E3, AMCF, beta-thromboglobulin, ENA-78, eotaxin, eotaxin-2, IP-10, KC, LIX, mig, MGSA, mob-1, NAP-2, NAP-3, NAP-4, PBSF, MGSA, mouse KC, MIP-2, MIP-1 alpha, NAP-2, ENA-78, GCP-2, ACT-2, C10, CCF18, DC-CK1, ELC, Exodus, FIC, GDCF, GDCF-2, HC-21, HCC-1, I-309, JE, LAG-1, MARC, MCAF, MCP-1, MCP-2, MCP-3, MCP-4, MCP-5, MRP-2, RANTES SDF, TARC, ATAC, Ltn, SCM-1, neurotactin.

59. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for an interferon.

60. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a mouse interferon.

61. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a human interferon.

62. The method of claim 59, wherein said interferon is chosen from the group: an interferon-alpha, an interferon-beta, an interferon gamma.

63. The method of claim 59, wherein said ligand for a cell surface polypeptide comprises at least about 5 contiguous amino acids of an interferon.

64. The method of claim 63, wherein said interferon is chosen from the group: an interferon-alpha, an interferon-beta, an interferon gamma.

65. The method of claim 59, wherein said ligand for a cell surface polypeptide comprises an interferon.

66. The method of claim 65, wherein said interferon is chosen from the group: an interferon-alpha, an interferon-beta, an interferon gamma.

67. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mouse TNF-alpha receptor.

68. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a mouse TNF-alpha.

69. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a mouse TNF-alpha.

70. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a human TNF-alpha receptor.

71. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a human TNF-alpha.

72. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a human TNF-alpha.

73. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mouse flt-3 receptor.

74. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a mouse flt-3.

75. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a mouse flt-3.

76. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a human flt-3 receptor.

77. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a human flt-3.

78. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a human flt-3.

79. The method of claim 10, wherein said fusion polypeptide further comprises a linker interposed between said first and second amino acid sequences.

80. The method of claim 79, wherein said linker has the formula (Gly_xSer)_n, wherein n is an integer between 1 and 15, and x is an integer between 1 and 10.

81. The method of claim 1, wherein said composition comprises said multifunctional molecule bound to a carbohydrate on said antigen bearing target.

82. The method of claim 1, in which at least some of said multifunctional molecule is not bound to said antigen bearing target.